Citrus Sinensis ID: 023220

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-----
Protein Sequence
MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPVSET
Secondary Structure (PSIPRED)
cccccccHHHHccccccEEEEEcccccccccHHHHHHHHHHccccccccccEEEEccccEEEEEEEEcccccHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHccccccccccccHHHHHHHHHHHHcccccccccccccccHHHccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHcccccccccccc
Secondary Structure Prediction (SSPRO)
ccEEEEEEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHHcHcHHHEEEEEEccccEEEEEEEcccccHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHHHHHccccEEEEcccHcHEEccccccccHcHccHHEEccccccEEEEEEEEEEcccccHHHHHHccccHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcccccccccccccccc
Coil and Loop (DISEMBL)
mrrwlcctcqveesypshenerlkspknypddeKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSlhdilhgrkgvqgaqpgpvldwMTRVRIAVDAARGLEylhekvqpsiihrdirssnvllfeDFKAkiadfnlsnqapdMAARLHSTRVLgtfgyhapeyamtgqltqksdvYSFGVVLLELLtgrkpvdhtmprgqqslvtwatprlsedkvkqcvdpklkgeyppkGVAKLAAVAALCVQYEAEFRPNMSIVVKALQpllkspppaapvset
Flexible Loop (DISEMBL)
mrrwlcctcqveesypshenerlkspknypdDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYlhekvqpsiihrdiRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTgrkpvdhtmprgqqslvtwatprlsedkvkqcvdpklkgeyppKGVAKLAAVAALCVQYEAEFRPNMSIVVKALqpllkspppaapvset
Low Complexity Region (SEG)
MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYppkgvaklaavaalCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPVSET
Disordered region (IsUnstruct)
***WLCCTCQV************************LVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH*******SLVTWATPRL***KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL****************
Disordered Region (DISOPRED)
*RRWLCCTCQVEESYPSHENE**********DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL****************
Disordered Region (DISEMBL)
MRRWLCCTCQVEE***********SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK***********
Disordered Region (DISPRO)
MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAA*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPVSET
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	285	2.2.26 [Sep-21-2011]
B9DFG5	408	PTI1-like tyrosine-protei	no	no	0.873	0.610	0.912	1e-126
O49339	366	PTI1-like tyrosine-protei	no	no	0.835	0.650	0.924	1e-125
Q8H1G6	361	PTI1-like tyrosine-protei	no	no	0.835	0.659	0.924	1e-123
Q41328	354	Pto-interacting protein 1	N/A	no	0.852	0.686	0.835	1e-114
O80719	365	Probable receptor-like pr	no	no	0.891	0.695	0.816	1e-112
P93749	365	Probable protein kinase A	no	no	0.894	0.698	0.789	1e-112
Q8RWW0	744	Receptor-like serine/thre	no	no	0.782	0.299	0.523	9e-62
Q9SGY7	718	Putative proline-rich rec	no	no	0.8	0.317	0.512	3e-61
Q9FE20	456	Serine/threonine-protein	no	no	0.810	0.506	0.506	5e-61
Q9LQQ8	423	Probable serine/threonine	no	no	0.856	0.576	0.490	6e-61

>sp|B9DFG5|PTI13_ARATH PTI1-like tyrosine-protein kinase 3 OS=Arabidopsis thaliana GN=PTI13 PE=1 SV=1

 Score =  452 bits (1162), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 228/250 (91%), Positives = 237/250 (94%), Gaps = 1/250 (0%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS VS+LKH+N VEL GYCVEGN R+LAYEFATMGSLHDILHGRKGVQGAQPGP LDW+ 
Sbjct: 159 VSRVSKLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQ 218

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           RVRIAVDAARGLEYLHEKVQP++IHRDIRSSNVLLFEDFKAKIADFNLSNQ+PDMAARLH
Sbjct: 219 RVRIAVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLH 278

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 279 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 338

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 276
           PRLSEDKVKQCVDPKLKGEYPPK VAKLAAVAALCVQYE+EFRPNMSIVVKALQPLL+S 
Sbjct: 339 PRLSEDKVKQCVDPKLKGEYPPKAVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLRSS 398

Query: 277 PPAA-PVSET 285
             AA PV E 
Sbjct: 399 TAAAVPVQEA 408

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2

>sp|O49339|PTI12_ARATH PTI1-like tyrosine-protein kinase 2 OS=Arabidopsis thaliana GN=PTI12 PE=1 SV=1

 Score =  446 bits (1147), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 220/238 (92%), Positives = 233/238 (97%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS+VSRLKHENL++L+GYCV+ NLRVLAYEFATMGSLHDILHGRKGVQGAQPGP LDW+T
Sbjct: 117 VSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWLT 176

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           RV+IAV+AARGLEYLHEKVQP +IHRDIRSSNVLLFED++AK+ADFNLSNQAPD AARLH
Sbjct: 177 RVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNAARLH 236

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 274
           PRLSEDKVKQCVDPKLKGEYPPK VAKLAAVAALCVQYE+EFRPNMSIVVKALQPLLK
Sbjct: 297 PRLSEDKVKQCVDPKLKGEYPPKSVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLK 354

Probable tyrosine-protein kinase involved in oxidative burst-mediated signaling leading to specific genes expression.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q8H1G6|PTI11_ARATH PTI1-like tyrosine-protein kinase 1 OS=Arabidopsis thaliana GN=PTI11 PE=1 SV=1

 Score =  442 bits (1138), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 220/238 (92%), Positives = 232/238 (97%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS+VSRLKHENL++LLG+CV+GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP LDW+T
Sbjct: 114 VSMVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIT 173

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           RV+IAV+AARGLEYLHEK QP +IHRDIRSSNVLLFED+KAKIADFNLSNQAPD AARLH
Sbjct: 174 RVKIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNAARLH 233

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 234 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 293

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 274
           PRLSEDKVKQC+DPKLK +YPPK VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK
Sbjct: 294 PRLSEDKVKQCIDPKLKADYPPKAVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 351

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q41328|PTI1_SOLLC Pto-interacting protein 1 OS=Solanum lycopersicum GN=PTI1 PE=1 SV=2

 Score =  410 bits (1055), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 203/243 (83%), Positives = 222/243 (91%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS+VSRLK EN+VELLGYCV+G  RVLAYE+A  GSLHDILHGRKGV+GAQPGPVL W  
Sbjct: 112 VSMVSRLKDENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQ 171

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           RV+IAV AA+GLEYLHEK QP IIHRDI+SSN+LLF+D  AKIADF+LSNQAPDMAARLH
Sbjct: 172 RVKIAVGAAKGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLH 231

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           STRVLGTFGYHAPEYAMTGQL+ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWAT
Sbjct: 232 STRVLGTFGYHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 276
           PRLSEDKVKQCVD +L  +YPPK +AK+AAVAALCVQYEA+FRPNMSIVVKALQPLL  P
Sbjct: 292 PRLSEDKVKQCVDARLNTDYPPKAIAKMAAVAALCVQYEADFRPNMSIVVKALQPLLPRP 351

Query: 277 PPA 279
            P+
Sbjct: 352 VPS 354

A serine-threonine kinase involved in the hypersensitive response (HR)-mediated signaling cascade.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O80719|Y2706_ARATH Probable receptor-like protein kinase At2g47060 OS=Arabidopsis thaliana GN=At2g47060 PE=2 SV=1

 Score =  404 bits (1038), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 209/256 (81%), Positives = 228/256 (89%), Gaps = 2/256 (0%)

Query: 21  ERLKSPKNYPDDE-KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           ++L S K  PD+E    VS+VSRLKH+N V+LLGYCV+GN R+L+YEFA  GSLHDILHG
Sbjct: 101 KKLDSNKQ-PDNEFLAQVSMVSRLKHDNFVQLLGYCVDGNSRILSYEFANNGSLHDILHG 159

Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
           RKGV+GAQPGPVL W  RV+IAV AARGLEYLHEK  P IIHRDI+SSNVLLFED  AKI
Sbjct: 160 RKGVKGAQPGPVLSWYQRVKIAVGAARGLEYLHEKANPHIIHRDIKSSNVLLFEDDVAKI 219

Query: 140 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           ADF+LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL  KSDVYSFGVVLLELLTGRKP
Sbjct: 220 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 279

Query: 200 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR 259
           VDH +PRGQQSLVTWATP+LSEDKVKQCVD +L G+YPPK VAKLAAVAALCVQYEA+FR
Sbjct: 280 VDHRLPRGQQSLVTWATPKLSEDKVKQCVDARLGGDYPPKAVAKLAAVAALCVQYEADFR 339

Query: 260 PNMSIVVKALQPLLKS 275
           PNMSIVVKALQPLL +
Sbjct: 340 PNMSIVVKALQPLLNA 355

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P93749|Y2197_ARATH Probable protein kinase At2g41970 OS=Arabidopsis thaliana GN=At2g41970 PE=2 SV=1

 Score =  403 bits (1036), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 203/257 (78%), Positives = 229/257 (89%), Gaps = 2/257 (0%)

Query: 30  PD-DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP 88
           PD D    +SVVSRLKH++ VELLGYC+E N R+L Y+FAT GSLHD+LHGRKGVQGA+P
Sbjct: 110 PDSDFTSQLSVVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEP 169

Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
           GPVL+W  RV+IA  AA+GLE+LHEKVQP I+HRD+RSSNVLLF+DF AK+ADFNL+N +
Sbjct: 170 GPVLNWNQRVKIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNAS 229

Query: 149 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
            D AARLHSTRVLGTFGYHAPEYAMTGQ+TQKSDVYSFGVVLLELLTGRKPVDHTMP+GQ
Sbjct: 230 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQ 289

Query: 209 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 268
           QSLVTWATPRLSEDKVKQC+DPKL  ++PPK VAKLAAVAALCVQYEA+FRPNM+IVVKA
Sbjct: 290 QSLVTWATPRLSEDKVKQCIDPKLNNDFPPKAVAKLAAVAALCVQYEADFRPNMTIVVKA 349

Query: 269 LQPLLKSPPPAAPVSET 285
           LQPLL S  PA P S +
Sbjct: 350 LQPLLNS-KPAGPESTS 365

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1

 Score =  237 bits (604), Expect = 9e-62,   Method: Compositional matrix adjust.
 Identities = 123/235 (52%), Positives = 162/235 (68%), Gaps = 12/235 (5%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++SRL H NLV+L+G C+EG  R L YE    GS+   LH     +G      LDW  
Sbjct: 394 VEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH-----EG-----TLDWDA 443

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R++IA+ AARGL YLHE   P +IHRD ++SNVLL +DF  K++DF L+ +A + +  + 
Sbjct: 444 RLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI- 502

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           STRV+GTFGY APEYAMTG L  KSDVYS+GVVLLELLTGR+PVD + P G+++LVTWA 
Sbjct: 503 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWAR 562

Query: 217 PRLSE-DKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 270
           P L+  + ++Q VDP L G Y    +AK+AA+A++CV  E   RP M  VV+AL+
Sbjct: 563 PLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALK 617

Required during the differentiation of the protoderm into shoots epidermis and cuticle.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2

 Score =  235 bits (599), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 123/240 (51%), Positives = 161/240 (67%), Gaps = 12/240 (5%)

Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           K  V ++SR+ H +LV L+GYC+    R L YEF    +L   LHG+         PVL+
Sbjct: 412 KAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNL-------PVLE 464

Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
           W  RVRIA+ AA+GL YLHE   P IIHRDI+SSN+LL ++F+A++ADF L+ +  D A 
Sbjct: 465 WSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLA-RLNDTAQ 523

Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 213
              STRV+GTFGY APEYA +G+LT +SDV+SFGVVLLEL+TGRKPVD + P G++SLV 
Sbjct: 524 SHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVE 583

Query: 214 WATPRLSE----DKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 269
           WA PRL E      + + VDP+L+ +Y    V K+   AA CV++ A  RP M  VV+AL
Sbjct: 584 WARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL 643

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1

 Score =  234 bits (597), Expect = 5e-61,   Method: Compositional matrix adjust.
 Identities = 120/237 (50%), Positives = 160/237 (67%), Gaps = 6/237 (2%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++S L H NLV L+GYC +G+ R+L YEF  +GSL D LH     + A     LDW  
Sbjct: 132 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA-----LDWNM 186

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R++IA  AA+GLE+LH+K  P +I+RD +SSN+LL E F  K++DF L+   P       
Sbjct: 187 RMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHV 246

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           STRV+GT+GY APEYAMTGQLT KSDVYSFGVV LEL+TGRK +D  MP G+Q+LV WA 
Sbjct: 247 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWAR 306

Query: 217 PRLSE-DKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 272
           P  ++  K  +  DP+LKG +P + + +  AVA++C+Q +A  RP ++ VV AL  L
Sbjct: 307 PLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYL 363

Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1

 Score =  234 bits (596), Expect = 6e-61,   Method: Compositional matrix adjust.
 Identities = 123/251 (49%), Positives = 169/251 (67%), Gaps = 7/251 (2%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V  +S   H NLV+L+G+C EG+ R+L YE+   GSL D LH      G +P   LDW T
Sbjct: 149 VLTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLEDHLHVLP--SGKKP---LDWNT 203

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R++IA  AARGLEYLH+++ P +I+RD++ SN+LL ED++ K++DF L+   P       
Sbjct: 204 RMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAKVGPSGDKTHV 263

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           STRV+GT+GY AP+YAMTGQLT KSD+YSFGVVLLEL+TGRK +D+T  R  Q+LV WA 
Sbjct: 264 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDNTKTRKDQNLVGWAR 323

Query: 217 PRLSEDK-VKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 275
           P   + +   + VDP L+G+YP +G+ +  A++A+CVQ +   RP +S VV AL  L  S
Sbjct: 324 PLFKDRRNFPKMVDPLLQGQYPVRGLYQALAISAMCVQEQPTMRPVVSDVVLALNFLASS 383

Query: 276 P-PPAAPVSET 285
              P +P S +
Sbjct: 384 KYDPNSPSSSS 394

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	285
224133038	363	predicted protein [Populus trichocarpa]	0.859	0.674	0.951	1e-135
449446223	366	PREDICTED: PTI1-like tyrosine-protein ki	0.835	0.650	0.953	1e-133
223452408	366	serine/threonine protein kinase [Glycine	0.838	0.653	0.949	1e-131
351722789	366	protein kinase Pti1 [Glycine max] gi|298	0.838	0.653	0.945	1e-131
297745178	401	unnamed protein product [Vitis vinifera]	0.863	0.613	0.967	1e-130
359478064	495	PREDICTED: PTI1-like tyrosine-protein ki	0.863	0.496	0.967	1e-130
326490425	367	predicted protein [Hordeum vulgare subsp	0.887	0.689	0.882	1e-129
224093188	368	predicted protein [Populus trichocarpa]	0.835	0.646	0.970	1e-128
255644386	366	unknown [Glycine max]	0.838	0.653	0.937	1e-128
358248396	363	PTI1-like tyrosine-protein kinase 3-like	0.866	0.680	0.947	1e-128

>gi|224133038|ref|XP_002327946.1| predicted protein [Populus trichocarpa] gi|118487306|gb|ABK95481.1| unknown [Populus trichocarpa] gi|222837355|gb|EEE75734.1| predicted protein [Populus trichocarpa]

 Score =  486 bits (1251), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 233/245 (95%), Positives = 242/245 (98%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS+VSRLK+EN+VELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW+ 
Sbjct: 117 VSMVSRLKNENVVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWIQ 176

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           RV+IAVDAARGLEYLHEK+QP+IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH
Sbjct: 177 RVKIAVDAARGLEYLHEKLQPAIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 236

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 276
           PRLSEDKVKQCVDPKLKGEYPPKGVAK+AAVAALCVQYE+EFRPNMSIVVKALQPLLKS 
Sbjct: 297 PRLSEDKVKQCVDPKLKGEYPPKGVAKMAAVAALCVQYESEFRPNMSIVVKALQPLLKSV 356

Query: 277 PPAAP 281
            PAAP
Sbjct: 357 APAAP 361

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449446223|ref|XP_004140871.1| PREDICTED: PTI1-like tyrosine-protein kinase 3-like [Cucumis sativus]

 Score =  480 bits (1235), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 227/238 (95%), Positives = 235/238 (98%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS VSRLKHENLVELLGYCVEGN+RVLAYE+ATMGSLHD+LHGRKGVQGAQPGPVLDWM 
Sbjct: 117 VSTVSRLKHENLVELLGYCVEGNIRVLAYEYATMGSLHDVLHGRKGVQGAQPGPVLDWMQ 176

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           RVRIAVD+A+GLEYLHEKVQP+IIHRDIRSSNVLLFEDFKAK+ADFNLSNQAPDMAARLH
Sbjct: 177 RVRIAVDSAKGLEYLHEKVQPAIIHRDIRSSNVLLFEDFKAKVADFNLSNQAPDMAARLH 236

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 274
           PRLSEDKVKQCVDP+LKGEYPPKGVAKLAAVA LCVQYEAEFRPNMSIVVKALQPLLK
Sbjct: 297 PRLSEDKVKQCVDPRLKGEYPPKGVAKLAAVATLCVQYEAEFRPNMSIVVKALQPLLK 354

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|223452408|gb|ACM89531.1| serine/threonine protein kinase [Glycine max]

 Score =  472 bits (1215), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 227/239 (94%), Positives = 232/239 (97%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS+VSRLK +N VEL GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP LDW+ 
Sbjct: 117 VSMVSRLKDDNFVELHGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQ 176

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           RVRIAVDAARGLEYLHEKVQP IIHRDIRSSNVL+FED+KAKIADFNLSNQAPDMAARLH
Sbjct: 177 RVRIAVDAARGLEYLHEKVQPPIIHRDIRSSNVLIFEDYKAKIADFNLSNQAPDMAARLH 236

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 275
           PRLSEDKVKQCVDPKLKGEYPPKGVAKL AVAALCVQYEAEFRPNMSIVVKALQPLLKS
Sbjct: 297 PRLSEDKVKQCVDPKLKGEYPPKGVAKLGAVAALCVQYEAEFRPNMSIVVKALQPLLKS 355

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351722789|ref|NP_001237256.1| protein kinase Pti1 [Glycine max] gi|29838544|gb|AAO92595.1| protein kinase Pti1 [Glycine max]

 Score =  472 bits (1214), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 226/239 (94%), Positives = 232/239 (97%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS+VSRLK +N VE+ GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP LDW+ 
Sbjct: 117 VSMVSRLKDDNFVEMHGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQ 176

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           RVRIAVDAARGLEYLHEKVQP IIHRDIRSSNVL+FED+KAKIADFNLSNQAPDMAARLH
Sbjct: 177 RVRIAVDAARGLEYLHEKVQPPIIHRDIRSSNVLIFEDYKAKIADFNLSNQAPDMAARLH 236

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 275
           PRLSEDKVKQCVDPKLKGEYPPKGVAKL AVAALCVQYEAEFRPNMSIVVKALQPLLKS
Sbjct: 297 PRLSEDKVKQCVDPKLKGEYPPKGVAKLGAVAALCVQYEAEFRPNMSIVVKALQPLLKS 355

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297745178|emb|CBI39170.3| unnamed protein product [Vitis vinifera]

 Score =  471 bits (1211), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 238/246 (96%), Positives = 241/246 (97%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS+VSRLKHENLVELLGYCV+GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 
Sbjct: 156 VSMVSRLKHENLVELLGYCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMQ 215

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH
Sbjct: 216 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 275

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 276 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 335

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 276
           PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK+ 
Sbjct: 336 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKAA 395

Query: 277 PPAAPV 282
            PA  V
Sbjct: 396 APAPEV 401

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359478064|ref|XP_002272354.2| PREDICTED: PTI1-like tyrosine-protein kinase 3 [Vitis vinifera]

 Score =  469 bits (1207), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 238/246 (96%), Positives = 241/246 (97%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS+VSRLKHENLVELLGYCV+GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 
Sbjct: 250 VSMVSRLKHENLVELLGYCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMQ 309

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH
Sbjct: 310 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 369

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 370 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 429

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 276
           PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK+ 
Sbjct: 430 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKAA 489

Query: 277 PPAAPV 282
            PA  V
Sbjct: 490 APAPEV 495

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326490425|dbj|BAJ84876.1| predicted protein [Hordeum vulgare subsp. vulgare] gi|326509979|dbj|BAJ87206.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  468 bits (1204), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 226/256 (88%), Positives = 242/256 (94%), Gaps = 3/256 (1%)

Query: 21  ERLKSPKNYPDDE--KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 78
           ++  + +N  +DE  KQ VS+VSRLKHENLVE+LGY VEGN R+LAYEFATMGSLHD+LH
Sbjct: 96  KKFDASENEHNDEFLKQ-VSLVSRLKHENLVEMLGYYVEGNYRILAYEFATMGSLHDVLH 154

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           GRKGVQGAQPGPVLDWM RV+IA++AA+G+EYLHEKVQPSIIHRDIRSSNVLLFEDFKAK
Sbjct: 155 GRKGVQGAQPGPVLDWMQRVKIAIEAAKGIEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 214

Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 198
           IADFNL NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK
Sbjct: 215 IADFNLLNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 274

Query: 199 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEF 258
           PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP+LKGEYPPKGVAKL AVAALCVQYEAEF
Sbjct: 275 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPRLKGEYPPKGVAKLGAVAALCVQYEAEF 334

Query: 259 RPNMSIVVKALQPLLK 274
           RPNMSIVVKAL PLL+
Sbjct: 335 RPNMSIVVKALSPLLQ 350

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224093188|ref|XP_002309825.1| predicted protein [Populus trichocarpa] gi|222852728|gb|EEE90275.1| predicted protein [Populus trichocarpa]

 Score =  465 bits (1196), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 231/238 (97%), Positives = 236/238 (99%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS+VSRLKHEN VELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 
Sbjct: 117 VSMVSRLKHENFVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMQ 176

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           RVRIAVDAARG+EYLHEKVQP++IHRD+RSSNVLLFEDFKAKIADFNLSNQAPDMAARLH
Sbjct: 177 RVRIAVDAARGMEYLHEKVQPAVIHRDVRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 236

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 274
           PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK
Sbjct: 297 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 354

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255644386|gb|ACU22698.1| unknown [Glycine max]

 Score =  465 bits (1196), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 224/239 (93%), Positives = 230/239 (96%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS+VS LK +N VEL GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP LDW+ 
Sbjct: 117 VSMVSGLKDDNFVELHGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQ 176

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           RVRIAVDAARGLEYLHEKVQP IIHRDI+SSNVL+FED+KAKIADFNLSNQAPDMAARLH
Sbjct: 177 RVRIAVDAARGLEYLHEKVQPPIIHRDIQSSNVLIFEDYKAKIADFNLSNQAPDMAARLH 236

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 275
           PRLSE KVKQCVDPKLKGEYPPKGVAKL AVAALCVQYEAEFRPNMSIVVKALQPLLKS
Sbjct: 297 PRLSEGKVKQCVDPKLKGEYPPKGVAKLGAVAALCVQYEAEFRPNMSIVVKALQPLLKS 355

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358248396|ref|NP_001239619.1| PTI1-like tyrosine-protein kinase 3-like [Glycine max] gi|223452369|gb|ACM89512.1| protein kinase Pti1 [Glycine max] gi|255638318|gb|ACU19471.1| unknown [Glycine max]

 Score =  464 bits (1194), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 234/247 (94%), Positives = 239/247 (96%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS+VSRLK+ N VEL GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP LDW+ 
Sbjct: 117 VSMVSRLKNGNFVELHGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQ 176

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           RVRIAVDAARGLEYLHEKVQP IIHRDIRSSNVL+FED+KAKIADFNLSNQAPDMAARLH
Sbjct: 177 RVRIAVDAARGLEYLHEKVQPPIIHRDIRSSNVLIFEDYKAKIADFNLSNQAPDMAARLH 236

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 276
           PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP
Sbjct: 297 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 356

Query: 277 PPAAPVS 283
            PAAP S
Sbjct: 357 APAAPES 363

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	285
TAIR|locus:2081277	408	AT3G59350 [Arabidopsis thalian	0.870	0.607	0.863	1.5e-123
TAIR|locus:2009115	361	AT1G06700 [Arabidopsis thalian	0.912	0.720	0.824	1.4e-120
TAIR|locus:2054502	366	AT2G30740 [Arabidopsis thalian	0.873	0.680	0.856	3.2e-113
TAIR|locus:2088990	364	AT3G17410 [Arabidopsis thalian	0.908	0.711	0.755	4.6e-103
TAIR|locus:2064557	365	AT2G41970 [Arabidopsis thalian	0.905	0.706	0.734	1.7e-100
TAIR|locus:2054492	338	AT2G30730 [Arabidopsis thalian	0.856	0.721	0.759	1.9e-99
TAIR|locus:2023767	363	AT1G48210 [Arabidopsis thalian	0.908	0.713	0.725	1.5e-97
TAIR|locus:2098083	361	AT3G62220 [Arabidopsis thalian	0.891	0.703	0.738	3.2e-97
TAIR|locus:2023752	364	AT1G48220 [Arabidopsis thalian	0.877	0.686	0.658	2.7e-84
TAIR|locus:2099009	400	AT3G58690 [Arabidopsis thalian	0.894	0.637	0.492	1.9e-58

TAIR|locus:2081277 AT3G59350 [Arabidopsis thaliana (taxid:3702)]

 Score = 1112 (396.5 bits), Expect = 1.5e-123, Sum P(2) = 1.5e-123
 Identities = 215/249 (86%), Positives = 224/249 (89%)

Query:    37 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
             VS VS+LKH+N VEL GYCVEGN R+LAYEFATMGSLHDILHGRKGVQGAQPGP LDW+ 
Sbjct:   159 VSRVSKLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQ 218

Query:    97 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
             RVRIAVDAARGLEYLHEKVQP++IHRDIRSSNVLLFEDFKAKIADFNLSNQ+PDMAARLH
Sbjct:   219 RVRIAVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLH 278

Query:   157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
             STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct:   279 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 338

Query:   217 PRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKSP 276
             PRLSEDKVKQCVDPKLKGEY              CVQYE+EFRPNMSIVVKALQPLL+S 
Sbjct:   339 PRLSEDKVKQCVDPKLKGEYPPKAVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLRSS 398

Query:   277 PPAA-PVSE 284
               AA PV E
Sbjct:   399 TAAAVPVQE 407

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2009115 AT1G06700 [Arabidopsis thaliana (taxid:3702)]

 Score = 1113 (396.9 bits), Expect = 1.4e-120, Sum P(2) = 1.4e-120
 Identities = 216/262 (82%), Positives = 231/262 (88%)

Query:    25 SPKNYPDDE-KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 83
             +P+   D E    VS+VSRLKHENL++LLG+CV+GNLRVLAYEFATMGSLHDILHGRKGV
Sbjct:   101 APEAETDTEFLSQVSMVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGV 160

Query:    84 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
             QGAQPGP LDW+TRV+IAV+AARGLEYLHEK QP +IHRDIRSSNVLLFED+KAKIADFN
Sbjct:   161 QGAQPGPTLDWITRVKIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFN 220

Query:   144 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT 203
             LSNQAPD AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT
Sbjct:   221 LSNQAPDNAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT 280

Query:   204 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMS 263
             MPRGQQSLVTWATPRLSEDKVKQC+DPKLK +Y              CVQYEAEFRPNMS
Sbjct:   281 MPRGQQSLVTWATPRLSEDKVKQCIDPKLKADYPPKAVAKLAAVAALCVQYEAEFRPNMS 340

Query:   264 IVVKALQPLLKSPPPAAPVSET 285
             IVVKALQPLLK PP AAP  E+
Sbjct:   341 IVVKALQPLLK-PPAAAPAPES 361

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2054502 AT2G30740 [Arabidopsis thaliana (taxid:3702)]

 Score = 1117 (398.3 bits), Expect = 3.2e-113, P = 3.2e-113
 Identities = 214/250 (85%), Positives = 228/250 (91%)

Query:    37 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
             VS+VSRLKHENL++L+GYCV+ NLRVLAYEFATMGSLHDILHGRKGVQGAQPGP LDW+T
Sbjct:   117 VSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWLT 176

Query:    97 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
             RV+IAV+AARGLEYLHEKVQP +IHRDIRSSNVLLFED++AK+ADFNLSNQAPD AARLH
Sbjct:   177 RVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNAARLH 236

Query:   157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
             STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct:   237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296

Query:   217 PRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKSP 276
             PRLSEDKVKQCVDPKLKGEY              CVQYE+EFRPNMSIVVKALQPLLK P
Sbjct:   297 PRLSEDKVKQCVDPKLKGEYPPKSVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLKPP 356

Query:   277 PPA-APVSET 285
              PA APV E+
Sbjct:   357 APAPAPVPES 366

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2088990 AT3G17410 [Arabidopsis thaliana (taxid:3702)]

 Score = 1000 (357.1 bits), Expect = 4.6e-103, Sum P(2) = 4.6e-103
 Identities = 198/262 (75%), Positives = 219/262 (83%)

Query:    21 ERLKSPKNYPDDE-KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
             ++L S K  PD E    VS+VSRL+ EN+V LLGYCV+G LRVLAYE+A  GSLHDILHG
Sbjct:    97 KKLDSSKQ-PDQEFLAQVSMVSRLRQENVVALLGYCVDGPLRVLAYEYAPNGSLHDILHG 155

Query:    80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
             RKGV+GAQPGPVL W  RV+IAV AARGLEYLHEK  P +IHRDI+SSNVLLF+D  AKI
Sbjct:   156 RKGVKGAQPGPVLSWHQRVKIAVGAARGLEYLHEKANPHVIHRDIKSSNVLLFDDDVAKI 215

Query:   140 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             ADF+LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG L+ KSDVYSFGVVLLELLTGRKP
Sbjct:   216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGTLSTKSDVYSFGVVLLELLTGRKP 275

Query:   200 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFR 259
             VDHT+PRGQQS+VTWATP+LSEDKVKQCVD +L GEY              CVQYEA+FR
Sbjct:   276 VDHTLPRGQQSVVTWATPKLSEDKVKQCVDARLNGEYPPKAVAKLAAVAALCVQYEADFR 335

Query:   260 PNMSIVVKALQPLLKSPPPAAP 281
             PNMSIVVKALQPLL +PP +AP
Sbjct:   336 PNMSIVVKALQPLL-NPPRSAP 356

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2064557 AT2G41970 [Arabidopsis thaliana (taxid:3702)]

 Score = 997 (356.0 bits), Expect = 1.7e-100, P = 1.7e-100
 Identities = 191/260 (73%), Positives = 216/260 (83%)

Query:    25 SPKNYPD-DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 83
             S    PD D    +SVVSRLKH++ VELLGYC+E N R+L Y+FAT GSLHD+LHGRKGV
Sbjct:   105 SSSEEPDSDFTSQLSVVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGV 164

Query:    84 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
             QGA+PGPVL+W  RV+IA  AA+GLE+LHEKVQP I+HRD+RSSNVLLF+DF AK+ADFN
Sbjct:   165 QGAEPGPVLNWNQRVKIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFN 224

Query:   144 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT 203
             L+N + D AARLHSTRVLGTFGYHAPEYAMTGQ+TQKSDVYSFGVVLLELLTGRKPVDHT
Sbjct:   225 LTNASSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHT 284

Query:   204 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMS 263
             MP+GQQSLVTWATPRLSEDKVKQC+DPKL  ++              CVQYEA+FRPNM+
Sbjct:   285 MPKGQQSLVTWATPRLSEDKVKQCIDPKLNNDFPPKAVAKLAAVAALCVQYEADFRPNMT 344

Query:   264 IVVKALQPLLKSPPPAAPVS 283
             IVVKALQPLL S P A P S
Sbjct:   345 IVVKALQPLLNSKP-AGPES 363

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

TAIR|locus:2054492 AT2G30730 [Arabidopsis thaliana (taxid:3702)]

 Score = 987 (352.5 bits), Expect = 1.9e-99, P = 1.9e-99
 Identities = 189/249 (75%), Positives = 212/249 (85%)

Query:    30 PDDEKQL-----VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
             P+DE        VS+VSRLKHENL++L+GYCV+ NLRVLAYEFATMGSLHDILHGRKGVQ
Sbjct:    81 PEDETNTEFLSQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQ 140

Query:    85 GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 144
              A PGP LDW+TRV+IAV+AARGLEYLHEKVQP +IHRDIRSSN+LLF+D++AKIADFNL
Sbjct:   141 DALPGPTLDWITRVKIAVEAARGLEYLHEKVQPQVIHRDIRSSNILLFDDYQAKIADFNL 200

Query:   145 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTM 204
             SNQ+PD AARL STRVLG+FGY++PEYAMTG+LT KSDVY FGVVLLELLTGRKPVDHTM
Sbjct:   201 SNQSPDNAARLQSTRVLGSFGYYSPEYAMTGELTHKSDVYGFGVVLLELLTGRKPVDHTM 260

Query:   205 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSI 264
             PRGQQSLVTWATP+LSED V++CVDPKLKGEY              CVQYE+  RP MS 
Sbjct:   261 PRGQQSLVTWATPKLSEDTVEECVDPKLKGEYSPKSVAKLAAVAALCVQYESNCRPKMST 320

Query:   265 VVKALQPLL 273
             VVKALQ LL
Sbjct:   321 VVKALQQLL 329

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2023767 AT1G48210 [Arabidopsis thaliana (taxid:3702)]

 Score = 969 (346.2 bits), Expect = 1.5e-97, P = 1.5e-97
 Identities = 190/262 (72%), Positives = 214/262 (81%)

Query:    21 ERLKSPKNYPDDE-KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
             ++L S K  PD E    +S+VSRL+H+N+  L+GYCV+G LRVLAYEFA  GSLHD LHG
Sbjct:    96 KKLDSSKQ-PDQEFLSQISMVSRLRHDNVTALMGYCVDGPLRVLAYEFAPKGSLHDTLHG 154

Query:    80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
             +KG +GA  GPV+ W  RV+IAV AARGLEYLHEKV P +IHRDI+SSNVLLF+D  AKI
Sbjct:   155 KKGAKGALRGPVMTWQQRVKIAVGAARGLEYLHEKVSPQVIHRDIKSSNVLLFDDDVAKI 214

Query:   140 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
              DF+LS+QAPDMAARLHSTRVLGTFGYHAPEYAMTG L+ KSDVYSFGVVLLELLTGRKP
Sbjct:   215 GDFDLSDQAPDMAARLHSTRVLGTFGYHAPEYAMTGTLSSKSDVYSFGVVLLELLTGRKP 274

Query:   200 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFR 259
             VDHT+PRGQQSLVTWATP+LSEDKVKQCVD +L GEY              CVQYEA FR
Sbjct:   275 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDARLLGEYPPKAVGKLAAVAALCVQYEANFR 334

Query:   260 PNMSIVVKALQPLLKSPPPAAP 281
             PNMSIVVKALQPLL +PP +AP
Sbjct:   335 PNMSIVVKALQPLL-NPPRSAP 355

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2098083 AT3G62220 [Arabidopsis thaliana (taxid:3702)]

 Score = 966 (345.1 bits), Expect = 3.2e-97, P = 3.2e-97
 Identities = 189/256 (73%), Positives = 214/256 (83%)

Query:    21 ERLKSPKNYPDDE-KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
             ++L S K  P++E    VS+VSRLKH N VELLGY V+GN R+L +EFA  GSLHDILHG
Sbjct:    97 KKLDSNKQ-PNEEFLAQVSMVSRLKHVNFVELLGYSVDGNSRILVFEFAQNGSLHDILHG 155

Query:    80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
             RKGV+GA+PGP+L W  RV+IAV AARGLEYLHEK  P +IHRDI+SSNVL+F++  AKI
Sbjct:   156 RKGVKGAKPGPLLSWHQRVKIAVGAARGLEYLHEKANPHVIHRDIKSSNVLIFDNDVAKI 215

Query:   140 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             ADF+LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL+ KSDVYSFGVVLLELLTGRKP
Sbjct:   216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLSAKSDVYSFGVVLLELLTGRKP 275

Query:   200 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFR 259
             VDHT+PRGQQSLVTWATP+LSEDKVKQCVD +L G+Y              CVQYEA+FR
Sbjct:   276 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDSRLGGDYPPKAVAKLAAVAALCVQYEADFR 335

Query:   260 PNMSIVVKALQPLLKS 275
             PNMSIVVKALQPLL +
Sbjct:   336 PNMSIVVKALQPLLNA 351

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2023752 AT1G48220 [Arabidopsis thaliana (taxid:3702)]

 Score = 844 (302.2 bits), Expect = 2.7e-84, P = 2.7e-84
 Identities = 166/252 (65%), Positives = 195/252 (77%)

Query:    26 PKNYPDDE-KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
             P   PD E    VS+VSRL HEN+V L+ YCV+G LRVLAYEFAT G+LHD+LHG+ GV 
Sbjct:   100 PTKQPDQEFLSQVSMVSRLHHENVVALMAYCVDGPLRVLAYEFATYGTLHDVLHGQTGVI 159

Query:    85 GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 144
             GA  GPV+ W  RV+IA+ AARGLEYLH+KV P +IHRDI++SN+LLF+D  AKI DF+L
Sbjct:   160 GALQGPVMTWQRRVKIALGAARGLEYLHKKVNPQVIHRDIKASNILLFDDDIAKIGDFDL 219

Query:   145 SNQAPDMAARLHSTRV-LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT 203
              +QAP+MA RLHS R+ LG    H PE+AMTG LT KSDVYSFGVVLLELLTGRKPVD T
Sbjct:   220 YDQAPNMAGRLHSCRMALGASRSHCPEHAMTGILTTKSDVYSFGVVLLELLTGRKPVDRT 279

Query:   204 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMS 263
             +PRGQQ+LVTWATP+LS+DKVKQCVD +L GEY              CV Y+ +FRP+MS
Sbjct:   280 LPRGQQNLVTWATPKLSKDKVKQCVDARLLGEYPPKAVAKLAAVSARCVHYDPDFRPDMS 339

Query:   264 IVVKALQPLLKS 275
             IVVKALQPLL S
Sbjct:   340 IVVKALQPLLNS 351

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)]

 Score = 600 (216.3 bits), Expect = 1.9e-58, P = 1.9e-58
 Identities = 127/258 (49%), Positives = 171/258 (66%)

Query:    27 KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA 86
             K   ++ K  V ++SRL+   L+ LLGYC + + ++L YEF   G L + L+      G+
Sbjct:   122 KQGEEEFKMEVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLY-LPNRSGS 180

Query:    87 QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 146
              P P LDW TR+RIAV+AA+GLEYLHE+V P +IHRD +SSN+LL  +F AK++DF L+ 
Sbjct:   181 VP-PRLDWETRMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLAK 239

Query:   147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPR 206
                D A    STRVLGT GY APEYA+TG LT KSDVYS+GVVLLELLTGR PVD     
Sbjct:   240 VGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRAT 299

Query:   207 GQQSLVTWATPRLSE-DKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIV 265
             G+  LV+WA P+L++ DKV   +DP L+G+Y              CVQ EA++RP M+ V
Sbjct:   300 GEGVLVSWALPQLADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPLMADV 359

Query:   266 VKALQPLLKSPPPAAPVS 283
             V++L PL+++   A+ +S
Sbjct:   360 VQSLVPLVRNRRSASKLS 377

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
B9DFG5	PTI13_ARATH	2, ., 7, ., 1, 0, ., 2	0.912	0.8736	0.6102	no	no
O49339	PTI12_ARATH	2, ., 7, ., 1, 0, ., 2	0.9243	0.8350	0.6502	no	no
Q41328	PTI1_SOLLC	2, ., 7, ., 1, 1, ., 1	0.8353	0.8526	0.6864	N/A	no
Q8H1G6	PTI11_ARATH	2, ., 7, ., 1, 0, ., 2	0.9243	0.8350	0.6592	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pm.C_640019 SubName- Full=Putative uncharacterized protein; (363 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	285
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-41
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-40
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-39
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-38
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-38
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-33
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-32
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-29
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-23
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-23
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-21
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-19
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-18
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-18
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-18
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-16
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-15
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-14
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-13
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-13
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-13
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-12
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-12
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-11
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-10
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-08
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-08
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-07
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-07
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-06
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-06
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-06
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-05
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-05
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-04
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-04
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-04
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	9e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	0.001
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	0.001
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.001
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.002
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	0.002
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.003
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.003

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  140 bits (355), Expect = 8e-41
 Identities = 57/159 (35%), Positives = 80/159 (50%), Gaps = 15/159 (9%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ +L H N+V+L G   + N   L  E+   GSL D+L   +G         L    
Sbjct: 42  IEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG--------KLSEDE 93

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQAPDMAARL 155
            +RI +    GLEYLH      IIHRD++  N+LL  D  K K+ADF LS       + L
Sbjct: 94  ILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL 150

Query: 156 HSTRVLGTFGYHAPE-YAMTGQLTQKSDVYSFGVVLLEL 193
            +    GT  Y APE     G  ++KSD++S GV+L EL
Sbjct: 151 KTIV--GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  141 bits (358), Expect = 1e-40
 Identities = 80/257 (31%), Positives = 114/257 (44%), Gaps = 33/257 (12%)

Query: 24  KSPKNYPDDE--KQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 78
           K+ K    +E  K  +    V+ +L H N+V LLG C E     L  E+   G L D L 
Sbjct: 29  KTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLR 88

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
             + V  +     L     +  A+  A+G+EYL  K     +HRD+ + N L+ ED   K
Sbjct: 89  KSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVK 145

Query: 139 IADFNLS-NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           I+DF LS +   D   R  +   L    + APE    G  T KSDV+SFGV+L E+ T G
Sbjct: 146 ISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLG 204

Query: 197 RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV---AKLAAVAALCVQ 253
             P                 P LS ++V + +    KG   PK      +L  +   C Q
Sbjct: 205 ATPY----------------PGLSNEEVLEYL---RKGYRLPKPEYCPDELYELMLSCWQ 245

Query: 254 YEAEFRPNMSIVVKALQ 270
            + E RP  S +V+ L+
Sbjct: 246 LDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  136 bits (344), Expect = 9e-39
 Identities = 72/256 (28%), Positives = 113/256 (44%), Gaps = 41/256 (16%)

Query: 24  KSPKNYPDDEKQL-----VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 78
           K+ K    +++         ++ +L H N+V+LLG C E    ++  E+   G L D L 
Sbjct: 34  KTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR 93

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
             +          L     +  A+  ARG+EYL  K   + IHRD+ + N L+ E+   K
Sbjct: 94  KNRP-------KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVK 143

Query: 139 IADFNLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           I+DF LS    D    ++   ++     + APE    G+ T KSDV+SFGV+L E+ T G
Sbjct: 144 ISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLG 201

Query: 197 RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY---PPKGVAKLAAVAALCVQ 253
            +P                 P +S  +V + +    KG     PP    +L  +   C  
Sbjct: 202 EEP----------------YPGMSNAEVLEYLK---KGYRLPKPPNCPPELYKLMLQCWA 242

Query: 254 YEAEFRPNMSIVVKAL 269
            + E RP  S +V+ L
Sbjct: 243 EDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  135 bits (343), Expect = 1e-38
 Identities = 73/267 (27%), Positives = 110/267 (41%), Gaps = 64/267 (23%)

Query: 24  KSPKNYPDDEKQL-----VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 78
           K+ K    +++         ++ +L H N+V+LLG C E     +  E+   G L   L 
Sbjct: 34  KTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR 93

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
             +        P L     +  A+  ARG+EYL  K   + IHRD+ + N L+ E+   K
Sbjct: 94  KNR--------PKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVK 142

Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYH------------APEYAMTGQLTQKSDVYSF 186
           I+DF LS             R L    Y+            APE    G+ T KSDV+SF
Sbjct: 143 ISDFGLS-------------RDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSF 189

Query: 187 GVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY---PPKGVA 242
           GV+L E+ T G +P                 P +S ++V + +     G     PP    
Sbjct: 190 GVLLWEIFTLGEQPY----------------PGMSNEEVLEYLK---NGYRLPQPPNCPP 230

Query: 243 KLAAVAALCVQYEAEFRPNMSIVVKAL 269
           +L  +   C   + E RP  S +V+ L
Sbjct: 231 ELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  135 bits (343), Expect = 2e-38
 Identities = 75/258 (29%), Positives = 116/258 (44%), Gaps = 43/258 (16%)

Query: 23  LKSPKNYPDDEKQL-----VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL 77
           +K+ K    +E++       S++ +L H N+V LLG C +G    +  E+   G L D L
Sbjct: 33  VKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL 92

Query: 78  HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
                    + G  L     +++A+  A+G+EYL  K   + +HRD+ + N L+ E+   
Sbjct: 93  R--------KHGEKLTLKDLLQMALQIAKGMEYLESK---NFVHRDLAARNCLVTENLVV 141

Query: 138 KIADFNLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT- 195
           KI+DF LS     D   R      L      APE    G+ T KSDV+SFGV+L E+ T 
Sbjct: 142 KISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APESLKDGKFTSKSDVWSFGVLLWEIFTL 200

Query: 196 GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY----PPKGVAKLAAVAALC 251
           G +P                 P +S ++V +     L+  Y    P     +L  +   C
Sbjct: 201 GEQPY----------------PGMSNEEVLE----LLEDGYRLPRPENCPDELYELMLQC 240

Query: 252 VQYEAEFRPNMSIVVKAL 269
             Y+ E RP  S +V+ L
Sbjct: 241 WAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  121 bits (305), Expect = 6e-33
 Identities = 63/195 (32%), Positives = 89/195 (45%), Gaps = 18/195 (9%)

Query: 22  RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 78
            LK        ++     + ++ RL H N+V L+    + +   L  E+   G L D L 
Sbjct: 31  ILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS 90

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
                        L      +IA+   RGLEYLH      IIHRD++  N+LL E+   K
Sbjct: 91  RGG---------PLSEDEAKKIALQILRGLEYLHSN---GIIHRDLKPENILLDENGVVK 138

Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 197
           IADF L+ +    ++   +T V GT  Y APE  + G     K DV+S GV+L ELLTG+
Sbjct: 139 IADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK 196

Query: 198 KPVDHTMPRGQQSLV 212
            P        Q  L+
Sbjct: 197 PPFSGENILDQLQLI 211

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  118 bits (299), Expect = 4e-32
 Identities = 54/163 (33%), Positives = 78/163 (47%), Gaps = 15/163 (9%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ +LKH N+V L     + +   L  E+   G L D+L  R  +         +   
Sbjct: 48  IKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLS--------EDEA 99

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R          LEYLH K    I+HRD++  N+LL ED   K+ADF L+ Q         
Sbjct: 100 R-FYLRQILSALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKL 153

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +T V GT  Y APE  +     +  D++S GV+L ELLTG+ P
Sbjct: 154 TTFV-GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  112 bits (283), Expect = 1e-29
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 16/166 (9%)

Query: 37  VSVVSRLKHENLVELLGYCV--EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           + ++S L+H N+V   G     E N   +  E+ + GSL  +L     +           
Sbjct: 50  IRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP---------- 99

Query: 95  MTRVRI-AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
              +R        GL YLH      I+HRDI+ +N+L+  D   K+ADF  + +  D+  
Sbjct: 100 EPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156

Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
              +  V GT  + APE     +  + +D++S G  ++E+ TG+ P
Sbjct: 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  105 bits (264), Expect = 5e-27
 Identities = 52/167 (31%), Positives = 83/167 (49%), Gaps = 22/167 (13%)

Query: 37  VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
           + ++ + KH N+V+  G Y  +  L  +  EF + GSL D+L                 +
Sbjct: 48  IQILKKCKHPNIVKYYGSYLKKDELW-IVMEFCSGGSLKDLLKSTNQT-----------L 95

Query: 96  TRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
           T  +IA    +  +GLEYLH      IIHRDI+++N+LL  D + K+ DF LS Q   ++
Sbjct: 96  TESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ---LS 149

Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                  ++GT  + APE         K+D++S G+  +EL  G+ P
Sbjct: 150 DTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 99.4 bits (248), Expect = 8e-25
 Identities = 59/165 (35%), Positives = 90/165 (54%), Gaps = 20/165 (12%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           SV++ L+H NLV+LLG  ++GN   +  E+   GSL D L  R    G     V+    +
Sbjct: 52  SVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR----GRA---VITLAQQ 104

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +  A+D   G+EYL EK   + +HRD+ + NVL+ ED  AK++DF L+ +A         
Sbjct: 105 LGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEA-------SQ 154

Query: 158 TRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            +  G     + APE     + + KSDV+SFG++L E+ + GR P
Sbjct: 155 GQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 96.6 bits (241), Expect = 1e-23
 Identities = 71/223 (31%), Positives = 101/223 (45%), Gaps = 33/223 (14%)

Query: 34  KQLV---SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           KQ++    ++ +     +V   G         +  E+   GSL  IL   K VQG  P  
Sbjct: 44  KQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPER 100

Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 150
           +L      +IAV   +GL YLHEK +  IIHRD++ SN+L+    + K+ DF +S Q  +
Sbjct: 101 ILG-----KIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153

Query: 151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV-----DHTMP 205
             A+   T V GT  Y APE       + KSD++S G+ L+EL TGR P           
Sbjct: 154 SLAK---TFV-GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI 209

Query: 206 RGQ-QSLVTWATPRLSEDK--------VKQCV--DPKLKGEYP 237
               Q +V    PRL   K        V  C+  DP+ +  Y 
Sbjct: 210 FELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYK 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 98.3 bits (243), Expect = 2e-23
 Identities = 57/229 (24%), Positives = 92/229 (40%), Gaps = 26/229 (11%)

Query: 20  NERLKSPKNYPDDEKQLVSVVSRLKHE-NLVELLGYCVEGNLRVLAYEFATMGSLHDILH 78
            ++L+S     +   + + +++ L H  N+V+L  +  +     L  E+   GSL D+L 
Sbjct: 31  AKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK 90

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKA 137
                        L  + ++         LEYLH K    IIHRDI+  N+LL  +    
Sbjct: 91  KIGRKGPLSESEALFILAQI------LSALEYLHSK---GIIHRDIKPENILLDRDGRVV 141

Query: 138 KIADFNLSNQAPDMAARLHSTR----VLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVL 190
           K+ DF L+   PD  +           +GT GY APE  +       +  SD++S G+ L
Sbjct: 142 KLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITL 201

Query: 191 LELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK 239
            ELLTG  P         +     +    +   + +   P L     P 
Sbjct: 202 YELLTGLPP--------FEGEKNSSATSQTLKIILELPTPSLASPLSPS 242

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 2e-23
 Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 24/171 (14%)

Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP--- 90
            Q + ++  LKH N+V+ +G     +   +  E+A  GSL  I+         + GP   
Sbjct: 47  MQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK--------KFGPFPE 98

Query: 91  --VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
             V  ++ +V       +GL YLHE+    +IHRDI+++N+L  +D   K+ADF ++ + 
Sbjct: 99  SLVAVYVYQV------LQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKL 149

Query: 149 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            D++    S  V+GT  + APE       +  SD++S G  ++ELLTG  P
Sbjct: 150 NDVSKDDAS--VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 95.3 bits (238), Expect = 3e-23
 Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 57/216 (26%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP---VLD 93
           V ++ +L H N+++      E     +  E+A  G L   +  +K  +  +P P   +LD
Sbjct: 50  VKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQK--KEGKPFPEEQILD 107

Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
           W  ++ +A      L+YLH +    I+HRDI+  N+ L  +   K+ DF +S        
Sbjct: 108 WFVQLCLA------LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV------ 152

Query: 154 RLHSTR-----VLGTFGYHAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 202
            L ST      V+GT  Y +PE      Y        KSD++S G VL EL T + P + 
Sbjct: 153 -LSSTVDLAKTVVGTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEG 205

Query: 203 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP 238
                   L           K+       LKG+YPP
Sbjct: 206 E---NLLELAL---------KI-------LKGQYPP 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 94.8 bits (236), Expect = 4e-23
 Identities = 63/183 (34%), Positives = 83/183 (45%), Gaps = 25/183 (13%)

Query: 25  SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
              +  DD  +  +++  L HENL+ L G  +   L  +  E A +GSL D L  RK   
Sbjct: 35  KLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPLGSLLDRL--RKDAL 91

Query: 85  GAQPGPVL-DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
           G      L D+      AV  A G+ YL  K     IHRD+ + N+LL  D K KI DF 
Sbjct: 92  GHFLISTLCDY------AVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFG 142

Query: 144 LSNQAPD------MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           L    P       M   L   +V   F + APE   T   +  SDV+ FGV L E+ T G
Sbjct: 143 LMRALPQNEDHYVMEEHL---KV--PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYG 197

Query: 197 RKP 199
            +P
Sbjct: 198 EEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 94.6 bits (235), Expect = 5e-23
 Identities = 66/236 (27%), Positives = 118/236 (50%), Gaps = 37/236 (15%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDWM 95
           +V+++L H+NLV LLG  +   L ++  E  + G+L + L   GR  V   Q        
Sbjct: 51  AVMTKLHHKNLVRLLGVILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQ-------- 101

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
             ++ ++D A G+EYL  K    ++HRD+ + N+L+ ED  AK++DF L+         +
Sbjct: 102 -LLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGS---MGV 154

Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
            ++++     + APE     + + KSDV+S+GV+L E+ + GR P               
Sbjct: 155 DNSKL--PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY-------------- 198

Query: 215 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 270
             P++S  +VK+CV+   + E P    A +  +   C + E + RP+   + + L+
Sbjct: 199 --PKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 90.7 bits (226), Expect = 2e-21
 Identities = 52/163 (31%), Positives = 80/163 (49%), Gaps = 27/163 (16%)

Query: 44  KHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 102
           +   +V+  G +  EG +  +  E+   GSL D+L     +    P PVL ++ R     
Sbjct: 57  ESPYVVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKI----PEPVLAYIAR----- 106

Query: 103 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLG 162
              +GL+YLH K    IIHRDI+ SN+L+    + KIADF +S    +   +  +T V G
Sbjct: 107 QILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNTFV-G 162

Query: 163 TFGYHAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           T  Y +PE      Y+        +D++S G+ LLE   G+ P
Sbjct: 163 TVTYMSPERIQGESYSY------AADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 90.1 bits (224), Expect = 2e-21
 Identities = 61/178 (34%), Positives = 90/178 (50%), Gaps = 26/178 (14%)

Query: 30  PDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG 89
           P+   Q   ++ +L+H+ LV+L   C E     +  E+ + GSL D L   +G       
Sbjct: 45  PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG--KKLRL 102

Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
           P L     V +A   A G+ YL  +   + IHRD+ + N+L+ E+   KIADF L     
Sbjct: 103 PQL-----VDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGL----- 149

Query: 150 DMAARL-----HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
              ARL     ++ R    F   + APE A  G+ T KSDV+SFG++L E++T GR P
Sbjct: 150 ---ARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 88.3 bits (219), Expect = 2e-20
 Identities = 55/176 (31%), Positives = 88/176 (50%), Gaps = 23/176 (13%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVLDW 94
             +++  +HEN+V+  G C EG+  ++ +E+   G L+  L  HG        P   +  
Sbjct: 59  AELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE 118

Query: 95  MTR---VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM 151
           +T    ++IAV  A G+ YL  +     +HRD+ + N L+  D   KI DF +S      
Sbjct: 119 LTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRD---- 171

Query: 152 AARLHST---RVLGT----FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
              +++T   RV G       +  PE  M  + T +SDV+SFGVVL E+ T G++P
Sbjct: 172 ---VYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 86.8 bits (215), Expect = 3e-20
 Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 36/228 (15%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPV-LDWMT 96
            V+++L    ++      ++     +  E+A  G LH +L  ++G    +P P    W  
Sbjct: 51  RVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG----RPLPEDQVW-- 104

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
             R  +    GL +LH K    I+HRDI+S N+ L      KI D  ++    D      
Sbjct: 105 --RFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNF 157

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           +  ++GT  Y +PE        +KSDV++ GVVL E  TG+ P D      Q +L+    
Sbjct: 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALIL--- 211

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGV---AKLAAVAALCVQYEAEFRPN 261
                 K+       ++G +PP       +LA +   C+  +   RP+
Sbjct: 212 ------KI-------IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPD 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 5e-20
 Identities = 54/169 (31%), Positives = 81/169 (47%), Gaps = 25/169 (14%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           SV+++L H  +V L+G C    L +L  E A +G L   L  R+ +  +    + +   +
Sbjct: 48  SVMAQLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQ 103

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V      A G+ YL  K     +HRD+ + NVLL    +AKI+DF +S      A    S
Sbjct: 104 V------AMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSR-----ALGAGS 149

Query: 158 TRVLGTFG------YHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
                T        ++APE    G+ + KSDV+S+GV L E  + G KP
Sbjct: 150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 86.6 bits (215), Expect = 5e-20
 Identities = 60/179 (33%), Positives = 87/179 (48%), Gaps = 14/179 (7%)

Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           D+ ++ V  +S+  H N+V+     V G+   L   + + GSL DI      ++ + P  
Sbjct: 44  DELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDI------MKSSYPRG 97

Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 150
            LD      +  +  +GLEYLH   Q   IHRDI++ N+LL ED   KIADF +S    D
Sbjct: 98  GLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLAD 154

Query: 151 MAARLHSTR--VLGTFGYHAPEYAMTGQ--LTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
              R    R   +GT  + APE  M        K+D++SFG+  +EL TG  P     P
Sbjct: 155 GGDRTRKVRKTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 86.7 bits (215), Expect = 6e-20
 Identities = 61/241 (25%), Positives = 98/241 (40%), Gaps = 33/241 (13%)

Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRV--LAYEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L HEN+V+  G C +   R   L  E+   GSL D L   +        
Sbjct: 52  DFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-------- 103

Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             ++    +  +    +G++YL  +     IHRD+ + N+L+  +   KI+DF L+   P
Sbjct: 104 DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160

Query: 150 --DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRK-------P 199
                  +        F Y APE   T + +  SDV+SFGV L EL T G          
Sbjct: 161 EDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF 219

Query: 200 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR 259
           +        Q +VT     L E +             PP    ++  +  LC + E + R
Sbjct: 220 LRMIGIAQGQMIVTRLLELLKEGERLPR---------PPSCPDEVYDLMKLCWEAEPQDR 270

Query: 260 P 260
           P
Sbjct: 271 P 271

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 86.0 bits (213), Expect = 9e-20
 Identities = 63/242 (26%), Positives = 98/242 (40%), Gaps = 33/242 (13%)

Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           DD  +   V+ +L H NLV+L G C +     +  E+   G L + L  RKG  G +   
Sbjct: 44  DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTE--- 100

Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 150
                  + +  D    +EYL        IHRD+ + N L+ ED   K++DF L+    D
Sbjct: 101 -----WLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152

Query: 151 MAARLHSTRVLGT---FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRG 207
                  T   GT     +  PE     + + KSDV+SFGV++ E+ +  K     MP  
Sbjct: 153 D----QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK-----MP-- 201

Query: 208 QQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 267
                     R S  +V + V    +   P     ++  +   C   + E RP    ++ 
Sbjct: 202 --------YERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253

Query: 268 AL 269
            L
Sbjct: 254 QL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 85.6 bits (212), Expect = 2e-19
 Identities = 58/191 (30%), Positives = 90/191 (47%), Gaps = 26/191 (13%)

Query: 30  PDDEKQLV---SVVSRLKHENLVELLGYCV---EGNLRVLAYEFATMGSLHDILHGRKGV 83
           PD +KQ++    +    K   +V+  G  +     ++ + A E+   GSL D ++ +   
Sbjct: 40  PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI-AMEYCEGGSL-DSIYKKVKK 97

Query: 84  QGAQPGPVLDWMTRV--RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
           +G + G       +V  +IA    +GL YLH +    IIHRDI+ SN+LL    + K+ D
Sbjct: 98  RGGRIG------EKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCD 148

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           F +S +  +  A    T   GT  Y APE       +  SDV+S G+ LLE+   R P  
Sbjct: 149 FGVSGELVNSLA---GTFT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204

Query: 202 HTMPRGQQSLV 212
              P G+  L 
Sbjct: 205 ---PEGEPPLG 212

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 84.8 bits (210), Expect = 2e-19
 Identities = 60/235 (25%), Positives = 109/235 (46%), Gaps = 28/235 (11%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++S L+H N++    + ++ N  ++  E+A  G+L+D +  +KG Q  +   VL ++ 
Sbjct: 50  IVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG-QLFEEEMVLWYLF 108

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           ++  AV       Y+H+     I+HRDI++ N+ L +    K+ DF +S           
Sbjct: 109 QIVSAVS------YIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS--EYSM 157

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           +  V+GT  Y +PE     +   KSD+++ G VL ELLT ++  D T P    +LV    
Sbjct: 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLVV--- 211

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 271
                 K+ Q     +   Y     ++L ++    +Q + E RP    V+     
Sbjct: 212 ------KIVQGNYTPVVSVYS----SELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 84.4 bits (209), Expect = 3e-19
 Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 12/159 (7%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V  + RL+H++L+ L   C  G    +  E    GSL   L   +G Q      ++D   
Sbjct: 53  VQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEG-QVLPVASLID--- 108

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
              +A   A G+ YL E+   + IHRD+ + N+L+ ED   K+ADF L+    +      
Sbjct: 109 ---MACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
             ++   + + APE A  G  + KSDV+SFG++L E+ T
Sbjct: 163 DKKI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 84.7 bits (209), Expect = 3e-19
 Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 24/255 (9%)

Query: 28  NYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQG 85
           N   D  +   +++ L+HE++V+  G CVEG+  ++ +E+   G L+  L  HG   V  
Sbjct: 49  NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLM 108

Query: 86  AQPGPV--LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
           A+      L     + IA   A G+ YL  +     +HRD+ + N L+ E+   KI DF 
Sbjct: 109 AEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG 165

Query: 144 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 202
           +S               +    +  PE  M  + T +SDV+S GVVL E+ T G++P   
Sbjct: 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--- 222

Query: 203 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 262
                      W   +LS ++V +C+      + P     ++  +   C Q E   R N+
Sbjct: 223 -----------WY--QLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNI 269

Query: 263 SIVVKALQPLLKSPP 277
             +   LQ L K+ P
Sbjct: 270 KEIHSLLQNLAKASP 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 84.8 bits (210), Expect = 4e-19
 Identities = 55/156 (35%), Positives = 83/156 (53%), Gaps = 23/156 (14%)

Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           +IAV   + LEYLH K+  S+IHRD++ SNVL+  + + K+ DF +S    D  A+   T
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---T 161

Query: 159 RVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLELLTGRKPVD--HTMPRGQQSL 211
              G   Y APE  +  +L Q     KSDV+S G+ ++EL TGR P D   T  +  + +
Sbjct: 162 IDAGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV 220

Query: 212 VTWATPRLSEDK--------VKQCV--DPKLKGEYP 237
           V   +P+L  +K        V +C+  + K +  YP
Sbjct: 221 VEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP 256

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 83.9 bits (207), Expect = 4e-19
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 29/209 (13%)

Query: 38  SVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
           SV+++L+H NLV+LLG  VE  G L ++  E+   GSL D L  R          VL   
Sbjct: 51  SVMTQLRHSNLVQLLGVIVEEKGGLYIVT-EYMAKGSLVDYLRSRGR-------SVLGGD 102

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
             ++ ++D    +EYL      + +HRD+ + NVL+ ED  AK++DF L+ +    A+  
Sbjct: 103 CLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE----ASST 155

Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT------GRKPVDHTMPR--- 206
             T  L    + APE     + + KSDV+SFG++L E+ +       R P+   +PR   
Sbjct: 156 QDTGKL-PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 214

Query: 207 GQQSLVTWATPRLSEDKVKQC--VDPKLK 233
           G +       P +  D +KQC  +D   +
Sbjct: 215 GYKMDAPDGCPPVVYDVMKQCWHLDAATR 243

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 83.9 bits (207), Expect = 6e-19
 Identities = 72/241 (29%), Positives = 111/241 (46%), Gaps = 33/241 (13%)

Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G   
Sbjct: 38  LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKG--- 93

Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
               + G  L     V +A   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 94  ----EMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 146

Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 147 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203

Query: 200 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR 259
                            P +   +V   V+   +   PP+    L  +   C + E E R
Sbjct: 204 Y----------------PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 247

Query: 260 P 260
           P
Sbjct: 248 P 248

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 83.3 bits (206), Expect = 7e-19
 Identities = 63/246 (25%), Positives = 108/246 (43%), Gaps = 32/246 (13%)

Query: 30  PDDEK----QLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG 85
           P D K    Q   ++ +  H N+V+L+G CV+     +  E    GSL   L  +K    
Sbjct: 32  PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR-- 89

Query: 86  AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 145
                 L     +++++DAA G+EYL  K   + IHRD+ + N L+ E+   KI+DF +S
Sbjct: 90  ------LTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMS 140

Query: 146 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTM 204
            +       +          + APE    G+ T +SDV+S+G++L E  + G  P     
Sbjct: 141 REEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPY---- 196

Query: 205 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSI 264
                       P +S  + ++ ++   +   P     ++  +   C  Y+ E RP+ S 
Sbjct: 197 ------------PGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSE 244

Query: 265 VVKALQ 270
           +   LQ
Sbjct: 245 IYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 83.6 bits (207), Expect = 9e-19
 Identities = 63/178 (35%), Positives = 84/178 (47%), Gaps = 19/178 (10%)

Query: 33  EKQLVSVVSRL-------KHENLVELLGYCV-EGNLRVLAYEFATMGSLHDILHGR---- 80
           EK L  +VS +       KH+N++ LLG C  EG L V+  E+A  G+L D L  R    
Sbjct: 56  EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPG 114

Query: 81  ---KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
                     P   L     V  A   ARG+E+L  K     IHRD+ + NVL+ ED   
Sbjct: 115 EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVM 171

Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           KIADF L+     +     +T       + APE       T +SDV+SFGV+L E+ T
Sbjct: 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 82.5 bits (204), Expect = 2e-18
 Identities = 56/185 (30%), Positives = 85/185 (45%), Gaps = 26/185 (14%)

Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P D      ++ +L+H  L++L   C       +  E    GSL + L G  G
Sbjct: 38  LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAG 97

Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                P         + +A   A G+ YL  +   + IHRD+ + NVL+ E+   K+ADF
Sbjct: 98  RALKLP-------QLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADF 147

Query: 143 NLSNQAPDMAARL-----HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            L        AR+     +  R    F   + APE A+  + + KSDV+SFG++L E++T
Sbjct: 148 GL--------ARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199

Query: 196 -GRKP 199
            GR P
Sbjct: 200 YGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 82.5 bits (204), Expect = 2e-18
 Identities = 55/179 (30%), Positives = 86/179 (48%), Gaps = 15/179 (8%)

Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK-------GV 83
            + +Q   ++S L+H N+V LLG C +     + +E+   G LH+ L             
Sbjct: 53  QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAES 112

Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
                   LD    + IA+  A G+EYL        +HRD+ + N L+ E    KI+DF 
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFG 169

Query: 144 LSNQ--APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           LS    + D   R+ S  +L    +  PE  + G+ T +SD++SFGVVL E+ + G +P
Sbjct: 170 LSRDIYSADY-YRVQSKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 82.0 bits (203), Expect = 2e-18
 Identities = 51/170 (30%), Positives = 77/170 (45%), Gaps = 21/170 (12%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + V+  LKH NLV+  G  V      +  E+ + G+L ++L           G +LD   
Sbjct: 50  MKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH---------GRILDEHV 100

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN----LSNQAPDMA 152
                +    GL YLH      I+HRDI+ +N+ L  +   K+ DF     L N    M 
Sbjct: 101 IRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157

Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQK---SDVYSFGVVLLELLTGRKP 199
             + S    GT  Y APE    G+       +D++S G V+LE+ TG++P
Sbjct: 158 EEVQSLA--GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 63/255 (24%), Positives = 119/255 (46%), Gaps = 22/255 (8%)

Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   +        ++ + +L+H N+V+L+G C       L +E+    +L ++L     
Sbjct: 720 VKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--- 776

Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                    L W  R +IA+  A+ L +LH +  P+++  ++    +++  D K +    
Sbjct: 777 ---------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII--DGKDEP--- 822

Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 202
           +L    P +      T+   +  Y APE   T  +T+KSD+Y FG++L+ELLTG+ P D 
Sbjct: 823 HLRLSLPGLLCT--DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880

Query: 203 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP--PKGVAKLAAVAALCVQYEAEFRP 260
                  S+V WA    S+  +   +DP ++G+       + ++  +A  C   +   RP
Sbjct: 881 EF-GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939

Query: 261 NMSIVVKALQPLLKS 275
             + V+K L+   +S
Sbjct: 940 CANDVLKTLESASRS 954

Length = 968

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 81.0 bits (200), Expect = 5e-18
 Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 16/164 (9%)

Query: 36  LVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
           L SV     H N++      ++GN   +  E+A  G L      +   +  +   ++   
Sbjct: 53  LASV----NHPNIISYKEAFLDGNKLCIVMEYAPFGDLS-----KAISKRKKKRKLIPEQ 103

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
              RI +   RGL+ LHE+    I+HRD++S+N+LL  +   KI D  +S       A+ 
Sbjct: 104 EIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK- 159

Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                +GT  Y APE       + KSD++S G +L E+ T   P
Sbjct: 160 ---TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.0 bits (200), Expect = 7e-18
 Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 17/193 (8%)

Query: 10  QVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFA 68
           QVE   P+    R  S  K+     +  +  +  L H N+V+ LG+        +  E+ 
Sbjct: 33  QVE--LPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYV 90

Query: 69  TMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 128
             GS+   L           G   + + R         GL YLH K    I+HRD+++ N
Sbjct: 91  PGGSIGSCLR--------TYGRFEEQLVR-FFTEQVLEGLAYLHSK---GILHRDLKADN 138

Query: 129 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LTQKSDVYSF 186
           +L+  D   KI+DF +S ++ D+     +  + G+  + APE   +     + K D++S 
Sbjct: 139 LLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSL 198

Query: 187 GVVLLELLTGRKP 199
           G V+LE+  GR+P
Sbjct: 199 GCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 81.1 bits (201), Expect = 8e-18
 Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 43/217 (19%)

Query: 37  VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
           + ++   KH N+V+    Y V   L V   E+   GSL DI+                 M
Sbjct: 66  ILIMKDCKHPNIVDYYDSYLVGDELWV-VMEYMDGGSLTDIITQNFVR-----------M 113

Query: 96  TRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
              +IA    +  +GLEYLH +   ++IHRDI+S N+LL +D   K+ADF         A
Sbjct: 114 NEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGF-------A 163

Query: 153 ARL---HSTR--VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP-VDHTMPR 206
           A+L    S R  V+GT  + APE         K D++S G++ +E+  G  P +     R
Sbjct: 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223

Query: 207 GQQSLVTWATPRLSE---------DKVKQC--VDPKL 232
               + T   P L           D + +C   DP+ 
Sbjct: 224 ALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEK 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 80.4 bits (199), Expect = 9e-18
 Identities = 37/105 (35%), Positives = 50/105 (47%), Gaps = 7/105 (6%)

Query: 96  TRVRI-AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
            +V+    +    LEYLH K    IIHRDI+  N+LL E     I DFN++ +       
Sbjct: 100 EQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---D 153

Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             +T   GT GY APE       +   D +S GV   E L G++P
Sbjct: 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 80.0 bits (198), Expect = 1e-17
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 33/206 (16%)

Query: 44  KHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 102
               +V+  G Y    +L ++  E+   GS+ DI+                 +T   IA 
Sbjct: 56  DSPYIVKYYGSYFKNTDLWIVM-EYCGAGSVSDIMKITNKT-----------LTEEEIAA 103

Query: 103 ---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR 159
                 +GLEYLH       IHRDI++ N+LL E+ +AK+ADF +S Q  D  A+ ++  
Sbjct: 104 ILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-- 158

Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTWATPR 218
           V+GT  + APE         K+D++S G+  +E+  G+ P     P R    +     P 
Sbjct: 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT 218

Query: 219 LSE---------DKVKQC--VDPKLK 233
           LS+         D VK+C   DP+ +
Sbjct: 219 LSDPEKWSPEFNDFVKKCLVKDPEER 244

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 80.7 bits (199), Expect = 1e-17
 Identities = 58/185 (31%), Positives = 93/185 (50%), Gaps = 17/185 (9%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL---- 77
           R  + KN  +D  + V ++SRLK  N++ LLG CV+ +   +  E+   G L+  L    
Sbjct: 55  RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHH 114

Query: 78  ------HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 131
                 +G   V  A   P + + + + +A+  A G++YL      + +HRD+ + N L+
Sbjct: 115 LDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLV 171

Query: 132 FEDFKAKIADFNLSNQ--APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVV 189
            E+   KIADF +S    A D   R+    VL    + A E  + G+ T  SDV++FGV 
Sbjct: 172 GENLTIKIADFGMSRNLYAGDY-YRIQGRAVL-PIRWMAWECILMGKFTTASDVWAFGVT 229

Query: 190 LLELL 194
           L E+L
Sbjct: 230 LWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 79.8 bits (197), Expect = 1e-17
 Identities = 52/170 (30%), Positives = 89/170 (52%), Gaps = 19/170 (11%)

Query: 34  KQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           KQL   ++++S+L+H N+V+ LG   E +   +  E    GSL  +L       G+ P P
Sbjct: 47  KQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEP 102

Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 150
           V+   TR  +      GLEYLH++   + +HRDI+ +N+L+  +   K+ADF ++ Q  +
Sbjct: 103 VIRLYTRQILL-----GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154

Query: 151 MAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKP 199
            +    +    G+  + APE     G     +D++S G  +LE+ TG+ P
Sbjct: 155 FSF---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.9 bits (197), Expect = 2e-17
 Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 18/194 (9%)

Query: 10  QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFAT 69
           QVE    S  ++  K  ++  D   + ++++  L+HEN+V+ LG  ++ +   +  E+  
Sbjct: 32  QVELPSVSASSKDRK--RSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVP 89

Query: 70  MGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 129
            GS+  +L+      GA    ++    R        +GL YLH +    IIHRDI+ +N+
Sbjct: 90  GGSVAALLNN----YGAFEETLVRNFVR-----QILKGLNYLHNR---GIIHRDIKGANI 137

Query: 130 LLFEDFKAKIADFNLSNQAP----DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYS 185
           L+      KI+DF +S +                + G+  + APE       T+K+D++S
Sbjct: 138 LVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWS 197

Query: 186 FGVVLLELLTGRKP 199
            G +++E+LTG+ P
Sbjct: 198 LGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 79.7 bits (196), Expect = 2e-17
 Identities = 58/178 (32%), Positives = 95/178 (53%), Gaps = 21/178 (11%)

Query: 25  SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
           SP+++ ++ +    ++ +L+H+ LV+L     E  + ++  E+ + GSL D L   +G  
Sbjct: 44  SPESFLEEAQ----IMKKLRHDKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKDGEGRA 98

Query: 85  GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 144
              P         V +A   A G+ Y+      + IHRD+RS+N+L+ +    KIADF L
Sbjct: 99  LKLP-------NLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGL 148

Query: 145 SNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           +    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL+T GR P
Sbjct: 149 ARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.1 bits (197), Expect = 3e-17
 Identities = 58/177 (32%), Positives = 88/177 (49%), Gaps = 17/177 (9%)

Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           +K L  +VS +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 58  DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGM 117

Query: 84  QGA-----QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
             +      P   L +   V  A   ARG+EYL  +     IHRD+ + NVL+ ED   K
Sbjct: 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMK 174

Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+    ++     +T       + APE       T +SDV+SFGV+L E+ T
Sbjct: 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 80.0 bits (197), Expect = 3e-17
 Identities = 60/183 (32%), Positives = 89/183 (48%), Gaps = 29/183 (15%)

Query: 33  EKQLVSVVSRL-------KHENLVELLGYCV-EGNLRVLAYEFATMGSLHDILHGRKGVQ 84
           +K L  ++S +       KH+N++ LLG C  EG L V+  E+A  G+L + L  R+   
Sbjct: 58  DKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARR--- 113

Query: 85  GAQPGP------------VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 132
              PGP             L +   V  A   ARG+EYL  +     IHRD+ + NVL+ 
Sbjct: 114 --PPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168

Query: 133 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLE 192
           ED   KIADF L+    D+     ++       + APE       T +SDV+SFG+++ E
Sbjct: 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWE 228

Query: 193 LLT 195
           + T
Sbjct: 229 IFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.9 bits (194), Expect = 6e-17
 Identities = 59/177 (33%), Positives = 87/177 (49%), Gaps = 17/177 (9%)

Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  ++S +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 64  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 123

Query: 84  Q-----GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           +        P   L +   V  A   ARG+EYL  K     IHRD+ + NVL+ ED   K
Sbjct: 124 EYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 180

Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+     +     +T       + APE       T +SDV+SFGV+L E+ T
Sbjct: 181 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 78.0 bits (192), Expect = 7e-17
 Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 18/193 (9%)

Query: 18  HENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL 77
             +  L + K Y   +++ V ++  LKH N+V+ LG C++ N   +  EF   GS+  IL
Sbjct: 35  DTSNVLAAEKEYEKLQEE-VDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL 93

Query: 78  HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
           +      G  P PV    T+         G+ YLH      ++HRDI+ +NV+L  +   
Sbjct: 94  NRF----GPLPEPVFCKYTK-----QILDGVAYLHNN---CVVHRDIKGNNVMLMPNGII 141

Query: 138 KIADFNLSNQAPDMAARLHSTRVL----GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 193
           K+ DF  + +   +      + +L    GT  + APE        +KSD++S G  + E+
Sbjct: 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEM 201

Query: 194 LTGRKPVDHTMPR 206
            TG+ P+  +M R
Sbjct: 202 ATGKPPLA-SMDR 213

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 77.7 bits (191), Expect = 8e-17
 Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 15/174 (8%)

Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D  +   V+ +L H  LV+L G C E +   L +EF   G L D L  ++G    +   
Sbjct: 44  EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQE--- 100

Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-P 149
                T + + +D   G+ YL      ++IHRD+ + N L+ E+   K++DF ++     
Sbjct: 101 -----TLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152

Query: 150 DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 202
           D       T+      + +PE     + + KSDV+SFGV++ E+ + G+ P ++
Sbjct: 153 DQYTSSTGTKF--PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 77.3 bits (190), Expect = 1e-16
 Identities = 52/175 (29%), Positives = 83/175 (47%), Gaps = 15/175 (8%)

Query: 33  EKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGR-----KGVQG 85
           E +L++V   L+H+++V   G C EG   ++ +E+   G L+  L  HG       G + 
Sbjct: 57  EAELLTV---LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113

Query: 86  AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 145
             PG  L     + IA   A G+ YL        +HRD+ + N L+ +    KI DF +S
Sbjct: 114 VAPGQ-LTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169

Query: 146 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
                        R +    +  PE  +  + T +SD++SFGVVL E+ T G++P
Sbjct: 170 RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 77.1 bits (190), Expect = 2e-16
 Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 13/164 (7%)

Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V++ + H ++V LLG C+   ++ L  +   +G L D +   K   G+Q   +L+W    
Sbjct: 62  VMASVDHPHVVRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQY--LLNW---- 114

Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
              V  A+G+ YL EK    ++HRD+ + NVL+      KI DF L+          H+ 
Sbjct: 115 --CVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE 169

Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
                  + A E  +    T KSDV+S+GV + EL+T G KP +
Sbjct: 170 GGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 76.6 bits (188), Expect = 2e-16
 Identities = 59/245 (24%), Positives = 98/245 (40%), Gaps = 26/245 (10%)

Query: 26  PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG 85
           P +      Q   ++ +  H N+V L+G C +     +  E    G     L        
Sbjct: 33  PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE----- 87

Query: 86  AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 145
              GP L     +++  +AA G+EYL  K     IHRD+ + N L+ E    KI+DF +S
Sbjct: 88  ---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMS 141

Query: 146 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
            +  D               + APE    G+ + +SDV+SFG++L E             
Sbjct: 142 REEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAF----------- 190

Query: 206 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIV 265
               SL       LS  + ++ ++  ++   P      +  +   C +Y+   RP+ S V
Sbjct: 191 ----SLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTV 246

Query: 266 VKALQ 270
            + LQ
Sbjct: 247 HQELQ 251

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 77.0 bits (189), Expect = 2e-16
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 12/177 (6%)

Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-----HGRKGVQGA 86
           + +Q  S+++ L H N+V LLG   +     + +E+   G LH+ L     H   G    
Sbjct: 53  EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112

Query: 87  QPGPV---LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
           + G V   LD    + IA+  A G+EYL        +H+D+ + N+L+ E    KI+D  
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLG 169

Query: 144 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           LS +           + L    +  PE  M G+ +  SD++SFGVVL E+ + G +P
Sbjct: 170 LSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 76.7 bits (188), Expect = 3e-16
 Identities = 65/245 (26%), Positives = 108/245 (44%), Gaps = 31/245 (12%)

Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           L+  ++  +D +Q ++V+S+     + +  G  ++     +  E+   GS  D+L     
Sbjct: 39  LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----- 93

Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
               +PGP LD      I  +  +GL+YLH + +   IHRDI+++NVLL E  + K+ADF
Sbjct: 94  ----EPGP-LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADF 145

Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 202
            ++ Q  D   ++     +GT  + APE         K+D++S G+  +EL  G  P   
Sbjct: 146 GVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203

Query: 203 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 262
             P     L+    P            P L+G Y       L      C+  E  FRP  
Sbjct: 204 LHPMKVLFLIPKNNP------------PTLEGNYS----KPLKEFVEACLNKEPSFRPTA 247

Query: 263 SIVVK 267
             ++K
Sbjct: 248 KELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 76.0 bits (187), Expect = 3e-16
 Identities = 69/241 (28%), Positives = 102/241 (42%), Gaps = 33/241 (13%)

Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++S   H N+V+LLG C+    + +  E    G L   L  R         P+L     +
Sbjct: 52  LMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELL 109

Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-----DFKAKIADFNLSNQAPDMAA 153
            I +D A+G  YL    Q   IHRD+ + N L+ E     D   KI DF L   A D+  
Sbjct: 110 DICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL---ARDIYK 163

Query: 154 ----RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 209
               R     +L    + APE  + G+ T +SDV+SFGV++ E+LT           GQQ
Sbjct: 164 SDYYRKEGEGLL-PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT----------LGQQ 212

Query: 210 SLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 269
                  P L+  +V Q V    + + P     K+  +   C   +   RP    + + L
Sbjct: 213 PY-----PALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267

Query: 270 Q 270
           Q
Sbjct: 268 Q 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 75.9 bits (187), Expect = 4e-16
 Identities = 63/237 (26%), Positives = 100/237 (42%), Gaps = 27/237 (11%)

Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-HGRKGVQGAQPGPVLDWMTR 97
           ++S+  H+N+V L+G   E   R +  E    G L   L   R   +  +P   L     
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPE--RPSS-LTMKDL 118

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAAR 154
           +  A D A+G +YL E      IHRDI + N LL        AKIADF ++      +  
Sbjct: 119 LFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175

Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 213
               R +    +  PE  + G  T K+DV+SFGV+L E+ + G  P              
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY------------- 222

Query: 214 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 270
              P  +  +V + V    + + P      +  +   C Q+  E RPN + +++ +Q
Sbjct: 223 ---PGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 75.5 bits (185), Expect = 5e-16
 Identities = 61/180 (33%), Positives = 93/180 (51%), Gaps = 17/180 (9%)

Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   ++ +L+H+ LV L     E  + ++  EF   GSL D L  ++G
Sbjct: 38  LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVT-EFMGKGSLLDFL--KEG 94

Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                 G  L     V +A   A G+ Y+      + IHRD+R++N+L+ ++   KIADF
Sbjct: 95  -----DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADF 146

Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL+T GR P
Sbjct: 147 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 76.2 bits (187), Expect = 5e-16
 Identities = 55/177 (31%), Positives = 88/177 (49%), Gaps = 17/177 (9%)

Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  +VS +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 61  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 120

Query: 84  QGAQ-----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   + +   V      ARG+EYL  +     IHRD+ + NVL+ E+   K
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 177

Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+    ++     +T       + APE       T +SDV+SFGV++ E+ T
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.8 bits (186), Expect = 6e-16
 Identities = 66/254 (25%), Positives = 112/254 (44%), Gaps = 27/254 (10%)

Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGV-----Q 84
           D ++   +++ L+HE++V+  G C +G+  ++ +E+   G L+  L  HG   +     Q
Sbjct: 53  DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 112

Query: 85  GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 144
             Q    L     + IA   A G+ YL  +     +HRD+ + N L+  +   KI DF +
Sbjct: 113 PRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGM 169

Query: 145 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHT 203
           S               +    +  PE  M  + T +SDV+SFGV+L E+ T G++P    
Sbjct: 170 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---- 225

Query: 204 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 263
                     W   +LS  +V +C+      E P     ++  +   C Q E + R N+ 
Sbjct: 226 ----------WF--QLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIK 273

Query: 264 IVVKALQPLLKSPP 277
            + K L  L K+ P
Sbjct: 274 EIYKILHALGKATP 287

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 75.9 bits (187), Expect = 7e-16
 Identities = 37/102 (36%), Positives = 58/102 (56%), Gaps = 6/102 (5%)

Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           +I++   RGL YL EK +  I+HRD++ SN+L+    + K+ DF +S Q  D  A     
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 156

Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE       T +SD++S G+ L+E+  GR P+
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 75.1 bits (184), Expect = 9e-16
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 17/160 (10%)

Query: 45  HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ-----GAQPGPVLDWMTR-- 97
           H N++ LLG C       LA E+A  G+L D L   + ++                ++  
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +  A D ARG++YL +K     IHRD+ + N+L+ E++ AKIADF LS         ++ 
Sbjct: 115 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 166

Query: 158 TRVLGTFG--YHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            + +G     + A E       T  SDV+S+GV+L E+++
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 17/161 (10%)

Query: 44  KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ-----GAQPGPVLDWMTR- 97
            H N++ LLG C       +A E+A  G+L D L   + ++       + G      ++ 
Sbjct: 61  HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 98  -VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            ++ A D A G++YL EK     IHRD+ + NVL+ E+  +KIADF LS         ++
Sbjct: 121 LLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVY 172

Query: 157 STRVLGTFG--YHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
             + +G     + A E       T KSDV+SFGV+L E+++
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 57/188 (30%), Positives = 90/188 (47%), Gaps = 23/188 (12%)

Query: 23  LKSPKNYP--DDEKQL---VSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDI 76
           +K  K Y   DD +     + V+ +L  H N++ LLG C       LA E+A  G+L D 
Sbjct: 39  IKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 98

Query: 77  LHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 129
           L   + ++              L     +  A D ARG++YL +K     IHRD+ + N+
Sbjct: 99  LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI 155

Query: 130 LLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG--YHAPEYAMTGQLTQKSDVYSFG 187
           L+ E++ AKIADF LS         ++  + +G     + A E       T  SDV+S+G
Sbjct: 156 LVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 210

Query: 188 VVLLELLT 195
           V+L E+++
Sbjct: 211 VLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 1e-15
 Identities = 51/181 (28%), Positives = 79/181 (43%), Gaps = 28/181 (15%)

Query: 32  DEKQL------VSVVSRLKHENLVELL-GYCVEGNLRVLAYEFATMGSLHDI-LHGRKGV 83
            E++L      + ++S  KH N+V L   Y  E  L +L  EF   G+L  I L   +G+
Sbjct: 42  SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL-IEFCDGGALDSIMLELERGL 100

Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
              Q   V   M            L +LH      +IHRD+++ N+LL  D   K+ADF 
Sbjct: 101 TEPQIRYVCRQMLE---------ALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFG 148

Query: 144 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLELLTGRK 198
           +S +      +  +   +GT  + APE              K+D++S G+ L+EL     
Sbjct: 149 VSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206

Query: 199 P 199
           P
Sbjct: 207 P 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 2e-15
 Identities = 53/177 (29%), Positives = 84/177 (47%), Gaps = 20/177 (11%)

Query: 30  PDDE----KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG 85
           P D+    +Q +S++   +H N+V   G  +  +   +  E+   GSL DI       +G
Sbjct: 40  PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV---TRG 96

Query: 86  AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 145
                 + ++ R     +  +GL YLHE      IHRDI+ +N+LL ED   K+ADF +S
Sbjct: 97  PLSELQIAYVCR-----ETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVS 148

Query: 146 NQAPDMAARLHSTRVLGTFGYHAPEYA---MTGQLTQKSDVYSFGVVLLELLTGRKP 199
            Q     A+  S   +GT  + APE A     G    K D+++ G+  +EL   + P
Sbjct: 149 AQLTATIAKRKS--FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 73.8 bits (181), Expect = 3e-15
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 19/241 (7%)

Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRV--LAYEFATMGSLHDILHGRKGVQGAQPGPV 91
           K+ ++++  L HEN+V+  G C E   +   L  E+  +GSL D L          P   
Sbjct: 54  KKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----------PKHK 103

Query: 92  LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD- 150
           L+    +  A     G+ YLH +     IHRD+ + NVLL  D   KI DF L+   P+ 
Sbjct: 104 LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160

Query: 151 -MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 209
               R+        F Y A E     + +  SDV+SFGV L ELLT       + P+  +
Sbjct: 161 HEYYRVREDGDSPVFWY-AVECLKENKFSYASDVWSFGVTLYELLTHCDS-KQSPPKKFE 218

Query: 210 SLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 269
            ++     +++  ++ + ++  ++   P     ++  +   C + EA+FRP    ++  L
Sbjct: 219 EMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Query: 270 Q 270
           +
Sbjct: 279 K 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 72.9 bits (180), Expect = 3e-15
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 5/96 (5%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            LEYLH      II+RD++  N+LL  D   K+ DF L+ +     +R ++    GT  Y
Sbjct: 105 ALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEY 159

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 202
            APE  +     +  D +S GV+L E+LTG+ P   
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 73.0 bits (179), Expect = 5e-15
 Identities = 54/160 (33%), Positives = 81/160 (50%), Gaps = 15/160 (9%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +V+  +KH NLV+LLG C       +  EF T G+L D L  R+  +      VL +M  
Sbjct: 54  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYM-- 109

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
              A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    ++
Sbjct: 110 ---ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYT 160

Query: 158 TRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
                 F   + APE     + + KSDV++FGV+L E+ T
Sbjct: 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 72.3 bits (177), Expect = 7e-15
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 31/233 (13%)

Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++ +  H N+V+L+G C +     +  E    G     L  +K          L     V
Sbjct: 45  ILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK--------DELKTKQLV 96

Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           + A+DAA G+ YL  K   + IHRD+ + N L+ E+   KI+DF +S Q  D    ++S+
Sbjct: 97  KFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDD---GIYSS 150

Query: 159 RVLGT--FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
             L      + APE    G+ + +SDV+S+G++L E                 SL     
Sbjct: 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETF---------------SLGVCPY 195

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 269
           P ++  + ++ V+   +   P K    +  V   C  Y+ E RP  S + K L
Sbjct: 196 PGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 72.4 bits (178), Expect = 7e-15
 Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 21/236 (8%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG-RKGVQGAQPGPVLDWMT 96
           SV+      ++V LLG    G   ++  E    G L   L   R   +            
Sbjct: 61  SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            +++A + A G+ YL  K     +HRD+ + N ++ ED   KI DF ++    +      
Sbjct: 121 FIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 215
             + L    + APE    G  T KSDV+SFGVVL E+ T   +P                
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY--------------- 222

Query: 216 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 271
              LS ++V + V      + P     KL  +  +C QY  + RP    +V +L+ 
Sbjct: 223 -QGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 72.6 bits (178), Expect = 8e-15
 Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 16/164 (9%)

Query: 45  HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR-------------KGVQGAQPGPV 91
           H N+V+LLG C  G    L +E+   G L++ L  R                +       
Sbjct: 67  HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126

Query: 92  LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM 151
           L    ++ IA   A G+ YL E+     +HRD+ + N L+ E+   KIADF LS      
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183

Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
                S        +  PE     + T +SDV+++GVVL E+ +
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 72.7 bits (178), Expect = 8e-15
 Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 8/178 (4%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
           R    K   +D  + + ++SRLK+ N++ LLG CV  +   +  E+   G L+  L  R+
Sbjct: 53  RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQRE 112

Query: 82  ---GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
                  A   P +     + +AV  A G++YL      + +HRD+ + N L+   +  K
Sbjct: 113 IESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIK 169

Query: 139 IADFNLS-NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF +S N       R+    VL    + A E  + G+ T  SDV++FGV L E+ T
Sbjct: 170 IADFGMSRNLYSGDYYRIQGRAVL-PIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 72.5 bits (178), Expect = 9e-15
 Identities = 51/146 (34%), Positives = 77/146 (52%), Gaps = 18/146 (12%)

Query: 57  EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPV-LDWMTRVRIAVDAARGLEYLHEKV 115
           E N+  +  EF   GSL  I   +KG      GP+ ++ + +  IAV    GL YL+   
Sbjct: 75  ENNI-CMCMEFMDCGSLDRIY--KKG------GPIPVEILGK--IAVAVVEGLTYLYNVH 123

Query: 116 QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 175
           +  I+HRDI+ SN+L+    + K+ DF +S +  +  A    T V GT  Y +PE    G
Sbjct: 124 R--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---DTFV-GTSTYMSPERIQGG 177

Query: 176 QLTQKSDVYSFGVVLLELLTGRKPVD 201
           + T KSDV+S G+ ++EL  G+ P  
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFA 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 71.8 bits (176), Expect = 1e-14
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 44/220 (20%)

Query: 25  SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKGV 83
           SPK   +  K+ V+V+S +KH N+V+      E GNL ++  ++   G L+  ++ ++GV
Sbjct: 39  SPKEREESRKE-VAVLSNMKHPNIVQYQESFEENGNLYIVM-DYCEGGDLYKKINAQRGV 96

Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
                  +LDW  ++ +A      L+++H++    I+HRDI+S N+ L +D   K+ DF 
Sbjct: 97  L-FPEDQILDWFVQICLA------LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFG 146

Query: 144 LSNQAPDMAARLHSTRVL-----GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 198
           +       A  L+ST  L     GT  Y +PE         KSD+++ G VL E+ T   
Sbjct: 147 I-------ARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT--- 196

Query: 199 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP 238
            + H    G                +K  V   ++G YPP
Sbjct: 197 -LKHAFEAGN---------------MKNLVLKIIRGSYPP 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.0 bits (176), Expect = 1e-14
 Identities = 63/245 (25%), Positives = 108/245 (44%), Gaps = 31/245 (12%)

Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           L+  ++  +D +Q ++V+S+     +    G  ++G    +  E+   GS  D+L     
Sbjct: 39  LEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL----- 93

Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
               +PGP L+      I  +  +GL+YLH + +   IHRDI+++NVLL E    K+ADF
Sbjct: 94  ----KPGP-LEETYIATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADF 145

Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 202
            ++ Q  D   ++     +GT  + APE         K+D++S G+  +EL  G  P   
Sbjct: 146 GVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203

Query: 203 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 262
             P     L+   +P            P L+G+Y              C+  +  FRP  
Sbjct: 204 LHPMRVLFLIPKNSP------------PTLEGQYS----KPFKEFVEACLNKDPRFRPTA 247

Query: 263 SIVVK 267
             ++K
Sbjct: 248 KELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 71.4 bits (175), Expect = 1e-14
 Identities = 60/243 (24%), Positives = 109/243 (44%), Gaps = 33/243 (13%)

Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           D+  +   V+ +L HE LV+L G C +     +  E+ + G L + L  R+  +  QP  
Sbjct: 44  DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQ 101

Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 150
           +L+      +  D   G+ YL  K     IHRD+ + N L+ +    K++DF LS    D
Sbjct: 102 LLE------MCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152

Query: 151 MAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRG 207
                +++ V   F   +  PE  +  + + KSDV++FGV++ E+ + G+ P +      
Sbjct: 153 DE---YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE------ 203

Query: 208 QQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 267
                     R +  +  + V   L+   P     K+ A+   C   +AE RP    ++ 
Sbjct: 204 ----------RFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253

Query: 268 ALQ 270
           +++
Sbjct: 254 SIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 71.9 bits (176), Expect = 2e-14
 Identities = 47/176 (26%), Positives = 82/176 (46%), Gaps = 24/176 (13%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +++ ++ H ++++L G C +    +L  E+A  GSL   L   + V    P  +     R
Sbjct: 55  NLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVG---PSYLGSDGNR 111

Query: 98  VRIAVDA------------------ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
               +D                   +RG++YL E     ++HRD+ + NVL+ E  K KI
Sbjct: 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKI 168

Query: 140 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           +DF LS    +  + +  ++      + A E       T +SDV+SFGV+L E++T
Sbjct: 169 SDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.5 bits (176), Expect = 2e-14
 Identities = 51/170 (30%), Positives = 87/170 (51%), Gaps = 17/170 (10%)

Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEG-NLRVLAYEFATMGSLHDILHGRKGVQGAQPG 89
           +D +Q +  +S+ +   + +  G  ++G  L ++  E+   GS  D+L         +PG
Sbjct: 44  EDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM-EYCGGGSCLDLL---------KPG 93

Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             LD      I  +   GLEYLHE+     IHRDI+++N+LL E+   K+ADF +S Q  
Sbjct: 94  K-LDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLT 149

Query: 150 DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
              ++ ++   +GT  + APE        +K+D++S G+  +EL  G  P
Sbjct: 150 STMSKRNTF--VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 71.2 bits (174), Expect = 2e-14
 Identities = 53/160 (33%), Positives = 82/160 (51%), Gaps = 16/160 (10%)

Query: 43  LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 102
           L+H+ LV L     +     +  E+   GSL D L   +G +   P  ++D+  ++    
Sbjct: 58  LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP-KLIDFSAQI---- 112

Query: 103 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLG 162
             A G+ Y+  K   + IHRD+R++NVL+ E    KIADF L+    D     ++ R   
Sbjct: 113 --AEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGA 164

Query: 163 TF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            F   + APE    G  T KSDV+SFG++L E++T G+ P
Sbjct: 165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 71.4 bits (175), Expect = 2e-14
 Identities = 51/178 (28%), Positives = 79/178 (44%), Gaps = 33/178 (18%)

Query: 32  DEKQLVSVVSRLK-------HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
            E++  +++S LK       HEN+V LLG C  G   ++  E+   G L + L  ++   
Sbjct: 80  SERE--ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES- 136

Query: 85  GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 144
                  L     +  +   A+G+ +L  K   + IHRD+ + NVLL      KI DF L
Sbjct: 137 ------FLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187

Query: 145 -------SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
                  SN      ARL          + APE       T +SDV+S+G++L E+ +
Sbjct: 188 ARDIMNDSNYVVKGNARL-------PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 71.5 bits (175), Expect = 2e-14
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 7/177 (3%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HG 79
           R  + KN  +D  + + ++SRLK  N++ LL  C+  +   +  E+   G L+  L  H 
Sbjct: 55  REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHE 114

Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
            +          + + T + +A   A G++YL      + +HRD+ + N L+ +++  KI
Sbjct: 115 PQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKI 171

Query: 140 ADFNLS-NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           ADF +S N       R+    VL    + + E  + G+ T  SDV++FGV L E+LT
Sbjct: 172 ADFGMSRNLYSGDYYRIQGRAVL-PIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 70.7 bits (173), Expect = 2e-14
 Identities = 57/185 (30%), Positives = 90/185 (48%), Gaps = 27/185 (14%)

Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+      +++ +L+H  LV L     +  + ++  E+   GSL D L   +G
Sbjct: 38  LKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPEG 96

Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           ++       L     + +A   A G+ ++  K   + IHRD+R++N+L+ E    KIADF
Sbjct: 97  IK-------LTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADF 146

Query: 143 NLSNQAPDMAARL-----HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            L        ARL     ++ R    F   + APE    G  T KSDV+SFG++L E++T
Sbjct: 147 GL--------ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198

Query: 196 -GRKP 199
            GR P
Sbjct: 199 YGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 70.7 bits (173), Expect = 3e-14
 Identities = 47/170 (27%), Positives = 82/170 (48%), Gaps = 23/170 (13%)

Query: 37  VSVVSRLKHENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
           + +++RL H +++ +LG   E  +  +   E+   GS+  +L         + G   + +
Sbjct: 54  IRLMARLNHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLS--------KYGAFKEAV 104

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK-AKIADFNLSNQAPDMAAR 154
             +       RGL YLHE     IIHRD++ +N+L+    +  +IADF     A  +AA+
Sbjct: 105 I-INYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFG---AAARLAAK 157

Query: 155 LHST-----RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                    ++LGT  + APE     Q  +  DV+S G V++E+ T + P
Sbjct: 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 69.8 bits (171), Expect = 6e-14
 Identities = 55/229 (24%), Positives = 95/229 (41%), Gaps = 18/229 (7%)

Query: 41  SRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI 100
            +L H+N+V LLG C E     +  E+  +G L   L   K        P L    +V +
Sbjct: 63  RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
               A G+++L        +HRD+ + N L+    + K++  +LS    +         +
Sbjct: 123 CTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179

Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLS 220
           +    + APE       + KSDV+SFGV++ E+ T  +     +P    S          
Sbjct: 180 I-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE-----LPFYGLS---------D 224

Query: 221 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 269
           E+ + +    KL+   P    ++L  +   C     + RP+ S +V AL
Sbjct: 225 EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.1 bits (172), Expect = 6e-14
 Identities = 45/128 (35%), Positives = 62/128 (48%), Gaps = 10/128 (7%)

Query: 100 IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR 159
           IAV   + L YL E+++  IIHRD++ SN+LL  +   K+ DF +S Q  D  A+   TR
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TR 166

Query: 160 VLGTFGYHAPEYAMTGQLTQ---KSDVYSFGVVLLELLTGRKPVDHTMPRGQQ--SLVTW 214
             G   Y APE            +SDV+S G+ L E+ TG+ P         Q   +V  
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG 226

Query: 215 ATPRLSED 222
             P LS  
Sbjct: 227 DPPILSNS 234

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 69.6 bits (170), Expect = 7e-14
 Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 13/158 (8%)

Query: 43  LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 102
           L H  +V LLG C   +L+ L  + + +GSL D +   +      P  +L+W       V
Sbjct: 66  LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLD--PQRLLNW------CV 116

Query: 103 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLG 162
             A+G+ YL E     ++HR++ + N+LL  D   +IADF +++       +   +    
Sbjct: 117 QIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173

Query: 163 TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
              + A E  + G+ T +SDV+S+GV + E+++ G +P
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 69.7 bits (170), Expect = 8e-14
 Identities = 61/245 (24%), Positives = 107/245 (43%), Gaps = 31/245 (12%)

Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           L+  ++  +D +Q ++V+S+     + +  G  ++G    +  E+   GS  D+L     
Sbjct: 39  LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL----- 93

Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
               + GP  D      +  +  +GL+YLH + +   IHRDI+++NVLL E    K+ADF
Sbjct: 94  ----RAGP-FDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADF 145

Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 202
            ++ Q  D   ++     +GT  + APE         K+D++S G+  +EL  G  P   
Sbjct: 146 GVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203

Query: 203 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 262
             P      V +  P+ +         P L GE+              C+  +  FRP  
Sbjct: 204 MHPM----RVLFLIPKNNP--------PTLTGEF----SKPFKEFIDACLNKDPSFRPTA 247

Query: 263 SIVVK 267
             ++K
Sbjct: 248 KELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 56/177 (31%), Positives = 83/177 (46%), Gaps = 20/177 (11%)

Query: 25  SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG---NLRVLAYEFATMGSLHDILHGRK 81
           S   +  D ++ + ++  L+H+N+V+  G C      NLR L  E+   GSL D L   +
Sbjct: 44  STAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHR 102

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
                     LD    +  A    +G+EYL  K     +HRD+ + N+L+  + + KI D
Sbjct: 103 --------ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGD 151

Query: 142 FNLSNQAPDMAARLHSTRVLG---TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           F L+   P      +  R  G    F Y APE     + +  SDV+SFGVVL EL T
Sbjct: 152 FGLTKVLP-QDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 68.8 bits (168), Expect = 1e-13
 Identities = 65/249 (26%), Positives = 117/249 (46%), Gaps = 36/249 (14%)

Query: 23  LKSPKNYPDDEKQLV---SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           LK+  N P  + +L+   +V+ +L +  +V ++G C E    +L  E A +G L+  L  
Sbjct: 30  LKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQK 88

Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
            K V       + + + +V +      G++YL E    + +HRD+ + NVLL     AKI
Sbjct: 89  NKHVTEKN---ITELVHQVSM------GMKYLEET---NFVHRDLAARNVLLVTQHYAKI 136

Query: 140 ADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           +DF LS +A       +  +  G +   ++APE     + + KSDV+SFGV++ E  + G
Sbjct: 137 SDFGLS-KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYG 195

Query: 197 RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEA 256
           +KP                   +  ++V Q ++   + E P +   ++  +  LC  Y  
Sbjct: 196 QKPYK----------------GMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239

Query: 257 EFRPNMSIV 265
           + RP  ++V
Sbjct: 240 DERPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 68.5 bits (167), Expect = 2e-13
 Identities = 54/165 (32%), Positives = 87/165 (52%), Gaps = 17/165 (10%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +V+  L+H+ LV+L     +  + ++  EF   GSL D L   +G    QP P L     
Sbjct: 53  NVMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEG--SKQPLPKL----- 104

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +  +   A G+ ++ ++   + IHRD+R++N+L+      KIADF L+    D     ++
Sbjct: 105 IDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YT 158

Query: 158 TRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            R    F   + APE    G  T KSDV+SFG++L+E++T GR P
Sbjct: 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 68.4 bits (167), Expect = 2e-13
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 16/172 (9%)

Query: 28  NYPDDEKQLVSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRKGVQG 85
           N+  D K+ + ++  L HEN+V+  G C E  GN   L  EF   GSL + L   K    
Sbjct: 48  NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-- 105

Query: 86  AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 145
                 ++   +++ AV   +G++YL  +     +HRD+ + NVL+  + + KI DF L+
Sbjct: 106 ------INLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156

Query: 146 NQAPDMAARLHSTRVLGT--FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
                          L +  F Y APE  +  +    SDV+SFGV L ELLT
Sbjct: 157 KAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 68.5 bits (167), Expect = 2e-13
 Identities = 56/234 (23%), Positives = 98/234 (41%), Gaps = 19/234 (8%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           SV+      ++V LLG   +G   ++  E  T G L   L   +      P      + +
Sbjct: 61  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 98  -VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            +++A + A G+ YL+       +HRD+ + N ++ EDF  KI DF ++    +      
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
             + L    + +PE    G  T  SDV+SFGVVL E+ T               L     
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPY 222

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 270
             +S ++V + V      + P      L  +  +C QY  + RP+   ++ +++
Sbjct: 223 QGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 68.3 bits (168), Expect = 2e-13
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 5/92 (5%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GL+YLH      I+HRDI+ SN+L+  D   K+ADF L+       +  ++ RV+ T  Y
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWY 167

Query: 167 HAPEYAM-TGQLTQKSDVYSFGVVLLELLTGR 197
             PE  +   +   + D++S G +L EL  G+
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 68.1 bits (166), Expect = 2e-13
 Identities = 61/242 (25%), Positives = 113/242 (46%), Gaps = 32/242 (13%)

Query: 27  KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA 86
           K+  D+  +   ++ +L +  +V ++G C    L +L  E A+ G L+  L G+K     
Sbjct: 36  KSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEAL-MLVMEMASGGPLNKFLSGKK--DEI 92

Query: 87  QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 146
               V++ M +V +      G++YL  K   + +HRD+ + NVLL     AKI+DF LS 
Sbjct: 93  TVSNVVELMHQVSM------GMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLS- 142

Query: 147 QAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHT 203
           +A       +  R  G +   ++APE     + + +SDV+S+G+ + E  + G+KP    
Sbjct: 143 KALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK-- 200

Query: 204 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 263
                         ++   +V   ++   + + P +   ++ A+   C  Y+ E RPN +
Sbjct: 201 --------------KMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFA 246

Query: 264 IV 265
            V
Sbjct: 247 KV 248

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 68.1 bits (166), Expect = 2e-13
 Identities = 50/179 (27%), Positives = 91/179 (50%), Gaps = 13/179 (7%)

Query: 24  KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 83
           K P    +  K+ V +++++KH N+V       E     +  E+   G L   ++ ++GV
Sbjct: 37  KMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGV 96

Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK-AKIADF 142
             ++   +L W  ++      + GL+++H++    I+HRDI+S N+ L ++   AK+ DF
Sbjct: 97  LFSE-DQILSWFVQI------SLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDF 146

Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            ++ Q  D +  L  T  +GT  Y +PE         K+D++S G VL EL T + P +
Sbjct: 147 GIARQLND-SMELAYT-CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 68.3 bits (167), Expect = 2e-13
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 20/169 (11%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +++ S LKH N+V+ LG   E     +  E    GSL  +L  + G         + + T
Sbjct: 56  IALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIIFYT 114

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA--KIADFNLSNQAPDMAAR 154
           +         GL+YLH+     I+HRDI+  NVL+   +    KI+DF  S +     A 
Sbjct: 115 K-----QILEGLKYLHDN---QIVHRDIKGDNVLV-NTYSGVVKISDFGTSKR----LAG 161

Query: 155 LH--STRVLGTFGYHAPEYAMTGQ--LTQKSDVYSFGVVLLELLTGRKP 199
           ++  +    GT  Y APE    G       +D++S G  ++E+ TG+ P
Sbjct: 162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 67.8 bits (165), Expect = 3e-13
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 21/198 (10%)

Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           +Q + ++   KH N+V   G  +  +   +  EF   GSL DI H    V G      + 
Sbjct: 54  QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH----VTGPLSESQIA 109

Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
           +++R     +  +GL YLH K +   +HRDI+ +N+LL ++   K+ADF +S Q     A
Sbjct: 110 YVSR-----ETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161

Query: 154 RLHSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 210
           +  S   +GT  + APE A     G   Q  D+++ G+  +EL   + P+    P     
Sbjct: 162 KRKS--FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF 219

Query: 211 LVT---WATPRLSEDKVK 225
           L+T   +  P+L +DK+K
Sbjct: 220 LMTKSNFQPPKL-KDKMK 236

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 68.1 bits (166), Expect = 3e-13
 Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 23/236 (9%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG---PVLDW 94
           SV+      ++V LLG   +G   ++  E    G L   L   +      PG   P L  
Sbjct: 61  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+ K     +HRD+ + N ++  DF  KI DF ++    +    
Sbjct: 121 M--IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 175

Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 214
               + L    + APE    G  T  SD++SFGVVL E+                SL   
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQ 220

Query: 215 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 270
               LS ++V + V      + P     ++  +  +C Q+  + RP    +V  L+
Sbjct: 221 PYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 67.4 bits (165), Expect = 5e-13
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 15/174 (8%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP--GPVLDW 94
           V ++SRL   N+  LLG C       +  E+   G L+  L                L +
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
            T + +A   A G+ YL      + +HRD+ + N L+ +++  KIADF +S    ++ + 
Sbjct: 130 STLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR---NLYSS 183

Query: 155 LHSTRVLGT----FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT--GRKPVDH 202
            +  RV G       + A E  + G+ T KSDV++FGV L E+LT    +P +H
Sbjct: 184 DYY-RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 67.1 bits (165), Expect = 6e-13
 Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 29/169 (17%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S++  LKH N+V+LL          L +E+  M  L   L  R G     P  +   M 
Sbjct: 49  ISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG--PLSPNLIKSIMY 105

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           ++       RGL Y H      I+HRD++  N+L+  D   K+ADF L        AR  
Sbjct: 106 QL------LRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGL--------ARAF 148

Query: 157 S------TRVLGTFGYHAPEYAMTGQLTQKS--DVYSFGVVLLELLTGR 197
                  T  + T  Y APE  + G     +  D++S G +  E++TG+
Sbjct: 149 GIPLRTYTHEVVTLWYRAPEILL-GSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 66.8 bits (164), Expect = 6e-13
 Identities = 34/111 (30%), Positives = 53/111 (47%), Gaps = 21/111 (18%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF--------NLSNQAPDMAARLHST 158
            LEYLH K    IIHRD++  N+LL +D   KI DF        N S ++    A    +
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 159 R----------VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +           +GT  Y +PE        + SD+++ G ++ ++LTG+ P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 66.4 bits (162), Expect = 8e-13
 Identities = 44/160 (27%), Positives = 68/160 (42%), Gaps = 14/160 (8%)

Query: 43  LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 102
           L H N+++ LG C+E    +L  EF  +G L + L   +G+               R+A 
Sbjct: 52  LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK----DVLQRMAC 107

Query: 103 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLG 162
           + A GL +LH   Q   IH D+   N  L  D   KI D+ L+ +       +       
Sbjct: 108 EVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV 164

Query: 163 TFGYHAPEYA-------MTGQLTQKSDVYSFGVVLLELLT 195
              + APE         +    T+KS+++S GV + EL T
Sbjct: 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 9/105 (8%)

Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           ++ V   + L YL EK    +IHRD++ SN+LL      K+ DF +S +  D  A+   T
Sbjct: 118 KMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---T 172

Query: 159 RVLGTFGYHAPEY----AMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           R  G   Y APE         +   ++DV+S G+ L+EL TG+ P
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 50/149 (33%), Positives = 71/149 (47%), Gaps = 26/149 (17%)

Query: 63  LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV------------DAARGLEY 110
           L Y F T G L+ IL   +G          D  TR+   V            + A  L++
Sbjct: 63  LHYAFQTEGKLYLILDFLRGG---------DLFTRLSKEVMFTEEDVKFYLAELALALDH 113

Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH      II+RD++  N+LL E+   K+ DF LS ++ D   + +S    GT  Y APE
Sbjct: 114 LHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPE 168

Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                  TQ +D +SFGV++ E+LTG  P
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 52/184 (28%), Positives = 89/184 (48%), Gaps = 22/184 (11%)

Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           ++++   RGL YL EK Q  I+HRD++ SN+L+    + K+ DF +S Q  D  A     
Sbjct: 107 KVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 160

Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 218
             +GT  Y +PE       + +SD++S G+ L+EL  GR P+    P  ++    +  P 
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI--PPPDAKELEAIFGRPV 218

Query: 219 L-SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 277
           +  E+     + P+ +   P + V+           +  + RP M+I  + L  ++  PP
Sbjct: 219 VDGEEGEPHSISPRPRP--PGRPVSG----------HGMDSRPAMAI-FELLDYIVNEPP 265

Query: 278 PAAP 281
           P  P
Sbjct: 266 PKLP 269

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.0 bits (161), Expect = 1e-12
 Identities = 46/180 (25%), Positives = 81/180 (45%), Gaps = 19/180 (10%)

Query: 24  KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAY-EFATMGSLHDILHGRKG 82
              K   +  +  + ++  L+HE +V+  G C+  +  +  + E+   GS+ D L     
Sbjct: 42  PETKKEVNALECEIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL----- 95

Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                 G + + +TR +       G+EYLH  +   I+HRDI+ +N+L       K+ DF
Sbjct: 96  ---KAYGALTETVTR-KYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDF 148

Query: 143 NLSNQAPDMAARLHST---RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             S +          T    V GT  + +PE        +K+DV+S G  ++E+LT + P
Sbjct: 149 GASKRL--QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 66.1 bits (162), Expect = 1e-12
 Identities = 33/99 (33%), Positives = 46/99 (46%), Gaps = 9/99 (9%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS------NQAPDMAARLHSTRV 160
            LEYLH      IIHRD++  N+L+  +   K+ DF LS       Q           R+
Sbjct: 105 ALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161

Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +GT  Y APE  +    ++  D +S G +L E L G  P
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 49/168 (29%), Positives = 81/168 (48%), Gaps = 25/168 (14%)

Query: 37  VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDIL-HGRKGVQGAQPGPVLDW 94
           V ++   +H N+VE+   Y V   L V+  EF   G+L DI+ H R              
Sbjct: 67  VVIMRDYQHPNIVEMYSSYLVGDELWVV-MEFLEGGALTDIVTHTR-------------- 111

Query: 95  MTRVRIA---VDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM 151
           M   +IA   +   + L +LH +    +IHRDI+S ++LL  D + K++DF    Q    
Sbjct: 112 MNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168

Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             R  S  ++GT  + APE         + D++S G++++E++ G  P
Sbjct: 169 VPRRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 48/159 (30%), Positives = 74/159 (46%), Gaps = 18/159 (11%)

Query: 43  LKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIA 101
           LKH N++ LL  +  + N+  L +EF     L  ++  +  V    P  +  +M      
Sbjct: 59  LKHPNIIGLLDVFGHKSNI-NLVFEFME-TDLEKVIKDKSIV--LTPADIKSYM------ 108

Query: 102 VDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL 161
           +   RGLEYLH      I+HRD++ +N+L+  D   K+ADF L+        R  + +V+
Sbjct: 109 LMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVV 164

Query: 162 GTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKP 199
            T  Y APE            D++S G +  ELL  R P
Sbjct: 165 -TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 65.7 bits (160), Expect = 2e-12
 Identities = 47/134 (35%), Positives = 63/134 (47%), Gaps = 20/134 (14%)

Query: 66  EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 125
           EF   GSL         V    P  VL      RIAV   +GL YL       I+HRD++
Sbjct: 79  EFMDGGSLD--------VYRKIPEHVLG-----RIAVAVVKGLTYLWSL---KILHRDVK 122

Query: 126 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYS 185
            SN+L+    + K+ DF +S Q  +  A+ +    +GT  Y APE     Q    SDV+S
Sbjct: 123 PSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY----VGTNAYMAPERISGEQYGIHSDVWS 178

Query: 186 FGVVLLELLTGRKP 199
            G+  +EL  GR P
Sbjct: 179 LGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 2e-12
 Identities = 35/99 (35%), Positives = 48/99 (48%), Gaps = 9/99 (9%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+E LH   Q  IIHRDI+  N+L+ +    K+ DF LS         L + + +GT  Y
Sbjct: 109 GVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDY 159

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
            APE  +     + SD +S G V+ E L G  P     P
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 2e-12
 Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 21/167 (12%)

Query: 44  KHENLVELLGYCVEGNLRV------LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
            H N+    G  ++ N         L  E    GS+ D++ G +          + ++ R
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
                +  RGL YLHE     +IHRDI+  N+LL ++ + K+ DF +S Q      R ++
Sbjct: 121 -----ETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172

Query: 158 TRVLGTFGYHAPE-----YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
              +GT  + APE              +SDV+S G+  +EL  G+ P
Sbjct: 173 --FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 3e-12
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 34/207 (16%)

Query: 30  PDDE----KQLVSVVSRLKH---ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           PDD+    ++ V+++S+L+     N+ +  G  ++G    +  E+A  GS+  ++     
Sbjct: 39  PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----- 93

Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
               + GP+ +    V I  +    L+Y+H+     +IHRDI+++N+L+      K+ DF
Sbjct: 94  ----KAGPIAEKYISV-IIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDF 145

Query: 143 NLSNQAPDMAARLHSTR-----VLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTG 196
            +       AA L+         +GT  + APE    G+    K+D++S G+ + E+ TG
Sbjct: 146 GV-------AALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198

Query: 197 RKPV-DHTMPRGQQSLVTWATPRLSED 222
             P  D    R    +     PRL ++
Sbjct: 199 NPPYSDVDAFRAMMLIPKSKPPRLEDN 225

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 65.1 bits (158), Expect = 3e-12
 Identities = 61/237 (25%), Positives = 96/237 (40%), Gaps = 31/237 (13%)

Query: 45  HENLVELLGYCVEGNLR------VLAYEFATMGSLHD-ILHGRKGVQGAQPGPV-LDWMT 96
           H N++ L+G C++          V+   F   G LH  +L+ R G       P  L    
Sbjct: 59  HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC-----PQYLPTQM 113

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            V+   D A G+EYL  K   S IHRD+ + N +L E+    +ADF LS +  +      
Sbjct: 114 LVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ 170

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
                    + A E       T KSDV+SFGV + E+ T          RGQ        
Sbjct: 171 GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT----------RGQTPY----- 215

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 273
           P +   ++   +    + + PP  +  L ++ + C     + RP+   +   L+  L
Sbjct: 216 PGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 64.8 bits (158), Expect = 4e-12
 Identities = 58/171 (33%), Positives = 81/171 (47%), Gaps = 32/171 (18%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH-GRKGVQGAQPGPVLDWM 95
           V  + +L+H N +E  G  +  +   L  E+  +GS  DIL   +K +Q           
Sbjct: 66  VRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQ----------- 113

Query: 96  TRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF-NLSNQAPDM 151
             V IA     A +GL YLH       IHRDI++ N+LL E    K+ADF + S  +P  
Sbjct: 114 -EVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167

Query: 152 AARLHSTRVLGTFGYHAPE--YAM-TGQLTQKSDVYSFGVVLLELLTGRKP 199
                +   +GT  + APE   AM  GQ   K DV+S G+  +E L  RKP
Sbjct: 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 64.5 bits (157), Expect = 4e-12
 Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 13/172 (7%)

Query: 29  YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP 88
             +D  +   V+ +L H  LV+L G C +     +  EF   G L + L  R+G      
Sbjct: 42  SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKD- 100

Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
             +L     + +  D   G+EYL    + S IHRD+ + N L+      K++DF ++   
Sbjct: 101 --ML-----LSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150

Query: 149 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            D      S+       +  PE     + + KSDV+SFGV++ E+ T G+ P
Sbjct: 151 LD-DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 64.8 bits (158), Expect = 4e-12
 Identities = 48/232 (20%), Positives = 99/232 (42%), Gaps = 41/232 (17%)

Query: 40  VSRLKHENLVELLGYCVE---GNLRV-LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
           + R+   N++++ G+ ++      R+ L  E+ T G L ++L   K          L + 
Sbjct: 72  LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD---------LSFK 122

Query: 96  TRVRIAVDAARGLEYLHEKV-QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           T++ +A+D  +GL  L++   +P   ++++ S + L+ E++K KI    L      + + 
Sbjct: 123 TKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEK----ILSS 175

Query: 155 LHSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 212
                V     Y + +       + T K D+YS GVVL E+ TG+ P ++          
Sbjct: 176 PPFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN---------- 224

Query: 213 TWATPRLSEDKVKQCVDPKLKGEY-PPKGVAKLAAVAALCVQYEAEFRPNMS 263
                 L+  ++   +  K      P     ++  +   C  +++  RPN+ 
Sbjct: 225 ------LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIK 270

Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 64.5 bits (157), Expect = 4e-12
 Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)

Query: 43  LKHENLVELLGYCVEGNLR------VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
             H N+++L+G C E +        ++   F   G LH  L   +     +  P+    T
Sbjct: 58  FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL---QT 114

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ--APDMAAR 154
            ++  VD A G+EYL  +   + IHRD+ + N +L ED    +ADF LS +  + D   +
Sbjct: 115 LLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ 171

Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
               ++     + A E       T KSDV++FGV + E+ T G+ P
Sbjct: 172 GRIAKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 64.6 bits (158), Expect = 5e-12
 Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 14/160 (8%)

Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
            +   +H  +V+LL     G+  VL  E+     L ++L            P+ +   + 
Sbjct: 52  ALQACQHPYVVKLLDVFPHGSGFVLVMEY-MPSDLSEVLRDE-------ERPLPEAQVK- 102

Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
                  +G+ Y+H      I+HRD++ +N+L+  D   KIADF L+    +   RL+S 
Sbjct: 103 SYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159

Query: 159 RVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGR 197
           +V  T  Y APE     +      D+++ G +  ELL G 
Sbjct: 160 QV-ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 64.0 bits (156), Expect = 6e-12
 Identities = 55/172 (31%), Positives = 80/172 (46%), Gaps = 38/172 (22%)

Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGP-VL 92
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P V 
Sbjct: 49  IMKDFSHPNVLSLLGICLPSEGSPLVVLPY----------MKHGDLRNFIRSETHNPTVK 98

Query: 93  DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD-- 150
           D +      +  A+G+EYL  K     +HRD+ + N +L E F  K+ADF L+    D  
Sbjct: 99  DLIG---FGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152

Query: 151 -------MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
                    A+L          + A E   T + T KSDV+SFGV+L EL+T
Sbjct: 153 YYSVHNHTGAKL-------PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 64.1 bits (156), Expect = 6e-12
 Identities = 43/166 (25%), Positives = 81/166 (48%), Gaps = 14/166 (8%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
             V+  L H N++E     +E    ++  E+A  G+L + +  R          +L +  
Sbjct: 50  CQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFV 108

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLSNQAPDMAARL 155
           ++ +A      L ++H K+   I+HRD+++ N+LL       KI DF +S     ++++ 
Sbjct: 109 QILLA------LHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKS 156

Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            +  V+GT  Y +PE        QKSD+++ G VL EL + ++  +
Sbjct: 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.0 bits (155), Expect = 6e-12
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 28/209 (13%)

Query: 31  DDEKQLVSVVSRLK----HENLVELLGYCVEGN------LRVLAYEFATMGSLHDILHGR 80
           D+E+++   ++ LK    H N+    G  ++ N         L  EF   GS+ D++   
Sbjct: 44  DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 103

Query: 81  KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 140
           KG    +     +W+    I  +  RGL +LH   Q  +IHRDI+  NVLL E+ + K+ 
Sbjct: 104 KGNTLKE-----EWIAY--ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLV 153

Query: 141 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLELLT 195
           DF +S Q      R ++   +GT  + APE     +        KSD++S G+  +E+  
Sbjct: 154 DFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 211

Query: 196 GRKPVDHTMPRGQQSLVTW-ATPRLSEDK 223
           G  P+    P     L+     PRL   K
Sbjct: 212 GAPPLCDMHPMRALFLIPRNPAPRLKSKK 240

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 64.7 bits (157), Expect = 6e-12
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 22/183 (12%)

Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           ++++   +GL YL EK +  I+HRD++ SN+L+    + K+ DF +S Q  D  A     
Sbjct: 107 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 160

Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 218
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+    P   + L       
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP---PPDAKELELMFGCP 217

Query: 219 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 278
           +  D  +    P+ +    P               Y  + RP M+I  + L  ++  PPP
Sbjct: 218 VEGDPAESETSPRPRPPGRPLS------------SYGPDSRPPMAI-FELLDYIVNEPPP 264

Query: 279 AAP 281
             P
Sbjct: 265 KLP 267

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.1 bits (156), Expect = 6e-12
 Identities = 55/191 (28%), Positives = 85/191 (44%), Gaps = 31/191 (16%)

Query: 66  EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 125
           E+   GSL D L+         P  VL      RI     +GL++L E+    IIHRD++
Sbjct: 79  EYMDAGSL-DKLYAGGVATEGIPEDVL-----RRITYAVVKGLKFLKEEHN--IIHRDVK 130

Query: 126 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ------ 179
            +NVL+  + + K+ DF +S     + A L  T + G   Y APE   +G   Q      
Sbjct: 131 PTNVLVNGNGQVKLCDFGVSGN---LVASLAKTNI-GCQSYMAPERIKSGGPNQNPTYTV 186

Query: 180 KSDVYSFGVVLLELLTGRKP----VDHTMPRGQQSLVTWATPRL-------SEDKVKQCV 228
           +SDV+S G+ +LE+  GR P        +     ++V    P L       ++D V +C+
Sbjct: 187 QSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCL 246

Query: 229 --DPKLKGEYP 237
              P  +  Y 
Sbjct: 247 NKIPNRRPTYA 257

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 64.0 bits (155), Expect = 7e-12
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 18/185 (9%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + V+  LK+ N+V  L   + G+   +  E+   GSL D++              +D   
Sbjct: 67  ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV----------TETCMDEAQ 116

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARL 155
              +  +  + LE+LH      +IHRDI+S NVLL  D   K+ DF    Q  P+ + R 
Sbjct: 117 IAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR- 172

Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 214
             + ++GT  + APE         K D++S G++ +E++ G  P  +  P R    + T 
Sbjct: 173 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 230

Query: 215 ATPRL 219
            TP L
Sbjct: 231 GTPEL 235

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 63.9 bits (155), Expect = 8e-12
 Identities = 64/242 (26%), Positives = 104/242 (42%), Gaps = 35/242 (14%)

Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           +++ + H +LV LLG C+   ++ L  +    G L D +H  K   G+Q   +L+W  ++
Sbjct: 62  IMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQL--LLNWCVQI 118

Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
                 A+G+ YL E+    ++HRD+ + NVL+      KI DF L+          ++ 
Sbjct: 119 ------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169

Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 217
                  + A E     + T +SDV+S+GV + EL+T G KP D         + T   P
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD--------GIPTREIP 221

Query: 218 RLSEDKVKQCVDPKLKGE---YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 274
            L E           KGE    PP     +  V   C   +A+ RP    +      + +
Sbjct: 222 DLLE-----------KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270

Query: 275 SP 276
            P
Sbjct: 271 DP 272

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 39/165 (23%), Positives = 68/165 (41%), Gaps = 21/165 (12%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++  L H N+++LL          L +EF        I   ++G+  +     L +  
Sbjct: 49  IKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYL-YQL 107

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARL 155
                    +GL + H      I+HRD++  N+L+  +   K+ADF L+      +    
Sbjct: 108 --------LQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156

Query: 156 H--STRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGR 197
           H   TR      Y APE  +     +   D++S G +  ELL+ R
Sbjct: 157 HYVVTR-----WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.1 bits (153), Expect = 1e-11
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 27/205 (13%)

Query: 2   RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL-GYCVEGNL 60
           R  L      ++ Y   E    KS     D  K+ V +++++KH N+V     +  +G+L
Sbjct: 15  RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAV-LLAKMKHPNIVAFKESFEADGHL 73

Query: 61  RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSII 120
            ++  E+   G L   +  ++G    +   +L W  ++ + V      +++HEK    ++
Sbjct: 74  YIVM-EYCDGGDLMQKIKLQRGKLFPED-TILQWFVQMCLGV------QHIHEK---RVL 122

Query: 121 HRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV------LGTFGYHAPEYAMT 174
           HRDI+S N+ L ++ K K+ DF         +ARL ++        +GT  Y  PE    
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFG--------SARLLTSPGAYACTYVGTPYYVPPEIWEN 174

Query: 175 GQLTQKSDVYSFGVVLLELLTGRKP 199
                KSD++S G +L EL T + P
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 63.4 bits (154), Expect = 1e-11
 Identities = 56/189 (29%), Positives = 85/189 (44%), Gaps = 26/189 (13%)

Query: 39  VVSRLKHENLVELL-GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           V+   KH N+V  L  Y V   L V+  E+   GSL D++                 M  
Sbjct: 69  VMRENKHPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVV-------------TETCMDE 114

Query: 98  VRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAA 153
            +IA    +  + LE+LH      +IHRDI+S N+LL  D   K+ DF    Q  P+ + 
Sbjct: 115 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171

Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLV 212
           R   + ++GT  + APE         K D++S G++ +E++ G  P  +  P R    + 
Sbjct: 172 R---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228

Query: 213 TWATPRLSE 221
           T  TP L  
Sbjct: 229 TNGTPELQN 237

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 62.8 bits (153), Expect = 2e-11
 Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 33/234 (14%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSL-HDILHGRKGVQGAQPGPVLDWM 95
           + ++ +L H N+++ L   +E N   +  E A  G L   I H +K         ++   
Sbjct: 53  IDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ------KRLIPER 106

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
           T  +  V     LE++H K    I+HRDI+ +NV +      K+ D  L           
Sbjct: 107 TIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163

Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 215
           HS  ++GT  Y +PE         KSD++S G +L E+   + P        + +L +  
Sbjct: 164 HS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLC 217

Query: 216 TPRLSEDKVKQCVDPKLKGEYPP----KGVAKLAAVAALCVQYEAEFRPNMSIV 265
                  K+++C       +YPP        +L  + + C+  + E RP++S V
Sbjct: 218 ------KKIEKC-------DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 49/171 (28%), Positives = 74/171 (43%), Gaps = 23/171 (13%)

Query: 33  EKQLVSVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQGAQPGPV 91
           EK++    +  +H  LV L   C +    V    E+A  G L  ++H    V        
Sbjct: 49  EKRIFETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDV-------- 97

Query: 92  LDWMTRVRIAVDAAR---GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
               +  R    AA    GL+YLHE     I++RD++  N+LL  +   KIADF L  + 
Sbjct: 98  ---FSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKE- 150

Query: 149 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             M     ++   GT  + APE       T+  D +  GV++ E+L G  P
Sbjct: 151 -GMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 27/203 (13%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-HGRKGVQGAQPGPVLDWM 95
           V ++   +HEN+VE+    + G+   +  EF   G+L DI+ H R              M
Sbjct: 68  VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--------------M 113

Query: 96  TRVRIA---VDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
              +IA   +   + L  LH +    +IHRDI+S ++LL  D + K++DF    Q     
Sbjct: 114 NEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170

Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSL 211
            R  S  ++GT  + APE         + D++S G++++E++ G  P  +  P +  + +
Sbjct: 171 PRRKS--LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228

Query: 212 VTWATPRLSEDKVKQCVDPKLKG 234
                P+L   K    V P LKG
Sbjct: 229 RDNLPPKL---KNLHKVSPSLKG 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 62.1 bits (151), Expect = 3e-11
 Identities = 32/106 (30%), Positives = 48/106 (45%), Gaps = 7/106 (6%)

Query: 95  MTRVRI-AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
             R    A     GLE+LH++    I++RD++  NVLL +    +I+D  L   A ++  
Sbjct: 94  EARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGL---AVELKG 147

Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                   GT GY APE           D ++ G  L E++ GR P
Sbjct: 148 GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 62.3 bits (152), Expect = 3e-11
 Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 11/94 (11%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD-MAARLHSTRVLGTF 164
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D M      T  + T 
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------TGYVATR 179

Query: 165 GYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGR 197
            Y APE  +      Q  D++S G ++ ELLTG+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 62.0 bits (151), Expect = 4e-11
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 7/102 (6%)

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A +   GL++LHE+    II+RD++  NVLL  +   KIADF +  +   +   + ++  
Sbjct: 102 AAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG--ILGGVTTSTF 156

Query: 161 LGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKPVD 201
            GT  Y APE  ++ Q    + D ++ GV+L E+L G+ P +
Sbjct: 157 CGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 36/93 (38%), Positives = 54/93 (58%), Gaps = 5/93 (5%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GL++LH+K    II+RD++  NVLL +D   KIADF +  +  +M     ++   GT  Y
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDY 162

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE     +  +  D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 62.0 bits (151), Expect = 4e-11
 Identities = 52/171 (30%), Positives = 77/171 (45%), Gaps = 31/171 (18%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSL-HDILHGRKGVQGAQPGPVLDWM 95
           ++++  L+H N+VEL    V  +L  +   F  M     D+              +LD M
Sbjct: 57  ITLLLNLRHPNIVELKEVVVGKHLDSI---FLVMEYCEQDL------------ASLLDNM 101

Query: 96  TR------VR-IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
                   V+ + +   RGL+YLHE     IIHRD++ SN+LL +    KIADF L+   
Sbjct: 102 PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158

Query: 149 PDMAARLHSTRVLGTFGYHAPE--YAMTGQLTQKSDVYSFGVVLLELLTGR 197
              A     T  + T  Y APE     T   T   D+++ G +L ELL  +
Sbjct: 159 GLPAK--PMTPKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 61.6 bits (149), Expect = 4e-11
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 17/170 (10%)

Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           +Q + +V   KH N+V   G  +      +  E+   GSL DI H    V G      + 
Sbjct: 54  QQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH----VTGPLSELQIA 109

Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
           ++ R     +  +GL YLH K +   +HRDI+ +N+LL ++   K+ADF ++ +     A
Sbjct: 110 YVCR-----ETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161

Query: 154 RLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPV 200
           +  S   +GT  + APE A     G   Q  D+++ G+  +EL   + P+
Sbjct: 162 KRKS--FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 61.7 bits (149), Expect = 4e-11
 Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 27/204 (13%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + V+   K+ N+V  L   + G+   +  E+   GSL D++              +D   
Sbjct: 68  ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQ 117

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARL 155
              +  +  + LE+LH      +IHRDI+S N+LL  D   K+ DF    Q  P+ + R 
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 173

Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 214
             + ++GT  + APE         K D++S G++ +E++ G  P  +  P R    + T 
Sbjct: 174 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231

Query: 215 ATPRLS---------EDKVKQCVD 229
            TP L           D + +C+D
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLD 255

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 61.6 bits (149), Expect = 5e-11
 Identities = 66/259 (25%), Positives = 104/259 (40%), Gaps = 33/259 (12%)

Query: 19  ENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 78
           EN   K+ K   D+   +  V S      +  LLG C+   ++ L  +    G L D + 
Sbjct: 46  ENTSPKANKEILDEAYVMAGVGSPY----VCRLLGICLTSTVQ-LVTQLMPYGCLLDYVR 100

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
             K   G+Q   +L+W       V  A+G+ YL E     ++HRD+ + NVL+      K
Sbjct: 101 ENKDRIGSQD--LLNW------CVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVK 149

Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GR 197
           I DF L+          H+        + A E  +  + T +SDV+S+GV + EL+T G 
Sbjct: 150 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGA 209

Query: 198 KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAE 257
           KP D    R    L+     RL +               PP     +  +   C   ++E
Sbjct: 210 KPYDGIPAREIPDLLE-KGERLPQ---------------PPICTIDVYMIMVKCWMIDSE 253

Query: 258 FRPNMSIVVKALQPLLKSP 276
            RP    +V     + + P
Sbjct: 254 CRPRFRELVDEFSRMARDP 272

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 60.7 bits (148), Expect = 7e-11
 Identities = 46/191 (24%), Positives = 75/191 (39%), Gaps = 47/191 (24%)

Query: 33  EKQL----VSVVSRLKHENLVELLG---------------YCVEGNLRVLAYEFATMGSL 73
           EKQ     V+++  LKH N+V                   YC  G+L            L
Sbjct: 42  EKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDL----------AQL 91

Query: 74  HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNVLL 131
             I   +K  +  +   +   +T++ +A      L   H +  P   ++HRD++ +N+ L
Sbjct: 92  --IQKCKKERKYIEEEFIWRILTQLLLA------LYECHNRSDPGNTVLHRDLKPANIFL 143

Query: 132 FEDFKAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGV 188
             +   K+ DF L+         A     T V GT  Y +PE        +KSD++S G 
Sbjct: 144 DANNNVKLGDFGLAKILGHDSSFA----KTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGC 198

Query: 189 VLLELLTGRKP 199
           ++ EL     P
Sbjct: 199 LIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.2 bits (151), Expect = 8e-11
 Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 21/173 (12%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLA-YEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
            ++ +RL H N+V LL         + A +E+    +L ++L       GA P       
Sbjct: 29  TALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL----AADGALPA-----G 79

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKIADFNLSNQAPDM- 151
              R+ +     L   H +    I+HRD++  N+++ +      AK+ DF +    P + 
Sbjct: 80  ETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVR 136

Query: 152 -AARLHSTR---VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
            A     TR   VLGT  Y APE      +T  SD+Y++G++ LE LTG++ V
Sbjct: 137 DADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 61.2 bits (148), Expect = 8e-11
 Identities = 54/169 (31%), Positives = 84/169 (49%), Gaps = 28/169 (16%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V  + +LKH N +E  G  ++ +   L  E+  +GS  D+L   K     +P      + 
Sbjct: 72  VKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHK-----KP------LQ 119

Query: 97  RVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
            V IA     A +GL YLH     ++IHRDI++ N+LL E  + K+ADF  ++++     
Sbjct: 120 EVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173

Query: 154 RLHSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKP 199
              +   +GT  + APE  +    GQ   K DV+S G+  +E L  RKP
Sbjct: 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 60.9 bits (147), Expect = 1e-10
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 21/167 (12%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V  + R+KH N +E  G  +  +   L  E+  +GS  D+L   K     +P   L  + 
Sbjct: 76  VKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHK-----KP---LQEVE 126

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
              I   A +GL YLH     ++IHRDI++ N+LL E  + K+ADF     +  +A+  +
Sbjct: 127 IAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG----SASIASPAN 179

Query: 157 STRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPV 200
           S   +GT  + APE  +    GQ   K DV+S G+  +EL   + P+
Sbjct: 180 S--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 5/93 (5%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GL++LH K    I++RD++  N+LL  D   KIADF +  +  +M     +    GT  Y
Sbjct: 108 GLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKE--NMLGDAKTCTFCGTPDY 162

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE  +  +     D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 5/93 (5%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GL++LH K    II+RD++  NV+L  D   KIADF +  +  ++     ++   GT  Y
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKE--NVFGDNRASTFCGTPDY 162

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE     + T   D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 37/97 (38%), Positives = 55/97 (56%), Gaps = 12/97 (12%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN-QAPDMAARLHSTRVLGTF 164
           RGL+Y+H      ++HRD++ SN+L+ E+   KI DF L+  Q P M   + STR     
Sbjct: 119 RGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV-STRY---- 170

Query: 165 GYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPV 200
            Y APE  +T Q    + D++S G +  E+L G KP+
Sbjct: 171 -YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 22/168 (13%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L    G               
Sbjct: 57  SIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--------FTVGQL 108

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL E      +HRD+ + N+L+  +   K++DF LS +  D  A  ++
Sbjct: 109 VGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT-YT 164

Query: 158 TR-----VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           T+     +  T    APE     + T  SDV+SFG+V+ E+++ G +P
Sbjct: 165 TKGGKIPIRWT----APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 14/162 (8%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V V+ +L+HEN+V L           L +E+    +L ++L        A PG +     
Sbjct: 51  VKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLE-------ASPGGLPPDAV 102

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R        + + Y H     +IIHRDI+  N+L+ E    K+ DF  +       A   
Sbjct: 103 R-SYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-P 157

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGR 197
            T  + T  Y APE  +      K  DV++ G ++ ELL G 
Sbjct: 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 59.7 bits (144), Expect = 2e-10
 Identities = 49/182 (26%), Positives = 88/182 (48%), Gaps = 27/182 (14%)

Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR------------K 81
           K    + SRL+H N+V LLG   +     + + + +   LH+ L  R            K
Sbjct: 56  KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115

Query: 82  GVQGA-QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 140
            V+   +P   +  +T++      A G+E+L       ++H+D+ + NVL+F+    KI+
Sbjct: 116 TVKSTLEPADFVHIVTQI------AAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKIS 166

Query: 141 DFNLSNQ--APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GR 197
           D  L  +  A D    + ++  L    + +PE  M G+ +  SD++S+GVVL E+ + G 
Sbjct: 167 DLGLFREVYAADYYKLMGNS--LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 224

Query: 198 KP 199
           +P
Sbjct: 225 QP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 66/239 (27%), Positives = 109/239 (45%), Gaps = 37/239 (15%)

Query: 34  KQLVSVVSRLKHENLVELL-GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL 92
           +Q   ++S+LKH N+V     +  E  L  +   F   G L+  L  +KG +      V+
Sbjct: 47  EQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKG-KLLPENQVV 105

Query: 93  DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN----LSNQA 148
           +W  ++ +A      L+YLHEK    I+HRD+++ NV L      K+ D      L NQ 
Sbjct: 106 EWFVQIAMA------LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156

Query: 149 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
            DMA+ L     +GT  Y +PE         KSDV++ G  + E+ T +   +    +  
Sbjct: 157 -DMASTL-----IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN---AKDM 207

Query: 209 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 267
            SLV     R+ E K+     P +  +Y P    +L  + A  +    E RP++  +++
Sbjct: 208 NSLVY----RIIEGKL-----PPMPKDYSP----ELGELIATMLSKRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.7 bits (144), Expect = 2e-10
 Identities = 53/229 (23%), Positives = 100/229 (43%), Gaps = 23/229 (10%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ +L H N+++ L   +E N   +  E A  G L  ++   K  +   P   + W  
Sbjct: 53  IDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-W-- 109

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
             +  V     +E++H +    ++HRDI+ +NV +      K+ D  L           H
Sbjct: 110 --KYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           S  ++GT  Y +PE         KSD++S G +L E+   + P        + +L +   
Sbjct: 165 S--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLFSLC- 217

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIV 265
                 K++QC  P L  E+  +   KL  + ++C+  + + RP++  V
Sbjct: 218 -----QKIEQCDYPPLPTEHYSE---KLRELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 17/148 (11%)

Query: 63  LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR 122
           L  EF   GS+ D++   KG    +     DW+    I  +  RGL +LH      +IHR
Sbjct: 96  LVMEFCGAGSVTDLVKNTKGNALKE-----DWIAY--ICREILRGLAHLHAH---KVIHR 145

Query: 123 DIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-----L 177
           DI+  NVLL E+ + K+ DF +S Q      R ++   +GT  + APE     +      
Sbjct: 146 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATY 203

Query: 178 TQKSDVYSFGVVLLELLTGRKPVDHTMP 205
             +SD++S G+  +E+  G  P+    P
Sbjct: 204 DYRSDIWSLGITAIEMAEGAPPLCDMHP 231

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 59.3 bits (143), Expect = 3e-10
 Identities = 49/185 (26%), Positives = 84/185 (45%), Gaps = 18/185 (9%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + V+   K+ N+V  L   + G+   +  E+   GSL D++              +D   
Sbjct: 67  ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQ 116

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARL 155
              +  +  + L++LH      +IHRDI+S N+LL  D   K+ DF    Q  P+ + R 
Sbjct: 117 IAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 172

Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 214
             + ++GT  + APE         K D++S G++ +E++ G  P  +  P R    + T 
Sbjct: 173 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 230

Query: 215 ATPRL 219
            TP L
Sbjct: 231 GTPEL 235

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.8 bits (145), Expect = 3e-10
 Identities = 43/120 (35%), Positives = 58/120 (48%), Gaps = 9/120 (7%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN-QAPDMAARLHSTRVLGTF 164
           RGL+YLH      I+HRDI+  N+L+  +   KI DF L+  + PD     H T+ + T 
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQ 168

Query: 165 GYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT--WATPRLSE 221
            Y APE  M  +  T   D++S G +  ELL  R       P  Q  L+T    TP L  
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 131 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 182

Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 59.2 bits (143), Expect = 4e-10
 Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 29/239 (12%)

Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V++ + + ++  LLG C+   ++++  +    G L D +   K   G+Q   +L+W    
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW---- 114

Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
              V  A+G+ YL E+    ++HRD+ + NVL+      KI DF L+          H+ 
Sbjct: 115 --CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169

Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 217
                  + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGE 228

Query: 218 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 276
           RL +               PP     +  +   C   +A+ RP    ++     + + P
Sbjct: 229 RLPQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 59.0 bits (143), Expect = 4e-10
 Identities = 53/195 (27%), Positives = 86/195 (44%), Gaps = 23/195 (11%)

Query: 15  YPSHENERL----KSPKNYPDDEK-----QLVSVVSRLKHENLVELLGYCVEGNLRVLAY 65
           Y S ENE++    K+ KN           Q   ++ +  H ++V+L+G   E  + ++  
Sbjct: 27  YMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIV-M 85

Query: 66  EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 125
           E A +G L   L   K          LD  + +  +   +  L YL  K     +HRDI 
Sbjct: 86  ELAPLGELRSYLQVNKYS--------LDLASLILYSYQLSTALAYLESK---RFVHRDIA 134

Query: 126 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYS 185
           + NVL+      K+ DF LS +  +  +   +++      + APE     + T  SDV+ 
Sbjct: 135 ARNVLVSSPDCVKLGDFGLS-RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWM 193

Query: 186 FGVVLLELLT-GRKP 199
           FGV + E+L  G KP
Sbjct: 194 FGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 58.7 bits (142), Expect = 4e-10
 Identities = 56/240 (23%), Positives = 99/240 (41%), Gaps = 31/240 (12%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  EF   G+L   L    G        V+  +  
Sbjct: 57  SIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG-----QFTVIQLVGM 111

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +R     A G++YL E    + +HRD+ + N+L+  +   K++DF LS    D  +    
Sbjct: 112 LR---GIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 165

Query: 158 TRVLG---TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 213
           T  LG      + APE     + T  SDV+S+G+V+ E+++ G +P              
Sbjct: 166 TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY------------- 212

Query: 214 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 273
           W    +S   V   ++   +   P      L  +   C Q +   RP    +V  L  ++
Sbjct: 213 W---DMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 4e-10
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 18/162 (11%)

Query: 43  LKHENLVELLGYCVEGNLRV--LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI 100
           LKHEN+V L+   +E   +   L +++A       I   R+  + + P  ++       +
Sbjct: 59  LKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK-----SL 113

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLL----FEDFKAKIADFNLSN--QAPDMAAR 154
                 G+ YLH      ++HRD++ +N+L+     E    KI D  L+    AP +   
Sbjct: 114 LWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP-LKPL 169

Query: 155 LHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLT 195
                V+ T  Y APE  +  +  T+  D+++ G +  ELLT
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 59.0 bits (143), Expect = 4e-10
 Identities = 39/118 (33%), Positives = 55/118 (46%), Gaps = 9/118 (7%)

Query: 97  RVRIAV-DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAAR 154
            VR+ + +    L++LH   Q  II+RDI+  N+LL  +    + DF LS +   +   R
Sbjct: 106 EVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER 162

Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS--DVYSFGVVLLELLTGRKPVDHTMPRGQQS 210
            +S    GT  Y APE    G        D +S GV+  ELLTG  P      +  QS
Sbjct: 163 AYS--FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 58.9 bits (142), Expect = 4e-10
 Identities = 50/190 (26%), Positives = 89/190 (46%), Gaps = 24/190 (12%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-HGRKGVQGAQPGPVLDWM 95
           V ++    HEN+V++    + G+   +  EF   G+L DI+ H R              M
Sbjct: 70  VVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--------------M 115

Query: 96  TRVRIA---VDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
              +IA   +   R L YLH +    +IHRDI+S ++LL  D + K++DF    Q     
Sbjct: 116 NEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172

Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSL 211
            +  S  ++GT  + APE         + D++S G++++E++ G  P  +  P +  + +
Sbjct: 173 PKRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230

Query: 212 VTWATPRLSE 221
                PR+ +
Sbjct: 231 RDNLPPRVKD 240

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 58.4 bits (141), Expect = 5e-10
 Identities = 52/168 (30%), Positives = 78/168 (46%), Gaps = 15/168 (8%)

Query: 43  LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 102
           L+H NL++ LG C E    +L  EF  +G L   L   +  +   P P     T  R+A 
Sbjct: 52  LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDP----TTLQRMAC 107

Query: 103 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLG 162
           + A GL +LH+    + IH D+   N LL  D   KI D+ LS+        +   ++  
Sbjct: 108 EIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV 164

Query: 163 TFGYHAPEYA--MTGQL-----TQKSDVYSFGVVLLELLT-GRKPVDH 202
              + APE    + G L     T++S+V+S GV + EL   G +P  H
Sbjct: 165 PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 58.5 bits (141), Expect = 6e-10
 Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 23/168 (13%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V  + +L+H N ++  G  +  +   L  E+  +GS  D+L   K     +P   L  + 
Sbjct: 66  VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHK-----KP---LQEVE 116

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF-NLSNQAPDMAARL 155
              +   A +GL YLH     ++IHRD+++ N+LL E    K+ DF + S  AP      
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167

Query: 156 HSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPV 200
            +   +GT  + APE  +    GQ   K DV+S G+  +EL   + P+
Sbjct: 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 58.5 bits (142), Expect = 7e-10
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 9/99 (9%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAARLHSTRVLG 162
           RGL+Y+H     ++IHRD++ SN+L+ ED + +I DF ++     +P        T  + 
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY-FMTEYVA 173

Query: 163 TFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPV 200
           T  Y APE  ++  + T   D++S G +  E+L GR+ +
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 57.9 bits (140), Expect = 8e-10
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)

Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 167
           L YLH++ +  I+HRD+  +N++L ED K  I DF L+ Q    +     T V+GT  Y 
Sbjct: 126 LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYS 180

Query: 168 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            PE        +K+DV++FG +L ++ T + P
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 58.5 bits (141), Expect = 8e-10
 Identities = 36/93 (38%), Positives = 51/93 (54%), Gaps = 9/93 (9%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SNV + ED + +I DF L+ QA D       T  + T  
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRW 180

Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELL G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 58.7 bits (142), Expect = 9e-10
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 11/98 (11%)

Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG-- 165
           + ++H K    +IHRDI+S+N+LL  +   K+ DF  S     M A   S  V  TF   
Sbjct: 156 VHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSK----MYAATVSDDVGRTFCGT 208

Query: 166 --YHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
             Y APE       ++K+D++S GV+L ELLT ++P D
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 21/102 (20%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS-------- 157
           RGL+Y+H     +++HRD++ SN+LL  +   KI DF L        AR+          
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL--------ARIADPEHDHTGF 165

Query: 158 -TRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGR 197
            T  + T  Y APE  +  +   K+ D++S G +L E+L+ R
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 37/103 (35%), Positives = 51/103 (49%), Gaps = 9/103 (8%)

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL--SNQAPDMAARLHST 158
           A + A GL +LH K    II+RD++  NV+L  +   KIADF +   N       R    
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR---- 159

Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              GT  Y APE        +  D ++FGV+L E+L G+ P D
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 52/172 (30%), Positives = 74/172 (43%), Gaps = 22/172 (12%)

Query: 45  HENLVELLG------YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           H N+V+  G        V G L  L  E    GS+ +++ G         G  LD     
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGL-----LICGQRLDEAMIS 131

Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
            I   A  GL++LH      IIHRD++ +N+LL  +   K+ DF +S Q    + RL   
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRN 186

Query: 159 RVLGTFGYHAPEYAMTGQLTQKS-----DVYSFGVVLLELLTGRKPVDHTMP 205
             +GT  + APE     Q    S     DV+S G+  +EL  G  P+    P
Sbjct: 187 TSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 38/99 (38%), Positives = 57/99 (57%), Gaps = 9/99 (9%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS---NQAPDMAARLHSTRVLG 162
            GL+Y+H     +++HRD++  N+L+  D + KI DF L+   ++ P   A    T  + 
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG-FMTEYVA 171

Query: 163 TFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKPV 200
           T  Y APE  ++ Q   K+ DV+S G +L ELL GRKPV
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 57.2 bits (139), Expect = 2e-09
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 5/94 (5%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+YLH     ++IHRD++ SN+L+  +   KI DF L+    PD   +   T  + T 
Sbjct: 114 RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170

Query: 165 GYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGR 197
            Y APE  ++    T+  D++S G +  ELLT +
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 56.2 bits (135), Expect = 3e-09
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 22/164 (13%)

Query: 37  VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDI-LHGRKGVQGAQPGPVLDW 94
           + +++   H  +V+LLG +  +G L ++  EF   G++  I L   +G+   Q   +   
Sbjct: 60  IEILATCNHPYIVKLLGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M            L+YLH      IIHRD+++ NVLL  D   K+ADF +S +      R
Sbjct: 119 MLE---------ALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166

Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLEL 193
             S   +GT  + APE  M   +       K+D++S G+ L+E+
Sbjct: 167 RDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.6 bits (134), Expect = 4e-09
 Identities = 67/251 (26%), Positives = 112/251 (44%), Gaps = 35/251 (13%)

Query: 24  KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 83
           KS +NY +   +  S++S+L H++LV   G CV G+  ++  E+   GSL   L   K  
Sbjct: 37  KSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN- 95

Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF--EDFKAKIAD 141
                  +++   ++ +A   A  L +L +K    + H ++ + NVLL   ED K     
Sbjct: 96  -------LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPP 145

Query: 142 F-NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTG-RK 198
           F  LS+    +   L    +L    +  PE     Q L+  +D +SFG  L E+ +G  K
Sbjct: 146 FIKLSDPGISITV-LPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDK 204

Query: 199 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEF 258
           P+       Q+ L      +  ED+  Q   PK           +LA +   C+ YE +F
Sbjct: 205 PLSALDS--QKKL------QFYEDR-HQLPAPKW---------TELANLINQCMDYEPDF 246

Query: 259 RPNMSIVVKAL 269
           RP+   +++ L
Sbjct: 247 RPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.1 bits (135), Expect = 4e-09
 Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 12/101 (11%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           +GL+Y+H      IIHRD++  N+ + ED + KI DF L+ Q          TR      
Sbjct: 129 KGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180

Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR---KPVDH 202
           Y APE  +     TQ  D++S G ++ E+LTG+   K  DH
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.9 bits (135), Expect = 4e-09
 Identities = 35/136 (25%), Positives = 63/136 (46%), Gaps = 8/136 (5%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLSN-QAPDMAARLHSTRVLGT 163
           RGL+Y+H     +++HRD++ +NV +  ED   KI DF L+    P  + + + +  L T
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 164 FGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATPRLS 220
             Y +P   ++    T+  D+++ G +  E+LTG+      H + + Q  L +    R  
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241

Query: 221 EDKVKQCVDPKLKGEY 236
           +      V P      
Sbjct: 242 DRNELLNVIPSFVRND 257

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.8 bits (135), Expect = 5e-09
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 13/99 (13%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL---SNQAPDMAARLHSTRVLG 162
           RGL+Y+H     +++HRD++ SN+LL  +   KI DF L   +++  D       TR   
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR--- 172

Query: 163 TFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPV 200
              Y APE  +   + T   DV+S G +  ELL GRKP+
Sbjct: 173 --WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 55.3 bits (133), Expect = 6e-09
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 17/164 (10%)

Query: 45  HENLVELLGYCV----EGNLRV--LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           H N+++L+G  +    +G L +  +   F   G LH  L   +   G +P   L   T V
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR--IGEEPF-TLPLQTLV 116

Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ--APDMAARLH 156
           R  +D A G+EYL  K   + IHRD+ + N +L E+    +ADF LS +  + D   +  
Sbjct: 117 RFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           ++++     + A E       T  SDV++FGV + E++T G+ P
Sbjct: 174 ASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 55.0 bits (132), Expect = 7e-09
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 26/166 (15%)

Query: 37  VSVVSRLKHENLVELL-GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
           + +++   H N+V+LL  +  E NL +L  EF   G++  ++     ++  +P      +
Sbjct: 53  IDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVM-----LELERP------L 100

Query: 96  TRVRIAVDAARGLE---YLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
           T  +I V   + LE   YLHE     IIHRD+++ N+L   D   K+ADF +S +     
Sbjct: 101 TEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157

Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLEL 193
            R  S   +GT  + APE  M           K+DV+S G+ L+E+
Sbjct: 158 QRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 55.0 bits (132), Expect = 8e-09
 Identities = 53/229 (23%), Positives = 98/229 (42%), Gaps = 23/229 (10%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ +L H N+++     +E N   +  E A  G L  ++   K  +   P   + W  
Sbjct: 53  IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-W-- 109

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
             +  V     LE++H +    ++HRDI+ +NV +      K+ D  L           H
Sbjct: 110 --KYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           S  ++GT  Y +PE         KSD++S G +L E+   + P  +       SL     
Sbjct: 165 S--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCK--- 218

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIV 265
                 K++QC  P L  ++  + + +L     +C+  + E RP+++ V
Sbjct: 219 ------KIEQCDYPPLPSDHYSEELRQL---VNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 55.4 bits (133), Expect = 8e-09
 Identities = 34/106 (32%), Positives = 51/106 (48%), Gaps = 3/106 (2%)

Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
           P L +M  V  +   A G+E+L  K   + +HRD+ + NVL+ E    KI DF L+    
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIM 290

Query: 150 DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
             +  +          + APE       T  SDV+SFG++L E+ T
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 55.2 bits (133), Expect = 9e-09
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 17/98 (17%)

Query: 105 ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMA----ARLHS 157
           ARG+E+L  +     IHRD+ + N+LL E+   KI DF L+    + PD      ARL  
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 237

Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
                   + APE       T +SDV+SFGV+L E+ +
Sbjct: 238 -----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 55.0 bits (132), Expect = 9e-09
 Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 25/168 (14%)

Query: 37  VSVVSRLKHENLVELL-GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
           V ++   +H+N+VE+   Y V   L VL  EF   G+L DI+   +             +
Sbjct: 69  VVIMRDYQHQNVVEMYKSYLVGEELWVLM-EFLQGGALTDIVSQTR-------------L 114

Query: 96  TRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDM 151
              +IA       + L YLH +    +IHRDI+S ++LL  D + K++DF    Q + D+
Sbjct: 115 NEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171

Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             R     ++GT  + APE         + D++S G++++E++ G  P
Sbjct: 172 PKR---KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.0 bits (132), Expect = 9e-09
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 33/203 (16%)

Query: 84  QGAQPGPVLD--WMTRVRI------AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 135
               P    D  W + + +      +   ARG+E+L  +     IHRD+ + N+LL E+ 
Sbjct: 155 GSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENN 211

Query: 136 KAKIADFNLSN---QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLE 192
             KI DF L+    + PD   R  S R+     + APE       T +SDV+SFGV+L E
Sbjct: 212 VVKICDFGLARDIYKDPDY-VRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWE 268

Query: 193 LLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALC 251
           + + G  P              +   +++E+  ++  D   +   P     ++  +   C
Sbjct: 269 IFSLGASP--------------YPGVQINEEFCQRLKD-GTRMRAPENATPEIYRIMLAC 313

Query: 252 VQYEAEFRPNMSIVVKALQPLLK 274
            Q + + RP  S +V+ L  LL+
Sbjct: 314 WQGDPKERPTFSALVEILGDLLQ 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 55.0 bits (132), Expect = 9e-09
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 5/101 (4%)

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A + + GL +LH +    II+RD++  NV+L  +   KIADF +  +   M   + +   
Sbjct: 107 AAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--HMVDGVTTRTF 161

Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            GT  Y APE        +  D +++GV+L E+L G+ P D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 55.4 bits (133), Expect = 9e-09
 Identities = 29/81 (35%), Positives = 47/81 (58%)

Query: 119 IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT 178
           ++HRD++S+N+ L      K+ DF  S Q  D  +   ++   GT  Y APE     + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249

Query: 179 QKSDVYSFGVVLLELLTGRKP 199
           +K+D++S GV+L ELLT  +P
Sbjct: 250 KKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 14/167 (8%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S++  L+H N+V L    ++ +   L +EF +M    D+   +K +     G  +D   
Sbjct: 50  ISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM----DL---KKYLDSLPKGQYMDAEL 102

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                    +G+ + H +    ++HRD++  N+L+      K+ADF L+ +A  +  R++
Sbjct: 103 VKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA-RAFGIPVRVY 158

Query: 157 STRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDH 202
           +  V+ T  Y APE  +     +   D++S G +  E+ T +KP+ H
Sbjct: 159 THEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFH 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 33/210 (15%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
            L + +  P    + +S++  LKHEN+V L       N  +L +E+     L   +    
Sbjct: 34  HLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTH- 91

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
           GV+GA     LD  T         +G+ + HE     ++HRD++  N+L+ +  + K+AD
Sbjct: 92  GVRGA-----LDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLAD 143

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGR--- 197
           F L+ +A  +     S  V+ T  Y AP+  +  +    S D++S G ++ E++TGR   
Sbjct: 144 FGLA-RAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201

Query: 198 -----------------KPVDHTMPRGQQS 210
                             P + T P   Q 
Sbjct: 202 PGTNNEDQLLKIFRIMGTPTESTWPGISQL 231

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GL Y H+K   + +HRDI+ SN+LL    + K+ADF L+       +R ++ +V+ T  Y
Sbjct: 128 GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWY 183

Query: 167 HAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKPV 200
             PE  +  +    + DV+S G +L EL T +KP+
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 24/173 (13%)

Query: 45  HENLVELLGY-----CVEGNLRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLDWMTR 97
           H N+V+  G         G+   L  E    GS+ D++ G  ++G +  +P         
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP-------II 126

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
             I  +A  GL++LH       IHRD++ +N+LL  +   K+ DF +S Q    + RL  
Sbjct: 127 AYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRR 181

Query: 158 TRVLGTFGYHAPEY-AMTGQL----TQKSDVYSFGVVLLELLTGRKPVDHTMP 205
              +GT  + APE  A   QL      + DV+S G+  +EL  G  P+    P
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.0 bits (130), Expect = 1e-08
 Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 38/241 (15%)

Query: 35  QLVSVVSRLKHENLVELLGYCV-EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           +  S++S+L H++LV+L G CV + N+ V   E+   G L   LH  K          L 
Sbjct: 50  ETASLMSQLSHKHLVKLYGVCVRDENIMVE--EYVKFGPLDVFLHREKN------NVSLH 101

Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL--FEDFKAKIADFNLSNQAPDM 151
           W   V  A   A  L YL +K    ++H ++   N+L+  +   +  +    LS+    +
Sbjct: 102 WKLDV--AKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156

Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQ--LTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQ 208
                  RV     + APE    GQ  LT  +D +SFG  LLE+ + G +P+        
Sbjct: 157 TVLSREERVERI-PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL-------- 207

Query: 209 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 268
                 +T   SE +       + +   P    A+LA +   C  Y+   RP+   +++ 
Sbjct: 208 ------STLSSSEKERFY----QDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRD 257

Query: 269 L 269
           L
Sbjct: 258 L 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 43/136 (31%), Positives = 61/136 (44%), Gaps = 19/136 (13%)

Query: 66  EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIA--VDAARGLEYLHEKVQPSIIHRD 123
           E+   G L  IL  R        G   ++  R  IA  V A    EYLH +    II+RD
Sbjct: 73  EYCLGGELWTILRDR--------GLFDEYTARFYIACVVLA---FEYLHNR---GIIYRD 118

Query: 124 IRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDV 183
           ++  N+LL  +   K+ DF  + +      +  +    GT  Y APE  +        D 
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAKKLKS-GQKTWT--FCGTPEYVAPEIILNKGYDFSVDY 175

Query: 184 YSFGVVLLELLTGRKP 199
           +S G++L ELLTGR P
Sbjct: 176 WSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 17/162 (10%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ +L+HENLV L+          L +EF     L D+     G         LD   
Sbjct: 51  IRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---------LDESR 101

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
             +      RG+E+ H     +IIHRDI+  N+L+ +    K+ DF     A  +AA   
Sbjct: 102 VRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF---ARTLAAPGE 155

Query: 157 S-TRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTG 196
             T  + T  Y APE  +      ++ D+++ G ++ E+LTG
Sbjct: 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 53.8 bits (129), Expect = 2e-08
 Identities = 43/166 (25%), Positives = 77/166 (46%), Gaps = 17/166 (10%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L    G            +  
Sbjct: 57  SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--------FTVIQL 108

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +      +HRD+ + N+L+  +   K++DF LS    D     ++
Sbjct: 109 VGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165

Query: 158 TRVLG---TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           TR  G      + APE     + T  SDV+S+G+V+ E+++ G +P
Sbjct: 166 TR--GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 53.7 bits (129), Expect = 3e-08
 Identities = 39/110 (35%), Positives = 51/110 (46%), Gaps = 22/110 (20%)

Query: 103 DAAR----GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS---NQAPDMAARL 155
           D AR    G+ YLH +    I+HRDI+ SN+L+      KIADF +S    Q  D     
Sbjct: 172 DVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC--- 225

Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQ------KSDVYSFGVVLLELLTGRKP 199
                +GT  Y +PE   T  L          D++S GV +LE   GR P
Sbjct: 226 --NSSVGTIAYMSPERINT-DLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 53.5 bits (128), Expect = 3e-08
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 5/101 (4%)

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A + A GL +LH K    II+RD++  NV+L  +   KIADF +  +  +M   + +   
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTF 161

Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            GT  Y APE        +  D ++FGV+L E+L G+ P +
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 53.3 bits (128), Expect = 3e-08
 Identities = 33/94 (35%), Positives = 48/94 (51%), Gaps = 7/94 (7%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR-VLGTFG 165
           GLE+LH   Q  II+RD++  NVLL  D   +I+D  L   A ++      T+   GT G
Sbjct: 109 GLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGL---AVELKDGQSKTKGYAGTPG 162

Query: 166 YHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           + APE     +     D ++ GV L E++  R P
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 52.8 bits (127), Expect = 4e-08
 Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 31/167 (18%)

Query: 43  LKHENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIA 101
           L H+N++ +L  C+E G    + Y +   G+L   L   +    A     L     V +A
Sbjct: 65  LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLG-EANNPQALSTQQLVHMA 123

Query: 102 VDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL 161
           +  A G+ YLH++    +IH+DI + N ++ E+ + KI D  LS             R L
Sbjct: 124 IQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALS-------------RDL 167

Query: 162 GTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT 195
               YH             A E  +  + +  SDV+SFGV+L EL+T
Sbjct: 168 FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 52.7 bits (126), Expect = 4e-08
 Identities = 54/242 (22%), Positives = 101/242 (41%), Gaps = 37/242 (15%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   G+L   L    G               
Sbjct: 58  SIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE--------FSSYQL 109

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +    + +HRD+ + N+L+  + + K++DF LS    D     ++
Sbjct: 110 VGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT 166

Query: 158 TRVLGTFG-----YHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSL 211
           T    + G     + APE     + T  SDV+SFG+V+ E+++ G +P            
Sbjct: 167 T----SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY----------- 211

Query: 212 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 271
             W    +S  +V + ++   +   P    + +  +   C Q +   RP    +V  L  
Sbjct: 212 --W---DMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266

Query: 272 LL 273
           LL
Sbjct: 267 LL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 53.0 bits (128), Expect = 4e-08
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 7/96 (7%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
            G+ +LH+     I+HRD+++SN+LL      KI DF L+ +          T+++ T  
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLW 171

Query: 166 YHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPV 200
           Y APE  +   + +   D++S G +  ELLT +KP+
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.2 bits (128), Expect = 4e-08
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 6/95 (6%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           R L+Y+H     ++ HRD++  N+L   D K KI DF L+  A  D    +  T  + T 
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 165 GYHAPEY--AMTGQLTQKSDVYSFGVVLLELLTGR 197
            Y APE   +   + T   D++S G +  E+LTG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 52.7 bits (126), Expect = 5e-08
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 8/100 (8%)

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A +   GLE++H +    +++RD++ +N+LL E    +I+D  L   A D + +     V
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL---ACDFSKKKPHASV 156

Query: 161 LGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKP 199
            GT GY APE    G     S D +S G +L +LL G  P
Sbjct: 157 -GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 52.7 bits (126), Expect = 5e-08
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 6/93 (6%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GLE LH   Q  I++RD++  N+LL +    +I+D  L+   P+   +    RV GT GY
Sbjct: 114 GLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGY 167

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE     + T   D ++ G +L E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 52.4 bits (125), Expect = 5e-08
 Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 15/166 (9%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           + ++  L+HE +V+  G   +   + L    E+   GS+ D L           G + + 
Sbjct: 55  IQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY--------GALTES 106

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           +TR +       G+ YLH  +   I+HRDI+ +N+L       K+ DF  S +   +   
Sbjct: 107 VTR-KYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162

Query: 155 LHSTR-VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
               R V GT  + +PE        +K+DV+S G  ++E+LT + P
Sbjct: 163 GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 52.3 bits (125), Expect = 6e-08
 Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 6/93 (6%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GLE LH   + + ++RD++  N+LL +    +I+D  L+ + P+        RV GT GY
Sbjct: 114 GLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGRV-GTVGY 167

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE     + T   D +  G ++ E++ G+ P
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 51.9 bits (124), Expect = 8e-08
 Identities = 47/186 (25%), Positives = 78/186 (41%), Gaps = 28/186 (15%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GLE++H +    +++RD++ +N+LL E    +I+D  L   A D + +     V GT GY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL---ACDFSKKKPHASV-GTHGY 161

Query: 167 HAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK 225
            APE    G     S D +S G +L +LL G  P      R  ++       +   D++ 
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF-----RQHKT-----KDKHEIDRMT 211

Query: 226 QCVDPKLKGEYPPKGVAKLAAVAALCVQ----------YEAEFRPNMSIVVKALQPLLKS 275
             +  +L   + P+  + L  +    V            E +  P    +   +  L K 
Sbjct: 212 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKY 271

Query: 276 PPPAAP 281
           PPP  P
Sbjct: 272 PPPLIP 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 50/190 (26%), Positives = 86/190 (45%), Gaps = 41/190 (21%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
           RL+  +  P    + VS++  LKH N+V                      +LHDI+H  +
Sbjct: 39  RLEHEEGAPCTAIREVSLLKNLKHANIV----------------------TLHDIIHTER 76

Query: 82  GV------------QGAQPGPVLDWMTRVRIAV-DAARGLEYLHEKVQPSIIHRDIRSSN 128
            +            Q       L  M  V+I +    RGL Y H++    I+HRD++  N
Sbjct: 77  CLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQN 133

Query: 129 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFG 187
           +L+ E  + K+ADF L+ +A  +  + +S  V+ T  Y  P+  + + + +   D++  G
Sbjct: 134 LLINEKGELKLADFGLA-RAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPIDMWGVG 191

Query: 188 VVLLELLTGR 197
            +L E+ TGR
Sbjct: 192 CILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 8/98 (8%)

Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 167
           L YLH      +++RD++  N++L +D   KI DF L  +     A + +    GT  Y 
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 162

Query: 168 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV---DH 202
           APE        +  D +  GVV+ E++ GR P    DH
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 29/109 (26%), Positives = 51/109 (46%), Gaps = 19/109 (17%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLL-------FEDFKAKIA-----DFNLSNQAPDMAAR 154
            +EY+H K    ++HRD++  N+LL         D+ A I      +  L     +    
Sbjct: 125 TIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 155 LHST----RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             S     +++GT  Y APE  +    ++ +D+Y+ GV+L ++LT   P
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 51.1 bits (122), Expect = 1e-07
 Identities = 47/185 (25%), Positives = 77/185 (41%), Gaps = 22/185 (11%)

Query: 19  ENERLKSPKNYPDDE---------KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFAT 69
             ERLK  K  P  E          Q   ++S+L H  +V+     +E +   +  E+  
Sbjct: 26  AEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCE 85

Query: 70  MGSLHDILHGRKGVQGAQPGP-VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 128
              L   L   K          V +W  ++ + V       Y+H++    I+HRD+++ N
Sbjct: 86  GRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH------YMHQR---RILHRDLKAKN 136

Query: 129 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGV 188
           + L  +   KI DF +S     M +   +T   GT  Y +PE         KSD++S G 
Sbjct: 137 IFLKNNL-LKIGDFGVSRLL--MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGC 193

Query: 189 VLLEL 193
           +L E+
Sbjct: 194 ILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 47/180 (26%), Positives = 77/180 (42%), Gaps = 42/180 (23%)

Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLDWMT 96
           +++ +KHEN++ L+   VEG       +F  +  + DI+    +K         V+D   
Sbjct: 73  IMNEIKHENIMGLVDVYVEG-------DFINL--VMDIMASDLKK---------VVDRKI 114

Query: 97  RVR------IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS----- 145
           R+       I +    GL  LH+      +HRD+  +N+ +      KIADF L+     
Sbjct: 115 RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGY 171

Query: 146 -------NQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGR 197
                  ++   M  R   T  + T  Y APE  M   +     D++S G +  ELLTG+
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 13/164 (7%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
              + +  H N+V L G    GN  ++  E+ + G+L   L   +G   A  G ++  + 
Sbjct: 57  ALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVA--GQLMGMLP 114

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            +      A G++YL E      +H+ + +  VL+  D   KI+ F    Q     A   
Sbjct: 115 GL------ASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFR-RLQEDKSEAIYT 164

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           +        + APE       +  SDV+SFG+V+ E+++ G +P
Sbjct: 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 46/146 (31%), Positives = 71/146 (48%), Gaps = 28/146 (19%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
            GL+Y+H      IIHRD++  N+ + ED + KI DF L+  A  +M      T  + T 
Sbjct: 128 CGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM------TGYVVTR 178

Query: 165 GYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDK 223
            Y APE  +      Q  D++S G ++ E+LTG+     T+ +G+  L          D+
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK-----TLFKGKDYL----------DQ 223

Query: 224 VKQCVDPKLKGEYPPKGVAKLAAVAA 249
           + Q +  K+ G   P+ V KL   AA
Sbjct: 224 LTQIL--KVTGVPGPEFVQKLEDKAA 247

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 39/116 (33%), Positives = 58/116 (50%), Gaps = 18/116 (15%)

Query: 92  LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL------- 144
           LD    +R +   A+G+++L  K   + IHRD+ + NVLL +   AKI DF L       
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265

Query: 145 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           SN      ARL          + APE       T +SDV+S+G++L E+ + G+ P
Sbjct: 266 SNYVVKGNARL-------PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 43/149 (28%), Positives = 66/149 (44%), Gaps = 20/149 (13%)

Query: 60  LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI-AVDAAR--------GLEY 110
           L  L Y F T   L  ++    G      G +   ++R R+   + AR         LEY
Sbjct: 57  LTALKYAFQTHDRLCFVMEYANG------GELFFHLSRERVFTEERARFYGAEIVSALEY 110

Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH +    +++RDI+  N++L +D   KI DF L  +     A + +    GT  Y APE
Sbjct: 111 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 165

Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                   +  D +  GVV+ E++ GR P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 37/103 (35%), Positives = 53/103 (51%), Gaps = 18/103 (17%)

Query: 105 ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMA----ARLHS 157
           A+G+E+L  +     IHRD+ + N+LL E+   KI DF L+    + PD      ARL  
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243

Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
                   + APE       T +SDV+SFGV+L E+ + G  P
Sbjct: 244 -----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 31/91 (34%), Positives = 44/91 (48%), Gaps = 8/91 (8%)

Query: 109 EYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHA 168
           EYLH K    II+RD++  N+LL      K+ DF  + + PD    L      GT  Y A
Sbjct: 132 EYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL-----CGTPEYLA 183

Query: 169 PEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           PE   +    +  D ++ GV+L E + G  P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 50.0 bits (119), Expect = 3e-07
 Identities = 45/168 (26%), Positives = 76/168 (45%), Gaps = 19/168 (11%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           + ++  L HE +V+  G   +   R L+   E    GS+ D L           G + + 
Sbjct: 55  IQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--------GALTEN 106

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           +TR +       G+ YLH  +   I+HRDI+ +N+L       K+ DF  S +   +   
Sbjct: 107 VTR-KYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC-- 160

Query: 155 LHST---RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           L  T    V GT  + +PE        +K+D++S G  ++E+LT + P
Sbjct: 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.0 bits (119), Expect = 4e-07
 Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 5/101 (4%)

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A +    L +LHE+    II+RD++  NVLL  D   K+ D+ +  +   +     ++  
Sbjct: 102 AAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG--LGPGDTTSTF 156

Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            GT  Y APE     +     D ++ GV++ E++ GR P D
Sbjct: 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 19/102 (18%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL---------SNQAPDMAARLH 156
           + L+Y+H     ++IHRD++ SN+LL  D + K+ADF L         + + P +     
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL----- 169

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGR 197
            T  + T  Y APE  +      K  D++S G +L E+L G+
Sbjct: 170 -TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 49.7 bits (118), Expect = 5e-07
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 5/93 (5%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            L+YLH      I++RD++  N++L +D   KI DF L  +    AA + +    GT  Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEY 161

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE        +  D +  GVV+ E++ GR P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 49.6 bits (119), Expect = 5e-07
 Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 13/101 (12%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL---------SNQAPDMAARLHS 157
           G+ YLHE     I+HRDI+++N+L+      KIADF L         + +          
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183

Query: 158 TRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGR 197
           T ++ T  Y  PE  +   + T   D++  G V  E+ T R
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 35/96 (36%), Positives = 48/96 (50%), Gaps = 8/96 (8%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARLHSTRVLGTFG 165
            LE+LH   +  II+RDI+  N+LL  +    + DF LS +   D   R +S    GT  
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS--FCGTIE 171

Query: 166 YHAPEYAMTGQLTQKS--DVYSFGVVLLELLTGRKP 199
           Y AP+    G        D +S GV++ ELLTG  P
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 49.9 bits (119), Expect = 6e-07
 Identities = 29/89 (32%), Positives = 46/89 (51%), Gaps = 6/89 (6%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
            GL YLH      IIHRD+++ N+ + +  +  I D   + Q P +A       + GT  
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAA-QFPVVAPAFLG--LAGTVE 221

Query: 166 YHAPEYAMTGQLTQKSDVYSFGVVLLELL 194
            +APE     +   K+D++S G+VL E+L
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 21/101 (20%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS-----TRV 160
           RG+++LH      I+HRD++  N+L+  D + KIADF L        AR++S     T V
Sbjct: 118 RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL--------ARIYSFEMALTSV 166

Query: 161 LGTFGYHAPEYAMTGQLTQKS--DVYSFGVVLLELLTGRKP 199
           + T  Y APE  +  Q +  +  D++S G +  EL   R+P
Sbjct: 167 VVTLWYRAPEVLL--QSSYATPVDMWSVGCIFAELFR-RRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 6/93 (6%)

Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 167
           LE+LH+     I++RD++  N+LL       + DF LS    ++     +    GT  Y 
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163

Query: 168 APEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKP 199
           APE  +  +  T+  D +S GV++ E+  G  P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 49.4 bits (118), Expect = 7e-07
 Identities = 40/141 (28%), Positives = 66/141 (46%), Gaps = 10/141 (7%)

Query: 63  LAYEFATMGSLHDILHGRKG----VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS 118
           L Y F T G L+ IL    G    +   + G  ++      ++ + +  LE+LH++    
Sbjct: 65  LIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-EISLALEHLHQQ---G 120

Query: 119 IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT 178
           II+RD++  N+LL      K+ DF L  ++       H+    GT  Y APE  M     
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYMAPEILMRSGHG 178

Query: 179 QKSDVYSFGVVLLELLTGRKP 199
           +  D +S G ++ ++LTG  P
Sbjct: 179 KAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 49.2 bits (117), Expect = 7e-07
 Identities = 35/120 (29%), Positives = 57/120 (47%), Gaps = 11/120 (9%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+ +LH      I++RD++  NVLL +    +++D  L+ +  D       T+  GT GY
Sbjct: 107 GILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGY 160

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV-DHTMPRGQQSLVTWATPRLSEDKVK 225
            APE       +   D ++ G  + E++ GR P  DH     ++ L      R  ED+VK
Sbjct: 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR----RTLEDEVK 216

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 49.2 bits (117), Expect = 8e-07
 Identities = 47/191 (24%), Positives = 86/191 (45%), Gaps = 43/191 (22%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
           RL+  +  P    + VS++  LKH N+V                      +LHDI+H  K
Sbjct: 40  RLEHEEGAPCTAIREVSLLKDLKHANIV----------------------TLHDIVHTDK 77

Query: 82  GVQGA-------------QPGPVLDWMTRVRIAV-DAARGLEYLHEKVQPSIIHRDIRSS 127
            +                  G ++  M  V+I +    RGL Y H +    ++HRD++  
Sbjct: 78  SLTLVFEYLDKDLKQYMDDCGNIMS-MHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQ 133

Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSF 186
           N+L+ E  + K+ADF L+ +A  +  + +S  V+ T  Y  P+  + + + + + D++  
Sbjct: 134 NLLINERGELKLADFGLA-RAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQIDMWGV 191

Query: 187 GVVLLELLTGR 197
           G +  E+ +GR
Sbjct: 192 GCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 17/100 (17%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS-----TRV 160
           RGL++LH      I+HRD++  N+L+    + K+ADF L        AR++S     T V
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL--------ARIYSCQMALTPV 167

Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
           + T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 19/161 (11%)

Query: 43  LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 102
           L+H N+++ LG CVE    +L +E+  +G L   L   +  +          +   R+A 
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNS-----QLLLLQRMAC 106

Query: 103 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL--SNQAPDMAARLHSTRV 160
           + A G+ ++H+    + +H D+   N  L  D   K+ D+ +  S    D          
Sbjct: 107 EIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET--EDDK 161

Query: 161 LGTFGYHAPEYA-------MTGQLTQKSDVYSFGVVLLELL 194
                + APE         +T + T+ S+V++ GV L EL 
Sbjct: 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 33/126 (26%), Positives = 46/126 (36%), Gaps = 36/126 (28%)

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS--------------- 145
           A+D+   L +         IHRDI+  N+L+  D   K+ADF L                
Sbjct: 113 ALDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLND 163

Query: 146 -NQAPDMAARLHSTR-----------VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 193
            +        L   R            +GT  Y APE         + D +S GV+L E+
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223

Query: 194 LTGRKP 199
           L G  P
Sbjct: 224 LYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 71/270 (26%), Positives = 105/270 (38%), Gaps = 60/270 (22%)

Query: 60  LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAAR--------GLEYL 111
           L  L Y F T   LH IL     V G +    L    R   + D  R         LE+L
Sbjct: 67  LVTLHYAFQTEAKLHLIL---DYVSGGEMFTHL--YQRDNFSEDEVRFYSGEIILALEHL 121

Query: 112 HEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARLHSTRVLGTFGYHAPE 170
           H   +  I++RDI+  N+LL  +    + DF LS +   +   R +S    GT  Y APE
Sbjct: 122 H---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIEYMAPE 176

Query: 171 Y--AMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR---------- 218
                 G   +  D +S G+++ ELLTG  P      R  QS V+    +          
Sbjct: 177 IIRGKGGH-GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIG 235

Query: 219 -LSEDKVKQ--CVDPKLKGEYPPKGVAKL-----------AAVAALCVQYEAEFRP---- 260
             ++D + +    DPK +    P+G +++            A+A   V     FRP    
Sbjct: 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVN--PPFRPSIRN 293

Query: 261 -----NMSIVVKALQPLLK---SPPPAAPV 282
                N +     L+P+     +PP  A V
Sbjct: 294 ELDVGNFAEEFTNLEPVYSPAGTPPSGARV 323

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 5/101 (4%)

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A +    L +LH+K    II+RD++  NVLL  +   K+ADF +  +   +     ++  
Sbjct: 102 AAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG--IFNGKTTSTF 156

Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            GT  Y APE           D ++ GV+L E+L G  P +
Sbjct: 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 47/190 (24%), Positives = 83/190 (43%), Gaps = 41/190 (21%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
           RL+  +  P    + VS++  LKH N+V                      +LHDI+H  K
Sbjct: 40  RLEHEEGAPCTAIREVSLLKDLKHANIV----------------------TLHDIIHTEK 77

Query: 82  GV------------QGAQPGPVLDWMTRVRIAV-DAARGLEYLHEKVQPSIIHRDIRSSN 128
            +            Q          M  V++ +    RGL Y H +    ++HRD++  N
Sbjct: 78  SLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQN 134

Query: 129 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFG 187
           +L+ E  + K+ADF L+ +A  +  + +S  V+ T  Y  P+  + +   + + D++  G
Sbjct: 135 LLINERGELKLADFGLA-RAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQIDMWGVG 192

Query: 188 VVLLELLTGR 197
            +  E+ TGR
Sbjct: 193 CIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 48.3 bits (115), Expect = 1e-06
 Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 6/93 (6%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GLE LH +    I++RD++  N+LL +    +I+D  L+ + P+        RV GT GY
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGRV-GTVGY 167

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE     + T   D +  G ++ E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 5/101 (4%)

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           + + +  L YLHE+    II+RD++  NVLL  +   K+ D+ +  +   +     ++  
Sbjct: 102 SAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTF 156

Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            GT  Y APE           D ++ GV++ E++ GR P D
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 4/93 (4%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            L+YLH   + ++++RD++  N++L +D   KI DF L  +     A + +    GT  Y
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 162

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE        +  D +  GVV+ E++ GR P
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 42/166 (25%), Positives = 77/166 (46%), Gaps = 15/166 (9%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           + ++  L+H+ +V+  G   +   + L+   E+   GS+ D L           G + + 
Sbjct: 55  IQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--------GALTEN 106

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           +TR R      +G+ YLH  +   I+HRDI+ +N+L       K+ DF  S +   +   
Sbjct: 107 VTR-RYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS 162

Query: 155 LHSTR-VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
               + V GT  + +PE        +K+DV+S    ++E+LT + P
Sbjct: 163 GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 6/110 (5%)

Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
           P  D    +  A +   GLE L  +    I++RD++  N+LL +    +I+D  L+ Q P
Sbjct: 97  PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIP 153

Query: 150 DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +        RV GT GY APE     + T   D +  G ++ E++ G+ P
Sbjct: 154 E--GETVRGRV-GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 17/100 (17%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS-----TRV 160
           RGL++LH      ++HRD++  N+L+    + K+ADF L        AR++S     T V
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMALTSV 169

Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
           + T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 47.5 bits (113), Expect = 3e-06
 Identities = 27/99 (27%), Positives = 50/99 (50%), Gaps = 5/99 (5%)

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A +    L +LH   +  +I+RD++  N+LL  +   K+ADF +  +   +   + +T  
Sbjct: 102 AAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEG--ILNGVTTTTF 156

Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            GT  Y APE     +     D ++ GV++ E++ G+ P
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 23/156 (14%)

Query: 45  HENLVELLGYCVEGNLRVLAYEFATM-GSLHDILHGRKGVQGAQPGP---VLDWMTRVRI 100
           H N++ L+    +     LA  F  M  +L++++ GRK     +P P   V  +M ++  
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRK-----RPLPEKRVKSYMYQL-- 109

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
                + L+++H      I HRDI+  N+L+ +D   K+ADF        + ++   T  
Sbjct: 110 ----LKSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADF---GSCRGIYSKPPYTEY 158

Query: 161 LGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLT 195
           + T  Y APE  +T G    K D+++ G V  E+L+
Sbjct: 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 47.2 bits (113), Expect = 3e-06
 Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 10/94 (10%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL-GTFG 165
            LEYLH      I++RD++  N+LL  D   KI DF  + +          T  L GT  
Sbjct: 113 ALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPE 163

Query: 166 YHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           Y APE  ++    +  D ++ G+++ E+L G  P
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 47.3 bits (112), Expect = 3e-06
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 3/91 (3%)

Query: 105 ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF 164
           ARG+E+L  K   + +HRD+ + NVLL +    KI DF L+      +  +         
Sbjct: 247 ARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303

Query: 165 GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            + APE       T  SDV+S+G++L E+ +
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 46.7 bits (111), Expect = 4e-06
 Identities = 42/163 (25%), Positives = 80/163 (49%), Gaps = 16/163 (9%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S++  L H N+V+LL      N   L +EF     LH  L  +K +  +    +   + 
Sbjct: 50  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDL--KKFMDASPLSGIP--LP 100

Query: 97  RVRIAV-DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
            ++  +    +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R 
Sbjct: 101 LIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRT 156

Query: 156 HSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 197
           ++  V+ T  Y APE  +  +  +   D++S G +  E++T R
Sbjct: 157 YTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 28/92 (30%), Positives = 43/92 (46%), Gaps = 4/92 (4%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           R ++YLHE     IIHRDI++ N+ +       + DF  +    D+ A  +     GT  
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-GTIA 248

Query: 166 YHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 197
            +APE           D++S G+VL E+ T  
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.9 bits (111), Expect = 4e-06
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 6/90 (6%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYY 188

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            APE  +     +  D++S G ++ EL+ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 45/169 (26%), Positives = 63/169 (37%), Gaps = 57/169 (33%)

Query: 120 IHRDIRSSNVLLFEDFKAKIADFNL--------------------------SNQAPD--- 150
           IHRDI+  N+L+  D   K+ DF L                          SN+  D   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 151 ------------MAARLH----STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELL 194
                        AAR H    +  ++GT  Y APE  +    TQ  D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 195 TGRKPVDHTMP-RGQQSLVTWAT-----------PRLSEDKVKQCVDPK 231
            G+ P     P   Q  ++ W T           P  S+  +K C  P+
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPE 291

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 47.1 bits (112), Expect = 4e-06
 Identities = 27/84 (32%), Positives = 41/84 (48%), Gaps = 5/84 (5%)

Query: 120 IHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT----G 175
           IHRD++  N+LL +    K+ADF    +  D    +     +GT  Y +PE   +    G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 176 QLTQKSDVYSFGVVLLELLTGRKP 199
              ++ D +S GV L E+L G  P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 5e-06
 Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 8/92 (8%)

Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 167
           LEYLH K    I++RD++  N+LL ++   K+ DF  + +  D    L      GT  Y 
Sbjct: 114 LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL-----CGTPEYL 165

Query: 168 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           APE   +    +  D ++ G+++ E+L G  P
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 46.6 bits (111), Expect = 6e-06
 Identities = 42/181 (23%), Positives = 71/181 (39%), Gaps = 35/181 (19%)

Query: 35  QLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVL 92
           Q +    +L+H N++  +   +  +   +       GS  D+L  H  +G          
Sbjct: 48  QEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG---------- 97

Query: 93  DWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS---- 145
             +  + IA    D    L+Y+H K     IHR +++S++LL  D K  ++    S    
Sbjct: 98  --LPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152

Query: 146 ----NQAPDMAARLHSTRVLGTFGYHAPEY---AMTGQLTQKSDVYSFGVVLLELLTGRK 198
                Q         S + L    + +PE     + G   +KSD+YS G+   EL  G  
Sbjct: 153 KHGKRQRVVHDFPKSSVKNLP---WLSPEVLQQNLQG-YNEKSDIYSVGITACELANGHV 208

Query: 199 P 199
           P
Sbjct: 209 P 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 44/197 (22%), Positives = 71/197 (36%), Gaps = 55/197 (27%)

Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           +++ L H  L  L           L  ++   G L  +L         QPG         
Sbjct: 54  ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQ-------RQPGK-------- 98

Query: 99  RIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-- 148
            ++ + AR         LEYLH      I++RD++  N+LL E     ++DF+LS Q+  
Sbjct: 99  CLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155

Query: 149 -------------PDMAARLHSTRVL------------GTFGYHAPEYAMTGQ-LTQKSD 182
                           +     +               GT  Y APE  ++G       D
Sbjct: 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVD 214

Query: 183 VYSFGVVLLELLTGRKP 199
            ++ G++L E+L G  P
Sbjct: 215 WWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.4 bits (110), Expect = 7e-06
 Identities = 34/103 (33%), Positives = 49/103 (47%), Gaps = 18/103 (17%)

Query: 105 ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL-------SNQAPDMAARLHS 157
           A+G+ +L  K   + IHRD+ + N+LL      KI DF L       SN      ARL  
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL-- 278

Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
                   + APE       T +SDV+S+G++L E+ + G  P
Sbjct: 279 -----PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 46.4 bits (110), Expect = 7e-06
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 5/94 (5%)

Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 167
           L +LHE+    II+RD++  NVLL  +   K+ D+ +  +   +     ++   GT  Y 
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--IRPGDTTSTFCGTPNYI 163

Query: 168 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           APE           D ++ GV++ E++ GR P D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 46.3 bits (110), Expect = 8e-06
 Identities = 30/99 (30%), Positives = 44/99 (44%), Gaps = 5/99 (5%)

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A + A  L YLH     +II+RD++  N+LL       + DF L  +   +     ++  
Sbjct: 102 AAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTF 156

Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            GT  Y APE        +  D +  G VL E+L G  P
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 8e-06
 Identities = 32/117 (27%), Positives = 52/117 (44%), Gaps = 6/117 (5%)

Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           V  + P P+   +T  R  ++A   L YLH +    IIHRD+++ N+ L E   A + DF
Sbjct: 176 VDRSGPLPLEQAITIQRRLLEA---LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDF 229

Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             + +              GT   ++PE         K+D++S G+VL E+      
Sbjct: 230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (109), Expect = 8e-06
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 9/94 (9%)

Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA--DFNLSNQAPDMAARLHSTRVLGTFG 165
           LE LH+    ++I+RD++  N+LL  D++  IA  DF L     +M     +    GT  
Sbjct: 106 LENLHKF---NVIYRDLKPENILL--DYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPE 158

Query: 166 YHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           Y APE  +    T+  D ++ GV+L E+LTG  P
Sbjct: 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 36/112 (32%), Positives = 48/112 (42%), Gaps = 14/112 (12%)

Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
           +M  +  AVDA      LHE      IHRD++  N L+      K+ DF LS      A 
Sbjct: 106 YMAEMFEAVDA------LHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA- 155

Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
             +S  V+G+  Y APE           D +S G +L E L G  P   + P
Sbjct: 156 --NS--VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 43/176 (24%), Positives = 84/176 (47%), Gaps = 15/176 (8%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
           RL+  +  P    +  S++  LKH N+V L           L +E+     L   +    
Sbjct: 39  RLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHP 97

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
           G  G  P  V  ++ ++       RGL Y+H++    I+HRD++  N+L+ +  + K+AD
Sbjct: 98  G--GLHPENVKLFLFQL------LRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLAD 146

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTG 196
           F L+ +A  + +  +S  V+ T  Y  P+  + + + +   D++  G + +E++ G
Sbjct: 147 FGLA-RAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 37/151 (24%), Positives = 57/151 (37%), Gaps = 45/151 (29%)

Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL----------------------S 145
           +E +H+      IHRDI+  N+L+  D   K+ DF L                      S
Sbjct: 114 IESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 146 NQAPDMAARLHSTR-------------------VLGTFGYHAPEYAMTGQLTQKSDVYSF 186
            +  +  + +   R                   ++GT  Y APE  +    TQ  D +S 
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230

Query: 187 GVVLLELLTGRKPVDHTMPRG-QQSLVTWAT 216
           GV+L E+L G+ P     P   Q  ++ W T
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLKVINWET 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 27/166 (16%)

Query: 39  VVSRLKHENLV---ELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
            + RL HEN++   E+L       +    Y+F     ++D           +  P+L   
Sbjct: 216 ALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD------EAFDWKDRPLL-KQ 268

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
           TR  I       +EY+H+K    +IHRDI+  N+ L  D K  + DF         A   
Sbjct: 269 TR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFG-------TAMPF 317

Query: 156 HSTRV------LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
              R       +GT   ++PE        + +D++S G++LL++L+
Sbjct: 318 EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 37/124 (29%), Positives = 54/124 (43%), Gaps = 17/124 (13%)

Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
           G +   M R+  A +    LEYLH      I+HRD++  N+L+      K+ DF LS   
Sbjct: 96  GALPVDMARMYFA-ETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151

Query: 149 -PDMAARLHS------TR------VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
              +   L+       TR      V GT  Y APE  +     +  D ++ G++L E L 
Sbjct: 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV 211

Query: 196 GRKP 199
           G  P
Sbjct: 212 GCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 41/175 (23%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV------------Q 84
            S++  LKH N+V                      +LHDI+H +K +            Q
Sbjct: 54  ASLLKDLKHANIV----------------------TLHDIIHTKKTLTLVFEYLDTDLKQ 91

Query: 85  GAQPGPVLDWMTRVRIAV-DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
                     M  VR+ +    RGL Y H++    ++HRD++  N+L+ E  + K+ADF 
Sbjct: 92  YMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFG 148

Query: 144 LSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGR 197
           L+ +A  + ++ +S  V+ T  Y  P+  + + + +   D++  G +  E+ TGR
Sbjct: 149 LA-RAKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 28/96 (29%), Positives = 53/96 (55%), Gaps = 6/96 (6%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           +GL + H     +++HRD++  N+L+ ++ + K+ADF L+ +A  +  R +S  V+ T  
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA-RAFGIPVRCYSAEVV-TLW 164

Query: 166 YHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKPV 200
           Y  P+     +L   S D++S G +  EL    +P+
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 61/239 (25%), Positives = 102/239 (42%), Gaps = 40/239 (16%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++S++ H +L  + G CV G+  ++  EF   G L   L   KG       PV  W  +
Sbjct: 68  SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV-----PV-AW--K 119

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD-----FNLSNQAPDMA 152
           + +A   A  L YL +K   +++H ++ + N+LL    +  +A+       LS+      
Sbjct: 120 ITVAQQLASALSYLEDK---NLVHGNVCAKNILL---ARLGLAEGTSPFIKLSDPGVSFT 173

Query: 153 ARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLEL-LTGRKPVDHTMPRGQQS 210
           A     RV     + APE    G  L+  +D +SFG  LLE+   G  P+    P  ++ 
Sbjct: 174 ALSREERV-ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE- 231

Query: 211 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 269
                  R  E K +           P     +LA + + C+ YE   RP+   +++ L
Sbjct: 232 -------RFYEKKHR----------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 5/85 (5%)

Query: 119 IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---- 174
           +IHRD++  N+LL +    K+ADF    +  D    +     +GT  Y +PE   +    
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 175 GQLTQKSDVYSFGVVLLELLTGRKP 199
           G   ++ D +S GV L E+L G  P
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 6/91 (6%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 197
            APE  +     +  D++S G ++ E++ G 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 22/67 (32%), Positives = 39/67 (58%), Gaps = 7/67 (10%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS---NQAPDMAARLHSTRVLGT 163
           GL Y+H      I+HRD++++N+L+ +D   K+ADF L+   + + +     ++ RV+ T
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186

Query: 164 FGYHAPE 170
             Y  PE
Sbjct: 187 LWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 44.2 bits (104), Expect = 3e-05
 Identities = 27/93 (29%), Positives = 53/93 (56%), Gaps = 6/93 (6%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL Y+H +    I+HRD++  N+L+    + K+ADF L+ +A  + ++ +S+ V+ T  
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLA-RAKSIPSQTYSSEVV-TLW 168

Query: 166 YHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGR 197
           Y  P+  +     +   D++  G + +E+L G+
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 44.3 bits (104), Expect = 3e-05
 Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 17/176 (9%)

Query: 37  VSVVSRLKHENLVELLG-YCVEGNLRV-LAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           ++++  LKH N++ L   +    + +V L +++A     H I   R      +P  +   
Sbjct: 49  IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 108

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF----EDFKAKIADFNLS---NQ 147
           M +  +      G+ YLH      ++HRD++ +N+L+     E  + KIAD   +   N 
Sbjct: 109 MVK-SLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 148 APDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDH 202
                A L    V+ TF Y APE  +  +  T+  D+++ G +  ELLT  +P+ H
Sbjct: 165 PLKPLADLDP--VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 29/163 (17%)

Query: 42  RLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIA 101
           +LKH NLV L+          L +E+     L+++    +GV               +I 
Sbjct: 56  QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGV---------PEHLIKKII 106

Query: 102 VDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS---- 157
               + + + H   + + IHRD++  N+L+ +  + K+ DF          AR+ +    
Sbjct: 107 WQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGF--------ARILTGPGD 155

Query: 158 --TRVLGTFGYHAPEYAMTG--QLTQKSDVYSFGVVLLELLTG 196
             T  + T  Y APE  + G  Q     DV++ G V  ELLTG
Sbjct: 156 DYTDYVATRWYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 10/93 (10%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--MAARLHSTRVLGTF 164
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A    M      TR     
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182

Query: 165 GYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 197
            Y APE  +     +  D++S G ++ E++ G 
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 43.5 bits (102), Expect = 5e-05
 Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 17/176 (9%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRV--LAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           ++++  LKH N++ L    +  + R   L +++A     H I   R      +P  +   
Sbjct: 49  IALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRS 108

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF----EDFKAKIADFNLS---NQ 147
           M +  +      G+ YLH      ++HRD++ +N+L+     E  + KIAD   +   N 
Sbjct: 109 MVK-SLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 148 APDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDH 202
                A L    V+ TF Y APE  +  +  T+  D+++ G +  ELLT  +P+ H
Sbjct: 165 PLKPLADLDP--VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 43.5 bits (102), Expect = 6e-05
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 38/120 (31%), Positives = 50/120 (41%), Gaps = 13/120 (10%)

Query: 100 IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN----LSNQAPDMAARL 155
           I   A RGL YLH   Q   IHR+I++S++L+  D    ++  +    L           
Sbjct: 106 ILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162

Query: 156 H----STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 211
                ST VL           + G    KSD+YS G+   EL TGR P    M R Q  L
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSVGITACELATGRVPF-QDMLRTQMLL 220

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 42.5 bits (101), Expect = 1e-04
 Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 32/187 (17%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLK---HENLVELLGYCVEGNLRVLAYEFATM-GSLHDIL 77
           ++K      ++   L  V S  K   H N+V+L     E +     +E+  M G+L+ ++
Sbjct: 31  KMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY--MEGNLYQLM 88

Query: 78  HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
             RKG        +   + ++       +GL ++H+       HRD++  N+L+      
Sbjct: 89  KDRKGKP-FSESVIRSIIYQI------LQGLAHIHKH---GFFHRDLKPENLLVSGPEVV 138

Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE-------YAMTGQLTQKSDVYSFGVVL 190
           KIADF L   A ++ +R   T  + T  Y APE       Y      +   D+++ G ++
Sbjct: 139 KIADFGL---AREIRSRPPYTDYVSTRWYRAPEILLRSTSY------SSPVDIWALGCIM 189

Query: 191 LELLTGR 197
            EL T R
Sbjct: 190 AELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 41.5 bits (97), Expect = 2e-04
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 6/94 (6%)

Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           +H   Q   +HRDI+  NVLL  +   ++ADF  S    +    + S+  +GT  Y +PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 171 Y--AM---TGQLTQKSDVYSFGVVLLELLTGRKP 199
              AM    G+   + D +S GV + E+L G  P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 15/111 (13%)

Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
           ++  + IA+D+   L Y         +HRDI+  N+L+  +   ++ADF    +  +   
Sbjct: 107 YLAEMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLME-DG 156

Query: 154 RLHSTRVLGTFGYHAPEY--AM---TGQLTQKSDVYSFGVVLLELLTGRKP 199
            + S+  +GT  Y +PE   AM    G+   + D +S GV + E+L G  P
Sbjct: 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 41.0 bits (96), Expect = 3e-04
 Identities = 43/171 (25%), Positives = 69/171 (40%), Gaps = 18/171 (10%)

Query: 47  NLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAAR 106
           N+V L  Y V  +   L  + A  G L   +     +       V  W   + +A+DA  
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEEC---VKRWAAEMVVALDA-- 100

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
               LH +    I+ RD+  +N+LL +    ++  F+  ++  D         +     Y
Sbjct: 101 ----LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----Y 148

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 217
            APE     + T+  D +S G +L ELLTG K +    P G  +  T   P
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIP 198

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 31/95 (32%), Positives = 43/95 (45%), Gaps = 7/95 (7%)

Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           +H   Q   +HRDI+  NVL+      K+ADF  S         ++S   +GT  Y APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPE 173

Query: 171 YAMTGQLTQKS------DVYSFGVVLLELLTGRKP 199
              T     K       D +S GV+  E++ GR P
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 40.6 bits (96), Expect = 4e-04
 Identities = 31/97 (31%), Positives = 46/97 (47%), Gaps = 16/97 (16%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI--ADFNLSNQAPDMAARLHSTRVL-GT 163
            L  LH+    +IIH DI+  NVL ++  K +I   D+ L          + +     GT
Sbjct: 121 ALNDLHKH---NIIHNDIKLENVL-YDRAKDRIYLCDYGLCK-------IIGTPSCYDGT 169

Query: 164 FGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKP 199
             Y +PE  + G     S D ++ GV+  ELLTG+ P
Sbjct: 170 LDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 40.8 bits (95), Expect = 4e-04
 Identities = 43/182 (23%), Positives = 81/182 (44%), Gaps = 21/182 (11%)

Query: 17  SHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL-GYCVEGNLRVLAYEFATMGSLHD 75
           S ENE +K      +   + + ++  LK EN+VEL   +   G L  L +E+     L  
Sbjct: 37  SEENEEVK------ETTLRELKMLRTLKQENIVELKEAFRRRGKL-YLVFEYVEKNMLEL 89

Query: 76  ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 135
           +    +   G  P  V  ++ ++       + + + H+     I+HRDI+  N+L+  + 
Sbjct: 90  L---EEMPNGVPPEKVRSYIYQL------IKAIHWCHKN---DIVHRDIKPENLLISHND 137

Query: 136 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
             K+ DF  +    +  +  + T  + T  Y +PE  +     +  D++S G +L EL  
Sbjct: 138 VLKLCDFGFARNLSE-GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSD 196

Query: 196 GR 197
           G+
Sbjct: 197 GQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 40.8 bits (96), Expect = 5e-04
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 19/166 (11%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDW 94
           +S++  L H N+V LL      N   L +EF  +    D+        + G  P  +  +
Sbjct: 49  ISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL----DLKKYMDSSPLTGLDPPLIKSY 104

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           + ++       +G+ Y H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 105 LYQL------LQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA-RAFGVPVR 154

Query: 155 LHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKP 199
            ++  V+ T  Y APE  +   Q +   D++S G +  E++  R+P
Sbjct: 155 TYTHEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 40.4 bits (94), Expect = 7e-04
 Identities = 30/99 (30%), Positives = 43/99 (43%), Gaps = 5/99 (5%)

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A + A  L YLH     +I++RD++  N+LL       + DF L  +    +    +T  
Sbjct: 102 AAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTF 156

Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            GT  Y APE           D +  G VL E+L G  P
Sbjct: 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 40.0 bits (93), Expect = 9e-04
 Identities = 29/99 (29%), Positives = 44/99 (44%), Gaps = 5/99 (5%)

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A + A  + YLH     +II+RD++  N+LL       + DF L  +   +     ++  
Sbjct: 102 AAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG--VEPEETTSTF 156

Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            GT  Y APE        +  D +  G VL E+L G  P
Sbjct: 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 39.8 bits (93), Expect = 9e-04
 Identities = 33/111 (29%), Positives = 53/111 (47%), Gaps = 15/111 (13%)

Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
           ++  + +A+D+   L Y         +HRDI+  NVLL ++   ++ADF  S        
Sbjct: 107 YLAEMVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADG 156

Query: 154 RLHSTRVLGTFGYHAPEY--AM---TGQLTQKSDVYSFGVVLLELLTGRKP 199
            + S   +GT  Y +PE   AM    G+   + D +S GV + E+L G  P
Sbjct: 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 39.2 bits (91), Expect = 0.001
 Identities = 29/99 (29%), Positives = 45/99 (45%), Gaps = 5/99 (5%)

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A + A  L YLH     +I++RD++  N+LL       + DF L  +  ++     ++  
Sbjct: 102 AAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTF 156

Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            GT  Y APE        +  D +  G VL E+L G  P
Sbjct: 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 14/95 (14%)

Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR---VLGTF 164
            EYL      +I++RD++  N+LL +D   K+ DF          A++  TR   + GT 
Sbjct: 144 FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGF--------AKVVDTRTYTLCGTP 192

Query: 165 GYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            Y APE  +     + +D ++ G+ + E+L G  P
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.5 bits (92), Expect = 0.001
 Identities = 19/51 (37%), Positives = 29/51 (56%), Gaps = 4/51 (7%)

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 145
           M    I+ + A  L+YLH   +  IIHRD++  N+L+  +   K+ DF LS
Sbjct: 105 MAVKYIS-EVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 35/141 (24%), Positives = 55/141 (39%), Gaps = 40/141 (28%)

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL---------- 144
            TR  IA +    ++ +H   +   IHRDI+  N+LL      K++DF L          
Sbjct: 102 ETRFYIA-ETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157

Query: 145 -----------SNQAPDMAARLHSTR---------------VLGTFGYHAPEYAMTGQLT 178
                      SN    ++  + S R                +GT  Y APE  +     
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN 217

Query: 179 QKSDVYSFGVVLLELLTGRKP 199
           ++ D +S GV++ E+L G  P
Sbjct: 218 KECDWWSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 26/84 (30%), Positives = 41/84 (48%), Gaps = 5/84 (5%)

Query: 120 IHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT----G 175
           IHRD++  N+LL +    K+ADF    +  +    +     +GT  Y +PE   +    G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 176 QLTQKSDVYSFGVVLLELLTGRKP 199
              ++ D +S GV L E+L G  P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 36/141 (25%), Positives = 53/141 (37%), Gaps = 46/141 (32%)

Query: 120 IHRDIRSSNVLLFEDFKAKIADFNL----------------------SNQAPDM------ 151
           IHRDI+  N+L+  D   K+ DF L                      S +  D+      
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 152 -------------AARLH----STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELL 194
                        A + H    +  ++GT  Y APE  +    TQ  D +S GV+L E+L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 195 TGRKPVDHTMP-RGQQSLVTW 214
            G+ P     P   Q  ++ W
Sbjct: 243 VGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 34/124 (27%), Positives = 51/124 (41%), Gaps = 33/124 (26%)

Query: 116 QPSIIHRDIRSSNVLLFEDFKAKIADF----------------NLSNQAP-DMAAR-LHS 157
           Q   IHRDI+  N+LL      K++DF                NL++  P D + + ++S
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 158 TR---------------VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 202
            R                +GT  Y APE  M     +  D +S GV++ E+L G  P   
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238

Query: 203 TMPR 206
             P+
Sbjct: 239 ETPQ 242

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 33/124 (26%), Positives = 48/124 (38%), Gaps = 33/124 (26%)

Query: 116 QPSIIHRDIRSSNVLLFEDFKAKIADF----------------NLSNQAPD--MAARLHS 157
           Q   IHRDI+  N+LL      K++DF                NL++  P       ++S
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 158 TR---------------VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 202
            R                +GT  Y APE  M     +  D +S GV++ E+L G  P   
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238

Query: 203 TMPR 206
             P+
Sbjct: 239 ETPQ 242

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	285
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.98
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.98
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
PRK09188	365	serine/threonine protein kinase; Provisional	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.75
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.73
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.73
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.71
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.7
PRK12274	218	serine/threonine protein kinase; Provisional	99.69
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.66
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.65
PRK10345	210	hypothetical protein; Provisional	99.64
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.58
smart00090	237	RIO RIO-like kinase.	99.57
KOG1243	690	consensus Protein kinase [General function predict	99.56
PRK14879	211	serine/threonine protein kinase; Provisional	99.54
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.49
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.48
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.44
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.4
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.37
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.33
COG4248	637	Uncharacterized protein with protein kinase and he	99.31
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.27
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.17
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.1
KOG3087	229	consensus Serine/threonine protein kinase [General	99.07
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.05
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.04
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.98
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.97
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.97
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.85
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.85
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.76
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.75
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.75
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.75
PRK09902	216	hypothetical protein; Provisional	98.52
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.3
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.25
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.18
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.95
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.78
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.77
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.73
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.72
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.69
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.51
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.37
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.99
PLN02876	822	acyl-CoA dehydrogenase	96.96
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	96.93
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.91
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.41
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.25
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.05
KOG2270	520	consensus Serine/threonine protein kinase involved	95.81
PRK10593	297	hypothetical protein; Provisional	95.25
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	94.35
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.16
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	93.84
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	93.73
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	93.67
PRK05231	319	homoserine kinase; Provisional	93.59
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	93.53
PF01636	239	APH: Phosphotransferase enzyme family This family	92.77
PRK10271	188	thiK thiamine kinase; Provisional	92.62
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	92.23
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	91.9
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	91.29
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	90.62
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	90.61
COG2334	331	Putative homoserine kinase type II (protein kinase	90.35
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	90.28
PLN02236	344	choline kinase	90.1
PTZ00384	383	choline kinase; Provisional	89.97
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	89.66
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	88.46
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	86.7
PRK11768	325	serine/threonine protein kinase; Provisional	86.15
PRK14559	645	putative protein serine/threonine phosphatase; Pro	85.63
PRK06148	1013	hypothetical protein; Provisional	85.32
KOG2269	531	consensus Serine/threonine protein kinase [Signal	84.11
PHA03111	444	Ser/Thr kinase; Provisional	82.4
COG4499	434	Predicted membrane protein [Function unknown]	81.95

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-48  Score=319.58  Aligned_cols=237  Identities=25%  Similarity=0.344  Sum_probs=201.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC-eeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN-LRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.-+.++..||.|.+ ..........++.+|++++++++|||||.+||.|.++. ...|+||||++|+|..++...
T Consensus        94 ~V~kv~Hk~t~~i~AlK~I-~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~  172 (364)
T KOG0581|consen   94 TVYKVRHKPTGKIYALKVI-LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV  172 (364)
T ss_pred             EEEEEEEcCCCeEEEEEee-cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc
Confidence            6999999999999999999 56666677899999999999999999999999999998 599999999999999999865


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      .         .+++...-.++.++++||.|||+ .   +|+||||||+|+|++..|.|||+|||.+....+.    ....
T Consensus       173 g---------~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~t  236 (364)
T KOG0581|consen  173 G---------RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANT  236 (364)
T ss_pred             C---------CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hccc
Confidence            3         28999999999999999999996 7   9999999999999999999999999998765443    2355


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCch-hhhhhhcCCccCCCCCh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSE-DKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  238 (285)
                      ..||..|||||.+.+..|+.++||||||+.++|+++|+.||....+           ..... +.+..+.+ +.....|.
T Consensus       237 fvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-----------~~~~~~~Ll~~Iv~-~ppP~lP~  304 (364)
T KOG0581|consen  237 FVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-----------PYLDIFELLCAIVD-EPPPRLPE  304 (364)
T ss_pred             ccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-----------CCCCHHHHHHHHhc-CCCCCCCc
Confidence            6799999999999999999999999999999999999999976411           01111 12222222 22223344


Q ss_pred             h-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          239 K-GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       239 ~-~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      + ++++++.|+..||++||.+|||+.++++
T Consensus       305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            4 8899999999999999999999999987

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-46  Score=324.50  Aligned_cols=240  Identities=24%  Similarity=0.339  Sum_probs=206.0

Q ss_pred             CCceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            1 MRRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         1 ~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      |++|.+.+..+++.||+|++.+..- ....++++.+||++-++|+|||||+++++|++.++.|||.|+|..++|..+++.
T Consensus        32 A~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr  111 (592)
T KOG0575|consen   32 ARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR  111 (592)
T ss_pred             eEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh
Confidence            5789999999999999998766443 445789999999999999999999999999999999999999999999999985


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..+++||+.|+.|||+.   +|+|||||..|++++++.+|||+|||+|.........  ..-
T Consensus       112 rk~---------ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er--k~T  177 (592)
T KOG0575|consen  112 RKP---------LTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER--KKT  177 (592)
T ss_pred             cCC---------CCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcccc--cce
Confidence            543         99999999999999999999999   9999999999999999999999999999876543222  233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|||.|+|||++.....+.-+||||+||++|-|+.|++||+...-.....               .+.....  ..|..
T Consensus       178 lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~---------------~Ik~~~Y--~~P~~  240 (592)
T KOG0575|consen  178 LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN---------------KIKLNEY--SMPSH  240 (592)
T ss_pred             ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH---------------HHHhcCc--ccccc
Confidence            579999999999999999999999999999999999999998765433322               2222222  34556


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      .+.+..++|.++|+.||.+|||+++++.  ..++
T Consensus       241 ls~~A~dLI~~lL~~~P~~Rpsl~~vL~--h~Ff  272 (592)
T KOG0575|consen  241 LSAEAKDLIRKLLRPNPSERPSLDEVLD--HPFF  272 (592)
T ss_pred             cCHHHHHHHHHHhcCCcccCCCHHHHhc--CHhh
Confidence            7888999999999999999999999997  4444

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=316.91  Aligned_cols=243  Identities=28%  Similarity=0.413  Sum_probs=208.6

Q ss_pred             ceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG   82 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~   82 (285)
                      ||.+.-. ...-+++|..+..   ....++|.+|+.+|++|+|++||+++++|..++.++|||||+..|+|.++++....
T Consensus       222 V~~g~~~-~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~  297 (468)
T KOG0197|consen  222 VWLGKWN-GSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREG  297 (468)
T ss_pred             EEEEEEc-CCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCC
Confidence            5666333 3445666666543   44568899999999999999999999999998899999999999999999987332


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccccc
Q 023220           83 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLG  162 (285)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  162 (285)
                      .       .+.....+.++.||++|++||+++   ++|||||..+|||++++..+||+|||+++.......... ....-
T Consensus       298 ~-------~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~-~~~kf  366 (468)
T KOG0197|consen  298 G-------LLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS-EGGKF  366 (468)
T ss_pred             C-------ccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeec-CCCCC
Confidence            2       388999999999999999999999   999999999999999999999999999996544333222 22234


Q ss_pred             ccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          163 TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       163 ~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      +..|.|||.+....++.+|||||||++|||++| |+.|+.                ..+..++.+.++.+.+...|..+|
T Consensus       367 PIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~----------------~msn~ev~~~le~GyRlp~P~~CP  430 (468)
T KOG0197|consen  367 PIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP----------------GMSNEEVLELLERGYRLPRPEGCP  430 (468)
T ss_pred             CceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC----------------CCCHHHHHHHHhccCcCCCCCCCC
Confidence            678999999999999999999999999999999 999985                445678888999999999999999


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      .++++++..||+.+|++|||++.+...|+.+....
T Consensus       431 ~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  431 DEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            99999999999999999999999999999887644

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-45  Score=313.74  Aligned_cols=238  Identities=33%  Similarity=0.470  Sum_probs=198.6

Q ss_pred             cChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC-eeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCC
Q 023220           15 YPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN-LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD   93 (285)
Q Consensus        15 ~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~   93 (285)
                      +++|.+..........++|.+|+.+|++++|||||+++|++.+.. .+++||||+.+|+|.+++......       .++
T Consensus        68 vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~-------~l~  140 (362)
T KOG0192|consen   68 VAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKR-------KLP  140 (362)
T ss_pred             EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccC-------CCC
Confidence            677766655544444789999999999999999999999999988 799999999999999999874111       299


Q ss_pred             HHHHHHHHHHHHHHHHHHhhcCCCC-eeeCCCCCCCeEEccCC-eeEEeccccCCCCCcccccccccccccccCcCCCcc
Q 023220           94 WMTRVRIAVDAARGLEYLHEKVQPS-IIHRDIRSSNVLLFEDF-KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEY  171 (285)
Q Consensus        94 ~~~~~~~~~qi~~~l~~lh~~~~~~-~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~  171 (285)
                      +..++.++.+|+.|+.|||+.   + ++|||||++|+|++.++ ++||+|||+++......  .......||+.|+|||+
T Consensus       141 ~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv  215 (362)
T KOG0192|consen  141 LKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEV  215 (362)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhh
Confidence            999999999999999999999   8 99999999999999997 99999999997654321  12233678999999999


Q ss_pred             cc--cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHH
Q 023220          172 AM--TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAA  249 (285)
Q Consensus       172 ~~--~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  249 (285)
                      +.  ...|+.++||||||+++|||++|+.||......               ...........+...+..+++.+..++.
T Consensus       216 ~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---------------~~~~~v~~~~~Rp~~p~~~~~~l~~l~~  280 (362)
T KOG0192|consen  216 LRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---------------QVASAVVVGGLRPPIPKECPPHLSSLME  280 (362)
T ss_pred             hcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---------------HHHHHHHhcCCCCCCCccCCHHHHHHHH
Confidence            99  568999999999999999999999999876541               1222233344445556668899999999


Q ss_pred             HhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          250 LCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       250 ~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                      +||+.||..||++.+++..|+.++......
T Consensus       281 ~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~  310 (362)
T KOG0192|consen  281 RCWLVDPSRRPSFLEIVSRLESIMSHISSA  310 (362)
T ss_pred             HhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence            999999999999999999999998755543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=305.17  Aligned_cols=236  Identities=24%  Similarity=0.305  Sum_probs=197.8

Q ss_pred             CCceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            1 MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         1 ~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      ++||+..-+.....+++|.+.+.+..+...+.+..||.+|++++|||||.+++++..++..|||||||.||+|.++++..
T Consensus        24 avVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~  103 (429)
T KOG0595|consen   24 AVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRR  103 (429)
T ss_pred             EEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHc
Confidence            47999999999999999999888878888999999999999999999999999999999999999999999999999877


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC------CeeEEeccccCCCCCccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED------FKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~------~~~~l~df~~~~~~~~~~~~  154 (285)
                      ..         +++.++..++.||+.|+++||++   +|+||||||+|||++..      ..+||+|||.++....... 
T Consensus       104 ~~---------l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~-  170 (429)
T KOG0595|consen  104 GR---------LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM-  170 (429)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH-
Confidence            53         99999999999999999999999   99999999999999764      5689999999998764332 


Q ss_pred             ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                        .....|++.|||||++...+|+.|+|+||+|+++|++++|+.||......+....+..              +.....
T Consensus       171 --a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k--------------~~~~~~  234 (429)
T KOG0595|consen  171 --AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK--------------GNEIVP  234 (429)
T ss_pred             --HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc--------------cccccC
Confidence              3456799999999999999999999999999999999999999986655433322211              112222


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHH
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIV  265 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  265 (285)
                      ..+...+..+.+++...++++|.+|.+..+-
T Consensus       235 ~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~  265 (429)
T KOG0595|consen  235 VLPAELSNPLRELLISLLQRNPKDRISFEDF  265 (429)
T ss_pred             chhhhccCchhhhhhHHHhcCccccCchHHh
Confidence            3344455566677777777777777766543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-45  Score=306.59  Aligned_cols=237  Identities=22%  Similarity=0.269  Sum_probs=193.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCC-----CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKN-----YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .|=+++++.+.+.||+|.+.+.+....     ......+|+++|++++||+||+++++|...+..|+||||++||.|.+.
T Consensus       187 ~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~  266 (475)
T KOG0615|consen  187 LVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDK  266 (475)
T ss_pred             EEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHH
Confidence            466888999999999998877775542     234467999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC---CeeEEeccccCCCCCcccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED---FKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~---~~~~l~df~~~~~~~~~~~  153 (285)
                      +-.+..         +.+..-..++.|++.|+.|||++   ||+||||||+|||+..+   ..+||.|||+++.......
T Consensus       267 vv~nk~---------l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sf  334 (475)
T KOG0615|consen  267 VVANKY---------LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSF  334 (475)
T ss_pred             HHhccc---------cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhhcccccee
Confidence            987653         77788899999999999999999   99999999999999766   7899999999987753222


Q ss_pred             cccccccccccCcCCCcccccCCC---CcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQL---TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~---~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                         ..-..||+.|.|||++.....   ..+.|+||+||++|-+++|.+||.......              .....+...
T Consensus       335 ---m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--------------sl~eQI~~G  397 (475)
T KOG0615|consen  335 ---MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--------------SLKEQILKG  397 (475)
T ss_pred             ---hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--------------cHHHHHhcC
Confidence               344679999999999986643   347899999999999999999997543221              011111121


Q ss_pred             ccC--CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          231 KLK--GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       231 ~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+.  ...-..++++..++|.+||..||++|||+.|+++
T Consensus       398 ~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  398 RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            111  1223467889999999999999999999999987

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.2e-46  Score=293.96  Aligned_cols=246  Identities=20%  Similarity=0.255  Sum_probs=200.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccce-EEEeCCe-eeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG-YCVEGNL-RVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~-~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||++....++..++.|.+.--.-....+++...|+.+|++|+|||||++++ .|.+++. ++|+||++++|+|.+.++.
T Consensus        34 ~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~  113 (375)
T KOG0591|consen   34 EVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKH  113 (375)
T ss_pred             heEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHH
Confidence            5899999999999999988766666677889999999999999999999999 4555555 8999999999999999976


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-CCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV-QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~-~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      -+..     ++.+++.++|.++.|++.||..+|.+- .+-++||||||.||+++.+|.+||+|||+++...+..  ....
T Consensus       114 ~K~q-----kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~--tfA~  186 (375)
T KOG0591|consen  114 FKKQ-----KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT--TFAH  186 (375)
T ss_pred             HHhc-----cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh--HHHH
Confidence            5432     224999999999999999999999931 1139999999999999999999999999998765533  2356


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC-
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP-  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  237 (285)
                      ..+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+..-                -.+.+.+...--...| 
T Consensus       187 S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~----------------~~L~~KI~qgd~~~~p~  250 (375)
T KOG0591|consen  187 SLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL----------------LSLCKKIEQGDYPPLPD  250 (375)
T ss_pred             hhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH----------------HHHHHHHHcCCCCCCcH
Confidence            67899999999999999999999999999999999999999986521                1111222222112234 


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      .-++.++.++|..|+..||..||+...++..++
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            567889999999999999999998555554443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.9e-44  Score=283.19  Aligned_cols=266  Identities=21%  Similarity=0.235  Sum_probs=219.9

Q ss_pred             CCceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            1 MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         1 ~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      ++||++.+..+++.+++|.++.........-...+||..|+.++|+||+.+.|+|.+.+.+.||+||++. +|...+++.
T Consensus        16 gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~   94 (318)
T KOG0659|consen   16 GVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDK   94 (318)
T ss_pred             EEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhccc
Confidence            3699999999999999999998877777788889999999999999999999999999999999999986 999999877


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      .-        .++...+..++.+++++++|||.+   .++|||+||.|+|++.+|.+||+|||+++.........  ...
T Consensus        95 ~i--------~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~--~~~  161 (318)
T KOG0659|consen   95 NI--------ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ--THQ  161 (318)
T ss_pred             cc--------ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc--ccc
Confidence            54        389999999999999999999999   99999999999999999999999999999877544432  333


Q ss_pred             ccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh---------hh--c
Q 023220          161 LGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK---------QC--V  228 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------~~--~  228 (285)
                      +-|.+|+|||.+.|. .|+...|+||+||++.||+.|.+.|.+.+..++...+-........+.+-         ++  .
T Consensus       162 V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~  241 (318)
T KOG0659|consen  162 VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQF  241 (318)
T ss_pred             eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcC
Confidence            678999999999876 78999999999999999999999999988888877665544443332111         11  1


Q ss_pred             CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCCCC
Q 023220          229 DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPV  282 (285)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  282 (285)
                      -+.......+..+.+..+++.+||..||.+|+|+.+.++  ....+..|+|.++
T Consensus       242 P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~--~~yf~~~P~pt~~  293 (318)
T KOG0659|consen  242 PKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK--HPYFKSLPLPTPP  293 (318)
T ss_pred             CCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc--chhhhcCCCCCCh
Confidence            111112244456777899999999999999999999998  5555554444443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.3e-45  Score=292.83  Aligned_cols=252  Identities=19%  Similarity=0.214  Sum_probs=207.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|..+.|.+.+|+|.+......+...+-.++||++|++++|+|+|.+.++|.....+++||||++. ++.+-++..+
T Consensus        17 vV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p   95 (396)
T KOG0593|consen   17 VVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYP   95 (396)
T ss_pred             EEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhcc
Confidence            689999999999999999988888887888889999999999999999999999999999999999998 6667776655


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..        ++...+..++.|++.|+.|+|++   +++||||||+|||++.+|.+||||||.|+.....+..  -+..+
T Consensus        96 ~G--------~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~--YTDYV  162 (396)
T KOG0593|consen   96 NG--------VPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN--YTDYV  162 (396)
T ss_pred             CC--------CCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcch--hhhhh
Confidence            42        88999999999999999999999   9999999999999999999999999999865432211  23456


Q ss_pred             cccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh-cCCc--------
Q 023220          162 GTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC-VDPK--------  231 (285)
Q Consensus       162 ~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--------  231 (285)
                      .|.+|+|||.+.+ .+|+...|||++||++.||++|.+.|.+.+..++...+....+.+...-..-+ -++.        
T Consensus       163 ATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~  242 (396)
T KOG0593|consen  163 ATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPE  242 (396)
T ss_pred             hhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCC
Confidence            7899999999887 68999999999999999999999999999888877666554444332111111 0111        


Q ss_pred             c-----CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          232 L-----KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       232 ~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .     .....+..+.-+.++++.||+.||++|++-++++.
T Consensus       243 ~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  243 PEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1     11122345668899999999999999999999874

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=6e-44  Score=293.83  Aligned_cols=229  Identities=21%  Similarity=0.231  Sum_probs=195.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCC-CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKN-YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +|+++.++.+++.||+|..++.+-.+. ..+...+|..+|.+++||.||+++-.|++.+.+|+|++|+.||.|...++++
T Consensus        40 kV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~e  119 (357)
T KOG0598|consen   40 KVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQRE  119 (357)
T ss_pred             eEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhc
Confidence            589999999999999998777665544 6788889999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+.-++..|+.||.|||++   ||+|||+||+|||+|.+|+++|+|||++...-....  .+...
T Consensus       120 g~---------F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~--~t~tf  185 (357)
T KOG0598|consen  120 GR---------FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD--ATRTF  185 (357)
T ss_pred             CC---------cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCC--ccccc
Confidence            54         89999999999999999999999   999999999999999999999999999975433222  23446


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .||+.|+|||++.+..|+..+|.||||+++|+|++|.+||...+....               ...++... ....+.-.
T Consensus       186 cGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~---------------~~~I~~~k-~~~~p~~l  249 (357)
T KOG0598|consen  186 CGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM---------------YDKILKGK-LPLPPGYL  249 (357)
T ss_pred             cCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH---------------HHHHhcCc-CCCCCccC
Confidence            899999999999999999999999999999999999999987653222               22221111 12334447


Q ss_pred             HHHHHHHHHHhcccCCCCCC
Q 023220          241 VAKLAAVAALCVQYEAEFRP  260 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp  260 (285)
                      +.+.+++++++|++||.+|.
T Consensus       250 s~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  250 SEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CHHHHHHHHHHhccCHHHhc
Confidence            88899999999999999995

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=8.6e-44  Score=319.62  Aligned_cols=252  Identities=27%  Similarity=0.431  Sum_probs=218.5

Q ss_pred             eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCC-C
Q 023220           10 QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ-P   88 (285)
Q Consensus        10 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-~   88 (285)
                      ..+..++||..+. ....+.+++|++|++++..++|||||+++|+|.+++-.++|||||..|+|.+++....+..... .
T Consensus       514 ~~~~lVAVK~LKd-~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~  592 (774)
T KOG1026|consen  514 QDEQLVAVKALKD-KAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLAS  592 (774)
T ss_pred             ccceehhHhhhcc-cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccC
Confidence            4466788887754 3344478999999999999999999999999999999999999999999999998665433222 1


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccccccc
Q 023220           89 ----GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF  164 (285)
Q Consensus        89 ----~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  164 (285)
                          ..+++..+.+.|+.||+.|+.||.++   .++|||+-.+|+|++++..|||+|||+++...+.+.-....+..-..
T Consensus       593 g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPI  669 (774)
T KOG1026|consen  593 GQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPI  669 (774)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeee
Confidence                33499999999999999999999999   99999999999999999999999999998777666555555566688


Q ss_pred             CcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHH
Q 023220          165 GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAK  243 (285)
Q Consensus       165 ~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (285)
                      +||+||.+.+.+|+..||||||||+|||+++ |..||.+.                +.+++.+.+..+...++|..+|.+
T Consensus       670 RWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl----------------Sn~EVIe~i~~g~lL~~Pe~CP~~  733 (774)
T KOG1026|consen  670 RWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL----------------SNQEVIECIRAGQLLSCPENCPTE  733 (774)
T ss_pred             ecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc----------------chHHHHHHHHcCCcccCCCCCCHH
Confidence            9999999999999999999999999999999 99999755                345666666666668999999999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCCC
Q 023220          244 LAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAP  281 (285)
Q Consensus       244 l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  281 (285)
                      +++||..||+.+|++||+++||-..|+.+..+.+.-+.
T Consensus       734 vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~~  771 (774)
T KOG1026|consen  734 VYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYSS  771 (774)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccccc
Confidence            99999999999999999999999999999988776543

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-43  Score=300.75  Aligned_cols=260  Identities=52%  Similarity=0.845  Sum_probs=215.6

Q ss_pred             ceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC-eeeEEEeeCCCCCHHHHhccCC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN-LRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      ||++.-.. +..+++|.........  ..+|.+|++++.+++|||+++++|+|.+.+ +.+||+||+.+|+|.+++....
T Consensus        91 VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~  167 (361)
T KOG1187|consen   91 VYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKK  167 (361)
T ss_pred             EEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCC
Confidence            55553222 2678888333222221  455999999999999999999999999998 5999999999999999998765


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCc-cccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD-MAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~  160 (285)
                      ..       .++|..+++|+.+++.||+|||..+.+.++|||||+.|||+|.++..||+|||++...+. ....   ...
T Consensus       168 ~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~---~~~  237 (361)
T KOG1187|consen  168 GE-------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSV---STT  237 (361)
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccce---eee
Confidence            32       289999999999999999999998777799999999999999999999999999976554 2211   111


Q ss_pred             -ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC-CCCCh
Q 023220          161 -LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK-GEYPP  238 (285)
Q Consensus       161 -~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  238 (285)
                       .||.+|+|||.......++++||||||+++.|+++|+.+.....+........|..+.+....+.+++|+.+. ...+.
T Consensus       238 ~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~  317 (361)
T KOG1187|consen  238 VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPD  317 (361)
T ss_pred             cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCCh
Confidence             6899999999998888999999999999999999999998876656666678887777777789999999987 55554


Q ss_pred             -hHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          239 -KGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       239 -~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                       .....+..+..+|++.+|.+||++.++++.|+.+...
T Consensus       318 ~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  318 EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence             5677799999999999999999999999999665544

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=296.03  Aligned_cols=249  Identities=24%  Similarity=0.276  Sum_probs=199.3

Q ss_pred             CCceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            1 MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         1 ~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      |+||++.-..+++++++|.+...+.... .+.+.+|+..|+.++||||++++..|..+..+|+||+||.+|++.+++...
T Consensus        40 a~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~  118 (516)
T KOG0582|consen   40 AVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTY  118 (516)
T ss_pred             eEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHH
Confidence            5799999999999999998877776665 799999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc-c-c
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH-S-T  158 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~-~  158 (285)
                      -..       .+.+..+..+++++++||.|||.+   |.+|||||+.|||++.+|.|+|+|||....+...+.... . .
T Consensus       119 ~~~-------Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~  188 (516)
T KOG0582|consen  119 YPD-------GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFN  188 (516)
T ss_pred             ccc-------cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeec
Confidence            432       289999999999999999999999   999999999999999999999999998755443332111 1 3


Q ss_pred             ccccccCcCCCcccccC--CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          159 RVLGTFGYHAPEYAMTG--QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ...|++.|+|||+++..  .|+.|+||||||++..||.+|..||....+..-..  ....+..+...     ...+..+.
T Consensus       189 tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl--~tLqn~pp~~~-----t~~~~~d~  261 (516)
T KOG0582|consen  189 TFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL--LTLQNDPPTLL-----TSGLDKDE  261 (516)
T ss_pred             cccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH--HHhcCCCCCcc-----cccCChHH
Confidence            35799999999997643  79999999999999999999999997554322111  11111111000     00111122


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..-.+.++++++..||++||.+|||++++++
T Consensus       262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  262 DKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             hhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            2334568999999999999999999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.1e-43  Score=296.87  Aligned_cols=257  Identities=18%  Similarity=0.204  Sum_probs=212.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC--CeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG--NLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++.+..+++.||.|.++..........-..+||.+|++|+||||+++.+...+.  ..+|||||||++ +|.-++..
T Consensus       132 ~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~  210 (560)
T KOG0600|consen  132 QVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSS  210 (560)
T ss_pred             heeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcC
Confidence            599999999999999999988888888888899999999999999999999999876  688999999998 88888765


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ..-.        +++.++..++.||+.||.|||.+   |++|||||..|||+|.+|.+||+|||+|+.......... +.
T Consensus       211 p~vk--------ft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~-T~  278 (560)
T KOG0600|consen  211 PGVK--------FTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPY-TS  278 (560)
T ss_pred             CCcc--------cChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCccc-cc
Confidence            4321        99999999999999999999999   999999999999999999999999999997665444332 34


Q ss_pred             cccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc-----C
Q 023220          160 VLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL-----K  233 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~  233 (285)
                      .+-|.+|+|||++.+. .|+...|+||+||++.||+.|++.|.+.....+...+-..-.......+...-.|..     .
T Consensus       279 rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~  358 (560)
T KOG0600|consen  279 RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQ  358 (560)
T ss_pred             ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCC
Confidence            5679999999999876 789999999999999999999999999888777766654444433333321111211     0


Q ss_pred             CC-------CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          234 GE-------YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       234 ~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ..       .....++...+|+..+|..||.+|.|+.+.++  ....
T Consensus       359 ~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~--seyF  403 (560)
T KOG0600|consen  359 QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ--SEYF  403 (560)
T ss_pred             CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc--Cccc
Confidence            01       12345678899999999999999999999987  4555

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-43  Score=293.17  Aligned_cols=240  Identities=26%  Similarity=0.355  Sum_probs=194.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC--eeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN--LRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||++...++++..++|.........  .+.+.+|+.+|++++|||||+++|......  .++++|||+.+|+|.+++..
T Consensus        32 ~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~  109 (313)
T KOG0198|consen   32 SVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKR  109 (313)
T ss_pred             EEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHH
Confidence            58999998889999999886652222  677899999999999999999999855554  68999999999999999987


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-CCeeEEeccccCCCCCc-ccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKIADFNLSNQAPD-MAARLHS  157 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~-~~~~~~~  157 (285)
                      ... +       +++..+..+.+|+++||.|||++   |++||||||+|||++. ++.+||+|||++..... .......
T Consensus       110 ~g~-~-------l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~  178 (313)
T KOG0198|consen  110 YGG-K-------LPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSE  178 (313)
T ss_pred             cCC-C-------CCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccccccccc
Confidence            653 2       89999999999999999999999   9999999999999999 79999999999876543 1111123


Q ss_pred             cccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCC-CCcccchhhhhhcccCchhhhhhhcCCccCCC
Q 023220          158 TRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHT-MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE  235 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
                      ....||+.|+|||++... ..+..+|||||||++.||+||..||... ..               ......+........
T Consensus       179 ~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~---------------~~~~~~ig~~~~~P~  243 (313)
T KOG0198|consen  179 LSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE---------------AEALLLIGREDSLPE  243 (313)
T ss_pred             ccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch---------------HHHHHHHhccCCCCC
Confidence            346799999999999853 3345999999999999999999999752 11               111122222222235


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL  269 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l  269 (285)
                      .+...+.+..+|+.+||++||+.|||++++|+.-
T Consensus       244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            6777889999999999999999999999999843

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-43  Score=301.71  Aligned_cols=235  Identities=23%  Similarity=0.342  Sum_probs=203.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||.+.+..+++.+++|.....+.  ...+-+.+|+.+|+..+|+|||.+++.|...+.+++||||++||+|.+.+....
T Consensus       288 ~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~  365 (550)
T KOG0578|consen  288 GVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR  365 (550)
T ss_pred             ceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc
Confidence            488999999999999997766553  346788899999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                +++.++..+++.++.||+|||.+   ||+|||||.+|||++.+|.+||+|||.+.........  ....+
T Consensus       366 ----------~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--R~TmV  430 (550)
T KOG0578|consen  366 ----------MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--RSTMV  430 (550)
T ss_pred             ----------ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc--ccccc
Confidence                      89999999999999999999999   9999999999999999999999999999776654432  34568


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ||+.|+|||++....|+++.||||||++++||+-|++||-...+......+...+              ......+.-.+
T Consensus       431 GTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng--------------~P~lk~~~klS  496 (550)
T KOG0578|consen  431 GTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG--------------TPKLKNPEKLS  496 (550)
T ss_pred             CCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC--------------CCCcCCccccC
Confidence            9999999999999999999999999999999999999997655433333222211              12224456678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+++|+.+||+.|+.+|+++.+||+
T Consensus       497 ~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  497 PELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             HHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            89999999999999999999999998

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=294.00  Aligned_cols=252  Identities=18%  Similarity=0.262  Sum_probs=204.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceEEEeCC-eeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGN-LRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++....+.+.||+|.-++.-..-+ .-.-.||+.-|++++ |||||++++++.+.+ .+++|||||+. +|.+++++
T Consensus        25 sV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~  102 (538)
T KOG0661|consen   25 SVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKD  102 (538)
T ss_pred             eEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhh
Confidence            589999999999999998776554422 112247999999998 999999999999888 99999999986 99999988


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ++.        .+++..+..|+.||+.||+|+|++   |+.|||+||+|||+.....+||+|||+|+...+...   -+.
T Consensus       103 R~r--------~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP---YTe  168 (538)
T KOG0661|consen  103 RNR--------LFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP---YTE  168 (538)
T ss_pred             cCC--------cCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCCC---cch
Confidence            743        499999999999999999999999   999999999999999888999999999987765332   234


Q ss_pred             cccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhh------hcCCcc
Q 023220          160 VLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQ------CVDPKL  232 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~  232 (285)
                      .+.|.+|+|||++.. ..|+.+.|+|++||+++|+++-++.|.+.++.++...+-.+.+........+      .++-.+
T Consensus       169 YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~  248 (538)
T KOG0661|consen  169 YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRF  248 (538)
T ss_pred             hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCC
Confidence            567899999999865 4679999999999999999999999999988777766555444433322211      111111


Q ss_pred             -------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 023220          233 -------KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL  269 (285)
Q Consensus       233 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l  269 (285)
                             ....-+..++++.++|.+|++.||++|||+.+.++.-
T Consensus       249 P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  249 PQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             CcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence                   1122234788999999999999999999999999853

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=295.40  Aligned_cols=242  Identities=26%  Similarity=0.397  Sum_probs=208.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||++.+..+++.+++|.+ .+...+...+++++|+.+|.+++++||.++|+.+..+..++++|||+.+|++.+.++...
T Consensus        28 ~Vyk~~d~~t~k~vAiKii-~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~  106 (467)
T KOG0201|consen   28 EVYKAIDNKTKKVVAIKII-DLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGN  106 (467)
T ss_pred             eeeeeeeccccceEEEEEe-chhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCC
Confidence            6999999999999999998 466677788999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +.+..+.-++++++.|+.|||..   +.+|||||+.||++..+|.++|+|||++-...+.....  ...+
T Consensus       107 ~---------~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~tfv  172 (467)
T KOG0201|consen  107 I---------LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--KTFV  172 (467)
T ss_pred             C---------CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc--cccc
Confidence            3         47778888999999999999999   99999999999999999999999999997766655443  5568


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ||+.|||||++.+..|+.++||||||++.+||++|.+|+...++..-...+....+            |    .....++
T Consensus       173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~P------------P----~L~~~~S  236 (467)
T KOG0201|consen  173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAP------------P----RLDGDFS  236 (467)
T ss_pred             ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCC------------C----ccccccC
Confidence            99999999999999999999999999999999999999987766333222221111            1    1233567


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      +.+++|+..||++||+.|||+.++++  .++++..
T Consensus       237 ~~~kEFV~~CL~k~P~~RpsA~~LLK--h~FIk~a  269 (467)
T KOG0201|consen  237 PPFKEFVEACLDKNPEFRPSAKELLK--HKFIKRA  269 (467)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhh--hHHHHhc
Confidence            78999999999999999999999998  5555553

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-42  Score=293.95  Aligned_cols=238  Identities=21%  Similarity=0.254  Sum_probs=199.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCC-CCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPK-NYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .|++|.++.++..||+|+..+.--.+ .-.+-+..|=+.|.+| .||+|++++-.|.+...+|+|+||+++|+|.++|+.
T Consensus        88 tV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K  167 (604)
T KOG0592|consen   88 TVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKK  167 (604)
T ss_pred             eEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHH
Confidence            58999999999999999766544332 2345556777888888 899999999999999999999999999999999988


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-----
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-----  154 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-----  154 (285)
                      ...         +.+.....++.+|+.||.|||..   |||||||||+|||+|++++++|.|||.+..+......     
T Consensus       168 ~Gs---------fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~  235 (604)
T KOG0592|consen  168 YGS---------FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPV  235 (604)
T ss_pred             hCc---------chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhccccCcc
Confidence            753         99999999999999999999999   9999999999999999999999999999766532222     


Q ss_pred             --ccc----cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhc
Q 023220          155 --LHS----TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV  228 (285)
Q Consensus       155 --~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
                        ...    ...+||..|.+||++.....+..+|+|+|||++|+|+.|.+||.+..+-            +   -..+++
T Consensus       236 ~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------------l---iFqkI~  300 (604)
T KOG0592|consen  236 DPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY------------L---IFQKIQ  300 (604)
T ss_pred             CcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH------------H---HHHHHH
Confidence              111    3367999999999999999999999999999999999999999755321            0   111222


Q ss_pred             CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          229 DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      .  +.-.+++..++...+|++++|..||.+|+|..+|.+.
T Consensus       301 ~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  301 A--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             H--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            1  2336778888999999999999999999999998773

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=291.89  Aligned_cols=241  Identities=22%  Similarity=0.291  Sum_probs=198.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCC---CCCChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP---KNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      +|+++....++..+++|...+.+..   ....+.+.+|+.++++++ ||||+++++++......++||||+.+|+|.+++
T Consensus        32 kV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i  111 (370)
T KOG0583|consen   32 KVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYI  111 (370)
T ss_pred             eEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHH
Confidence            6888888888899999966654322   245777789999999998 999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC-CeeEEeccccCCCCCccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQAPDMAARLH  156 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~  156 (285)
                      .....         +.+..+..+++|+++|+.|||..   |++||||||+||+++.+ +++||+|||++.......  ..
T Consensus       112 ~~~g~---------l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~--~~  177 (370)
T KOG0583|consen  112 VNKGR---------LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGED--GL  177 (370)
T ss_pred             HHcCC---------CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccCCCC--Cc
Confidence            87332         88899999999999999999999   99999999999999999 999999999998763111  12


Q ss_pred             ccccccccCcCCCcccccCC-CC-cccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          157 STRVLGTFGYHAPEYAMTGQ-LT-QKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~~-~~-~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      .....|++.|+|||++.+.. |+ .++||||+|++||.|++|..||........               ...+....  -
T Consensus       178 l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l---------------~~ki~~~~--~  240 (370)
T KOG0583|consen  178 LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL---------------YRKIRKGE--F  240 (370)
T ss_pred             ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH---------------HHHHhcCC--c
Confidence            24457999999999999887 85 889999999999999999999986432111               11121111  1


Q ss_pred             CCChhH-HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          235 EYPPKG-VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       235 ~~~~~~-~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      .++..+ ++++..++++||..||..|+|+.+++  ...+++.
T Consensus       241 ~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~--~h~w~~~  280 (370)
T KOG0583|consen  241 KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL--EHPWFQK  280 (370)
T ss_pred             cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh--hChhhcc
Confidence            344455 88999999999999999999999999  4666654

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.7e-42  Score=296.74  Aligned_cols=234  Identities=23%  Similarity=0.252  Sum_probs=204.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+..++.+-+++++|.+-+....+.....+.+|++++++++||||+.++++|+...++++|+||+.| +|+.++....
T Consensus        17 ~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~   95 (808)
T KOG0597|consen   17 RVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDG   95 (808)
T ss_pred             eeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhcc
Confidence            799999999999999999988888887888899999999999999999999999999999999999986 9999998765


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         ++++.+..++.++++||.|||++   +|+|||+||+||+++.++.+|++|||+++.+.....  ......
T Consensus        96 ~---------lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~--vltsik  161 (808)
T KOG0597|consen   96 K---------LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS--VLTSIK  161 (808)
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCce--eeeecc
Confidence            3         99999999999999999999999   999999999999999999999999999987765332  345678


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      |||.|+|||++.+..|+..+|.||+||++||++.|++||...+.-.               -+..+....  ...|...+
T Consensus       162 GtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~---------------Lv~~I~~d~--v~~p~~~S  224 (808)
T KOG0597|consen  162 GTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ---------------LVKSILKDP--VKPPSTAS  224 (808)
T ss_pred             CcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH---------------HHHHHhcCC--CCCccccc
Confidence            9999999999999999999999999999999999999997543211               111111100  12355778


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .++..++..+|.+||..|.|..+++.
T Consensus       225 ~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  225 SSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HHHHHHHHHHhhcChhhcccHHHHhc
Confidence            89999999999999999999999986

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-41  Score=296.46  Aligned_cols=245  Identities=22%  Similarity=0.251  Sum_probs=202.7

Q ss_pred             ceeeeeeeeccccChhhhhhc-cCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            3 RWLCCTCQVEESYPSHENERL-KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      |-++.-..|++..++|.+.+. +........+.+||.+|+.+.|||++.+++++++..++|+|.||+++|-|++++-...
T Consensus        28 vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG  107 (786)
T KOG0588|consen   28 VRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG  107 (786)
T ss_pred             ehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhC
Confidence            445555788899999977666 5556678899999999999999999999999999999999999999999999997665


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +++..+..++.||+.|+.|||..   +|+|||+||+|+|+|..+++||+|||+|..-.... .  -....
T Consensus       108 ~---------l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-l--LeTSC  172 (786)
T KOG0588|consen  108 P---------LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-L--LETSC  172 (786)
T ss_pred             C---------CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc-c--ccccC
Confidence            3         88999999999999999999999   99999999999999999999999999997543322 1  12346


Q ss_pred             cccCcCCCcccccCCCC-cccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLT-QKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      |.+.|.|||++++.+|+ .++||||.|++||.|++|+.||++.........+                 ..-.-+.|..+
T Consensus       173 GSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV-----------------~~G~f~MPs~I  235 (786)
T KOG0588|consen  173 GSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV-----------------QRGVFEMPSNI  235 (786)
T ss_pred             CCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH-----------------HcCcccCCCcC
Confidence            89999999999999995 8999999999999999999999844321111111                 01112467888


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCCC
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAP  281 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  281 (285)
                      +.+++++|.+||..||..|+|++|+++  .-+++..+..++
T Consensus       236 s~eaQdLLr~ml~VDp~~RiT~~eI~k--HP~l~g~~~~~~  274 (786)
T KOG0588|consen  236 SSEAQDLLRRMLDVDPSTRITTEEILK--HPFLSGYTSLPS  274 (786)
T ss_pred             CHHHHHHHHHHhccCccccccHHHHhh--CchhhcCCCCCh
Confidence            999999999999999999999999999  556655544443

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.3e-41  Score=273.71  Aligned_cols=264  Identities=19%  Similarity=0.209  Sum_probs=216.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEE--eCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV--EGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++.++.+++.+|.|..+-.+......=.-.+||.+|.+++|||||.+-.++.  +-+..|+||||+++ +|.+++..
T Consensus        91 iVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~  169 (419)
T KOG0663|consen   91 VVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMET  169 (419)
T ss_pred             eEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHh
Confidence            5999999999999999999999988888888899999999999999999999876  34578999999997 99999987


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ..+        .+....+.-++.|++.|++|||.+   .|+|||+|++|+|++..|.+||+|||+|+...+....  -+.
T Consensus       170 m~q--------~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~--~T~  236 (419)
T KOG0663|consen  170 MKQ--------PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP--YTP  236 (419)
T ss_pred             ccC--------CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCccc--Ccc
Confidence            653        399999999999999999999999   9999999999999999999999999999987664332  345


Q ss_pred             cccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhc----------
Q 023220          160 VLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV----------  228 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------  228 (285)
                      .+-|.+|+|||++.+. .|+...|+||+||++.||+++.+.|.+.+..++...+-......+...+-.+.          
T Consensus       237 lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f  316 (419)
T KOG0663|consen  237 LVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTF  316 (419)
T ss_pred             eEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcccc
Confidence            6679999999999876 68999999999999999999999999988877766555444333322111110          


Q ss_pred             ----CCccCCCCChh-HHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCCC
Q 023220          229 ----DPKLKGEYPPK-GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAP  281 (285)
Q Consensus       229 ----~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  281 (285)
                          -..++..++.. .++.-++++..+|.+||.+|.|+++.|+  ..+....|-|.+
T Consensus       317 ~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--h~~F~e~P~p~~  372 (419)
T KOG0663|consen  317 SEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--HEYFRETPLPID  372 (419)
T ss_pred             CCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--ccccccCCCCCC
Confidence                11122223322 5688999999999999999999999998  666655444433

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-40  Score=287.76  Aligned_cols=254  Identities=23%  Similarity=0.320  Sum_probs=191.2

Q ss_pred             Cceeeee-----eeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCC-eeeEEEeeCCCCCHH
Q 023220            2 RRWLCCT-----CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGN-LRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~   74 (285)
                      .||++..     ......+++|..+... .....+.+.+|++++..+ +||||+++++++...+ ..+++|||+.+|+|.
T Consensus        22 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~  100 (338)
T cd05102          22 KVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLS  100 (338)
T ss_pred             eEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHH
Confidence            5788753     2344678888775322 223356788999999999 8999999999887644 578999999999999


Q ss_pred             HHhccCCCCCC-----------------------------------------------------CCCCCCCCHHHHHHHH
Q 023220           75 DILHGRKGVQG-----------------------------------------------------AQPGPVLDWMTRVRIA  101 (285)
Q Consensus        75 ~~l~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~~~~  101 (285)
                      +++........                                                     ......+++..+..++
T Consensus       101 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  180 (338)
T cd05102         101 NFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYS  180 (338)
T ss_pred             HHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHH
Confidence            99975321000                                                     0001247888999999


Q ss_pred             HHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccccCCCCccc
Q 023220          102 VDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKS  181 (285)
Q Consensus       102 ~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  181 (285)
                      .|++.||.|||+.   |++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++
T Consensus       181 ~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s  257 (338)
T cd05102         181 FQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQS  257 (338)
T ss_pred             HHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCccc
Confidence            9999999999999   9999999999999999999999999998754322211112233456789999999888899999


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCC
Q 023220          182 DVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP  260 (285)
Q Consensus       182 DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (285)
                      |||||||++|+|++ |..||........               ....+........+..+++.+.+++.+||+.||.+||
T Consensus       258 DiwslG~il~el~~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  322 (338)
T cd05102         258 DVWSFGVLLWEIFSLGASPYPGVQINEE---------------FCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP  322 (338)
T ss_pred             CHHHHHHHHHHHHhCCCCCCCCCCccHH---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence            99999999999997 9999976432111               0000111111123445677899999999999999999


Q ss_pred             CHHHHHHHhchhhc
Q 023220          261 NMSIVVKALQPLLK  274 (285)
Q Consensus       261 s~~~ll~~l~~~~~  274 (285)
                      |+.++++.|++++.
T Consensus       323 s~~el~~~l~~~~~  336 (338)
T cd05102         323 TFSALVEILGDLLQ  336 (338)
T ss_pred             CHHHHHHHHHHHHh
Confidence            99999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1e-40  Score=281.69  Aligned_cols=239  Identities=19%  Similarity=0.301  Sum_probs=188.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEe----CCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVE----GNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++..  .++.+++|..+..... +...+.+.+|+.++++++||||+++++++.+    ....+++|||+.+|+|.++
T Consensus        35 ~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~  112 (283)
T PHA02988         35 SIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREV  112 (283)
T ss_pred             EEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHH
Confidence            3566643  5667888877654322 2235778899999999999999999999877    3467999999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH  156 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  156 (285)
                      +.....         +++...+.++.+++.|+.|||+..  +++||||+|+||+++.++.++|+|||++.......    
T Consensus       113 l~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----  177 (283)
T PHA02988        113 LDKEKD---------LSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----  177 (283)
T ss_pred             HhhCCC---------CChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence            976532         788899999999999999999732  78899999999999999999999999986543211    


Q ss_pred             ccccccccCcCCCccccc--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          157 STRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                       ....++..|+|||.+.+  ..++.++|||||||++|+|++|..||.........               ..+.......
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~---------------~~i~~~~~~~  241 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY---------------DLIINKNNSL  241 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH---------------HHHHhcCCCC
Confidence             22357889999999876  67899999999999999999999999755322111               1111111122


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ..+..+++.+.+++.+||+.||++|||+.++++.|+.+-
T Consensus       242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            334457788999999999999999999999999998764

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1e-40  Score=282.27  Aligned_cols=253  Identities=17%  Similarity=0.189  Sum_probs=195.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|..+.........+.+.+|++++++++||||+++++++..++..++||||+.++++..+.....
T Consensus        16 ~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~   95 (287)
T cd07848          16 VVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN   95 (287)
T ss_pred             EEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCC
Confidence            58999998889999999887666556667888999999999999999999999999999999999999876655543221


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                               .+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++......... ......
T Consensus        96 ---------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~  162 (287)
T cd07848          96 ---------GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYV  162 (287)
T ss_pred             ---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccc
Confidence                     288899999999999999999999   9999999999999999999999999998765322211 112345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhc-CC--------cc
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV-DP--------KL  232 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--------~~  232 (285)
                      |+..|+|||.+.+..++.++|+||+||++|+|++|+.||...........+.......+........ ++        ..
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (287)
T cd07848         163 ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAV  242 (287)
T ss_pred             cccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcc
Confidence            7889999999988889999999999999999999999998754433222222222222211111100 00        00


Q ss_pred             ------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          233 ------KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       233 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                            ........+.++.+++++||+.||.+|||++++++
T Consensus       243 ~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         243 NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                  01112235678999999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=277.97  Aligned_cols=253  Identities=22%  Similarity=0.260  Sum_probs=211.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe-----CCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE-----GNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~   76 (285)
                      .|+.+.++.+++.+|+|.+..--.+....++..+|+.+|+.++|+||+.+.+++..     -+..|+|+|+|+. +|.+.
T Consensus        37 vVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMet-DL~~i  115 (359)
T KOG0660|consen   37 VVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMET-DLHQI  115 (359)
T ss_pred             eEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHhh-HHHHH
Confidence            36777788999999999888777777788899999999999999999999999875     3477999999965 99999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH  156 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  156 (285)
                      ++.+..         ++...+..++.|++.|++|+|+.   +++|||+||.|++++.+..+||+|||+|+..........
T Consensus       116 ik~~~~---------L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~  183 (359)
T KOG0660|consen  116 IKSQQD---------LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGF  183 (359)
T ss_pred             HHcCcc---------ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcccc
Confidence            998764         89999999999999999999999   999999999999999999999999999987654322222


Q ss_pred             ccccccccCcCCCcccc-cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc---
Q 023220          157 STRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL---  232 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  232 (285)
                      .+..+.|.+|+|||++. ...|+...||||+||++.||++|++.|.+.+...+...+....+..+.+.+..+-+...   
T Consensus       184 mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~y  263 (359)
T KOG0660|consen  184 MTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPY  263 (359)
T ss_pred             hhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHH
Confidence            34556789999999875 45799999999999999999999999999998888888777777766655544432111   


Q ss_pred             --------C---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          233 --------K---GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       233 --------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                              .   ....+..++...+++.+||.+||.+|+|+++.++
T Consensus       264 i~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  264 IKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                    0   1112355778999999999999999999999987

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.7e-40  Score=277.02  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=193.4

Q ss_pred             Cceeeeeeeec-----cccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVE-----ESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++......     ..+++|..+... .....+.+.+|++++++++||||+++++++......+++|||+.+++|.++
T Consensus        20 ~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~   98 (283)
T cd05048          20 KVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEF   98 (283)
T ss_pred             cEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHH
Confidence            57777655443     456666554221 222356788999999999999999999999998899999999999999999


Q ss_pred             hccCCCCCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCC
Q 023220           77 LHGRKGVQGAQ-------PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP  149 (285)
Q Consensus        77 l~~~~~~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~  149 (285)
                      +..........       ....++...++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++....
T Consensus        99 l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~  175 (283)
T cd05048          99 LVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY  175 (283)
T ss_pred             HHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEEECCCcceeecc
Confidence            97653321110       012388899999999999999999999   99999999999999999999999999986543


Q ss_pred             cccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhc
Q 023220          150 DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV  228 (285)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
                      ............+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+....                .+...+
T Consensus       176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----------------~~~~~i  239 (283)
T cd05048         176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----------------EVIEMI  239 (283)
T ss_pred             ccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----------------HHHHHH
Confidence            2222112233446788999999988889999999999999999998 99999754332                111112


Q ss_pred             CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          229 DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      ........+..++.++.+++.+||+.||++||++.++++.|+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            12222234566788999999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1e-40  Score=286.94  Aligned_cols=235  Identities=19%  Similarity=0.201  Sum_probs=192.3

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|..++... .......+.+|++++++++||||+++++++...+..++||||+.+++|.+++...
T Consensus        10 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   89 (323)
T cd05571          10 KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE   89 (323)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc
Confidence            589999888899999997765432 2334466778999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  .....
T Consensus        90 ~~---------~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~  155 (323)
T cd05571          90 RV---------FSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTF  155 (323)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccce
Confidence            42         88999999999999999999999   999999999999999999999999999864322111  12234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||.+.+..++.++|+||+||++|+|++|..||...+.......               +...  ...++...
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~---------------~~~~--~~~~p~~~  218 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---------------ILME--EIRFPRTL  218 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH---------------HHcC--CCCCCCCC
Confidence            589999999999988999999999999999999999999975432211111               1110  11334566


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRP-----NMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp-----s~~~ll~  267 (285)
                      +.++.++|.+||+.||++||     ++.++++
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            78899999999999999999     7998876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.2e-41  Score=285.93  Aligned_cols=238  Identities=22%  Similarity=0.307  Sum_probs=205.9

Q ss_pred             ceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCe-eeEEEeeCCCCCHHHHhccCC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL-RVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .|++..+.-...|+.|.+.........++...+|+.++++++|||||.+.+.|..++. ++|+|+|++||++.+.+.+++
T Consensus        20 a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k   99 (426)
T KOG0589|consen   20 ALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQK   99 (426)
T ss_pred             hhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHh
Confidence            4566666666678888888777777778889999999999999999999999999887 899999999999999998876


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.|+.|++.|+.|||++   +++|||||+.||++++++.|+|+|||+++.+.....  ......
T Consensus       100 ~~-------~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~--~a~tvv  167 (426)
T KOG0589|consen  100 GV-------LFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS--LASTVV  167 (426)
T ss_pred             hc-------cccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchh--hhheec
Confidence            32       399999999999999999999999   999999999999999999999999999998766442  245578


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ||+.|++||++.+.+|..++|||||||++|||++-+++|...+...                +...+.+....+.+..++
T Consensus       168 GTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~----------------Li~ki~~~~~~Plp~~ys  231 (426)
T KOG0589|consen  168 GTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE----------------LILKINRGLYSPLPSMYS  231 (426)
T ss_pred             CCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH----------------HHHHHhhccCCCCCcccc
Confidence            9999999999999999999999999999999999999998665322                222222333456677888


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      .++..+++.||+.+|..||++.+++..
T Consensus       232 ~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  232 SELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            999999999999999999999999975

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.1e-39  Score=270.83  Aligned_cols=242  Identities=24%  Similarity=0.332  Sum_probs=195.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.....+..+++|..+.   .....+.+.+|++++++++|+||+++++++..++..+++|||+.+++|.+++....
T Consensus        21 ~v~~~~~~~~~~~~~~K~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   97 (263)
T cd05052          21 EVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN   97 (263)
T ss_pred             eEEEEEEecCCceEEEEEecC---CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCC
Confidence            589998888888898887653   22235678899999999999999999999999999999999999999999986543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.|++.+++|||++   |++|+||+|+||+++.++.++|+|||++......... ......
T Consensus        98 ~~-------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~  166 (263)
T cd05052          98 RQ-------EVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAK  166 (263)
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCC
Confidence            21       278899999999999999999999   9999999999999999999999999998765432211 111223


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+.+..++.++|+|||||++|+|++ |..||.......                ....+........+..+
T Consensus       167 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~  230 (263)
T cd05052         167 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEKGYRMERPEGC  230 (263)
T ss_pred             CccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----------------HHHHHHCCCCCCCCCCC
Confidence            4567999999988889999999999999999998 999986543211                11111222223445566


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      +.++.+++.+||+.+|++|||+.++++.|+.++
T Consensus       231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         231 PPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence            788999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.5e-40  Score=277.22  Aligned_cols=251  Identities=20%  Similarity=0.268  Sum_probs=191.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..++..+++|..+... .......+.+|++++++++||||+++++++.+.+..++||||+.+ +|.+++....
T Consensus        20 ~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~   97 (288)
T cd07871          20 TVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCG   97 (288)
T ss_pred             EEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcC
Confidence            58999988889999999875433 334456788999999999999999999999999999999999975 8988886543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .++...+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++........  ......
T Consensus        98 ~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~  164 (288)
T cd07871          98 N--------LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEV  164 (288)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cccCce
Confidence            2        278889999999999999999999   999999999999999999999999999865432211  112345


Q ss_pred             cccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh---------hhcCCc
Q 023220          162 GTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK---------QCVDPK  231 (285)
Q Consensus       162 ~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~  231 (285)
                      +++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.........+.........+...         ....+.
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (288)
T cd07871         165 VTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQ  244 (288)
T ss_pred             ecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCc
Confidence            7889999998865 467899999999999999999999998765433322222111111111111         111111


Q ss_pred             cCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          232 LKG----EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       232 ~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...    ......+.+..++|++||+.||.+|||++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         245 YRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            100    011234667899999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.5e-39  Score=270.01  Aligned_cols=241  Identities=23%  Similarity=0.341  Sum_probs=191.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.....++.+++|..... ........+.+|++++++++||||+++++++......++||||+.+++|.+++....
T Consensus        10 ~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   88 (252)
T cd05084          10 EVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG   88 (252)
T ss_pred             cEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCC
Confidence            5899988888888998876532 223345678999999999999999999999999999999999999999999986432


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||++................
T Consensus        89 ~--------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          89 P--------RLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            2        278899999999999999999999   99999999999999999999999999986543211111111112


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+.+..++.++|+||||+++|+|++ |..||......                .....+........+..+
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~  221 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ----------------QTREAIEQGVRLPCPELC  221 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH----------------HHHHHHHcCCCCCCcccC
Confidence            3456999999988889999999999999999997 88888643321                111111122222344556


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      +..+.+++.+||+.+|++|||+.++++.|+
T Consensus       222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            778999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.6e-40  Score=283.14  Aligned_cols=253  Identities=19%  Similarity=0.247  Sum_probs=189.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC-----CeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG-----NLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++.+..++..+++|..............+.+|++++++++||||+++++++...     ...+++|||+. ++|.++
T Consensus        15 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~   93 (338)
T cd07859          15 VVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQV   93 (338)
T ss_pred             EEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHH
Confidence            589999888899999997765444444456788999999999999999999988643     25799999996 589998


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-c
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-L  155 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~  155 (285)
                      +.....         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......... .
T Consensus        94 l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  161 (338)
T cd07859          94 IKANDD---------LTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI  161 (338)
T ss_pred             HHhccc---------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccccCccc
Confidence            875432         88999999999999999999999   9999999999999999999999999998754322111 1


Q ss_pred             cccccccccCcCCCccccc--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh------
Q 023220          156 HSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC------  227 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------  227 (285)
                      ......|++.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.........+..............+      
T Consensus       162 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  241 (338)
T cd07859         162 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKAR  241 (338)
T ss_pred             cccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHH
Confidence            1123468899999998865  57889999999999999999999999765432222211111111111111110      


Q ss_pred             -----cCCccC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          228 -----VDPKLK---GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       228 -----~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                           +.+...   ....+..++.+.+++.+||+.||++|||++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         242 RYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                 000000   0111234667899999999999999999999997

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=281.06  Aligned_cols=233  Identities=21%  Similarity=0.242  Sum_probs=191.4

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|....... .....+.+.+|++++++++||||+++++++.+.+..+++|||+.+++|.+++...
T Consensus        16 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   95 (291)
T cd05612          16 RVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS   95 (291)
T ss_pred             EEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHc
Confidence            589999988899999997754322 2234567889999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.|++.||.|||++   |++||||+|+||+++.++.++|+|||++......     ....
T Consensus        96 ~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~  158 (291)
T cd05612          96 GR---------FSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTL  158 (291)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccc
Confidence            42         78899999999999999999999   9999999999999999999999999998754321     1234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||.+.+..++.++|||||||++|+|++|..||.........               ..+....  ...+...
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~---------------~~i~~~~--~~~~~~~  221 (291)
T cd05612         159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY---------------EKILAGK--LEFPRHL  221 (291)
T ss_pred             cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---------------HHHHhCC--cCCCccC
Confidence            5789999999998888999999999999999999999999765432111               1111111  1234455


Q ss_pred             HHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPN-----MSIVVKA  268 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps-----~~~ll~~  268 (285)
                      +..+.++|++||+.||.+||+     ++++++.
T Consensus       222 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         222 DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            778999999999999999995     8888864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=8.6e-40  Score=276.45  Aligned_cols=240  Identities=19%  Similarity=0.250  Sum_probs=191.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|....+++.+++|........ ......+.+|+.++++++|++|+++++++.+++..+++|||+.+|+|.+++...
T Consensus        15 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~   94 (285)
T cd05631          15 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM   94 (285)
T ss_pred             EEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhh
Confidence            5899988888999999976543322 233456788999999999999999999999999999999999999998887543


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...       .+++..+..++.|++.|+.|||+.   |++||||||+||+++.++.++|+|||++........   ....
T Consensus        95 ~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~  161 (285)
T cd05631          95 GNP-------GFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGR  161 (285)
T ss_pred             CCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCC
Confidence            221       288899999999999999999999   999999999999999999999999999865432211   1234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|+..|+|||.+.+..++.++|||||||++|+|++|+.||..........            .+...+ .......+...
T Consensus       162 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~------------~~~~~~-~~~~~~~~~~~  228 (285)
T cd05631         162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE------------EVDRRV-KEDQEEYSEKF  228 (285)
T ss_pred             CCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH------------HHHHHh-hcccccCCccC
Confidence            68899999999998899999999999999999999999997654321111            111110 01112344556


Q ss_pred             HHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPN-----MSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps-----~~~ll~  267 (285)
                      +..+.+++.+||+.||.+||+     ++++++
T Consensus       229 s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         229 SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            788999999999999999997     788887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.8e-40  Score=284.07  Aligned_cols=233  Identities=21%  Similarity=0.241  Sum_probs=191.7

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|....+++.+++|..+.... .....+.+.+|+.++++++||||+++++++.+++..+++|||+.+++|.+++...
T Consensus        33 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  112 (329)
T PTZ00263         33 RVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA  112 (329)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHc
Confidence            589999888899999997765432 2344677889999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++.......     ...
T Consensus       113 ~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~  175 (329)
T PTZ00263        113 GR---------FPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTL  175 (329)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----cee
Confidence            32         78889999999999999999999   99999999999999999999999999987543221     234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||.+.+..++.++|+|||||++|+|++|..||........               ...+....  ...+..+
T Consensus       176 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---------------~~~i~~~~--~~~p~~~  238 (329)
T PTZ00263        176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI---------------YEKILAGR--LKFPNWF  238 (329)
T ss_pred             cCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH---------------HHHHhcCC--cCCCCCC
Confidence            588999999999988899999999999999999999999975432111               11111111  1234446


Q ss_pred             HHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPN-----MSIVVKA  268 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps-----~~~ll~~  268 (285)
                      +..+.+++.+||+.||.+||+     +++++..
T Consensus       239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            678999999999999999997     6887743

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-40  Score=281.71  Aligned_cols=235  Identities=17%  Similarity=0.176  Sum_probs=190.7

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.+..++..+++|..+... ........+.+|++++++++||||+++++++...+..++||||+.+|+|.+++...
T Consensus         8 ~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~   87 (312)
T cd05585           8 KVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQRE   87 (312)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhc
Confidence            58999998888999999775432 23344567788999999999999999999999999999999999999999999754


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  .....
T Consensus        88 ~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~  153 (312)
T cd05585          88 GR---------FDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTF  153 (312)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccc
Confidence            32         88899999999999999999999   999999999999999999999999999865322111  12334


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||.+.+..++.++||||+||++|+|++|..||.......               ....+...  ....+...
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---------------~~~~~~~~--~~~~~~~~  216 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---------------MYRKILQE--PLRFPDGF  216 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---------------HHHHHHcC--CCCCCCcC
Confidence            58999999999998889999999999999999999999997543211               11111111  11334566


Q ss_pred             HHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPN---MSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps---~~~ll~  267 (285)
                      ++.+.+++.+||+.||.+||+   +.+++.
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            788999999999999999985   566654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=258.17  Aligned_cols=248  Identities=21%  Similarity=0.260  Sum_probs=193.3

Q ss_pred             ceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC-----eeeEEEeeCCCCCHHHHh
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN-----LRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l   77 (285)
                      ||++-...+...|+.|.+....  .+..+..++|++.-++++|||+++++++...+.     ..||+++|+..|+|.+.+
T Consensus        37 v~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i  114 (302)
T KOG2345|consen   37 VDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEI  114 (302)
T ss_pred             eeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHH
Confidence            5566566778888888776544  556788899999999999999999999876443     379999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~--~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      +.....     +..+++..++.|+.++++||.+||+.   .  +.||||||.||++++.+.+++.|||.+...+-.....
T Consensus       115 ~~~k~k-----g~~~sE~~iL~if~gic~gL~~lH~~---~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~  186 (302)
T KOG2345|consen  115 ERLKIK-----GNFVSEAQILWIFLGICRGLEALHEK---EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGS  186 (302)
T ss_pred             HHHhhc-----CCccCHHHHHHHHHHHHHHHHHHhcc---CCcccccCCCcceeEecCCCceEEEeccCccccceEeech
Confidence            765422     22499999999999999999999999   6  9999999999999999999999999997664222111


Q ss_pred             c-------ccccccccCcCCCcccc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh
Q 023220          156 H-------STRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK  225 (285)
Q Consensus       156 ~-------~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
                      .       .....++..|+|||.+.   +...++++|||||||++|.|++|..||+..-..+. +            ...
T Consensus       187 ~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-S------------laL  253 (302)
T KOG2345|consen  187 RQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-S------------LAL  253 (302)
T ss_pred             HHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-e------------EEE
Confidence            1       11235789999999885   34568999999999999999999999974322111 0            011


Q ss_pred             hhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          226 QCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ...++...-.....+++.+.++|++|++.||.+||++.+++..++.++
T Consensus       254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            111222222223347889999999999999999999999999998765

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-39  Score=285.58  Aligned_cols=253  Identities=23%  Similarity=0.352  Sum_probs=191.7

Q ss_pred             Cceeeeeeee-----ccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQV-----EESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~-----~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      +||++....+     ...|++|..+... .....+.+.+|+++++.+ +|+||+++++++...+..+++|||+.+|+|.+
T Consensus        53 ~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~  131 (374)
T cd05106          53 KVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLN  131 (374)
T ss_pred             cEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHH
Confidence            5777765332     2467777765432 223356788999999999 89999999999999999999999999999999


Q ss_pred             HhccCCCC-------------------------------------------------------------CCCCCCCCCCH
Q 023220           76 ILHGRKGV-------------------------------------------------------------QGAQPGPVLDW   94 (285)
Q Consensus        76 ~l~~~~~~-------------------------------------------------------------~~~~~~~~~~~   94 (285)
                      ++......                                                             ........+++
T Consensus       132 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  211 (374)
T cd05106         132 FLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDL  211 (374)
T ss_pred             HHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCH
Confidence            98643210                                                             00011224788


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCccccc
Q 023220           95 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT  174 (285)
Q Consensus        95 ~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  174 (285)
                      ..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++................++..|+|||.+..
T Consensus       212 ~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  288 (374)
T cd05106         212 DDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD  288 (374)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC
Confidence            89999999999999999999   999999999999999999999999999875433221111122334567999999988


Q ss_pred             CCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcc
Q 023220          175 GQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQ  253 (285)
Q Consensus       175 ~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  253 (285)
                      ..++.++|||||||++|+|++ |..||........               .............+...+.++.+++.+||+
T Consensus       289 ~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  353 (374)
T cd05106         289 CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---------------FYKMVKRGYQMSRPDFAPPEIYSIMKMCWN  353 (374)
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---------------HHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence            889999999999999999997 9999975432111               111111122222334456789999999999


Q ss_pred             cCCCCCCCHHHHHHHhchhh
Q 023220          254 YEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       254 ~~p~~Rps~~~ll~~l~~~~  273 (285)
                      .||++|||+.++++.|++++
T Consensus       354 ~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         354 LEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CChhhCcCHHHHHHHHHHHh
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.6e-40  Score=281.42  Aligned_cols=236  Identities=19%  Similarity=0.194  Sum_probs=192.6

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..++..+++|..++... .......+.+|+++++.++||||+++++++...+..++||||+.+|+|..++...
T Consensus        10 ~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~   89 (328)
T cd05593          10 KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE   89 (328)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhc
Confidence            589999988899999997765432 2334567788999999999999999999999999999999999999999888654


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++........  .....
T Consensus        90 ~~---------l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~  155 (328)
T cd05593          90 RV---------FSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTF  155 (328)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--ccccc
Confidence            32         88999999999999999999999   999999999999999999999999999865322111  11234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+......               .+...  ....+..+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~---------------~~~~~--~~~~p~~~  218 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---------------LILME--DIKFPRTL  218 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH---------------HhccC--CccCCCCC
Confidence            58899999999988889999999999999999999999997543221111               11110  11345567


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRP-----NMSIVVKA  268 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp-----s~~~ll~~  268 (285)
                      +.++.+++.+||+.||++||     ++.++++.
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            78899999999999999997     89998863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.1e-40  Score=272.70  Aligned_cols=234  Identities=21%  Similarity=0.268  Sum_probs=196.7

Q ss_pred             ceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      |-++.+......+++|.+++.+-. ++-.-.+.+||++|+.|+||||+.++++|++.+..+|||||..+|.|.+|+....
T Consensus        69 Vk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~  148 (668)
T KOG0611|consen   69 VKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERG  148 (668)
T ss_pred             eeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhc
Confidence            556677778889999988876643 3345567899999999999999999999999999999999999999999998776


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +++..+..+++||++|+.|+|++   +++|||+|.+|||+|.+++++|+|||++........   ..-..
T Consensus       149 ~---------LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf---LqTFC  213 (668)
T KOG0611|consen  149 S---------LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF---LQTFC  213 (668)
T ss_pred             c---------ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccccH---HHHhc
Confidence            4         99999999999999999999999   999999999999999999999999999876543222   23356


Q ss_pred             cccCcCCCcccccCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      |++.|.+||++.+..| ++-.|-||||++||-|+.|..||.+.+.               ...++++-....   ..++.
T Consensus       214 GSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---------------k~lvrQIs~GaY---rEP~~  275 (668)
T KOG0611|consen  214 GSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---------------KRLVRQISRGAY---REPET  275 (668)
T ss_pred             CCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---------------HHHHHHhhcccc---cCCCC
Confidence            8999999999999988 5889999999999999999999987653               122333333222   23445


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKAL  269 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l  269 (285)
                      |.+..-+|++||-.||.+|.|++|+...+
T Consensus       276 PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  276 PSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            66788899999999999999999998754

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-40  Score=283.12  Aligned_cols=241  Identities=19%  Similarity=0.172  Sum_probs=193.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|..+..... ......+.+|++++.+++||||+++++++.+.+..++||||+.+++|.+++...
T Consensus        16 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~   95 (333)
T cd05600          16 QVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL   95 (333)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHc
Confidence            5899998888999999987654322 234567889999999999999999999999999999999999999999999754


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.|++.||.|||+.   |++||||+|+||+++.++.++|+|||++.....     .....
T Consensus        96 ~~---------l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~  158 (333)
T cd05600          96 GV---------LSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSV  158 (333)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCc
Confidence            32         78899999999999999999999   999999999999999999999999999875433     12345


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||.+.+..++.++|||||||++|+|++|..||...........+......        ...+.. ......+
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------~~~~~~-~~~~~~~  229 (333)
T cd05600         159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET--------LQRPVY-DDPRFNL  229 (333)
T ss_pred             ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc--------ccCCCC-Ccccccc
Confidence            6889999999999889999999999999999999999999765432221111000000        000000 0001245


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      +.++.+++.+||..+|.+||++.++++.
T Consensus       230 s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         230 SDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            7789999999999999999999999974

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.5e-39  Score=283.54  Aligned_cols=252  Identities=21%  Similarity=0.299  Sum_probs=191.2

Q ss_pred             Cceeeee-----eeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCT-----CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|..     ..+...+++|..+.... ....+.+.+|+++++.+ +||||+++++++...+..++||||+.+|+|.+
T Consensus        50 ~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~  128 (375)
T cd05104          50 KVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLN  128 (375)
T ss_pred             eEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHH
Confidence            4677742     34455788887754332 23456788999999999 89999999999999999999999999999999


Q ss_pred             HhccCCCCCC------------------------------------------------------------------CCCC
Q 023220           76 ILHGRKGVQG------------------------------------------------------------------AQPG   89 (285)
Q Consensus        76 ~l~~~~~~~~------------------------------------------------------------------~~~~   89 (285)
                      ++........                                                                  ....
T Consensus       129 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  208 (375)
T cd05104         129 FLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDE  208 (375)
T ss_pred             HHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccC
Confidence            9975431100                                                                  0011


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCC
Q 023220           90 PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAP  169 (285)
Q Consensus        90 ~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aP  169 (285)
                      ..+++..++.++.|++.|+.|||+.   |++||||||+||+++.++.++|+|||++................++..|+||
T Consensus       209 ~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  285 (375)
T cd05104         209 LALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAP  285 (375)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeCh
Confidence            2378889999999999999999999   9999999999999999999999999998755432221112223345679999


Q ss_pred             cccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHH
Q 023220          170 EYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVA  248 (285)
Q Consensus       170 E~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  248 (285)
                      |.+.+..++.++|+|||||++|+|++ |..||.......               .....+........+...+.++.+++
T Consensus       286 E~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li  350 (375)
T cd05104         286 ESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---------------KFYKMIKEGYRMLSPECAPSEMYDIM  350 (375)
T ss_pred             hHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---------------HHHHHHHhCccCCCCCCCCHHHHHHH
Confidence            99998899999999999999999998 888986542211               11111121222222334567899999


Q ss_pred             HHhcccCCCCCCCHHHHHHHhchh
Q 023220          249 ALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       249 ~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      .+||+.||++|||+.++++.|++.
T Consensus       351 ~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         351 KSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHccCChhHCcCHHHHHHHHHhh
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.1e-39  Score=280.64  Aligned_cols=235  Identities=20%  Similarity=0.208  Sum_probs=191.3

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.+..++..+++|..+.... .+.....+.+|++++++++||||+++++.+...+..++||||+.+++|..++...
T Consensus        10 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~   89 (323)
T cd05595          10 KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE   89 (323)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHc
Confidence            589998888899999997765432 2334556778999999999999999999999999999999999999999888765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  .....
T Consensus        90 ~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~  155 (323)
T cd05595          90 RV---------FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTF  155 (323)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccc
Confidence            42         88999999999999999999999   999999999999999999999999998864322111  11234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+......               .+....  ...+..+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~---------------~~~~~~--~~~p~~~  218 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---------------LILMEE--IRFPRTL  218 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH---------------HHhcCC--CCCCCCC
Confidence            58899999999988889999999999999999999999997554321111               111111  1234566


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRP-----NMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp-----s~~~ll~  267 (285)
                      ++++.++|.+||+.||.+||     ++.++++
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            78899999999999999998     8888876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=258.77  Aligned_cols=236  Identities=19%  Similarity=0.230  Sum_probs=197.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|+...+++.|+.|.+...+....-.+++.+|+++-+.|+||||+++.+.+.+....|+|||++.|++|..-+-.+.
T Consensus        26 vVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~  105 (355)
T KOG0033|consen   26 VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE  105 (355)
T ss_pred             HHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHH
Confidence            58999999999999999988888777788999999999999999999999999999999999999999998855543332


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEc---cCCeeEEeccccCCCCCccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                               .+++..+-.+++||++|+.|+|.+   ||+|||+||.|+++.   ..--+||+|||++....   ......
T Consensus       106 ---------~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g~~~~  170 (355)
T KOG0033|consen  106 ---------FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---DGEAWH  170 (355)
T ss_pred             ---------HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC---Cccccc
Confidence                     388999999999999999999999   999999999999994   34568999999997655   222346


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc--CCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL--KGEY  236 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  236 (285)
                      ...|+|.|+|||++....|+..+|||+.|+++|-|+.|.+||.+.+......               .+.....  ....
T Consensus       171 G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye---------------~I~~g~yd~~~~~  235 (355)
T KOG0033|consen  171 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYE---------------QIKAGAYDYPSPE  235 (355)
T ss_pred             cccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHH---------------HHhccccCCCCcc
Confidence            6789999999999999999999999999999999999999998754322211               1111111  1112


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      =+.++++.++++++||..||.+|+|+.|.|+
T Consensus       236 w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  236 WDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            2456789999999999999999999999876

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.5e-39  Score=278.36  Aligned_cols=251  Identities=19%  Similarity=0.234  Sum_probs=191.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..++..+++|..... ......+.+.+|++++++++||||+++++++..++..+++|||+.+++|.+++....
T Consensus        20 ~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   98 (331)
T cd06649          20 VVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK   98 (331)
T ss_pred             EEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC
Confidence            4788888888888888877542 122345678999999999999999999999999999999999999999999997654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +++..+..++.|++.|+.|||+..  +++|+||||+||+++.++.++|+|||++.......    .....
T Consensus        99 ~---------~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~  163 (331)
T cd06649          99 R---------IPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFV  163 (331)
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc----cccCC
Confidence            2         788999999999999999999851  59999999999999999999999999986543221    23345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhc-------------------------
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT-------------------------  216 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-------------------------  216 (285)
                      |+..|+|||.+.+..++.++|+|||||++|+|++|+.||................                         
T Consensus       164 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (331)
T cd06649         164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGH  243 (331)
T ss_pred             CCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccccccc
Confidence            8899999999998889999999999999999999999997543221111000000                         


Q ss_pred             -----ccCchhhhhhhcCCccCC-CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          217 -----PRLSEDKVKQCVDPKLKG-EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       217 -----~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                           +..........+...... .....++.++.++|.+||+.||++|||+.++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         244 GMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                 000000000001001111 1122457789999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.9e-39  Score=269.16  Aligned_cols=243  Identities=22%  Similarity=0.284  Sum_probs=188.3

Q ss_pred             Cceeeeee---eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTC---QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++...   .....+++|..+.... ......+.+|+.++++++||||+++++++..++..++||||+.+|+|.+++.
T Consensus        20 ~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   98 (266)
T cd05064          20 ELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR   98 (266)
T ss_pred             eEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHH
Confidence            46666432   3345677776654322 2334678899999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....        .+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++++|||.+........ ....
T Consensus        99 ~~~~--------~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  166 (266)
T cd05064          99 KHEG--------QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTM  166 (266)
T ss_pred             hCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccch-hccc
Confidence            5432        288999999999999999999999   999999999999999999999999998754322111 1111


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...++..|+|||.+.+..++.++|||||||++|++++ |..||........                ...+........+
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~  230 (266)
T cd05064         167 SGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV----------------IKAVEDGFRLPAP  230 (266)
T ss_pred             CCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH----------------HHHHHCCCCCCCC
Confidence            2234568999999988889999999999999999775 9999975432211                1111111122335


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ..++..+.+++.+||+.+|.+||+++++++.|++++
T Consensus       231 ~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~  266 (266)
T cd05064         231 RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV  266 (266)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence            567788999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-40  Score=261.35  Aligned_cols=224  Identities=22%  Similarity=0.297  Sum_probs=194.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCC-CCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPK-NYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      ||-++..+.++.+||+|.-.+.+.-+ ...+...+|-++|+.+.||.++++++.+.+...+++||||..||.|+++++..
T Consensus        59 rV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~  138 (355)
T KOG0616|consen   59 RVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKS  138 (355)
T ss_pred             eEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhc
Confidence            67788889999999999665444332 24677778999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+.-++.|++.|+.|||..   ++++||+||+|||+|.+|.++|.|||.+......     +.-.
T Consensus       139 ~r---------F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~Tl  201 (355)
T KOG0616|consen  139 GR---------FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTL  201 (355)
T ss_pred             CC---------CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-----EEEe
Confidence            53         89999999999999999999999   9999999999999999999999999999765432     3446


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|||.|+|||++....+..++|-|+||+++|||+.|.+||....+.               ....+++...+  .+|.-.
T Consensus       202 CGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~---------------~iY~KI~~~~v--~fP~~f  264 (355)
T KOG0616|consen  202 CGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI---------------QIYEKILEGKV--KFPSYF  264 (355)
T ss_pred             cCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH---------------HHHHHHHhCcc--cCCccc
Confidence            7999999999999999999999999999999999999999876543               22334444333  567778


Q ss_pred             HHHHHHHHHHhcccCCCCC
Q 023220          241 VAKLAAVAALCVQYEAEFR  259 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~R  259 (285)
                      +.++.++++++|+.|-.+|
T Consensus       265 s~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  265 SSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             CHHHHHHHHHHHhhhhHhh
Confidence            8899999999999999999

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.4e-39  Score=290.85  Aligned_cols=240  Identities=19%  Similarity=0.249  Sum_probs=187.0

Q ss_pred             Cceeeeeeee-ccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQV-EESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.+... ++.+++|....  ........+.+|+++++.++||||+++++++..++..++||||+.+|+|.+++...
T Consensus        82 ~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~  159 (478)
T PTZ00267         82 AAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQR  159 (478)
T ss_pred             EEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHH
Confidence            4688877665 56666665432  12223456778999999999999999999999999999999999999999888643


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...     ...+++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++...............
T Consensus       160 ~~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~  231 (478)
T PTZ00267        160 LKE-----HLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF  231 (478)
T ss_pred             Hhc-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccccccc
Confidence            211     11388899999999999999999999   9999999999999999999999999998765432222122334


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||.+.+..++.++|||||||++|+|++|+.||........               ...+.... ....+..+
T Consensus       232 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~---------------~~~~~~~~-~~~~~~~~  295 (478)
T PTZ00267        232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI---------------MQQVLYGK-YDPFPCPV  295 (478)
T ss_pred             CCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH---------------HHHHHhCC-CCCCCccC
Confidence            589999999999888899999999999999999999999975432111               11111111 11234456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +.++.++|.+||+.||++||++++++.
T Consensus       296 s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        296 SSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            778999999999999999999999864

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=302.29  Aligned_cols=254  Identities=25%  Similarity=0.329  Sum_probs=207.9

Q ss_pred             ceeeeeeeeccc-----cChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            3 RWLCCTCQVEES-----YPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         3 ~~~~~~~~~~~~-----~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      ||...-...+..     +++|..++ ..+.+...+|.+|..+|+.++||||++++|++.+....+|++|||.+|+|..++
T Consensus       708 VY~g~~~~~~~~~~~~~vaiK~l~~-~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sfl  786 (1025)
T KOG1095|consen  708 VYEGTYSDVPGSVSPIQVAVKSLKR-LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFL  786 (1025)
T ss_pred             eEEEEEecCCCCccceEEEEEeccc-cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHH
Confidence            566655555554     66666543 344556889999999999999999999999999998999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      ++.+....+  ...++....+.++.+++++..||+++   +++||||..+|+|++....|||+|||+++.+.....-...
T Consensus       787 r~~r~~~~~--~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~  861 (1025)
T KOG1095|consen  787 RESRPAPFQ--PSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKH  861 (1025)
T ss_pred             HhcccccCC--CCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHhhhhchheecc
Confidence            887544333  22489999999999999999999999   9999999999999999999999999999854433332222


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....-...|||||.+....++.++|||||||++||+++ |..||...+                ..++...+..+-+.+.
T Consensus       862 ~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~----------------n~~v~~~~~~ggRL~~  925 (1025)
T KOG1095|consen  862 GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS----------------NFEVLLDVLEGGRLDP  925 (1025)
T ss_pred             CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc----------------hHHHHHHHHhCCccCC
Confidence            33344578999999999999999999999999999999 999996543                2334342222336788


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                      |..||+.++++|.+||+.+|++||++..+++.+..+++...+
T Consensus       926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~  967 (1025)
T KOG1095|consen  926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG  967 (1025)
T ss_pred             CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence            999999999999999999999999999999999888865443

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.2e-39  Score=266.74  Aligned_cols=242  Identities=24%  Similarity=0.360  Sum_probs=191.2

Q ss_pred             Cceeeee--eeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCT--CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++..  ..+...+++|..+.........+.+.+|+.+++.++||||+++++++.. ...+++|||+.+++|.+++..
T Consensus        10 ~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~   88 (257)
T cd05116          10 TVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQK   88 (257)
T ss_pred             ceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHh
Confidence            5788743  3456778888776544445567788999999999999999999998864 467899999999999999965


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc-cc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH-ST  158 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~  158 (285)
                      ...         +++..++.++.|++.|+.|||++   |++|+||+|+||+++.++.++|+|||++........... ..
T Consensus        89 ~~~---------~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          89 NKH---------VTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            432         88999999999999999999999   999999999999999999999999999876543221111 11


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...++..|+|||.+....++.++|+|||||++|+|++ |..||.......                ....+........+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~i~~~~~~~~~  220 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE----------------VTQMIESGERMECP  220 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHCCCCCCCC
Confidence            1223578999999887788999999999999999998 999997543211                11112222223445


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      ..+++++.++|.+||+.||++||++.+|.+.|+++
T Consensus       221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            56778899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3e-39  Score=265.66  Aligned_cols=256  Identities=19%  Similarity=0.192  Sum_probs=204.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCc-ccccceEEEeCC------eeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHEN-LVELLGYCVEGN------LRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~------~~~lv~e~~~~~~L~   74 (285)
                      +||++..+.+++.|++|.++.....+..+....+|+.++++++|+| |+.+++++...+      .+++||||.+. +|.
T Consensus        26 ~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~  104 (323)
T KOG0594|consen   26 VVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLK  104 (323)
T ss_pred             EEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHH
Confidence            6999999999999999999877776778888999999999999999 999999998877      78999999986 999


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  154 (285)
                      .++.......     ..++...+..+++||+.|++|||++   +|+||||||+||+++++|.+||+|||+++...-... 
T Consensus       105 ~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~-  175 (323)
T KOG0594|consen  105 KYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR-  175 (323)
T ss_pred             HHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcCCcc-
Confidence            9998765321     1266789999999999999999999   999999999999999999999999999975432111 


Q ss_pred             ccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh---hhhc--
Q 023220          155 LHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV---KQCV--  228 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--  228 (285)
                       .-...++|.+|+|||++.+. .|+...||||+||++.||++++..|.+.....+...+-......+...+   ....  
T Consensus       176 -~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~  254 (323)
T KOG0594|consen  176 -TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDY  254 (323)
T ss_pred             -cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccc
Confidence             12345678999999999887 7899999999999999999999999988776665554444333332211   1111  


Q ss_pred             CCccCC--------CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          229 DPKLKG--------EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       229 ~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      ++....        ...+....+..+++.+||+.+|.+|.|++..++.
T Consensus       255 k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  255 KAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            111100        0111222488999999999999999999999984

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.2e-39  Score=274.64  Aligned_cols=244  Identities=25%  Similarity=0.323  Sum_probs=181.3

Q ss_pred             ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCC--------
Q 023220           14 SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG--------   85 (285)
Q Consensus        14 ~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--------   85 (285)
                      .+++|...... ......++.+|++++++++||||+++++++.+.+..+++|||+.+++|.+++........        
T Consensus        48 ~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  126 (304)
T cd05096          48 LVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV  126 (304)
T ss_pred             EEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhcccccccccccccc
Confidence            46677654322 223356788999999999999999999999999999999999999999999865421110        


Q ss_pred             --CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccc
Q 023220           86 --AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGT  163 (285)
Q Consensus        86 --~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  163 (285)
                        ......+++..++.++.|++.|+.|||+.   |++|+||||+||+++.++.++|+|||++................++
T Consensus       127 ~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~  203 (304)
T cd05096         127 PPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP  203 (304)
T ss_pred             ccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCC
Confidence              11123478889999999999999999999   9999999999999999999999999998754332221122333457


Q ss_pred             cCcCCCcccccCCCCcccchHhHHHHHHHHHh--CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          164 FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT--GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       164 ~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ..|+|||.+.+..++.++|+||||+++|+|++  +..||...........   ....     .. ..........++.++
T Consensus       204 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~---~~~~-----~~-~~~~~~~~~~~~~~~  274 (304)
T cd05096         204 IRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN---AGEF-----FR-DQGRQVYLFRPPPCP  274 (304)
T ss_pred             ccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHH---HHHH-----hh-hccccccccCCCCCC
Confidence            78999999888889999999999999999987  5677765432211100   0000     00 000011112244567


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      ..+.+++.+||+.||.+|||+.++.+.|+
T Consensus       275 ~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         275 QGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            78999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.5e-39  Score=269.10  Aligned_cols=250  Identities=24%  Similarity=0.374  Sum_probs=191.9

Q ss_pred             Cceeeeeee-----eccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQ-----VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++....     .+..+++|..+... .....+.+.+|+++++.++|+||+++++++......+++|||+.+++|.++
T Consensus        20 ~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   98 (280)
T cd05049          20 KVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKF   98 (280)
T ss_pred             eEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHH
Confidence            577775532     34667777665322 222457889999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcc
Q 023220           77 LHGRKGVQG-----AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM  151 (285)
Q Consensus        77 l~~~~~~~~-----~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~  151 (285)
                      +........     ......+++..+..++.|++.++.+||++   |++|+||+|+||+++.++.++|+|||++......
T Consensus        99 i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~  175 (280)
T cd05049          99 LRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT  175 (280)
T ss_pred             HHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEECCcccceecccC
Confidence            976532110     11122378899999999999999999999   9999999999999999999999999998654322


Q ss_pred             cccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                      ..........++..|+|||.+.+..++.++|||||||++|+|++ |..||.......                ....+..
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~----------------~~~~~~~  239 (280)
T cd05049         176 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE----------------VIECITQ  239 (280)
T ss_pred             cceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHHHHc
Confidence            21111223345678999999998889999999999999999998 999986543211                1111111


Q ss_pred             ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          231 KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      ......+..++..+.+++.+||+.||++||++.++++.|++
T Consensus       240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            11222344567789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.2e-39  Score=274.34  Aligned_cols=246  Identities=22%  Similarity=0.331  Sum_probs=191.6

Q ss_pred             Cceeeeeeeeccc----cChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEES----YPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~----~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||++.....++.    +++|..+. .......+++.+|+.+++.++||||+++++++... ..+++++|+.+|+|.+++
T Consensus        22 ~Vy~~~~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l   99 (316)
T cd05108          22 TVYKGLWIPEGEKVKIPVAIKELRE-ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV   99 (316)
T ss_pred             eEEEEEEecCCCccceeEEEEeccc-cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHH
Confidence            5788865544443    66666643 22233467788999999999999999999999865 467999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      .....        .++...++.++.|++.||+|||+.   |++||||||+||+++.++.++|+|||++............
T Consensus       100 ~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  168 (316)
T cd05108         100 REHKD--------NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA  168 (316)
T ss_pred             Hhccc--------cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCCcceec
Confidence            76542        278889999999999999999999   9999999999999999999999999999765432221111


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....                ....+.........
T Consensus       169 ~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~  232 (316)
T cd05108         169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----------------EISSILEKGERLPQ  232 (316)
T ss_pred             cCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----------------HHHHHHhCCCCCCC
Confidence            22234567999999988889999999999999999997 99999754321                11112222222233


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      +..++.++.+++.+||+.+|++||++.+++..+.++...+
T Consensus       233 ~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         233 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            4456678999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.6e-39  Score=266.93  Aligned_cols=241  Identities=21%  Similarity=0.259  Sum_probs=199.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|....+...||+|+..+..-. .....+.+.|-++|+.++||.++.+|..|+.+...|++||||.||+|..+++.+
T Consensus        92 ~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQ  171 (459)
T KOG0610|consen   92 TVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQ  171 (459)
T ss_pred             eEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhC
Confidence            6999999999999999976554433 445667777999999999999999999999999999999999999999999988


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCc----------
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD----------  150 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~----------  150 (285)
                      ...       .+++..+.-++..++.||.|||-.   |||+||+||+|||+.++|++-|.||+++.....          
T Consensus       172 p~~-------~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~  241 (459)
T KOG0610|consen  172 PGK-------RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSP  241 (459)
T ss_pred             CCC-------ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCC
Confidence            755       399999999999999999999999   999999999999999999999999999632210          


Q ss_pred             -----------------------ccc---------------------cccccccccccCcCCCcccccCCCCcccchHhH
Q 023220          151 -----------------------MAA---------------------RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSF  186 (285)
Q Consensus       151 -----------------------~~~---------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diwsl  186 (285)
                                             ...                     .......+||-.|+|||++.+...+.+.|.|+|
T Consensus       242 ~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtf  321 (459)
T KOG0610|consen  242 RSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTF  321 (459)
T ss_pred             CCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHH
Confidence                                   000                     011223568899999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCC----H
Q 023220          187 GVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN----M  262 (285)
Q Consensus       187 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~  262 (285)
                      |+++|||++|..||.+....+..               ..++...+.-...+.++..++++|+++|.+||++|..    +
T Consensus       322 GIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA  386 (459)
T KOG0610|consen  322 GIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGA  386 (459)
T ss_pred             HHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccch
Confidence            99999999999999887654333               3333333332334467789999999999999999998    7


Q ss_pred             HHHHH
Q 023220          263 SIVVK  267 (285)
Q Consensus       263 ~~ll~  267 (285)
                      .||-+
T Consensus       387 ~eIK~  391 (459)
T KOG0610|consen  387 AEIKR  391 (459)
T ss_pred             HHhhc
Confidence            77754

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.7e-38  Score=267.71  Aligned_cols=248  Identities=21%  Similarity=0.332  Sum_probs=189.3

Q ss_pred             Cceeeeeeeeccc----cChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEES----YPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~----~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||++........    +++|.... ........++..|+..+++++||||+++++++.. ...++++||+.+|+|.+++
T Consensus        22 ~vy~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l   99 (279)
T cd05111          22 TVHKGIWIPEGDSIKIPVAIKTIQD-RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHV   99 (279)
T ss_pred             ceEEEEEcCCCCceeeEEEEeeccc-ccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHH
Confidence            4788876555554    44444321 1222334667788889999999999999998764 4568899999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      .....        .+++..+..++.|++.|+.|||++   |++|+||+|+||+++.++.++|+|||++............
T Consensus       100 ~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  168 (279)
T cd05111         100 RQHRD--------SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY  168 (279)
T ss_pred             Hhccc--------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCccccc
Confidence            75432        288999999999999999999999   9999999999999999999999999998754332221112


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....++..|+|||.+.+..++.++|+||||+++|++++ |..||.+..+...                ..++........
T Consensus       169 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~----------------~~~~~~~~~~~~  232 (279)
T cd05111         169 SEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV----------------PDLLEKGERLAQ  232 (279)
T ss_pred             CCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH----------------HHHHHCCCcCCC
Confidence            23345678999999988889999999999999999998 9999976543211                111111111222


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                      +..++.++.+++.+||..||++|||+.++++.|.++..++++
T Consensus       233 ~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~  274 (279)
T cd05111         233 PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPR  274 (279)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcc
Confidence            334566789999999999999999999999999998887643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-38  Score=264.53  Aligned_cols=249  Identities=28%  Similarity=0.344  Sum_probs=197.4

Q ss_pred             Cceeeeeeee---ccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQV---EESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||+|.....   +..+++|......... ..+.+.+|+++++.++|+|++++++++..+...+++|||+.+++|.+++.
T Consensus        10 ~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   88 (262)
T cd00192          10 EVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLR   88 (262)
T ss_pred             EEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHh
Confidence            4788877755   7778888776544333 46788999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      .............+++..++.++.|++.|+.+||++   |++|+||+|+||+++.++.++|+|||.+.............
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  165 (262)
T cd00192          89 KSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT  165 (262)
T ss_pred             hccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccccccccccc
Confidence            752111001112389999999999999999999999   99999999999999999999999999997765433222233


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...++..|+|||.+....++.++|+||+|+++|+|++ |..||........                ...+........+
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~  229 (262)
T cd00192         166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV----------------LEYLRKGYRLPKP  229 (262)
T ss_pred             CCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH----------------HHHHHcCCCCCCC
Confidence            4556789999999888889999999999999999999 6999976532111                1111112222345


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      ..++.++.+++.+||+.+|.+|||+.++++.|+
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         230 EYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            566788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.3e-38  Score=267.50  Aligned_cols=227  Identities=26%  Similarity=0.395  Sum_probs=180.8

Q ss_pred             ChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHH
Q 023220           30 PDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ-------GAQPGPVLDWMTRVRIAV  102 (285)
Q Consensus        30 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~  102 (285)
                      .+.+.+|++.+++++|+||+++++++......++||||+.+++|.+++.......       .......+++..++.++.
T Consensus        51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  130 (291)
T cd05094          51 RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS  130 (291)
T ss_pred             HHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHH
Confidence            4678899999999999999999999999999999999999999999997643210       011122388999999999


Q ss_pred             HHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccccCCCCcccc
Q 023220          103 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSD  182 (285)
Q Consensus       103 qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D  182 (285)
                      |++.|+.|||++   |++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|
T Consensus       131 ~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  207 (291)
T cd05094         131 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD  207 (291)
T ss_pred             HHHHHHHHHHhC---CeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhh
Confidence            999999999999   99999999999999999999999999987544322222223344677899999998888999999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCC
Q 023220          183 VYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN  261 (285)
Q Consensus       183 iwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  261 (285)
                      +||||+++|+|++ |..||........                ............+...+..+.+++.+||+.+|++|||
T Consensus       208 i~slG~il~el~t~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt  271 (291)
T cd05094         208 VWSFGVILWEIFTYGKQPWFQLSNTEV----------------IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLN  271 (291)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcC
Confidence            9999999999998 9999865432111                1111111111223445678999999999999999999


Q ss_pred             HHHHHHHhchhhcC
Q 023220          262 MSIVVKALQPLLKS  275 (285)
Q Consensus       262 ~~~ll~~l~~~~~~  275 (285)
                      +.++++.|+.+.+.
T Consensus       272 ~~~v~~~l~~~~~~  285 (291)
T cd05094         272 IKEIYKILHALGKA  285 (291)
T ss_pred             HHHHHHHHHHHHhh
Confidence            99999999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-38  Score=278.20  Aligned_cols=254  Identities=17%  Similarity=0.249  Sum_probs=189.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|...        .+.+.+|++++++++||||+++++++......+++++++. ++|..++....
T Consensus       107 ~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~  177 (391)
T PHA03212        107 FAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKR  177 (391)
T ss_pred             EEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcC
Confidence            48999999999999998643        3457889999999999999999999999999999999996 58888886543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......... ......
T Consensus       178 ~---------l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~  244 (391)
T PHA03212        178 N---------IAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-KYYGWA  244 (391)
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc-cccccc
Confidence            2         78899999999999999999999   9999999999999999999999999998643221111 122346


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCccc--------chhhhhhcccC------chhhhhhh
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ--------QSLVTWATPRL------SEDKVKQC  227 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~  227 (285)
                      |++.|+|||++.+..++.++|||||||++|+|++|..||........        ..++.......      ........
T Consensus       245 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~  324 (391)
T PHA03212        245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEI  324 (391)
T ss_pred             CccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHH
Confidence            89999999999888899999999999999999999988754321110        00111110000      00001100


Q ss_pred             c---------CCccCCC--CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          228 V---------DPKLKGE--YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       228 ~---------~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                      .         .+..+..  .....+.++.++|.+||+.||.+|||++++++  ..++...+.|
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~--hp~f~~~~~~  385 (391)
T PHA03212        325 YIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD--FAAFQDIPDP  385 (391)
T ss_pred             HHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc--ChhhccCCCC
Confidence            0         0000000  01135678999999999999999999999997  5555544333

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-38  Score=265.65  Aligned_cols=244  Identities=23%  Similarity=0.313  Sum_probs=190.4

Q ss_pred             Cceeeeeeee---ccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQV---EESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      +||++.....   ...+++|..+.. .......++.+|+.++++++||||+++++++...+..+++|||+.+++|.+++.
T Consensus        19 ~vy~~~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~   97 (266)
T cd05033          19 EVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR   97 (266)
T ss_pred             eEEEEEEccCCCCcceEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHH
Confidence            4677765433   345677765432 223345678889999999999999999999999999999999999999999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....        .+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++.............
T Consensus        98 ~~~~--------~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  166 (266)
T cd05033          98 ENDG--------KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK  166 (266)
T ss_pred             hccC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccccceecc
Confidence            6432        288999999999999999999999   99999999999999999999999999997664222211122


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......                ....+........+
T Consensus       167 ~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~  230 (266)
T cd05033         167 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD----------------VIKAVEDGYRLPPP  230 (266)
T ss_pred             CCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH----------------HHHHHHcCCCCCCC
Confidence            2334578999999988889999999999999999997 999986433211                11111111122234


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ..++..+.+++.+||+.+|++||++.++++.|++++
T Consensus       231 ~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         231 MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            456778999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.1e-38  Score=268.99  Aligned_cols=244  Identities=18%  Similarity=0.216  Sum_probs=190.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.+..+++.+++|........ ....+.+..|++++++++|+||+++.+++......+++|||+.+|+|..++...
T Consensus         8 ~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~   87 (280)
T cd05608           8 EVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNV   87 (280)
T ss_pred             eEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhc
Confidence            5899998888899999976543322 223466778999999999999999999999999999999999999998887432


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...     ...+++..++.++.|++.||.|||+.   |++||||+|+||+++.++.++|+|||++........  .....
T Consensus        88 ~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~  157 (280)
T cd05608          88 DEE-----NPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGY  157 (280)
T ss_pred             ccc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccccc
Confidence            211     11288999999999999999999999   999999999999999999999999999865433221  12234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||.+.+..++.++|+|||||++|+|++|+.||..........           .........  ....+..+
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-----------~~~~~~~~~--~~~~~~~~  224 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-----------ELKQRILND--SVTYPDKF  224 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH-----------HHHHhhccc--CCCCcccC
Confidence            57889999999999899999999999999999999999997543211110           001111111  11234456


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRP-----NMSIVVKA  268 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp-----s~~~ll~~  268 (285)
                      +..+.+++.+||+.||++||     +++++++.
T Consensus       225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            78899999999999999999     77888863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.4e-39  Score=269.32  Aligned_cols=240  Identities=16%  Similarity=0.178  Sum_probs=187.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++....+++.|++|........ ......+..|++++++++||||+++++++.++...+++|||+.+++|.+++...
T Consensus         8 ~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~   87 (277)
T cd05607           8 EVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV   87 (277)
T ss_pred             EEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhc
Confidence            5899988888999999876543322 223445667999999999999999999999999999999999999999888644


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...       .+++..++.++.|++.|+.|||+.   |++||||+|+||+++.++.++|+|||++........   ....
T Consensus        88 ~~~-------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~  154 (277)
T cd05607          88 GER-------GLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQR  154 (277)
T ss_pred             ccc-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eecc
Confidence            321       278889999999999999999999   999999999999999999999999999865543221   1234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|+..|+|||.+.+..++.++|+||+||++|+|++|..||..........           ........... ......+
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~-----------~~~~~~~~~~~-~~~~~~~  222 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE-----------ELKRRTLEDEV-KFEHQNF  222 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH-----------HHHHHhhcccc-ccccccC
Confidence            57889999999988889999999999999999999999997543211110           00111111111 1112345


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVV  266 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll  266 (285)
                      +.++.+++.+||+.||++||++++++
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~  248 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKN  248 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccch
Confidence            77899999999999999999996654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.3e-38  Score=270.09  Aligned_cols=252  Identities=26%  Similarity=0.365  Sum_probs=191.8

Q ss_pred             Cceeeeeeeec-----cccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVE-----ESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||++......     ..+++|....... ......+.+|+++++++ +|+||+++++++..++..+++|||+.+++|.+
T Consensus        27 ~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~  105 (293)
T cd05053          27 QVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRD  105 (293)
T ss_pred             cEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHH
Confidence            46776654332     5566666543222 22345688899999999 89999999999999999999999999999999


Q ss_pred             HhccCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCC
Q 023220           76 ILHGRKGVQGA-------QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA  148 (285)
Q Consensus        76 ~l~~~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~  148 (285)
                      ++.........       .....+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++...
T Consensus       106 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~  182 (293)
T cd05053         106 FLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDI  182 (293)
T ss_pred             HHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeEEeCcccccccc
Confidence            99754311000       1122488999999999999999999999   9999999999999999999999999998765


Q ss_pred             CcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhh
Q 023220          149 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC  227 (285)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (285)
                      .............++..|+|||.+.+..++.++|+|||||++|++++ |..||......                .....
T Consensus       183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----------------~~~~~  246 (293)
T cd05053         183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----------------ELFKL  246 (293)
T ss_pred             ccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH----------------HHHHH
Confidence            43222111222334567999999888889999999999999999997 99998654321                11111


Q ss_pred             cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          228 VDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       228 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      .........+..++..+.+++.+||+.||++|||+.++++.|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         247 LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            1222222334456778999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.2e-39  Score=276.60  Aligned_cols=254  Identities=20%  Similarity=0.237  Sum_probs=203.8

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.++.|+++||+|..++.. ......+.++.|-.+|...++|.||+++-.|.+...+||||||++||++..+|...
T Consensus       156 eVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~  235 (550)
T KOG0605|consen  156 EVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRK  235 (550)
T ss_pred             eEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhc
Confidence            59999999999999999766554 45667888899999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCc----------
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD----------  150 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~----------  150 (285)
                      ..         |++..+..++.+.+.||..+|+.   |++||||||+|+|+|..|++||.|||++.-...          
T Consensus       236 ~~---------L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~  303 (550)
T KOG0605|consen  236 DT---------LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLD  303 (550)
T ss_pred             Cc---------CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcch
Confidence            53         99999999999999999999999   999999999999999999999999999731100          


Q ss_pred             ------------cccc-----cc------------------ccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh
Q 023220          151 ------------MAAR-----LH------------------STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT  195 (285)
Q Consensus       151 ------------~~~~-----~~------------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~  195 (285)
                                  ....     ..                  ....+|||.|+|||++.+.+|+..+|.|||||++|||+.
T Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLv  383 (550)
T KOG0605|consen  304 EQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLV  383 (550)
T ss_pred             hhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHh
Confidence                        0000     00                  113579999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcccchhhh-hhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCC---HHHHHHH---
Q 023220          196 GRKPVDHTMPRGQQSLVT-WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN---MSIVVKA---  268 (285)
Q Consensus       196 g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~---  268 (285)
                      |.+||...++......+. |..              .+.-+....++.+..++|.+|+. ||++|..   ++||.+.   
T Consensus       384 GyPPF~s~tp~~T~rkI~nwr~--------------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF  448 (550)
T KOG0605|consen  384 GYPPFCSETPQETYRKIVNWRE--------------TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFF  448 (550)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhh--------------hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcc
Confidence            999999887654443222 211              11112223445789999999999 9999975   6666542   


Q ss_pred             ----hchhhcCCCCCCCC
Q 023220          269 ----LQPLLKSPPPAAPV  282 (285)
Q Consensus       269 ----l~~~~~~~~~~~~~  282 (285)
                          .+.+.+.++|=.|.
T Consensus       449 ~~v~W~~l~~~~apfvP~  466 (550)
T KOG0605|consen  449 KGVDWDHLREMPAPFVPQ  466 (550)
T ss_pred             ccCCcchhhcCCCCCCCC
Confidence                34455555555554

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=273.25  Aligned_cols=239  Identities=24%  Similarity=0.305  Sum_probs=189.2

Q ss_pred             ceeeeeeeeccccChhhhhhccCCC------------CCChhHHHHHHHHccCCCCcccccceEEEeC--CeeeEEEeeC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPK------------NYPDDEKQLVSVVSRLKHENLVELLGYCVEG--NLRVLAYEFA   68 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~   68 (285)
                      |=++.+...++.||+|..-+.+-..            ...++.++||.+|++|.|||||+++++..+.  +.+|||+||+
T Consensus       113 VkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~  192 (576)
T KOG0585|consen  113 VKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYC  192 (576)
T ss_pred             EEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEec
Confidence            5567777888888888655444221            1236899999999999999999999999764  5889999999


Q ss_pred             CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCC
Q 023220           69 TMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA  148 (285)
Q Consensus        69 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~  148 (285)
                      ..|.+...-...         +.+++.+++.+++.++.||.|||.+   ||+||||||+|+|++.+|++||+|||.+...
T Consensus       193 s~G~v~w~p~d~---------~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~  260 (576)
T KOG0585|consen  193 SKGEVKWCPPDK---------PELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISDFGVSNEF  260 (576)
T ss_pred             cCCccccCCCCc---------ccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeeccceeeec
Confidence            988774442222         1289999999999999999999999   9999999999999999999999999998755


Q ss_pred             Ccc---cccccccccccccCcCCCcccccC---C-CCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCch
Q 023220          149 PDM---AARLHSTRVLGTFGYHAPEYAMTG---Q-LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSE  221 (285)
Q Consensus       149 ~~~---~~~~~~~~~~~~~~~~aPE~~~~~---~-~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  221 (285)
                      ...   .....-....|||.|+|||...+.   . .+.+.||||+|++||.|+.|+.||.+...               .
T Consensus       261 ~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~---------------~  325 (576)
T KOG0585|consen  261 PQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE---------------L  325 (576)
T ss_pred             ccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---------------H
Confidence            211   111112236799999999998763   2 35789999999999999999999976532               2


Q ss_pred             hhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          222 DKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      +-..++++..+.-...+++.+.+.++|.+||.+||+.|+++.++...
T Consensus       326 ~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  326 ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            33455555555545555778899999999999999999999999764

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.4e-39  Score=280.06  Aligned_cols=236  Identities=19%  Similarity=0.207  Sum_probs=191.2

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.+..++..+++|..+.... .......+.+|+++++.++||||+++.+++...+..++||||+.+|+|..++...
T Consensus        10 ~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~   89 (325)
T cd05594          10 KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE   89 (325)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhc
Confidence            589998888899999998765432 2334567778999999999999999999999999999999999999999988654


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ..         +++..+..++.|++.||.|||+ .   |++||||||+||+++.++.++|+|||++.........  ...
T Consensus        90 ~~---------l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~  155 (325)
T cd05594          90 RV---------FSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKT  155 (325)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--ccc
Confidence            32         8899999999999999999997 7   9999999999999999999999999998643221111  123


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||.+.+..++.++|||||||++|+|++|..||...........               +...  ....+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~---------------i~~~--~~~~p~~  218 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---------------ILME--EIRFPRT  218 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH---------------HhcC--CCCCCCC
Confidence            4588999999999888899999999999999999999999975432211111               1110  1123445


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRP-----NMSIVVKA  268 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~~  268 (285)
                      .++++.+++.+||+.||++|+     ++.++++.
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            677899999999999999997     89998863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.4e-38  Score=264.40  Aligned_cols=239  Identities=22%  Similarity=0.307  Sum_probs=193.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .+|++....+.+.+++|............+.+.+|++++++++|||++++++++.+.+..+++|||+.+++|.+++....
T Consensus        15 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   94 (256)
T cd08529          15 VVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQR   94 (256)
T ss_pred             EEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhc
Confidence            47888888788888888776554445567888999999999999999999999999999999999999999999997642


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .++...++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++.........  .....
T Consensus        95 ~~-------~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~  162 (256)
T cd08529          95 GR-------PLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--ANTIV  162 (256)
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch--hhccc
Confidence            21       288899999999999999999999   9999999999999999999999999988755432211  12235


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      +++.|+|||...+..++.++|+||||+++++|++|..||.......               ....... ......+..++
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------~~~~~~~-~~~~~~~~~~~  226 (256)
T cd08529         163 GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---------------LILKIIR-GVFPPVSQMYS  226 (256)
T ss_pred             cCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---------------HHHHHHc-CCCCCCccccC
Confidence            7788999999988889999999999999999999999997543211               1111111 11122333567


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      .++.+++.+||+.+|++||++.++++.
T Consensus       227 ~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         227 QQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            789999999999999999999999873

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6e-39  Score=276.10  Aligned_cols=234  Identities=22%  Similarity=0.259  Sum_probs=187.1

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHH---ccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVV---SRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||++....+++.+++|..++... .....+.+.+|++++   +.++||||+++++++.+.+..++||||+.+++|..++
T Consensus        14 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~   93 (324)
T cd05589          14 KVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI   93 (324)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHh
Confidence            589998888899999998765432 233455666776654   5678999999999999999999999999999999888


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      ....          +++..++.++.|++.|+.|||++   |++||||||+||+++.++.++|+|||++........  ..
T Consensus        94 ~~~~----------l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~  158 (324)
T cd05589          94 HTDV----------FSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--RT  158 (324)
T ss_pred             hcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC--cc
Confidence            6532          89999999999999999999999   999999999999999999999999998864322111  12


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ....|++.|+|||.+.+..++.++|+|||||++|+|++|..||.........               ..+....  ...+
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~---------------~~i~~~~--~~~p  221 (324)
T cd05589         159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF---------------DSIVNDE--VRYP  221 (324)
T ss_pred             cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH---------------HHHHhCC--CCCC
Confidence            2345889999999999888999999999999999999999999765432111               1111111  1234


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK  267 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~  267 (285)
                      ..++..+.++|.+||+.||.+||     ++.++++
T Consensus       222 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         222 RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            55678899999999999999999     5777766

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.6e-38  Score=265.85  Aligned_cols=248  Identities=19%  Similarity=0.259  Sum_probs=194.5

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++....+++.+++|...... ........+.+|++++++++||||+++++++...+..++++||+.+++|.+++...
T Consensus        17 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~   96 (267)
T cd08228          17 EVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYF   96 (267)
T ss_pred             eEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHh
Confidence            58899888888999998665432 22334567888999999999999999999999999999999999999999888643


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ....     ..++...++.++.|++.|+.|||++   |++|+||+|+||+++.++.++|+|||++.........  ....
T Consensus        97 ~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~  166 (267)
T cd08228          97 KKQK-----RLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSL  166 (267)
T ss_pred             hhcc-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhHH--HhcC
Confidence            2111     1278899999999999999999999   9999999999999999999999999988765432211  1234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .++..|+|||.+.+..++.++|+||+|+++|+|++|+.||........ ...            ..+.............
T Consensus       167 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~------------~~~~~~~~~~~~~~~~  233 (267)
T cd08228         167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLC------------QKIEQCDYPPLPTEHY  233 (267)
T ss_pred             CCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHH------------HHHhcCCCCCCChhhc
Confidence            577889999999888889999999999999999999999865432110 000            0110111111122345


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      +..+.+++.+||+.+|++||++.++++.++++
T Consensus       234 ~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         234 SEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            67899999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.1e-38  Score=263.24  Aligned_cols=248  Identities=20%  Similarity=0.257  Sum_probs=196.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++....+++.+++|..+..... ....+.+.+|++++++++|+|++++++.+..++..+++|||+.+++|.+++...
T Consensus        17 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   96 (267)
T cd08224          17 VVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHF   96 (267)
T ss_pred             EEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHh
Confidence            5788888878888999977643333 334778899999999999999999999999999999999999999999998643


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...     ...++...++.++.+++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++.........  ....
T Consensus        97 ~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~  166 (267)
T cd08224          97 KKQ-----KRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSL  166 (267)
T ss_pred             ccc-----CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--ccee
Confidence            211     11278899999999999999999999   9999999999999999999999999988654332211  1234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh-h
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP-K  239 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  239 (285)
                      .++..|.|||.+.+..++.++|+||||+++|+|++|..||........              .+...+........+. .
T Consensus       167 ~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~  232 (267)
T cd08224         167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--------------SLCKKIEKCDYPPLPADH  232 (267)
T ss_pred             cCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH--------------HHHhhhhcCCCCCCChhh
Confidence            577889999999888899999999999999999999999965432110              0111111111112222 5


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      .+..+.++|.+||+.+|++|||+.++++.|+.+.
T Consensus       233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         233 YSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            6678999999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=264.24  Aligned_cols=240  Identities=20%  Similarity=0.285  Sum_probs=192.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCC---CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP---KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||+|....++..+++|........   ....+.+.+|++++++++||||+++++++.+....++++||+.+++|.+++.
T Consensus        17 ~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~   96 (263)
T cd06625          17 RVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK   96 (263)
T ss_pred             EEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHH
Confidence            5799988888888998876543322   2235678899999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc-c
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH-S  157 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~  157 (285)
                      ....         ++...+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++........... .
T Consensus        97 ~~~~---------~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~  164 (263)
T cd06625          97 AYGA---------LTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM  164 (263)
T ss_pred             HhCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccc
Confidence            6532         78889999999999999999999   999999999999999999999999999865432211110 0


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ....++..|+|||.+.+..++.++|+||+|+++|++++|+.||........               .............+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~  229 (263)
T cd06625         165 KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---------------IFKIATQPTNPQLP  229 (263)
T ss_pred             cCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---------------HHHHhccCCCCCCC
Confidence            223467789999999988899999999999999999999999975432111               11111112223345


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      ...+..+.+++.+||+.+|++|||+.++++.
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         230 SHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            5677789999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=280.84  Aligned_cols=239  Identities=20%  Similarity=0.253  Sum_probs=194.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.|++|..+..... ......+.+|++++..++||||+++++++.+++..++||||+.+++|.+++...
T Consensus        16 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   95 (350)
T cd05573          16 EVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK   95 (350)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc
Confidence            5899999888999999987654433 245677889999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc--------
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA--------  152 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~--------  152 (285)
                      .         .++...+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.......        
T Consensus        96 ~---------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~  163 (350)
T cd05573          96 D---------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLND  163 (350)
T ss_pred             C---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccc
Confidence            3         288999999999999999999999   99999999999999999999999999987554322        


Q ss_pred             -------------------ccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 023220          153 -------------------ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT  213 (285)
Q Consensus       153 -------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~  213 (285)
                                         .........|++.|+|||.+.+..++.++|||||||++|+|++|+.||..........   
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~---  240 (350)
T cd05573         164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN---  240 (350)
T ss_pred             cccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH---
Confidence                               0011223468999999999999899999999999999999999999997654321111   


Q ss_pred             hhcccCchhhhhhhcC--CccCCCCChhHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 023220          214 WATPRLSEDKVKQCVD--PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-MSIVVKA  268 (285)
Q Consensus       214 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~ll~~  268 (285)
                                  .+..  ..........+++.+.++|.+||. ||.+||+ ++++++.
T Consensus       241 ------------~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         241 ------------KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             ------------HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence                        1111  111111222357889999999998 9999999 9999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.1e-38  Score=276.42  Aligned_cols=249  Identities=19%  Similarity=0.213  Sum_probs=187.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC------eeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN------LRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~   75 (285)
                      .||++.+..++..+++|..............+.+|+.+++.++||||+++++++....      ..+++|||+.+ +|.+
T Consensus        36 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~  114 (359)
T cd07876          36 IVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQ  114 (359)
T ss_pred             EEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHH
Confidence            5899988888999999987655545555678889999999999999999999986543      46999999975 6766


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      .+...           ++...+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.......   
T Consensus       115 ~~~~~-----------~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---  177 (359)
T cd07876         115 VIHME-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---  177 (359)
T ss_pred             HHhcc-----------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccccCc---
Confidence            66432           77888999999999999999999   99999999999999999999999999986543211   


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchh-------hhhhhc
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED-------KVKQCV  228 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~  228 (285)
                      ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..................       .+....
T Consensus       178 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (359)
T cd07876         178 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYV  257 (359)
T ss_pred             cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence            1233467889999999999899999999999999999999999998664322211111100000000       000000


Q ss_pred             CC--cc----------------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          229 DP--KL----------------KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       229 ~~--~~----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      ..  ..                ........++.+.++|.+||+.||++|||+.++++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         258 ENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             hhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00  00                001112335678999999999999999999999983

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9e-39  Score=274.87  Aligned_cols=235  Identities=20%  Similarity=0.251  Sum_probs=188.1

Q ss_pred             Cceeeeee---eeccccChhhhhhcc--CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTC---QVEESYPSHENERLK--SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~---~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||+|.+.   ..++.+++|..+...  ........+.+|++++++++||||+++++.+..++..+++|||+.+++|.++
T Consensus        11 ~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   90 (323)
T cd05584          11 KVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMH   90 (323)
T ss_pred             EEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHH
Confidence            47888653   356778888765432  2223345678899999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH  156 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  156 (285)
                      +.....         +.+..+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++........  .
T Consensus        91 ~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  156 (323)
T cd05584          91 LEREGI---------FMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--V  156 (323)
T ss_pred             HHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--c
Confidence            876542         77888999999999999999999   999999999999999999999999999864322111  1


Q ss_pred             ccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||........               ...+....  ...
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~---------------~~~~~~~~--~~~  219 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT---------------IDKILKGK--LNL  219 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH---------------HHHHHcCC--CCC
Confidence            2234588999999999888889999999999999999999999976442211               11111111  133


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK  267 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~  267 (285)
                      +...+.++.++|.+||+.||++||     ++.++++
T Consensus       220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            555678899999999999999999     7888876

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.8e-39  Score=278.14  Aligned_cols=233  Identities=19%  Similarity=0.196  Sum_probs=188.0

Q ss_pred             Cceeeeeeeec-cccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVE-ESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~-~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++...... ..+++|...... ......+.+.+|+++++.++||||+++++++.+.+..+++|||+.+|+|.+++..
T Consensus        45 ~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~  124 (340)
T PTZ00426         45 RVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR  124 (340)
T ss_pred             EEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH
Confidence            47887654433 567888664433 2334566788999999999999999999999999999999999999999999976


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......     ...
T Consensus       125 ~~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~  187 (340)
T PTZ00426        125 NKR---------FPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYT  187 (340)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cce
Confidence            542         88999999999999999999999   9999999999999999999999999998754321     123


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||.+.+..++.++|+|||||++|+|++|..||...++....               ..+....  ...+..
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~---------------~~i~~~~--~~~p~~  250 (340)
T PTZ00426        188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY---------------QKILEGI--IYFPKF  250 (340)
T ss_pred             ecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH---------------HHHhcCC--CCCCCC
Confidence            46889999999998888999999999999999999999999765432111               1111111  123445


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRP-----NMSIVVKA  268 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~~  268 (285)
                      .+..+.+++++||+.||.+|+     +++++++.
T Consensus       251 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        251 LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            667899999999999999995     89988774

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.8e-38  Score=274.02  Aligned_cols=254  Identities=17%  Similarity=0.231  Sum_probs=189.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..++..+++|...... .....+.+.+|++++++++||||+++++++.+++..+++|||+.+++|.+++....
T Consensus        20 ~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   98 (333)
T cd06650          20 VVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG   98 (333)
T ss_pred             EEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC
Confidence            47888888788888888665321 22345678899999999999999999999999999999999999999999997543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +++..+..++.|++.|+.|||+..  +++|+||||+||+++.++.++|+|||++.......    .....
T Consensus        99 ~---------~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~~~~  163 (333)
T cd06650          99 R---------IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFV  163 (333)
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----cccCC
Confidence            2         788899999999999999999741  69999999999999999999999999986543211    12345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc-c----------------------
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP-R----------------------  218 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~----------------------  218 (285)
                      |+..|+|||.+.+..++.++|+|||||++|+|++|+.||................. .                      
T Consensus       164 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (333)
T cd06650         164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGP  243 (333)
T ss_pred             CCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcc
Confidence            78899999999888899999999999999999999999975433211111000000 0                      


Q ss_pred             -----CchhhhhhhcCCccCCCC-ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          219 -----LSEDKVKQCVDPKLKGEY-PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       219 -----~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                           .........+........ ....+.++.+++.+||+.||++|||++++++  ..++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~--h~~~  302 (333)
T cd06650         244 DSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV--HAFI  302 (333)
T ss_pred             cccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh--CHHH
Confidence                 000000000000000011 1124567999999999999999999999976  4444

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-38  Score=262.41  Aligned_cols=240  Identities=26%  Similarity=0.370  Sum_probs=189.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.... ...+++|..+..   ....+++.+|++++++++||||+++++++...+..+++|||+.+++|.+++....
T Consensus        21 ~v~~~~~~~-~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   96 (261)
T cd05068          21 EVWEGLWNN-TTPVAVKTLKPG---TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA   96 (261)
T ss_pred             cEEEEEecC-CeEEEEEeeCCC---cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccC
Confidence            578877644 345777766432   2235678899999999999999999999999999999999999999999997654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..+..++.|++.|+.+||+.   |++|+||+|+||+++.++.++|+|||++......... ......
T Consensus        97 ~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~  165 (261)
T cd05068          97 GR-------ALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREGAK  165 (261)
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCCCc
Confidence            21       288999999999999999999999   9999999999999999999999999998765422111 111122


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .+..|+|||...+..++.++|+||||+++|+|++ |+.||.+.....                ....+........+...
T Consensus       166 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~  229 (261)
T cd05068         166 FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE----------------VLQQVDQGYRMPCPPGC  229 (261)
T ss_pred             CceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHHHHcCCCCCCCCcC
Confidence            3457999999988889999999999999999999 999997543211                11111111222334456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      +..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         230 PKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            78899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.6e-38  Score=262.93  Aligned_cols=240  Identities=27%  Similarity=0.390  Sum_probs=193.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.... +..+++|.....  .....+.+.+|+.+++.++|+||+++++++......+++|||+.+++|.+++....
T Consensus        21 ~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   97 (261)
T cd05148          21 EVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE   97 (261)
T ss_pred             cEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCC
Confidence            578887766 777777776432  22345678899999999999999999999999999999999999999999997643


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||.+.........  .....
T Consensus        98 ~~-------~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~~~~  165 (261)
T cd05148          98 GQ-------VLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SSDKK  165 (261)
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc--ccCCC
Confidence            22       278899999999999999999999   9999999999999999999999999998765332211  12233


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|++||......++.++|+||||+++|+|++ |..||......                ..............+..+
T Consensus       166 ~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~  229 (261)
T cd05148         166 IPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH----------------EVYDQITAGYRMPCPAKC  229 (261)
T ss_pred             CceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH----------------HHHHHHHhCCcCCCCCCC
Confidence            5678999999888888999999999999999998 89999654321                111111122233445667


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      ++.+.+++.+||+.||++|||+.++++.|+.+
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         230 PQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            78899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-38  Score=264.88  Aligned_cols=250  Identities=22%  Similarity=0.272  Sum_probs=190.6

Q ss_pred             Cceeeeeee---eccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCe------eeEEEeeCCCCC
Q 023220            2 RRWLCCTCQ---VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL------RVLAYEFATMGS   72 (285)
Q Consensus         2 ~~~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~~   72 (285)
                      .||++....   +...+++|..+.........+.+.+|++.++.++||||+++++++.....      .++++||+.+++
T Consensus        14 ~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~   93 (273)
T cd05035          14 SVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGD   93 (273)
T ss_pred             eEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCC
Confidence            467775543   34678888776544444445678999999999999999999998876554      799999999999


Q ss_pred             HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc
Q 023220           73 LHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA  152 (285)
Q Consensus        73 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~  152 (285)
                      |..++........   ...+++..++.++.|++.||.|||+.   |++|+||+|+||++++++.++|+|||++.......
T Consensus        94 l~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  167 (273)
T cd05035          94 LHSFLLYSRLGGL---PEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD  167 (273)
T ss_pred             HHHHHHHhhccCC---cccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccceeeccccc
Confidence            9999855432111   11388999999999999999999999   99999999999999999999999999987554322


Q ss_pred             ccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc
Q 023220          153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK  231 (285)
Q Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
                      .........++..|+|||.+.+..++.++|+|||||++|+|++ |..||.......                ....+...
T Consensus       168 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~----------------~~~~~~~~  231 (273)
T cd05035         168 YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE----------------IYDYLRHG  231 (273)
T ss_pred             cccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcC
Confidence            2111122234568999999888889999999999999999999 889986543211                11111111


Q ss_pred             cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          232 LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      .....+..++.++.+++.+||+.||++|||+.++++.|++++
T Consensus       232 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         232 NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            112234556778999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.2e-38  Score=270.02  Aligned_cols=252  Identities=18%  Similarity=0.231  Sum_probs=185.7

Q ss_pred             Cceeeeeee-eccccChhhhhhccCCCCCChhHHHHHHHHccC---CCCcccccceEEEe-----CCeeeEEEeeCCCCC
Q 023220            2 RRWLCCTCQ-VEESYPSHENERLKSPKNYPDDEKQLVSVVSRL---KHENLVELLGYCVE-----GNLRVLAYEFATMGS   72 (285)
Q Consensus         2 ~~~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~   72 (285)
                      +||+|.+.. .+..+++|..+...........+.+|+.+++.+   +||||+++++++..     ....+++|||+. ++
T Consensus        16 ~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~   94 (290)
T cd07862          16 KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QD   94 (290)
T ss_pred             EEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CC
Confidence            588887754 356788887765555555556677788777765   69999999999862     446899999997 58


Q ss_pred             HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc
Q 023220           73 LHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA  152 (285)
Q Consensus        73 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~  152 (285)
                      |.+++......       .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++...... 
T Consensus        95 l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  163 (290)
T cd07862          95 LTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-  163 (290)
T ss_pred             HHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEeccCC-
Confidence            99998754322       278899999999999999999999   9999999999999999999999999998654322 


Q ss_pred             ccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh-------
Q 023220          153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK-------  225 (285)
Q Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------  225 (285)
                        .......|++.|+|||.+.+..++.++|+|||||++|+|++|.+||.+.........+.............       
T Consensus       164 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  241 (290)
T cd07862         164 --MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR  241 (290)
T ss_pred             --cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccc
Confidence              11233457899999999988889999999999999999999999998765433322221111110000000       


Q ss_pred             hhcCCccC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          226 QCVDPKLK---GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       226 ~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ....+...   ....+..++.+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         242 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00000000   0112345678899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-38  Score=275.10  Aligned_cols=243  Identities=19%  Similarity=0.221  Sum_probs=190.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||+|....++..+++|..++.... ....+.+.+|..+++++ +||||+++++++.+.+..++||||+.+|+|.+++..
T Consensus        10 ~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~   89 (329)
T cd05588          10 KVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR   89 (329)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH
Confidence            5899998888999999987654332 33456678899999988 799999999999999999999999999999988865


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.|+.|||++   |++||||||+||+++.++.++|+|||++........  ....
T Consensus        90 ~~~---------l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~~  155 (329)
T cd05588          90 QRK---------LPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTST  155 (329)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC--cccc
Confidence            432         89999999999999999999999   999999999999999999999999998864221111  1223


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh-hhhcCCccCCCCCh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV-KQCVDPKLKGEYPP  238 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  238 (285)
                      ..|++.|+|||.+.+..++.++|+|||||++|+|++|+.||..........       ....... ..+....  ...+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~--~~~p~  226 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD-------QNTEDYLFQVILEKQ--IRIPR  226 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc-------ccchHHHHHHHHcCC--CCCCC
Confidence            458899999999998889999999999999999999999996432211000       0000001 1111111  13455


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPN------MSIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps------~~~ll~  267 (285)
                      .++..+.+++.+||+.||.+||+      ++++++
T Consensus       227 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            66788999999999999999997      677764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.9e-38  Score=267.44  Aligned_cols=253  Identities=24%  Similarity=0.337  Sum_probs=190.6

Q ss_pred             Cceeeee-----eeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCT-----CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++..     ...+..+++|.....  .....+.+.+|++++++++||||+++++++...+..++++||+.+++|.++
T Consensus        20 ~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   97 (288)
T cd05093          20 KVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF   97 (288)
T ss_pred             eEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHH
Confidence            4566642     223344556655422  223356788999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc
Q 023220           77 LHGRKGVQG----AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA  152 (285)
Q Consensus        77 l~~~~~~~~----~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~  152 (285)
                      +........    ......+++..++.++.|++.||.|||+.   |++||||+|+||+++.++.++|+|||++.......
T Consensus        98 i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  174 (288)
T cd05093          98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD  174 (288)
T ss_pred             HHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCCccccccCCc
Confidence            975432100    01111389999999999999999999999   99999999999999999999999999987553322


Q ss_pred             ccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc
Q 023220          153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK  231 (285)
Q Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
                      .........++..|+|||.+.+..++.++|+|||||++|+|++ |..||........               ...+.. .
T Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---------------~~~i~~-~  238 (288)
T cd05093         175 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---------------IECITQ-G  238 (288)
T ss_pred             eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---------------HHHHHc-C
Confidence            2111223335678999999988889999999999999999998 8999865432111               111111 1


Q ss_pred             cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          232 LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      .....+..++.++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            11122334567899999999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.4e-38  Score=272.84  Aligned_cols=235  Identities=20%  Similarity=0.220  Sum_probs=187.3

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++....+++.+++|..+.... .....+.+..|..++... +||||+++++++..++..++||||+.+|+|.+++..
T Consensus        10 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~   89 (316)
T cd05592          10 KVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS   89 (316)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH
Confidence            589998888899999997765432 233445566677777654 899999999999999999999999999999999875


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         ++...+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.......  .....
T Consensus        90 ~~~---------~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~  155 (316)
T cd05592          90 SGR---------FDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAST  155 (316)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccccc
Confidence            432         88899999999999999999999   99999999999999999999999999986432211  12233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.......               ..+..  .....+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~---------------~~i~~--~~~~~~~~  218 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF---------------DSILN--DRPHFPRW  218 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH---------------HHHHc--CCCCCCCC
Confidence            46899999999999888999999999999999999999999765431111               11111  11223455


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMS-IVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~-~ll~  267 (285)
                      ++.++.+++.+||+.||.+||++. ++++
T Consensus       219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            677899999999999999999875 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.1e-38  Score=264.92  Aligned_cols=250  Identities=23%  Similarity=0.275  Sum_probs=188.7

Q ss_pred             Cceeeeeeeecc--ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC------CeeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQVEE--SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG------NLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~~~--~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L   73 (285)
                      +||++.......  .+++|..+.........+.+.+|+++++.++|+||+++++++...      ...+++++|+.+++|
T Consensus        14 ~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l   93 (272)
T cd05075          14 SVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDL   93 (272)
T ss_pred             eEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcH
Confidence            578887655544  467776655444445567888999999999999999999987432      246899999999999


Q ss_pred             HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc
Q 023220           74 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        74 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  153 (285)
                      .+++.......   ....+++..+..++.|++.|+.|||++   |++|+||||+||+++.++.++|+|||++........
T Consensus        94 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  167 (272)
T cd05075          94 HSFLLYSRLGD---CPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY  167 (272)
T ss_pred             HHHHHHhcccC---CcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccccCcccc
Confidence            99874322110   111388999999999999999999999   999999999999999999999999999876543221


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL  232 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
                      ........+++.|++||...+..++.++|+||||+++|+|++ |..||..........                .+....
T Consensus       168 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~----------------~~~~~~  231 (272)
T cd05075         168 YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD----------------YLRQGN  231 (272)
T ss_pred             eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----------------HHHcCC
Confidence            111122235678999999988889999999999999999999 889996543211111                111111


Q ss_pred             CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          233 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ....+..++..+.+++.+||+.||++|||+.++++.|++++
T Consensus       232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         232 RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            11223456678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-39  Score=277.16  Aligned_cols=221  Identities=27%  Similarity=0.435  Sum_probs=187.2

Q ss_pred             ccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCC
Q 023220           12 EESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPV   91 (285)
Q Consensus        12 ~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~   91 (285)
                      .+.+++|.++.++         ..+|.-|++|+||||+.+.|+|....-+|||||||..|-|.+.++..+.         
T Consensus       147 netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~---------  208 (904)
T KOG4721|consen  147 NETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRP---------  208 (904)
T ss_pred             CceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCc---------
Confidence            4567777666433         3578899999999999999999999999999999999999999998764         


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcc
Q 023220           92 LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEY  171 (285)
Q Consensus        92 ~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~  171 (285)
                      +.......|..+|+.++.|||.+   .|||||+|.-||||+-+..|||+|||-++.......   .-...||..|||||+
T Consensus       209 itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kMSFaGTVaWMAPEv  282 (904)
T KOG4721|consen  209 ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---KMSFAGTVAWMAPEV  282 (904)
T ss_pred             cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhh---hhhhhhhHhhhCHHH
Confidence            88889999999999999999999   999999999999999999999999998875543321   234569999999999


Q ss_pred             cccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHh
Q 023220          172 AMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALC  251 (285)
Q Consensus       172 ~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  251 (285)
                      +...+++++.|||||||+||||+||..||..-+....    .|.-           ....+....|.++|..+.-++++|
T Consensus       283 IrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----IwGV-----------GsNsL~LpvPstcP~GfklL~Kqc  347 (904)
T KOG4721|consen  283 IRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IWGV-----------GSNSLHLPVPSTCPDGFKLLLKQC  347 (904)
T ss_pred             hhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EEec-----------cCCcccccCcccCchHHHHHHHHH
Confidence            9999999999999999999999999999975443211    1111           122334567888999999999999


Q ss_pred             cccCCCCCCCHHHHHHHhch
Q 023220          252 VQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       252 l~~~p~~Rps~~~ll~~l~~  271 (285)
                      |+-.|.+|||+++++..|+=
T Consensus       348 w~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  348 WNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             HhcCCCCCccHHHHHHHHhh
Confidence            99999999999999998864

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.2e-38  Score=264.94  Aligned_cols=253  Identities=23%  Similarity=0.351  Sum_probs=191.5

Q ss_pred             Cceeeeeeeec-----cccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVE-----ESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      +||++......     ..+++|...... .....+++.+|+.+++.++||||+++++.+...+..++++||+.+++|.++
T Consensus        15 ~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   93 (290)
T cd05045          15 KVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSF   93 (290)
T ss_pred             ceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHH
Confidence            57777654322     234444443211 112246788999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEec
Q 023220           77 LHGRKGVQG---------------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD  141 (285)
Q Consensus        77 l~~~~~~~~---------------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~d  141 (285)
                      +........               ......+++..++.++.|++.||.|||+.   |++||||+|+||+++.++.++|+|
T Consensus        94 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~~~~~~kl~d  170 (290)
T cd05045          94 LRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISD  170 (290)
T ss_pred             HHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEcCCCcEEecc
Confidence            865321100               01112388999999999999999999999   999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCc
Q 023220          142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLS  220 (285)
Q Consensus       142 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  220 (285)
                      ||++................++..|+|||.+.+..++.++||||||+++++|++ |..||.+..+.              
T Consensus       171 fg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------------  236 (290)
T cd05045         171 FGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE--------------  236 (290)
T ss_pred             ccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH--------------
Confidence            999875433222111222334668999999888889999999999999999998 99999654322              


Q ss_pred             hhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          221 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                        .+............+..++.++.+++.+||+.+|++||++.++++.|++++.
T Consensus       237 --~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         237 --RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             --HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence              1112222222233445567789999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-38  Score=261.05  Aligned_cols=240  Identities=25%  Similarity=0.370  Sum_probs=190.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+.. +..+++|........ ...+.+.+|++++++++|+||+++++++......++++||+.+++|.+++....
T Consensus        10 ~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~   87 (251)
T cd05041          10 DVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK   87 (251)
T ss_pred             eEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcC
Confidence            588998777 888888876543322 345678899999999999999999999999999999999999999999986543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .++...+..++.+++.++.|||++   +++|+||+|+||+++.++.++|+|||.+................
T Consensus        88 ~--------~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          88 N--------RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            2        278889999999999999999999   99999999999999999999999999987543211111111122


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+.+..++.++|+||||+++|+|++ |..||........                ...+........+...
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~  220 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT----------------RERIESGYRMPAPQLC  220 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH----------------HHHHhcCCCCCCCccC
Confidence            3456999999888889999999999999999998 8888865432111                1111111122334456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      +..+.+++.+||+.+|++|||+.++++.|+
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            778999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.3e-38  Score=274.52  Aligned_cols=238  Identities=21%  Similarity=0.243  Sum_probs=186.9

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++....+++.+++|..++... .....+.+.+|+.++.++ +||||+++++++...+..++||||+.+++|..++..
T Consensus        10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~   89 (329)
T cd05618          10 KVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR   89 (329)
T ss_pred             EEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHH
Confidence            589999888899999998765432 233456677899888877 899999999999999999999999999999988865


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ....
T Consensus        90 ~~~---------l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~  155 (329)
T cd05618          90 QRK---------LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTST  155 (329)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--cccc
Confidence            432         88999999999999999999999   999999999999999999999999999864322111  1223


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhh-hcCCccCCCCCh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQ-CVDPKLKGEYPP  238 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (285)
                      ..|+..|+|||.+.+..++.++|+|||||++|+|++|..||..........       ......+.. +...  ....+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~-------~~~~~~~~~~i~~~--~~~~p~  226 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------QNTEDYLFQVILEK--QIRIPR  226 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc-------cccHHHHHHHHhcC--CCCCCC
Confidence            458899999999999899999999999999999999999996422111000       000011111 1111  123456


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNM  262 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~  262 (285)
                      ..+..+.++|.+||+.||.+||++
T Consensus       227 ~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         227 SLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCHHHHHHHHHHhcCCHHHcCCC
Confidence            677889999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-38  Score=262.43  Aligned_cols=241  Identities=25%  Similarity=0.342  Sum_probs=188.4

Q ss_pred             Cceeeeeeeec---cccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVE---ESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||+|......   ..+++|........ ...+++.+|++++++++|+||+++++++. .+..+++|+|+.+++|.+++.
T Consensus        10 ~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~   87 (257)
T cd05060          10 SVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLK   87 (257)
T ss_pred             eEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHH
Confidence            57888665444   56777766543332 34567889999999999999999999876 456799999999999999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc-c
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH-S  157 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~  157 (285)
                      ....         +++..++.++.|++.++.|||..   +++|+||+|+||+++.++.++|+|||++........... .
T Consensus        88 ~~~~---------~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          88 KRRE---------IPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             hCCC---------CCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            6542         88999999999999999999999   999999999999999999999999999875543221111 1


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....++..|+|||...+..++.++|+||||+++|++++ |..||...+...                +...+........
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~  219 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE----------------VIAMLESGERLPR  219 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH----------------HHHHHHcCCcCCC
Confidence            11123457999999988889999999999999999997 999996543211                1111111112234


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      +..++..+.+++.+||+.+|++||++.++++.|++.
T Consensus       220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            455678899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=268.13  Aligned_cols=241  Identities=20%  Similarity=0.262  Sum_probs=191.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++....++..+++|........ ......+.+|++++++++||||+++++.+..++..+++|||+.+++|.+++...
T Consensus        15 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   94 (285)
T cd05605          15 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM   94 (285)
T ss_pred             EEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhc
Confidence            4788888778889999877543322 223456778999999999999999999999999999999999999999888643


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...       .+++..+..++.|++.|+.|||+.   |++|+||+|+||++++++.++|+|||++........   ....
T Consensus        95 ~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~  161 (285)
T cd05605          95 GNP-------GFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGR  161 (285)
T ss_pred             CcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccc
Confidence            221       288999999999999999999999   999999999999999999999999999865432211   1234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|+..|+|||.+.+..++.++|+||+||++|+|++|..||.+.......            +.+...+.. .....+..+
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~------------~~~~~~~~~-~~~~~~~~~  228 (285)
T cd05605         162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR------------EEVERRVKE-DQEEYSEKF  228 (285)
T ss_pred             cCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH------------HHHHHHhhh-cccccCccc
Confidence            6788999999998888999999999999999999999999764322111            111111111 112334557


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRP-----NMSIVVKA  268 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp-----s~~~ll~~  268 (285)
                      +..+.+++.+||+.||++||     +++++++.
T Consensus       229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         229 SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             CHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            78899999999999999999     88899763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.8e-39  Score=274.88  Aligned_cols=230  Identities=20%  Similarity=0.215  Sum_probs=186.0

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++....+++.+++|..++.. ......+.+.+|.+++..+ +||||+++++++...+..++||||+.+|+|.+++..
T Consensus        10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~   89 (320)
T cd05590          10 KVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK   89 (320)
T ss_pred             EEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHH
Confidence            58999888888999999776433 2334456677888888876 799999999999999999999999999999998876


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ....
T Consensus        90 ~~~---------l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~~  155 (320)
T cd05590          90 SRR---------FDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTST  155 (320)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cccc
Confidence            542         88999999999999999999999   999999999999999999999999999864322111  1233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||.+.+..++.++|+|||||++|+|++|+.||..........               .+....  ...+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~---------------~i~~~~--~~~~~~  218 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE---------------AILNDE--VVYPTW  218 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH---------------HHhcCC--CCCCCC
Confidence            458999999999988889999999999999999999999997654321111               111111  122344


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNM  262 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~  262 (285)
                      .+.++.+++++||+.||.+||++
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         219 LSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCC
Confidence            67789999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.9e-39  Score=269.49  Aligned_cols=233  Identities=27%  Similarity=0.450  Sum_probs=177.7

Q ss_pred             eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCC
Q 023220           10 QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG   89 (285)
Q Consensus        10 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~   89 (285)
                      ..+..+++|..+. .......+.+.+|++.+++++||||++++|++...+..++|+||+.+|+|.+++......      
T Consensus        26 ~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~------   98 (259)
T PF07714_consen   26 DKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKE------   98 (259)
T ss_dssp             SSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTT------
T ss_pred             CCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccccccccccccccccccccc------
Confidence            3445566666633 222223688999999999999999999999999888899999999999999999877221      


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCC
Q 023220           90 PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAP  169 (285)
Q Consensus        90 ~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aP  169 (285)
                       .+++..++.|+.|++.|+.|||+.   +++|++|+++||+++.++.+||+|||+.................+...|+||
T Consensus        99 -~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aP  174 (259)
T PF07714_consen   99 -PLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAP  174 (259)
T ss_dssp             -TSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-H
T ss_pred             -cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence             289999999999999999999999   9999999999999999999999999998765222222222334467789999


Q ss_pred             cccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHH
Q 023220          170 EYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVA  248 (285)
Q Consensus       170 E~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  248 (285)
                      |.+.+..++.++||||||+++||+++ |+.||.....                ..+...+........+..++..+.+++
T Consensus       175 E~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (259)
T PF07714_consen  175 EVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----------------EEIIEKLKQGQRLPIPDNCPKDIYSLI  238 (259)
T ss_dssp             HHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----------------HHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccc----------------ccccccccccccceeccchhHHHHHHH
Confidence            99988889999999999999999999 7889865422                122122222233344556788899999


Q ss_pred             HHhcccCCCCCCCHHHHHHHh
Q 023220          249 ALCVQYEAEFRPNMSIVVKAL  269 (285)
Q Consensus       249 ~~~l~~~p~~Rps~~~ll~~l  269 (285)
                      .+||+.||.+|||+.++++.|
T Consensus       239 ~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  239 QQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHT-SSGGGS--HHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHhcC
Confidence            999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.6e-38  Score=268.04  Aligned_cols=246  Identities=22%  Similarity=0.330  Sum_probs=188.3

Q ss_pred             Cceeeeee-----eeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTC-----QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||++...     .....+++|..+... .....+.+.+|+++++++ +||||+++++++...+..+++|||+.+++|.+
T Consensus        50 ~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  128 (302)
T cd05055          50 KVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLN  128 (302)
T ss_pred             eEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHH
Confidence            35666532     223345666554322 122346788999999999 89999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++......       .+++..++.++.|++.|+.|||++   +++|+||+|+||+++.++.++++|||++..........
T Consensus       129 ~i~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  198 (302)
T cd05055         129 FLRRKRES-------FLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV  198 (302)
T ss_pred             HHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccCCCcee
Confidence            99754321       278999999999999999999999   99999999999999999999999999987554322111


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      ......++..|+|||.+.+..++.++||||+||++|+|++ |..||.......               ............
T Consensus       199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---------------~~~~~~~~~~~~  263 (302)
T cd05055         199 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---------------KFYKLIKEGYRM  263 (302)
T ss_pred             ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---------------HHHHHHHcCCcC
Confidence            1222345678999999988889999999999999999998 999986543211               111111112222


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|++++
T Consensus       264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~  302 (302)
T cd05055         264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL  302 (302)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence            233445678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.2e-39  Score=277.13  Aligned_cols=232  Identities=22%  Similarity=0.227  Sum_probs=186.2

Q ss_pred             Cceeeeee---eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTC---QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++.+.   .+++.+++|..+...........+.+|++++++++||||+++++++.+++..++||||+.+++|.+++.
T Consensus        11 ~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   90 (318)
T cd05582          11 KVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS   90 (318)
T ss_pred             EEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence            47777653   456788888776544433445667889999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....         +++..+..++.|++.||.|||+.   |++||||+|+||+++.++.++|+|||++........  ...
T Consensus        91 ~~~~---------l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~  156 (318)
T cd05582          91 KEVM---------FTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAY  156 (318)
T ss_pred             HcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--cee
Confidence            5432         88999999999999999999999   999999999999999999999999999865433211  123


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ...|++.|+|||.+.+..++.++|+|||||++|+|++|+.||........               ...+....  ...+.
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---------------~~~i~~~~--~~~p~  219 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---------------MTMILKAK--LGMPQ  219 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---------------HHHHHcCC--CCCCC
Confidence            34688999999999888889999999999999999999999976432211               11111111  12345


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSI  264 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~  264 (285)
                      ..+..+.+++.+||+.||.+||++.+
T Consensus       220 ~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         220 FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            56788999999999999999999443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1e-38  Score=274.01  Aligned_cols=235  Identities=21%  Similarity=0.223  Sum_probs=190.3

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||++....+++.+++|..++.. ......+.+.+|+++++.+ +||||+++++++.+.+..++||||+.+++|..++..
T Consensus        10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   89 (318)
T cd05570          10 KVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR   89 (318)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH
Confidence            58999988889999999776543 2233456677898999887 799999999999999999999999999999998876


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||++........  ....
T Consensus        90 ~~~---------l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~  155 (318)
T cd05570          90 SGR---------FDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTST  155 (318)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccc
Confidence            532         88999999999999999999999   999999999999999999999999998864221111  1223


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.........               ..+....  ...+..
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~---------------~~i~~~~--~~~~~~  218 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF---------------QSILEDE--VRYPRW  218 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH---------------HHHHcCC--CCCCCc
Confidence            45789999999999989999999999999999999999999754321111               1111111  123445


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNM-----SIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~-----~~ll~  267 (285)
                      .+..+.++|.+||+.||.+|||+     .++++
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            67789999999999999999999     88875

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.9e-38  Score=268.58  Aligned_cols=258  Identities=17%  Similarity=0.210  Sum_probs=188.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||++.+..+++.+++|..+.... ......+.+|+++++.++||||+++++++.+....++||||+. ++|.+++....
T Consensus        20 ~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   97 (303)
T cd07869          20 TVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHP   97 (303)
T ss_pred             EEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCC
Confidence            589998888889999998764332 3345567889999999999999999999999999999999996 58888876543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .++...+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ......
T Consensus        98 ~--------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~  164 (303)
T cd07869          98 G--------GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEV  164 (303)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCc
Confidence            2        278889999999999999999999   999999999999999999999999999864322111  122345


Q ss_pred             cccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccc-hhhhhhcccCchhhh---h--hhcCCc-cC
Q 023220          162 GTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ-SLVTWATPRLSEDKV---K--QCVDPK-LK  233 (285)
Q Consensus       162 ~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~---~--~~~~~~-~~  233 (285)
                      +++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+....... ...............   .  ....+. ..
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (303)
T cd07869         165 VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFT  244 (303)
T ss_pred             ccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccccc
Confidence            7889999998865 45788999999999999999999999764321111 001000000000000   0  000000 00


Q ss_pred             CCCC---------hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          234 GEYP---------PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       234 ~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      ...+         ...+.++.+++.+||+.||.+|||+.++++  ..+....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~--h~~f~~~  294 (303)
T cd07869         245 LYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS--HEYFSDL  294 (303)
T ss_pred             ccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc--CcccccC
Confidence            0000         012457889999999999999999999997  4555443

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.5e-38  Score=264.29  Aligned_cols=247  Identities=26%  Similarity=0.314  Sum_probs=188.7

Q ss_pred             Cceeeeeee-----eccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQ-----VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++....     +...+++|...... .......+.+|+.++++++|+||+++++++.+....+++|||+.+++|.++
T Consensus        21 ~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~   99 (277)
T cd05036          21 EVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSF   99 (277)
T ss_pred             cEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHH
Confidence            578776655     55666677554322 122345688999999999999999999999988889999999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC---eeEEeccccCCCCCcccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF---KAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~---~~~l~df~~~~~~~~~~~  153 (285)
                      +........  ....+++..++.++.|++.++.|||++   +++|+||+|+||+++.++   .++|+|||++........
T Consensus       100 i~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~  174 (277)
T cd05036         100 LRENRPRPE--RPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY  174 (277)
T ss_pred             HHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCccccccCCccc
Confidence            976542211  112389999999999999999999999   999999999999998654   589999999876532221


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL  232 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
                      .........+..|+|||.+.+..++.++|||||||++|+|++ |..||.......                ....+....
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~----------------~~~~~~~~~  238 (277)
T cd05036         175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE----------------VMEFVTGGG  238 (277)
T ss_pred             eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----------------HHHHHHcCC
Confidence            111122233567999999988889999999999999999997 999997543321                111111112


Q ss_pred             CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          233 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      ....+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            22345566788999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7e-38  Score=267.11  Aligned_cols=245  Identities=24%  Similarity=0.363  Sum_probs=189.4

Q ss_pred             ccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCC------
Q 023220           14 SYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA------   86 (285)
Q Consensus        14 ~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~------   86 (285)
                      .+++|...... .....+.+.+|+.+++.+ +||||+++++++......+++|||+.+++|.+++.........      
T Consensus        49 ~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  127 (304)
T cd05101          49 TVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIA  127 (304)
T ss_pred             eEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccc
Confidence            46666554321 223356788999999999 8999999999999999999999999999999999765321100      


Q ss_pred             -CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccC
Q 023220           87 -QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG  165 (285)
Q Consensus        87 -~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  165 (285)
                       .....+++..++.++.|++.|+.|||++   |++|+||+|+||+++.++.++|+|||++................++..
T Consensus       128 ~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~  204 (304)
T cd05101         128 RVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK  204 (304)
T ss_pred             cCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCce
Confidence             1122378889999999999999999999   999999999999999999999999999876544332222223345678


Q ss_pred             cCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHH
Q 023220          166 YHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKL  244 (285)
Q Consensus       166 ~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (285)
                      |+|||.+.+..++.++||||||+++|++++ |..||......                .....+........+..++..+
T Consensus       205 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~  268 (304)
T cd05101         205 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----------------ELFKLLKEGHRMDKPANCTNEL  268 (304)
T ss_pred             eeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----------------HHHHHHHcCCcCCCCCCCCHHH
Confidence            999999988889999999999999999998 78888644321                1111111112223345567889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          245 AAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                      .+++.+||+.+|++|||+.++++.|++++...++
T Consensus       269 ~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~  302 (304)
T cd05101         269 YMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN  302 (304)
T ss_pred             HHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence            9999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.1e-38  Score=264.76  Aligned_cols=249  Identities=25%  Similarity=0.347  Sum_probs=188.4

Q ss_pred             eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC--CeeeEEEeeCCCCCHHHHhccCCCCCCCC
Q 023220           10 QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG--NLRVLAYEFATMGSLHDILHGRKGVQGAQ   87 (285)
Q Consensus        10 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   87 (285)
                      ..+..+++|..+... .......+.+|++++++++||||+++++++...  ...+++|||+.+++|.+++....      
T Consensus        31 ~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~------  103 (283)
T cd05080          31 GTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK------  103 (283)
T ss_pred             CCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcC------
Confidence            345567777665332 223457788999999999999999999988753  46799999999999999997543      


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc-ccccccccCc
Q 023220           88 PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH-STRVLGTFGY  166 (285)
Q Consensus        88 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~~  166 (285)
                          +++..++.++.|++.|+.|||++   |++|+||+|+||+++.++.++|+|||++........... .....++..|
T Consensus       104 ----l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~  176 (283)
T cd05080         104 ----LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW  176 (283)
T ss_pred             ----CCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCcee
Confidence                89999999999999999999999   999999999999999999999999999876543221110 1122345679


Q ss_pred             CCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHH
Q 023220          167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAA  246 (285)
Q Consensus       167 ~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  246 (285)
                      +|||.+.+..++.++||||||+++|+|++|..||........ ...................+.......+..++..+.+
T Consensus       177 ~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (283)
T cd05080         177 YAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYI  255 (283)
T ss_pred             eCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHH
Confidence            999998888889999999999999999999999865432111 1111111111112222223333333445667789999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          247 VAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       247 li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ++.+||+.+|++|||+.++++.|+.+.
T Consensus       256 li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         256 LMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             HHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.1e-38  Score=275.87  Aligned_cols=235  Identities=22%  Similarity=0.270  Sum_probs=182.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..+++.|++|..... ......+.+.+|+++++.++|+||+++++++...+..++||||+.+++|.+..    
T Consensus        89 ~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~----  163 (353)
T PLN00034         89 TVYKVIHRPTGRLYALKVIYGN-HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH----  163 (353)
T ss_pred             EEEEEEECCCCCEEEEEEEecC-CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc----
Confidence            5899988888889999976432 22234567889999999999999999999999999999999999999886432    


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                               ......+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++.........  .....
T Consensus       164 ---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~~~~~  229 (353)
T PLN00034        164 ---------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSV  229 (353)
T ss_pred             ---------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc--ccccc
Confidence                     156678889999999999999999   9999999999999999999999999998754322111  12346


Q ss_pred             cccCcCCCccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          162 GTFGYHAPEYAMT-----GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       162 ~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      |+..|+|||.+..     ...+.++|||||||++|+|++|+.||............             ...........
T Consensus       230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~-------------~~~~~~~~~~~  296 (353)
T PLN00034        230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM-------------CAICMSQPPEA  296 (353)
T ss_pred             cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH-------------HHHhccCCCCC
Confidence            8899999998743     23356899999999999999999999733221111110             00001111223


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      +..++.++.++|.+||+.||++|||+.++++.
T Consensus       297 ~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        297 PATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            44567789999999999999999999999984

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9.8e-39  Score=274.45  Aligned_cols=236  Identities=18%  Similarity=0.201  Sum_probs=189.9

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||+|.+..+++.+++|..++... .....+.+..|.+++..+ +||||+++++++.+.+..++||||+.+++|..++..
T Consensus        10 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~   89 (321)
T cd05591          10 KVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR   89 (321)
T ss_pred             EEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHH
Confidence            589999888889999998765432 233456677888888866 899999999999999999999999999999998875


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ....
T Consensus        90 ~~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~  155 (321)
T cd05591          90 SRK---------FDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTT  155 (321)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccc
Confidence            542         78899999999999999999999   999999999999999999999999998864322111  1233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.........               ..+....  ...+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~---------------~~i~~~~--~~~p~~  218 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF---------------ESILHDD--VLYPVW  218 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH---------------HHHHcCC--CCCCCC
Confidence            45889999999998888999999999999999999999999765432111               1111111  122344


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRP-------NMSIVVKA  268 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rp-------s~~~ll~~  268 (285)
                      .+.++.+++.+||+.||.+||       ++.++++.
T Consensus       219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            567899999999999999999       78888753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.6e-38  Score=272.46  Aligned_cols=235  Identities=21%  Similarity=0.222  Sum_probs=187.3

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++....+++.+++|..+.... .......+..|..++... +||||+++++++.+.+..++||||+.+|+|.+++..
T Consensus        10 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~   89 (316)
T cd05619          10 KVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS   89 (316)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH
Confidence            589999888899999997765432 233445667788888764 999999999999999999999999999999999975


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ....
T Consensus        90 ~~~---------~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~  155 (316)
T cd05619          90 CHK---------FDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCT  155 (316)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceee
Confidence            432         78889999999999999999999   999999999999999999999999998864321111  1233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|+..|+|||.+.+..++.++|+||+||++|+|++|..||...........+.             ...    ...+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~-------------~~~----~~~~~~  218 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR-------------MDN----PCYPRW  218 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------hCC----CCCCcc
Confidence            458899999999998889999999999999999999999997644221111100             001    122344


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMS-IVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~-~ll~  267 (285)
                      .+.++.+++.+||+.||++||++. ++++
T Consensus       219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         219 LTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            567899999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.4e-38  Score=277.01  Aligned_cols=254  Identities=21%  Similarity=0.305  Sum_probs=191.8

Q ss_pred             Cceeeeeeeec-----cccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVE-----ESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|......     ..+++|..+.. ......+.+.+|+++++++. ||||+++++++.+....++||||+.+|+|.+
T Consensus        52 ~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~  130 (400)
T cd05105          52 KVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVN  130 (400)
T ss_pred             eEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHH
Confidence            46777653322     34677766432 22334577889999999995 9999999999999999999999999999999


Q ss_pred             HhccCCCCCC----------------------------------------------------------------------
Q 023220           76 ILHGRKGVQG----------------------------------------------------------------------   85 (285)
Q Consensus        76 ~l~~~~~~~~----------------------------------------------------------------------   85 (285)
                      ++..+.....                                                                      
T Consensus       131 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (400)
T cd05105         131 YLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDR  210 (400)
T ss_pred             HHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccc
Confidence            9865321000                                                                      


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCC
Q 023220           86 -----------------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA  148 (285)
Q Consensus        86 -----------------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~  148 (285)
                                       ......+++..++.++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus       211 ~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL~DfGla~~~  287 (400)
T cd05105         211 PASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDI  287 (400)
T ss_pred             cccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEEEEeCCcceec
Confidence                             00112378888999999999999999999   9999999999999999999999999998754


Q ss_pred             CcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhh
Q 023220          149 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC  227 (285)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (285)
                      .............++..|+|||.+.+..++.++|||||||++|+|++ |..||........               ....
T Consensus       288 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---------------~~~~  352 (400)
T cd05105         288 MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---------------FYNK  352 (400)
T ss_pred             cccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH---------------HHHH
Confidence            33222112223345678999999988889999999999999999997 9999865322110               1111


Q ss_pred             cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          228 VDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       228 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      +........+..++..+.+++.+||+.||++|||+.++.+.|+++++
T Consensus       353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            11111223344567789999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.4e-38  Score=265.05  Aligned_cols=251  Identities=21%  Similarity=0.297  Sum_probs=191.7

Q ss_pred             Cceeeeeeee-----ccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQV-----EESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~-----~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++....+     ...+++|...... .....+.+.+|+.++++++||||+++++++......+++++|+.+++|.++
T Consensus        20 ~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~   98 (283)
T cd05091          20 KVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEF   98 (283)
T ss_pred             eEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHH
Confidence            5788865432     4567777765322 222356788999999999999999999999999999999999999999999


Q ss_pred             hccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCC
Q 023220           77 LHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP  149 (285)
Q Consensus        77 l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~  149 (285)
                      +.......       .......+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++....
T Consensus        99 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (283)
T cd05091          99 LVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY  175 (283)
T ss_pred             HHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEecccccccccc
Confidence            85432110       001122378889999999999999999999   99999999999999999999999999987553


Q ss_pred             cccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhc
Q 023220          150 DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV  228 (285)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
                      ............+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+.....                ....+
T Consensus       176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~i  239 (283)
T cd05091         176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD----------------VIEMI  239 (283)
T ss_pred             cchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH----------------HHHHH
Confidence            3222211233345678999999988889999999999999999998 888886543211                11111


Q ss_pred             CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          229 DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      ........+..++..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  283 (283)
T cd05091         240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW  283 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence            11122234556788899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-37  Score=260.93  Aligned_cols=248  Identities=24%  Similarity=0.332  Sum_probs=191.2

Q ss_pred             Cceeeeeeeec------cccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVE------ESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||++....+.      ..+++|..... ........+.+|+.+++.++||||+++++++......+++|||+.+++|.+
T Consensus        10 ~vy~~~~~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   88 (269)
T cd05044          10 EVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLS   88 (269)
T ss_pred             eEEeeeecccccCcccceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHH
Confidence            47777655443      67888876532 222346678899999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC-----eeEEeccccCCCCCc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-----KAKIADFNLSNQAPD  150 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~-----~~~l~df~~~~~~~~  150 (285)
                      ++.......  .....+++..++.++.|++.|+.|||+.   +++|+||+|+||+++.++     .++++|||++.....
T Consensus        89 ~l~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~  163 (269)
T cd05044          89 YLRDARVER--FGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK  163 (269)
T ss_pred             HHHHhhhcc--cCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccccccccc
Confidence            997543211  0122378899999999999999999999   999999999999999877     899999999865433


Q ss_pred             ccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcC
Q 023220          151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD  229 (285)
Q Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
                      ...........++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......                ....+.
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~----------------~~~~~~  227 (269)
T cd05044         164 SDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE----------------VLQHVT  227 (269)
T ss_pred             ccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH----------------HHHHHh
Confidence            222111222345678999999998889999999999999999998 999996433211                111111


Q ss_pred             CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          230 PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       230 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      .......+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         228 AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            111223345567889999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=277.65  Aligned_cols=240  Identities=18%  Similarity=0.201  Sum_probs=189.4

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|..+.... .......+.+|+++++.++||||+++++.+.+++..++||||+.+|+|.+++...
T Consensus        16 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~   95 (364)
T cd05599          16 EVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK   95 (364)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHc
Confidence            589999988899999998765432 2334566788999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc------
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR------  154 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~------  154 (285)
                      ..         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.........      
T Consensus        96 ~~---------l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  163 (364)
T cd05599          96 DT---------FTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL  163 (364)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccc
Confidence            32         88999999999999999999999   9999999999999999999999999998643211100      


Q ss_pred             ------------------------------ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Q 023220          155 ------------------------------LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTM  204 (285)
Q Consensus       155 ------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~  204 (285)
                                                    .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~  243 (364)
T cd05599         164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDN  243 (364)
T ss_pred             cccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCC
Confidence                                          00012358999999999998899999999999999999999999997654


Q ss_pred             CcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 023220          205 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN---MSIVVK  267 (285)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~  267 (285)
                      .......+.            .. ...........+++++.++|.+|+. +|.+|++   +.++++
T Consensus       244 ~~~~~~~i~------------~~-~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         244 PQETYRKII------------NW-KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HHHHHHHHH------------cC-CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            321111000            00 0011111112356789999999997 9999998   888877

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.2e-39  Score=264.81  Aligned_cols=254  Identities=20%  Similarity=0.232  Sum_probs=198.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC-----eeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN-----LRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~   76 (285)
                      +||++.-..+.+.+|+|..-....-+      .+|+.+|+.+.|||||.+.-+|....     ...+||||++. +|.+.
T Consensus        39 ~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~  111 (364)
T KOG0658|consen   39 VVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRV  111 (364)
T ss_pred             eEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHH
Confidence            58888877778888888665433322      36999999999999999998887432     44789999986 99999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC-CeeEEeccccCCCCCcccccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++.....     .+.++...+..+..||+.|++|||..   |++||||||+|+|+|.+ |.+||+|||+|+.......  
T Consensus       112 ~r~~~~~-----~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep--  181 (364)
T KOG0658|consen  112 IRHYTRA-----NQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP--  181 (364)
T ss_pred             HHHHhhc-----CCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC--
Confidence            9852110     01277888999999999999999999   99999999999999976 8899999999976543222  


Q ss_pred             cccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC----
Q 023220          156 HSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP----  230 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  230 (285)
                       +....++..|+|||.+.+. .|+.+.||||.||++.||+.|++.|.+.+...+...+....+..+.+++..+--.    
T Consensus       182 -niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~  260 (364)
T KOG0658|consen  182 -NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEF  260 (364)
T ss_pred             -ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccc
Confidence             2334578899999999876 7899999999999999999999999998887777777766666666655443211    


Q ss_pred             ---ccCC-----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH--Hhchhh
Q 023220          231 ---KLKG-----EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLL  273 (285)
Q Consensus       231 ---~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~--~l~~~~  273 (285)
                         ....     -.....+++..+++.++|+.+|.+|.++.+++.  +++.+.
T Consensus       261 ~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  261 KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR  313 (364)
T ss_pred             cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence               1111     134566789999999999999999999999885  344444

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.5e-38  Score=264.26  Aligned_cols=250  Identities=21%  Similarity=0.305  Sum_probs=186.2

Q ss_pred             Cceeeeee-----eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTC-----QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++...     .....+++|...... ......++.+|+.+++.++||||+++++++..+...+++|||+.+++|.++
T Consensus        21 ~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   99 (277)
T cd05062          21 MVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY   99 (277)
T ss_pred             eEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHH
Confidence            46665432     123456676553321 122345688999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           77 LHGRKGVQG-AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        77 l~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      +........ ......+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++..........
T Consensus       100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  176 (277)
T cd05062         100 LRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR  176 (277)
T ss_pred             HHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCCCccccCCcceee
Confidence            865432111 01112367889999999999999999999   99999999999999999999999999986543322211


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.........               ...... ...
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~---------------~~~~~~-~~~  240 (277)
T cd05062         177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL---------------RFVMEG-GLL  240 (277)
T ss_pred             cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---------------HHHHcC-CcC
Confidence            1122334678999999988889999999999999999998 78898654322111               011111 111


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      ..+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            2344566789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.3e-38  Score=285.93  Aligned_cols=243  Identities=19%  Similarity=0.248  Sum_probs=192.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC--------eeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN--------LRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~~~L   73 (285)
                      .||++.+..+++.|++|..............+.+|+..+..++|+|++++++.+....        ..++||||+.+|+|
T Consensus        47 ~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL  126 (496)
T PTZ00283         47 TVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDL  126 (496)
T ss_pred             EEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcH
Confidence            4899988888999999987655544455667889999999999999999988775432        36899999999999


Q ss_pred             HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc
Q 023220           74 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        74 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  153 (285)
                      .+++......     ...+++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........
T Consensus       127 ~~~l~~~~~~-----~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~  198 (496)
T PTZ00283        127 RQEIKSRAKT-----NRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS  198 (496)
T ss_pred             HHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccCeecccccc
Confidence            9998754311     11388999999999999999999999   999999999999999999999999999875443222


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                      ........|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......               .+..... ...
T Consensus       199 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---------------~~~~~~~-~~~  262 (496)
T PTZ00283        199 DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---------------VMHKTLA-GRY  262 (496)
T ss_pred             ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---------------HHHHHhc-CCC
Confidence            222233568999999999998889999999999999999999999997543211               1111111 111


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          234 GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      ...+..+++++.+++.+||+.||.+||++.++++.
T Consensus       263 ~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        263 DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            23455677889999999999999999999999863

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7e-38  Score=264.42  Aligned_cols=251  Identities=23%  Similarity=0.325  Sum_probs=188.7

Q ss_pred             Cceeeeee----eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTC----QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||++...    .....+++|..+... .......+.+|++++++++||||+++++++......+++|||+.+++|.+++
T Consensus        20 ~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   98 (283)
T cd05090          20 KIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFL   98 (283)
T ss_pred             ceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHH
Confidence            46666532    233556666665322 2233467889999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC--------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCC
Q 023220           78 HGRKGVQ--------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP  149 (285)
Q Consensus        78 ~~~~~~~--------~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~  149 (285)
                      .......        .......+++..+..++.|++.|+.|||++   |++|+||+|+||+++.++.++|+|||++....
T Consensus        99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (283)
T cd05090          99 IMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIY  175 (283)
T ss_pred             HhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEecccccccccc
Confidence            5432100        000112378889999999999999999999   99999999999999999999999999987653


Q ss_pred             cccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhc
Q 023220          150 DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV  228 (285)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
                      ............++..|+|||.+.+..++.++|+||||+++|+|++ |..||......                .+.+.+
T Consensus       176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~----------------~~~~~~  239 (283)
T cd05090         176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ----------------EVIEMV  239 (283)
T ss_pred             CCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----------------HHHHHH
Confidence            3222111222334667999999988889999999999999999998 98898654321                111111


Q ss_pred             CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          229 DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      ........+..+++.+.+++.+||+.||++||++.++++.|+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05090         240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW  283 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence            11222233445677899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.6e-38  Score=261.40  Aligned_cols=240  Identities=24%  Similarity=0.331  Sum_probs=187.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.... ...+++|.....   ....+.+.+|+.++++++|+||+++++.+...+..++++||+.+++|.+++....
T Consensus        21 ~v~~~~~~~-~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   96 (261)
T cd05072          21 EVWMGYYNN-STKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDE   96 (261)
T ss_pred             eEEEEEecC-CceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhc
Confidence            477776443 345666654421   2235788999999999999999999999999999999999999999999997543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++......... ......
T Consensus        97 ~~-------~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~  165 (261)
T cd05072          97 GG-------KVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAK  165 (261)
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCc
Confidence            22       278889999999999999999999   9999999999999999999999999998765432211 112233


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+.+..++.++|+|||||++|+|++ |..||...........                +...........+
T Consensus       166 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----------------~~~~~~~~~~~~~  229 (261)
T cd05072         166 FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA----------------LQRGYRMPRMENC  229 (261)
T ss_pred             cceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH----------------HHcCCCCCCCCCC
Confidence            5668999999888888999999999999999998 9999965432211111                1111111223346


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      +.++.+++.+||+.+|++|||++++++.|+.+
T Consensus       230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         230 PDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            67899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.9e-38  Score=272.03  Aligned_cols=234  Identities=21%  Similarity=0.197  Sum_probs=186.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++.+..+++.+++|..++.... ....+....|.+++... +||||+++++++.+.+..++||||+.+++|..++..
T Consensus        10 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~   89 (316)
T cd05620          10 KVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD   89 (316)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH
Confidence            5899999888999999977654322 23445667788888754 899999999999999999999999999999999876


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++........  ....
T Consensus        90 ~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~  155 (316)
T cd05620          90 KGR---------FDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAST  155 (316)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--ceec
Confidence            432         78899999999999999999999   999999999999999999999999998764221111  1233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||.+.+..++.++|+||+||++|+|++|..||...+.......               +...  ....+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~---------------~~~~--~~~~~~~  218 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES---------------IRVD--TPHYPRW  218 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---------------HHhC--CCCCCCC
Confidence            4589999999999988999999999999999999999999975542211111               0000  1123344


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMS-IVV  266 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~-~ll  266 (285)
                      ++.++.+++.+||+.||.+||++. +++
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         219 ITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            667899999999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.7e-38  Score=270.46  Aligned_cols=255  Identities=22%  Similarity=0.324  Sum_probs=190.7

Q ss_pred             Cceeeeeeee-----ccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEe-CCeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQV-----EESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVE-GNLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~-----~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~   74 (285)
                      +||++....+     ...+++|..+... .....+.+.+|+.+++++ +|+||+++++++.. +...++++||+.+++|.
T Consensus        22 ~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~  100 (337)
T cd05054          22 KVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLS  100 (337)
T ss_pred             eEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHH
Confidence            4777764333     3567777665322 222345677899999999 89999999998864 45678999999999999


Q ss_pred             HHhccCCCCCC----------------------------------------------------CCCCCCCCHHHHHHHHH
Q 023220           75 DILHGRKGVQG----------------------------------------------------AQPGPVLDWMTRVRIAV  102 (285)
Q Consensus        75 ~~l~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~~~~~  102 (285)
                      +++........                                                    ......+++..+..++.
T Consensus       101 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  180 (337)
T cd05054         101 NYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSF  180 (337)
T ss_pred             HHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHH
Confidence            99864321000                                                    00012478999999999


Q ss_pred             HHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccccCCCCcccc
Q 023220          103 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSD  182 (285)
Q Consensus       103 qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D  182 (285)
                      |++.|+.|||++   |++||||||.||+++.++.++|+|||++................++..|+|||.+.+..++.++|
T Consensus       181 qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  257 (337)
T cd05054         181 QVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSD  257 (337)
T ss_pred             HHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCcccc
Confidence            999999999999   99999999999999999999999999997654322222223344567899999999999999999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCC
Q 023220          183 VYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN  261 (285)
Q Consensus       183 iwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  261 (285)
                      ||||||++|+|++ |..||.+......               ....+........+...++++.+++.+||+.+|++||+
T Consensus       258 i~SlGv~l~el~t~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs  322 (337)
T cd05054         258 VWSFGVLLWEIFSLGASPYPGVQIDEE---------------FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT  322 (337)
T ss_pred             HHHHHHHHHHHHHcCCCCCCCCCccHH---------------HHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence            9999999999998 9999975432111               11111111112234455678999999999999999999


Q ss_pred             HHHHHHHhchhhcC
Q 023220          262 MSIVVKALQPLLKS  275 (285)
Q Consensus       262 ~~~ll~~l~~~~~~  275 (285)
                      +.++++.|+++++.
T Consensus       323 ~~ell~~l~~~~~~  336 (337)
T cd05054         323 FSELVEILGDLLQE  336 (337)
T ss_pred             HHHHHHHHHHHHhc
Confidence            99999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-38  Score=259.78  Aligned_cols=237  Identities=24%  Similarity=0.309  Sum_probs=186.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||++... .+..+++|.....   ....+++.+|++++++++||||+++++++...+..+++|||+.+++|.+++....
T Consensus        19 ~v~~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   94 (256)
T cd05059          19 VVHLGKWR-GKIDVAIKMIREG---AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK   94 (256)
T ss_pred             eEEEeEec-CCccEEEEEeccC---CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc
Confidence            57877554 4566777765421   2234678899999999999999999999999999999999999999999987543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.|++|||+.   |++|+||+|+||+++.++.++|+|||++......... ......
T Consensus        95 ~--------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~  162 (256)
T cd05059          95 G--------KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTK  162 (256)
T ss_pred             c--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc-ccCCCC
Confidence            2        288999999999999999999999   9999999999999999999999999988654321111 111122


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+.+..++.++|+||||+++|++++ |..||.........                ...........+..+
T Consensus       163 ~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~  226 (256)
T cd05059         163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV----------------ESVSAGYRLYRPKLA  226 (256)
T ss_pred             CCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH----------------HHHHcCCcCCCCCCC
Confidence            3457999999988889999999999999999998 89999754322111                111111122334456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      +..+.+++.+||+.+|++|||+.++++.|.
T Consensus       227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.6e-37  Score=258.44  Aligned_cols=237  Identities=24%  Similarity=0.311  Sum_probs=183.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++... .+..+++|..+..   ....+++.+|++++++++||||+++++++......+++|||+.+|+|.+++....
T Consensus        19 ~vy~~~~~-~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~   94 (256)
T cd05114          19 VVHLGKWR-AQIKVAIKAINEG---AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ   94 (256)
T ss_pred             eEEEEEec-cCceEEEEecccC---CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCc
Confidence            46776443 3445677765422   2235688899999999999999999999999999999999999999999987543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.|+.|||++   |++|+||+|+||+++.++.++|+|||.+......... ......
T Consensus        95 ~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~  162 (256)
T cd05114          95 G--------KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAK  162 (256)
T ss_pred             c--------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCC
Confidence            2        278899999999999999999999   9999999999999999999999999988754322211 112223


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+.+..++.++|+||||+++|+|++ |+.||..........               .+.. ......+...
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~---------------~i~~-~~~~~~~~~~  226 (256)
T cd05114         163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE---------------MISR-GFRLYRPKLA  226 (256)
T ss_pred             CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH---------------HHHC-CCCCCCCCCC
Confidence            4567999999988889999999999999999999 899996543211111               1100 1111123334


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      +..+.+++.+||+.+|++|||+.++++.|.
T Consensus       227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         227 SMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            567999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1e-37  Score=259.92  Aligned_cols=242  Identities=23%  Similarity=0.346  Sum_probs=187.3

Q ss_pred             Cceeeeee--eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTC--QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||++...  .....+++|..... ......+.+.+|+.++++++||||+++++++.. ...++||||+.+++|.+++..
T Consensus        10 ~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~   87 (257)
T cd05115          10 CVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSG   87 (257)
T ss_pred             cEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHh
Confidence            57776543  22334677766433 233345678899999999999999999998864 467999999999999999875


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc-ccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL-HST  158 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~  158 (285)
                      ...        .+++..++.++.|++.|+.|||++   |++|+||+|+||+++.++.++|+|||++.......... ...
T Consensus        88 ~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          88 KKD--------EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CCC--------CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            432        288999999999999999999999   99999999999999999999999999986443221110 011


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...++..|+|||.+....++.++|+||||+++|++++ |..||......                .+...+........+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~  220 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----------------EVMSFIEQGKRLDCP  220 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----------------HHHHHHHCCCCCCCC
Confidence            1223568999999888888999999999999999996 99999754321                122222222233455


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      ..+++++.+++.+||+.+|++||++.++.+.|+.+
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            66788999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.1e-38  Score=274.95  Aligned_cols=241  Identities=19%  Similarity=0.176  Sum_probs=186.7

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.+..+++.+++|..+.... .......+.+|+.++.+++|+||+++++.+.+....++||||+.+|+|.+++...
T Consensus        16 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~   95 (363)
T cd05628          16 EVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK   95 (363)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhc
Confidence            589999988899999998764332 2334567888999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc------
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR------  154 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~------  154 (285)
                      ..         +++..+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++.........      
T Consensus        96 ~~---------l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~  163 (363)
T cd05628          96 DT---------LTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNL  163 (363)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccc
Confidence            32         88999999999999999999999   9999999999999999999999999998644221000      


Q ss_pred             ---------------------------ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcc
Q 023220          155 ---------------------------LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRG  207 (285)
Q Consensus       155 ---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~  207 (285)
                                                 .......||+.|+|||.+.+..++.++|+|||||++|+|++|..||.......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~  243 (363)
T cd05628         164 NHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE  243 (363)
T ss_pred             cccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHH
Confidence                                       00112468999999999998899999999999999999999999997654322


Q ss_pred             cchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCC---CCCCHHHHHHH
Q 023220          208 QQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAE---FRPNMSIVVKA  268 (285)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~---~Rps~~~ll~~  268 (285)
                      ....+.            .. .....-.....+++++.++|.+++. +|.   .||+++++++.
T Consensus       244 ~~~~i~------------~~-~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         244 TYKKVM------------NW-KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HHHHHH------------cC-cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence            111110            00 0000001111246678889888664 444   46899999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-38  Score=263.87  Aligned_cols=250  Identities=24%  Similarity=0.312  Sum_probs=189.5

Q ss_pred             Cceeeeeeeec-----cccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVE-----ESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++....+.     ..+++|...... .......+.+|+.+++.++|+||+++++++......+++|||+.+++|.++
T Consensus        21 ~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~   99 (277)
T cd05032          21 MVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSY   99 (277)
T ss_pred             eEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHH
Confidence            46776665433     566666653221 112245678899999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           77 LHGRKGVQGA-QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        77 l~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      +......... .....+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++..........
T Consensus       100 l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~  176 (277)
T cd05032         100 LRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR  176 (277)
T ss_pred             HHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcccchhhccCcccc
Confidence            9754322111 1112378889999999999999999999   99999999999999999999999999987554322211


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      ......++..|+|||.+.+..++.++|+|||||++|++++ |..||........                ..........
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~----------------~~~~~~~~~~  240 (277)
T cd05032         177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV----------------LKFVIDGGHL  240 (277)
T ss_pred             cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH----------------HHHHhcCCCC
Confidence            1223345678999999988889999999999999999998 9999965432211                1111111112


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      ..+..++..+.+++.+||+.+|++|||+.++++.|++
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            3344567889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.8e-39  Score=256.30  Aligned_cols=236  Identities=21%  Similarity=0.318  Sum_probs=190.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCC------CChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKN------YPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~------~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   74 (285)
                      +|-+|+.+.+...|++|.+......+.      ..+.-.+|+++|+++ .||||+.+.|+++.+...++|++.+..|.|+
T Consensus        32 ~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELF  111 (411)
T KOG0599|consen   32 VVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELF  111 (411)
T ss_pred             hhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHH
Confidence            355777778888888886655443322      244556799999999 8999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  154 (285)
                      +++...-.         ++++....+++|+++++.|||..   +|+|||+||+|||++++-+++|+|||.++........
T Consensus       112 DyLts~Vt---------lSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekL  179 (411)
T KOG0599|consen  112 DYLTSKVT---------LSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKL  179 (411)
T ss_pred             HHhhhhee---------ecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCCchhH
Confidence            99987653         89999999999999999999999   9999999999999999999999999999877654433


Q ss_pred             ccccccccccCcCCCccccc------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhc
Q 023220          155 LHSTRVLGTFGYHAPEYAMT------GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV  228 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
                         ....|||+|+|||.+..      ..|+...|+|++|+++|-|+.|.+||-......               .++.+.
T Consensus       180 ---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml---------------MLR~Im  241 (411)
T KOG0599|consen  180 ---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML---------------MLRMIM  241 (411)
T ss_pred             ---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH---------------HHHHHH
Confidence               45679999999998853      367888999999999999999999995322111               111111


Q ss_pred             CCcc--CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          229 DPKL--KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       229 ~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ....  ..+-=.+++....++|++||+.||.+|.|+++.+.
T Consensus       242 eGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  242 EGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             hcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            2111  11122456778999999999999999999999986

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.6e-38  Score=265.54  Aligned_cols=252  Identities=20%  Similarity=0.228  Sum_probs=187.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC---CCCcccccceEEEe-----CCeeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL---KHENLVELLGYCVE-----GNLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L   73 (285)
                      .||++.+..+++.+++|..+...........+.+|+++++.+   +||||+++++++..     ....+++||++.+ +|
T Consensus        15 ~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l   93 (288)
T cd07863          15 TVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DL   93 (288)
T ss_pred             EEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CH
Confidence            589999998999999998766544444555666777777665   79999999998864     2457999999975 89


Q ss_pred             HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc
Q 023220           74 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        74 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  153 (285)
                      .+++......       .+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........
T Consensus        94 ~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~  163 (288)
T cd07863          94 RTYLDKVPPP-------GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA  163 (288)
T ss_pred             HHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccccCccc
Confidence            8888754321       288999999999999999999999   999999999999999999999999999875543211


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh-------h
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK-------Q  226 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------~  226 (285)
                         .....++..|+|||.+.+..++.++||||+||++|+|++|.+||...........+.............       .
T Consensus       164 ---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07863         164 ---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRG  240 (288)
T ss_pred             ---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccccc
Confidence               123457889999999988889999999999999999999999997654322211111100000000000       0


Q ss_pred             hcCC---ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          227 CVDP---KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       227 ~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...+   .......+.++..+.+++.+||+.||++|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         241 AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000   0001122345678999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.5e-38  Score=273.12  Aligned_cols=249  Identities=18%  Similarity=0.211  Sum_probs=187.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC------CeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG------NLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~   75 (285)
                      .||++.+..++..+++|..............+.+|+.+++.++||||+++++++...      ...++||||+.+ +|.+
T Consensus        39 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~  117 (364)
T cd07875          39 IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQ  117 (364)
T ss_pred             EEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHH
Confidence            588998888889999998765544455567788999999999999999999987643      356999999975 7777


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      .+...           ++...+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++.......   
T Consensus       118 ~~~~~-----------~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---  180 (364)
T cd07875         118 VIQME-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---  180 (364)
T ss_pred             HHHhc-----------CCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---
Confidence            77532           77889999999999999999999   99999999999999999999999999997543321   


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh-------hhhc
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV-------KQCV  228 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~  228 (285)
                      ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.........+..       ....
T Consensus       181 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (364)
T cd07875         181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV  260 (364)
T ss_pred             cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHH
Confidence            123345789999999999989999999999999999999999999866543222211111111000000       0000


Q ss_pred             C--C------------cc----CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          229 D--P------------KL----KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       229 ~--~------------~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      .  +            ..    ........+..+.++|.+||+.||.+|||+.++++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0  0            00    001112234578999999999999999999999983

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.4e-38  Score=270.53  Aligned_cols=256  Identities=16%  Similarity=0.204  Sum_probs=189.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++....+++.+++|............+.+++|+++++.++||||+++++++..++..++||||+.+++|.+++....
T Consensus        15 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~   94 (327)
T cd08227          15 TVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF   94 (327)
T ss_pred             EEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhc
Confidence            58999999999999999886655444456678889999999999999999999999999999999999999999986542


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc-----c
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL-----H  156 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-----~  156 (285)
                      ..       .+++..++.++.|++.||.|||++   |++||||||+||+++.++.+++.||+............     .
T Consensus        95 ~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  164 (327)
T cd08227          95 MD-------GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDF  164 (327)
T ss_pred             cC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccc
Confidence            21       278899999999999999999999   99999999999999999999999997653322111100     0


Q ss_pred             ccccccccCcCCCccccc--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccc-hhhhhhccc------Cchhhhh--
Q 023220          157 STRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ-SLVTWATPR------LSEDKVK--  225 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~------~~~~~~~--  225 (285)
                      .....++..|+|||.+.+  ..++.++|+|||||++|+|++|..||......... .......+.      ...+...  
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (327)
T cd08227         165 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMK  244 (327)
T ss_pred             cccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccC
Confidence            112345677999999875  45889999999999999999999999753221110 000000000      0000000  


Q ss_pred             ---hhc-----------------CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          226 ---QCV-----------------DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       226 ---~~~-----------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                         ...                 ............++.+.+++.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         245 PSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             CcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence               000                 000011123345678999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-38  Score=275.26  Aligned_cols=238  Identities=18%  Similarity=0.166  Sum_probs=190.3

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|..+.... .....+.+.+|+.+++.++|+||+++++++.+.+..++||||+.+++|.+++...
T Consensus        16 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   95 (330)
T cd05601          16 EVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRY   95 (330)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHh
Confidence            589999888899999998765443 3345667889999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..        .+++..+..++.|++.||.|||+.   |++||||+|+||+++.++.++|+|||++......... .....
T Consensus        96 ~~--------~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~  163 (330)
T cd05601          96 ED--------QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLP  163 (330)
T ss_pred             cC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecc
Confidence            32        288999999999999999999999   9999999999999999999999999998754332211 12234


Q ss_pred             ccccCcCCCcccc------cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc--c
Q 023220          161 LGTFGYHAPEYAM------TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK--L  232 (285)
Q Consensus       161 ~~~~~~~aPE~~~------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  232 (285)
                      .|++.|+|||.+.      ...++.++|||||||++|+|++|..||.........               ..+....  .
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~---------------~~i~~~~~~~  228 (330)
T cd05601         164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY---------------NNIMNFQRFL  228 (330)
T ss_pred             cCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH---------------HHHHcCCCcc
Confidence            5789999999886      446788999999999999999999999754432111               1111100  1


Q ss_pred             CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          233 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .......++.++.+++.+||+ +|.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         229 KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            111123467789999999998 9999999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.5e-38  Score=272.12  Aligned_cols=231  Identities=19%  Similarity=0.191  Sum_probs=183.4

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHH-HHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVS-VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++.+..+++.+++|....... .......+..|.. +++.++||||+++++.+.+.+..++||||+.+|+|..++..
T Consensus        10 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~   89 (323)
T cd05575          10 KVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR   89 (323)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh
Confidence            589999998999999997754332 2223344555544 56788999999999999999999999999999999999876


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++........  ....
T Consensus        90 ~~~---------~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~  155 (323)
T cd05575          90 ERS---------FPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTST  155 (323)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--cccc
Confidence            542         88899999999999999999999   999999999999999999999999999864322111  1233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+....               ...+....  ...++.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---------------~~~i~~~~--~~~~~~  218 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM---------------YDNILNKP--LRLKPN  218 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH---------------HHHHHcCC--CCCCCC
Confidence            4588999999999988899999999999999999999999975432111               11111111  122344


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMS  263 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~  263 (285)
                      .+..+.++|.+||+.||.+||++.
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         219 ISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCHHHHHHHHHHhhcCHHhCCCCC
Confidence            577899999999999999999884

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.7e-38  Score=274.52  Aligned_cols=249  Identities=18%  Similarity=0.199  Sum_probs=187.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC------CeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG------NLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.+..++..+++|..............+.+|+.+++.++||||+++++++...      ...+++|||+.+ ++.+
T Consensus        32 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~  110 (355)
T cd07874          32 IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQ  110 (355)
T ss_pred             EEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHH
Confidence            588998888888999997765554555567788999999999999999999988643      356999999975 7777


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      .+...           ++...+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.......   
T Consensus       111 ~~~~~-----------l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---  173 (355)
T cd07874         111 VIQME-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---  173 (355)
T ss_pred             HHhhc-----------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCCcc---
Confidence            76532           78889999999999999999999   99999999999999999999999999987543321   


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchh-------hhhhhc
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED-------KVKQCV  228 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~  228 (285)
                      ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+.................+       .+..+.
T Consensus       174 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (355)
T cd07874         174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV  253 (355)
T ss_pred             ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHH
Confidence            1233457899999999998889999999999999999999999997654322211110000000000       000000


Q ss_pred             CC----------cc--------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          229 DP----------KL--------KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       229 ~~----------~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      +.          ..        ........+..+.++|.+||+.||.+|||+.++++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            00          00        011122345678999999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.9e-38  Score=275.54  Aligned_cols=238  Identities=17%  Similarity=0.195  Sum_probs=189.3

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||++.+..+++.+++|...+... .....+.+.+|+.+++.++||||+++++++.+++..++||||+.+|+|.+++...
T Consensus        58 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~  137 (370)
T cd05596          58 EVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY  137 (370)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc
Confidence            589998888899999998754332 2233456778999999999999999999999999999999999999999998754


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      .          ++...+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........ ......
T Consensus       138 ~----------l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~  203 (370)
T cd05596         138 D----------IPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTA  203 (370)
T ss_pred             C----------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCC
Confidence            2          78888999999999999999999   999999999999999999999999999865432211 111234


Q ss_pred             ccccCcCCCcccccC----CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          161 LGTFGYHAPEYAMTG----QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~----~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      .|++.|+|||.+.+.    .++.++|+|||||++|+|++|..||........               ...+........+
T Consensus       204 ~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---------------~~~i~~~~~~~~~  268 (370)
T cd05596         204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---------------YSKIMDHKNSLTF  268 (370)
T ss_pred             CCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---------------HHHHHcCCCcCCC
Confidence            589999999988653    378899999999999999999999976543211               1111111111111


Q ss_pred             C--hhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 023220          237 P--PKGVAKLAAVAALCVQYEAEF--RPNMSIVVKA  268 (285)
Q Consensus       237 ~--~~~~~~l~~li~~~l~~~p~~--Rps~~~ll~~  268 (285)
                      +  ..++.++.++|++||+.+|.+  |+|++++++.
T Consensus       269 ~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         269 PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            2  246788999999999999988  9999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-37  Score=262.07  Aligned_cols=247  Identities=22%  Similarity=0.320  Sum_probs=189.7

Q ss_pred             Cceeeeeeeeccc----cChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEES----YPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~----~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||++.....+..    +++|..+.. ........+.+|+.+++.+.||||+++++++... ..+++++|+.+|+|.+++
T Consensus        22 ~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l   99 (279)
T cd05109          22 TVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYV   99 (279)
T ss_pred             eEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHH
Confidence            5787765544443    566655422 2223356788899999999999999999998754 468999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      .....        .+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||++............
T Consensus       100 ~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~  168 (279)
T cd05109         100 RENKD--------RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA  168 (279)
T ss_pred             hhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccceeec
Confidence            76432        288999999999999999999999   9999999999999999999999999998765432221111


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....++..|+|||...+..++.++|||||||++|+|++ |..||......                .....+........
T Consensus       169 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~  232 (279)
T cd05109         169 DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR----------------EIPDLLEKGERLPQ  232 (279)
T ss_pred             CCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----------------HHHHHHHCCCcCCC
Confidence            22234568999999988889999999999999999998 89998654321                11111112222223


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                      +..++.++.+++.+||+.||++||++.+++..|+.+...+.
T Consensus       233 ~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05109         233 PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS  273 (279)
T ss_pred             CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence            44567789999999999999999999999999998877663

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-39  Score=249.47  Aligned_cols=235  Identities=23%  Similarity=0.279  Sum_probs=201.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||++..+++.-.+++|+.-+.+-. .+...++.+|+++-+.|+||||++++++|.+....|+++||...|.|...+..+
T Consensus        37 ~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~  116 (281)
T KOG0580|consen   37 NVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEG  116 (281)
T ss_pred             cEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhc
Confidence            6999999999999999977666643 446788889999999999999999999999999999999999999999999866


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...+       +++.....+..|++.|+.|+|.+   +++||||||+|+|++..+.++++|||-+...++..    ..-.
T Consensus       117 ~~~~-------f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k----R~tl  182 (281)
T KOG0580|consen  117 RMKR-------FDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK----RKTL  182 (281)
T ss_pred             cccc-------ccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCCC----ceee
Confidence            5433       88889999999999999999999   99999999999999999999999999876543211    2335


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .||..|++||...+...+...|+|++|++.||++.|.+||+.....               +.+.++..  ....+|..+
T Consensus       183 cgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---------------etYkrI~k--~~~~~p~~i  245 (281)
T KOG0580|consen  183 CGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---------------ETYKRIRK--VDLKFPSTI  245 (281)
T ss_pred             ecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---------------HHHHHHHH--ccccCCccc
Confidence            6899999999999999999999999999999999999999865422               22222222  123456788


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +....++|++|+..+|.+|.+..+++.
T Consensus       246 s~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  246 SGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ChhHHHHHHHHhccCccccccHHHHhh
Confidence            899999999999999999999999886

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.2e-37  Score=260.57  Aligned_cols=248  Identities=18%  Similarity=0.239  Sum_probs=194.2

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.....+..+++|....... .....+++.+|+++++.++|+||+++++++..++..+++|||+.+++|.+++...
T Consensus        17 ~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~   96 (267)
T cd08229          17 EVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHF   96 (267)
T ss_pred             EEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHh
Confidence            478888887888888886654332 2334567889999999999999999999999999999999999999999988643


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...     ...+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++.........  ....
T Consensus        97 ~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~  166 (267)
T cd08229          97 KKQ-----KRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSL  166 (267)
T ss_pred             hcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccc
Confidence            211     11388999999999999999999999   9999999999999999999999999988654332211  1234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||.........             ....+.............
T Consensus       167 ~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~  233 (267)
T cd08229         167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-------------LCKKIEQCDYPPLPSDHY  233 (267)
T ss_pred             cCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-------------HhhhhhcCCCCCCCcccc
Confidence            5788999999998888899999999999999999999999654321110             000110111111112346


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      ++.+.+++.+||+.||++|||+.++++.++++
T Consensus       234 ~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         234 SEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             cHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            77899999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-39  Score=277.39  Aligned_cols=238  Identities=27%  Similarity=0.410  Sum_probs=192.8

Q ss_pred             ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCC
Q 023220           14 SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD   93 (285)
Q Consensus        14 ~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~   93 (285)
                      -+|+|..+-.....+..+.|++|+.++++-+|-||+-+.|++..... .||+-+|+|.+|..+++-....        +.
T Consensus       416 dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etk--------fd  486 (678)
T KOG0193|consen  416 DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETK--------FD  486 (678)
T ss_pred             ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhh--------hh
Confidence            35677666666666678999999999999999999999999999887 9999999999999999876542        89


Q ss_pred             HHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccc
Q 023220           94 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM  173 (285)
Q Consensus        94 ~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  173 (285)
                      ..+.++|++|++.|+.|||.+   +|+|+|+|..||++.+++.|+|+|||++................|...|+|||++.
T Consensus       487 m~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIR  563 (678)
T KOG0193|consen  487 MNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIR  563 (678)
T ss_pred             HHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHh
Confidence            999999999999999999999   99999999999999999999999999996544332222233455788999999986


Q ss_pred             c---CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHH
Q 023220          174 T---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAAL  250 (285)
Q Consensus       174 ~---~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  250 (285)
                      .   .+|+..+||||||+++|||++|..||.....+....+....   ....+.         ......++.++.+|+..
T Consensus       564 mqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG---~l~pd~---------s~~~s~~pk~mk~Ll~~  631 (678)
T KOG0193|consen  564 MQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG---YLMPDL---------SKIRSNCPKAMKRLLSD  631 (678)
T ss_pred             hcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc---ccCccc---------hhhhccCHHHHHHHHHH
Confidence            3   47899999999999999999999999844433332222211   111111         12244677889999999


Q ss_pred             hcccCCCCCCCHHHHHHHhchhhcC
Q 023220          251 CVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       251 ~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      ||.+++++||.+.+|+..|+.+...
T Consensus       632 C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  632 CWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             HHhcCcccCccHHHHHHHHHHhhhc
Confidence            9999999999999999988888763

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.8e-38  Score=276.94  Aligned_cols=252  Identities=20%  Similarity=0.224  Sum_probs=190.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC-----eeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN-----LRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~   76 (285)
                      .||++.+..+++.+++|............+++.+|+++++.++|+||+++++++....     ..++|+||+. ++|.++
T Consensus        15 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   93 (372)
T cd07853          15 VVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKI   93 (372)
T ss_pred             EEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHH
Confidence            5899988888899999977544333334567889999999999999999999998776     7899999997 488888


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH  156 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  156 (285)
                      +....         .++...+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......... .
T Consensus        94 ~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~  160 (372)
T cd07853          94 IVSPQ---------PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-H  160 (372)
T ss_pred             HhcCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCccc-c
Confidence            76543         288999999999999999999999   9999999999999999999999999998654322111 1


Q ss_pred             ccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh-------hhc
Q 023220          157 STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK-------QCV  228 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~  228 (285)
                      .....++..|+|||.+.+. .++.++||||+||++|+|++|+.||....+......+.........+...       ..+
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  240 (372)
T cd07853         161 MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI  240 (372)
T ss_pred             CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHH
Confidence            1233568899999998764 47899999999999999999999998766543333322221111111110       000


Q ss_pred             CCcc--------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          229 DPKL--------KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       229 ~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ....        ........++++.++|.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            0000        00122334678999999999999999999999987

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=285.46  Aligned_cols=249  Identities=21%  Similarity=0.275  Sum_probs=196.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceE-EEe------CCeeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGY-CVE------GNLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-~~~------~~~~~lv~e~~~~~~L   73 (285)
                      -||++.+......|++|..-.  .++..-+.+.+||++|++|. |+|||.++|. ...      .....|+||||.+|.|
T Consensus        52 ~VYla~~~~~~~~~AlKrm~~--~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~L  129 (738)
T KOG1989|consen   52 QVYLAQDVKGGKKYALKRMYV--NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSL  129 (738)
T ss_pred             EEEEEEecCCCceeeeeeeec--CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcH
Confidence            488888877656666664322  25566788889999999995 9999999993 321      1366999999999999


Q ss_pred             HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc
Q 023220           74 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        74 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  153 (285)
                      -++++.+-...       |++..+++|+.+++.|+++||.. .+.++|||||.+|+|++.+|+.||||||.+.-.-....
T Consensus       130 vd~mn~Rlq~~-------lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~  201 (738)
T KOG1989|consen  130 VDFMNTRLQTR-------LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPT  201 (738)
T ss_pred             HHHHHHHHhcc-------CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCc
Confidence            99998665432       99999999999999999999997 44599999999999999999999999999863321110


Q ss_pred             -ccc------ccccccccCcCCCccc---ccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhh
Q 023220          154 -RLH------STRVLGTFGYHAPEYA---MTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDK  223 (285)
Q Consensus       154 -~~~------~~~~~~~~~~~aPE~~---~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (285)
                       ...      .-....|+.|+|||.+   .+..+++|+|||+|||+||.||+...||+.....                 
T Consensus       202 ~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----------------  264 (738)
T KOG1989|consen  202 SAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----------------  264 (738)
T ss_pred             cHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----------------
Confidence             000      0113468999999986   4678899999999999999999999999865322                 


Q ss_pred             hhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          224 VKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                        .+++..+.-+..+.++..+..||..||+.||.+||++-++++.+-++...+.|.
T Consensus       265 --aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~  318 (738)
T KOG1989|consen  265 --AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI  318 (738)
T ss_pred             --eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence              233444444445678999999999999999999999999999999888765543

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7.2e-38  Score=260.31  Aligned_cols=238  Identities=22%  Similarity=0.304  Sum_probs=191.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++....+.+.+++|..+.... ....+.+.+|+.++++++|+||+++++.+..++..++++||+.+++|.+++....
T Consensus        15 ~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~   93 (255)
T cd08219          15 RALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQR   93 (255)
T ss_pred             EEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhcc
Confidence            478888888888888887754332 3346778899999999999999999999999999999999999999999886543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .++...++.++.|++.|+.+||+.   |++|+||+|+||+++.++.++++|||.+........  ......
T Consensus        94 ~~-------~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  161 (255)
T cd08219          94 GK-------LFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYV  161 (255)
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc--cccccc
Confidence            22       278899999999999999999999   999999999999999999999999999865433211  122345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..||...+....               .... ........+..++
T Consensus       162 ~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---------------~~~~-~~~~~~~~~~~~~  225 (255)
T cd08219         162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---------------ILKV-CQGSYKPLPSHYS  225 (255)
T ss_pred             CCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---------------HHHH-hcCCCCCCCcccC
Confidence            78889999999888899999999999999999999999975432111               1111 1111122344566


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      ..+.+++.+||+.||++|||+.+++..
T Consensus       226 ~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         226 YELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.7e-38  Score=276.90  Aligned_cols=242  Identities=20%  Similarity=0.212  Sum_probs=188.3

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||++.+..+++.|++|....... .....+.+.+|++++++++||||+++++++.+.+..++||||+.+|+|.+++...
T Consensus        16 ~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~   95 (381)
T cd05626          16 EVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM   95 (381)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhc
Confidence            589999999999999998765432 2334567889999999999999999999999999999999999999999998764


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc-------
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA-------  153 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-------  153 (285)
                      ..         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........       
T Consensus        96 ~~---------~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~  163 (381)
T cd05626          96 EV---------FPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG  163 (381)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccccc
Confidence            32         78899999999999999999999   999999999999999999999999998743210000       


Q ss_pred             --------------------------------------cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh
Q 023220          154 --------------------------------------RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT  195 (285)
Q Consensus       154 --------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~  195 (285)
                                                            ........|++.|+|||.+.+..++.++|||||||++|+|++
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ellt  243 (381)
T cd05626         164 SHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLV  243 (381)
T ss_pred             ccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHh
Confidence                                                  000112458999999999988889999999999999999999


Q ss_pred             CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhc--ccCCCCCCCHHHHHHH
Q 023220          196 GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCV--QYEAEFRPNMSIVVKA  268 (285)
Q Consensus       196 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~~p~~Rps~~~ll~~  268 (285)
                      |..||...........+..             ............+++++.++|.+|+  ..+|..||++.+++..
T Consensus       244 G~~Pf~~~~~~~~~~~i~~-------------~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         244 GQPPFLAPTPTETQLKVIN-------------WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             CCCCCcCCCHHHHHHHHHc-------------cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            9999976543221111100             0001111112235678999999854  5566669999999873

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.8e-37  Score=263.77  Aligned_cols=254  Identities=25%  Similarity=0.311  Sum_probs=190.3

Q ss_pred             Cceeeeeeeeccc--cChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEES--YPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~--~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++........  +++|..+.. ......+.+.+|++++.++ +||||+++++++...+..++++||+.+++|.+++.
T Consensus        17 ~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   95 (297)
T cd05089          17 QVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLR   95 (297)
T ss_pred             eEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHH
Confidence            4777766554432  344443321 1222346788999999999 79999999999999999999999999999999997


Q ss_pred             cCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcc
Q 023220           79 GRKGVQG-------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM  151 (285)
Q Consensus        79 ~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~  151 (285)
                      .......       ......+++..++.++.|++.|+.|||+.   |++|+||||+||+++.++.++|+|||++......
T Consensus        96 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  172 (297)
T cd05089          96 KSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVY  172 (297)
T ss_pred             hccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCcCCCccccce
Confidence            5432110       01112388999999999999999999999   9999999999999999999999999998643221


Q ss_pred             cccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                      ..   ......+..|+|||...+..++.++|||||||++|+|++ |..||........                ......
T Consensus       173 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~----------------~~~~~~  233 (297)
T cd05089         173 VK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL----------------YEKLPQ  233 (297)
T ss_pred             ec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH----------------HHHHhc
Confidence            11   111223457999999988889999999999999999997 9999975432111                111111


Q ss_pred             ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          231 KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                      ......+..++..+.+++.+||+.+|.+|||++++++.|..+......
T Consensus       234 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            122233445677899999999999999999999999999988865544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.1e-37  Score=266.58  Aligned_cols=251  Identities=20%  Similarity=0.262  Sum_probs=190.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..+++.+++|..+... .......+.+|++++++++||||+++++++..++..+++|||+.+ +|.+++....
T Consensus        21 ~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~   98 (309)
T cd07872          21 TVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCG   98 (309)
T ss_pred             EEEEEEecCCCCeEEEEEeeccc-cCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcC
Confidence            58999888888899999876443 233455678899999999999999999999999999999999975 8888876543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .++...+..++.|++.||.|||+.   |++||||+|+||+++.++.++|+|||++........  ......
T Consensus        99 ~--------~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~  165 (309)
T cd07872          99 N--------IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEV  165 (309)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc--cccccc
Confidence            2        278889999999999999999999   999999999999999999999999999865432211  112235


Q ss_pred             cccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhc---------CCc
Q 023220          162 GTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV---------DPK  231 (285)
Q Consensus       162 ~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~  231 (285)
                      ++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...+.......+..............+.         .+.
T Consensus       166 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (309)
T cd07872         166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPK  245 (309)
T ss_pred             ccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCc
Confidence            6889999998765 457899999999999999999999998765433322222211111111111100         000


Q ss_pred             cC----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          232 LK----GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       232 ~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..    ......++.++.++|.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         246 YKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             cCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00    0111245678999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.6e-37  Score=260.02  Aligned_cols=244  Identities=21%  Similarity=0.305  Sum_probs=188.4

Q ss_pred             Cceeeeeeeecc---ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEE---SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~---~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++......+   .+++|..+... .....+.+.+|++++++++|+|++++++++...+..+++|||+.+++|.+++.
T Consensus        20 ~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   98 (268)
T cd05063          20 EVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLR   98 (268)
T ss_pred             cEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHH
Confidence            477776654433   56777664322 22335678899999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc-
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS-  157 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-  157 (285)
                      ....        .+++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++++|||++............ 
T Consensus        99 ~~~~--------~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  167 (268)
T cd05063          99 DHDG--------EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT  167 (268)
T ss_pred             hcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccccceec
Confidence            5432        278899999999999999999999   9999999999999999999999999998654322211111 


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      .....+..|+|||.+....++.++|+|||||++|++++ |..||.......                ....+........
T Consensus       168 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~----------------~~~~i~~~~~~~~  231 (268)
T cd05063         168 SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE----------------VMKAINDGFRLPA  231 (268)
T ss_pred             cCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH----------------HHHHHhcCCCCCC
Confidence            11123457999999988888999999999999999987 999996543211                1111111112223


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      +..++..+.+++.+||+.+|++||++.++++.|++++
T Consensus       232 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         232 PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            3446678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.1e-37  Score=262.78  Aligned_cols=238  Identities=23%  Similarity=0.330  Sum_probs=180.7

Q ss_pred             cccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCC------CC
Q 023220           13 ESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ------GA   86 (285)
Q Consensus        13 ~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------~~   86 (285)
                      ..+++|..+.  ......+.+.+|+++++.++|+||+++++++......+++|||+.+++|.+++.......      ..
T Consensus        36 ~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~  113 (280)
T cd05092          36 MLVAVKALKE--ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED  113 (280)
T ss_pred             eEEEEEecCc--CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhccccc
Confidence            3455554432  222345678999999999999999999999999999999999999999999987543210      00


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCc
Q 023220           87 QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY  166 (285)
Q Consensus        87 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~  166 (285)
                      .....+++..++.++.|++.|+.|||+.   |++|+||+|+||++++++.++|+|||++................++..|
T Consensus       114 ~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y  190 (280)
T cd05092         114 VAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW  190 (280)
T ss_pred             CCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccc
Confidence            1112378899999999999999999999   9999999999999999999999999998644322211111223346789


Q ss_pred             CCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHH
Q 023220          167 HAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLA  245 (285)
Q Consensus       167 ~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  245 (285)
                      +|||.+.+..++.++|+|||||++|+|++ |..||........               .... ........+..+++.+.
T Consensus       191 ~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---------------~~~~-~~~~~~~~~~~~~~~~~  254 (280)
T cd05092         191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---------------IECI-TQGRELERPRTCPPEVY  254 (280)
T ss_pred             cCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---------------HHHH-HcCccCCCCCCCCHHHH
Confidence            99999988889999999999999999998 8999865432111               1111 11111122345677899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          246 AVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      +++.+||+.||++||++.++++.|++
T Consensus       255 ~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         255 AIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHHHccCChhhCCCHHHHHHHHhC
Confidence            99999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.7e-37  Score=265.16  Aligned_cols=242  Identities=27%  Similarity=0.374  Sum_probs=185.7

Q ss_pred             ccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCC-------C
Q 023220           14 SYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ-------G   85 (285)
Q Consensus        14 ~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~   85 (285)
                      .+++|..+... .....+.+.+|+++++.+ +||||+++++++...+..+++|||+.+++|.+++.......       .
T Consensus        52 ~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~  130 (307)
T cd05098          52 KVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPT  130 (307)
T ss_pred             eEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccc
Confidence            46666554321 222345688899999999 89999999999999999999999999999999997653211       0


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccC
Q 023220           86 AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG  165 (285)
Q Consensus        86 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  165 (285)
                      ......+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||.+................++..
T Consensus       131 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~  207 (307)
T cd05098         131 QVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK  207 (307)
T ss_pred             cCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccc
Confidence            11122388899999999999999999999   999999999999999999999999999875543221111122223468


Q ss_pred             cCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHH
Q 023220          166 YHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKL  244 (285)
Q Consensus       166 ~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (285)
                      |+|||.+.+..++.++|+|||||++|+|++ |..||......                .+...+........+...+.++
T Consensus       208 y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~  271 (307)
T cd05098         208 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----------------ELFKLLKEGHRMDKPSNCTNEL  271 (307)
T ss_pred             eeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----------------HHHHHHHcCCCCCCCCcCCHHH
Confidence            999999988889999999999999999998 88888644321                1111111122223445567789


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          245 AAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      .+++.+||+.+|++|||+.++++.|+++++.
T Consensus       272 ~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         272 YMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.2e-38  Score=272.74  Aligned_cols=233  Identities=19%  Similarity=0.174  Sum_probs=183.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHH-HHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLV-SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||+|.+..+++.+++|........ ......+..|. .+++.++||||+++++++...+..++||||+.+++|.+++..
T Consensus        10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   89 (325)
T cd05602          10 KVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR   89 (325)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh
Confidence            5899999888899999987654322 22223344444 456788999999999999999999999999999999999976


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +....+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ....
T Consensus        90 ~~~---------~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~  155 (325)
T cd05602          90 ERC---------FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTST  155 (325)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Cccc
Confidence            432         77888999999999999999999   999999999999999999999999999864322111  1233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||.+.+..++.++||||+||++|+|++|..||........               ...+....  ...++.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---------------~~~i~~~~--~~~~~~  218 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---------------YDNILNKP--LQLKPN  218 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---------------HHHHHhCC--cCCCCC
Confidence            4589999999999988999999999999999999999999975432211               11111111  123345


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIV  265 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~l  265 (285)
                      ++..+.+++.+||+.||.+||++.+.
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~~~  244 (325)
T cd05602         219 ITNSARHLLEGLLQKDRTKRLGAKDD  244 (325)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCCCCC
Confidence            67789999999999999999988743

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.3e-37  Score=257.60  Aligned_cols=237  Identities=23%  Similarity=0.303  Sum_probs=183.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++... .+..+++|..+..   ....+.+.+|+.++++++||||+++++++......+++|||+.+++|.+++....
T Consensus        19 ~vy~~~~~-~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~   94 (256)
T cd05113          19 VVKYGKWR-GQYDVAIKMIKEG---SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG   94 (256)
T ss_pred             eEEEEEec-CCCcEEEEEcCCC---cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcC
Confidence            46666332 2344777765422   2234678999999999999999999999998888999999999999999987543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.|+.|||+.   |++|+||+|.||+++.++.++|+|||.+........ .......
T Consensus        95 ~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~  162 (256)
T cd05113          95 K--------RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSK  162 (256)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecCCCc
Confidence            2        278999999999999999999999   999999999999999999999999998865432211 1112233


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|++||...+..++.++|+||||+++|+|++ |..||........               ...+ ........+...
T Consensus       163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---------------~~~~-~~~~~~~~~~~~  226 (256)
T cd05113         163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---------------VEKV-SQGLRLYRPHLA  226 (256)
T ss_pred             cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---------------HHHH-hcCCCCCCCCCC
Confidence            4567999999988889999999999999999998 9999865432111               1111 111111223345


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      +..+.+++.+||+.+|.+||++.++++.|+
T Consensus       227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         227 SEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            678999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-37  Score=257.53  Aligned_cols=235  Identities=29%  Similarity=0.405  Sum_probs=187.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||++...  +..+++|.......   ..+++.+|+.++++++|+||+++++++.+....+++|||+.+++|.+++....
T Consensus        21 ~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~   95 (256)
T cd05039          21 DVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG   95 (256)
T ss_pred             eEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcC
Confidence            46777543  56677776643322   46788899999999999999999999998889999999999999999997654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||.+.......     ....
T Consensus        96 ~~-------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~~~  160 (256)
T cd05039          96 RA-------VITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DSGK  160 (256)
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc-----ccCC
Confidence            21       289999999999999999999999   99999999999999999999999999987653211     1223


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+....++.++|+||||++++++++ |..||......                .....+........+..+
T Consensus       161 ~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~  224 (256)
T cd05039         161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------------DVVPHVEKGYRMEAPEGC  224 (256)
T ss_pred             CcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH----------------HHHHHHhcCCCCCCccCC
Confidence            4567999999888888999999999999999997 99998644321                111111111222334456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      ++.+.+++.+||+.+|++|||++++++.|+++
T Consensus       225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         225 PPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            78899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=276.36  Aligned_cols=236  Identities=32%  Similarity=0.415  Sum_probs=200.5

Q ss_pred             cChhhhhhc-cCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCC
Q 023220           15 YPSHENERL-KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD   93 (285)
Q Consensus        15 ~~~k~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~   93 (285)
                      +++|..+.. ...+....++.+|.++|++++||||++++|+.....-+++|||++.||+|.++++.....        ++
T Consensus       189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~--------v~  260 (474)
T KOG0194|consen  189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKS--------LP  260 (474)
T ss_pred             eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCC--------CC
Confidence            777777652 355667889999999999999999999999999999999999999999999999987642        89


Q ss_pred             HHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccc
Q 023220           94 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM  173 (285)
Q Consensus        94 ~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  173 (285)
                      ....+.++.+++.||.|||++   +++||||-.+|+|++.++.+||+|||+++.....  ........-+..|+|||.+.
T Consensus       261 ~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~--~~~~~~~klPirWLAPEtl~  335 (474)
T KOG0194|consen  261 TLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY--VMKKFLKKLPIRWLAPETLN  335 (474)
T ss_pred             HHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcce--eeccccccCcceecChhhhc
Confidence            999999999999999999999   9999999999999999999999999998765411  11111223568999999999


Q ss_pred             cCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhh-hcCCccCCCCChhHHHHHHHHHHHh
Q 023220          174 TGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQ-CVDPKLKGEYPPKGVAKLAAVAALC  251 (285)
Q Consensus       174 ~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~  251 (285)
                      ...|+.++|||||||++||+++ |..||.+...                ..+.. ++....+...+...|..+..++.+|
T Consensus       336 ~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~----------------~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c  399 (474)
T KOG0194|consen  336 TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN----------------YEVKAKIVKNGYRMPIPSKTPKELAKVMKQC  399 (474)
T ss_pred             cCccccccchhheeeeEEeeeccCCCCCCCCCH----------------HHHHHHHHhcCccCCCCCCCHHHHHHHHHHh
Confidence            8899999999999999999999 7889975532                23333 3355666677778899999999999


Q ss_pred             cccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          252 VQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       252 l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                      |..+|++|||+.++.+.++.+.....++
T Consensus       400 ~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  400 WKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             ccCChhhccCHHHHHHHHHHHHhccccc
Confidence            9999999999999999999998776653

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.6e-37  Score=260.29  Aligned_cols=244  Identities=21%  Similarity=0.309  Sum_probs=188.6

Q ss_pred             Cceeeeeeeecc---ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEE---SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~---~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      +||++.....+.   .+++|..... ........+..|+.++++++||||+++++++..+...+++|||+.+++|.+++.
T Consensus        19 ~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   97 (269)
T cd05065          19 EVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLR   97 (269)
T ss_pred             eEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHh
Confidence            577776654433   4777766432 123345678899999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....        .+++..++.++.|++.|+.|||++   |++|+||+|+||+++.++.++|+|||++.............
T Consensus        98 ~~~~--------~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  166 (269)
T cd05065          98 QNDG--------QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT  166 (269)
T ss_pred             hCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCccccccc
Confidence            5432        278899999999999999999999   99999999999999999999999999886543322111111


Q ss_pred             -ccc--cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          159 -RVL--GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       159 -~~~--~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                       ...  .+..|+|||.+.+..++.++|+||+||++|++++ |..||.......                ....+......
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~----------------~~~~i~~~~~~  230 (269)
T cd05065         167 SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----------------VINAIEQDYRL  230 (269)
T ss_pred             cccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH----------------HHHHHHcCCcC
Confidence             111  1347999999988889999999999999999886 999996543211                11111111122


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ..+..++..+.+++.+||+.+|++||++.+++..|++++
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  269 (269)
T cd05065         231 PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI  269 (269)
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            234456778999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-38  Score=266.65  Aligned_cols=241  Identities=20%  Similarity=0.243  Sum_probs=202.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +|-++.-.-+++-+++|++.+.+-..-....+.+|++-|+.++|||||++|++......+|||.|.-++|+|++||.+..
T Consensus        33 VVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe  112 (864)
T KOG4717|consen   33 VVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHE  112 (864)
T ss_pred             hhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhh
Confidence            34455556678889999999988888888999999999999999999999999999999999999999999999997655


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE-ccCCeeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~-~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..        +.+..+.++++||+.||.|+|+.   .++|||+||+|+.+ .+-|.|||.|||.+..+......   .-.
T Consensus       113 ~G--------l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL---~Ts  178 (864)
T KOG4717|consen  113 EG--------LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL---TTS  178 (864)
T ss_pred             cc--------ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcchh---hcc
Confidence            32        99999999999999999999999   99999999999776 46689999999998766543322   334


Q ss_pred             ccccCcCCCcccccCCCC-cccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          161 LGTFGYHAPEYAMTGQLT-QKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      .|...|-|||++.+..|+ ++.||||||++||-|++|+.||+....               .+.+..++|=.  ...|.-
T Consensus       179 CGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---------------SETLTmImDCK--YtvPsh  241 (864)
T KOG4717|consen  179 CGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---------------SETLTMIMDCK--YTVPSH  241 (864)
T ss_pred             cchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---------------hhhhhhhhccc--ccCchh
Confidence            688999999999999997 789999999999999999999975432               22333333322  255777


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      ++.+++++|..||.+||++|.|+++|..  ..+++.
T Consensus       242 vS~eCrdLI~sMLvRdPkkRAslEeI~s--~~Wlq~  275 (864)
T KOG4717|consen  242 VSKECRDLIQSMLVRDPKKRASLEEIVS--TSWLQA  275 (864)
T ss_pred             hhHHHHHHHHHHHhcCchhhccHHHHhc--cccccC
Confidence            8899999999999999999999999987  455543

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.3e-38  Score=270.21  Aligned_cols=235  Identities=20%  Similarity=0.198  Sum_probs=188.1

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCC-CcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKH-ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||++.+..+++.+++|..++... .....+.+..|.+++..++| ++|+.+++.+.+.+..++||||+.+|+|.+++..
T Consensus        15 ~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~   94 (324)
T cd05587          15 KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ   94 (324)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHH
Confidence            589999988889999997765432 23345677889999999976 5688899999999999999999999999999875


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ....
T Consensus        95 ~~~---------~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~  160 (324)
T cd05587          95 VGK---------FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRT  160 (324)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceee
Confidence            532         78899999999999999999999   999999999999999999999999998764321111  1223


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||.+.+..++.++|+||+||++|+|++|+.||.........               ..+...  ....+..
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~---------------~~i~~~--~~~~~~~  223 (324)
T cd05587         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---------------QSIMEH--NVSYPKS  223 (324)
T ss_pred             ecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---------------HHHHcC--CCCCCCC
Confidence            45889999999999888999999999999999999999999755422111               111111  1233455


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNM-----SIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~-----~~ll~  267 (285)
                      .+.++.+++.+||+.||.+|++.     .++++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         224 LSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            67789999999999999999976     56654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=268.87  Aligned_cols=244  Identities=21%  Similarity=0.260  Sum_probs=206.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCC-CCChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPK-NYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||+|..+.+++.+++|.+.+..... ...+.+.+|+++|+++. ||||+.++++|++....++|||++.||.|.+.+..
T Consensus        50 ~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~  129 (382)
T KOG0032|consen   50 VVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVK  129 (382)
T ss_pred             EEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHH
Confidence            68999999999999999887766543 35789999999999998 99999999999999999999999999999999987


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC----CeeEEeccccCCCCCcccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED----FKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~----~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ..          +++..+..++.|++.+++|||..   |++|||+||+|+|+...    +.++++|||++.....   ..
T Consensus       130 ~~----------~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~  193 (382)
T KOG0032|consen  130 KH----------YSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GE  193 (382)
T ss_pred             cc----------CCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---Cc
Confidence            61          88999999999999999999999   99999999999999633    4799999999987655   11


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE  235 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
                      ......|++.|+|||++....|+..+|+||+|+++|.|++|.+||.+.........+...             +..+...
T Consensus       194 ~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~-------------~~~f~~~  260 (382)
T KOG0032|consen  194 RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG-------------DFDFTSE  260 (382)
T ss_pred             eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC-------------CCCCCCC
Confidence            235578999999999999999999999999999999999999999876543332222111             1123334


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      .-..++..+.+++++|+..||.+|+|+.++++  ..++...
T Consensus       261 ~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~--HpWi~~~  299 (382)
T KOG0032|consen  261 PWDDISESAKDFIRKLLEFDPRKRLTAAQALQ--HPWIKSI  299 (382)
T ss_pred             CccccCHHHHHHHHHhcccCcccCCCHHHHhc--CccccCC
Confidence            45567889999999999999999999999999  4666554

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-37  Score=259.80  Aligned_cols=246  Identities=24%  Similarity=0.333  Sum_probs=189.7

Q ss_pred             Cceeeeeeeecc----ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEE----SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||++....+++    .+++|....... ......+.+|+.++++++||||+++++++.. ...++++||+.+|+|.+++
T Consensus        22 ~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l   99 (279)
T cd05057          22 TVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYV   99 (279)
T ss_pred             cEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHH
Confidence            467776544333    355554432221 2345678889999999999999999999987 6789999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      .....        .+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++............
T Consensus       100 ~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~  168 (279)
T cd05057         100 RNHKD--------NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHA  168 (279)
T ss_pred             HhccC--------CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCcccceec
Confidence            76543        288999999999999999999999   9999999999999999999999999998765432221111


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....++..|+|||.+....++.++|+||||+++|++++ |..||.......                +...+........
T Consensus       169 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~  232 (279)
T cd05057         169 EGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE----------------IPDLLEKGERLPQ  232 (279)
T ss_pred             CCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH----------------HHHHHhCCCCCCC
Confidence            11223567999999888888999999999999999998 999997543221                1111111112233


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      +..++..+.+++.+||..+|++||++.++++.|.++.+.+
T Consensus       233 ~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         233 PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence            4445678999999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-38  Score=271.65  Aligned_cols=247  Identities=21%  Similarity=0.258  Sum_probs=184.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC------CeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG------NLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~   75 (285)
                      +||+|.+..++..+++|............+.+.+|++++++++||||+++++++...      ...+++++++ +++|.+
T Consensus        30 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~  108 (343)
T cd07878          30 SVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNN  108 (343)
T ss_pred             EEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHH
Confidence            589999888899999997765443344456778899999999999999999988643      3468999988 569988


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++....          ++...+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......    
T Consensus       109 ~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~----  171 (343)
T cd07878         109 IVKCQK----------LSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----  171 (343)
T ss_pred             HHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCCC----
Confidence            886432          88999999999999999999999   9999999999999999999999999998754331    


Q ss_pred             cccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh--------hh
Q 023220          156 HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV--------KQ  226 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~  226 (285)
                       .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.........+..        ..
T Consensus       172 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07878         172 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK  250 (343)
T ss_pred             -cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHH
Confidence             123457899999999876 46789999999999999999999999765432221111111111111100        00


Q ss_pred             hcCC--ccC----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          227 CVDP--KLK----GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       227 ~~~~--~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ....  ...    .......++.+.+++.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000  000    0011123456889999999999999999999997

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-38  Score=276.86  Aligned_cols=241  Identities=19%  Similarity=0.165  Sum_probs=186.7

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.+..+++.+++|...+.. ......+.+.+|++++++++||||+++++++.+....++||||+.+|+|.+++...
T Consensus        16 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~   95 (377)
T cd05629          16 EVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY   95 (377)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhc
Confidence            58999998899999999765432 22334567889999999999999999999999999999999999999999999754


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc-------
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA-------  153 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-------  153 (285)
                      ..         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........       
T Consensus        96 ~~---------~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  163 (377)
T cd05629          96 DT---------FSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKL  163 (377)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccc
Confidence            32         88899999999999999999999   999999999999999999999999999853211000       


Q ss_pred             -----c---------------------------------ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh
Q 023220          154 -----R---------------------------------LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT  195 (285)
Q Consensus       154 -----~---------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~  195 (285)
                           .                                 .......|++.|+|||++.+..++.++|+|||||++|+|++
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt  243 (377)
T cd05629         164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI  243 (377)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhc
Confidence                 0                                 00012358999999999998889999999999999999999


Q ss_pred             CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 023220          196 GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR---PNMSIVVKA  268 (285)
Q Consensus       196 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~~ll~~  268 (285)
                      |..||...........+..            . ...........++.++.++|.+||. +|.+|   +|+.++++.
T Consensus       244 G~~Pf~~~~~~~~~~~i~~------------~-~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         244 GWPPFCSENSHETYRKIIN------------W-RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             CCCCCCCCCHHHHHHHHHc------------c-CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            9999976543221111100            0 0000001112356789999999998 77765   599998874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.6e-38  Score=270.52  Aligned_cols=240  Identities=20%  Similarity=0.217  Sum_probs=186.3

Q ss_pred             Cceeeeee---eeccccChhhhhhccC--CCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTC---QVEESYPSHENERLKS--PKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~---~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      +||++.+.   .++..+++|..++...  .....+.+.+|+.+++.+ +|+||+++++++...+..+++|||+.+|+|.+
T Consensus        15 ~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~   94 (332)
T cd05614          15 KVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFT   94 (332)
T ss_pred             EEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHH
Confidence            47877653   3567888887654332  233456778899999999 58999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++.....         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......... 
T Consensus        95 ~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-  161 (332)
T cd05614          95 HLYQRDN---------FSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-  161 (332)
T ss_pred             HHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC-
Confidence            9875432         88999999999999999999999   9999999999999999999999999998754322211 


Q ss_pred             cccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      ......|+..|+|||.+.+. .++.++|||||||++|+|++|..||............           ...+..  ...
T Consensus       162 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-----------~~~~~~--~~~  228 (332)
T cd05614         162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-----------SRRILK--CDP  228 (332)
T ss_pred             ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH-----------HHHHhc--CCC
Confidence            12234689999999998765 4788999999999999999999999754322111100           011111  112


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK  267 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~  267 (285)
                      ..+..++..+.+++.+||+.||++||     +++++++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         229 PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            33455677899999999999999999     7778875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-37  Score=258.23  Aligned_cols=249  Identities=25%  Similarity=0.334  Sum_probs=187.2

Q ss_pred             Cceeeeeeeeccc--cChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEES--YPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~--~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++....++..  +++|..+.. ......+.+.+|++++.++ +||||+++++++...+..+++|||+.+++|.+++.
T Consensus        10 ~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~   88 (270)
T cd05047          10 QVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR   88 (270)
T ss_pred             eEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHH
Confidence            5788876655443  344444321 1223456788899999999 89999999999999999999999999999999997


Q ss_pred             cCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcc
Q 023220           79 GRKGVQG-------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM  151 (285)
Q Consensus        79 ~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~  151 (285)
                      .......       ......+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++++|||++......
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~  165 (270)
T cd05047          89 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY  165 (270)
T ss_pred             hccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCCccccchh
Confidence            6432110       01112378999999999999999999999   9999999999999999999999999987532211


Q ss_pred             cccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                      ..   ......+..|+|||.+....++.++|+||||+++|+|++ |..||.......                ....+..
T Consensus       166 ~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~----------------~~~~~~~  226 (270)
T cd05047         166 VK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----------------LYEKLPQ  226 (270)
T ss_pred             hh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH----------------HHHHHhC
Confidence            11   111223457999999888888999999999999999997 999996543211                1111111


Q ss_pred             ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          231 KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ......+...+.++.+++.+||+.||.+|||+.++++.|++++
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         227 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            1112233445678999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.1e-37  Score=264.35  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=190.1

Q ss_pred             Cceeeeee-------eeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCH
Q 023220            2 RRWLCCTC-------QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   73 (285)
                      .||++...       .....+++|..+.... ....+.+.+|+++++++ +||||+++++++......+++|||+.+++|
T Consensus        27 ~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  105 (314)
T cd05099          27 QVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL  105 (314)
T ss_pred             cEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcH
Confidence            46776532       1233566666543221 22345688899999999 699999999999998899999999999999


Q ss_pred             HHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220           74 HDILHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus        74 ~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      .+++.......       .......+++..+..++.|++.|+.|||++   |++|+||+|+||+++.++.++|+|||.+.
T Consensus       106 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~Dfg~~~  182 (314)
T cd05099         106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR  182 (314)
T ss_pred             HHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCCcEEEccccccc
Confidence            99997643210       001122488999999999999999999999   99999999999999999999999999997


Q ss_pred             CCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhh
Q 023220          147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVK  225 (285)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
                      ...............++..|+|||.+.+..++.++|+||||+++|+|++ |..||.........                
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~----------------  246 (314)
T cd05099         183 GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF----------------  246 (314)
T ss_pred             cccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH----------------
Confidence            6543222111122223467999999988889999999999999999998 88998654322111                


Q ss_pred             hhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          226 QCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ..+........+..++.++.+++.+||+.+|++|||+.++++.|+++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            1111111123345567789999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.8e-37  Score=258.62  Aligned_cols=244  Identities=21%  Similarity=0.283  Sum_probs=188.2

Q ss_pred             Cceeeeeeeecc---ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEE---SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~---~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++....+++   .+++|..+... .....+.+.+|+.++++++||||+++++++..++..+++|||+.+++|.+++.
T Consensus        19 ~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   97 (267)
T cd05066          19 EVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR   97 (267)
T ss_pred             ceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHH
Confidence            467776554433   46666554321 22335678899999999999999999999999999999999999999999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc-c
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH-S  157 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~  157 (285)
                      ....        .+++..++.++.|++.|+.+||+.   |++|+||+|+||+++.++.++|+|||++........... .
T Consensus        98 ~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd05066          98 KHDG--------QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT  166 (267)
T ss_pred             hcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeec
Confidence            5432        278899999999999999999999   999999999999999999999999999876543221111 1


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....++..|+|||.+.+..++.++|+||||+++|++++ |..||..........               .+. .......
T Consensus       167 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~---------------~~~-~~~~~~~  230 (267)
T cd05066         167 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK---------------AIE-EGYRLPA  230 (267)
T ss_pred             CCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHH---------------HHh-CCCcCCC
Confidence            11223457999999988889999999999999999886 999996543221111               111 1111222


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      +..+++.+.+++.+||+.+|.+||++.++++.|++++
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         231 PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence            3456778999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.7e-37  Score=264.63  Aligned_cols=252  Identities=25%  Similarity=0.328  Sum_probs=189.0

Q ss_pred             Cceeeeeeeecccc--ChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESY--PSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~--~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++....++..+  ++|..+. .........+.+|++++.++ +|+||+++++++..++..+++|||+.+++|.+++.
T Consensus        22 ~V~~a~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  100 (303)
T cd05088          22 QVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR  100 (303)
T ss_pred             eEEEEEEccCCceeeEEEEEecc-cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHH
Confidence            57888766555443  3333321 12233456788899999999 89999999999999999999999999999999997


Q ss_pred             cCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcc
Q 023220           79 GRKGVQGA-------QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM  151 (285)
Q Consensus        79 ~~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~  151 (285)
                      ........       .....++...++.++.|++.|+.|||+.   |++||||+|+||+++.++.++|+|||++......
T Consensus       101 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  177 (303)
T cd05088         101 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY  177 (303)
T ss_pred             hcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCccccCcccchh
Confidence            54321100       1112388999999999999999999999   9999999999999999999999999988532211


Q ss_pred             cccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                      .   ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........                ......
T Consensus       178 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----------------~~~~~~  238 (303)
T cd05088         178 V---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----------------YEKLPQ  238 (303)
T ss_pred             h---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH----------------HHHHhc
Confidence            1   1111223567999999888888999999999999999998 9999965432211                111111


Q ss_pred             ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          231 KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      ......+...+.++.+++.+||+.+|++||++.++++.|.+++..-
T Consensus       239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            1111223345678999999999999999999999999998877543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4e-38  Score=276.87  Aligned_cols=240  Identities=20%  Similarity=0.194  Sum_probs=187.0

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.+..+++.+++|....... .....+.+.+|++++++++|+||+++++.+.+++..++||||+.+|+|.+++...
T Consensus        16 ~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~   95 (382)
T cd05625          16 EVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM   95 (382)
T ss_pred             EEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc
Confidence            589999999999999997754322 2334567889999999999999999999999999999999999999999998764


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc--------
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA--------  152 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~--------  152 (285)
                      ..         +++..+..++.|++.||.|||+.   |++||||||+|||++.++.++|+|||++.......        
T Consensus        96 ~~---------~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~  163 (382)
T cd05625          96 GI---------FPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG  163 (382)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccc
Confidence            32         78899999999999999999999   99999999999999999999999999874221000        


Q ss_pred             -------------------------------------ccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh
Q 023220          153 -------------------------------------ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT  195 (285)
Q Consensus       153 -------------------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~  195 (285)
                                                           .........|++.|+|||++.+..++.++|+||+||++|+|++
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ellt  243 (382)
T cd05625         164 DHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV  243 (382)
T ss_pred             cccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHh
Confidence                                                 0000112358899999999998899999999999999999999


Q ss_pred             CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 023220          196 GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN---MSIVVK  267 (285)
Q Consensus       196 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~  267 (285)
                      |+.||....+......+.            . .............++++.++|.+|+ .+|.+|++   +.++++
T Consensus       244 G~~Pf~~~~~~~~~~~i~------------~-~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         244 GQPPFLAQTPLETQMKVI------------N-WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             CCCCCCCCCHHHHHHHHH------------c-cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999997654321111100            0 0111111122345677889998876 59999997   888775

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.8e-37  Score=262.01  Aligned_cols=254  Identities=16%  Similarity=0.147  Sum_probs=189.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++....+++.+++|..+.........+.+.+|+.++++++|||++++++++.+++..++||||+. ++|.+++....
T Consensus        15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~   93 (285)
T cd07861          15 VVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLP   93 (285)
T ss_pred             EEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCC
Confidence            58899888888899999876655555566788899999999999999999999999999999999997 58888886533


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..      ..++...++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        94 ~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  162 (285)
T cd07861          94 KG------QYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEV  162 (285)
T ss_pred             CC------CcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCc
Confidence            21      1288999999999999999999999   999999999999999999999999999865432211  112234


Q ss_pred             cccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhh-hhccc----Cc----hhhhhhhcC--
Q 023220          162 GTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT-WATPR----LS----EDKVKQCVD--  229 (285)
Q Consensus       162 ~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~~~----~~----~~~~~~~~~--  229 (285)
                      ++..|+|||.+.+. .++.++|+|||||++|+|++|+.||............. .....    +.    .........  
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (285)
T cd07861         163 VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKW  242 (285)
T ss_pred             ccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhcccc
Confidence            67889999987654 46889999999999999999999997654321111100 00000    00    000000000  


Q ss_pred             -CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          230 -PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       230 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                       ..........+++++.++|.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         243 KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             CcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence             00011122346778999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.5e-38  Score=277.68  Aligned_cols=241  Identities=20%  Similarity=0.215  Sum_probs=189.1

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.+..+++.+++|...+... .....+.+.+|++++++++|+||+++++.+.+++..++||||+.+|+|.+++...
T Consensus        16 ~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~   95 (376)
T cd05598          16 EVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL   95 (376)
T ss_pred             EEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc
Confidence            589999988899999997754332 2334677889999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc--------
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA--------  152 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~--------  152 (285)
                      .         .++...+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++.......        
T Consensus        96 ~---------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~  163 (376)
T cd05598          96 G---------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKG  163 (376)
T ss_pred             C---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccc
Confidence            3         278889999999999999999999   99999999999999999999999999874221000        


Q ss_pred             ---------------------------------ccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCC
Q 023220          153 ---------------------------------ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP  199 (285)
Q Consensus       153 ---------------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p  199 (285)
                                                       .........|++.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~P  243 (376)
T cd05598         164 DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP  243 (376)
T ss_pred             cccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCC
Confidence                                             00001123589999999999988999999999999999999999999


Q ss_pred             CCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 023220          200 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP---NMSIVVKA  268 (285)
Q Consensus       200 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~  268 (285)
                      |....+......+..             ............++..+.++|.+|+ .+|.+|+   ++.++++.
T Consensus       244 f~~~~~~~~~~~i~~-------------~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         244 FLADTPAETQLKVIN-------------WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             CCCCCHHHHHHHHhc-------------cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            976543222111100             0011111112345677889999976 5999999   89999874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.9e-37  Score=256.09  Aligned_cols=242  Identities=26%  Similarity=0.296  Sum_probs=188.5

Q ss_pred             Cceeeeeeeecc---ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEE---SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~---~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++.....+.   .+++|........ ...+.+.+|++++++++||||+++++++.. ...++++||+.+++|.+++.
T Consensus        10 ~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~   87 (257)
T cd05040          10 VVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLR   87 (257)
T ss_pred             cEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHH
Confidence            577776644222   3677766544433 556788899999999999999999999988 88899999999999999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc-cc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL-HS  157 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~  157 (285)
                      .....       .+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||++.......... ..
T Consensus        88 ~~~~~-------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          88 KDALG-------HFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             hcccc-------cCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            65421       288999999999999999999999   99999999999999999999999999987654322111 11


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||............               .........
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---------------~~~~~~~~~  222 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI---------------DKEGERLER  222 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---------------HhcCCcCCC
Confidence            12345678999999888889999999999999999998 99999654322111100               001111122


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      +...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            3456778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.4e-37  Score=261.29  Aligned_cols=259  Identities=24%  Similarity=0.354  Sum_probs=190.3

Q ss_pred             Cceeee----eeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC--CeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCC----TCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG--NLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.    ...++..+++|..+.. ......+.+.+|++++++++|||++++++++...  ...+++|||+++++|.+
T Consensus        19 ~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~   97 (284)
T cd05079          19 KVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE   97 (284)
T ss_pred             eEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHH
Confidence            467775    2456777888877543 2344567899999999999999999999998875  56799999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-  154 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-  154 (285)
                      ++.....        .+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||++......... 
T Consensus        98 ~l~~~~~--------~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  166 (284)
T cd05079          98 YLPRNKN--------KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY  166 (284)
T ss_pred             HHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccccCccce
Confidence            9865432        278899999999999999999999   9999999999999999999999999998765432211 


Q ss_pred             ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      .......++..|+|||.+.+..++.++|+||||+++|+|+++..|+............. ....................
T Consensus       167 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  245 (284)
T cd05079         167 TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGP-THGQMTVTRLVRVLEEGKRL  245 (284)
T ss_pred             eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccc-ccccccHHHHHHHHHcCccC
Confidence            11122345667999999888889999999999999999999877653321100000000 00000001111111112222


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ..+..++..+.+++.+||+.+|++|||+.++++.|+.++
T Consensus       246 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         246 PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            334557788999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.1e-38  Score=269.36  Aligned_cols=241  Identities=20%  Similarity=0.210  Sum_probs=190.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||+|....++..+++|..++.... ....+.+.+|+.++.++ +||+|+.+++.+.+.+..++||||+.+++|..++..
T Consensus        10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   89 (327)
T cd05617          10 KVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR   89 (327)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH
Confidence            5899998888999999988754332 23456678899999888 699999999999999999999999999999988865


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.|+.|||++   |++||||||+||+++.++.++|+|||++........  ....
T Consensus        90 ~~~---------l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~  155 (327)
T cd05617          90 QRK---------LPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTST  155 (327)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ceec
Confidence            432         89999999999999999999999   999999999999999999999999998864321111  1223


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh-hhcCCccCCCCCh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK-QCVDPKLKGEYPP  238 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  238 (285)
                      ..|++.|+|||.+.+..++.++|+|||||++|+|++|..||...........         ..... .+...  ....+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~---------~~~~~~~~~~~--~~~~p~  224 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT---------EDYLFQVILEK--PIRIPR  224 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc---------HHHHHHHHHhC--CCCCCC
Confidence            4588999999999988999999999999999999999999965332111100         01111 11111  112455


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNM------SIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~------~~ll~  267 (285)
                      ..+..+.+++.+||+.||.+|+++      +++++
T Consensus       225 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  259 (327)
T cd05617         225 FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS  259 (327)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence            567889999999999999999984      56654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-38  Score=272.30  Aligned_cols=232  Identities=26%  Similarity=0.371  Sum_probs=203.1

Q ss_pred             cChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCH
Q 023220           15 YPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW   94 (285)
Q Consensus        15 ~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~   94 (285)
                      +++|.   ++..-...++|..|..+|+.+.|||+|+++|+|....-+|||+|||..|+|.+|+++.+..       .++.
T Consensus       295 vAVKt---LKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~-------ev~a  364 (1157)
T KOG4278|consen  295 VAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRS-------EVPA  364 (1157)
T ss_pred             eehhh---hhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchh-------hcch
Confidence            45554   3455566899999999999999999999999999999999999999999999999876543       2677


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCccccc
Q 023220           95 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT  174 (285)
Q Consensus        95 ~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  174 (285)
                      -..+.++.||.+|+.||..+   ++||||+-.+|+|+.++..||+.|||+++.+.........+ ....+-|.|||.+..
T Consensus       365 vvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG-AKFPIKWTAPEsLAy  440 (1157)
T KOG4278|consen  365 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY  440 (1157)
T ss_pred             hHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC-ccCcccccCcccccc
Confidence            78889999999999999999   99999999999999999999999999999887655433222 234678999999999


Q ss_pred             CCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcc
Q 023220          175 GQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQ  253 (285)
Q Consensus       175 ~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  253 (285)
                      ..++.++|||+||++|||+.| |-.||.+-                ....+..+++.+++.+-|..||+.+++++..||+
T Consensus       441 NtFSiKSDVWAFGVLLWEIATYGMsPYPGi----------------dlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~  504 (1157)
T KOG4278|consen  441 NTFSIKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWN  504 (1157)
T ss_pred             cccccchhhHHHHHHHHHHHhcCCCCCCCc----------------cHHHHHHHHhccccccCCCCCCHHHHHHHHHHhc
Confidence            999999999999999999988 88898543                4567788889999999999999999999999999


Q ss_pred             cCCCCCCCHHHHHHHhchhhcCC
Q 023220          254 YEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       254 ~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      .+|.+||++.|+-+.|+.++++.
T Consensus       505 WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  505 WSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             CCcccCccHHHHHHHHHHHhccc
Confidence            99999999999999999988653

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.2e-37  Score=255.88  Aligned_cols=240  Identities=29%  Similarity=0.413  Sum_probs=186.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++..... ..+++|..+..   ....+.+.+|++++++++||||+++++++.. ...+++|||+.+++|.+++....
T Consensus        21 ~v~~~~~~~~-~~valK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~   95 (262)
T cd05071          21 EVWMGTWNGT-TRVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEM   95 (262)
T ss_pred             cEEEEEecCC-ceEEEEecccC---ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhcc
Confidence            5788765443 34777766532   2234678999999999999999999998754 45799999999999999997543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+......... ......
T Consensus        96 ~~-------~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~  164 (262)
T cd05071          96 GK-------YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAK  164 (262)
T ss_pred             cc-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCc
Confidence            21       278899999999999999999999   9999999999999999999999999998654322211 112234


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||...+..++.++|+||||+++|+|++ |..||..........                ..........+...
T Consensus       165 ~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~----------------~~~~~~~~~~~~~~  228 (262)
T cd05071         165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD----------------QVERGYRMPCPPEC  228 (262)
T ss_pred             ccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH----------------HHhcCCCCCCcccc
Confidence            5667999999888889999999999999999999 888886543221111                11111112234556


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      +..+.+++.+||+.+|++||++.++++.|+...
T Consensus       229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         229 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            788999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.9e-37  Score=262.38  Aligned_cols=235  Identities=21%  Similarity=0.305  Sum_probs=188.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+......+++|......  ....+.+.+|+.++++++|+|++++++.+..+...++||||+.+++|.+++....
T Consensus        35 ~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  112 (296)
T cd06654          35 TVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC  112 (296)
T ss_pred             EEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhcC
Confidence            47888877777788887654322  2235778899999999999999999999999999999999999999999986542


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                ++...+..++.|++.|+.|||..   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus       113 ----------~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~  177 (296)
T cd06654         113 ----------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMV  177 (296)
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc--ccCccc
Confidence                      78889999999999999999999   999999999999999999999999998865432211  112345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      +++.|+|||.+.+..++.++|+|||||++|+|++|+.||....+.......              ..........+...+
T Consensus       178 ~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~  243 (296)
T cd06654         178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--------------ATNGTPELQNPEKLS  243 (296)
T ss_pred             CCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH--------------hcCCCCCCCCccccC
Confidence            788999999998888899999999999999999999999755432111100              001111112234566


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+.+++.+||..+|++|||+.++++
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         244 AIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             HHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            78999999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.5e-37  Score=261.70  Aligned_cols=250  Identities=24%  Similarity=0.326  Sum_probs=187.5

Q ss_pred             Cceeeeee-----eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTC-----QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++...     .++..+++|..... ........+.+|+.++++++||||+++++++.++...++++||+.+++|.++
T Consensus        20 ~v~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   98 (288)
T cd05050          20 RVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF   98 (288)
T ss_pred             cEEEEEEcccCCCCcceeEEEEecCCC-cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHH
Confidence            46776542     24566777765422 1222346788999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccc
Q 023220           77 LHGRKGVQGA-------------QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN  143 (285)
Q Consensus        77 l~~~~~~~~~-------------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~  143 (285)
                      +.........             .....+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||
T Consensus        99 l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  175 (288)
T cd05050          99 LRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFG  175 (288)
T ss_pred             HHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEecCCCceEECccc
Confidence            9754321100             1112378889999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchh
Q 023220          144 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSED  222 (285)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (285)
                      .+................++..|+|||.+.+..++.++|+|||||++|+|++ |..||........              
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~--------------  241 (288)
T cd05050         176 LSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV--------------  241 (288)
T ss_pred             cceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------
Confidence            8865432221111122234567999999888889999999999999999997 8888865432211              


Q ss_pred             hhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          223 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                       ...+ ........+...+.++.+++.+||+.+|++|||+.++++.|++
T Consensus       242 -~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         242 -IYYV-RDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -HHHH-hcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence             1111 1111112344567789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6e-38  Score=275.05  Aligned_cols=247  Identities=19%  Similarity=0.238  Sum_probs=195.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-C-----CcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-H-----ENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .|-+|.+..|++.+|+|.++.   .+.+..+.+.|+.+|..|+ |     -|+|.++++|...+++|||+|.++. +|.+
T Consensus       201 QVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~-NLYe  276 (586)
T KOG0667|consen  201 QVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLST-NLYE  276 (586)
T ss_pred             eeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhh-hHHH
Confidence            367899999999999998874   4556677788999999996 3     4999999999999999999999975 9999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC--CeeEEeccccCCCCCcccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED--FKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~--~~~~l~df~~~~~~~~~~~  153 (285)
                      +++.+.-..       ++...+..++.||+.+|.+||+.   ||||+||||+|||+...  ..+||+|||+++...... 
T Consensus       277 llK~n~f~G-------lsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v-  345 (586)
T KOG0667|consen  277 LLKNNKFRG-------LSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV-  345 (586)
T ss_pred             HHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccCCcc-
Confidence            999876543       99999999999999999999999   99999999999999643  479999999997654322 


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhh------h
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQ------C  227 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~  227 (285)
                          .....+..|+|||++.+.+|+.+.|||||||++.||++|.+.|.+.+.-++...+....+..+...+..      +
T Consensus       346 ----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kf  421 (586)
T KOG0667|consen  346 ----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKF  421 (586)
T ss_pred             ----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccccee
Confidence                233456789999999999999999999999999999999999988876666544443333333211110      0


Q ss_pred             cCC-----------------------------cc-----------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          228 VDP-----------------------------KL-----------KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       228 ~~~-----------------------------~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+.                             ..           ........-..+.+++++||..||.+|+|+.+.++
T Consensus       422 f~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  422 FTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN  501 (586)
T ss_pred             hhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000                             00           00111133457899999999999999999999987

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.8e-37  Score=271.80  Aligned_cols=253  Identities=25%  Similarity=0.371  Sum_probs=193.2

Q ss_pred             Cceeeee-----eeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCT-----CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|..     ...+..+++|..+... .....+.+.+|++++.++. ||||+++++++...+..++||||+.+|+|.+
T Consensus        52 ~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~  130 (401)
T cd05107          52 RVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVD  130 (401)
T ss_pred             eEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHH
Confidence            4777763     3345568888776432 2223457889999999997 9999999999999999999999999999999


Q ss_pred             HhccCCCCC-----------------------------------------------------------------------
Q 023220           76 ILHGRKGVQ-----------------------------------------------------------------------   84 (285)
Q Consensus        76 ~l~~~~~~~-----------------------------------------------------------------------   84 (285)
                      +++......                                                                       
T Consensus       131 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (401)
T cd05107         131 YLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYE  210 (401)
T ss_pred             HHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcC
Confidence            997543100                                                                       


Q ss_pred             ------------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220           85 ------------------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus        85 ------------------~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                                        .......+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~kL~DfGla~  287 (401)
T cd05107         211 SPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLAR  287 (401)
T ss_pred             CchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEEEEEecCcce
Confidence                              001123477888999999999999999999   99999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhh
Q 023220          147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVK  225 (285)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
                      ...............++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......               ...
T Consensus       288 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~---------------~~~  352 (401)
T cd05107         288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE---------------QFY  352 (401)
T ss_pred             ecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH---------------HHH
Confidence            5432221111223346778999999988888999999999999999998 899986432111               111


Q ss_pred             hhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          226 QCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ..+........+..++.++.+++.+||..+|.+||++.++++.|++++
T Consensus       353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            111222222334556788999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-37  Score=259.42  Aligned_cols=253  Identities=21%  Similarity=0.250  Sum_probs=193.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .+|++....+++.+++|..+.........+.+.+|++++++++|+||+++++++..++..++++||+.++.+..+.....
T Consensus        16 ~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~   95 (288)
T cd07833          16 VVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG   95 (288)
T ss_pred             eEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCC
Confidence            57899888888899999888776667778899999999999999999999999999999999999999866665554332


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                               .++...++.++.|++.|+.|||+.   |++|+|++|+||+++.++.++|+|||.+......... ......
T Consensus        96 ---------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~  162 (288)
T cd07833          96 ---------GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYV  162 (288)
T ss_pred             ---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcc
Confidence                     278899999999999999999999   9999999999999999999999999998765443221 112345


Q ss_pred             cccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh--------------h
Q 023220          162 GTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK--------------Q  226 (285)
Q Consensus       162 ~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------------~  226 (285)
                      ++..|+|||.+.+. .++.++|+||||+++|+|++|..||.........................              .
T Consensus       163 ~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (288)
T cd07833         163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPE  242 (288)
T ss_pred             cccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCC
Confidence            67889999999887 78899999999999999999999997653322111111100010100000              0


Q ss_pred             hcCCc-cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          227 CVDPK-LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       227 ~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...+. ....++..++.++.++|.+||+.+|++|||++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         243 PSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00000 001123345788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3e-37  Score=260.12  Aligned_cols=238  Identities=21%  Similarity=0.237  Sum_probs=186.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..+++.+++|...... .......+.+|++++++++||||+++++++...+..+++|||+.+++|..+..   
T Consensus        16 ~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---   91 (279)
T cd06619          16 TVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRK---   91 (279)
T ss_pred             EEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhhc---
Confidence            58999888889999999775322 23345678899999999999999999999999999999999999998865521   


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                +++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++.......    .....
T Consensus        92 ----------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~  154 (279)
T cd06619          92 ----------IPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYV  154 (279)
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCC
Confidence                      67888999999999999999999   99999999999999999999999999986543221    23346


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..||..........        ..........+...........+
T Consensus       155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~  226 (279)
T cd06619         155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL--------MPLQLLQCIVDEDPPVLPVGQFS  226 (279)
T ss_pred             CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc--------chHHHHHHHhccCCCCCCCCcCC
Confidence            7889999999988889999999999999999999999996532211100        00111111111111111123356


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      +++.+++.+||+.+|++||+++++++.
T Consensus       227 ~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         227 EKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            789999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.3e-37  Score=255.40  Aligned_cols=238  Identities=28%  Similarity=0.400  Sum_probs=185.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++... .+..+++|......   ...+++.+|+.++++++|+|++++++++.. ...+++|||+.+++|.+++....
T Consensus        21 ~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~   95 (260)
T cd05070          21 EVWMGTWN-GNTKVAVKTLKPGT---MSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGE   95 (260)
T ss_pred             eEEEEEec-CCceeEEEEecCCC---CCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcC
Confidence            47888554 34557777655322   235678999999999999999999998854 45789999999999999997543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++......... ......
T Consensus        96 ~~-------~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~  164 (260)
T cd05070          96 GR-------ALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAK  164 (260)
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCC
Confidence            21       278999999999999999999999   9999999999999999999999999998654322111 111223


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||...+..++.++|+||||+++|+|++ |..||.......                ....+........+...
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~  228 (260)
T cd05070         165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE----------------VLEQVERGYRMPCPQDC  228 (260)
T ss_pred             CCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHHHHcCCCCCCCCcC
Confidence            4567999999888888999999999999999999 899996543211                11111112222345566


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      +..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         229 PISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            7889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.6e-37  Score=258.96  Aligned_cols=253  Identities=25%  Similarity=0.332  Sum_probs=190.5

Q ss_pred             Cceeeeeee----eccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe-CCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQ----VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE-GNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~   76 (285)
                      +||++....    ....+++|..+.. ......+.+.+|+.++++++|+||+++++++.. +...+++++|+.+++|.++
T Consensus        21 ~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~   99 (280)
T cd05043          21 RIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLF   99 (280)
T ss_pred             eEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHH
Confidence            577777655    2455666654422 122335678889999999999999999998776 4677899999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH  156 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  156 (285)
                      +........ .....+++..++.++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++...........
T Consensus       100 l~~~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  175 (280)
T cd05043         100 LQQCRLGEA-NNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL  175 (280)
T ss_pred             HHhcccccc-ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEe
Confidence            876432210 0112388999999999999999999999   999999999999999999999999999875432222111


Q ss_pred             ccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC
Q 023220          157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE  235 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
                      .....++..|+|||.+.+..++.++||||||+++|++++ |+.||....+..                ....+.......
T Consensus       176 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~  239 (280)
T cd05043         176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE----------------MAAYLKDGYRLA  239 (280)
T ss_pred             CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH----------------HHHHHHcCCCCC
Confidence            122335667999999988889999999999999999998 999997543211                111111111112


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      .+..+++++.+++.+||+.+|++|||+.++++.|+.+.+.
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            2334567899999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7.9e-37  Score=254.88  Aligned_cols=238  Identities=28%  Similarity=0.403  Sum_probs=183.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++..... ..+++|.....   ....+.+.+|++++++++|+|++++++++.. +..+++|||+.+++|.+++....
T Consensus        21 ~v~~~~~~~~-~~~~lK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~   95 (260)
T cd05069          21 EVWMGTWNGT-TKVAIKTLKPG---TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGD   95 (260)
T ss_pred             eEEEEEEcCC-ceEEEEEcccC---CccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCC
Confidence            4777765443 34666654322   2245778899999999999999999998864 45789999999999999997543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++......... ......
T Consensus        96 ~~-------~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~  164 (260)
T cd05069          96 GK-------YLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAK  164 (260)
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCc
Confidence            21       278899999999999999999999   9999999999999999999999999998654322111 112233


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||...+..++.++|+||||+++|+|++ |..||.........                ..+........+...
T Consensus       165 ~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~  228 (260)
T cd05069         165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL----------------EQVERGYRMPCPQGC  228 (260)
T ss_pred             cchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------------HHHHcCCCCCCCccc
Confidence            5667999999888889999999999999999999 89999754321111                111111112334456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      +..+.+++.+||+.||++||++.+++++|+.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         229 PESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            7889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-38  Score=275.56  Aligned_cols=229  Identities=22%  Similarity=0.265  Sum_probs=194.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +|+++-.+.++++||+|..++..-. .+..+..+.|-+++... +||.++.++..|...+++++||||..||++..+.+.
T Consensus       383 kV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~  462 (694)
T KOG0694|consen  383 KVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHT  462 (694)
T ss_pred             eEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEec
Confidence            5788888999999999988776644 55688888999998887 699999999999999999999999999996666554


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ..          +++..+.-++..++.||.|||++   ||++||+|.+|||+|..|++||+|||+++..-..+.  .+.-
T Consensus       463 ~~----------F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~--~TsT  527 (694)
T KOG0694|consen  463 DV----------FSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD--RTST  527 (694)
T ss_pred             cc----------ccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCCC--cccc
Confidence            43          99999999999999999999999   999999999999999999999999999986543332  3455


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..||+.|+|||++.+..|+...|.|||||++|||+.|+.||.+.+.++               -...++.-..  .+|..
T Consensus       528 fCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee---------------~FdsI~~d~~--~yP~~  590 (694)
T KOG0694|consen  528 FCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE---------------VFDSIVNDEV--RYPRF  590 (694)
T ss_pred             ccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH---------------HHHHHhcCCC--CCCCc
Confidence            679999999999999999999999999999999999999998765422               1222222221  45777


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNM  262 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~  262 (285)
                      ++.+...|++++|.+||.+|-..
T Consensus       591 ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  591 LSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ccHHHHHHHHHHhccCcccccCC
Confidence            88899999999999999999854

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.2e-37  Score=255.76  Aligned_cols=238  Identities=23%  Similarity=0.302  Sum_probs=192.0

Q ss_pred             ceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG   82 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~   82 (285)
                      +|.+.....++.+++|............+++.+|++++++++|+||+++++++.+....+++|||+.+++|.+++.....
T Consensus        16 v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~   95 (256)
T cd08221          16 ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG   95 (256)
T ss_pred             EEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccc
Confidence            56666667777788887655444455567888999999999999999999999999999999999999999999976532


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccccc
Q 023220           83 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLG  162 (285)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  162 (285)
                      .       .+++..+..++.|++.++.|||+.   |++|+||+|+||+++.++.++|+|||++........  ......+
T Consensus        96 ~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~  163 (256)
T cd08221          96 Q-------LFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVG  163 (256)
T ss_pred             c-------CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCC
Confidence            1       288999999999999999999999   999999999999999999999999999865543221  1233457


Q ss_pred             ccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHH
Q 023220          163 TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVA  242 (285)
Q Consensus       163 ~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (285)
                      +..|.|||.+.+..++.++|+||||+++++|++|..||........               ...+.... ....+..++.
T Consensus       164 ~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~---------------~~~~~~~~-~~~~~~~~~~  227 (256)
T cd08221         164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL---------------VVKIVQGN-YTPVVSVYSS  227 (256)
T ss_pred             CccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH---------------HHHHHcCC-CCCCccccCH
Confidence            8899999999888889999999999999999999999975432211               11111111 1122345677


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          243 KLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      .+.+++.+||+.+|.+|||++++++.
T Consensus       228 ~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         228 ELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHhhC
Confidence            89999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.2e-37  Score=267.83  Aligned_cols=235  Identities=21%  Similarity=0.204  Sum_probs=187.5

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||+|.+..++..+++|..++... .....+.+..|..++..+ .|++|+++++.+.+.+..++||||+.+|+|.+++..
T Consensus        15 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~   94 (323)
T cd05616          15 KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ   94 (323)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHH
Confidence            589999888889999997765432 222345567788888877 589999999999999999999999999999999875


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ....
T Consensus        95 ~~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~--~~~~  160 (323)
T cd05616          95 VGR---------FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKT  160 (323)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC--cccc
Confidence            432         88899999999999999999999   999999999999999999999999999864322111  1233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.........               ..+....  ...+..
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~---------------~~i~~~~--~~~p~~  223 (323)
T cd05616         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---------------QSIMEHN--VAYPKS  223 (323)
T ss_pred             CCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH---------------HHHHhCC--CCCCCc
Confidence            45889999999999989999999999999999999999999765432111               1111111  133456


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNM-----SIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~-----~~ll~  267 (285)
                      .+.++.+++.+||+.||.+|++.     .++++
T Consensus       224 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         224 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence            67889999999999999999984     56554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.2e-37  Score=262.83  Aligned_cols=250  Identities=19%  Similarity=0.228  Sum_probs=187.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++....++..+++|..... ......+++.+|++++++++||||+++++.+.+++..+++|||+.+++|.+++....
T Consensus        16 ~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~   94 (308)
T cd06615          16 VVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG   94 (308)
T ss_pred             EEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC
Confidence            4788877777777777766432 122235668899999999999999999999999999999999999999999997653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      .         +++..+..++.|++.|+.|||+ .   +++|+||+|+||+++.++.++|+|||++.......    ....
T Consensus        95 ~---------~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~  158 (308)
T cd06615          95 R---------IPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSF  158 (308)
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCcccccccc----cccC
Confidence            2         7889999999999999999997 6   89999999999999999999999999886543221    1234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCch-------------------
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSE-------------------  221 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------  221 (285)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.................                   
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (308)
T cd06615         159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA  238 (308)
T ss_pred             CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhh
Confidence            5788999999988888899999999999999999999999754432221111110000000                   


Q ss_pred             --hhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          222 --DKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       222 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                        +.................++.++.+++.+||+.+|++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             HHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00000110000000111356789999999999999999999999884

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.9e-37  Score=257.53  Aligned_cols=238  Identities=22%  Similarity=0.345  Sum_probs=189.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCC-------CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKN-------YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   74 (285)
                      .||++.+...+..+++|..........       ..+.+.+|+.++++++||||+++++++...+..++++||+.+++|.
T Consensus        15 ~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   94 (267)
T cd06628          15 SVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVA   94 (267)
T ss_pred             EEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHH
Confidence            578888777788888886654333221       2356888999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  154 (285)
                      +++.....         ++...+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||.+.........
T Consensus        95 ~~l~~~~~---------l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06628          95 ALLNNYGA---------FEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLS  162 (267)
T ss_pred             HHHHhccC---------ccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccccccccc
Confidence            99976432         78889999999999999999999   9999999999999999999999999998765421111


Q ss_pred             c----cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          155 L----HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       155 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                      .    ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......               .+..... 
T Consensus       163 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------------~~~~~~~-  226 (267)
T cd06628         163 TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---------------AIFKIGE-  226 (267)
T ss_pred             CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---------------HHHHHhc-
Confidence            0    0112346788999999988888999999999999999999999997543211               1111111 


Q ss_pred             ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          231 KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ......+...+..+.++|.+||+.||++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            1112334556788999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.2e-37  Score=255.02  Aligned_cols=237  Identities=22%  Similarity=0.293  Sum_probs=191.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .+|++....+++.+++|..............+.+|++++++++|||++++++.+..++..++||||+.+++|.+++....
T Consensus        15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   94 (256)
T cd08220          15 IVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRC   94 (256)
T ss_pred             EEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhc
Confidence            47888888889999999876554444556788999999999999999999999999999999999999999999997643


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC-CeeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..       .+++..++.++.|++.++.|||++   |++|+||+|+||+++.+ +.++|+|||.+........   ....
T Consensus        95 ~~-------~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~  161 (256)
T cd08220          95 NS-------LLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTV  161 (256)
T ss_pred             cc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---cccc
Confidence            21       278899999999999999999999   99999999999999854 4679999999876543221   1234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+....               ...... ......+...
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---------------~~~~~~-~~~~~~~~~~  225 (256)
T cd08220         162 VGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---------------VLKIMS-GTFAPISDRY  225 (256)
T ss_pred             ccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---------------HHHHHh-cCCCCCCCCc
Confidence            578899999999888889999999999999999999999975432211               111111 1112234456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +..+.+++.+||+.+|++|||+.++++
T Consensus       226 ~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         226 SPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            778999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4e-37  Score=255.98  Aligned_cols=238  Identities=23%  Similarity=0.294  Sum_probs=189.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe-CCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.+....+.+++|............+.+.+|++++++++|+|++++++.+.. +...++++||+.+++|.+++...
T Consensus        15 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~   94 (257)
T cd08223          15 EVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ   94 (257)
T ss_pred             EEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHh
Confidence            47888887777888888876555555566788999999999999999999998764 44679999999999999999754


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...       .+++..++.++.+++.++.+||+.   |++|+||+|+||+++.++.++|+|||++........  .....
T Consensus        95 ~~~-------~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~  162 (257)
T cd08223          95 KGK-------LLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTL  162 (257)
T ss_pred             cCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccc
Confidence            321       288999999999999999999999   999999999999999999999999999865433221  12234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .+++.|+|||...+..++.++|+||+|+++++|++|+.||...+....               ...+.. ......+...
T Consensus       163 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~---------------~~~~~~-~~~~~~~~~~  226 (257)
T cd08223         163 IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL---------------VYRIIE-GKLPPMPKDY  226 (257)
T ss_pred             cCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---------------HHHHHh-cCCCCCcccc
Confidence            578899999999888899999999999999999999999975432110               011111 1111234456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ++.+.+++.+||+.||++|||+.++++
T Consensus       227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         227 SPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            778999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.5e-37  Score=262.46  Aligned_cols=251  Identities=20%  Similarity=0.268  Sum_probs=188.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..+++.+++|..+... .......+.+|+.++++++||||+++++++...+..+++|||+. ++|.+++....
T Consensus        21 ~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~   98 (301)
T cd07873          21 TVYKGRSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG   98 (301)
T ss_pred             EEEEEEEcCCCcEEEEEEEeccc-ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcC
Confidence            58999888888889999775433 23345567889999999999999999999999999999999997 48988886543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .++...+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        99 ~--------~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~  165 (301)
T cd07873          99 N--------SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEV  165 (301)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--cccccc
Confidence            2        278899999999999999999999   999999999999999999999999999865432111  112234


Q ss_pred             cccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC---------Cc
Q 023220          162 GTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD---------PK  231 (285)
Q Consensus       162 ~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~  231 (285)
                      +++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+..............+..         +.
T Consensus       166 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (301)
T cd07873         166 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPK  245 (301)
T ss_pred             eeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCc
Confidence            67899999987654 578899999999999999999999987654332222111111111111111100         11


Q ss_pred             cCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          232 LKG----EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       232 ~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...    .....++..+.++|.+||+.||.+|||++++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         246 YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            100    112345678999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.7e-37  Score=254.10  Aligned_cols=239  Identities=26%  Similarity=0.353  Sum_probs=186.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++... .+..+++|...... .......+.+|++++++++||||+++++++......+++|||+.+++|.+++....
T Consensus        10 ~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   87 (250)
T cd05085          10 EVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK   87 (250)
T ss_pred             eEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcC
Confidence            47887643 46667777654322 22234568899999999999999999999999999999999999999999986543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+.+..++.++.|++.++.|+|+.   |++|+||+|+||+++.++.++|+|||++......... ......
T Consensus        88 ~--------~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~  155 (250)
T cd05085          88 D--------ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQ  155 (250)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCC
Confidence            2        278899999999999999999999   9999999999999999999999999988643321111 111123


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+.+..++.++|+||||+++|++++ |..||........                ...+........+..+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~  219 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA----------------REQVEKGYRMSCPQKC  219 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH----------------HHHHHcCCCCCCCCCC
Confidence            3567999999988888999999999999999998 9999965432111                1111111222334556


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      +..+.+++.+||+.+|++||++.++++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-37  Score=261.59  Aligned_cols=244  Identities=23%  Similarity=0.302  Sum_probs=179.7

Q ss_pred             cChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCC---CCCCCCC
Q 023220           15 YPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ---GAQPGPV   91 (285)
Q Consensus        15 ~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~   91 (285)
                      +++|..... ......+.+.+|++++++++|+|++++++++...+..+++|||+.+++|.+++.......   .......
T Consensus        47 vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~  125 (295)
T cd05097          47 VAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS  125 (295)
T ss_pred             EEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCc
Confidence            566655432 122335678899999999999999999999999999999999999999999986532110   0111123


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcc
Q 023220           92 LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEY  171 (285)
Q Consensus        92 ~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~  171 (285)
                      +++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++................++..|+|||.
T Consensus       126 ~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  202 (295)
T cd05097         126 VSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWES  202 (295)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhh
Confidence            78889999999999999999999   999999999999999999999999999865432221111222344678999999


Q ss_pred             cccCCCCcccchHhHHHHHHHHHh--CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHH
Q 023220          172 AMTGQLTQKSDVYSFGVVLLELLT--GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAA  249 (285)
Q Consensus       172 ~~~~~~~~~~DiwslG~~l~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  249 (285)
                      ..+..++.++|+||||+++|+|++  +..||.............   ...      ...........+...++.+.+++.
T Consensus       203 ~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~---~~~------~~~~~~~~~~~~~~~~~~l~~li~  273 (295)
T cd05097         203 ILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTG---EFF------RNQGRQIYLSQTPLCPSPVFKLMM  273 (295)
T ss_pred             hccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHH---Hhh------hhccccccCCCCCCCCHHHHHHHH
Confidence            988889999999999999999988  667776543211110000   000      000000111223445678999999


Q ss_pred             HhcccCCCCCCCHHHHHHHhch
Q 023220          250 LCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       250 ~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      +||+.||.+|||+.++++.|++
T Consensus       274 ~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         274 RCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHcCCCchhCcCHHHHHHHHhC
Confidence            9999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-37  Score=254.56  Aligned_cols=239  Identities=24%  Similarity=0.314  Sum_probs=188.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++....++..+++|......  ....+.+.+|++++++++||||+++++++.+....+++|||+.+++|.+++....
T Consensus        18 ~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~   95 (262)
T cd06613          18 DVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR   95 (262)
T ss_pred             EEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc
Confidence            47888777777788888775332  2256788999999999999999999999999999999999999999999987652


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .++...+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||.+........  ......
T Consensus        96 ~--------~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~  162 (262)
T cd06613          96 G--------PLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFI  162 (262)
T ss_pred             c--------CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh--cccccc
Confidence            2        288999999999999999999999   999999999999999999999999999876543221  112345


Q ss_pred             cccCcCCCcccccC---CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          162 GTFGYHAPEYAMTG---QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       162 ~~~~~~aPE~~~~~---~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ++..|+|||.+...   .++.++|+||||+++|+|++|..||....+.........  ..         .. ........
T Consensus       163 ~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~--~~---------~~-~~~~~~~~  230 (262)
T cd06613         163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK--SN---------FP-PPKLKDKE  230 (262)
T ss_pred             CCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cc---------CC-Cccccchh
Confidence            67889999998766   788999999999999999999999975443211111000  00         00 00011234


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+.++.+++.+||+.+|.+|||+.+++.
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             hhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            56778999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.7e-38  Score=273.41  Aligned_cols=235  Identities=20%  Similarity=0.281  Sum_probs=185.7

Q ss_pred             CceeeeeeeeccccChhhhh--hccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCe--eeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENE--RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL--RVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~--~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~e~~~~~~L~~~l   77 (285)
                      +||+++|..++-.++-...+  .........++|..|+++|+.|+||||+++++++.+...  ..+|+|.+.+|+|..|+
T Consensus        55 tVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~  134 (632)
T KOG0584|consen   55 TVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYR  134 (632)
T ss_pred             eeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHH
Confidence            58999997666665543333  333334445999999999999999999999999986654  78999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-CCeeEEeccccCCCCCccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKIADFNLSNQAPDMAARLH  156 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~  156 (285)
                      ++.+.         .+...+..|++||+++|.|||.+ ++.|+|||||.+||+++. .|.|||+|+|+|.......    
T Consensus       135 kk~~~---------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~----  200 (632)
T KOG0584|consen  135 KKHRR---------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH----  200 (632)
T ss_pred             HHhcc---------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc----
Confidence            87763         88999999999999999999997 778999999999999975 5899999999997654322    


Q ss_pred             ccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC-CC
Q 023220          157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK-GE  235 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  235 (285)
                      .....|||.|||||+.. ..|++..||||||++++||+|+..||.-.....+.               .+.+..+.. ..
T Consensus       201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI---------------YKKV~SGiKP~s  264 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI---------------YKKVTSGIKPAA  264 (632)
T ss_pred             cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH---------------HHHHHcCCCHHH
Confidence            23468999999999876 67999999999999999999999999654322221               111111111 11


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +..--.+++++||.+||.. ..+|||+.|+|.
T Consensus       265 l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  265 LSKVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             hhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            1112245799999999999 999999999997

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.4e-38  Score=269.83  Aligned_cols=232  Identities=19%  Similarity=0.188  Sum_probs=183.4

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHH-HHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVS-VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++.+..+++.+++|....... .......+..|.. +++.++||||+++++.+...+..++||||+.+++|..++..
T Consensus        10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   89 (325)
T cd05604          10 KVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR   89 (325)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH
Confidence            589999888899999997754432 2223345555554 46778999999999999999999999999999999988875


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ....
T Consensus        90 ~~~---------~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~  155 (325)
T cd05604          90 ERS---------FPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTT  155 (325)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Cccc
Confidence            432         88999999999999999999999   999999999999999999999999999864322111  1233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+....               ...+.....  ..++.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---------------~~~~~~~~~--~~~~~  218 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM---------------YDNILHKPL--VLRPG  218 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH---------------HHHHHcCCc--cCCCC
Confidence            4588999999999988899999999999999999999999976532211               111111111  22334


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSI  264 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~  264 (285)
                      .+..+.+++.+||+.+|.+||++.+
T Consensus       219 ~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         219 ASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCHHHHHHHHHHhccCHHhcCCCCC
Confidence            5678999999999999999998853

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4e-37  Score=259.86  Aligned_cols=258  Identities=23%  Similarity=0.309  Sum_probs=185.5

Q ss_pred             Cceeee----eeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe--CCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCC----TCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.    +......+++|.....  .....+.+.+|++++++++||||+++++++..  ....++++||+.+++|.+
T Consensus        19 ~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~   96 (284)
T cd05081          19 SVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRD   96 (284)
T ss_pred             eEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHH
Confidence            466664    2334566777765432  22334678899999999999999999998754  346799999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++.....        .+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++..........
T Consensus        97 ~l~~~~~--------~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~  165 (284)
T cd05081          97 YLQKHRE--------RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYY  165 (284)
T ss_pred             HHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCCcce
Confidence            9965432        278899999999999999999999   99999999999999999999999999987654322111


Q ss_pred             c-ccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          156 H-STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       156 ~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      . .....++..|+|||.+.+..++.++|+||||+++++|++|..++...........................+......
T Consensus       166 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (284)
T cd05081         166 KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRL  245 (284)
T ss_pred             eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcC
Confidence            0 111223446899999988889999999999999999999877764332111100000000000111111222222222


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      ..+..++.++.+++.+||+.+|++|||+.++++.|+.+
T Consensus       246 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         246 PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            33455678899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.1e-37  Score=260.86  Aligned_cols=240  Identities=19%  Similarity=0.271  Sum_probs=189.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.+..++..+++|........ ....+.+.+|+.++++++|++++++++.+.+++..+++|||+.+++|.+++...
T Consensus        15 ~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~   94 (285)
T cd05630          15 EVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM   94 (285)
T ss_pred             EEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHh
Confidence            4789988888999999976544322 223456778999999999999999999999999999999999999999988543


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...       .+++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++........   ....
T Consensus        95 ~~~-------~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~  161 (285)
T cd05630          95 GEA-------GFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGR  161 (285)
T ss_pred             ccc-------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCC
Confidence            321       288899999999999999999999   999999999999999999999999998865432211   1234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.........            +....... ......+..+
T Consensus       162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~------------~~~~~~~~-~~~~~~~~~~  228 (285)
T cd05630         162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR------------EEVERLVK-EVQEEYSEKF  228 (285)
T ss_pred             CCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH------------HHHHhhhh-hhhhhcCccC
Confidence            6889999999998888999999999999999999999999754321110            00111100 0011233456


Q ss_pred             HHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPN-----MSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps-----~~~ll~  267 (285)
                      +.++.+++.+||+.||.+|||     ++++++
T Consensus       229 ~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         229 SPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             CHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            678999999999999999999     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8e-37  Score=254.94  Aligned_cols=245  Identities=22%  Similarity=0.305  Sum_probs=182.0

Q ss_pred             Cceeeeeee---eccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEE-eCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQ---VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV-EGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||+|....   .+..+++|...... .....+.+.+|+.+++.++||||+++++++. .++..+++++|+.+++|.+++
T Consensus        10 ~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   88 (262)
T cd05058          10 CVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI   88 (262)
T ss_pred             eEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHH
Confidence            478776543   23456666543221 1223567888999999999999999999775 455678999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc--cc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA--RL  155 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~  155 (285)
                      ......        .+...+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........  ..
T Consensus        89 ~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          89 RSETHN--------PTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             HhcCCC--------CCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            754321        56778899999999999999999   999999999999999999999999999865432111  11


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhC-CCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG-RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      ......++..|+|||...+..++.++||||||+++|+|++| .+||........                ...+......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~----------------~~~~~~~~~~  221 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI----------------TVYLLQGRRL  221 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH----------------HHHHhcCCCC
Confidence            11223356689999998888899999999999999999995 556653322110                0011111111


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ..+...+..+.+++.+||+.+|++||++.++++.|++++.
T Consensus       222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            2233456789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.2e-37  Score=276.23  Aligned_cols=248  Identities=19%  Similarity=0.239  Sum_probs=181.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC--------CeeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG--------NLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L   73 (285)
                      +||++....+++.+++|.....      .....+|+.++++++||||+++++++...        ..++++|||+.+ +|
T Consensus        81 ~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l  153 (440)
T PTZ00036         81 VVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TV  153 (440)
T ss_pred             EEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cH
Confidence            5899988888888998865321      23445799999999999999999887432        246799999975 77


Q ss_pred             HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC-eeEEeccccCCCCCccc
Q 023220           74 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-KAKIADFNLSNQAPDMA  152 (285)
Q Consensus        74 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~  152 (285)
                      .+++......     ...+++..++.++.|++.||.|||+.   |++||||||+||+++.++ .++|+|||++.......
T Consensus       154 ~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  225 (440)
T PTZ00036        154 HKYMKHYARN-----NHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ  225 (440)
T ss_pred             HHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhccCCC
Confidence            7776532110     11388999999999999999999999   999999999999998664 69999999997553322


Q ss_pred             ccccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh----
Q 023220          153 ARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC----  227 (285)
Q Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----  227 (285)
                      .   .....|++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.........+.........+.....    
T Consensus       226 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~  302 (440)
T PTZ00036        226 R---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNY  302 (440)
T ss_pred             C---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhh
Confidence            1   1234578899999987654 6899999999999999999999999876543332222211111111111110    


Q ss_pred             --------cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          228 --------VDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       228 --------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                              ....+...++...+.++.++|.+||+.||.+|||+.++++
T Consensus       303 ~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        303 ADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             hcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                    0011111233445678999999999999999999999985

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.8e-37  Score=264.06  Aligned_cols=255  Identities=25%  Similarity=0.355  Sum_probs=190.7

Q ss_pred             Cceeeeeeeec-------cccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQVE-------ESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~~-------~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   73 (285)
                      .||++.+....       ..+++|..+.. ......+.+.+|+++++++ +||||+++++++...+..++++||+.+++|
T Consensus        27 ~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  105 (334)
T cd05100          27 QVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL  105 (334)
T ss_pred             cEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcH
Confidence            46777643221       24566654422 1222356788999999999 899999999999999999999999999999


Q ss_pred             HHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220           74 HDILHGRKGVQG-------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus        74 ~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      .+++........       ......+++..++.++.|++.|+.|||++   |++|+||+|+||+++.++.++|+|||++.
T Consensus       106 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~~~kL~Dfg~~~  182 (334)
T cd05100         106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR  182 (334)
T ss_pred             HHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCcccce
Confidence            999976432100       01122378889999999999999999999   99999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhh
Q 023220          147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVK  225 (285)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
                      ...............++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......                ..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----------------~~  246 (334)
T cd05100         183 DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----------------LF  246 (334)
T ss_pred             ecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----------------HH
Confidence            5443221111122233467999999988889999999999999999998 888886543211                11


Q ss_pred             hhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          226 QCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      ..+........+...+..+.+++.+||+.+|.+|||+.++++.|++++...
T Consensus       247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         247 KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            111111222334456678999999999999999999999999999988443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.7e-37  Score=271.29  Aligned_cols=238  Identities=16%  Similarity=0.192  Sum_probs=187.4

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++....+++.+++|...+... .....+.+.+|+.+++.++||||+++++.+.+++..++||||+.+|+|.+++...
T Consensus        58 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~  137 (370)
T cd05621          58 EVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY  137 (370)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc
Confidence            588998888889999997754332 2233456788999999999999999999999999999999999999999999654


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      .          ++...+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........ ......
T Consensus       138 ~----------~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~  203 (370)
T cd05621         138 D----------VPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTA  203 (370)
T ss_pred             C----------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCc-eecccC
Confidence            2          78889999999999999999999   999999999999999999999999999875432111 111234


Q ss_pred             ccccCcCCCcccccC----CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          161 LGTFGYHAPEYAMTG----QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~----~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      .|++.|+|||++.+.    .++.++|+||+||++|+|++|..||........               ...+.+.......
T Consensus       204 ~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~---------------~~~i~~~~~~~~~  268 (370)
T cd05621         204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT---------------YSKIMDHKNSLNF  268 (370)
T ss_pred             CCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH---------------HHHHHhCCcccCC
Confidence            689999999998654    378899999999999999999999976543211               1112221111111


Q ss_pred             --ChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 023220          237 --PPKGVAKLAAVAALCVQYEAEF--RPNMSIVVKA  268 (285)
Q Consensus       237 --~~~~~~~l~~li~~~l~~~p~~--Rps~~~ll~~  268 (285)
                        ....+..+.+++.+||..++.+  |+++.++++.
T Consensus       269 p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         269 PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence              2345778999999999865544  8999999985

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.1e-38  Score=269.54  Aligned_cols=231  Identities=19%  Similarity=0.184  Sum_probs=182.5

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHH-HHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVS-VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++.+...++.+++|...+... .......+..|.. +++.++||||+++++++.+.+..++||||+.+++|...+..
T Consensus        10 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   89 (321)
T cd05603          10 KVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR   89 (321)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH
Confidence            589999988899999997754332 2223344555554 57889999999999999999999999999999999988865


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ....
T Consensus        90 ~~~---------~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~  155 (321)
T cd05603          90 ERC---------FLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTST  155 (321)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--cccc
Confidence            432         78889999999999999999999   999999999999999999999999999864322111  1233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.....               ..+...  ....+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---------------~~i~~~--~~~~~~~  218 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY---------------DNILHK--PLQLPGG  218 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH---------------HHHhcC--CCCCCCC
Confidence            45789999999998888999999999999999999999999765321111               111111  1123445


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMS  263 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~  263 (285)
                      .+..+.+++.+||+.||.+||++.
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         219 KTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCHHHHHHHHHHccCCHhhcCCCC
Confidence            667899999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.4e-37  Score=259.95  Aligned_cols=258  Identities=23%  Similarity=0.344  Sum_probs=193.0

Q ss_pred             Cceeeeee----eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe--CCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTC----QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~   75 (285)
                      .||++...    .+...+++|........ ...+.+.+|++++++++|+||+++++++..  ....+++|||+.+++|.+
T Consensus        19 ~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~   97 (284)
T cd05038          19 KVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRD   97 (284)
T ss_pred             eEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHH
Confidence            46776532    33667888876543332 346789999999999999999999999887  557899999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-  154 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-  154 (285)
                      ++.....        .+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        98 ~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  166 (284)
T cd05038          98 YLQRHRD--------QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYY  166 (284)
T ss_pred             HHHhCcc--------ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcce
Confidence            9976542        288899999999999999999999   9999999999999999999999999998765422111 


Q ss_pred             ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      .......++..|++||...+..++.++|+||||+++++|++|..|+......... .................+......
T Consensus       167 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  245 (284)
T cd05038         167 YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLELLKEGERL  245 (284)
T ss_pred             eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccccccccHHHHHHHHHcCCcC
Confidence            1111223455699999988888899999999999999999999998654321110 000000001112222222333333


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      ..+..++.++.+++.+||+.+|++|||+.+++++|+++
T Consensus       246 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         246 PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            34455678899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.5e-37  Score=261.06  Aligned_cols=252  Identities=17%  Similarity=0.203  Sum_probs=187.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..+++.+++|..............+.+|++++++++||||+++++++.+....++++||+.+ +|.+++....
T Consensus        15 ~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~   93 (284)
T cd07839          15 TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCN   93 (284)
T ss_pred             EEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcC
Confidence            589998888888999998766555555667888999999999999999999999999999999999975 8888776432


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        94 ~--------~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  160 (284)
T cd07839          94 G--------DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--CYSAEV  160 (284)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--CcCCCc
Confidence            2        288999999999999999999999   999999999999999999999999999875432211  112235


Q ss_pred             cccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCC-cccchhhhhhcccCchh---hhhhhcCCccC---
Q 023220          162 GTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTWATPRLSED---KVKQCVDPKLK---  233 (285)
Q Consensus       162 ~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~~~~---  233 (285)
                      ++..|+|||.+.+. .++.++|+|||||++|+|++|..||..... ......+..........   ......+....   
T Consensus       161 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd07839         161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY  240 (284)
T ss_pred             cccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCC
Confidence            67889999988764 468999999999999999999888643322 11111110000000000   00000000000   


Q ss_pred             ------CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          234 ------GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       234 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                            ....+..++++.+++.+||+.||.+|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         241 PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                  1122345678999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-37  Score=271.76  Aligned_cols=239  Identities=19%  Similarity=0.214  Sum_probs=188.0

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|....+++.+++|..+... ........+.+|+.++.+++||+|+++++.+.+.+..++||||+.+|+|.+++...
T Consensus        16 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~   95 (360)
T cd05627          16 EVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK   95 (360)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhc
Confidence            58999998889999999776433 23445677889999999999999999999999999999999999999999999755


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc-------
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA-------  153 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-------  153 (285)
                      ..         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........       
T Consensus        96 ~~---------l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~  163 (360)
T cd05627          96 DT---------LSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNL  163 (360)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccccccccc
Confidence            32         88999999999999999999999   999999999999999999999999999864321100       


Q ss_pred             --------------------------cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcc
Q 023220          154 --------------------------RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRG  207 (285)
Q Consensus       154 --------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~  207 (285)
                                                ........|++.|+|||++.+..++.++|+|||||++|+|++|..||....+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~  243 (360)
T cd05627         164 THNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE  243 (360)
T ss_pred             ccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHH
Confidence                                      000112358999999999999999999999999999999999999997654322


Q ss_pred             cchhhhhhcccCchhhhhhhcCCccCCCCC--hhHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 023220          208 QQSLVTWATPRLSEDKVKQCVDPKLKGEYP--PKGVAKLAAVAALCVQYEAEFRPN---MSIVVKA  268 (285)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~  268 (285)
                      ...               .+........++  ...++++.++|.+|+. ||.+|++   +.++++.
T Consensus       244 ~~~---------------~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         244 TYR---------------KVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             HHH---------------HHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            111               111100000111  2256789999999874 9999985   6777664

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-37  Score=290.65  Aligned_cols=242  Identities=20%  Similarity=0.236  Sum_probs=186.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe--CCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||+|.+..++..+++|..............+.+|+.++++++||||++++++|.+  ...++|||||+.+++|.+++..
T Consensus        28 tVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k  107 (1021)
T PTZ00266         28 EVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK  107 (1021)
T ss_pred             EEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHH
Confidence            58999999999999999877655555567789999999999999999999998864  3568999999999999999875


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----CCCeeeCCCCCCCeEEcc-----------------CCeeE
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV----QPSIIHRDIRSSNVLLFE-----------------DFKAK  138 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~----~~~~~h~di~~~nil~~~-----------------~~~~~  138 (285)
                      .....     ..+++..++.|+.||+.||.|||...    ..+|+|+||||+|||++.                 .+.++
T Consensus       108 ~~~~~-----g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVK  182 (1021)
T PTZ00266        108 CYKMF-----GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK  182 (1021)
T ss_pred             Hhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceE
Confidence            32110     12899999999999999999999851    015999999999999964                 23489


Q ss_pred             EeccccCCCCCcccccccccccccccCcCCCccccc--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 023220          139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT  216 (285)
Q Consensus       139 l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  216 (285)
                      |+|||++.......   ......|++.|+|||++.+  ..++.++|||||||++|+|++|..||........        
T Consensus       183 LsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q--------  251 (1021)
T PTZ00266        183 IGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ--------  251 (1021)
T ss_pred             EccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH--------
Confidence            99999987553221   1233468999999998854  4578999999999999999999999965432111        


Q ss_pred             ccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                             +...+.... .......+.++.+||.+||+.+|.+||++.+++.
T Consensus       252 -------li~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        252 -------LISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             -------HHHHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence                   101111000 0111234678999999999999999999999985

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.3e-37  Score=255.52  Aligned_cols=235  Identities=23%  Similarity=0.331  Sum_probs=188.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .+|++........+++|.......    .+.+.+|++++++++|+||+++++.+.+....++++||+.+++|.+++....
T Consensus        18 ~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~   93 (256)
T cd06612          18 SVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN   93 (256)
T ss_pred             EEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCc
Confidence            468887776677788876643322    6789999999999999999999999999999999999999999999986543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..+..++.|++.|+.|||+.   +++|+|++|+||+++.++.++|+|||++........  ......
T Consensus        94 ~--------~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  160 (256)
T cd06612          94 K--------TLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVI  160 (256)
T ss_pred             c--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--cccccc
Confidence            2        288999999999999999999999   999999999999999999999999999876543221  122344


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..||....+........            ..  .......+..++
T Consensus       161 ~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~------------~~--~~~~~~~~~~~~  226 (256)
T cd06612         161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP------------NK--PPPTLSDPEKWS  226 (256)
T ss_pred             CCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc------------cC--CCCCCCchhhcC
Confidence            6789999999988889999999999999999999999997543321111000            00  000111233456


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .++.+++.+||+.||++|||+.++++
T Consensus       227 ~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         227 PEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             HHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            78999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.7e-37  Score=260.60  Aligned_cols=235  Identities=22%  Similarity=0.313  Sum_probs=189.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||++.+...++.+++|.....  .....+.+.+|+++++.++|||++++++++...+..++++||+.+++|.+++....
T Consensus        34 ~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  111 (296)
T cd06655          34 TVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC  111 (296)
T ss_pred             EEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhcC
Confidence            5788888778888888866432  22345778899999999999999999999999999999999999999999986542


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                +++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus       112 ----------l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~  176 (296)
T cd06655         112 ----------MDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMV  176 (296)
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCcC
Confidence                      78999999999999999999999   999999999999999999999999998865433221  122345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ++..|+|||.+.+..++.++|+|||||++|+|++|..||...++.........              ........+..++
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~  242 (296)
T cd06655         177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--------------NGTPELQNPEKLS  242 (296)
T ss_pred             CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------cCCcccCCcccCC
Confidence            78899999999888889999999999999999999999976543222111100              0000112234566


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+.++|.+||..||++|||+.+++.
T Consensus       243 ~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         243 PIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            78999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-37  Score=262.34  Aligned_cols=241  Identities=20%  Similarity=0.239  Sum_probs=191.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCC-CCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPK-NYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|....++..+++|......... ...+.+.+|+++++.++|+||+++++.+..+...+++|||+.+++|.+++...
T Consensus        16 ~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   95 (316)
T cd05574          16 RVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQ   95 (316)
T ss_pred             EEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhC
Confidence            58999888888999999776543322 34567889999999999999999999999999999999999999999998754


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc-----
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL-----  155 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-----  155 (285)
                      ...       .+++..+..++.|++.+|.|||+.   |++|+||+|+||+++.++.++|+|||++..........     
T Consensus        96 ~~~-------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  165 (316)
T cd05574          96 PGK-------CLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR  165 (316)
T ss_pred             CCC-------ccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccc
Confidence            322       288999999999999999999999   99999999999999999999999999876443211100     


Q ss_pred             ----------------------cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 023220          156 ----------------------HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT  213 (285)
Q Consensus       156 ----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~  213 (285)
                                            ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+....     
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-----  240 (316)
T cd05574         166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET-----  240 (316)
T ss_pred             cccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH-----
Confidence                                  01123567889999999888889999999999999999999999975543211     


Q ss_pred             hhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 023220          214 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN----MSIVVK  267 (285)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~ll~  267 (285)
                                .................+..+.+++.+||+.||++|||    +++++.
T Consensus       241 ----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         241 ----------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             ----------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence                      11111111111112225788999999999999999999    888887

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.5e-37  Score=259.21  Aligned_cols=252  Identities=22%  Similarity=0.326  Sum_probs=187.0

Q ss_pred             Cceeeeeee-----eccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQ-----VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      +||++..+.     ....+++|....... ......+.+|+.+++.++||||+++++++.+....+++|||+.+|+|.++
T Consensus        21 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~   99 (288)
T cd05061          21 MVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY   99 (288)
T ss_pred             EEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHH
Confidence            477765432     123566665442221 12234677899999999999999999999999999999999999999999


Q ss_pred             hccCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           77 LHGRKGVQ-GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        77 l~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      +....... .......+....+..++.|++.||.|||++   |++||||+|+||+++.++.++|+|||++..........
T Consensus       100 l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~  176 (288)
T cd05061         100 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR  176 (288)
T ss_pred             HHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCcccccccccccc
Confidence            97533211 011122367788999999999999999999   99999999999999999999999999987543322211


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.........               ..+.+.. ..
T Consensus       177 ~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~---------------~~~~~~~-~~  240 (288)
T cd05061         177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL---------------KFVMDGG-YL  240 (288)
T ss_pred             ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---------------HHHHcCC-CC
Confidence            1222334667999999988889999999999999999998 78898654321111               1111111 11


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ..+..+++.+.+++.+||+.||++|||+.++++.|+..+
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            223345678999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1e-36  Score=259.83  Aligned_cols=246  Identities=23%  Similarity=0.326  Sum_probs=187.4

Q ss_pred             Cceeeeeeeeccc----cChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEES----YPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~----~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||++....+.+.    +++|...... .......+.+|+.++++++||||+++++++... ..+++++|+.+|+|.+++
T Consensus        22 ~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~   99 (303)
T cd05110          22 TVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYV   99 (303)
T ss_pred             cEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHH
Confidence            4788776555553    3444443211 122234678899999999999999999998754 467899999999999998


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      .....        .+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||++............
T Consensus       100 ~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  168 (303)
T cd05110         100 HEHKD--------NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA  168 (303)
T ss_pred             Hhccc--------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccccccc
Confidence            75432        278889999999999999999999   9999999999999999999999999999765432222112


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....++..|+|||.+.+..++.++||||||+++|++++ |..||.......                ...++........
T Consensus       169 ~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~  232 (303)
T cd05110         169 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----------------IPDLLEKGERLPQ  232 (303)
T ss_pred             CCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHCCCCCCC
Confidence            22335678999999988889999999999999999997 899996542211                1111111112222


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      +..++.++.+++.+||..+|++||+++++++.|+++..+.
T Consensus       233 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         233 PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            3445678999999999999999999999999999887554

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.2e-37  Score=258.29  Aligned_cols=234  Identities=23%  Similarity=0.326  Sum_probs=188.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.....+..+++|...... .....+.+.+|++++++++||||+++++.+..+...++|+||+.+++|.+++..+.
T Consensus        19 ~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   97 (277)
T cd06642          19 EVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP   97 (277)
T ss_pred             eEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcCC
Confidence            57888877777788888765332 22345678899999999999999999999999999999999999999999986532


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                +++..+..++.|++.|+.|||++   |++|+||+|+||+++.++.++++|||++........  ......
T Consensus        98 ----------~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  162 (277)
T cd06642          98 ----------LEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFV  162 (277)
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch--hhhccc
Confidence                      78899999999999999999999   999999999999999999999999999865543211  112235


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..||....+.....                .+............+
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----------------~~~~~~~~~~~~~~~  226 (277)
T cd06642         163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF----------------LIPKNSPPTLEGQYS  226 (277)
T ss_pred             CcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh----------------hhhcCCCCCCCcccC
Confidence            6788999999988888999999999999999999999987543221110                011111112233456


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .++.+++.+||+.+|++||++.++++
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         227 KPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHH
Confidence            78999999999999999999999998

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1e-36  Score=258.99  Aligned_cols=245  Identities=22%  Similarity=0.306  Sum_probs=181.0

Q ss_pred             ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCC--CCCCCC
Q 023220           14 SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG--AQPGPV   91 (285)
Q Consensus        14 ~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~   91 (285)
                      .+++|..+.. ......+++.+|+++++.++|+||+++++++...+..+++|||+.+++|.+++........  ......
T Consensus        48 ~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  126 (296)
T cd05095          48 LVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT  126 (296)
T ss_pred             EEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccc
Confidence            4555555422 1223356788999999999999999999999999999999999999999999976432111  112223


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcc
Q 023220           92 LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEY  171 (285)
Q Consensus        92 ~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~  171 (285)
                      +++.++..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++................++..|++||.
T Consensus       127 ~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~  203 (296)
T cd05095         127 ISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWES  203 (296)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHH
Confidence            78889999999999999999999   999999999999999999999999999875433222111222334578999998


Q ss_pred             cccCCCCcccchHhHHHHHHHHHh--CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHH
Q 023220          172 AMTGQLTQKSDVYSFGVVLLELLT--GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAA  249 (285)
Q Consensus       172 ~~~~~~~~~~DiwslG~~l~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  249 (285)
                      ..+..++.++|+|||||++|+|++  |..||..........   ...     +..... ........+..++..+.+++.
T Consensus       204 ~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~---~~~-----~~~~~~-~~~~~~~~~~~~~~~~~~li~  274 (296)
T cd05095         204 ILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE---NTG-----EFFRDQ-GRQVYLPKPALCPDSLYKLML  274 (296)
T ss_pred             HhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH---HHH-----HHHhhc-cccccCCCCCCCCHHHHHHHH
Confidence            888889999999999999999998  778886543221110   000     000000 000011223446678999999


Q ss_pred             HhcccCCCCCCCHHHHHHHhch
Q 023220          250 LCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       250 ~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      +||+.||.+||++.++++.|++
T Consensus       275 ~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         275 SCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHcCCCcccCCCHHHHHHHHhC
Confidence            9999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.8e-37  Score=255.65  Aligned_cols=245  Identities=22%  Similarity=0.314  Sum_probs=188.3

Q ss_pred             Cceeeeeeee---ccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQV---EESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++.....   +..+++|...... .....+.+.+|+.++++++||||+++++++.+. ..+++|||+.+++|.+++.
T Consensus        21 ~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~   98 (270)
T cd05056          21 DVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQ   98 (270)
T ss_pred             eEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEEEEcCCCCcHHHHHH
Confidence            4777765443   3345666553222 233456888999999999999999999998764 5689999999999999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....        .+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++......... ...
T Consensus        99 ~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~  166 (270)
T cd05056          99 VNKY--------SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY-KAS  166 (270)
T ss_pred             hCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccccce-ecC
Confidence            5432        278999999999999999999999   9999999999999999999999999998654332111 112


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...++..|+|||.+....++.++|+||||+++|++++ |..||...........                +........+
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----------------~~~~~~~~~~  230 (270)
T cd05056         167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR----------------IENGERLPMP  230 (270)
T ss_pred             CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----------------HHcCCcCCCC
Confidence            2234467999999888888999999999999999986 9999975542211110                0111111234


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      ..++..+.+++.+||..+|++|||+.++++.|+.+....
T Consensus       231 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         231 PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            566788999999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-38  Score=271.07  Aligned_cols=236  Identities=17%  Similarity=0.130  Sum_probs=182.2

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccC---CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRL---KHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      +||++.+..+++.+++|....... .......+..|..++...   +||||+.+++.+.+....++||||+.+|+|..++
T Consensus         8 ~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l   87 (330)
T cd05586           8 QVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHL   87 (330)
T ss_pred             EEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHH
Confidence            589999998999999997654321 222234445566666655   7999999999999999999999999999999988


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      .....         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ..
T Consensus        88 ~~~~~---------~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~  153 (330)
T cd05586          88 QKEGR---------FSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TT  153 (330)
T ss_pred             HhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Cc
Confidence            75432         88999999999999999999999   999999999999999999999999999865322111  12


Q ss_pred             cccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....|+..|+|||.+.+. .++.++|||||||++|+|++|..||..........               .+...... ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~---------------~i~~~~~~-~~  217 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR---------------NIAFGKVR-FP  217 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHH---------------HHHcCCCC-CC
Confidence            334589999999988754 47899999999999999999999997643221111               11110010 01


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRP----NMSIVVK  267 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rp----s~~~ll~  267 (285)
                      ....+.++.+++.+||+.||++||    ++.++++
T Consensus       218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            123567899999999999999998    5666665

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-36  Score=253.66  Aligned_cols=239  Identities=28%  Similarity=0.416  Sum_probs=187.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.... ...+++|....   .....+++.+|+.++++++|+||+++++++......+++|||+.+++|.+++....
T Consensus        21 ~v~~~~~~~-~~~~~vK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~   96 (261)
T cd05034          21 EVWMGTWNG-TTKVAVKTLKP---GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGE   96 (261)
T ss_pred             EEEEEEEcC-CceEEEEEecC---CccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccc
Confidence            477776543 34567776543   22345788999999999999999999999999889999999999999999997653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..+..++.|++.|+.|||++   |++|+||+|+||+++.++.++|+|||++......... ......
T Consensus        97 ~~-------~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~  165 (261)
T cd05034          97 GK-------KLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-AREGAK  165 (261)
T ss_pred             cC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh-hhhccC
Confidence            22       288999999999999999999999   9999999999999999999999999998765431111 111223


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+.+..++.++|+||+|++++++++ |+.||........               . ..+........+...
T Consensus       166 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---------------~-~~~~~~~~~~~~~~~  229 (261)
T cd05034         166 FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---------------L-EQVERGYRMPRPPNC  229 (261)
T ss_pred             CCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---------------H-HHHHcCCCCCCCCCC
Confidence            4567999999988889999999999999999998 9999965432111               1 111111122334445


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      +.++.+++.+||+.+|++||++.++++.|+.
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         230 PEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            7789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.4e-37  Score=255.60  Aligned_cols=238  Identities=21%  Similarity=0.230  Sum_probs=194.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+.+.+++|...+.... ....+.+.+|+.++++++||||+++++.+.++...++++||+.+++|.+++...
T Consensus         8 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   87 (262)
T cd05572           8 RVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR   87 (262)
T ss_pred             EEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhc
Confidence            5899988888889999987654433 345678999999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         ++...+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||.+.......   .....
T Consensus        88 ~~---------l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~  152 (262)
T cd05572          88 GL---------FDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF  152 (262)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence            32         78899999999999999999999   99999999999999999999999999987654322   12234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .++..|++||.+.+..++.++|+||+|+++|+|++|..||.......             ................+...
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~  219 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-------------MEIYNDILKGNGKLEFPNYI  219 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-------------HHHHHHHhccCCCCCCCccc
Confidence            57889999999888888999999999999999999999997654211             11112222212223445555


Q ss_pred             HHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPN-----MSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps-----~~~ll~  267 (285)
                      +.++.+++.+||+.+|++||+     ++++++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            788999999999999999999     888876

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-37  Score=265.53  Aligned_cols=238  Identities=20%  Similarity=0.355  Sum_probs=194.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||++.... ++.|+.|.+.......+..+-+.+|+..|.+| .|.+||.++||=..++.+|+||||-+. +|..+++..
T Consensus       376 kV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~-DL~kiL~k~  453 (677)
T KOG0596|consen  376 KVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDI-DLNKILKKK  453 (677)
T ss_pred             eeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccc-cHHHHHHhc
Confidence            567775555 46677777778888888999999999999999 789999999999989999999999875 999999876


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...        .+...+..+..|++.|+.++|+.   ||||.|+||.|+++-+ |.+||+|||+|..+............
T Consensus       454 ~~~--------~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQ  521 (677)
T KOG0596|consen  454 KSI--------DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQ  521 (677)
T ss_pred             cCC--------CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccc
Confidence            542        34348889999999999999999   9999999999998864 59999999999988877766667778


Q ss_pred             ccccCcCCCcccccC-----------CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC
Q 023220          161 LGTFGYHAPEYAMTG-----------QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD  229 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~-----------~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
                      .||..||+||.+...           +.+.++|||||||+||+|+.|++||.....              ....+..+.+
T Consensus       522 vGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--------------~~aKl~aI~~  587 (677)
T KOG0596|consen  522 VGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--------------QIAKLHAITD  587 (677)
T ss_pred             cCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--------------HHHHHHhhcC
Confidence            899999999988532           356889999999999999999999963211              1123444556


Q ss_pred             CccCCCCChhHHH-HHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          230 PKLKGEYPPKGVA-KLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       230 ~~~~~~~~~~~~~-~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      |...-+++..-+. ++.++++.||.+||++|||..++|+
T Consensus       588 P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  588 PNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             CCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            6444344432222 3999999999999999999999998

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-36  Score=256.40  Aligned_cols=235  Identities=22%  Similarity=0.329  Sum_probs=190.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+....+.+++|..+... .....+.+.+|+.++++++|+||+++++.+.++...++||||+.+++|.+++....
T Consensus        19 ~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~   97 (277)
T cd06640          19 EVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP   97 (277)
T ss_pred             EEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcCC
Confidence            57888887778888888765322 23345678899999999999999999999999999999999999999999987542


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                ++...+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++........  ......
T Consensus        98 ----------l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  162 (277)
T cd06640          98 ----------FDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFV  162 (277)
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--cccccc
Confidence                      78889999999999999999999   999999999999999999999999999865543221  122345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..||....+.....                .............++
T Consensus       163 ~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----------------~~~~~~~~~~~~~~~  226 (277)
T cd06640         163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF----------------LIPKNNPPTLTGEFS  226 (277)
T ss_pred             CcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh----------------hhhcCCCCCCchhhh
Confidence            6788999999988888999999999999999999999997543321110                111111123345677


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      ..+.+++.+||+.+|++||++.+++..
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         227 KPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            889999999999999999999999774

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.9e-37  Score=260.79  Aligned_cols=244  Identities=25%  Similarity=0.325  Sum_probs=180.4

Q ss_pred             cChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCC--CCCCCC
Q 023220           15 YPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA--QPGPVL   92 (285)
Q Consensus        15 ~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~--~~~~~~   92 (285)
                      +++|....... ....+.+.+|++++++++||||+++++++..+...++++|++.+++|.+++.........  .....+
T Consensus        49 va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~  127 (296)
T cd05051          49 VAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL  127 (296)
T ss_pred             EEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCC
Confidence            45554432221 234567888999999999999999999999999999999999999999999765421110  111238


Q ss_pred             CHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCccc
Q 023220           93 DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYA  172 (285)
Q Consensus        93 ~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~  172 (285)
                      ++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++................++..|+|||.+
T Consensus       128 ~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  204 (296)
T cd05051         128 SFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV  204 (296)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHc---CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh
Confidence            8999999999999999999999   9999999999999999999999999998654332222222334456789999998


Q ss_pred             ccCCCCcccchHhHHHHHHHHHh--CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHH
Q 023220          173 MTGQLTQKSDVYSFGVVLLELLT--GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAAL  250 (285)
Q Consensus       173 ~~~~~~~~~DiwslG~~l~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  250 (285)
                      .+..++.++|||||||++|+|++  +..||.........   .......      ...........+..++.++.+++.+
T Consensus       205 ~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~---~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~  275 (296)
T cd05051         205 LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI---ENAGHFF------RDDGRQIYLPRPPNCPKDIYELMLE  275 (296)
T ss_pred             hcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH---HHHHhcc------ccccccccCCCccCCCHHHHHHHHH
Confidence            88889999999999999999998  67788643321110   0000000      0001111112234456789999999


Q ss_pred             hcccCCCCCCCHHHHHHHhch
Q 023220          251 CVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       251 ~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      ||+.||++|||+.++++.|++
T Consensus       276 cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         276 CWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HhccChhcCCCHHHHHHHhcC
Confidence            999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.5e-37  Score=261.39  Aligned_cols=245  Identities=21%  Similarity=0.343  Sum_probs=191.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++....++..+++|.....  .....+.+.+|+..+++++|+||+++++.+..++..+++|||+.+++|.+++....
T Consensus        37 ~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  114 (292)
T cd06658          37 IVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR  114 (292)
T ss_pred             EEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcCC
Confidence            4788887777888888865432  22345678899999999999999999999999999999999999999999886432


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                +++..++.++.|++.++.|||+.   |++||||+|+||+++.++.++|+|||++........  ......
T Consensus       115 ----------l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~  179 (292)
T cd06658         115 ----------MNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLV  179 (292)
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceee
Confidence                      78899999999999999999999   999999999999999999999999998865432221  122345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ++..|+|||...+..++.++|+||||+++|+|++|..||...........            ......+..  ......+
T Consensus       180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~------------~~~~~~~~~--~~~~~~~  245 (292)
T cd06658         180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR------------IRDNLPPRV--KDSHKVS  245 (292)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------------HHhcCCCcc--ccccccC
Confidence            78899999999888889999999999999999999999975433211110            011111111  1112345


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                      ..+.+++.+||..||++|||++++++  ..+....++|
T Consensus       246 ~~~~~li~~~l~~~P~~Rpt~~~il~--~~~~~~~~~~  281 (292)
T cd06658         246 SVLRGFLDLMLVREPSQRATAQELLQ--HPFLKLAGPP  281 (292)
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhh--ChhhhccCCc
Confidence            67999999999999999999999998  4555444433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.5e-37  Score=258.86  Aligned_cols=241  Identities=17%  Similarity=0.234  Sum_probs=189.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||++....+.+.+++|........ ......+.+|++++++++|+|++.+.+.+..++..+++|||+.+++|.+++...
T Consensus        15 ~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   94 (285)
T cd05632          15 EVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM   94 (285)
T ss_pred             EEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHh
Confidence            4788888778888988876543322 223456788999999999999999999999999999999999999999888643


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...       .+++..+..++.|++.||.|||+.   |++||||+|+||+++.++.++|+|||++........   ....
T Consensus        95 ~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~  161 (285)
T cd05632          95 GNP-------GFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGR  161 (285)
T ss_pred             cCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCC
Confidence            221       289999999999999999999999   999999999999999999999999998865432111   1234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.............            ... .......+...
T Consensus       162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~------------~~~-~~~~~~~~~~~  228 (285)
T cd05632         162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD------------RRV-LETEEVYSAKF  228 (285)
T ss_pred             CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------Hhh-hccccccCccC
Confidence            57899999999988889999999999999999999999997543221111110            000 00011234456


Q ss_pred             HHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPN-----MSIVVKA  268 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps-----~~~ll~~  268 (285)
                      +..+.+++.+||+.||.+||+     +.+++..
T Consensus       229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             CHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            678999999999999999999     7777774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.4e-36  Score=252.45  Aligned_cols=240  Identities=27%  Similarity=0.376  Sum_probs=190.0

Q ss_pred             Cceeeeeeeec----cccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVE----ESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||+|.....+    ..+++|..+.. ......+.+.+|++++++++|+||+++++++.+.+..+++||++.+++|.+++
T Consensus        14 ~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~   92 (258)
T smart00219       14 EVYKGTLKGLSGEKEVEVAVKTLKED-ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYL   92 (258)
T ss_pred             ceEEEEecCCCCCCCceEEEEEccCC-CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHH
Confidence            57888777655    77888876432 22225678899999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      .......       +++..+..++.|++.|+.+||+.   |++|+||+|+||+++.++.++|+|||++.......... .
T Consensus        93 ~~~~~~~-------~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~  161 (258)
T smart00219       93 RKNRPKE-------LSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK-K  161 (258)
T ss_pred             Hhhhhcc-------CCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccccccc-c
Confidence            7654211       78999999999999999999999   99999999999999999999999999987654432111 1


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....++..|+|||.+.+..++.++|+||+|+++++|++ |..||......                ..............
T Consensus       162 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~  225 (258)
T smart00219      162 KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE----------------EVLEYLKKGYRLPK  225 (258)
T ss_pred             ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHhcCCCCCC
Confidence            12336788999999888888999999999999999998 78888653221                11111111112233


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL  269 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l  269 (285)
                      +...+.++.+++.+||+.+|++|||+.++++.|
T Consensus       226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            444678899999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7e-37  Score=260.16  Aligned_cols=240  Identities=21%  Similarity=0.312  Sum_probs=191.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+....+.+++|.....  .....+.+.+|+.+++.++|+|++++++++..+...++||||+.+++|.+++....
T Consensus        34 ~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  111 (297)
T cd06656          34 TVYTAIDIATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC  111 (297)
T ss_pred             EEEEEEECCCCCEEEEEEEecC--ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhCC
Confidence            4788888778888988876432  22335678899999999999999999999999999999999999999999986542


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                ++...+..++.|++.++.|||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus       112 ----------~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~  176 (297)
T cd06656         112 ----------MDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMV  176 (297)
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcCccc
Confidence                      78889999999999999999999   999999999999999999999999998865433221  112345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      +++.|+|||.+.+..++.++|+||||+++|++++|..||...++.........              ........+...+
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~  242 (297)
T cd06656         177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--------------NGTPELQNPERLS  242 (297)
T ss_pred             CCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc--------------CCCCCCCCccccC
Confidence            78889999999888889999999999999999999999976543221111000              0000111234456


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ..+.+++.+||+.+|++||+++++++  ..++.
T Consensus       243 ~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~  273 (297)
T cd06656         243 AVFRDFLNRCLEMDVDRRGSAKELLQ--HPFLK  273 (297)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc--Cchhc
Confidence            77999999999999999999999998  44443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.6e-36  Score=252.46  Aligned_cols=234  Identities=28%  Similarity=0.371  Sum_probs=180.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEE-eCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV-EGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++...  ...+++|..+.    ....+.+.+|+.++++++|+|++++++++. .++..++++||+.+++|.+++...
T Consensus        21 ~v~~~~~~--~~~~~~k~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   94 (256)
T cd05082          21 DVMLGDYR--GNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR   94 (256)
T ss_pred             eEEEEEEc--CCcEEEEEeCC----CchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhc
Confidence            35665332  44455554432    233567889999999999999999999764 456789999999999999998754


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...       .+++..++.++.|++.|+.|||++   |++|+||+|+||+++.++.++|+|||++.......     ...
T Consensus        95 ~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~  159 (256)
T cd05082          95 GRS-------VLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTG  159 (256)
T ss_pred             CCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-----CCC
Confidence            321       278899999999999999999999   99999999999999999999999999886443211     122


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      .++..|+|||.+.+..++.++|+|||||++|+|++ |+.||......                .....+........+..
T Consensus       160 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~  223 (256)
T cd05082         160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------------DVVPRVEKGYKMDAPDG  223 (256)
T ss_pred             ccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHhcCCCCCCCCC
Confidence            34567999999988889999999999999999997 99998643221                11111111122233455


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      ++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            678899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.4e-36  Score=253.30  Aligned_cols=238  Identities=26%  Similarity=0.369  Sum_probs=185.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.... .+.+++|.....   ....+++.+|+.++++++|+||+++++++.. +..+++|||+.+++|.+++....
T Consensus        21 ~v~~~~~~~-~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~   95 (260)
T cd05067          21 EVWMGYYNG-HTKVAIKSLKQG---SMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPE   95 (260)
T ss_pred             eEEeeecCC-CceEEEEEecCC---CCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcEEEEEcCCCCCHHHHHHhcC
Confidence            478887544 456777765432   2235688999999999999999999998754 56899999999999999986543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++......... ......
T Consensus        96 ~~-------~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~  164 (260)
T cd05067          96 GI-------KLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAK  164 (260)
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-cccCCc
Confidence            22       278899999999999999999999   9999999999999999999999999998654321111 112233


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+....++.++|+||||+++|++++ |..||........                ...+........+...
T Consensus       165 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~  228 (260)
T cd05067         165 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV----------------IQNLERGYRMPRPDNC  228 (260)
T ss_pred             ccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH----------------HHHHHcCCCCCCCCCC
Confidence            5678999999888888999999999999999998 9999975432111                1111111222334445


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      +.++.+++.+||+.+|++|||++++++.|+.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         229 PEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            6789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.5e-36  Score=260.31  Aligned_cols=258  Identities=17%  Similarity=0.212  Sum_probs=178.8

Q ss_pred             Cceeeeee--eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe--CCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTC--QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l   77 (285)
                      +||+|...  .+...+++|..+..    .....+.+|++++++++||||+++++++..  +...+++|||+.+ +|.+++
T Consensus        16 ~Vy~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~   90 (317)
T cd07868          16 HVYKAKRKDGKDDRDYALKQIEGT----GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHII   90 (317)
T ss_pred             EEEEEEEccCCCCceEEEEEECCC----CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHH
Confidence            58999754  35567778766432    234567899999999999999999999864  4567999999965 888887


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE----ccCCeeEEeccccCCCCCcccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL----FEDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~----~~~~~~~l~df~~~~~~~~~~~  153 (285)
                      ..............++...+..++.|++.||.|||++   |++||||||+||++    +..+.++|+|||++........
T Consensus        91 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~  167 (317)
T cd07868          91 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK  167 (317)
T ss_pred             HhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCc
Confidence            6443221111122388999999999999999999999   99999999999999    4567899999999976543221


Q ss_pred             c-ccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccch---------hhhhhcccCchh
Q 023220          154 R-LHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS---------LVTWATPRLSED  222 (285)
Q Consensus       154 ~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~---------~~~~~~~~~~~~  222 (285)
                      . .......+++.|+|||.+.+. .++.++|+||+||++|+|++|++||..........         .+..........
T Consensus       168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (317)
T cd07868         168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK  247 (317)
T ss_pred             cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChH
Confidence            1 112334678899999998764 57899999999999999999999997543221110         000000000000


Q ss_pred             h---hhhh---------cCCccCC---------CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          223 K---VKQC---------VDPKLKG---------EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       223 ~---~~~~---------~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .   ....         .......         ......+..+.++|.+||+.||.+|||++++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         248 DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             HhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0   0000         0000000         000112346889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-37  Score=256.43  Aligned_cols=234  Identities=24%  Similarity=0.339  Sum_probs=190.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..+++.+++|..... ......+.+.+|++++++++|+|++++++++.++...++++||+.+++|.+++....
T Consensus        16 ~v~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~   94 (274)
T cd06609          16 EVYKAIDKRTNQVVAIKVIDLE-EAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK   94 (274)
T ss_pred             EEEEEEECCCCeEEEEEEeecc-ccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhcC
Confidence            5789988888889999977543 233445678899999999999999999999999999999999999999999997652


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                +++..++.++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        95 ----------~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~  159 (274)
T cd06609          95 ----------LDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFV  159 (274)
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc--cccccc
Confidence                      88999999999999999999999   999999999999999999999999999876543321  123345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh-H
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK-G  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  240 (285)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..||...++......+                ........+.. +
T Consensus       160 ~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~----------------~~~~~~~~~~~~~  223 (274)
T cd06609         160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI----------------PKNNPPSLEGNKF  223 (274)
T ss_pred             CCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh----------------hhcCCCCCccccc
Confidence            778899999998888999999999999999999999999754422111000                00011111112 5


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +..+.+++.+||..+|++|||++++++
T Consensus       224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         224 SKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            678999999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.6e-37  Score=270.40  Aligned_cols=238  Identities=16%  Similarity=0.166  Sum_probs=186.5

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|....+++.+++|....... .....+.+.+|+.+++.++||||+++++.+.++...++||||+.+|+|.+++...
T Consensus        58 ~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~  137 (371)
T cd05622          58 EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY  137 (371)
T ss_pred             EEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc
Confidence            589999998999999997754332 2223456778999999999999999999999999999999999999999998754


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      .          ++...+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......... .....
T Consensus       138 ~----------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~-~~~~~  203 (371)
T cd05622         138 D----------VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTA  203 (371)
T ss_pred             C----------CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc-cccCc
Confidence            2          78888999999999999999999   9999999999999999999999999998754322111 12234


Q ss_pred             ccccCcCCCcccccC----CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc--cCC
Q 023220          161 LGTFGYHAPEYAMTG----QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK--LKG  234 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~----~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  234 (285)
                      .|++.|+|||++.+.    .++.++|+|||||++|+|++|..||.........               ..+....  ...
T Consensus       204 ~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---------------~~i~~~~~~~~~  268 (371)
T cd05622         204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY---------------SKIMNHKNSLTF  268 (371)
T ss_pred             ccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH---------------HHHHcCCCcccC
Confidence            689999999998654    3788999999999999999999999765432111               1111111  111


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEF--RPNMSIVVKA  268 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~ll~~  268 (285)
                      .....++..+.++|.+||+.++.+  |++++++++.
T Consensus       269 ~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         269 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            122356778999999999844433  7899998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.3e-37  Score=256.33  Aligned_cols=240  Identities=23%  Similarity=0.308  Sum_probs=185.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.....++.+++|.....  .....+.+.+|+.++++++||||+++++.+...+..+++|||+.+++|.+++....
T Consensus        24 ~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~  101 (267)
T cd06646          24 DVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG  101 (267)
T ss_pred             EEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC
Confidence            4788887777888888876532  22334568899999999999999999999999999999999999999999986543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +++..+..++.|++.|+.|||+.   |++|+|++|+||+++.++.++|+|||++........  ......
T Consensus       102 ~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  167 (267)
T cd06646         102 P---------LSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFI  167 (267)
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccc
Confidence            2         78999999999999999999999   999999999999999999999999999875532211  112345


Q ss_pred             cccCcCCCcccc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          162 GTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       162 ~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ++..|+|||.+.   ...++.++|+||+||++|+|++|+.||....+........  ...        ...+.  .....
T Consensus       168 ~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~--~~~--------~~~~~--~~~~~  235 (267)
T cd06646         168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS--KSN--------FQPPK--LKDKT  235 (267)
T ss_pred             cCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee--cCC--------CCCCC--Ccccc
Confidence            778899999874   3457889999999999999999999986443221111000  000        00000  01122


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVKAL  269 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l  269 (285)
                      .++..+.+++.+||+.+|++|||++++++.+
T Consensus       236 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         236 KWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            4567899999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=268.24  Aligned_cols=233  Identities=27%  Similarity=0.389  Sum_probs=200.0

Q ss_pred             ccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCC
Q 023220           12 EESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPV   91 (285)
Q Consensus        12 ~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~   91 (285)
                      +--+++|..+....... .+.|.+|..+|+.++||||++++|+|.+.. .+||||.+..|.|.++++.+...        
T Consensus       418 ~iaVAvKtCK~d~t~d~-tekflqEa~iMrnfdHphIikLIGv~~e~P-~WivmEL~~~GELr~yLq~nk~s--------  487 (974)
T KOG4257|consen  418 RIAVAVKTCKTDCTPDD-TEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWIVMELAPLGELREYLQQNKDS--------  487 (974)
T ss_pred             ceeeeeehhccCCChhh-HHHHHHHHHHHHhCCCcchhheeeeeeccc-eeEEEecccchhHHHHHHhcccc--------
Confidence            33477888876555554 899999999999999999999999998765 59999999999999999988754        


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcc
Q 023220           92 LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEY  171 (285)
Q Consensus        92 ~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~  171 (285)
                      ++..+...++.||+.|++|||+.   .++||||-.+|||+.....|||+|||+++.......-.. ....-..-|+|||.
T Consensus       488 L~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka-S~~kLPIKWmaPES  563 (974)
T KOG4257|consen  488 LPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA-SRGKLPIKWMAPES  563 (974)
T ss_pred             chHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccchhhc-cccccceeecCccc
Confidence            89999999999999999999999   999999999999999999999999999988765433221 22334678999999


Q ss_pred             cccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHH
Q 023220          172 AMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAAL  250 (285)
Q Consensus       172 ~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  250 (285)
                      +..+.++.++|||.||+++||++. |..||.+-.                +.++...++.+-+.++|+.||+.++.++.+
T Consensus       564 INfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk----------------NsDVI~~iEnGeRlP~P~nCPp~LYslmsk  627 (974)
T KOG4257|consen  564 INFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK----------------NSDVIGHIENGERLPCPPNCPPALYSLMSK  627 (974)
T ss_pred             cchhcccchhhHHHHHHHHHHHHHhcCCcccccc----------------ccceEEEecCCCCCCCCCCCChHHHHHHHH
Confidence            999999999999999999999987 999997542                234445566677788999999999999999


Q ss_pred             hcccCCCCCCCHHHHHHHhchhhc
Q 023220          251 CVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       251 ~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ||..+|.+||++.++...|..+.+
T Consensus       628 cWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  628 CWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             HhccCcccCCcHHHHHHHHHHHHH
Confidence            999999999999999888877665

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-36  Score=256.59  Aligned_cols=252  Identities=19%  Similarity=0.232  Sum_probs=189.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+...++.+++|............+.+.+|+.++++++|+|++++++++......+++|||+.+++|..++....
T Consensus        16 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~   95 (286)
T cd07847          16 VVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR   95 (286)
T ss_pred             EEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC
Confidence            47888888788889999776555444556778899999999999999999999999999999999999888877765432


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +++..+..++.|++.++.|||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        96 ~---------~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  161 (286)
T cd07847          96 G---------VPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYV  161 (286)
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcc
Confidence            1         88999999999999999999999   999999999999999999999999999876543221  112234


Q ss_pred             cccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchh---------hhhhhcCCc
Q 023220          162 GTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED---------KVKQCVDPK  231 (285)
Q Consensus       162 ~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~  231 (285)
                      ++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.........+..........         .......+.
T Consensus       162 ~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (286)
T cd07847         162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPE  241 (286)
T ss_pred             cccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCC
Confidence            6788999998865 457889999999999999999999998654322211111000000000         000000000


Q ss_pred             cCC-----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          232 LKG-----EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       232 ~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...     ...+..+..+.+++.+||+.+|++|||+.+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         242 PETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            000     011234678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.1e-36  Score=255.36  Aligned_cols=249  Identities=24%  Similarity=0.286  Sum_probs=179.8

Q ss_pred             Cceeeeee--eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTC--QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||++...  .+...+++|..+.... ......+.+|+.++++++||||+++++.+.+....++||||+.+|+|.+++..
T Consensus        10 ~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~   88 (269)
T cd05087          10 KVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRS   88 (269)
T ss_pred             eEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHH
Confidence            46776432  3344566665543322 22335788899999999999999999999998889999999999999999975


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      .....    ....+...+..++.|++.|+.|||+.   |++|+||||+||+++.++.++|+|||.+..............
T Consensus        89 ~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~  161 (269)
T cd05087          89 CRKAE----LMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQ  161 (269)
T ss_pred             hhhcc----cccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCC
Confidence            43211    11256778889999999999999999   999999999999999999999999999865433222212223


Q ss_pred             cccccCcCCCcccccC-------CCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc
Q 023220          160 VLGTFGYHAPEYAMTG-------QLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK  231 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~-------~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
                      ..++..|+|||.+.+.       .++.++|+||||+++|+|++ |..||............. .      +.......+.
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-~------~~~~~~~~~~  234 (269)
T cd05087         162 LWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV-R------EQQLKLPKPR  234 (269)
T ss_pred             cCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh-h------cccCCCCCCc
Confidence            4467789999987532       35789999999999999996 999997543322111100 0      0000111111


Q ss_pred             cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          232 LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                          .....+..+.+++.+|| .+|++|||+.+++..|+
T Consensus       235 ----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         235 ----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence                12234567899999999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.1e-37  Score=255.36  Aligned_cols=238  Identities=24%  Similarity=0.308  Sum_probs=185.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..++..+++|..+...  ......+.+|+.+++.++||||+++++.+...+..++++||+.+++|.+++....
T Consensus        24 ~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  101 (267)
T cd06645          24 DVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG  101 (267)
T ss_pred             EEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC
Confidence            47888888888889988765332  2234567889999999999999999999999999999999999999999986543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +++..++.++.|++.++.|||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus       102 ~---------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  167 (267)
T cd06645         102 P---------LSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KRKSFI  167 (267)
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--cccccc
Confidence            2         88999999999999999999999   999999999999999999999999999865432211  123345


Q ss_pred             cccCcCCCcccc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          162 GTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       162 ~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      |+..|+|||.+.   ...++.++|+||+||++|+|++|..||....+.........  ....        .+..  ....
T Consensus       168 ~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~--~~~~--------~~~~--~~~~  235 (267)
T cd06645         168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK--SNFQ--------PPKL--KDKM  235 (267)
T ss_pred             CcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc--cCCC--------CCcc--cccC
Confidence            788999999874   44578899999999999999999999865433211111000  0000        0000  0111


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .++..+.+++.+||+.+|++|||+.++++
T Consensus       236 ~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            34567999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9e-37  Score=284.73  Aligned_cols=258  Identities=17%  Similarity=0.183  Sum_probs=196.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|........ ....+++.+|++++++++||||+++++++.+++..+++|||+.+++|.+++...
T Consensus        17 ~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~   96 (932)
T PRK13184         17 EVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSV   96 (932)
T ss_pred             EEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHh
Confidence            5899998888899999977643322 234567889999999999999999999999999999999999999999998643


Q ss_pred             CCCC--CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc-----
Q 023220           81 KGVQ--GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA-----  153 (285)
Q Consensus        81 ~~~~--~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-----  153 (285)
                      ....  ........++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........     
T Consensus        97 ~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l  173 (932)
T PRK13184         97 WQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI  173 (932)
T ss_pred             hhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcceeccccccccccc
Confidence            2110  001111266778899999999999999999   999999999999999999999999999875421100     


Q ss_pred             -----------cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchh
Q 023220          154 -----------RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED  222 (285)
Q Consensus       154 -----------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (285)
                                 ........|++.|+|||.+.+..++.++|+||+||++|+|++|..||...........           
T Consensus       174 ~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~-----------  242 (932)
T PRK13184        174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR-----------  242 (932)
T ss_pred             ccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh-----------
Confidence                       0001124589999999999988899999999999999999999999975332111000           


Q ss_pred             hhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhchhhcCC
Q 023220          223 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-NMSIVVKALQPLLKSP  276 (285)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~ll~~l~~~~~~~  276 (285)
                        .....+.. ......+++.+.+++.+||+.||++|| +++++++.|+..++..
T Consensus       243 --~~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~  294 (932)
T PRK13184        243 --DVILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS  294 (932)
T ss_pred             --hhccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence              00001100 011235667899999999999999996 7788888888887653

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.2e-37  Score=257.90  Aligned_cols=252  Identities=17%  Similarity=0.191  Sum_probs=189.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..+++.+++|............+.+.+|++++++++||||+++++++.+++..+++|||+. ++|.+++....
T Consensus        15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~   93 (284)
T cd07860          15 VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASP   93 (284)
T ss_pred             EEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCC
Confidence            57899888888899999776555555566788999999999999999999999999999999999996 58988886543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.|++.|++|||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        94 ~~-------~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  161 (284)
T cd07860          94 LS-------GIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEV  161 (284)
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--cccccc
Confidence            22       288999999999999999999999   999999999999999999999999999865432211  112234


Q ss_pred             cccCcCCCcccccCC-CCcccchHhHHHHHHHHHhCCCCCCCCCCcccchh-hhhhcccCch-----hhh-------hhh
Q 023220          162 GTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL-VTWATPRLSE-----DKV-------KQC  227 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~-----~~~-------~~~  227 (285)
                      ++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||........... ..........     ...       ..+
T Consensus       162 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd07860         162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKW  241 (284)
T ss_pred             ccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccc
Confidence            577899999876644 58889999999999999999999976543221111 1111100000     000       000


Q ss_pred             cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          228 VDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       228 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .... .....+..+..+.++|.+||+.||.+|||++++++
T Consensus       242 ~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         242 ARQD-FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             cccC-HHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0000 00112235667899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.6e-37  Score=268.83  Aligned_cols=247  Identities=17%  Similarity=0.231  Sum_probs=180.4

Q ss_pred             Cceeeeeee--eccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQ--VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||+|....  ....+++|....       .....+|++++++++||||+++++++......+++|+++. ++|.+++..
T Consensus       107 ~Vy~~~~~~~~~~~~v~vK~~~~-------~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~  178 (392)
T PHA03207        107 EVFVCTKHGDEQRKKVIVKAVTG-------GKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDR  178 (392)
T ss_pred             EEEEEEEcCCccceeEEEEeccc-------cccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHh
Confidence            578876432  234455554332       2345689999999999999999999999999999999996 588888843


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ..         .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++..............
T Consensus       179 ~~---------~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~  246 (392)
T PHA03207        179 SG---------PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG  246 (392)
T ss_pred             cC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccc
Confidence            32         289999999999999999999999   999999999999999999999999999876543322222234


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhh----hcc---cCch---hhh-h--h
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW----ATP---RLSE---DKV-K--Q  226 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~~~---~~~~---~~~-~--~  226 (285)
                      ..|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+............    ...   ....   ... .  .
T Consensus       247 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  326 (392)
T PHA03207        247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFK  326 (392)
T ss_pred             cccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHH
Confidence            5689999999999988899999999999999999999999976543221111100    000   0000   000 0  0


Q ss_pred             hcCCccCCC--CC-----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          227 CVDPKLKGE--YP-----PKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       227 ~~~~~~~~~--~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      ......+..  .+     ...+.++.++|++||..||++|||+.+++..
T Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        327 QYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000001100  00     1235678999999999999999999999984

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.1e-36  Score=257.23  Aligned_cols=265  Identities=20%  Similarity=0.218  Sum_probs=194.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCC---CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP---KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++.+...++.+++|..+.....   ......+.+|++++++++|+||+++++++.+.+..++||||+ +++|.+++.
T Consensus        15 ~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~   93 (298)
T cd07841          15 VVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIK   93 (298)
T ss_pred             EEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHh
Confidence            5788888877888999887654433   334556778999999999999999999999999999999999 789999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....        .+++..++.++.|+++||.|||++   |++|+||+|+||+++.++.++|+|||++.........  ..
T Consensus        94 ~~~~--------~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~  160 (298)
T cd07841          94 DKSI--------VLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MT  160 (298)
T ss_pred             ccCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--cc
Confidence            6431        288999999999999999999999   9999999999999999999999999998765432211  12


Q ss_pred             ccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh------hhhcCCc
Q 023220          159 RVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV------KQCVDPK  231 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~  231 (285)
                      ...++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||........................      .......
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T cd07841         161 HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFK  240 (298)
T ss_pred             ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccccc
Confidence            2345678999998754 45689999999999999999998888765432221111100000000000      0000000


Q ss_pred             c-----CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCCCC
Q 023220          232 L-----KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPV  282 (285)
Q Consensus       232 ~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  282 (285)
                      .     ........+..+.+++.+||+.+|++|||+.++++  ..++...+-+.++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~--~~~~~~~~~~~~~  294 (298)
T cd07841         241 PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE--HPYFSNDPAPTPP  294 (298)
T ss_pred             ccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh--CccccCCCCCCCC
Confidence            0     01112345678999999999999999999999999  6666543333333

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-36  Score=270.30  Aligned_cols=247  Identities=18%  Similarity=0.206  Sum_probs=181.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.....+..+++|..        ....+.+|++++++++|+||+++++++..++..+++|+++. ++|.+++....
T Consensus       184 ~Vy~a~~~~~~~~vavK~~--------~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~  254 (461)
T PHA03211        184 CVFESSHPDYPQRVVVKAG--------WYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARL  254 (461)
T ss_pred             EEEEEEECCCCCEEEEecc--------cccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcC
Confidence            4788888887888888743        23456789999999999999999999999999999999996 58888886542


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.||.|||+.   |++||||||+|||++.++.++|+|||++................
T Consensus       255 ~--------~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  323 (461)
T PHA03211        255 R--------PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA  323 (461)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccC
Confidence            2        289999999999999999999999   99999999999999999999999999987543322221122345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCc-c-------cchhhhhhcc---cCc---hhhh-hh
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPR-G-------QQSLVTWATP---RLS---EDKV-KQ  226 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~-------~~~~~~~~~~---~~~---~~~~-~~  226 (285)
                      |+..|+|||.+.+..++.++|||||||++|+|++|..++...... .       ....+.....   .+.   ...+ ..
T Consensus       324 GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~  403 (461)
T PHA03211        324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQ  403 (461)
T ss_pred             CCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHH
Confidence            899999999999989999999999999999999987665432111 0       0011111000   000   0000 00


Q ss_pred             hcCC---ccCCC-------CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          227 CVDP---KLKGE-------YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       227 ~~~~---~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      +...   .....       .....+..+.+||.+||+.||.+|||+.|+++.
T Consensus       404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        404 YRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0000   00000       001234578999999999999999999999973

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1e-36  Score=253.49  Aligned_cols=238  Identities=20%  Similarity=0.292  Sum_probs=190.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .+|++.....+..+++|............+++.+|++++++++||||+++++.+...+..++++||+.+++|.+++....
T Consensus        15 ~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~   94 (256)
T cd08218          15 KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQR   94 (256)
T ss_pred             EEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhcc
Confidence            36777777777888888765443344455688999999999999999999999999999999999999999999987543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++++|||++.........  .....
T Consensus        95 ~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~  162 (256)
T cd08218          95 GV-------LFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--ARTCI  162 (256)
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--hhhcc
Confidence            21       278899999999999999999999   9999999999999999999999999998755432211  12234


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ++..|+|||...+..++.++|+||||+++++|++|..||......               +.+..+... .....+...+
T Consensus       163 ~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---------------~~~~~~~~~-~~~~~~~~~~  226 (256)
T cd08218         163 GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---------------NLVLKIIRG-SYPPVSSHYS  226 (256)
T ss_pred             CCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---------------HHHHHHhcC-CCCCCcccCC
Confidence            778899999998888899999999999999999999999644321               111111111 1122345567


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .++.++|.+||+.+|++||++.++++
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         227 YDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             HHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            78999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-36  Score=252.75  Aligned_cols=232  Identities=24%  Similarity=0.430  Sum_probs=178.7

Q ss_pred             Cceeeeeeeecc-------ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQVEE-------SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~-------~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   74 (285)
                      .||++.....++       .+++|....  ......+.+.+|+.+++.++|||++++++++..+...++||||+.+|+|.
T Consensus        10 ~Vy~~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~   87 (258)
T cd05078          10 KIFKGIRREVGDYGELHKTEVLLKVLDK--SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLD   87 (258)
T ss_pred             hheeeeecccccccccccchhhHHhhcc--hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHH
Confidence            578887654332       355555432  22334567888999999999999999999999989999999999999999


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCe--------eEEeccccCC
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK--------AKIADFNLSN  146 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~--------~~l~df~~~~  146 (285)
                      +++..+..        .+++..++.++.|++.|+.|||+.   |++||||+|+||+++.++.        ++++|||.+.
T Consensus        88 ~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          88 TYLKKNKN--------LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             HHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            99976542        278889999999999999999999   9999999999999987654        6899999875


Q ss_pred             CCCcccccccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCC-CCCCCCCCcccchhhhhhcccCchhhh
Q 023220          147 QAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR-KPVDHTMPRGQQSLVTWATPRLSEDKV  224 (285)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
                      .....      ....++..|+|||.+.+. .++.++|+||||+++|+|++|. .||...++.....              
T Consensus       157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~--------------  216 (258)
T cd05078         157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ--------------  216 (258)
T ss_pred             ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH--------------
Confidence            43321      223467789999998764 5788999999999999999984 5654433221111              


Q ss_pred             hhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          225 KQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                        ....  ....+...+.++.+++.+||+.||++|||++++++.|.
T Consensus       217 --~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         217 --FYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --HHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence              0000  11234445567999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.1e-36  Score=255.13  Aligned_cols=249  Identities=23%  Similarity=0.289  Sum_probs=177.3

Q ss_pred             Cceeeeeee--eccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQ--VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++....  ....+++|.... .........+.+|++.++.++|+||+++++.+......+++|||+.+|+|.+++..
T Consensus        10 ~v~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~   88 (269)
T cd05042          10 KVLLGEAHRGMSKARVVVKELRA-SATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRS   88 (269)
T ss_pred             eEEEEEEecCCCCeEEEEeecCc-cCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHh
Confidence            467764322  223344444332 12233345678899999999999999999999999999999999999999999976


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      .......    ...+..+..++.|++.|+.|||+.   |++||||||+||+++.++.++|+|||++..............
T Consensus        89 ~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~  161 (269)
T cd05042          89 NRGMVAQ----MAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC  161 (269)
T ss_pred             ccccccc----cccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheeccCC
Confidence            5432111    156778899999999999999999   999999999999999999999999999865332211111122


Q ss_pred             cccccCcCCCccccc-------CCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc
Q 023220          160 VLGTFGYHAPEYAMT-------GQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK  231 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
                      ..++..|+|||+...       ..++.++|+|||||++|+|++ |..||...............       .......  
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-------~~~~~~~--  232 (269)
T cd05042         162 HAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE-------QDIKLPK--  232 (269)
T ss_pred             CCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc-------cCccCCC--
Confidence            345667999998642       356789999999999999999 78888654322111000000       0000011  


Q ss_pred             cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          232 LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                        ...+..++..+.+++..|| .||++|||++++++.|.
T Consensus       233 --~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         233 --PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             --CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence              1223456677889999999 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.1e-37  Score=263.46  Aligned_cols=230  Identities=20%  Similarity=0.210  Sum_probs=184.3

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||+|.+..++..+++|...+... .....+.+..|.+++..+. |++|+++++++.+.+..++||||+.+|+|.+++..
T Consensus        15 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~   94 (323)
T cd05615          15 KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ   94 (323)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHH
Confidence            589999888899999997764332 2333456778888988885 57788899999999999999999999999999876


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ....
T Consensus        95 ~~~---------l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~  160 (323)
T cd05615          95 VGK---------FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRT  160 (323)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc--cccC
Confidence            432         88999999999999999999999   999999999999999999999999999864322111  1223


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||.+.+..++.++|+||+||++|+|++|..||........               ...+....  ...+..
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---------------~~~i~~~~--~~~p~~  223 (323)
T cd05615         161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---------------FQSIMEHN--VSYPKS  223 (323)
T ss_pred             ccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---------------HHHHHhCC--CCCCcc
Confidence            4588999999999888899999999999999999999999976543211               11111111  123445


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNM  262 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~  262 (285)
                      .+.++.+++.+||+.+|.+|++.
T Consensus       224 ~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         224 LSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCHHHHHHHHHHcccCHhhCCCC
Confidence            67789999999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-36  Score=252.25  Aligned_cols=236  Identities=22%  Similarity=0.298  Sum_probs=189.7

Q ss_pred             CceeeeeeeeccccChhhhhhccC---CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS---PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++......+.+++|.......   .++..+.+.+|++++++++|+||+++++++.+....++++||+.+++|.+++.
T Consensus        15 ~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   94 (258)
T cd06632          15 SVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK   94 (258)
T ss_pred             eEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHH
Confidence            578888877788888887654332   23356778899999999999999999999999999999999999999999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....         +++..++.++.|++.++.|||+.   |++|+||+|+||+++.++.++|+|||++.......   ...
T Consensus        95 ~~~~---------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~  159 (258)
T cd06632          95 KYGS---------FPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAK  159 (258)
T ss_pred             hcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc---ccc
Confidence            5432         78889999999999999999999   99999999999999999999999999886543322   123


Q ss_pred             ccccccCcCCCcccccCC-CCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...++..|++||.+.... ++.++|+||||+++|+|++|..||........               .............+
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~  224 (258)
T cd06632         160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA---------------VFKIGRSKELPPIP  224 (258)
T ss_pred             ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH---------------HHHHHhcccCCCcC
Confidence            345788899999887665 88999999999999999999999975432111               11111101112334


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+++.+.+++.+||+.+|++||++.+++.
T Consensus       225 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         225 DHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            556788999999999999999999999986

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.9e-36  Score=252.23  Aligned_cols=243  Identities=21%  Similarity=0.316  Sum_probs=187.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCC--------CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKN--------YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   73 (285)
                      .||++....+++.+++|..+.......        ..+.+.+|+.++++++|+|++++++++...+..++|+||+.+++|
T Consensus        16 ~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   95 (272)
T cd06629          16 RVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSI   95 (272)
T ss_pred             EEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcH
Confidence            578888887888899987653222111        235678899999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc
Q 023220           74 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        74 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  153 (285)
                      .+++....         .++...+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++........
T Consensus        96 ~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  163 (272)
T cd06629          96 GSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYD  163 (272)
T ss_pred             HHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccccccccc
Confidence            99987653         278889999999999999999999   999999999999999999999999999876543222


Q ss_pred             cccccccccccCcCCCcccccCC--CCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQ--LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK  231 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
                      ........++..|+|||.+....  ++.++|+||||++++++++|..||.............           .....+.
T Consensus       164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-----------~~~~~~~  232 (272)
T cd06629         164 NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG-----------NKRSAPP  232 (272)
T ss_pred             ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh-----------ccccCCc
Confidence            21122345778999999887654  7899999999999999999999996432211100000           0000011


Q ss_pred             cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          232 LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ........++.++.+++.+||..+|++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         233 IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            111223345778999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-37  Score=259.69  Aligned_cols=242  Identities=25%  Similarity=0.379  Sum_probs=189.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||++.+...++.+++|................+|+.++++++||||+++++++.+....+++|+++.+++|.+++....
T Consensus        14 ~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~   93 (260)
T PF00069_consen   14 TVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNK   93 (260)
T ss_dssp             EEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHS
T ss_pred             EEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccccccccccccc
Confidence            58999999988899999887655444444444569999999999999999999999999999999999889999998333


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                               .++...++.++.|++.||.+||+.   |++|+||+|+||+++.++.++|+|||.+.....  .........
T Consensus        94 ---------~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~  159 (260)
T PF00069_consen   94 ---------PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNENFNPFV  159 (260)
T ss_dssp             ---------SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSEBSSSS
T ss_pred             ---------cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--ccccccccc
Confidence                     289999999999999999999999   999999999999999999999999999864211  111223456


Q ss_pred             cccCcCCCcccc-cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|.|||... +..++.++|+||+|+++++|++|..||.......................          .......
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~  229 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS----------SQQSREK  229 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH----------TTSHTTS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc----------ccccchh
Confidence            788999999988 77889999999999999999999999986521111111111000000000          0001112


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +..+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  230 SEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             HHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            378999999999999999999999986

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.3e-36  Score=249.70  Aligned_cols=237  Identities=24%  Similarity=0.400  Sum_probs=183.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.... +..+++|....   .....+++.+|++++++++|||++++++++......++++||+.+++|.+++....
T Consensus        19 ~v~~~~~~~-~~~~~~k~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~   94 (256)
T cd05112          19 LVWLGYWLE-KRKVAIKTIRE---GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR   94 (256)
T ss_pred             eEEEEEEeC-CCeEEEEECCC---CCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCc
Confidence            477776543 45677775542   22235678999999999999999999999999999999999999999999987543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.++++||+.   +++|+||+|+||+++.++.++|+|||.+......... ......
T Consensus        95 ~--------~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~  162 (256)
T cd05112          95 G--------KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTK  162 (256)
T ss_pred             c--------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCCCc
Confidence            2        278899999999999999999999   9999999999999999999999999988654322111 111223


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+.+..++.++|+||||+++|+|++ |..||.........                ..+........+...
T Consensus       163 ~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~  226 (256)
T cd05112         163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV----------------ETINAGFRLYKPRLA  226 (256)
T ss_pred             cchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH----------------HHHhCCCCCCCCCCC
Confidence            4568999999988889999999999999999998 99999754321110                001111111123334


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      +..+.+++.+||+.+|++|||+.++++.|.
T Consensus       227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         227 SQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            678999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.2e-36  Score=252.04  Aligned_cols=242  Identities=22%  Similarity=0.350  Sum_probs=191.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCC----CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKN----YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||++.+..+++.+++|..........    ..+.+.+|++++++++|+||+++++++.+++..++++||+.+++|.+++
T Consensus        15 ~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l   94 (268)
T cd06630          15 SCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL   94 (268)
T ss_pred             EEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHH
Confidence            578888888888999987764432221    3567889999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC-eeEEeccccCCCCCccccc--
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-KAKIADFNLSNQAPDMAAR--  154 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~--  154 (285)
                      ....         .+++..++.++.|++.|+.|||++   |++|+||+|+||+++.++ .++|+|||.+.........  
T Consensus        95 ~~~~---------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  162 (268)
T cd06630          95 SKYG---------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG  162 (268)
T ss_pred             HHhC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCC
Confidence            7543         278899999999999999999999   999999999999998765 6899999998665432111  


Q ss_pred             ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      .......++..|+|||.+.+..++.++|+||+|+++++|++|..||...........            ...........
T Consensus       163 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~------------~~~~~~~~~~~  230 (268)
T cd06630         163 EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL------------IFKIASATTAP  230 (268)
T ss_pred             ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH------------HHHHhccCCCC
Confidence            011223567899999999888889999999999999999999999965432111111            11111111122


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+...+.++.+++.+||+.+|++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            345567788999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=255.04  Aligned_cols=253  Identities=19%  Similarity=0.193  Sum_probs=190.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..++..+++|............+.+.+|++++++++|||++++++++.+++..++++||+. ++|.+++....
T Consensus        14 ~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~   92 (283)
T cd07835          14 VVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSP   92 (283)
T ss_pred             EEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCC
Confidence            47888888888899999876555445556788899999999999999999999999999999999996 58999987654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        93 ~~-------~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~  160 (283)
T cd07835          93 LT-------GLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEV  160 (283)
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--ccCccc
Confidence            21       288999999999999999999999   999999999999999999999999999865432211  112234


Q ss_pred             cccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh---------hh-h--c
Q 023220          162 GTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV---------KQ-C--V  228 (285)
Q Consensus       162 ~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~-~--~  228 (285)
                      ++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+............         .. .  .
T Consensus       161 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd07835         161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKW  240 (283)
T ss_pred             cccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccc
Confidence            57889999987654 5688999999999999999999999765432221111110000000000         00 0  0


Q ss_pred             CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          229 DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ............+..+.+++.+||+.+|.+|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         241 ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000111223345678999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.3e-36  Score=255.02  Aligned_cols=237  Identities=21%  Similarity=0.280  Sum_probs=183.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..++..+++|.....  .....+.+.+|+++++.++|||++++++++...+..++++||+.+++|..++....
T Consensus        20 ~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~   97 (282)
T cd06643          20 KVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE   97 (282)
T ss_pred             EEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcC
Confidence            4678877777777777765322  12235678889999999999999999999999999999999999999988876432


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        98 ~--------~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~  164 (282)
T cd06643          98 R--------PLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFI  164 (282)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc--cccccc
Confidence            1        288999999999999999999999   999999999999999999999999999865432211  122345


Q ss_pred             cccCcCCCcccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          162 GTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       162 ~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ++..|+|||.+.     +..++.++|+||+||++|+|++|..||............  ...          ..+  ....
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~--~~~----------~~~--~~~~  230 (282)
T cd06643         165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI--AKS----------EPP--TLAQ  230 (282)
T ss_pred             ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH--hhc----------CCC--CCCC
Confidence            788999999874     345778999999999999999999999754321111000  000          000  1122


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +..++.++.++|.+||+.||.+||++.++++
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            3446678999999999999999999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.1e-36  Score=253.15  Aligned_cols=238  Identities=21%  Similarity=0.309  Sum_probs=185.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCC---CCCChhHHHHHHHHccCCCCcccccceEEEe--CCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP---KNYPDDEKQLVSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~   76 (285)
                      +||++.+..++..+++|........   ....+.+.+|+.++++++||||+++++++..  +...++++||+.+++|.++
T Consensus        17 ~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~   96 (266)
T cd06651          17 RVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQ   96 (266)
T ss_pred             EEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHH
Confidence            5788888888888988876543322   2234568889999999999999999999875  3577899999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-c
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-L  155 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~  155 (285)
                      +.....         ++....+.++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++......... .
T Consensus        97 l~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  164 (266)
T cd06651          97 LKAYGA---------LTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGT  164 (266)
T ss_pred             HHHcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCC
Confidence            975432         78889999999999999999999   9999999999999999999999999998654321111 0


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE  235 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
                      ......++..|+|||.+.+..++.++|+||+||++|+|++|+.||.......               .............
T Consensus       165 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~---------------~~~~~~~~~~~~~  229 (266)
T cd06651         165 GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---------------AIFKIATQPTNPQ  229 (266)
T ss_pred             ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH---------------HHHHHhcCCCCCC
Confidence            1122346788999999988889999999999999999999999997543211               1111111111223


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+...++.+..++ +||..+|++||+++++++
T Consensus       230 ~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         230 LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            3555677788888 688889999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.3e-36  Score=256.94  Aligned_cols=252  Identities=21%  Similarity=0.273  Sum_probs=190.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|....+++.+++|............+.+.+|+++++.++||||+++++++...+..++++||+.+++|..+.....
T Consensus        16 ~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~   95 (286)
T cd07846          16 MVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN   95 (286)
T ss_pred             EEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccC
Confidence            47999888788899999876655555567788999999999999999999999999999999999999888887765432


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +++..++.++.|++.++.|||+.   |++|+|++|+||+++.++.++|+|||++.........  .....
T Consensus        96 ~---------~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~  161 (286)
T cd07846          96 G---------LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YTDYV  161 (286)
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc--cCccc
Confidence            1         78999999999999999999999   9999999999999999999999999998654332211  12234


Q ss_pred             cccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh---------hhhcCCc
Q 023220          162 GTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV---------KQCVDPK  231 (285)
Q Consensus       162 ~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~  231 (285)
                      ++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...........+......+.....         .....+.
T Consensus       162 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (286)
T cd07846         162 ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE  241 (286)
T ss_pred             ceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccccc
Confidence            6788999998865 34678899999999999999999999754432111111111111100000         0000000


Q ss_pred             c-----CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          232 L-----KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       232 ~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .     .....+.++..+.+++.+||+.+|++||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0     00112345778999999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.8e-36  Score=253.89  Aligned_cols=253  Identities=19%  Similarity=0.235  Sum_probs=191.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+...++.+++|............+.+.+|+.++++++||||+++++++..+...++|+||+ +++|.+++....
T Consensus        15 ~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~   93 (286)
T cd07832          15 IVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE   93 (286)
T ss_pred             EEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcC
Confidence            5788888878888999987665544556778999999999999999999999999999999999999 889999986543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.++.|||+.   |++|+||+|+||+++.++.++|+|||++........ .......
T Consensus        94 ~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~  161 (286)
T cd07832          94 R--------PLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQV  161 (286)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccccccc
Confidence            2        288999999999999999999999   999999999999999999999999999876543221 1112345


Q ss_pred             cccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh---------hhhcCCc
Q 023220          162 GTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV---------KQCVDPK  231 (285)
Q Consensus       162 ~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~  231 (285)
                      ++..|+|||.+.+. .++.++||||+|+++++|++|.+||........................         ..+..+.
T Consensus       162 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (286)
T cd07832         162 ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPE  241 (286)
T ss_pred             CcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCC
Confidence            78899999988654 4689999999999999999998888655432221111111000000000         0000000


Q ss_pred             c----CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          232 L----KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       232 ~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .    .....+..+..+.+++.+||+.+|++|||++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         242 SKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0    00112344678999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.1e-36  Score=252.74  Aligned_cols=239  Identities=23%  Similarity=0.305  Sum_probs=189.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.....++.+++|....... ....+++.+|++++++++||||+++++.+...+..++++||+.+++|.+++....
T Consensus        16 ~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   94 (265)
T cd06605          16 VVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ   94 (265)
T ss_pred             EEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc
Confidence            478998888888898887654322 2456778899999999999999999999999999999999999899999997653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      .        .++...+..++.|++.++.|||+ .   |++|+||+|+||+++.++.++|+|||.+........    ...
T Consensus        95 ~--------~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~  159 (265)
T cd06605          95 G--------RIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTF  159 (265)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcc
Confidence            1        28889999999999999999999 8   999999999999999999999999998865432211    124


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh-
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK-  239 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  239 (285)
                      .++..|+|||.+.+..++.++|+||||+++++|++|..||.........          ............. ...+.. 
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----------~~~~~~~~~~~~~-~~~~~~~  228 (265)
T cd06605         160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG----------IFELLQYIVNEPP-PRLPSGK  228 (265)
T ss_pred             cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc----------HHHHHHHHhcCCC-CCCChhh
Confidence            5778899999998888999999999999999999999999754321000          0011111111111 112222 


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ++..+.++|.+||..||.+|||+.+++.
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         229 FSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             cCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            6778999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.9e-36  Score=253.82  Aligned_cols=240  Identities=19%  Similarity=0.222  Sum_probs=189.8

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.+..+++.+++|....... .......+.+|++++++++|||++++++.+...+..++||||+.+++|.+++...
T Consensus         8 ~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   87 (277)
T cd05577           8 EVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV   87 (277)
T ss_pred             eEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHc
Confidence            589998888888999987654332 2334556778999999999999999999999999999999999999999998755


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...       .+++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||.+.......   .....
T Consensus        88 ~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~  154 (277)
T cd05577          88 GEP-------GFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR  154 (277)
T ss_pred             CcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence            421       288999999999999999999999   99999999999999999999999999886543211   11233


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .++..|+|||...+..++.++|+||+|+++|+|++|+.||............            ..... ......+...
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------~~~~~-~~~~~~~~~~  221 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL------------KRRTL-EMAVEYPDKF  221 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH------------Hhccc-cccccCCccC
Confidence            5677899999988888899999999999999999999999754431111111            00000 0112234456


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRP-----NMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp-----s~~~ll~  267 (285)
                      ++.+.++|.+||+.||.+||     ++.++++
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            78899999999999999999     7777875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.3e-36  Score=255.17  Aligned_cols=232  Identities=21%  Similarity=0.248  Sum_probs=190.0

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.....++.+++|....... .....+.+.+|++++++++||||+++++++.+++..+++|||+.+++|.+++...
T Consensus        16 ~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~   95 (290)
T cd05580          16 RVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS   95 (290)
T ss_pred             EEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc
Confidence            578888887888899987654432 2335678889999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         ++...+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++......     ....
T Consensus        96 ~~---------l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~  158 (290)
T cd05580          96 GR---------FPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTL  158 (290)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCC
Confidence            32         88999999999999999999999   9999999999999999999999999998765432     2234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .+++.|+|||.+.+..++.++|+||||+++|+|++|..||........               ...+...  ....+...
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~~~~--~~~~~~~~  221 (290)
T cd05580         159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI---------------YEKILEG--KVRFPSFF  221 (290)
T ss_pred             CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---------------HHHHhcC--CccCCccC
Confidence            578899999998888889999999999999999999999975542111               1111111  11234455


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRP-----NMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp-----s~~~ll~  267 (285)
                      +..+.+++.+||+.||.+|+     +++++++
T Consensus       222 ~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         222 SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            77899999999999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.1e-36  Score=257.28  Aligned_cols=236  Identities=21%  Similarity=0.269  Sum_probs=188.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+...+..+++|......  ....+.+.+|+.+++.++|||++++++++..++..++++||+.+++|.+++....
T Consensus        36 ~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~  113 (297)
T cd06659          36 IVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR  113 (297)
T ss_pred             eEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhcC
Confidence            47888887778889888764322  2345678899999999999999999999999999999999999999999875432


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                +++..++.++.|++.|+.|||++   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus       114 ----------~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~  178 (297)
T cd06659         114 ----------LNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLV  178 (297)
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccccee
Confidence                      78899999999999999999999   999999999999999999999999998864432211  112345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.........   ..           +..........+
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~-----------~~~~~~~~~~~~  244 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR---DS-----------PPPKLKNAHKIS  244 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cc-----------CCCCccccCCCC
Confidence            7889999999988889999999999999999999999997544321111100   00           000011123456


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      ..+.+++.+||+.+|++||+++++++.
T Consensus       245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         245 PVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            679999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.3e-36  Score=251.69  Aligned_cols=238  Identities=23%  Similarity=0.297  Sum_probs=185.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCC----CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP----KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||++.+ .+++.+++|..+.....    ....+.+.+|++++++++|+||+++++++.+.+..++++||+.+++|.+++
T Consensus        15 ~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   93 (265)
T cd06631          15 TVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL   93 (265)
T ss_pred             EEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHH
Confidence            4677754 35667788866543222    223466888999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc----
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA----  153 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~----  153 (285)
                      .....         +++..+..++.|++.++.|||+.   |++|+||+|+||+++.++.++|+|||.+........    
T Consensus        94 ~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (265)
T cd06631          94 NRFGP---------LPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH  161 (265)
T ss_pred             HhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccc
Confidence            76432         78889999999999999999999   999999999999999999999999998865421110    


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC-cc
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP-KL  232 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  232 (285)
                      ........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+......               ..... ..
T Consensus       162 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~---------------~~~~~~~~  226 (265)
T cd06631         162 SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF---------------YIGAHRGL  226 (265)
T ss_pred             cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH---------------HhhhccCC
Confidence            001122357888999999988888999999999999999999999997543211110               00000 11


Q ss_pred             CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          233 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ....+..++.++.+++.+||+.+|++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            12234456778999999999999999999999886

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.3e-36  Score=253.14  Aligned_cols=236  Identities=21%  Similarity=0.236  Sum_probs=192.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|........ ....+.+.+|++++++++||||+++++.+..+...++++||+.+++|.+++...
T Consensus        15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   94 (258)
T cd05578          15 KVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK   94 (258)
T ss_pred             eEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc
Confidence            5899988888899999977654432 246788999999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      .         .++...+..++.|++.++.|||++   |++|+||+|+||+++.++.++|+|||.+.......   .....
T Consensus        95 ~---------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~  159 (258)
T cd05578          95 V---------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTST  159 (258)
T ss_pred             C---------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---ccccc
Confidence            2         288999999999999999999999   99999999999999999999999999987654322   12334


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||..........             ....... .....+...
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------------~~~~~~~-~~~~~~~~~  225 (258)
T cd05578         160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ-------------IRAKQET-ADVLYPATW  225 (258)
T ss_pred             CCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH-------------HHHHhcc-ccccCcccC
Confidence            57788999999988888999999999999999999999997654321111             1111110 122345566


Q ss_pred             HHHHHHHHHHhcccCCCCCCCH--HHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNM--SIVV  266 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~--~~ll  266 (285)
                      +..+.++|.+||+.||.+||+.  .+++
T Consensus       226 ~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         226 STEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            7899999999999999999999  6655

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.7e-36  Score=248.78  Aligned_cols=231  Identities=26%  Similarity=0.404  Sum_probs=181.0

Q ss_pred             ceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG   82 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~   82 (285)
                      ||++.  .++..+++|..+.    ....+.+.+|+.++++++|||++++++++..+. .+++|||+.+++|.+++.....
T Consensus        22 v~~~~--~~~~~~~iK~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~   94 (254)
T cd05083          22 VLQGE--YTGQKVAVKNIKC----DVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGR   94 (254)
T ss_pred             eEecc--cCCCceEEEeecC----cchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCCHHHHHHhcCc
Confidence            55553  3455666665532    123467889999999999999999999987654 6999999999999999975432


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccccc
Q 023220           83 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLG  162 (285)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  162 (285)
                      .       .+++..++.++.|++.|+.|||+.   |++||||+|+||+++.++.++|+|||.+.......     .....
T Consensus        95 ~-------~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~  159 (254)
T cd05083          95 A-------LVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKL  159 (254)
T ss_pred             C-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCC
Confidence            2       278889999999999999999999   99999999999999999999999999886532211     12233


Q ss_pred             ccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          163 TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       163 ~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      +..|+|||.+.+..++.++|+||||+++|+|++ |..||.......                ....+........+..++
T Consensus       160 ~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~  223 (254)
T cd05083         160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE----------------VKECVEKGYRMEPPEGCP  223 (254)
T ss_pred             CceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH----------------HHHHHhCCCCCCCCCcCC
Confidence            567999999888889999999999999999997 999997543221                111112222223344567


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      ..+.+++.+||+.+|++||++.++++.|++
T Consensus       224 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         224 ADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.8e-36  Score=256.38  Aligned_cols=254  Identities=20%  Similarity=0.238  Sum_probs=190.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .+|++....++..+++|............+.+.+|++++++++|+||+++++++.+.+..+++|||+.+++|.+++....
T Consensus        15 ~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~   94 (314)
T cd08216          15 IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHF   94 (314)
T ss_pred             eEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhc
Confidence            46777777789999999876543444566789999999999999999999999999999999999999999999997643


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-----cc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-----LH  156 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~  156 (285)
                      ..       .+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++++||+.+.........     ..
T Consensus        95 ~~-------~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~  164 (314)
T cd08216          95 PE-------GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF  164 (314)
T ss_pred             cc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence            22       278889999999999999999999   9999999999999999999999999987544321110     01


Q ss_pred             ccccccccCcCCCccccc--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC---------ch--hh
Q 023220          157 STRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL---------SE--DK  223 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------~~--~~  223 (285)
                      .....++..|+|||.+..  ..++.++|+||+||++|+|++|..||.........  ........         +.  ..
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
T cd08216         165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLLDKSTYPLYEDS  242 (314)
T ss_pred             cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCccccccCchhhhcCC
Confidence            122345678999998865  35789999999999999999999999764322110  00000000         00  00


Q ss_pred             hhh----hcCC----ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          224 VKQ----CVDP----KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       224 ~~~----~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...    ..++    ..........+.++.+++.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            000    0000    0111223455678999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.2e-36  Score=260.38  Aligned_cols=255  Identities=22%  Similarity=0.300  Sum_probs=188.7

Q ss_pred             Cceeeeee-----eeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeC-CeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTC-----QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEG-NLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~   74 (285)
                      +||+|.+.     .+...+++|..+... .....+.+.+|+.++.++ +||||+++++++... ...+++|||+.+|+|.
T Consensus        22 ~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~  100 (343)
T cd05103          22 QVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS  100 (343)
T ss_pred             eEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHH
Confidence            57888642     345678888775332 222356788999999999 689999999988654 4678999999999999


Q ss_pred             HHhccCCCCCC----------------------------------------------------------CCCCCCCCHHH
Q 023220           75 DILHGRKGVQG----------------------------------------------------------AQPGPVLDWMT   96 (285)
Q Consensus        75 ~~l~~~~~~~~----------------------------------------------------------~~~~~~~~~~~   96 (285)
                      +++........                                                          ......+++..
T Consensus       101 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (343)
T cd05103         101 NYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLED  180 (343)
T ss_pred             HHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHH
Confidence            99865321000                                                          00112367888


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccccCC
Q 023220           97 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ  176 (285)
Q Consensus        97 ~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  176 (285)
                      +..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++................++..|+|||.+.+..
T Consensus       181 ~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  257 (343)
T cd05103         181 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV  257 (343)
T ss_pred             HHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCC
Confidence            999999999999999999   99999999999999999999999999987543222111122233566799999998888


Q ss_pred             CCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccC
Q 023220          177 LTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYE  255 (285)
Q Consensus       177 ~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  255 (285)
                      ++.++|+||||+++|+|++ |..||........               ....+........+...++++.+++.+||+.+
T Consensus       258 ~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~  322 (343)
T cd05103         258 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  322 (343)
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCCCCccccHH---------------HHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence            9999999999999999997 9999865432111               00111111111223334567999999999999


Q ss_pred             CCCCCCHHHHHHHhchhhcC
Q 023220          256 AEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       256 p~~Rps~~~ll~~l~~~~~~  275 (285)
                      |++|||+.++++.|+.+++.
T Consensus       323 p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         323 PSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             hhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.9e-36  Score=249.20  Aligned_cols=238  Identities=24%  Similarity=0.349  Sum_probs=183.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++... ....+++|..+..   ....+.+.+|++++++++|+||+++++++.. ...+++|||+.+++|.+++....
T Consensus        21 ~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~   95 (260)
T cd05073          21 EVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDE   95 (260)
T ss_pred             EEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCC
Confidence            46777533 2344666654421   2235678899999999999999999999887 67899999999999999997643


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||.+........ .......
T Consensus        96 ~~-------~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~  164 (260)
T cd05073          96 GS-------KQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAK  164 (260)
T ss_pred             cc-------ccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccccCCc
Confidence            22       278889999999999999999999   999999999999999999999999998865432111 1112233


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+....++.++|+||||+++|++++ |..||...+....                ...+........+...
T Consensus       165 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~  228 (260)
T cd05073         165 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV----------------IRALERGYRMPRPENC  228 (260)
T ss_pred             ccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH----------------HHHHhCCCCCCCcccC
Confidence            5567999999988888999999999999999998 9999975432111                1111111112233456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      +.++.+++.+||+.+|++||++.++++.|+.
T Consensus       229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         229 PEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            6789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.1e-35  Score=249.87  Aligned_cols=250  Identities=23%  Similarity=0.355  Sum_probs=186.6

Q ss_pred             Cceeeeeeee-----ccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQV-----EESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~-----~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++..+.+     ...+++|..... ......+.+.+|++++++++|+||+++++++.+....+++|||+.+++|.++
T Consensus        20 ~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   98 (275)
T cd05046          20 EVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQF   98 (275)
T ss_pred             EEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHH
Confidence            4677765433     334555544321 1122456789999999999999999999999998889999999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH  156 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  156 (285)
                      +..............+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++++|||++........ ..
T Consensus        99 i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~-~~  174 (275)
T cd05046          99 LRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY-YK  174 (275)
T ss_pred             HHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccccccCcccc-cc
Confidence            97654221111111389999999999999999999999   999999999999999999999999998764322111 11


Q ss_pred             ccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC
Q 023220          157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE  235 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
                      .....++..|+|||.+.+..++.++|+||||+++|++++ |..||........               +...........
T Consensus       175 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---------------~~~~~~~~~~~~  239 (275)
T cd05046         175 LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---------------LNRLQAGKLELP  239 (275)
T ss_pred             cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---------------HHHHHcCCcCCC
Confidence            122345667999999888888999999999999999998 8889864332111               111111111122


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      .+..++..+.+++.+||+.+|.+|||+.+++..|.+
T Consensus       240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            234567789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3e-36  Score=251.42  Aligned_cols=240  Identities=18%  Similarity=0.207  Sum_probs=190.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe--CCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++....++..+++|............+.+.+|++++++++|+||+++++++..  ....++++||+.+++|.+++..
T Consensus        15 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~   94 (265)
T cd08217          15 TVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQK   94 (265)
T ss_pred             EEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHH
Confidence            57888888888888888765444444456778889999999999999999998764  4567999999999999999865


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH-----EKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh-----~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  154 (285)
                      ....     ...+++..++.++.|++.|+.+||     +.   +++|+||+|+||+++.++.++|+|||++.........
T Consensus        95 ~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  166 (265)
T cd08217          95 CKKE-----RKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF  166 (265)
T ss_pred             Hhhc-----ccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccccccCCccc
Confidence            4211     112889999999999999999999     77   9999999999999999999999999998766543221


Q ss_pred             ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                        .....++..|+|||.+.+..++.++|+||||+++++|++|..||.......                ....+......
T Consensus       167 --~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~~  228 (265)
T cd08217         167 --AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ----------------LASKIKEGKFR  228 (265)
T ss_pred             --ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH----------------HHHHHhcCCCC
Confidence              123457889999999988888999999999999999999999997543211                11111111122


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+...+..+.+++.+||+.+|++||++.++++
T Consensus       229 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         229 RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            345566788999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.2e-36  Score=251.39  Aligned_cols=236  Identities=24%  Similarity=0.335  Sum_probs=183.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeC------CeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEG------NLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~   74 (285)
                      .||++.....++.+++|.....   ......+.+|+.+++++ +|+|++++++++...      ...+++|||+.+++|.
T Consensus        21 ~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~   97 (272)
T cd06637          21 QVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT   97 (272)
T ss_pred             EEEEEEEcCCCcEEEEEEEEcC---CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHH
Confidence            5788888888888888876532   23456788999999998 799999999998753      4679999999999999


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  154 (285)
                      +++......       .+++..+..++.|++.|++|||+.   +++|+|++|+||+++.++.++|+|||++........ 
T Consensus        98 ~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~-  166 (272)
T cd06637          98 DLIKNTKGN-------TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-  166 (272)
T ss_pred             HHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccccc-
Confidence            998764322       288899999999999999999999   999999999999999999999999999865432211 


Q ss_pred             ccccccccccCcCCCcccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC
Q 023220          155 LHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD  229 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
                       ......|+..|+|||.+.     +..++.++|+||+||++|+|++|..||....+.......               ..
T Consensus       167 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~---------------~~  230 (272)
T cd06637         167 -RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---------------PR  230 (272)
T ss_pred             -cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH---------------hc
Confidence             123345788999999875     335788999999999999999999999654322111110               00


Q ss_pred             CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          230 PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       230 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..........++.++.+++.+||+.+|.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            01111122345668999999999999999999999976

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.7e-36  Score=254.01  Aligned_cols=246  Identities=21%  Similarity=0.243  Sum_probs=189.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.....+..+++|..... ......+.+.+|+++++.++||||+++++++...+..++++||+.+++|.+++....
T Consensus        20 ~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   98 (284)
T cd06620          20 SVSKVKHIPTGTVMAKKVVHIG-AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG   98 (284)
T ss_pred             EEEEEEEcCCCcEEEEEEEEec-CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc
Confidence            5788888777888888866432 234456788999999999999999999999999999999999999999999887543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                               .+++..+..++.+++.++.|||+ .   +++|+||+|+||+++.++.++|+|||++.......    ....
T Consensus        99 ---------~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~  162 (284)
T cd06620          99 ---------PIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTF  162 (284)
T ss_pred             ---------CCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCcc
Confidence                     28899999999999999999996 6   89999999999999999999999999876432211    1234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|+..|+|||.+.+..++.++|+|||||++|++++|..||..............    ...+.................+
T Consensus       163 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd06620         163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM----GILDLLQQIVQEPPPRLPSSDF  238 (284)
T ss_pred             ccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhh----HHHHHHHHHhhccCCCCCchhc
Confidence            578899999998888889999999999999999999999986543211000000    0001111111111111111236


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      +..+.+++.+||+.||++|||+.++++.
T Consensus       239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         239 PEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            6789999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.6e-36  Score=251.32  Aligned_cols=249  Identities=21%  Similarity=0.275  Sum_probs=186.9

Q ss_pred             Cceeeeee---eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC------eeeEEEeeCCCCC
Q 023220            2 RRWLCCTC---QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN------LRVLAYEFATMGS   72 (285)
Q Consensus         2 ~~~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~   72 (285)
                      .||++...   .+...+++|............+++.+|++++++++||||+++++++....      ..+++++|+.+++
T Consensus        14 ~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (273)
T cd05074          14 SVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGD   93 (273)
T ss_pred             CEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCc
Confidence            57777643   24567888877655544445677889999999999999999999886532      2378889999999


Q ss_pred             HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc
Q 023220           73 LHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA  152 (285)
Q Consensus        73 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~  152 (285)
                      |.+++.........   ..++...++.++.|++.|++|||+.   |++|+||+|+||+++.++.++++|||.+.......
T Consensus        94 l~~~~~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~  167 (273)
T cd05074          94 LHTFLLMSRIGEEP---FTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD  167 (273)
T ss_pred             HHHHHHHhcccCCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccccccCCc
Confidence            98887533211111   1278889999999999999999999   99999999999999999999999999987553322


Q ss_pred             ccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc
Q 023220          153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK  231 (285)
Q Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
                      .........++..|++||.+....++.++|+|||||++|+|++ |..||...........               +.. .
T Consensus       168 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~---------------~~~-~  231 (273)
T cd05074         168 YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY---------------LIK-G  231 (273)
T ss_pred             ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHH---------------HHc-C
Confidence            1111222334568999999888888999999999999999999 8899865432211110               000 0


Q ss_pred             cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          232 LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      .....+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            01112234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-36  Score=260.78  Aligned_cols=243  Identities=17%  Similarity=0.254  Sum_probs=177.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.+..++..+++|....        .....|+.++++++||||+++++++......++|++++. ++|.+++....
T Consensus        81 ~Vy~~~~~~~~~~valK~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~  151 (357)
T PHA03209         81 RVFVATKPGQPDPVVLKIGQK--------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRS  151 (357)
T ss_pred             EEEEEEECCCCceEEEEeCCc--------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhcc
Confidence            589998888888888886321        233569999999999999999999999999999999996 58888886533


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.......   ......
T Consensus       152 ~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~  217 (357)
T PHA03209        152 R--------PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLA  217 (357)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc---cccccc
Confidence            2        288999999999999999999999   99999999999999999999999999986432211   122345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCC-CCCCCCcccch-------h---hhhhc---ccCc----hhh
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP-VDHTMPRGQQS-------L---VTWAT---PRLS----EDK  223 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p-f~~~~~~~~~~-------~---~~~~~---~~~~----~~~  223 (285)
                      |+..|+|||.+.+..++.++|+|||||++|+|+++..+ |..........       +   +....   ..+.    ...
T Consensus       218 gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  297 (357)
T PHA03209        218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRL  297 (357)
T ss_pred             ccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHH
Confidence            88999999999988899999999999999999985444 44322110000       0   00000   0000    000


Q ss_pred             hhhhcCC--ccCCCC-------ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          224 VKQCVDP--KLKGEY-------PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       224 ~~~~~~~--~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...+.+.  ..+...       ....+.++..+|.+||+.||.+|||+.++++
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        298 VRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             HHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            0111000  000000       0133556778999999999999999999987

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-35  Score=247.09  Aligned_cols=230  Identities=23%  Similarity=0.362  Sum_probs=176.9

Q ss_pred             Cceeeeeeeecc----------ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCC
Q 023220            2 RRWLCCTCQVEE----------SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMG   71 (285)
Q Consensus         2 ~~~~~~~~~~~~----------~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   71 (285)
                      .||++.......          .++.|......   .....+.+|+.++++++||||+++++++.. ...+++|||+.++
T Consensus        10 ~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   85 (259)
T cd05037          10 NIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFG   85 (259)
T ss_pred             eEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCC
Confidence            467776665442          24444433222   116788899999999999999999999988 6789999999999


Q ss_pred             CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC-------eeEEecccc
Q 023220           72 SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-------KAKIADFNL  144 (285)
Q Consensus        72 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~-------~~~l~df~~  144 (285)
                      +|.+++.....        .++...+..++.|++.||.|||+.   |++|+||+|+||+++.++       .++|+|||+
T Consensus        86 ~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          86 PLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             cHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            99999976542        278899999999999999999999   999999999999999887       799999999


Q ss_pred             CCCCCcccccccccccccccCcCCCcccccC--CCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCch
Q 023220          145 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSE  221 (285)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  221 (285)
                      +.....      .....+...|+|||.+.+.  .++.++|+||||+++|+|++ |..||.............        
T Consensus       155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~--------  220 (259)
T cd05037         155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ--------  220 (259)
T ss_pred             cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh--------
Confidence            875433      1223456789999998766  78899999999999999999 577776543221111110        


Q ss_pred             hhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          222 DKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                             .+.   ..+......+.+++.+||..+|.+|||+.++++.|+
T Consensus       221 -------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 -------DQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -------cCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                   000   011111267999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-36  Score=254.25  Aligned_cols=239  Identities=21%  Similarity=0.284  Sum_probs=186.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||++.....+..+++|..+.. ......+.+.+|+.++++++|+||+++++.+...+..+++|||+.+++|.+++....
T Consensus        16 ~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~   94 (286)
T cd06622          16 SVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGV   94 (286)
T ss_pred             EEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhcc
Confidence            5788888878888988876532 122234678899999999999999999999999999999999999999999887542


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      .      ...+++..+..++.|++.|+.|||+ .   |++|+||+|+||+++.++.++|+|||.+.......    ....
T Consensus        95 ~------~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~  161 (286)
T cd06622          95 A------TEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTN  161 (286)
T ss_pred             c------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccC
Confidence            1      0128999999999999999999996 6   89999999999999999999999999886543221    1223


Q ss_pred             ccccCcCCCcccccC------CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          161 LGTFGYHAPEYAMTG------QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~------~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      .++..|+|||.+.+.      .++.++|+|||||++|+|++|..||..........            ....+.. ....
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~------------~~~~~~~-~~~~  228 (286)
T cd06622         162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA------------QLSAIVD-GDPP  228 (286)
T ss_pred             CCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH------------HHHHHhh-cCCC
Confidence            467889999987543      34789999999999999999999996543211110            1111111 1112


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+..++.++.++|.+||+.+|++||++.+++.
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         229 TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            345557888999999999999999999999998

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=254.70  Aligned_cols=236  Identities=21%  Similarity=0.268  Sum_probs=186.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.....+..+++|.....  .....+.+.+|++++++++||||+++++++..+...+++|||+.+++|.+++....
T Consensus        20 ~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   97 (280)
T cd06611          20 KVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE   97 (280)
T ss_pred             eEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhc
Confidence            5788888777888888876432  22334678899999999999999999999999999999999999999999987543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.++.|||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        98 ~--------~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~  164 (280)
T cd06611          98 R--------GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFI  164 (280)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc--ccceee
Confidence            2        288999999999999999999999   999999999999999999999999998765432211  122345


Q ss_pred             cccCcCCCcccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc-cCCC
Q 023220          162 GTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK-LKGE  235 (285)
Q Consensus       162 ~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  235 (285)
                      ++..|+|||.+.     ...++.++|+||||+++|+|++|..||...+......               .+.... ....
T Consensus       165 ~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~~~~~~~  229 (280)
T cd06611         165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL---------------KILKSEPPTLD  229 (280)
T ss_pred             cchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH---------------HHhcCCCCCcC
Confidence            788899999874     3456789999999999999999999997653321111               110000 0112


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+..++.++.+++.+||+.+|.+||++.++++
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            23456678999999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.6e-36  Score=250.77  Aligned_cols=239  Identities=23%  Similarity=0.302  Sum_probs=183.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+...+..+++|......  ....+.+.+|+.++++++|+||+++++++..++..++++||+.+++|.+++....
T Consensus        23 ~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  100 (268)
T cd06624          23 IVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKW  100 (268)
T ss_pred             EEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhc
Confidence            57888877777778888654322  2235678899999999999999999999999999999999999999999997542


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-CCeeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...      ..+...+..++.|++.|+.|||+.   |++|+||+|+||+++. ++.++|+|||.+........  .....
T Consensus       101 ~~~------~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~  169 (268)
T cd06624         101 GPL------KDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETF  169 (268)
T ss_pred             ccC------CCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccC
Confidence            210      027788899999999999999999   9999999999999976 67899999998865432211  11223


Q ss_pred             ccccCcCCCcccccC--CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          161 LGTFGYHAPEYAMTG--QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      .++..|+|||.+...  .++.++|+||+|+++|+|++|..||..........              ............+.
T Consensus       170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--------------~~~~~~~~~~~~~~  235 (268)
T cd06624         170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--------------FKVGMFKIHPEIPE  235 (268)
T ss_pred             CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH--------------hhhhhhccCCCCCc
Confidence            478899999987654  37889999999999999999999996432211100              00000011123345


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..++++.+++.+||+.+|++|||+.++++
T Consensus       236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         236 SLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            56778999999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.6e-36  Score=253.95  Aligned_cols=236  Identities=22%  Similarity=0.265  Sum_probs=184.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++....+...+++|.....  .....+.+.+|+.+++.++|+|++++++.+..++..+++|||+.+++|..++....
T Consensus        27 ~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~  104 (292)
T cd06644          27 KVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD  104 (292)
T ss_pred             EEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhc
Confidence            4788877777777877776432  23345678889999999999999999999999999999999999999988875432


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..+..++.|++.++.|||+.   |++|+||+|+||+++.++.++|+|||++.......  .......
T Consensus       105 ~--------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~  171 (292)
T cd06644         105 R--------GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFI  171 (292)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc--cccceec
Confidence            2        278899999999999999999999   99999999999999999999999999876432211  1112345


Q ss_pred             cccCcCCCcccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc-cCCC
Q 023220          162 GTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK-LKGE  235 (285)
Q Consensus       162 ~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  235 (285)
                      ++..|+|||.+.     ...++.++|+|||||++|+|++|..||........               ...+.... ....
T Consensus       172 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~  236 (292)
T cd06644         172 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---------------LLKIAKSEPPTLS  236 (292)
T ss_pred             CCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH---------------HHHHhcCCCccCC
Confidence            678899999874     34568899999999999999999999975432111               01110000 0112


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+..++.++.+++.+||+.||++||+++++++
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            23456678999999999999999999999987

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.7e-36  Score=261.59  Aligned_cols=240  Identities=16%  Similarity=0.135  Sum_probs=185.3

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||++....++..+++|...+... .....+.+.+|+.++..++|++|+.+++++.+.+..++||||+.+|+|.+++...
T Consensus        16 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~   95 (331)
T cd05624          16 EVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF   95 (331)
T ss_pred             EEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHh
Confidence            589998888888999997754322 2233556788999999999999999999999999999999999999999999763


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..        .+++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......... .....
T Consensus        96 ~~--------~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~  163 (331)
T cd05624          96 ED--------RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVA  163 (331)
T ss_pred             cC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-eeccc
Confidence            22        278899999999999999999999   9999999999999999999999999998654332211 11224


Q ss_pred             ccccCcCCCccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC-
Q 023220          161 LGTFGYHAPEYAMT-----GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG-  234 (285)
Q Consensus       161 ~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  234 (285)
                      .|++.|+|||.+.+     ..++.++|+||+||++|+|++|+.||.........               ..+.....+. 
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~---------------~~i~~~~~~~~  228 (331)
T cd05624         164 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY---------------GKIMNHEERFQ  228 (331)
T ss_pred             cCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH---------------HHHHcCCCccc
Confidence            58999999998865     45788999999999999999999999754322111               1111111111 


Q ss_pred             --CCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 023220          235 --EYPPKGVAKLAAVAALCVQYEAEF--RPNMSIVVKA  268 (285)
Q Consensus       235 --~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~ll~~  268 (285)
                        .....+++.+.+++.+|+..++++  |++++++++.
T Consensus       229 ~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence              112335678999999999876654  4688888753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3e-36  Score=257.16  Aligned_cols=242  Identities=18%  Similarity=0.200  Sum_probs=185.8

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++....+++.+++|....... .....+.+.+|+++++.++||||+++++.+..++..+++|||+.+++|.+++...
T Consensus        16 ~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~   95 (305)
T cd05609          16 AVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI   95 (305)
T ss_pred             eEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHc
Confidence            578888888888898887654322 2334567889999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc--------
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA--------  152 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~--------  152 (285)
                      ..         +++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++.......        
T Consensus        96 ~~---------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  163 (305)
T cd05609          96 GA---------LPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH  163 (305)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccc
Confidence            32         78899999999999999999999   99999999999999999999999999875321000        


Q ss_pred             -----ccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh
Q 023220          153 -----ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC  227 (285)
Q Consensus       153 -----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (285)
                           .........++..|+|||.+.+..++.++|+||||+++|++++|..||.+......               ....
T Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~---------------~~~~  228 (305)
T cd05609         164 IEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL---------------FGQV  228 (305)
T ss_pred             cccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---------------HHHH
Confidence                 00001123467789999998888899999999999999999999999975432111               1111


Q ss_pred             cCCccC-CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          228 VDPKLK-GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       228 ~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      ...... .......+.++.+++.+||+.+|++||+...+++.|+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            111000 0111245678999999999999999998655544443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.1e-36  Score=251.45  Aligned_cols=235  Identities=23%  Similarity=0.322  Sum_probs=189.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+......+++|...... .....+.+.+|+..+++++||||+++++++..+...++||||+.+++|.+++....
T Consensus        19 ~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~   97 (277)
T cd06641          19 EVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP   97 (277)
T ss_pred             EEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcCC
Confidence            58888877778888888764322 23345678899999999999999999999999999999999999999999986432


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                ++...+..++.|++.++.+||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        98 ----------~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  162 (277)
T cd06641          98 ----------LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFV  162 (277)
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhcccc
Confidence                      78899999999999999999999   999999999999999999999999998865443221  112235


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ++..|+|||.+.+..++.++|+||+||++|+|++|..||..........                .+........+..++
T Consensus       163 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----------------~~~~~~~~~~~~~~~  226 (277)
T cd06641         163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF----------------LIPKNNPPTLEGNYS  226 (277)
T ss_pred             CCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH----------------HHhcCCCCCCCcccC
Confidence            6788999999888888999999999999999999999996543211110                011111112344567


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      .++.+++.+||+.+|.+||++.++++.
T Consensus       227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         227 KPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            789999999999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.3e-36  Score=259.48  Aligned_cols=256  Identities=19%  Similarity=0.233  Sum_probs=188.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||++.+..+++.+++|............+.+.+|+.+++.++||||++++++|..++..++++||+.+++|.+++....
T Consensus        15 ~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~   94 (328)
T cd08226          15 SVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF   94 (328)
T ss_pred             eEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhc
Confidence            58999988899999999876554444456788999999999999999999999999999999999999999999987643


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc-----
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH-----  156 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-----  156 (285)
                      ..       .+++..+..++.|++.||.|||+.   |++||||||+||+++.++.+++.||+.+...........     
T Consensus        95 ~~-------~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (328)
T cd08226          95 PE-------GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDF  164 (328)
T ss_pred             cc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccc
Confidence            21       278889999999999999999999   999999999999999999999999975432211110000     


Q ss_pred             ccccccccCcCCCcccccC--CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc-------cCch------
Q 023220          157 STRVLGTFGYHAPEYAMTG--QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP-------RLSE------  221 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-------~~~~------  221 (285)
                      .....++..|+|||.+.+.  .++.++|+||+||++|+|++|..||.................       ..+.      
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (328)
T cd08226         165 PQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMK  244 (328)
T ss_pred             cccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhc
Confidence            0111245679999998763  478999999999999999999999976532211100000000       0000      


Q ss_pred             ------------hhh-----hhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          222 ------------DKV-----KQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       222 ------------~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                                  ...     ...............++..+.+++++||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         245 NSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             cchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                        000     0001111122234456788999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=259.86  Aligned_cols=240  Identities=16%  Similarity=0.134  Sum_probs=185.1

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||++....+++.|++|...+... .....+.+.+|+.++..++|+||+++++++.+++..++||||+.+++|.+++...
T Consensus        16 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~   95 (331)
T cd05597          16 EVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKF   95 (331)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHh
Confidence            588998888899999998754332 2234566888999999999999999999999999999999999999999999653


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..        .+++..+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++........ ......
T Consensus        96 ~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~  163 (331)
T cd05597          96 ED--------RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVA  163 (331)
T ss_pred             cC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-ccccce
Confidence            22        288899999999999999999999   999999999999999999999999999865432211 111224


Q ss_pred             ccccCcCCCccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc---
Q 023220          161 LGTFGYHAPEYAMT-----GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL---  232 (285)
Q Consensus       161 ~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  232 (285)
                      .|++.|+|||++..     ..++.++|+||+||++|+|++|+.||..........               .+.....   
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~---------------~i~~~~~~~~  228 (331)
T cd05597         164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---------------KIMNHKEHFQ  228 (331)
T ss_pred             eccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH---------------HHHcCCCccc
Confidence            58999999999863     356889999999999999999999997543221111               1111000   


Q ss_pred             CCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 023220          233 KGEYPPKGVAKLAAVAALCVQYEAEF--RPNMSIVVKA  268 (285)
Q Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~ll~~  268 (285)
                      .......++.++.+++.+||..+++.  |+++.++++.
T Consensus       229 ~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            01112236778999999988654443  7899999885

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6.2e-36  Score=252.86  Aligned_cols=244  Identities=20%  Similarity=0.324  Sum_probs=190.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||++.....+..+++|.....  .....+.+.+|+.++++++|||++++++++...+..++++||+.+++|.+++....
T Consensus        34 ~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~  111 (285)
T cd06648          34 IVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR  111 (285)
T ss_pred             EEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhCC
Confidence            4678777767777888865322  22335668899999999999999999999999999999999999999999987632


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                ++...+..++.|++.|+.+||+.   |++||||+|+||+++.++.++|+|||.+........  ......
T Consensus       112 ----------~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~  176 (285)
T cd06648         112 ----------MNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLV  176 (285)
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cccccc
Confidence                      78899999999999999999999   999999999999999999999999998765432211  112245


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      |+..|+|||...+..++.++|+||||+++|+|++|..||....+........            ....+..  ..+..++
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~------------~~~~~~~--~~~~~~~  242 (285)
T cd06648         177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR------------DNLPPKL--KNLHKVS  242 (285)
T ss_pred             CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH------------hcCCCCC--cccccCC
Confidence            7889999999988888999999999999999999999997543221111110            0000011  1122356


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                      ..+.+++.+||+.+|++|||+.++++  ..++....+
T Consensus       243 ~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~~~~~  277 (285)
T cd06648         243 PRLRSFLDRMLVRDPAQRATAAELLN--HPFLAKAGP  277 (285)
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHcc--CcccccCCC
Confidence            78999999999999999999999997  455544444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.1e-36  Score=256.99  Aligned_cols=258  Identities=18%  Similarity=0.216  Sum_probs=177.5

Q ss_pred             Cceeeeeee--eccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe--CCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQ--VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||+|....  +...+++|.....    .....+.+|++++++++||||+++++++..  +...++++||+.+ +|.+++
T Consensus        16 ~Vy~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~   90 (317)
T cd07867          16 HVYKAKRKDGKDEKEYALKQIEGT----GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHII   90 (317)
T ss_pred             eEEEEEecCCCccceEEEEEecCC----CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHH
Confidence            588887543  4466777765432    234567899999999999999999998853  5577999999975 888887


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE----ccCCeeEEeccccCCCCCcccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL----FEDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~----~~~~~~~l~df~~~~~~~~~~~  153 (285)
                      ..............+++..+..++.|++.||.|||+.   |++||||||+||++    +.++.++|+|||++........
T Consensus        91 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~  167 (317)
T cd07867          91 KFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK  167 (317)
T ss_pred             HhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcc
Confidence            5432211111122388899999999999999999999   99999999999999    4567899999999976543221


Q ss_pred             c-ccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchh---------hhhhcccCchh
Q 023220          154 R-LHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL---------VTWATPRLSED  222 (285)
Q Consensus       154 ~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~---------~~~~~~~~~~~  222 (285)
                      . .......++..|+|||.+.+. .++.++||||+||++|+|++|.+||...........         +..........
T Consensus       168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (317)
T cd07867         168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADK  247 (317)
T ss_pred             cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChh
Confidence            1 112234578899999988764 578999999999999999999999975432111000         00000000000


Q ss_pred             hhhh-------------hcCC-----cc---CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          223 KVKQ-------------CVDP-----KL---KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       223 ~~~~-------------~~~~-----~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ....             ....     ..   ........+..+.+++.+||+.||.+|||++++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         248 DWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             hhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            0000             0000     00   00011122456889999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.1e-36  Score=260.10  Aligned_cols=240  Identities=14%  Similarity=0.140  Sum_probs=185.4

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||++....++..+++|...+... .....+.+.+|+.++..++|++|+++++.+.+.+..++||||+.+|+|.+++...
T Consensus        16 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~   95 (332)
T cd05623          16 EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF   95 (332)
T ss_pred             EEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHh
Confidence            578888888888899987654322 2333456788999999999999999999999999999999999999999999763


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..        .+++..+..++.|++.|+.|||+.   |++||||||+||+++.++.++|+|||++........ ......
T Consensus        96 ~~--------~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~  163 (332)
T cd05623          96 ED--------RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVA  163 (332)
T ss_pred             cC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc-ceeccc
Confidence            22        288899999999999999999999   999999999999999999999999999864432111 111234


Q ss_pred             ccccCcCCCcccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC--
Q 023220          161 LGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK--  233 (285)
Q Consensus       161 ~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  233 (285)
                      .|++.|+|||++.     ...++.++|+|||||++|+|++|+.||...+......               .+......  
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~---------------~i~~~~~~~~  228 (332)
T cd05623         164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---------------KIMNHKERFQ  228 (332)
T ss_pred             ccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH---------------HHhCCCcccc
Confidence            5899999999886     3457889999999999999999999997654321111               11111111  


Q ss_pred             -CCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 023220          234 -GEYPPKGVAKLAAVAALCVQYEAEF--RPNMSIVVKA  268 (285)
Q Consensus       234 -~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~ll~~  268 (285)
                       ......++.++.+++++|+..+++.  |++++++++.
T Consensus       229 ~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence             1112345778999999999765544  6899999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.4e-36  Score=254.11  Aligned_cols=252  Identities=19%  Similarity=0.221  Sum_probs=189.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC--CeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG--NLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++.+..++..+++|..+...........+.+|+.++++++||||+++++++...  ...++++||+.+ +|.+++..
T Consensus        20 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~   98 (293)
T cd07843          20 VVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMET   98 (293)
T ss_pred             EEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHh
Confidence            588998887788888887765554455556778899999999999999999998877  789999999975 99888875


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...        .+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++.........  ...
T Consensus        99 ~~~--------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~  165 (293)
T cd07843          99 MKQ--------PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--YTQ  165 (293)
T ss_pred             ccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc--ccc
Confidence            432        289999999999999999999999   9999999999999999999999999988765432211  123


Q ss_pred             cccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh--------------
Q 023220          160 VLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV--------------  224 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------------  224 (285)
                      ..++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...........+............              
T Consensus       166 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (293)
T cd07843         166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTF  245 (293)
T ss_pred             ccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccccc
Confidence            4467889999988754 4588999999999999999999999865433222111100000000000              


Q ss_pred             hhhcCCccCCCCChh-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          225 KQCVDPKLKGEYPPK-GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       225 ~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...........++.. .+..+.++|.+||+.+|++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         246 TKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            000001111222222 5778999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=277.03  Aligned_cols=236  Identities=23%  Similarity=0.367  Sum_probs=203.0

Q ss_pred             cccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCC
Q 023220           13 ESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL   92 (285)
Q Consensus        13 ~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~   92 (285)
                      ..+++|..|. ...+..+.+|..|..+|-+++||||+.+-|++...+-..||+|||++|+|..+++.+...        +
T Consensus       658 ~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq--------f  728 (996)
T KOG0196|consen  658 ITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ--------F  728 (996)
T ss_pred             eeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc--------e
Confidence            3455555432 344556888999999999999999999999999999999999999999999999877643        8


Q ss_pred             CHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc-cccccccCcCCCcc
Q 023220           93 DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS-TRVLGTFGYHAPEY  171 (285)
Q Consensus        93 ~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~  171 (285)
                      .+.++..+++.|+.+++||.+.   |++||||-.+|||++.+..+|++|||+++........... ....-..+|.|||.
T Consensus       729 tviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEA  805 (996)
T KOG0196|consen  729 TVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEA  805 (996)
T ss_pred             EeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhH
Confidence            9999999999999999999999   9999999999999999999999999999865432211111 11112478999999


Q ss_pred             cccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHH
Q 023220          172 AMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAAL  250 (285)
Q Consensus       172 ~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  250 (285)
                      +..++++.++|+||+|+++||.++ |..||=                .+++.++.+.++.+++.+.|-++|..|++|+..
T Consensus       806 Ia~RKFTsASDVWSyGIVmWEVmSyGERPYW----------------dmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMld  869 (996)
T KOG0196|consen  806 IAYRKFTSASDVWSYGIVMWEVMSYGERPYW----------------DMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLD  869 (996)
T ss_pred             hhhcccCchhhccccceEEEEecccCCCccc----------------ccchHHHHHHHHhccCCCCCCCCcHHHHHHHHH
Confidence            999999999999999999999887 999984                335677888888999999999999999999999


Q ss_pred             hcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          251 CVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       251 ~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      ||++|-.+||.+.+|+..|++++..+
T Consensus       870 CWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  870 CWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             HHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            99999999999999999999999654

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-35  Score=254.03  Aligned_cols=259  Identities=23%  Similarity=0.236  Sum_probs=191.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC--CeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG--NLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++.+..+++.+++|..+...........+.+|++++++++|+||+++++++...  +..++||||+.+ +|.+++..
T Consensus        22 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~  100 (309)
T cd07845          22 IVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDN  100 (309)
T ss_pred             EEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHh
Confidence            589998888899999998765554444556677899999999999999999998754  467999999975 88888865


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...        .+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++.........  ...
T Consensus       101 ~~~--------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~  167 (309)
T cd07845         101 MPT--------PFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTP  167 (309)
T ss_pred             ccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCc
Confidence            431        288999999999999999999999   9999999999999999999999999998765432211  122


Q ss_pred             cccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC----Cc--c
Q 023220          160 VLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD----PK--L  232 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~--~  232 (285)
                      ..++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.......+..............+..    ..  .
T Consensus       168 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (309)
T cd07845         168 KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTL  247 (309)
T ss_pred             ccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccc
Confidence            335678999998865 4578999999999999999999999986654333222211111100000000000    00  0


Q ss_pred             C-------CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          233 K-------GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       233 ~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      .       .......++++.++|.+||+.||++|||+.++++  ..+....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~--h~~f~~~  296 (309)
T cd07845         248 PKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE--SSYFKEK  296 (309)
T ss_pred             cCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc--ChhhccC
Confidence            0       0001224678899999999999999999999997  5555433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.9e-36  Score=248.95  Aligned_cols=238  Identities=21%  Similarity=0.291  Sum_probs=192.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .+|++....+++.+++|........ ...+.+.+|++.+++++|+|++++++++...+..++++||+.+++|.+++....
T Consensus        16 ~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   94 (264)
T cd06623          16 VVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG   94 (264)
T ss_pred             EEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcC
Confidence            4788888888888988876543322 456789999999999999999999999999999999999999999999997653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                               .++...++.++.|++.++.|||+ .   |++|+||+|+||+++.++.++|+|||.+.........  ....
T Consensus        95 ---------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~  160 (264)
T cd06623          95 ---------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTF  160 (264)
T ss_pred             ---------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccce
Confidence                     28999999999999999999999 9   9999999999999999999999999998765432221  1234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh-
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK-  239 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  239 (285)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||.........            .....+.. ......+.. 
T Consensus       161 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~------------~~~~~~~~-~~~~~~~~~~  227 (264)
T cd06623         161 VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF------------ELMQAICD-GPPPSLPAEE  227 (264)
T ss_pred             eecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHH------------HHHHHHhc-CCCCCCCccc
Confidence            5678899999998888899999999999999999999999765421111            11111111 111222333 


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ++..+.+++.+||+.+|++|||+.++++
T Consensus       228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         228 FSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            6788999999999999999999999998

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.4e-36  Score=247.59  Aligned_cols=240  Identities=22%  Similarity=0.291  Sum_probs=196.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC--CeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG--NLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .+|++....++..+++|............+.+.+|++++++++|+||+++++.+...  ...++++|++.+++|.+++..
T Consensus        15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   94 (260)
T cd06606          15 SVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK   94 (260)
T ss_pred             EEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHH
Confidence            478888877788888888766555556678899999999999999999999999988  889999999999999999976


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..++.++.|++.++.|||+.   |++|+|++|+||+++.++.++|+|||.+..............
T Consensus        95 ~~~---------~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  162 (260)
T cd06606          95 FGK---------LPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS  162 (260)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccC
Confidence            542         89999999999999999999999   999999999999999999999999999876554332111233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..++..|.+||...+..++.++|+||||+++++|++|..||......              ................+..
T Consensus       163 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------------~~~~~~~~~~~~~~~~~~~  228 (260)
T cd06606         163 VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--------------MAALYKIGSSGEPPEIPEH  228 (260)
T ss_pred             CCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--------------HHHHHhccccCCCcCCCcc
Confidence            45788999999998888999999999999999999999999765411              0111111112222334555


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+..+.+++.+||+.+|++||++.++++
T Consensus       229 ~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         229 LSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             cCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            6788999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-36  Score=253.62  Aligned_cols=252  Identities=17%  Similarity=0.200  Sum_probs=192.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.....++.+++|..............+.+|++++++++|+||+++++++.++...++++||+.+ +|.+++....
T Consensus        14 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~   92 (283)
T cd05118          14 VVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQ   92 (283)
T ss_pred             eEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhc
Confidence            478888877888899997766555545678889999999999999999999999999999999999975 8888886643


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||.+........  ......
T Consensus        93 ~--------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~  159 (283)
T cd05118          93 R--------GLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYV  159 (283)
T ss_pred             c--------cCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCcc
Confidence            1        288999999999999999999999   999999999999999999999999998865543221  112234


Q ss_pred             cccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC-----------
Q 023220          162 GTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD-----------  229 (285)
Q Consensus       162 ~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------  229 (285)
                      ++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+........................+           
T Consensus       160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05118         160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK  239 (283)
T ss_pred             CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence            67789999998776 788999999999999999999999976554332222211111111111000000           


Q ss_pred             --CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          230 --PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       230 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                        ........+..+.++.++|.+||+.||.+||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence              00001122346788999999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.9e-35  Score=247.64  Aligned_cols=222  Identities=22%  Similarity=0.308  Sum_probs=166.7

Q ss_pred             CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 023220           29 YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGL  108 (285)
Q Consensus        29 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l  108 (285)
                      ..+.+.+|+.+++.++||||+++++.+......+++|||+.+|+|.+++.......     .......+..++.|++.||
T Consensus        38 ~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~al  112 (268)
T cd05086          38 EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHR-----RNSQLLLLQRMACEIAAGV  112 (268)
T ss_pred             HHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhccc-----ccccHHHHHHHHHHHHHHH
Confidence            45788999999999999999999999999999999999999999999997643211     1266778889999999999


Q ss_pred             HHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCccccc-------CCCCccc
Q 023220          109 EYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-------GQLTQKS  181 (285)
Q Consensus       109 ~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~  181 (285)
                      .|||+.   +++|+||+|+||+++.++.++|+|||++................++..|+|||.+..       ..++.++
T Consensus       113 ~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~  189 (268)
T cd05086         113 THMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPS  189 (268)
T ss_pred             HHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcc
Confidence            999999   999999999999999999999999998753222111111223456788999998743       2457899


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCC
Q 023220          182 DVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP  260 (285)
Q Consensus       182 DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (285)
                      |+||||+++|+|++ |..||.............       .+......+    .......++.+.+++..|| .+|++||
T Consensus       190 DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-------~~~~~~~~~----~~~~~~~~~~~~~l~~~c~-~~P~~Rp  257 (268)
T cd05086         190 NVWALGVTLWELFENAAQPYSHLSDREVLNHVI-------KDQQVKLFK----PQLELPYSERWYEVLQFCW-LSPEKRA  257 (268)
T ss_pred             hhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------hhcccccCC----CccCCCCcHHHHHHHHHHh-hCcccCC
Confidence            99999999999997 577886443211111000       000011111    2223345678999999999 6799999


Q ss_pred             CHHHHHHHhc
Q 023220          261 NMSIVVKALQ  270 (285)
Q Consensus       261 s~~~ll~~l~  270 (285)
                      ++.++++.|.
T Consensus       258 ~~~~i~~~l~  267 (268)
T cd05086         258 TAEEVHRLLT  267 (268)
T ss_pred             CHHHHHHHhc
Confidence            9999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-35  Score=251.77  Aligned_cols=244  Identities=25%  Similarity=0.307  Sum_probs=187.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC--CeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG--NLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||+|.+..+++.+++|....... .....++.+|++++++++||||+++++++.+.  +.++++|||+.+++|.+++..
T Consensus        16 ~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   94 (287)
T cd06621          16 SVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK   94 (287)
T ss_pred             EEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHH
Confidence            578998888889999997764322 24567889999999999999999999998653  468999999999999988754


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ....     ...++...+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........    ..
T Consensus        95 ~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~  162 (287)
T cd06621          95 VKKR-----GGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GT  162 (287)
T ss_pred             HHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc----cc
Confidence            3211     11278899999999999999999999   999999999999999999999999999865432211    22


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCc--ccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPR--GQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||......  .......+....         -.+.......
T Consensus       163 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~  233 (287)
T cd06621         163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---------PNPELKDEPG  233 (287)
T ss_pred             ccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---------CchhhccCCC
Confidence            34678899999998888999999999999999999999999765321  011111111100         0011111111


Q ss_pred             --hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          238 --PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       238 --~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                        ...++.+.+++.+||+.+|.+|||+.++++
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence              235678999999999999999999999998

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8.8e-36  Score=247.80  Aligned_cols=238  Identities=24%  Similarity=0.342  Sum_probs=189.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++........+++|............+.+.+|+.++++++|+||+++++.+..+...++++||+.+++|.+++....
T Consensus        15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   94 (257)
T cd08225          15 KIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQR   94 (257)
T ss_pred             eEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhcc
Confidence            47888777777788888776544444456788899999999999999999999999999999999999999999987543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC-eeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-KAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..       .+++..+..++.|++.|+.|||+.   +++|+|++|+||+++.++ .++++|||.+.........  ....
T Consensus        95 ~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~  162 (257)
T cd08225          95 GV-------LFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL--AYTC  162 (257)
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCccc--cccc
Confidence            22       278899999999999999999999   999999999999998875 4699999988765432211  1223


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||...+..++.++|+||||++++++++|..||.......               ......... .....+..
T Consensus       163 ~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------------~~~~~~~~~-~~~~~~~~  226 (257)
T cd08225         163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ---------------LVLKICQGY-FAPISPNF  226 (257)
T ss_pred             CCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---------------HHHHHhccc-CCCCCCCC
Confidence            57888999999888888999999999999999999999996543211               111111111 11223455


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +.++.+++.+||..+|++|||+.++++
T Consensus       227 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         227 SRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-37  Score=265.20  Aligned_cols=243  Identities=23%  Similarity=0.292  Sum_probs=195.3

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      -||-+.+..+.+++++|.--... .+..--+++..|+++|.+++|||+|.+.|.|......+||||||-| +-.+++.-.
T Consensus        41 AVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVh  119 (948)
T KOG0577|consen   41 AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVH  119 (948)
T ss_pred             eeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-cHHHHHHHH
Confidence            38999999999999988432221 1122245677899999999999999999999988889999999975 777777533


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..        ++.+-.+..|+.+.+.||+|||+.   +.||||||..|||+++.|.|||+|||.+.....      .+..
T Consensus       120 kK--------plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------AnsF  182 (948)
T KOG0577|consen  120 KK--------PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------ANSF  182 (948)
T ss_pred             hc--------cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc------hhcc
Confidence            21        388899999999999999999999   999999999999999999999999999875433      3567


Q ss_pred             ccccCcCCCcccc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          161 LGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       161 ~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      +|||.|+|||++.   .+.|+-+.||||||+++.+|.-.++|+....               ....+..+.-...-.-..
T Consensus       183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN---------------AMSALYHIAQNesPtLqs  247 (948)
T KOG0577|consen  183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---------------AMSALYHIAQNESPTLQS  247 (948)
T ss_pred             cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch---------------HHHHHHHHHhcCCCCCCC
Confidence            8999999999985   5689999999999999999999999975432               222333333322222235


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                      ++++..+..|+..||++-|++|||.++++.  .+++...-|+
T Consensus       248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~--H~fv~R~Rp~  287 (948)
T KOG0577|consen  248 NEWSDYFRNFVDSCLQKIPQERPTSEELLK--HRFVLRERPP  287 (948)
T ss_pred             chhHHHHHHHHHHHHhhCcccCCcHHHHhh--cchhccCCCc
Confidence            678999999999999999999999999998  5566555444

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.2e-36  Score=269.84  Aligned_cols=245  Identities=16%  Similarity=0.203  Sum_probs=179.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCC------CcccccceEEEeC-CeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH------ENLVELLGYCVEG-NLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~   74 (285)
                      +||+|.+..+++.+++|..+..   ......+..|+++++.++|      .+++.+++++... .+.++||+++ +++|.
T Consensus       144 ~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~  219 (467)
T PTZ00284        144 KVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLL  219 (467)
T ss_pred             EEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHH
Confidence            5899999888999999987532   1234556678888777755      4588888888754 5789999988 56888


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCC----------------ee
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDF----------------KA  137 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~----------------~~  137 (285)
                      +++.....         +++..+..++.|++.||.|||. .   |++||||||+|||++.++                .+
T Consensus       220 ~~l~~~~~---------l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~v  287 (467)
T PTZ00284        220 DWIMKHGP---------FSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV  287 (467)
T ss_pred             HHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccccCCCCceE
Confidence            88865432         8899999999999999999997 7   999999999999998765                49


Q ss_pred             EEeccccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 023220          138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP  217 (285)
Q Consensus       138 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  217 (285)
                      +|+|||.+.....     ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus       288 kl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g  362 (467)
T PTZ00284        288 RICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG  362 (467)
T ss_pred             EECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Confidence            9999998754221     12345689999999999999999999999999999999999999987654333322222222


Q ss_pred             cCchhhh--------hhhcCCc--cC---------------CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          218 RLSEDKV--------KQCVDPK--LK---------------GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       218 ~~~~~~~--------~~~~~~~--~~---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+....        ..+.+..  +.               ..........+.+||.+||+.||.+|||++++++
T Consensus       363 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            2111100        0000000  00               0000112456789999999999999999999998

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.5e-36  Score=259.81  Aligned_cols=249  Identities=18%  Similarity=0.180  Sum_probs=186.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC------CeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG------NLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~   75 (285)
                      .||++.+..++..+++|............+.+.+|+.++++++|+||+++++++...      ...++||||+.+ +|.+
T Consensus        31 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~  109 (353)
T cd07850          31 IVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQ  109 (353)
T ss_pred             EEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHH
Confidence            478998888889999997754433444556778899999999999999999988643      356999999965 8888


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      .+...           ++...+..++.|++.||.|||..   |++|+||+|+||+++.++.++|+|||++........  
T Consensus       110 ~~~~~-----------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--  173 (353)
T cd07850         110 VIQMD-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--  173 (353)
T ss_pred             HHhhc-----------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC--
Confidence            87543           67888999999999999999999   999999999999999999999999999875533221  


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchh-------------
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED-------------  222 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------  222 (285)
                       .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+.........+             
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (353)
T cd07850         174 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYV  252 (353)
T ss_pred             -CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHh
Confidence             122346788999999999899999999999999999999999997654322111111000000000             


Q ss_pred             ---------hhhhhc----CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          223 ---------KVKQCV----DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       223 ---------~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                               ......    .+..........+..+.++|.+||+.||++|||+.++++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         253 ENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                     000000    0000111123456789999999999999999999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.2e-35  Score=248.74  Aligned_cols=243  Identities=23%  Similarity=0.281  Sum_probs=186.4

Q ss_pred             Cceeeeeee-eccccChhhhhhcc--------CCCCCChhHHHHHHHHcc-CCCCcccccceEEEeCCeeeEEEeeCCCC
Q 023220            2 RRWLCCTCQ-VEESYPSHENERLK--------SPKNYPDDEKQLVSVVSR-LKHENLVELLGYCVEGNLRVLAYEFATMG   71 (285)
Q Consensus         2 ~~~~~~~~~-~~~~~~~k~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   71 (285)
                      +||++.... .++.+++|......        .......++.+|+.++.+ ++||||+++++++..++..+++|||+.++
T Consensus        15 ~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   94 (269)
T cd08528          15 CVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGA   94 (269)
T ss_pred             eEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCC
Confidence            578887766 66778887654322        222234556778888875 79999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCc
Q 023220           72 SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD  150 (285)
Q Consensus        72 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~  150 (285)
                      +|.+++......     ...++...++.++.|++.++.|||+ .   |++|+||+|+||+++.++.++|+|||.+.....
T Consensus        95 ~l~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  166 (269)
T cd08528          95 PLGEHFNSLKEK-----KQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP  166 (269)
T ss_pred             cHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecccceeeccc
Confidence            999988542211     0128889999999999999999996 6   899999999999999999999999999876543


Q ss_pred             ccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                      ..   ......++..|++||.+.+..++.++|+||||+++|+|++|..||........               .....+.
T Consensus       167 ~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---------------~~~~~~~  228 (269)
T cd08528         167 ES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---------------ATKIVEA  228 (269)
T ss_pred             cc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---------------HHHHhhc
Confidence            22   12344578899999999888889999999999999999999999965432111               1111111


Q ss_pred             ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          231 KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      .........++..+.+++.+||+.||++||++.++.+.+.
T Consensus       229 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1111112235678999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-35  Score=248.00  Aligned_cols=206  Identities=21%  Similarity=0.383  Sum_probs=163.4

Q ss_pred             CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 023220           29 YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGL  108 (285)
Q Consensus        29 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l  108 (285)
                      ....+.+|+.+++.++||||+++++++......+++|||+.+++|..++.....        .+++..++.++.|++.|+
T Consensus        47 ~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~~l  118 (262)
T cd05077          47 ISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD--------VLTTPWKFKVAKQLASAL  118 (262)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHH
Confidence            345778899999999999999999999998889999999999999888865332        278899999999999999


Q ss_pred             HHHhhcCCCCeeeCCCCCCCeEEccCCe-------eEEeccccCCCCCcccccccccccccccCcCCCcccc-cCCCCcc
Q 023220          109 EYLHEKVQPSIIHRDIRSSNVLLFEDFK-------AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQK  180 (285)
Q Consensus       109 ~~lh~~~~~~~~h~di~~~nil~~~~~~-------~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~  180 (285)
                      .|||++   |++||||+|+||+++.++.       ++++|||++......      ....++..|+|||.+. +..++.+
T Consensus       119 ~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~  189 (262)
T cd05077         119 SYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIA  189 (262)
T ss_pred             HHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCch
Confidence            999999   9999999999999986654       899999988644221      2234677899999876 4568899


Q ss_pred             cchHhHHHHHHHHH-hCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCC
Q 023220          181 SDVYSFGVVLLELL-TGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR  259 (285)
Q Consensus       181 ~DiwslG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  259 (285)
                      +|||||||++|+|+ .|..||.........                .......  ......+.++.+++.+||+.||.+|
T Consensus       190 ~DiwslG~~l~el~~~~~~p~~~~~~~~~~----------------~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~R  251 (262)
T cd05077         190 ADKWSFGTTLWEICYNGEIPLKDKTLAEKE----------------RFYEGQC--MLVTPSCKELADLMTHCMNYDPNQR  251 (262)
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCCcchhHHH----------------HHHhcCc--cCCCCChHHHHHHHHHHcCCChhhC
Confidence            99999999999997 488887643321110                0101111  1112235679999999999999999


Q ss_pred             CCHHHHHHHh
Q 023220          260 PNMSIVVKAL  269 (285)
Q Consensus       260 ps~~~ll~~l  269 (285)
                      |++.++++.+
T Consensus       252 p~~~~il~~~  261 (262)
T cd05077         252 PFFRAIMRDI  261 (262)
T ss_pred             cCHHHHHHhc
Confidence            9999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=251.33  Aligned_cols=251  Identities=20%  Similarity=0.250  Sum_probs=183.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+...++.|++|....... ......+.+|++++++++|+||+++++++.+++..++||||+.+ +|.+++....
T Consensus        20 ~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~   97 (291)
T cd07844          20 TVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCG   97 (291)
T ss_pred             EEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCC
Confidence            589998887888899998764332 23345677899999999999999999999999999999999985 8999887543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        98 ~--------~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~  164 (291)
T cd07844          98 G--------GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TYSNEV  164 (291)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc--cccccc
Confidence            2        278899999999999999999999   999999999999999999999999998864322111  112234


Q ss_pred             cccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCc-ccchhhhhhcccCchhhhhhh------------
Q 023220          162 GTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPR-GQQSLVTWATPRLSEDKVKQC------------  227 (285)
Q Consensus       162 ~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~------------  227 (285)
                      ++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...... .....+...............            
T Consensus       165 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (291)
T cd07844         165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFP  244 (291)
T ss_pred             cccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccccc
Confidence            5778999998865 45789999999999999999999999755411 111111100000000000000            


Q ss_pred             -cCCccCCCCChhH--HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          228 -VDPKLKGEYPPKG--VAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       228 -~~~~~~~~~~~~~--~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                       ..+..........  ...+.+++.+||+.+|.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         245 FYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence             0000000000112  267889999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.4e-35  Score=246.57  Aligned_cols=238  Identities=20%  Similarity=0.280  Sum_probs=185.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCC---CCCChhHHHHHHHHccCCCCcccccceEEEeC--CeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP---KNYPDDEKQLVSVVSRLKHENLVELLGYCVEG--NLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++.+..++..+++|........   ....+.+.+|++++++++||||+++++.+.+.  ..++++|||+.+++|.++
T Consensus        17 ~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~   96 (265)
T cd06652          17 RVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQ   96 (265)
T ss_pred             EEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHH
Confidence            4788888888888888876432222   22345788899999999999999999998763  467899999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-c
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-L  155 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~  155 (285)
                      +.....         ++...+..++.|++.+|.|||+.   |++|+||+|+||+++.++.++|+|||++......... .
T Consensus        97 l~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  164 (265)
T cd06652          97 LKSYGA---------LTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGT  164 (265)
T ss_pred             HHHcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccccccccc
Confidence            875432         78888999999999999999999   9999999999999999999999999988654321111 0


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE  235 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|..||........               ............
T Consensus       165 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~  229 (265)
T cd06652         165 GMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA---------------IFKIATQPTNPV  229 (265)
T ss_pred             ccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH---------------HHHHhcCCCCCC
Confidence            11223477889999999888889999999999999999999999975432111               111111111223


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+...+..+.+++.+|+. +|++||+++++++
T Consensus       230 ~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         230 LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            455667789999999995 9999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.8e-36  Score=258.49  Aligned_cols=257  Identities=20%  Similarity=0.263  Sum_probs=190.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC-----CeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG-----NLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~   76 (285)
                      +||++.+..++..+++|..............+.+|+.+++.++|+||+++++++...     ...++++||+. ++|.++
T Consensus        20 ~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~   98 (337)
T cd07858          20 IVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQI   98 (337)
T ss_pred             EEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHH
Confidence            578888888889999997765444444456778899999999999999999988644     35799999996 589888


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH  156 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  156 (285)
                      +.....         +++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++........  .
T Consensus        99 ~~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~  164 (337)
T cd07858          99 IRSSQT---------LSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--F  164 (337)
T ss_pred             HhcCCC---------CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc--c
Confidence            875432         88999999999999999999999   999999999999999999999999999876543211  1


Q ss_pred             ccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh--------hhh
Q 023220          157 STRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV--------KQC  227 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~  227 (285)
                      .....++..|+|||.+.. ..++.++|+|||||++|+|++|..||.+.+.......+.........+..        ...
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (337)
T cd07858         165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY  244 (337)
T ss_pred             ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHH
Confidence            123346788999998764 46889999999999999999999999765422211111111111111110        000


Q ss_pred             cCC---ccC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hchhh
Q 023220          228 VDP---KLK---GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA--LQPLL  273 (285)
Q Consensus       228 ~~~---~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~--l~~~~  273 (285)
                      +..   ...   ....+.++.++.+++.+||+.+|++|||++++++.  +..+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         245 IRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             HHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence            000   000   01123467789999999999999999999999986  55543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.5e-35  Score=246.12  Aligned_cols=240  Identities=23%  Similarity=0.316  Sum_probs=195.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      ++|++....++..+++|............+.+.+|++++++++|+|++++.+.+...+..++++|++++++|.+++....
T Consensus        15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   94 (258)
T cd08215          15 KVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQK   94 (258)
T ss_pred             EEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhh
Confidence            57888888788889999877655555667788999999999999999999999999999999999999999999997653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .     ....++...++.++.+++.|+.+||+.   |++|+||+|+||+++.++.++|+|||.+........  ......
T Consensus        95 ~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  164 (258)
T cd08215          95 K-----EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVV  164 (258)
T ss_pred             c-----cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcc--eeccee
Confidence            1     011389999999999999999999999   999999999999999999999999999876543321  123345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      +++.|+|||...+..++.++|+||+|+++++|++|..||........               ..... .......+...+
T Consensus       165 ~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---------------~~~~~-~~~~~~~~~~~~  228 (258)
T cd08215         165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL---------------ALKIL-KGQYPPIPSQYS  228 (258)
T ss_pred             eeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH---------------HHHHh-cCCCCCCCCCCC
Confidence            78889999998888889999999999999999999999965432111               11111 111223344667


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+.+++.+||..+|++|||+.++++
T Consensus       229 ~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         229 SELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            78999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=248.76  Aligned_cols=238  Identities=20%  Similarity=0.290  Sum_probs=188.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC---CCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK---HENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .+|++.+...+..+++|.... .......+++.+|+.++++++   |||++++++++..+...+++|||+.+++|.+++.
T Consensus        16 ~v~~~~~~~~~~~~~iK~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   94 (277)
T cd06917          16 AVYRGKHVPTGRVVALKIINL-DTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK   94 (277)
T ss_pred             eEEEEEEcCCCcEEEEEEecC-CCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHH
Confidence            578998888888999997653 223344567889999999996   9999999999999999999999999999999986


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ...          +++..++.++.|++.++.|||+.   |++|+||+|+||+++.++.++|+|||++.........  ..
T Consensus        95 ~~~----------l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~  159 (277)
T cd06917          95 AGP----------IAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RS  159 (277)
T ss_pred             ccC----------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc--cc
Confidence            542          88999999999999999999999   9999999999999999999999999998765433211  22


Q ss_pred             ccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||............               .... ....+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---------------~~~~-~~~~~  223 (277)
T cd06917         160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI---------------PKSK-PPRLE  223 (277)
T ss_pred             cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc---------------ccCC-CCCCC
Confidence            3457888999998764 45689999999999999999999999754332111100               0000 00111


Q ss_pred             h-hHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          238 P-KGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       238 ~-~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      . ..+.++.+++.+||+.||++||++.++++  ..++
T Consensus       224 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~--~~~~  258 (277)
T cd06917         224 DNGYSKLLREFVAACLDEEPKERLSAEELLK--SKWI  258 (277)
T ss_pred             cccCCHHHHHHHHHHcCCCcccCcCHHHHhh--ChHh
Confidence            1 25678999999999999999999999987  4444

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=266.84  Aligned_cols=238  Identities=25%  Similarity=0.325  Sum_probs=195.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||.+.+..++-++++|.+....  .+..+-+..||.+=++++|.|||++.|.+..++.+-|.||..+||+|.++++...
T Consensus       590 ~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskW  667 (1226)
T KOG4279|consen  590 TVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKW  667 (1226)
T ss_pred             EEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhcc
Confidence            58999999999999999886433  2346677889999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-CCeeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      +..+      -++.++-.+..||+++|+|||++   .|+|||||-+|+|++. .|.+||+|||-++.....  .+.+.-.
T Consensus       668 GPlK------DNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETF  736 (1226)
T KOG4279|consen  668 GPLK------DNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETF  736 (1226)
T ss_pred             CCCc------cchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC--Ccccccc
Confidence            4210      27889999999999999999999   9999999999999975 578899999988765432  2223445


Q ss_pred             ccccCcCCCcccccC--CCCcccchHhHHHHHHHHHhCCCCCCCCC-CcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          161 LGTFGYHAPEYAMTG--QLTQKSDVYSFGVVLLELLTGRKPVDHTM-PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      -||..|||||++..+  .|+..+|||||||++.||.||++||.... ++........-               ..-...|
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy---------------KvHP~iP  801 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY---------------KVHPPIP  801 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce---------------ecCCCCc
Confidence            689999999999754  68999999999999999999999996543 22221111110               1123567


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+.+.+.+.+|.+|+..+|.+||++.++++
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            888999999999999999999999999997

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.8e-35  Score=249.24  Aligned_cols=237  Identities=18%  Similarity=0.221  Sum_probs=183.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCC-ChhHHHHHHHH---ccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNY-PDDEKQLVSVV---SRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||++.+..++..+++|...+....... ...+.+|..++   ...+|||++.+++.+...+..++||||+.+++|.+++
T Consensus         9 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i   88 (279)
T cd05633           9 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   88 (279)
T ss_pred             EEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHH
Confidence            5899988888889999977654433222 23334444333   3447999999999999999999999999999999988


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      .....         +++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++.......    .
T Consensus        89 ~~~~~---------l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~  152 (279)
T cd05633          89 SQHGV---------FSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (279)
T ss_pred             HhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence            75432         89999999999999999999999   99999999999999999999999999886443211    1


Q ss_pred             cccccccCcCCCcccc-cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....|+..|+|||... +..++.++|+||+||++|+|++|..||.........             ..... ........
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------------~~~~~-~~~~~~~~  218 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-------------EIDRM-TLTVNVEL  218 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-------------HHHHH-hhcCCcCC
Confidence            2345789999999876 456789999999999999999999999754321111             01000 01111234


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVKA  268 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~~  268 (285)
                      +..++.++.++|++||+.||.+||     |+.++++.
T Consensus       219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            556678899999999999999999     69999884

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.5e-36  Score=247.65  Aligned_cols=238  Identities=24%  Similarity=0.330  Sum_probs=192.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .+|++....+++.+++|..............+.+|++++++++|+||+++++++......++++||+.+++|.+++....
T Consensus        15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~   94 (256)
T cd08530          15 SVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRK   94 (256)
T ss_pred             eEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHH
Confidence            47888777778888888776544344456677889999999999999999999999999999999999999999987632


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..     ...+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++.......    .....
T Consensus        95 ~~-----~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----~~~~~  162 (256)
T cd08530          95 KK-----RKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQI  162 (256)
T ss_pred             hh-----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC----ccccc
Confidence            11     11388899999999999999999999   99999999999999999999999999987654431    22345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ++..|++||.+.+..++.++|+||+|+++++|++|+.||...+....                ............+...+
T Consensus       163 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~  226 (256)
T cd08530         163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL----------------RYKVQRGKYPPIPPIYS  226 (256)
T ss_pred             CCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHhcCCCCCCchhhC
Confidence            77899999999888889999999999999999999999975543211                11111111223344667


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .++.+++.+||+.+|++|||+.++++
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         227 QDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            88999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.4e-35  Score=247.82  Aligned_cols=244  Identities=28%  Similarity=0.333  Sum_probs=188.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||++.....+..+++|......... ..+.+.+|++.++.++|+|++++++.+...+..++++|++.+++|.+++....
T Consensus        16 ~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~   94 (267)
T cd06610          16 VVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSY   94 (267)
T ss_pred             EEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhc
Confidence            57888776677778888664333222 56788999999999999999999999999999999999999999999997543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc--cccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL--HSTR  159 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~  159 (285)
                      ..      ..+++..+..++.|++.|+.+||+.   |++|+|++|+||+++.++.++|+|||++..........  ....
T Consensus        95 ~~------~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  165 (267)
T cd06610          95 PR------GGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT  165 (267)
T ss_pred             cc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccccccc
Confidence            20      1278899999999999999999999   99999999999999999999999999886544322111  1123


Q ss_pred             cccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC-CC
Q 023220          160 VLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE-YP  237 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  237 (285)
                      ..++..|+|||.+... .++.++|+||||+++++|++|..||...........  ....          ..+..... ..
T Consensus       166 ~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~--~~~~----------~~~~~~~~~~~  233 (267)
T cd06610         166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML--TLQN----------DPPSLETGADY  233 (267)
T ss_pred             ccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH--HhcC----------CCCCcCCcccc
Confidence            3578899999988766 678999999999999999999999975433211110  0000          00111111 12


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+++.+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         234 KKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            356778999999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.5e-35  Score=246.04  Aligned_cols=239  Identities=23%  Similarity=0.328  Sum_probs=188.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .+|++........+++|............+.+.+|++++++++|+||+++++++...+..++++||+.+++|.+++....
T Consensus        15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   94 (264)
T cd06626          15 KVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR   94 (264)
T ss_pred             EEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC
Confidence            47888777777888888776544444467889999999999999999999999999999999999999999999987643


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc--ccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH--STR  159 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~--~~~  159 (285)
                               .+++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++...........  ...
T Consensus        95 ---------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~  162 (264)
T cd06626          95 ---------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS  162 (264)
T ss_pred             ---------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccC
Confidence                     277889999999999999999999   999999999999999999999999999876543222111  112


Q ss_pred             cccccCcCCCcccccCC---CCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          160 VLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ..++..|+|||.+.+..   ++.++|+||||++++++++|+.||...+........              ... ......
T Consensus       163 ~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~--------------~~~-~~~~~~  227 (264)
T cd06626         163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--------------VGA-GHKPPI  227 (264)
T ss_pred             CcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH--------------Hhc-CCCCCC
Confidence            34678999999987665   789999999999999999999999754321111100              000 001111


Q ss_pred             C--hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          237 P--PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       237 ~--~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +  ..++..+.+++.+||+.+|++|||+.+++.
T Consensus       228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         228 PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            2  233677899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.4e-36  Score=258.37  Aligned_cols=253  Identities=19%  Similarity=0.264  Sum_probs=189.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe----CCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE----GNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||++.+..++..+++|............+.+.+|+.++++++||||+++++++..    ....++|+||+. ++|.+++
T Consensus        20 ~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~   98 (334)
T cd07855          20 VVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHII   98 (334)
T ss_pred             EEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHh
Confidence            47899888889999999776544444567788899999999999999999998863    346799999996 5898988


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc--c
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR--L  155 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~  155 (285)
                      .....         +++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++.........  .
T Consensus        99 ~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  166 (334)
T cd07855          99 HSDQP---------LTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY  166 (334)
T ss_pred             ccCCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCc
Confidence            65432         88999999999999999999999   9999999999999999999999999998654322111  0


Q ss_pred             cccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh--------hh
Q 023220          156 HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV--------KQ  226 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~  226 (285)
                      ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+.......+.......+....        ..
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~  246 (334)
T cd07855         167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRK  246 (334)
T ss_pred             ccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHH
Confidence            1122357889999998765 45789999999999999999999999765443222222221111111111        11


Q ss_pred             hcCC-ccCCC-----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          227 CVDP-KLKGE-----YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       227 ~~~~-~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .... .....     ..+..+.++.++|.+||+.+|++|||+++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         247 YIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            1100 00001     11345788999999999999999999999888

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.1e-35  Score=250.65  Aligned_cols=256  Identities=16%  Similarity=0.160  Sum_probs=187.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceEEEeCCe-----eeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNL-----RVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~-----~~lv~e~~~~~~L~~   75 (285)
                      .||++.+..+++.+++|..+...........+.+|+.++++++ |+||+++++++...+.     .+++|||+.+ +|.+
T Consensus        16 ~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~   94 (295)
T cd07837          16 KVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKK   94 (295)
T ss_pred             EEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHH
Confidence            5899988888899999987665555556678899999999995 6999999999987665     7999999986 8888


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-CCeeEEeccccCCCCCccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~  154 (285)
                      ++.......    ...+++..++.++.|++.||.|||+.   |++|+||+|+||+++. ++.++|+|||.+.........
T Consensus        95 ~~~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~  167 (295)
T cd07837          95 FMDSNGRGP----GRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS  167 (295)
T ss_pred             HHHHhcccC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceecCCCccc
Confidence            886543211    11389999999999999999999999   9999999999999998 889999999988654321111


Q ss_pred             ccccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhh---hhhhc--
Q 023220          155 LHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDK---VKQCV--  228 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--  228 (285)
                        .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+...........   .....  
T Consensus       168 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (295)
T cd07837         168 --YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDW  245 (295)
T ss_pred             --cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccch
Confidence              122345778999998765 4578999999999999999999999976543222111110000000000   00000  


Q ss_pred             ------CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          229 ------DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       229 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                            .+.......+..+..+.++|.+||+.||++||++.+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         246 HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                  000000111345778999999999999999999999886

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-36  Score=238.84  Aligned_cols=241  Identities=17%  Similarity=0.198  Sum_probs=190.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeC----CeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEG----NLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~   76 (285)
                      .|-.|+.+.+++-|+.|+...       ....++|+++=-.. .|||||.++++|.+.    .-+.+|||+++||.|++.
T Consensus        77 kV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsr  149 (400)
T KOG0604|consen   77 KVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSR  149 (400)
T ss_pred             ceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHH
Confidence            467899999999999998874       34556777764444 899999999998753    356889999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc---CCeeEEeccccCCCCCcccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~  153 (285)
                      ++++...       .+++..+..|+.||..|+.|||..   +|.|||+||+|+|+..   +-.+||+|||.++.......
T Consensus       150 iq~~g~~-------afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~  219 (400)
T KOG0604|consen  150 IQDRGDQ-------AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGD  219 (400)
T ss_pred             HHHcccc-------cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCCcc
Confidence            9887654       399999999999999999999999   9999999999999964   45689999999986543222


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                      .   .....|+.|.|||++...+|+..+|+||+|+++|-|++|.+||........           +......+....+.
T Consensus       220 L---~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-----------spgMk~rI~~gqy~  285 (400)
T KOG0604|consen  220 L---MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKRRIRTGQYE  285 (400)
T ss_pred             c---cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-----------ChhHHhHhhccCcc
Confidence            1   234568999999999999999999999999999999999999986543211           22222222222221


Q ss_pred             CC--CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          234 GE--YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       234 ~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      -.  -=..+++...++|+.+|..+|.+|.|+++++.  ..++..
T Consensus       286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~--hpwi~~  327 (400)
T KOG0604|consen  286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD--HPWINQ  327 (400)
T ss_pred             CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc--Cchhcc
Confidence            11  11467889999999999999999999999987  555543

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=248.65  Aligned_cols=238  Identities=24%  Similarity=0.356  Sum_probs=182.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCC------eeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGN------LRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~   74 (285)
                      .+|++.....++.+++|......   ...+++.+|+++++++ +|+||+++++++....      ..+++|||+.+++|.
T Consensus        21 ~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~   97 (275)
T cd06608          21 KVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT   97 (275)
T ss_pred             EEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHH
Confidence            47888887777788888664322   2346788999999999 7999999999997644      589999999999999


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  154 (285)
                      +++.......     ..++...+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++.........
T Consensus        98 ~~~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~  169 (275)
T cd06608          98 DLVKGLRKKG-----KRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR  169 (275)
T ss_pred             HHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecccchhh
Confidence            9986533110     1288999999999999999999999   9999999999999999999999999998654432221


Q ss_pred             ccccccccccCcCCCccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC
Q 023220          155 LHSTRVLGTFGYHAPEYAMT-----GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD  229 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
                        .....++..|+|||.+..     ..++.++|+||||+++|+|++|..||..........               .+..
T Consensus       170 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~  232 (275)
T cd06608         170 --RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF---------------KIPR  232 (275)
T ss_pred             --hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH---------------Hhhc
Confidence              233457889999998753     346789999999999999999999997543211111               1110


Q ss_pred             -CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          230 -PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       230 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                       .......+..++..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             00011223346678999999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.3e-35  Score=250.32  Aligned_cols=253  Identities=16%  Similarity=0.187  Sum_probs=186.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+...++.+++|............+.+.+|++++++++||||+++++++.++...++||||+. ++|.+++....
T Consensus        17 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   95 (294)
T PLN00009         17 VVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSP   95 (294)
T ss_pred             EEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCC
Confidence            47888887778889999876655444556788899999999999999999999999999999999996 48888876543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-CCeeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..       .++...+..++.|++.|+.|||++   |++|+||+|+||+++. ++.++|+|||++.........  ....
T Consensus        96 ~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~--~~~~  163 (294)
T PLN00009         96 DF-------AKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHE  163 (294)
T ss_pred             CC-------CcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc--cccC
Confidence            22       157788899999999999999999   9999999999999985 567899999998654332111  1223


Q ss_pred             ccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh---------hhh---
Q 023220          161 LGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV---------KQC---  227 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~~---  227 (285)
                      .++..|+|||.+.+. .++.++|+||+|+++|+|++|..||........................         ...   
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (294)
T PLN00009        164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPK  243 (294)
T ss_pred             ceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhccc
Confidence            467889999987654 5789999999999999999999999765432222111100000000000         000   


Q ss_pred             cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          228 VDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       228 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+.......+..+..+.+++.+||+.+|++||++.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        244 WPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             CCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000000112345677999999999999999999999987

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.3e-35  Score=251.99  Aligned_cols=254  Identities=18%  Similarity=0.242  Sum_probs=185.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC--------eeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN--------LRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~~~L   73 (285)
                      .||++.+..+++.+++|..............+.+|++++++++||||+++++++....        ..+++|||+.+ +|
T Consensus        27 ~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l  105 (310)
T cd07865          27 EVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DL  105 (310)
T ss_pred             EEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CH
Confidence            5899988888999999977655545555667788999999999999999999987543        45999999975 88


Q ss_pred             HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc
Q 023220           74 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        74 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  153 (285)
                      .+++.....        .+++..++.++.|+++|+.|||+.   |++|+||+|+||+++.++.++|+|||++........
T Consensus       106 ~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  174 (310)
T cd07865         106 AGLLSNKNV--------KFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKN  174 (310)
T ss_pred             HHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcc
Confidence            888765431        288999999999999999999999   999999999999999999999999999875533221


Q ss_pred             cc--cccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh-----
Q 023220          154 RL--HSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK-----  225 (285)
Q Consensus       154 ~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----  225 (285)
                      ..  ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.......+.+...     
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (310)
T cd07865         175 SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKL  254 (310)
T ss_pred             cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccch
Confidence            11  11223467789999987654 46889999999999999999999997765433322222211111111000     


Q ss_pred             ----hhcCCcc-CCC-----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          226 ----QCVDPKL-KGE-----YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       226 ----~~~~~~~-~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                          ....+.. ...     .+...+..+.++|.+||+.||.+|||++++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         255 ELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                0000000 000     00112456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.3e-35  Score=250.28  Aligned_cols=236  Identities=23%  Similarity=0.312  Sum_probs=182.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEe------CCeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVE------GNLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~   74 (285)
                      .||++....+++.+++|.....   ......+..|+.+++++ +|+||+++++++..      ....+++|||+.+++|.
T Consensus        31 ~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~  107 (282)
T cd06636          31 QVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVT  107 (282)
T ss_pred             EEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHH
Confidence            4788888888888888865432   22346778899999998 79999999999853      45789999999999999


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  154 (285)
                      +++......       .+++..++.++.|++.|+.|||+.   |++|+|++|+||+++.++.++|+|||++........ 
T Consensus       108 ~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~-  176 (282)
T cd06636         108 DLVKNTKGN-------ALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-  176 (282)
T ss_pred             HHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc-
Confidence            999754322       277888999999999999999999   999999999999999999999999999865432211 


Q ss_pred             ccccccccccCcCCCcccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC
Q 023220          155 LHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD  229 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
                       ......|+..|+|||.+.     ...++.++|+|||||++|+|++|..||....+......               ...
T Consensus       177 -~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~---------------~~~  240 (282)
T cd06636         177 -RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL---------------IPR  240 (282)
T ss_pred             -CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh---------------Hhh
Confidence             122345788999999875     34578899999999999999999999975433211111               111


Q ss_pred             CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          230 PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       230 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..........++.++.++|.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            11111122346678999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=247.92  Aligned_cols=236  Identities=19%  Similarity=0.212  Sum_probs=180.6

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHH-HccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSV-VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++.+...++.+++|...+... .......+..|..+ ..+.+|+|++++++.+..++..++++||+.+++|.+++..
T Consensus        11 ~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   90 (260)
T cd05611          11 SVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT   90 (260)
T ss_pred             eEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHH
Confidence            589998888888999997754321 12222334445444 4455999999999999999999999999999999999975


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         ++...+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++.....      ...
T Consensus        91 ~~~---------~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~  152 (260)
T cd05611          91 LGG---------LPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKK  152 (260)
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc------ccc
Confidence            432         78899999999999999999999   999999999999999999999999998764322      123


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||...............             ...........
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~  219 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR-------------RINWPEEVKEF  219 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-------------ccCCCCccccc
Confidence            35678899999988877899999999999999999999999754332111110000             00011112234


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      ++..+.+++.+||+.+|++||++..+.+.
T Consensus       220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         220 CSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             CCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence            67789999999999999999976544443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=256.19  Aligned_cols=257  Identities=19%  Similarity=0.249  Sum_probs=188.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC-----CeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG-----NLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++.+..+++.+++|..... ........+.+|+.++++++|+||+++++++...     ...++++||+.+ +|.++
T Consensus        20 ~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~   97 (336)
T cd07849          20 MVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKL   97 (336)
T ss_pred             EEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHH
Confidence            4788888888888999877532 2334566788899999999999999999987654     357999999975 88888


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc-
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL-  155 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-  155 (285)
                      +....          +++..+..++.|++.||.+||+.   |++||||+|+||+++.++.++|+|||++.......... 
T Consensus        98 ~~~~~----------l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  164 (336)
T cd07849          98 IKTQH----------LSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTG  164 (336)
T ss_pred             HhcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccccccC
Confidence            76542          88999999999999999999999   99999999999999999999999999986543322111 


Q ss_pred             cccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc--
Q 023220          156 HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL--  232 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  232 (285)
                      ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.+.......+.........+....+.+...  
T Consensus       165 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (336)
T cd07849         165 FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARN  244 (336)
T ss_pred             CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhh
Confidence            1122357888999998654 4678999999999999999999999976543221111111111111111111111110  


Q ss_pred             -------CC-----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hchhh
Q 023220          233 -------KG-----EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA--LQPLL  273 (285)
Q Consensus       233 -------~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~--l~~~~  273 (285)
                             ..     ...+..+.++.+++.+||+.+|.+|||+.++++.  ++...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         245 YIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence                   00     0112346779999999999999999999999985  55544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=6.2e-36  Score=241.09  Aligned_cols=260  Identities=18%  Similarity=0.233  Sum_probs=197.2

Q ss_pred             Cceeeeeeeecc----ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe-CCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEE----SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE-GNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||+++...++.    .|++|.++..+.-........+|+.++++++|+|++.+..+|.+ +...+++++|.+. +|.++
T Consensus        39 ~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~I  117 (438)
T KOG0666|consen   39 KVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHI  117 (438)
T ss_pred             eeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHH
Confidence            488887665554    78999888877766778888999999999999999999999987 7788999999998 99999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC----CeeEEeccccCCCCCccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED----FKAKIADFNLSNQAPDMA  152 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~----~~~~l~df~~~~~~~~~~  152 (285)
                      |+........    .++...+..++.||+.++.|||++   =++|||+||.||++..+    |.|||+|||+++...+..
T Consensus       118 I~fHr~~~~~----~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~pl  190 (438)
T KOG0666|consen  118 IKFHRASKAK----QLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPL  190 (438)
T ss_pred             HHHhccchhc----cCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccHHHHhhccc
Confidence            9876654432    389999999999999999999999   99999999999999877    999999999998876655


Q ss_pred             ccc-cccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccch---------hhhhhcccCch
Q 023220          153 ARL-HSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS---------LVTWATPRLSE  221 (285)
Q Consensus       153 ~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~---------~~~~~~~~~~~  221 (285)
                      ... .....+-|.+|+|||++.+. .|+.+.|+|++||++.||++..+.|.+........         .+-......+.
T Consensus       191 kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~  270 (438)
T KOG0666|consen  191 KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTD  270 (438)
T ss_pred             cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCcc
Confidence            444 23445678999999999876 58999999999999999999999997653221111         11111111111


Q ss_pred             hh---hhhhc---------CCccCCCC--------ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 023220          222 DK---VKQCV---------DPKLKGEY--------PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL  269 (285)
Q Consensus       222 ~~---~~~~~---------~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l  269 (285)
                      ..   +.+.-         ........        ...-+++..+++.++|..||.+|.|+++.++.-
T Consensus       271 ~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  271 KDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             ccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            10   00000         00000000        001234588999999999999999999998853

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=252.64  Aligned_cols=258  Identities=18%  Similarity=0.234  Sum_probs=187.3

Q ss_pred             Cceeeeeee--eccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeC--CeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQ--VEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG--NLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~--~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++.+..  .+..+++|...... ......+.+.+|+.++++++||||+++++++.+.  ...++||||+.+ +|.++
T Consensus        15 ~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~   93 (316)
T cd07842          15 RVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQI   93 (316)
T ss_pred             EEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHH
Confidence            478888877  78899999777543 3345567888999999999999999999999988  789999999975 77777


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc----CCeeEEeccccCCCCCccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE----DFKAKIADFNLSNQAPDMA  152 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~----~~~~~l~df~~~~~~~~~~  152 (285)
                      +........    ..++...++.++.|++.|+.|||+.   +++|+||+|+||+++.    ++.++|+|||++.......
T Consensus        94 ~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~  166 (316)
T cd07842          94 IKFHRQAKR----VSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL  166 (316)
T ss_pred             HHhhccCCC----cCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCc
Confidence            654332111    1388999999999999999999999   9999999999999999    8999999999987654322


Q ss_pred             c-cccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccch----------hhhhhcccCc
Q 023220          153 A-RLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS----------LVTWATPRLS  220 (285)
Q Consensus       153 ~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~----------~~~~~~~~~~  220 (285)
                      . ........++..|+|||.+.+. .++.++|+||||+++++|++|..||.+........          ..........
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  246 (316)
T cd07842         167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTE  246 (316)
T ss_pred             ccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCch
Confidence            2 1112234567889999987664 57899999999999999999999998654432100          0000000000


Q ss_pred             h--------hhhhhhcCCccCCCCC-----------hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          221 E--------DKVKQCVDPKLKGEYP-----------PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       221 ~--------~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .        .......+.......+           ...+..+.+++.+||+.||++|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         247 KDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             hHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0        0000000000001111           134567999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.6e-35  Score=248.22  Aligned_cols=235  Identities=23%  Similarity=0.313  Sum_probs=187.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++........+++|.......   ..+.+.+|++++++++|+|++++++.+......++++||+.+++|.+++....
T Consensus        34 ~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  110 (286)
T cd06614          34 EVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF  110 (286)
T ss_pred             EEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc
Confidence            478887776677788887653222   46778899999999999999999999999999999999999999999998754


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .++...+..++.|++.++.|||+.   |++|+|++|+||+++.++.++|+|||.+........  ......
T Consensus       111 ~--------~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  177 (286)
T cd06614         111 V--------RMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVV  177 (286)
T ss_pred             c--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhcccc
Confidence            1        288999999999999999999999   999999999999999999999999998754432211  112234


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc-CCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL-KGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  240 (285)
                      ++..|++||.+.+..++.++|+||||+++|+|++|..||....+.....               .+..... ....+..+
T Consensus       178 ~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~  242 (286)
T cd06614         178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF---------------LITTKGIPPLKNPEKW  242 (286)
T ss_pred             CCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH---------------HHHhcCCCCCcchhhC
Confidence            6788999999888888999999999999999999999997543321111               0100000 01112235


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +..+.++|.+||+.+|.+|||+.++++
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         243 SPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            678999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.8e-35  Score=246.21  Aligned_cols=248  Identities=19%  Similarity=0.238  Sum_probs=182.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceEEEeC--CeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEG--NLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++.+...+..+++|..+........ ....+|+.+++++. |+|++++++++.++  +..++++||+.+ +|.+.+.
T Consensus        14 ~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~   91 (282)
T cd07831          14 EVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIK   91 (282)
T ss_pred             eEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHH
Confidence            5889988888889999977654332222 23457888899884 99999999999987  889999999975 8888876


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....        .+++..++.++.|++.||.|||+.   |++|+||+|+||+++. +.++|+|||++.........   .
T Consensus        92 ~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~  156 (282)
T cd07831          92 GRKR--------PLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---T  156 (282)
T ss_pred             hccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCc---C
Confidence            5432        289999999999999999999999   9999999999999999 99999999998765332211   2


Q ss_pred             ccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC----
Q 023220          159 RVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK----  233 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  233 (285)
                      ...++..|+|||.+.. ..++.++|+||+||++|+|++|..||...+.................. +.........    
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  235 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAE-VLKKFRKSRHMNYN  235 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHH-HHHhhccccccccc
Confidence            2346788999997654 456889999999999999999999997654322211111111111110 0000000000    


Q ss_pred             ---------CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          234 ---------GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       234 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                               .......+..+.++|.+||+.+|++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                     0112345789999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.6e-35  Score=248.93  Aligned_cols=240  Identities=22%  Similarity=0.311  Sum_probs=182.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEE-----eCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCV-----EGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~   75 (285)
                      +||++.+...++.+++|.....   ....+.+.+|+.+++.+ +||||+++++++.     .++..+++|||+.+++|.+
T Consensus        33 ~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~  109 (286)
T cd06638          33 KVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD  109 (286)
T ss_pred             EEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHH
Confidence            5788888888888888865432   22346678899999999 7999999999874     4457899999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++......     ...+++..+..++.|++.|+.|||+.   +++|+|++|+||+++.++.++|+|||++........  
T Consensus       110 ~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--  179 (286)
T cd06638         110 LVKGFLKR-----GERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--  179 (286)
T ss_pred             HHHHhhcc-----CccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecccCCC--
Confidence            87643211     11278889999999999999999999   999999999999999999999999999865432211  


Q ss_pred             cccccccccCcCCCcccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          156 HSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                      ......|+..|+|||.+.     ...++.++|+||+||++|+|++|+.||.............            ..  .
T Consensus       180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~------------~~--~  245 (286)
T cd06638         180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP------------RN--P  245 (286)
T ss_pred             ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc------------cc--C
Confidence            122345788999999874     2457889999999999999999999997543221110000            00  0


Q ss_pred             ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          231 KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      ......+..++..+.+++.+||+.||++|||+.++++.
T Consensus       246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            00011122345679999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3e-35  Score=249.66  Aligned_cols=236  Identities=22%  Similarity=0.302  Sum_probs=187.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||++.+...+..+++|.....  .....+.+.+|+.++++++|||++++++.+...+..++|+||+.+++|.+++....
T Consensus        34 ~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  111 (293)
T cd06647          34 TVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC  111 (293)
T ss_pred             EEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcC
Confidence            4788877767777888866422  22335678899999999999999999999999999999999999999999987542


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                ++...+..++.|++.|+.|||++   |++|+|++|+||+++.++.++|+|||++........  ......
T Consensus       112 ----------l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~  176 (293)
T cd06647         112 ----------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMV  176 (293)
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--cccccc
Confidence                      78889999999999999999999   999999999999999999999999998765433221  122345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      +++.|++||.+....++.++|+||||+++|++++|..||..............              .+......+...+
T Consensus       177 ~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~  242 (293)
T cd06647         177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--------------NGTPELQNPEKLS  242 (293)
T ss_pred             CChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--------------CCCCCCCCccccC
Confidence            77889999999888889999999999999999999999976543221111000              0000011233456


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      ..+.+++.+||+.+|++||++.+++..
T Consensus       243 ~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         243 AIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            679999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.9e-35  Score=254.56  Aligned_cols=253  Identities=21%  Similarity=0.287  Sum_probs=187.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeC--CeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEG--NLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .+|++.+..+++.+++|..............+.+|+.+++++ +||||+++++++...  ...++||||+.+ +|.+++.
T Consensus        22 ~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~  100 (337)
T cd07852          22 IVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIR  100 (337)
T ss_pred             eEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccccc-CHHHHHh
Confidence            478888887788888887654333334456677899999999 999999999998653  367999999974 9999887


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc---c
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR---L  155 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~  155 (285)
                      ...          +.+..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++.........   .
T Consensus       101 ~~~----------~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~  167 (337)
T cd07852         101 ANI----------LEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP  167 (337)
T ss_pred             cCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCc
Confidence            542          78889999999999999999999   9999999999999999999999999998755432211   1


Q ss_pred             cccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh--------h
Q 023220          156 HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK--------Q  226 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~  226 (285)
                      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.........................        .
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (337)
T cd07852         168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAAT  247 (337)
T ss_pred             chhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHH
Confidence            1223457888999998765 456889999999999999999999997654433222221111111111110        0


Q ss_pred             hcC----Ccc--CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          227 CVD----PKL--KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       227 ~~~----~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      +++    ...  .....+..+.++.+++.+||+.||++|||+.++++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         248 MLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            110    000  011122357789999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=249.68  Aligned_cols=253  Identities=18%  Similarity=0.244  Sum_probs=190.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC--CeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG--NLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++....+++.+++|..............+.+|++++++++|+|++++++++...  +..+++++|+.+ +|.+++..
T Consensus        14 ~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   92 (287)
T cd07840          14 QVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS   92 (287)
T ss_pred             EEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhc
Confidence            578998888888999998876654555667888999999999999999999999988  789999999975 88888865


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...        .+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++......... ....
T Consensus        93 ~~~--------~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~  160 (287)
T cd07840          93 PEV--------KFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTN  160 (287)
T ss_pred             cCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-cccc
Confidence            421        288999999999999999999999   9999999999999999999999999998755433211 1122


Q ss_pred             cccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh--------cCC
Q 023220          160 VLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC--------VDP  230 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~  230 (285)
                      ..++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........................        ..+
T Consensus       161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (287)
T cd07840         161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP  240 (287)
T ss_pred             cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence            345778999997765 45789999999999999999999999765543222211111111110000000        000


Q ss_pred             ------ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          231 ------KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       231 ------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                            .+.......++..+.+++.+||+.+|.+||+++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                  0000111113678999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.4e-35  Score=247.31  Aligned_cols=251  Identities=18%  Similarity=0.199  Sum_probs=182.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.+...+..+++|...... .......+.+|+.+++.++|+||+++++++.++...++++||+. +++.+++....
T Consensus        20 ~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   97 (291)
T cd07870          20 TVYKGISRINGQLVALKVISMKT-EEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHP   97 (291)
T ss_pred             EEEEEEEcCCCcEEEEEEecccC-cCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCC
Confidence            58899888888899999875433 23445577889999999999999999999999999999999996 57777765432


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+....+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        98 ~--------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~  164 (291)
T cd07870          98 G--------GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TYSSEV  164 (291)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--CCCCcc
Confidence            2        167788899999999999999999   999999999999999999999999998865432211  112334


Q ss_pred             cccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhc-ccCchhh------hh----hhc-
Q 023220          162 GTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT-PRLSEDK------VK----QCV-  228 (285)
Q Consensus       162 ~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~------~~----~~~-  228 (285)
                      ++..|+|||.+.+. .++.++|+||||+++|+|++|..||.............+.. .......      ..    ... 
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (291)
T cd07870         165 VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFL  244 (291)
T ss_pred             ccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhcc
Confidence            67899999988754 57889999999999999999999997654321111000000 0000000      00    000 


Q ss_pred             --CCccCCC--CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          229 --DPKLKGE--YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       229 --~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                        .+.....  .....+..+.+++.+|+..||.+|||+.+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         245 PCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence              0000000  00012467899999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.9e-35  Score=248.22  Aligned_cols=245  Identities=21%  Similarity=0.325  Sum_probs=189.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++....+++.+++|.....  .....+.+.+|+.+++.++|+|++++++.+..++..+++|||+.+++|.+++....
T Consensus        35 ~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  112 (292)
T cd06657          35 IVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR  112 (292)
T ss_pred             EEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcCC
Confidence            3677766677788888865322  22345678899999999999999999999999999999999999999999875432


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                +++..+..++.|++.+++|||+.   |++|+||+|+||+++.++.++|+|||.+........  ......
T Consensus       113 ----------~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  177 (292)
T cd06657         113 ----------MNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV  177 (292)
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence                      78899999999999999999999   999999999999999999999999998765432211  112345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ++..|++||.+.+..++.++|+||+|+++|+|++|..||............            .....+..  ......+
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~------------~~~~~~~~--~~~~~~~  243 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------------RDNLPPKL--KNLHKVS  243 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------HhhCCccc--CCcccCC
Confidence            778899999988888899999999999999999999999754322111110            00011111  1123356


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                      ..+.+++.+||+.+|.+||++.++++  ..++..-.+|
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~--~~~~~~~~~~  279 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPP  279 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhc--ChHHhccCCC
Confidence            67999999999999999999999998  5555444443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-35  Score=255.50  Aligned_cols=259  Identities=20%  Similarity=0.232  Sum_probs=196.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC-----eeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN-----LRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~   76 (285)
                      .||+|....+++.+++|............+.+.+|++++++++|+||+++.+++....     ..+++|+|+.+ +|.++
T Consensus        15 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~   93 (330)
T cd07834          15 VVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKV   93 (330)
T ss_pred             EEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhh-hHHHH
Confidence            4789988888888999877655444556778999999999999999999999998775     78999999974 89888


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-c
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-L  155 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~  155 (285)
                      +....         .+++..++.++.|++.|+.+||+.   |++|+||+|+||+++.++.++|+|||++......... .
T Consensus        94 l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~  161 (330)
T cd07834          94 IKSPQ---------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG  161 (330)
T ss_pred             HhCCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccc
Confidence            87543         289999999999999999999999   9999999999999999999999999998765432210 1


Q ss_pred             cccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh--------h
Q 023220          156 HSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK--------Q  226 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~  226 (285)
                      ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...........+.............        .
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  241 (330)
T cd07834         162 FLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARN  241 (330)
T ss_pred             cccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhh
Confidence            12234567889999999877 78999999999999999999999998765433222222111111111110        0


Q ss_pred             hcC---Cc---cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hchhh
Q 023220          227 CVD---PK---LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA--LQPLL  273 (285)
Q Consensus       227 ~~~---~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~--l~~~~  273 (285)
                      .+.   ..   ......+..+..+.+++.+||+.+|.+|||++++++.  |+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         242 YLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             HHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            000   00   0011123357789999999999999999999999983  44433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.2e-35  Score=246.20  Aligned_cols=239  Identities=23%  Similarity=0.286  Sum_probs=188.5

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||++.+..+++.+++|....... .+...+.+.+|++++++++||||+++++.+..+...++++||+.+++|.+++...
T Consensus         8 ~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   87 (265)
T cd05579           8 RVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV   87 (265)
T ss_pred             EEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHc
Confidence            589998888888899997754322 2345678889999999999999999999999999999999999999999999764


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc------c
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA------R  154 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~------~  154 (285)
                      .         .+++..+..++.|++.+|.|||+.   |++|+||+|+||+++.++.++|+|||++........      .
T Consensus        88 ~---------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          88 G---------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             C---------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            3         288999999999999999999999   999999999999999999999999998865432211      0


Q ss_pred             ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      .......++..|++||......++.++|+||||+++|++++|..||.........               ........  
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~--  218 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF---------------QNILNGKI--  218 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---------------HHHhcCCc--
Confidence            0122345678899999988888899999999999999999999999754422111               11111011  


Q ss_pred             CCChh--HHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 023220          235 EYPPK--GVAKLAAVAALCVQYEAEFRPNMSIVVKAL  269 (285)
Q Consensus       235 ~~~~~--~~~~l~~li~~~l~~~p~~Rps~~~ll~~l  269 (285)
                      ..+..  .+..+.+++.+||+.+|.+|||+..+.+.|
T Consensus       219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            11222  377899999999999999999994444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-37  Score=245.84  Aligned_cols=242  Identities=23%  Similarity=0.334  Sum_probs=199.2

Q ss_pred             ceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG   82 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~   82 (285)
                      ||+++-+-++.++++|.+..    ..-.+++..||.+++++..|++|++||.+.....+++|||||..|+..++++.++.
T Consensus        49 V~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K  124 (502)
T KOG0574|consen   49 VHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRK  124 (502)
T ss_pred             HHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcC
Confidence            56666666677777765532    22345677899999999999999999999999999999999999999999986653


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccccc
Q 023220           83 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLG  162 (285)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  162 (285)
                              .+++..+..+++.-+++|.|||..   .-+|||||..|||++.+|..+|.|||.+.........  .+-..|
T Consensus       125 --------~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK--RNTVIG  191 (502)
T KOG0574|consen  125 --------PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK--RNTVIG  191 (502)
T ss_pred             --------CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh--hCcccc
Confidence                    399999999999999999999999   9999999999999999999999999999765543332  345679


Q ss_pred             ccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHH
Q 023220          163 TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVA  242 (285)
Q Consensus       163 ~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (285)
                      |+.|+|||++..-.|+.++||||||++..||..|++||...++.....++....+.            .  -..|..++.
T Consensus       192 TPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPP------------T--F~KPE~WS~  257 (502)
T KOG0574|consen  192 TPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPP------------T--FKKPEEWSS  257 (502)
T ss_pred             CcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCC------------C--CCChHhhhh
Confidence            99999999999999999999999999999999999999887776555544322211            0  123567888


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          243 KLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                      ++-+++++||.++|++|-|+..+++  ..+++..+
T Consensus       258 ~F~DFi~~CLiK~PE~R~TA~~L~~--H~FiknA~  290 (502)
T KOG0574|consen  258 EFNDFIRSCLIKKPEERKTALRLCE--HTFIKNAP  290 (502)
T ss_pred             HHHHHHHHHhcCCHHHHHHHHHHhh--hhhhcCCC
Confidence            9999999999999999999999887  34444333

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.3e-35  Score=246.95  Aligned_cols=239  Identities=22%  Similarity=0.306  Sum_probs=181.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeC-----CeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEG-----NLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~   75 (285)
                      +||++.....++.+++|.....   ....+.+.+|+.+++++ +|||++++++++...     +..++++||+.+++|.+
T Consensus        37 ~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~  113 (291)
T cd06639          37 KVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTE  113 (291)
T ss_pred             EEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHH
Confidence            4788888777888888876532   22346778899999999 899999999998753     35799999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++......     ...+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++........  
T Consensus       114 ~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--  183 (291)
T cd06639         114 LVKGLLIC-----GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--  183 (291)
T ss_pred             HHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcccccc--
Confidence            88642211     11278999999999999999999999   999999999999999999999999999865432221  


Q ss_pred             cccccccccCcCCCcccccC-----CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTG-----QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                      ......++..|+|||.+...     .++.++|+|||||++|+|++|+.||..........  ....            .+
T Consensus       184 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~--~~~~------------~~  249 (291)
T cd06639         184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF--KIPR------------NP  249 (291)
T ss_pred             cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH--HHhc------------CC
Confidence            11234578889999987543     36889999999999999999999997543211110  0000            00


Q ss_pred             ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          231 KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ......+...+..+.+++.+||+.+|++||++.++++
T Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            0001112334567999999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.7e-35  Score=248.78  Aligned_cols=253  Identities=19%  Similarity=0.212  Sum_probs=185.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC----------eeeEEEeeCCCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN----------LRVLAYEFATMG   71 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----------~~~lv~e~~~~~   71 (285)
                      .||++.....++.+++|..+...........+.+|++++++++|||++++++++.+..          ..++++||+.+ 
T Consensus        22 ~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-  100 (302)
T cd07864          22 QVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-  100 (302)
T ss_pred             EEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-
Confidence            4788888878888999987655545556677889999999999999999999987654          78999999986 


Q ss_pred             CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcc
Q 023220           72 SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM  151 (285)
Q Consensus        72 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~  151 (285)
                      ++...+.....        .+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++......
T Consensus       101 ~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  169 (302)
T cd07864         101 DLMGLLESGLV--------HFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE  169 (302)
T ss_pred             cHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccccccccCC
Confidence            77777764421        288999999999999999999999   9999999999999999999999999998755432


Q ss_pred             cccccccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh---
Q 023220          152 AARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC---  227 (285)
Q Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---  227 (285)
                      ... ......++..|+|||.+.+ ..++.++|+||+||++++|++|+.||...........+..............+   
T Consensus       170 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (302)
T cd07864         170 ESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKL  248 (302)
T ss_pred             ccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccc
Confidence            211 1112235678999998764 35688999999999999999999999754432221111111001000000000   


Q ss_pred             -----cCCc-----cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          228 -----VDPK-----LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       228 -----~~~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                           .++.     .........+..+.+++.+||+.+|++|||+++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         249 PYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 0000     000111234678999999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.3e-35  Score=247.17  Aligned_cols=240  Identities=23%  Similarity=0.235  Sum_probs=180.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHH-HccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSV-VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.+..+++.+++|..+...... ...++..|+.. ++.++||||+++++++..++..+++|||+. ++|.+++...
T Consensus        16 ~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~   93 (283)
T cd06617          16 VVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKV   93 (283)
T ss_pred             EEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHh
Confidence            58999888889999999776443222 23445556665 566699999999999999999999999997 5888887653


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ....     ..+++..++.++.|++.|+.|||++.  +++||||+|+||+++.++.++|+|||++.......   .....
T Consensus        94 ~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~  163 (283)
T cd06617          94 YDKG-----LTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTID  163 (283)
T ss_pred             ccCC-----CCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccc---ccccc
Confidence            2111     13899999999999999999999842  79999999999999999999999999987543221   11224


Q ss_pred             ccccCcCCCccccc----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          161 LGTFGYHAPEYAMT----GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       161 ~~~~~~~aPE~~~~----~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      .++..|+|||.+.+    ..++.++|+|||||++|+|++|+.||.......              +.+............
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~~~  229 (283)
T cd06617         164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--------------QQLKQVVEEPSPQLP  229 (283)
T ss_pred             cCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--------------HHHHHHHhcCCCCCC
Confidence            57788999998764    356889999999999999999999996432110              111111111111111


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...++.++.+++.+||..+|++||++.++++
T Consensus       230 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2235678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.3e-34  Score=248.48  Aligned_cols=242  Identities=24%  Similarity=0.316  Sum_probs=186.6

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++........+++|....... .......+.+|++++++++|||++++++++.++...+++|||+.+ +|.+++...
T Consensus        40 ~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~  118 (317)
T cd06635          40 AVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVH  118 (317)
T ss_pred             EEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHh
Confidence            467887777778888886643322 223345788899999999999999999999999999999999975 787777543


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..        .+++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++.....      ....
T Consensus       119 ~~--------~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~  181 (317)
T cd06635         119 KK--------PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSF  181 (317)
T ss_pred             cC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC------cccc
Confidence            22        288899999999999999999999   999999999999999999999999998764332      1233


Q ss_pred             ccccCcCCCcccc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          161 LGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       161 ~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      .++..|+|||.+.   ...++.++|+|||||++|+|++|..||........               ...+..........
T Consensus       182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~  246 (317)
T cd06635         182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---------------LYHIAQNESPTLQS  246 (317)
T ss_pred             cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHhccCCCCCC
Confidence            5778899999874   34678899999999999999999999865432111               11111111111123


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      ..++..+.+++.+||+.+|.+||++.++++..-.+...+
T Consensus       247 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            345678999999999999999999999998665544443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-36  Score=259.31  Aligned_cols=239  Identities=26%  Similarity=0.333  Sum_probs=190.6

Q ss_pred             ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCC
Q 023220           14 SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD   93 (285)
Q Consensus        14 ~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~   93 (285)
                      -+|+|.-+... .+..+.+|.+|+++|.+|+||||++++|+|..++.+++|+||+++|+|.+++.......       +.
T Consensus       564 kVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt-------~~  635 (807)
T KOG1094|consen  564 KVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT-------AE  635 (807)
T ss_pred             EEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc-------cc
Confidence            44555544332 23457899999999999999999999999999999999999999999999998764211       34


Q ss_pred             HHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccc
Q 023220           94 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM  173 (285)
Q Consensus        94 ~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  173 (285)
                      ......++.||++|++||.+.   +++|||+.+.|+|++.++++||+|||+++...........+..+-...|+|+|.+.
T Consensus       636 t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsil  712 (807)
T KOG1094|consen  636 TAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESIL  712 (807)
T ss_pred             cchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHH
Confidence            456677999999999999999   99999999999999999999999999998766666555566667789999999999


Q ss_pred             cCCCCcccchHhHHHHHHHHHh--CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHh
Q 023220          174 TGQLTQKSDVYSFGVVLLELLT--GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALC  251 (285)
Q Consensus       174 ~~~~~~~~DiwslG~~l~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  251 (285)
                      ..+++.++|+|+||+++||+++  ...||.....++.-   .....-+.      --.+......|+.++..++++|-+|
T Consensus       713 lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~~~~~------~~~~~~~l~~P~~cp~~lyelml~C  783 (807)
T KOG1094|consen  713 LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAGEFFR------DQGRQVVLSRPPACPQGLYELMLRC  783 (807)
T ss_pred             hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---HhhhhhcC------CCCcceeccCCCcCcHHHHHHHHHH
Confidence            9999999999999999999866  78898654322111   10000000      0011122356778899999999999


Q ss_pred             cccCCCCCCCHHHHHHHhchh
Q 023220          252 VQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       252 l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      |.++-.+|||++++...|+..
T Consensus       784 w~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  784 WRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hchhhhcCCCHHHHHHHHHHh
Confidence            999999999999999988754

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.7e-35  Score=251.31  Aligned_cols=248  Identities=19%  Similarity=0.234  Sum_probs=186.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe-CCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.+..++..+++|...+........+.+.+|++++++++||||+++.+++.. +...++++||+. ++|.+++...
T Consensus        25 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~  103 (328)
T cd07856          25 LVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG-TDLHRLLTSR  103 (328)
T ss_pred             EEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehhc-cCHHHHHhcC
Confidence            57888888888899998765544444566788899999999999999999999875 557899999985 5898888654


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      .          ++...+..++.|+++||.|||+.   |++|+||+|+||+++.++.++|+|||.+......     ....
T Consensus       104 ~----------~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~  165 (328)
T cd07856         104 P----------LEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGY  165 (328)
T ss_pred             C----------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCC
Confidence            2          77888899999999999999999   9999999999999999999999999988654321     1223


Q ss_pred             ccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC---------C
Q 023220          161 LGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD---------P  230 (285)
Q Consensus       161 ~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~  230 (285)
                      .++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...................+.+......+         -
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (328)
T cd07856         166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL  245 (328)
T ss_pred             cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhc
Confidence            46778999998765 5688999999999999999999999976543222111111111111111110000         0


Q ss_pred             ccCC-----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          231 KLKG-----EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       231 ~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      ....     ...+..+..+.++|.+||+.+|++|||+++++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000     1112356789999999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=9.5e-35  Score=240.29  Aligned_cols=236  Identities=25%  Similarity=0.357  Sum_probs=187.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .+|++.....++.+++|.......  ...+.+.+|++++++++|+|++++++++..+...++++||+.+++|.+++....
T Consensus        15 ~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~   92 (253)
T cd05122          15 EVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN   92 (253)
T ss_pred             EEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC
Confidence            467777766677787777654332  356788999999999999999999999999999999999999899999987653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..+..++.|++.++.+||..   |++|+||+|+||+++.++.++|+|||.+........   .....
T Consensus        93 ~--------~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~  158 (253)
T cd05122          93 Q--------TLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMV  158 (253)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---cccee
Confidence            1        289999999999999999999999   999999999999999999999999998876543221   23345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ++..|++||.+.+..++.++|+||||+++++|++|+.||...+.........            .  ...........++
T Consensus       159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------~--~~~~~~~~~~~~~  224 (253)
T cd05122         159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA------------T--NGPPGLRNPEKWS  224 (253)
T ss_pred             cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH------------h--cCCCCcCcccccC
Confidence            7889999999988888999999999999999999999997543211111000            0  0000001122236


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+.+++.+||+.||++|||+.++++
T Consensus       225 ~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         225 DEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhc
Confidence            78999999999999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.1e-35  Score=248.61  Aligned_cols=234  Identities=24%  Similarity=0.308  Sum_probs=182.2

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.....++.+++|...... ......+++.+|+++++.++|||++++++++.+.+..++|+||+. |++.+++...
T Consensus        30 ~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~  108 (307)
T cd06607          30 AVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVH  108 (307)
T ss_pred             EEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHc
Confidence            47888777778888888664332 222334678899999999999999999999999999999999997 4777777543


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..        .+++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++......      ...
T Consensus       109 ~~--------~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~  171 (307)
T cd06607         109 KK--------PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSF  171 (307)
T ss_pred             cc--------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC------CCc
Confidence            22        288999999999999999999999   9999999999999999999999999988654321      223


Q ss_pred             ccccCcCCCcccc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          161 LGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       161 ~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      .++..|+|||.+.   ...++.++|+||||+++|+|++|..||.............               .........
T Consensus       172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~---------------~~~~~~~~~  236 (307)
T cd06607         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---------------QNDSPTLSS  236 (307)
T ss_pred             cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh---------------cCCCCCCCc
Confidence            4678899999874   3467889999999999999999999997543221111100               000001112


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      ..++..+.+++.+||+.+|++||++.+++..
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             hhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            3456789999999999999999999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-35  Score=241.77  Aligned_cols=236  Identities=25%  Similarity=0.338  Sum_probs=191.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .+|++.+....+.+++|............+.+.+|++++++++|+|++++++++.+.+..+++++++.+++|.+++....
T Consensus        15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~   94 (254)
T cd06627          15 VVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG   94 (254)
T ss_pred             EEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc
Confidence            46777777677788888776655444566789999999999999999999999999999999999999999999987653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                               .+++..++.++.|++.++.+||+.   |++|+||+|+||+++.++.++|+|||.+.........  .....
T Consensus        95 ---------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~  160 (254)
T cd06627          95 ---------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVV  160 (254)
T ss_pred             ---------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccc
Confidence                     289999999999999999999999   9999999999999999999999999998765432221  12345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ++..|+|||...+..++.++|+||+|+++++|++|..||..........               ... .......+...+
T Consensus       161 ~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~---------------~~~-~~~~~~~~~~~~  224 (254)
T cd06627         161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF---------------RIV-QDDHPPLPEGIS  224 (254)
T ss_pred             cchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHH---------------HHh-ccCCCCCCCCCC
Confidence            6888999999887778899999999999999999999997543211110               000 111123344567


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+.+++.+||+.+|++|||+.+++.
T Consensus       225 ~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         225 PELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            78999999999999999999999885

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=282.13  Aligned_cols=240  Identities=24%  Similarity=0.275  Sum_probs=202.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||-|....+++.-++|.++---..........+|..++..++|||++.++|+=.+.+..+|.||||++|+|.+.++..+
T Consensus      1250 ~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gr 1329 (1509)
T KOG4645|consen 1250 KVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGR 1329 (1509)
T ss_pred             eeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcc
Confidence            68999999999999999987666666678888999999999999999999999999999999999999999999998775


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc--ccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA--ARLHSTR  159 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~  159 (285)
                      -         ..+.....+..|++.|++|||++   |||||||||.||+++.+|.+|++|||.|....+..  .......
T Consensus      1330 i---------~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~ 1397 (1509)
T KOG4645|consen 1330 I---------EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQS 1397 (1509)
T ss_pred             h---------hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHh
Confidence            3         66777788999999999999999   99999999999999999999999999997765432  1222345


Q ss_pred             cccccCcCCCcccccC---CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          160 VLGTFGYHAPEYAMTG---QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~---~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ..||+.|||||++.+.   .-..++||||+||++.||+||+.||...+...+               +.-.+-.+-..+.
T Consensus      1398 ~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a---------------IMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1398 MMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA---------------IMYHVAAGHKPQI 1462 (1509)
T ss_pred             hcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH---------------HHhHHhccCCCCC
Confidence            6799999999999865   346789999999999999999999976543222               2222233334456


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      |...+.+-.++|..||..||.+|-++.++++.
T Consensus      1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            77788999999999999999999999988874

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.7e-35  Score=241.62  Aligned_cols=216  Identities=19%  Similarity=0.194  Sum_probs=174.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.+..+++.|++|......       .+.+|...+....||||+++++++...+..+++|||+.+++|.+++....
T Consensus         8 ~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   80 (237)
T cd05576           8 KVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL   80 (237)
T ss_pred             eEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc
Confidence            68999999999999999876432       23345555566689999999999999999999999999999999987543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++++|||.+.......     ....
T Consensus        81 ~---------l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~  143 (237)
T cd05576          81 N---------IPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEA  143 (237)
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCC
Confidence            2         88999999999999999999999   99999999999999999999999999875543211     2233


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ++..|+|||...+..++.++|+||+|+++|+|++|..|+.......                     ........+..++
T Consensus       144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------------~~~~~~~~~~~~~  202 (237)
T cd05576         144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------------NTHTTLNIPEWVS  202 (237)
T ss_pred             cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------------ccccccCCcccCC
Confidence            4667999999888888999999999999999999998875321100                     0000112344566


Q ss_pred             HHHHHHHHHhcccCCCCCCCH
Q 023220          242 AKLAAVAALCVQYEAEFRPNM  262 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~  262 (285)
                      +.+.++|.+||+.||++||++
T Consensus       203 ~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         203 EEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHHHccCCHHHhcCC
Confidence            789999999999999999986

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-34  Score=243.29  Aligned_cols=206  Identities=26%  Similarity=0.422  Sum_probs=163.2

Q ss_pred             ChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 023220           30 PDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLE  109 (285)
Q Consensus        30 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~  109 (285)
                      ...+.+|+.++++++||||+++++++..+...++||||+.+++|..++.....        .+++..+..++.|++.|+.
T Consensus        60 ~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~  131 (274)
T cd05076          60 ALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--------RVPVAWKITVAQQLASALS  131 (274)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHH
Confidence            45678899999999999999999999999999999999999999999865332        2788999999999999999


Q ss_pred             HHhhcCCCCeeeCCCCCCCeEEccCC-------eeEEeccccCCCCCcccccccccccccccCcCCCccccc-CCCCccc
Q 023220          110 YLHEKVQPSIIHRDIRSSNVLLFEDF-------KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKS  181 (285)
Q Consensus       110 ~lh~~~~~~~~h~di~~~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~  181 (285)
                      |||++   |++||||+|+||+++..+       .++++|||++......      ....++..|+|||.+.+ ..++.++
T Consensus       132 ~lH~~---~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~  202 (274)
T cd05076         132 YLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAA  202 (274)
T ss_pred             HHHcC---CccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHH
Confidence            99999   999999999999997643       4799999987543221      12245778999998865 5678999


Q ss_pred             chHhHHHHHHHHH-hCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCC
Q 023220          182 DVYSFGVVLLELL-TGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP  260 (285)
Q Consensus       182 DiwslG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (285)
                      |+||||+++|+++ +|..||....+.......                ...  ...+...+..+.++|.+||+.+|.+||
T Consensus       203 Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~----------------~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp  264 (274)
T cd05076         203 DKWSFGTTLLEICFDGEVPLKERTPSEKERFY----------------EKK--HRLPEPSCKELATLISQCLTYEPTQRP  264 (274)
T ss_pred             HHHHHHHHHHHHHhCCCCCccccChHHHHHHH----------------Hhc--cCCCCCCChHHHHHHHHHcccChhhCc
Confidence            9999999999995 699999754332111110                000  011222345799999999999999999


Q ss_pred             CHHHHHHHhc
Q 023220          261 NMSIVVKALQ  270 (285)
Q Consensus       261 s~~~ll~~l~  270 (285)
                      |+.++++.|.
T Consensus       265 s~~~il~~L~  274 (274)
T cd05076         265 SFRTILRDLT  274 (274)
T ss_pred             CHHHHHHhhC
Confidence            9999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-34  Score=244.92  Aligned_cols=253  Identities=20%  Similarity=0.241  Sum_probs=188.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..+++.+++|..+... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+.+ +|.+++....
T Consensus        15 ~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~   92 (284)
T cd07836          15 TVYKGRNRTTGEIVALKEIHLDA-EEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHG   92 (284)
T ss_pred             EEEEEEECCCCeEEEEEEecccc-cccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcC
Confidence            57899888888889999775432 233456778899999999999999999999999999999999985 8888876543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..      ..+++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        93 ~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~  161 (284)
T cd07836          93 VR------GALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEV  161 (284)
T ss_pred             CC------CCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--cccccc
Confidence            11      1289999999999999999999999   999999999999999999999999999865432111  112234


Q ss_pred             cccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC-CccC------
Q 023220          162 GTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD-PKLK------  233 (285)
Q Consensus       162 ~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~------  233 (285)
                      ++..|++||.+.+. .++.++|+||||+++|+|++|..||...+......................+.. +...      
T Consensus       162 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd07836         162 VTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRY  241 (284)
T ss_pred             ccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCC
Confidence            67889999987654 568899999999999999999999987654332221111111111111100000 0000      


Q ss_pred             -----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          234 -----GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       234 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                           ....+..+..+.+++.+||+.||.+||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         242 PPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 1112234678999999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.3e-34  Score=243.95  Aligned_cols=236  Identities=20%  Similarity=0.248  Sum_probs=182.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCC-CCChhHHHHH---HHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPK-NYPDDEKQLV---SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||++.+..+++.+++|......... .....+..|.   +.++...||+|+.+.+.+...+..++||||+.+++|..++
T Consensus         9 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l   88 (278)
T cd05606           9 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL   88 (278)
T ss_pred             EEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHH
Confidence            58999888888999999765433221 1122233343   3445568999999999999999999999999999999988


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      ....         .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.......    .
T Consensus        89 ~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~  152 (278)
T cd05606          89 SQHG---------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (278)
T ss_pred             HhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence            6543         289999999999999999999999   99999999999999999999999999986543221    1


Q ss_pred             cccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....|+..|+|||.+.+. .++.++|+||+|+++|+|++|..||..........             ..... .......
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-------------~~~~~-~~~~~~~  218 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-------------IDRMT-LTMAVEL  218 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-------------HHHHh-hccCCCC
Confidence            234578899999998744 68899999999999999999999997653221110             00000 0011223


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK  267 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~  267 (285)
                      +...+.++.+++.+||+.+|.+||     ++.++++
T Consensus       219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            445578899999999999999999     9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4e-35  Score=254.14  Aligned_cols=260  Identities=17%  Similarity=0.242  Sum_probs=186.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC--------------CeeeEEEee
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG--------------NLRVLAYEF   67 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------------~~~~lv~e~   67 (285)
                      +||++.+..++..+++|.......  ...+.+.+|++++++++||||+++++++...              ...++++||
T Consensus        20 ~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~   97 (342)
T cd07854          20 LVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEY   97 (342)
T ss_pred             EEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeec
Confidence            589999988899999987654332  4457788999999999999999999876654              357899999


Q ss_pred             CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-CCeeEEeccccCC
Q 023220           68 ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKIADFNLSN  146 (285)
Q Consensus        68 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-~~~~~l~df~~~~  146 (285)
                      +. ++|.+++....          +++..++.++.|+++|+.|||+.   |++|+||+|+||+++. ++.++++|||.+.
T Consensus        98 ~~-~~L~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~~~  163 (342)
T cd07854          98 ME-TDLANVLEQGP----------LSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLAR  163 (342)
T ss_pred             cc-ccHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcccce
Confidence            97 48988886442          88999999999999999999999   9999999999999974 5678999999986


Q ss_pred             CCCcccccc-cccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh
Q 023220          147 QAPDMAARL-HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV  224 (285)
Q Consensus       147 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
                      ......... ......++..|+|||.+.. ..++.++|+|||||++|+|++|+.||....+...........+.......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (342)
T cd07854         164 IVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR  243 (342)
T ss_pred             ecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            543221110 1122346788999997654 46788999999999999999999999765432221111111111000000


Q ss_pred             hhh--------cCCccC-----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          225 KQC--------VDPKLK-----GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       225 ~~~--------~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                      ...        ......     .......+.++.+++.+||+.||.+|||+.+++.  ..+++..+.|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~--h~~~~~~~~~  309 (342)
T cd07854         244 NELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM--HPYMSCYSCP  309 (342)
T ss_pred             hhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC--CCccccccCC
Confidence            000        000000     0112245678999999999999999999999986  4555444333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.3e-35  Score=252.91  Aligned_cols=253  Identities=21%  Similarity=0.271  Sum_probs=185.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC------eeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN------LRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~   75 (285)
                      .||++.+..+++.+++|...+..........+.+|++++++++||||+++++++....      ..+++++|+.. +|.+
T Consensus        30 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~  108 (342)
T cd07879          30 SVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQK  108 (342)
T ss_pred             EEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHH
Confidence            4788887777888999877654444445667889999999999999999999987543      46999999964 7777


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++..           .++...+..++.|++.|+.|||+.   |++||||+|+||+++.++.++|+|||++......    
T Consensus       109 ~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~----  170 (342)
T cd07879         109 IMGH-----------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----  170 (342)
T ss_pred             HHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC----
Confidence            6532           178899999999999999999999   9999999999999999999999999998654321    


Q ss_pred             cccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC-----
Q 023220          156 HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD-----  229 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  229 (285)
                       .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+....+.........+.+     
T Consensus       171 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (342)
T cd07879         171 -MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKS  249 (342)
T ss_pred             -CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHH
Confidence             122346788999998866 4678999999999999999999999986543222221111111111111100000     


Q ss_pred             -----Ccc-C---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hchhhc
Q 023220          230 -----PKL-K---GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA--LQPLLK  274 (285)
Q Consensus       230 -----~~~-~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~--l~~~~~  274 (285)
                           +.. .   ....+..+..+.++|.+||+.||.+||++.+++..  ++.+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                 000 0   00112345678999999999999999999999953  655543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=244.03  Aligned_cols=252  Identities=21%  Similarity=0.232  Sum_probs=186.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC---CCCcccccceEEEeCCe-----eeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL---KHENLVELLGYCVEGNL-----RVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~-----~~lv~e~~~~~~L   73 (285)
                      .||++....++..+++|..+...........+.+|+.+++++   +|+|++++++++...+.     .+++|||+.+ +|
T Consensus        14 ~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l   92 (287)
T cd07838          14 TVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DL   92 (287)
T ss_pred             EEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CH
Confidence            578998877888999998875544444456677788777665   69999999999988776     8999999975 89


Q ss_pred             HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc
Q 023220           74 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        74 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  153 (285)
                      .+++......       .+++..++.++.|++.||.|||+.   +++|+|++|+||+++.++.++|+|||.+........
T Consensus        93 ~~~l~~~~~~-------~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~  162 (287)
T cd07838          93 ATYLSKCPKP-------GLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA  162 (287)
T ss_pred             HHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceeccCCcc
Confidence            8888654321       288999999999999999999999   999999999999999999999999998866543221


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh-------hh
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV-------KQ  226 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~  226 (285)
                         .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+............       ..
T Consensus       163 ---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07838         163 ---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS  239 (287)
T ss_pred             ---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence               12234678899999998888999999999999999999999999765432221111100000000000       00


Q ss_pred             hcCCcc---CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          227 CVDPKL---KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       227 ~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ......   .....+..+..+.+++.+||+.||++||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            000000   01122345678899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=239.81  Aligned_cols=238  Identities=19%  Similarity=0.264  Sum_probs=187.0

Q ss_pred             CceeeeeeeeccccChhhhhhcc---CCCCCChhHHHHHHHHccCCCCcccccceEEEeC--CeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLK---SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG--NLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++.+..++..+++|......   ........+.+|++++++++|+||+++++.+.+.  ..+++++||+.+++|.++
T Consensus        17 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~   96 (264)
T cd06653          17 EVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQ   96 (264)
T ss_pred             EEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHH
Confidence            47888888888889888653221   2233456888999999999999999999998764  467899999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-c
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-L  155 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~  155 (285)
                      +.....         +++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++......... .
T Consensus        97 ~~~~~~---------l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  164 (264)
T cd06653          97 LKAYGA---------LTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT  164 (264)
T ss_pred             HHHcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccccccCc
Confidence            875432         78889999999999999999999   9999999999999999999999999998754321111 0


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE  235 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
                      ......++..|+|||.+.+..++.++|+|||||++|+|++|..||......               ..............
T Consensus       165 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~  229 (264)
T cd06653         165 GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---------------AAIFKIATQPTKPM  229 (264)
T ss_pred             cccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---------------HHHHHHHcCCCCCC
Confidence            112234778899999998888899999999999999999999999754221               11122222222234


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+...++.+.+++.+||+ +|..||++.+++.
T Consensus       230 ~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         230 LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            566778889999999999 5799999998876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=257.58  Aligned_cols=236  Identities=21%  Similarity=0.274  Sum_probs=190.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||++..+.++-.-+.|++....  ....+++.-||++|..|.||+|+++++.|...+.++|+.|||.||.+..++-.-.
T Consensus        47 KVyKA~nket~~lAAaKvIetks--eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~  124 (1187)
T KOG0579|consen   47 KVYKAVNKETKLLAAAKVIETKS--EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELG  124 (1187)
T ss_pred             hhhhhhcccchhhhhhhhhcccc--hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhc
Confidence            57888777777777777765332  3346778889999999999999999999999999999999999999988876543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        ++.+.++..++.|++.||.|||++   +|+|||+|..|||++-+|.++|+|||.+.....  .........
T Consensus       125 r--------~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRDsFI  191 (1187)
T KOG0579|consen  125 R--------VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFI  191 (1187)
T ss_pred             c--------ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh--HHhhhcccc
Confidence            2        399999999999999999999999   999999999999999999999999999865432  222345578


Q ss_pred             cccCcCCCcccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC-CC
Q 023220          162 GTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK-GE  235 (285)
Q Consensus       162 ~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  235 (285)
                      |||.|+|||+.+     ..+|+-++||||||++|.+|..+.+|-....+.               ..+.++.....- .-
T Consensus       192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM---------------RVllKiaKSePPTLl  256 (1187)
T KOG0579|consen  192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM---------------RVLLKIAKSEPPTLL  256 (1187)
T ss_pred             CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH---------------HHHHHHhhcCCCccc
Confidence            999999999875     457899999999999999999999997543321               112222211111 12


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      -|.-++..+.+|+++||.+||..||++.++++
T Consensus       257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            34567788999999999999999999999997

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.2e-34  Score=280.33  Aligned_cols=253  Identities=24%  Similarity=0.441  Sum_probs=193.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.....+..+++|......      .....|++.+++++||||++++|++.+.+..++||||+++|+|.++++.  
T Consensus       705 ~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--  776 (968)
T PLN00113        705 ASYKGKSIKNGMQFVVKEINDVN------SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--  776 (968)
T ss_pred             eEEEEEECCCCcEEEEEEccCCc------cccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc--
Confidence            58899877778888888765322      1223568899999999999999999999999999999999999999952  


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                +++..+..++.|++.|++|||..++.+++|||+||+||+++.++..++. ++.......      .....
T Consensus       777 ----------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~  839 (968)
T PLN00113        777 ----------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCF  839 (968)
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCcc
Confidence                      7888999999999999999994444499999999999999988877765 544322111      12235


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC--CCChh
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG--EYPPK  239 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  239 (285)
                      ++..|+|||.+.+..++.++|||||||++|||++|+.||...... ......|............+.++....  ..+..
T Consensus       840 ~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  918 (968)
T PLN00113        840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN  918 (968)
T ss_pred             ccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccccCCCCccHH
Confidence            688999999999889999999999999999999999999543221 122223322222222334445555433  23445


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCC
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAA  280 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  280 (285)
                      ...++.+++.+||+.||++|||++++++.|+++.+..+.+.
T Consensus       919 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~~  959 (968)
T PLN00113        919 EIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCV  959 (968)
T ss_pred             HHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccccc
Confidence            56678899999999999999999999999999987665443

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-34  Score=259.86  Aligned_cols=231  Identities=16%  Similarity=0.181  Sum_probs=164.9

Q ss_pred             CCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHH
Q 023220           28 NYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARG  107 (285)
Q Consensus        28 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~  107 (285)
                      .....+.+|+.++++++||||+++++++.+.+..+++++++.+ +|.+++........    .......+..++.|++.|
T Consensus       205 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~----~~~~~~~~~~i~~ql~~a  279 (501)
T PHA03210        205 RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWK----DRPLLKQTRAIMKQLLCA  279 (501)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhcccccc----ccccHHHHHHHHHHHHHH
Confidence            3456788999999999999999999999999999999999965 77777754331110    114466788999999999


Q ss_pred             HHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHH
Q 023220          108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG  187 (285)
Q Consensus       108 l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG  187 (285)
                      |.|||++   |++||||||+|||++.++.++|+|||++........ .......|+..|+|||.+.+..++.++||||||
T Consensus       280 L~yLH~~---gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  355 (501)
T PHA03210        280 VEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCG  355 (501)
T ss_pred             HHHHHhC---CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHH
Confidence            9999999   999999999999999999999999999976543211 112234689999999999998999999999999


Q ss_pred             HHHHHHHhCCCC-CCCCCCcccchhhhhhc------ccCch--hhhhhhcCCccCC----CC-----ChhHHHHHHHHHH
Q 023220          188 VVLLELLTGRKP-VDHTMPRGQQSLVTWAT------PRLSE--DKVKQCVDPKLKG----EY-----PPKGVAKLAAVAA  249 (285)
Q Consensus       188 ~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~------~~~~~--~~~~~~~~~~~~~----~~-----~~~~~~~l~~li~  249 (285)
                      |++|+|++|..+ +................      ..++.  .....+++.....    ..     ....+.++.++|.
T Consensus       356 vil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  435 (501)
T PHA03210        356 LILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLV  435 (501)
T ss_pred             HHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHH
Confidence            999999998754 43322111111111000      00000  0111111100000    00     0123456788899


Q ss_pred             HhcccCCCCCCCHHHHHH
Q 023220          250 LCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       250 ~~l~~~p~~Rps~~~ll~  267 (285)
                      +||+.||++|||+.+++.
T Consensus       436 kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        436 KMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHhccCcccCcCHHHHhh
Confidence            999999999999999987

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=243.41  Aligned_cols=252  Identities=23%  Similarity=0.263  Sum_probs=192.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++....+++.+++|............+.+.+|++++++++|+|++++++++.+....++++|++.+ +|.+++....
T Consensus        14 ~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~i~~~~   92 (282)
T cd07829          14 VVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRP   92 (282)
T ss_pred             eEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-CHHHHHHhhc
Confidence            578898888899999998876655566678888999999999999999999999999999999999984 9999997653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .++...+..++.|++.++.+||+.   |++|+||+|+||+++.++.++|+|||.+.........  .....
T Consensus        93 ~--------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~  159 (282)
T cd07829          93 G--------PLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEV  159 (282)
T ss_pred             c--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc--cCccc
Confidence            1        288999999999999999999999   9999999999999999999999999998765432211  12233


Q ss_pred             cccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh------------c
Q 023220          162 GTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC------------V  228 (285)
Q Consensus       162 ~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~  228 (285)
                      ++..|+|||.+.+. .++.++|+||||++++++++|..||...........+...............            .
T Consensus       160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
T cd07829         160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF  239 (282)
T ss_pred             cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence            56789999988766 7889999999999999999999999765432221111111111111100000            0


Q ss_pred             CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          229 DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .........+..+..+.+++.+||+.+|.+||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000011112234678999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=239.01  Aligned_cols=235  Identities=22%  Similarity=0.242  Sum_probs=189.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .+|++.....++.+++|........ ....+.+.+|+.++++++|+||+++++.+..++..+++||++.+++|.+++...
T Consensus         8 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~   87 (250)
T cd05123           8 KVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE   87 (250)
T ss_pred             EEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhc
Confidence            4788888777888888876554332 235678889999999999999999999999999999999999989999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++........  .....
T Consensus        88 ~~---------l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (250)
T cd05123          88 GR---------FSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTF  153 (250)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCC
Confidence            42         88999999999999999999999   999999999999999999999999999866543211  12334


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .++..|++||...+..++.++|+||||+++|++++|..||...+...               .......  .....+...
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---------------~~~~~~~--~~~~~~~~~  216 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---------------IYEKILK--DPLRFPEFL  216 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---------------HHHHHhc--CCCCCCCCC
Confidence            56788999999988888999999999999999999999996543211               1111111  112344455


Q ss_pred             HHHHHHHHHHhcccCCCCCCCH---HHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNM---SIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~---~~ll~  267 (285)
                      +..+.+++.+||..||++||++   +++++
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            7789999999999999999999   55543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.6e-34  Score=240.74  Aligned_cols=228  Identities=18%  Similarity=0.214  Sum_probs=177.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|....+...+++|.........       .|+.....+ +|||++++++.+...+..++||||+.+++|.+++...
T Consensus        31 ~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~  103 (267)
T PHA03390         31 KVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE  103 (267)
T ss_pred             EEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc
Confidence            47889888888888888775432211       122222212 7999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC-eeEEeccccCCCCCcccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-KAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ..         +++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++ .++|+|||++......      ..
T Consensus       104 ~~---------l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~  165 (267)
T PHA03390        104 GK---------LSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SC  165 (267)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------cc
Confidence            32         89999999999999999999999   999999999999999988 9999999988654321      12


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||.........           .........  ........
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~~--~~~~~~~~  232 (267)
T PHA03390        166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD-----------LESLLKRQQ--KKLPFIKN  232 (267)
T ss_pred             CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh-----------HHHHHHhhc--ccCCcccc
Confidence            34788999999998888999999999999999999999999754322110           011111111  11123345


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPN-MSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps-~~~ll~  267 (285)
                      .++.+.++|.+||+.+|.+||+ ++++++
T Consensus       233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        233 VSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             cCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            7788999999999999999995 688875

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-35  Score=258.23  Aligned_cols=227  Identities=23%  Similarity=0.329  Sum_probs=189.3

Q ss_pred             cChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCH
Q 023220           15 YPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW   94 (285)
Q Consensus        15 ~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~   94 (285)
                      ++||..+...... ..++|.+|+.+|.+|+|+|++++||++.+ ....+|||.+..|+|.+.+.+....       .|..
T Consensus       141 VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~-------~llv  211 (1039)
T KOG0199|consen  141 VAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKA-------ILLV  211 (1039)
T ss_pred             EEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhcccc-------ceeH
Confidence            4455444433333 68999999999999999999999999998 5578999999999999999872211       3889


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc-cccccccccCcCCCcccc
Q 023220           95 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL-HSTRVLGTFGYHAPEYAM  173 (285)
Q Consensus        95 ~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~  173 (285)
                      .....++.||+.|+.||..+   ++||||+-.+|+++-..-.|||+|||+.+........- ......-...|.|||.+.
T Consensus       212 ~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr  288 (1039)
T KOG0199|consen  212 SRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLR  288 (1039)
T ss_pred             HHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhc
Confidence            99999999999999999999   99999999999999888899999999998665332211 112223456899999999


Q ss_pred             cCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhc
Q 023220          174 TGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCV  252 (285)
Q Consensus       174 ~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  252 (285)
                      ..+++.++|+|+|||++|||++ |..||.+..                ...+.+.+|.+.+...+..|+++++++++.||
T Consensus       289 h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~----------------g~qIL~~iD~~erLpRPk~csedIY~imk~cW  352 (1039)
T KOG0199|consen  289 HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR----------------GIQILKNIDAGERLPRPKYCSEDIYQIMKNCW  352 (1039)
T ss_pred             cccccccchhhhhhhhHHhhhccCCCCCCCCC----------------HHHHHHhccccccCCCCCCChHHHHHHHHHhc
Confidence            9999999999999999999999 899997553                34556666777777889999999999999999


Q ss_pred             ccCCCCCCCHHHHHHHh
Q 023220          253 QYEAEFRPNMSIVVKAL  269 (285)
Q Consensus       253 ~~~p~~Rps~~~ll~~l  269 (285)
                      ..+|++|||+.+|.+.+
T Consensus       353 ah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  353 AHNPADRPTFSAIREDL  369 (1039)
T ss_pred             cCCccccccHHHHHHhH
Confidence            99999999999998544

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=235.09  Aligned_cols=246  Identities=22%  Similarity=0.296  Sum_probs=189.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.-+.++...++|.-.+..+. ...+++...+.++... ..|+||+.+|+|..+...++.||.|.. .+..++..-
T Consensus       107 ~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkri  184 (391)
T KOG0983|consen  107 QVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRI  184 (391)
T ss_pred             ceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHh
Confidence            5899999998999999977654443 3456666667766655 589999999999999999999999964 777777654


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..        ++++..+-.+...+++||.||-++-  |++|||+||+|||+|..|++||+|||++..+-...   .+...
T Consensus       185 k~--------piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---Ahtrs  251 (391)
T KOG0983|consen  185 KG--------PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---AHTRS  251 (391)
T ss_pred             cC--------CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc---ccccc
Confidence            32        3888888899999999999998764  89999999999999999999999999986543322   23445


Q ss_pred             ccccCcCCCccccc---CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc-CCCC
Q 023220          161 LGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL-KGEY  236 (285)
Q Consensus       161 ~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  236 (285)
                      .|-+.|+|||.+..   .+|+.++||||||++++||.||+.||.+...+              -+.+..+++.+. ....
T Consensus       252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--------------Fe~ltkvln~ePP~L~~  317 (391)
T KOG0983|consen  252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--------------FEVLTKVLNEEPPLLPG  317 (391)
T ss_pred             cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--------------HHHHHHHHhcCCCCCCc
Confidence            67789999999864   47899999999999999999999999874321              111222222111 0111


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                      ...+++.+.+++..||.+|+.+||.+.++++  +.++..+.+
T Consensus       318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~--h~Fi~~ye~  357 (391)
T KOG0983|consen  318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE--HPFIKRYET  357 (391)
T ss_pred             ccCcCHHHHHHHHHHhhcCcccCcchHHHhc--Ccceeecch
Confidence            1236788999999999999999999999998  555555444

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-34  Score=250.68  Aligned_cols=253  Identities=22%  Similarity=0.257  Sum_probs=186.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC------eeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN------LRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~   75 (285)
                      .||++.+...+..+++|............+.+.+|++++++++||||+++++++..+.      ..++|++++ +++|.+
T Consensus        30 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~  108 (343)
T cd07880          30 TVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGK  108 (343)
T ss_pred             EEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHH
Confidence            4788888778888999877544334445667889999999999999999999987553      458999998 569988


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++....          +++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++......    
T Consensus       109 ~~~~~~----------l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~----  171 (343)
T cd07880         109 LMKHEK----------LSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----  171 (343)
T ss_pred             HHhcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccC----
Confidence            886432          88999999999999999999999   9999999999999999999999999998754321    


Q ss_pred             cccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhc------
Q 023220          156 HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV------  228 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  228 (285)
                       .....++..|+|||.+.+ ..++.++|+||+|+++|++++|..||...........+.........+....+.      
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07880         172 -MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN  250 (343)
T ss_pred             -ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHH
Confidence             122346788999998875 457889999999999999999999997654322211111111111111000000      


Q ss_pred             --C--CccC----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH--Hhchhh
Q 023220          229 --D--PKLK----GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLL  273 (285)
Q Consensus       229 --~--~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~--~l~~~~  273 (285)
                        .  +...    .......+..+.++|.+||+.||.+|||+.+++.  .++.+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         251 YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             HHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence              0  0000    0112345667999999999999999999999994  444443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.5e-35  Score=246.85  Aligned_cols=240  Identities=24%  Similarity=0.252  Sum_probs=181.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++....+++.+++|........ .....+.+|+.++.++. |+||+++++++...+..+++||++.. ++.++....
T Consensus        19 ~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~   96 (288)
T cd06616          19 TVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYV   96 (288)
T ss_pred             EEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHH
Confidence            5788888888889999976543322 34567888999999995 99999999999998889999999864 665543211


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ....    ...+++..+..++.|++.|++|||+ .   +++||||+|+||+++.++.++|+|||++........   ...
T Consensus        97 ~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~  166 (288)
T cd06616          97 YEVL----KSVIPEEILGKIAVATVKALNYLKEEL---KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTR  166 (288)
T ss_pred             HHhh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---ccc
Confidence            0000    0128899999999999999999996 5   899999999999999999999999999864332111   122


Q ss_pred             cccccCcCCCcccccC---CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh---cCCccC
Q 023220          160 VLGTFGYHAPEYAMTG---QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC---VDPKLK  233 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~---~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  233 (285)
                      ..++..|+|||.+.+.   .++.++|+||+|+++|+|++|+.||.......              +.....   ..+...
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~~~  232 (288)
T cd06616         167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF--------------DQLTQVVKGDPPILS  232 (288)
T ss_pred             ccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH--------------HHHhhhcCCCCCcCC
Confidence            3567889999998765   68899999999999999999999996543100              001110   011122


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          234 GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ......++.++.+++.+||+.+|++|||+.++++
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2223446778999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4e-34  Score=244.99  Aligned_cols=233  Identities=24%  Similarity=0.342  Sum_probs=181.9

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||++.+..+.+.+++|....... .....+.+.+|+++++.++|||++++++++.+....+++|||+. +++.+++...
T Consensus        36 ~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~  114 (313)
T cd06633          36 AVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVH  114 (313)
T ss_pred             EEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc
Confidence            578888877788888886654322 22334578889999999999999999999999999999999996 4787777543


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..        .+++..+..++.|++.++.|||+.   |++|+||+|+||+++.++.++|+|||++.....      ....
T Consensus       115 ~~--------~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~  177 (313)
T cd06633         115 KK--------PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSF  177 (313)
T ss_pred             CC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCc
Confidence            32        278899999999999999999999   999999999999999999999999998754321      1234


Q ss_pred             ccccCcCCCcccc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          161 LGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       161 ~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      .|+..|+|||.+.   ...++.++|+||||+++|+|++|..||............               ..........
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~---------------~~~~~~~~~~  242 (313)
T cd06633         178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---------------AQNDSPTLQS  242 (313)
T ss_pred             cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---------------HhcCCCCCCc
Confidence            5788899999874   356788999999999999999999998654321111110               0000111112


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..++..+.+++.+||+.+|.+||++.+++.
T Consensus       243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         243 NEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            334567999999999999999999999997

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.9e-35  Score=244.63  Aligned_cols=237  Identities=22%  Similarity=0.292  Sum_probs=191.2

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++.....++.+++|....... .....+.+.+|++++++++ |+||+++++++..++..+++||++.+++|.+++..
T Consensus        16 ~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   95 (280)
T cd05581          16 TVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK   95 (280)
T ss_pred             EEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHH
Confidence            588998888888999987765322 2233567888999999998 99999999999999999999999999999999976


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-----
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-----  154 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-----  154 (285)
                      ..         .+++..++.++.|++.|+.+||+.   |++|+||+|+||+++.++.++++|||++.........     
T Consensus        96 ~~---------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~  163 (280)
T cd05581          96 YG---------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG  163 (280)
T ss_pred             cC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCC
Confidence            54         289999999999999999999999   9999999999999999999999999998755432211     


Q ss_pred             -------------ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCch
Q 023220          155 -------------LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSE  221 (285)
Q Consensus       155 -------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  221 (285)
                                   .......++..|+|||......++.++|+||||++++++++|..||........             
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------------  230 (280)
T cd05581         164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-------------  230 (280)
T ss_pred             CCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-------------
Confidence                         111223467889999998888889999999999999999999999975542110             


Q ss_pred             hhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 023220          222 DKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM----SIVVK  267 (285)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~----~~ll~  267 (285)
                        .....  ......+...++.+.+++.+||+.+|.+|||+    +++++
T Consensus       231 --~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 --FQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             --HHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence              11111  11223445567889999999999999999999    77765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.7e-34  Score=248.32  Aligned_cols=253  Identities=20%  Similarity=0.222  Sum_probs=185.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCC------------CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKN------------YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFAT   69 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   69 (285)
                      .||++.+...++.+++|..+.......            ....+.+|++++++++|+||+++++++...+..+++|||+.
T Consensus        24 ~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  103 (335)
T PTZ00024         24 KVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA  103 (335)
T ss_pred             eEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc
Confidence            588998888888899887654332220            12357789999999999999999999999999999999997


Q ss_pred             CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCC
Q 023220           70 MGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP  149 (285)
Q Consensus        70 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~  149 (285)
                       ++|.+++....         .++...+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++....
T Consensus       104 -~~l~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~  170 (335)
T PTZ00024        104 -SDLKKVVDRKI---------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYG  170 (335)
T ss_pred             -cCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccceeecc
Confidence             58999886543         288999999999999999999999   99999999999999999999999999986543


Q ss_pred             ccc------------ccccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 023220          150 DMA------------ARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT  216 (285)
Q Consensus       150 ~~~------------~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  216 (285)
                      ...            .........++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+....
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~  250 (335)
T PTZ00024        171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL  250 (335)
T ss_pred             cccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            110            00011123357789999988764 46889999999999999999999998665433221111110


Q ss_pred             ccCchhhhhhh--------c---CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          217 PRLSEDKVKQC--------V---DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       217 ~~~~~~~~~~~--------~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...........        .   .+..........+..+.+++.+||+.+|.+|||+++++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            00000000000        0   000000112234677999999999999999999999997

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.1e-35  Score=252.35  Aligned_cols=247  Identities=21%  Similarity=0.249  Sum_probs=185.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCe------eeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL------RVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~~L~~   75 (285)
                      .||++....+++.+++|............+.+.+|+.++++++|+|++++.+++...+.      .+++++|+ +++|.+
T Consensus        30 ~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~  108 (343)
T cd07851          30 QVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNN  108 (343)
T ss_pred             EEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHH
Confidence            47888887788889999776544444455778889999999999999999998876554      89999999 459999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++....          +++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++......    
T Consensus       109 ~~~~~~----------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----  171 (343)
T cd07851         109 IVKCQK----------LSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----  171 (343)
T ss_pred             HHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc----
Confidence            987532          88999999999999999999999   9999999999999999999999999998765322    


Q ss_pred             cccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhh--------
Q 023220          156 HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQ--------  226 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------  226 (285)
                       .....++..|+|||.+.+ ..++.++|+||||+++|++++|+.||...........+....+.........        
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07851         172 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARN  250 (343)
T ss_pred             -ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHH
Confidence             122346788999998765 3678999999999999999999999976543322211111111111111000        


Q ss_pred             hcCC---ccCC---CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          227 CVDP---KLKG---EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       227 ~~~~---~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +...   ....   ......+..+.+++.+||+.+|++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0000   0000   011234678999999999999999999999987

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.1e-34  Score=245.13  Aligned_cols=235  Identities=22%  Similarity=0.304  Sum_probs=182.3

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.+....+.+++|...... ......+++.+|+++++.++|+|++++.+++......++|+||+. +++.+++...
T Consensus        30 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~  108 (308)
T cd06634          30 AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH  108 (308)
T ss_pred             EEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHc
Confidence            47888887777888888665322 222334567889999999999999999999999999999999997 5887777543


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..        .++...+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++.....      ....
T Consensus       109 ~~--------~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------~~~~  171 (308)
T cd06634         109 KK--------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXF  171 (308)
T ss_pred             CC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC------cccc
Confidence            22        278899999999999999999999   999999999999999999999999998865432      1223


Q ss_pred             ccccCcCCCcccc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          161 LGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       161 ~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      .++..|+|||.+.   ...++.++|||||||++|+|++|..||.........               .............
T Consensus       172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---------------~~~~~~~~~~~~~  236 (308)
T cd06634         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------------YHIAQNESPALQS  236 (308)
T ss_pred             cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH---------------HHHhhcCCCCcCc
Confidence            4678899999874   345788999999999999999999998653221111               1111111111123


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL  269 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l  269 (285)
                      ..++..+.++|.+||+.+|.+||++.++++.-
T Consensus       237 ~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             ccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            35667899999999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.8e-34  Score=246.56  Aligned_cols=254  Identities=20%  Similarity=0.230  Sum_probs=183.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC--------eeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN--------LRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~~~L   73 (285)
                      .||++....+++.+++|..............+.+|++++++++||||+++++++....        ..+++++|+.+ ++
T Consensus        23 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l  101 (311)
T cd07866          23 EVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DL  101 (311)
T ss_pred             EEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CH
Confidence            4788888888888999977655544545667889999999999999999999875433        46999999975 77


Q ss_pred             HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc
Q 023220           74 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        74 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  153 (285)
                      .+.+.....        .+++..+..++.|+++||.|||+.   |++|+||+|+||+++.++.++|+|||++........
T Consensus       102 ~~~~~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  170 (311)
T cd07866         102 SGLLENPSV--------KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPP  170 (311)
T ss_pred             HHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhccCCCc
Confidence            777764322        289999999999999999999999   999999999999999999999999999865432211


Q ss_pred             ccc---------ccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhh
Q 023220          154 RLH---------STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDK  223 (285)
Q Consensus       154 ~~~---------~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (285)
                      ...         .....++..|+|||.+.+. .++.++|+||||+++|+|++|.+||.+.........+...........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (311)
T cd07866         171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEET  250 (311)
T ss_pred             ccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            111         1123457789999987654 578999999999999999999999976554322221111111100000


Q ss_pred             ------hhhhcCCccCCCC-------ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          224 ------VKQCVDPKLKGEY-------PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       224 ------~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                            +....+.......       .....+.+.+++.+||+.||.+|||+.+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         251 WPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             chhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                  0000000000000       1123467899999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-35  Score=242.41  Aligned_cols=247  Identities=15%  Similarity=0.222  Sum_probs=196.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCC--C----cccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH--E----NLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      +|=.|.+..++..+++|.++..   ..+++..+-|+++|.++.+  |    -++.+.++|...++.|||+|.+. -|+.+
T Consensus       104 kV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfellG-~S~~d  179 (415)
T KOG0671|consen  104 KVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELLG-LSTFD  179 (415)
T ss_pred             ceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEeccC-hhHHH
Confidence            4567888888999999988753   3567778889999999932  2    46777888999999999999994 49999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc--------------------CC
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE--------------------DF  135 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~--------------------~~  135 (285)
                      ++..+...+       ++..++..++.|++++++|||+.   +++|-|+||+|||+..                    +.
T Consensus       180 Flk~N~y~~-------fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~  249 (415)
T KOG0671|consen  180 FLKENNYIP-------FPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKST  249 (415)
T ss_pred             HhccCCccc-------cchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceeccCCCc
Confidence            999887653       99999999999999999999999   9999999999999941                    34


Q ss_pred             eeEEeccccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 023220          136 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA  215 (285)
Q Consensus       136 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  215 (285)
                      .++++|||.+.......     ...+.|..|+|||++.+-+|+..+||||+||+|+|+++|...|++.+..+-..++...
T Consensus       250 ~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerI  324 (415)
T KOG0671|consen  250 AIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERI  324 (415)
T ss_pred             ceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHh
Confidence            68999999997654322     4456789999999999999999999999999999999999999988765555566655


Q ss_pred             cccCchhhhhhh-----cCCc-c-----------------------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 023220          216 TPRLSEDKVKQC-----VDPK-L-----------------------KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVV  266 (285)
Q Consensus       216 ~~~~~~~~~~~~-----~~~~-~-----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll  266 (285)
                      .+..+...+...     ...+ +                       ..........++.+++++||.+||.+|+|+.|++
T Consensus       325 lGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL  404 (415)
T KOG0671|consen  325 LGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREAL  404 (415)
T ss_pred             hCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHh
Confidence            555554333222     0000 0                       0011123455899999999999999999999998


Q ss_pred             H
Q 023220          267 K  267 (285)
Q Consensus       267 ~  267 (285)
                      .
T Consensus       405 ~  405 (415)
T KOG0671|consen  405 S  405 (415)
T ss_pred             c
Confidence            7

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-34  Score=250.97  Aligned_cols=252  Identities=22%  Similarity=0.252  Sum_probs=184.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC------CeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG------NLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~   75 (285)
                      .||++.+..+++.+++|..++........+.+.+|++++++++||||+++++++...      ...+++++++ +++|.+
T Consensus        32 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~  110 (345)
T cd07877          32 SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNN  110 (345)
T ss_pred             EEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHH
Confidence            478888878888899987765333333456788899999999999999999988643      3467888877 679988


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++....          +++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++......    
T Consensus       111 ~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~----  173 (345)
T cd07877         111 IVKCQK----------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----  173 (345)
T ss_pred             HHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccccccc----
Confidence            886542          88999999999999999999999   9999999999999999999999999998654321    


Q ss_pred             cccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh---------
Q 023220          156 HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK---------  225 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------  225 (285)
                       .....++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...........+.............         
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (345)
T cd07877         174 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  252 (345)
T ss_pred             -ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHH
Confidence             123456788999998766 467889999999999999999999997654322211111111111100000         


Q ss_pred             --hhcCCccC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          226 --QCVDPKLK---GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       226 --~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                        ........   .......++.+.++|.+||+.||.+||++.+++.  ..++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~f~  304 (345)
T cd07877         253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFA  304 (345)
T ss_pred             HHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc--Chhhh
Confidence              00000000   0011134667999999999999999999999987  34443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=253.76  Aligned_cols=227  Identities=19%  Similarity=0.270  Sum_probs=182.0

Q ss_pred             ceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +-+|....+.+.+++|.+.+.      ..+..+|+.++... +||||+++.+.+.++.+.++|||.+.++-+.+.+....
T Consensus       338 ~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~  411 (612)
T KOG0603|consen  338 VKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP  411 (612)
T ss_pred             eeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcc
Confidence            446777788888888888755      23344577666665 89999999999999999999999999987777766554


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE-ccCCeeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~-~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      .         .. ..+..|+++|+.|+.|||.+   |++|||+||+|||+ +..++++|+|||.++..+..     -...
T Consensus       412 ~---------~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp  473 (612)
T KOG0603|consen  412 E---------FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTP  473 (612)
T ss_pred             h---------hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hccc
Confidence            2         33 67778999999999999999   99999999999999 68899999999999766543     1122


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .-|..|.|||++....|++++|+||||++||+|++|+.||......               ..+...+   ....+...+
T Consensus       474 ~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---------------~ei~~~i---~~~~~s~~v  535 (612)
T KOG0603|consen  474 ALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---------------IEIHTRI---QMPKFSECV  535 (612)
T ss_pred             chhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---------------HHHHHhh---cCCcccccc
Confidence            4578899999999999999999999999999999999999754322               1111111   112233677


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      +...++++.+||++||.+||++.+++.  ..++
T Consensus       536 S~~AKdLl~~LL~~dP~~Rl~~~~i~~--h~w~  566 (612)
T KOG0603|consen  536 SDEAKDLLQQLLQVDPALRLGADEIGA--HPWF  566 (612)
T ss_pred             CHHHHHHHHHhccCChhhCcChhhhcc--Ccch
Confidence            889999999999999999999999988  5666

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.4e-34  Score=247.40  Aligned_cols=253  Identities=20%  Similarity=0.228  Sum_probs=183.4

Q ss_pred             Cceeeeeeee--ccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeC----CeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQV--EESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEG----NLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~----~~~~lv~e~~~~~~L~   74 (285)
                      .||++.+...  +..+++|............+.+.+|+++++++ .||||+++++.+...    ...+++++++. ++|.
T Consensus        15 ~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~   93 (332)
T cd07857          15 IVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLH   93 (332)
T ss_pred             EEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHH
Confidence            4788887766  77888887765444444567788999999999 599999999875432    45688889886 5899


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  154 (285)
                      +++.....         +++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||++.........
T Consensus        94 ~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~  161 (332)
T cd07857          94 QIIRSGQP---------LTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE  161 (332)
T ss_pred             HHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceeccccccc
Confidence            88865432         88999999999999999999999   9999999999999999999999999998754322111


Q ss_pred             --ccccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc
Q 023220          155 --LHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK  231 (285)
Q Consensus       155 --~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
                        .......|+..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||...+.......+.........+....+..+.
T Consensus       162 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
T cd07857         162 NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPK  241 (332)
T ss_pred             ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhh
Confidence              11122457889999998765 467899999999999999999999997654322211111111111111111111100


Q ss_pred             --------------cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          232 --------------LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       232 --------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                                    ......+..+..+.+++.+||+.||.+|||+.+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         242 AQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                          000111234678999999999999999999999986

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=232.04  Aligned_cols=247  Identities=21%  Similarity=0.313  Sum_probs=191.3

Q ss_pred             CCceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            1 MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         1 ~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      ++|--|...++...|++|.+.+..  ...+.++.+|++++.++ .|+||++++++|+++..+|||||.+.||+|.+.|.+
T Consensus        92 asVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~  169 (463)
T KOG0607|consen   92 ASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQK  169 (463)
T ss_pred             eeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHH
Confidence            367789999999999999998764  44578999999999999 799999999999999999999999999999999988


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC---eeEEeccccCCCCCcc-----
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF---KAKIADFNLSNQAPDM-----  151 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~---~~~l~df~~~~~~~~~-----  151 (285)
                      +..         +++..+..+...|+.||.|||.+   ||.|||+||+|||.....   -+||+||++..-+...     
T Consensus       170 ~~~---------F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  170 RKH---------FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             hhh---------ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            764         89999999999999999999999   999999999999996544   3699999987533211     


Q ss_pred             cccccccccccccCcCCCcccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCc---hhh
Q 023220          152 AARLHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLS---EDK  223 (285)
Q Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~  223 (285)
                      ...+......|+..|||||+..     ...|+.++|.||||+++|-|+.|.+||.+.=..+.    .|.....-   .+.
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC----GWdrGe~Cr~CQ~~  313 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC----GWDRGEVCRVCQNK  313 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC----CccCCCccHHHHHH
Confidence            1111122356788999999763     22578999999999999999999999986421111    11111100   011


Q ss_pred             h-hhhcCCccCCCCC----hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          224 V-KQCVDPKLKGEYP----PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       224 ~-~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      + ..+-+..+  ++|    .-++.+..++++.+|.+++.+|-++..++.
T Consensus       314 LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  314 LFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            1 11111111  223    245788999999999999999999998887

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-34  Score=252.16  Aligned_cols=234  Identities=22%  Similarity=0.255  Sum_probs=197.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .|-++....++..+++|.+.+........+.+.+|+++|+.++||||++++.+......+|+||||+.+|.+++++....
T Consensus        71 ~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~g  150 (596)
T KOG0586|consen   71 KVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHG  150 (596)
T ss_pred             EEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcc
Confidence            46677778889999999999988888888889999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         ..+..+..++.|+++|++|||++   +++|||||.+|++++.+.+++|+|||.+........   .....
T Consensus       151 r---------~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~---lqt~c  215 (596)
T KOG0586|consen  151 R---------MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM---LQTFC  215 (596)
T ss_pred             c---------chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccccc---ccccC
Confidence            3         66689999999999999999999   999999999999999999999999999976653222   23456


Q ss_pred             cccCcCCCcccccCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      |++.|.|||++.+.+| ++.+|+||+|+++|.|+.|..||++..-...+.               ..+...+  ..+-..
T Consensus       216 gsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~---------------rvl~gk~--rIp~~m  278 (596)
T KOG0586|consen  216 GSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP---------------RVLRGKY--RIPFYM  278 (596)
T ss_pred             CCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc---------------hheeeee--ccccee
Confidence            8999999999998887 589999999999999999999998653211111               0011111  234445


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +.++.++|+++|..+|.+|++..++.+
T Consensus       279 s~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  279 SCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             echhHHHHHHhhccCccccCCHHHhhh
Confidence            678999999999999999999999876

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1e-33  Score=236.02  Aligned_cols=239  Identities=20%  Similarity=0.246  Sum_probs=182.4

Q ss_pred             CceeeeeeeeccccChhhhhhccC---CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS---PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++.+......+.+|..+....   ......++.+|+.++++++||||+++++++.+....++++||+.+++|.+++.
T Consensus        15 ~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~   94 (260)
T cd08222          15 TVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLE   94 (260)
T ss_pred             eEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHH
Confidence            467777666655565555544332   22334567789999999999999999999999999999999999999999886


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      .....     ...+++..++.++.|++.|+.|||+.   |++|+|++|+||+++. +.++|+|||.+........  ...
T Consensus        95 ~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~  163 (260)
T cd08222          95 ELKHT-----GKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LAT  163 (260)
T ss_pred             HHhhc-----ccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCCcc--ccc
Confidence            42211     11389999999999999999999999   9999999999999975 5699999998865432211  112


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ...++..|+|||...+..++.++|+||+|+++|+|++|..||.......               ...... .......+.
T Consensus       164 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------------~~~~~~-~~~~~~~~~  227 (260)
T cd08222         164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---------------VVLRIV-EGPTPSLPE  227 (260)
T ss_pred             CCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---------------HHHHHH-cCCCCCCcc
Confidence            3446788999999888888999999999999999999999996432111               011111 111122345


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .++.++.++|.+||+.+|++||++.++++
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         228 TYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             hhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            66788999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-34  Score=238.88  Aligned_cols=251  Identities=19%  Similarity=0.240  Sum_probs=184.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++....+++.+++|........ .......+|+..+++++ |+|++++++++..++..++||||+ +++|.+++...
T Consensus        14 ~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~   91 (283)
T cd07830          14 SVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDR   91 (283)
T ss_pred             EEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhc
Confidence            4788888777888888876543322 12334557999999998 999999999999999999999999 67998888765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...       .+++..++.++.|++.++.|||++   |++|+||+|+||+++.++.++|+|||.+........   ....
T Consensus        92 ~~~-------~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~  158 (283)
T cd07830          92 KGK-------PFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDY  158 (283)
T ss_pred             ccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCC
Confidence            411       289999999999999999999999   999999999999999999999999999865433211   1223


Q ss_pred             ccccCcCCCcccc-cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh------hhhcCCcc-
Q 023220          161 LGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV------KQCVDPKL-  232 (285)
Q Consensus       161 ~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~-  232 (285)
                      .++..|+|||.+. ...++.++|+||||+++++|++|..||........................      ....+... 
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07830         159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP  238 (283)
T ss_pred             CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence            4678899999875 445789999999999999999999999765433222111111111010000      00000000 


Q ss_pred             ------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          233 ------KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       233 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                            ........+..+.+++.+||+.+|++|||+++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                  00111122578999999999999999999999876

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=9.7e-34  Score=239.70  Aligned_cols=243  Identities=20%  Similarity=0.224  Sum_probs=183.8

Q ss_pred             Cceeeeee---eeccccChhhhhhcc--CCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTC---QVEESYPSHENERLK--SPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~---~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||++.+.   ..+..+++|..+...  ......+.+.+|++++.++ +||||+++.+.+..+...++||||+.+++|.+
T Consensus        15 ~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   94 (288)
T cd05583          15 KVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFT   94 (288)
T ss_pred             eEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHH
Confidence            46777643   244667777665332  1233456788999999999 69999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++.....         +++..+..++.|++.+|.|||+.   |++|+||+|+||+++.++.++|+|||++........ .
T Consensus        95 ~~~~~~~---------~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~  161 (288)
T cd05583          95 HLYQREH---------FTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-E  161 (288)
T ss_pred             HHhhcCC---------cCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccccccc-c
Confidence            9865432         78899999999999999999999   999999999999999999999999999865433211 1


Q ss_pred             cccccccccCcCCCcccccCC--CCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQ--LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                      ......++..|+|||.+.+..  .+.++|+||||+++|+|++|..||..........           +.......  ..
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----------~~~~~~~~--~~  228 (288)
T cd05583         162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS-----------EISRRILK--SK  228 (288)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH-----------HHHHHHHc--cC
Confidence            122234788999999887654  6889999999999999999999996432211100           00011111  11


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          234 GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      ...+...+..+.+++.+||+.||++|||+.++.+.|+
T Consensus       229 ~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         229 PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            2334456678999999999999999999887766554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.3e-33  Score=240.02  Aligned_cols=237  Identities=22%  Similarity=0.300  Sum_probs=178.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++....++..+++|..+.... ......+.+|+.++.+. .|+||+++++++.++...+++|||+.+ ++.+++...
T Consensus        30 ~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~l~~~~  107 (296)
T cd06618          30 QVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRI  107 (296)
T ss_pred             EEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc-CHHHHHHHh
Confidence            478888777788889888754322 22344566677766666 599999999999999999999999864 787777653


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ..        .+++..+..++.|++.++.|||+ .   |++|+||+|+||+++.++.++|+|||++........   ...
T Consensus       108 ~~--------~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~~~  173 (296)
T cd06618         108 QG--------PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTR  173 (296)
T ss_pred             cC--------CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc---ccC
Confidence            22        28889999999999999999996 6   899999999999999999999999999865432221   122


Q ss_pred             cccccCcCCCcccccCC----CCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC-C
Q 023220          160 VLGTFGYHAPEYAMTGQ----LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK-G  234 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~----~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  234 (285)
                      ..++..|+|||.+.+..    ++.++|+||||+++|+|++|+.||.......              +.....+..... .
T Consensus       174 ~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~~  239 (296)
T cd06618         174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--------------EVLTKILQEEPPSL  239 (296)
T ss_pred             CCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--------------HHHHHHhcCCCCCC
Confidence            34677899999886543    7889999999999999999999996432110              001111111100 0


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      .....++.++.+++.+||+.||++||++.++++.
T Consensus       240 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1112356789999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=259.25  Aligned_cols=244  Identities=26%  Similarity=0.360  Sum_probs=199.5

Q ss_pred             ccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCC-CC
Q 023220           12 EESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ-PG   89 (285)
Q Consensus        12 ~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-~~   89 (285)
                      ...+++|..+..... ...+++..|+++|+.+ .|+||+.+.|.+..++..++|+||+..|+|.++++..+...... .+
T Consensus       328 ~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~  406 (609)
T KOG0200|consen  328 YVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSG  406 (609)
T ss_pred             eEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccC
Confidence            345667766655555 6688999999999999 79999999999999999999999999999999998776100000 00


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc-ccccccc
Q 023220           90 ------PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL-HSTRVLG  162 (285)
Q Consensus        90 ------~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~  162 (285)
                            ..++....+.++.||+.|+.||++.   +++|||+-.+|||+.++..++|+|||+++.......-. ..+...-
T Consensus       407 ~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~L  483 (609)
T KOG0200|consen  407 VFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTL  483 (609)
T ss_pred             CCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCcc
Confidence                  2388999999999999999999999   99999999999999999999999999998544322221 1111113


Q ss_pred             ccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          163 TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       163 ~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ...|+|||.+....|+.++||||||+++||+++ |..||.+-.               ....+.+.+..+.+...|..++
T Consensus       484 P~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~---------------~~~~l~~~l~~G~r~~~P~~c~  548 (609)
T KOG0200|consen  484 PVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP---------------PTEELLEFLKEGNRMEQPEHCS  548 (609)
T ss_pred             ceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC---------------cHHHHHHHHhcCCCCCCCCCCC
Confidence            456999999999999999999999999999999 999996421               1234455777788888888999


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      .+++++++.||+.+|++||++.++.++|...+.
T Consensus       549 ~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  549 DEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             HHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            999999999999999999999999999988654

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.2e-33  Score=236.74  Aligned_cols=240  Identities=20%  Similarity=0.251  Sum_probs=182.8

Q ss_pred             Cceeeeee---eeccccChhhhhhccC--CCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTC---QVEESYPSHENERLKS--PKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~---~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||++.+.   ..+..+++|..+....  .....+.+.+|+++++++ +|+||+++++.+..+...++++||+.+++|.+
T Consensus        15 ~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   94 (290)
T cd05613          15 KVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFT   94 (290)
T ss_pred             eEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHH
Confidence            46777653   3567788887654322  233457788899999999 68999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++.....         ++...+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++........ .
T Consensus        95 ~l~~~~~---------l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~  161 (290)
T cd05613          95 HLSQRER---------FKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-E  161 (290)
T ss_pred             HHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecccccc-c
Confidence            9876532         78889999999999999999999   999999999999999999999999999865432211 1


Q ss_pred             cccccccccCcCCCcccccC--CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          156 HSTRVLGTFGYHAPEYAMTG--QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                      ......|+..|+|||.+...  .++.++|+||||+++|+|++|..||...........+           .......  .
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-----------~~~~~~~--~  228 (290)
T cd05613         162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-----------SRRILKS--E  228 (290)
T ss_pred             ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHH-----------HHHhhcc--C
Confidence            11223477889999988653  4678999999999999999999999643221111000           0111110  1


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 023220          234 GEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK  267 (285)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~  267 (285)
                      ...+..++..+.+++.+||+.||++||     ++++++.
T Consensus       229 ~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            123445677899999999999999997     7777776

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=232.39  Aligned_cols=236  Identities=20%  Similarity=0.222  Sum_probs=194.9

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +|-+|.++.+...|++|..++... .++....-..|-++|+.++||.+..+.-.|...+++|+||||..||.|+-.+...
T Consensus       183 KVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsre  262 (516)
T KOG0690|consen  183 KVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRE  262 (516)
T ss_pred             eEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhh
Confidence            467899999999999998876553 3444555567889999999999999999999999999999999999998888765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      +         .+++....-+-..|++||.|||.+   +|++||+|.+|.++|++|++||.|||+.+.....+.  ...-.
T Consensus       263 r---------~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~--t~kTF  328 (516)
T KOG0690|consen  263 R---------VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD--TTKTF  328 (516)
T ss_pred             h---------cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccccc--eeccc
Confidence            5         388889999999999999999999   999999999999999999999999999975433222  23446


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|||.|+|||++....|+.+.|.|.+|+++|||++|+.||...+....-.++..               .  ...+|...
T Consensus       329 CGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~---------------e--d~kFPr~l  391 (516)
T KOG0690|consen  329 CGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM---------------E--DLKFPRTL  391 (516)
T ss_pred             cCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh---------------h--hccCCccC
Confidence            799999999999999999999999999999999999999987654322222111               1  12467788


Q ss_pred             HHHHHHHHHHhcccCCCCCC--CHHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRP--NMSIVVKA  268 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp--s~~~ll~~  268 (285)
                      +++...++..+|.+||.+|.  ...|..+.
T Consensus       392 s~eAktLLsGLL~kdP~kRLGgGpdDakEi  421 (516)
T KOG0690|consen  392 SPEAKTLLSGLLKKDPKKRLGGGPDDAKEI  421 (516)
T ss_pred             CHHHHHHHHHHhhcChHhhcCCCchhHHHH
Confidence            88999999999999999995  34444443

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=247.59  Aligned_cols=191  Identities=24%  Similarity=0.292  Sum_probs=164.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC------CeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG------NLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~   75 (285)
                      .||+...+.++..+|+|.++... +...++.-.+|+++|++++|+|||+++|+=+..      ...+++||||.+|+|..
T Consensus        28 ~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~  106 (732)
T KOG4250|consen   28 NVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRK  106 (732)
T ss_pred             eeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHH
Confidence            58999889999999999998766 566788889999999999999999999976543      35699999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC----CeeEEeccccCCCCCcc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED----FKAKIADFNLSNQAPDM  151 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~----~~~~l~df~~~~~~~~~  151 (285)
                      .++......      .+++...+.++..+..|+.|||++   ||+||||||.||++..+    ...||+|||.|+..+..
T Consensus       107 ~L~~PEN~~------GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~  177 (732)
T KOG4250|consen  107 VLNSPENAY------GLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN  177 (732)
T ss_pred             HhcCccccc------CCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccCCCC
Confidence            997644322      399999999999999999999999   99999999999999532    34699999999877654


Q ss_pred             cccccccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCC
Q 023220          152 AARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMP  205 (285)
Q Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~  205 (285)
                      .   .-....||..|++||+... ..|+...|.|||||++|+.+||..||.....
T Consensus       178 s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  178 S---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             C---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            4   2356789999999999984 7889999999999999999999999976543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=7.5e-33  Score=227.42  Aligned_cols=235  Identities=28%  Similarity=0.324  Sum_probs=188.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .+|++....+++.+++|.......... .+.+.+|++.+++++|+|++++++.+......++++|++.+++|.+++....
T Consensus         4 ~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~   82 (244)
T smart00220        4 KVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG   82 (244)
T ss_pred             EEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc
Confidence            578888877788888887654332221 6889999999999999999999999999999999999999889999987654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         ++...++.++.+++.++.+||+.   +++|+||+|+||+++.++.++++|||.+.......   ......
T Consensus        83 ~---------~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~  147 (244)
T smart00220       83 R---------LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFV  147 (244)
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---cccccc
Confidence            2         78899999999999999999999   99999999999999999999999999987654432   123345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhc-CCccCCCCC-hh
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV-DPKLKGEYP-PK  239 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~  239 (285)
                      ++..|++||...+..++.++|+||+|++++++++|..||......               ....... ......... ..
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~  212 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL---------------LELFKKIGKPKPPFPPPEWK  212 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---------------HHHHHHHhccCCCCcccccc
Confidence            778899999998888899999999999999999999999653211               1111111 111100111 11


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ++.++.+++.+||..+|++||++.++++
T Consensus       213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      213 ISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             CCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            5678999999999999999999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.2e-32  Score=232.23  Aligned_cols=213  Identities=17%  Similarity=0.191  Sum_probs=156.0

Q ss_pred             HHHHHccCCCCcccccceEEEeCC----eeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 023220           36 LVSVVSRLKHENLVELLGYCVEGN----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYL  111 (285)
Q Consensus        36 e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l  111 (285)
                      ++..+..++|++++.+++.+....    ..+++++++.. ++.+.+.....         .+...+..++.|++.|+.||
T Consensus        73 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~l  142 (294)
T PHA02882         73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKC---------KNKKLIKNIMKDMLTTLEYI  142 (294)
T ss_pred             HHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhcc---------CCHHHHHHHHHHHHHHHHHH
Confidence            444566779999999998765443    34677787754 77776654321         56778899999999999999


Q ss_pred             hhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-----ccccccccccCcCCCcccccCCCCcccchHhH
Q 023220          112 HEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSF  186 (285)
Q Consensus       112 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Diwsl  186 (285)
                      |+.   +++||||||+||+++.++.++|+|||++.........     .......|++.|+|||...+..++.++||||+
T Consensus       143 H~~---~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSl  219 (294)
T PHA02882        143 HEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESL  219 (294)
T ss_pred             HhC---CeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHH
Confidence            999   9999999999999999999999999998654321111     11122458999999999998899999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 023220          187 GVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVV  266 (285)
Q Consensus       187 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll  266 (285)
                      ||++|+|++|..||.............      ....+..+..+..   .....+..+.++++.|++.+|++||++.+++
T Consensus       220 G~~l~el~~g~~P~~~~~~~~~~~~~~------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~  290 (294)
T PHA02882        220 GYCMLKWAGIKLPWKGFGHNGNLIHAA------KCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALI  290 (294)
T ss_pred             HHHHHHHHhCCCCCCccccchHHHHHh------HHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence            999999999999997653211100000      0000111111111   1234567899999999999999999999999


Q ss_pred             HHhc
Q 023220          267 KALQ  270 (285)
Q Consensus       267 ~~l~  270 (285)
                      +.|+
T Consensus       291 ~~~~  294 (294)
T PHA02882        291 KIFD  294 (294)
T ss_pred             HhhC
Confidence            8763

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-33  Score=209.45  Aligned_cols=252  Identities=19%  Similarity=0.241  Sum_probs=203.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||++....+.+.++.|..+.....+..+....+||-+++.+.|.||++++++...++.+.+|+|||.. +|..+...-+
T Consensus        17 tvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdsln   95 (292)
T KOG0662|consen   17 TVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLN   95 (292)
T ss_pred             eeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcC
Confidence            578888889999999999999999999999999999999999999999999999999999999999975 9988887665


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..        +....+..++.|++.++.|+|+.   ++.|||+||+|.+++.+|.+++.|||+++..+-...  .-....
T Consensus        96 g~--------~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr--cysaev  162 (292)
T KOG0662|consen   96 GD--------LDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--CYSAEV  162 (292)
T ss_pred             Cc--------CCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE--eeecee
Confidence            43        88899999999999999999999   999999999999999999999999999976542211  111234


Q ss_pred             cccCcCCCcccccCC-CCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhh---hhhcCCccCCCC
Q 023220          162 GTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKV---KQCVDPKLKGEY  236 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  236 (285)
                      -|.+|++|+++.+.+ |+...|+||.||++.|+.. |++.|.+.+..++...+-+.....+...+   .+.-|-..-..+
T Consensus       163 vtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~y  242 (292)
T KOG0662|consen  163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIY  242 (292)
T ss_pred             eeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCc
Confidence            588999999998875 6889999999999999988 77788888777776666555544443322   111111111111


Q ss_pred             C---------hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          237 P---------PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       237 ~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +         +.....-++++.++|.-+|..|++++..++
T Consensus       243 pattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  243 PATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            1         233445678999999999999999998876

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-33  Score=235.43  Aligned_cols=234  Identities=19%  Similarity=0.261  Sum_probs=188.2

Q ss_pred             ceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            3 RWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      ||-|....|..-|+.|...+.. -.+.-.....+|-.+|++++.+.||.+--.|+..+.+|+|+..|.||+|.-.|....
T Consensus       201 V~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g  280 (591)
T KOG0986|consen  201 VCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHG  280 (591)
T ss_pred             eeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccC
Confidence            6778888889999987443322 223345566788999999999999999999999999999999999999987775443


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .       +.+++..+.-++.+|+.+|.+||+.   +|++||+||+|||+|+.|+++|+|+|+|..+......   ....
T Consensus       281 ~-------~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~---~~rv  347 (591)
T KOG0986|consen  281 N-------PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI---RGRV  347 (591)
T ss_pred             C-------CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc---cccc
Confidence            2       1399999999999999999999999   9999999999999999999999999999877654332   3348


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ||.+|||||++.+..|+...|.||+||++|+|+.|+.||........            .+++....... ...++...+
T Consensus       348 GT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk------------~eEvdrr~~~~-~~ey~~kFS  414 (591)
T KOG0986|consen  348 GTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK------------REEVDRRTLED-PEEYSDKFS  414 (591)
T ss_pred             CcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh------------HHHHHHHHhcc-hhhcccccC
Confidence            99999999999999999999999999999999999999964332211            12222211111 113456778


Q ss_pred             HHHHHHHHHhcccCCCCCCCH
Q 023220          242 AKLAAVAALCVQYEAEFRPNM  262 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~  262 (285)
                      ++..++.+.+|.+||.+|-..
T Consensus       415 ~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  415 EEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             HHHHHHHHHHHccCHHHhccC
Confidence            899999999999999998643

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=7.6e-33  Score=247.30  Aligned_cols=238  Identities=23%  Similarity=0.341  Sum_probs=204.0

Q ss_pred             eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCC
Q 023220           10 QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG   89 (285)
Q Consensus        10 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~   89 (285)
                      .+|--+++|+.. .....+..+++.+|...|.+++|||++++++++..+. .-||++|++.|+|.++++..+..      
T Consensus       723 ~vKipVaiKvl~-~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~------  794 (1177)
T KOG1025|consen  723 NVKIPVAIKVLI-EFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDN------  794 (1177)
T ss_pred             eecceeEEEEee-ccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhcc------
Confidence            444455555543 2334455788899999999999999999999998776 78899999999999999887653      


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCC
Q 023220           90 PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAP  169 (285)
Q Consensus        90 ~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aP  169 (285)
                        +..+..+.|+.||++|+.|||++   +++||||-.+|+|+..-..+++.|||++.........-........+.|+|-
T Consensus       795 --igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmal  869 (1177)
T KOG1025|consen  795 --IGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMAL  869 (1177)
T ss_pred             --ccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHH
Confidence              88899999999999999999999   9999999999999999999999999999877665554444444457789999


Q ss_pred             cccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHH
Q 023220          170 EYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVA  248 (285)
Q Consensus       170 E~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  248 (285)
                      |.+....|++.+|||||||++||++| |..|+.+.                +.+++..++....+.+.|+.++-++.-++
T Consensus       870 e~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi----------------~~~eI~dlle~geRLsqPpiCtiDVy~~m  933 (1177)
T KOG1025|consen  870 ESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI----------------PAEEIPDLLEKGERLSQPPICTIDVYMVM  933 (1177)
T ss_pred             HHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC----------------CHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence            99999999999999999999999998 99999654                44566666777777888999999999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          249 ALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       249 ~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      .+||..|++.||+++++...+.++.+++
T Consensus       934 vkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  934 VKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             HHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            9999999999999999999999888765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.98  E-value=1.8e-32  Score=253.65  Aligned_cols=237  Identities=22%  Similarity=0.290  Sum_probs=179.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe------------------------
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE------------------------   57 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------------------------   57 (285)
                      .||+|..+.-+..||+|.+.... +......+.+|+.+|++|+|||||.++..+.+                        
T Consensus       494 ~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~  572 (1351)
T KOG1035|consen  494 SVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASK  572 (1351)
T ss_pred             eEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcccCCC
Confidence            58999999999999999997665 67778889999999999999999999864410                        


Q ss_pred             --------------------------------------------------------------------------------
Q 023220           58 --------------------------------------------------------------------------------   57 (285)
Q Consensus        58 --------------------------------------------------------------------------------   57 (285)
                                                                                                      
T Consensus       573 ~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~  652 (1351)
T KOG1035|consen  573 YNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESI  652 (1351)
T ss_pred             cccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhhhhc
Confidence                                                                                            


Q ss_pred             -------C--------CeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeC
Q 023220           58 -------G--------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR  122 (285)
Q Consensus        58 -------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~  122 (285)
                             .        -.+||-||||+..++.+++..+...        -.....|.++++|++||+|+|++   |++||
T Consensus       653 ~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--------~~~d~~wrLFreIlEGLaYIH~~---giIHR  721 (1351)
T KOG1035|consen  653 PKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--------SQRDEAWRLFREILEGLAYIHDQ---GIIHR  721 (1351)
T ss_pred             cccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--------hhhHHHHHHHHHHHHHHHHHHhC---ceeec
Confidence                   0        1237788888876666666655421        13678899999999999999999   99999


Q ss_pred             CCCCCCeEEccCCeeEEeccccCCCCC----------------cccccccccccccccCcCCCcccccC---CCCcccch
Q 023220          123 DIRSSNVLLFEDFKAKIADFNLSNQAP----------------DMAARLHSTRVLGTFGYHAPEYAMTG---QLTQKSDV  183 (285)
Q Consensus       123 di~~~nil~~~~~~~~l~df~~~~~~~----------------~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di  183 (285)
                      ||||.||+++.+..|||+|||++....                ........+...||..|.|||++.+.   .|+.|+|+
T Consensus       722 DLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDm  801 (1351)
T KOG1035|consen  722 DLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDM  801 (1351)
T ss_pred             cCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhh
Confidence            999999999999999999999997611                11111123456799999999998765   49999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC--CCCChhHHHHHHHHHHHhcccCCCCCCC
Q 023220          184 YSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK--GEYPPKGVAKLAAVAALCVQYEAEFRPN  261 (285)
Q Consensus       184 wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps  261 (285)
                      ||||++++||+.   ||.+.......  +            ..+-++.+.  ..+.....+.-..+|.+|++.||.+|||
T Consensus       802 YSLGIVlFEM~y---PF~TsMERa~i--L------------~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPt  864 (1351)
T KOG1035|consen  802 YSLGIVLFEMLY---PFGTSMERASI--L------------TNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPT  864 (1351)
T ss_pred             HHHHHHHHHHhc---cCCchHHHHHH--H------------HhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCC
Confidence            999999999985   57655432111  1            111111111  1122233445678999999999999999


Q ss_pred             HHHHHH
Q 023220          262 MSIVVK  267 (285)
Q Consensus       262 ~~~ll~  267 (285)
                      +.++|.
T Consensus       865 A~eLL~  870 (1351)
T KOG1035|consen  865 ATELLN  870 (1351)
T ss_pred             HHHHhh
Confidence            999987

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=5.2e-32  Score=229.79  Aligned_cols=258  Identities=20%  Similarity=0.316  Sum_probs=192.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-----C---CcccccceEEEe----CCeeeEEEeeCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-----H---ENLVELLGYCVE----GNLRVLAYEFAT   69 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~~----~~~~~lv~e~~~   69 (285)
                      +||+|.+.+.+.++|+|+.+   +.+.+.+....||.+|++++     |   .+||+++|+|..    +.+.|+|+|++.
T Consensus        93 TVWLawDtq~~r~VAlKVvK---SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLG  169 (590)
T KOG1290|consen   93 TVWLAWDTQNKRYVALKVVK---SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLG  169 (590)
T ss_pred             eeEEEeeccCCeEEEEEEEe---hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhh
Confidence            69999999999999999886   45667888999999999983     2   489999999974    569999999994


Q ss_pred             CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC---------------
Q 023220           70 MGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED---------------  134 (285)
Q Consensus        70 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~---------------  134 (285)
                       .+|..+|.....+.       ++...+..|++|++.||.|||..+  ||+|-||||+|||+..+               
T Consensus       170 -dnLLklI~~s~YrG-------lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~  239 (590)
T KOG1290|consen  170 -DNLLKLIKYSNYRG-------LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAREAGEAT  239 (590)
T ss_pred             -hHHHHHHHHhCCCC-------CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhhhhcccc
Confidence             59999998776543       899999999999999999999998  99999999999999400               


Q ss_pred             --------------------------------------------------------------------------------
Q 023220          135 --------------------------------------------------------------------------------  134 (285)
Q Consensus       135 --------------------------------------------------------------------------------  134 (285)
                                                                                                      
T Consensus       240 ~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~  319 (590)
T KOG1290|consen  240 TSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERS  319 (590)
T ss_pred             ccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhc
Confidence                                                                                            


Q ss_pred             -----------------------------------------------------------------------CeeEEeccc
Q 023220          135 -----------------------------------------------------------------------FKAKIADFN  143 (285)
Q Consensus       135 -----------------------------------------------------------------------~~~~l~df~  143 (285)
                                                                                             ..|||.|||
T Consensus       320 ~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlG  399 (590)
T KOG1290|consen  320 TLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLG  399 (590)
T ss_pred             ccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeecc
Confidence                                                                                   014555555


Q ss_pred             cCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcc----cch--hhhhhcc
Q 023220          144 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRG----QQS--LVTWATP  217 (285)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~----~~~--~~~~~~~  217 (285)
                      -|++....-     +....|..|+|||++.+..|+..+||||++|++|||+||...|+..+-..    .+.  .+.....
T Consensus       400 NACW~~khF-----T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG  474 (590)
T KOG1290|consen  400 NACWVHKHF-----TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLG  474 (590)
T ss_pred             chhhhhhhh-----chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHh
Confidence            554432211     12335778999999999999999999999999999999999997543211    111  1111111


Q ss_pred             cCch------hhhhhhcCCc-------------------cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          218 RLSE------DKVKQCVDPK-------------------LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       218 ~~~~------~~~~~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      ..+.      .-.+.+++..                   -...++.+...++.+|+.-||+++|.+|||+.+.++  ..+
T Consensus       475 ~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~--hPw  552 (590)
T KOG1290|consen  475 KIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK--HPW  552 (590)
T ss_pred             hccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc--Ccc
Confidence            1111      0111121111                   023456677889999999999999999999999997  566


Q ss_pred             hcCCCCC
Q 023220          273 LKSPPPA  279 (285)
Q Consensus       273 ~~~~~~~  279 (285)
                      +..-+-|
T Consensus       553 Ln~~~~~  559 (590)
T KOG1290|consen  553 LNPVAGP  559 (590)
T ss_pred             ccCCCCC
Confidence            6544443

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4e-32  Score=249.79  Aligned_cols=236  Identities=19%  Similarity=0.191  Sum_probs=192.9

Q ss_pred             ceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      |.++.-+.+.++||+|...+-.-. ......|..|-.+|.--+.+=|+.++-.|.++.++|+||+|+.||+|..++....
T Consensus        91 V~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~  170 (1317)
T KOG0612|consen   91 VALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD  170 (1317)
T ss_pred             eEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC
Confidence            566777889999999977663333 3446677788888888899999999999999999999999999999999998765


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +++.-+..++..++.||.-+|+.   |+|||||||+|||+|..|+++|+|||.+-.+...+.. .....+
T Consensus       171 ~---------~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V-~s~~aV  237 (1317)
T KOG0612|consen  171 R---------LPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV-RSSVAV  237 (1317)
T ss_pred             C---------ChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCCcE-Eecccc
Confidence            2         89999999999999999999999   9999999999999999999999999998776543332 334578


Q ss_pred             cccCcCCCcccc----c-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          162 GTFGYHAPEYAM----T-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       162 ~~~~~~aPE~~~----~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      |||.|.+||++.    + +.|++-+|.||+|+++|||++|..||...+-.+.+..+.               +-.....+
T Consensus       238 GTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm---------------~hk~~l~F  302 (1317)
T KOG0612|consen  238 GTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM---------------NHKESLSF  302 (1317)
T ss_pred             CCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh---------------chhhhcCC
Confidence            999999999985    3 468899999999999999999999998654333333222               22222233


Q ss_pred             C--hhHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 023220          237 P--PKGVAKLAAVAALCVQYEAEFRPN---MSIVVK  267 (285)
Q Consensus       237 ~--~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~  267 (285)
                      |  ..++++..++|++.+. +|..|..   ++++..
T Consensus       303 P~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  303 PDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             CcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            4  5588999999999885 7888887   888875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.2e-31  Score=250.00  Aligned_cols=133  Identities=24%  Similarity=0.297  Sum_probs=117.5

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+...+..|++|..+.... .......+.+|+.++..++||||+++++.+......++||||+.+++|.+++...
T Consensus        19 ~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~   98 (669)
T cd05610          19 KVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY   98 (669)
T ss_pred             EEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhc
Confidence            589999988899999998764332 2333567888999999999999999999999999999999999999999999754


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      ..         +++..++.++.||+.||.|||..   |++||||||+|||++.++.++|+|||++.
T Consensus        99 ~~---------l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          99 GY---------FDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            32         78889999999999999999999   99999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.1e-32  Score=214.98  Aligned_cols=253  Identities=19%  Similarity=0.287  Sum_probs=191.0

Q ss_pred             ceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe--------CCeeeEEEeeCCCCCHH
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--------GNLRVLAYEFATMGSLH   74 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~~~L~   74 (285)
                      ||++..+.+++-+++|.+--....+.+.....+|+.+|..+.|+|++.+++.|..        ...+++||++|++ +|.
T Consensus        33 VFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLa  111 (376)
T KOG0669|consen   33 VFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLA  111 (376)
T ss_pred             HHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHH
Confidence            6667666666667777766555667789999999999999999999999998853        3357999999997 888


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc--
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA--  152 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~--  152 (285)
                      -++.....+        ++..++..++.++.++|.|+|.+   .++|||+|+.|+||+++|.++|+|||+++......  
T Consensus       112 GlLsn~~vr--------~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~  180 (376)
T KOG0669|consen  112 GLLSNRKVR--------FSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNV  180 (376)
T ss_pred             HHhcCcccc--------ccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceeccccc
Confidence            888765432        89999999999999999999999   99999999999999999999999999996443211  


Q ss_pred             ccccccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCc--------hhh
Q 023220          153 ARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLS--------EDK  223 (285)
Q Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~  223 (285)
                      ....-+..+-|.+|++||.+.+ ..|++..|+|+.||++.+|+++.+-+.+.....+...+...-...+        .-.
T Consensus       181 ~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lp  260 (376)
T KOG0669|consen  181 VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLP  260 (376)
T ss_pred             CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccch
Confidence            1111223345899999998875 5789999999999999999999999998877666544432222111        111


Q ss_pred             hhhhc--CCccCCCCC--hh------HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          224 VKQCV--DPKLKGEYP--PK------GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       224 ~~~~~--~~~~~~~~~--~~------~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +.+-+  .|...+.+.  .+      -..+..+++.+++..||.+|+++.+++.
T Consensus       261 L~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  261 LYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             HHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            11111  111111110  11      1236788999999999999999999987

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=4.8e-32  Score=219.28  Aligned_cols=243  Identities=19%  Similarity=0.194  Sum_probs=186.9

Q ss_pred             eeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC------eeeEEEeeCCCCCHHHHhccCC
Q 023220            8 TCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN------LRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         8 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +....+.+++|....--.......+..+|..++..++|+||++++.+|.-..      ..|+|||++.. +|.+.+... 
T Consensus        37 D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~~e-  114 (369)
T KOG0665|consen   37 DQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVILME-  114 (369)
T ss_pred             hhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHHHh-
Confidence            3444555555543333444667788889999999999999999999997544      45999999975 999988733 


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                +.=.++..++.|.+.|+++||+.   ||+|||+||+||++..+..+||.|||++......   ...+...
T Consensus       115 ----------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyV  178 (369)
T KOG0665|consen  115 ----------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYV  178 (369)
T ss_pred             ----------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc---cccCchh
Confidence                      66678999999999999999999   9999999999999999999999999999764432   3345667


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhc-------------
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV-------------  228 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------  228 (285)
                      .+..|+|||++.+..+.+..||||+||++.||++|...|.+.+...+...+....+........++.             
T Consensus       179 vtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y  258 (369)
T KOG0665|consen  179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQY  258 (369)
T ss_pred             heeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHh
Confidence            7889999999999889999999999999999999999999887766655544433333322111110             


Q ss_pred             ----------CCccC--CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          229 ----------DPKLK--GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       229 ----------~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                                |....  .+.+..-....++++.+||..||++|.|+.++|+.
T Consensus       259 ~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  259 QAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                      00000  01112234578899999999999999999999983

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.7e-32  Score=230.67  Aligned_cols=226  Identities=20%  Similarity=0.253  Sum_probs=191.2

Q ss_pred             ccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCC
Q 023220           12 EESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP   90 (285)
Q Consensus        12 ~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~   90 (285)
                      +..|+.|..++.- ......+.+..|-.+|.+++.|.|+++|-.|.+++..|++||.|-||.|...+.+...        
T Consensus       445 ~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~--------  516 (732)
T KOG0614|consen  445 KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGS--------  516 (732)
T ss_pred             chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCC--------
Confidence            3458888766544 3334567778899999999999999999999999999999999999999999988764        


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCc
Q 023220           91 VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE  170 (285)
Q Consensus        91 ~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE  170 (285)
                       +...+..-++.-+++|+.|||.+   ||++||+||+|.+++.+|.+||.|||.++...+...   +.-..||+.|.|||
T Consensus       517 -Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K---TwTFcGTpEYVAPE  589 (732)
T KOG0614|consen  517 -FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---TWTFCGTPEYVAPE  589 (732)
T ss_pred             -cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCc---eeeecCCcccccch
Confidence             88889999999999999999999   999999999999999999999999999988765332   34467999999999


Q ss_pred             ccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHH
Q 023220          171 YAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAAL  250 (285)
Q Consensus       171 ~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  250 (285)
                      ++.....+.+.|.||||+++|||++|.+||.+.++...++.+......               -.+|.-++....++|++
T Consensus       590 IILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~---------------i~~Pr~I~k~a~~Lik~  654 (732)
T KOG0614|consen  590 IILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK---------------IEFPRRITKTATDLIKK  654 (732)
T ss_pred             hhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh---------------hhcccccchhHHHHHHH
Confidence            999999999999999999999999999999988876665554422222               24566677788999999


Q ss_pred             hcccCCCCCCC-----HHHHHH
Q 023220          251 CVQYEAEFRPN-----MSIVVK  267 (285)
Q Consensus       251 ~l~~~p~~Rps-----~~~ll~  267 (285)
                      +...+|.+|..     +.|+..
T Consensus       655 LCr~~P~ERLG~~~~gI~DIkk  676 (732)
T KOG0614|consen  655 LCRDNPTERLGYQKGGINDIKK  676 (732)
T ss_pred             HHhcCcHhhhccccCChHHHHh
Confidence            99999999975     555544

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=234.54  Aligned_cols=237  Identities=24%  Similarity=0.353  Sum_probs=195.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEE-----eCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCV-----EGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||++..+++++..++|......   ...+++.-|.++++.. .|||++.++|+|.     .++.++||||||.+|+..+
T Consensus        34 kv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTD  110 (953)
T KOG0587|consen   34 KVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTD  110 (953)
T ss_pred             eEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHH
Confidence            47888888888888888765433   3446677788899887 8999999999986     3568999999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      +++.....       .+.+..+..|++.++.|+.+||.+   .++|||||-.|||++.++.|||+|||++...+...  .
T Consensus       111 LVKn~~g~-------rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~--g  178 (953)
T KOG0587|consen  111 LVKNTKGN-------RLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV--G  178 (953)
T ss_pred             HHhhhccc-------chhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeeccc--c
Confidence            99876533       289999999999999999999999   99999999999999999999999999987655433  2


Q ss_pred             cccccccccCcCCCcccccC-----CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTG-----QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                      ..+-..||+.|+|||++...     .|+.++|+||||++..||.-|.+|+-..++.-....+..              +|
T Consensus       179 rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR--------------NP  244 (953)
T KOG0587|consen  179 RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--------------NP  244 (953)
T ss_pred             cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC--------------CC
Confidence            34456799999999998643     578899999999999999999999987766444333321              22


Q ss_pred             ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          231 KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      -.....+.-.+.++-++|+.||.+|..+||++.++++
T Consensus       245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            2223345677889999999999999999999999987

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-30  Score=212.53  Aligned_cols=227  Identities=23%  Similarity=0.291  Sum_probs=189.6

Q ss_pred             CCCChhHHHHHHHHccCCCCcccccceEEEeC-CeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHH
Q 023220           27 KNYPDDEKQLVSVVSRLKHENLVELLGYCVEG-NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAA  105 (285)
Q Consensus        27 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~  105 (285)
                      +.....+.+|--++..+.|||+.++.++..+. ...+.++++..-|+|+.++...+.... ...+.++..+...++.|++
T Consensus       328 ~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~-~~aqtvtt~qlV~masQla  406 (563)
T KOG1024|consen  328 QIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDP-SYAQTVTTIQLVLMASQLA  406 (563)
T ss_pred             HHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCC-ccccchhHHHHHHHHHHHH
Confidence            34567777888888889999999999987654 456888899988999999983332111 1122378889999999999


Q ss_pred             HHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHh
Q 023220          106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYS  185 (285)
Q Consensus       106 ~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  185 (285)
                      .|+.|||+.   |++|.||-.+|++|++..++||+|-.+++..-..+......+...+..|++||.+....|++.+|+||
T Consensus       407 ~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWs  483 (563)
T KOG1024|consen  407 MAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWS  483 (563)
T ss_pred             HHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHH
Confidence            999999999   99999999999999999999999999888766666665555555678999999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHH
Q 023220          186 FGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSI  264 (285)
Q Consensus       186 lG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  264 (285)
                      ||+++|||++ |+.|+..-++                .++...+..+.+..-|-++|.+++.++--||...|++||++++
T Consensus       484 fGVllWELmtlg~~PyaeIDP----------------fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Q  547 (563)
T KOG1024|consen  484 FGVLLWELMTLGKLPYAEIDP----------------FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQ  547 (563)
T ss_pred             HHHHHHHHHhcCCCCccccCH----------------HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHH
Confidence            9999999999 9999965443                4555666667777888899999999999999999999999999


Q ss_pred             HHHHhchhh
Q 023220          265 VVKALQPLL  273 (285)
Q Consensus       265 ll~~l~~~~  273 (285)
                      +..-|+.+-
T Consensus       548 lv~cLseF~  556 (563)
T KOG1024|consen  548 LVICLSEFH  556 (563)
T ss_pred             HHHHHHHHH
Confidence            988777654

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.7e-31  Score=218.77  Aligned_cols=227  Identities=22%  Similarity=0.218  Sum_probs=184.5

Q ss_pred             ceeeeeeeeccccChhhhhhccCCC-CCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPK-NYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      |-++-.+.+.+.|++|..++....+ +-.+--+.|-++|..- +-|.++.++..|..-+.+|+||||+.||+|--.++.-
T Consensus       365 VlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~  444 (683)
T KOG0696|consen  365 VLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV  444 (683)
T ss_pred             eeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHh
Confidence            4556667889999999877654332 2344445566677665 6789999999999999999999999999998888765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +.+..+.-++..|+-+|-|||++   ||++||+|.+|++++.+|+++|.|||+....-.  ....+.-.
T Consensus       445 Gk---------FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~--~~~TTkTF  510 (683)
T KOG0696|consen  445 GK---------FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF--DGVTTKTF  510 (683)
T ss_pred             cc---------cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc--CCcceeee
Confidence            43         77788999999999999999999   999999999999999999999999999865322  22223446


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .||+.|+|||++...+|+...|.||+|++||||+.|++||++.+....-               ..+.+..  -.+|...
T Consensus       511 CGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF---------------~aI~ehn--vsyPKsl  573 (683)
T KOG0696|consen  511 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---------------QAIMEHN--VSYPKSL  573 (683)
T ss_pred             cCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---------------HHHHHcc--CcCcccc
Confidence            7999999999999999999999999999999999999999987653222               2222211  2567788


Q ss_pred             HHHHHHHHHHhcccCCCCCC
Q 023220          241 VAKLAAVAALCVQYEAEFRP  260 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp  260 (285)
                      +.+..++.+..|.++|.+|.
T Consensus       574 SkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  574 SKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             cHHHHHHHHHHhhcCCcccc
Confidence            88999999999999999985

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.7e-30  Score=226.88  Aligned_cols=195  Identities=22%  Similarity=0.291  Sum_probs=165.3

Q ss_pred             ceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      |-++.|..|+..|+.|..++.... .+.....+.|-.+|..-+++-||++|-.|.+.+.+|+||+|+.||++-.++-...
T Consensus       645 V~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg  724 (1034)
T KOG0608|consen  645 VCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG  724 (1034)
T ss_pred             eEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc
Confidence            567888999999999977654433 4456777889999999999999999999999999999999999999999887654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCC--------ccc-
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP--------DMA-  152 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~--------~~~-  152 (285)
                               .+.+..+..++..+.+|+.+.|+.   |+|||||||+|||||.+|++||.|||++.=+.        ..+ 
T Consensus       725 ---------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gd  792 (1034)
T KOG0608|consen  725 ---------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGD  792 (1034)
T ss_pred             ---------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccccccCCC
Confidence                     288999999999999999999999   99999999999999999999999999973110        000 


Q ss_pred             -------------------------------ccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCC
Q 023220          153 -------------------------------ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD  201 (285)
Q Consensus       153 -------------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~  201 (285)
                                                     ........+||+.|+|||++....++..+|.||.|++||+|+.|+.||-
T Consensus       793 H~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~  872 (1034)
T KOG0608|consen  793 HHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFL  872 (1034)
T ss_pred             ccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCcc
Confidence                                           0011224678999999999999999999999999999999999999998


Q ss_pred             CCCCcccc
Q 023220          202 HTMPRGQQ  209 (285)
Q Consensus       202 ~~~~~~~~  209 (285)
                      ...+.+.+
T Consensus       873 ~~tp~~tq  880 (1034)
T KOG0608|consen  873 ADTPGETQ  880 (1034)
T ss_pred             CCCCCcce
Confidence            87765544

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=228.75  Aligned_cols=235  Identities=18%  Similarity=0.215  Sum_probs=193.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh-ccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-HGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~~   80 (285)
                      .||=..-++++.-+++|++.++.......+.+++|+++|+++.||+|+.+--.|+..+..++|||.+.| +..+.+ ...
T Consensus       579 ~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILSsE  657 (888)
T KOG4236|consen  579 TVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILSSE  657 (888)
T ss_pred             eeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHHhh
Confidence            467777788999999999999998888889999999999999999999999999999999999999976 555555 443


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc---CCeeEEeccccCCCCCcccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      ..+        +++..-..++.||+.||.|||-+   +|+|+|+||+|+|+..   -..+||+|||.++.++....   .
T Consensus       658 kgR--------L~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---R  723 (888)
T KOG4236|consen  658 KGR--------LPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---R  723 (888)
T ss_pred             ccc--------chHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh---h
Confidence            332        89999999999999999999999   9999999999999964   45799999999998876443   3


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCccc-chhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ-QSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ...+||+.|+|||++....|...-|+||+|+++|--+.|-.||+....... .......-+..+                
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~P----------------  787 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNP----------------  787 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCc----------------
Confidence            567899999999999999999999999999999999999999975432111 111111111111                


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      =.++++...++|..+|+..-.+|.|....+.
T Consensus       788 W~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            1355677889999999999999999887654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-30  Score=217.38  Aligned_cols=259  Identities=27%  Similarity=0.363  Sum_probs=195.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHc--cCCCCcccccceEEEeCC----eeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVS--RLKHENLVELLGYCVEGN----LRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~--~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~   75 (285)
                      .||++.-  .++.+|||.+.     .+..+.++.|-++++  .+.|+||+++++.=....    .++||++|++.|+|.+
T Consensus       225 ~V~KaqL--~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~d  297 (534)
T KOG3653|consen  225 CVWKAQL--DNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCD  297 (534)
T ss_pred             eeehhhc--cCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHH
Confidence            3565522  24778888775     334567777777766  459999999998876554    7899999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeeeCCCCCCCeEEccCCeeEEeccccCCCCC
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV------QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP  149 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~------~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~  149 (285)
                      ++..+.          ++|.....++..++.||+|||+-.      .++|+|||||..|||+..++++.|+|||++....
T Consensus       298 yL~~nt----------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~  367 (534)
T KOG3653|consen  298 YLKANT----------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE  367 (534)
T ss_pred             HHHhcc----------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence            999875          899999999999999999999762      5679999999999999999999999999998776


Q ss_pred             cccccccccccccccCcCCCcccccCC-CC-----cccchHhHHHHHHHHHhCCCCCC-CCCCcccchhhhhhcccCchh
Q 023220          150 DMAARLHSTRVLGTFGYHAPEYAMTGQ-LT-----QKSDVYSFGVVLLELLTGRKPVD-HTMPRGQQSLVTWATPRLSED  222 (285)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-----~~~DiwslG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~  222 (285)
                      ...........+||.+|||||++.+.- +.     .+.||||+|.++||+++.-.-+. +..++-+...-...+...+.+
T Consensus       368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e  447 (534)
T KOG3653|consen  368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE  447 (534)
T ss_pred             CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence            544444445578999999999987652 22     46899999999999998655443 222222223333455555555


Q ss_pred             hhhhhcCCcc-CCCCCh-----hHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          223 KVKQCVDPKL-KGEYPP-----KGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       223 ~~~~~~~~~~-~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                      ++...+-... +..++.     ....-+.+.+.-||+.||+.|.|+.=+.+.+..++...+
T Consensus       448 ~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  448 EMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             HHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            5544432222 222222     335679999999999999999999999999888876554

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-32  Score=215.18  Aligned_cols=254  Identities=20%  Similarity=0.250  Sum_probs=198.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC-----eeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN-----LRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~   76 (285)
                      +||-+.+.....+++.|........--..+.+.+|+.+|..++|.|++...|+..-..     ..|+++|.+.. +|..+
T Consensus        68 VVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKI  146 (449)
T KOG0664|consen   68 VVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKI  146 (449)
T ss_pred             EEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhhe
Confidence            5788888777777777754433333334678889999999999999999999876443     45889999975 89888


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH  156 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  156 (285)
                      +-....         ++...+.-++.||+.+|+|||+.   +|.||||||.|.+++.+-.+||+|||+++......... 
T Consensus       147 IVSPQ~---------Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h-  213 (449)
T KOG0664|consen  147 IVSPQA---------LTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN-  213 (449)
T ss_pred             eccCCC---------CCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhhh-
Confidence            865442         88899999999999999999999   99999999999999999999999999998765444332 


Q ss_pred             ccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh--------
Q 023220          157 STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC--------  227 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  227 (285)
                      .+..+-|..|+|||++++. .|+...||||+||++.||+..+..|+...+..+..++.......+.+..+..        
T Consensus       214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~  293 (449)
T KOG0664|consen  214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV  293 (449)
T ss_pred             hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence            2334457889999999986 6899999999999999999999999999998888888877777666554332        


Q ss_pred             cCCccCCC---------CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 023220          228 VDPKLKGE---------YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL  269 (285)
Q Consensus       228 ~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l  269 (285)
                      +....+..         .+..-..+...++.++|.+||+.|.+.++.+..+
T Consensus       294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            12111111         1112234677889999999999999999887643

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=220.05  Aligned_cols=243  Identities=22%  Similarity=0.292  Sum_probs=187.1

Q ss_pred             ceeeeeeeeccccChhhhhh-----ccCCCCCChhHHHHHHHHccCCCCcccccceEEEe-CCeeeEEEeeCCCCCHHHH
Q 023220            3 RWLCCTCQVEESYPSHENER-----LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE-GNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~   76 (285)
                      ||++++..-..++++|.--.     ......+.+...+|.++-+.|.||.||++|++|.- ...+|-|+||++|.+|.=+
T Consensus       479 VyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFY  558 (775)
T KOG1151|consen  479 VYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFY  558 (775)
T ss_pred             HHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHH
Confidence            79999988888888873211     11223456677889999999999999999999974 4577999999999999888


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc---CCeeEEeccccCCCCCcccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~  153 (285)
                      ++....         ++++.+..|+.||+.||.||.+. ++.|+|-|+||.|||+-.   .|.++|.|||++..+.....
T Consensus       559 LKQhkl---------mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy  628 (775)
T KOG1151|consen  559 LKQHKL---------MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSY  628 (775)
T ss_pred             HHhhhh---------hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCcc
Confidence            887653         89999999999999999999986 668999999999999954   46789999999987754333


Q ss_pred             c-----ccccccccccCcCCCcccc----cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh
Q 023220          154 R-----LHSTRVLGTFGYHAPEYAM----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV  224 (285)
Q Consensus       154 ~-----~~~~~~~~~~~~~aPE~~~----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
                      .     -.+....||.+|++||.+-    ..+++.+.||||+|+++|..+.|+.||.....+......            
T Consensus       629 ~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe------------  696 (775)
T KOG1151|consen  629 NSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE------------  696 (775)
T ss_pred             CcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh------------
Confidence            2     1233456899999999874    236789999999999999999999999865432221100            


Q ss_pred             hhhcCCcc-CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          225 KQCVDPKL-KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       225 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      -.++.+.. .-+.-+.++.+...+|++||+.--.+|....++..
T Consensus       697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            01111111 11223567888999999999999999998887754

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-32  Score=216.24  Aligned_cols=244  Identities=22%  Similarity=0.198  Sum_probs=176.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHcc-CCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSR-LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +|++..-+......++|.++.....+ ...++..|.++..+ -+.||||++||.....+..++-||.|+- ||..+.+.-
T Consensus        79 ~V~KM~hk~sg~~mAVKrIr~~n~~k-eq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~v  156 (361)
T KOG1006|consen   79 TVNKMLHKPSGKLMAVKRIRSNNIEK-EQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRV  156 (361)
T ss_pred             hhhhhhcCccCcEEEEEEeeeccchH-HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHH
Confidence            35666667778888999887655433 35566666665544 4789999999999988899999999975 665554321


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      -..+..    .+++..+-.+..-.+.||.||-+..  .++|||+||+|||++..|.+||||||++...-....   .+..
T Consensus       157 y~vq~~----~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA---kT~d  227 (361)
T KOG1006|consen  157 YSVQKS----RIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA---KTVD  227 (361)
T ss_pred             HHHHhc----cCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHH---hhhc
Confidence            100001    2788888888888999999998765  899999999999999999999999999854432221   2344


Q ss_pred             ccccCcCCCccccc--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC-CCC
Q 023220          161 LGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG-EYP  237 (285)
Q Consensus       161 ~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  237 (285)
                      .|-..|+|||.+..  ..|+.+||+||||+++||+.||..|+...+.. ...+........          |.+.. ...
T Consensus       228 aGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-feql~~Vv~gdp----------p~l~~~~~~  296 (361)
T KOG1006|consen  228 AGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-FEQLCQVVIGDP----------PILLFDKEC  296 (361)
T ss_pred             cCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-HHHHHHHHcCCC----------CeecCcccc
Confidence            56778999999864  35899999999999999999999999755431 111111111110          00111 111


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      -.++..+..+|..||.+|-.+||++.++++
T Consensus       297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            346778999999999999999999999986

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.1e-30  Score=214.14  Aligned_cols=238  Identities=24%  Similarity=0.318  Sum_probs=179.6

Q ss_pred             ccccChhhhhhccCCCCCChhHHHHHHHHccC--CCCcccccceEEEeCC----eeeEEEeeCCCCCHHHHhccCCCCCC
Q 023220           12 EESYPSHENERLKSPKNYPDDEKQLVSVVSRL--KHENLVELLGYCVEGN----LRVLAYEFATMGSLHDILHGRKGVQG   85 (285)
Q Consensus        12 ~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~   85 (285)
                      ++.+|||.+-.     ...+...+|.++++..  +|+||+-+++.-..++    +++||++|++.|||+++++.+.    
T Consensus       234 Ge~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t----  304 (513)
T KOG2052|consen  234 GEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT----  304 (513)
T ss_pred             CCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhcc----
Confidence            45566665542     2356778888898865  9999999998765443    7799999999999999999864    


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc--ccccc
Q 023220           86 AQPGPVLDWMTRVRIAVDAARGLEYLHEK-----VQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA--RLHST  158 (285)
Q Consensus        86 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~-----~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~  158 (285)
                            ++....+.++..++++|++||..     +.+.+.|||||..|||+.+++.+.|+|+|+|....+...  ....+
T Consensus       305 ------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N  378 (513)
T KOG2052|consen  305 ------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPN  378 (513)
T ss_pred             ------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCC
Confidence                  89999999999999999999965     477899999999999999999999999999965443321  22234


Q ss_pred             ccccccCcCCCcccccC------CCCcccchHhHHHHHHHHHhC----------CCCCCCCCCcccchhhhhhcccCchh
Q 023220          159 RVLGTFGYHAPEYAMTG------QLTQKSDVYSFGVVLLELLTG----------RKPVDHTMPRGQQSLVTWATPRLSED  222 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~~l~~l~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (285)
                      ..+||.+|||||++...      .--..+||||||+++||++..          ++||..-.+           ...+-+
T Consensus       379 ~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp-----------~DPs~e  447 (513)
T KOG2052|consen  379 PRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP-----------SDPSFE  447 (513)
T ss_pred             CccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC-----------CCCCHH
Confidence            57799999999998643      123579999999999999762          345543322           222222


Q ss_pred             hhhhhc-CCccCCCCC-----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          223 KVKQCV-DPKLKGEYP-----PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       223 ~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      +..+.+ ...++...|     ...-..+.++++.||..||.-|-|+--+.+.|.++.+.
T Consensus       448 eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  448 EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            222221 122222222     24456889999999999999999999999999998854

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=1.6e-30  Score=222.41  Aligned_cols=248  Identities=18%  Similarity=0.179  Sum_probs=185.3

Q ss_pred             ceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC------CCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK------HENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      |-+|.+..-.+.||+|.++.-.   -..+.=+.|+++|++|+      -.|++.++-+|.+.+++|||||.+.- +|.++
T Consensus       448 Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Lsl-NLRev  523 (752)
T KOG0670|consen  448 VVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSL-NLREV  523 (752)
T ss_pred             eeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhhc-hHHHH
Confidence            4456666667788888776321   12233356999999994      35999999999999999999999964 99999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC-CeeEEeccccCCCCCcccccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++.-...-      .|....+..++.|++-||..|-.-   |++|.||||+|||++++ ..++|||||.|........  
T Consensus       524 LKKyG~nv------GL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei--  592 (752)
T KOG0670|consen  524 LKKYGRNV------GLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASFASENEI--  592 (752)
T ss_pred             HHHhCccc------ceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccccccccccc--
Confidence            97654221      278889999999999999999998   99999999999999875 4569999999976543221  


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhh--hcCCccC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQ--CVDPKLK  233 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  233 (285)
                        +...-+..|+|||++.|..|+...|+||+||+||||+||+..|.+.....-..+.......++...+.+  +++..+.
T Consensus       593 --tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD  670 (752)
T KOG0670|consen  593 --TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFD  670 (752)
T ss_pred             --cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcc
Confidence              222335679999999999999999999999999999999999988765444444444444444422211  1111110


Q ss_pred             --------------------------------------CCCC---hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          234 --------------------------------------GEYP---PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       234 --------------------------------------~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                                                            ...+   ...-.++.+|+.+||..||++|.|..+.|.
T Consensus       671 ~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  671 QDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             cccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                                                  0111   123457889999999999999999999886

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=227.37  Aligned_cols=225  Identities=22%  Similarity=0.330  Sum_probs=168.9

Q ss_pred             cccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCC
Q 023220           13 ESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPV   91 (285)
Q Consensus        13 ~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~   91 (285)
                      ..+|||...     ....+-.++||..|+.- +|||||++++.=.+....||..|.|.. +|.++++.....  ...   
T Consensus       534 R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d--~~~---  602 (903)
T KOG1027|consen  534 REVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLD--VEM---  602 (903)
T ss_pred             ceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccc--hhh---
Confidence            466777665     34466778999999988 899999999998899999999999975 999999874110  000   


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-----CCeeEEeccccCCCCCccccc-ccccccccccC
Q 023220           92 LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-----DFKAKIADFNLSNQAPDMAAR-LHSTRVLGTFG  165 (285)
Q Consensus        92 ~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-----~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~  165 (285)
                      ......+..+.|+++|+++||..   +|+|||+||+||||+.     ...++|+|||++......... .......|+.+
T Consensus       603 ~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~G  679 (903)
T KOG1027|consen  603 QSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSG  679 (903)
T ss_pred             cccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCccc
Confidence            12245688999999999999999   9999999999999976     257899999999877543322 22344679999


Q ss_pred             cCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHH
Q 023220          166 YHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKL  244 (285)
Q Consensus       166 ~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (285)
                      |+|||.+....-+...||||+||++|+.++ |.+||+..-..+..  +.  ...   ..+..       ......+  +.
T Consensus       680 W~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--Il--~~~---~~L~~-------L~~~~d~--eA  743 (903)
T KOG1027|consen  680 WQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--IL--TGN---YTLVH-------LEPLPDC--EA  743 (903)
T ss_pred             ccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--hh--cCc---cceee-------eccCchH--HH
Confidence            999999988877889999999999999998 59999754322110  00  000   00000       0111111  68


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHH
Q 023220          245 AAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .++|.+|++.+|..||++.+++.
T Consensus       744 ~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  744 KDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             HHHHHHhcCCCcccCCCHHHHhC
Confidence            89999999999999999999874

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.7e-29  Score=203.16  Aligned_cols=234  Identities=19%  Similarity=0.249  Sum_probs=184.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCC-CChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKN-YPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +|-++.-+.+.+.|++|++++.....+ -.+=.+.|-.++.+- +||.++-++..|.....+++|.||..||+|-=.++.
T Consensus       265 kvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqr  344 (593)
T KOG0695|consen  265 KVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR  344 (593)
T ss_pred             hhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhh
Confidence            455566678899999999988765543 455566677777766 899999999999999999999999999999766665


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ++.         ++++.+..+...|+.||.|||+.   ||++||+|.+|+|++..|++||.|+|+.+.....+.  .+.-
T Consensus       345 qrk---------lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~gd--~tst  410 (593)
T KOG0695|consen  345 QRK---------LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD--TTST  410 (593)
T ss_pred             hhc---------CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCCc--cccc
Confidence            543         89999999999999999999999   999999999999999999999999999875433222  2344


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhh-hhh-hcCCccCCCCC
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDK-VKQ-CVDPKLKGEYP  237 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~  237 (285)
                      ..||+.|.|||++.+..|....|.|+||++++||+.|+.||..-....         +....+. +.. +++...  ..|
T Consensus       411 fcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n---------~d~ntedylfqvilekqi--rip  479 (593)
T KOG0695|consen  411 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN---------PDMNTEDYLFQVILEKQI--RIP  479 (593)
T ss_pred             ccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC---------cccchhHHHHHHHhhhcc--ccc
Confidence            679999999999999999999999999999999999999997422111         1111111 111 222222  345


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCC
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRP  260 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rp  260 (285)
                      ...+.....+++.-|++||.+|.
T Consensus       480 rslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  480 RSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ceeehhhHHHHHHhhcCCcHHhc
Confidence            56667788899999999999985

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=5.8e-28  Score=193.75  Aligned_cols=205  Identities=30%  Similarity=0.448  Sum_probs=171.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .+|++.....++.+++|......... ..+.+.+|++.++.++|++++++++++......++++|++.+++|.+++....
T Consensus         8 ~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~   86 (215)
T cd00180           8 TVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE   86 (215)
T ss_pred             EEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc
Confidence            46777666557777777665332221 35789999999999999999999999999999999999999889999987652


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-CCeeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      .        .++...++.++.+++.++.+||+.   |++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        87 ~--------~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          87 G--------KLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            1        278899999999999999999999   9999999999999999 89999999998865433211  12234


Q ss_pred             ccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          161 LGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      .+...|.+||..... ..+.++|+|++|++++++                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            567889999988776 778999999999999999                                              


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                        ..+.+++.+|++.||++||++.++++.
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence              358899999999999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=1e-27  Score=218.94  Aligned_cols=262  Identities=15%  Similarity=0.129  Sum_probs=156.6

Q ss_pred             Cceeeeeeee----ccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceE------EEeCCeeeEEEeeCCCC
Q 023220            2 RRWLCCTCQV----EESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY------CVEGNLRVLAYEFATMG   71 (285)
Q Consensus         2 ~~~~~~~~~~----~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~~~~~~~lv~e~~~~~   71 (285)
                      .||++....+    +..+++|......    ..+....+  .++...+.++..+...      ...+...+++++|+.++
T Consensus       147 ~VYka~~~~~~~~~~~~vAvK~~~~~~----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~g  220 (566)
T PLN03225        147 VVYKASLVNKQSKKEGKYVLKKATEYG----AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGES  220 (566)
T ss_pred             EEEEEEEcCCccccCcEEEEEEecccc----hhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCC
Confidence            5889888777    6777777543211    11111111  1222223333332222      23456789999999999


Q ss_pred             CHHHHhccCCCCC-----------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-CCeeEE
Q 023220           72 SLHDILHGRKGVQ-----------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKI  139 (285)
Q Consensus        72 ~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-~~~~~l  139 (285)
                      +|.+++.......           ............+..++.|++.||.|||+.   |++||||||+|||++. ++.++|
T Consensus       221 sL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NILl~~~~~~~KL  297 (566)
T PLN03225        221 TLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIFSEGSGSFKI  297 (566)
T ss_pred             cHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEEEeCCCCcEEE
Confidence            9999987543100           000000122345678999999999999999   9999999999999985 578999


Q ss_pred             eccccCCCCCcccccccccccccccCcCCCcccccC----------------------CCCcccchHhHHHHHHHHHhCC
Q 023220          140 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG----------------------QLTQKSDVYSFGVVLLELLTGR  197 (285)
Q Consensus       140 ~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------------------~~~~~~DiwslG~~l~~l~~g~  197 (285)
                      +|||++......... ......+++.|+|||.+...                      .++.++|||||||++|+|+++.
T Consensus       298 ~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~  376 (566)
T PLN03225        298 IDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPN  376 (566)
T ss_pred             EeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCc
Confidence            999999754322111 11234578899999965322                      2345679999999999999977


Q ss_pred             CCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC------CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          198 KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE------YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       198 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      .++.....   .....................+.....      ..........+||++||++||.+|||+.++++  ..
T Consensus       377 ~~~~~~~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~--Hp  451 (566)
T PLN03225        377 LRSDSNLI---QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALA--HP  451 (566)
T ss_pred             CCCchHHH---HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhC--Cc
Confidence            66432110   000000000111111111111111000      00111234568999999999999999999998  45


Q ss_pred             hhcCCCC
Q 023220          272 LLKSPPP  278 (285)
Q Consensus       272 ~~~~~~~  278 (285)
                      ++....+
T Consensus       452 ff~~~~~  458 (566)
T PLN03225        452 YFDREGL  458 (566)
T ss_pred             CcCCCCc
Confidence            5544433

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.8e-27  Score=186.91  Aligned_cols=168  Identities=22%  Similarity=0.187  Sum_probs=125.3

Q ss_pred             CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCc
Q 023220           71 GSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD  150 (285)
Q Consensus        71 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~  150 (285)
                      |+|.+++.....        .+++..++.++.|++.||.|||+.   +      ||+||+++.++.+++  ||++.....
T Consensus         1 GsL~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~   61 (176)
T smart00750        1 VSLADILEVRGR--------PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTP   61 (176)
T ss_pred             CcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecc
Confidence            588899875332        289999999999999999999999   7      999999999999998  998765432


Q ss_pred             ccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                      .       ...|++.|+|||++.+..++.++|||||||++|+|++|+.||........... ........       ..+
T Consensus        62 ~-------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~-------~~~  126 (176)
T smart00750       62 E-------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILE-ILLNGMPA-------DDP  126 (176)
T ss_pred             c-------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHH-HHHHHhcc-------CCc
Confidence            1       12578999999999999999999999999999999999999965432111100 00000000       000


Q ss_pred             ccCCCCChhHHH--HHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          231 KLKGEYPPKGVA--KLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       231 ~~~~~~~~~~~~--~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      . ....+...+.  .+.+++.+||+.+|.+||++.++++.+....
T Consensus       127 ~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      127 R-DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             c-ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            0 0011223333  6999999999999999999999999886654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=8.8e-28  Score=186.57  Aligned_cols=248  Identities=14%  Similarity=0.200  Sum_probs=175.5

Q ss_pred             eeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceEEEeC--CeeeEEEeeCCCCCHHHHhccC
Q 023220            4 WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEG--NLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         4 ~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      |......+++-..+|..++.+     .+.+++|+.+|+.++ ||||++++++..+.  ....++||+..+.++..+... 
T Consensus        55 Feg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t-  128 (338)
T KOG0668|consen   55 FEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT-  128 (338)
T ss_pred             hcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh-
Confidence            334444455555556555444     456889999999996 99999999999764  466899999999888777653 


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC-CeeEEeccccCCCCCcccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                                 ++...+..++.++++||.|||+.   ||.|||+||.|+++|.. -.++|+|+|+|...-....   -+-
T Consensus       129 -----------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e---YnV  191 (338)
T KOG0668|consen  129 -----------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNV  191 (338)
T ss_pred             -----------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCce---eee
Confidence                       77788999999999999999999   99999999999999854 4689999999975432111   112


Q ss_pred             cccccCcCCCcccc-cCCCCcccchHhHHHHHHHHHhCCCCCCCC-CCcccchhhhhhccc-------------------
Q 023220          160 VLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPVDHT-MPRGQQSLVTWATPR-------------------  218 (285)
Q Consensus       160 ~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~-------------------  218 (285)
                      .+.+.-|-.||++- ...|+-.-|+|||||++..|++.+-||... +..++.-.+....+.                   
T Consensus       192 RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~  271 (338)
T KOG0668|consen  192 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFE  271 (338)
T ss_pred             eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHh
Confidence            23455678999875 456788899999999999999988887643 333332222221111                   


Q ss_pred             -----CchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hchhhcCCCC
Q 023220          219 -----LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA--LQPLLKSPPP  278 (285)
Q Consensus       219 -----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~--l~~~~~~~~~  278 (285)
                           .+...+..++.++.+.    -.+++..+++.++|..|.++|+|+.|.+..  +...+++.+.
T Consensus       272 ~i~~~~~rk~w~~Fi~~~n~h----l~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~  334 (338)
T KOG0668|consen  272 DILGRHSRKPWSRFINSENQH----LVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESS  334 (338)
T ss_pred             hHhhccccccHHHhCCccccc----cCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhc
Confidence                 1111222222222221    124678999999999999999999998763  3444444433

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-28  Score=212.78  Aligned_cols=184  Identities=20%  Similarity=0.285  Sum_probs=156.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCC------CChhHHHHHHHHccCC---CCcccccceEEEeCCeeeEEEeeCCCC-
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKN------YPDDEKQLVSVVSRLK---HENLVELLGYCVEGNLRVLAYEFATMG-   71 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~------~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~-   71 (285)
                      .||+|..+...-.+.+|.+.+..-..+      --..+-.||++|..++   |+||++++++|++++.+||+||.+..| 
T Consensus       576 kV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gI  655 (772)
T KOG1152|consen  576 KVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGI  655 (772)
T ss_pred             eEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCc
Confidence            489999988888888887766553322      1223345999999996   999999999999999999999988654 


Q ss_pred             CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcc
Q 023220           72 SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM  151 (285)
Q Consensus        72 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~  151 (285)
                      +|+++++..+.         +.+..+..|+.|++.|+++||++   ||+|||||.+|+.++.+|-++|+|||.+....+.
T Consensus       656 DLFd~IE~kp~---------m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~ksg  723 (772)
T KOG1152|consen  656 DLFDFIEFKPR---------MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG  723 (772)
T ss_pred             chhhhhhccCc---------cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhhcCC
Confidence            99999987654         89999999999999999999999   9999999999999999999999999998765432


Q ss_pred             cccccccccccccCcCCCcccccCCC-CcccchHhHHHHHHHHHhCCCCCC
Q 023220          152 AARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD  201 (285)
Q Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~pf~  201 (285)
                      -.    .-.+||..|.|||++.+.+| +..-|||++|+++|-+++...||.
T Consensus       724 pf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  724 PF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             Cc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            22    23568999999999999888 577999999999999999888885

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=5.8e-28  Score=230.16  Aligned_cols=199  Identities=19%  Similarity=0.230  Sum_probs=139.1

Q ss_pred             HHccCCC-CcccccceEE-------EeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 023220           39 VVSRLKH-ENLVELLGYC-------VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEY  110 (285)
Q Consensus        39 ~l~~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~  110 (285)
                      -.+.++| +||+.++|+|       .....+++++|++. ++|.+++.....        .++...++.++.||+.||.|
T Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~   95 (793)
T PLN00181         25 GSKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDR--------SVDAFECFHVFRQIVEIVNA   95 (793)
T ss_pred             ccchhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccc--------cccHHHHHHHHHHHHHHHHH
Confidence            3456677 6888899987       23345678889885 599999975321        28899999999999999999


Q ss_pred             HhhcCCCCeeeCCCCCCCeEEccCCee-------------------EEeccccCCCCCcccc----c----------ccc
Q 023220          111 LHEKVQPSIIHRDIRSSNVLLFEDFKA-------------------KIADFNLSNQAPDMAA----R----------LHS  157 (285)
Q Consensus       111 lh~~~~~~~~h~di~~~nil~~~~~~~-------------------~l~df~~~~~~~~~~~----~----------~~~  157 (285)
                      ||++   ||+||||||+|||++..+.+                   +++|||+++.......    .          ...
T Consensus        96 lH~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (793)
T PLN00181         96 AHSQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQ  172 (793)
T ss_pred             HHhC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccc
Confidence            9999   99999999999999654444                   5555555432110000    0          000


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ....|++.|+|||++.+..++.++|||||||++|||++|..|+......    ....         ......+.     .
T Consensus       173 ~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~~---------~~~~~~~~-----~  234 (793)
T PLN00181        173 ILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSSL---------RHRVLPPQ-----I  234 (793)
T ss_pred             cccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHHH---------HHhhcChh-----h
Confidence            1134678899999999989999999999999999999988886532110    0000         00000000     0


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .........++.+||+.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        235 LLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            011234568889999999999999999986

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=2.3e-28  Score=186.93  Aligned_cols=184  Identities=26%  Similarity=0.286  Sum_probs=146.9

Q ss_pred             eeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCC
Q 023220            9 CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ   87 (285)
Q Consensus         9 ~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   87 (285)
                      ..+....++|.++...+++ ...+..+|+.+..+. .+|.++.+||........++.||.|+. ||..+..+--. +   
T Consensus        68 ~~sg~imAvKri~~tvn~q-~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~-~---  141 (282)
T KOG0984|consen   68 IQSGTIMAVKRIRATVNSQ-EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLK-K---  141 (282)
T ss_pred             ccCCeEEEEeeehhhcChH-HHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHh-c---
Confidence            4667778888887666543 456666788777766 789999999999999999999999975 88766543211 1   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcC
Q 023220           88 PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH  167 (285)
Q Consensus        88 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~  167 (285)
                       +..+++..+-+|+..++.|+.|||++.  .++|||+||.|||++..|+||+||||.+-...+....   +...|-..|+
T Consensus       142 -g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk---t~daGCkpYm  215 (282)
T KOG0984|consen  142 -GGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK---TMDAGCKPYM  215 (282)
T ss_pred             -CCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHH---HHhcCCCccC
Confidence             112888899999999999999999986  8999999999999999999999999998654432221   2234567899


Q ss_pred             CCcccc----cCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Q 023220          168 APEYAM----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTM  204 (285)
Q Consensus       168 aPE~~~----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~  204 (285)
                      |||.+.    ...|+.++||||||+++.||.+++.||....
T Consensus       216 aPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  216 APERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             ChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            999875    3478999999999999999999999997643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=216.14  Aligned_cols=237  Identities=23%  Similarity=0.295  Sum_probs=194.8

Q ss_pred             ceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG   82 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~   82 (285)
                      ||++.++.+.+.-++|+++.....  ...-+++|+-+++.++||||+.+++.+.....+++.|||+.+|+|.+..+-.. 
T Consensus        31 vyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tg-  107 (829)
T KOG0576|consen   31 VYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTG-  107 (829)
T ss_pred             hhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecc-
Confidence            799999999999999999765433  35666789999999999999999999999999999999999999999887654 


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccccc
Q 023220           83 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLG  162 (285)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  162 (285)
                              .+++.++...++..+.+++|||.+   |-+|||||-.||+++..|.+++.|||.+-.+.....  ......|
T Consensus       108 --------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~--KrksfiG  174 (829)
T KOG0576|consen  108 --------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA--KRKSFIG  174 (829)
T ss_pred             --------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhh--hhhcccC
Confidence                    389999999999999999999999   999999999999999999999999999866543322  2355679


Q ss_pred             ccCcCCCcccc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          163 TFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       163 ~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      |+.|+|||+..   ...|...+|||++|++..|+-.-++|....++.....++..-....          |.+  .-...
T Consensus       175 tpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qp----------p~l--kDk~k  242 (829)
T KOG0576|consen  175 TPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQP----------PTL--KDKTK  242 (829)
T ss_pred             CccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCC----------Ccc--cCCcc
Confidence            99999999864   4578899999999999999999999987666544433332111111          111  11234


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .++.+.+|++.+|..+|++||+++.++.
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee
Confidence            5678999999999999999999999886

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.94  E-value=5.9e-26  Score=202.97  Aligned_cols=228  Identities=19%  Similarity=0.213  Sum_probs=150.5

Q ss_pred             hHHHHHHHHccCCCCcc-----cccceEEEe--------CCeeeEEEeeCCCCCHHHHhccCCCCC--------------
Q 023220           32 DEKQLVSVVSRLKHENL-----VELLGYCVE--------GNLRVLAYEFATMGSLHDILHGRKGVQ--------------   84 (285)
Q Consensus        32 ~~~~e~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~--------------   84 (285)
                      ....|+.++.+++|.++     ++++++|..        .+..++|+||+.+++|.+++.......              
T Consensus       218 ~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l  297 (507)
T PLN03224        218 TGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKI  297 (507)
T ss_pred             hhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCch
Confidence            34457777777766544     667777653        345799999999999999987532100              


Q ss_pred             -CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccc
Q 023220           85 -GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGT  163 (285)
Q Consensus        85 -~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  163 (285)
                       .......+.+..+..++.|++.++.|||+.   +++||||||+||+++.++.++|+|||++........ .......++
T Consensus       298 ~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~t  373 (507)
T PLN03224        298 PDNMPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLD  373 (507)
T ss_pred             hhhcccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCC
Confidence             000111256778899999999999999999   999999999999999999999999999865432111 111122347


Q ss_pred             cCcCCCcccccCC--------------------C--CcccchHhHHHHHHHHHhCCC-CCCCCCCcccchhhhhhcccCc
Q 023220          164 FGYHAPEYAMTGQ--------------------L--TQKSDVYSFGVVLLELLTGRK-PVDHTMPRGQQSLVTWATPRLS  220 (285)
Q Consensus       164 ~~~~aPE~~~~~~--------------------~--~~~~DiwslG~~l~~l~~g~~-pf~~~~~~~~~~~~~~~~~~~~  220 (285)
                      +.|+|||.+....                    +  ..+.|+||+||++++|++|.. ||.....-...    .......
T Consensus       374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~----~~~~~~~  449 (507)
T PLN03224        374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE----LRQYDND  449 (507)
T ss_pred             cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH----Hhhccch
Confidence            8999999875322                    1  134699999999999999875 66432110000    0000000


Q ss_pred             hhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 023220          221 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEA---EFRPNMSIVVK  267 (285)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p---~~Rps~~~ll~  267 (285)
                      .............-......++...+++.+||..+|   .+|+|++++++
T Consensus       450 ~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        450 LNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             HHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            011111111111122234567789999999999876   68999999987

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=8.6e-27  Score=195.18  Aligned_cols=246  Identities=19%  Similarity=0.228  Sum_probs=175.8

Q ss_pred             ceeeeeee---eccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            3 RWLCCTCQ---VEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         3 ~~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      ||++....   ....++.|.+..    -..+.++..|+++|..+ .+.||+++.+.+..++..++|+||+++....++..
T Consensus        52 v~~a~~~~~~~~~~~valk~i~~----ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~  127 (418)
T KOG1167|consen   52 VYKATDIEQDTKRRYVALKAIYR----TSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR  127 (418)
T ss_pred             hhhhhHhhhccccceEeeeeccc----ccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh
Confidence            44444433   455566665543    34577899999999999 78999999999999999999999999999999987


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-CCeeEEeccccCCCCC--------
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKIADFNLSNQAP--------  149 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-~~~~~l~df~~~~~~~--------  149 (285)
                      .            ++...+..+++.++.||.++|.+   ||+||||||.|++++. .+.-.|+|||++....        
T Consensus       128 ~------------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s  192 (418)
T KOG1167|consen  128 S------------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS  192 (418)
T ss_pred             c------------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence            5            77889999999999999999999   9999999999999985 4678999999985110        


Q ss_pred             ---------c-------------------------ccccccccccccccCcCCCcccc-cCCCCcccchHhHHHHHHHHH
Q 023220          150 ---------D-------------------------MAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELL  194 (285)
Q Consensus       150 ---------~-------------------------~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~  194 (285)
                               .                         .......-...||++|+|||++. ....+.++||||.|+++.-++
T Consensus       193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll  272 (418)
T KOG1167|consen  193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL  272 (418)
T ss_pred             hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence                     0                         00000011235899999999986 456789999999999999999


Q ss_pred             hCCCCCCCCCC-cccchh------------hhhhccc--C-------chhhh-hhhcCC------------ccCCCCChh
Q 023220          195 TGRKPVDHTMP-RGQQSL------------VTWATPR--L-------SEDKV-KQCVDP------------KLKGEYPPK  239 (285)
Q Consensus       195 ~g~~pf~~~~~-~~~~~~------------~~~~~~~--~-------~~~~~-~~~~~~------------~~~~~~~~~  239 (285)
                      +++.||..... ......            .+.....  .       ..... ..+...            .........
T Consensus       273 s~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~  352 (418)
T KOG1167|consen  273 SRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDV  352 (418)
T ss_pred             ccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccccc
Confidence            99999864321 111100            0000000  0       00000 000000            001112233


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+..+.+++.+||..||.+|.|+++.|+
T Consensus       353 ~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  353 FPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            4568999999999999999999999986

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=1.2e-25  Score=182.70  Aligned_cols=188  Identities=29%  Similarity=0.353  Sum_probs=156.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .+|++.....++.+++|........ ...+.+.+|++.+++++|+|++++++++......++++|++.+++|.+++....
T Consensus        14 ~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~   92 (225)
T smart00221       14 KVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKG   92 (225)
T ss_pred             EEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcc
Confidence            5788877766777888877643322 246788899999999999999999999999899999999999889999997654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..        +++..+..++.+++.++.+||+.   +++|+|+++.||+++.++.++|+|||.+......... ......
T Consensus        93 ~~--------~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~  160 (225)
T smart00221       93 GK--------LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVK  160 (225)
T ss_pred             cC--------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-ccccee
Confidence            21        67889999999999999999999   9999999999999999999999999988765432200 112345


Q ss_pred             cccCcCCCccc-ccCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 023220          162 GTFGYHAPEYA-MTGQLTQKSDVYSFGVVLLELLTGRKPVDH  202 (285)
Q Consensus       162 ~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~pf~~  202 (285)
                      +...|++||.. ....++.++|+|+||+++++|++|+.||..
T Consensus       161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            67789999988 666778899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.1e-25  Score=178.88  Aligned_cols=231  Identities=19%  Similarity=0.289  Sum_probs=168.4

Q ss_pred             eeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceE-EEeCCeeeEEEeeCCCCCHHHHhccCCC
Q 023220            5 LCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGY-CVEGNLRVLAYEFATMGSLHDILHGRKG   82 (285)
Q Consensus         5 ~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~   82 (285)
                      +|--+.+++.++.|.+.+-..   ...+|.+|..---.| -|.||+.-|++ |...+.+++++||++.|+|.+-+.... 
T Consensus        42 L~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G-  117 (378)
T KOG1345|consen   42 LAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG-  117 (378)
T ss_pred             eeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc-
Confidence            454566777777776653222   356788887654455 58999998875 778889999999999999999987754 


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEc--cCCeeEEeccccCCCCCccccccccccc
Q 023220           83 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF--EDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                               +.+.....++.|+++||.|+|++   +++|||||.+|||+-  +..++||+|||+....+....     ..
T Consensus       118 ---------igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~-----~~  180 (378)
T KOG1345|consen  118 ---------IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK-----YL  180 (378)
T ss_pred             ---------ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCceeh-----hh
Confidence                     88889999999999999999999   999999999999994  345899999999876554332     23


Q ss_pred             ccccCcCCCccccc---C--CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccc--hhhhhhcccCchhhhhhhcCCccC
Q 023220          161 LGTFGYHAPEYAMT---G--QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ--SLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       161 ~~~~~~~aPE~~~~---~--~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                      .....|.+||+...   .  ...+.+|+|.||+++|..++|..||+.....+..  ....|....          .+.+ 
T Consensus       181 ~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk----------~~~~-  249 (378)
T KOG1345|consen  181 EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK----------NPAL-  249 (378)
T ss_pred             hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc----------CccC-
Confidence            34567899997642   2  3478899999999999999999999854332221  122222222          2211 


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 023220          234 GEYPPKGVAKLAAVAALCVQYEAEFR---PNMSIVVK  267 (285)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~~ll~  267 (285)
                      .....-.++.+..+.++-|..+|++|   -++++...
T Consensus       250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence            11223456678899999999999999   44444433

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=6.8e-25  Score=200.12  Aligned_cols=250  Identities=19%  Similarity=0.230  Sum_probs=187.5

Q ss_pred             ceeeeeeeeccccChhhhh----hccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            3 RWLCCTCQVEESYPSHENE----RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~----~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      ++.+......+.++.|..+    .......+...+..|+-+=..+.|||++.....+.+.....-.|||+++ +|..++.
T Consensus       334 ~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~  412 (601)
T KOG0590|consen  334 VRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVM  412 (601)
T ss_pred             eEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHh
Confidence            4455666667777777665    2233333344456677777788999999999888776655556999998 9999998


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc--cc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR--LH  156 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~  156 (285)
                      ....         +....+..++.|++.|+.|+|..   |+.|||+|++|++++.+|.++|+|||.+.........  ..
T Consensus       413 ~~~~---------~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~  480 (601)
T KOG0590|consen  413 SNGK---------LTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHE  480 (601)
T ss_pred             cccc---------cchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcchhhhh
Confidence            7621         77889999999999999999999   9999999999999999999999999998755433332  44


Q ss_pred             ccccccccCcCCCcccccCCCCc-ccchHhHHHHHHHHHhCCCCCCCCCCcccch-hhhhhcccCchhhhhhhcCCccCC
Q 023220          157 STRVLGTFGYHAPEYAMTGQLTQ-KSDVYSFGVVLLELLTGRKPVDHTMPRGQQS-LVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~-~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      .....|...|+|||++.+..|++ ..||||.|+++..|.+|+.||......+... .............         ..
T Consensus       481 ~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~---------~~  551 (601)
T KOG0590|consen  481 SSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG---------PN  551 (601)
T ss_pred             hcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC---------hH
Confidence            55677899999999999999974 5899999999999999999998665443321 1110000000000         01


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      ......+...+.+|.+||+.||.+|.|++++++  ..+++..
T Consensus       552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~--d~W~~~i  591 (601)
T KOG0590|consen  552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN--DEWIRSI  591 (601)
T ss_pred             HHHHhchhhHHHHHHHHccCChhheecHHHHhh--ChHhhhc
Confidence            123456778999999999999999999999998  5555443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=7.9e-22  Score=169.33  Aligned_cols=250  Identities=19%  Similarity=0.227  Sum_probs=183.2

Q ss_pred             Cceeeeeeeec-cccChhhhhhccCCCCCChhHHHHHHHHccCCC----CcccccceEE-EeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVE-ESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH----ENLVELLGYC-VEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h----~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.+...+ ..+++|..........  ..+..|+.++..+..    +|+..+++.+ ......++||+.+ |.+|.+
T Consensus        33 ~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~d  109 (322)
T KOG1164|consen   33 AVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLED  109 (322)
T ss_pred             eEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHH
Confidence            36777776654 5666665544332222  277889999998863    6999999999 4777789999988 469999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC-----CeeEEeccccCC--CC
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-----FKAKIADFNLSN--QA  148 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~-----~~~~l~df~~~~--~~  148 (285)
                      +.......       .++..+++.++.|++.+|.++|+.   |++||||||+|+++...     -.+.|+|||+++  ..
T Consensus       110 l~~~~~~~-------~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~  179 (322)
T KOG1164|consen  110 LRKRNPPG-------RFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKY  179 (322)
T ss_pred             HHHhCCCC-------CcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccc
Confidence            88655422       299999999999999999999999   99999999999999865     368999999998  32


Q ss_pred             Ccccc----ccc--ccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchh
Q 023220          149 PDMAA----RLH--STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED  222 (285)
Q Consensus       149 ~~~~~----~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (285)
                      .....    ...  .....||..|.++....+...+.+.|+||++.++.+++.|..||.............         
T Consensus       180 ~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~---------  250 (322)
T KOG1164|consen  180 VGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE---------  250 (322)
T ss_pred             cCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH---------
Confidence            11111    111  123459999999999999999999999999999999999999996544322211110         


Q ss_pred             hhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          223 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                         ...............+..+.++...+-..+..++|.+..+...++......
T Consensus       251 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  251 ---KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             ---HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence               100000000123344567888888888899999999999999998887654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1e-22  Score=162.36  Aligned_cols=227  Identities=22%  Similarity=0.352  Sum_probs=176.9

Q ss_pred             hhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHH
Q 023220           17 SHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT   96 (285)
Q Consensus        17 ~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~   96 (285)
                      .|..+..........+|..|.-.|+-+.||||+++++.|....++.++..|++.|+|.+.++++...       .....+
T Consensus       218 akil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~v-------vvd~sq  290 (448)
T KOG0195|consen  218 AKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSV-------VVDHSQ  290 (448)
T ss_pred             hhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccE-------EEecch
Confidence            3444444455556678889999999999999999999999999999999999999999999987653       366678


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccccCC
Q 023220           97 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ  176 (285)
Q Consensus        97 ~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  176 (285)
                      +..++..++.+++|||+.. +-+..-.++...+++|++.+.+|.--+ .+      ...........+.|++||.+...+
T Consensus       291 av~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad-~k------fsfqe~gr~y~pawmspealqrkp  362 (448)
T KOG0195|consen  291 AVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMAD-TK------FSFQEVGRAYSPAWMSPEALQRKP  362 (448)
T ss_pred             HHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheeccc-ce------eeeeccccccCcccCCHHHHhcCc
Confidence            8999999999999999973 123333588889999998777764211 00      011112223478999999987664


Q ss_pred             CC---cccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcc
Q 023220          177 LT---QKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQ  253 (285)
Q Consensus       177 ~~---~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  253 (285)
                      -+   ..+|+|||++++|||.|...||....+.+.               -.++...+++...|+.++..+.++++-|.+
T Consensus       363 ed~n~raadmwsfaillwel~trevpfadlspmec---------------gmkialeglrv~ippgis~hm~klm~icmn  427 (448)
T KOG0195|consen  363 EDLNIRAADMWSFAILLWELNTREVPFADLSPMEC---------------GMKIALEGLRVHIPPGISRHMNKLMNICMN  427 (448)
T ss_pred             hhcchhhhhHHHHHHHHHHhhccccccccCCchhh---------------hhhhhhccccccCCCCccHHHHHHHHHHhc
Confidence            43   579999999999999999999986654322               234455667777899999999999999999


Q ss_pred             cCCCCCCCHHHHHHHhchhh
Q 023220          254 YEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       254 ~~p~~Rps~~~ll~~l~~~~  273 (285)
                      .||.+||.+..++-.|++++
T Consensus       428 edpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  428 EDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CCCCcCCCcceehhhHHHhc
Confidence            99999999999988888764

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=3.1e-20  Score=158.59  Aligned_cols=245  Identities=24%  Similarity=0.314  Sum_probs=179.1

Q ss_pred             ceeeeeeeeccccChhhhhhccCCCC-CChhHHHHHHHHccCCCC-cccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPKN-YPDDEKQLVSVVSRLKHE-NLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      ||++...   ..+++|.......... ....+.+|+.+++.+.|+ +++++.+++......+++++++.++++.+++...
T Consensus        16 v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~   92 (384)
T COG0515          16 VYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKI   92 (384)
T ss_pred             EEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhc
Confidence            4444444   3445555544444443 678899999999999988 7999999998877789999999999999777655


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC-eeEEeccccCCCCCcccccc----
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-KAKIADFNLSNQAPDMAARL----  155 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~----  155 (285)
                      ...      ..+.......++.|++.++.++|..   +++|||+||+||+++..+ .++++|||.+..........    
T Consensus        93 ~~~------~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (384)
T COG0515          93 GRK------GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPA  163 (384)
T ss_pred             ccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccc
Confidence            321      1288899999999999999999999   999999999999999988 79999999987544332221    


Q ss_pred             cccccccccCcCCCccccc---CCCCcccchHhHHHHHHHHHhCCCCCCCCCCc-ccchhhhhhcccCchhhhhhhcCCc
Q 023220          156 HSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPR-GQQSLVTWATPRLSEDKVKQCVDPK  231 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
                      ......|+..|++||.+.+   ...+...|+||+|++++++++|..||...... ......         ..+.....+.
T Consensus       164 ~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~---------~~~~~~~~~~  234 (384)
T COG0515         164 LPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL---------KIILELPTPS  234 (384)
T ss_pred             cccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHH---------HHHHhcCCcc
Confidence            2245678999999999987   57789999999999999999999997655421 000000         0000000000


Q ss_pred             cCCCCC----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          232 LKGEYP----PKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       232 ~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      ......    ......+.+++..++..+|..|.+..+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            000111    2223578999999999999999988877664

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.85  E-value=5.2e-22  Score=183.41  Aligned_cols=233  Identities=19%  Similarity=0.166  Sum_probs=165.8

Q ss_pred             eeccccChhhhhhccCCCCCChhHHH---HHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCC
Q 023220           10 QVEESYPSHENERLKSPKNYPDDEKQ---LVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA   86 (285)
Q Consensus        10 ~~~~~~~~k~~~~~~~~~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~   86 (285)
                      +-+..+.+|++.+....-.. +.+.+   |++ ...+++||.+++.-+...+...|||-+|..+ +|.+.+..++     
T Consensus        44 ~~eG~vVvKVFvk~~p~~sL-~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRP-----  115 (1431)
T KOG1240|consen   44 DREGLVVVKVFVKQDPTISL-RPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRP-----  115 (1431)
T ss_pred             CCCceEEEEEEeccCCCCCc-hHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccch-----
Confidence            34555778876654433322 22333   333 4555999999999998888888999999976 9999998775     


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc-----cc
Q 023220           87 QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR-----VL  161 (285)
Q Consensus        87 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~-----~~  161 (285)
                          .+......=|+.|++.|+.-+|+.   |++|||||.+|||++.=+.+.|.||..-+........+....     ..
T Consensus       116 ----FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSr  188 (1431)
T KOG1240|consen  116 ----FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSR  188 (1431)
T ss_pred             ----HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCC
Confidence                377778888999999999999999   999999999999999999999999987643221111111000     11


Q ss_pred             cccCcCCCccccc----------CC-CCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcC
Q 023220          162 GTFGYHAPEYAMT----------GQ-LTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD  229 (285)
Q Consensus       162 ~~~~~~aPE~~~~----------~~-~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
                      .-..|+|||.+-.          .. .+++.||||+||++.||++ |++||+-.     +.......+....+.+.+.+.
T Consensus       189 RRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~~~~~e~~Le~Ie  263 (1431)
T KOG1240|consen  189 RRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGNADDPEQLLEKIE  263 (1431)
T ss_pred             ceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccCccCHHHHHHhCc
Confidence            2357999997632          12 4678999999999999999 78888522     111111111333333333222


Q ss_pred             CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          230 PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       230 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                                 ...+++++..|+++||.+|.|+++.|+..++.+
T Consensus       264 -----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~  296 (1431)
T KOG1240|consen  264 -----------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV  296 (1431)
T ss_pred             -----------CccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence                       225899999999999999999999999876654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=4.2e-21  Score=150.61  Aligned_cols=246  Identities=18%  Similarity=0.177  Sum_probs=183.5

Q ss_pred             ceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCC-CcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH-ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +|+....+..+.+|+|.-.....    ..++..|..+.+.+++ .+|..+..++.+..+-++||+.+ |.+|.++.+-..
T Consensus        31 Iy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~  105 (341)
T KOG1163|consen   31 IYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCS  105 (341)
T ss_pred             eeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHh
Confidence            46666666777777775544333    3345668889998976 78888888888888899999999 569999987543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc---CCeeEEeccccCCCCCcccccc---
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKIADFNLSNQAPDMAARL---  155 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~---  155 (285)
                      ..        ++.++++-++-|++.-+.|+|..   +++||||||+|+|..-   ...+.++|||++..........   
T Consensus       106 R~--------ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIp  174 (341)
T KOG1163|consen  106 RR--------FTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIP  174 (341)
T ss_pred             hh--------hhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccccccCc
Confidence            32        99999999999999999999999   9999999999999964   3578999999997654332222   


Q ss_pred             --cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          156 --HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       156 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                        ......||..|.+--...+...+.+.|+-|+|.++.++-.|..||++............         +.+.......
T Consensus       175 yre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk---------I~EkK~s~~i  245 (341)
T KOG1163|consen  175 YREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK---------ISEKKMSTPI  245 (341)
T ss_pred             cccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH---------HHHhhcCCCH
Confidence              23345688888888777777789999999999999999999999998654333322221         1111111111


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          234 GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ...-...|.++.-.+..|-...-++-|.+.-+.+.++-+.
T Consensus       246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf  285 (341)
T KOG1163|consen  246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF  285 (341)
T ss_pred             HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence            1223455777888999999999999999999888877655

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.2e-20  Score=157.90  Aligned_cols=198  Identities=19%  Similarity=0.218  Sum_probs=146.6

Q ss_pred             CCCcccccceEEEe---------------------------CCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHH
Q 023220           44 KHENLVELLGYCVE---------------------------GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT   96 (285)
Q Consensus        44 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~   96 (285)
                      +|||||.++++|.+                           +..+|+||.-+.. +|..++-.+.          .+..+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----------~s~r~  342 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----------RSYRT  342 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----------CchHH
Confidence            69999999988742                           3456999999976 9999998765          67788


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEc----cCCeeEEeccccCCCCCccccc----ccccccccccCcCC
Q 023220           97 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF----EDFKAKIADFNLSNQAPDMAAR----LHSTRVLGTFGYHA  168 (285)
Q Consensus        97 ~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~----~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~~~~a  168 (285)
                      ...++.|+++|+.|||++   |+.|||+|.+||++.    .-..+++.|||++.-..+.+-.    .......|+...+|
T Consensus       343 ~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA  419 (598)
T KOG4158|consen  343 GRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA  419 (598)
T ss_pred             HHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence            999999999999999999   999999999999993    3356789999987543332111    01122446778899


Q ss_pred             CcccccC--C----CCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHH
Q 023220          169 PEYAMTG--Q----LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVA  242 (285)
Q Consensus       169 PE~~~~~--~----~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (285)
                      ||+....  +    --.++|.|+.|.+.||+++...||........           ....+++--.|    ..+..+++
T Consensus       420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-----------~~r~Yqe~qLP----alp~~vpp  484 (598)
T KOG4158|consen  420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-----------DTRTYQESQLP----ALPSRVPP  484 (598)
T ss_pred             hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-----------chhhhhhhhCC----CCcccCCh
Confidence            9987532  1    13689999999999999999999986332111           11112222122    34566778


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          243 KLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      .+++++.-.|++||.+|+|..-....|+
T Consensus       485 ~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  485 VARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            8999999999999999999876665553

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=2e-20  Score=153.04  Aligned_cols=242  Identities=17%  Similarity=0.192  Sum_probs=182.7

Q ss_pred             eeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCC
Q 023220            9 CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ   87 (285)
Q Consensus         9 ~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   87 (285)
                      ..+.+.+++|.--.    +...-++..|.+..+.| ..++|...+-+...+.+-.||++.+ |.||.++..-...     
T Consensus        50 l~nne~VAIKfEPr----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR-----  119 (449)
T KOG1165|consen   50 LYNNEPVAIKFEPR----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGR-----  119 (449)
T ss_pred             cccCceEEEEeccc----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcC-----
Confidence            34556666665433    33345677799999988 5699999998888888889999999 4589888753322     


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-----CCeeEEeccccCCCCCcccccc-----cc
Q 023220           88 PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-----DFKAKIADFNLSNQAPDMAARL-----HS  157 (285)
Q Consensus        88 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-----~~~~~l~df~~~~~~~~~~~~~-----~~  157 (285)
                         .++.+++..++.|++.-+.++|++   .+|.|||||+|+||..     ...+.++|||+++.........     ..
T Consensus       120 ---~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~  193 (449)
T KOG1165|consen  120 ---RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREH  193 (449)
T ss_pred             ---cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccc
Confidence               199999999999999999999999   9999999999999974     3468899999997665333222     23


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ....||..||+---..+.+.+.+.|.-|||.++++++-|..||++.-....+.....++..-....+.         ...
T Consensus       194 KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~---------~Lc  264 (449)
T KOG1165|consen  194 KSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE---------VLC  264 (449)
T ss_pred             cccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH---------HHH
Confidence            44678999999988889999999999999999999999999998864433332222222111111111         112


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      ..+|.++..-+...-..+-.+-|.++.+...|..++.+
T Consensus       265 ~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr  302 (449)
T KOG1165|consen  265 EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR  302 (449)
T ss_pred             hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence            34677888888888888999999999999888877643

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=1.8e-20  Score=164.33  Aligned_cols=217  Identities=26%  Similarity=0.405  Sum_probs=163.6

Q ss_pred             HccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 023220           40 VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSI  119 (285)
Q Consensus        40 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~  119 (285)
                      |+.+.|.|+.+++|.+.++...+.|.+|+.-|+|.+.+......        +.+.......+.|+.++.|+|..   .+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~--------~d~~F~~s~~rdi~~Gl~ylh~s---~i   69 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIK--------LDYFFILSFIRDISKGLAYLHNS---PI   69 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccC--------ccHHHHHHHHHHHHHHHHHHhcC---cc
Confidence            46789999999999999999999999999999999999874332        88889999999999999999988   55


Q ss_pred             -eeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccccCC-------CCcccchHhHHHHHH
Q 023220          120 -IHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-------LTQKSDVYSFGVVLL  191 (285)
Q Consensus       120 -~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~DiwslG~~l~  191 (285)
                       .|+.++..|++++....+|+.|||+.................-...|.|||.+....       .+.++|+||+|++++
T Consensus        70 ~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~  149 (484)
T KOG1023|consen   70 GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMY  149 (484)
T ss_pred             eeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHH
Confidence             999999999999999999999999987653211111112222456899999887541       366799999999999


Q ss_pred             HHHhCCCCCCCCCCccc-chhhhhhcccCchhhhhhhcCCccCCCCC--hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          192 ELLTGRKPVDHTMPRGQ-QSLVTWATPRLSEDKVKQCVDPKLKGEYP--PKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       192 ~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      |+++...||........ ..++.....         ...+.++....  .+.++.+..++..||..+|.+||+++.+...
T Consensus       150 ei~~r~~~~~~~~~~~~~~eii~~~~~---------~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~  220 (484)
T KOG1023|consen  150 EILFRSGPFDLRNLVEDPDEIILRVKK---------GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK  220 (484)
T ss_pred             HHHhccCccccccccCChHHHHHHHHh---------cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence            99999999975322111 111111111         01111111111  1455579999999999999999999999999


Q ss_pred             hchhhcCC
Q 023220          269 LQPLLKSP  276 (285)
Q Consensus       269 l~~~~~~~  276 (285)
                      ++.+....
T Consensus       221 ~~~~~~~~  228 (484)
T KOG1023|consen  221 LLTINKGG  228 (484)
T ss_pred             hhhhcccc
Confidence            88877643

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=2e-20  Score=154.65  Aligned_cols=223  Identities=18%  Similarity=0.184  Sum_probs=141.0

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCC----------CCcccccceEEEeC------------
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLK----------HENLVELLGYCVEG------------   58 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~----------h~~iv~~~~~~~~~------------   58 (285)
                      .||.+.+..+++.+++|...... ......+++++|.-....+.          |-.++..++.....            
T Consensus        27 ~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~  106 (288)
T PF14531_consen   27 IVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQ  106 (288)
T ss_dssp             EEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETT
T ss_pred             EEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCC
Confidence            37888888899999998654433 22334566666665555532          33445555544311            


Q ss_pred             C-----eeeEEEeeCCCCCHHHHhcc---CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeE
Q 023220           59 N-----LRVLAYEFATMGSLHDILHG---RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL  130 (285)
Q Consensus        59 ~-----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil  130 (285)
                      .     ..+++|+-+.+ +|.+++..   ....     ...+.....+.+..|++..+++||..   |++|+||+|+|++
T Consensus       107 ~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~-----~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~nfl  177 (288)
T PF14531_consen  107 SIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQT-----HSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKPENFL  177 (288)
T ss_dssp             EEEEEESEEEEEE--SE-EHHHHHHHHHHHTTT-----SHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEE
T ss_pred             ccceeehhhhccchhhh-cHHHHHHHHhhcccc-----cchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccceeeEE
Confidence            1     23778888864 88777642   2111     00145556678889999999999999   9999999999999


Q ss_pred             EccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccccC--------CCCcccchHhHHHHHHHHHhCCCCCCC
Q 023220          131 LFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--------QLTQKSDVYSFGVVLLELLTGRKPVDH  202 (285)
Q Consensus       131 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~DiwslG~~l~~l~~g~~pf~~  202 (285)
                      ++.+|.+.|+||+.....+....    . ...+..|.+||.....        .++.+.|.|+||+++|.|.+|..||+.
T Consensus       178 l~~~G~v~Lg~F~~~~r~g~~~~----~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~  252 (288)
T PF14531_consen  178 LDQDGGVFLGDFSSLVRAGTRYR----C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL  252 (288)
T ss_dssp             E-TTS-EEE--GGGEEETTEEEE----G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred             EcCCCCEEEcChHHHeecCceee----c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence            99999999999987765443222    1 2335678999876432        468889999999999999999999975


Q ss_pred             CCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCC
Q 023220          203 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR  259 (285)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  259 (285)
                      ..+......                    ....+. ..|+.++.+|..+|++||.+|
T Consensus       253 ~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  253 SSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             CGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            543221110                    123455 889999999999999999988

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=8.3e-20  Score=157.17  Aligned_cols=151  Identities=16%  Similarity=0.046  Sum_probs=109.1

Q ss_pred             Cceeeeeee-eccccChhhhhhccC---CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQ-VEESYPSHENERLKS---PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      +||+|.... .++.+++|.......   .....+.+.+|+++|++++|+|+++.+..   .+..++||||+.+++|.. +
T Consensus        33 ~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~-~  108 (365)
T PRK09188         33 TVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHL-A  108 (365)
T ss_pred             EEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHH-h
Confidence            689997654 566678876542211   22345678999999999999999853322   245799999999989963 2


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC-CCCCeEEccCCeeEEeccccCCCCCccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDI-RSSNVLLFEDFKAKIADFNLSNQAPDMAARLH  156 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di-~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  156 (285)
                      ..            ..   ...++.|++.+|.|||+.   |++|||| ||.||+++.++.++|+|||++...........
T Consensus       109 ~~------------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~  170 (365)
T PRK09188        109 RP------------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYR  170 (365)
T ss_pred             Cc------------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhh
Confidence            11            11   146788999999999999   9999999 99999999999999999999975543221111


Q ss_pred             ------ccccccccCcCCCccccc
Q 023220          157 ------STRVLGTFGYHAPEYAMT  174 (285)
Q Consensus       157 ------~~~~~~~~~~~aPE~~~~  174 (285)
                            .....++..|.|||.+..
T Consensus       171 ~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        171 IAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             hhhhhhhhhhhccCccCCcccCCh
Confidence                  123346677899998754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=8.1e-20  Score=160.84  Aligned_cols=213  Identities=25%  Similarity=0.263  Sum_probs=171.0

Q ss_pred             eeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCC
Q 023220            9 CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ   87 (285)
Q Consensus         9 ~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   87 (285)
                      .+....|+.|+-++..........-..|-.++..++ ||.++++.-.+..+...+++.++..+|.|...+.....     
T Consensus        19 ~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~-----   93 (612)
T KOG0603|consen   19 ADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVM-----   93 (612)
T ss_pred             ccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCc-----
Confidence            456677777766554444333335556777888885 99999999999999999999999999999888776553     


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcC
Q 023220           88 PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH  167 (285)
Q Consensus        88 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~  167 (285)
                          +.+.....+...++-++.++|+.   +++++|+|++||+++.+|++++.|||+.+..-....      ..|+..|+
T Consensus        94 ----f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------~cgt~eym  160 (612)
T KOG0603|consen   94 ----FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYR  160 (612)
T ss_pred             ----hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh------cccchhhh
Confidence                67778888899999999999999   999999999999999999999999999865432221      26899999


Q ss_pred             CCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHH
Q 023220          168 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAV  247 (285)
Q Consensus       168 aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  247 (285)
                      |||++.  ..+..+|-||||++.++|++|-.||.+                   +....++.  .....|.+.+.....+
T Consensus       161 ApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------------------~~~~~Il~--~~~~~p~~l~~~a~~~  217 (612)
T KOG0603|consen  161 APEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------------------DTMKRILK--AELEMPRELSAEARSL  217 (612)
T ss_pred             hhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------------------HHHHHHhh--hccCCchhhhHHHHHH
Confidence            999987  467889999999999999999999975                   11122211  1235678888899999


Q ss_pred             HHHhcccCCCCCCCH
Q 023220          248 AALCVQYEAEFRPNM  262 (285)
Q Consensus       248 i~~~l~~~p~~Rps~  262 (285)
                      +..++..+|.+|--.
T Consensus       218 ~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  218 FRQLFKRNPENRLGA  232 (612)
T ss_pred             HHHHHhhCHHHHhcc
Confidence            999999999999754

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.75  E-value=3.5e-18  Score=135.33  Aligned_cols=131  Identities=15%  Similarity=0.037  Sum_probs=98.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCC-------Ch-----------------hHHHHHHHHccCCCCcccccceEEEe
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNY-------PD-----------------DEKQLVSVVSRLKHENLVELLGYCVE   57 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~-------~~-----------------~~~~e~~~l~~l~h~~iv~~~~~~~~   57 (285)
                      .||++... +++.+++|..+........       ..                 ...+|++.+.++.++++.....+.. 
T Consensus        12 ~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~-   89 (190)
T cd05147          12 NVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILL-   89 (190)
T ss_pred             EEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEe-
Confidence            58999876 7889999987654322111       11                 2234999999998888755443322 


Q ss_pred             CCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeeCCCCCCCeEEccCCe
Q 023220           58 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYL-HEKVQPSIIHRDIRSSNVLLFEDFK  136 (285)
Q Consensus        58 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l-h~~~~~~~~h~di~~~nil~~~~~~  136 (285)
                      .. .+|||||+.++++........         .++...+..++.|++.++.++ |+.   |++||||||+||+++ ++.
T Consensus        90 ~~-~~iVmE~i~g~~l~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          90 KS-HVLVMEFIGDDGWAAPRLKDA---------PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             cC-CEEEEEEeCCCCCcchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCc
Confidence            22 389999999876654432221         278899999999999999999 799   999999999999998 478


Q ss_pred             eEEeccccCCCC
Q 023220          137 AKIADFNLSNQA  148 (285)
Q Consensus       137 ~~l~df~~~~~~  148 (285)
                      ++|+|||++...
T Consensus       156 v~LiDFG~a~~~  167 (190)
T cd05147         156 LYIIDVSQSVEH  167 (190)
T ss_pred             EEEEEccccccC
Confidence            999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.73  E-value=3.4e-18  Score=137.39  Aligned_cols=156  Identities=14%  Similarity=0.184  Sum_probs=112.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCC-CCChh------HHHHHHHHccCCCCcccccceEEEeC--------CeeeEEEe
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPK-NYPDD------EKQLVSVVSRLKHENLVELLGYCVEG--------NLRVLAYE   66 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e   66 (285)
                      +||+. +. ...-+++|..++..... .....      +.+|+..+.+++|++|..+.+++...        ...+++||
T Consensus        46 ~v~l~-~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmE  123 (232)
T PRK10359         46 KVSLI-DT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIE  123 (232)
T ss_pred             EEEEE-ec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEE
Confidence            46664 33 24457777665433222 12222      57899999999999999999987643        34789999


Q ss_pred             eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220           67 FATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus        67 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      |++|.+|.++..             ++.    ....++..++..+|..   |++|||++|.||+++.++ ++|+|||...
T Consensus       124 yi~G~tL~~~~~-------------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~liDfg~~~  182 (232)
T PRK10359        124 YIEGVELNDMPE-------------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRIIDLSGKR  182 (232)
T ss_pred             EECCccHHHhhh-------------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEEEECCCcc
Confidence            999989988732             222    2456899999999999   999999999999999988 9999999775


Q ss_pred             CCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHH
Q 023220          147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELL  194 (285)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~  194 (285)
                      .......    .          ...+....++.++|+||||+++..+.
T Consensus       183 ~~~e~~a----~----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        183 CTAQRKA----K----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cccchhh----H----------HHHHHHhHhcccccccceeEeehHHH
Confidence            4321110    0          00344555677899999999977654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.73  E-value=1.6e-18  Score=149.91  Aligned_cols=171  Identities=25%  Similarity=0.391  Sum_probs=128.6

Q ss_pred             eeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEE
Q 023220           60 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI  139 (285)
Q Consensus        60 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l  139 (285)
                      .++|.|+++...+|.+|+.......      ..+....+.++.|++.++.|   +   +.+|+|++|.||++..+..++|
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e------~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kI  397 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGE------ERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKI  397 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCccc------ccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhh
Confidence            5799999999999999997554322      25677899999999999999   7   9999999999999999989999


Q ss_pred             eccccCCCCCccc----ccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 023220          140 ADFNLSNQAPDMA----ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW  214 (285)
Q Consensus       140 ~df~~~~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~  214 (285)
                      +|||+........    .........|+..|++||.+.+..|+.++|||+||++++|++. =...|+...          
T Consensus       398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------  467 (516)
T KOG1033|consen  398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------  467 (516)
T ss_pred             hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------
Confidence            9999987665433    1223455679999999999999999999999999999999987 333332110          


Q ss_pred             hcccCchhhhh-hhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 023220          215 ATPRLSEDKVK-QCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM  262 (285)
Q Consensus       215 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  262 (285)
                           +...++ ..+.+......+     .-..++.+++...|.+||++
T Consensus       468 -----t~~d~r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~  506 (516)
T KOG1033|consen  468 -----TLTDIRDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSA  506 (516)
T ss_pred             -----hhhhhhcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchH
Confidence                 001111 111112212222     34579999999999999943

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.71  E-value=4.3e-17  Score=129.45  Aligned_cols=131  Identities=15%  Similarity=0.062  Sum_probs=99.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCC-------------------C-----ChhHHHHHHHHccCCCCcccccceEEEe
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKN-------------------Y-----PDDEKQLVSVVSRLKHENLVELLGYCVE   57 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~-------------------~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~   57 (285)
                      .||++... +++.+++|..+.......                   .     ...+.+|++.+.++.|+++.....+...
T Consensus        12 ~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~   90 (190)
T cd05145          12 NVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLK   90 (190)
T ss_pred             EEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEec
Confidence            58999876 788999997765421100                   0     1223578999999999988655544433


Q ss_pred             CCeeeEEEeeCCCCCHHHH-hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCC
Q 023220           58 GNLRVLAYEFATMGSLHDI-LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDF  135 (285)
Q Consensus        58 ~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~  135 (285)
                      .  .++||||+.++++... +....          ++......++.|++.++.++|. .   |++||||||.||+++ ++
T Consensus        91 ~--~~lVmE~~~g~~~~~~~l~~~~----------~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~  154 (190)
T cd05145          91 K--NVLVMEFIGDDGSPAPRLKDVP----------LEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DG  154 (190)
T ss_pred             C--CEEEEEEecCCCchhhhhhhcc----------CCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CC
Confidence            2  4899999988754333 33221          6778899999999999999999 9   999999999999999 78


Q ss_pred             eeEEeccccCCCCC
Q 023220          136 KAKIADFNLSNQAP  149 (285)
Q Consensus       136 ~~~l~df~~~~~~~  149 (285)
                      .++|+|||++....
T Consensus       155 ~~~liDFG~a~~~~  168 (190)
T cd05145         155 KPYIIDVSQAVELD  168 (190)
T ss_pred             CEEEEEcccceecC
Confidence            99999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=1.5e-17  Score=136.26  Aligned_cols=221  Identities=21%  Similarity=0.297  Sum_probs=152.1

Q ss_pred             hccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC-----eeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHH
Q 023220           22 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN-----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT   96 (285)
Q Consensus        22 ~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~   96 (285)
                      .+++.+...+....-+.-|-++.|.||++++.++.+.+     ...+++||++.|++.+++++......     .+....
T Consensus       103 ~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~-----a~~~~~  177 (458)
T KOG1266|consen  103 ERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQK-----ALFQKA  177 (458)
T ss_pred             HhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhh-----hhhHHH
Confidence            44455555666666777788889999999999987644     46899999999999999987653221     277888


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEecc--ccCCCCCcccccccccccccccCcCCCccccc
Q 023220           97 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF--NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT  174 (285)
Q Consensus        97 ~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df--~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  174 (285)
                      ..+|+.||++||.|||.. ++.++|+++..+.|++..+|.+++..-  ......-............+.++|.+||.-..
T Consensus       178 wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~  256 (458)
T KOG1266|consen  178 WKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT  256 (458)
T ss_pred             HHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc
Confidence            899999999999999995 788999999999999998888887531  11111111111111223446788999998766


Q ss_pred             CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhccc
Q 023220          175 GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQY  254 (285)
Q Consensus       175 ~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  254 (285)
                      -+-+..+|||+||+...+|.-+..--.........        ......+..    .+...       --+.++.+|++-
T Consensus       257 tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~--------ee~ia~~i~----~len~-------lqr~~i~kcl~~  317 (458)
T KOG1266|consen  257 TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEV--------EENIANVII----GLENG-------LQRGSITKCLEG  317 (458)
T ss_pred             cccccchhhhhhhHHHHHHHHheeccCCCcceeeh--------hhhhhhhee----eccCc-------cccCcCcccccC
Confidence            66778899999999999998876542221110000        000000000    00001       134578999999


Q ss_pred             CCCCCCCHHHHHH
Q 023220          255 EAEFRPNMSIVVK  267 (285)
Q Consensus       255 ~p~~Rps~~~ll~  267 (285)
                      .|+.||++.+++.
T Consensus       318 eP~~rp~ar~llf  330 (458)
T KOG1266|consen  318 EPNGRPDARLLLF  330 (458)
T ss_pred             CCCCCcchhhhhc
Confidence            9999999998864

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=1.6e-16  Score=125.30  Aligned_cols=149  Identities=17%  Similarity=0.131  Sum_probs=110.7

Q ss_pred             hHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 023220           32 DEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEY  110 (285)
Q Consensus        32 ~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~  110 (285)
                      .+.+|+++|+++. |+++++++++    +..+++|+|+.|.+|.+.+..                ....++.|++.++.+
T Consensus        47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~----------------~~~~~~~qi~~~L~~  106 (218)
T PRK12274         47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR----------------GDLAYFRAARRLLQQ  106 (218)
T ss_pred             HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh----------------hhHHHHHHHHHHHHH
Confidence            5889999999995 4889888886    346899999998888654311                113577899999999


Q ss_pred             HhhcCCCCeeeCCC-CCCCeEEccCCeeEEeccccCCCCCccccc---cc--------ccccccccCcCCCcccccC-CC
Q 023220          111 LHEKVQPSIIHRDI-RSSNVLLFEDFKAKIADFNLSNQAPDMAAR---LH--------STRVLGTFGYHAPEYAMTG-QL  177 (285)
Q Consensus       111 lh~~~~~~~~h~di-~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~--------~~~~~~~~~~~aPE~~~~~-~~  177 (285)
                      +|+.   |++|||| +|.||+++.++.++|+|||++.........   ..        ......++.+++|+.-.-. ..
T Consensus       107 lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~  183 (218)
T PRK12274        107 LHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRT  183 (218)
T ss_pred             HHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccc
Confidence            9999   9999999 799999999999999999999754432211   00        1112346677777643221 23


Q ss_pred             C-cccchHhHHHHHHHHHhCCCCCCCC
Q 023220          178 T-QKSDVYSFGVVLLELLTGRKPVDHT  203 (285)
Q Consensus       178 ~-~~~DiwslG~~l~~l~~g~~pf~~~  203 (285)
                      + .+.+-++.|+-+|.++|++.++-+.
T Consensus       184 ~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        184 SWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             hhHHHHHHHhcchHHHHHhccCCcccc
Confidence            3 5667789999999999999987543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.66  E-value=1.1e-16  Score=148.30  Aligned_cols=139  Identities=24%  Similarity=0.311  Sum_probs=106.8

Q ss_pred             HHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCc-------------ccccccccccccccCcCCCcc
Q 023220          105 ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD-------------MAARLHSTRVLGTFGYHAPEY  171 (285)
Q Consensus       105 ~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~-------------~~~~~~~~~~~~~~~~~aPE~  171 (285)
                      +.+++|+|..   |++|||+||+|.+|+.-|++|+.|||+......             ...........||+.|+|||+
T Consensus       153 vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV  229 (1205)
T KOG0606|consen  153 VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV  229 (1205)
T ss_pred             hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence            7899999999   999999999999999999999999999753311             111111233578999999999


Q ss_pred             cccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHh
Q 023220          172 AMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALC  251 (285)
Q Consensus       172 ~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  251 (285)
                      +....|+...|.|++|+++|+++-|..||.+..+++.........-.++              +-....+++.++++.++
T Consensus       230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp--------------E~dea~p~Ea~dli~~L  295 (1205)
T KOG0606|consen  230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP--------------EEDEALPPEAQDLIEQL  295 (1205)
T ss_pred             hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc--------------ccCcCCCHHHHHHHHHH
Confidence            9999999999999999999999999999998766543321111111111              11233456799999999


Q ss_pred             cccCCCCCC
Q 023220          252 VQYEAEFRP  260 (285)
Q Consensus       252 l~~~p~~Rp  260 (285)
                      |+.+|..|-
T Consensus       296 L~qnp~~Rl  304 (1205)
T KOG0606|consen  296 LRQNPLCRL  304 (1205)
T ss_pred             HHhChHhhc
Confidence            999999995

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=4.1e-16  Score=146.33  Aligned_cols=232  Identities=19%  Similarity=0.208  Sum_probs=162.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC---CCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK---HENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++.... ++.+++|.-++-..=+-+.     ..+++.+|+   -+.|..+...+.-.+..++|++|.+.|+|.++++
T Consensus       713 ~vy~a~~~~-~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N  786 (974)
T KOG1166|consen  713 SVYVATHSN-GKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN  786 (974)
T ss_pred             EEEEeecCC-CcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc
Confidence            578887766 8888888777554443332     223444444   3556666666667777899999999999999999


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-------CCeeEEeccccCCCCCcc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-------DFKAKIADFNLSNQAPDM  151 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-------~~~~~l~df~~~~~~~~~  151 (285)
                      ...         ...+..+..+..|++..+..||..   +||||||||+|+++..       ...++|+|||.+-.+...
T Consensus       787 ~~~---------~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lf  854 (974)
T KOG1166|consen  787 TNK---------VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLF  854 (974)
T ss_pred             cCC---------CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceeeeEc
Confidence            544         388899999999999999999999   9999999999999953       456899999998544322


Q ss_pred             cccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc
Q 023220          152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK  231 (285)
Q Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
                      -....=...+++-.|-.+|...|.+|+-.+|.|+|+.+++-|++|+..=...+.       -|...    ..+...++. 
T Consensus       855 p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~-------~~~~~----~~~~Ry~~~-  922 (974)
T KOG1166|consen  855 PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGS-------SWMVK----TNFPRYWKR-  922 (974)
T ss_pred             CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCc-------ceecc----ccchhhhhH-
Confidence            222112345678899999999999999999999999999999998663100000       00000    001111111 


Q ss_pred             cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          232 LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                                .-+.+|+..+|+.|-..=|.+.+|+..|+.+.
T Consensus       923 ----------~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~  954 (974)
T KOG1166|consen  923 ----------DMWNKFFDLLLNPDCDTLPNLQELRTELEEVL  954 (974)
T ss_pred             ----------HHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence                      12667788888744444467777777766554

>PRK10345 hypothetical protein; Provisional

Probab=99.64  E-value=1.2e-15  Score=122.18  Aligned_cols=100  Identities=12%  Similarity=0.127  Sum_probs=81.1

Q ss_pred             CChhHHHHHHHHccC-----CCCcccccceEEEeCC---e-eeEEEee--CCCCCHHHHhccCCCCCCCCCCCCCCHHHH
Q 023220           29 YPDDEKQLVSVVSRL-----KHENLVELLGYCVEGN---L-RVLAYEF--ATMGSLHDILHGRKGVQGAQPGPVLDWMTR   97 (285)
Q Consensus        29 ~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~-~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~   97 (285)
                      ..+.+.+|+..++++     .||||++++|++.++.   . +.+|+||  +.+++|.+++....          +++.  
T Consensus        39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~----------~~e~--  106 (210)
T PRK10345         39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCR----------YEED--  106 (210)
T ss_pred             hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHccc----------ccHh--
Confidence            457789999999999     6799999999999874   3 3478999  44789999996542          4444  


Q ss_pred             HHHHHHHHHHH-HHHhhcCCCCeeeCCCCCCCeEEccC----CeeEEeccc
Q 023220           98 VRIAVDAARGL-EYLHEKVQPSIIHRDIRSSNVLLFED----FKAKIADFN  143 (285)
Q Consensus        98 ~~~~~qi~~~l-~~lh~~~~~~~~h~di~~~nil~~~~----~~~~l~df~  143 (285)
                      ..++.+++.++ .|||++   +|+||||||+||+++..    +.++|+|++
T Consensus       107 ~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345        107 VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            35677888777 999999   99999999999999743    379999944

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=2e-16  Score=144.85  Aligned_cols=217  Identities=23%  Similarity=0.280  Sum_probs=165.4

Q ss_pred             CCChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCHHHHh-ccCCCCCCCCCCCCCCHHHHHHHHHHHH
Q 023220           28 NYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-HGRKGVQGAQPGPVLDWMTRVRIAVDAA  105 (285)
Q Consensus        28 ~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~qi~  105 (285)
                      ...+....|..+-..+. |.|++.+++...+....++.+++..++++.+.+ .....        ..+...+-.++.|+.
T Consensus        62 ~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~--------~~~~~~~~~~~~ql~  133 (601)
T KOG0590|consen   62 DSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDST--------GTSSSSASRYLPQLN  133 (601)
T ss_pred             chhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCcc--------CCCCcchhhhhhhhc
Confidence            34444555777777776 999999999999999999999999999998888 33321        155667788999999


Q ss_pred             HHHHHHh-hcCCCCeeeCCCCCCCeEEccCC-eeEEeccccCCCCCc-cccccccccccc-ccCcCCCcccccCC-CCcc
Q 023220          106 RGLEYLH-EKVQPSIIHRDIRSSNVLLFEDF-KAKIADFNLSNQAPD-MAARLHSTRVLG-TFGYHAPEYAMTGQ-LTQK  180 (285)
Q Consensus       106 ~~l~~lh-~~~~~~~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~-~~~~~~~~~~~~-~~~~~aPE~~~~~~-~~~~  180 (285)
                      .++.|+| ..   ++.|+|++|+|.+++..+ ..++.|||++..... .+.........| ++.|.|||...+.. ..+.
T Consensus       134 s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~  210 (601)
T KOG0590|consen  134 SGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPS  210 (601)
T ss_pred             cCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCC
Confidence            9999999 88   999999999999999999 999999999987665 333333344567 99999999988854 4688


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCC
Q 023220          181 SDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP  260 (285)
Q Consensus       181 ~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (285)
                      .|+||.|+++..+++|..|+.......... ..|....           .................++.+++..+|..|.
T Consensus       211 ~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~  278 (601)
T KOG0590|consen  211 VDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKSNK-----------GRFTQLPWNSISDQAHDLLHKILKENPSNRL  278 (601)
T ss_pred             cccccccccccccccCCCCccccccccccc-eeecccc-----------cccccCccccCChhhhhcccccccCCchhcc
Confidence            999999999999999999998765433221 1111110           0001122334455688899999999999999


Q ss_pred             CHHHHHH
Q 023220          261 NMSIVVK  267 (285)
Q Consensus       261 s~~~ll~  267 (285)
                      +.+++-.
T Consensus       279 s~~~~~~  285 (601)
T KOG0590|consen  279 SIEELKL  285 (601)
T ss_pred             ccccccc
Confidence            9988754

>smart00090 RIO RIO-like kinase

Probab=99.57  E-value=6.8e-15  Score=120.47  Aligned_cols=132  Identities=14%  Similarity=0.008  Sum_probs=95.9

Q ss_pred             Cceeee-eeeeccccChhhhhhccCCCC----------------------CChhHHHHHHHHccCCCCcccccceEEEeC
Q 023220            2 RRWLCC-TCQVEESYPSHENERLKSPKN----------------------YPDDEKQLVSVVSRLKHENLVELLGYCVEG   58 (285)
Q Consensus         2 ~~~~~~-~~~~~~~~~~k~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   58 (285)
                      .||+|. +..+++.+++|..+.......                      ....+.+|++.+.++.+. .+.+...+...
T Consensus        43 ~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~-~i~~p~~~~~~  121 (237)
T smart00090       43 NVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA-GVPVPKPIAWR  121 (237)
T ss_pred             eEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc-CCCCCeeeEec
Confidence            588997 556788899997765432110                      012356899999999753 33333333333


Q ss_pred             CeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eeeCCCCCCCeEEccCCee
Q 023220           59 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS-IIHRDIRSSNVLLFEDFKA  137 (285)
Q Consensus        59 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~-~~h~di~~~nil~~~~~~~  137 (285)
                       ..++||||+.+++|.........         +....+..++.|++.++.+||+.   | ++|+||+|+||+++ ++.+
T Consensus       122 -~~~lV~E~~~g~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~-~~~i  187 (237)
T smart00090      122 -RNVLVMEFIGGDGLPAPRLKDVE---------PEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH-DGKV  187 (237)
T ss_pred             -CceEEEEEecCCcccccccccCC---------cchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE-CCCE
Confidence             34899999998887665432221         45566789999999999999999   9 99999999999999 7899


Q ss_pred             EEeccccCCCC
Q 023220          138 KIADFNLSNQA  148 (285)
Q Consensus       138 ~l~df~~~~~~  148 (285)
                      +|+|||.+...
T Consensus       188 ~LiDFg~a~~~  198 (237)
T smart00090      188 VIIDVSQSVEL  198 (237)
T ss_pred             EEEEChhhhcc
Confidence            99999987643

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.56  E-value=6.3e-14  Score=125.07  Aligned_cols=149  Identities=19%  Similarity=0.267  Sum_probs=120.3

Q ss_pred             CCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHH
Q 023220           28 NYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARG  107 (285)
Q Consensus        28 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~  107 (285)
                      ...+...+.+..|+.++||+|+++++.+...+..|+|+|-+.  .|..+++.            +....+.-.+.||+.|
T Consensus        51 ~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------------l~~~~v~~Gl~qIl~A  116 (690)
T KOG1243|consen   51 EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------------LGKEEVCLGLFQILAA  116 (690)
T ss_pred             hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------------hHHHHHHHHHHHHHHH
Confidence            556778899999999999999999999999999999999985  78888875            3456777889999999


Q ss_pred             HHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHH
Q 023220          108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG  187 (285)
Q Consensus       108 l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG  187 (285)
                      |.|||+.+  +++|++|+-+.++++..|..+|++|.++........  ..........|..|+.+....  -..|.|.||
T Consensus       117 L~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg  190 (690)
T KOG1243|consen  117 LSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLG  190 (690)
T ss_pred             HHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHH
Confidence            99998665  999999999999999999999999998865443222  112222334567777554433  237999999


Q ss_pred             HHHHHHHhC
Q 023220          188 VVLLELLTG  196 (285)
Q Consensus       188 ~~l~~l~~g  196 (285)
                      |++++++.|
T Consensus       191 ~li~el~ng  199 (690)
T KOG1243|consen  191 CLIEELFNG  199 (690)
T ss_pred             HHHHHHhCc
Confidence            999999998

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.54  E-value=3.2e-14  Score=114.88  Aligned_cols=100  Identities=21%  Similarity=0.340  Sum_probs=88.1

Q ss_pred             hhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 023220           31 DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEY  110 (285)
Q Consensus        31 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~  110 (285)
                      ..+.+|++++..+.|+++.....++......+++|||++|++|.+++....            . ....++.+++.++.+
T Consensus        44 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~------------~-~~~~i~~~i~~~l~~  110 (211)
T PRK14879         44 ERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG------------M-EELELSREIGRLVGK  110 (211)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc------------H-HHHHHHHHHHHHHHH
Confidence            457789999999999999888888777778899999999999999986431            2 788999999999999


Q ss_pred             HhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       111 lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      +|+.   |++|+|++|.||+++ ++.++++|||.+..
T Consensus       111 lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879        111 LHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999   999999999999999 77899999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.49  E-value=1.4e-13  Score=110.10  Aligned_cols=97  Identities=21%  Similarity=0.349  Sum_probs=82.9

Q ss_pred             hhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 023220           31 DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEY  110 (285)
Q Consensus        31 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~  110 (285)
                      .++.+|++++..++|+++.....++......+++|||++|++|.+++....          .      .++.+++.++.+
T Consensus        42 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~----------~------~~~~~i~~~l~~  105 (199)
T TIGR03724        42 ERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN----------D------ELLREIGRLVGK  105 (199)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH----------H------HHHHHHHHHHHH
Confidence            556789999999998887666666666777799999999999998875421          1      789999999999


Q ss_pred             HhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       111 lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      +|+.   |++|+|++|.||+++ ++.++++|||++..
T Consensus       106 lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724       106 LHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             HHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999   999999999999999 78999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.48  E-value=7.8e-14  Score=127.75  Aligned_cols=97  Identities=19%  Similarity=0.323  Sum_probs=85.6

Q ss_pred             ChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 023220           30 PDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLE  109 (285)
Q Consensus        30 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~  109 (285)
                      .+++.+|+++++.++|++++....++......++||||+.+++|.+++.                 ....++.+++.++.
T Consensus       380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~  442 (535)
T PRK09605        380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVA  442 (535)
T ss_pred             HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHH
Confidence            3568899999999999999988877777777899999999999998874                 24578999999999


Q ss_pred             HHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          110 YLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       110 ~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      +||+.   |++|||+||+||++ .++.++|+|||++..
T Consensus       443 ~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        443 KLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             HHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999   99999999999999 577899999998864

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.44  E-value=6.4e-13  Score=109.03  Aligned_cols=102  Identities=17%  Similarity=0.113  Sum_probs=81.3

Q ss_pred             CChhHHHHHHHHccCCCCcc--cccceEEEeCC----eeeEEEeeCCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHH
Q 023220           29 YPDDEKQLVSVVSRLKHENL--VELLGYCVEGN----LRVLAYEFATM-GSLHDILHGRKGVQGAQPGPVLDWMTRVRIA  101 (285)
Q Consensus        29 ~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~  101 (285)
                      ....+.+|++++.+++|+++  +..+++.....    ..++|||++++ .+|.+++....          ++..    .+
T Consensus        83 ~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~----------l~~~----~~  148 (239)
T PRK01723         83 ERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAP----------LSEE----QW  148 (239)
T ss_pred             hhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCC----------CCHH----HH
Confidence            45678899999999998875  66666644322    23599999997 58998886532          4433    35


Q ss_pred             HHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          102 VDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       102 ~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      .+++.++.+||+.   |++|+||+|.|||++.++.++|+|||.+..
T Consensus       149 ~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        149 QAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            7899999999999   999999999999999888999999998754

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.40  E-value=5.2e-13  Score=106.75  Aligned_cols=124  Identities=13%  Similarity=0.048  Sum_probs=90.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCC--------------------CCCChhHHHHHHHHccCCCCc--ccccceEEEeCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP--------------------KNYPDDEKQLVSVVSRLKHEN--LVELLGYCVEGN   59 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~--------------------~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~   59 (285)
                      .||++... +.+.+++|........                    ........+|+..+..+.|++  +.+.++    ..
T Consensus        30 ~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~----~~  104 (198)
T cd05144          30 DVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPID----WN  104 (198)
T ss_pred             EEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceee----cC
Confidence            47777654 5777888864332100                    011224678899999997774  333333    23


Q ss_pred             eeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEE
Q 023220           60 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI  139 (285)
Q Consensus        60 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l  139 (285)
                      ..+++|||+.+++|......               .....++.+++.++.++|+.   |++|+||+|.||+++.++.++|
T Consensus       105 ~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~~~~l  166 (198)
T cd05144         105 RHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDEKIYI  166 (198)
T ss_pred             CceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCCcEEE
Confidence            45899999999888765321               23457889999999999999   9999999999999999999999


Q ss_pred             eccccCCCC
Q 023220          140 ADFNLSNQA  148 (285)
Q Consensus       140 ~df~~~~~~  148 (285)
                      +|||++...
T Consensus       167 iDfg~~~~~  175 (198)
T cd05144         167 IDWPQMVST  175 (198)
T ss_pred             EECCccccC
Confidence            999988543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.37  E-value=2.6e-12  Score=97.55  Aligned_cols=124  Identities=20%  Similarity=0.208  Sum_probs=96.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCC--CcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH--ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .+|++....  ..+.+|.......    ...+.+|++.++.++|  .++.++++++...+..++++||+.++.+..+   
T Consensus        13 ~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~---   83 (155)
T cd05120          13 RVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV---   83 (155)
T ss_pred             ceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC---
Confidence            356665433  4566665543222    5678899999999976  5889998888887888999999988766543   


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                                   +......++.+++.+++.+|.....+++|+|++|.||+++..+.++++||+.+..
T Consensus        84 -------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          84 -------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             -------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence                         2345667889999999999985223699999999999999989999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.33  E-value=3.2e-11  Score=105.17  Aligned_cols=220  Identities=13%  Similarity=0.151  Sum_probs=156.2

Q ss_pred             ceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEE----eCCeeeEEEeeCCCC-CHHHHh
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV----EGNLRVLAYEFATMG-SLHDIL   77 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~~-~L~~~l   77 (285)
                      -|+|..+..+..|+.|+.  .....+.......-++.++++.|+|+|++.++|.    .+..+++|++|+++. +|.++.
T Consensus       292 tyk~~s~~DG~~YvLkRl--hg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  292 TYKATSNVDGNAYVLKRL--HGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             eEeeeeccCCceeeeeee--ccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            478888888888887766  2223344555667899999999999999999987    344679999999864 888877


Q ss_pred             ccCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcc
Q 023220           78 HGRKGVQ------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM  151 (285)
Q Consensus        78 ~~~~~~~------~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~  151 (285)
                      -......      ........++..+|.++.|+..||.++|..   |+..+-+.+.+|+++.+.+++|..+|........
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            5544332      011222378899999999999999999999   9999999999999999889999887765433221


Q ss_pred             cccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc
Q 023220          152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK  231 (285)
Q Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
                      .              .+|  +.   -..+-|.-.||.++..|.+|..--...+.              ..+.-       
T Consensus       447 ~--------------~~~--le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~--------------~~~s~-------  486 (655)
T KOG3741|consen  447 P--------------TEP--LE---SQQQNDLRDLGLLLLALATGTENSNRTDS--------------TQSSH-------  486 (655)
T ss_pred             C--------------Ccc--hh---HHhhhhHHHHHHHHHHHhhcccccccccc--------------hHHHH-------
Confidence            1              011  11   13457888999999999998442111110              00000       


Q ss_pred             cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 023220          232 LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL  269 (285)
Q Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l  269 (285)
                       .......++.++++++......++.+ -++.+++.++
T Consensus       487 -~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  487 -LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             -HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence             01124567788999999999999987 6788877665

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.31  E-value=1e-10  Score=99.81  Aligned_cols=213  Identities=18%  Similarity=0.169  Sum_probs=142.2

Q ss_pred             eeEEEeeCCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEE
Q 023220           61 RVLAYEFATMG-SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI  139 (285)
Q Consensus        61 ~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l  139 (285)
                      ..++|+...+. ....+++....   .+..+...|...+..++.++.+.+-||+.   |..-||+++.|+|+++++.|.|
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tR---Rqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~L  158 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATR---RQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVL  158 (637)
T ss_pred             eEEecccCCCccchhhhcCchhh---cccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEE
Confidence            67888888764 44444433222   22333488999999999999999999999   9999999999999999999999


Q ss_pred             eccccCCCCCcccccccccccccccCcCCCcccc-----cCCCCcccchHhHHHHHHHHHhC-CCCCCCCCCcccc---h
Q 023220          140 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTG-RKPVDHTMPRGQQ---S  210 (285)
Q Consensus       140 ~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g-~~pf~~~~~~~~~---~  210 (285)
                      .|-+.-....+..   .....+|...|.+||...     +..-++.+|.|.||+++++++.| ++||.+---....   .
T Consensus       159 VdsDsfqi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~  235 (637)
T COG4248         159 VDSDSFQINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL  235 (637)
T ss_pred             EcccceeeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc
Confidence            9865543322211   123356889999999754     34557889999999999999885 9999753211000   0


Q ss_pred             hhhhhcccCch-hhhhhhcCCccCCCCChhHHHHHHHHHHHhccc--CCCCCCCHHHHHHHhchhhcCCCCCCCC
Q 023220          211 LVTWATPRLSE-DKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQY--EAEFRPNMSIVVKALQPLLKSPPPAAPV  282 (285)
Q Consensus       211 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--~p~~Rps~~~ll~~l~~~~~~~~~~~~~  282 (285)
                      ........+.- ..-..-..+........-.++++..+..+|+..  ++.-|||++-++..|..+.....+|...
T Consensus       236 E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~  310 (637)
T COG4248         236 ETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVS  310 (637)
T ss_pred             hhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhc
Confidence            00000000000 000000011111111234577899999999984  4678999999999999999888887654

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.27  E-value=9.8e-12  Score=98.34  Aligned_cols=127  Identities=16%  Similarity=0.109  Sum_probs=85.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhH----------------------HHHHHHHccCCCCc--ccccceEEEe
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDE----------------------KQLVSVVSRLKHEN--LVELLGYCVE   57 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~h~~--iv~~~~~~~~   57 (285)
                      +||++.+. .++.+++|..+............                      ..|.+.+.++.+.+  +.+.++.   
T Consensus        12 ~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~---   87 (187)
T cd05119          12 DVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL---   87 (187)
T ss_pred             eEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec---
Confidence            58888766 67788888765433221111111                      34566666664433  3333332   


Q ss_pred             CCeeeEEEeeCCCCCHHH-HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCC
Q 023220           58 GNLRVLAYEFATMGSLHD-ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDF  135 (285)
Q Consensus        58 ~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~  135 (285)
                       ...+++|||+.++.+.. .+....          .. ..+..++.+++.++.++|. .   |++|+|++|+||+++ ++
T Consensus        88 -~~~~lv~e~~~g~~~~~~~l~~~~----------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          88 -NRHVLVMEFIGGDGIPAPRLKDVR----------LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DG  151 (187)
T ss_pred             -CCCEEEEEEeCCCCccChhhhhhh----------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CC
Confidence             23589999999854321 111110          11 4678899999999999999 8   999999999999999 88


Q ss_pred             eeEEeccccCCCC
Q 023220          136 KAKIADFNLSNQA  148 (285)
Q Consensus       136 ~~~l~df~~~~~~  148 (285)
                      .++++|||.+...
T Consensus       152 ~~~liDfg~a~~~  164 (187)
T cd05119         152 KVYIIDVPQAVEI  164 (187)
T ss_pred             cEEEEECcccccc
Confidence            9999999988543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.17  E-value=5.8e-11  Score=105.14  Aligned_cols=226  Identities=21%  Similarity=0.215  Sum_probs=158.5

Q ss_pred             cccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCC
Q 023220           13 ESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPV   91 (285)
Q Consensus        13 ~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~   91 (285)
                      ..+++|..+.--.......+=.+|+..-+.+ .|++.++.+..+..++..++-+|.+. .+|.++.......        
T Consensus       144 ~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~--------  214 (524)
T KOG0601|consen  144 HKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNF--------  214 (524)
T ss_pred             cccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhccccc--------
Confidence            3444444332222223334445677666666 68999999999999999999999996 5888887665432        


Q ss_pred             CCHHHHHHHHHHHHH----HHHHHhhcCCCCeeeCCCCCCCeEEccC-CeeEEeccccCCCCCccccccc---ccccccc
Q 023220           92 LDWMTRVRIAVDAAR----GLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQAPDMAARLH---STRVLGT  163 (285)
Q Consensus        92 ~~~~~~~~~~~qi~~----~l~~lh~~~~~~~~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~---~~~~~~~  163 (285)
                      ++...++..+.+...    |+.++|..   +++|.|++|.||+...+ ..++++|||+...+........   .....|.
T Consensus       215 ~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~  291 (524)
T KOG0601|consen  215 LPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGD  291 (524)
T ss_pred             CCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCC
Confidence            667778888888888    99999999   99999999999999988 8899999999876654331111   1223678


Q ss_pred             cCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHH
Q 023220          164 FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAK  243 (285)
Q Consensus       164 ~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (285)
                      ..|++||...+ -++..+|++++|.++.+..++..+.-..-.      .       .+...+...   ...++....+.+
T Consensus       292 ~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~-------~W~~~r~~~---ip~e~~~~~s~~  354 (524)
T KOG0601|consen  292 CIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN------S-------SWSQLRQGY---IPLEFCEGGSSS  354 (524)
T ss_pred             ceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC------C-------Ccccccccc---CchhhhcCcchh
Confidence            89999997654 468889999999999999887766532200      0       001111111   111223334556


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 023220          244 LAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       244 l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +...+.+|++.+|-.|++...+..
T Consensus       355 l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  355 LRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             hhhHHHHhcCcchhhhhHHHHHhc
Confidence            777999999999999999887764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.10  E-value=3.9e-10  Score=88.97  Aligned_cols=96  Identities=18%  Similarity=0.163  Sum_probs=71.0

Q ss_pred             HHHHHHccCCC--CcccccceEEEeCCeeeEEEeeCCCCCHH-HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 023220           35 QLVSVVSRLKH--ENLVELLGYCVEGNLRVLAYEFATMGSLH-DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYL  111 (285)
Q Consensus        35 ~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l  111 (285)
                      +|++.|+++..  -++.+.+++    ..-+|||||+.++.+. ..+....          ++......+..+++.++..+
T Consensus        75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~----------~~~~~~~~i~~~i~~~l~~l  140 (197)
T cd05146          75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAK----------LNDEEMKNAYYQVLSMMKQL  140 (197)
T ss_pred             HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccc----------cCHHHHHHHHHHHHHHHHHH
Confidence            79999999944  455555554    3458999999764332 1222211          44556677889999999988


Q ss_pred             -hhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCC
Q 023220          112 -HEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA  148 (285)
Q Consensus       112 -h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~  148 (285)
                       |+.   |++|||+++.||+++. +.++++|||.+...
T Consensus       141 ~H~~---glVHGDLs~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         141 YKEC---NLVHADLSEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             HHhC---CeecCCCCHHHEEEEC-CcEEEEECCCceeC
Confidence             898   9999999999999974 68999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.07  E-value=5.5e-10  Score=85.36  Aligned_cols=129  Identities=18%  Similarity=0.184  Sum_probs=103.3

Q ss_pred             eeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCC-CCHHHHhccCCCCCCCC
Q 023220            9 CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATM-GSLHDILHGRKGVQGAQ   87 (285)
Q Consensus         9 ~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~   87 (285)
                      +++|.++..+..-+....+-...+.++|++.|.++.--+|.-..-++.+.+.-.|+|||.++ .++.+++.......   
T Consensus        33 ~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~---  109 (229)
T KOG3087|consen   33 AIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDE---  109 (229)
T ss_pred             eEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCc---
Confidence            57888888777766666666788889999999999877888777788887777899999986 38888887654321   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC---eeEEeccccCCC
Q 023220           88 PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF---KAKIADFNLSNQ  147 (285)
Q Consensus        88 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~---~~~l~df~~~~~  147 (285)
                          .........+.+|-..+.-||.+   +++|||+..+||++..++   .+.++|||++..
T Consensus       110 ----~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  110 ----SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             ----ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence                33334478999999999999999   999999999999986543   358999998754

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.05  E-value=5.7e-10  Score=85.53  Aligned_cols=98  Identities=18%  Similarity=0.327  Sum_probs=81.1

Q ss_pred             ChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 023220           30 PDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLE  109 (285)
Q Consensus        30 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~  109 (285)
                      .++-.+|.+++.+++--+|.-..-+..+.+...|+|||..|..|.+.+....                ..++..+-.-+.
T Consensus        43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~~----------------~~~~r~vG~~vg  106 (204)
T COG3642          43 RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEAR----------------PDLLREVGRLVG  106 (204)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhcc----------------hHHHHHHHHHHH
Confidence            4566779999999877777766666667777789999999989998987641                357778888889


Q ss_pred             HHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          110 YLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       110 ~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      -||..   |++|+|+.++||.+..+ .+.++|||++..
T Consensus       107 ~lH~~---givHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642         107 KLHKA---GIVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             HHHhc---CeecCCCccceEEEeCC-cEEEEECCcccc
Confidence            99999   99999999999999866 499999999864

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.04  E-value=9.7e-10  Score=85.40  Aligned_cols=121  Identities=15%  Similarity=0.085  Sum_probs=81.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccc-cceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVE-LLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      ++|++...  +..|.+|.......   ....+..|+.+++.+.+.++++ ++++.  ....++|||++++.++.+.   .
T Consensus        13 ~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~---~   82 (170)
T cd05151          13 KNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE---D   82 (170)
T ss_pred             ceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc---c
Confidence            46666432  45677776543221   2335678999999886655443 44333  3345799999998777543   0


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV--QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                                 ..   ....+.+++.+++.||...  ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus        83 -----------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          83 -----------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             -----------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence                       11   1245678999999999981  11259999999999999 66899999997753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.98  E-value=3.1e-10  Score=102.24  Aligned_cols=160  Identities=18%  Similarity=0.247  Sum_probs=111.4

Q ss_pred             CHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc-------cccccC
Q 023220           93 DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR-------VLGTFG  165 (285)
Q Consensus        93 ~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~-------~~~~~~  165 (285)
                      ..+....-+.+.+.|+.|+|...  +++|++|.|++|.++.++..||+.|+.+.............+       ..-...
T Consensus        97 aTe~~f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~  174 (700)
T KOG2137|consen   97 ATEDGFANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLN  174 (700)
T ss_pred             cccHhhhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcc
Confidence            33445555666678999999876  899999999999999999999999988754433111111111       112457


Q ss_pred             cCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHH
Q 023220          166 YHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKL  244 (285)
Q Consensus       166 ~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (285)
                      |.|||.+.+...+.++|+||+|+++|.++. |+.-+.........+..             ...+..........+|+++
T Consensus       175 f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el  241 (700)
T KOG2137|consen  175 FLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSEL  241 (700)
T ss_pred             cccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHH
Confidence            999999988777899999999999999984 65555443221111111             1111111223346778899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHH
Q 023220          245 AAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+-+.+++..++.-||++..+..
T Consensus       242 ~~~l~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  242 RESLKKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHHHHHHhcCCcccCcchhhhhc
Confidence            99999999999999997766654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.97  E-value=5.4e-10  Score=99.08  Aligned_cols=232  Identities=17%  Similarity=0.103  Sum_probs=151.0

Q ss_pred             Cceeeeee-eeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTC-QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +++.|.+. -....|++|..............-..|+-+...+ .|.|++.++..+....+.++--||+.++++...+..
T Consensus       280 ~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~  359 (524)
T KOG0601|consen  280 SVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT  359 (524)
T ss_pred             cceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHH
Confidence            34444433 3455666665543333222222223455555555 688889988888877777899999988866555421


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC-CeeEEeccccCCCCCccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ..         .+.+...+.+..|++.++.++|+.   .++|.|++|.||++..+ +..++.||+.+.......     .
T Consensus       360 ~~---------~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-----~  422 (524)
T KOG0601|consen  360 SQ---------MLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-----G  422 (524)
T ss_pred             HH---------hcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceec-----c
Confidence            11         167788999999999999999999   99999999999999875 778999999886432211     1


Q ss_pred             ccccccCcC--CCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          159 RVLGTFGYH--APEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       159 ~~~~~~~~~--aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      -..+...+.  ++.......+..+.|++|||..+.+..++...-.....                  +..+..  -....
T Consensus       423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------------~~~i~~--~~~p~  482 (524)
T KOG0601|consen  423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------------SLTIRS--GDTPN  482 (524)
T ss_pred             cccccccccccchhhccccccccccccccccccccccccCcccCccccc------------------ceeeec--ccccC
Confidence            111222333  44444445667899999999999999987664321110                  000000  00111


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      .+.....+..+.+.+...++..||.+.++....+
T Consensus       483 ~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  483 LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             CCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            2233367888999999999999999988765543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.97  E-value=5.5e-10  Score=104.66  Aligned_cols=192  Identities=21%  Similarity=0.221  Sum_probs=136.3

Q ss_pred             CcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 023220           46 ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR  125 (285)
Q Consensus        46 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~  125 (285)
                      |-++..+-.+.-....+++++|+.+++|...++.-..         .+..........+..+..+||..   .+.|+|++
T Consensus       864 P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~---------~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~  931 (1205)
T KOG0606|consen  864 PAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC---------LSAEPARSPILERVQSLESLHSS---LRKHRDLK  931 (1205)
T ss_pred             CceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC---------cccccccchhHHHHhhhhccccc---hhhccccc
Confidence            4444333333345567999999999999999876542         44445556666788899999998   89999999


Q ss_pred             CCCeEEccCCeeEEeccccCCCCCcc-----------------------------cccccccccccccCcCCCcccccCC
Q 023220          126 SSNVLLFEDFKAKIADFNLSNQAPDM-----------------------------AARLHSTRVLGTFGYHAPEYAMTGQ  176 (285)
Q Consensus       126 ~~nil~~~~~~~~l~df~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~aPE~~~~~~  176 (285)
                      |.|++...++...+.||+........                             +.........+++.|.+||...+..
T Consensus       932 p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~ 1011 (1205)
T KOG0606|consen  932 PDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR 1011 (1205)
T ss_pred             ccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc
Confidence            99999999999999998743222100                             0001123356899999999999999


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCC
Q 023220          177 LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEA  256 (285)
Q Consensus       177 ~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  256 (285)
                      ....+|.|++|+++++.++|.+||+...++..-..+......++              .-+...+.....++...+..+|
T Consensus      1012 hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p--------------~g~~~~s~~aq~~~~~ll~~~~ 1077 (1205)
T KOG0606|consen 1012 HGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWP--------------EGPEEGSYEAQDLINRLLTEEP 1077 (1205)
T ss_pred             CCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCC--------------CCccccChhhhhhhhhhhccCc
Confidence            99999999999999999999999987655433211111111111              1233445678889999999999


Q ss_pred             CCCCCHH
Q 023220          257 EFRPNMS  263 (285)
Q Consensus       257 ~~Rps~~  263 (285)
                      .+|-.+.
T Consensus      1078 ~qr~~a~ 1084 (1205)
T KOG0606|consen 1078 TQRLGAK 1084 (1205)
T ss_pred             hhccCcc
Confidence            9997765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.85  E-value=6.1e-09  Score=92.90  Aligned_cols=104  Identities=24%  Similarity=0.254  Sum_probs=71.0

Q ss_pred             hHHHHHHHHccC----CCCcccccceEE-EeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q 023220           32 DEKQLVSVVSRL----KHENLVELLGYC-VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAAR  106 (285)
Q Consensus        32 ~~~~e~~~l~~l----~h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~  106 (285)
                      ++.+|.+.+.++    +|.+-+.+-.++ ......+++|||++|++|.++.......        .   ....++.+++.
T Consensus       199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--------~---~~~~ia~~~~~  267 (437)
T TIGR01982       199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--------L---DRKALAENLAR  267 (437)
T ss_pred             CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--------C---CHHHHHHHHHH
Confidence            355566666665    232223333333 2244569999999999998876432110        2   12345555555


Q ss_pred             -HHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCC
Q 023220          107 -GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP  149 (285)
Q Consensus       107 -~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~  149 (285)
                       .+..+|..   |++|+|++|.||+++.++.++++|||++....
T Consensus       268 ~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       268 SFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             46788998   99999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.85  E-value=2.4e-08  Score=83.04  Aligned_cols=105  Identities=17%  Similarity=0.136  Sum_probs=79.8

Q ss_pred             hHHHHHHHHccCCCCcc--cccceEEEe-----CCeeeEEEeeCCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHH
Q 023220           32 DEKQLVSVVSRLKHENL--VELLGYCVE-----GNLRVLAYEFATMG-SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVD  103 (285)
Q Consensus        32 ~~~~e~~~l~~l~h~~i--v~~~~~~~~-----~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~q  103 (285)
                      .+.+|.+.+.+|..-+|  .+.++++..     ....+||||++++. +|.+++......       .........++.+
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~-------~~~~~~~~~ll~~  146 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATN-------PPDPRLKRMLIKR  146 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhccc-------CCCHHHHHHHHHH
Confidence            57789988888844333  334555543     23468999999875 899888542211       1455677899999


Q ss_pred             HHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-------CCeeEEeccccCC
Q 023220          104 AARGLEYLHEKVQPSIIHRDIRSSNVLLFE-------DFKAKIADFNLSN  146 (285)
Q Consensus       104 i~~~l~~lh~~~~~~~~h~di~~~nil~~~-------~~~~~l~df~~~~  146 (285)
                      ++..+.-||+.   |++|+|+++.|||++.       ++.+.++||+.+.
T Consensus       147 la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        147 VATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            99999999999   9999999999999975       4689999999764

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.76  E-value=4.9e-08  Score=79.06  Aligned_cols=134  Identities=19%  Similarity=0.172  Sum_probs=88.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCc--ccccceEEEeC---CeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHEN--LVELLGYCVEG---NLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~---~~~~lv~e~~~~~~L~~~   76 (285)
                      .+|++.... ++.|.+|........ ....++.+|+++++.+++.+  +.+++.+....   +..++|||+++|.++.+.
T Consensus        13 ~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~   90 (223)
T cd05154          13 LTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDR   90 (223)
T ss_pred             eEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCC
Confidence            356664322 356767765433222 24667889999999997644  56667666553   256899999998877665


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc------------------------------------------
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEK------------------------------------------  114 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~------------------------------------------  114 (285)
                      +...          .++......++.+++.++..||+.                                          
T Consensus        91 ~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          91 LLRP----------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CCCC----------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            4311          144555555666666666666532                                          


Q ss_pred             -----------CCCCeeeCCCCCCCeEEcc--CCeeEEeccccCCC
Q 023220          115 -----------VQPSIIHRDIRSSNVLLFE--DFKAKIADFNLSNQ  147 (285)
Q Consensus       115 -----------~~~~~~h~di~~~nil~~~--~~~~~l~df~~~~~  147 (285)
                                 ....++|+|+.+.||+++.  ++.+.++||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                       0236899999999999998  66789999987754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.75  E-value=3.7e-08  Score=77.41  Aligned_cols=99  Identities=19%  Similarity=0.220  Sum_probs=64.8

Q ss_pred             ChhHHHHHHHHccCCCCc--ccccceEEEeCCeeeEEEeeCC--CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHH
Q 023220           30 PDDEKQLVSVVSRLKHEN--LVELLGYCVEGNLRVLAYEFAT--MGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAA  105 (285)
Q Consensus        30 ~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~  105 (285)
                      ....++|++.|.++..-+  +.+.+++-    .-+|||||+.  |..+..+....           ++......++.+++
T Consensus        52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~-----------~~~~~~~~~~~~il  116 (188)
T PF01163_consen   52 REWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD-----------LSPEEPKELLEEIL  116 (188)
T ss_dssp             HHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG-----------GGGSTHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc-----------ccchhHHHHHHHHH
Confidence            345678999999997764  45555432    2379999998  55555444322           22234566777777


Q ss_pred             HHHH-HHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          106 RGLE-YLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       106 ~~l~-~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      ..+. .+|..   |++|||+++.||+++.+ .+.++|||.+..
T Consensus       117 ~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen  117 EEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             HHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred             HHHHHHHHhc---CceecCCChhhEEeecc-eEEEEecCccee
Confidence            7444 46788   99999999999999987 999999997743

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.75  E-value=3e-09  Score=96.30  Aligned_cols=103  Identities=12%  Similarity=0.075  Sum_probs=64.4

Q ss_pred             HHHHHHHHccCC----CCcccccceEEEe-CCeeeEEEeeCCCCCHHHHh--ccCCCCCCCCCCCCCCHHHHHHHHHHHH
Q 023220           33 EKQLVSVVSRLK----HENLVELLGYCVE-GNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVLDWMTRVRIAVDAA  105 (285)
Q Consensus        33 ~~~e~~~l~~l~----h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~qi~  105 (285)
                      +.+|...+.+++    +...+.+-.++.+ ....+|||||+.|+.+.++-  .....     +...+....+..++.|++
T Consensus       203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-----d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-----DMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-----CHHHHHHHHHHHHHHHHH
Confidence            334444444442    3333444444432 44568999999999997742  21110     000133444444555543


Q ss_pred             HHHHHHhhcCCCCeeeCCCCCCCeEEccCC----eeEEeccccCCCCCc
Q 023220          106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSNQAPD  150 (285)
Q Consensus       106 ~~l~~lh~~~~~~~~h~di~~~nil~~~~~----~~~l~df~~~~~~~~  150 (285)
                             ..   |++|+|++|.||+++.++    .++++|||++.....
T Consensus       278 -------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                   46   999999999999999887    999999999866543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.75  E-value=1.1e-07  Score=76.38  Aligned_cols=106  Identities=24%  Similarity=0.225  Sum_probs=82.9

Q ss_pred             ChhHHHHHHHHccCCC--CcccccceEEEeCC----eeeEEEeeCCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHH
Q 023220           30 PDDEKQLVSVVSRLKH--ENLVELLGYCVEGN----LRVLAYEFATMG-SLHDILHGRKGVQGAQPGPVLDWMTRVRIAV  102 (285)
Q Consensus        30 ~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  102 (285)
                      .....+|.+.+..|..  =...+.+++.....    ..++|+|++++. +|.+++.....         .+......++.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---------~~~~~~~~ll~  125 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---------LDPSQRRELLR  125 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---------cchhhHHHHHH
Confidence            4567788888887743  33455666665422    458999999874 89999876432         44566788999


Q ss_pred             HHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC---eeEEeccccCCC
Q 023220          103 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF---KAKIADFNLSNQ  147 (285)
Q Consensus       103 qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~---~~~l~df~~~~~  147 (285)
                      +++..++-||+.   |++|+|+++.|||++.++   .+.++||+.+..
T Consensus       126 ~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  126 ALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999   999999999999999887   899999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.52  E-value=9.7e-07  Score=70.06  Aligned_cols=107  Identities=14%  Similarity=0.044  Sum_probs=80.7

Q ss_pred             CChhHHHHHHHHccCCCCc--ccccceEEEe-----CCeeeEEEeeCCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHH
Q 023220           29 YPDDEKQLVSVVSRLKHEN--LVELLGYCVE-----GNLRVLAYEFATM-GSLHDILHGRKGVQGAQPGPVLDWMTRVRI  100 (285)
Q Consensus        29 ~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~-----~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~  100 (285)
                      =...|.+|+..|.++..-+  +.+.. ++..     ....+||+|-+.+ .+|.+++......+       .+......+
T Consensus        62 g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~-------~~~~~k~~i  133 (216)
T PRK09902         62 GRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSP-------YSDEVRQAM  133 (216)
T ss_pred             CchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCC-------cchHHHHHH
Confidence            3577889999999884322  44444 3321     1245899997764 39999986543221       566777899


Q ss_pred             HHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCe--eEEeccccCC
Q 023220          101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK--AKIADFNLSN  146 (285)
Q Consensus       101 ~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~--~~l~df~~~~  146 (285)
                      +.+++.+++-||+.   |+.|+|+.+.||+++.++.  +.++||.-.+
T Consensus       134 l~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        134 LKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             HHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            99999999999999   9999999999999986667  8999997654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.30  E-value=3.5e-05  Score=60.80  Aligned_cols=104  Identities=23%  Similarity=0.224  Sum_probs=80.0

Q ss_pred             HHHHHHHccCCC-CcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 023220           34 KQLVSVVSRLKH-ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH  112 (285)
Q Consensus        34 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh  112 (285)
                      ..|.-+++.+.+ +++++++|+|-    .+++.|+...+++......-..      -...+|..+.+++.+++..+.+++
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~------~~~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ------FLQSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc------ccccCHHHHHHHHHHHHHHHHHHh
Confidence            358888888866 69999999993    3678899987655432100000      001689999999999999999999


Q ss_pred             hcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          113 EKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       113 ~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      ..-.+.+.-.|++++|+-++.++.++++|.+.+..
T Consensus        77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   77 HGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             cCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            86444688899999999999999999999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.25  E-value=2.9e-06  Score=69.29  Aligned_cols=97  Identities=16%  Similarity=0.172  Sum_probs=72.1

Q ss_pred             ChhHHHHHHHHccCCCC--cccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHH
Q 023220           30 PDDEKQLVSVVSRLKHE--NLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARG  107 (285)
Q Consensus        30 ~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~  107 (285)
                      +...++|.+.|.+|..-  .+.+.+++-    .-.+|||+.+|-.|....              +.......++..|+..
T Consensus       153 Rl~A~rEf~~L~~L~~~G~~VP~P~~~n----RHaVvMe~ieG~eL~~~r--------------~~~en~~~il~~il~~  214 (304)
T COG0478         153 RLAAEREFEALQRLYPEGVKVPKPIAWN----RHAVVMEYIEGVELYRLR--------------LDVENPDEILDKILEE  214 (304)
T ss_pred             HHHHHHHHHHHHHhhhcCCCCCCccccc----cceeeeehcccceeeccc--------------CcccCHHHHHHHHHHH
Confidence            45667899999998544  666666543    337999999986664443              2234455666667776


Q ss_pred             HHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       108 l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      +.-+-..   |++|||+++-||+++++|.++++||-.+..
T Consensus       215 ~~~~~~~---GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         215 VRKAYRR---GIVHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             HHHHHHc---CccccCCchheEEEecCCCEEEEeCccccc
Confidence            6666777   999999999999999999999999976543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.18  E-value=6.8e-06  Score=65.61  Aligned_cols=65  Identities=25%  Similarity=0.299  Sum_probs=50.9

Q ss_pred             eeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEE
Q 023220           60 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI  139 (285)
Q Consensus        60 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l  139 (285)
                      ..+++|||++|..|.+...             +..    .+...+..++.-+|+.   |+.|||.+|.|++++.+ .+++
T Consensus       117 ~~~ll~EYIeG~~l~d~~~-------------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~i  175 (229)
T PF06176_consen  117 SYVLLMEYIEGVELNDIED-------------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRI  175 (229)
T ss_pred             EEEEEEEEecCeecccchh-------------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEE
Confidence            4578999999988766532             222    2445677788999999   99999999999999865 5999


Q ss_pred             eccccC
Q 023220          140 ADFNLS  145 (285)
Q Consensus       140 ~df~~~  145 (285)
                      +||+..
T Consensus       176 ID~~~k  181 (229)
T PF06176_consen  176 IDTQGK  181 (229)
T ss_pred             EECccc
Confidence            999754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.95  E-value=3.4e-05  Score=74.29  Aligned_cols=193  Identities=20%  Similarity=0.220  Sum_probs=133.7

Q ss_pred             HHHHHHccCCCCcccccceEEEeCCee----eEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 023220           35 QLVSVVSRLKHENLVELLGYCVEGNLR----VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEY  110 (285)
Q Consensus        35 ~e~~~l~~l~h~~iv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~  110 (285)
                      -|+..+....|+|+..++.+.......    .+..+++...++...+..-..         .+..+...+..++.+++.+
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---------i~~~~~r~~~~~~~~GL~~  301 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---------IPLETLRILHQKLLEGLAY  301 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---------cCHHHHHHHHHHHhhhHHH
Confidence            466677888999999999987754432    344577777788887766542         8889999999999999999


Q ss_pred             HhhcCCCCeeeCCCCCC---CeEEccCCeeEEe--ccccCCCCCcccccccccccccccCcCCCcccccCCC--Ccccch
Q 023220          111 LHEKVQPSIIHRDIRSS---NVLLFEDFKAKIA--DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL--TQKSDV  183 (285)
Q Consensus       111 lh~~~~~~~~h~di~~~---nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~Di  183 (285)
                      +|..   ...|.-+...   +-..+..+.+...  ||+...........   ........+-++|.......  +...|+
T Consensus       302 ~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL  375 (1351)
T KOG1035|consen  302 LHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDL  375 (1351)
T ss_pred             HHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHH
Confidence            9998   7777666555   4444556666666  88877655433221   22334556778887765544  345799


Q ss_pred             HhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHH
Q 023220          184 YSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS  263 (285)
Q Consensus       184 wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  263 (285)
                      |.+|.....+..|..+-.....                  ...++        +............+|+..++++|+++.
T Consensus       376 ~~lgll~~~~~~~~~i~~~~~~------------------~~~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~~~  429 (1351)
T KOG1035|consen  376 WCLGLLLLQLSQGEDISEKSAV------------------PVSLL--------DVLSTSELLDALPKCLDEDSEERLSAL  429 (1351)
T ss_pred             HHHHHHHhhhhhcCcccccccc------------------hhhhh--------ccccchhhhhhhhhhcchhhhhccchh
Confidence            9999999999887665321110                  00111        111112577889999999999999999


Q ss_pred             HHHHH
Q 023220          264 IVVKA  268 (285)
Q Consensus       264 ~ll~~  268 (285)
                      +++..
T Consensus       430 ~ll~~  434 (1351)
T KOG1035|consen  430 ELLTH  434 (1351)
T ss_pred             hhhhc
Confidence            99874

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.78  E-value=0.00018  Score=59.29  Aligned_cols=47  Identities=9%  Similarity=0.002  Sum_probs=34.0

Q ss_pred             ChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220           30 PDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus        30 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .....+|+++++.+. +--+.+++++...++..++||++.+|.++...
T Consensus        35 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150          35 TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            345677898888873 34456677777766667999999998777644

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.77  E-value=8.7e-06  Score=73.67  Aligned_cols=152  Identities=20%  Similarity=0.208  Sum_probs=109.2

Q ss_pred             hhHHHHHHHHccCCCCc-ccccceEEEeCCeeeEEEeeCCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 023220           31 DDEKQLVSVVSRLKHEN-LVELLGYCVEGNLRVLAYEFATMG-SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGL  108 (285)
Q Consensus        31 ~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l  108 (285)
                      ....-++++|.+++||| .+..++-+.-.....+.++++.++ +.........-        .+.......+++.-...+
T Consensus       278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~--------~~~~~~~~~~~r~et~~l  349 (829)
T KOG0576|consen  278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEI--------ALEQYQFAYPLRKETRPL  349 (829)
T ss_pred             hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhH--------hhhhhhhhhhhhhhcccc
Confidence            34445889999999999 666666666677889999999876 22111111000        144445566777778889


Q ss_pred             HHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHH
Q 023220          109 EYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGV  188 (285)
Q Consensus       109 ~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~  188 (285)
                      +++|+.   .-+|+|    ||+-.+ +..+..||+.........   ......+++.++|||+.....++.+.|.|++|.
T Consensus       350 ~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~  418 (829)
T KOG0576|consen  350 AELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAV  418 (829)
T ss_pred             cccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCc
Confidence            999987   667877    666544 578999999876554433   234456899999999999999999999999998


Q ss_pred             HHHHHHhCCCCCC
Q 023220          189 VLLELLTGRKPVD  201 (285)
Q Consensus       189 ~l~~l~~g~~pf~  201 (285)
                      -..++.-|-+|-.
T Consensus       419 ~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  419 SAIQMAPGLPPRS  431 (829)
T ss_pred             chhhcCCCCCCCC
Confidence            7777777777643

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.73  E-value=0.0004  Score=55.19  Aligned_cols=95  Identities=16%  Similarity=0.191  Sum_probs=69.9

Q ss_pred             ChhHHHHHHHHccCC------CCcccccceEEEeCCeeeEEEeeCCC------CCHHHHhccCCCCCCCCCCCCCCHHHH
Q 023220           30 PDDEKQLVSVVSRLK------HENLVELLGYCVEGNLRVLAYEFATM------GSLHDILHGRKGVQGAQPGPVLDWMTR   97 (285)
Q Consensus        30 ~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~~~~   97 (285)
                      .++..+|+.-..++.      +.+|.+++|+.+++-...+|+|...+      -+|.+++....          ++.   
T Consensus        55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----------~~~---  121 (199)
T PF10707_consen   55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----------LTE---  121 (199)
T ss_pred             hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----------ccH---
Confidence            455666666666555      88999999999999999999987632      27888886543          443   


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC----eeEEec
Q 023220           98 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIAD  141 (285)
Q Consensus        98 ~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~----~~~l~d  141 (285)
                       .+...+-....+|-+.   +|+.+|++|.||++....    .++|+|
T Consensus       122 -~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  122 -ELRQALDEFKRYLLDH---HIVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             -HHHHHHHHHHHHHHHc---CCeecCCCcccEEEEecCCCceEEEEEe
Confidence             3344444556788888   999999999999996432    567776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.72  E-value=0.00014  Score=65.92  Aligned_cols=81  Identities=22%  Similarity=0.245  Sum_probs=54.6

Q ss_pred             eCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCe
Q 023220           57 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK  136 (285)
Q Consensus        57 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~  136 (285)
                      ....-+|+|||++|..+.+...-....        .+.+.+.....++.  +..+-..   |+.|+|..|.||+++.+|.
T Consensus       237 ~t~~~VLtmE~i~Gi~i~d~~~l~~~g--------~d~k~ia~~~~~~f--~~q~~~d---gffHaDpHpGNi~v~~~g~  303 (517)
T COG0661         237 YTTRRVLTMEWIDGIKISDIAALKSAG--------IDRKELAELLVRAF--LRQLLRD---GFFHADPHPGNILVRSDGR  303 (517)
T ss_pred             ccCCcEEEEEeeCCEecccHHHHHhcC--------CCHHHHHHHHHHHH--HHHHHhc---CccccCCCccceEEecCCc
Confidence            355669999999998887774222111        33333322222221  2233334   9999999999999999999


Q ss_pred             eEEeccccCCCCCc
Q 023220          137 AKIADFNLSNQAPD  150 (285)
Q Consensus       137 ~~l~df~~~~~~~~  150 (285)
                      +.+.|||+......
T Consensus       304 i~~lDfGi~g~l~~  317 (517)
T COG0661         304 IVLLDFGIVGRLDP  317 (517)
T ss_pred             EEEEcCcceecCCH
Confidence            99999999866543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.69  E-value=0.00054  Score=55.80  Aligned_cols=115  Identities=10%  Similarity=0.051  Sum_probs=65.3

Q ss_pred             CChhHHHHHHHHccCCCCc--ccccceEEEeCCeeeEEEeeCCCCC-HHHHhccCC-----------------CCCCCCC
Q 023220           29 YPDDEKQLVSVVSRLKHEN--LVELLGYCVEGNLRVLAYEFATMGS-LHDILHGRK-----------------GVQGAQP   88 (285)
Q Consensus        29 ~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~~~-----------------~~~~~~~   88 (285)
                      ......+|.++++.+..-+  +.+.+++...++...++|++++|.+ +...+....                 ..-.. .
T Consensus        35 ~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~  113 (226)
T TIGR02172        35 DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-D  113 (226)
T ss_pred             CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-C
Confidence            3456788999999986443  4677778777888899999998853 221211100                 00000 0


Q ss_pred             CCCCCHHHHHH-HHHH----------HHH-HHHHHhhc-CCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220           89 GPVLDWMTRVR-IAVD----------AAR-GLEYLHEK-VQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus        89 ~~~~~~~~~~~-~~~q----------i~~-~l~~lh~~-~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                        ......... +..+          +.. ...+|... ....++|+|+.|.|+++++++ +.++||+.+..
T Consensus       114 --~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       114 --TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             --CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence              011111110 1000          011 11222211 133678999999999999887 99999987653

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.51  E-value=0.00051  Score=55.80  Aligned_cols=97  Identities=16%  Similarity=0.169  Sum_probs=62.3

Q ss_pred             HHHHHHccCCCC--cccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 023220           35 QLVSVVSRLKHE--NLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH  112 (285)
Q Consensus        35 ~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh  112 (285)
                      .|++-|+++...  .+.+.+++.    .-.|||||+....     ...+..+   +- .+.......+..+++..+.-|-
T Consensus       117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g-----~pAP~Lk---Dv-~~e~~e~~~~~~~~v~~~~~l~  183 (268)
T COG1718         117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDG-----LPAPRLK---DV-PLELEEAEGLYEDVVEYMRRLY  183 (268)
T ss_pred             HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCC-----CCCCCcc---cC-CcCchhHHHHHHHHHHHHHHHH
Confidence            366666666333  334444443    2379999996531     0000000   00 1233356677777887777777


Q ss_pred             h-cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCC
Q 023220          113 E-KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA  148 (285)
Q Consensus       113 ~-~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~  148 (285)
                      . .   +++|+|++.-|||+. ++.+.++|++.+...
T Consensus       184 ~~a---~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         184 KEA---GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             Hhc---CcccccchhhheEEE-CCeEEEEECcccccc
Confidence            6 5   999999999999999 779999999988654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.37  E-value=0.001  Score=60.42  Aligned_cols=77  Identities=19%  Similarity=0.223  Sum_probs=50.8

Q ss_pred             CeeeEEEeeCCCCCHHH--HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc---
Q 023220           59 NLRVLAYEFATMGSLHD--ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---  133 (285)
Q Consensus        59 ~~~~lv~e~~~~~~L~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~---  133 (285)
                      ...+|+|||++|..+.+  .+....          ++...+..-+.+...-  .+-..   |++|+|-.|.||++..   
T Consensus       275 t~RVLtME~~~G~~i~Dl~~i~~~g----------i~~~~i~~~l~~~~~~--qIf~~---GffHaDPHPGNilv~~~~~  339 (538)
T KOG1235|consen  275 TKRVLTMEYVDGIKINDLDAIDKRG----------ISPHDILNKLVEAYLE--QIFKT---GFFHADPHPGNILVRPNPE  339 (538)
T ss_pred             cceEEEEEecCCccCCCHHHHHHcC----------CCHHHHHHHHHHHHHH--HHHhc---CCccCCCCCCcEEEecCCC
Confidence            35699999999874433  333332          4555444333333222  22233   9999999999999983   


Q ss_pred             -CCeeEEeccccCCCCCc
Q 023220          134 -DFKAKIADFNLSNQAPD  150 (285)
Q Consensus       134 -~~~~~l~df~~~~~~~~  150 (285)
                       ++.+.+.|||+......
T Consensus       340 ~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  340 GDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccEEEEcccccccccH
Confidence             67889999999866543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.99  E-value=6e-05  Score=74.67  Aligned_cols=164  Identities=10%  Similarity=-0.032  Sum_probs=113.4

Q ss_pred             hhHHHHHHHHccCCCCcccccceEEEe--CCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 023220           31 DDEKQLVSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGL  108 (285)
Q Consensus        31 ~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l  108 (285)
                      +....|..-+++..|+++...+.-...  +...+..++++.+|.+++.+-.+.....     .+...-+.....+.+...
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~-----~ld~~~v~~~~kvsvl~~ 1348 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESP-----DLDRSPVHLRHKVSVLNR 1348 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCC-----cchhchHHHHHHHHHhcc
Confidence            444445555566688888877766553  3355889999999999999976543221     133333334444446666


Q ss_pred             HHHhhcCCC--CeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhH
Q 023220          109 EYLHEKVQP--SIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSF  186 (285)
Q Consensus       109 ~~lh~~~~~--~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diwsl  186 (285)
                      .-+|...+.  -.+|+++++.|.++..+.++++.++|+.+.......  ..+-..+++.|++|+....-+++.++|+|..
T Consensus      1349 ~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1349 NVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRR 1426 (2724)
T ss_pred             chhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHH
Confidence            666655322  267899999999999999999999999872222111  1233456777888887777788888999999


Q ss_pred             HHHHHHHHhCCCCCC
Q 023220          187 GVVLLELLTGRKPVD  201 (285)
Q Consensus       187 G~~l~~l~~g~~pf~  201 (285)
                      |+.+|...-|..+|-
T Consensus      1427 s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             HHHHHHHhcccHHHH
Confidence            999999988888873

>PLN02876 acyl-CoA dehydrogenase

Probab=96.96  E-value=0.005  Score=59.87  Aligned_cols=43  Identities=12%  Similarity=0.213  Sum_probs=32.2

Q ss_pred             ChhHHHHHHHHccCC-CCcc--cccceEEEeC---CeeeEEEeeCCCCC
Q 023220           30 PDDEKQLVSVVSRLK-HENL--VELLGYCVEG---NLRVLAYEFATMGS   72 (285)
Q Consensus        30 ~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv~e~~~~~~   72 (285)
                      ...+.+|+++++.+. |.++  .+++.++.+.   +..++|||+++|..
T Consensus        82 ~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~  130 (822)
T PLN02876         82 AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI  130 (822)
T ss_pred             HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence            356889999999995 6665  6667777654   35689999998754

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=96.93  E-value=0.0049  Score=50.47  Aligned_cols=31  Identities=23%  Similarity=0.380  Sum_probs=26.0

Q ss_pred             CCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          117 PSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       117 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      .+++|+|+.+.|++++.++...|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3699999999999998776667999987643

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.91  E-value=0.0011  Score=55.99  Aligned_cols=93  Identities=15%  Similarity=0.131  Sum_probs=68.2

Q ss_pred             hHHHHHHHHccCCC--CcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 023220           32 DEKQLVSVVSRLKH--ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLE  109 (285)
Q Consensus        32 ~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~  109 (285)
                      ...+|+..|+.|..  --+.+.+++..    -++||++..+-.|.+..+-.               .+..+...+...|.
T Consensus       156 aa~kEfafmkaL~e~gfpVPkpiD~~R----H~Vvmelv~g~Pl~~v~~v~---------------d~~~ly~~lm~~Iv  216 (465)
T KOG2268|consen  156 AATKEFAFMKALYERGFPVPKPIDHNR----HCVVMELVDGYPLRQVRHVE---------------DPPTLYDDLMGLIV  216 (465)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCcccccc----eeeHHHhhcccceeeeeecC---------------ChHHHHHHHHHHHH
Confidence            34568888888732  44555555543    48999999887776654322               22345556666777


Q ss_pred             HHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220          110 YLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus       110 ~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      -|...   |+||||.+--||++..++.++++||-...
T Consensus       217 ~la~~---GlIHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  217 RLANH---GLIHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             HHHHc---CceecccchheeEEecCCCEEEeechHhh
Confidence            88888   99999999999999999999999997653

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.41  E-value=0.0037  Score=56.05  Aligned_cols=49  Identities=27%  Similarity=0.347  Sum_probs=38.2

Q ss_pred             hHHHHHHHHccCCCCcccccceEEEe-CCeeeEEEeeCCCCCHHHHhccCC
Q 023220           32 DEKQLVSVVSRLKHENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus        32 ~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      ++.--..+++.+.|+|...++++... .....+|+|++.. +|.+++..+.
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~   77 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN   77 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc
Confidence            34456678899999999999988763 3457889999964 9999987664

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.25  E-value=0.029  Score=45.16  Aligned_cols=104  Identities=13%  Similarity=-0.016  Sum_probs=64.0

Q ss_pred             cChhhhhhccCCCC--CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCC
Q 023220           15 YPSHENERLKSPKN--YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL   92 (285)
Q Consensus        15 ~~~k~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~   92 (285)
                      ++....|+..+..-  ...-+..+.+++.++.  +|+++..=  ++..+.++.|.|-...                    
T Consensus        85 iG~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~--------------------  140 (308)
T PF07387_consen   85 IGPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK--------------------  140 (308)
T ss_pred             cchhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc--------------------
Confidence            33333444443322  3455567888888763  45555421  3445678888874311                    


Q ss_pred             CHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccC
Q 023220           93 DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS  145 (285)
Q Consensus        93 ~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~  145 (285)
                       ....-.+... +++|.-.|+. +++.+|||..|+||+-|..|.+||.|-+..
T Consensus       141 -i~~~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  141 -INFSNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             -cchhHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence             1111112221 4667778853 448999999999999999999999997654

The function of this family is unknown.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.05  E-value=0.024  Score=48.92  Aligned_cols=72  Identities=18%  Similarity=0.188  Sum_probs=55.9

Q ss_pred             eeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEE
Q 023220           60 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI  139 (285)
Q Consensus        60 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l  139 (285)
                      ..|++|++. |+++... ..            ..+.++..++.+.+..+.-+..+-  .+-||++.-+||+++ +|++.|
T Consensus       300 y~yl~~kdh-gt~is~i-k~------------~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtL  362 (488)
T COG5072         300 YLYLHFKDH-GTPISII-KA------------DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTL  362 (488)
T ss_pred             EEEEEEecC-Cceeeee-ec------------ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEE
Confidence            557777777 3455332 21            456788899999888888887653  788999999999999 889999


Q ss_pred             eccccCCCC
Q 023220          140 ADFNLSNQA  148 (285)
Q Consensus       140 ~df~~~~~~  148 (285)
                      +||.+++..
T Consensus       363 IDfklsRl~  371 (488)
T COG5072         363 IDFKLSRLS  371 (488)
T ss_pred             EEeeeeecc
Confidence            999998743

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.81  E-value=0.038  Score=47.87  Aligned_cols=98  Identities=20%  Similarity=0.181  Sum_probs=67.0

Q ss_pred             HHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCH-HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 023220           35 QLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSL-HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE  113 (285)
Q Consensus        35 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~  113 (285)
                      .|++-|.+++..+|.- -.-..-.++ +|||+|+..... .-.++.-          .++...+..+-.+++.-+.-|.+
T Consensus       215 KE~RNLkRl~~aGIP~-PePIlLk~h-VLVM~FlGrdgw~aPkLKd~----------~ls~~ka~~~Y~~~v~~MR~lY~  282 (520)
T KOG2270|consen  215 KEMRNLKRLNNAGIPC-PEPILLKNH-VLVMEFLGRDGWAAPKLKDA----------SLSTSKARELYQQCVRIMRRLYQ  282 (520)
T ss_pred             HHHHHHHHHHhcCCCC-CCceeeecc-eEeeeeccCCCCcCcccccc----------cCChHHHHHHHHHHHHHHHHHHH
Confidence            4777788887777433 322222222 799999864211 1111111          26667788888888888888877


Q ss_pred             cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          114 KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       114 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      .|  ++||.||+--|+|+.. |.++++|.+.+..
T Consensus       283 ~c--~LVHADLSEfN~Lyhd-G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  283 KC--RLVHADLSEFNLLYHD-GKLYIIDVSQSVE  313 (520)
T ss_pred             Hh--ceeccchhhhhheEEC-CEEEEEEcccccc
Confidence            77  9999999999999874 5899999887644

>PRK10593 hypothetical protein; Provisional

Probab=95.25  E-value=0.19  Score=42.70  Aligned_cols=44  Identities=20%  Similarity=0.097  Sum_probs=33.0

Q ss_pred             ChhHHHHHHHHccCCC---CcccccceEEEe---CCeeeEEEeeCCCCCH
Q 023220           30 PDDEKQLVSVVSRLKH---ENLVELLGYCVE---GNLRVLAYEFATMGSL   73 (285)
Q Consensus        30 ~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv~e~~~~~~L   73 (285)
                      ...+..|.+.|+.+..   -.+.++++++..   .+..+||||+++++++
T Consensus        51 ~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         51 PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence            4688899999998843   357777877654   3567999999987654

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=94.35  E-value=0.085  Score=42.98  Aligned_cols=29  Identities=24%  Similarity=0.421  Sum_probs=25.7

Q ss_pred             CeeeCCCCCCCeEEcc-CCeeEEeccccCC
Q 023220          118 SIIHRDIRSSNVLLFE-DFKAKIADFNLSN  146 (285)
Q Consensus       118 ~~~h~di~~~nil~~~-~~~~~l~df~~~~  146 (285)
                      +++|+|+.+.||+++. ++.+.++||..+.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            6999999999999997 5789999998664

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.16  E-value=0.099  Score=44.62  Aligned_cols=31  Identities=29%  Similarity=0.406  Sum_probs=27.0

Q ss_pred             CCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          117 PSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       117 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      .+++|+|+.+.|++++.++.+.++||+.+..
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            4899999999999999887778999987643

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=93.84  E-value=0.26  Score=38.31  Aligned_cols=100  Identities=14%  Similarity=0.139  Sum_probs=66.7

Q ss_pred             cCCCCCChhHHHHHHHHccCCCCccccc-ceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHH
Q 023220           24 KSPKNYPDDEKQLVSVVSRLKHENLVEL-LGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV  102 (285)
Q Consensus        24 ~~~~~~~~~~~~e~~~l~~l~h~~iv~~-~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  102 (285)
                      .-...-+..+..|.++|..+.-.++-+= +.+..    -++.|||..|-.|.++.....                .+-..
T Consensus        53 rr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L~~~~~~~~----------------rk~l~  112 (201)
T COG2112          53 RRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPLGKLEIGGD----------------RKHLL  112 (201)
T ss_pred             ecCCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcchhhhhhccc----------------HHHHH
Confidence            3345567888899999998877666553 32222    245599999878877755321                12334


Q ss_pred             HHHHHHHHHhhcCCCCeeeCCCCC-CCeEEccCCeeEEeccccCC
Q 023220          103 DAARGLEYLHEKVQPSIIHRDIRS-SNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus       103 qi~~~l~~lh~~~~~~~~h~di~~-~nil~~~~~~~~l~df~~~~  146 (285)
                      .++++..-|-..   ||-|+.++- ..+++..++.+.|+||+.|+
T Consensus       113 ~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112         113 RVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             HHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchh
Confidence            455665666777   999999764 44445555599999999886

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=93.73  E-value=0.18  Score=42.98  Aligned_cols=29  Identities=24%  Similarity=0.408  Sum_probs=25.0

Q ss_pred             CCeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220          117 PSIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus       117 ~~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      .+++|||+.+.|++++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            48999999999999987 578999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=93.67  E-value=0.21  Score=42.42  Aligned_cols=30  Identities=27%  Similarity=0.486  Sum_probs=26.1

Q ss_pred             CCeeeCCCCCCCeEEccC----CeeEEeccccCC
Q 023220          117 PSIIHRDIRSSNVLLFED----FKAKIADFNLSN  146 (285)
Q Consensus       117 ~~~~h~di~~~nil~~~~----~~~~l~df~~~~  146 (285)
                      ..++|+|+.+.||+++.+    +.+.++||+.+.
T Consensus       179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            368999999999999874    789999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=93.59  E-value=0.059  Score=46.23  Aligned_cols=31  Identities=29%  Similarity=0.399  Sum_probs=26.2

Q ss_pred             CCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          117 PSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       117 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      .+++|+|+.+.||+++.+....++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            3899999999999999765568999987653

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=93.53  E-value=0.13  Score=43.45  Aligned_cols=31  Identities=29%  Similarity=0.400  Sum_probs=26.8

Q ss_pred             CCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          117 PSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       117 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      .+++|+|+.|.|++++.++.+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            3799999999999999887778999987654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=92.77  E-value=0.078  Score=42.79  Aligned_cols=58  Identities=14%  Similarity=0.197  Sum_probs=35.4

Q ss_pred             ccChhhhhhccCCCCCChhHHHHHHHHccCCCC--cccccceEEEe---CCeeeEEEeeCCCCCHHH
Q 023220           14 SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHE--NLVELLGYCVE---GNLRVLAYEFATMGSLHD   75 (285)
Q Consensus        14 ~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~---~~~~~lv~e~~~~~~L~~   75 (285)
                      .|.+|.....    .....+.+|..+++.+...  .+..++.....   ....+++|++..+..+..
T Consensus        22 ~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~   84 (239)
T PF01636_consen   22 RYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD   84 (239)
T ss_dssp             EEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred             EEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence            5555554322    2356777898898888433  34556654432   335689999998877766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.62  E-value=0.14  Score=40.27  Aligned_cols=30  Identities=13%  Similarity=0.325  Sum_probs=25.7

Q ss_pred             CeeeCCCCCCCeEEccCCeeEEeccccCCCC
Q 023220          118 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQA  148 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~  148 (285)
                      ..+|+|+.|.|+++++++ ++++|++.+...
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            579999999999998776 889999987543

>TIGR02721 ycfN_thiK thiamine kinase

Probab=92.23  E-value=0.14  Score=42.34  Aligned_cols=29  Identities=17%  Similarity=0.363  Sum_probs=25.4

Q ss_pred             CeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          118 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      .++|+|+.|.||+++.++ +.++||+.+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            589999999999999876 78999987754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=91.90  E-value=0.11  Score=41.70  Aligned_cols=29  Identities=28%  Similarity=0.526  Sum_probs=20.5

Q ss_pred             CeeeCCCCCCCeEE-ccCCeeEEeccccCC
Q 023220          118 SIIHRDIRSSNVLL-FEDFKAKIADFNLSN  146 (285)
Q Consensus       118 ~~~h~di~~~nil~-~~~~~~~l~df~~~~  146 (285)
                      .++|+|+.+.||++ +.++.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            58999999999999 788899999998763

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=91.29  E-value=0.21  Score=41.83  Aligned_cols=31  Identities=19%  Similarity=0.268  Sum_probs=27.4

Q ss_pred             CeeeCCCCCCCeEEccCCeeEEeccccCCCC
Q 023220          118 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQA  148 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~  148 (285)
                      -++|+|+.|.|++.+..+.++|+||..+...
T Consensus       154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~  184 (269)
T COG0510         154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN  184 (269)
T ss_pred             eeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence            4899999999999999899999999877543

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=90.62  E-value=0.18  Score=43.10  Aligned_cols=32  Identities=16%  Similarity=0.218  Sum_probs=28.1

Q ss_pred             CCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          116 QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       116 ~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      ..+++|+|+.++|++++.++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34799999999999999988999999987754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=90.61  E-value=0.31  Score=41.00  Aligned_cols=31  Identities=19%  Similarity=0.458  Sum_probs=25.6

Q ss_pred             CeeeCCCCCCCeEEccCCe-eEEeccccCCCC
Q 023220          118 SIIHRDIRSSNVLLFEDFK-AKIADFNLSNQA  148 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~~~-~~l~df~~~~~~  148 (285)
                      .++|+|+++.||+++.++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            5899999999999997454 569999987543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=90.35  E-value=0.76  Score=39.66  Aligned_cols=28  Identities=36%  Similarity=0.572  Sum_probs=24.7

Q ss_pred             eeeCCCCCCCeEEccCCe-eEEeccccCC
Q 023220          119 IIHRDIRSSNVLLFEDFK-AKIADFNLSN  146 (285)
Q Consensus       119 ~~h~di~~~nil~~~~~~-~~l~df~~~~  146 (285)
                      ++|+|+.|+||+++.+.. +.++||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            899999999999998874 8899998653

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=90.28  E-value=0.94  Score=35.91  Aligned_cols=29  Identities=28%  Similarity=0.458  Sum_probs=24.3

Q ss_pred             CeeeCCCCCCCeEEccCC-----eeEEeccccCC
Q 023220          118 SIIHRDIRSSNVLLFEDF-----KAKIADFNLSN  146 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~~-----~~~l~df~~~~  146 (285)
                      .++|||+.+.|+++..++     .+.++||..+.
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            689999999999997543     58999998664

subfamily of choline kinases

>PLN02236 choline kinase

Probab=90.10  E-value=0.59  Score=40.69  Aligned_cols=30  Identities=20%  Similarity=0.397  Sum_probs=25.7

Q ss_pred             CeeeCCCCCCCeEEcc-CCeeEEeccccCCC
Q 023220          118 SIIHRDIRSSNVLLFE-DFKAKIADFNLSNQ  147 (285)
Q Consensus       118 ~~~h~di~~~nil~~~-~~~~~l~df~~~~~  147 (285)
                      .++|+|+++.||++++ ++.+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            6899999999999986 46799999987643

>PTZ00384 choline kinase; Provisional

Probab=89.97  E-value=1.5  Score=38.83  Aligned_cols=28  Identities=25%  Similarity=0.393  Sum_probs=23.6

Q ss_pred             CeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220          118 SIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      .++|.|+.+.||+.+. +.+.++||..+.
T Consensus       228 VfCHNDL~~gNIL~~~-~~l~lID~EYA~  255 (383)
T PTZ00384        228 LFCHNDLFFTNILDFN-QGIYFIDFDFAG  255 (383)
T ss_pred             eeeeccCCcccEEecC-CCEEEEEecccc
Confidence            6899999999998765 469999998664

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=89.66  E-value=0.4  Score=41.03  Aligned_cols=42  Identities=19%  Similarity=0.438  Sum_probs=33.9

Q ss_pred             HHHHhhcC-----CCCeeeCCCCCCCeEEccCCeeEEeccccCCCCC
Q 023220          108 LEYLHEKV-----QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP  149 (285)
Q Consensus       108 l~~lh~~~-----~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~  149 (285)
                      ..+++...     .+.++|||+.+.|++++.++-+-++||+++...+
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            55565542     3469999999999999998889999999987654

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=88.46  E-value=1.2  Score=36.38  Aligned_cols=48  Identities=10%  Similarity=0.097  Sum_probs=36.5

Q ss_pred             CCCChhHHHHHHHHccC---CCCcccccceEEEeCCeeeEEEeeCCCCCHH
Q 023220           27 KNYPDDEKQLVSVVSRL---KHENLVELLGYCVEGNLRVLAYEFATMGSLH   74 (285)
Q Consensus        27 ~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   74 (285)
                      ......|..|+.-|+.+   +.-.+.+++.+..+..+.|+|++|++.+.+.
T Consensus        49 ~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          49 REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            33456778888888777   3356778888888899999999999875443

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=86.70  E-value=0.63  Score=40.22  Aligned_cols=29  Identities=31%  Similarity=0.427  Sum_probs=25.0

Q ss_pred             eeeCCCCCCCeEEcc-CCeeEEeccccCCC
Q 023220          119 IIHRDIRSSNVLLFE-DFKAKIADFNLSNQ  147 (285)
Q Consensus       119 ~~h~di~~~nil~~~-~~~~~l~df~~~~~  147 (285)
                      ++|+|+.+.||++++ ++.++++||+.+..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            899999999999975 46899999987743

>PRK11768 serine/threonine protein kinase; Provisional

Probab=86.15  E-value=1.7  Score=37.53  Aligned_cols=29  Identities=21%  Similarity=0.276  Sum_probs=24.1

Q ss_pred             CCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          117 PSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       117 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      .+++|+|+.+.||+++ + .+.++||+-+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            3799999999999995 4 578999987653

>PRK14559 putative protein serine/threonine phosphatase; Provisional

Probab=85.63  E-value=2.9  Score=39.57  Aligned_cols=86  Identities=13%  Similarity=0.098  Sum_probs=68.7

Q ss_pred             CCCcccccceEEEeCCeeeEEEeeCCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeC
Q 023220           44 KHENLVELLGYCVEGNLRVLAYEFATM-GSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR  122 (285)
Q Consensus        44 ~h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~  122 (285)
                      ++.||.++||++..++..++++|+... .+|.+......          ++....+.|+.||+.-=.-|...   |+..-
T Consensus       178 ~~~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w~~~~----------~~~l~~l~Wl~q~~~LW~~l~~~---~~~~s  244 (645)
T PRK14559        178 FPTEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLWQDQT----------LPTLQILYWLNQMTQLWKALEPW---GCCQS  244 (645)
T ss_pred             ccccCcchheeecCCCCcEEEeCCCCCCchHHHHhhhcC----------CcHHHHHHHHHHHHHHHHHHHhc---Ceehh
Confidence            345699999999988888899888753 26666665542          56678999999999999999999   99999


Q ss_pred             CCCCCCeEEccCCeeEEecc
Q 023220          123 DIRSSNVLLFEDFKAKIADF  142 (285)
Q Consensus       123 di~~~nil~~~~~~~~l~df  142 (285)
                      =+.++|+-++++..+.|..|
T Consensus       245 ll~~~nlrv~~~~~~~l~~l  264 (645)
T PRK14559        245 LLELENLRVDEDQTLGLQQL  264 (645)
T ss_pred             ccchhheeeCCCceehHhhh
Confidence            99999999987666666554

>PRK06148 hypothetical protein; Provisional

Probab=85.32  E-value=2  Score=43.16  Aligned_cols=30  Identities=27%  Similarity=0.399  Sum_probs=25.2

Q ss_pred             CeeeCCCCCCCeEEccCC--ee-EEeccccCCC
Q 023220          118 SIIHRDIRSSNVLLFEDF--KA-KIADFNLSNQ  147 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~~--~~-~l~df~~~~~  147 (285)
                      +++|+|+++.||+++.++  .+ -|+|||-+..
T Consensus       204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            799999999999999775  44 4999997654

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=84.11  E-value=4.4  Score=35.02  Aligned_cols=71  Identities=21%  Similarity=0.148  Sum_probs=50.9

Q ss_pred             eEEEeeCCCCCHH-HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEe
Q 023220           62 VLAYEFATMGSLH-DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA  140 (285)
Q Consensus        62 ~lv~e~~~~~~L~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~  140 (285)
                      +|||.|+...-+. --++.-          .++.......-.|+..++.-|..-+  -++|.|++--|+|+..+ .|.++
T Consensus       359 vLVMsFiGd~~~aAPkLK~v----------~l~d~E~~~aY~q~~~~M~~lY~Ec--~LVHADlSEyN~Lw~~g-Kvw~I  425 (531)
T KOG2269|consen  359 VLVMSFIGDQGLAAPKLKNV----------ELTDDERRNAYDQVQSIMCRLYKEC--LLVHADLSEYNLLWTPG-KVWVI  425 (531)
T ss_pred             eEEEEeecCCCCCCcccccc----------ccChHHHHHHHHHHHHHHHHHHHhh--heeecchhhhhheecCC-ceEEE
Confidence            6899988543221 111111          1677777777788888877776555  79999999999999877 89999


Q ss_pred             ccccC
Q 023220          141 DFNLS  145 (285)
Q Consensus       141 df~~~  145 (285)
                      |...+
T Consensus       426 DVsQs  430 (531)
T KOG2269|consen  426 DVSQS  430 (531)
T ss_pred             echhc
Confidence            97655

>PHA03111 Ser/Thr kinase; Provisional

Probab=82.40  E-value=3.8  Score=35.39  Aligned_cols=41  Identities=20%  Similarity=0.156  Sum_probs=28.3

Q ss_pred             CHHHHHHHHHHHHHHHHHHhhc-CCCCeeeCCCCCCCeEEcc
Q 023220           93 DWMTRVRIAVDAARGLEYLHEK-VQPSIIHRDIRSSNVLLFE  133 (285)
Q Consensus        93 ~~~~~~~~~~qi~~~l~~lh~~-~~~~~~h~di~~~nil~~~  133 (285)
                      ...-+.-++.|++--.-.+.+. +-.+++|.||||+|||+-.
T Consensus       277 ~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd  318 (444)
T PHA03111        277 LVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD  318 (444)
T ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence            3455667777877665444333 2337999999999999953

>COG4499 Predicted membrane protein [Function unknown]

Probab=81.95  E-value=7.8  Score=33.74  Aligned_cols=82  Identities=13%  Similarity=0.146  Sum_probs=55.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcc
Q 023220           92 LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEY  171 (285)
Q Consensus        92 ~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~  171 (285)
                      ......++++.|.+..+.-+-.    ...|--+.|+||+++.++.+.+.-+|+-...+              |.=+.||.
T Consensus        82 ~~k~~Klr~a~~~I~~l~e~~~----tr~~~~laPeNilf~~~l~p~~vH~Glk~~lp--------------Pye~tee~  143 (434)
T COG4499          82 KEKTRKLRLALQNIATLSELNN----TRYTFFLAPENILFDGGLTPFFVHRGLKNSLP--------------PYEMTEER  143 (434)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhc----cceeEEecchheEEcCCCceEEEecchhccCC--------------CCCCCHHH
Confidence            3445566767777777665544    35677789999999999999998888653321              11133443


Q ss_pred             cccCCCCcccchHhHHHHHHHHHhCCCCCC
Q 023220          172 AMTGQLTQKSDVYSFGVVLLELLTGRKPVD  201 (285)
Q Consensus       172 ~~~~~~~~~~DiwslG~~l~~l~~g~~pf~  201 (285)
                      +.          -++-+++..++.|..+|+
T Consensus       144 f~----------~~ykA~~~~~fn~k~~Fe  163 (434)
T COG4499         144 FL----------KEYKALAIYAFNGKFSFE  163 (434)
T ss_pred             HH----------HHHHHHHHHHHcCCccHH
Confidence            22          167778888899999985

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	285
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-38
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-37
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-36
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-36
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-33
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-32
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-32
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-32
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		8e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		9e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		9e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-09
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		9e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-06
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-06
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		8e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		9e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-05
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-05
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-05
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-05
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-05
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-05
3soa_A	444	Full-Length Human Camkii Length = 444		6e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		9e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-05
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-04
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-04

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 128/235 (54%), Gaps = 8/235 (3%)
Query: 40  VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVR 99
           +S  +H +LV L+G+C E N  +L Y++   G+L   L+G        P   + W  R+ 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD-----LPTMSMSWEQRLE 143
Query: 100 IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR 159
           I + AARGL YLH +   +IIHRD++S N+LL E+F  KI DF +S +  ++        
Sbjct: 144 ICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXV 200
Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 219
           V GT GY  PEY + G+LT+KSDVYSFGVVL E+L  R  +  ++PR   +L  WA    
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 220 SEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
           +  +++Q VDP L  +               C+   +E RP+M  V+  L+  L+
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 128/235 (54%), Gaps = 8/235 (3%)
Query: 40  VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVR 99
           +S  +H +LV L+G+C E N  +L Y++   G+L   L+G        P   + W  R+ 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD-----LPTMSMSWEQRLE 143
Query: 100 IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR 159
           I + AARGL YLH +   +IIHRD++S N+LL E+F  KI DF +S +  ++        
Sbjct: 144 ICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXV 200
Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 219
           V GT GY  PEY + G+LT+KSDVYSFGVVL E+L  R  +  ++PR   +L  WA    
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 220 SEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
           +  +++Q VDP L  +               C+   +E RP+M  V+  L+  L+
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 88/236 (37%), Positives = 126/236 (53%), Gaps = 8/236 (3%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++S   H NL+ L G+C+    R+L Y +   GS+   L  R   Q     P LDW  
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-----PPLDWPK 140
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R RIA+ +ARGL YLH+   P IIHRD++++N+LL E+F+A + DF L+ +  D      
Sbjct: 141 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDXHV 199
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS--LVTW 214
              V GT G+ APEY  TG+ ++K+DV+ +GV+LLEL+TG++  D           L+ W
Sbjct: 200 XXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 259
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQ 270
               L E K++  VD  L+G Y              C Q     RP MS VV+ L+
Sbjct: 260 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  147 bits (371), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 87/236 (36%), Positives = 125/236 (52%), Gaps = 8/236 (3%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++S   H NL+ L G+C+    R+L Y +   GS+   L  R   Q     P LDW  
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-----PPLDWPK 132
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R RIA+ +ARGL YLH+   P IIHRD++++N+LL E+F+A + DF L+ +  D      
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDXHV 191
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS--LVTW 214
              V G  G+ APEY  TG+ ++K+DV+ +GV+LLEL+TG++  D           L+ W
Sbjct: 192 XXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQ 270
               L E K++  VD  L+G Y              C Q     RP MS VV+ L+
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  137 bits (344), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 78/173 (45%), Positives = 106/173 (61%), Gaps = 11/173 (6%)
Query: 35  QLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           Q + V ++ +HENLVELLG+  +G+   L Y +   GSL D L    G       P L W
Sbjct: 70  QEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGT------PPLSW 123
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             R +IA  AA G+ +LHE      IHRDI+S+N+LL E F AKI+DF L+  +   A  
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD-HTMPR 206
           +  +R++GT  Y APE A+ G++T KSD+YSFGVVLLE++TG   VD H  P+
Sbjct: 181 VXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 232

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/173 (45%), Positives = 107/173 (61%), Gaps = 11/173 (6%)
Query: 35  QLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           Q + V+++ +HENLVELLG+  +G+   L Y +   GSL D L    G       P L W
Sbjct: 79  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT------PPLSW 132
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             R +IA  AA G+ +LHE      IHRDI+S+N+LL E F AKI+DF L+  +   A  
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD-HTMPR 206
           +  +R++GT  Y APE A+ G++T KSD+YSFGVVLLE++TG   VD H  P+
Sbjct: 190 VMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/173 (45%), Positives = 106/173 (61%), Gaps = 11/173 (6%)
Query: 35  QLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           Q + V+++ +HENLVELLG+  +G+   L Y +   GSL D L    G       P L W
Sbjct: 79  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT------PPLSW 132
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             R +IA  AA G+ +LHE      IHRDI+S+N+LL E F AKI+DF L+  +   A  
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD-HTMPR 206
           +   R++GT  Y APE A+ G++T KSD+YSFGVVLLE++TG   VD H  P+
Sbjct: 190 VMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/173 (45%), Positives = 106/173 (61%), Gaps = 11/173 (6%)
Query: 35  QLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           Q + V+++ +HENLVELLG+  +G+   L Y +   GSL D L    G       P L W
Sbjct: 73  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT------PPLSW 126
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             R +IA  AA G+ +LHE      IHRDI+S+N+LL E F AKI+DF L+  +   A  
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD-HTMPR 206
           +   R++GT  Y APE A+ G++T KSD+YSFGVVLLE++TG   VD H  P+
Sbjct: 184 VMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 235

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 124/244 (50%), Gaps = 26/244 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V+++ RL+H N+V  +G   +     +  E+ + GSL+ +LH      GA+    LD   
Sbjct: 85  VAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK----SGAREQ--LDERR 138
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R+ +A D A+G+ YLH +  P I+HRD++S N+L+ + +  K+ DF LS      +  L 
Sbjct: 139 RLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ASXFLX 195
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           S    GT  + APE        +KSDVYSFGV+L EL T ++P  +  P    + V +  
Sbjct: 196 SKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC 255
Query: 217 PRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS- 275
            RL   ++ + ++P++                  C   E   RP+ + ++  L+PL+KS 
Sbjct: 256 KRL---EIPRNLNPQVAA------------IIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
Query: 276 -PPP 278
            PPP
Sbjct: 301 VPPP 304

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 124/244 (50%), Gaps = 26/244 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V+++ RL+H N+V  +G   +     +  E+ + GSL+ +LH      GA+    LD   
Sbjct: 85  VAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK----SGAREQ--LDERR 138
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R+ +A D A+G+ YLH +  P I+HR+++S N+L+ + +  K+ DF LS      +  L 
Sbjct: 139 RLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLS 195
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           S    GT  + APE        +KSDVYSFGV+L EL T ++P  +  P    + V +  
Sbjct: 196 SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC 255
Query: 217 PRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS- 275
            RL   ++ + ++P++                  C   E   RP+ + ++  L+PL+KS 
Sbjct: 256 KRL---EIPRNLNPQVAA------------IIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
Query: 276 -PPP 278
            PPP
Sbjct: 301 VPPP 304

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 99/193 (51%), Gaps = 30/193 (15%)
Query: 23  LKSPKNYPDDE--------KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLH 74
           +K+ ++ PD++        +Q   + + LKH N++ L G C++     L  EFA  G L+
Sbjct: 35  VKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLN 94
Query: 75  DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 134
            +L G++      P  +++W      AV  ARG+ YLH++    IIHRD++SSN+L+ + 
Sbjct: 95  RVLSGKR----IPPDILVNW------AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQK 144
Query: 135 FK--------AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSF 186
            +         KI DF L+ +      R       G + + APE       ++ SDV+S+
Sbjct: 145 VENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSY 200
Query: 187 GVVLLELLTGRKP 199
           GV+L ELLTG  P
Sbjct: 201 GVLLWELLTGEVP 213

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 40  VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVR 99
           +SR+ H N+V+L G C+  N   L  E+A  GSL+++LHG      A+P P       + 
Sbjct: 56  LSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHG------AEPLPYYTAAHAMS 107
Query: 100 IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA-KIADFNLSNQAPDMAARLHST 158
             +  ++G+ YLH     ++IHRD++  N+LL       KI DF     A D+  + H T
Sbjct: 108 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG---TACDI--QTHMT 162
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
              G+  + APE       ++K DV+S+G++L E++T RKP D     G    + WA 
Sbjct: 163 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWAV 218

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 40  VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVR 99
           +SR+ H N+V+L G C+  N   L  E+A  GSL+++LHG      A+P P       + 
Sbjct: 55  LSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHG------AEPLPYYTAAHAMS 106
Query: 100 IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA-KIADFNLSNQAPDMAARLHST 158
             +  ++G+ YLH     ++IHRD++  N+LL       KI DF     A D+  + H T
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG---TACDI--QTHMT 161
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
              G+  + APE       ++K DV+S+G++L E++T RKP D     G    + WA 
Sbjct: 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWAV 217

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 97/191 (50%), Gaps = 18/191 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V+V+ + +H N++  +GY  + NL ++  ++    SL+  LH    VQ  +         
Sbjct: 83  VAVLRKTRHVNILLFMGYMTKDNLAIVT-QWCEGSSLYKHLH----VQETK----FQMFQ 133
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            + IA   A+G++YLH K   +IIHRD++S+N+ L E    KI DF L+      +    
Sbjct: 134 LIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190
Query: 157 STRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 213
             +  G+  + APE          + +SDVYS+G+VL EL+TG  P  H   R Q   + 
Sbjct: 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250
Query: 214 ---WATPRLSE 221
              +A+P LS+
Sbjct: 251 GRGYASPDLSK 261

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 92/178 (51%), Gaps = 15/178 (8%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           K  V V+ + +H N++  +GY  +  L ++  ++    SL+  LH  +           +
Sbjct: 68  KNEVGVLRKTRHVNILLFMGYSTKPQLAIVT-QWCEGSSLYHHLHASE--------TKFE 118
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
               + IA   ARG++YLH K   SIIHRD++S+N+ L ED   KI DF L+ +    + 
Sbjct: 119 MKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175
Query: 154 RLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
                ++ G+  + APE      +   + +SDVY+FG+VL EL+TG+ P  +   R Q
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 91/178 (51%), Gaps = 15/178 (8%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           K  V V+ + +H N++  +GY     L ++  ++    SL+  LH  +           +
Sbjct: 68  KNEVGVLRKTRHVNILLFMGYSTAPQLAIVT-QWCEGSSLYHHLHASE--------TKFE 118
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
               + IA   ARG++YLH K   SIIHRD++S+N+ L ED   KI DF L+ +    + 
Sbjct: 119 MKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175
Query: 154 RLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
                ++ G+  + APE      +   + +SDVY+FG+VL EL+TG+ P  +   R Q
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 91/178 (51%), Gaps = 15/178 (8%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           K  V V+ + +H N++  +GY  +  L ++  ++    SL+  LH  +           +
Sbjct: 56  KNEVGVLRKTRHVNILLFMGYSTKPQLAIVT-QWCEGSSLYHHLHASE--------TKFE 106
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
               + IA   ARG++YLH K   SIIHRD++S+N+ L ED   KI DF L+      + 
Sbjct: 107 MKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSG 163
Query: 154 RLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
                ++ G+  + APE      +   + +SDVY+FG+VL EL+TG+ P  +   R Q
Sbjct: 164 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 221

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 92/178 (51%), Gaps = 15/178 (8%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           K  V V+ + +H N++  +GY  +  L ++  ++    SL+  LH  +           +
Sbjct: 52  KNEVGVLRKTRHVNILLFMGYSTKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFE 102
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
            +  + IA   A+G++YLH K   SIIHRD++S+N+ L ED   KI DF L+ +    + 
Sbjct: 103 MIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSG 159
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
                ++ G+  + APE          + +SDVY+FG+VL EL+TG+ P  +   R Q
Sbjct: 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/173 (35%), Positives = 92/173 (53%), Gaps = 25/173 (14%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++S L H N+V+L  Y +  N   +  EF   G L+  L     +  A P   + W  
Sbjct: 74  VFIMSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRL-----LDKAHP---IKWSV 123
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-----FEDFKAKIADFNLSNQAPDM 151
           ++R+ +D A G+EY+  +  P I+HRD+RS N+ L          AK+ADF+LS Q+   
Sbjct: 124 KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS--- 179
Query: 152 AARLHS-TRVLGTFGYHAPEY--AMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              +HS + +LG F + APE   A     T+K+D YSF ++L  +LTG  P D
Sbjct: 180 ---VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/173 (35%), Positives = 91/173 (52%), Gaps = 25/173 (14%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++S L H N+V+L  Y +  N   +  EF   G L+  L     +  A P   + W  
Sbjct: 74  VFIMSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRL-----LDKAHP---IKWSV 123
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-----FEDFKAKIADFNLSNQAPDM 151
           ++R+ +D A G+EY+  +  P I+HRD+RS N+ L          AK+ADF LS Q+   
Sbjct: 124 KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--- 179
Query: 152 AARLHS-TRVLGTFGYHAPEY--AMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              +HS + +LG F + APE   A     T+K+D YSF ++L  +LTG  P D
Sbjct: 180 ---VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 92/180 (51%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G  G
Sbjct: 43  LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETG 101
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                P         V +A   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 102 KYLRLP-------QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 151
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 152 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 92/178 (51%), Gaps = 15/178 (8%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           K  V V+ + +H N++  +GY  +  L ++  ++    SL+  LH  +           +
Sbjct: 72  KNEVGVLRKTRHVNILLFMGYSTKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFE 122
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
            +  + IA   A+G++YLH K   SIIHRD++S+N+ L ED   KI DF L+ +    + 
Sbjct: 123 MIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSG 179
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
                ++ G+  + APE          + +SDVY+FG+VL EL+TG+ P  +   R Q
Sbjct: 180 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 237

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 92/178 (51%), Gaps = 15/178 (8%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           K  V V+ + +H N++  +GY  +  L ++  ++    SL+  LH  +           +
Sbjct: 80  KNEVGVLRKTRHVNILLFMGYSTKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFE 130
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
            +  + IA   A+G++YLH K   SIIHRD++S+N+ L ED   KI DF L+ +    + 
Sbjct: 131 MIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSG 187
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
                ++ G+  + APE          + +SDVY+FG+VL EL+TG+ P  +   R Q
Sbjct: 188 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 245

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 92/180 (51%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G  G
Sbjct: 39  LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGEMG 97
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                P         V +A   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 98  KYLRLP-------QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 147
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 148 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 204

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 92/180 (51%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G  G
Sbjct: 41  LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGEMG 99
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                P         V +A   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 100 KYLRLP-------QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 149
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 150 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 206

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 92/180 (51%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G  G
Sbjct: 50  LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVC-EYMSKGSLLDFLKGEMG 108
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                P         V +A   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 109 KYLRLP-------QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 158
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 159 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 94/180 (52%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G   
Sbjct: 216 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVG-EYMSKGSLLDFLKG--- 271
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
               + G  L     V +A   A G+ Y+    + + +HRD+R++N+L+ E+   K+ADF
Sbjct: 272 ----ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF 324
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 325 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 92/180 (51%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G  G
Sbjct: 50  LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGEMG 108
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                P         V +A   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 109 KYLRLP-------QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 158
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 159 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 94/180 (52%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G   
Sbjct: 216 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKG--- 271
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
               + G  L     V +A   A G+ Y+    + + +HRD+R++N+L+ E+   K+ADF
Sbjct: 272 ----ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF 324
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 325 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 94/180 (52%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G   
Sbjct: 216 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKG--- 271
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
               + G  L     V +A   A G+ Y+    + + +HRD+R++N+L+ E+   K+ADF
Sbjct: 272 ----ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF 324
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 325 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 91/180 (50%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G  G
Sbjct: 40  LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIXIVT-EYMSKGSLLDFLKGETG 98
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                P         V +A   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 99  KYLRLP-------QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 148
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D      + R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 149 GLARLIEDNEX---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 205

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 91/178 (51%), Gaps = 15/178 (8%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           K  V V+ + +H N++  +GY  +  L ++  ++    SL+  LH  +           +
Sbjct: 57  KNEVGVLRKTRHVNILLFMGYSTKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFE 107
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
            +  + IA   A+G++YLH K   SIIHRD++S+N+ L ED   KI DF L+      + 
Sbjct: 108 MIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 164
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
                ++ G+  + APE          + +SDVY+FG+VL EL+TG+ P  +   R Q
Sbjct: 165 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 222

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 91/178 (51%), Gaps = 15/178 (8%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           K  V V+ + +H N++  +GY  +  L ++  ++    SL+  LH  +           +
Sbjct: 52  KNEVGVLRKTRHVNILLFMGYSTKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFE 102
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
            +  + IA   A+G++YLH K   SIIHRD++S+N+ L ED   KI DF L+      + 
Sbjct: 103 MIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
                ++ G+  + APE          + +SDVY+FG+VL EL+TG+ P  +   R Q
Sbjct: 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 92/180 (51%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G  G
Sbjct: 50  LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMG 108
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                P         V +A   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 109 KYLRLP-------QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 158
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 159 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 93/180 (51%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G   
Sbjct: 299 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKG--- 354
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
               + G  L     V +A   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 355 ----ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 407
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 408 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 91/178 (51%), Gaps = 15/178 (8%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           K  V V+ + +H N++  +GY  +  L ++  ++    SL+  LH  +           +
Sbjct: 57  KNEVGVLRKTRHVNILLFMGYSTKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFE 107
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
            +  + IA   A+G++YLH K   SIIHRD++S+N+ L ED   KI DF L+      + 
Sbjct: 108 MIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 164
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
                ++ G+  + APE          + +SDVY+FG+VL EL+TG+ P  +   R Q
Sbjct: 165 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 222

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 91/178 (51%), Gaps = 15/178 (8%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           K  V V+ + +H N++  +GY  +  L ++  ++    SL+  LH  +           +
Sbjct: 54  KNEVGVLRKTRHVNILLFMGYSTKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFE 104
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
            +  + IA   A+G++YLH K   SIIHRD++S+N+ L ED   KI DF L+      + 
Sbjct: 105 MIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 161
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
                ++ G+  + APE          + +SDVY+FG+VL EL+TG+ P  +   R Q
Sbjct: 162 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 219

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 114/263 (43%), Gaps = 28/263 (10%)
Query: 25  SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKG 82
           +  N   D  +   +++ L+HE++V+  G CVEG+  ++ +E+   G L+  L  HG   
Sbjct: 54  ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDA 113
Query: 83  VQGAQPGP--VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 140
           V  A+  P   L     + IA   A G+ YL  +     +HRD+ + N L+ E+   KI 
Sbjct: 114 VLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG 170
Query: 141 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           DF +S               +    +  PE  M  + T +SDV+S GVVL E+ T G++P
Sbjct: 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230
Query: 200 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFR 259
                         W   +LS ++V +C+      +               C Q E   R
Sbjct: 231 --------------WY--QLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMR 274
Query: 260 PNMSIVVKALQPLLKSPPPAAPV 282
            N    +K +  LL++   A+PV
Sbjct: 275 KN----IKGIHTLLQNLAKASPV 293

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 92/180 (51%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +++HE LV+L     E  + ++  E+ + GSL D L G  G
Sbjct: 50  LKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGEMG 108
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                P         V +A   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 109 KYLRLP-------QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 158
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 159 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 91/178 (51%), Gaps = 15/178 (8%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           K  V V+ + +H N++  +GY  +  L ++  ++    SL+  LH  +           +
Sbjct: 79  KNEVGVLRKTRHVNILLFMGYSTKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFE 129
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
            +  + IA   A+G++YLH K   SIIHRD++S+N+ L ED   KI DF L+      + 
Sbjct: 130 MIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 186
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
                ++ G+  + APE          + +SDVY+FG+VL EL+TG+ P  +   R Q
Sbjct: 187 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 244

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 91/178 (51%), Gaps = 15/178 (8%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           K  V V+ + +H N++  +GY  +  L ++  ++    SL+  LH  +           +
Sbjct: 80  KNEVGVLRKTRHVNILLFMGYSTKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFE 130
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
            +  + IA   A+G++YLH K   SIIHRD++S+N+ L ED   KI DF L+      + 
Sbjct: 131 MIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 187
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
                ++ G+  + APE          + +SDVY+FG+VL EL+TG+ P  +   R Q
Sbjct: 188 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 245

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 93/180 (51%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G   
Sbjct: 217 LKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKG--- 272
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
               + G  L     V +A   A G+ Y+    + + +HRD+R++N+L+ E+   K+ADF
Sbjct: 273 ----EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF 325
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L     D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 326 GLGRLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 90/178 (50%), Gaps = 15/178 (8%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           K  V V+ + +H N++  +GY     L ++  ++    SL+  LH  +           +
Sbjct: 52  KNEVGVLRKTRHVNILLFMGYSTAPQLAIVT-QWCEGSSLYHHLHIIE--------TKFE 102
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
            +  + IA   A+G++YLH K   SIIHRD++S+N+ L ED   KI DF L+      + 
Sbjct: 103 MIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
                ++ G+  + APE          + +SDVY+FG+VL EL+TG+ P  +   R Q
Sbjct: 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/173 (34%), Positives = 90/173 (52%), Gaps = 25/173 (14%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++S L H N+V+L  Y +  N   +  EF   G L+  L     +  A P   + W  
Sbjct: 74  VFIMSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRL-----LDKAHP---IKWSV 123
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-----FEDFKAKIADFNLSNQAPDM 151
           ++R+ +D A G+EY+  +  P I+HRD+RS N+ L          AK+ADF  S Q+   
Sbjct: 124 KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS--- 179
Query: 152 AARLHS-TRVLGTFGYHAPEY--AMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              +HS + +LG F + APE   A     T+K+D YSF ++L  +LTG  P D
Sbjct: 180 ---VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 92/180 (51%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+   GSL D L G   
Sbjct: 47  LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMNKGSLLDFLKG--- 102
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
               + G  L     V ++   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 103 ----ETGKYLRLPQLVDMSAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 155
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 156 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 87/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  ++S +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 133
Query: 84  QGA-----QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   L     V  A   ARG+EYL  K     IHRD+ + NVL+ ED   K
Sbjct: 134 EFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 190
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+     +     +T       + APE       T +SDV+SFGV+L E+ T
Sbjct: 191 IADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + G L D L G  G
Sbjct: 50  LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGCLLDFLKGEMG 108
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                P         V +A   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 109 KYLRLP-------QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 158
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 159 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 91/180 (50%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G  G
Sbjct: 50  LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMG 108
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                P         V +A   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 109 KYLRLP-------QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 158
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D      + R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 159 GLARLIEDNEX---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  ++S +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 59  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 84  Q-----GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           +        P   L     V  A   ARG+EYL  K     IHRD+ + NVL+ ED   K
Sbjct: 119 EYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 175
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+     +     +T       + APE       T +SDV+SFGV+L E+ T
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 87/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  ++S +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 63  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 122
Query: 84  QGA-----QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   L     V  A   ARG+EYL  K     IHRD+ + NVL+ ED   K
Sbjct: 123 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 179
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+     +     +T       + APE       T +SDV+SFGV+L E+ T
Sbjct: 180 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 87/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  ++S +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 66  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 125
Query: 84  QGA-----QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   L     V  A   ARG+EYL  K     IHRD+ + NVL+ ED   K
Sbjct: 126 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 182
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+     +     +T       + APE       T +SDV+SFGV+L E+ T
Sbjct: 183 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + G L D L G  G
Sbjct: 50  LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVM-EYMSKGCLLDFLKGEMG 108
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                P         V +A   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 109 KYLRLP-------QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 158
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 159 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 87/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  ++S +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 67  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 126
Query: 84  QGA-----QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   L     V  A   ARG+EYL  K     IHRD+ + NVL+ ED   K
Sbjct: 127 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 183
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+     +     +T       + APE       T +SDV+SFGV+L E+ T
Sbjct: 184 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  ++S +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 133
Query: 84  Q-----GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           +        P   L     V  A   ARG+EYL  K     IHRD+ + NVL+ ED   K
Sbjct: 134 EYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 190
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+     +     +T       + APE       T +SDV+SFGV+L E+ T
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 87/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  ++S +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 133
Query: 84  QGA-----QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   L     V  A   ARG+EYL  K     IHRD+ + NVL+ ED   K
Sbjct: 134 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 190
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+     +     +T       + APE       T +SDV+SFGV+L E+ T
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+   GSL D L G  G
Sbjct: 47  LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMNKGSLLDFLKGETG 105
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                P         V ++   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 106 KYLRLP-------QLVDMSAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 155
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D      + R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 156 GLARLIEDNE---WTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 87/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  ++S +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGL 133
Query: 84  QGA-----QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   L     V  A   ARG+EYL  K     IHRD+ + NVL+ ED   K
Sbjct: 134 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 190
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+     +     +T       + APE       T +SDV+SFGV+L E+ T
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G  G
Sbjct: 50  LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGEMG 108
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                P         V +A   A G+ Y+      + +HRD+ ++N+L+ E+   K+ADF
Sbjct: 109 KYLRLP-------QLVDMAAQIASGMAYVERM---NYVHRDLAAANILVGENLVCKVADF 158
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 159 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 87/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  ++S +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 115 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 174
Query: 84  QGA-----QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   L     V  A   ARG+EYL  K     IHRD+ + NVL+ ED   K
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 231
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+     +     +T       + APE       T +SDV+SFGV+L E+ T
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/168 (36%), Positives = 93/168 (55%), Gaps = 25/168 (14%)
Query: 38  SVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGR-KGVQGAQPGPVLDW 94
           SV+++L+H NLV+LLG  VE  G L ++  E+   GSL D L  R + V G   G  L  
Sbjct: 238 SVMTQLRHSNLVQLLGVIVEEKGGLYIVT-EYMAKGSLVDYLRSRGRSVLG---GDCL-- 291
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
              ++ ++D    +EYL      + +HRD+ + NVL+ ED  AK++DF L+ +A      
Sbjct: 292 ---LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----- 340
Query: 155 LHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
             ST+  G     + APE     + + KSDV+SFG++L E+ + GR P
Sbjct: 341 --STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/168 (35%), Positives = 91/168 (54%), Gaps = 25/168 (14%)
Query: 38  SVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGR-KGVQGAQPGPVLDW 94
           SV+++L+H NLV+LLG  VE  G L ++  E+   GSL D L  R + V G         
Sbjct: 51  SVMTQLRHSNLVQLLGVIVEEKGGLYIVT-EYMAKGSLVDYLRSRGRSVLGGD------- 102
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
              ++ ++D    +EYL      + +HRD+ + NVL+ ED  AK++DF L+ +A      
Sbjct: 103 -CLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----- 153
Query: 155 LHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
             ST+  G     + APE     + + KSDV+SFG++L E+ + GR P
Sbjct: 154 --STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/168 (35%), Positives = 90/168 (53%), Gaps = 25/168 (14%)
Query: 38  SVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGR-KGVQGAQPGPVLDW 94
           SV+++L+H NLV+LLG  VE  G L ++  E+   GSL D L  R + V G         
Sbjct: 57  SVMTQLRHSNLVQLLGVIVEEKGGLYIVT-EYMAKGSLVDYLRSRGRSVLGGD------- 108
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
              ++ ++D    +EYL      + +HRD+ + NVL+ ED  AK++DF L+ +A      
Sbjct: 109 -CLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----- 159
Query: 155 LHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
             ST+  G     + APE       + KSDV+SFG++L E+ + GR P
Sbjct: 160 --STQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/168 (35%), Positives = 91/168 (54%), Gaps = 25/168 (14%)
Query: 38  SVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGR-KGVQGAQPGPVLDW 94
           SV+++L+H NLV+LLG  VE  G L ++  E+   GSL D L  R + V G         
Sbjct: 66  SVMTQLRHSNLVQLLGVIVEEKGGLYIVT-EYMAKGSLVDYLRSRGRSVLGGD------- 117
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
              ++ ++D    +EYL      + +HRD+ + NVL+ ED  AK++DF L+ +A      
Sbjct: 118 -CLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----- 168
Query: 155 LHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
             ST+  G     + APE     + + KSDV+SFG++L E+ + GR P
Sbjct: 169 --STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  +VS +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 84  QGAQ-----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   + +   V      ARG+EYL  +     IHRD+ + NVL+ E+   K
Sbjct: 141 EXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 197
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+    ++     +T       + APE       T +SDV+SFGV++ E+ T
Sbjct: 198 IADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   +   ++ +LKH+ LV+L     E  + ++  E+   GSL D L   +G
Sbjct: 41  LKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEEPIYIVT-EYMNKGSLLDFLKDGEG 99
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                P         V +A   A G+ Y+    + + IHRD+RS+N+L+      KIADF
Sbjct: 100 RALKLP-------NLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGNGLICKIADF 149
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D      + R    F   + APE A+ G+ T KSDV+SFG++L EL+T GR P
Sbjct: 150 GLARLIEDNEX---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 206

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  +VS +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 84  QGAQ-----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   + +   V      ARG+EYL  +     IHRD+ + NVL+ E+   K
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 197
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+    ++     +T       + APE       T +SDV+SFGV++ E+ T
Sbjct: 198 IADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  +VS +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 84  QGAQ-----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   + +   V      ARG+EYL  +     IHRD+ + NVL+ E+   K
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 197
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+    ++    ++T       + APE       T +SDV+SFGV++ E+ T
Sbjct: 198 IADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  +VS +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 68  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 127
Query: 84  QGAQ-----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   + +   V      ARG+EYL  +     IHRD+ + NVL+ E+   K
Sbjct: 128 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMK 184
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+    ++     +T       + APE       T +SDV+SFGV++ E+ T
Sbjct: 185 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  +VS +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 127 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186
Query: 84  QGAQ-----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   + +   V      ARG+EYL  +     IHRD+ + NVL+ E+   K
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 243
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+    ++     +T       + APE       T +SDV+SFGV++ E+ T
Sbjct: 244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  +VS +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 70  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 129
Query: 84  QGAQ-----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   + +   V      ARG+EYL  +     IHRD+ + NVL+ E+   K
Sbjct: 130 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 186
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+    ++     +T       + APE       T +SDV+SFGV++ E+ T
Sbjct: 187 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  +VS +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 73  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 132
Query: 84  QGAQ-----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   + +   V      ARG+EYL  +     IHRD+ + NVL+ E+   K
Sbjct: 133 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 189
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+    ++     +T       + APE       T +SDV+SFGV++ E+ T
Sbjct: 190 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  +VS +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 84  QGAQ-----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   + +   V      ARG+EYL  +     IHRD+ + NVL+ E+   K
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 197
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+    ++     +T       + APE       T +SDV+SFGV++ E+ T
Sbjct: 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 88/165 (53%), Gaps = 17/165 (10%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +V+  L+H+ LV+L     +  + ++  EF   GSL D L   +G +  QP P L     
Sbjct: 62  NVMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL----- 113
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +  +   A G+ ++ ++   + IHRD+R++N+L+      KIADF L+    D     ++
Sbjct: 114 IDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED---NEYT 167
Query: 158 TRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            R    F   + APE    G  T KSDV+SFG++L+E++T GR P
Sbjct: 168 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  +VS +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 84  QGAQ-----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   + +   V      ARG+EYL  +     IHRD+ + NVL+ E+   K
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 197
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+    ++     +T       + APE       T +SDV+SFGV++ E+ T
Sbjct: 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  +VS +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 84  QGAQ-----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   + +   V      ARG+EYL  +     IHRD+ + NVL+ E+   +
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMR 197
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+    ++     +T       + APE       T +SDV+SFGV++ E+ T
Sbjct: 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K      DD  +   V+ +L H  LV+L G C+E     L +EF   G L D L  ++G
Sbjct: 59  IKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG 118
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +  A+        T + + +D   G+ YL E     +IHRD+ + N L+ E+   K++DF
Sbjct: 119 LFAAE--------TLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDF 167
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
            ++    D      ST       + +PE     + + KSDV+SFGV++ E+ + G+ P +
Sbjct: 168 GMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 226
Query: 202 H 202
           +
Sbjct: 227 N 227

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 88/166 (53%), Gaps = 17/166 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
            +V+  L+H+ LV+L     +  + ++  EF   GSL D L   +G +  QP P L    
Sbjct: 234 ANVMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL---- 286
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            +  +   A G+ ++ ++   + IHRD+R++N+L+      KIADF L+    D     +
Sbjct: 287 -IDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---Y 339
Query: 157 STRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           + R    F   + APE    G  T KSDV+SFG++L+E++T GR P
Sbjct: 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 88/173 (50%), Gaps = 13/173 (7%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D  +   V+ +L H  LV+L G C+E     L +EF   G L D L  ++G+  A+   
Sbjct: 47  EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--- 103
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 150
                T + + +D   G+ YL E    S+IHRD+ + N L+ E+   K++DF ++    D
Sbjct: 104 -----TLLGMCLDVCEGMAYLEE---ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 155
Query: 151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 202
                 ST       + +PE     + + KSDV+SFGV++ E+ + G+ P ++
Sbjct: 156 -DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           E+ L  +VS +       KH+N++ LLG C +     +  E+A+ G+L + L  R+  G+
Sbjct: 81  EEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 84  QGAQ-----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   + +   V      ARG+EYL  +     IHRD+ + NVL+ E+   K
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 197
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+    ++     +T       + APE       T +SDV+SFGV++ E+ T
Sbjct: 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 86/176 (48%), Gaps = 16/176 (9%)
Query: 24  KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRK 81
           +S  N+  D K+ + ++  L HEN+V+  G C E  GN   L  EF   GSL + L   K
Sbjct: 61  ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK 120
Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
                     ++   +++ AV   +G++YL  +     +HRD+ + NVL+  + + KI D
Sbjct: 121 NK--------INLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD 169
Query: 142 FNLSN--QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           F L+   +       +   R    F Y APE  M  +    SDV+SFGV L ELLT
Sbjct: 170 FGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 108/254 (42%), Gaps = 28/254 (11%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HG-----RKGVQ 84
           D ++   +++ L+H+++V   G C EG   ++ +E+   G L+  L  HG       G +
Sbjct: 66  DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 125
Query: 85  GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 144
              PGP L     + +A   A G+ YL        +HRD+ + N L+ +    KI DF +
Sbjct: 126 DVAPGP-LGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGM 181
Query: 145 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHT 203
           S             R +    +  PE  +  + T +SDV+SFGVVL E+ T G++P    
Sbjct: 182 SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP---- 237
Query: 204 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMS 263
                     W   +LS  +   C+    + E               C Q E + R ++ 
Sbjct: 238 ----------WY--QLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIK 285
Query: 264 IVVKALQPLLKSPP 277
            V   LQ L ++PP
Sbjct: 286 DVHARLQALAQAPP 299

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 108/254 (42%), Gaps = 28/254 (11%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HG-----RKGVQ 84
           D ++   +++ L+H+++V   G C EG   ++ +E+   G L+  L  HG       G +
Sbjct: 89  DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 148
Query: 85  GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 144
              PGP L     + +A   A G+ YL        +HRD+ + N L+ +    KI DF +
Sbjct: 149 DVAPGP-LGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGM 204
Query: 145 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHT 203
           S             R +    +  PE  +  + T +SDV+SFGVVL E+ T G++P    
Sbjct: 205 SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP---- 260
Query: 204 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMS 263
                     W   +LS  +   C+    + E               C Q E + R ++ 
Sbjct: 261 ----------WY--QLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIK 308
Query: 264 IVVKALQPLLKSPP 277
            V   LQ L ++PP
Sbjct: 309 DVHARLQALAQAPP 322

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 86/176 (48%), Gaps = 16/176 (9%)
Query: 24  KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRK 81
           +S  N+  D K+ + ++  L HEN+V+  G C E  GN   L  EF   GSL + L   K
Sbjct: 49  ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK 108
Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
                     ++   +++ AV   +G++YL  +     +HRD+ + NVL+  + + KI D
Sbjct: 109 NK--------INLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD 157
Query: 142 FNLSN--QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           F L+   +       +   R    F Y APE  M  +    SDV+SFGV L ELLT
Sbjct: 158 FGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  +VS +       KH+N++ LLG C +     +   +A+ G+L + L  R+  G+
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGM 140
Query: 84  QGAQ-----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   + +   V      ARG+EYL  +     IHRD+ + NVL+ E+   K
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 197
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+    ++     +T       + APE       T +SDV+SFGV++ E+ T
Sbjct: 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 108/254 (42%), Gaps = 28/254 (11%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HG-----RKGVQ 84
           D ++   +++ L+H+++V   G C EG   ++ +E+   G L+  L  HG       G +
Sbjct: 60  DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 119
Query: 85  GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 144
              PGP L     + +A   A G+ YL        +HRD+ + N L+ +    KI DF +
Sbjct: 120 DVAPGP-LGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGM 175
Query: 145 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHT 203
           S             R +    +  PE  +  + T +SDV+SFGVVL E+ T G++P    
Sbjct: 176 SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP---- 231
Query: 204 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMS 263
                     W   +LS  +   C+    + E               C Q E + R ++ 
Sbjct: 232 ----------WY--QLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIK 279
Query: 264 IVVKALQPLLKSPP 277
            V   LQ L ++PP
Sbjct: 280 DVHARLQALAQAPP 293

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D  +   V+ +L H  LV+L G C+E     L +EF   G L D L  ++G+  A+   
Sbjct: 50  EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--- 106
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 150
                T + + +D   G+ YL E     +IHRD+ + N L+ E+   K++DF ++    D
Sbjct: 107 -----TLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158
Query: 151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 202
                 ST       + +PE     + + KSDV+SFGV++ E+ + G+ P ++
Sbjct: 159 -DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 210

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D  +   V+ +L H  LV+L G C+E     L +EF   G L D L  ++G+  A+   
Sbjct: 47  EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--- 103
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 150
                T + + +D   G+ YL E     +IHRD+ + N L+ E+   K++DF ++    D
Sbjct: 104 -----TLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 155
Query: 151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 202
                 ST       + +PE     + + KSDV+SFGV++ E+ + G+ P ++
Sbjct: 156 -DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D  +   V+ +L H  LV+L G C+E     L +EF   G L D L  ++G+  A+   
Sbjct: 45  EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--- 101
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 150
                T + + +D   G+ YL E     +IHRD+ + N L+ E+   K++DF ++    D
Sbjct: 102 -----TLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153
Query: 151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 202
                 ST       + +PE     + + KSDV+SFGV++ E+ + G+ P ++
Sbjct: 154 -DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 86/166 (51%), Gaps = 27/166 (16%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
            +V+  L+H+ LV+L     +  + ++  EF   GSL D L   +G +  QP P L    
Sbjct: 228 ANVMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL---- 280
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            +  +   A G+ ++ ++   + IHRD+R++N+L+      KIADF L+           
Sbjct: 281 -IDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA----------- 325
Query: 157 STRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
             RV   F   + APE    G  T KSDV+SFG++L+E++T GR P
Sbjct: 326 --RVGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 369

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 17/177 (9%)
Query: 33  EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 83
           EK L  +VS +       KH+N++ LLG C +     +   +A+ G+L + L  R+  G+
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGM 140
Query: 84  QGAQ-----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           + +      P   + +   V      ARG+EYL  +     IHRD+ + NVL+ E+   K
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 197
Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+    ++     +T       + APE       T +SDV+SFGV++ E+ T
Sbjct: 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 104/242 (42%), Gaps = 25/242 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++S+L H+N+V  +G  ++   R +  E    G L   L   +  + +QP   L  +  +
Sbjct: 101 IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR-PRPSQPS-SLAMLDLL 158
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARL 155
            +A D A G +YL E      IHRDI + N LL        AKI DF ++      +   
Sbjct: 159 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
                +    +  PE  M G  T K+D +SFGV+L E+ + G  P      +  Q ++ +
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEF 272
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
            T     D  K C  P  +                 C Q++ E RPN +I+++ ++   +
Sbjct: 273 VTSGGRMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNFAIILERIEYCTQ 319
Query: 275 SP 276
            P
Sbjct: 320 DP 321

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 104/242 (42%), Gaps = 25/242 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++S+L H+N+V  +G  ++   R +  E    G L   L   +  + +QP   L  +  +
Sbjct: 87  IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR-PRPSQPS-SLAMLDLL 144
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARL 155
            +A D A G +YL E      IHRDI + N LL        AKI DF ++      +   
Sbjct: 145 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
                +    +  PE  M G  T K+D +SFGV+L E+ + G  P      +  Q ++ +
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEF 258
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
            T     D  K C  P  +                 C Q++ E RPN +I+++ ++   +
Sbjct: 259 VTSGGRMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNFAIILERIEYCTQ 305
Query: 275 SP 276
            P
Sbjct: 306 DP 307

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 108/254 (42%), Gaps = 27/254 (10%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGV-----Q 84
           D ++   +++ L+HE++V+  G C +G+  ++ +E+   G L+  L  HG   +     Q
Sbjct: 63  DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 85  GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 144
             Q    L     + IA   A G+ YL  +     +HRD+ + N L+  +   KI DF +
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGM 179
Query: 145 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHT 203
           S               +    +  PE  M  + T +SDV+SFGV+L E+ T G++P    
Sbjct: 180 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---- 235
Query: 204 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMS 263
                     W   +LS  +V +C+      E               C Q E + R N+ 
Sbjct: 236 ----------WF--QLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIK 283
Query: 264 IVVKALQPLLKSPP 277
            + K L  L K+ P
Sbjct: 284 EIYKILHALGKATP 297

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 20/191 (10%)
Query: 15  YPSHENERLKSPKN---YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMG 71
           Y  H    +KS K     PD      +++ +L+H+ LV L     +  + ++  E+   G
Sbjct: 39  YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENG 97
Query: 72  SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 131
           SL D L    G++      +LD      +A   A G+ ++ E+   + IHRD+R++N+L+
Sbjct: 98  SLVDFLKTPSGIK-LTINKLLD------MAAQIAEGMAFIEER---NYIHRDLRAANILV 147
Query: 132 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVV 189
            +    KIADF L+    D     ++ R    F   + APE    G  T KSDV+SFG++
Sbjct: 148 SDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 204
Query: 190 LLELLT-GRKP 199
           L E++T GR P
Sbjct: 205 LTEIVTHGRIP 215

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 20/191 (10%)
Query: 15  YPSHENERLKSPKN---YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMG 71
           Y  H    +KS K     PD      +++ +L+H+ LV L     +  + ++  E+   G
Sbjct: 40  YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENG 98
Query: 72  SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 131
           SL D L    G++      +LD      +A   A G+ ++ E+   + IHRD+R++N+L+
Sbjct: 99  SLVDFLKTPSGIK-LTINKLLD------MAAQIAEGMAFIEER---NYIHRDLRAANILV 148
Query: 132 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVV 189
            +    KIADF L+    D     ++ R    F   + APE    G  T KSDV+SFG++
Sbjct: 149 SDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 205
Query: 190 LLELLT-GRKP 199
           L E++T GR P
Sbjct: 206 LTEIVTHGRIP 216

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 20/191 (10%)
Query: 15  YPSHENERLKSPKN---YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMG 71
           Y  H    +KS K     PD      +++ +L+H+ LV L     +  + ++  E+   G
Sbjct: 34  YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENG 92
Query: 72  SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 131
           SL D L    G++      +LD      +A   A G+ ++ E+   + IHRD+R++N+L+
Sbjct: 93  SLVDFLKTPSGIK-LTINKLLD------MAAQIAEGMAFIEER---NYIHRDLRAANILV 142
Query: 132 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVV 189
            +    KIADF L+    D     ++ R    F   + APE    G  T KSDV+SFG++
Sbjct: 143 SDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 190 LLELLT-GRKP 199
           L E++T GR P
Sbjct: 200 LTEIVTHGRIP 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 91/180 (50%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     PD      +++ +L+H+ LV L     +  + ++  E+   GSL D L    G
Sbjct: 55  LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSG 113
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           ++      +LD      +A   A G+ ++ E+   + IHRD+R++N+L+ +    KIADF
Sbjct: 114 IK-LTINKLLD------MAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 163
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D     ++ R    F   + APE    G  T KSDV+SFG++L E++T GR P
Sbjct: 164 GLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 220

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 20/191 (10%)
Query: 15  YPSHENERLKSPKN---YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMG 71
           Y  H    +KS K     PD      +++ +L+H+ LV L     +  + ++  E+   G
Sbjct: 29  YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENG 87
Query: 72  SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 131
           SL D L    G++      +LD      +A   A G+ ++ E+   + IHRD+R++N+L+
Sbjct: 88  SLVDFLKTPSGIK-LTINKLLD------MAAQIAEGMAFIEER---NYIHRDLRAANILV 137
Query: 132 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVV 189
            +    KIADF L+    D     ++ R    F   + APE    G  T KSDV+SFG++
Sbjct: 138 SDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 194
Query: 190 LLELLT-GRKP 199
           L E++T GR P
Sbjct: 195 LTEIVTHGRIP 205

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 25/242 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++S+  H+N+V  +G  ++   R +  E    G L   L   +  + +QP   L  +  +
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETR-PRPSQPS-SLAMLDLL 158
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARL 155
            +A D A G +YL E      IHRDI + N LL        AKI DF ++      +   
Sbjct: 159 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
                +    +  PE  M G  T K+D +SFGV+L E+ + G  P      +  Q ++ +
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEF 272
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
            T     D  K C  P  +                 C Q++ E RPN +I+++ ++   +
Sbjct: 273 VTSGGRMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNFAIILERIEYCTQ 319
Query: 275 SP 276
            P
Sbjct: 320 DP 321

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 94/191 (49%), Gaps = 20/191 (10%)
Query: 15  YPSHENERLKSPKN---YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMG 71
           Y  H    +KS K     PD      +++ +L+H+ LV L     +  + ++  E+   G
Sbjct: 34  YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENG 92
Query: 72  SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 131
           SL D L    G++      +LD      +A   A G+ ++ E+   + IHRD+R++N+L+
Sbjct: 93  SLVDFLKTPSGIK-LTINKLLD------MAAQIAEGMAFIEER---NYIHRDLRAANILV 142
Query: 132 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVV 189
            +    KIADF L+    D      + R    F   + APE    G  T KSDV+SFG++
Sbjct: 143 SDTLSCKIADFGLARLIEDAEX---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 190 LLELLT-GRKP 199
           L E++T GR P
Sbjct: 200 LTEIVTHGRIP 210

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 25/242 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++S+  H+N+V  +G  ++   R +  E    G L   L   +  + +QP   L  +  +
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETR-PRPSQPS-SLAMLDLL 143
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARL 155
            +A D A G +YL E      IHRDI + N LL        AKI DF ++      +   
Sbjct: 144 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
                +    +  PE  M G  T K+D +SFGV+L E+ + G  P      +  Q ++ +
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEF 257
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
            T     D  K C  P  +                 C Q++ E RPN +I+++ ++   +
Sbjct: 258 VTSGGRMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNFAIILERIEYCTQ 304
Query: 275 SP 276
            P
Sbjct: 305 DP 306

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 25/242 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++S+  H+N+V  +G  ++   R +  E    G L   L   +  + +QP   L  +  +
Sbjct: 87  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR-PRPSQPS-SLAMLDLL 144
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARL 155
            +A D A G +YL E      IHRDI + N LL        AKI DF ++      +   
Sbjct: 145 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYR 201
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
                +    +  PE  M G  T K+D +SFGV+L E+ + G  P      +  Q ++ +
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEF 258
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
            T     D  K C  P  +                 C Q++ E RPN +I+++ ++   +
Sbjct: 259 VTSGGRMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNFAIILERIEYCTQ 305
Query: 275 SP 276
            P
Sbjct: 306 DP 307

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 25/242 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++S+  H+N+V  +G  ++   R +  E    G L   L   +  + +QP   L  +  +
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SLAMLDLL 143
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARL 155
            +A D A G +YL E      IHRDI + N LL        AKI DF ++      +   
Sbjct: 144 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
                +    +  PE  M G  T K+D +SFGV+L E+ + G  P      +  Q ++ +
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEF 257
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
            T     D  K C  P  +                 C Q++ E RPN +I+++ ++   +
Sbjct: 258 VTSGGRMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNFAIILERIEYCTQ 304
Query: 275 SP 276
            P
Sbjct: 305 DP 306

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 25/242 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++S+  H+N+V  +G  ++   R +  E    G L   L   +  + +QP   L  +  +
Sbjct: 103 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SLAMLDLL 160
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARL 155
            +A D A G +YL E      IHRDI + N LL        AKI DF ++      +   
Sbjct: 161 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 217
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
                +    +  PE  M G  T K+D +SFGV+L E+ + G  P      +  Q ++ +
Sbjct: 218 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEF 274
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
            T     D  K C  P  +                 C Q++ E RPN +I+++ ++   +
Sbjct: 275 VTSGGRMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNFAIILERIEYCTQ 321
Query: 275 SP 276
            P
Sbjct: 322 DP 323

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 25/242 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++S+  H+N+V  +G  ++   R +  E    G L   L   +  + +QP   L  +  +
Sbjct: 78  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR-PRPSQPS-SLAMLDLL 135
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARL 155
            +A D A G +YL E      IHRDI + N LL        AKI DF ++      +   
Sbjct: 136 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 192
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
                +    +  PE  M G  T K+D +SFGV+L E+ + G  P      +  Q ++ +
Sbjct: 193 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEF 249
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
            T     D  K C  P  +                 C Q++ E RPN +I+++ ++   +
Sbjct: 250 VTSGGRMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNFAIILERIEYCTQ 296
Query: 275 SP 276
            P
Sbjct: 297 DP 298

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/183 (34%), Positives = 84/183 (45%), Gaps = 31/183 (16%)
Query: 43  LKHENLVELLGYCVEG-NLRV---LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           +KHENL++ +     G NL V   L   F   GSL D L G           ++ W    
Sbjct: 66  MKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGN----------IITWNELC 115
Query: 99  RIAVDAARGLEYLHEKV--------QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 150
            +A   +RGL YLHE V        +PSI HRD +S NVLL  D  A +ADF L+ +   
Sbjct: 116 HVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEP 175
Query: 151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKS-----DVYSFGVVLLELLTGRK----PVD 201
                 +   +GT  Y APE        Q+      D+Y+ G+VL EL++  K    PVD
Sbjct: 176 GKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVD 235
Query: 202 HTM 204
             M
Sbjct: 236 EYM 238

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 25/242 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++S+  H+N+V  +G  ++   R +  E    G L   L   +  + +QP   L  +  +
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR-PRPSQPS-SLAMLDLL 158
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARL 155
            +A D A G +YL E      IHRDI + N LL        AKI DF ++      +   
Sbjct: 159 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
                +    +  PE  M G  T K+D +SFGV+L E+ + G  P      +  Q ++ +
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEF 272
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
            T     D  K C  P  +                 C Q++ E RPN +I+++ ++   +
Sbjct: 273 VTSGGRMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNFAIILERIEYCTQ 319
Query: 275 SP 276
            P
Sbjct: 320 DP 321

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 25/242 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++S+  H+N+V  +G  ++   R +  E    G L   L   +  + +QP   L  +  +
Sbjct: 87  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR-PRPSQPS-SLAMLDLL 144
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARL 155
            +A D A G +YL E      IHRDI + N LL        AKI DF ++      +   
Sbjct: 145 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
                +    +  PE  M G  T K+D +SFGV+L E+ + G  P      +  Q ++ +
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEF 258
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
            T     D  K C  P  +                 C Q++ E RPN +I+++ ++   +
Sbjct: 259 VTSGGRMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNFAIILERIEYCTQ 305
Query: 275 SP 276
            P
Sbjct: 306 DP 307

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 25/242 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++S+  H+N+V  +G  ++   R +  E    G L   L   +  + +QP   L  +  +
Sbjct: 93  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SLAMLDLL 150
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARL 155
            +A D A G +YL E      IHRDI + N LL        AKI DF ++      +   
Sbjct: 151 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 207
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
                +    +  PE  M G  T K+D +SFGV+L E+ + G  P      +  Q ++ +
Sbjct: 208 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEF 264
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
            T     D  K C  P  +                 C Q++ E RPN +I+++ ++   +
Sbjct: 265 VTSGGRMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNFAIILERIEYCTQ 311
Query: 275 SP 276
            P
Sbjct: 312 DP 313

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 102/242 (42%), Gaps = 25/242 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++S+  H+N+V  +G  ++   R +  E    G L   L   +  + +QP   L  +  +
Sbjct: 104 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR-PRPSQPS-SLAMLDLL 161
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARL 155
            +A D A G +YL E      IHRDI + N LL        AKI DF ++          
Sbjct: 162 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 218
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
                +    +  PE  M G  T K+D +SFGV+L E+ + G  P      +  Q ++ +
Sbjct: 219 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEF 275
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
            T     D  K C  P  +                 C Q++ E RPN +I+++ ++   +
Sbjct: 276 VTSGGRMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNFAIILERIEYCTQ 322
Query: 275 SP 276
            P
Sbjct: 323 DP 324

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 25/242 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++S+  H+N+V  +G  ++   R +  E    G L   L   +  + +QP   L  +  +
Sbjct: 113 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SLAMLDLL 170
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARL 155
            +A D A G +YL E      IHRDI + N LL        AKI DF ++      +   
Sbjct: 171 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 227
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
                +    +  PE  M G  T K+D +SFGV+L E+ + G  P      +  Q ++ +
Sbjct: 228 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEF 284
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
            T     D  K C  P  +                 C Q++ E RPN +I+++ ++   +
Sbjct: 285 VTSGGRMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNFAIILERIEYCTQ 331
Query: 275 SP 276
            P
Sbjct: 332 DP 333

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 102/242 (42%), Gaps = 25/242 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++S+  H+N+V  +G  ++   R +  E    G L   L   +  + +QP   L  +  +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR-PRPSQPS-SLAMLDLL 184
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARL 155
            +A D A G +YL E      IHRDI + N LL        AKI DF ++          
Sbjct: 185 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 241
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
                +    +  PE  M G  T K+D +SFGV+L E+ + G  P      +  Q ++ +
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEF 298
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
            T     D  K C  P  +                 C Q++ E RPN +I+++ ++   +
Sbjct: 299 VTSGGRMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNFAIILERIEYCTQ 345
Query: 275 SP 276
            P
Sbjct: 346 DP 347

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     PD      +++ +L+H+ LV L     +  + ++  E+   GSL D L    G
Sbjct: 51  LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSG 109
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           ++      +LD      +A   A G+ ++ E+   + IHRD+R++N+L+ +    KIADF
Sbjct: 110 IK-LTINKLLD------MAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 159
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D      + R    F   + APE    G  T KSDV+SFG++L E++T GR P
Sbjct: 160 GLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D  +   V+ +L H  LV+L G C+E     L  EF   G L D L  ++G+  A+   
Sbjct: 48  EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE--- 104
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 150
                T + + +D   G+ YL E     +IHRD+ + N L+ E+   K++DF ++    D
Sbjct: 105 -----TLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156
Query: 151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 202
                 ST       + +PE     + + KSDV+SFGV++ E+ + G+ P ++
Sbjct: 157 -DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 94/191 (49%), Gaps = 20/191 (10%)
Query: 15  YPSHENERLKSPKN---YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMG 71
           Y  H    +KS K     PD      +++ +L+H+ LV L     +  + ++  E+   G
Sbjct: 34  YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENG 92
Query: 72  SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 131
           SL D L    G++      +LD      +A   A G+ ++ E+   + IHRD+R++N+L+
Sbjct: 93  SLVDFLKTPSGIK-LTINKLLD------MAAQIAEGMAFIEER---NYIHRDLRAANILV 142
Query: 132 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVV 189
            +    KIADF L+    D      + R    F   + APE    G  T KSDV+SFG++
Sbjct: 143 SDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 190 LLELLT-GRKP 199
           L E++T GR P
Sbjct: 200 LTEIVTHGRIP 210

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 94/191 (49%), Gaps = 20/191 (10%)
Query: 15  YPSHENERLKSPKN---YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMG 71
           Y  H    +KS K     PD      +++ +L+H+ LV L     +  + ++  E+   G
Sbjct: 34  YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENG 92
Query: 72  SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 131
           SL D L    G++      +LD      +A   A G+ ++ E+   + IHRD+R++N+L+
Sbjct: 93  SLVDFLKTPSGIK-LTINKLLD------MAAQIAEGMAFIEER---NYIHRDLRAANILV 142
Query: 132 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVV 189
            +    KIADF L+    D      + R    F   + APE    G  T KSDV+SFG++
Sbjct: 143 SDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 190 LLELLT-GRKP 199
           L E++T GR P
Sbjct: 200 LTEIVTHGRIP 210

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 90/188 (47%), Gaps = 23/188 (12%)
Query: 23  LKSPKNYP--DDEKQL---VSVVSRLKHE-NLVELLGYCVEGNLRVLAYEFATMGSLHDI 76
           +K  K Y   DD +     + V+ +L H  N++ LLG C       LA E+A  G+L D 
Sbjct: 47  IKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 106
Query: 77  LHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 129
           L   + ++              L     +  A D ARG++YL +K     IHRD+ + N+
Sbjct: 107 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI 163
Query: 130 LLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFG 187
           L+ E++ AKIADF LS         ++  + +G     + A E       T  SDV+S+G
Sbjct: 164 LVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 218
Query: 188 VVLLELLT 195
           V+L E+++
Sbjct: 219 VLLWEIVS 226

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 94/191 (49%), Gaps = 20/191 (10%)
Query: 15  YPSHENERLKSPKN---YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMG 71
           Y  H    +KS K     PD      +++ +L+H+ LV L     +  + ++  E+   G
Sbjct: 36  YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENG 94
Query: 72  SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 131
           SL D L    G++      +LD      +A   A G+ ++ E+   + IHRD+R++N+L+
Sbjct: 95  SLVDFLKTPSGIK-LTINKLLD------MAAQIAEGMAFIEER---NYIHRDLRAANILV 144
Query: 132 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVV 189
            +    KIADF L+    D      + R    F   + APE    G  T KSDV+SFG++
Sbjct: 145 SDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 201
Query: 190 LLELLT-GRKP 199
           L E++T GR P
Sbjct: 202 LTEIVTHGRIP 212

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 94/191 (49%), Gaps = 20/191 (10%)
Query: 15  YPSHENERLKSPKN---YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMG 71
           Y  H    +KS K     PD      +++ +L+H+ LV L     +  + ++  E+   G
Sbjct: 35  YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENG 93
Query: 72  SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 131
           SL D L    G++      +LD      +A   A G+ ++ E+   + IHRD+R++N+L+
Sbjct: 94  SLVDFLKTPSGIK-LTINKLLD------MAAQIAEGMAFIEER---NYIHRDLRAANILV 143
Query: 132 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVV 189
            +    KIADF L+    D      + R    F   + APE    G  T KSDV+SFG++
Sbjct: 144 SDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 200
Query: 190 LLELLT-GRKP 199
           L E++T GR P
Sbjct: 201 LTEIVTHGRIP 211

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 90/188 (47%), Gaps = 23/188 (12%)
Query: 23  LKSPKNYP--DDEKQL---VSVVSRLKHE-NLVELLGYCVEGNLRVLAYEFATMGSLHDI 76
           +K  K Y   DD +     + V+ +L H  N++ LLG C       LA E+A  G+L D 
Sbjct: 57  IKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116
Query: 77  LHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 129
           L   + ++              L     +  A D ARG++YL +K     IHRD+ + N+
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI 173
Query: 130 LLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFG 187
           L+ E++ AKIADF LS         ++  + +G     + A E       T  SDV+S+G
Sbjct: 174 LVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 228
Query: 188 VVLLELLT 195
           V+L E+++
Sbjct: 229 VLLWEIVS 236

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     PD      +++ +L+H+ LV L     +  + ++  E+   GSL D L    G
Sbjct: 54  LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSG 112
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           ++      +LD      +A   A G+ ++ E+   + IHRD+R++N+L+ +    KIADF
Sbjct: 113 IK-LTINKLLD------MAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 162
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D      + R    F   + APE    G  T KSDV+SFG++L E++T GR P
Sbjct: 163 GLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 219

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     PD      +++ +L+H+ LV L     +  + ++  E+   GSL D L    G
Sbjct: 53  LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSG 111
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           ++      +LD      +A   A G+ ++ E+   + IHRD+R++N+L+ +    KIADF
Sbjct: 112 IK-LTINKLLD------MAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 161
Query: 143 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            L+    D      + R    F   + APE    G  T KSDV+SFG++L E++T GR P
Sbjct: 162 GLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 218

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 31/234 (13%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           +Q ++V+S+     + +  G  ++     +  E+   GS  D+L         +PGP LD
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---------EPGP-LD 117
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
                 I  +  +GL+YLH + +   IHRDI+++NVLL E  + K+ADF ++ Q  D   
Sbjct: 118 ETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--T 172
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 213
           ++     +GT  + APE         K+D++S G+  +EL  G  P     P     L+ 
Sbjct: 173 QIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP 232
Query: 214 WATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVK 267
              P            P L+G Y              C+  E  FRP    ++K
Sbjct: 233 KNNP------------PTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLK 270

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 20/167 (11%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDWM 95
           +V+  +KH NLV+LLG C       +  EF T G+L D L    R+ V       VL +M
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAV----VLLYM 121
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
                A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    
Sbjct: 122 -----ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDT 170
Query: 156 HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           ++      F   + APE     + + KSDV++FGV+L E+ T G  P
Sbjct: 171 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 20/167 (11%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDWM 95
           +V+  +KH NLV+LLG C       +  EF T G+L D L    R+ V       VL +M
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYM 121
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
                A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    
Sbjct: 122 -----ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDT 170
Query: 156 HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           ++      F   + APE     + + KSDV++FGV+L E+ T G  P
Sbjct: 171 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 20/167 (11%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDWM 95
           +V+  +KH NLV+LLG C       +  EF T G+L D L    R+ V       VL +M
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYM 120
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
                A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    
Sbjct: 121 -----ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDT 169
Query: 156 HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           ++      F   + APE     + + KSDV++FGV+L E+ T G  P
Sbjct: 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +V+  +KH NLV+LLG C       +  EF T G+L D L  R+  +      VL +M  
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYM-- 116
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
              A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    ++
Sbjct: 117 ---ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYT 167
Query: 158 TRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
                 F   + APE     + + KSDV++FGV+L E+ T G  P
Sbjct: 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 81/160 (50%), Gaps = 15/160 (9%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +V+  +KH NLV+LLG C       +  EF T G+L D L  R+  +      VL +M  
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYM-- 121
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
              A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    ++
Sbjct: 122 ---ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYT 172
Query: 158 TRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
                 F   + APE     + + KSDV++FGV+L E+ T
Sbjct: 173 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 81/160 (50%), Gaps = 15/160 (9%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +V+  +KH NLV+LLG C       +  EF T G+L D L  R+  +      VL +M  
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYM-- 116
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
              A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    ++
Sbjct: 117 ---ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYT 167
Query: 158 TRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
                 F   + APE     + + KSDV++FGV+L E+ T
Sbjct: 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 31/234 (13%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           +Q ++V+S+     + +  G  ++     +  E+   GS  D+L         +PGP LD
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---------EPGP-LD 102
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
                 I  +  +GL+YLH + +   IHRDI+++NVLL E  + K+ADF ++ Q  D   
Sbjct: 103 ETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--T 157
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 213
           ++     +GT  + APE         K+D++S G+  +EL  G  P     P     L+ 
Sbjct: 158 QIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP 217
Query: 214 WATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVK 267
              P            P L+G Y              C+  E  FRP    ++K
Sbjct: 218 KNNP------------PTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 79/160 (49%), Gaps = 15/160 (9%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDWM 95
           +V+  +KH NLV+LLG C       +  EF T G+L D L    R+ V       VL +M
Sbjct: 62  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAV----VLLYM 117
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
                A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS          
Sbjct: 118 -----ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTA 169
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           H+        + APE     + + KSDV++FGV+L E+ T
Sbjct: 170 HAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +V+  +KH NLV+LLG C       +  EF T G+L D L  R+  +      VL +M  
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYM-- 116
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
              A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    ++
Sbjct: 117 ---ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYT 167
Query: 158 TRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
                 F   + APE     + + KSDV++FGV+L E+ T G  P
Sbjct: 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 81/163 (49%), Gaps = 12/163 (7%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +V+  +KH NLV+LLG C       +  EF T G+L D L  R+  +      VL +M  
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYM-- 114
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
              A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS          H+
Sbjct: 115 ---ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHA 168
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
                   + APE     + + KSDV++FGV+L E+ T G  P
Sbjct: 169 GAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 81/160 (50%), Gaps = 15/160 (9%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +V+  +KH NLV+LLG C       +  EF T G+L D L  R+  +      VL +M  
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYM-- 116
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
              A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    ++
Sbjct: 117 ---ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYT 167
Query: 158 TRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
                 F   + APE     + + KSDV++FGV+L E+ T
Sbjct: 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 31/234 (13%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           +Q ++V+S+     + +  G  ++     +  E+   GS  D+L         +PGP LD
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---------EPGP-LD 102
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
                 I  +  +GL+YLH + +   IHRDI+++NVLL E  + K+ADF ++ Q  D   
Sbjct: 103 ETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--T 157
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 213
           ++     +GT  + APE         K+D++S G+  +EL  G  P     P     L+ 
Sbjct: 158 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP 217
Query: 214 WATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVK 267
              P            P L+G Y              C+  E  FRP    ++K
Sbjct: 218 KNNP------------PTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 81/165 (49%), Gaps = 16/165 (9%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDWM 95
           +V+  +KH NLV+LLG C       +  EF T G+L D L    R+ V       VL +M
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYM 121
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
                A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS          
Sbjct: 122 -----ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTA 173
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           H+        + APE     + + KSDV++FGV+L E+ T G  P
Sbjct: 174 HAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 20/167 (11%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDWM 95
           +V+  +KH NLV+LLG C       +  EF T G+L D L    R+ V       VL +M
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYM 116
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
                A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    
Sbjct: 117 -----ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDT 165
Query: 156 HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           ++      F   + APE     + + KSDV++FGV+L E+ T G  P
Sbjct: 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/185 (34%), Positives = 86/185 (46%), Gaps = 36/185 (19%)
Query: 43  LKHENLVELLG-----YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +KHEN+++ +G       V+ +L ++   F   GSL D L             V+ W   
Sbjct: 75  MKHENILQFIGAEKRGTSVDVDLWLIT-AFHEKGSLSDFLKAN----------VVSWNEL 123
Query: 98  VRIAVDAARGLEYLHEKV-------QPSIIHRDIRSSNVLLFEDFKAKIADFNLS--NQA 148
             IA   ARGL YLHE +       +P+I HRDI+S NVLL  +  A IADF L+   +A
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 149 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKS-----DVYSFGVVLLELLT----GRKP 199
              A   H    +GT  Y APE        Q+      D+Y+ G+VL EL +       P
Sbjct: 184 GKSAGDTHGQ--VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
Query: 200 VDHTM 204
           VD  M
Sbjct: 242 VDEYM 246

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 81/162 (50%), Gaps = 19/162 (11%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDWM 95
           +V+  +KH NLV+LLG C       +  EF T G+L D L    R+ V       VL +M
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYM 121
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
                A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    
Sbjct: 122 -----ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDT 170
Query: 156 HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           ++      F   + APE     + + KSDV++FGV+L E+ T
Sbjct: 171 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 20/167 (11%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDWM 95
           +V+  +KH NLV+LLG C       +  EF T G+L D L    R+ V       VL +M
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYM 116
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
                A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    
Sbjct: 117 -----ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDT 165
Query: 156 HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           ++      F   + APE     + + KSDV++FGV+L E+ T G  P
Sbjct: 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 95/191 (49%), Gaps = 20/191 (10%)
Query: 15  YPSHENERLKSPKN---YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMG 71
           Y  H    +KS K     PD      +++ +L+H+ LV L     +  + ++  E+   G
Sbjct: 30  YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENG 88
Query: 72  SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 131
           SL D L    G++      +LD      +A   A G+ ++ E+   + IHR++R++N+L+
Sbjct: 89  SLVDFLKTPSGIK-LTINKLLD------MAAQIAEGMAFIEER---NYIHRNLRAANILV 138
Query: 132 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVV 189
            +    KIADF L+    D     ++ R    F   + APE    G  T KSDV+SFG++
Sbjct: 139 SDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 195
Query: 190 LLELLT-GRKP 199
           L E++T GR P
Sbjct: 196 LTEIVTHGRIP 206

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 20/167 (11%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDWM 95
           +V+  +KH NLV+LLG C       +  EF T G+L D L    R+ V       VL +M
Sbjct: 74  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYM 129
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
                A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    
Sbjct: 130 -----ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDT 178
Query: 156 HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           ++      F   + APE     + + KSDV++FGV+L E+ T G  P
Sbjct: 179 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 225

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 31/234 (13%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           +Q ++V+S+     + +  G  ++     +  E+   GS  D+L         +PGP LD
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---------EPGP-LD 122
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
                 I  +  +GL+YLH + +   IHRDI+++NVLL E  + K+ADF ++ Q  D   
Sbjct: 123 ETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--T 177
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 213
           ++     +GT  + APE         K+D++S G+  +EL  G  P     P     L+ 
Sbjct: 178 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP 237
Query: 214 WATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVK 267
              P            P L+G Y              C+  E  FRP    ++K
Sbjct: 238 KNNP------------PTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLK 275

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 81/162 (50%), Gaps = 19/162 (11%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDWM 95
           +V+  +KH NLV+LLG C       +  EF T G+L D L    R+ V       VL +M
Sbjct: 63  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYM 118
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
                A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    
Sbjct: 119 -----ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDT 167
Query: 156 HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           ++      F   + APE     + + KSDV++FGV+L E+ T
Sbjct: 168 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 79/158 (50%), Gaps = 11/158 (6%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +V+  +KH NLV+LLG C       +  EF T G+L D L  R+  +      VL +M  
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYM-- 114
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
              A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS          H+
Sbjct: 115 ---ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHA 168
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
                   + APE     + + KSDV++FGV+L E+ T
Sbjct: 169 GAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 81/162 (50%), Gaps = 19/162 (11%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDWM 95
           +V+  +KH NLV+LLG C       +  EF T G+L D L    R+ V       VL +M
Sbjct: 63  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYM 118
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
                A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    
Sbjct: 119 -----ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDT 167
Query: 156 HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           ++      F   + APE     + + KSDV++FGV+L E+ T
Sbjct: 168 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 13/161 (8%)
Query: 40  VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVR 99
           +  L H ++V LLG C   +L+ L  ++  +GSL D +   +G  G  P  +L+W     
Sbjct: 87  IGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALG--PQLLLNW----- 138
Query: 100 IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR 159
             V  A+G+ YL E     ++HR++ + NVLL    + ++ADF +++  P    +L  + 
Sbjct: 139 -GVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 194
Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
                 + A E    G+ T +SDV+S+GV + EL+T G +P
Sbjct: 195 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 79/158 (50%), Gaps = 11/158 (6%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +V+  +KH NLV+LLG C       +  EF T G+L D L  R+  +      VL +M  
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYM-- 114
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
              A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS          H+
Sbjct: 115 ---ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHA 168
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
                   + APE     + + KSDV++FGV+L E+ T
Sbjct: 169 GAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +++  L+H+ LV L           +  E+   GSL D L   +G +   P  ++D+  +
Sbjct: 60  NLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLP-KLIDFSAQ 118
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +      A G+ Y+  K   + IHRD+R++NVL+ E    KIADF L+    D     ++
Sbjct: 119 I------AEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED---NEYT 166
Query: 158 TRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            R    F   + APE    G  T KSDV+SFG++L E++T G+ P
Sbjct: 167 AREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIP 211

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 81/162 (50%), Gaps = 19/162 (11%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDWM 95
           +V+  +KH NLV+LLG C       +  EF T G+L D L    R+ V       VL +M
Sbjct: 62  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYM 117
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
                A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    
Sbjct: 118 -----ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDT 166
Query: 156 HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           ++      F   + APE     + + KSDV++FGV+L E+ T
Sbjct: 167 YTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 13/161 (8%)
Query: 40  VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVR 99
           +  L H ++V LLG C   +L+ L  ++  +GSL D +   +G  G  P  +L+W     
Sbjct: 69  IGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALG--PQLLLNW----- 120
Query: 100 IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR 159
             V  A+G+ YL E     ++HR++ + NVLL    + ++ADF +++  P    +L  + 
Sbjct: 121 -GVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
                 + A E    G+ T +SDV+S+GV + EL+T G +P
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 85/165 (51%), Gaps = 16/165 (9%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +++  L+H+ LV L     +     +  EF   GSL D L   +G +   P  ++D+  +
Sbjct: 59  NLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLP-KLIDFSAQ 117
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +      A G+ Y+  K   + IHRD+R++NVL+ E    KIADF L+    D     ++
Sbjct: 118 I------AEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED---NEYT 165
Query: 158 TRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            R    F   + APE    G  T KS+V+SFG++L E++T G+ P
Sbjct: 166 AREGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 90/188 (47%), Gaps = 23/188 (12%)
Query: 23  LKSPKNYP--DDEKQL---VSVVSRLKHE-NLVELLGYCVEGNLRVLAYEFATMGSLHDI 76
           +K  K Y   DD +     + V+ +L H  N++ LLG C       LA E+A  G+L D 
Sbjct: 54  IKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 113
Query: 77  LHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 129
           L   + ++              L     +  A D ARG++YL +K     IHR++ + N+
Sbjct: 114 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNI 170
Query: 130 LLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFG 187
           L+ E++ AKIADF LS         ++  + +G     + A E       T  SDV+S+G
Sbjct: 171 LVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 225
Query: 188 VVLLELLT 195
           V+L E+++
Sbjct: 226 VLLWEIVS 233

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 81/162 (50%), Gaps = 19/162 (11%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDWM 95
           +V+  +KH NLV+LLG C       +  EF T G+L D L    R+ V       VL +M
Sbjct: 63  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYM 118
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
                A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    
Sbjct: 119 -----ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDT 167
Query: 156 HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           ++      F   + APE     + + KSDV++FGV+L E+ T
Sbjct: 168 YTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 135
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 136 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 188
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 189 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 109
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 110 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 162
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 163 RTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 76  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 126
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 127 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 179
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 180 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 109
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 110 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 162
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 163 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 114
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 115 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 167
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 168 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 97/240 (40%), Gaps = 26/240 (10%)
Query: 35  QLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           Q   ++ +  H N+V L+G C +     +  E    G     L      +GA+    L  
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR----TEGAR----LRV 212
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
            T +++  DAA G+EYL  K     IHRD+ + N L+ E    KI+DF +S +  D    
Sbjct: 213 KTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXA 269
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 214
                      + APE    G+ + +SDV+SFG++L E                 SL   
Sbjct: 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF---------------SLGAS 314
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
             P LS  + ++ V+   +                 C  YE   RP+ S + + LQ + K
Sbjct: 315 PYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 112
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 113 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 165
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 166 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 84/181 (46%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + + + L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 42  MKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 102 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 149
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
Query: 202 H 202
Sbjct: 210 Q 210

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 114
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 115 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 167
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 168 RTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 79/167 (47%), Gaps = 8/167 (4%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +  +S+  H N+V      V  +   L  +  + GS+ DI+      +G     VLD  T
Sbjct: 64  IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIK-HIVAKGEHKSGVLDEST 122
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS---NQAPDMAA 153
              I  +   GLEYLH+  Q   IHRD+++ N+LL ED   +IADF +S       D+  
Sbjct: 123 IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 154 RLHSTRVLGTFGYHAPE-YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                  +GT  + APE          K+D++SFG+  +EL TG  P
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
            +V+  +KH NLV+LLG C       +  EF T G+L D L  R+  +      VL +M 
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYM- 323
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
               A   +  +EYL +K   + IHR++ + N L+ E+   K+ADF LS     M    +
Sbjct: 324 ----ATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL---MTGDTY 373
Query: 157 STRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           +      F   + APE     + + KSDV++FGV+L E+ T
Sbjct: 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 114
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 115 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 167
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 168 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 110
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 111 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 163
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 79/167 (47%), Gaps = 8/167 (4%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +  +S+  H N+V      V  +   L  +  + GS+ DI+      +G     VLD  T
Sbjct: 59  IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIK-HIVAKGEHKSGVLDEST 117
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS---NQAPDMAA 153
              I  +   GLEYLH+  Q   IHRD+++ N+LL ED   +IADF +S       D+  
Sbjct: 118 IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 174
Query: 154 RLHSTRVLGTFGYHAPE-YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                  +GT  + APE          K+D++SFG+  +EL TG  P
Sbjct: 175 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 109
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 110 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 162
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 163 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 40  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 99
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 100 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 147
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207
Query: 202 H 202
Sbjct: 208 Q 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 102 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 149
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
Query: 202 H 202
Sbjct: 210 Q 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 109
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 110 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 162
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 163 RTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 109
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 110 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 162
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 163 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 101 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 148
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208
Query: 202 H 202
Sbjct: 209 Q 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 102 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 149
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
Query: 202 H 202
Sbjct: 210 Q 210

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 81/163 (49%), Gaps = 19/163 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDW 94
            +V+  +KH NLV+LLG C       +  EF T G+L D L    R+ V       VL +
Sbjct: 306 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLY 361
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M     A   +  +EYL +K   + IHR++ + N L+ E+   K+ADF LS     M   
Sbjct: 362 M-----ATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL---MTGD 410
Query: 155 LHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            ++      F   + APE     + + KSDV++FGV+L E+ T
Sbjct: 411 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 101 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 148
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208
Query: 202 H 202
Sbjct: 209 Q 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 101 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 148
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208
Query: 202 H 202
Sbjct: 209 Q 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 101 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 148
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208
Query: 202 H 202
Sbjct: 209 Q 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 101 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 148
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208
Query: 202 H 202
Sbjct: 209 Q 209

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 58  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 108
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 109 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 161
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 162 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 102 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 149
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
Query: 202 H 202
Sbjct: 210 Q 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 102 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 149
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
Query: 202 H 202
Sbjct: 210 Q 210

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 101 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 148
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208
Query: 202 H 202
Sbjct: 209 Q 209

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 97/240 (40%), Gaps = 26/240 (10%)
Query: 35  QLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           Q   ++ +  H N+V L+G C +     +  E    G     L      +GA+    L  
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR----TEGAR----LRV 212
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
            T +++  DAA G+EYL  K     IHRD+ + N L+ E    KI+DF +S +  D    
Sbjct: 213 KTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 214
                      + APE    G+ + +SDV+SFG++L E                 SL   
Sbjct: 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF---------------SLGAS 314
Query: 215 ATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLK 274
             P LS  + ++ V+   +                 C  YE   RP+ S + + LQ + K
Sbjct: 315 PYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 102 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 149
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
Query: 202 H 202
Sbjct: 210 Q 210

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 102 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 149
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
Query: 202 H 202
Sbjct: 210 Q 210

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 113
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 114 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 166
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 167 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 110
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 111 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSS----R 163
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 164 RTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 41  MKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 101 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 148
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208
Query: 202 H 202
Sbjct: 209 Q 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 101 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 148
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 149 GLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208
Query: 202 H 202
Sbjct: 209 Q 209

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 112
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 113 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 165
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 166 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 101 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 148
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 149 GLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208
Query: 202 H 202
Sbjct: 209 Q 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 101 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 148
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208
Query: 202 H 202
Sbjct: 209 Q 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 42  MKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 102 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 149
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 150 GLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
Query: 202 H 202
Sbjct: 210 Q 210

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 75/161 (46%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG---PVLDW 94
           SV+      ++V LLG   +G   ++  E    G L   L   +      PG   P L  
Sbjct: 72  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+ K     +HRD+ + N ++  DF  KI DF ++    + A  
Sbjct: 132 M--IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYY 186
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + APE    G  T  SD++SFGVVL E+ +
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 58  GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQP 117
           G L  +  E+    +L DI+H          GP+      + +  DA + L + H   Q 
Sbjct: 88  GPLPYIVMEYVDGVTLRDIVHTE--------GPMTPKRA-IEVIADACQALNFSH---QN 135
Query: 118 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR-VLGTFGYHAPEYAMTGQ 176
            IIHRD++ +N+L+      K+ DF ++    D    +  T  V+GT  Y +PE A    
Sbjct: 136 GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDS 195
Query: 177 LTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
           +  +SDVYS G VL E+LTG  P     P
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 56  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 106
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 107 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 159
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 160 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 41  MKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 101 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 148
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 149 GLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208
Query: 202 H 202
Sbjct: 209 Q 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 85/188 (45%), Gaps = 13/188 (6%)
Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    G
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +    P P        R       G+ YLH      I HRDI+  N+LL E    KI+DF
Sbjct: 101 M----PEP-----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 148
Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P D
Sbjct: 149 GLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208
Query: 202 HTMPRGQQ 209
                 Q+
Sbjct: 209 QPSDSXQE 216

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 80/177 (45%), Gaps = 24/177 (13%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V V+  L+H N+++ +G   +        E+   G+L  I+   K +    P     W  
Sbjct: 58  VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII---KSMDSQYP-----WSQ 109
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           RV  A D A G+ YLH     +IIHRD+ S N L+ E+    +ADF L+    D   +  
Sbjct: 110 RVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166
Query: 157 STR------------VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
             R            V+G   + APE        +K DV+SFG+VL E++ GR   D
Sbjct: 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 75/168 (44%), Gaps = 17/168 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSRFDEQR 113
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL  + + KIADF  S  AP       
Sbjct: 114 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS----R 166
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD-HT 203
            T + GT  Y  PE        +K D++S GV+  E L G  P + HT
Sbjct: 167 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 72/165 (43%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 135
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 136 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 188
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 189 RDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG---PVLDW 94
           SV+      ++V LLG   +G   ++  E    G L   L   +      PG   P L  
Sbjct: 72  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+ K     +HRD+ + N ++  DF  KI DF ++    +    
Sbjct: 132 M--IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXX 186
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + APE    G  T  SD++SFGVVL E+ +
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG---PVLDW 94
           SV+      ++V LLG   +G   ++  E    G L   L   +      PG   P L  
Sbjct: 69  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 128
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+ K     +HRD+ + N ++  DF  KI DF ++    +    
Sbjct: 129 M--IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXX 183
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + APE    G  T  SD++SFGVVL E+ +
Sbjct: 184 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG---PVLDW 94
           SV+      ++V LLG   +G   ++  E    G L   L   +      PG   P L  
Sbjct: 72  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+ K     +HRD+ + N ++  DF  KI DF ++    +    
Sbjct: 132 M--IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXX 186
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + APE    G  T  SD++SFGVVL E+ +
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 111
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIA+F  S  AP       
Sbjct: 112 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS----R 164
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 165 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A  G ++  L         Q     D   
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---------QKLSKFDEQR 114
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 115 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 167
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 168 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 18/168 (10%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           ++ ++ V+V++ +KH N+V+      E     +  ++   G L   ++ +KGV   Q   
Sbjct: 68  EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQEDQ 126
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS---NQ 147
           +LDW  ++ +A      L+++H++    I+HRDI+S N+ L +D   ++ DF ++   N 
Sbjct: 127 ILDWFVQICLA------LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177
Query: 148 APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
             ++A        +GT  Y +PE         KSD+++ G VL EL T
Sbjct: 178 TVELA-----RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 72/165 (43%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 111
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 112 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 164
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 165 RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 72/167 (43%), Gaps = 20/167 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVLDW 94
           + + S L+H N++ +  Y  +     L  EFA  G L+  L  HGR            D 
Sbjct: 65  IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-----------FDE 113
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                   + A  L Y HE+    +IHRDI+  N+L+    + KIADF  S  AP +  R
Sbjct: 114 QRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
                + GT  Y  PE        +K D++  GV+  E L G  P D
Sbjct: 171 X----MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 72/167 (43%), Gaps = 20/167 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVLDW 94
           + + S L+H N++ +  Y  +     L  EFA  G L+  L  HGR            D 
Sbjct: 66  IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-----------FDE 114
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                   + A  L Y HE+    +IHRDI+  N+L+    + KIADF  S  AP +  R
Sbjct: 115 QRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 171
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
                + GT  Y  PE        +K D++  GV+  E L G  P D
Sbjct: 172 X----MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 16/168 (9%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L+H+N+V+  G C     R L    E+   GSL D L   K        
Sbjct: 57  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------- 108
Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             +D +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+   P
Sbjct: 109 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165
Query: 150 DMAARLHSTRVLGT--FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
                    +  G     ++APE     + +  SDV+SFGVVL EL T
Sbjct: 166 -QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP---GPVLDW 94
           SV+      ++V LLG   +G   ++  E  T G L   L   +      P    P L  
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+       +HRD+ + N ++ EDF  KI DF ++    +    
Sbjct: 140 M--IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 58  GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQP 117
           G L  +  E+    +L DI+H          GP+      + +  DA + L + H   Q 
Sbjct: 88  GPLPYIVMEYVDGVTLRDIVHTE--------GPMTPKRA-IEVIADACQALNFSH---QN 135
Query: 118 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR-VLGTFGYHAPEYAMTGQ 176
            IIHRD++ +N+++      K+ DF ++    D    +  T  V+GT  Y +PE A    
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 177 LTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
           +  +SDVYS G VL E+LTG  P     P
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 15/172 (8%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           +Q ++V+S+     + +  G  ++G+   +  E+   GS  D+L         + GP  D
Sbjct: 69  QQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLL---------RAGP-FD 118
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
                 +  +  +GL+YLH + +   IHRDI+++NVLL E    K+ADF ++ Q  D   
Sbjct: 119 EFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--T 173
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
           ++     +GT  + APE         K+D++S G+  +EL  G  P     P
Sbjct: 174 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP 225

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 58  GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQP 117
           G L  +  E+    +L DI+H          GP+      + +  DA + L + H   Q 
Sbjct: 88  GPLPYIVMEYVDGVTLRDIVHTE--------GPMTPKRA-IEVIADACQALNFSH---QN 135
Query: 118 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR-VLGTFGYHAPEYAMTGQ 176
            IIHRD++ +N+++      K+ DF ++    D    +  T  V+GT  Y +PE A    
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 177 LTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
           +  +SDVYS G VL E+LTG  P     P
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 58  GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQP 117
           G L  +  E+    +L DI+H          GP+      + +  DA + L + H   Q 
Sbjct: 88  GPLPYIVMEYVDGVTLRDIVHTE--------GPMTPKRA-IEVIADACQALNFSH---QN 135
Query: 118 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR-VLGTFGYHAPEYAMTGQ 176
            IIHRD++ +N+++      K+ DF ++    D    +  T  V+GT  Y +PE A    
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 177 LTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
           +  +SDVYS G VL E+LTG  P     P
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 58  GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQP 117
           G L  +  E+    +L DI+H          GP+      + +  DA + L + H   Q 
Sbjct: 88  GPLPYIVMEYVDGVTLRDIVHTE--------GPMTPKRA-IEVIADACQALNFSH---QN 135
Query: 118 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR-VLGTFGYHAPEYAMTGQ 176
            IIHRD++ +N+++      K+ DF ++    D    +  T  V+GT  Y +PE A    
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 177 LTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
           +  +SDVYS G VL E+LTG  P     P
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 14/167 (8%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L+H+N+V+  G C     R L    E+   GSL D L   K        
Sbjct: 60  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------- 111
Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             +D +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+   P
Sbjct: 112 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 168
Query: 150 -DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            D               ++APE     + +  SDV+SFGVVL EL T
Sbjct: 169 QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 72/165 (43%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 112
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 113 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 165
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 166 RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 112
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIA+F  S  AP       
Sbjct: 113 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS----R 165
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 166 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 14/167 (8%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L+H+N+V+  G C     R L    E+   GSL D L   K        
Sbjct: 57  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------- 108
Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             +D +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+   P
Sbjct: 109 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165
Query: 150 -DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            D               ++APE     + +  SDV+SFGVVL EL T
Sbjct: 166 QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 58/102 (56%), Gaps = 6/102 (5%)
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           ++++   RGL YL EK Q  I+HRD++ SN+L+    + K+ DF +S Q  D  A     
Sbjct: 118 KVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 171
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y APE       + +SD++S G+ L+EL  GR P+
Sbjct: 172 SFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 14/167 (8%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L+H+N+V+  G C     R L    E+   GSL D L   K        
Sbjct: 61  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------- 112
Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             +D +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+   P
Sbjct: 113 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 169
Query: 150 -DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            D               ++APE     + +  SDV+SFGVVL EL T
Sbjct: 170 QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 14/167 (8%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L+H+N+V+  G C     R L    E+   GSL D L   K        
Sbjct: 56  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------- 107
Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             +D +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+   P
Sbjct: 108 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 164
Query: 150 -DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            D               ++APE     + +  SDV+SFGVVL EL T
Sbjct: 165 QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 14/167 (8%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L+H+N+V+  G C     R L    E+   GSL D L   K        
Sbjct: 55  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------- 106
Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             +D +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+   P
Sbjct: 107 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 163
Query: 150 -DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            D               ++APE     + +  SDV+SFGVVL EL T
Sbjct: 164 QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 14/167 (8%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L+H+N+V+  G C     R L    E+   GSL D L   K        
Sbjct: 62  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------- 113
Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             +D +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+   P
Sbjct: 114 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 170
Query: 150 -DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            D               ++APE     + +  SDV+SFGVVL EL T
Sbjct: 171 QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 76/165 (46%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 110
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP  ++R  
Sbjct: 111 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRD 165
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           +  + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 166 T--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP---GPVLDW 94
           SV+      ++V LLG   +G   ++  E  T G L   L   +      P    P L  
Sbjct: 70  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 129
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+       +HRD+ + N ++ EDF  KI DF ++    +    
Sbjct: 130 M--IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 184
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 185 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 14/167 (8%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L+H+N+V+  G C     R L    E+   GSL D L   K        
Sbjct: 88  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------- 139
Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             +D +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+   P
Sbjct: 140 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196
Query: 150 -DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            D               ++APE     + +  SDV+SFGVVL EL T
Sbjct: 197 QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 14/167 (8%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L+H+N+V+  G C     R L    E+   GSL D L   K        
Sbjct: 64  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------- 115
Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             +D +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+   P
Sbjct: 116 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 172
Query: 150 -DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            D               ++APE     + +  SDV+SFGVVL EL T
Sbjct: 173 QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 14/167 (8%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L+H+N+V+  G C     R L    E+   GSL D L   K        
Sbjct: 57  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------- 108
Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             +D +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+   P
Sbjct: 109 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165
Query: 150 -DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            D               ++APE     + +  SDV+SFGVVL EL T
Sbjct: 166 QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 72/165 (43%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 109
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 110 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 162
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 163 RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP---GPVLDW 94
           SV+      ++V LLG   +G   ++  E  T G L   L   +      P    P L  
Sbjct: 65  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 124
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+       +HRD+ + N ++ EDF  KI DF ++    +    
Sbjct: 125 M--IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 180 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 14/167 (8%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L+H+N+V+  G C     R L    E+   GSL D L   K        
Sbjct: 63  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------- 114
Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             +D +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+   P
Sbjct: 115 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 171
Query: 150 -DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            D               ++APE     + +  SDV+SFGVVL EL T
Sbjct: 172 QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 77/165 (46%), Gaps = 13/165 (7%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V +  +LKH +++EL  Y  + N   L  E    G ++  L  R  V+         +M 
Sbjct: 62  VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMH 119
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           ++        G+ YLH      I+HRD+  SN+LL  +   KIADF L+ Q   M    H
Sbjct: 120 QI------ITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK-MPHEKH 169
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            T + GT  Y +PE A       +SDV+S G +   LL GR P D
Sbjct: 170 YT-LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 12/176 (6%)
Query: 29  YPDDEKQLVS---VVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
           + D+++ L+S   ++S L +HEN+V LLG C  G   ++  E+   G L + L  +  V 
Sbjct: 89  HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVL 148
Query: 85  GAQPG-----PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
              P        L     +  +   A+G+ +L  K   + IHRD+ + NVLL     AKI
Sbjct: 149 ETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKI 205
Query: 140 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            DF L+    + +  +          + APE       T +SDV+S+G++L E+ +
Sbjct: 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 12/176 (6%)
Query: 29  YPDDEKQLVS---VVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
           + D+++ L+S   ++S L +HEN+V LLG C  G   ++  E+   G L + L  +  V 
Sbjct: 89  HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVL 148
Query: 85  GAQPGPVLDWMTR-----VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
              P   +   T      +  +   A+G+ +L  K   + IHRD+ + NVLL     AKI
Sbjct: 149 ETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKI 205
Query: 140 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            DF L+    + +  +          + APE       T +SDV+S+G++L E+ +
Sbjct: 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 72/165 (43%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 109
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 110 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 162
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 163 RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 72/165 (43%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL---------QKLSKFDEQR 109
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 110 TATYITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 162
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 163 RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 72/165 (43%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 112
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 113 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 165
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 166 RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 14/167 (8%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L+H+N+V+  G C     R L    E+   GSL D L   K        
Sbjct: 75  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------- 126
Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             +D +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+   P
Sbjct: 127 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 183
Query: 150 -DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            D               ++APE     + +  SDV+SFGVVL EL T
Sbjct: 184 QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 14/167 (8%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L+H+N+V+  G C     R L    E+   GSL D L   K        
Sbjct: 75  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------- 126
Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             +D +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+   P
Sbjct: 127 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 183
Query: 150 -DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            D               ++APE     + +  SDV+SFGVVL EL T
Sbjct: 184 QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 8/172 (4%)
Query: 29  YPDDEKQLVS---VVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
           + D+++ L+S   ++S L +HEN+V LLG C  G   ++  E+   G L + L  +    
Sbjct: 81  HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAD 140
Query: 85  -GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
              + G  L+    +  +   A+G+ +L  K   + IHRD+ + NVLL     AKI DF 
Sbjct: 141 LDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFG 197
Query: 144 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           L+    + +  +          + APE       T +SDV+S+G++L E+ +
Sbjct: 198 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 86/192 (44%), Gaps = 35/192 (18%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG------------ 79
           D ++  ++++   + N+V+LLG C  G    L +E+   G L++ L              
Sbjct: 96  DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 155
Query: 80  ----RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 135
               R  V    P P L    ++ IA   A G+ YL E+     +HRD+ + N L+ E+ 
Sbjct: 156 DLSTRARVSSPGPPP-LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 211
Query: 136 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHA-------PEYAMTGQLTQKSDVYSFGV 188
             KIADF LS         ++S       G  A       PE     + T +SDV+++GV
Sbjct: 212 VVKIADFGLSRN-------IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 264
Query: 189 VLLELLT-GRKP 199
           VL E+ + G +P
Sbjct: 265 VLWEIFSYGLQP 276

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 8/172 (4%)
Query: 29  YPDDEKQLVS---VVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
           + D+++ L+S   ++S L +HEN+V LLG C  G   ++  E+   G L + L  +    
Sbjct: 89  HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAD 148
Query: 85  -GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
              + G  L+    +  +   A+G+ +L  K   + IHRD+ + NVLL     AKI DF 
Sbjct: 149 LDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFG 205
Query: 144 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           L+    + +  +          + APE       T +SDV+S+G++L E+ +
Sbjct: 206 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 72/165 (43%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQR 112
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 113 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 165
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 166 RDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 58  GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQP 117
           G L  +  E+    +L DI+H          GP+      + +  DA + L + H   Q 
Sbjct: 105 GPLPYIVMEYVDGVTLRDIVHTE--------GPMTPKRA-IEVIADACQALNFSH---QN 152
Query: 118 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR-VLGTFGYHAPEYAMTGQ 176
            IIHRD++ +N+++      K+ DF ++    D    +  T  V+GT  Y +PE A    
Sbjct: 153 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 212
Query: 177 LTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
           +  +SDVYS G VL E+LTG  P     P
Sbjct: 213 VDARSDVYSLGCVLYEVLTGEPPFTGDSP 241

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 14/167 (8%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L+H+N+V+  G C     R L    EF   GSL + L   K        
Sbjct: 60  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHK-------- 111
Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             +D +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+   P
Sbjct: 112 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 168
Query: 150 -DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            D               ++APE     + +  SDV+SFGVVL EL T
Sbjct: 169 QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 79/170 (46%), Gaps = 20/170 (11%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +DE+ ++S+V+   H  ++ + G   +     +  ++   G L  +L   +      P P
Sbjct: 54  NDERLMLSIVT---HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF----PNP 106
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 150
           V  +      A +    LEYLH K    II+RD++  N+LL ++   KI DF  +   PD
Sbjct: 107 VAKFY-----AAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158
Query: 151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
           +   L      GT  Y APE   T    +  D +SFG+++ E+L G  P 
Sbjct: 159 VTYXL-----CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP---GPVLDW 94
           SV+      ++V LLG   +G   ++  E  T G L   L   +      P    P L  
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+       +HRD+ + N ++ EDF  KI DF ++    +    
Sbjct: 134 M--IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 188
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 189 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG---PVLDW 94
           SV+      ++V LLG   +G   ++  E    G L   L   +      PG   P L  
Sbjct: 72  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+ K     +HRD+ + N ++  DF  KI DF ++    +    
Sbjct: 132 M--IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 186
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + APE    G  T  SD++SFGVVL E+ +
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG---PVLDW 94
           SV+      ++V LLG   +G   ++  E    G L   L   +      PG   P L  
Sbjct: 71  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 130
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+ K     +HRD+ + N ++  DF  KI DF ++    +    
Sbjct: 131 M--IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 185
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + APE    G  T  SD++SFGVVL E+ +
Sbjct: 186 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 31/234 (13%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           +Q ++V+S+     +    G  ++     +  E+   GS  D+L         +PGP L+
Sbjct: 65  QQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL---------KPGP-LE 114
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
                 I  +  +GL+YLH + +   IHRDI+++NVLL E    K+ADF ++ Q  D   
Sbjct: 115 ETYIATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--T 169
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 213
           ++     +GT  + APE         K+D++S G+  +EL  G  P     P     L+ 
Sbjct: 170 QIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP 229
Query: 214 WATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVK 267
             +P            P L+G++              C+  +  FRP    ++K
Sbjct: 230 KNSP------------PTLEGQH----SKPFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 16/168 (9%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L+H+N+V+  G C     R L    E+   GSL D L   K        
Sbjct: 58  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------- 109
Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             +D +  ++      +G+EYL  K     IHR++ + N+L+  + + KI DF L+   P
Sbjct: 110 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRNLATRNILVENENRVKIGDFGLTKVLP 166
Query: 150 DMAARLHSTRVLGT--FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
                 +  +  G     ++APE     + +  SDV+SFGVVL EL T
Sbjct: 167 -QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 92/182 (50%), Gaps = 18/182 (9%)
Query: 23  LKSPKNYPDDEKQL--VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR 80
           LK      D E+ +    ++ +L +  +V L+G C +    +L  E A  G LH  L G+
Sbjct: 45  LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK 103
Query: 81  KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 140
           +     +  PV +      +    + G++YL EK   + +HRD+ + NVLL     AKI+
Sbjct: 104 R-----EEIPVSN---VAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKIS 152
Query: 141 DFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GR 197
           DF LS +A       ++ R  G +   ++APE     + + +SDV+S+GV + E L+ G+
Sbjct: 153 DFGLS-KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 211
Query: 198 KP 199
           KP
Sbjct: 212 KP 213

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A +G+++  L         Q     D   
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSRFDEQR 113
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL  + + KIADF  S  AP  ++R  
Sbjct: 114 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAP--SSRRD 168
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD-HT 203
           +  + GT  Y  PE        +K D++S GV+  E L G  P + HT
Sbjct: 169 T--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 14/167 (8%)
Query: 32  DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPG 89
           D ++ + ++  L+H+N+V+  G C     R L    E+   GSL D L            
Sbjct: 60  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAH--------A 111
Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             +D +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+   P
Sbjct: 112 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 168
Query: 150 -DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            D               ++APE     + +  SDV+SFGVVL EL T
Sbjct: 169 QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 81/165 (49%), Gaps = 16/165 (9%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +V+  +KH NLV+LLG C       +  E+   G+L D L  R+  +      VL +M  
Sbjct: 80  AVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL--RECNREEVTAVVLLYM-- 135
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
              A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS     M    ++
Sbjct: 136 ---ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRL---MTGDTYT 186
Query: 158 TRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
                 F   + APE       + KSDV++FGV+L E+ T G  P
Sbjct: 187 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSP 231

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 70/165 (42%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V + S L+H N++ L GY  +     L  E+A  G ++  L         Q     D   
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---------QKLSKFDEQR 114
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                 + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP       
Sbjct: 115 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 167
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              + GT  Y  PE        +K D++S GV+  E L G+ P +
Sbjct: 168 RXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP---GPVLDW 94
           SV+      ++V LLG   +G   ++  E  T G L   L   +      P    P L  
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 139
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+       +HRD+ + N ++ EDF  KI DF ++    +    
Sbjct: 140 M--IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S++ +    ++V+  G   +     +  E+   GS+ DI+  R              +T
Sbjct: 75  ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-----------LT 123
Query: 97  RVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
              IA       +GLEYLH   +   IHRDI++ N+LL  +  AK+ADF ++ Q  D  A
Sbjct: 124 EDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMA 180
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV- 212
           +     V+GT  + APE          +D++S G+  +E+  G+ P     P     ++ 
Sbjct: 181 K--RNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP 238
Query: 213 -----TWATPRLSEDK----VKQCV 228
                T+  P L  D     VKQC+
Sbjct: 239 TNPPPTFRKPELWSDNFTDFVKQCL 263

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP---GPVLDW 94
           SV+      ++V LLG   +G   ++  E  T G L   L   +      P    P L  
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+       +HRD+ + N ++ EDF  KI DF ++    +    
Sbjct: 133 M--IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 188 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP---GPVLDW 94
           SV+      ++V LLG   +G   ++  E  T G L   L   +      P    P L  
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+       +HRD+ + N ++ EDF  KI DF ++    +    
Sbjct: 127 M--IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 75/166 (45%), Gaps = 18/166 (10%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVL--AYEFATMGSLHDILHGRKGVQGAQPGPV 91
           KQ + ++  L HE++++  G C +     L    E+  +GSL D L          P   
Sbjct: 81  KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----------PRHS 130
Query: 92  LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM 151
           +     +  A     G+ YLH +     IHRD+ + NVLL  D   KI DF L+   P+ 
Sbjct: 131 IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE- 186
Query: 152 AARLHSTRVLGT--FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               +  R  G     ++APE     +    SDV+SFGV L ELLT
Sbjct: 187 GHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP---GPVLDW 94
           SV+      ++V LLG   +G   ++  E  T G L   L   +      P    P L  
Sbjct: 71  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 130
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+       +HRD+ + N ++ EDF  KI DF ++    +    
Sbjct: 131 M--IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 185
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 186 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 23  LKSPKNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           LK+  N P  + +L++   V+ +L +  +V ++G C E    +L  E A +G L+  L  
Sbjct: 62  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 120
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
            + V+             + +    + G++YL E    + +HRD+ + NVLL     AKI
Sbjct: 121 NRHVKDKNI---------IELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKI 168
Query: 140 ADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           +DF LS +A       +  +  G +   ++APE     + + KSDV+SFGV++ E  + G
Sbjct: 169 SDFGLS-KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 227
Query: 197 RKP--------VDHTMPRGQQSLVTWATPRLSEDKVKQC 227
           +KP        V   + +G++       PR   D +  C
Sbjct: 228 QKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 266

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 23  LKSPKNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           LK+  N P  + +L++   V+ +L +  +V ++G C E    +L  E A +G L+  L  
Sbjct: 62  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 120
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
            + V+             + +    + G++YL E    + +HRD+ + NVLL     AKI
Sbjct: 121 NRHVKDKNI---------IELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKI 168
Query: 140 ADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           +DF LS +A       +  +  G +   ++APE     + + KSDV+SFGV++ E  + G
Sbjct: 169 SDFGLS-KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 227
Query: 197 RKP--------VDHTMPRGQQSLVTWATPRLSEDKVKQC 227
           +KP        V   + +G++       PR   D +  C
Sbjct: 228 QKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 266

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 23  LKSPKNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           LK+  N P  + +L++   V+ +L +  +V ++G C E    +L  E A +G L+  L  
Sbjct: 60  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 118
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
            + V+             + +    + G++YL E    + +HRD+ + NVLL     AKI
Sbjct: 119 NRHVKDKNI---------IELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKI 166
Query: 140 ADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           +DF LS +A       +  +  G +   ++APE     + + KSDV+SFGV++ E  + G
Sbjct: 167 SDFGLS-KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 225
Query: 197 RKP--------VDHTMPRGQQSLVTWATPRLSEDKVKQC 227
           +KP        V   + +G++       PR   D +  C
Sbjct: 226 QKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 264

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP---GPVLDW 94
           SV+      ++V LLG   +G   ++  E  T G L   L   +      P    P L  
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+       +HRD+ + N ++ EDF  KI DF ++    +    
Sbjct: 133 M--IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 188 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 23  LKSPKNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           LK+  N P  + +L++   V+ +L +  +V ++G C E    +L  E A +G L+  L  
Sbjct: 52  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 110
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
            + V+             + +    + G++YL E    + +HRD+ + NVLL     AKI
Sbjct: 111 NRHVKDKNI---------IELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKI 158
Query: 140 ADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           +DF LS +A       +  +  G +   ++APE     + + KSDV+SFGV++ E  + G
Sbjct: 159 SDFGLS-KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 217
Query: 197 RKP--------VDHTMPRGQQSLVTWATPRLSEDKVKQC 227
           +KP        V   + +G++       PR   D +  C
Sbjct: 218 QKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 256

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP---GPVLDW 94
           SV+      ++V LLG   +G   ++  E  T G L   L   +      P    P L  
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+       +HRD+ + N ++ EDF  KI DF ++    +    
Sbjct: 134 M--IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 188
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 189 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 88/178 (49%), Gaps = 14/178 (7%)
Query: 29  YPDDEKQLVS---VVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--G 82
           + D+++ L+S   ++S L +HEN+V LLG C  G   ++  E+   G L + L  ++  G
Sbjct: 89  HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPG 148
Query: 83  VQGA-----QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
           ++ +      P   L     +  +   A+G+ +L  K   + IHRD+ + NVLL     A
Sbjct: 149 LEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVA 205
Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           KI DF L+    + +  +          + APE       T +SDV+S+G++L E+ +
Sbjct: 206 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 23  LKSPKNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           LK+  N P  + +L++   V+ +L +  +V ++G C E    +L  E A +G L+  L  
Sbjct: 46  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 104
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
            + V+             + +    + G++YL E    + +HRD+ + NVLL     AKI
Sbjct: 105 NRHVKDKNI---------IELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKI 152
Query: 140 ADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           +DF LS +A       +  +  G +   ++APE     + + KSDV+SFGV++ E  + G
Sbjct: 153 SDFGLS-KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 211
Query: 197 RKP--------VDHTMPRGQQSLVTWATPRLSEDKVKQC 227
           +KP        V   + +G++       PR   D +  C
Sbjct: 212 QKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 250

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 23  LKSPKNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           LK+  N P  + +L++   V+ +L +  +V ++G C E    +L  E A +G L+  L  
Sbjct: 42  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 100
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
            + V+             + +    + G++YL E    + +HRD+ + NVLL     AKI
Sbjct: 101 NRHVKDKNI---------IELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKI 148
Query: 140 ADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           +DF LS +A       +  +  G +   ++APE     + + KSDV+SFGV++ E  + G
Sbjct: 149 SDFGLS-KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 207
Query: 197 RKP--------VDHTMPRGQQSLVTWATPRLSEDKVKQC 227
           +KP        V   + +G++       PR   D +  C
Sbjct: 208 QKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 246

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 27/185 (14%)
Query: 31  DDEKQLVSVVSRLK----HENLVELLGYCVEGN------LRVLAYEFATMGSLHDILHGR 80
           D+E+++   ++ LK    H N+    G  ++ N         L  EF   GS+ D++   
Sbjct: 62  DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 121
Query: 81  KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 140
           KG    +     +W+    I  +  RGL +LH   Q  +IHRDI+  NVLL E+ + K+ 
Sbjct: 122 KGNTLKE-----EWI--AYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLV 171
Query: 141 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-----LTQKSDVYSFGVVLLELLT 195
           DF +S Q      R ++   +GT  + APE     +        KSD++S G+  +E+  
Sbjct: 172 DFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229
Query: 196 GRKPV 200
           G  P+
Sbjct: 230 GAPPL 234

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 23  LKSPKNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           LK+  N P  + +L++   V+ +L +  +V ++G C E    +L  E A +G L+  L  
Sbjct: 46  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 104
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
            + V+             + +    + G++YL E    + +HRD+ + NVLL     AKI
Sbjct: 105 NRHVKDKNI---------IELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKI 152
Query: 140 ADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           +DF LS +A       +  +  G +   ++APE     + + KSDV+SFGV++ E  + G
Sbjct: 153 SDFGLS-KALRADENXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 211
Query: 197 RKP--------VDHTMPRGQQSLVTWATPRLSEDKVKQC 227
           +KP        V   + +G++       PR   D +  C
Sbjct: 212 QKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 250

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG---PVLDW 94
           SV+      ++V LLG   +G   ++  E    G L   L   +      PG   P L  
Sbjct: 72  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+ K     +HR++ + N ++  DF  KI DF ++    +    
Sbjct: 132 M--IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 186
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + APE    G  T  SD++SFGVVL E+ +
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 81/174 (46%), Gaps = 20/174 (11%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG--VQGAQP 88
           DD  + V+ +  L H NL+ L G  +   ++++  E A +GSL D L   +G  + G   
Sbjct: 56  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLG--- 111
Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
                  T  R AV  A G+ YL  K     IHRD+ + N+LL      KI DF L    
Sbjct: 112 -------TLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161
Query: 149 P--DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           P  D    +   R +  F + APE   T   +  SD + FGV L E+ T G++P
Sbjct: 162 PQNDDHXVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 23  LKSPKNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           LK+  N P  + +L++   V+ +L +  +V ++G C E    +L  E A +G L+  L  
Sbjct: 40  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 98
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
            + V+             + +    + G++YL E    + +HRD+ + NVLL     AKI
Sbjct: 99  NRHVKDKNI---------IELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKI 146
Query: 140 ADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           +DF LS +A       +  +  G +   ++APE     + + KSDV+SFGV++ E  + G
Sbjct: 147 SDFGLS-KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 205
Query: 197 RKP--------VDHTMPRGQQSLVTWATPRLSEDKVKQC 227
           +KP        V   + +G++       PR   D +  C
Sbjct: 206 QKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 244

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 25/174 (14%)
Query: 41  SRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR------------KGVQGAQP 88
           +RL+H N+V LLG   +     + + + + G LH+ L  R            + V+ A  
Sbjct: 84  ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 143
Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ- 147
            P       V +    A G+EYL       ++H+D+ + NVL+++    KI+D  L  + 
Sbjct: 144 PPDF-----VHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREV 195
Query: 148 -APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            A D    L ++  L    + APE  M G+ +  SD++S+GVVL E+ + G +P
Sbjct: 196 YAADYYKLLGNS--LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP---GPVLDW 94
           SV+      ++V LLG   +G   ++  E  T G L   L   +      P    P L  
Sbjct: 102 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 161
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+       +HRD+ + N ++ EDF  KI DF ++    +    
Sbjct: 162 M--IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 216
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 217 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 81/174 (46%), Gaps = 20/174 (11%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG--VQGAQP 88
           DD  + V+ +  L H NL+ L G  +   ++++  E A +GSL D L   +G  + G   
Sbjct: 66  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLG--- 121
Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
                  T  R AV  A G+ YL  K     IHRD+ + N+LL      KI DF L    
Sbjct: 122 -------TLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171
Query: 149 P--DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           P  D    +   R +  F + APE   T   +  SD + FGV L E+ T G++P
Sbjct: 172 PQNDDHXVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG---PVLDW 94
           SV+      ++V LLG   +G   ++  E    G L   L   +      PG   P L  
Sbjct: 73  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 132
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+ K     +HR++ + N ++  DF  KI DF ++    +    
Sbjct: 133 M--IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 187
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + APE    G  T  SD++SFGVVL E+ +
Sbjct: 188 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 13/164 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           +++ + H +LV LLG C+   ++ L  +    G L + +H  K   G+Q   +L+W    
Sbjct: 93  IMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQL--LLNW---- 145
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
              V  A+G+ YL E+    ++HRD+ + NVL+      KI DF L+          ++ 
Sbjct: 146 --CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 200
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
                  + A E     + T +SDV+S+GV + EL+T G KP D
Sbjct: 201 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 244

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 18/166 (10%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVL--AYEFATMGSLHDILHGRKGVQGAQPGPV 91
           KQ + ++  L HE++++  G C +   + L    E+  +GSL D L          P   
Sbjct: 64  KQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----------PRHS 113
Query: 92  LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM 151
           +     +  A     G+ YLH +     IHR++ + NVLL  D   KI DF L+   P+ 
Sbjct: 114 IGLAQLLLFAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE- 169
Query: 152 AARLHSTRVLGT--FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               +  R  G     ++APE     +    SDV+SFGV L ELLT
Sbjct: 170 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 81/174 (46%), Gaps = 20/174 (11%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG--VQGAQP 88
           DD  + V+ +  L H NL+ L G  +   ++++  E A +GSL D L   +G  + G   
Sbjct: 60  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLG--- 115
Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
                  T  R AV  A G+ YL  K     IHRD+ + N+LL      KI DF L    
Sbjct: 116 -------TLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165
Query: 149 P--DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           P  D    +   R +  F + APE   T   +  SD + FGV L E+ T G++P
Sbjct: 166 PQNDDHYVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 25/174 (14%)
Query: 41  SRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR------------KGVQGAQP 88
           +RL+H N+V LLG   +     + + + + G LH+ L  R            + V+ A  
Sbjct: 67  ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ- 147
            P       V +    A G+EYL       ++H+D+ + NVL+++    KI+D  L  + 
Sbjct: 127 PPDF-----VHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 148 -APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            A D    L ++  L    + APE  M G+ +  SD++S+GVVL E+ + G +P
Sbjct: 179 YAADYYKLLGNS--LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 81/174 (46%), Gaps = 20/174 (11%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG--VQGAQP 88
           DD  + V+ +  L H NL+ L G  +   ++++  E A +GSL D L   +G  + G   
Sbjct: 56  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLG--- 111
Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
                  T  R AV  A G+ YL  K     IHRD+ + N+LL      KI DF L    
Sbjct: 112 -------TLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161
Query: 149 P--DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           P  D    +   R +  F + APE   T   +  SD + FGV L E+ T G++P
Sbjct: 162 PQNDDHYVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 81/174 (46%), Gaps = 20/174 (11%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG--VQGAQP 88
           DD  + V+ +  L H NL+ L G  +   ++++  E A +GSL D L   +G  + G   
Sbjct: 56  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLG--- 111
Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
                  T  R AV  A G+ YL  K     IHRD+ + N+LL      KI DF L    
Sbjct: 112 -------TLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161
Query: 149 P--DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           P  D    +   R +  F + APE   T   +  SD + FGV L E+ T G++P
Sbjct: 162 PQNDDHYVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 81/174 (46%), Gaps = 20/174 (11%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG--VQGAQP 88
           DD  + V+ +  L H NL+ L G  +   ++++  E A +GSL D L   +G  + G   
Sbjct: 66  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLG--- 121
Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
                  T  R AV  A G+ YL  K     IHRD+ + N+LL      KI DF L    
Sbjct: 122 -------TLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171
Query: 149 P--DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           P  D    +   R +  F + APE   T   +  SD + FGV L E+ T G++P
Sbjct: 172 PQNDDHYVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 81/174 (46%), Gaps = 20/174 (11%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG--VQGAQP 88
           DD  + V+ +  L H NL+ L G  +   ++++  E A +GSL D L   +G  + G   
Sbjct: 60  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLG--- 115
Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
                  T  R AV  A G+ YL  K     IHRD+ + N+LL      KI DF L    
Sbjct: 116 -------TLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165
Query: 149 P--DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           P  D    +   R +  F + APE   T   +  SD + FGV L E+ T G++P
Sbjct: 166 PQNDDHYVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 18/166 (10%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVL--AYEFATMGSLHDILHGRKGVQGAQPGPV 91
           KQ + ++  L HE++++  G C +   + L    E+  +GSL D L          P   
Sbjct: 64  KQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----------PRHS 113
Query: 92  LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM 151
           +     +  A     G+ YLH +     IHR++ + NVLL  D   KI DF L+   P+ 
Sbjct: 114 IGLAQLLLFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE- 169
Query: 152 AARLHSTRVLGT--FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               +  R  G     ++APE     +    SDV+SFGV L ELLT
Sbjct: 170 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 8/161 (4%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP---GPVLDW 94
           SV+      ++V LLG   +G   ++  E  T G L   L   +      P    P L  
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M  +++A + A G+ YL+       +HRD+ + N  + EDF  KI DF ++    +    
Sbjct: 127 M--IQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
               + L    + +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           +++ + H +LV LLG C+   ++ L  +    G L + +H  K   G+Q   +L+W  ++
Sbjct: 70  IMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQL--LLNWCVQI 126
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
                 A+G+ YL E+    ++HRD+ + NVL+      KI DF L+          ++ 
Sbjct: 127 ------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 177
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
                  + A E     + T +SDV+S+GV + EL+T G KP D
Sbjct: 178 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 28/219 (12%)
Query: 23  LKSPKNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           LK+  N P  + +L++   V+ +L +  +V ++G C E    +L  E A +G L+  L  
Sbjct: 404 LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 462
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
            + V+      +++ + +V +      G++YL E    + +HRD+ + NVLL     AKI
Sbjct: 463 NRHVKDKN---IIELVHQVSM------GMKYLEES---NFVHRDLAARNVLLVTQHYAKI 510
Query: 140 ADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           +DF LS +A       +  +  G +   ++APE     + + KSDV+SFGV++ E  + G
Sbjct: 511 SDFGLS-KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 569
Query: 197 RKP--------VDHTMPRGQQSLVTWATPRLSEDKVKQC 227
           +KP        V   + +G++       PR   D +  C
Sbjct: 570 QKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 608

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 96/183 (52%), Gaps = 20/183 (10%)
Query: 23  LKSPKNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           LK+  N P  + +L++   V+ +L +  +V ++G C E    +L  E A +G L+  L  
Sbjct: 405 LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 463
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
            + V+      +++ + +V +      G++YL E    + +HRD+ + NVLL     AKI
Sbjct: 464 NRHVKDKN---IIELVHQVSM------GMKYLEES---NFVHRDLAARNVLLVTQHYAKI 511
Query: 140 ADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           +DF LS +A       +  +  G +   ++APE     + + KSDV+SFGV++ E  + G
Sbjct: 512 SDFGLS-KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 570
Query: 197 RKP 199
           +KP
Sbjct: 571 QKP 573

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 92/182 (50%), Gaps = 18/182 (9%)
Query: 23  LKSPKNYPDDEKQL--VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR 80
           LK      D E+ +    ++ +L +  +V L+G C +    +L  E A  G LH  L G+
Sbjct: 371 LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK 429
Query: 81  KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 140
           +     +  PV +      +    + G++YL EK   + +HR++ + NVLL     AKI+
Sbjct: 430 R-----EEIPVSN---VAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKIS 478
Query: 141 DFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GR 197
           DF LS +A       ++ R  G +   ++APE     + + +SDV+S+GV + E L+ G+
Sbjct: 479 DFGLS-KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 537
Query: 198 KP 199
           KP
Sbjct: 538 KP 539

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 13/161 (8%)
Query: 41  SRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI 100
           S+L H+N+V ++    E +   L  E+    +L + +           GP L   T +  
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--------GP-LSVDTAINF 116
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
                 G+++ H+     I+HRDI+  N+L+  +   KI DF ++ +A    +   +  V
Sbjct: 117 TNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNHV 172
Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           LGT  Y +PE A      + +D+YS G+VL E+L G  P +
Sbjct: 173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 21/185 (11%)
Query: 29  YPDDEKQLVS---VVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH------ 78
           + D+++ L+S   ++S L +HEN+V LLG C  G   ++  E+   G L + L       
Sbjct: 74  HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAM 133
Query: 79  -GRKGVQGAQP-------GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 130
            G     G  P       G  L+    +  +   A+G+ +L  K   + IHRD+ + NVL
Sbjct: 134 LGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 190
Query: 131 LFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVL 190
           L     AKI DF L+    + +  +          + APE       T +SDV+S+G++L
Sbjct: 191 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 250
Query: 191 LELLT 195
            E+ +
Sbjct: 251 WEIFS 255

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + V+   K+ N+V  L   + G+   +  E+   GSL D++              +D   
Sbjct: 68  ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQ 117
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARL 155
              +  +  + LE+LH      +IHRDI+S N+LL  D   K+ DF    Q  P+ + R 
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 173
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 214
             + ++GT  + APE         K D++S G++ +E++ G  P  +  P R    + T 
Sbjct: 174 --SEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 215 ATPRLSE---------DKVKQCVD 229
            TP L           D + +C+D
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLD 255

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/112 (38%), Positives = 59/112 (52%), Gaps = 8/112 (7%)
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD---MAAR 154
           +   +  ARG+EYL E+     +HRD+ + N +L E F  K+ADF L+    D    + +
Sbjct: 127 ISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ 183
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMP 205
            H    L    + A E   T + T KSDV+SFGV+L ELLT G  P  H  P
Sbjct: 184 QHRHARLPV-KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 66/132 (50%), Gaps = 13/132 (9%)
Query: 63  LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR 122
           +  EF   G+L   +  R+G +       LD +  + +     +G++Y+H K    +IHR
Sbjct: 111 IQMEFCDKGTLEQWIEKRRGEK-------LDKVLALELFEQITKGVDYIHSK---KLIHR 160
Query: 123 DIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSD 182
           D++ SN+ L +  + KI DF L     +   R   TR  GT  Y +PE   +    ++ D
Sbjct: 161 DLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVD 217
Query: 183 VYSFGVVLLELL 194
           +Y+ G++L ELL
Sbjct: 218 LYALGLILAELL 229

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 71/150 (47%), Gaps = 26/150 (17%)
Query: 63  LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV------------DAARGLEY 110
           L Y F T G L+ IL   +G          D  TR+   V            + A  L++
Sbjct: 91  LHYAFQTEGKLYLILDFLRGG---------DLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH      II+RD++  N+LL E+   K+ DF LS ++ D   + +S    GT  Y APE
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPE 196
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
                  TQ +D +SFGV++ E+LTG  P 
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/132 (36%), Positives = 70/132 (53%), Gaps = 13/132 (9%)
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           +IAV   + LE+LH K+  S+IHRD++ SNVL+    + K+ DF +S    D  A+   T
Sbjct: 157 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAK---T 211
Query: 159 RVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLELLTGRKPVDHTMPRGQQ--SL 211
              G   Y APE  +  +L Q     KSD++S G+ ++EL   R P D      QQ   +
Sbjct: 212 IDAGCKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 270
Query: 212 VTWATPRLSEDK 223
           V   +P+L  DK
Sbjct: 271 VEEPSPQLPADK 282

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + V+   K+ N+V  L   + G+   +  E+   GSL D++              +D   
Sbjct: 68  ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQ 117
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARL 155
              +  +  + LE+LH      +IHRDI+S N+LL  D   K+ DF    Q  P+ + R 
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 173
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 214
             + ++GT  + APE         K D++S G++ +E++ G  P  +  P R    + T 
Sbjct: 174 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 215 ATPRLSE---------DKVKQCVD 229
            TP L           D + +C+D
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLD 255

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 58/102 (56%), Gaps = 6/102 (5%)
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           ++++   +GL YL EK +  I+HRD++ SN+L+    + K+ DF +S Q  D  A     
Sbjct: 170 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 223
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 224 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 71/149 (47%), Gaps = 26/149 (17%)
Query: 63  LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV------------DAARGLEY 110
           L Y F T G L+ IL   +G          D  TR+   V            + A  L++
Sbjct: 91  LHYAFQTEGKLYLILDFLRGG---------DLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH      II+RD++  N+LL E+   K+ DF LS ++ D   + +S    GT  Y APE
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPE 196
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                  TQ +D +SFGV++ E+LTG  P
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 58/102 (56%), Gaps = 6/102 (5%)
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           ++++   +GL YL EK +  I+HRD++ SN+L+    + K+ DF +S Q  D  A     
Sbjct: 108 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 161
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 58/102 (56%), Gaps = 6/102 (5%)
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           ++++   +GL YL EK +  I+HRD++ SN+L+    + K+ DF +S Q  D  A     
Sbjct: 108 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 161
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 18/185 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + V+   K+ N+V  L   + G+   +  E+   GSL D++              +D   
Sbjct: 68  ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQ 117
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARL 155
              +  +  + LE+LH      +IHRDI+S N+LL  D   K+ DF    Q  P+ + R 
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 173
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 214
             + ++GT  + APE         K D++S G++ +E++ G  P  +  P R    + T 
Sbjct: 174 --SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 215 ATPRL 219
            TP L
Sbjct: 232 GTPEL 236

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 71/149 (47%), Gaps = 26/149 (17%)
Query: 63  LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV------------DAARGLEY 110
           L Y F T G L+ IL   +G          D  TR+   V            + A  L++
Sbjct: 92  LHYAFQTEGKLYLILDFLRGG---------DLFTRLSKEVMFTEEDVKFYLAELALALDH 142
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH      II+RD++  N+LL E+   K+ DF LS ++ D   + +S    GT  Y APE
Sbjct: 143 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPE 197
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                  TQ +D +SFGV++ E+LTG  P
Sbjct: 198 VVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 58/102 (56%), Gaps = 6/102 (5%)
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           ++++   +GL YL EK +  I+HRD++ SN+L+    + K+ DF +S Q  D  A     
Sbjct: 135 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 188
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 58/102 (56%), Gaps = 6/102 (5%)
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           ++++   +GL YL EK +  I+HRD++ SN+L+    + K+ DF +S Q  D  A     
Sbjct: 108 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 161
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 18/185 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + V+   K+ N+V  L   + G+   +  E+   GSL D++              +D   
Sbjct: 69  ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQ 118
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARL 155
              +  +  + LE+LH      +IHRDI+S N+LL  D   K+ DF    Q  P+ + R 
Sbjct: 119 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 174
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 214
             + ++GT  + APE         K D++S G++ +E++ G  P  +  P R    + T 
Sbjct: 175 --SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 232
Query: 215 ATPRL 219
            TP L
Sbjct: 233 GTPEL 237

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 82/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 83  IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 132
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM-A 152
            +  +   +  A+G++YL  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 133 DL--IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEX 187
Query: 153 ARLHS-TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             +H+ T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 188 XSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 58/102 (56%), Gaps = 6/102 (5%)
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           ++++   +GL YL EK +  I+HRD++ SN+L+    + K+ DF +S Q  D  A     
Sbjct: 108 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 161
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 58/102 (56%), Gaps = 6/102 (5%)
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           ++++   +GL YL EK +  I+HRD++ SN+L+    + K+ DF +S Q  D  A     
Sbjct: 108 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 161
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 83/168 (49%), Gaps = 20/168 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVLDW 94
           V ++  L H N+V+L           L  E+A+ G + D L  HGR   + A+       
Sbjct: 62  VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR------- 114
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
            ++ R  V A   ++Y H+K    I+HRD+++ N+LL  D   KIADF  SN+   +  +
Sbjct: 115 -SKFRQIVSA---VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGK 166
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQ-KSDVYSFGVVLLELLTGRKPVD 201
           L +    G+  Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 167 LDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 74/165 (44%), Gaps = 17/165 (10%)
Query: 45  HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR--------------KGVQGAQPGP 90
           HEN+V LLG C       L +E+   G L + L  +              K ++  +   
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 150
           VL +   +  A   A+G+E+L  K   S +HRD+ + NVL+      KI DF L+     
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            +  +          + APE    G  T KSDV+S+G++L E+ +
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 6/102 (5%)
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           ++++   +GL YL EK    I+HRD++ SN+L+    + K+ DF +S Q  D  A     
Sbjct: 127 KVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 180
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 181 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 17/166 (10%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G    G L ++  E+   GSL   L    G            M  
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--------FTIMQL 153
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS---NQAPDMAAR 154
           V +      G+ YL +      +HRD+ + NVL+  +   K++DF LS      PD A  
Sbjct: 154 VGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT 210
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
               ++     + APE       +  SDV+SFGVV+ E+L  G +P
Sbjct: 211 TTGGKI--PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 27/187 (14%)
Query: 30  PDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA 86
           P + + L+S   V+ ++ H ++++L G C +    +L  E+A  GSL   L   + V   
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG-- 124
Query: 87  QPGPV------------------LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 128
            PG +                  L     +  A   ++G++YL E    S++HRD+ + N
Sbjct: 125 -PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---SLVHRDLAARN 180
Query: 129 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGV 188
           +L+ E  K KI+DF LS    +  + +  ++      + A E       T +SDV+SFGV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 189 VLLELLT 195
           +L E++T
Sbjct: 241 LLWEIVT 247

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 81/168 (48%), Gaps = 20/168 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVLDW 94
           V ++  L H N+V+L           L  E+A+ G + D L  HGR   + A+       
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR------- 116
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             + R  V A   ++Y H+K    I+HRD+++ N+LL  D   KIADF  SN+      +
Sbjct: 117 -AKFRQIVSA---VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNK 168
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQ-KSDVYSFGVVLLELLTGRKPVD 201
           L +    G+  Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 169 LDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 81/168 (48%), Gaps = 20/168 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVLDW 94
           V ++  L H N+V+L           L  E+A+ G + D L  HGR   + A+       
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR------- 116
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             + R  V A   ++Y H+K    I+HRD+++ N+LL  D   KIADF  SN+      +
Sbjct: 117 -AKFRQIVSA---VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNK 168
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQ-KSDVYSFGVVLLELLTGRKPVD 201
           L +    G+  Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 169 LDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 81/168 (48%), Gaps = 20/168 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVLDW 94
           V ++  L H N+V+L           L  E+A+ G + D L  HGR   + A+       
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR------- 116
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             + R  V A   ++Y H+K    I+HRD+++ N+LL  D   KIADF  SN+      +
Sbjct: 117 -AKFRQIVSA---VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNK 168
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQ-KSDVYSFGVVLLELLTGRKPVD 201
           L +    G+  Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 169 LDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 133
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  +   +  A+G++YL  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 134 DL--IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 188
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  + T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 189 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 103 IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 152
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  +   +  A+G++YL  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 153 DL--IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 207
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  + T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 208 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 133
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  +   +  A+G++YL  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 134 DL--IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 188
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  + T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 189 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 82/168 (48%), Gaps = 20/168 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVLDW 94
           V ++  L H N+V+L           L  E+A+ G + D L  HGR   + A+       
Sbjct: 65  VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR------- 117
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
            ++ R  V A   ++Y H+K    I+HRD+++ N+LL  D   KIADF  SN+   +  +
Sbjct: 118 -SKFRQIVSA---VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGK 169
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQ-KSDVYSFGVVLLELLTGRKPVD 201
           L +    G   Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 170 LDA--FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-HGRKGVQGAQPGPVLDWM 95
           V ++   +HEN+VE+    + G+   +  EF   G+L DI+ H R   +          +
Sbjct: 199 VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---------QI 249
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
             V +AV  A  L  LH +    +IHRDI+S ++LL  D + K++DF    Q      R 
Sbjct: 250 AAVCLAVLQA--LSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 303
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 214
               ++GT  + APE         + D++S G++++E++ G  P  +  P +  + +   
Sbjct: 304 -RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 362
Query: 215 ATPRLSEDKVKQCVDPKLKG 234
             PRL   K    V P LKG
Sbjct: 363 LPPRL---KNLHKVSPSLKG 379

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 81  IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 130
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  +   +  A+G++YL  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 131 DL--IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 185
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  + T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 186 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 83  IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 132
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  +   +  A+G++YL  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 133 DL--IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 187
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  + T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 188 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 82  IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 131
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  +   +  A+G++YL  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 132 DL--IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 186
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  + T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 187 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 76  IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 125
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  +   +  A+G++YL  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 126 DL--IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 180
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  + T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 181 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 102 IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 151
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  +   +  A+G++YL  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 152 DL--IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 206
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  + T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 207 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 82/168 (48%), Gaps = 20/168 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVLDW 94
           V ++  L H N+V+L           L  E+A+ G + D L  HGR   + A+       
Sbjct: 65  VRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR------- 117
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             + R  V A   ++Y H+K    I+HRD+++ N+LL  D   KIADF  SN+   +  +
Sbjct: 118 -AKFRQIVSA---VQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFT-VGNK 169
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQ-KSDVYSFGVVLLELLTGRKPVD 201
           L +    G+  Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 170 LDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 17/166 (10%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G    G L ++  E+   GSL   L    G            M  
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--------FTIMQL 153
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS---NQAPDMAAR 154
           V +      G+ YL +      +HRD+ + NVL+  +   K++DF LS      PD A  
Sbjct: 154 VGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
               ++     + APE       +  SDV+SFGVV+ E+L  G +P
Sbjct: 211 TTGGKI--PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 79  IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 128
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  +   +  A+G++YL  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 129 DL--IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  + T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 71/149 (47%), Gaps = 26/149 (17%)
Query: 63  LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV------------DAARGLEY 110
           L Y F T G L+ IL   +G          D  TR+   V            + A GL++
Sbjct: 95  LHYAFQTEGKLYLILDFLRGG---------DLFTRLSKEVMFTEEDVKFYLAELALGLDH 145
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH      II+RD++  N+LL E+   K+ DF LS +A D   + +S    GT  Y APE
Sbjct: 146 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEYMAPE 200
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                  +  +D +S+GV++ E+LTG  P
Sbjct: 201 VVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 37  VSVVSRLKHENLVELLGYCV-EGNLRV-LAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           + ++  L HE++V+  G C  +G   V L  E+  +GSL D L          P   +  
Sbjct: 61  IEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----------PRHCVGL 110
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
              +  A     G+ YLH +     IHR + + NVLL  D   KI DF L+   P+    
Sbjct: 111 AQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE-GHE 166
Query: 155 LHSTRVLGT--FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            +  R  G     ++APE     +    SDV+SFGV L ELLT
Sbjct: 167 YYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 37  VSVVSRLKHENLVELLGYCV-EGNLRV-LAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           + ++  L HE++V+  G C  +G   V L  E+  +GSL D L          P   +  
Sbjct: 62  IEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----------PRHCVGL 111
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
              +  A     G+ YLH +     IHR + + NVLL  D   KI DF L+   P+    
Sbjct: 112 AQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE-GHE 167
Query: 155 LHSTRVLGT--FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            +  R  G     ++APE     +    SDV+SFGV L ELLT
Sbjct: 168 YYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 93/187 (49%), Gaps = 22/187 (11%)
Query: 21  ERLKSPKNYPDDEKQLVSVVSRLKHEN---LVELLGYCVEGNLRVLAYEFATMGSLHDIL 77
           ++++   N  ++++ L+ +   LK  +   +V+  G  +      +A E   MG+  + L
Sbjct: 56  KQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL--MGTCAEKL 113
Query: 78  HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
             +K +QG  P  +L  MT     V   + L YL EK    +IHRD++ SN+LL E  + 
Sbjct: 114 --KKRMQGPIPERILGKMT-----VAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQI 164
Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLE 192
           K+ DF +S +  D  A+    R  G   Y APE       T+     ++DV+S G+ L+E
Sbjct: 165 KLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
Query: 193 LLTGRKP 199
           L TG+ P
Sbjct: 222 LATGQFP 228

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/105 (39%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           +I +   + L +L E ++  IIHRDI+ SN+LL      K+ DF +S Q  D  A+   T
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---T 183
Query: 159 RVLGTFGYHAPEYAMTGQLTQ----KSDVYSFGVVLLELLTGRKP 199
           R  G   Y APE        Q    +SDV+S G+ L EL TGR P
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 80/168 (47%), Gaps = 20/168 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVLDW 94
           V ++  L H N+V+L           L  E+A+ G + D L  HGR   + A+       
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR------- 116
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             + R  V A   ++Y H+K    I+HRD+++ N+LL  D   KIADF  SN+      +
Sbjct: 117 -AKFRQIVSA---VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNK 168
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQ-KSDVYSFGVVLLELLTGRKPVD 201
           L +    G   Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 169 LDA--FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-HGRKGVQGAQPGPVLDWM 95
           V ++   +HEN+VE+    + G+   +  EF   G+L DI+ H R   +          +
Sbjct: 122 VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---------QI 172
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
             V +AV  A  L  LH +    +IHRDI+S ++LL  D + K++DF    Q      R 
Sbjct: 173 AAVCLAVLQA--LSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 226
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 214
               ++GT  + APE         + D++S G++++E++ G  P  +  P +  + +   
Sbjct: 227 -RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 285
Query: 215 ATPRLSEDKVKQCVDPKLKG 234
             PRL   K    V P LKG
Sbjct: 286 LPPRL---KNLHKVSPSLKG 302

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 80/168 (47%), Gaps = 20/168 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVLDW 94
           V ++  L H N+V+L           L  E+A+ G + D L  HGR   + A+       
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR------- 116
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             + R  V A   ++Y H+K    I+HRD+++ N+LL  D   KIADF  SN+      +
Sbjct: 117 -AKFRQIVSA---VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNK 168
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQ-KSDVYSFGVVLLELLTGRKPVD 201
           L      G+  Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 169 LDE--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 57/101 (56%), Gaps = 6/101 (5%)
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           ++++   +GL YL EK +  I+HRD++ SN+L+    + K+ DF +S Q  D  A     
Sbjct: 111 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMA----N 164
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             +GT  Y +PE       + +SD++S G+ L+E+  GR P
Sbjct: 165 EFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-HGRKGVQGAQPGPVLDWM 95
           V ++   +HEN+VE+    + G+   +  EF   G+L DI+ H R   +          +
Sbjct: 77  VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ---------I 127
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
             V +AV   + L  LH +    +IHRDI+S ++LL  D + K++DF    Q      R 
Sbjct: 128 AAVCLAV--LQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 181
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 214
               ++GT  + APE         + D++S G++++E++ G  P  +  P +  + +   
Sbjct: 182 -RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 240
Query: 215 ATPRLSEDKVKQCVDPKLKG 234
             PRL   K    V P LKG
Sbjct: 241 LPPRL---KNLHKVSPSLKG 257

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A +   GL++LH K    I++RD++  N+LL +D   KIADF +  +  +M     +   
Sbjct: 125 AAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKTNEF 179
Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
            GT  Y APE  +  +     D +SFGV+L E+L G+ P 
Sbjct: 180 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 85  IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 134
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  +   +  A+G+++L  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 135 DL--IGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEF 189
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  + T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 190 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 133
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  +   +  A+G+++L  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 134 DL--IGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 188
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  + T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 189 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 192
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  +   +  A+G+++L  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 193 DL--IGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  + T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D  A   +TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----W 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 82  IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 131
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  +   +  A+G+++L  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 132 DL--IGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 186
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  + T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 187 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D  A   +TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----W 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-HGRKGVQGAQPGPVLDWM 95
           V ++   +HEN+VE+    + G+   +  EF   G+L DI+ H R   +          +
Sbjct: 79  VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---------QI 129
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
             V +AV  A  L  LH +    +IHRDI+S ++LL  D + K++DF    Q      R 
Sbjct: 130 AAVCLAVLQA--LSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 183
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 214
               ++GT  + APE         + D++S G++++E++ G  P  +  P +  + +   
Sbjct: 184 -RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 242
Query: 215 ATPRLSEDKVKQCVDPKLKG 234
             PRL   K    V P LKG
Sbjct: 243 LPPRL---KNLHKVSPSLKG 259

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 89  IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 138
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  +   +  A+G+++L  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 139 DL--IGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 193
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  + T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 194 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 86/176 (48%), Gaps = 32/176 (18%)
Query: 35  QLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           Q ++++ +L H N+V+L+    + N   L   F  +                  GPV++ 
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ----------------GPVMEV 128
Query: 95  MTRVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 146
            T   ++ D AR        G+EYLH +    IIHRDI+ SN+L+ ED   KIADF +SN
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LTQKS-DVYSFGVVLLELLTGRKP 199
           +     A L +T  +GT  + APE     +   + K+ DV++ GV L   + G+ P
Sbjct: 186 EFKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 85  IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 134
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  +   +  A+G+++L  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 135 DL--IGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 189
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  + T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 190 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 39  VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 93
           ++    H N++ LLG C+  EG+ L VL Y          + HG  R  ++     P + 
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPY----------MKHGDLRNFIRNETHNPTVK 133
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  +   +  A+G+++L  K     +HRD+ + N +L E F  K+ADF L+    D   
Sbjct: 134 DL--IGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 188
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  + T       + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 189 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D  A   +TR      
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----W 183
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A +   GL++LH K    I++RD++  N+LL +D   KIADF +  +  +M     +   
Sbjct: 124 AAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKTNXF 178
Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
            GT  Y APE  +  +     D +SFGV+L E+L G+ P 
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 27/187 (14%)
Query: 30  PDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA 86
           P + + L+S   V+ ++ H ++++L G C +    +L  E+A  GSL   L   + V   
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG-- 124
Query: 87  QPGPV------------------LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 128
            PG +                  L     +  A   ++G++YL E     ++HRD+ + N
Sbjct: 125 -PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN 180
Query: 129 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGV 188
           +L+ E  K KI+DF LS    +  + +  ++      + A E       T +SDV+SFGV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 189 VLLELLT 195
           +L E++T
Sbjct: 241 LLWEIVT 247

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-HGRKGVQGAQPGPVLDWM 95
           V ++   +HEN+VE+    + G+   +  EF   G+L DI+ H R   +          +
Sbjct: 68  VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ---------I 118
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
             V +AV   + L  LH +    +IHRDI+S ++LL  D + K++DF    Q      R 
Sbjct: 119 AAVCLAV--LQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 172
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 214
               ++GT  + APE         + D++S G++++E++ G  P  +  P +  + +   
Sbjct: 173 -RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 231
Query: 215 ATPRLSEDKVKQCVDPKLKG 234
             PRL   K    V P LKG
Sbjct: 232 LPPRL---KNLHKVSPSLKG 248

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 84/185 (45%), Gaps = 18/185 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + V+   K+ N+V  L   + G+   +  E+   GSL D++              +D   
Sbjct: 69  ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQ 118
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARL 155
              +  +  + LE+LH      +IHR+I+S N+LL  D   K+ DF    Q  P+ + R 
Sbjct: 119 IAAVCRECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 174
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 214
             + ++GT  + APE         K D++S G++ +E++ G  P  +  P R    + T 
Sbjct: 175 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 232
Query: 215 ATPRL 219
            TP L
Sbjct: 233 GTPEL 237

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-HGRKGVQGAQPGPVLDWM 95
           V ++   +HEN+VE+    + G+   +  EF   G+L DI+ H R   +          +
Sbjct: 72  VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---------QI 122
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
             V +AV   + L  LH +    +IHRDI+S ++LL  D + K++DF    Q      R 
Sbjct: 123 AAVCLAV--LQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 176
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 214
               ++GT  + APE         + D++S G++++E++ G  P  +  P +  + +   
Sbjct: 177 -RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 235
Query: 215 ATPRLSEDKVKQCVDPKLKG 234
             PRL   K    V P LKG
Sbjct: 236 LPPRL---KNLHKVSPSLKG 252

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 79/168 (47%), Gaps = 20/168 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVLDW 94
           V +   L H N+V+L           L  E+A+ G + D L  HGR   + A+       
Sbjct: 64  VRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEAR------- 116
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             + R  V A   ++Y H+K    I+HRD+++ N+LL  D   KIADF  SN+      +
Sbjct: 117 -AKFRQIVSA---VQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFT-FGNK 168
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQ-KSDVYSFGVVLLELLTGRKPVD 201
           L +    G   Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 169 LDA--FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 21/172 (12%)
Query: 37  VSVVSRLKHENLV------ELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           + ++ +L H N+V      + L      +L +LA E+   G L   L+  +   G + GP
Sbjct: 63  IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 122
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQ 147
           +   ++      D +  L YLHE     IIHRD++  N++L    +    KI D      
Sbjct: 123 IRTLLS------DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY--- 170
Query: 148 APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           A ++      T  +GT  Y APE     + T   D +SFG +  E +TG +P
Sbjct: 171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 69/132 (52%), Gaps = 13/132 (9%)
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           +IAV   + LE+LH K+  S+IHRD++ SNVL+    + K+ DF +S    D  A+    
Sbjct: 113 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 159 RVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLELLTGRKPVDHTMPRGQQ--SL 211
              G   Y APE  +  +L Q     KSD++S G+ ++EL   R P D      QQ   +
Sbjct: 171 ---GCKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
Query: 212 VTWATPRLSEDK 223
           V   +P+L  DK
Sbjct: 227 VEEPSPQLPADK 238

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 21/172 (12%)
Query: 37  VSVVSRLKHENLV------ELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           + ++ +L H N+V      + L      +L +LA E+   G L   L+  +   G + GP
Sbjct: 64  IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 123
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQ 147
           +   ++      D +  L YLHE     IIHRD++  N++L    +    KI D      
Sbjct: 124 IRTLLS------DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY--- 171
Query: 148 APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           A ++      T  +GT  Y APE     + T   D +SFG +  E +TG +P
Sbjct: 172 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 82/183 (44%), Gaps = 19/183 (10%)
Query: 23  LKSPKNYPDD---EKQLVSVVS--RLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL 77
           +K+ KN   D   EK L   ++  +  H ++V+L+G   E  + ++  E  T+G L   L
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFL 101
Query: 78  HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
             RK          LD  + +  A   +  L YL  K     +HRDI + NVL+  +   
Sbjct: 102 QVRKFS--------LDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV 150
Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           K+ DF LS    D      S   L    + APE     + T  SDV+ FGV + E+L  G
Sbjct: 151 KLGDFGLSRYMEDSTXXKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 209
Query: 197 RKP 199
            KP
Sbjct: 210 VKP 212

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 27/187 (14%)
Query: 30  PDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA 86
           P + + L+S   V+ ++ H ++++L G C +    +L  E+A  GSL   L   + V   
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG-- 124
Query: 87  QPGPV------------------LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 128
            PG +                  L     +  A   ++G++YL E     ++HRD+ + N
Sbjct: 125 -PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN 180
Query: 129 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGV 188
           +L+ E  K KI+DF LS    +  + +  ++      + A E       T +SDV+SFGV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 189 VLLELLT 195
           +L E++T
Sbjct: 241 LLWEIVT 247

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 15/166 (9%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  EF   GSL   L    G            +  
Sbjct: 86  SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ--------FTVIQL 137
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +    + +HRD+ + N+L+  +   K++DF LS    D  +    
Sbjct: 138 VGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 194
Query: 158 TRVLGT---FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           T  LG      + APE     + T  SDV+S+G+V+ E+++ G +P
Sbjct: 195 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-HGRKGVQGAQPGPVLDWM 95
           V ++    H+N+V++    + G+   +  EF   G+L DI+ H R   +           
Sbjct: 93  VVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI--------- 143
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
               + +   R L YLH +    +IHRDI+S ++LL  D + K++DF    Q      + 
Sbjct: 144 --ATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK- 197
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
               ++GT  + APE         + D++S G++++E++ G  P
Sbjct: 198 -RKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 45  HENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR---VRI 100
           H N+V LLG C + G   ++  EF   G+L   L  ++           D++T    +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAARLHS 157
           +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+    + PD   R   
Sbjct: 150 SFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY-VRKGD 205
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            R+     + APE       T +SDV+SFGV+L E+ +
Sbjct: 206 ARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 73  EGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 131
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W       V  A+G+ YL ++    ++HRD+ + 
Sbjct: 132 MPFGCLLDYVREHKDNIGSQY--LLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 180
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 181 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 240
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 241 VTVWELMTFGSKPYD 255

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 14/163 (8%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           V+SRL H   V+L  +C + + ++     +A  G L   +         + G   +  TR
Sbjct: 90  VMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTR 140
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
              A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  +
Sbjct: 141 FYTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 196
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
              +GT  Y +PE        + SD+++ G ++ +L+ G  P 
Sbjct: 197 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 39  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 97
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W       V  A+G+ YL ++    ++HRD+ + 
Sbjct: 98  MPFGCLLDYVREHKDNIGSQY--LLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 146
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 207 VTVWELMTFGSKPYD 221

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 13/164 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V++ + + ++  LLG C+   ++++  +    G L D +   K   G+Q   +L+W    
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW---- 132
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
              V  A+G+ YL ++    ++HRD+ + NVL+      KI DF L+          H+ 
Sbjct: 133 --CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 187
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
                  + A E  +    T +SDV+S+GV + EL+T G KP D
Sbjct: 188 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 45  HENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI--- 100
           H N+V LLG C + G   ++  EF   G+L   L  ++           D++T   +   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAARLHS 157
           +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+    + PD   R   
Sbjct: 150 SFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGD 205
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            R+     + APE       T +SDV+SFGV+L E+ +
Sbjct: 206 ARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 19/183 (10%)
Query: 23  LKSPKNYPDD---EKQLVSVVS--RLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL 77
           +K+ KN   D   EK L   ++  +  H ++V+L+G   E  + ++  E  T+G L   L
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFL 101
Query: 78  HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
             RK          LD  + +  A   +  L YL  K     +HRDI + NVL+  +   
Sbjct: 102 QVRKYS--------LDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV 150
Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           K+ DF LS    D +    +++      + APE     + T  SDV+ FGV + E+L  G
Sbjct: 151 KLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 209
Query: 197 RKP 199
            KP
Sbjct: 210 VKP 212

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 39  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 97
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 98  MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 146
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 207 VTVWELMTFGSKPYD 221

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 39  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 97
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 98  MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 146
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 207 VTVWELMTFGSKPYD 221

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 88/195 (45%), Gaps = 23/195 (11%)
Query: 15  YPSHENERL----KSPKNYPDD---EKQLVSVVS--RLKHENLVELLGYCVEGNLRVLAY 65
           Y S EN  L    K+ KN   D   EK L   ++  +  H ++V+L+G   E  + ++  
Sbjct: 28  YMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM- 86
Query: 66  EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 125
           E  T+G L   L  RK          LD  + +  A   +  L YL  K     +HRDI 
Sbjct: 87  ELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLESK---RFVHRDIA 135
Query: 126 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYS 185
           + NVL+  +   K+ DF LS    D +    +++      + APE     + T  SDV+ 
Sbjct: 136 ARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFTSASDVWM 194
Query: 186 FGVVLLELLT-GRKP 199
           FGV + E+L  G KP
Sbjct: 195 FGVCMWEILMHGVKP 209

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 88/195 (45%), Gaps = 23/195 (11%)
Query: 15  YPSHENERL----KSPKNYPDD---EKQLVSVVS--RLKHENLVELLGYCVEGNLRVLAY 65
           Y S EN  L    K+ KN   D   EK L   ++  +  H ++V+L+G   E  + ++  
Sbjct: 31  YMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM- 89
Query: 66  EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 125
           E  T+G L   L  RK          LD  + +  A   +  L YL  K     +HRDI 
Sbjct: 90  ELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLESK---RFVHRDIA 138
Query: 126 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYS 185
           + NVL+  +   K+ DF LS    D +    +++      + APE     + T  SDV+ 
Sbjct: 139 ARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFTSASDVWM 197
Query: 186 FGVVLLELLT-GRKP 199
           FGV + E+L  G KP
Sbjct: 198 FGVCMWEILMHGVKP 212

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 33  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 91
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W       V  A+G+ YL ++    ++HRD+ + 
Sbjct: 92  MPFGCLLDYVREHKDNIGSQY--LLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 140
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 141 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 200
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 201 VTVWELMTFGSKPYD 215

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 86/195 (44%), Gaps = 23/195 (11%)
Query: 15  YPSHENERL----KSPKNYPDD---EKQLVSVVS--RLKHENLVELLGYCVEGNLRVLAY 65
           Y S EN  L    K+ KN   D   EK L   ++  +  H ++V+L+G   E  + ++  
Sbjct: 33  YMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM- 91
Query: 66  EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 125
           E  T+G L   L  RK          LD  + +  A   +  L YL  K     +HRDI 
Sbjct: 92  ELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLESK---RFVHRDIA 140
Query: 126 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYS 185
           + NVL+  +   K+ DF LS    D      S   L    + APE     + T  SDV+ 
Sbjct: 141 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWM 199
Query: 186 FGVVLLELLT-GRKP 199
           FGV + E+L  G KP
Sbjct: 200 FGVCMWEILMHGVKP 214

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 46  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 104
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 105 MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 153
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 154 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 213
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 214 VTVWELMTFGSKPYD 228

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 86/195 (44%), Gaps = 23/195 (11%)
Query: 15  YPSHENERL----KSPKNYPDD---EKQLVSVVS--RLKHENLVELLGYCVEGNLRVLAY 65
           Y S EN  L    K+ KN   D   EK L   ++  +  H ++V+L+G   E  + ++  
Sbjct: 34  YMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM- 92
Query: 66  EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 125
           E  T+G L   L  RK          LD  + +  A   +  L YL  K     +HRDI 
Sbjct: 93  ELCTLGELRSFLQVRK--------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIA 141
Query: 126 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYS 185
           + NVL+  +   K+ DF LS    D      S   L    + APE     + T  SDV+ 
Sbjct: 142 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWM 200
Query: 186 FGVVLLELLT-GRKP 199
           FGV + E+L  G KP
Sbjct: 201 FGVCMWEILMHGVKP 215

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 88/195 (45%), Gaps = 23/195 (11%)
Query: 15  YPSHENERL----KSPKNYPDD---EKQLVSVVS--RLKHENLVELLGYCVEGNLRVLAY 65
           Y S EN  L    K+ KN   D   EK L   ++  +  H ++V+L+G   E  + ++  
Sbjct: 59  YMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM- 117
Query: 66  EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 125
           E  T+G L   L  RK          LD  + +  A   +  L YL  K     +HRDI 
Sbjct: 118 ELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLESK---RFVHRDIA 166
Query: 126 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYS 185
           + NVL+  +   K+ DF LS    D +    +++      + APE     + T  SDV+ 
Sbjct: 167 ARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFTSASDVWM 225
Query: 186 FGVVLLELLT-GRKP 199
           FGV + E+L  G KP
Sbjct: 226 FGVCMWEILMHGVKP 240

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 45  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 103
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 104 MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 152
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 153 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 212
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 213 VTVWELMTFGSKPYD 227

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 39  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 97
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 98  MPFGXLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 146
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 207 VTVWELMTFGSKPYD 221

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRW 194
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 42  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 100
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 101 MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 149
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 150 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 209
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 210 VTVWELMTFGSKPYD 224

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 77/169 (45%), Gaps = 25/169 (14%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++ +L H N+++L     + +   +  E  T G L D +  RK               
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA------- 124
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSN---QAPD 150
             RI      G+ Y+H   + +I+HRD++  N+LL    +D   KI DF LS    Q   
Sbjct: 125 --RIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179
Query: 151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           M  R+      GT  Y APE  + G   +K DV+S GV+L  LL+G  P
Sbjct: 180 MKDRI------GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 42  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 100
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 101 MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 149
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 150 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 209
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 210 VTVWELMTFGSKPYD 224

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 42  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 100
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W       V  A+G+ YL ++    ++HRD+ + 
Sbjct: 101 MPFGCLLDYVREHKDNIGSQY--LLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 149
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 150 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 209
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 210 VTVWELMTFGSKPYD 224

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 81/164 (49%), Gaps = 13/164 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V++ + + ++  LLG C+   ++++  +    G L D +   K   G+Q   +L+W  ++
Sbjct: 95  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNWCVQI 151
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
                 A+G+ YL ++    ++HRD+ + NVL+      KI DF L+          H+ 
Sbjct: 152 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 202
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
                  + A E  +    T +SDV+S+GV + EL+T G KP D
Sbjct: 203 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 41  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 99
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 100 MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 148
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 149 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 208
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 209 VTVWELMTFGSKPYD 223

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 77/169 (45%), Gaps = 25/169 (14%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++ +L H N+++L     + +   +  E  T G L D +  RK               
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA------- 124
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSN---QAPD 150
             RI      G+ Y+H   + +I+HRD++  N+LL    +D   KI DF LS    Q   
Sbjct: 125 --RIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179
Query: 151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           M  R+      GT  Y APE  + G   +K DV+S GV+L  LL+G  P
Sbjct: 180 MKDRI------GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 86/195 (44%), Gaps = 23/195 (11%)
Query: 15  YPSHENERL----KSPKNYPDD---EKQLVSVVS--RLKHENLVELLGYCVEGNLRVLAY 65
           Y S EN  L    K+ KN   D   EK L   ++  +  H ++V+L+G   E  + ++  
Sbjct: 36  YMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM- 94
Query: 66  EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 125
           E  T+G L   L  RK          LD  + +  A   +  L YL  K     +HRDI 
Sbjct: 95  ELCTLGELRSFLQVRK--------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIA 143
Query: 126 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYS 185
           + NVL+  +   K+ DF LS    D      S   L    + APE     + T  SDV+ 
Sbjct: 144 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWM 202
Query: 186 FGVVLLELLT-GRKP 199
           FGV + E+L  G KP
Sbjct: 203 FGVCMWEILMHGVKP 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++ L  + 
Sbjct: 40  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQL 98
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 99  MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 147
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 148 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 207
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 208 VTVWELMTFGSKPYD 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++ L  + 
Sbjct: 39  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQL 97
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 98  MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 146
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 207 VTVWELMTFGSKPYD 221

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 141 RGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTGYVATRW 192
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRW 194
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 147 RGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTGYVATRW 198
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 141 RGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTGYVATRW 192
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 46  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 104
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 105 MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 153
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 154 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 213
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 214 VTVWELMTFGSKPYD 228

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++ L  + 
Sbjct: 43  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQL 101
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 102 MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 150
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 151 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 210
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 211 VTVWELMTFGSKPYD 225

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRW 194
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++ L  + 
Sbjct: 42  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQL 100
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 101 MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 149
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 150 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 209
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 210 VTVWELMTFGSKPYD 224

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++ L  + 
Sbjct: 40  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQL 98
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 99  MPFGXLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 147
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 148 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 207
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 208 VTVWELMTFGSKPYD 222

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++ L  + 
Sbjct: 41  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQL 99
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 100 MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 148
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 149 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 208
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 209 VTVWELMTFGSKPYD 223

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 11/158 (6%)
Query: 43  LKHENLVELLGYCVEGNLR-----VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
             H N++ LLG C+E + +     ++   F   G LH  L   +   G +  P+    T 
Sbjct: 93  FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL---QTL 149
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           ++  VD A G+EYL  +   + +HRD+ + N +L +D    +ADF LS +          
Sbjct: 150 LKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
                   + A E       T KSDV++FGV + E+ T
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 29/241 (12%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
            ++ +  H N++ L G   +    ++  E+   G+L   L  + G        VL  +  
Sbjct: 98  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGM 152
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +R     A G++YL      + +HRD+ + N+L+  +   K++DF LS    D     ++
Sbjct: 153 LR---GIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 215
           T        + APE     + T  SDV+SFG+V+ E++T G +P              W 
Sbjct: 207 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY-------------W- 252
Query: 216 TPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS 275
              LS  +V + ++   +                 C Q E   RP  + +V  L  L+++
Sbjct: 253 --ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310
Query: 276 P 276
           P
Sbjct: 311 P 311

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++ L  + 
Sbjct: 46  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQL 104
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 105 MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 153
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 154 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 213
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 214 VTVWELMTFGSKPYD 228

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 194
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 146 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 197
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 198 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 148 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 199
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 138 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 189
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 142 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 193
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGXVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 147 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 198
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 141 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 192
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 138 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 189
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 135 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 186
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 187 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 133 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 184
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 159 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 210
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 138 RGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD-----EMTGYVATRW 189
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 141 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 192
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 156 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 207
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 156 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 207
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 183
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 155 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 206
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 148 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 199
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 183
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 148 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 199
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 155 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 206
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 133 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 184
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 138 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 189
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 183
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 10/158 (6%)
Query: 45  HENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKG--VQGAQPGPVL-DWMTRVRI 100
           H N+V LLG C + G   ++  EF   G+L   L  ++   V    P  +  D++T   +
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 101 ---AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
              +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+         +  
Sbjct: 151 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
                   + APE       T +SDV+SFGV+L E+ +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 142 RGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD-----EMTGYVATRW 193
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 79/172 (45%), Gaps = 13/172 (7%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           D+  Q    + +L H  LV+  G C +     +  E+ + G L + L  R   +G +P  
Sbjct: 48  DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQ 105
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 150
           +L+      +  D   G+ +L        IHRD+ + N L+  D   K++DF ++    D
Sbjct: 106 LLE------MCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156
Query: 151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
               + S        + APE     + + KSDV++FG+++ E+ + G+ P D
Sbjct: 157 -DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 45  HENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKG----VQGAQPGPVLDWMTRVR 99
           H N+V LLG C + G   ++  EF   G+L   L  ++      + A      D++T   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 100 I---AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAA 153
           +   +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+    + PD   
Sbjct: 150 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XV 205
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           R    R+     + APE       T +SDV+SFGV+L E+ +
Sbjct: 206 RKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 45  HENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKG----VQGAQPGPVLDWMTRVR 99
           H N+V LLG C + G   ++  EF   G+L   L  ++      + A      D++T   
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEH 151
Query: 100 I---AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAA 153
           +   +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+    + PD   
Sbjct: 152 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-V 207
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           R    R+     + APE       T +SDV+SFGV+L E+ +
Sbjct: 208 RKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 20/168 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVLDW 94
           V ++  L H N+V+L           L  E+A+ G + D L  HG    + A+       
Sbjct: 57  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEAR------- 109
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             + R  V A   ++Y H+K    I+HRD+++ N+LL  D   KIADF  SN+      +
Sbjct: 110 -AKFRQIVSA---VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNK 161
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQ-KSDVYSFGVVLLELLTGRKPVD 201
           L +    G+  Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 162 LDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 134 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 185
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 142 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 193
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 142 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 193
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 45  HENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKG----VQGAQPGPVLDWMTR-- 97
           H N+V LLG C + G   ++  EF   G+L   L  ++      + A      D++T   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 98  -VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAA 153
            +  +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+    + PD   
Sbjct: 150 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-XV 205
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           R    R+     + APE       T +SDV+SFGV+L E+ +
Sbjct: 206 RKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 13/152 (8%)
Query: 51  LLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEY 110
           LLG C+   ++ L  +    G L D +   +G  G+Q   +L+W  ++      A+G+ Y
Sbjct: 84  LLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQD--LLNWCMQI------AKGMSY 134
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           L +     ++HRD+ + NVL+      KI DF L+          H+        + A E
Sbjct: 135 LEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
             +  + T +SDV+S+GV + EL+T G KP D
Sbjct: 192 SILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 36  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 94
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W       V  A G+ YL ++    ++HRD+ + 
Sbjct: 95  MPFGCLLDYVREHKDNIGSQY--LLNW------CVQIAEGMNYLEDR---RLVHRDLAAR 143
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF L+          H+        + A E  +    T +SDV+S+G
Sbjct: 144 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 203
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 204 VTVWELMTFGSKPYD 218

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 45  HENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKG--VQGAQPGPVLDWMTR---V 98
           H N+V LLG C + G   ++  EF   G+L   L  ++   V         D++T    +
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAARL 155
             +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+    + PD   R 
Sbjct: 152 XYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRK 207
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
              R+     + APE       T +SDV+SFGV+L E+ +
Sbjct: 208 GDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 21/168 (12%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N+V L G    G   ++  EF   G+L   L    G        V+  +  
Sbjct: 96  SIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDG-----QFTVIQLVGM 150
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +R     A G+ YL +      +HRD+ + N+L+  +   K++DF LS    D    +++
Sbjct: 151 LR---GIAAGMRYLADM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYT 204
Query: 158 TRVLGTFG-----YHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           T    T G     + APE     + T  SDV+S+G+V+ E+++ G +P
Sbjct: 205 T----TGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 45  HENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKG----VQGAQPGPVLDWMTR-- 97
           H N+V LLG C + G   ++  EF   G+L   L  ++      + A      D++T   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 98  -VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAA 153
            +  +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+    + PD   
Sbjct: 150 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-V 205
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           R    R+     + APE       T +SDV+SFGV+L E+ +
Sbjct: 206 RKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 31/175 (17%)
Query: 37  VSVVSRLKHENLVELLGYCVEG-----------------NLRVLAYEFATMGSLHDILHG 79
           V  +++L H N+V   G C +G                     +  EF   G+L   +  
Sbjct: 55  VKALAKLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
           R+G +       LD +  + +     +G++Y+H K    +I+RD++ SN+ L +  + KI
Sbjct: 114 RRGEK-------LDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKI 163
Query: 140 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELL 194
            DF L     +   R  S    GT  Y +PE   +    ++ D+Y+ G++L ELL
Sbjct: 164 GDFGLVTSLKNDGKRXRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+  L HE LV+L G C +     +  E+   G L + L  R+     Q   +L+     
Sbjct: 56  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLE----- 108
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
            +  D    +EYL  K     +HRD+ + N L+ +    K++DF LS    D     +++
Sbjct: 109 -MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTS 161
Query: 159 RVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
            V   F   +  PE  M  + + KSD+++FGV++ E+ + G+ P +
Sbjct: 162 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 45  HENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKG----VQGAQPGPVLDWMTRVR 99
           H N+V LLG C + G   ++  EF   G+L   L  ++      + A      D++T   
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 100 I---AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAA 153
           +   +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+    + PD   
Sbjct: 141 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XV 196
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           R    R+     + APE       T +SDV+SFGV+L E+ +
Sbjct: 197 RKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 19/183 (10%)
Query: 23  LKSPKNYPDD---EKQLVSVVS--RLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL 77
           +K+ KN   D   EK L   ++  +  H ++V+L+G   E  + ++  E  T+G L   L
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFL 101
Query: 78  HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
             RK          LD  + +  A   +  L YL  K     +HRDI + NVL+      
Sbjct: 102 QVRKFS--------LDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCV 150
Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           K+ DF LS    D +    +++      + APE     + T  SDV+ FGV + E+L  G
Sbjct: 151 KLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 209
Query: 197 RKP 199
            KP
Sbjct: 210 VKP 212

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 67/132 (50%), Gaps = 13/132 (9%)
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
           +IAV   + LE+LH K+  S+IHRD++ SNVL+    + K  DF +S    D  A+    
Sbjct: 140 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 159 RVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLELLTGRKPVDHTMPRGQQ--SL 211
              G   Y APE  +  +L Q     KSD++S G+  +EL   R P D      QQ   +
Sbjct: 198 ---GCKPYXAPE-RINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQV 253
Query: 212 VTWATPRLSEDK 223
           V   +P+L  DK
Sbjct: 254 VEEPSPQLPADK 265

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 45  HENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKG----VQGAQPGPVLDWMTR-- 97
           H N+V LLG C + G   ++  EF   G+L   L  ++      + A      D++T   
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186
Query: 98  -VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAA 153
            +  +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+    + PD   
Sbjct: 187 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-V 242
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           R    R+     + APE       T +SDV+SFGV+L E+ +
Sbjct: 243 RKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 12/162 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIR--------KIGSFDETCTRF 136
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 137 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE       ++ SD+++ G ++ +L+ G  P 
Sbjct: 193 SFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 77/169 (45%), Gaps = 25/169 (14%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++ +L H N+++L     + +   +  E  T G L D +  RK               
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA------- 124
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSN---QAPD 150
             RI      G+ Y+H   + +I+HRD++  N+LL    +D   KI DF LS    Q   
Sbjct: 125 --RIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179
Query: 151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           M  R+      GT  Y APE  + G   +K DV+S GV+L  LL+G  P
Sbjct: 180 MKDRI------GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 63  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 114
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 115 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 170
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE        + SD+++ G ++ +L+ G  P 
Sbjct: 171 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D      +TR      
Sbjct: 156 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR-----W 207
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 79/163 (48%), Gaps = 19/163 (11%)
Query: 45  HENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRKG----VQGAQPGPVLDWMTR- 97
           H N+V LLG C +  G L V+  EF   G+L   L  ++      + A      D++T  
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIT-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 98  --VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMA 152
             +  +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+    + PD  
Sbjct: 140 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY- 195
Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            R    R+     + APE       T +SDV+SFGV+L E+ +
Sbjct: 196 VRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D      +TR      
Sbjct: 159 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----W 210
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+  L HE LV+L G C +     +  E+   G L + L  R+     Q   +L+     
Sbjct: 52  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLE----- 104
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
            +  D    +EYL  K     +HRD+ + N L+ +    K++DF LS    D     +++
Sbjct: 105 -MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTS 157
Query: 159 RVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
            V   F   +  PE  M  + + KSD+++FGV++ E+ + G+ P +
Sbjct: 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 45  HENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKG----VQGAQPGPVLDWMTRVR 99
           H N+V LLG C + G   ++  EF   G+L   L  ++      + A      D++T   
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 100 I---AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAA 153
           +   +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+    + PD   
Sbjct: 141 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XV 196
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           R    R+     + APE       T +SDV+SFGV+L E+ +
Sbjct: 197 RKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 82/183 (44%), Gaps = 19/183 (10%)
Query: 23  LKSPKNYPDD---EKQLVSVVS--RLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL 77
           +K+ KN   D   EK L   ++  +  H ++V+L+G   E  + ++  E  T+G L   L
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFL 481
Query: 78  HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
             RK          LD  + +  A   +  L YL  K     +HRDI + NVL+  +   
Sbjct: 482 QVRKFS--------LDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV 530
Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           K+ DF LS    D      S   L    + APE     + T  SDV+ FGV + E+L  G
Sbjct: 531 KLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 589
Query: 197 RKP 199
            KP
Sbjct: 590 VKP 592

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 14/165 (8%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S+   L H+++V   G+  + +   +  E     SL ++   RK +      P   +  
Sbjct: 68  ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEARYYL 123
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R         G +YLH      +IHRD++  N+ L ED + KI DF L+ +      R  
Sbjct: 124 R-----QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-- 173
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              + GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 174 KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 62  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 113
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 114 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 169
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE        + SD+++ G ++ +L+ G  P 
Sbjct: 170 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 14/165 (8%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S+   L H+++V   G+  + +   +  E     SL + LH R+    A   P   +  
Sbjct: 68  ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRK---ALTEPEARYYL 123
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R         G +YLH      +IHRD++  N+ L ED + KI DF L+ +      R  
Sbjct: 124 R-----QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-- 173
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              + GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 174 KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 29/241 (12%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L  RK    AQ       +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQ----FTVIQL 149
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +      +HRD+ + N+L+  +   K++DF LS    D     ++
Sbjct: 150 VGMLRGIASGMKYLSDM---GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 215
           TR       + +PE     + T  SDV+S+G+VL E+++ G +P              W 
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W- 252
Query: 216 TPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS 275
              +S   V + VD   +                 C Q +   RP    +V  L  L+++
Sbjct: 253 --EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310
Query: 276 P 276
           P
Sbjct: 311 P 311

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SNV + ED + +I DF L+ QA +       T  + T  
Sbjct: 134 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADE-----EMTGYVATRW 185
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELL G+
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L     D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 14/165 (8%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S+   L H+++V   G+  + +   +  E     SL ++   RK +      P   +  
Sbjct: 72  ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEARYYL 127
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R         G +YLH      +IHRD++  N+ L ED + KI DF L+ +      R  
Sbjct: 128 R-----QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 179
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           +  + GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 180 T--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+  L HE LV+L G C +     +  E+   G L + L  R+     Q   +L+     
Sbjct: 57  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLE----- 109
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
            +  D    +EYL  K     +HRD+ + N L+ +    K++DF LS    D     +++
Sbjct: 110 -MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTS 162
Query: 159 RVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
            V   F   +  PE  M  + + KSD+++FGV++ E+ + G+ P +
Sbjct: 163 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 45  HENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKG----VQGAQPGPVLDWMTR-- 97
           H N+V LLG C + G   ++  EF   G+L   L  ++      + A      D++T   
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 98  -VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAA 153
            +  +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+    + PD   
Sbjct: 141 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-V 196
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           R    R+     + APE       T +SDV+SFGV+L E+ +
Sbjct: 197 RKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 18/168 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +++   LKH+N+V+ LG   E     +  E    GSL  +L        ++ GP+ D   
Sbjct: 70  IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLR-------SKWGPLKDNEQ 122
Query: 97  RVRIAVDAA-RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA--KIADFNLSNQAPDMAA 153
            +         GL+YLH+     I+HRDI+  NVL+   +    KI+DF  S +   +  
Sbjct: 123 TIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLI-NTYSGVLKISDFGTSKRLAGINP 178
Query: 154 RLHSTRVLGTFGYHAPEYAMTG--QLTQKSDVYSFGVVLLELLTGRKP 199
              +    GT  Y APE    G     + +D++S G  ++E+ TG+ P
Sbjct: 179 CTET--FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+  L HE LV+L G C +     +  E+   G L + L  R+     Q   +L+     
Sbjct: 72  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLE----- 124
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
            +  D    +EYL  K     +HRD+ + N L+ +    K++DF LS    D     +++
Sbjct: 125 -MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTS 177
Query: 159 RVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
            V   F   +  PE  M  + + KSD+++FGV++ E+ + G+ P +
Sbjct: 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 15/166 (9%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ + +H N++ L G        ++  EF   G+L   L    G            +  
Sbjct: 69  SIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQ--------FTVIQL 120
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G+ YL E    S +HRD+ + N+L+  +   K++DF LS    + ++    
Sbjct: 121 VGMLRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTE 177
Query: 158 TRVLGT---FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           T  LG      + APE     + T  SD +S+G+V+ E+++ G +P
Sbjct: 178 TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 60  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 111
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 112 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 167
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE        + SD+++ G ++ +L+ G  P 
Sbjct: 168 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 69/165 (41%), Gaps = 16/165 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + + + L H N++ L  Y  +     L  E+A  G L+  L         Q     D   
Sbjct: 74  IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL---------QKSCTFDEQR 124
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
              I  + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  AP     L 
Sbjct: 125 TATIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPS----LR 177
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              + GT  Y  PE        +K D++  GV+  ELL G  P +
Sbjct: 178 RKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 61  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 112
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 113 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE        + SD+++ G ++ +L+ G  P 
Sbjct: 169 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SNV + ED + +I DF L+ QA +       T  + T  
Sbjct: 142 RGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADE-----EMTGYVATRW 193
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELL G+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SNV + ED + +I DF L+ QA +       T  + T  
Sbjct: 142 RGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADE-----EMTGYVATRW 193
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELL G+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+  L HE LV+L G C +     +  E+   G L + L  R+     Q   +L+     
Sbjct: 63  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLE----- 115
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
            +  D    +EYL  K     +HRD+ + N L+ +    K++DF LS    D     +++
Sbjct: 116 -MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTS 168
Query: 159 RVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
            V   F   +  PE  M  + + KSD+++FGV++ E+ + G+ P +
Sbjct: 169 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 214

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 16/166 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S+   L H+++V   G+  + +   +  E     SL ++   RK +      P   +  
Sbjct: 92  ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEARYYL 147
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R         G +YLH      +IHRD++  N+ L ED + KI DF L+ +      R  
Sbjct: 148 R-----QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-- 197
Query: 157 STRVL-GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
             +VL GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 198 -KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 16/166 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S+   L H+++V   G+  + +   +  E     SL ++   RK +      P   +  
Sbjct: 90  ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEARYYL 145
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R         G +YLH      +IHRD++  N+ L ED + KI DF L+ +      R  
Sbjct: 146 R-----QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-- 195
Query: 157 STRVL-GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
             +VL GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 196 -KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 86  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 137
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 138 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 193
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE        + SD+++ G ++ +L+ G  P 
Sbjct: 194 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 16/166 (9%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S+   L H+++V   G+  + +   +  E     SL + LH R+    A   P   +  
Sbjct: 66  ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRK---ALTEPEARYYL 121
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R         G +YLH      +IHRD++  N+ L ED + KI DF L+ +      R  
Sbjct: 122 R-----QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-- 171
Query: 157 STRVL-GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
             +VL GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 172 -KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI D+ L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 86  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 137
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 138 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 193
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE        + SD+++ G ++ +L+ G  P 
Sbjct: 194 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 10/177 (5%)
Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
           +L S +  P    + +S++  LKHEN+V L       N   L +EF     L   +  R 
Sbjct: 39  KLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRT 97
Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
            V     G  L+ +   +  +   +GL + HE     I+HRD++  N+L+ +  + K+ D
Sbjct: 98  -VGNTPRGLELNLVKYFQWQL--LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGD 151
Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGR 197
           F L+ +A  +     S+ V+ T  Y AP+  M  +    S D++S G +L E++TG+
Sbjct: 152 FGLA-RAFGIPVNTFSSEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 77/184 (41%), Gaps = 16/184 (8%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 136
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 137 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 218
             +GT  Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +
Sbjct: 193 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEGLIFAKIIK 248
Query: 219 LSED 222
           L  D
Sbjct: 249 LEYD 252

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 136
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 137 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE        + SD+++ G ++ +L+ G  P 
Sbjct: 193 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 29/241 (12%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L  RK    AQ       +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQ----FTVIQL 149
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +      +HRD+ + N+L+  +   K++DF LS    D     ++
Sbjct: 150 VGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 215
           TR       + +PE     + T  SDV+S+G+VL E+++ G +P              W 
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W- 252
Query: 216 TPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS 275
              +S   V + VD   +                 C Q +   RP    +V  L  L+++
Sbjct: 253 --EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310
Query: 276 P 276
           P
Sbjct: 311 P 311

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 29/241 (12%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L  RK    AQ       +  
Sbjct: 96  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQ----FTVIQL 147
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +      +HRD+ + N+L+  +   K++DF LS    D     ++
Sbjct: 148 VGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 204
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 215
           TR       + +PE     + T  SDV+S+G+VL E+++ G +P              W 
Sbjct: 205 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W- 250
Query: 216 TPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS 275
              +S   V + VD   +                 C Q +   RP    +V  L  L+++
Sbjct: 251 --EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 308
Query: 276 P 276
           P
Sbjct: 309 P 309

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 29/241 (12%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L  RK    AQ       +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQ----FTVIQL 149
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +      +HRD+ + N+L+  +   K++DF LS    D     ++
Sbjct: 150 VGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 215
           TR       + +PE     + T  SDV+S+G+VL E+++ G +P              W 
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W- 252
Query: 216 TPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS 275
              +S   V + VD   +                 C Q +   RP    +V  L  L+++
Sbjct: 253 --EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310
Query: 276 P 276
           P
Sbjct: 311 P 311

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 29/241 (12%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L  RK    AQ       +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQ----FTVIQL 149
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +      +HRD+ + N+L+  +   K++DF LS    D     ++
Sbjct: 150 VGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 215
           TR       + +PE     + T  SDV+S+G+VL E+++ G +P              W 
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W- 252
Query: 216 TPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS 275
              +S   V + VD   +                 C Q +   RP    +V  L  L+++
Sbjct: 253 --EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310
Query: 276 P 276
           P
Sbjct: 311 P 311

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 29/241 (12%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L  RK    AQ       +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQ----FTVIQL 149
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +      +HRD+ + N+L+  +   K++DF LS    D     ++
Sbjct: 150 VGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 215
           TR       + +PE     + T  SDV+S+G+VL E+++ G +P              W 
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W- 252
Query: 216 TPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS 275
              +S   V + VD   +                 C Q +   RP    +V  L  L+++
Sbjct: 253 --EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310
Query: 276 P 276
           P
Sbjct: 311 P 311

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 62/119 (52%), Gaps = 16/119 (13%)
Query: 89  GPVLDWMTRVRIAVDAAR----------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           G + D++ R R  +DA+R          G+EYL  +     +HRD+ + N+L+  +   K
Sbjct: 99  GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVK 155
Query: 139 IADFNLSNQAPDMAARLHSTRVLGT--FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+   P +    +  R  G     ++APE       +++SDV+SFGVVL EL T
Sbjct: 156 IADFGLAKLLP-LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 134
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 135 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE        + SD+++ G ++ +L+ G  P 
Sbjct: 191 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 15/166 (9%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ + +H N++ L G        ++  EF   G+L   L    G            +  
Sbjct: 67  SIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQ--------FTVIQL 118
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G+ YL E    S +HRD+ + N+L+  +   K++DF LS    + ++    
Sbjct: 119 VGMLRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTY 175
Query: 158 TRVLGT---FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           T  LG      + APE     + T  SD +S+G+V+ E+++ G +P
Sbjct: 176 TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 19/168 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++ +L H N+++L  +  +     L  E  T G L D +  RK               
Sbjct: 83  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------- 135
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMAA 153
             RI      G+ Y+H   +  I+HRD++  N+LL    +D   +I DF LS       A
Sbjct: 136 --RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEA 187
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
                  +GT  Y APE  + G   +K DV+S GV+L  LL+G  P +
Sbjct: 188 SKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 134
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 135 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE        + SD+++ G ++ +L+ G  P 
Sbjct: 191 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 134
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 135 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE        + SD+++ G ++ +L+ G  P 
Sbjct: 191 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 62/119 (52%), Gaps = 16/119 (13%)
Query: 89  GPVLDWMTRVRIAVDAAR----------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           G + D++ R R  +DA+R          G+EYL  +     +HRD+ + N+L+  +   K
Sbjct: 98  GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVK 154
Query: 139 IADFNLSNQAPDMAARLHSTRVLGT--FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+   P +    +  R  G     ++APE       +++SDV+SFGVVL EL T
Sbjct: 155 IADFGLAKLLP-LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 136
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 137 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE        + SD+++ G ++ +L+ G  P 
Sbjct: 193 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 18/168 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +++   LKH+N+V+ LG   E     +  E    GSL  +L        ++ GP+ D   
Sbjct: 56  IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLR-------SKWGPLKDNEQ 108
Query: 97  RVRIAVDAA-RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA--KIADFNLSNQAPDMAA 153
            +         GL+YLH+     I+HRDI+  NVL+   +    KI+DF  S +   +  
Sbjct: 109 TIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLI-NTYSGVLKISDFGTSKRLAGINP 164
Query: 154 RLHSTRVLGTFGYHAPEYAMTG--QLTQKSDVYSFGVVLLELLTGRKP 199
              +    GT  Y APE    G     + +D++S G  ++E+ TG+ P
Sbjct: 165 CTET--FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 136
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 137 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE        + SD+++ G ++ +L+ G  P 
Sbjct: 193 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 88  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 139
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 140 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 195
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE        + SD+++ G ++ +L+ G  P 
Sbjct: 196 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 134
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 135 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
             +GT  Y +PE        + SD+++ G ++ +L+ G  P 
Sbjct: 191 AFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 77/184 (41%), Gaps = 16/184 (8%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 136
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 137 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 218
             +GT  Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +
Sbjct: 193 XFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP----FRAGNEGLIFAKIIK 248
Query: 219 LSED 222
           L  D
Sbjct: 249 LEYD 252

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 76/163 (46%), Gaps = 22/163 (13%)
Query: 43  LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVLDWMTRVRI 100
            +H ++++L       +   +  E+ + G L D +  +GR           LD     R+
Sbjct: 73  FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR-----------LDEKESRRL 121
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
                 G++Y H  +   ++HRD++  NVLL     AKIADF LSN   D      S   
Sbjct: 122 FQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC-- 176
Query: 161 LGTFGYHAPEYAMTGQLTQ--KSDVYSFGVVLLELLTGRKPVD 201
            G+  Y APE  ++G+L    + D++S GV+L  LL G  P D
Sbjct: 177 -GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 62/119 (52%), Gaps = 16/119 (13%)
Query: 89  GPVLDWMTRVRIAVDAAR----------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           G + D++ R R  +DA+R          G+EYL  +     +HRD+ + N+L+  +   K
Sbjct: 111 GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVK 167
Query: 139 IADFNLSNQAPDMAARLHSTRVLGT--FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+   P +    +  R  G     ++APE       +++SDV+SFGVVL EL T
Sbjct: 168 IADFGLAKLLP-LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 39  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 97
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 98  MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 146
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF  +          H+        + A E  +    T +SDV+S+G
Sbjct: 147 NVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 207 VTVWELMTFGSKPYD 221

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 77/184 (41%), Gaps = 16/184 (8%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 67  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 118
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 119 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 174
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 218
             +GT  Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +
Sbjct: 175 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIK 230
Query: 219 LSED 222
           L  D
Sbjct: 231 LEYD 234

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+  L HE LV+L G C +     +  E+   G L + L  R+     Q   +L+     
Sbjct: 72  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLE----- 124
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
            +  D    +EYL  K     +HRD+ + N L+ +    K++DF LS    D      ++
Sbjct: 125 -MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---ETS 177
Query: 159 RVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
            V   F   +  PE  M  + + KSD+++FGV++ E+ + G+ P +
Sbjct: 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  EF   GSL   L    G        V+  +  
Sbjct: 60  SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGM 114
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +R     A G++YL +    + +HR + + N+L+  +   K++DF LS    D  +    
Sbjct: 115 LR---GIAAGMKYLADM---NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 168
Query: 158 TRVLGT---FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           T  LG      + APE     + T  SDV+S+G+V+ E+++ G +P
Sbjct: 169 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 60/118 (50%), Gaps = 14/118 (11%)
Query: 89  GPVLDWMTRVRIAVDAAR----------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           G + D++ R R  +DA+R          G+EYL  +     +HRD+ + N+L+  +   K
Sbjct: 95  GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVK 151
Query: 139 IADFNLSNQAP-DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
           IADF L+   P D    +          ++APE       +++SDV+SFGVVL EL T
Sbjct: 152 IADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 29/241 (12%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L  RK    AQ       +  
Sbjct: 86  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQ----FTVIQL 137
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +      +HRD+ + N+L+  +   K++DF LS    D     ++
Sbjct: 138 VGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 194
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 215
           TR       + +PE     + T  SDV+S+G+VL E+++ G +P              W 
Sbjct: 195 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W- 240
Query: 216 TPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS 275
              +S   V + VD   +                 C Q +   RP    +V  L  L+++
Sbjct: 241 --EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 298
Query: 276 P 276
           P
Sbjct: 299 P 299

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 77/184 (41%), Gaps = 16/184 (8%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 82  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 133
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 134 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 189
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 218
             +GT  Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +
Sbjct: 190 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIK 245
Query: 219 LSED 222
           L  D
Sbjct: 246 LEYD 249

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 99/241 (41%), Gaps = 29/241 (12%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L    G        V+  +  
Sbjct: 75  SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDG-----QFTVIQLVGM 129
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +R     + G++YL +      +HRD+ + N+L+  +   K++DF LS    D     ++
Sbjct: 130 LR---GISAGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 183
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 215
           TR       + APE     + T  SDV+S+G+V+ E+++ G +P              W 
Sbjct: 184 TRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPY-------------W- 229
Query: 216 TPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS 275
              ++   V + V+   +                 C Q E   RP    +V  L  L+++
Sbjct: 230 --EMTNQDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRN 287
Query: 276 P 276
           P
Sbjct: 288 P 288

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 41  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 99
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 100 MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 148
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF  +          H+        + A E  +    T +SDV+S+G
Sbjct: 149 NVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 208
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 209 VTVWELMTFGSKPYD 223

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 77/184 (41%), Gaps = 16/184 (8%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+SRL H   V+L     +         +A  G L   +         + G   +  TR 
Sbjct: 82  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRF 133
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             A +    LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  + 
Sbjct: 134 YTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 189
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 218
             +GT  Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +
Sbjct: 190 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIK 245
Query: 219 LSED 222
           L  D
Sbjct: 246 LEYD 249

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 29/241 (12%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L  RK    AQ       +  
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQ----FTVIQL 120
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +      +HRD+ + N+L+  +   K++DF LS    D     ++
Sbjct: 121 VGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 215
           TR       + +PE     + T  SDV+S+G+VL E+++ G +P              W 
Sbjct: 178 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W- 223
Query: 216 TPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS 275
              +S   V + VD   +                 C Q +   RP    +V  L  L+++
Sbjct: 224 --EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 281
Query: 276 P 276
           P
Sbjct: 282 P 282

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D       T  + T  
Sbjct: 165 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 216
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +         D++S G ++ ELLTGR
Sbjct: 217 YRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 81/183 (44%), Gaps = 19/183 (10%)
Query: 23  LKSPKNYPDD---EKQLVSVVS--RLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL 77
           +K+ KN   D   EK L   ++  +  H ++V+L+G   E  + ++  E  T+G L   L
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFL 481
Query: 78  HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
             RK          LD  + +  A   +  L YL  K     +HRDI + NVL+      
Sbjct: 482 QVRKFS--------LDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCV 530
Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
           K+ DF LS    D      S   L    + APE     + T  SDV+ FGV + E+L  G
Sbjct: 531 KLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 589
Query: 197 RKP 199
            KP
Sbjct: 590 VKP 592

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++++  + 
Sbjct: 46  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QL 104
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W       V  A+G+ YL ++    ++HRD+ + 
Sbjct: 105 MPFGCLLDYVREHKDNIGSQY--LLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 153
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF  +          H+        + A E  +    T +SDV+S+G
Sbjct: 154 NVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 213
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 214 VTVWELMTFGSKPYD 228

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 80/163 (49%), Gaps = 17/163 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S++  L H N+V L+          L +EF        +   + G+Q +Q         
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQ--------- 120
Query: 97  RVRIAV-DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
            ++I +    RG+ + H   Q  I+HRD++  N+L+  D   K+ADF L+ +A  +  R 
Sbjct: 121 -IKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLA-RAFGIPVRS 175
Query: 156 HSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGR 197
           ++  V+ T  Y AP+  M + + +   D++S G +  E++TG+
Sbjct: 176 YTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V++ + + ++  LLG C+   ++ L  +    G L D +   K   G+Q   +L+W    
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY--LLNW---- 126
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
              V  A+G+ YL ++    ++HRD+ + NVL+      KI DF  +          H+ 
Sbjct: 127 --CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 181
Query: 159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
                  + A E  +    T +SDV+S+GV + EL+T G KP D
Sbjct: 182 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++ L  + 
Sbjct: 41  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQL 99
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W  ++      A+G+ YL ++    ++HRD+ + 
Sbjct: 100 MPFGCLLDYVREHKDNIGSQY--LLNWCVQI------AKGMNYLEDR---RLVHRDLAAR 148
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF  +          H+        + A E  +    T +SDV+S+G
Sbjct: 149 NVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 208
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 209 VTVWELMTFGSKPYD 223

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 89/195 (45%), Gaps = 24/195 (12%)
Query: 19  ENERLKSP--------KNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEF 67
           E E++K P           P   K+++    V++ + + ++  LLG C+   ++ L  + 
Sbjct: 41  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQL 99
Query: 68  ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 127
              G L D +   K   G+Q   +L+W       V  A+G+ YL ++    ++HRD+ + 
Sbjct: 100 MPFGCLLDYVREHKDNIGSQY--LLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 148
Query: 128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
           NVL+      KI DF  +          H+        + A E  +    T +SDV+S+G
Sbjct: 149 NVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 208
Query: 188 VVLLELLT-GRKPVD 201
           V + EL+T G KP D
Sbjct: 209 VTVWELMTFGSKPYD 223

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 14/174 (8%)
Query: 37  VSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH-GRKGVQGAQPGPVL-- 92
           + V+S L  H N+V LLG C  G   ++  E+   G L + L   R     ++  P +  
Sbjct: 100 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 159
Query: 93  ------DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 146
                 D    +  +   A+G+ +L  K   + IHRD+ + N+LL      KI DF L+ 
Sbjct: 160 DDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR 216
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
              + +  +          + APE       T +SDV+S+G+ L EL + G  P
Sbjct: 217 HIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 14/174 (8%)
Query: 37  VSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH-GRKGVQGAQPGPVL-- 92
           + V+S L  H N+V LLG C  G   ++  E+   G L + L   R     ++  P +  
Sbjct: 95  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 154
Query: 93  ------DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 146
                 D    +  +   A+G+ +L  K   + IHRD+ + N+LL      KI DF L+ 
Sbjct: 155 DDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR 211
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
              + +  +          + APE       T +SDV+S+G+ L EL + G  P
Sbjct: 212 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 265

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 80/163 (49%), Gaps = 17/163 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S++  L H N+V L+          L +EF        +   + G+Q +Q         
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQ--------- 120
Query: 97  RVRIAV-DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
            ++I +    RG+ + H   Q  I+HRD++  N+L+  D   K+ADF L+ +A  +  R 
Sbjct: 121 -IKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLA-RAFGIPVRS 175
Query: 156 HSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGR 197
           ++  V+ T  Y AP+  M + + +   D++S G +  E++TG+
Sbjct: 176 YTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 14/174 (8%)
Query: 37  VSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH-GRKGVQGAQPGPVL-- 92
           + V+S L  H N+V LLG C  G   ++  E+   G L + L   R     ++  P +  
Sbjct: 100 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 159
Query: 93  ------DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 146
                 D    +  +   A+G+ +L  K   + IHRD+ + N+LL      KI DF L+ 
Sbjct: 160 DDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR 216
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
              + +  +          + APE       T +SDV+S+G+ L EL + G  P
Sbjct: 217 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 100/241 (41%), Gaps = 29/241 (12%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L  RK    AQ       +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQ----FTVIQL 149
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +      +HRD+ + N+L+  +   K++DF L+    D     ++
Sbjct: 150 VGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYT 206
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 215
           TR       + +PE     + T  SDV+S+G+VL E+++ G +P              W 
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W- 252
Query: 216 TPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS 275
              +S   V + VD   +                 C Q +   RP    +V  L  L+++
Sbjct: 253 --EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310
Query: 276 P 276
           P
Sbjct: 311 P 311

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 14/174 (8%)
Query: 37  VSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH-GRKGVQGAQPGPVL-- 92
           + V+S L  H N+V LLG C  G   ++  E+   G L + L   R     ++  P +  
Sbjct: 93  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 152
Query: 93  ------DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 146
                 D    +  +   A+G+ +L  K   + IHRD+ + N+LL      KI DF L+ 
Sbjct: 153 DDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR 209
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
              + +  +          + APE       T +SDV+S+G+ L EL + G  P
Sbjct: 210 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 263

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 13/164 (7%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L    G            +  
Sbjct: 82  SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR--------FTVIQL 133
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +      G++YL +    S +HRD+ + N+L+  +   K++DF +S    D     ++
Sbjct: 134 VGMLRGIGSGMKYLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 190
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           TR       + APE     + T  SDV+S+G+V+ E+++ G +P
Sbjct: 191 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 19/168 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++ +L H N+++L  +  +     L  E  T G L D +  RK               
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------- 129
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMAA 153
             RI      G+ Y+H   +  I+HRD++  N+LL    +D   +I DF LS       A
Sbjct: 130 --RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEA 181
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
                  +GT  Y APE  + G   +K DV+S GV+L  LL+G  P +
Sbjct: 182 SKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 37  VSVVSRLKHENLVELL-GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
           + +++   H N+V+LL  +  E NL +L  EF   G++  ++     ++  +P      +
Sbjct: 85  IDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVM-----LELERP------L 132
Query: 96  TRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
           T  +I V        L YLH+     IIHRD+++ N+L   D   K+ADF +S +     
Sbjct: 133 TESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXI 189
Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQ-----LTQKSDVYSFGVVLLEL 193
            R  S   +GT  + APE  M           K+DV+S G+ L+E+
Sbjct: 190 QRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 37  VSVVSRLKHENLVELL-GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
           + +++   H N+V+LL  +  E NL +L  EF   G++  ++     ++  +P      +
Sbjct: 85  IDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVM-----LELERP------L 132
Query: 96  TRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
           T  +I V        L YLH+     IIHRD+++ N+L   D   K+ADF +S +     
Sbjct: 133 TESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 189
Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQ-----LTQKSDVYSFGVVLLEL 193
            R  S   +GT  + APE  M           K+DV+S G+ L+E+
Sbjct: 190 QRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 80/165 (48%), Gaps = 19/165 (11%)
Query: 37  VSVVSRLKHENLVELL-GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
           V ++   +H N+VE+   Y V   L VL  EF   G+L DI+   +          L+  
Sbjct: 93  VVIMRDYQHFNVVEMYKSYLVGEELWVLM-EFLQGGALTDIVSQVR----------LNEE 141
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAAR 154
               +     + L YLH +    +IHRDI+S ++LL  D + K++DF    Q + D+  R
Sbjct: 142 QIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 198
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                ++GT  + APE         + D++S G++++E++ G  P
Sbjct: 199 ---KXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 19/167 (11%)
Query: 39  VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           V+  L HE LV+L G C +     +  E+   G L + L  R+     Q   +L+     
Sbjct: 57  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLE----- 109
Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
            +  D    +EYL  K     +HRD+ + N L+ +    K++DF LS    D      S+
Sbjct: 110 -MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSS 163
Query: 159 RVLGT---FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
           R  G+     +  PE  M  + + KSD+++FGV++ E+ + G+ P +
Sbjct: 164 R--GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI  F L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 14/174 (8%)
Query: 37  VSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH-GRKGVQGAQPGPVL-- 92
           + V+S L  H N+V LLG C  G   ++  E+   G L + L   R     ++  P +  
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 93  ------DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 146
                 D    +  +   A+G+ +L  K   + IHRD+ + N+LL      KI DF L+ 
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
              + +  +          + APE       T +SDV+S+G+ L EL + G  P
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L    G        V+  +  
Sbjct: 67  SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG-----RFTVIQLVGM 121
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +R       G++YL +    S +HRD+ + N+L+  +   K++DF +S    D     ++
Sbjct: 122 LR---GIGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 175
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           TR       + APE     + T  SDV+S+G+V+ E+++ G +P
Sbjct: 176 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/124 (34%), Positives = 63/124 (50%), Gaps = 18/124 (14%)
Query: 89  GPVLDWMT-RVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
           G + D++  + R+  D  R         +EY H   +  I+HRD++  N+LL ++   KI
Sbjct: 93  GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKI 149
Query: 140 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ--KSDVYSFGVVLLELLTGR 197
           ADF LSN   D      S    G+  Y APE  + G+L    + DV+S G+VL  +L GR
Sbjct: 150 ADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
Query: 198 KPVD 201
            P D
Sbjct: 206 LPFD 209

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L    G        V+  +  
Sbjct: 61  SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG-----RFTVIQLVGM 115
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +R       G++YL +    S +HRD+ + N+L+  +   K++DF +S    D     ++
Sbjct: 116 LR---GIGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 169
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           TR       + APE     + T  SDV+S+G+V+ E+++ G +P
Sbjct: 170 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 99/241 (41%), Gaps = 29/241 (12%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L  RK    AQ       +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQ----FTVIQL 149
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +      +HRD+ + N+L+  +   K++DF L     D     ++
Sbjct: 150 VGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 215
           TR       + +PE     + T  SDV+S+G+VL E+++ G +P              W 
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W- 252
Query: 216 TPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS 275
              +S   V + VD   +                 C Q +   RP    +V  L  L+++
Sbjct: 253 --EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310
Query: 276 P 276
           P
Sbjct: 311 P 311

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 14/165 (8%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +++   L + ++V   G+  + +   +  E     SL ++   RK V      P   +  
Sbjct: 93  IAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE----PEARYFM 148
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R  I     +G++YLH      +IHRD++  N+ L +D   KI DF L+ +      R  
Sbjct: 149 RQTI-----QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKK 200
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           +  + GT  Y APE       + + D++S G +L  LL G+ P +
Sbjct: 201 T--LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 99/241 (41%), Gaps = 29/241 (12%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E    GSL   L  RK    AQ       +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RK--HDAQ----FTVIQL 149
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +      +HRD+ + N+L+  +   K++DF LS    D     ++
Sbjct: 150 VGMLRGIASGMKYLSDM---GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 215
           TR       + +PE     + T  SDV+S+G+VL E+++ G +P              W 
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W- 252
Query: 216 TPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS 275
              +S   V + VD   +                 C Q +   RP    +V  L  L+++
Sbjct: 253 --EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310
Query: 276 P 276
           P
Sbjct: 311 P 311

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 99/241 (41%), Gaps = 29/241 (12%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E    GSL   L  RK    AQ       +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RK--HDAQ----FTVIQL 149
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +      +HRD+ + N+L+  +   K++DF LS    D     ++
Sbjct: 150 VGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 215
           TR       + +PE     + T  SDV+S+G+VL E+++ G +P              W 
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W- 252
Query: 216 TPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS 275
              +S   V + VD   +                 C Q +   RP    +V  L  L+++
Sbjct: 253 --EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310
Query: 276 P 276
           P
Sbjct: 311 P 311

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 14/165 (8%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +++   L + ++V   G+  + +   +  E     SL ++   RK V      P   +  
Sbjct: 93  IAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE----PEARYFM 148
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R  I     +G++YLH      +IHRD++  N+ L +D   KI DF L+ +      R  
Sbjct: 149 RQTI-----QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-- 198
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              + GT  Y APE       + + D++S G +L  LL G+ P +
Sbjct: 199 KKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI D  L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 19/168 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++ +L H N+++L  +  +     L  E  T G L D +  RK               
Sbjct: 100 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA-------- 151
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMAA 153
             RI      G+ Y+H   +  I+HRD++  N+LL    +D   +I DF LS       A
Sbjct: 152 -ARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEA 204
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
                  +GT  Y APE  + G   +K DV+S GV+L  LL+G  P +
Sbjct: 205 SKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 251

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 14/165 (8%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +++   L + ++V   G+  + +   +  E     SL ++   RK V      P   +  
Sbjct: 93  IAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE----PEARYFM 148
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R  I     +G++YLH      +IHRD++  N+ L +D   KI DF L+ +      R  
Sbjct: 149 RQTI-----QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-- 198
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              + GT  Y APE       + + D++S G +L  LL G+ P +
Sbjct: 199 KKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 19/168 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++ +L H N+++L  +  +     L  E  T G L D +  RK               
Sbjct: 101 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA-------- 152
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMAA 153
             RI      G+ Y+H   +  I+HRD++  N+LL    +D   +I DF LS       A
Sbjct: 153 -ARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEA 205
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
                  +GT  Y APE  + G   +K DV+S GV+L  LL+G  P +
Sbjct: 206 SKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 252

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 79/172 (45%), Gaps = 22/172 (12%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPV 91
           K+ +  +   +H ++++L           +  E+ + G L D +  HGR           
Sbjct: 59  KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR----------- 107
Query: 92  LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM 151
           ++ M   R+       ++Y H  +   ++HRD++  NVLL     AKIADF LSN   D 
Sbjct: 108 VEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQ--KSDVYSFGVVLLELLTGRKPVD 201
                S    G+  Y APE  ++G+L    + D++S GV+L  LL G  P D
Sbjct: 165 EFLRDSC---GSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 14/165 (8%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +++   L + ++V   G+  + +   +  E     SL ++   RK V      P   +  
Sbjct: 77  IAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE----PEARYFM 132
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R  I     +G++YLH      +IHRD++  N+ L +D   KI DF L+ +      R  
Sbjct: 133 RQTI-----QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-- 182
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
              + GT  Y APE       + + D++S G +L  LL G+ P +
Sbjct: 183 KKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI D  L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI D  L+    D       T  + T  
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDD-----EMTGYVATRW 187
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 267

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 165 GYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGR 197
            Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 67/133 (50%), Gaps = 9/133 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATPRLSE 221
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P  S+
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP--SQ 249
Query: 222 DKVKQCVDPKLKG 234
           + +   ++ K + 
Sbjct: 250 EDLNXIINLKARN 262

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 99/241 (41%), Gaps = 29/241 (12%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E    GSL   L  RK    AQ       +  
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RK--HDAQ----FTVIQL 120
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +      +HRD+ + N+L+  +   K++DF LS    D     ++
Sbjct: 121 VGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 158 TRVLGT-FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 215
           TR       + +PE     + T  SDV+S+G+VL E+++ G +P              W 
Sbjct: 178 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W- 223
Query: 216 TPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKS 275
              +S   V + VD   +                 C Q +   RP    +V  L  L+++
Sbjct: 224 --EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 281
Query: 276 P 276
           P
Sbjct: 282 P 282

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 133 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 245

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 79/172 (45%), Gaps = 22/172 (12%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPV 91
           K+ +  +   +H ++++L           +  E+ + G L D +  HGR           
Sbjct: 59  KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR----------- 107
Query: 92  LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM 151
           ++ M   R+       ++Y H  +   ++HRD++  NVLL     AKIADF LSN   D 
Sbjct: 108 VEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQ--KSDVYSFGVVLLELLTGRKPVD 201
                S    G+  Y APE  ++G+L    + D++S GV+L  LL G  P D
Sbjct: 165 EFLRTSC---GSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 143 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 199
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 200 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 255

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 135 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 247

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 165 GYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +  T+  D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 140 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 196
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 252

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 249

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 141 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 197
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 198 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 253

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 132 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 188
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 189 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 244

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 249

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 267

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 133 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 245

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 165 GYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +  T+  D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 247

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 9/133 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATR 191
Query: 165 GYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATPRLSE 221
            Y APE  +  +  T+  D++S G +L E+L+ R   P  H + +    L    +P  S+
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP--SQ 249
Query: 222 DKVKQCVDPKLKG 234
           + +   ++ K + 
Sbjct: 250 EDLNXIINLKARN 262

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 81/171 (47%), Gaps = 29/171 (16%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V  + +L+H N ++  G  +  +   L  E+  +GS  D+L   K     +P      + 
Sbjct: 105 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHK-----KP------LQ 152
Query: 97  RVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF-NLSNQAPDMA 152
            V IA     A +GL YLH     ++IHRD+++ N+LL E    K+ DF + S  AP   
Sbjct: 153 EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 206
Query: 153 ARLHSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPV 200
               +   +GT  + APE  +    GQ   K DV+S G+  +EL   + P+
Sbjct: 207 ----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 37  VSVVSRLKHENLVELL-GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
           + +++   H N+V+LL  +  E NL +L  EF   G++  ++     ++  +P      +
Sbjct: 85  IDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVM-----LELERP------L 132
Query: 96  TRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
           T  +I V        L YLH+     IIHRD+++ N+L   D   K+ADF +S +     
Sbjct: 133 TESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXI 189
Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQ-----LTQKSDVYSFGVVLLEL 193
            R      +GT  + APE  M           K+DV+S G+ L+E+
Sbjct: 190 QR--RDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD       T  + T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 249

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 81/171 (47%), Gaps = 29/171 (16%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V  + +L+H N ++  G  +  +   L  E+  +GS  D+L   K     +P      + 
Sbjct: 66  VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHK-----KP------LQ 113
Query: 97  RVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF-NLSNQAPDMA 152
            V IA     A +GL YLH     ++IHRD+++ N+LL E    K+ DF + S  AP   
Sbjct: 114 EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167
Query: 153 ARLHSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPV 200
               +   +GT  + APE  +    GQ   K DV+S G+  +EL   + P+
Sbjct: 168 ----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 62/130 (47%), Gaps = 17/130 (13%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           +GL Y+H      IIHRD++  N+ + ED + KI DF L+ QA         TR      
Sbjct: 139 KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR-----W 190
Query: 166 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR---KPVDHTMPRGQQSLVTWATP---- 217
           Y APE  +   + TQ  D++S G ++ E++TG+   K  DH     +   VT   P    
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250
Query: 218 -RLSEDKVKQ 226
            RL  D+ K 
Sbjct: 251 QRLQSDEAKN 260

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 73/168 (43%), Gaps = 19/168 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++ +L H N+ +L  +  +     L  E  T G L D +  RK               
Sbjct: 77  VQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------- 129
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMAA 153
             RI      G+ Y H   +  I+HRD++  N+LL    +D   +I DF LS       A
Sbjct: 130 --RIIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEA 181
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
                  +GT  Y APE  + G   +K DV+S GV+L  LL+G  P +
Sbjct: 182 SKKXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 18/166 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           ++V+ ++KHEN+V L       N   L  +  + G L D +   KG    +     D  T
Sbjct: 71  IAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRI-VEKGFYTEK-----DAST 124
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 153
            +R  +DA   + YLH   +  I+HRD++  N+L +   E+ K  I+DF LS    +   
Sbjct: 125 LIRQVLDA---VYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKG 176
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            + ST   GT GY APE       ++  D +S GV+   LL G  P
Sbjct: 177 DVMST-ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GLE+LH++   +II+RD++  NVLL +D   +I+D  L+ +    A +  +    GT G+
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGTPGF 355
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
            APE  +  +     D ++ GV L E++  R P 
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GLE+LH++   +II+RD++  NVLL +D   +I+D  L+ +    A +  +    GT G+
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGTPGF 355
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
            APE  +  +     D ++ GV L E++  R P 
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GLE+LH++   +II+RD++  NVLL +D   +I+D  L+ +    A +  +    GT G+
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGTPGF 355
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
            APE  +  +     D ++ GV L E++  R P 
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GLE+LH++   +II+RD++  NVLL +D   +I+D  L+ +    A +  +    GT G+
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGTPGF 355
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
            APE  +  +     D ++ GV L E++  R P 
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 111/267 (41%), Gaps = 42/267 (15%)
Query: 18  HENERL-----KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGS 72
           HE E L     K+ +NY +   +  S++S+L H++LV   G CV G+  +L  EF   GS
Sbjct: 39  HETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGS 98
Query: 73  LHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 132
           L   L   K          ++ + ++ +A   A  + +L E    ++IH ++ + N+LL 
Sbjct: 99  LDTYLKKNKN--------CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLI 147
Query: 133 EDFKAKIAD---FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLTQKSDVYSFG 187
            +   K  +     LS+  P ++  +    +L       P   +     L   +D +SFG
Sbjct: 148 REEDRKTGNPPFIKLSD--PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFG 205
Query: 188 VVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXX 246
             L E+ + G KP+         +L +    +  ED+  Q   PK               
Sbjct: 206 TTLWEICSGGDKPL--------SALDSQRKLQFYEDR-HQLPAPK---------AAELAN 247
Query: 247 XXXXCVQYEAEFRPNMSIVVKALQPLL 273
               C+ YE + RP+   +++ L  L 
Sbjct: 248 LINNCMDYEPDHRPSFRAIIRDLNSLF 274

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 27/138 (19%)
Query: 71  GSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV-----QPSIIHRDIR 125
           GSL+D L      Q  +P   L      R+AV AA GL +LH ++     +P+I HRD +
Sbjct: 91  GSLYDFLQR----QTLEPHLAL------RLAVSAACGLAHLHVEIFGTQGKPAIAHRDFK 140
Query: 126 SSNVLLFEDFKAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT---- 178
           S NVL+  + +  IAD  L+   +Q  D     ++ RV GT  Y APE  +  Q+     
Sbjct: 141 SRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTKRYMAPE-VLDEQIRTDCF 198
Query: 179 ---QKSDVYSFGVVLLEL 193
              + +D+++FG+VL E+
Sbjct: 199 ESYKWTDIWAFGLVLWEI 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 91/179 (50%), Gaps = 30/179 (16%)
Query: 33  EKQLVSVVSRLKHENLVELLGYCV----EGNLRVLAYEFATMGSLHDILHGRKGVQGAQP 88
           E +L + V  L+HEN++  +   +          L   +  MGSL+D L           
Sbjct: 79  ETELYNTV-MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--------- 128
Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFEDFKAKIADFN 143
              LD ++ +RI +  A GL +LH ++     +P+I HRD++S N+L+ ++ +  IAD  
Sbjct: 129 -TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 187
Query: 144 LS---NQAPDMAARLHSTRVLGTFGYHAPEYA-MTGQLT-----QKSDVYSFGVVLLEL 193
           L+   +Q+ +     ++ RV GT  Y APE    T Q+      ++ D+++FG+VL E+
Sbjct: 188 LAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAAR 154
           +  +   ARG+E+L  +     IHRD+ + N+LL E+   KI DF L+    + PD   R
Sbjct: 202 ISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDY-VR 257
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
              TR+     + APE       + KSDV+S+GV+L E+ +
Sbjct: 258 KGDTRL--PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 5/104 (4%)
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V  A + + GL +LH++    II+RD++  NV+L  +   KIADF +  +   M   + +
Sbjct: 123 VFYAAEISIGLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEH--MMDGVTT 177
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
               GT  Y APE        +  D +++GV+L E+L G+ P D
Sbjct: 178 REFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 83/198 (41%), Gaps = 33/198 (16%)
Query: 21  ERLKSPKNYPDDEKQL--VSVVSRLKHENLVELLGYCVEGNL---------RVLAY---E 66
           +R++ P      EK +  V  +++L+H  +V      +E N          +V  Y   +
Sbjct: 36  KRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQ 95
Query: 67  FATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRS 126
                +L D ++GR  ++  +    L       I +  A  +E+LH K    ++HRD++ 
Sbjct: 96  LCRKENLKDWMNGRCTIEERERSVCL------HIFLQIAEAVEFLHSK---GLMHRDLKP 146
Query: 127 SNVLLFEDFKAKIADFNLSNQAPD----------MAARLHSTRVLGTFGYHAPEYAMTGQ 176
           SN+    D   K+ DF L                M A    T  +GT  Y +PE      
Sbjct: 147 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206
Query: 177 LTQKSDVYSFGVVLLELL 194
            + K D++S G++L ELL
Sbjct: 207 YSHKVDIFSLGLILFELL 224

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 19/179 (10%)
Query: 24  KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 83
           KSP       +  ++V+ ++KHEN+V L           L  +  + G L D +  R GV
Sbjct: 44  KSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER-GV 102
Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIA 140
              +   ++  + +V  AV      +YLHE     I+HRD++  N+L     E+ K  I 
Sbjct: 103 YTEKDASLV--IQQVLSAV------KYLHEN---GIVHRDLKPENLLYLTPEENSKIMIT 151
Query: 141 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           DF LS     M      +   GT GY APE       ++  D +S GV+   LL G  P
Sbjct: 152 DFGLSK----MEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 60/134 (44%), Gaps = 7/134 (5%)
Query: 67  FATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRS 126
           F   G LH  L   +   G  P   L   T VR  VD A G+EYL  +   + IHRD+ +
Sbjct: 112 FMKHGDLHAFLLASR--IGENPFN-LPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAA 165
Query: 127 SNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSF 186
            N +L ED    +ADF LS +                  + A E       T  SDV++F
Sbjct: 166 RNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225
Query: 187 GVVLLELLT-GRKP 199
           GV + E++T G+ P
Sbjct: 226 GVTMWEIMTRGQTP 239

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 43  LKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI 100
             H N++ +LG C         L   +   GSL+++LH            V+D    V+ 
Sbjct: 64  FSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-------VVDQSQAVKF 116
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI--ADFNLSNQAPDMAARLHST 158
           A+D ARG+ +LH  ++P I    + S +V++ ED  A+I  AD   S Q+P    R+   
Sbjct: 117 ALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP---GRM--- 169
Query: 159 RVLGTFGYHAPEYAMTGQLTQK--------SDVYSFGVVLLELLTGRKP 199
                   +AP +     L +K        +D++SF V+L EL+T   P
Sbjct: 170 --------YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 91/179 (50%), Gaps = 30/179 (16%)
Query: 33  EKQLVSVVSRLKHENLVELLGYCV----EGNLRVLAYEFATMGSLHDILHGRKGVQGAQP 88
           E +L + V  L+HEN++  +   +          L   +  MGSL+D L           
Sbjct: 50  ETELYNTV-MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--------- 99
Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFEDFKAKIADFN 143
              LD ++ +RI +  A GL +LH ++     +P+I HRD++S N+L+ ++ +  IAD  
Sbjct: 100 -TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158
Query: 144 LS---NQAPDMAARLHSTRVLGTFGYHAPEYA-MTGQLT-----QKSDVYSFGVVLLEL 193
           L+   +Q+ +     ++ RV GT  Y APE    T Q+      ++ D+++FG+VL E+
Sbjct: 159 LAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 91/179 (50%), Gaps = 30/179 (16%)
Query: 33  EKQLVSVVSRLKHENLVELLGYCV----EGNLRVLAYEFATMGSLHDILHGRKGVQGAQP 88
           E +L + V  L+HEN++  +   +          L   +  MGSL+D L           
Sbjct: 50  ETELYNTV-MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--------- 99
Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFEDFKAKIADFN 143
              LD ++ +RI +  A GL +LH ++     +P+I HRD++S N+L+ ++ +  IAD  
Sbjct: 100 -TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158
Query: 144 LS---NQAPDMAARLHSTRVLGTFGYHAPEYA-MTGQLT-----QKSDVYSFGVVLLEL 193
           L+   +Q+ +     ++ RV GT  Y APE    T Q+      ++ D+++FG+VL E+
Sbjct: 159 LAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 54/125 (43%), Gaps = 27/125 (21%)
Query: 93  DWMTR------------VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 140
           DWM R            + I +  A  +E+LH K    ++HRD++ SN+    D   K+ 
Sbjct: 150 DWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 206
Query: 141 DFNLSNQ-----------APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVV 189
           DF L               P  A   H  +V GT  Y +PE       + K D++S G++
Sbjct: 207 DFGLVTAMDQDEEEQTVLTPMPAYATHXGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLI 265
Query: 190 LLELL 194
           L ELL
Sbjct: 266 LFELL 270

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 60/129 (46%), Gaps = 35/129 (27%)
Query: 93  DWMTRVRIAVDAARGLEYLHEKV------QPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 146
           DW++  R+A    RGL YLH ++      +P+I HRD+ S NVL+  D    I+DF LS 
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS- 167
Query: 147 QAPDMAARLHSTRV-------------LGTFGYHAPEYAMTGQLT--------QKSDVYS 185
                  RL   R+             +GT  Y APE  + G +         ++ D+Y+
Sbjct: 168 ------MRLTGNRLVRPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYA 220
Query: 186 FGVVLLELL 194
            G++  E+ 
Sbjct: 221 LGLIYWEIF 229

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 79/186 (42%), Gaps = 31/186 (16%)
Query: 29  YPDDEKQL----------VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 78
           Y DD K +          +S++  L H N+++L     +     L  EF   G L + + 
Sbjct: 79  YSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII 138
Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED---F 135
            R          ++  +           G+ YLH   + +I+HRDI+  N+LL       
Sbjct: 139 NRHKFDECDAANIMKQIL---------SGICYLH---KHNIVHRDIKPENILLENKNSLL 186
Query: 136 KAKIADFNLSN-QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELL 194
             KI DF LS+  + D   R      LGT  Y APE  +  +  +K DV+S GV++  LL
Sbjct: 187 NIKIVDFGLSSFFSKDYKLRDR----LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILL 241
Query: 195 TGRKPV 200
            G  P 
Sbjct: 242 CGYPPF 247

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD          + T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 195
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+  A PD          + T 
Sbjct: 140 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 196
Query: 165 GYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATP 217
            Y APE  +  +   KS D++S G +L E+L+ R   P  H + +    L    +P
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 252

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 72/163 (44%), Gaps = 10/163 (6%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ +L H N+++     +E N   +  E A  G L  ++   K  +   P   + W  
Sbjct: 83  IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV-WKY 141
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            V++       LE++H +    ++HRDI+ +NV +      K+ D  L           H
Sbjct: 142 FVQLC----SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 194
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           S  ++GT  Y +PE         KSD++S G +L E+   + P
Sbjct: 195 S--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 11/163 (6%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ R +HEN++ +        L  +   +     +   L+     Q      +  ++ 
Sbjct: 92  IQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLY 151
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARL 155
           ++       RGL+Y+H     +++HRD++ SN+L+      KI DF L+  A P+     
Sbjct: 152 QI------LRGLKYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTG 202
Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGR 197
             T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 203 FLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 18/166 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           ++V+ ++KH N+V L      G    L  +  + G L D +   KG    +         
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-VEKGFYTERDAS------ 119
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 153
             R+       ++YLH+     I+HRD++  N+L +   ED K  I+DF LS +  D  +
Sbjct: 120 --RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGS 173
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            L +    GT GY APE       ++  D +S GV+   LL G  P
Sbjct: 174 VLSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 18/166 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           ++V+ ++KH N+V L      G    L  +  + G L D +   KG    +         
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDAS------ 119
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 153
             R+       ++YLH+     I+HRD++  N+L +   ED K  I+DF LS +  D  +
Sbjct: 120 --RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGS 173
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            L  +   GT GY APE       ++  D +S GV+   LL G  P
Sbjct: 174 VL--STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 37  VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDI-LHGRKGVQGAQPGPVLDW 94
           + +++   H  +V+LLG Y  +G L ++  EF   G++  I L   +G+   Q   V   
Sbjct: 67  IEILATCDHPYIVKLLGAYYHDGKLWIM-IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 125
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M            L +LH K    IIHRD+++ NVL+  +   ++ADF +S  A ++   
Sbjct: 126 MLE---------ALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTL 171
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLEL 193
                 +GT  + APE  M   +       K+D++S G+ L+E+
Sbjct: 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 19/176 (10%)
Query: 24  KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEF--ATMGSLHDILHGRK 81
           K  +  P    + +S++  LKH N+V+L          VL +E     +  L D+  G  
Sbjct: 38  KEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG- 96
Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
                     L+ +T     +    G+ Y H++    ++HRD++  N+L+  + + KIAD
Sbjct: 97  ----------LESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIAD 143
Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTG 196
           F L+ +A  +  R ++  V+ T  Y AP+  M + + +   D++S G +  E++ G
Sbjct: 144 FGLA-RAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 19/176 (10%)
Query: 24  KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEF--ATMGSLHDILHGRK 81
           K  +  P    + +S++  LKH N+V+L          VL +E     +  L D+  G  
Sbjct: 38  KEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG- 96
Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
                     L+ +T     +    G+ Y H++    ++HRD++  N+L+  + + KIAD
Sbjct: 97  ----------LESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIAD 143
Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTG 196
           F L+ +A  +  R ++  V+ T  Y AP+  M + + +   D++S G +  E++ G
Sbjct: 144 FGLA-RAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 37  VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDI-LHGRKGVQGAQPGPVLDW 94
           + +++   H  +V+LLG Y  +G L ++  EF   G++  I L   +G+   Q   V   
Sbjct: 59  IEILATCDHPYIVKLLGAYYHDGKLWIM-IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 117
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
           M            L +LH K    IIHRD+++ NVL+  +   ++ADF +S  A ++   
Sbjct: 118 MLE---------ALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTL 163
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLEL 193
                 +GT  + APE  M   +       K+D++S G+ L+E+
Sbjct: 164 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 22/166 (13%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH----GRKGVQGAQPGPVLD 93
           +++  +KH  +V+L+            Y F T G L+ IL     G   +Q  + G  ++
Sbjct: 73  NILEEVKHPFIVDLI------------YAFQTGGKLYLILEYLSGGELFMQLEREGIFME 120
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
                 +A + +  L +LH+K    II+RD++  N++L      K+ DF L  ++     
Sbjct: 121 DTACFYLA-EISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             H+    GT  Y APE  M     +  D +S G ++ ++LTG  P
Sbjct: 177 VTHT--FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 18/166 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           ++V+ ++KH N+V L      G    L  +  + G L D +   KG    +         
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-VEKGFYTERDAS------ 119
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 153
             R+       ++YLH+     I+HRD++  N+L +   ED K  I+DF LS +  D  +
Sbjct: 120 --RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGS 173
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            L +    GT GY APE       ++  D +S GV+   LL G  P
Sbjct: 174 VLSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 18/166 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           ++V+ ++KH N+V L      G    L  +  + G L D +   KG    +         
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDAS------ 119
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 153
             R+       ++YLH+     I+HRD++  N+L +   ED K  I+DF LS +  D  +
Sbjct: 120 --RLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGS 173
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            L +    GT GY APE       ++  D +S GV+   LL G  P
Sbjct: 174 VLSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 19/176 (10%)
Query: 24  KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEF--ATMGSLHDILHGRK 81
           K  +  P    + +S++  LKH N+V+L          VL +E     +  L D+  G  
Sbjct: 38  KEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG- 96
Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
                     L+ +T     +    G+ Y H++    ++HRD++  N+L+  + + KIAD
Sbjct: 97  ----------LESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIAD 143
Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTG 196
           F L+ +A  +  R ++  ++ T  Y AP+  M + + +   D++S G +  E++ G
Sbjct: 144 FGLA-RAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 37  VSVVSRLKHENLVELL--------------GYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           + ++ RL H+N+V++               G   E N   +  E+     L ++L     
Sbjct: 59  IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL----- 112
Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIAD 141
               + GP+L+   R+       RGL+Y+H     +++HRD++ +N+ +  ED   KI D
Sbjct: 113 ----EQGPLLEEHARL-FMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGD 164
Query: 142 FNLSN-QAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKP 199
           F L+    P  + + H +  L T  Y +P   ++    T+  D+++ G +  E+LTG+  
Sbjct: 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224
Query: 200 VDHTMPRGQQSLVTWATPRLSEDKVKQCV 228
                   Q  L+  + P + E+  ++ +
Sbjct: 225 FAGAHELEQMQLILESIPVVHEEDRQELL 253

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/267 (23%), Positives = 110/267 (41%), Gaps = 42/267 (15%)
Query: 18  HENERL-----KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGS 72
           HE E L     K+ +NY +   +  S++S+L H++LV   G C  G+  +L  EF   GS
Sbjct: 39  HETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGS 98
Query: 73  LHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 132
           L   L   K          ++ + ++ +A   A  + +L E    ++IH ++ + N+LL 
Sbjct: 99  LDTYLKKNKN--------CINILWKLEVAKQLAWAMHFLEEN---TLIHGNVCAKNILLI 147
Query: 133 EDFKAKIAD---FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLTQKSDVYSFG 187
            +   K  +     LS+  P ++  +    +L       P   +     L   +D +SFG
Sbjct: 148 REEDRKTGNPPFIKLSD--PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFG 205
Query: 188 VVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXX 246
             L E+ + G KP+         +L +    +  ED+  Q   PK               
Sbjct: 206 TTLWEICSGGDKPL--------SALDSQRKLQFYEDR-HQLPAPK---------AAELAN 247
Query: 247 XXXXCVQYEAEFRPNMSIVVKALQPLL 273
               C+ YE + RP+   +++ L  L 
Sbjct: 248 LINNCMDYEPDHRPSFRAIIRDLNSLF 274

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V  A + A GL +L  K    II+RD++  NV+L  +   KIADF +  +  ++   + +
Sbjct: 445 VFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTT 499
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
               GT  Y APE        +  D ++FGV+L E+L G+ P +
Sbjct: 500 KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 6/105 (5%)
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V  A +   GLE LH +    I++RD++  N+LL +    +I+D  L+   P+   +   
Sbjct: 289 VFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIK 343
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 202
            RV GT GY APE     + T   D ++ G +L E++ G+ P   
Sbjct: 344 GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD-ILHGRKGVQGAQPGPVLDWM 95
           V+V+  L H N+++L  +  +     L  E    G L D I+H  K           + +
Sbjct: 87  VAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK----------FNEV 136
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLS----NQA 148
               I      G+ YLH   + +I+HRD++  N+LL    +D   KI DF LS    NQ 
Sbjct: 137 DAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193
Query: 149 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             M  RL      GT  Y APE  +  +  +K DV+S GV+L  LL G  P
Sbjct: 194 K-MKERL------GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA--RLHSTRVLGT 163
           RGL+Y+H      +IHRD++ SN+L+ E+ + KI DF ++       A  +   T  + T
Sbjct: 170 RGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 164 FGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRK 198
             Y APE  ++  + TQ  D++S G +  E+L  R+
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 22/166 (13%)
Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH----GRKGVQGAQPGPVLD 93
           +++  +KH  +V+L+            Y F T G L+ IL     G   +Q  + G  ++
Sbjct: 73  NILEEVKHPFIVDLI------------YAFQTGGKLYLILEYLSGGELFMQLEREGIFME 120
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
                 +A + +  L +LH+K    II+RD++  N++L      K+ DF L  ++     
Sbjct: 121 DTACFYLA-EISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             H     GT  Y APE  M     +  D +S G ++ ++LTG  P
Sbjct: 177 VTHX--FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 6/105 (5%)
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V  A +   GLE LH +    I++RD++  N+LL +    +I+D  L+   P+   +   
Sbjct: 289 VFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIK 343
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 202
            RV GT GY APE     + T   D ++ G +L E++ G+ P   
Sbjct: 344 GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 19/183 (10%)
Query: 20  NERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           N +  S +++   E++   +  +L+H N+V L     E +   L ++  T G L + +  
Sbjct: 39  NTKKLSARDFQKLERE-ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 97
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA-- 137
           R+    A     +  +            + Y H      I+HR+++  N+LL    K   
Sbjct: 98  REFYSEADASHCIQQILE---------SIAYCHSN---GIVHRNLKPENLLLASKAKGAA 145
Query: 138 -KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            K+ADF L+ +  D  A  H     GT GY +PE       ++  D+++ GV+L  LL G
Sbjct: 146 VKLADFGLAIEVNDSEA-WHG--FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202
Query: 197 RKP 199
             P
Sbjct: 203 YPP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 19/183 (10%)
Query: 20  NERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           N +  S +++   E++   +  +L+H N+V L     E +   L ++  T G L + +  
Sbjct: 40  NTKKLSARDFQKLERE-ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 98
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA-- 137
           R+    A     +  +            + Y H      I+HR+++  N+LL    K   
Sbjct: 99  REFYSEADASHCIQQILE---------SIAYCHSN---GIVHRNLKPENLLLASKAKGAA 146
Query: 138 -KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            K+ADF L+ +  D  A  H     GT GY +PE       ++  D+++ GV+L  LL G
Sbjct: 147 VKLADFGLAIEVNDSEA-WHG--FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
Query: 197 RKP 199
             P
Sbjct: 204 YPP 206

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 60  LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI-AVDAAR--------GLEY 110
           L  L Y F T   L  ++      + A  G +   ++R R+ + D AR         L+Y
Sbjct: 210 LTALKYSFQTHDRLCFVM------EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 263
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH   + ++++RD++  N++L +D   KI DF L  +     A + +    GT  Y APE
Sbjct: 264 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPE 319
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
                   +  D +  GVV+ E++ GR P 
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 60  LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI-AVDAAR--------GLEY 110
           L  L Y F T   L  ++      + A  G +   ++R R+ + D AR         L+Y
Sbjct: 213 LTALKYSFQTHDRLCFVM------EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 266
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH   + ++++RD++  N++L +D   KI DF L  +     A + +    GT  Y APE
Sbjct: 267 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPE 322
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
                   +  D +  GVV+ E++ GR P 
Sbjct: 323 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 52/97 (53%), Gaps = 9/97 (9%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            +EY H   +  I+HRD++  N+LL E    KIADF LSN   D      S    G+  Y
Sbjct: 115 AVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 168
Query: 167 HAPEYAMTGQLTQ--KSDVYSFGVVLLELLTGRKPVD 201
            APE  ++G+L    + DV+S GV+L  +L  R P D
Sbjct: 169 AAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 83/189 (43%), Gaps = 19/189 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD-ILHGRKGVQGAQPGPVLDWM 95
           + V+  L H N++++     + +   +  E    G L + I+  +   +    G V + M
Sbjct: 71  IEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELM 130
Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK----AKIADFNLSNQAPDM 151
            ++  A      L Y H +    ++H+D++  N+L F+D       KI DF L   A   
Sbjct: 131 KQMMNA------LAYFHSQ---HVVHKDLKPENIL-FQDTSPHSPIKIIDFGL---AELF 177
Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 211
            +  HST   GT  Y APE      +T K D++S GVV+  LLTG  P   T     Q  
Sbjct: 178 KSDEHSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236
Query: 212 VTWATPRLS 220
            T+  P  +
Sbjct: 237 ATYKEPNYA 245

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V  A + A GL +L  K    II+RD++  NV+L  +   KIADF +  +  ++   + +
Sbjct: 124 VFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTT 178
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
               GT  Y APE        +  D ++FGV+L E+L G+ P +
Sbjct: 179 KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 39  VVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           ++  ++HEN++ LL  +    +LR     +  M  +   L    G++ ++         +
Sbjct: 94  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSE--------EK 145
Query: 98  VRIAV-DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           ++  V    +GL+Y+H      ++HRD++  N+ + ED + KI DF L+  A        
Sbjct: 146 IQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD-----AE 197
Query: 157 STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 197
            T  + T  Y APE  ++     Q  D++S G ++ E+LTG+
Sbjct: 198 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 52/97 (53%), Gaps = 9/97 (9%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            +EY H   +  I+HRD++  N+LL E    KIADF LSN   D      S    G+  Y
Sbjct: 125 AVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 178
Query: 167 HAPEYAMTGQLTQ--KSDVYSFGVVLLELLTGRKPVD 201
            APE  ++G+L    + DV+S GV+L  +L  R P D
Sbjct: 179 AAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 52/97 (53%), Gaps = 9/97 (9%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            +EY H   +  I+HRD++  N+LL E    KIADF LSN   D      S    G+  Y
Sbjct: 124 AVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 177
Query: 167 HAPEYAMTGQLTQ--KSDVYSFGVVLLELLTGRKPVD 201
            APE  ++G+L    + DV+S GV+L  +L  R P D
Sbjct: 178 AAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 84/176 (47%), Gaps = 24/176 (13%)
Query: 39  VVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           ++  ++HEN++ LL  +    +LR     +  M  +   L    G++ ++         +
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSE--------EK 127
Query: 98  VRIAV-DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           ++  V    +GL+Y+H      ++HRD++  N+ + ED + KI DF L+  A        
Sbjct: 128 IQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD-----AE 179
Query: 157 STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 211
            T  + T  Y APE  ++     Q  D++S G ++ E+LTG+     T+ +G+  L
Sbjct: 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-----TLFKGKDYL 230

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 52/97 (53%), Gaps = 9/97 (9%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            +EY H   +  I+HRD++  N+LL E    KIADF LSN   D      S    G+  Y
Sbjct: 119 AVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 172
Query: 167 HAPEYAMTGQLTQ--KSDVYSFGVVLLELLTGRKPVD 201
            APE  ++G+L    + DV+S GV+L  +L  R P D
Sbjct: 173 AAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 65/149 (43%), Gaps = 20/149 (13%)
Query: 60  LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI---------AVDAARGLEY 110
           L  L Y F T   L  ++      + A  G +   ++R R+           +    LEY
Sbjct: 67  LTALKYAFQTHDRLCFVM------EYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH +    +++RDI+  N++L +D   KI DF L  +     A + +    GT  Y APE
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 175
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                   +  D +  GVV+ E++ GR P
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 19/183 (10%)
Query: 20  NERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           N +  S +++   E++   +  +L+H N+V L     E +   L ++  T G L + +  
Sbjct: 40  NTKKLSARDFQKLERE-ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 98
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA-- 137
           R+    A     +  +            + Y H      I+HR+++  N+LL    K   
Sbjct: 99  REFYSEADASHCIQQILE---------SIAYCHSN---GIVHRNLKPENLLLASKAKGAA 146
Query: 138 -KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            K+ADF L+ +  D  A  H     GT GY +PE       ++  D+++ GV+L  LL G
Sbjct: 147 VKLADFGLAIEVNDSEA-WHG--FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
Query: 197 RKP 199
             P
Sbjct: 204 YPP 206

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 16/184 (8%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S++  L H N+V+LL      N   L +EF +M  L D +     + G  P P++    
Sbjct: 55  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDA-SALTGI-PLPLIK--- 108
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                    +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R +
Sbjct: 109 --SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTY 162
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVT 213
              V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +   T
Sbjct: 163 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 221
Query: 214 WATP 217
             TP
Sbjct: 222 LGTP 225

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 65/149 (43%), Gaps = 20/149 (13%)
Query: 60  LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI---------AVDAARGLEY 110
           L  L Y F T   L  ++      + A  G +   ++R R+           +    LEY
Sbjct: 67  LTALKYAFQTHDRLCFVM------EYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH +    +++RDI+  N++L +D   KI DF L  +     A + +    GT  Y APE
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 175
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                   +  D +  GVV+ E++ GR P
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 16/184 (8%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S++  L H N+V+LL      N   L +EF +M  L D +     + G  P P++    
Sbjct: 56  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDA-SALTGI-PLPLIK--- 109
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                    +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R +
Sbjct: 110 --SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTY 163
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVT 213
              V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +   T
Sbjct: 164 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 222
Query: 214 WATP 217
             TP
Sbjct: 223 LGTP 226

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 82/191 (42%), Gaps = 13/191 (6%)
Query: 25  SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
           SP    +D K+  S+   LKH ++VELL       +  + +EF     L       + V+
Sbjct: 65  SPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL-----CFEIVK 119
Query: 85  GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA---KIAD 141
            A  G V                L Y H+    +IIHRD++  NVLL     +   K+ D
Sbjct: 120 RADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGD 176
Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           F ++ Q  + +  +   RV GT  + APE        +  DV+  GV+L  LL+G  P  
Sbjct: 177 FGVAIQLGE-SGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234
Query: 202 HTMPRGQQSLV 212
            T  R  + ++
Sbjct: 235 GTKERLFEGII 245

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA--RLHSTRVLGT 163
           RGL+Y+H      +IHRD++ SN+L+ E+ + KI DF ++       A  +   T  + T
Sbjct: 169 RGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 164 FGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRK 198
             Y APE  ++  + TQ  D++S G +  E+L  R+
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 65/149 (43%), Gaps = 20/149 (13%)
Query: 60  LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI---------AVDAARGLEY 110
           L  L Y F T   L  ++      + A  G +   ++R R+           +    LEY
Sbjct: 70  LTALKYAFQTHDRLCFVM------EYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 123
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH +    +++RDI+  N++L +D   KI DF L  +     A + +    GT  Y APE
Sbjct: 124 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 178
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                   +  D +  GVV+ E++ GR P
Sbjct: 179 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 20/149 (13%)
Query: 60  LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI---------AVDAARGLEY 110
           L  L Y F T   L  ++      + A  G +   ++R R+           +    LEY
Sbjct: 67  LTALKYAFQTHDRLCFVM------EYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH +    +++RDI+  N++L +D   KI DF L  +     A +      GT  Y APE
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--FCGTPEYLAPE 175
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                   +  D +  GVV+ E++ GR P
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 31/170 (18%)
Query: 43  LKHENLVELLGYCVEGNLR----VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 98
           ++HEN++  +   ++G        L  ++   GSL+D L              LD  + +
Sbjct: 88  MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS----------TTLDAKSML 137
Query: 99  RIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
           ++A  +  GL +LH ++     +P+I HRD++S N+L+ ++    IAD  L+ +      
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 154 RLH---STRVLGTFGYHAPEYAMTGQLTQK-------SDVYSFGVVLLEL 193
            +    +TRV GT  Y  PE  +   L +        +D+YSFG++L E+
Sbjct: 198 EVDIPPNTRV-GTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 26/176 (14%)
Query: 31  DDEKQL-------VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 83
           DD+K +       + ++ +L+HENLV LL  C +     L +EF     L D+     G 
Sbjct: 62  DDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG- 120
Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
                   LD+    +       G+ + H     +IIHRDI+  N+L+ +    K+ DF 
Sbjct: 121 --------LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG 169
Query: 144 LSNQ--APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTG 196
            +    AP     ++   V  T  Y APE  +      K+ DV++ G ++ E+  G
Sbjct: 170 FARTLAAP---GEVYDDEV-ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 19/183 (10%)
Query: 20  NERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           N +  S +++   E++   +  +L+H N+V L     E +   L ++  T G L + +  
Sbjct: 63  NTKKLSARDFQKLERE-ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 121
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA-- 137
           R+    A     +  +            + Y H      I+HR+++  N+LL    K   
Sbjct: 122 REFYSEADASHCIQQILE---------SIAYCHSN---GIVHRNLKPENLLLASKAKGAA 169
Query: 138 -KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            K+ADF L+ +  D  A  H     GT GY +PE       ++  D+++ GV+L  LL G
Sbjct: 170 VKLADFGLAIEVNDSEA-WHG--FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
Query: 197 RKP 199
             P
Sbjct: 227 YPP 229

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 70/173 (40%), Gaps = 20/173 (11%)
Query: 33  EKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL 92
           E  L+  +   +H N+V L+  C          E         +    +      P P L
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRT---DREIKVTLVFEHVDQDLRTYLDKAPPPGL 117
Query: 93  DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
              T   +     RGL++LH      I+HRD++  N+L+      K+ADF L        
Sbjct: 118 PAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL-------- 166
Query: 153 ARLHS-----TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
           AR++S     T V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 19/166 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V+V+ +L H N+++L  +  +     L  E    G L D +  R+         ++    
Sbjct: 72  VAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK--- 128
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMAA 153
                     G  YLH   + +I+HRD++  N+LL     D   KI DF LS    ++  
Sbjct: 129 ------QVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGG 178
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           ++     LGT  Y APE  +  +  +K DV+S GV+L  LL G  P
Sbjct: 179 KMKER--LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 20/149 (13%)
Query: 60  LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI---------AVDAARGLEY 110
           L  L Y F T   L  ++      + A  G +   ++R R+           +    LEY
Sbjct: 67  LTALKYAFQTHDRLCFVM------EYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH +    +++RDI+  N++L +D   KI DF L  +     A +      GT  Y APE
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--FCGTPEYLAPE 175
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                   +  D +  GVV+ E++ GR P
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 20/149 (13%)
Query: 60  LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI---------AVDAARGLEY 110
           L  L Y F T   L  ++      + A  G +   ++R R+           +    LEY
Sbjct: 67  LTALKYAFQTHDRLCFVM------EYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH +    +++RDI+  N++L +D   KI DF L  +     A +      GT  Y APE
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--FCGTPEYLAPE 175
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                   +  D +  GVV+ E++ GR P
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 64/150 (42%), Gaps = 20/150 (13%)
Query: 60  LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI---------AVDAARGLEY 110
           L  L Y F T   L  ++      + A  G +   ++R R+           +    LEY
Sbjct: 72  LTALKYAFQTHDRLCFVM------EYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 125
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH +    +++RDI+  N++L +D   KI DF L  +     A +      GT  Y APE
Sbjct: 126 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--FCGTPEYLAPE 180
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
                   +  D +  GVV+ E++ GR P 
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 19/150 (12%)
Query: 60  LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI-AVDAAR--------GLEY 110
           L  L Y F T   L  ++      + A  G +   ++R R+ + D AR         L+Y
Sbjct: 72  LTALKYSFQTHDRLCFVM------EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 125
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH   + ++++RD++  N++L +D   KI DF L  +     A +      GT  Y APE
Sbjct: 126 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX--FCGTPEYLAPE 181
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
                   +  D +  GVV+ E++ GR P 
Sbjct: 182 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 72/169 (42%), Gaps = 34/169 (20%)
Query: 43  LKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI 100
             H N++ +LG C         L   +   GSL+++LH            V+D    V+ 
Sbjct: 64  FSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNF-------VVDQSQAVKF 116
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI--ADFNLSNQAPDMAARLHST 158
           A+D ARG  +LH  ++P I    + S +V + ED  A+I  AD   S Q+P         
Sbjct: 117 ALDXARGXAFLH-TLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRX------ 169
Query: 159 RVLGTFGYHAPEYAMTGQLTQK--------SDVYSFGVVLLELLTGRKP 199
                   +AP +     L +K        +D +SF V+L EL+T   P
Sbjct: 170 --------YAPAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVP 210

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 19/150 (12%)
Query: 60  LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI-AVDAAR--------GLEY 110
           L  L Y F T   L  ++      + A  G +   ++R R+ + D AR         L+Y
Sbjct: 71  LTALKYSFQTHDRLCFVM------EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 124
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH   + ++++RD++  N++L +D   KI DF L  +     A +      GT  Y APE
Sbjct: 125 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX--FCGTPEYLAPE 180
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
                   +  D +  GVV+ E++ GR P 
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 19/150 (12%)
Query: 60  LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI-AVDAAR--------GLEY 110
           L  L Y F T   L  ++      + A  G +   ++R R+ + D AR         L+Y
Sbjct: 70  LTALKYSFQTHDRLCFVM------EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 123
Query: 111 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 170
           LH   + ++++RD++  N++L +D   KI DF L  +     A +      GT  Y APE
Sbjct: 124 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX--FCGTPEYLAPE 179
Query: 171 YAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
                   +  D +  GVV+ E++ GR P 
Sbjct: 180 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 21/172 (12%)
Query: 33  EKQL----VSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRKGVQGA 86
           EKQ+    V+++  LKH N+V      ++       +  E+   G L  ++      +G 
Sbjct: 48  EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-----TKGT 102
Query: 87  QPGPVLDWMTRVRIAVDAARGLEYLHEKVQP--SIIHRDIRSSNVLLFEDFKAKIADFNL 144
           +    LD    +R+       L+  H +     +++HRD++ +NV L      K+ DF L
Sbjct: 103 KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162
Query: 145 S---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 193
           +   N   D A        +GT  Y +PE        +KSD++S G +L EL
Sbjct: 163 ARILNHDEDFAKEF-----VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 17/100 (17%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS-----TRV 160
           RGL++LH      ++HRD++  N+L+    + K+ADF L        AR++S     T V
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMALTSV 179
Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
           + T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A +   GLE++H +    +++RD++ +N+LL E    +I+D  L   A D + +     V
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL---ACDFSKKKPHASV 351
Query: 161 LGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKP 199
            GT GY APE    G     S D +S G +L +LL G  P
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A +   GLE++H +    +++RD++ +N+LL E    +I+D  L   A D + +     V
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL---ACDFSKKKPHASV 351
Query: 161 LGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKP 199
            GT GY APE    G     S D +S G +L +LL G  P
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 21/164 (12%)
Query: 45  HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDA 104
           H N+++L           L ++    G L D L  +  +   +   ++  +  V  A   
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA--- 139
Query: 105 ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF 164
                 LH   + +I+HRD++  N+LL +D   K+ DF  S Q  D   +L S  V GT 
Sbjct: 140 ------LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLRS--VCGTP 187
Query: 165 GYHAPEYAMTGQ------LTQKSDVYSFGVVLLELLTGRKPVDH 202
            Y APE              ++ D++S GV++  LL G  P  H
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 8/101 (7%)
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A +   GLE++H +    +++RD++ +N+LL E    +I+D  L   A D + +     V
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL---ACDFSKKKPHASV 351
Query: 161 LGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKPV 200
            GT GY APE    G     S D +S G +L +LL G  P 
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 8/101 (7%)
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A +   GLE++H +    +++RD++ +N+LL E    +I+D  L   A D + +     V
Sbjct: 297 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL---ACDFSKKKPHASV 350
Query: 161 LGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKPV 200
            GT GY APE    G     S D +S G +L +LL G  P 
Sbjct: 351 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 17/100 (17%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS-----TRV 160
           RGL++LH      ++HRD++  N+L+    + K+ADF L        AR++S     T V
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMALTSV 179
Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
           + T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 17/100 (17%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS-----TRV 160
           RGL++LH      ++HRD++  N+L+    + K+ADF L        AR++S     T V
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMALTSV 179
Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
           + T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 20/173 (11%)
Query: 33  EKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL 92
           E  L+  +   +H N+V L+  C          E         +    +      P P L
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTD---REIKVTLVFEHVDQDLRTYLDKAPPPGL 109
Query: 93  DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
              T   +     RGL++LH      I+HRD++  N+L+      K+ADF L        
Sbjct: 110 PAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL-------- 158
Query: 153 ARLHSTR-----VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
           AR++S +     V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 159 ARIYSYQMALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            APE  +     +  D++S GV++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAARLHS 157
           +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+    + PD   R   
Sbjct: 204 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGD 259
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            R+     + APE       T +SDV+SFGV+L E+ +
Sbjct: 260 ARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAARLHS 157
           +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+    + PD   R   
Sbjct: 206 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGD 261
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            R+     + APE       T +SDV+SFGV+L E+ +
Sbjct: 262 ARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            APE  +     +  D++S GV++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 20/173 (11%)
Query: 33  EKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL 92
           E  L+  +   +H N+V L+  C          E         +    +      P P L
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRT---DREIKVTLVFEHVDQDLRTYLDKAPPPGL 109
Query: 93  DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
              T   +     RGL++LH      I+HRD++  N+L+      K+ADF L        
Sbjct: 110 PAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL-------- 158
Query: 153 ARLHSTR-----VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
           AR++S +     V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 159 ARIYSYQMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAARLHS 157
           +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+    + PD   R   
Sbjct: 197 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGD 252
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            R+     + APE       T +SDV+SFGV+L E+ +
Sbjct: 253 ARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAARLHS 157
           +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+    + PD   R   
Sbjct: 199 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGD 254
Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
            R+     + APE       T +SDV+SFGV+L E+ +
Sbjct: 255 ARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 20/173 (11%)
Query: 33  EKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL 92
           E  L+  +   +H N+V L+  C          E         +    +      P P L
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRT---DREIKVTLVFEHVDQDLRTYLDKAPPPGL 109
Query: 93  DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
              T   +     RGL++LH      I+HRD++  N+L+      K+ADF L        
Sbjct: 110 PAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL-------- 158
Query: 153 ARLHSTR-----VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
           AR++S +     V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 159 ARIYSYQMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 19/166 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V+V+ +L H N+++L  +  +     L  E    G L D +  R+         ++    
Sbjct: 55  VAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK--- 111
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMAA 153
                     G  YLH   + +I+HRD++  N+LL     D   KI DF LS    ++  
Sbjct: 112 ------QVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGG 161
Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           ++     LGT  Y APE  +  +  +K DV+S GV+L  LL G  P
Sbjct: 162 KMKER--LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPP 204

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 23/129 (17%)
Query: 87  QPGPVLDWMTR--------VRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFE 133
           + G + D++ R        +++A+  A GL +LH ++     +P+I HRD++S N+L+ +
Sbjct: 85  EHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 144
Query: 134 DFKAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTG------QLTQKSDVY 184
           +    IAD  L+   + A D      + RV GT  Y APE           +  +++D+Y
Sbjct: 145 NGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMAPEVLDDSINMKHFESFKRADIY 203
Query: 185 SFGVVLLEL 193
           + G+V  E+
Sbjct: 204 AMGLVFWEI 212

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 80/188 (42%), Gaps = 28/188 (14%)
Query: 20  NERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           N +  S +++   E++   +   LKH N+V L     E     L ++  T G L + +  
Sbjct: 38  NTKKLSARDHQKLERE-ARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA 96
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV----QPSIIHRDIRSSNVLLFEDF 135
           R+    A                DA+  ++ + E V    Q  ++HRD++  N+LL    
Sbjct: 97  REYYSEA----------------DASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKC 140
Query: 136 KA---KIADFNLSNQAP-DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLL 191
           K    K+ADF L+ +   D  A        GT GY +PE        +  D+++ GV+L 
Sbjct: 141 KGAAVKLADFGLAIEVQGDQQAWF---GFAGTPGYLSPEVLRKEAYGKPVDIWACGVILY 197
Query: 192 ELLTGRKP 199
            LL G  P
Sbjct: 198 ILLVGYPP 205

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 23/127 (18%)
Query: 89  GPVLDWMTR--------VRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFEDF 135
           G + D++ R        +++A+  A GL +LH ++     +P+I HRD++S N+L+ ++ 
Sbjct: 125 GSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184
Query: 136 KAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTG------QLTQKSDVYSF 186
              IAD  L+   + A D      + RV GT  Y APE           +  +++D+Y+ 
Sbjct: 185 TCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMAPEVLDDSINMKHFESFKRADIYAM 243
Query: 187 GVVLLEL 193
           G+V  E+
Sbjct: 244 GLVFWEI 250

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 23/129 (17%)
Query: 87  QPGPVLDWMTR--------VRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFE 133
           + G + D++ R        +++A+  A GL +LH ++     +P+I HRD++S N+L+ +
Sbjct: 110 EHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 169
Query: 134 DFKAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTG------QLTQKSDVY 184
           +    IAD  L+   + A D      + RV GT  Y APE           +  +++D+Y
Sbjct: 170 NGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMAPEVLDDSINMKHFESFKRADIY 228
Query: 185 SFGVVLLEL 193
           + G+V  E+
Sbjct: 229 AMGLVFWEI 237

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 23/129 (17%)
Query: 87  QPGPVLDWMTR--------VRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFE 133
           + G + D++ R        +++A+  A GL +LH ++     +P+I HRD++S N+L+ +
Sbjct: 84  EHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143
Query: 134 DFKAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTG------QLTQKSDVY 184
           +    IAD  L+   + A D      + RV GT  Y APE           +  +++D+Y
Sbjct: 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMAPEVLDDSINMKHFESFKRADIY 202
Query: 185 SFGVVLLEL 193
           + G+V  E+
Sbjct: 203 AMGLVFWEI 211

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 23/129 (17%)
Query: 87  QPGPVLDWMTR--------VRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFE 133
           + G + D++ R        +++A+  A GL +LH ++     +P+I HRD++S N+L+ +
Sbjct: 87  EHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 146
Query: 134 DFKAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTG------QLTQKSDVY 184
           +    IAD  L+   + A D      + RV GT  Y APE           +  +++D+Y
Sbjct: 147 NGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMAPEVLDDSINMKHFESFKRADIY 205
Query: 185 SFGVVLLEL 193
           + G+V  E+
Sbjct: 206 AMGLVFWEI 214

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 69/164 (42%), Gaps = 21/164 (12%)
Query: 45  HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDA 104
           H N+++L           L ++    G L D L  +  +   +   ++  +  V  A   
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA--- 126
Query: 105 ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF 164
                 LH   + +I+HRD++  N+LL +D   K+ DF  S Q  D   +L    V GT 
Sbjct: 127 ------LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLR--EVCGTP 174
Query: 165 GYHAPEYAMTGQ------LTQKSDVYSFGVVLLELLTGRKPVDH 202
            Y APE              ++ D++S GV++  LL G  P  H
Sbjct: 175 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 218

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 23/129 (17%)
Query: 87  QPGPVLDWMTR--------VRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFE 133
           + G + D++ R        +++A+  A GL +LH ++     +P+I HRD++S N+L+ +
Sbjct: 90  EHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 149
Query: 134 DFKAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTG------QLTQKSDVY 184
           +    IAD  L+   + A D      + RV GT  Y APE           +  +++D+Y
Sbjct: 150 NGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMAPEVLDDSINMKHFESFKRADIY 208
Query: 185 SFGVVLLEL 193
           + G+V  E+
Sbjct: 209 AMGLVFWEI 217

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 85/184 (46%), Gaps = 16/184 (8%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S++  L H N+V+LL      N   L +EF +M  L   +     + G  P P++    
Sbjct: 56  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDA-SALTGI-PLPLIK--- 109
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                    +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R +
Sbjct: 110 --SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTY 163
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVT 213
              V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +   T
Sbjct: 164 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 222
Query: 214 WATP 217
             TP
Sbjct: 223 LGTP 226

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            L+YL  +    IIHRD++  N+LL E     I DFN++   P        T + GT  Y
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPY 180
Query: 167 HAPEYAMTGQLTQKS---DVYSFGVVLLELLTGRKP 199
            APE   + +    S   D +S GV   ELL GR+P
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 85/184 (46%), Gaps = 16/184 (8%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S++  L H N+V+LL      N   L +EF +M  L   +     + G  P P++    
Sbjct: 54  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDA-SALTGI-PLPLIK--- 107
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                    +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R +
Sbjct: 108 --SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTY 161
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVT 213
              V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +   T
Sbjct: 162 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 220
Query: 214 WATP 217
             TP
Sbjct: 221 LGTP 224

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 88/193 (45%), Gaps = 25/193 (12%)
Query: 17  SHENERLKSPKNYPDDEK------QLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFAT- 69
           +HE   LK  +   DDE       + + ++  LKH+N+V L           L +EF   
Sbjct: 26  THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85
Query: 70  -MGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 128
            +    D  +G        P  V  ++ ++       +GL + H +   +++HRD++  N
Sbjct: 86  DLKKYFDSCNG-----DLDPEIVKSFLFQL------LKGLGFCHSR---NVLHRDLKPQN 131
Query: 129 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFG 187
           +L+  + + K+ADF L+ +A  +  R +S  V+ T  Y  P+     +L   S D++S G
Sbjct: 132 LLINRNGELKLADFGLA-RAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAG 189
Query: 188 VVLLELLTGRKPV 200
            +  EL    +P+
Sbjct: 190 CIFAELANAARPL 202

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 85/202 (42%), Gaps = 34/202 (16%)
Query: 43  LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 102
           L+  N V+ +    + +   +  E+   G+L+D++H     Q         W    R+  
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY----W----RLFR 123
Query: 103 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL--------------SNQA 148
                L Y+H +    IIHRD++  N+ + E    KI DF L              S   
Sbjct: 124 QILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 149 PDMAARLHSTRVLGTFGYHAPEYA-MTGQLTQKSDVYSFGVVLLELL----TGRKPVDHT 203
           P  +  L  T  +GT  Y A E    TG   +K D+YS G++  E++    TG + V+  
Sbjct: 181 PGSSDNL--TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVN-- 236
Query: 204 MPRGQQSLVTWATPRLSEDKVK 225
           + +  +S+     P   ++K+K
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMK 258

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A   +     T  + T  Y
Sbjct: 136 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---STNFMMTPYVVTRYY 189
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            APE  +     +  D++S G ++ EL+ G
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 69/164 (42%), Gaps = 21/164 (12%)
Query: 45  HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDA 104
           H N+++L           L ++    G L D L  +  +   +   ++  +  V  A   
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA--- 139
Query: 105 ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF 164
                 LH   + +I+HRD++  N+LL +D   K+ DF  S Q  D   +L    V GT 
Sbjct: 140 ------LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLR--EVCGTP 187
Query: 165 GYHAPEYAMTGQ------LTQKSDVYSFGVVLLELLTGRKPVDH 202
            Y APE              ++ D++S GV++  LL G  P  H
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 3/101 (2%)
Query: 121 HRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA-ARLHSTRVLGTFGYHAPEYAMTGQLTQ 179
           HRD++  N+L+  D  A + DF +++   D    +L +T  +GT  Y APE       T 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT--VGTLYYXAPERFSESHATY 214
Query: 180 KSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLS 220
           ++D+Y+   VL E LTG  P          + +  A PR S
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAIPRPS 255

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 5/101 (4%)
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           + + +  L YLHE+    II+RD++  NVLL  +   K+ D+ +  +   +     ++  
Sbjct: 116 SAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSXF 170
Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            GT  Y APE           D ++ GV++ E++ GR P D
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 72/170 (42%), Gaps = 26/170 (15%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + V+ RL H N+++L           L  E  T G L D +   KG              
Sbjct: 99  IGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV-EKGYYSE---------- 147
Query: 97  RVRIAVDAAR----GLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKIADFNLSNQAP 149
             R A DA +     + YLHE     I+HRD++  N+L      D   KIADF LS    
Sbjct: 148 --RDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-- 200
Query: 150 DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +  ++    V GT GY APE         + D++S G++   LL G +P
Sbjct: 201 -VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 5/101 (4%)
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           + + +  L YLHE+    II+RD++  NVLL  +   K+ D+ +  +   +     ++  
Sbjct: 159 SAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTF 213
Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            GT  Y APE           D ++ GV++ E++ GR P D
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 5/101 (4%)
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           + + +  L YLHE+    II+RD++  NVLL  +   K+ D+ +  +   +     ++  
Sbjct: 112 SAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSXF 166
Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            GT  Y APE           D ++ GV++ E++ GR P D
Sbjct: 167 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 5/101 (4%)
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           + + +  L YLHE+    II+RD++  NVLL  +   K+ D+ +  +   +     ++  
Sbjct: 127 SAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSXF 181
Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            GT  Y APE           D ++ GV++ E++ GR P D
Sbjct: 182 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 66/160 (41%), Gaps = 17/160 (10%)
Query: 43  LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 102
           LKH N+V L     E     L ++  T G L + +  R+    A     +  +       
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQI------- 139
Query: 103 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA---KIADFNLSNQAPDMAARLHSTR 159
                LE ++   Q  I+HRD++  N+LL    K    K+ADF L+ +            
Sbjct: 140 -----LESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG-- 192
Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             GT GY +PE        +  D+++ GV+L  LL G  P
Sbjct: 193 FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            APE  +     +  D++S G ++ E++ G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            APE  +     +  D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYY 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            APE  +        D++S G ++ EL+ G
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            APE  +     +  D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 66/149 (44%), Gaps = 17/149 (11%)
Query: 60  LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR-----VRIAV-DAARGLEYLHE 113
           L  L Y F T   LH IL     + G +    L    R     V+I V +    LE+LH 
Sbjct: 121 LVTLHYAFQTETKLHLIL---DYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH- 176
Query: 114 KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARLHSTRVLGTFGYHAPEYA 172
             +  II+RDI+  N+LL  +    + DF LS +   D   R +     GT  Y AP+  
Sbjct: 177 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTIEYMAPDIV 232
Query: 173 MTGQLTQKS--DVYSFGVVLLELLTGRKP 199
             G        D +S GV++ ELLTG  P
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 106
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 107 ----SYLFQLLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 158
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            ++  V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 159 TYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 212 VTWATP 217
            T  TP
Sbjct: 218 RTLGTP 223

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            APE  +     +  D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S++  L H N+V+LL      N   L +EF     L D +     + G  P P++    
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDA-SALTGI-PLPLIK--- 106
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                    +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R +
Sbjct: 107 --SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTY 160
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVT 213
              V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +   T
Sbjct: 161 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 219
Query: 214 WATP 217
             TP
Sbjct: 220 LGTP 223

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 74/172 (43%), Gaps = 21/172 (12%)
Query: 33  EKQL----VSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRKGVQGA 86
           EKQ+    V+++  LKH N+V      ++       +  E+   G L  ++      +G 
Sbjct: 48  EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-----TKGT 102
Query: 87  QPGPVLDWMTRVRIAVDAARGLEYLHEKVQP--SIIHRDIRSSNVLLFEDFKAKIADFNL 144
           +    LD    +R+       L+  H +     +++HRD++ +NV L      K+ DF L
Sbjct: 103 KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162
Query: 145 S---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 193
           +   N     A        +GT  Y +PE        +KSD++S G +L EL
Sbjct: 163 ARILNHDTSFAKTF-----VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            APE  +     +  D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            APE  +     +  D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 5/101 (4%)
Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 160
           A +    L +LH+K    II+RD++  NVLL  +   K+ADF +  +   +   + +   
Sbjct: 130 AAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG--ICNGVTTATF 184
Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
            GT  Y APE           D ++ GV+L E+L G  P +
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 106
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 107 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 158
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            ++  V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 159 TYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 212 VTWATP 217
            T  TP
Sbjct: 218 RTLGTP 223

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 105
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 106 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 157
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            ++  V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 158 TYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216
Query: 212 VTWATP 217
            T  TP
Sbjct: 217 RTLGTP 222

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 60  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 113
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 114 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 165
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            ++  V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 166 TYTHEVV-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 224
Query: 212 VTWATP 217
            T  TP
Sbjct: 225 RTLGTP 230

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 106
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 107 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 158
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            ++  V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 159 TYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 212 VTWATP 217
            T  TP
Sbjct: 218 RTLGTP 223

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 105
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 106 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 157
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            ++  V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 158 TYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216
Query: 212 VTWATP 217
            T  TP
Sbjct: 217 RTLGTP 222

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 105
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 106 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 157
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            ++  V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 158 TYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216
Query: 212 VTWATP 217
            T  TP
Sbjct: 217 RTLGTP 222

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 57  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 110
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 111 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 162
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            ++  V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 163 TYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 221
Query: 212 VTWATP 217
            T  TP
Sbjct: 222 RTLGTP 227

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            APE  +     +  D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 106
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 107 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 158
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            ++  V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 159 TYTHEVV-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 212 VTWATP 217
            T  TP
Sbjct: 218 RTLGTP 223

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPEVVTRYY 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            APE  +     +  D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 74/172 (43%), Gaps = 21/172 (12%)
Query: 33  EKQL----VSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRKGVQGA 86
           EKQ+    V+++  LKH N+V      ++       +  E+   G L  ++      +G 
Sbjct: 48  EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-----TKGT 102
Query: 87  QPGPVLDWMTRVRIAVDAARGLEYLHEKVQP--SIIHRDIRSSNVLLFEDFKAKIADFNL 144
           +    LD    +R+       L+  H +     +++HRD++ +NV L      K+ DF L
Sbjct: 103 KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162
Query: 145 S---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 193
           +   N     A        +GT  Y +PE        +KSD++S G +L EL
Sbjct: 163 ARILNHDTSFAKAF-----VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 106
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 107 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 158
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            ++  V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 159 TYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 212 VTWATP 217
            T  TP
Sbjct: 218 RTLGTP 223

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 54  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 107
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 108 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 159
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            ++  V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 160 TYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 218
Query: 212 VTWATP 217
            T  TP
Sbjct: 219 RTLGTP 224

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 60  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 113
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 114 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 165
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            ++  V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 166 TYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 224
Query: 212 VTWATP 217
            T  TP
Sbjct: 225 RTLGTP 230

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 35/177 (19%)
Query: 45  HENLVELLGYCVEGNLRVLAYEFATMGS-LHDILHGRKGVQGAQPGPVLDWMTRVRIAVD 103
           HEN+V LL      N R +   F  M + LH ++             +L+ + +  +   
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN----------ILEPVHKQYVVYQ 117
Query: 104 AARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS------ 157
             + ++YLH      ++HRD++ SN+LL  +   K+ADF LS    ++    ++      
Sbjct: 118 LIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 158 -------------TRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPV 200
                        T  + T  Y APE  + + + T+  D++S G +L E+L G KP+
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/190 (23%), Positives = 80/190 (42%), Gaps = 41/190 (21%)
Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
           RL+  +  P    + VS++  LKH N+V                      +LHDI+H  K
Sbjct: 36  RLEHEEGAPCTAIREVSLLKDLKHANIV----------------------TLHDIIHTEK 73
Query: 82  GVQGA-------------QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 128
            +                  G +++            RGL Y H +    ++HRD++  N
Sbjct: 74  SLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQN 130
Query: 129 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFG 187
           +L+ E  + K+ADF L+ +A  +  + +   V+ T  Y  P+  + +   + + D++  G
Sbjct: 131 LLINERGELKLADFGLA-RAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYSTQIDMWGVG 188
Query: 188 VVLLELLTGR 197
            +  E+ TGR
Sbjct: 189 CIFYEMATGR 198

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 19/167 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS++ ++ H N++ L          VL  E  + G L D L  ++ +   +    +  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSNQAPDMA 152
                     G+ YLH K    I H D++  N++L +        K+ DF L+++  D  
Sbjct: 126 D---------GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-- 171
Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             +    + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 172 -GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 7/100 (7%)
Query: 104 AARGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLS-NQAPDMAAR--LHSTR 159
           A  GLEYLH +    I+H D+++ NVLL  D  +A + DF  +    PD   +  L    
Sbjct: 175 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 231
Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           + GT  + APE  M      K D++S   ++L +L G  P
Sbjct: 232 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 7/100 (7%)
Query: 104 AARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-KAKIADFNLS-NQAPDMAAR--LHSTR 159
           A  GLEYLH +    I+H D+++ NVLL  D  +A + DF  +    PD   +  L    
Sbjct: 159 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           + GT  + APE  M      K D++S   ++L +L G  P
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 19/167 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS++ ++ H N++ L          VL  E  + G L D L  ++ +   +    +  + 
Sbjct: 66  VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI- 124
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSNQAPDMA 152
                     G+ YLH K    I H D++  N++L +        K+ DF L+++  D  
Sbjct: 125 --------LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG- 172
Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             +    + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 173 --VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 106
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 107 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 158
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            +   V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 159 TYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 212 VTWATP 217
            T  TP
Sbjct: 218 RTLGTP 223

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 106
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 107 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 158
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            +   V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 159 TYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 212 VTWATP 217
            T  TP
Sbjct: 218 RTLGTP 223

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 19/167 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS++ ++ H N++ L          VL  E  + G L D L  ++ +   +    +  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSNQAPDMA 152
                     G+ YLH K    I H D++  N++L +        K+ DF L+++  D  
Sbjct: 126 D---------GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-- 171
Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             +    + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 172 -GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 19/167 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS++ ++ H N++ L          VL  E  + G L D L  ++ +   +    +  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSNQAPDMA 152
                     G+ YLH K    I H D++  N++L +        K+ DF L+++  D  
Sbjct: 126 D---------GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-- 171
Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             +    + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 172 -GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 105
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 106 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 157
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            +   V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 158 TYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216
Query: 212 VTWATP 217
            T  TP
Sbjct: 217 RTLGTP 222

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 55  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 108
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 109 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 160
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            +   V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 161 TYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 219
Query: 212 VTWATP 217
            T  TP
Sbjct: 220 RTLGTP 225

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 19/167 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS++ ++ H N++ L          VL  E  + G L D L  ++ +   +    +  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSNQAPDMA 152
                     G+ YLH K    I H D++  N++L +        K+ DF L+++  D  
Sbjct: 126 D---------GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-- 171
Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             +    + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 172 -GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 55  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 108
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 109 ----SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVR 160
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            +   V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 161 TYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 219
Query: 212 VTWATP 217
            T  TP
Sbjct: 220 RTLGTP 225

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 83/191 (43%), Gaps = 21/191 (10%)
Query: 17  SHENERLKSPKNYPDDEK------QLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATM 70
           +HE   LK  +   DDE       + + ++  LKH+N+V L           L +EF   
Sbjct: 26  THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD- 84
Query: 71  GSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 130
               D+        G      LD            +GL + H +   +++HRD++  N+L
Sbjct: 85  ---QDLKKYFDSCNGD-----LDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLL 133
Query: 131 LFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVV 189
           +  + + K+A+F L+ +A  +  R +S  V+ T  Y  P+     +L   S D++S G +
Sbjct: 134 INRNGELKLANFGLA-RAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCI 191
Query: 190 LLELLTGRKPV 200
             EL    +P+
Sbjct: 192 FAELANAGRPL 202

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 19/167 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS++ ++ H N++ L          VL  E  + G L D L  ++ +   +    +  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSNQAPDMA 152
                     G+ YLH K    I H D++  N++L +        K+ DF L+++  D  
Sbjct: 126 D---------GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-- 171
Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             +    + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 172 -GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 105
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 106 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 157
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            +   V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 158 TYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216
Query: 212 VTWATP 217
            T  TP
Sbjct: 217 RTLGTP 222

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 106
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 107 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 158
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            +   V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 159 TYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 212 VTWATP 217
            T  TP
Sbjct: 218 RTLGTP 223

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 7/100 (7%)
Query: 104 AARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-KAKIADFNLS-NQAPDMAAR--LHSTR 159
           A  GLEYLH +    I+H D+++ NVLL  D  +A + DF  +    PD   +  L    
Sbjct: 173 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 229
Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           + GT  + APE  M      K D++S   ++L +L G  P
Sbjct: 230 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 56  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 109
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 110 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 161
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            +   V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 162 TYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 220
Query: 212 VTWATP 217
            T  TP
Sbjct: 221 RTLGTP 226

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 55  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 108
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 109 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 160
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            +   V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 161 TYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 219
Query: 212 VTWATP 217
            T  TP
Sbjct: 220 RTLGTP 225

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 19/173 (10%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D ++ VS++  ++H N++ L          +L  E    G L D L  ++ +   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSN 146
            L  +           G+ YLH      I H D++  N++L +      + KI DF L++
Sbjct: 119 FLKQILN---------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 54  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 107
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 108 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 159
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            +   V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 160 TYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 218
Query: 212 VTWATP 217
            T  TP
Sbjct: 219 RTLGTP 224

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A            + T  Y
Sbjct: 140 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMVPFVVTRYY 193
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            APE  +     +  D++S G ++ E++ G
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 54  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 107
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 108 ----SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVR 159
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            +   V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 160 TYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 218
Query: 212 VTWATP 217
            T  TP
Sbjct: 219 RTLGTP 224

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 54  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 107
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 108 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 159
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            +   V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 160 TYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 218
Query: 212 VTWATP 217
            T  TP
Sbjct: 219 RTLGTP 224

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 106
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 107 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 158
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            +   V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 159 TYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 212 VTWATP 217
            T  TP
Sbjct: 218 RTLGTP 223

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 69/165 (41%), Gaps = 27/165 (16%)
Query: 43  LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 102
           LKH N+V L     E     L ++  T G L + +  R+    A                
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA---------------- 103
Query: 103 DAARGLEYLHEKVQ----PSIIHRDIRSSNVLLFEDFKA---KIADFNLSNQAP-DMAAR 154
           DA+  ++ + E V       I+HRD++  N+LL    K    K+ADF L+ +   D  A 
Sbjct: 104 DASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW 163
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                  GT GY +PE        +  D+++ GV+L  LL G  P
Sbjct: 164 FG---FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 56  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 109
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 110 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 161
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            +   V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 162 TYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 220
Query: 212 VTWATP 217
            T  TP
Sbjct: 221 RTLGTP 226

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 56  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKTFMDASALTGIPLPLIK- 109
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 110 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 161
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            +   V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 162 TYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 220
Query: 212 VTWATP 217
            T  TP
Sbjct: 221 RTLGTP 226

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +EF     LH  L            P P++  
Sbjct: 57  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK- 110
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 111 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 162
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            +   V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 163 TYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 221
Query: 212 VTWATP 217
            T  TP
Sbjct: 222 RTLGTP 227

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 69/165 (41%), Gaps = 27/165 (16%)
Query: 43  LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 102
           LKH N+V L     E     L ++  T G L + +  R+    A                
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA---------------- 103
Query: 103 DAARGLEYLHEKVQ----PSIIHRDIRSSNVLLFEDFKA---KIADFNLSNQAP-DMAAR 154
           DA+  ++ + E V       I+HRD++  N+LL    K    K+ADF L+ +   D  A 
Sbjct: 104 DASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW 163
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                  GT GY +PE        +  D+++ GV+L  LL G  P
Sbjct: 164 FG---FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 74/165 (44%), Gaps = 23/165 (13%)
Query: 45  HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDA 104
           H +++ L+      +   L ++    G L D L  +  +   +   ++      R  ++A
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM------RSLLEA 212
Query: 105 ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS-NQAPDMAARLHSTRVLGT 163
              + +LH     +I+HRD++  N+LL ++ + +++DF  S +  P    R     + GT
Sbjct: 213 ---VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR----ELCGT 262
Query: 164 FGYHAPEYAMTGQ------LTQKSDVYSFGVVLLELLTGRKPVDH 202
            GY APE              ++ D+++ GV+L  LL G  P  H
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 37  VSVVSRLKHENLVELLG-YCVEGNLRV-LAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           ++++  LKH N++ L   +    + +V L +++A     H I   R      +P  +   
Sbjct: 69  IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 128
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF----EDFKAKIADFN---LSNQ 147
           M +  +      G+ YLH      ++HRD++ +N+L+     E  + KIAD     L N 
Sbjct: 129 MVK-SLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 148 APDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDH 202
                A L    V+ TF Y APE  +  +  T+  D+++ G +  ELLT  +P+ H
Sbjct: 185 PLKPLADLDP--VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 237

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 19/173 (10%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D ++ VS++  ++H N++ L          +L  E    G L D L  ++ +   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSN 146
            L  +           G+ YLH      I H D++  N++L +      + KI DF L++
Sbjct: 119 FLKQILN---------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 7/100 (7%)
Query: 104 AARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK-AKIADFNLS-NQAPDMAAR--LHSTR 159
           A  GLEYLH +    I+H D+++ NVLL  D   A + DF  +    PD   +  L    
Sbjct: 194 ALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY 250
Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           + GT  + APE  +      K DV+S   ++L +L G  P
Sbjct: 251 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 19/173 (10%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D ++ VS++  ++H N++ L          +L  E    G L D L  ++ +   +   
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSN 146
            L  +           G+ YLH      I H D++  N++L +      + KI DF L++
Sbjct: 118 FLKQILN---------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 166 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 19/173 (10%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D ++ VS++  ++H N++ L          +L  E    G L D L  ++ +   +   
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSN 146
            L  +           G+ YLH      I H D++  N++L +      + KI DF L++
Sbjct: 118 FLKQILN---------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 166 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 19/173 (10%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D ++ VS++  ++H N++ L          +L  E    G L D L  ++ +   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSN 146
            L  +           G+ YLH      I H D++  N++L +      + KI DF L++
Sbjct: 119 FLKQILN---------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 176 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 229
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 19/173 (10%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D ++ VS++  ++H N++ L          +L  E    G L D L  ++ +   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSN 146
            L  +           G+ YLH      I H D++  N++L +      + KI DF L++
Sbjct: 119 FLKQILN---------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 139 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 234

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 7/100 (7%)
Query: 104 AARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK-AKIADFNLS-NQAPDMAAR--LHSTR 159
           A  GLEYLH +    I+H D+++ NVLL  D   A + DF  +    PD   +  L    
Sbjct: 175 ALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY 231
Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           + GT  + APE  +      K DV+S   ++L +L G  P
Sbjct: 232 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 139 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 234

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 137 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 190
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 232

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 176 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 229
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 132 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 227

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 132 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 227

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 19/173 (10%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D ++ VS++  ++H N++ L          +L  E    G L D L  ++ +   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSN 146
            L  +           G+ YLH      I H D++  N++L +      + KI DF L++
Sbjct: 119 FLKQILN---------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V+++  ++H N++ L          VL  E  + G L D L  ++ +   +    L  + 
Sbjct: 66  VNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL 125
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE----DFKAKIADFNLSNQAPDMA 152
                     G+ YLH K    I H D++  N++L +    + + K+ DF ++++   + 
Sbjct: 126 D---------GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IE 170
Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           A      + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 171 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 80/191 (41%), Gaps = 13/191 (6%)
Query: 25  SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
           SP    +D K+  S+   LKH ++VELL       +  + +EF     L   +     V+
Sbjct: 67  SPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI-----VK 121
Query: 85  GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA---KIAD 141
            A  G V                L Y H+    +IIHRD++   VLL     +   K+  
Sbjct: 122 RADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGG 178
Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           F ++ Q  + +  +   RV GT  + APE        +  DV+  GV+L  LL+G  P  
Sbjct: 179 FGVAIQLGE-SGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 236
Query: 202 HTMPRGQQSLV 212
            T  R  + ++
Sbjct: 237 GTKERLFEGII 247

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 78/187 (41%), Gaps = 26/187 (13%)
Query: 20  NERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           N +  S +++   E++   +   LKH N+V L     E     L ++  T G L + +  
Sbjct: 56  NTKKLSARDHQKLERE-ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA 114
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV----QPSIIHRDIRSSNVLLFEDF 135
           R+    A                DA+  ++ + E V    Q  ++HRD++  N+LL    
Sbjct: 115 REYYSEA----------------DASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKL 158
Query: 136 KA---KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLE 192
           K    K+ADF L+ +              GT GY +PE        +  D+++ GV+L  
Sbjct: 159 KGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYI 216
Query: 193 LLTGRKP 199
           LL G  P
Sbjct: 217 LLVGYPP 223

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 19/173 (10%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D ++ VS++  ++H N++ L          +L  E    G L D L  ++ +   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSN 146
            L  +           G+ YLH      I H D++  N++L +      + KI DF L++
Sbjct: 119 FLKQILN---------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 19/173 (10%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D ++ VS++  ++H N++ L          +L  E    G L D L  ++ +   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSN 146
            L  +           G+ YLH      I H D++  N++L +      + KI DF L++
Sbjct: 119 FLKQILN---------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 19/173 (10%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D ++ VS++  ++H N++ L          +L  E    G L D L  ++ +   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSN 146
            L  +           G+ YLH      I H D++  N++L +      + KI DF L++
Sbjct: 119 FLKQILN---------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 80/191 (41%), Gaps = 13/191 (6%)
Query: 25  SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
           SP    +D K+  S+   LKH ++VELL       +  + +EF     L       + V+
Sbjct: 65  SPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL-----CFEIVK 119
Query: 85  GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA---KIAD 141
            A  G V                L Y H+    +IIHRD++   VLL     +   K+  
Sbjct: 120 RADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGG 176
Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           F ++ Q  + +  +   RV GT  + APE        +  DV+  GV+L  LL+G  P  
Sbjct: 177 FGVAIQLGE-SGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234
Query: 202 HTMPRGQQSLV 212
            T  R  + ++
Sbjct: 235 GTKERLFEGII 245

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 19/173 (10%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D ++ VS++  ++H N++ L          +L  E    G L D L  ++ +   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSN 146
            L  +           G+ YLH      I H D++  N++L +      + KI DF L++
Sbjct: 119 FLKQILN---------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 19/173 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++   KHEN++ +       +       +     +   LH     Q      +  ++ 
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY 119
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA--- 153
           +   AV    G          ++IHRD++ SN+L+  +   K+ DF L+    + AA   
Sbjct: 120 QTLRAVKVLHG---------SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 154 -----RLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPV 200
                +   T  + T  Y APE  +T  + ++  DV+S G +L EL   R+P+
Sbjct: 171 EPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V+++  ++H N++ L          VL  E  + G L D L  ++ +   +    L  + 
Sbjct: 59  VNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL 118
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE----DFKAKIADFNLSNQAPDMA 152
                     G+ YLH K    I H D++  N++L +    + + K+ DF ++++   + 
Sbjct: 119 D---------GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IE 163
Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           A      + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 19/173 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++   KHEN++ +       +       +     +   LH     Q      +  ++ 
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY 119
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA--- 153
           +   AV    G          ++IHRD++ SN+L+  +   K+ DF L+    + AA   
Sbjct: 120 QTLRAVKVLHG---------SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 154 -----RLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPV 200
                +   T  + T  Y APE  +T  + ++  DV+S G +L EL   R+P+
Sbjct: 171 EPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 19/173 (10%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D ++ VS++  ++H N++ L          +L  E    G L D L  ++ +   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSN 146
            L  +           G+ YLH      I H D++  N++L +      + KI DF L++
Sbjct: 119 FLKQILN---------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 24/170 (14%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ +L H  ++++  +  +     +  E    G L D + G K ++ A       +  
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---YFY 121
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 153
           ++ +AV      +YLHE     IIHRD++  NVLL    ED   KI DF  S     +  
Sbjct: 122 QMLLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK----ILG 168
Query: 154 RLHSTRVL-GTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKP 199
                R L GT  Y APE  +   T    +  D +S GV+L   L+G  P
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 24/170 (14%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ +L H  ++++  +  +     +  E    G L D + G K ++ A       +  
Sbjct: 65  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---YFY 120
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 153
           ++ +AV      +YLHE     IIHRD++  NVLL    ED   KI DF  S     +  
Sbjct: 121 QMLLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK----ILG 167
Query: 154 RLHSTRVL-GTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKP 199
                R L GT  Y APE  +   T    +  D +S GV+L   L+G  P
Sbjct: 168 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 23/191 (12%)
Query: 32  DEKQLVSVVSRL-KHENLVELLGYCVE----GNLRVLAYEFATMGSLHDILHGRKGVQGA 86
           +E Q  + + RL  H N++ L+ YC+      +   L   F   G+L + +   K     
Sbjct: 71  EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLK----- 125
Query: 87  QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 146
             G  L     + + +   RGLE +H K      HRD++ +N+LL ++ +  + D    N
Sbjct: 126 DKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182
Query: 147 QAPDMAARLHSTRVLG-------TFGYHAPE-YAMTGQ--LTQKSDVYSFGVVLLELLTG 196
           QA            L        T  Y APE +++     + +++DV+S G VL  ++ G
Sbjct: 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
Query: 197 RKPVDHTMPRG 207
             P D    +G
Sbjct: 243 EGPYDMVFQKG 253

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 10/92 (10%)
Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ--APDMAARLHSTRVLGT 163
           +GLEYLH   Q  I+HRD++ +N+LL E+   K+ADF L+    +P+   R +  +V+ T
Sbjct: 123 QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN---RAYXHQVV-T 175
Query: 164 FGYHAPEYAMTGQLTQKS-DVYSFGVVLLELL 194
             Y APE     ++     D+++ G +L ELL
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 24/170 (14%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ +L H  ++++  +  +     +  E    G L D + G K ++ A       +  
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---YFY 121
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 153
           ++ +AV      +YLHE     IIHRD++  NVLL    ED   KI DF  S     +  
Sbjct: 122 QMLLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK----ILG 168
Query: 154 RLHSTRVL-GTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKP 199
                R L GT  Y APE  +   T    +  D +S GV+L   L+G  P
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 34/183 (18%)
Query: 31  DDEKQL------VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
           D+E QL      V    + +HEN+V  +G C+      +        +L+ ++   K   
Sbjct: 68  DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--- 124
Query: 85  GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 144
                 VLD     +IA +  +G+ YLH K    I+H+D++S NV  +++ K  I DF L
Sbjct: 125 -----IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNV-FYDNGKVVITDFGL 175
Query: 145 SNQAPDMAA--RLHSTRVLGTFGYH-APEYAMTGQL-----------TQKSDVYSFGVVL 190
            + +  + A  R    R+   +  H APE  +  QL           ++ SDV++ G + 
Sbjct: 176 FSISGVLQAGRREDKLRIQNGWLCHLAPE--IIRQLSPDTEEDKLPFSKHSDVFALGTIW 233
Query: 191 LEL 193
            EL
Sbjct: 234 YEL 236

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 24/170 (14%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ +L H  ++++  +  +     +  E    G L D + G K ++ A       +  
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---YFY 121
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 153
           ++ +AV      +YLHE     IIHRD++  NVLL    ED   KI DF  S     +  
Sbjct: 122 QMLLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK----ILG 168
Query: 154 RLHSTRVL-GTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKP 199
                R L GT  Y APE  +   T    +  D +S GV+L   L+G  P
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 68/167 (40%), Gaps = 28/167 (16%)
Query: 43  LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 102
           L+  N V+ +    + +   +  E+    +L+D++H     Q         W    R+  
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY----W----RLFR 123
Query: 103 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL--------------SNQA 148
                L Y+H +    IIHRD++  N+ + E    KI DF L              S   
Sbjct: 124 QILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 149 PDMAARLHSTRVLGTFGYHAPEYA-MTGQLTQKSDVYSFGVVLLELL 194
           P  +  L  T  +GT  Y A E    TG   +K D+YS G++  E++
Sbjct: 181 PGSSDNL--TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 143 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 196
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 197 RAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 238

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 24/170 (14%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ +L H  ++++  +  +     +  E    G L D + G K ++ A       +  
Sbjct: 72  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---YFY 127
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 153
           ++ +AV      +YLHE     IIHRD++  NVLL    ED   KI DF  S     +  
Sbjct: 128 QMLLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK----ILG 174
Query: 154 RLHSTRVL-GTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKP 199
                R L GT  Y APE  +   T    +  D +S GV+L   L+G  P
Sbjct: 175 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 9/105 (8%)
Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF---KAKIADFNLSNQAPDMAAR 154
           +R+      G+ YLH   Q +I+H D++  N+LL   +     KI DF +S +    A  
Sbjct: 134 IRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH-ACE 189
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           L    ++GT  Y APE      +T  +D+++ G++   LLT   P
Sbjct: 190 LR--EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 31/180 (17%)
Query: 34  KQLVSVVSRLKHENLVELLG--YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPV 91
           K+ + ++ RL+H+N+++L+   Y  E     +  E+   G                   +
Sbjct: 54  KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE----------------M 97
Query: 92  LDWMTRVRIAVDAARG--------LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
           LD +   R  V  A G        LEYLH +    I+H+DI+  N+LL      KI+   
Sbjct: 98  LDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALG 154
Query: 144 LSNQAPDMAARLHSTRVLGTFGYHAPEYA--MTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           ++      AA        G+  +  PE A  +      K D++S GV L  + TG  P +
Sbjct: 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V+++  ++H N++ L          VL  E  + G L D L  ++ +   +    L  + 
Sbjct: 80  VNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL 139
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE----DFKAKIADFNLSNQAPDMA 152
                     G+ YLH K    I H D++  N++L +    + + K+ DF ++++   + 
Sbjct: 140 D---------GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IE 184
Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           A      + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 185 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 24/170 (14%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ +L H  ++++  +  +     +  E    G L D + G K ++ A       +  
Sbjct: 191 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---YFY 246
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 153
           ++ +AV      +YLHE     IIHRD++  NVLL    ED   KI DF  S     +  
Sbjct: 247 QMLLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK----ILG 293
Query: 154 RLHSTRVL-GTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKP 199
                R L GT  Y APE  +   T    +  D +S GV+L   L+G  P
Sbjct: 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 19/173 (10%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D ++ VS++  ++H N++ L          +L  E    G L D L  ++ +   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATE 118
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSN 146
            L  +           G+ YLH      I H D++  N++L +      + KI DF L++
Sbjct: 119 FLKQILN---------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 24/170 (14%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ +L H  ++++  +  +     +  E    G L D + G K ++ A       +  
Sbjct: 205 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---YFY 260
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 153
           ++ +AV      +YLHE     IIHRD++  NVLL    ED   KI DF  S     +  
Sbjct: 261 QMLLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK----ILG 307
Query: 154 RLHSTRVL-GTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKP 199
                R L GT  Y APE  +   T    +  D +S GV+L   L+G  P
Sbjct: 308 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 132 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 227

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 61/139 (43%), Gaps = 16/139 (11%)
Query: 62  VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIH 121
           VL  E  T G+L   L   K  +  +   +  W  ++       +GL++LH +  P IIH
Sbjct: 105 VLVTELXTSGTLKTYL---KRFKVXKIKVLRSWCRQI------LKGLQFLHTRT-PPIIH 154
Query: 122 RDIRSSNVLLFE-DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQK 180
           RD++  N+ +       KI D  L+       A+     V+GT  + APE     +  + 
Sbjct: 155 RDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFXAPE-XYEEKYDES 209
Query: 181 SDVYSFGVVLLELLTGRKP 199
            DVY+FG   LE  T   P
Sbjct: 210 VDVYAFGXCXLEXATSEYP 228

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 77/169 (45%), Gaps = 18/169 (10%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           ++ +  +S L+H  LV L     + N  V+ YEF + G L + +              ++
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVE 259
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF--EDFKAKIADFNLSNQ-APD 150
           +M +V       +GL ++HE    + +H D++  N++       + K+ DF L+    P 
Sbjct: 260 YMRQV------CKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310
Query: 151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            + ++      GT  + APE A    +   +D++S GV+   LL+G  P
Sbjct: 311 QSVKV----TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 25/168 (14%)
Query: 45  HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDA 104
           ++N++EL+ +  +     L +E    GS+   +  +K     +           R+  D 
Sbjct: 70  NKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREAS---------RVVRDV 120
Query: 105 ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA---KIADFNLS-----NQAPDMAARLH 156
           A  L++LH K    I HRD++  N+L     K    KI DF+L      N +        
Sbjct: 121 AAALDFLHTK---GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPE 177
Query: 157 STRVLGTFGYHAPEYA--MTGQLT---QKSDVYSFGVVLLELLTGRKP 199
            T   G+  Y APE     T Q T   ++ D++S GVVL  +L+G  P
Sbjct: 178 LTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 19/173 (10%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
           +D ++ VS++  ++H N++ L          +L  E    G L D L  ++ +   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 91  VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSN 146
            L  +           G+ YLH      I H D++  N++L +      + KI DF L++
Sbjct: 119 FLKQILN---------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 77/169 (45%), Gaps = 18/169 (10%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           ++ +  +S L+H  LV L     + N  V+ YEF + G L + +              ++
Sbjct: 96  RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVE 153
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF--EDFKAKIADFNLSNQ-APD 150
           +M +V       +GL ++HE    + +H D++  N++       + K+ DF L+    P 
Sbjct: 154 YMRQV------CKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 204
Query: 151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            + ++      GT  + APE A    +   +D++S GV+   LL+G  P
Sbjct: 205 QSVKV----TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 5/86 (5%)
Query: 118 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--- 174
            +IHRD++  N+LL +    K+ADF    +  D    +H    +GT  Y +PE   +   
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVHCDTAVGTPDYISPEVLKSQGG 252
Query: 175 -GQLTQKSDVYSFGVVLLELLTGRKP 199
            G   ++ D +S GV L E+L G  P
Sbjct: 253 DGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 76/169 (44%), Gaps = 18/169 (10%)
Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
           K  +SV+++L H NL++L       N  VL  E+   G L D +              L 
Sbjct: 134 KNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI--------IDESYNLT 185
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL-LFEDFKA-KIADFNLSNQ-APD 150
            +  +        G+ ++H   Q  I+H D++  N+L +  D K  KI DF L+ +  P 
Sbjct: 186 ELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242
Query: 151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
              +++     GT  + APE      ++  +D++S GV+   LL+G  P
Sbjct: 243 EKLKVN----FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 79/194 (40%), Gaps = 31/194 (15%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ +LKH NLV LL          L +E+     LH++   ++GV       +  W T
Sbjct: 53  IRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSI-TWQT 111
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                    + + + H+    + IHRD++  N+L+ +    K+ DF  +      +   +
Sbjct: 112 --------LQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--Y 158
Query: 157 STRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTG----------------RKP 199
               + T  Y +PE  +   Q     DV++ G V  ELL+G                RK 
Sbjct: 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKT 218
Query: 200 VDHTMPRGQQSLVT 213
           +   +PR QQ   T
Sbjct: 219 LGDLIPRHQQVFST 232

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 26/187 (13%)
Query: 20  NERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           N +  S +++   E++   +   LKH N+V L     E     L ++  T G L + +  
Sbjct: 45  NTKKLSARDHQKLERE-ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA 103
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV----QPSIIHRDIRSSNVLLFEDF 135
           R+    A                DA+  ++ + E V    Q  ++HR+++  N+LL    
Sbjct: 104 REYYSEA----------------DASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL 147
Query: 136 KA---KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLE 192
           K    K+ADF L+ +              GT GY +PE        +  D+++ GV+L  
Sbjct: 148 KGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYI 205
Query: 193 LLTGRKP 199
           LL G  P
Sbjct: 206 LLVGYPP 212

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 23/198 (11%)
Query: 12  EESYPSHENERL----KSPKN--YPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRV 62
           E  Y +H+ E++    K+ K     D++++ +S   ++  L H ++V+L+G  +E     
Sbjct: 26  EGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG-IIEEEPTW 84
Query: 63  LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR 122
           +  E    G L   L   K          L  +T V  ++   + + YL      + +HR
Sbjct: 85  IIMELYPYGELGHYLERNKNS--------LKVLTLVLYSLQICKAMAYLE---SINCVHR 133
Query: 123 DIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSD 182
           DI   N+L+      K+ DF LS    D      S   L    + +PE     + T  SD
Sbjct: 134 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFRRFTTASD 192
Query: 183 VYSFGVVLLELLT-GRKP 199
           V+ F V + E+L+ G++P
Sbjct: 193 VWMFAVCMWEILSFGKQP 210

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 23/198 (11%)
Query: 12  EESYPSHENERL----KSPKN--YPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRV 62
           E  Y +H+ E++    K+ K     D++++ +S   ++  L H ++V+L+G  +E     
Sbjct: 30  EGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG-IIEEEPTW 88
Query: 63  LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR 122
           +  E    G L   L   K          L  +T V  ++   + + YL      + +HR
Sbjct: 89  IIMELYPYGELGHYLERNKNS--------LKVLTLVLYSLQICKAMAYLE---SINCVHR 137
Query: 123 DIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSD 182
           DI   N+L+      K+ DF LS    D      S   L    + +PE     + T  SD
Sbjct: 138 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFRRFTTASD 196
Query: 183 VYSFGVVLLELLT-GRKP 199
           V+ F V + E+L+ G++P
Sbjct: 197 VWMFAVCMWEILSFGKQP 214

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 23/198 (11%)
Query: 12  EESYPSHENERL----KSPKN--YPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRV 62
           E  Y +H+ E++    K+ K     D++++ +S   ++  L H ++V+L+G  +E     
Sbjct: 42  EGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG-IIEEEPTW 100
Query: 63  LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR 122
           +  E    G L   L   K          L  +T V  ++   + + YL      + +HR
Sbjct: 101 IIMELYPYGELGHYLERNKNS--------LKVLTLVLYSLQICKAMAYLE---SINCVHR 149
Query: 123 DIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSD 182
           DI   N+L+      K+ DF LS    D      S   L    + +PE     + T  SD
Sbjct: 150 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFRRFTTASD 208
Query: 183 VYSFGVVLLELLT-GRKP 199
           V+ F V + E+L+ G++P
Sbjct: 209 VWMFAVCMWEILSFGKQP 226

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/173 (21%), Positives = 71/173 (41%), Gaps = 19/173 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++   KHEN++ +       +       +     +   LH     Q      +  ++ 
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY 119
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA--- 153
           +   AV    G          ++IHRD++ SN+L+  +   K+ DF L+    + AA   
Sbjct: 120 QTLRAVKVLHG---------SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 154 -----RLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPV 200
                +      + T  Y APE  +T  + ++  DV+S G +L EL   R+P+
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 66/160 (41%), Gaps = 18/160 (11%)
Query: 44  KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVD 103
           +H N++ L     +G    +  E    G L D +  +K     +   VL  +T+      
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT----- 128
Query: 104 AARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSNQAPDMAARLHSTR 159
               +EYLH +    ++HRD++ SN+L  ++       +I DF  + Q       L +  
Sbjct: 129 ----VEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
               F   APE           D++S GV+L  +LTG  P
Sbjct: 182 YTANFV--APEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 85/190 (44%), Gaps = 22/190 (11%)
Query: 19  ENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFA-TMGSLHDIL 77
           ENE+    + +P    + + ++  LKHEN+V L+  C     R  A  +    GS++ + 
Sbjct: 54  ENEK----EGFPITALREIKILQLLKHENVVNLIEIC-----RTKASPYNRCKGSIYLVF 104
Query: 78  HGRKGVQGAQPGPVLDWMTRV---RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 134
              +         VL   T     R+      GL Y+H      I+HRD++++NVL+  D
Sbjct: 105 DFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRD 161
Query: 135 FKAKIADFNLSNQ---APDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVL 190
              K+ADF L+     A +     +  RV+ T  Y  PE  +  +      D++  G ++
Sbjct: 162 GVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIM 220
Query: 191 LELLTGRKPV 200
            E+ T R P+
Sbjct: 221 AEMWT-RSPI 229

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 85/190 (44%), Gaps = 22/190 (11%)
Query: 19  ENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFA-TMGSLHDIL 77
           ENE+    + +P    + + ++  LKHEN+V L+  C     R  A  +    GS++ + 
Sbjct: 54  ENEK----EGFPITALREIKILQLLKHENVVNLIEIC-----RTKASPYNRCKGSIYLVF 104
Query: 78  HGRKGVQGAQPGPVLDWMTRV---RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 134
              +         VL   T     R+      GL Y+H      I+HRD++++NVL+  D
Sbjct: 105 DFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRD 161
Query: 135 FKAKIADFNLSNQ---APDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVL 190
              K+ADF L+     A +     +  RV+ T  Y  PE  +  +      D++  G ++
Sbjct: 162 GVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIM 220
Query: 191 LELLTGRKPV 200
            E+ T R P+
Sbjct: 221 AEMWT-RSPI 229

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 85/190 (44%), Gaps = 22/190 (11%)
Query: 19  ENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFA-TMGSLHDIL 77
           ENE+    + +P    + + ++  LKHEN+V L+  C     R  A  +    GS++ + 
Sbjct: 53  ENEK----EGFPITALREIKILQLLKHENVVNLIEIC-----RTKASPYNRCKGSIYLVF 103
Query: 78  HGRKGVQGAQPGPVLDWMTRV---RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 134
              +         VL   T     R+      GL Y+H      I+HRD++++NVL+  D
Sbjct: 104 DFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRD 160
Query: 135 FKAKIADFNLSNQ---APDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVL 190
              K+ADF L+     A +     +  RV+ T  Y  PE  +  +      D++  G ++
Sbjct: 161 GVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIM 219
Query: 191 LELLTGRKPV 200
            E+ T R P+
Sbjct: 220 AEMWT-RSPI 228

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 70/168 (41%), Gaps = 23/168 (13%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           ++++SR++H N++++L          L  E    GS  D+             P LD   
Sbjct: 80  IAILSRVEHANIIKVLDIFENQGFFQLVME--KHGSGLDLF------AFIDRHPRLDEPL 131
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
              I       + YL  K    IIHRDI+  N+++ EDF  K+ DF         AA L 
Sbjct: 132 ASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG-------SAAYLE 181
Query: 157 STRVL----GTFGYHAPEYAMTGQLTQ-KSDVYSFGVVLLELLTGRKP 199
             ++     GT  Y APE  M       + +++S GV L  L+    P
Sbjct: 182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A    + +    V+  + Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMEPEVVTRY-Y 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQ 233

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 78/183 (42%), Gaps = 24/183 (13%)
Query: 24  KSPKNYPDDE---KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD-ILHG 79
           K PK + +D    KQ + ++  L H N++ L     +     L  E  T G L + ++H 
Sbjct: 41  KIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK 100
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFK 136
           R          V       RI  D    + Y H   + ++ HRD++  N L      D  
Sbjct: 101 R----------VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSP 147
Query: 137 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            K+ DF L+  A     ++  T+V GT  Y +P+  + G    + D +S GV++  LL G
Sbjct: 148 LKLIDFGLA--ARFKPGKMMRTKV-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
Query: 197 RKP 199
             P
Sbjct: 204 YPP 206

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ--PGPVLDW 94
           +S++  L H N+V+LL      N   L +E      +H  L            P P++  
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFE-----HVHQDLKTFMDASALTGIPLPLIK- 105
Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
                      +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R
Sbjct: 106 ----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVR 157
Query: 155 LHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSL 211
            ++  V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +  
Sbjct: 158 TYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216
Query: 212 VTWATP 217
            T  TP
Sbjct: 217 RTLGTP 222

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 78/183 (42%), Gaps = 24/183 (13%)
Query: 24  KSPKNYPDDE---KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD-ILHG 79
           K PK + +D    KQ + ++  L H N++ L     +     L  E  T G L + ++H 
Sbjct: 58  KIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK 117
Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFK 136
           R          V       RI  D    + Y H   + ++ HRD++  N L      D  
Sbjct: 118 R----------VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSP 164
Query: 137 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            K+ DF L+  A     ++  T+V GT  Y +P+  + G    + D +S GV++  LL G
Sbjct: 165 LKLIDFGLA--ARFKPGKMMRTKV-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220
Query: 197 RKP 199
             P
Sbjct: 221 YPP 223

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 65/160 (40%), Gaps = 18/160 (11%)
Query: 44  KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVD 103
           +H N++ L     +G    +  E    G L D +  +K     +   VL  +T+      
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKT----- 128
Query: 104 AARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSNQAPDMAARLHSTR 159
               +EYLH +    ++HRD++ SN+L  ++       +I DF  + Q       L +  
Sbjct: 129 ----VEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPC 181
Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
               F   APE           D++S GV+L   LTG  P
Sbjct: 182 YTANFV--APEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 7/90 (7%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GL  LHE     ++HRD+   N+LL ++    I DFNL+ +     A  + T  +    Y
Sbjct: 146 GLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLARED---TADANKTHYVTHRWY 199
Query: 167 HAPEYAMTGQ-LTQKSDVYSFGVVLLELLT 195
            APE  M  +  T+  D++S G V+ E+  
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 7/90 (7%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GL  LHE     ++HRD+   N+LL ++    I DFNL+ +     A  + T  +    Y
Sbjct: 146 GLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLARED---TADANKTHYVTHRWY 199
Query: 167 HAPEYAMTGQ-LTQKSDVYSFGVVLLELLT 195
            APE  M  +  T+  D++S G V+ E+  
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 12/102 (11%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G+++LH      IIHRD++ SN+++  D   KI DF L+  A    + +    V+  + Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMEPEVVTRY-Y 191
Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 202
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 192 RAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 233

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 82/184 (44%), Gaps = 16/184 (8%)
Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S++  L H N+V+LL      N   L +E      L   +     + G  P P++    
Sbjct: 56  ISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDA-SALTGI-PLPLIK--- 109
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                    +GL + H      ++HRD++  N+L+  +   K+ADF L+ +A  +  R +
Sbjct: 110 --SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTY 163
Query: 157 STRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVT 213
              V+ T  Y APE  +  +    + D++S G +  E++T R   P D  + +  +   T
Sbjct: 164 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 222
Query: 214 WATP 217
             TP
Sbjct: 223 LGTP 226

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 14/104 (13%)
Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTFGY 166
           LE +H   Q  I+H D++ +N L+  D   K+ DF ++NQ  PD  + +  ++V GT  Y
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNY 174
Query: 167 HAPEYAMTGQLTQKS-----------DVYSFGVVLLELLTGRKP 199
             PE       ++++           DV+S G +L  +  G+ P
Sbjct: 175 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 218

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 14/104 (13%)
Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTFGY 166
           LE +H   Q  I+H D++ +N L+  D   K+ DF ++NQ  PD  + +  ++V GT  Y
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNY 178
Query: 167 HAPEYAMTGQLTQKS-----------DVYSFGVVLLELLTGRKP 199
             PE       ++++           DV+S G +L  +  G+ P
Sbjct: 179 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 222

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 14/104 (13%)
Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTFGY 166
           LE +H   Q  I+H D++ +N L+  D   K+ DF ++NQ  PD  + +  ++V GT  Y
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNY 222
Query: 167 HAPEYAMTGQLTQKS-----------DVYSFGVVLLELLTGRKP 199
             PE       ++++           DV+S G +L  +  G+ P
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 26/183 (14%)
Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLR--VLAYEFATMGSLHDILHGRKGVQGAQP 88
           D + +   V+ +L H+N+V+L     E   R  VL  EF   GSL+ +L       G   
Sbjct: 52  DVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL-- 109
Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL--LFEDFKA--KIADFNL 144
            P  +++  +R   D   G+ +L E     I+HR+I+  N++  + ED ++  K+ DF  
Sbjct: 110 -PESEFLIVLR---DVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162
Query: 145 SNQAPDMAARLHSTRVLGTFGYHAP---EYAMTGQLTQKS-----DVYSFGVVLLELLTG 196
           + +  D         + GT  Y  P   E A+  +  QK      D++S GV      TG
Sbjct: 163 ARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
Query: 197 RKP 199
             P
Sbjct: 220 SLP 222

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 26/175 (14%)
Query: 39  VVSRLKHENLVELLGYCVEGNLR--VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V+ +L H+N+V+L     E   R  VL  EF   GSL+ +L       G    P  +++ 
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL---PESEFLI 116
Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL--LFEDFKA--KIADFNLSNQAPDMA 152
            +R   D   G+ +L E     I+HR+I+  N++  + ED ++  K+ DF  + +  D  
Sbjct: 117 VLR---DVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 153 ARLHSTRVLGTFGYHAP---EYAMTGQLTQKS-----DVYSFGVVLLELLTGRKP 199
                  + GT  Y  P   E A+  +  QK      D++S GV      TG  P
Sbjct: 171 ---QFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 54/111 (48%), Gaps = 15/111 (13%)
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
           ++  + +A+D+   L Y         +HRDI+  NVLL  +   ++ADF    +  D   
Sbjct: 180 YIGEMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMND-DG 229
Query: 154 RLHSTRVLGTFGYHAPEY--AM---TGQLTQKSDVYSFGVVLLELLTGRKP 199
            + S+  +GT  Y +PE   AM    G+   + D +S GV + E+L G  P
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 14/104 (13%)
Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTFGY 166
           LE +H   Q  I+H D++ +N L+  D   K+ DF ++NQ  PD  + +  ++V GT  Y
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNY 175
Query: 167 HAPEYAMTGQLTQKS-----------DVYSFGVVLLELLTGRKP 199
             PE       ++++           DV+S G +L  +  G+ P
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 14/104 (13%)
Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTFGY 166
           LE +H   Q  I+H D++ +N L+  D   K+ DF ++NQ  PD  + +  ++V GT  Y
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNY 194
Query: 167 HAPEYAMTGQLTQKS-----------DVYSFGVVLLELLTGRKP 199
             PE       ++++           DV+S G +L  +  G+ P
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 54/111 (48%), Gaps = 15/111 (13%)
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
           ++  + +A+D+   L Y         +HRDI+  NVLL  +   ++ADF    +  D   
Sbjct: 196 YIGEMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMND-DG 245
Query: 154 RLHSTRVLGTFGYHAPEY--AM---TGQLTQKSDVYSFGVVLLELLTGRKP 199
            + S+  +GT  Y +PE   AM    G+   + D +S GV + E+L G  P
Sbjct: 246 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 87/192 (45%), Gaps = 26/192 (13%)
Query: 19  ENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEF----ATMGSLH 74
           ENE+    + +P    + + ++  LKHEN+V L+  C     R  A  +    A++  + 
Sbjct: 54  ENEK----EGFPITALREIKILQLLKHENVVNLIEIC-----RTKASPYNRCKASIYLVF 104
Query: 75  DIL-HGRKGV-QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 132
           D   H   G+         L  + RV   +    GL Y+H      I+HRD++++NVL+ 
Sbjct: 105 DFCEHDLAGLLSNVLVKFTLSEIKRVMQML--LNGLYYIHRN---KILHRDMKAANVLIT 159
Query: 133 EDFKAKIADFNLSNQ---APDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGV 188
            D   K+ADF L+     A +     +  RV+ T  Y  PE  +  +      D++  G 
Sbjct: 160 RDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGC 218
Query: 189 VLLELLTGRKPV 200
           ++ E+ T R P+
Sbjct: 219 IMAEMWT-RSPI 229

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 14/104 (13%)
Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARLHSTRVLGTFGY 166
           LE +H   Q  I+H D++ +N L+  D   K+ DF ++NQ  PD  + +  ++V GT  Y
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNY 222
Query: 167 HAPEYAMTGQLTQKS-----------DVYSFGVVLLELLTGRKP 199
             PE       ++++           DV+S G +L  +  G+ P
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 44/103 (42%), Gaps = 20/103 (19%)
Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL--------------SNQAPDMA 152
            L Y+H +    IIHR+++  N+ + E    KI DF L              S   P  +
Sbjct: 128 ALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 153 ARLHSTRVLGTFGYHAPEYA-MTGQLTQKSDVYSFGVVLLELL 194
             L  T  +GT  Y A E    TG   +K D YS G++  E +
Sbjct: 185 DNL--TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 15/111 (13%)
Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
           ++  + IA+D+   L Y         +HRDI+  N+L+  +   ++ADF    +  +   
Sbjct: 180 YLAEMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLME-DG 229
Query: 154 RLHSTRVLGTFGYHAPEY--AM---TGQLTQKSDVYSFGVVLLELLTGRKP 199
            + S+  +GT  Y +PE   AM    G+   + D +S GV + E+L G  P
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 14/104 (13%)
Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTFGY 166
           LE +H   Q  I+H D++ +N L+  D   K+ DF ++NQ  PD    +  ++V GT  Y
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDXXXVVKDSQV-GTVNY 194
Query: 167 HAPEYAMTGQLTQKS-----------DVYSFGVVLLELLTGRKP 199
             PE       ++++           DV+S G +L  +  G+ P
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 8/98 (8%)
Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 167
            EYLH      +I+RD++  N+L+ +    K+ADF  + +      +  +  + GT  Y 
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGRTWXLCGTPEYL 205
Query: 168 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
           APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 8/98 (8%)
Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 167
            EYLH      +I+RD++  N+L+ +    K+ADF  + +      +  +  + GT  Y 
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGRTWXLCGTPEYL 206
Query: 168 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
           APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 8/98 (8%)
Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 167
            EYLH      +I+RD++  N+L+ +    K+ADF  + +      +  +  + GT  Y 
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGRTWXLCGTPEYL 205
Query: 168 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
           APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 8/98 (8%)
Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 167
            EYLH      +I+RD++  N+L+ +    K+ADF  + +      +  +  + GT  Y 
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGRTWXLCGTPEYL 205
Query: 168 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
           APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 65/160 (40%), Gaps = 18/160 (11%)
Query: 44  KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVD 103
           +H N++ L     +G    L  E    G L D +  +K     +   VL  +        
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTI-------- 130
Query: 104 AARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA----KIADFNLSNQAPDMAARLHSTR 159
             + +EYLH +    ++HRD++ SN+L  ++       +I DF  + Q       L +  
Sbjct: 131 -GKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC 186
Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
               F   APE        +  D++S G++L  +L G  P
Sbjct: 187 YTANF--VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 65/160 (40%), Gaps = 18/160 (11%)
Query: 44  KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVD 103
           +H N++ L     +G    L  E    G L D +  +K     +   VL  +        
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTI-------- 130
Query: 104 AARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA----KIADFNLSNQAPDMAARLHSTR 159
             + +EYLH +    ++HRD++ SN+L  ++       +I DF  + Q       L +  
Sbjct: 131 -GKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC 186
Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
               F   APE        +  D++S G++L  +L G  P
Sbjct: 187 YTANF--VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	285
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-118
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-116
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-116
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-72
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-53
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-53
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-51
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-51
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-51
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-50
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-49
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-48
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-48
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-47
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-47
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-46
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-45
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-44
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-30
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-28
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-28
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-28
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-28
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-28
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-27
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-27
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-27
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-27
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-27
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-27
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-27
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-26
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-26
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-26
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-26
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-26
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-25
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-25
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-25
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-25
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-25
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-25
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-25
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-25
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-25
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-25
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-24
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-24
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-24
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-24
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-24
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-24
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-24
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-24
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-23
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-23
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-23
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-23
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-22
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-22
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-22
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-21
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-21
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-21
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-21
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-21
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-21
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-21
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-20
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-20
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-20
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-20
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-20
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-19
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-19
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-19
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-18
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-18
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-18
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-18
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-18
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-18
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-18
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-15
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-15
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-14
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-14
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-14
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-14
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-14
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-13
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-13
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-13
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-13
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-12
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-12
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-12
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-12
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-12
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-12
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-12
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-12
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-12
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-12
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-12
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-12
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-12
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-12
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-12
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-11
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-11
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-11
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-11
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-11
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-11
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-11
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-11
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-11
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-11
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-11
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-11
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-11
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-11
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-10
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-10
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-10
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-10
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-10
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-10
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-10
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-09
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-09
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-09
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-09
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-09
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-09
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-09
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-09
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-09
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-09
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-08
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-08
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-08
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-08
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-08
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-08
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-08
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-08
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-08
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-08
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-08
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	9e-08
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-07
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-07
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-07
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-07
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-07
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-04
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  341 bits (878), Expect = e-118
 Identities = 92/239 (38%), Positives = 137/239 (57%), Gaps = 10/239 (4%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +  +S  +H +LV L+G+C E N  +L Y++   G+L   L+G        P   + W  
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL-----PTMSMSWEQ 140

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R+ I + AARGL YLH     +IIHRD++S N+LL E+F  KI DF +S +  ++  + H
Sbjct: 141 RLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELD-QTH 196

Query: 157 -STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 215
            ST V GT GY  PEY + G+LT+KSDVYSFGVVL E+L  R  +  ++PR   +L  WA
Sbjct: 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256

Query: 216 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 274
               +  +++Q VDP L  +  P+ + K    A  C+   +E RP+M  V+  L+  L+
Sbjct: 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  337 bits (866), Expect = e-116
 Identities = 94/236 (39%), Positives = 133/236 (56%), Gaps = 10/236 (4%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++S   H NL+ L G+C+    R+L Y +   GS+   L  R   Q     P LDW  
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-----PPLDWPK 132

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R RIA+ +ARGL YLH+   P IIHRD++++N+LL E+F+A + DF L+          H
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--H 190

Query: 157 -STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS--LVT 213
            +T V GT G+ APEY  TG+ ++K+DV+ +GV+LLEL+TG++  D           L+ 
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250

Query: 214 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 269
           W    L E K++  VD  L+G Y  + V +L  VA LC Q     RP MS VV+ L
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  335 bits (861), Expect = e-116
 Identities = 91/240 (37%), Positives = 136/240 (56%), Gaps = 14/240 (5%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + V+++ +HENLVELLG+  +G+   L Y +   GSL D L    G       P L W  
Sbjct: 81  IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG------TPPLSWHM 134

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           R +IA  AA G+ +LHE      IHRDI+S+N+LL E F AKI+DF L+  +   A  + 
Sbjct: 135 RCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           ++R++GT  Y APE  + G++T KSD+YSFGVVLLE++TG   VD    R  Q L+    
Sbjct: 192 TSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLLDIKE 248

Query: 217 PRLSEDK-VKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 275
               E+K ++  +D K+  +     V  + +VA+ C+  +   RP++  V + LQ +  S
Sbjct: 249 EIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  223 bits (569), Expect = 8e-72
 Identities = 69/261 (26%), Positives = 105/261 (40%), Gaps = 32/261 (12%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRV----LAYEFATMGSLHDILHGRKGVQGAQPGPVL 92
           V  +  +KHEN+++ +G    G        L   F   GSL D L             V+
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----------VV 118

Query: 93  DWMTRVRIAVDAARGLEYLHEKVQ-------PSIIHRDIRSSNVLLFEDFKAKIADFNLS 145
            W     IA   ARGL YLHE +        P+I HRDI+S NVLL  +  A IADF L+
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178

Query: 146 NQAPDMAARLHSTRVLGTFGYHAPEYAMTG-----QLTQKSDVYSFGVVLLELLTGRKPV 200
            +     +   +   +GT  Y APE              + D+Y+ G+VL EL +     
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238

Query: 201 DHTMPRGQQSLVTWATPRLSEDKVKQCV-----DPKLKGEYPP-KGVAKLAAVAALCVQY 254
           D  +               S + +++ V      P L+  +    G+A L      C  +
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298

Query: 255 EAEFRPNMSIVVKALQPLLKS 275
           +AE R +   V + +  + + 
Sbjct: 299 DAEARLSAGCVGERITQMQRL 319

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  175 bits (446), Expect = 1e-53
 Identities = 67/244 (27%), Positives = 111/244 (45%), Gaps = 28/244 (11%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +  +SR+ H N+V+L G C+     V+  E+A  GSL+++LHG +      P P      
Sbjct: 52  LRQLSRVNHPNIVKLYGACLNPVCLVM--EYAEGGSLYNVLHGAE------PLPYYTAAH 103

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK-AKIADFNLSNQAPDMAARL 155
            +   +  ++G+ YLH     ++IHRD++  N+LL       KI DF  +          
Sbjct: 104 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----- 158

Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 215
           H T   G+  + APE       ++K DV+S+G++L E++T RKP D       +  + WA
Sbjct: 159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWA 216

Query: 216 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 275
                   V     P L    P      + ++   C   +   RP+M  +VK +  L++ 
Sbjct: 217 --------VHNGTRPPLIKNLPK----PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264

Query: 276 PPPA 279
            P A
Sbjct: 265 FPGA 268

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  175 bits (446), Expect = 2e-53
 Identities = 73/260 (28%), Positives = 121/260 (46%), Gaps = 27/260 (10%)

Query: 22  RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 78
            L     + +   +    V+++ RL+H N+V  +G   +     +  E+ + GSL+ +LH
Sbjct: 67  ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH 126

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
                        LD   R+ +A D A+G+ YLH +  P I+HR+++S N+L+ + +  K
Sbjct: 127 KSG------AREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVK 179

Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 198
           + DF LS           S    GT  + APE        +KSDVYSFGV+L EL T ++
Sbjct: 180 VCDFGLSRLKASTFLSSKSAA--GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237

Query: 199 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEF 258
           P  + +   Q   V  A          +C   ++     P    ++AA+   C   E   
Sbjct: 238 PWGN-LNPAQ---VVAAV-------GFKCKRLEIPRNLNP----QVAAIIEGCWTNEPWK 282

Query: 259 RPNMSIVVKALQPLLKSPPP 278
           RP+ + ++  L+PL+KS  P
Sbjct: 283 RPSFATIMDLLRPLIKSAVP 302

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  167 bits (426), Expect = 8e-51
 Identities = 65/259 (25%), Positives = 117/259 (45%), Gaps = 29/259 (11%)

Query: 22  RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 78
            L      P   +     V V+ + +H N++  +GY     L ++  ++    SL+  LH
Sbjct: 53  MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT-QWCEGSSLYHHLH 111

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
             +           +    + IA   ARG++YLH K   SIIHRD++S+N+ L ED   K
Sbjct: 112 ASE--------TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVK 160

Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPE---YAMTGQLTQKSDVYSFGVVLLELLT 195
           I DF L+ +    +      ++ G+  + APE      +   + +SDVY+FG+VL EL+T
Sbjct: 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220

Query: 196 GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYE 255
           G+ P  +   R Q   +     R            K++   P     ++  + A C++ +
Sbjct: 221 GQLPYSNINNRDQ---IIEMVGR----GSLSPDLSKVRSNCPK----RMKRLMAECLKKK 269

Query: 256 AEFRPNMSIVVKALQPLLK 274
            + RP+   ++  ++ L +
Sbjct: 270 RDERPSFPRILAEIEELAR 288

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  169 bits (429), Expect = 8e-51
 Identities = 61/284 (21%), Positives = 100/284 (35%), Gaps = 49/284 (17%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRV-----LAYEFATMGSLHDILHGRKGVQGAQPGPV 91
           +  V  ++H+N+   +               L  E+   GSL   L              
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---------- 107

Query: 92  LDWMTRVRIAVDAARGLEYLHEKV------QPSIIHRDIRSSNVLLFEDFKAKIADFNLS 145
            DW++  R+A    RGL YLH ++      +P+I HRD+ S NVL+  D    I+DF LS
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

Query: 146 ------NQAPDMAARLHSTRVLGTFGYHAPEYAM-------TGQLTQKSDVYSFGVVLLE 192
                            +   +GT  Y APE               ++ D+Y+ G++  E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227

Query: 193 LLTGRKPVDH--TMPRGQQSLVTWATPRLSEDKVKQCVD-----PKLKGEYP--PKGVAK 243
           +      +    ++P  Q +  T      + + ++  V      PK    +      V  
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287

Query: 244 LAAVAALCVQYEAEFRPNMSIVVKALQPLL------KSPPPAAP 281
           L      C   +AE R       + +  L+      KS  P A 
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  165 bits (419), Expect = 7e-50
 Identities = 71/244 (29%), Positives = 113/244 (46%), Gaps = 38/244 (15%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V ++S L H N+V+L G        V+  EF   G L+  L  +           + W  
Sbjct: 74  VFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP--------IKWSV 123

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-----DFKAKIADFNLSNQAPDM 151
           ++R+ +D A G+EY+  +  P I+HRD+RS N+ L          AK+ADF LS Q+   
Sbjct: 124 KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS 182

Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQL---TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
                 + +LG F + APE  +  +    T+K+D YSF ++L  +LTG  P D     G+
Sbjct: 183 -----VSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDE-YSYGK 235

Query: 209 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 268
              +            ++ + P +  + PP    +L  V  LC   + + RP+ S +VK 
Sbjct: 236 IKFINMI--------REEGLRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKE 283

Query: 269 LQPL 272
           L  L
Sbjct: 284 LSEL 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  165 bits (419), Expect = 1e-49
 Identities = 62/276 (22%), Positives = 104/276 (37%), Gaps = 41/276 (14%)

Query: 23  LKSPKNYPDDEKQL----VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 78
           +K    + ++ ++     V V+  L+H N+++ +G   +        E+   G+L  I+ 
Sbjct: 40  MKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK 99

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
                          W  RV  A D A G+ YLH     +IIHRD+ S N L+ E+    
Sbjct: 100 SMDSQ--------YPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVV 148

Query: 139 IADFNLS------------NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSF 186
           +ADF L+             ++     R     V+G   + APE        +K DV+SF
Sbjct: 149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208

Query: 187 GVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAA 246
           G+VL E++         +PR     +           V+  +D       PP        
Sbjct: 209 GIVLCEIIGRVNADPDYLPRTMDFGL----------NVRGFLDRYCPPNCPP----SFFP 254

Query: 247 VAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPV 282
           +   C   + E RP+   +   L+ L        P+
Sbjct: 255 ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  163 bits (414), Expect = 1e-48
 Identities = 54/269 (20%), Positives = 96/269 (35%), Gaps = 44/269 (16%)

Query: 22  RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 78
            +   ++  D  K     V    + +HEN+V  +G C+      +        +L+ ++ 
Sbjct: 62  LIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
             K         VLD     +IA +  +G+ YLH      I+H+D++S NV   ++ K  
Sbjct: 122 DAK--------IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFY-DNGKVV 169

Query: 139 IADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL---------TQKSDVYSF 186
           I DF L                    G   + APE                ++ SDV++ 
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229

Query: 187 GVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV-AKLA 245
           G +  EL     P     P      + W             +   +K      G+  +++
Sbjct: 230 GTIWYELHAREWPFKT-QPAEA---IIWQ------------MGTGMKPNLSQIGMGKEIS 273

Query: 246 AVAALCVQYEAEFRPNMSIVVKALQPLLK 274
            +   C  +E E RP  + ++  L+ L K
Sbjct: 274 DILLFCWAFEQEERPTFTKLMDMLEKLPK 302

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  161 bits (410), Expect = 1e-48
 Identities = 52/244 (21%), Positives = 93/244 (38%), Gaps = 37/244 (15%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAY--EFATMGSLHDILHGRKGVQGAQPGPVLDW 94
              +    H N++ +LG C             +   GSL+++LH            V+D 
Sbjct: 58  CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-------FVVDQ 110

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
              V+ A+D ARG+ +LH   +P I    + S +V++ ED  A+I+         D+   
Sbjct: 111 SQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMA-------DVKFS 162

Query: 155 LHSTRVLGTFGYHAPEYAMTGQ----LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 210
             S   +    + APE A+  +      + +D++SF V+L EL+T   P           
Sbjct: 163 FQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM 221

Query: 211 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 270
            V     R                  PP     ++ +  +C+  +   RP   ++V  L+
Sbjct: 222 KVALEGLRP---------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266

Query: 271 PLLK 274
            +  
Sbjct: 267 KMQD 270

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  159 bits (403), Expect = 6e-47
 Identities = 52/262 (19%), Positives = 100/262 (38%), Gaps = 34/262 (12%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAY----EFATMGSLHDILHGRKGVQGAQPGPVL 92
           +     ++HEN++  +   ++G           ++   GSL+D L              L
Sbjct: 82  IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----------L 131

Query: 93  DWMTRVRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFEDFKAKIADFNLS-- 145
           D  + +++A  +  GL +LH ++     +P+I HRD++S N+L+ ++    IAD  L+  
Sbjct: 132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191

Query: 146 NQAPDMAARLHSTRVLGTFGYHAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             +      +     +GT  Y  PE           Q    +D+YSFG++L E+   R  
Sbjct: 192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCV 250

Query: 200 VDHTMPRGQQSLVTWATPRLSEDKVKQCVD-----PKLKGEYPPKGV-AKLAAVAALCVQ 253
               +   Q           S + +++ V      P     +       ++  +   C  
Sbjct: 251 SGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310

Query: 254 YEAEFRPNMSIVVKALQPLLKS 275
           +    R     V K L  + +S
Sbjct: 311 HNPASRLTALRVKKTLAKMSES 332

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  157 bits (398), Expect = 8e-47
 Identities = 63/244 (25%), Positives = 102/244 (41%), Gaps = 37/244 (15%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
             + + LKH N++ L G C++     L  EFA  G L+ +L G++          +    
Sbjct: 57  AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----------IPPDI 106

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK--------AKIADFNLSNQA 148
            V  AV  ARG+ YLH++    IIHRD++SSN+L+ +  +         KI DF L+   
Sbjct: 107 LVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-- 164

Query: 149 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
                R       G + + APE       ++ SDV+S+GV+L ELLTG  P    +    
Sbjct: 165 --EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG-IDGLA 221

Query: 209 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 268
              V +             +   +    P       A +   C   +   RP+ + ++  
Sbjct: 222 ---VAYG-------VAMNKLALPIPSTCPE----PFAKLMEDCWNPDPHSRPSFTNILDQ 267

Query: 269 LQPL 272
           L  +
Sbjct: 268 LTTI 271

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  154 bits (391), Expect = 2e-45
 Identities = 56/262 (21%), Positives = 106/262 (40%), Gaps = 40/262 (15%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAY----EFATMGSLHDILHGRKGVQGAQPGPVL 92
           +     L+HEN++  +   +              +  MGSL+D L              L
Sbjct: 53  LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----------L 102

Query: 93  DWMTRVRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFEDFKAKIADFNLS-- 145
           D ++ +RI +  A GL +LH ++     +P+I HRD++S N+L+ ++ +  IAD  L+  
Sbjct: 103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162

Query: 146 -NQAPDMAARLHSTRVLGTFGYHAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRK 198
            +Q+ +     ++ RV GT  Y APE              ++ D+++FG+VL E+   R 
Sbjct: 163 HSQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RM 220

Query: 199 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP--------KGVAKLAAVAAL 250
             +  +   +           S + +++ V   +  + P           +  LA +   
Sbjct: 221 VSNGIVEDYKPPFYDVVPNDPSFEDMRKVV--CVDQQRPNIPNRWFSDPTLTSLAKLMKE 278

Query: 251 CVQYEAEFRPNMSIVVKALQPL 272
           C       R     + K L  +
Sbjct: 279 CWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  153 bits (387), Expect = 2e-44
 Identities = 54/266 (20%), Positives = 103/266 (38%), Gaps = 42/266 (15%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAY----EFATMGSLHDILHGRKGVQGAQPGPVL 92
           +     L+HEN++  +    + N          ++   GSL D L+             +
Sbjct: 87  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------V 136

Query: 93  DWMTRVRIAVDAARGLEYLHEKVQ-----PSIIHRDIRSSNVLLFEDFKAKIADFNLS-- 145
                +++A+  A GL +LH ++      P+I HRD++S N+L+ ++    IAD  L+  
Sbjct: 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196

Query: 146 -NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-------TQKSDVYSFGVVLLELLTGR 197
            + A D      + RV GT  Y APE  +   +        +++D+Y+ G+V  E+   R
Sbjct: 197 HDSATDTIDIAPNHRV-GTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR-R 253

Query: 198 KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP--------KGVAKLAAVAA 249
             +       Q           S +++++ V    +   P         + +  +A +  
Sbjct: 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV--CEQKLRPNIPNRWQSCEALRVMAKIMR 311

Query: 250 LCVQYEAEFRPNMSIVVKALQPLLKS 275
            C       R     + K L  L + 
Sbjct: 312 ECWYANGAARLTALRIKKTLSQLSQQ 337

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  125 bits (316), Expect = 1e-33
 Identities = 64/256 (25%), Positives = 98/256 (38%), Gaps = 60/256 (23%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
            ++ +  H N+V L+G C +     +  E    G     L           G  L   T 
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--------GARLRVKTL 215

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +++  DAA G+EYL  K     IHRD+ + N L+ E    KI+DF +S            
Sbjct: 216 LQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMS------------ 260

Query: 158 TRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHT 203
            R      Y              APE    G+ + +SDV+SFG++L E  + G  P    
Sbjct: 261 -REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY--- 316

Query: 204 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRP 260
                        P LS  + ++ V+   KG     P+     +  +   C  YE   RP
Sbjct: 317 -------------PNLSNQQTREFVE---KGGRLPCPELCPDAVFRLMEQCWAYEPGQRP 360

Query: 261 NMSIVVKALQPLLKSP 276
           + S + + LQ + K  
Sbjct: 361 SFSTIYQELQSIRKRH 376

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  115 bits (291), Expect = 8e-30
 Identities = 71/249 (28%), Positives = 107/249 (42%), Gaps = 49/249 (19%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAY---EFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           SV+++L+H NLV+LLG  VE    +  Y   E+   GSL D L  R          VL  
Sbjct: 238 SVMTQLRHSNLVQLLGVIVEEKGGL--YIVTEYMAKGSLVDYLRSRGR-------SVLGG 288

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
              ++ ++D    +EYL      + +HRD+ + NVL+ ED  AK++DF L         +
Sbjct: 289 DCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL--------TK 337

Query: 155 -LHSTRVLGTFGYH--APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQS 210
              ST+  G       APE     + + KSDV+SFG++L E+ + GR P           
Sbjct: 338 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY---------- 387

Query: 211 LVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPNMSIVVK 267
                 PR+    V   V+   KG     P G    +  V   C   +A  RP    + +
Sbjct: 388 ------PRIPLKDVVPRVE---KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438

Query: 268 ALQPLLKSP 276
            L+ +    
Sbjct: 439 QLEHIRTHE 447

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  115 bits (290), Expect = 2e-29
 Identities = 60/242 (24%), Positives = 104/242 (42%), Gaps = 32/242 (13%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +V+  +KH NLV+LLG C       +  EF T G+L D L              +  +  
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVL 320

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           + +A   +  +EYL +K   + IHR++ + N L+ E+   K+ADF LS          ++
Sbjct: 321 LYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYT 374

Query: 158 TRVLGTFGYH--APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
                 F     APE     + + KSDV++FGV+L E+ T G  P               
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-------------- 420

Query: 215 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 274
             P +   +V + ++   + E P     K+  +   C Q+    RP+ + + +A + + +
Sbjct: 421 --PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478

Query: 275 SP 276
             
Sbjct: 479 ES 480

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  114 bits (286), Expect = 4e-29
 Identities = 73/260 (28%), Positives = 110/260 (42%), Gaps = 35/260 (13%)

Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G  G
Sbjct: 216 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETG 274

Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                    L     V +A   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 275 -------KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 324

Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
            L+    D               + APE A+ G+ T KSDV+SFG++L EL T GR P  
Sbjct: 325 GLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY- 382

Query: 202 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEF 258
                          P +   +V   V+   +G     P      L  +   C + E E 
Sbjct: 383 ---------------PGMVNREVLDQVE---RGYRMPCPPECPESLHDLMCQCWRKEPEE 424

Query: 259 RPNMSIVVKALQPLLKSPPP 278
           RP    +   L+    S  P
Sbjct: 425 RPTFEYLQAFLEDYFTSTEP 444

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  109 bits (275), Expect = 1e-28
 Identities = 55/247 (22%), Positives = 98/247 (39%), Gaps = 26/247 (10%)

Query: 40  VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVR 99
            S+L H+N+V ++    E +   L  E+    +L + +           GP L   T + 
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--------GP-LSVDTAIN 115

Query: 100 IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR 159
                  G+++ H+     I+HRDI+  N+L+  +   KI DF ++ +A    +   +  
Sbjct: 116 FTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNH 171

Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 219
           VLGT  Y +PE A      + +D+YS G+VL E+L G  P +          V+ A   +
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHI 225

Query: 220 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-NMSIVVKALQPLLKSPPP 278
            +        P +  +        L+ V     + +   R   +  +   L  +L     
Sbjct: 226 QDSV------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279

Query: 279 AAPVSET 285
              V E 
Sbjct: 280 NEDVYEL 286

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  108 bits (272), Expect = 3e-28
 Identities = 60/255 (23%), Positives = 102/255 (40%), Gaps = 59/255 (23%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
            V+ +L H  LV+L G C+E     L  EF   G L D L  ++G+            T 
Sbjct: 55  EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL--------FAAETL 106

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           + + +D   G+ YL E     +IHRD+ + N L+ E+   K++DF ++            
Sbjct: 107 LGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT------------ 151

Query: 158 TRVLGTFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTM 204
            R +    Y             +PE     + + KSDV+SFGV++ E+ + G+ P     
Sbjct: 152 -RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY---- 206

Query: 205 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPN 261
                          S  +V + +     G   Y P+     +  +   C +   E RP 
Sbjct: 207 ------------ENRSNSEVVEDIS---TGFRLYKPRLASTHVYQIMNHCWRERPEDRPA 251

Query: 262 MSIVVKALQPLLKSP 276
            S +++ L  + +S 
Sbjct: 252 FSRLLRQLAEIAESG 266

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  112 bits (281), Expect = 3e-28
 Identities = 73/260 (28%), Positives = 110/260 (42%), Gaps = 35/260 (13%)

Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           LK     P+   Q   V+ +L+HE LV+L     E  + ++  E+ + GSL D L G  G
Sbjct: 299 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETG 357

Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                    L     V +A   A G+ Y+      + +HRD+R++N+L+ E+   K+ADF
Sbjct: 358 -------KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 407

Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
            L+    D               + APE A+ G+ T KSDV+SFG++L EL T GR P  
Sbjct: 408 GLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY- 465

Query: 202 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEF 258
                          P +   +V   V+   +G     P      L  +   C + E E 
Sbjct: 466 ---------------PGMVNREVLDQVE---RGYRMPCPPECPESLHDLMCQCWRKEPEE 507

Query: 259 RPNMSIVVKALQPLLKSPPP 278
           RP    +   L+    S  P
Sbjct: 508 RPTFEYLQAFLEDYFTSTEP 527

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  108 bits (272), Expect = 7e-28
 Identities = 64/254 (25%), Positives = 105/254 (41%), Gaps = 29/254 (11%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAY---EFATMGSLHDILHGRKGVQGAQPGPVLD 93
           + ++  L HE++++  G C +     L     E+  +GSL D L              + 
Sbjct: 84  IDILRTLYHEHIIKYKGCCEDAGAASL-QLVMEYVPLGSLRDYLPRHS----------IG 132

Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
               +  A     G+ YLH +     IHRD+ + NVLL  D   KI DF L+   P+   
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189

Query: 154 --RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQS 210
             R+        F Y APE     +    SDV+SFGV L ELLT             +  
Sbjct: 190 YYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248

Query: 211 LVTWATPRLSEDKVKQCVDPKLKGEY---PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 267
            +     +++  ++ + ++   +GE    P K  A++  +   C + EA FRP    ++ 
Sbjct: 249 GIAQ--GQMTVLRLTELLE---RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303

Query: 268 ALQPLLKSPPPAAP 281
            L+ + +     AP
Sbjct: 304 ILKTVHEKYQGQAP 317

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  107 bits (270), Expect = 7e-28
 Identities = 65/265 (24%), Positives = 110/265 (41%), Gaps = 59/265 (22%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR-------KGVQGAQPG 89
             +++ L+HE++V+  G C +G+  ++ +E+   G L+  L             Q  Q  
Sbjct: 68  AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             L     + IA   A G+ YL  +     +HRD+ + N L+  +   KI DF +S    
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS---- 180

Query: 150 DMAARLHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT- 195
                    R + +  Y+              PE  M  + T +SDV+SFGV+L E+ T 
Sbjct: 181 ---------RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 231

Query: 196 GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY--PPKGV-AKLAAVAALCV 252
           G++P                  +LS  +V +C+    +G     P+    ++  V   C 
Sbjct: 232 GKQPW----------------FQLSNTEVIECIT---QGRVLERPRVCPKEVYDVMLGCW 272

Query: 253 QYEAEFRPNMSIVVKALQPLLKSPP 277
           Q E + R N+  + K L  L K+ P
Sbjct: 273 QREPQQRLNIKEIYKILHALGKATP 297

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  107 bits (270), Expect = 1e-27
 Identities = 58/282 (20%), Positives = 104/282 (36%), Gaps = 54/282 (19%)

Query: 28  NYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAY---EFATMGSLHDILHGRK 81
           + PD ++       ++  L  + +V+  G       + L     E+   G L D L   +
Sbjct: 63  SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL-RLVMEYLPSGCLRDFLQRHR 121

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
                     LD    +  +    +G+EYL  +     +HRD+ + N+L+  +   KIAD
Sbjct: 122 --------ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIAD 170

Query: 142 FNLSNQAPDMAARLHSTRVLGTFG--YH------------APEYAMTGQLTQKSDVYSFG 187
           F L+             ++L      Y             APE       +++SDV+SFG
Sbjct: 171 FGLA-------------KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFG 217

Query: 188 VVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG---EYPPKGVAK 243
           VVL EL T   K    +       ++       +  ++ + ++   +G     PP   A+
Sbjct: 218 VVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELLE---EGQRLPAPPACPAE 272

Query: 244 LAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPVSET 285
           +  +  LC     + RP+ S +   L  L          + T
Sbjct: 273 VHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFT 314

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  106 bits (267), Expect = 2e-27
 Identities = 43/183 (23%), Positives = 70/183 (38%), Gaps = 27/183 (14%)

Query: 27  KNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLR----VLAYEFATMGSLHDIL-- 77
           K    + ++      ++  L+H N+V                VL  E  T G+L   L  
Sbjct: 63  KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 122

Query: 78  HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFK 136
                         +             +GL++LH +  P IIHRD++  N+ +      
Sbjct: 123 FKV-----------MKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGS 170

Query: 137 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            KI D  L+       A+     V+GT  + APE     +  +  DVY+FG+ +LE+ T 
Sbjct: 171 VKIGDLGLATLKRASFAK----AVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATS 225

Query: 197 RKP 199
             P
Sbjct: 226 EYP 228

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  106 bits (268), Expect = 3e-27
 Identities = 42/176 (23%), Positives = 75/176 (42%), Gaps = 39/176 (22%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
            V++ + + ++  LLG C+   ++++  +    G L D +   K          +     
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYL 119

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +   V  A+G+ YL ++    ++HRD+ + NVL+      KI DF L+            
Sbjct: 120 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA------------ 164

Query: 158 TRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            ++LG                  A E  +    T +SDV+S+GV + EL+T G KP
Sbjct: 165 -KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  108 bits (272), Expect = 3e-27
 Identities = 61/247 (24%), Positives = 105/247 (42%), Gaps = 39/247 (15%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +V+  L+H+ LV+L     +  + ++  EF   GSL D L   +G               
Sbjct: 235 NVMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEG-------SKQPLPKL 286

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +  +   A G+ ++ ++   + IHRD+R++N+L+      KIADF L+    D     ++
Sbjct: 287 IDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YT 340

Query: 158 TRVLGTFGYH--APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
            R    F     APE    G  T KSDV+SFG++L+E++T GR P               
Sbjct: 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-------------- 386

Query: 215 ATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPNMSIVVKALQP 271
             P +S  +V + ++   +G     P+    +L  +   C +   E RP    +   L  
Sbjct: 387 --PGMSNPEVIRALE---RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441

Query: 272 LLKSPPP 278
              +   
Sbjct: 442 FYTATES 448

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  106 bits (267), Expect = 4e-27
 Identities = 62/259 (23%), Positives = 95/259 (36%), Gaps = 61/259 (23%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G    G L ++  E+   GSL   L    G            M  
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--------FTIMQL 153

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +      G+ YL +      +HRD+ + NVL+  +   K++DF LS            
Sbjct: 154 VGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLS------------ 198

Query: 158 TRVLG--TFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 202
            RVL       +            APE       +  SDV+SFGVV+ E+L  G +P   
Sbjct: 199 -RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY-- 255

Query: 203 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKG-VAKLAAVAALCVQYEAEFR 259
                           ++   V   V+   +G     P G    L  +   C   +   R
Sbjct: 256 --------------WNMTNRDVISSVE---EGYRLPAPMGCPHALHQLMLDCWHKDRAQR 298

Query: 260 PNMSIVVKALQPLLKSPPP 278
           P  S +V  L  L++SP  
Sbjct: 299 PRFSQIVSVLDALIRSPES 317

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  106 bits (267), Expect = 5e-27
 Identities = 55/275 (20%), Positives = 105/275 (38%), Gaps = 50/275 (18%)

Query: 27  KNYPDDEKQL----VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
                 E++     V+V++ +KH N+V+      E     +  ++   G L   ++ +KG
Sbjct: 60  SRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119

Query: 83  VQGAQPGP---VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
                      +LDW  ++         L+++H++    I+HRDI+S N+ L +D   ++
Sbjct: 120 ----VLFQEDQILDWFVQI------CLALKHVHDR---KILHRDIKSQNIFLTKDGTVQL 166

Query: 140 ADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            DF ++   N   ++A       + GT  Y +PE         KSD+++ G VL EL T 
Sbjct: 167 GDFGIARVLNSTVELA----RACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL 221

Query: 197 RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEA 256
           +   +       ++LV          K+     P +   Y       L ++ +   +   
Sbjct: 222 KHAFEA---GSMKNLVL---------KIISGSFPPVSLHYSY----DLRSLVSQLFKRNP 265

Query: 257 EFRP------NMSIVVKALQPLLKSPPPAAPVSET 285
             RP          + K ++  L     A      
Sbjct: 266 RDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLK 300

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  106 bits (266), Expect = 6e-27
 Identities = 56/257 (21%), Positives = 105/257 (40%), Gaps = 43/257 (16%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
            ++ +  H N++ L G   +    ++  E+   G+L   L  + G            +  
Sbjct: 98  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQL 149

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL      + +HRD+ + N+L+  +   K++DF LS    D     ++
Sbjct: 150 VGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206

Query: 158 TR-----VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSL 211
           T      +  T    APE     + T  SDV+SFG+V+ E++T G +P            
Sbjct: 207 TSGGKIPIRWT----APEAISYRKFTSASDVWSFGIVMWEVMTYGERPY----------- 251

Query: 212 VTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPNMSIVVKA 268
                  LS  +V + ++    G     P    + +  +   C Q E   RP  + +V  
Sbjct: 252 -----WELSNHEVMKAIN---DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303

Query: 269 LQPLLKSPPPAAPVSET 285
           L  L+++P     +++ 
Sbjct: 304 LDKLIRAPDSLKTLADF 320

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  105 bits (265), Expect = 7e-27
 Identities = 47/177 (26%), Positives = 73/177 (41%), Gaps = 31/177 (17%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP-GPVLDWMT 96
           SV+      ++V LLG   +G   ++  E  T G L   L   +      P         
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            +++A + A G+ YL+       +HRD+ + N ++ EDF  KI DF ++           
Sbjct: 140 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT----------- 185

Query: 157 STRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
             R +    Y+             +PE    G  T  SDV+SFGVVL E+ T   +P
Sbjct: 186 --RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  104 bits (262), Expect = 8e-27
 Identities = 50/253 (19%), Positives = 92/253 (36%), Gaps = 59/253 (23%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
             + +L H  LV+  G C +     +  E+ + G L + L           G  L+    
Sbjct: 55  QTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH--------GKGLEPSQL 106

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           + +  D   G+ +L        IHRD+ + N L+  D   K++DF ++            
Sbjct: 107 LEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT------------ 151

Query: 158 TRVLGTFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTM 204
            R +    Y             APE     + + KSDV++FG+++ E+ + G+ P     
Sbjct: 152 -RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY---- 206

Query: 205 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPN 261
                          +  +V   V    +G   Y P      +  +   C     E RP 
Sbjct: 207 ------------DLYTNSEVVLKVS---QGHRLYRPHLASDTIYQIMYSCWHELPEKRPT 251

Query: 262 MSIVVKALQPLLK 274
              ++ +++PL +
Sbjct: 252 FQQLLSSIEPLRE 264

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  105 bits (263), Expect = 8e-27
 Identities = 62/252 (24%), Positives = 105/252 (41%), Gaps = 52/252 (20%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +V+  +KH NLV+LLG C       +  EF T G+L D L              +  +  
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVL 113

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           + +A   +  +EYL +K   + IHRD+ + N L+ E+   K+ADF LS            
Sbjct: 114 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS------------ 158

Query: 158 TRVLGTFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTM 204
            R++    Y             APE     + + KSDV++FGV+L E+ T G  P     
Sbjct: 159 -RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---- 213

Query: 205 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSI 264
                       P +   +V + ++   + E P     K+  +   C Q+    RP+ + 
Sbjct: 214 ------------PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAE 261

Query: 265 VVKALQPLLKSP 276
           + +A + + +  
Sbjct: 262 IHQAFETMFQES 273

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  104 bits (262), Expect = 9e-27
 Identities = 70/247 (28%), Positives = 108/247 (43%), Gaps = 45/247 (18%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           SV+++L+H NLV+LLG  VE    + +  E+   GSL D L  R          VL    
Sbjct: 66  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDC 118

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-L 155
            ++ ++D    +EYL      + +HRD+ + NVL+ ED  AK++DF L         +  
Sbjct: 119 LLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEA 167

Query: 156 HSTRVLGTFGYH--APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLV 212
            ST+  G       APE     + + KSDV+SFG++L E+ + GR P             
Sbjct: 168 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY------------ 215

Query: 213 TWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPNMSIVVKAL 269
               PR+    V   V+   KG     P G    +  V   C   +A  RP+   + + L
Sbjct: 216 ----PRIPLKDVVPRVE---KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 268

Query: 270 QPLLKSP 276
           + +    
Sbjct: 269 EHIKTHE 275

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  104 bits (262), Expect = 1e-26
 Identities = 52/245 (21%), Positives = 97/245 (39%), Gaps = 39/245 (15%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
            V+  L HE LV+L G C +     +  E+   G L + L   +                
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQL 122

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           + +  D    +EYL  K     +HRD+ + N L+ +    K++DF LS     +    ++
Sbjct: 123 LEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYT 176

Query: 158 TRVLGTFGYH--APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
           + V   F      PE  M  + + KSD+++FGV++ E+ + G+ P               
Sbjct: 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY-------------- 222

Query: 215 ATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPNMSIVVKALQP 271
              R +  +  + +    +G   Y P     K+  +   C   +A+ RP   I++  +  
Sbjct: 223 --ERFTNSETAEHIA---QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277

Query: 272 LLKSP 276
           ++   
Sbjct: 278 VMDEE 282

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  105 bits (263), Expect = 1e-26
 Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 17/165 (10%)

Query: 40  VSRLKHENLVELLGY-CVEGNLRVLAY---EFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
            + L H  +V +      E     L Y   E+    +L DI+H          GP +   
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--------GP-MTPK 116

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
             + +  DA + L + H+     IIHRD++ +N+++      K+ DF ++    D    +
Sbjct: 117 RAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173

Query: 156 HST-RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             T  V+GT  Y +PE A    +  +SDVYS G VL E+LTG  P
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  104 bits (261), Expect = 1e-26
 Identities = 53/260 (20%), Positives = 95/260 (36%), Gaps = 48/260 (18%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAY---EFATMGSLHDILHGRKGVQGAQPGPVLD 93
           + ++  L+H+N+V+  G C     R L     E+   GSL D L   K          +D
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNL-KLIMEYLPYGSLRDYLQKHKER--------ID 112

Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
            +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+        
Sbjct: 113 HIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT-------- 161

Query: 154 RLHSTRVL--GTFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                +VL      +             APE     + +  SDV+SFGVVL EL T  + 
Sbjct: 162 -----KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 216

Query: 200 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG---EYPPKGVAKLAAVAALCVQYEA 256
                    + +      ++    + + +           P     ++  +   C     
Sbjct: 217 SKSPPAEFMRMIGNDKQGQMIVFHLIELLK---NNGRLPRPDGCPDEIYMIMTECWNNNV 273

Query: 257 EFRPNMSIVVKALQPLLKSP 276
             RP+   +   +  +  + 
Sbjct: 274 NQRPSFRDLALRVDQIRDNM 293

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  105 bits (264), Expect = 2e-26
 Identities = 58/248 (23%), Positives = 101/248 (40%), Gaps = 43/248 (17%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++ +  H N++ L G   +    ++  E+   GSL   L                 +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--------FTVIQL 149

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V +    A G++YL +      +HRD+ + N+L+  +   K++DF L     D     ++
Sbjct: 150 VGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206

Query: 158 TR-----VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSL 211
           TR     +  T    +PE     + T  SDV+S+G+VL E+++ G +P            
Sbjct: 207 TRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY----------- 251

Query: 212 VTWATPRLSEDKVKQCVDPKLKGE--YPPKG-VAKLAAVAALCVQYEAEFRPNMSIVVKA 268
                  +S   V + VD   +G    PP    A L  +   C Q +   RP    +V  
Sbjct: 252 -----WEMSNQDVIKAVD---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303

Query: 269 LQPLLKSP 276
           L  L+++P
Sbjct: 304 LDKLIRNP 311

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (260), Expect = 3e-26
 Identities = 54/247 (21%), Positives = 95/247 (38%), Gaps = 24/247 (9%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAY---EFATMGSLHDILHGRKGVQGAQPGPVLD 93
           + ++  L+H+N+V+  G C     R L     E+   GSL D L   K          +D
Sbjct: 93  IEILKSLQHDNIVKYKGVCYSAGRRNL-KLIMEYLPYGSLRDYLQKHKER--------ID 143

Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 151
            +  ++      +G+EYL  K     IHRD+ + N+L+  + + KI DF L+   P    
Sbjct: 144 HIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200

Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 211
             ++        F Y APE     + +  SDV+SFGVVL EL T  +          + +
Sbjct: 201 YYKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259

Query: 212 VTWATPRLSEDKVKQCVDPKLKG---EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 268
                 ++    + + +           P     ++  +   C       RP+   +   
Sbjct: 260 GNDKQGQMIVFHLIELLK---NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316

Query: 269 LQPLLKS 275
           +  +   
Sbjct: 317 VDQIRDQ 323

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  103 bits (260), Expect = 3e-26
 Identities = 56/286 (19%), Positives = 106/286 (37%), Gaps = 58/286 (20%)

Query: 23  LKSPKNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAY------EFATMGSL 73
           LK+      D ++ +     +    H ++ +L+G  +    +           F   G L
Sbjct: 59  LKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDL 118

Query: 74  HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 133
           H  L   +  +     P+      VR  VD A G+EYL  +   + IHRD+ + N +L E
Sbjct: 119 HAFLLASRIGENPFNLPLQT---LVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAE 172

Query: 134 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH-------------APEYAMTGQLTQK 180
           D    +ADF LS             R + +  Y+             A E       T  
Sbjct: 173 DMTVCVADFGLS-------------RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVH 219

Query: 181 SDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK 239
           SDV++FGV + E++T G+ P                   +   ++   +    + + PP+
Sbjct: 220 SDVWAFGVTMWEIMTRGQTPY----------------AGIENAEIYNYLIGGNRLKQPPE 263

Query: 240 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPVSET 285
            + ++  +   C   + + RP+ + +   L+ +L      +   + 
Sbjct: 264 CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  103 bits (258), Expect = 3e-26
 Identities = 54/260 (20%), Positives = 92/260 (35%), Gaps = 60/260 (23%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
            ++  L H ++V+L+G   E    ++  E    G L   L   K          L  +T 
Sbjct: 65  VIMKNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNS--------LKVLTL 115

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           V  ++   + + YL      + +HRDI   N+L+      K+ DF LS            
Sbjct: 116 VLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLS------------ 160

Query: 158 TRVLGTFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTM 204
            R +    Y+            +PE     + T  SDV+ F V + E+L+ G++P     
Sbjct: 161 -RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF---- 215

Query: 205 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPN 261
                         L    V   ++   KG+    P      L  +   C  Y+   RP 
Sbjct: 216 ------------FWLENKDVIGVLE---KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPR 260

Query: 262 MSIVVKALQPLLKSPPPAAP 281
            + +V +L  + +     A 
Sbjct: 261 FTELVCSLSDVYQMEKDIAM 280

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  102 bits (257), Expect = 5e-26
 Identities = 46/184 (25%), Positives = 78/184 (42%), Gaps = 37/184 (20%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR-------KGVQGAQPG 89
             + +RL+H N+V LLG   +     + + + + G LH+ L  R                
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
             L+    V +    A G+EYL       ++H+D+ + NVL+++    KI+D  L     
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF---- 175

Query: 150 DMAARLHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT- 195
                    R +    Y+             APE  M G+ +  SD++S+GVVL E+ + 
Sbjct: 176 ---------REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 226

Query: 196 GRKP 199
           G +P
Sbjct: 227 GLQP 230

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  103 bits (258), Expect = 5e-26
 Identities = 57/258 (22%), Positives = 102/258 (39%), Gaps = 51/258 (19%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAY---EFATMGSLHDILHGRKGVQGAQPGPVLDW 94
            ++  L HEN+V+  G C E     +     EF   GSL + L   K          ++ 
Sbjct: 75  EILRNLYHENIVKYKGICTEDGGNGI-KLIMEFLPSGSLKEYLPKNKNK--------INL 125

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             +++ AV   +G++YL  +     +HRD+ + NVL+  + + KI DF L+         
Sbjct: 126 KQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT--------- 173

Query: 155 LHSTRVL--GTFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
               + +      Y             APE  M  +    SDV+SFGV L ELLT     
Sbjct: 174 ----KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229

Query: 200 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG---EYPPKGVAKLAAVAALCVQYEA 256
                   +    T    +++  ++   +    +G     PP    ++  +   C +++ 
Sbjct: 230 SSPMALFLKMIGPTH--GQMTVTRLVNTLK---EGKRLPCPPNCPDEVYQLMRKCWEFQP 284

Query: 257 EFRPNMSIVVKALQPLLK 274
             R +   +++  + LLK
Sbjct: 285 SNRTSFQNLIEGFEALLK 302

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  102 bits (257), Expect = 5e-26
 Identities = 56/190 (29%), Positives = 76/190 (40%), Gaps = 40/190 (21%)

Query: 25  SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
           S     DD  + V+ +  L H NL+ L G  +   ++++  E A +GSL D L   +G  
Sbjct: 60  SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGH- 117

Query: 85  GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 144
                      T  R AV  A G+ YL  K     IHRD+ + N+LL      KI DF L
Sbjct: 118 -------FLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGL 167

Query: 145 SNQAPDMAARLHSTRVLGTFG--YH------------APEYAMTGQLTQKSDVYSFGVVL 190
                         R L      Y             APE   T   +  SD + FGV L
Sbjct: 168 M-------------RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214

Query: 191 LELLT-GRKP 199
            E+ T G++P
Sbjct: 215 WEMFTYGQEP 224

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  102 bits (256), Expect = 7e-26
 Identities = 63/247 (25%), Positives = 109/247 (44%), Gaps = 39/247 (15%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +++ +L+H+ LV L     +  + ++  E+   GSL D L    G++       L     
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKL 111

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           + +A   A G+ ++ E+   + IHRD+R++N+L+ +    KIADF L+    D     ++
Sbjct: 112 LDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YT 165

Query: 158 TRVLGTFGYH--APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 214
            R    F     APE    G  T KSDV+SFG++L E++T GR P               
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-------------- 211

Query: 215 ATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPNMSIVVKALQP 271
             P ++  +V Q ++   +G     P     +L  +  LC +   E RP    +   L+ 
Sbjct: 212 --PGMTNPEVIQNLE---RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266

Query: 272 LLKSPPP 278
              +   
Sbjct: 267 FFTATEG 273

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  102 bits (257), Expect = 1e-25
 Identities = 62/260 (23%), Positives = 100/260 (38%), Gaps = 57/260 (21%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
             ++S+  H+N+V  +G  ++   R +  E    G L   L   +          L  + 
Sbjct: 84  ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS--QPSSLAMLD 141

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 153
            + +A D A G +YL E      IHRDI + N LL        AKI DF ++        
Sbjct: 142 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-------- 190

Query: 154 RLHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
                R +    Y+              PE  M G  T K+D +SFGV+L E+ + G  P
Sbjct: 191 -----RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

Query: 200 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG---EYPPKGVAKLAAVAALCVQYEA 256
                            P  S  +V + V     G   + P      +  +   C Q++ 
Sbjct: 246 Y----------------PSKSNQEVLEFVT---SGGRMDPPKNCPGPVYRIMTQCWQHQP 286

Query: 257 EFRPNMSIVVKALQPLLKSP 276
           E RPN +I+++ ++   + P
Sbjct: 287 EDRPNFAIILERIEYCTQDP 306

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  102 bits (257), Expect = 1e-25
 Identities = 42/176 (23%), Positives = 75/176 (42%), Gaps = 39/176 (22%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
            V++ + + ++  LLG C+   ++++  +    G L D +   K          +     
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYL 119

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +   V  A+G+ YL ++    ++HRD+ + NVL+      KI DF L+            
Sbjct: 120 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA------------ 164

Query: 158 TRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            ++LG                  A E  +    T +SDV+S+GV + EL+T G KP
Sbjct: 165 -KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  101 bits (255), Expect = 1e-25
 Identities = 61/262 (23%), Positives = 105/262 (40%), Gaps = 62/262 (23%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
             ++ +L +  +V L+G C    L ++  E A  G LH  L G++          +    
Sbjct: 61  AQIMHQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREE--------IPVSN 111

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
              +    + G++YL EK   + +HRD+ + NVLL     AKI+DF LS           
Sbjct: 112 VAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLS----------- 157

Query: 157 STRVLGT--FGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 201
             + LG     Y             APE     + + +SDV+S+GV + E L+ G+KP  
Sbjct: 158 --KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY- 214

Query: 202 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEF 258
                           ++   +V   ++   +G+    P     +L A+ + C  Y+ E 
Sbjct: 215 ---------------KKMKGPEVMAFIE---QGKRMECPPECPPELYALMSDCWIYKWED 256

Query: 259 RPNMSIVVKALQPLLKSPPPAA 280
           RP+   V + ++    S     
Sbjct: 257 RPDFLTVEQRMRACYYSLASKV 278

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  102 bits (256), Expect = 1e-25
 Identities = 46/176 (26%), Positives = 79/176 (44%), Gaps = 39/176 (22%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
             +  L H ++V LLG C   +L+++  ++  +GSL D +   +G  G Q          
Sbjct: 67  LAIGSLDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALGPQ--------LL 117

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +   V  A+G+ YL E     ++HR++ + NVLL    + ++ADF ++            
Sbjct: 118 LNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVA------------ 162

Query: 158 TRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
             +L                   A E    G+ T +SDV+S+GV + EL+T G +P
Sbjct: 163 -DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  102 bits (256), Expect = 1e-25
 Identities = 48/199 (24%), Positives = 82/199 (41%), Gaps = 41/199 (20%)

Query: 23  LKSPKNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAY-----EFATMGSLH 74
           +K   +   + ++ +S    +    H N++ LLG C+E + + +        F   G LH
Sbjct: 70  MKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLH 129

Query: 75  DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 134
             L   +          +   T ++  VD A G+EYL  +   + +HRD+ + N +L +D
Sbjct: 130 TYLLYSRL---ETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183

Query: 135 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH-------------APEYAMTGQLTQKS 181
               +ADF LS             + + +  Y+             A E       T KS
Sbjct: 184 MTVCVADFGLS-------------KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKS 230

Query: 182 DVYSFGVVLLELLT-GRKP 199
           DV++FGV + E+ T G  P
Sbjct: 231 DVWAFGVTMWEIATRGMTP 249

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  101 bits (255), Expect = 2e-25
 Identities = 61/265 (23%), Positives = 105/265 (39%), Gaps = 58/265 (21%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
             +++ L+H+++V   G C EG   ++ +E+   G L+  L           G       
Sbjct: 94  AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153

Query: 97  R------VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 150
                  + +A   A G+ YL        +HRD+ + N L+ +    KI DF +S     
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMS----- 205

Query: 151 MAARLHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-G 196
                   R + +  Y+              PE  +  + T +SDV+SFGVVL E+ T G
Sbjct: 206 --------RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257

Query: 197 RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY--PPKGV-AKLAAVAALCVQ 253
           ++P                  +LS  +   C+    +G     P+    ++ A+   C Q
Sbjct: 258 KQPW----------------YQLSNTEAIDCIT---QGRELERPRACPPEVYAIMRGCWQ 298

Query: 254 YEAEFRPNMSIVVKALQPLLKSPPP 278
            E + R ++  V   LQ L ++PP 
Sbjct: 299 REPQQRHSIKDVHARLQALAQAPPV 323

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  101 bits (254), Expect = 2e-25
 Identities = 38/160 (23%), Positives = 59/160 (36%), Gaps = 13/160 (8%)

Query: 40  VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVR 99
             RL+  ++V +  +        +         L  +L  +        GP L     V 
Sbjct: 88  AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ--------GP-LAPPRAVA 138

Query: 100 IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR 159
           I       L+  H        HRD++  N+L+  D  A + DF ++  A           
Sbjct: 139 IVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIA-SATTDEKLTQLGN 194

Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            +GT  Y APE       T ++D+Y+   VL E LTG  P
Sbjct: 195 TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  100 bits (252), Expect = 3e-25
 Identities = 55/273 (20%), Positives = 99/273 (36%), Gaps = 55/273 (20%)

Query: 37  VSVVSRLKHENLVELLGYCVEGN---------LRVLAY---EFATMGSLHDILHGRKGVQ 84
           V  +++L+H  +V      +E N          +V  Y   +     +L D ++GR  ++
Sbjct: 54  VKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE 113

Query: 85  GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 144
             +    L    ++      A  +E+LH K    ++HRD++ SN+    D   K+ DF L
Sbjct: 114 ERERSVCLHIFLQI------AEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGL 164

Query: 145 S-----------NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 193
                          P  A   H+ +V GT  Y +PE       + K D++S G++L EL
Sbjct: 165 VTAMDQDEEEQTVLTPMPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

Query: 194 LTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQ 253
           L    P    M R +               V+    P L  +  P        +    + 
Sbjct: 224 LY---PFSTQMERVRTL-----------TDVRNLKFPPLFTQKYP----CEYVMVQDMLS 265

Query: 254 YEAEFRPNMSIVVKALQPLLKS--PPPAAPVSE 284
                RP    +++    + +    P    + +
Sbjct: 266 PSPMERPEAINIIE--NAVFEDLDFPGKTVLRQ 296

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  101 bits (254), Expect = 3e-25
 Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 37/177 (20%)

Query: 44  KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ-------GAQPGPVLDWMT 96
           KH+N++ LLG C +     +  E+A+ G+L + L  R+             P   + +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            V      ARG+EYL  +     IHRD+ + NVL+ E+   KIADF L+           
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA----------- 204

Query: 157 STRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
             R +    Y+             APE       T +SDV+SFGV++ E+ T G  P
Sbjct: 205 --RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  100 bits (252), Expect = 3e-25
 Identities = 55/257 (21%), Positives = 97/257 (37%), Gaps = 63/257 (24%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           S++S+L H++LV   G CV G+  +L  EF   GSL   L   K          ++ + +
Sbjct: 64  SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN--------CINILWK 115

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK--------AKIADFNLSNQAP 149
           + +A   A  + +L E    ++IH ++ + N+LL  +           K++D  +S    
Sbjct: 116 LEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---- 168

Query: 150 DMAARLHSTRVLGTFGYH-------APEYAMTGQL-TQKSDVYSFGVVLLELLT-GRKPV 200
                      +              PE     +     +D +SFG  L E+ + G KP+
Sbjct: 169 ---------ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219

Query: 201 DHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGVAKLAAVAALCVQYEAEF 258
                             L   +  Q  +          PK  A+LA +   C+ YE + 
Sbjct: 220 ----------------SALDSQRKLQFYE---DRHQLPAPKA-AELANLINNCMDYEPDH 259

Query: 259 RPNMSIVVKALQPLLKS 275
           RP+   +++ L  L   
Sbjct: 260 RPSFRAIIRDLNSLFTP 276

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  100 bits (250), Expect = 4e-25
 Identities = 48/175 (27%), Positives = 72/175 (41%), Gaps = 38/175 (21%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
             + +  H ++V+L+G   E  + ++  E  T+G L   L  RK          LD  + 
Sbjct: 68  LTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYS--------LDLASL 118

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +  A   +  L YL  K     +HRDI + NVL+  +   K+ DF LS            
Sbjct: 119 ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS------------ 163

Query: 158 TRVLGTFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            R +    Y+            APE     + T  SDV+ FGV + E+L  G KP
Sbjct: 164 -RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 99.7 bits (249), Expect = 6e-25
 Identities = 43/188 (22%), Positives = 78/188 (41%), Gaps = 35/188 (18%)

Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAY----------------EFATMGSLH 74
           +  ++ V  +++L H N+V   G     +                      EF   G+L 
Sbjct: 49  EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE 108

Query: 75  DILHGRKGVQGAQPGP---VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 131
             +  R+G    +       L+   ++       +G++Y+H K    +I+RD++ SN+ L
Sbjct: 109 QWIEKRRG----EKLDKVLALELFEQI------TKGVDYIHSK---KLINRDLKPSNIFL 155

Query: 132 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLL 191
            +  + KI DF L     +   R   TR  GT  Y +PE   +    ++ D+Y+ G++L 
Sbjct: 156 VDTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILA 212

Query: 192 ELLTGRKP 199
           ELL     
Sbjct: 213 ELLHVCDT 220

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  101 bits (254), Expect = 6e-25
 Identities = 65/254 (25%), Positives = 100/254 (39%), Gaps = 53/254 (20%)

Query: 44  KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ-------PGPVLDWMT 96
           KH+N++ LLG C +     +  E+A+ G+L + L  R+             P   L    
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            V  A   ARG+EYL  K     IHRD+ + NVL+ ED   KIADF L+           
Sbjct: 193 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLA----------- 238

Query: 157 STRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 202
             R +    Y+             APE       T +SDV+SFGV+L E+ T G  P   
Sbjct: 239 --RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--- 293

Query: 203 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 262
                         P +  +++ + +    + + P     +L  +   C       RP  
Sbjct: 294 -------------YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 340

Query: 263 SIVVKALQPLLKSP 276
             +V+ L  ++   
Sbjct: 341 KQLVEDLDRIVALT 354

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  103 bits (257), Expect = 6e-25
 Identities = 61/243 (25%), Positives = 94/243 (38%), Gaps = 36/243 (14%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
             + +  H ++V+L+G   E  + ++  E  T+G L   L  RK          LD  + 
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRK--------FSLDLASL 493

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           +  A   +  L YL  K     +HRDI + NVL+  +   K+ DF LS    D      S
Sbjct: 494 ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 550

Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 216
              L      APE     + T  SDV+ FGV + E+L  G KP                 
Sbjct: 551 KGKLPIKWM-APESINFRRFTSASDVWMFGVCMWEILMHGVKPF---------------- 593

Query: 217 PRLSEDKVKQCVDPKLKGEY---PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 273
             +  + V   ++    GE    PP     L ++   C  Y+   RP  + +   L  +L
Sbjct: 594 QGVKNNDVIGRIE---NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

Query: 274 KSP 276
           +  
Sbjct: 651 EEE 653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  101 bits (253), Expect = 7e-25
 Identities = 63/260 (24%), Positives = 101/260 (38%), Gaps = 57/260 (21%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
             ++S+  H+N+V  +G  ++   R +  E    G L   L   +          L  + 
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP--RPSQPSSLAMLD 182

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 153
            + +A D A G +YL E      IHRDI + N LL        AKI DF ++        
Sbjct: 183 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-------- 231

Query: 154 RLHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
                R +   GY+              PE  M G  T K+D +SFGV+L E+ + G  P
Sbjct: 232 -----RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

Query: 200 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG---EYPPKGVAKLAAVAALCVQYEA 256
                            P  S  +V + V     G   + P      +  +   C Q++ 
Sbjct: 287 Y----------------PSKSNQEVLEFVT---SGGRMDPPKNCPGPVYRIMTQCWQHQP 327

Query: 257 EFRPNMSIVVKALQPLLKSP 276
           E RPN +I+++ ++   + P
Sbjct: 328 EDRPNFAIILERIEYCTQDP 347

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  100 bits (250), Expect = 8e-25
 Identities = 52/231 (22%), Positives = 96/231 (41%), Gaps = 31/231 (13%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP---VLD 93
           + ++ +L H N+++     +E N   +  E A  G L  ++   K  +  +  P   V  
Sbjct: 83  IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK--KQKRLIPERTVWK 140

Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 153
           +  ++         LE++H +    ++HRDI+ +NV +      K+ D  L         
Sbjct: 141 YFVQL------CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191

Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 213
             HS  ++GT  Y +PE         KSD++S G +L E+   + P  +       SL  
Sbjct: 192 AAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCK 248

Query: 214 WATPRLSEDKVKQCVDPKL-KGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 263
                    K++QC  P L    Y      +L  +  +C+  + E RP+++
Sbjct: 249 ---------KIEQCDYPPLPSDHYSE----ELRQLVNMCINPDPEKRPDVT 286

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 99.3 bits (248), Expect = 9e-25
 Identities = 55/238 (23%), Positives = 94/238 (39%), Gaps = 41/238 (17%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAY---EFATMGSLHDILHGRKGVQGAQPGP--- 90
           V+++  LKH N+V      ++     L Y   E+   G L  ++   KG +  Q      
Sbjct: 56  VNLLRELKHPNIVRYYDRIIDRTNTTL-YIVMEYCEGGDLASVI--TKGTKERQYLDEEF 112

Query: 91  VLDWMTRVRIAVDAARGLEYLHEK--VQPSIIHRDIRSSNVLLFEDFKAKIADFNLS--- 145
           VL  MT++         L+  H +     +++HRD++ +NV L      K+ DF L+   
Sbjct: 113 VLRVMTQL------TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166

Query: 146 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
           N     A     T V GT  Y +PE        +KSD++S G +L EL     P      
Sbjct: 167 NHDTSFA----KTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA--- 218

Query: 206 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 263
             Q+ L           K+++    ++   Y      +L  +    +  +   RP++ 
Sbjct: 219 FSQKELA---------GKIREGKFRRIPYRYSD----ELNEIITRMLNLKDYHRPSVE 263

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  100 bits (252), Expect = 1e-24
 Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 37/177 (20%)

Query: 44  KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ-------PGPVLDWMT 96
           KH+N++ LLG C +     +  E+A+ G+L + L  R+             P   + +  
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            V      ARG+EYL  +     IHRD+ + NVL+ E+   KIADF L+           
Sbjct: 205 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA----------- 250

Query: 157 STRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
             R +    Y+             APE       T +SDV+SFGV++ E+ T G  P
Sbjct: 251 --RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 99.2 bits (248), Expect = 1e-24
 Identities = 46/177 (25%), Positives = 78/177 (44%), Gaps = 41/177 (23%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
           +V+ +L +  +V ++G C   +  ++  E A +G L+  L   + V+             
Sbjct: 70  NVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNRHVKDKN---------I 119

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
           + +    + G++YL E    + +HRD+ + NVLL     AKI+DF LS            
Sbjct: 120 IELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS------------ 164

Query: 158 TRVLGTFG--YH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            + L      Y             APE     + + KSDV+SFGV++ E  + G+KP
Sbjct: 165 -KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 98.9 bits (247), Expect = 2e-24
 Identities = 47/174 (27%), Positives = 72/174 (41%), Gaps = 31/174 (17%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLA-YEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
            ++    H N++ LLG C+      L    +   G L + +                   
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--------HNPTVKD 129

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-L 155
            +   +  A+G++YL  K     +HRD+ + N +L E F  K+ADF L+        R +
Sbjct: 130 LIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA--------RDM 178

Query: 156 HST---RVLGTFGYH------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
           +      V    G        A E   T + T KSDV+SFGV+L EL+T G  P
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 98.9 bits (247), Expect = 2e-24
 Identities = 49/179 (27%), Positives = 73/179 (40%), Gaps = 41/179 (22%)

Query: 38  SVVSRLKHENLVELLGYCVEGN-LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
            ++  L H N++ L+G  +    L  +   +   G L   +          P        
Sbjct: 74  LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR--------SPQRNPTVKD 125

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            +   +  ARG+EYL E+     +HRD+ + N +L E F  K+ADF L+           
Sbjct: 126 LISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLA----------- 171

Query: 157 STRVLGTFGYH---------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
             R +    Y+               A E   T + T KSDV+SFGV+L ELLT G  P
Sbjct: 172 --RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 99.8 bits (249), Expect = 2e-24
 Identities = 39/193 (20%), Positives = 82/193 (42%), Gaps = 13/193 (6%)

Query: 11  VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRV-LAYEFAT 69
            ++   +  N    S K+  DD K  + +++ +K+E  +   G  +     V + YE+  
Sbjct: 68  EKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYME 126

Query: 70  MGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 129
             S+         +       +   + +  I         Y+H   + +I HRD++ SN+
Sbjct: 127 NDSILKFDEYFFVLDKNYTCFIPIQVIK-CIIKSVLNSFSYIHN--EKNICHRDVKPSNI 183

Query: 130 LLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT---QKSDVYSF 186
           L+ ++ + K++DF  S    D   ++  +R  GT+ +  PE   + + +    K D++S 
Sbjct: 184 LMDKNGRVKLSDFGESEYMVD--KKIKGSR--GTYEFMPPE-FFSNESSYNGAKVDIWSL 238

Query: 187 GVVLLELLTGRKP 199
           G+ L  +     P
Sbjct: 239 GICLYVMFYNVVP 251

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 99.3 bits (248), Expect = 3e-24
 Identities = 61/278 (21%), Positives = 104/278 (37%), Gaps = 67/278 (24%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--------------- 81
            ++++   + N+V+LLG C  G    L +E+   G L++ L                   
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
               +   P L    ++ IA   A G+ YL E+     +HRD+ + N L+ E+   KIAD
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIAD 217

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGV 188
           F LS             R + +  Y+              PE     + T +SDV+++GV
Sbjct: 218 FGLS-------------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 264

Query: 189 VLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG---EYPPKGVAKL 244
           VL E+ + G +P                   ++ ++V   V     G     P     +L
Sbjct: 265 VLWEIFSYGLQPY----------------YGMAHEEVIYYVR---DGNILACPENCPLEL 305

Query: 245 AAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPV 282
             +  LC       RP+   + + LQ + +       V
Sbjct: 306 YNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGTVGV 343

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  101 bits (252), Expect = 3e-24
 Identities = 60/259 (23%), Positives = 105/259 (40%), Gaps = 62/259 (23%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
            ++ +L +  +V L+G C    L ++  E A  G LH  L G++          +     
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREE--------IPVSNV 438

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
             +    + G++YL EK   + +HR++ + NVLL     AKI+DF LS            
Sbjct: 439 AELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLS------------ 483

Query: 158 TRVLGT--FGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 202
            + LG     Y             APE     + + +SDV+S+GV + E L+ G+KP   
Sbjct: 484 -KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY-- 540

Query: 203 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFR 259
                          ++   +V   ++   +G+    P     +L A+ + C  Y+ E R
Sbjct: 541 --------------KKMKGPEVMAFIE---QGKRMECPPECPPELYALMSDCWIYKWEDR 583

Query: 260 PNMSIVVKALQPLLKSPPP 278
           P+   V + ++    S   
Sbjct: 584 PDFLTVEQRMRACYYSLAS 602

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 98.7 bits (246), Expect = 4e-24
 Identities = 46/174 (26%), Positives = 72/174 (41%), Gaps = 16/174 (9%)

Query: 30  PDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG 89
                + +   + L    +V L G   EG    +  E    GSL  ++  ++   G  P 
Sbjct: 94  EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQM--GCLPE 149

Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQ- 147
               +         A  GLEYLH +    I+H D+++ NVLL  D  +A + DF  +   
Sbjct: 150 DRALYYLG-----QALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL 201

Query: 148 APDMAARLHSTR--VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            PD   +   T   + GT  + APE  M      K D++S   ++L +L G  P
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 98.5 bits (246), Expect = 4e-24
 Identities = 55/169 (32%), Positives = 79/169 (46%), Gaps = 24/169 (14%)

Query: 44  KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ-------PGPVLDWMT 96
            H N++ LLG C       LA E+A  G+L D L   + ++              L    
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            +  A D ARG++YL +K     IHRD+ + N+L+ E++ AKIADF LS        R  
Sbjct: 144 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS--------RGQ 192

Query: 157 STRVLGTFG-----YHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
              V  T G     + A E       T  SDV+S+GV+L E+++ G  P
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 97.7 bits (244), Expect = 7e-24
 Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 33/174 (18%)

Query: 44  KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP-----GPVLDWMTRV 98
           +HEN+V LLG C  G   ++  E+   G L + L  +  V    P              +
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 99  RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 158
             +   A+G+ +L  K   + IHRD+ + NVLL     AKI DF L        AR    
Sbjct: 168 HFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGL--------ARD--- 213

Query: 159 RVLGTFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
            ++    Y             APE       T +SDV+S+G++L E+ + G  P
Sbjct: 214 -IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 97.3 bits (243), Expect = 8e-24
 Identities = 47/178 (26%), Positives = 70/178 (39%), Gaps = 38/178 (21%)

Query: 44  KHENLVELLGYC-VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ-------PGPVLDWM 95
            H N+V LLG C   G   ++  EF   G+L   L  ++                 L   
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
             +  +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+          
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA---------- 195

Query: 156 HSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
              R +     +             APE       T +SDV+SFGV+L E+ + G  P
Sbjct: 196 ---RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 98.0 bits (244), Expect = 9e-24
 Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 20/222 (9%)

Query: 30  PDDEKQLV---SVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQG 85
           P    Q++    V+       +V   G +  +G +  +  E    GSL  +L     +  
Sbjct: 72  PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRI-- 128

Query: 86  AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 145
             P  +L      ++++   +GL YL EK +  I+HRD++ SN+L+    + K+ DF +S
Sbjct: 129 --PEQIL-----GKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 179

Query: 146 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
            Q  D  A    + V GT  Y +PE       + +SD++S G+ L+E+  GR P+     
Sbjct: 180 GQLIDSMAN---SFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235

Query: 206 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAV 247
           +  + +        + +   +   P               A+
Sbjct: 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI 277

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 97.0 bits (242), Expect = 9e-24
 Identities = 47/176 (26%), Positives = 75/176 (42%), Gaps = 19/176 (10%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +++   LKH+N+V+ LG   E     +  E    GSL  +L  + G     P    +   
Sbjct: 70  IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG-----PLKDNEQTI 124

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLSNQAPDMAARL 155
                     GL+YLH+     I+HRDI+  NVL+       KI+DF  S +   +    
Sbjct: 125 GF-YTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180

Query: 156 HSTRVLGTFGYHAPE---YAMTGQLTQKSDVYSFGVVLLELLTGRKP---VDHTMP 205
            +    GT  Y APE       G   + +D++S G  ++E+ TG+ P   +     
Sbjct: 181 ET--FTGTLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIEMATGKPPFYELGEPQA 233

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.9 bits (242), Expect = 1e-23
 Identities = 45/179 (25%), Positives = 69/179 (38%), Gaps = 39/179 (21%)

Query: 44  KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ---------PGPVLDW 94
            H N+V LLG C  G   ++  E+   G L + L  ++                   LD 
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
              +  +   A+G+ +L  K   + IHRD+ + N+LL      KI DF L+         
Sbjct: 145 EDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA--------- 192

Query: 155 LHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
               R +     +             APE       T +SDV+S+G+ L EL + G  P
Sbjct: 193 ----RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 95.8 bits (239), Expect = 2e-23
 Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 37/225 (16%)

Query: 30  PDDEKQLVS----VVSRLKHENLVELLG-YCVEGNLRVLAYEFATM-GSLHDILHGRKGV 83
             ++K+L+      +  +     V   G    EG++  +  E   M  SL          
Sbjct: 46  SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV-WICMEL--MDTSLDKFYKQVIDK 102

Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
               P  +L      +IAV   + LE+LH K+   +IHRD++ SNVL+    + K+ DF 
Sbjct: 103 GQTIPEDIL-----GKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFG 155

Query: 144 LSNQAPDMAARLHSTRVLGTFGYHAPE----YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +S    D  A+       G   Y APE           + KSD++S G+ ++EL   R P
Sbjct: 156 ISGYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

Query: 200 ---VDHTMPRGQQSLVTWATPRLSEDK--------VKQCV--DPK 231
                    + +Q +V   +P+L  DK          QC+  + K
Sbjct: 213 YDSWGTPFQQLKQ-VVEEPSPQLPADKFSAEFVDFTSQCLKKNSK 256

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 96.3 bits (240), Expect = 2e-23
 Identities = 50/265 (18%), Positives = 96/265 (36%), Gaps = 43/265 (16%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAY----EFATMGSLHDILHGRKGVQGAQPGPVL 92
             +     H N++ L+ YC+              F   G+L + +   K       G  L
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLK-----DKGNFL 131

Query: 93  DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
                + + +   RGLE +H        HRD++ +N+LL ++ +  + D    NQA    
Sbjct: 132 TEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188

Query: 153 ARLHSTRVL-------GTFGYHAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                   L        T  Y APE      + +   + +++DV+S G VL  ++ G  P
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV---IDERTDVWSLGCVLYAMMFGEGP 245

Query: 200 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR 259
            D    +G    +           V+  +       +       L  +    +  +   R
Sbjct: 246 YDMVFQKGDSVAL----------AVQNQLSIPQSPRHSS----ALWQLLNSMMTVDPHQR 291

Query: 260 PNMSIVVKALQPLLKSPPPAAPVSE 284
           P++ +++  L+  L+ P P    ++
Sbjct: 292 PHIPLLLSQLE-ALQPPAPGQHTTQ 315

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 96.7 bits (241), Expect = 3e-23
 Identities = 44/179 (24%), Positives = 70/179 (39%), Gaps = 41/179 (22%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVL-AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
            ++    H N++ LLG C+      L    +   G L + +                   
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--------HNPTVKD 193

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            +   +  A+G+++L  K     +HRD+ + N +L E F  K+ADF L+           
Sbjct: 194 LIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA----------- 239

Query: 157 STRVLGTFGYH---------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
             R +    +                A E   T + T KSDV+SFGV+L EL+T G  P
Sbjct: 240 --RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 95.9 bits (239), Expect = 3e-23
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 33/218 (15%)

Query: 30  PDDEKQLVSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP 88
             +  + +S++ +    ++V+  G Y    +L ++  E+   GS+ DI+  R        
Sbjct: 68  LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM-EYCGAGSVSDIIRLRNKT----- 121

Query: 89  GPVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 145
                 +T   IA       +GLEYLH       IHRDI++ N+LL  +  AK+ADF ++
Sbjct: 122 ------LTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA 172

Query: 146 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 205
            Q  D  A+ ++  V+GT  + APE          +D++S G+  +E+  G+ P     P
Sbjct: 173 GQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230

Query: 206 -RGQQSLVTWATPRLSEDK---------VKQC--VDPK 231
            R    + T   P   + +         VKQC    P+
Sbjct: 231 MRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPE 268

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 95.8 bits (239), Expect = 4e-23
 Identities = 48/191 (25%), Positives = 79/191 (41%), Gaps = 45/191 (23%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ---------- 87
           +V+ ++ H ++++L G C +    +L  E+A  GSL   L   + V              
Sbjct: 78  NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137

Query: 88  -----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                    L     +  A   ++G++YL E     ++HRD+ + N+L+ E  K KI+DF
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDF 194

Query: 143 NLSNQAPDMAARLHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVV 189
            LS             R +     +             A E       T +SDV+SFGV+
Sbjct: 195 GLS-------------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241

Query: 190 LLELLT-GRKP 199
           L E++T G  P
Sbjct: 242 LWEIVTLGGNP 252

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 93.9 bits (234), Expect = 1e-22
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 39/222 (17%)

Query: 30  PDDEKQL----VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
              +K+L    + V+   K+ N+V  L  Y V   L V+  E+   GSL D++       
Sbjct: 57  QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETC--- 112

Query: 85  GAQPGPVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
                     M   +IA    +  + LE+LH      +IHRDI+S N+LL  D   K+ D
Sbjct: 113 ----------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 159

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           F    Q     ++  +  ++GT  + APE         K D++S G++ +E++ G  P  
Sbjct: 160 FGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217

Query: 202 HTMP-RGQQSLVTWATPRLSE---------DKVKQC--VDPK 231
           +  P R    + T  TP L           D + +C  +D +
Sbjct: 218 NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVE 259

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 93.4 bits (233), Expect = 1e-22
 Identities = 54/171 (31%), Positives = 77/171 (45%), Gaps = 21/171 (12%)

Query: 33  EKQL---VSVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQGAQP 88
           E QL   V + S L+H N++ L GY      RV L  E+A +G+++  L         + 
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL--------QKL 103

Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
               +  T      + A  L Y H K    +IHRDI+  N+LL    + KIADF  S  A
Sbjct: 104 SKFDEQRTA-TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159

Query: 149 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           P       +  + GT  Y  PE        +K D++S GV+  E L G+ P
Sbjct: 160 PS---SRRTD-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 93.0 bits (232), Expect = 2e-22
 Identities = 50/174 (28%), Positives = 76/174 (43%), Gaps = 18/174 (10%)

Query: 30  PDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQG 85
               +++   V +  +LKH +++EL  Y  E +  V L  E    G ++  L        
Sbjct: 52  AGMVQRVQNEVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLK------- 103

Query: 86  AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 145
            +  P  +   R         G+ YLH      I+HRD+  SN+LL  +   KIADF L+
Sbjct: 104 NRVKPFSENEAR-HFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLA 159

Query: 146 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            Q      + ++    GT  Y +PE A       +SDV+S G +   LL GR P
Sbjct: 160 TQLKMPHEKHYTL--CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 93.9 bits (234), Expect = 2e-22
 Identities = 50/184 (27%), Positives = 77/184 (41%), Gaps = 44/184 (23%)

Query: 44  KHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--------------HGRKGVQGAQPG 89
            HEN+V LLG C       L +E+   G L + L                +K ++  +  
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 90  PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 149
            VL +   +  A   A+G+E+L  K   S +HRD+ + NVL+      KI DF L+    
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA---- 219

Query: 150 DMAARLHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT- 195
                    R + +   +             APE    G  T KSDV+S+G++L E+ + 
Sbjct: 220 ---------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270

Query: 196 GRKP 199
           G  P
Sbjct: 271 GVNP 274

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 93.0 bits (231), Expect = 4e-22
 Identities = 45/204 (22%), Positives = 78/204 (38%), Gaps = 22/204 (10%)

Query: 6   CCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAY 65
               Q E      ++E    P + P         + R+   +    +G     + +V  Y
Sbjct: 78  PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLY 137

Query: 66  ---EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR 122
              +     +L D ++ R  ++  + G  L    ++      A  +E+LH K    ++HR
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQI------AEAVEFLHSK---GLMHR 188

Query: 123 DIRSSNVLLFEDFKAKIADFNLS----------NQAPDMAARLHSTRVLGTFGYHAPEYA 172
           D++ SN+    D   K+ DF L                M A    T  +GT  Y +PE  
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248

Query: 173 MTGQLTQKSDVYSFGVVLLELLTG 196
                + K D++S G++L ELL  
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYS 272

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 92.3 bits (229), Expect = 1e-21
 Identities = 31/178 (17%), Positives = 55/178 (30%), Gaps = 18/178 (10%)

Query: 33  EKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL 92
             QL+  +        ++     +  N  VL  E  + G+L + ++  K      P  V+
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK----NTPEKVM 169

Query: 93  DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA-----------KIAD 141
                +  A+     +E +H+     IIH DI+  N +L   F              + D
Sbjct: 170 PQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
              S            T    T G+   E         + D +     +  +L G   
Sbjct: 227 LGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 91.2 bits (227), Expect = 1e-21
 Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 33/223 (14%)

Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRK 81
           L+  ++  +D +Q ++V+S+     + +  G Y  +  L ++  E+   GS  D+L    
Sbjct: 57  LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM-EYLGGGSALDLL---- 111

Query: 82  GVQGAQPGPVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
                +PGP    +   +IA    +  +GL+YLH +     IHRDI+++NVLL E  + K
Sbjct: 112 -----EPGP----LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVK 159

Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 198
           +ADF ++ Q  D   + ++   +GT  + APE         K+D++S G+  +EL  G  
Sbjct: 160 LADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP 217

Query: 199 PVDHTMP-RGQQSLVTWATPRLSE-------DKVKQC--VDPK 231
           P     P +    +     P L         + V+ C   +P 
Sbjct: 218 PHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS 260

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 91.2 bits (227), Expect = 1e-21
 Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 42/227 (18%)

Query: 30  PDDEKQL----VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
            ++E +     + +++   H  +V+LLG Y  +G L ++  EF   G++  I+       
Sbjct: 56  SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI-EFCPGGAVDAIMLELDRG- 113

Query: 85  GAQPGPVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
                     +T  +I V        L +LH K    IIHRD+++ NVL+  +   ++AD
Sbjct: 114 ----------LTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLAD 160

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLELLTG 196
           F +S +      +  S   +GT  + APE  M   +       K+D++S G+ L+E+   
Sbjct: 161 FGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

Query: 197 RKPVDHTMP-RGQQSLVTWATPRLSE---------DKVKQC--VDPK 231
             P     P R    +     P L           D +K     +P+
Sbjct: 219 EPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPE 265

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 93.4 bits (232), Expect = 1e-21
 Identities = 31/176 (17%), Positives = 64/176 (36%), Gaps = 29/176 (16%)

Query: 40  VSRLKHENLVELLGYCVEGNLRVLAYEFATM-----GSLHDILHGRKGVQGAQPGPVLDW 94
           ++ + H ++V++  +    +       +  M      SL      +           L  
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----------LPV 181

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
              +   ++    L YLH      +++ D++  N++L E+ + K+ D           +R
Sbjct: 182 AEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA-------VSR 230

Query: 155 LHST-RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 209
           ++S   + GT G+ APE       T  +D+Y+ G  L  L       +     G  
Sbjct: 231 INSFGYLYGTPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP 285

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 91.2 bits (227), Expect = 2e-21
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 26/210 (12%)

Query: 30  PDDEKQLV---SVVSRL-KHENLVELLG-YCVEGNLRVLAYEFATM-GSLHDILHGRKGV 83
             ++KQL+    VV R      +V+  G    EG+   +  E   M  S          V
Sbjct: 61  EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC-WICMEL--MSTSFDKFYKYVYSV 117

Query: 84  QGAQ-PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                P  +L      +I +   + L +L E ++  IIHRDI+ SN+LL      K+ DF
Sbjct: 118 LDDVIPEEIL-----GKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDF 170

Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPE----YAMTGQLTQKSDVYSFGVVLLELLTGRK 198
            +S Q  D  A+   TR  G   Y APE     A       +SDV+S G+ L EL TGR 
Sbjct: 171 GISGQLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227

Query: 199 PVD--HTMPRGQQSLVTWATPRLSEDKVKQ 226
           P    +++      +V    P+LS  + ++
Sbjct: 228 PYPKWNSVFDQLTQVVKGDPPQLSNSEERE 257

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 91.8 bits (228), Expect = 3e-21
 Identities = 35/165 (21%), Positives = 64/165 (38%), Gaps = 21/165 (12%)

Query: 44  KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVD 103
           +H N++       +   + +A E     +L + +         Q       +  + +   
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--------EQKDFAHLGLEPITLLQQ 126

Query: 104 AARGLEYLHEKVQPSIIHRDIRSSNVLLFE-----DFKAKIADFNLSNQ-APDMAARLHS 157
              GL +LH     +I+HRD++  N+L+         KA I+DF L  + A    +    
Sbjct: 127 TTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183

Query: 158 TRVLGTFGYHAPEY---AMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           + V GT G+ APE          T   D++S G V   +++    
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 90.5 bits (225), Expect = 3e-21
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 39/222 (17%)

Query: 30  PDDEKQL----VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 84
               ++L    V ++   +H N+VE+   Y V   L VL  EF   G+L DI+   +   
Sbjct: 82  KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM-EFLQGGALTDIVSQVR--- 137

Query: 85  GAQPGPVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
                     +   +IA       + L YLH +    +IHRDI+S ++LL  D + K++D
Sbjct: 138 ----------LNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSD 184

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           F    Q      +  S  ++GT  + APE         + D++S G++++E++ G  P  
Sbjct: 185 FGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF 242

Query: 202 HTMP-RGQQSLVTWATPRLSE---------DKVKQC--VDPK 231
              P +  + L     P+L           D +++    DP+
Sbjct: 243 SDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQ 284

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 90.1 bits (224), Expect = 4e-21
 Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 40/226 (17%)

Query: 30  PDDEKQLV---SVVSRL-KHENLVELLG-YCVEGNLRVLAYEFATMG-SLHDILHGRKGV 83
            ++ K+++    VV +      +V+  G +    ++  +A E   MG     +    K +
Sbjct: 64  KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV-FIAMEL--MGTCAEKLK---KRM 117

Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
           QG  P  +L      ++ V   + L YL EK    +IHRD++ SN+LL E  + K+ DF 
Sbjct: 118 QGPIPERIL-----GKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFG 170

Query: 144 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLELLTGRK 198
           +S +  D  A+    R  G   Y APE       T+     ++DV+S G+ L+EL TG+ 
Sbjct: 171 ISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227

Query: 199 PVD--HTMPRGQQSLVTWATPRLSEDK---------VKQCV--DPK 231
           P     T       ++    P L             VK C+  D +
Sbjct: 228 PYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHR 273

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 89.2 bits (222), Expect = 5e-21
 Identities = 51/171 (29%), Positives = 74/171 (43%), Gaps = 21/171 (12%)

Query: 33  EKQL---VSVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQGAQP 88
           E QL   + + S L+H N++ +  Y      R+ L  EFA  G L+  L         + 
Sbjct: 58  EHQLRREIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL--------QKH 108

Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
           G   +  +      + A  L Y HE+    +IHRDI+  N+L+    + KIADF  S  A
Sbjct: 109 GRFDEQRSA-TFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHA 164

Query: 149 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           P    R  +    GT  Y  PE        +K D++  GV+  E L G  P
Sbjct: 165 PS--LRRRTM--CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 89.7 bits (223), Expect = 5e-21
 Identities = 42/182 (23%), Positives = 66/182 (36%), Gaps = 20/182 (10%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRL----KHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL 77
           R  SP   P D  + ++ V       +H   V L     EG +  L  E     SL    
Sbjct: 89  RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHC 147

Query: 78  HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
                      G  L          D    L +LH +    ++H D++ +N+ L    + 
Sbjct: 148 E--------AWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRC 196

Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 197
           K+ DF L  +     A     +  G   Y APE  + G     +DV+S G+ +LE+    
Sbjct: 197 KLGDFGLLVELGTAGAG--EVQE-GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNM 252

Query: 198 KP 199
           + 
Sbjct: 253 EL 254

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 89.3 bits (222), Expect = 6e-21
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 17/211 (8%)

Query: 31  DDEKQLVSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG 89
           D+  + +  +S+  H N+V     + V+  L ++  +  + GS+ DI+         + G
Sbjct: 58  DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM-KLLSGGSVLDIIKHIVAKGEHKSG 116

Query: 90  PVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 146
                +    IA    +   GLEYLH+      IHRD+++ N+LL ED   +IADF +S 
Sbjct: 117 V----LDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169

Query: 147 Q-APDMAARLHSTR--VLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDH 202
             A       +  R   +GT  + APE     +    K+D++SFG+  +EL TG  P   
Sbjct: 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229

Query: 203 TMP-RGQQSLVTWATPRLSEDKVKQCVDPKL 232
             P +     +    P L      + +  K 
Sbjct: 230 YPPMKVLMLTLQNDPPSLETGVQDKEMLKKY 260

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 90.0 bits (223), Expect = 8e-21
 Identities = 35/187 (18%), Positives = 61/187 (32%), Gaps = 25/187 (13%)

Query: 24  KSPKNYPDDEKQLVSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKG 82
                     +  + V     H N+V     +  +  L V+   F   GS  D++     
Sbjct: 64  ACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV-TSFMAYGSAKDLICTHF- 121

Query: 83  VQGAQPGPVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
                       M  + IA       + L+Y+H       +HR +++S++L+  D K  +
Sbjct: 122 -----MDG----MNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYL 169

Query: 140 ADFNLSNQAPDMAARLHSTRVL-----GTFGYHAPEYAMTGQL--TQKSDVYSFGVVLLE 192
           +    +        R                + +PE           KSD+YS G+   E
Sbjct: 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229

Query: 193 LLTGRKP 199
           L  G  P
Sbjct: 230 LANGHVP 236

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 88.5 bits (220), Expect = 1e-20
 Identities = 35/179 (19%), Positives = 68/179 (37%), Gaps = 27/179 (15%)

Query: 37  VSVVSRLKHENL--VELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           ++ +++L+  +   + L  Y +      +  E      L+  L  +K          +D 
Sbjct: 77  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDP 126

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             R     +    +  +H+     I+H D++ +N  L  D   K+ DF ++NQ       
Sbjct: 127 WERKSYWKNMLEAVHTIHQH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTS 182

Query: 155 LHSTRVLGTFGYHAPE-----------YAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 202
           +     +GT  Y  PE                +++ KSDV+S G +L  +  G+ P   
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 88.6 bits (220), Expect = 2e-20
 Identities = 35/179 (19%), Positives = 69/179 (38%), Gaps = 27/179 (15%)

Query: 37  VSVVSRLKH--ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           ++ +++L+   + ++ L  Y +      +  E      L+  L  +K          +D 
Sbjct: 58  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDP 107

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             R     +    +  +H+     I+H D++ +N  L  D   K+ DF ++NQ       
Sbjct: 108 WERKSYWKNMLEAVHTIHQH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTS 163

Query: 155 LHSTRVLGTFGYHAPE-----------YAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 202
           +     +GT  Y  PE                +++ KSDV+S G +L  +  G+ P   
Sbjct: 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 87.0 bits (216), Expect = 4e-20
 Identities = 43/186 (23%), Positives = 70/186 (37%), Gaps = 37/186 (19%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAY-------------EFATMGSLHDILHGRKGV 83
           V +++ L H+ +V      +E    V                E+   G+L+D++H     
Sbjct: 53  VMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN 112

Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
           Q  Q         ++         L Y+H +    IIHRD++  N+ + E    KI DF 
Sbjct: 113 Q--QRDEYWRLFRQI------LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFG 161

Query: 144 LSNQAPDMAARLHS------------TRVLGTFGYHAPE-YAMTGQLTQKSDVYSFGVVL 190
           L+         L              T  +GT  Y A E    TG   +K D+YS G++ 
Sbjct: 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF 221

Query: 191 LELLTG 196
            E++  
Sbjct: 222 FEMIYP 227

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 88.2 bits (218), Expect = 5e-20
 Identities = 21/193 (10%), Positives = 57/193 (29%), Gaps = 18/193 (9%)

Query: 39  VVSRLKHENLVELLG----YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           +V   + + ++ +        V     +     + + +  ++L        +     L  
Sbjct: 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-----LVH 210

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             R+++ +   R L  LH      ++H  +R  +++L +     +  F         +A 
Sbjct: 211 HARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL-VRDGASAV 266

Query: 155 LHSTRVLGTFGYHAPE-----YAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 209
               R        A             +T   D ++ G+ +  +     P       G  
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326

Query: 210 SLVTWATPRLSED 222
             +  +   + + 
Sbjct: 327 EWIFRSCKNIPQP 339

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 87.6 bits (217), Expect = 7e-20
 Identities = 34/179 (18%), Positives = 67/179 (37%), Gaps = 27/179 (15%)

Query: 37  VSVVSRLKHENL--VELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           ++ +++L+  +   + L  Y +      +  E      L+  L  +K          +D 
Sbjct: 105 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDP 154

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             R     +    +  +H+     I+H D++ +N  L  D   K+ DF ++NQ       
Sbjct: 155 WERKSYWKNMLEAVHTIHQH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTS 210

Query: 155 LHSTRVLGTFGYHAPE-----------YAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 202
           +     +G   Y  PE                +++ KSDV+S G +L  +  G+ P   
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 85.3 bits (212), Expect = 1e-19
 Identities = 48/184 (26%), Positives = 76/184 (41%), Gaps = 35/184 (19%)

Query: 30  PDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQG 85
           P   +++   +S+   L H+++V   G+  E N  V +  E     SL ++   RK    
Sbjct: 56  PHQREKMSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK---- 110

Query: 86  AQPGPVLDWMTRVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
                         +    AR        G +YLH      +IHRD++  N+ L ED + 
Sbjct: 111 -------------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEV 154

Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 197
           KI DF L+ +      R       GT  Y APE       + + DV+S G ++  LL G+
Sbjct: 155 KIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

Query: 198 KPVD 201
            P +
Sbjct: 213 PPFE 216

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 85.9 bits (213), Expect = 1e-19
 Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 41/227 (18%)

Query: 31  DDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAY------EFATMGSLHDILHGRKGV 83
           ++ KQ ++++ +   H N+    G  ++ N   +        EF   GS+ D++   KG 
Sbjct: 65  EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG- 123

Query: 84  QGAQPGPVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 140
                      +    IA    +  RGL +LH+     +IHRDI+  NVLL E+ + K+ 
Sbjct: 124 -----NT----LKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 171

Query: 141 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLELLT 195
           DF +S Q      R ++   +GT  + APE     +        KSD++S G+  +E+  
Sbjct: 172 DFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229

Query: 196 GRKPVDHTMP-RGQQSLVTWATPRLSEDK--------VKQC--VDPK 231
           G  P+    P R    +     PRL   K        ++ C   +  
Sbjct: 230 GAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHS 276

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 24/188 (12%)

Query: 27  KNYPDDEKQL---VSVVSRLKHENLVELL------GYCVEGNLRVLAYEFATMGSLHDIL 77
           +  P + ++    + ++ +L H N+V               +L +LA E+   G L   L
Sbjct: 50  ELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL 109

Query: 78  HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
           +  +   G      L       +  D +  L YLHE     IIHRD++  N++L    + 
Sbjct: 110 NQFENCCG------LKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQR 160

Query: 138 ---KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELL 194
              KI D   + +       L +  V GT  Y APE     + T   D +SFG +  E +
Sbjct: 161 LIHKIIDLGYAKELDQ--GELCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECI 217

Query: 195 TGRKPVDH 202
           TG +P   
Sbjct: 218 TGFRPFLP 225

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 85.0 bits (211), Expect = 3e-19
 Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 35/182 (19%)

Query: 30  PDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQG 85
           P   +++   +S+   L H+++V   G+  E N  V +  E     SL ++   RK    
Sbjct: 82  PHQREKMSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK---- 136

Query: 86  AQPGPVLDWMTRVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
                         +    AR        G +YLH      +IHRD++  N+ L ED + 
Sbjct: 137 -------------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEV 180

Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 197
           KI DF L+ +      R       GT  Y APE       + + DV+S G ++  LL G+
Sbjct: 181 KIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

Query: 198 KP 199
            P
Sbjct: 239 PP 240

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 84.4 bits (209), Expect = 6e-19
 Identities = 55/228 (24%), Positives = 89/228 (39%), Gaps = 52/228 (22%)

Query: 30  PDDEKQL----VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATM----GSLHDILHGR 80
            +++ Q     V  + +L+H N ++  G Y  E    ++      M    GS  D+L   
Sbjct: 94  SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV------MEYCLGSASDLLEVH 147

Query: 81  KGVQGAQPGPVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
           K             +  V IA     A +GL YLH     ++IHRD+++ N+LL E    
Sbjct: 148 KKP-----------LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLV 193

Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ---KSDVYSFGVVLLELL 194
           K+ DF  ++    MA        +GT  + APE  +     Q   K DV+S G+  +EL 
Sbjct: 194 KLGDFGSASI---MAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247

Query: 195 TGRKPVDHTMP-RGQQSLVTWATPRLSEDK--------VKQC--VDPK 231
             + P+ +         +    +P L            V  C    P+
Sbjct: 248 ERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQ 295

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 83.3 bits (206), Expect = 1e-18
 Identities = 45/203 (22%), Positives = 73/203 (35%), Gaps = 30/203 (14%)

Query: 27  KNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLR--VLAYEFATMGSLHDILHGRK 81
            ++            V+ +L H+N+V+L     E   R  VL  EF   GSL+ +L    
Sbjct: 45  ISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS 104

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF----EDFKA 137
              G      L  +  V        G+ +L E     I+HR+I+  N++           
Sbjct: 105 NAYGLPESEFLIVLRDV------VGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVY 155

Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE--------YAMTGQLTQKSDVYSFGVV 189
           K+ DF  + +  D   +  S  + GT  Y  P+             +     D++S GV 
Sbjct: 156 KLTDFGAARELED-DEQFVS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212

Query: 190 LLELLTGRKP-VDHTMPRGQQSL 211
                TG  P      PR  + +
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEV 235

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 83.9 bits (207), Expect = 1e-18
 Identities = 23/201 (11%), Positives = 62/201 (30%), Gaps = 29/201 (14%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNL--RVLAYEFA--TMGSLHDILHGRKGVQGAQPGPVL 92
             +V   + + ++ +     +  +  R   Y      + +  ++L        +     L
Sbjct: 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-----L 203

Query: 93  DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
               R+++ +   R L  LH      ++H  +R  +++L +     +  F    +     
Sbjct: 204 VHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG--- 257

Query: 153 ARLHSTRVLGTFGYHAPEYAMT-----------GQLTQKSDVYSFGVVLLELLTGRKPVD 201
                     + G+  PE                 +T   D ++ G+V+  +     P+ 
Sbjct: 258 ---ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314

Query: 202 HTMPRGQQSLVTWATPRLSED 222
                G    +  +   + + 
Sbjct: 315 KDAALGGSEWIFRSCKNIPQP 335

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 82.3 bits (204), Expect = 2e-18
 Identities = 53/181 (29%), Positives = 84/181 (46%), Gaps = 33/181 (18%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           ++++ +L H N+V+L    V         +      L+ +            GPV++  T
Sbjct: 87  IAILKKLDHPNVVKL--VEV--------LDDPNEDHLYMVFELVNQ------GPVMEVPT 130

Query: 97  RVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
              ++ D AR        G+EYLH +    IIHRDI+ SN+L+ ED   KIADF +SN+ 
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 149 PDMAARLHSTRVLGTFGYHAPEYAMTGQLT---QKSDVYSFGVVLLELLTGRKP-VDHTM 204
               A L +T   GT  + APE     +     +  DV++ GV L   + G+ P +D  +
Sbjct: 188 KGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245

Query: 205 P 205
            
Sbjct: 246 M 246

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 37/179 (20%), Positives = 68/179 (37%), Gaps = 28/179 (15%)

Query: 43  LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 102
             H N++             +A E     +L D++  +      +   +      + +  
Sbjct: 66  DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKN--VSDENLKLQKEYNPISLLR 122

Query: 103 DAARGLEYLHEKVQPSIIHRDIRSSNVLL-------------FEDFKAKIADFNLSNQ-- 147
             A G+ +LH      IIHRD++  N+L+              E+ +  I+DF L  +  
Sbjct: 123 QIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

Query: 148 APDMAARLHSTRVLGTFGYHAPE-------YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +   + R +     GT G+ APE            +LT+  D++S G V   +L+  K 
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 82.4 bits (203), Expect = 4e-18
 Identities = 20/152 (13%), Positives = 39/152 (25%), Gaps = 13/152 (8%)

Query: 61  RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSII 120
            +L    A+   L   L           G     +    +     R    L  K    ++
Sbjct: 163 YLLLMPAAS-VDLEL-LFSTLDFVYVFRGD-EGILALHILTAQLIRLAANLQSK---GLV 216

Query: 121 HRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM--TGQLT 178
           H      N+ +  D +  + D +   +                  Y   E+    T   T
Sbjct: 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFT 271

Query: 179 QKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 210
              + +  G+ +  +     P     P  + S
Sbjct: 272 HALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 82.2 bits (203), Expect = 5e-18
 Identities = 45/203 (22%), Positives = 73/203 (35%), Gaps = 30/203 (14%)

Query: 27  KNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLR--VLAYEFATMGSLHDILHGRK 81
            ++            V+ +L H+N+V+L     E   R  VL  EF   GSL+ +L    
Sbjct: 45  ISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS 104

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF----EDFKA 137
              G      L  +  V        G+ +L E     I+HR+I+  N++           
Sbjct: 105 NAYGLPESEFLIVLRDV------VGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVY 155

Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE--------YAMTGQLTQKSDVYSFGVV 189
           K+ DF  + +  D   +  S  + GT  Y  P+             +     D++S GV 
Sbjct: 156 KLTDFGAARELED-DEQFVS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212

Query: 190 LLELLTGRKP-VDHTMPRGQQSL 211
                TG  P      PR  + +
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEV 235

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 80.8 bits (200), Expect = 5e-18
 Identities = 44/242 (18%), Positives = 81/242 (33%), Gaps = 51/242 (21%)

Query: 22  RLKSPKNYPDDEKQL---VSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL 77
           R K P     DE+     V   + L +H ++V       E +  ++  E+   GSL D +
Sbjct: 43  RSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI 102

Query: 78  HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED--- 134
                +        L       + +   RGL Y+H     S++H DI+ SN+ +      
Sbjct: 103 SENYRIMSYFKEAEL-----KDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIP 154

Query: 135 ----------------FKAKIADFNLSNQAPDMAARLHSTRVL-GTFGYHAPE-YAMTGQ 176
                              KI D            R+ S +V  G   + A E       
Sbjct: 155 NAASEEGDEDDWASNKVMFKIGDLGH-------VTRISSPQVEEGDSRFLANEVLQENYT 207

Query: 177 LTQKSDVYSFGVVLLELLTGRKPVD-----HTMPRGQQSLVTWATPRLSE---DKVKQCV 228
              K+D+++  + ++               H + +G+   +      LS+   + +K  +
Sbjct: 208 HLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRI---PQVLSQEFTELLKVMI 264

Query: 229 DP 230
            P
Sbjct: 265 HP 266

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 81.0 bits (200), Expect = 9e-18
 Identities = 39/190 (20%), Positives = 66/190 (34%), Gaps = 28/190 (14%)

Query: 31  DDEKQLVSVVSRLK-HENLVELLGYCV-------EGNLRVLAYEFATMGSLHDILHGRKG 82
               Q V  + +L  H N+V+              G    L       G L + L   + 
Sbjct: 70  RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES 129

Query: 83  VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
                   VL             R ++++H + +P IIHRD++  N+LL      K+ DF
Sbjct: 130 RGPLSCDTVLKIFY------QTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDF 182

Query: 143 NLSNQA---PDMAARLHSTRVL-------GTFGYHAPE---YAMTGQLTQKSDVYSFGVV 189
             +      PD +       ++        T  Y  PE         + +K D+++ G +
Sbjct: 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242

Query: 190 LLELLTGRKP 199
           L  L   + P
Sbjct: 243 LYLLCFRQHP 252

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 53/184 (28%), Positives = 78/184 (42%), Gaps = 26/184 (14%)

Query: 24  KSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD--ILH 78
           K       D++ L   V ++ +L H N+++L  +  +     L  E  T G L D  I  
Sbjct: 61  KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR 120

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDF 135
            R     A            RI      G+ Y+H+     I+HRD++  N+LL    +D 
Sbjct: 121 KRFSEVDAA-----------RIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDA 166

Query: 136 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
             +I DF LS               +GT  Y APE  + G   +K DV+S GV+L  LL+
Sbjct: 167 NIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS 222

Query: 196 GRKP 199
           G  P
Sbjct: 223 GCPP 226

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 51/188 (27%), Positives = 77/188 (40%), Gaps = 26/188 (13%)

Query: 20  NERLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD- 75
                  KN     +++   +S++  L H N+++L     +     L  EF   G L + 
Sbjct: 77  GRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQ 136

Query: 76  -ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF-- 132
            I   +     A             I      G+ YLH+    +I+HRDI+  N+LL   
Sbjct: 137 IINRHKFDECDAA-----------NIMKQILSGICYLHKH---NIVHRDIKPENILLENK 182

Query: 133 -EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLL 191
                 KI DF LS+       +L     LGT  Y APE  +  +  +K DV+S GV++ 
Sbjct: 183 NSLLNIKIVDFGLSSFFSK-DYKLRD--RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMY 238

Query: 192 ELLTGRKP 199
            LL G  P
Sbjct: 239 ILLCGYPP 246

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 73.6 bits (181), Expect = 6e-15
 Identities = 50/168 (29%), Positives = 72/168 (42%), Gaps = 23/168 (13%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD--ILHGRKGVQGAQPGPVLDW 94
           V+V+  L H N+++L  +  +     L  E    G L D  I   +     A        
Sbjct: 87  VAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA------- 139

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDM 151
                I      G+ YLH+    +I+HRD++  N+LL    +D   KI DF LS    + 
Sbjct: 140 ----VIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192

Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                    LGT  Y APE  +  +  +K DV+S GV+L  LL G  P
Sbjct: 193 KKM---KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 71.9 bits (176), Expect = 1e-14
 Identities = 33/113 (29%), Positives = 50/113 (44%), Gaps = 4/113 (3%)

Query: 88  PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 147
               L     +  +   A+G+E+L  +     IHRD+ + N+LL E    KI DF L+  
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 242

Query: 148 APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 199
                  +          + APE       T +SDV+SFGV+L E+ + G  P
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 71.8 bits (176), Expect = 1e-14
 Identities = 47/216 (21%), Positives = 69/216 (31%), Gaps = 43/216 (19%)

Query: 24  KSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR 80
           K  +  P D +++   V ++ +L H N+  L     +     L  E    G L D L+  
Sbjct: 63  KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122

Query: 81  KGVQGAQPGPVLDWMTRVRIAV------------------------DAAR-------GLE 109
                 +    +                                    +         L 
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182

Query: 110 YLHEKVQPSIIHRDIRSSNVLLF--EDFKAKIADFNLSN--QAPDMAARLHSTRVLGTFG 165
           YLH +    I HRDI+  N L    + F+ K+ DF LS      +       T   GT  
Sbjct: 183 YLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239

Query: 166 YHAPE--YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           + APE           K D +S GV+L  LL G  P
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 70.5 bits (173), Expect = 2e-14
 Identities = 36/243 (14%), Positives = 63/243 (25%), Gaps = 54/243 (22%)

Query: 40  VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVR 99
           +SR+    +  +L         ++  E+   GSL ++        GA           +R
Sbjct: 85  LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA-----------IR 133

Query: 100 IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR 159
                A   +  H      +       S V +  D                         
Sbjct: 134 AMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVV--------------------- 169

Query: 160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 219
            L                  + D+   G  L  LL  R P+     R   S +  A    
Sbjct: 170 -LAYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVR---SGLAPAERDT 218

Query: 220 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA 279
           +         P    +       +++AVAA  VQ +   R   S ++  +Q         
Sbjct: 219 AG-------QPIEPADIDRDIPFQISAVAARSVQGDGGIRSA-STLLNLMQQATAVADRT 270

Query: 280 APV 282
             +
Sbjct: 271 EVL 273

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 70.4 bits (173), Expect = 3e-14
 Identities = 35/124 (28%), Positives = 54/124 (43%), Gaps = 17/124 (13%)

Query: 91  VLDWMTRVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 142
           +LD +   R  V  A         GLEYLH +    I+H+DI+  N+LL      KI+  
Sbjct: 97  MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISAL 153

Query: 143 NLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTGQL--TQKSDVYSFGVVLLELLTGRK 198
            ++      AA     +++  G+  +  PE A         K D++S GV L  + TG  
Sbjct: 154 GVAEALHPFAADDTCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLY 211

Query: 199 PVDH 202
           P + 
Sbjct: 212 PFEG 215

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 69.6 bits (171), Expect = 7e-14
 Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 10/102 (9%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            ++Y H+K    I+HRD+++ N+LL  D   KIADF  SN+              G   Y
Sbjct: 126 AVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFC-GAPPY 179

Query: 167 HAPEYAMTGQL--TQKSDVYSFGVVLLELLTGRKP-VDHTMP 205
            APE    G+     + DV+S GV+L  L++G  P     + 
Sbjct: 180 AAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 70.1 bits (172), Expect = 8e-14
 Identities = 44/171 (25%), Positives = 68/171 (39%), Gaps = 26/171 (15%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD--ILHGRKGVQGAQPGPVLDW 94
           + ++ +L H  ++++  +    +   +  E    G L D  + + R      +       
Sbjct: 191 IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK------- 242

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDM 151
                        ++YLHE     IIHRD++  NVLL    ED   KI DF  S    + 
Sbjct: 243 ----LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295

Query: 152 AARLHSTRVLGTFGYHAPE---YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +  L  T   GT  Y APE      T    +  D +S GV+L   L+G  P
Sbjct: 296 S--LMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 68.4 bits (168), Expect = 1e-13
 Identities = 50/193 (25%), Positives = 74/193 (38%), Gaps = 47/193 (24%)

Query: 24  KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 83
           KSP       +  ++V+ ++KHEN+V L           L  +  + G L D        
Sbjct: 44  KSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFD-------- 95

Query: 84  QGAQPGPVLDWMTRVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIRSSNV 129
                          RI         DA+         ++YLHE     I+HRD++  N+
Sbjct: 96  ---------------RILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENL 137

Query: 130 LLF---EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSF 186
           L     E+ K  I DF LS    +    + +    GT GY APE       ++  D +S 
Sbjct: 138 LYLTPEENSKIMITDFGLSKMEQN--GIMST--ACGTPGYVAPEVLAQKPYSKAVDCWSI 193

Query: 187 GVVLLELLTGRKP 199
           GV+   LL G  P
Sbjct: 194 GVITYILLCGYPP 206

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 68.4 bits (168), Expect = 1e-13
 Identities = 51/180 (28%), Positives = 75/180 (41%), Gaps = 41/180 (22%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + +   L HEN+V+  G+  EGN++ L  E+ + G L D +                   
Sbjct: 56  ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----------------EP 98

Query: 97  RVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
            + +    A+        G+ YLH      I HRDI+  N+LL E    KI+DF L+   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155

Query: 149 PD-MAARLHSTRVLGTFGYHAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
                 RL +    GT  Y APE      +       +  DV+S G+VL  +L G  P D
Sbjct: 156 RYNNRERLLNKMC-GTLPYVAPELLKRREFH--A---EPVDVWSCGIVLTAMLAGELPWD 209

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 50/168 (29%), Positives = 76/168 (45%), Gaps = 23/168 (13%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD--ILHGRKGVQGAQPGPVLDW 94
           V ++ +L H N+++L     + +   +  E  T G L D  I   R     A        
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA------- 124

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDM 151
               RI      G+ Y+H+    +I+HRD++  N+LL    +D   KI DF LS      
Sbjct: 125 ----RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ- 176

Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             ++     +GT  Y APE  + G   +K DV+S GV+L  LL+G  P
Sbjct: 177 NTKMKD--RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 67.3 bits (165), Expect = 4e-13
 Identities = 51/180 (28%), Positives = 75/180 (41%), Gaps = 41/180 (22%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + +   L HEN+V+  G+  EGN++ L  E+ + G L D +                   
Sbjct: 56  ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----------------EP 98

Query: 97  RVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
            + +    A+        G+ YLH      I HRDI+  N+LL E    KI+DF L+   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155

Query: 149 PD-MAARLHSTRVLGTFGYHAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
                 RL +    GT  Y APE      +       +  DV+S G+VL  +L G  P D
Sbjct: 156 RYNNRERLLNKMC-GTLPYVAPELLKRREFH--A---EPVDVWSCGIVLTAMLAGELPWD 209

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 67.3 bits (165), Expect = 6e-13
 Identities = 35/96 (36%), Positives = 48/96 (50%), Gaps = 9/96 (9%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            L+YL  +    IIHRD++  N+LL E     I DFN++   P       +T + GT  Y
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGTKPY 180

Query: 167 HAPE--YAMTGQLTQKS-DVYSFGVVLLELLTGRKP 199
            APE   +  G     + D +S GV   ELL GR+P
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 67.0 bits (164), Expect = 7e-13
 Identities = 28/92 (30%), Positives = 45/92 (48%), Gaps = 6/92 (6%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
            G+++LH      IIHRD++ SN+++  D   KI DF L   A         T  + T  
Sbjct: 138 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRY 191

Query: 166 YHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +     +  D++S G ++ E++ G 
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 65.5 bits (160), Expect = 2e-12
 Identities = 31/97 (31%), Positives = 46/97 (47%), Gaps = 9/97 (9%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            + YL  K    IIHRDI+  N+++ EDF  K+ DF  +        +L  T   GT  Y
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--GKLFYTFC-GTIEY 195

Query: 167 HAPEYAMTGQLTQ--KSDVYSFGVVLLELLTGRKPVD 201
            APE  + G   +  + +++S GV L  L+    P  
Sbjct: 196 CAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 46/195 (23%), Positives = 77/195 (39%), Gaps = 51/195 (26%)

Query: 26  PKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
              YP D+  +   +S++++L H  L+ L     +    VL  EF + G L D       
Sbjct: 85  NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD------- 137

Query: 83  VQGAQPGPVLDWMTRVRIA--------VDAAR-------GLEYLHEKVQPSIIHRDIRSS 127
                           RIA         +          GL+++HE    SI+H DI+  
Sbjct: 138 ----------------RIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPE 178

Query: 128 NVLLF--EDFKAKIADFNLSNQA-PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVY 184
           N++    +    KI DF L+ +  PD   ++       T  + APE      +   +D++
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDEIVKV----TTATAEFAAPEIVDREPVGFYTDMW 234

Query: 185 SFGVVLLELLTGRKP 199
           + GV+   LL+G  P
Sbjct: 235 AIGVLGYVLLSGLSP 249

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 65.4 bits (160), Expect = 2e-12
 Identities = 51/186 (27%), Positives = 68/186 (36%), Gaps = 46/186 (24%)

Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 90
              +  + V+ RL H N+++L           L  E  T G L D               
Sbjct: 93  KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFD--------------- 137

Query: 91  VLDWMTRVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIRSSNVLLF---E 133
                   RI         DAA         + YLHE     I+HRD++  N+L      
Sbjct: 138 --------RIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAP 186

Query: 134 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 193
           D   KIADF LS         L  T   GT GY APE         + D++S G++   L
Sbjct: 187 DAPLKIADFGLSKIVEH--QVLMKTVC-GTPGYCAPEILRGCAYGPEVDMWSVGIITYIL 243

Query: 194 LTGRKP 199
           L G +P
Sbjct: 244 LCGFEP 249

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 65.0 bits (159), Expect = 3e-12
 Identities = 38/97 (39%), Positives = 54/97 (55%), Gaps = 9/97 (9%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            +EY H      I+HRD++  N+LL ++   KIADF LSN   D    L ++   G+  Y
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTS--CGSPNY 173

Query: 167 HAPEYAMTGQLTQ--KSDVYSFGVVLLELLTGRKPVD 201
            APE  + G+L    + DV+S G+VL  +L GR P D
Sbjct: 174 AAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 65.7 bits (160), Expect = 3e-12
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 8/94 (8%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GLE++H +    +++RD++ +N+LL E    +I+D  L+              V GT GY
Sbjct: 304 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASV-GTHGY 356

Query: 167 HAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKP 199
            APE    G     S D +S G +L +LL G  P
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 65.1 bits (159), Expect = 3e-12
 Identities = 50/185 (27%), Positives = 71/185 (38%), Gaps = 52/185 (28%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAY--EFATMGSLHDIL--HGRKGVQGAQPGPVL 92
           +     L+H N+V      V      LA   E+A+ G L++ +   GR            
Sbjct: 67  IINHRSLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYERICNAGR------------ 112

Query: 93  DWMTRVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA--KIADF 142
                   + D AR        G+ Y H      I HRD++  N LL        KI DF
Sbjct: 113 -------FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDF 162

Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPE------YAMTGQLTQKSDVYSFGVVLLELLTG 196
             S  +    ++  ST  +GT  Y APE      Y   G+    +DV+S GV L  +L G
Sbjct: 163 GYSKSSVL-HSQPKST--VGTPAYIAPEVLLRQEYD--GK---IADVWSCGVTLYVMLVG 214

Query: 197 RKPVD 201
             P +
Sbjct: 215 AYPFE 219

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 65.0 bits (159), Expect = 3e-12
 Identities = 43/174 (24%), Positives = 66/174 (37%), Gaps = 21/174 (12%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
            S+   LKH ++VELL       +  + +EF     L   +  R               +
Sbjct: 77  ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR--------ADAGFVYS 128

Query: 97  RVRIAVDAAR----GLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAP 149
              +A    R     L Y H+    +IIHRD++   VLL         K+  F ++ Q  
Sbjct: 129 E-AVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184

Query: 150 DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT 203
           +          +GT  + APE        +  DV+  GV+L  LL+G  P   T
Sbjct: 185 ESGLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 65.2 bits (159), Expect = 3e-12
 Identities = 43/183 (23%), Positives = 77/183 (42%), Gaps = 27/183 (14%)

Query: 26  PKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
              +  D++ +   +  +S L+H  LV L     + N  V+ YEF + G L + +     
Sbjct: 191 MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 250

Query: 83  VQGAQPGPVLDWMTRVRIAVDAAR----GLEYLHEKVQPSIIHRDIRSSNVLLF--EDFK 136
                       M+    AV+  R    GL ++HE    + +H D++  N++       +
Sbjct: 251 K-----------MSE-DEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNE 295

Query: 137 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
            K+ DF L+     +  +       GT  + APE A    +   +D++S GV+   LL+G
Sbjct: 296 LKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

Query: 197 RKP 199
             P
Sbjct: 353 LSP 355

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 65.0 bits (159), Expect = 3e-12
 Identities = 40/195 (20%), Positives = 69/195 (35%), Gaps = 47/195 (24%)

Query: 24  KSPKNYPDDE--KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
               +  D +  ++   +   LKH N+V L     E     L ++  T G L +      
Sbjct: 46  TKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE------ 99

Query: 82  GVQGAQPGPVLDWMTRVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIRSS 127
                             I         DA+         + + H+     ++HR+++  
Sbjct: 100 -----------------DIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPE 139

Query: 128 NVLLF---EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVY 184
           N+LL    +    K+ADF L+ +              GT GY +PE        +  D++
Sbjct: 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLW 197

Query: 185 SFGVVLLELLTGRKP 199
           + GV+L  LL G  P
Sbjct: 198 ACGVILYILLVGYPP 212

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 64.7 bits (158), Expect = 4e-12
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 11/94 (11%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS-NQAPDMAARLHSTRVLGTF 164
           +GL Y+H      IIHRD++  N+ + ED + KI DF L+     +M      T  + T 
Sbjct: 139 KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTR 189

Query: 165 GYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 197
            Y APE  +     TQ  D++S G ++ E++TG+
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 64.6 bits (158), Expect = 4e-12
 Identities = 30/94 (31%), Positives = 52/94 (55%), Gaps = 11/94 (11%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS-NQAPDMAARLHSTRVLGTF 164
           +GL+Y+H      ++HRD++  N+ + ED + KI DF L+ +   +M      T  + T 
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM------TGYVVTR 187

Query: 165 GYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 197
            Y APE  ++     Q  D++S G ++ E+LTG+
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 64.7 bits (158), Expect = 4e-12
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           RGL+Y+H      IIHRD++ SN+ + ED + KI DF L+    D      +TR      
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194

Query: 166 YHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 197
           Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 63.8 bits (156), Expect = 5e-12
 Identities = 41/182 (22%), Positives = 74/182 (40%), Gaps = 26/182 (14%)

Query: 26  PKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD--ILHGR 80
           PK + +D  +    + ++  L H N++ L     +     L  E  T G L +  +    
Sbjct: 43  PKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV 102

Query: 81  KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKA 137
                A           ++  + A   + Y H+    ++ HRD++  N L      D   
Sbjct: 103 FRESDAA--------RIMKDVLSA---VAYCHKL---NVAHRDLKPENFLFLTDSPDSPL 148

Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 197
           K+ DF L+ +      ++  T+V GT  Y +P+  + G    + D +S GV++  LL G 
Sbjct: 149 KLIDFGLAARFKP--GKMMRTKV-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGY 204

Query: 198 KP 199
            P
Sbjct: 205 PP 206

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 64.2 bits (157), Expect = 5e-12
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 3/92 (3%)

Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 167
           LEYLH K    IIHRD++  N+LL ED   +I DF  +      + +  +   +GT  Y 
Sbjct: 143 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199

Query: 168 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +PE        + SD+++ G ++ +L+ G  P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 63.8 bits (156), Expect = 5e-12
 Identities = 39/175 (22%), Positives = 67/175 (38%), Gaps = 18/175 (10%)

Query: 31  DDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ 87
              +Q+   + V+  L H N++++     + +   +  E    G L + +   +      
Sbjct: 62  VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-- 119

Query: 88  PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNL 144
               L       +       L Y H +    ++H+D++  N+L          KI DF L
Sbjct: 120 ---ALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGL 173

Query: 145 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           +           +    GT  Y APE      +T K D++S GVV+  LLTG  P
Sbjct: 174 AELFKS--DEHSTNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 63.4 bits (155), Expect = 6e-12
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 42/179 (23%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLR--VLAYEFATMGSLHDIL--HGRKGVQGAQPGPVL 92
           +  +   +H ++++L  Y V        +  E+ + G L D +  HGR            
Sbjct: 62  IQNLKLFRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHGR------------ 107

Query: 93  DWMTRVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 144
                  +    AR         ++Y H      ++HRD++  NVLL     AKIADF L
Sbjct: 108 -------VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGL 157

Query: 145 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ--KSDVYSFGVVLLELLTGRKPVD 201
           SN   D    L ++   G+  Y APE  ++G+L    + D++S GV+L  LL G  P D
Sbjct: 158 SNMMSD-GEFLRTS--CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 64.1 bits (156), Expect = 7e-12
 Identities = 27/92 (29%), Positives = 46/92 (50%), Gaps = 6/92 (6%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
            G+++LH      IIHRD++ SN+++  D   KI DF L+  A         T  + T  
Sbjct: 175 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRY 228

Query: 166 YHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 197
           Y APE  +     +  D++S G ++ E++  +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 64.4 bits (157), Expect = 7e-12
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 5/93 (5%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GLE+LH++   +II+RD++  NVLL +D   +I+D  L+ +      +       GT G+
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK-GYA-GTPGF 355

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE  +  +     D ++ GV L E++  R P
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 63.4 bits (155), Expect = 7e-12
 Identities = 43/201 (21%), Positives = 76/201 (37%), Gaps = 55/201 (27%)

Query: 22  RLKSPKNYPDDE--KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           RL S +     E  ++ V+++  ++H N++ L          VL  E  + G L D    
Sbjct: 42  RLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD---- 97

Query: 80  RKGVQGAQPGPVLDWMTRVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIR 125
                               +A        +A +       G+ YLH K    I H D++
Sbjct: 98  -------------------FLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLK 135

Query: 126 SSNVLL----FEDFKAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT 178
             N++L      + + K+ DF ++       +         + GT  + APE      L 
Sbjct: 136 PENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF------KNIFGTPEFVAPEIVNYEPLG 189

Query: 179 QKSDVYSFGVVLLELLTGRKP 199
            ++D++S GV+   LL+G  P
Sbjct: 190 LEADMWSIGVITYILLSGASP 210

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 63.5 bits (155), Expect = 9e-12
 Identities = 37/99 (37%), Positives = 46/99 (46%), Gaps = 12/99 (12%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARLHSTRVLGT 163
            ++YLHE     IIHRD++  NVLL    ED   KI DF  S    +    L  T   GT
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLC-GT 179

Query: 164 FGYHAPE---YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             Y APE      T    +  D +S GV+L   L+G  P
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 63.0 bits (154), Expect = 9e-12
 Identities = 30/102 (29%), Positives = 45/102 (44%), Gaps = 12/102 (11%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            +  LH+    +I+HRD++  N+LL +D   K+ DF  S Q              GT  Y
Sbjct: 136 VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVC-GTPSY 189

Query: 167 HAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 202
            APE              ++ D++S GV++  LL G  P  H
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 63.4 bits (155), Expect = 1e-11
 Identities = 36/181 (19%), Positives = 66/181 (36%), Gaps = 48/181 (26%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S+++  +H N++ L          V+ +EF +   + +                     
Sbjct: 52  ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE--------------------- 90

Query: 97  RVRIA--------VDAAR-------GLEYLHEKVQPSIIHRDIRSSNVLLF--EDFKAKI 139
             RI          +           L++LH     +I H DIR  N++         KI
Sbjct: 91  --RINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKI 145

Query: 140 ADFNLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 198
            +F  + Q  P    RL    +     Y+APE      ++  +D++S G ++  LL+G  
Sbjct: 146 IEFGQARQLKPGDNFRL----LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201

Query: 199 P 199
           P
Sbjct: 202 P 202

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 7/93 (7%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
            GL  LHE     ++HRD+   N+LL ++    I DFNL+ +     A  + T  +    
Sbjct: 145 LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLARED---TADANKTHYVTHRW 198

Query: 166 YHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGR 197
           Y APE  M     T+  D++S G V+ E+   +
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 63.1 bits (154), Expect = 1e-11
 Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 9/98 (9%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
            +++ H +    ++HRDI+  N+L+      AK+ DF       D           GT  
Sbjct: 151 AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDF--DGTRV 203

Query: 166 YHAPEYAMTGQLT-QKSDVYSFGVVLLELLTGRKPVDH 202
           Y  PE+    Q     + V+S G++L +++ G  P + 
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 63.1 bits (154), Expect = 1e-11
 Identities = 23/98 (23%), Positives = 46/98 (46%), Gaps = 9/98 (9%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
            + + H      ++HRDI+  N+L+     + K+ DF       D    +++    GT  
Sbjct: 161 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFD-GTRV 213

Query: 166 YHAPEYAMTGQLT-QKSDVYSFGVVLLELLTGRKPVDH 202
           Y  PE+    +   + + V+S G++L +++ G  P +H
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 63.1 bits (154), Expect = 1e-11
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 5/94 (5%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS-NQAPDMAARLHSTRVLGTF 164
           RGL+Y+H     +++HRD++ SN+LL      KI DF L+    PD       T  + T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195

Query: 165 GYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 197
            Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 62.7 bits (153), Expect = 1e-11
 Identities = 44/201 (21%), Positives = 73/201 (36%), Gaps = 55/201 (27%)

Query: 22  RLKSPKNYPDDE--KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           R KS +     E  ++ VS++  ++H N++ L          +L  E    G L D    
Sbjct: 48  RTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD---- 103

Query: 80  RKGVQGAQPGPVLDWMTRVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIR 125
                               +A        +A         G+ YLH      I H D++
Sbjct: 104 -------------------FLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLK 141

Query: 126 SSNVLL----FEDFKAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT 178
             N++L        + KI DF L+   +   +         + GT  + APE      L 
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF------KNIFGTPEFVAPEIVNYEPLG 195

Query: 179 QKSDVYSFGVVLLELLTGRKP 199
            ++D++S GV+   LL+G  P
Sbjct: 196 LEADMWSIGVITYILLSGASP 216

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 6/93 (6%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GLE LH +    I++RD++  N+LL +    +I+D  L+   P+   +    RV GT GY
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGY 351

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE     + T   D ++ G +L E++ G+ P
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 62.3 bits (152), Expect = 2e-11
 Identities = 41/180 (22%), Positives = 68/180 (37%), Gaps = 46/180 (25%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
             +  +L+H N+V L     E +   L ++  T G L +                     
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE--------------------- 117

Query: 97  RVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKI 139
              I         DA+         + Y H      I+HR+++  N+LL    +    K+
Sbjct: 118 --DIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL 172

Query: 140 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           ADF L+ +  D  +        GT GY +PE       ++  D+++ GV+L  LL G  P
Sbjct: 173 ADFGLAIEVND--SEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 61.9 bits (151), Expect = 3e-11
 Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 23/174 (13%)

Query: 31  DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD--ILHGRKGVQGAQP 88
               + V ++ +L H N+++L     + +   +  E  T G L D  I   R     A  
Sbjct: 66  STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA- 124

Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLS 145
                    ++        + Y+H+    +I+HRD++  N+LL    +D   KI DF LS
Sbjct: 125 -------RIIKQVFSG---ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171

Query: 146 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                        R+ GT  Y APE  + G   +K DV+S GV+L  LL+G  P
Sbjct: 172 TCFQQ--NTKMKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 42/177 (23%), Positives = 68/177 (38%), Gaps = 40/177 (22%)

Query: 43  LKHENLVELLGYCVEGNLR--VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI 100
           LKH N++ L    +    R   L +++A    L  I+   +  +  +    L       +
Sbjct: 75  LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 133

Query: 101 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA----KIADFNLSNQAPDMAARL- 155
                 G+ YLH      ++HRD++ +N+L+  +       KIAD           ARL 
Sbjct: 134 LYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF--------ARLF 182

Query: 156 --------HSTRVLGTFGYHAPE-------YAMTGQLTQKSDVYSFGVVLLELLTGR 197
                       V+ TF Y APE       Y      T+  D+++ G +  ELLT  
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 62.0 bits (151), Expect = 4e-11
 Identities = 42/201 (20%), Positives = 73/201 (36%), Gaps = 55/201 (27%)

Query: 22  RLKSPKNYPDDE--KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           + ++ +     E  ++ VS++ ++ H N++ L          VL  E  + G L D    
Sbjct: 49  QSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFD---- 104

Query: 80  RKGVQGAQPGPVLDWMTRVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIR 125
                               +A        +A         G+ YLH K    I H D++
Sbjct: 105 -------------------FLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLK 142

Query: 126 SSNVLL----FEDFKAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT 178
             N++L          K+ DF L+       +         + GT  + APE      L 
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF------KNIFGTPEFVAPEIVNYEPLG 196

Query: 179 QKSDVYSFGVVLLELLTGRKP 199
            ++D++S GV+   LL+G  P
Sbjct: 197 LEADMWSIGVITYILLSGASP 217

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 61.9 bits (151), Expect = 4e-11
 Identities = 29/101 (28%), Positives = 47/101 (46%), Gaps = 12/101 (11%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           R ++ LH     ++IHRD++ SN+L+  +   K+ DF L+    + AA         +  
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 166 --------YHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 197
                   Y APE  +T    ++  DV+S G +L EL   R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 61.5 bits (150), Expect = 4e-11
 Identities = 42/198 (21%), Positives = 76/198 (38%), Gaps = 49/198 (24%)

Query: 22  RLKSPKNYPDDE--KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
           + ++ +     E  ++ VS++ ++ H N++ L          VL  E  + G L D    
Sbjct: 49  QSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD---- 104

Query: 80  RKGVQGAQPGPVLDWMTRVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIR 125
                               +A        +A         G+ YLH K    I H D++
Sbjct: 105 -------------------FLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLK 142

Query: 126 SSNVLLF----EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKS 181
             N++L          K+ DF L+++   +   +    + GT  + APE      L  ++
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA 199

Query: 182 DVYSFGVVLLELLTGRKP 199
           D++S GV+   LL+G  P
Sbjct: 200 DMWSIGVITYILLSGASP 217

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 61.7 bits (150), Expect = 5e-11
 Identities = 38/97 (39%), Positives = 54/97 (55%), Gaps = 9/97 (9%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           G++Y H      ++HRD++  NVLL     AKIADF LSN   D    L ++   G+  Y
Sbjct: 128 GVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTS--CGSPNY 181

Query: 167 HAPEYAMTGQLTQ--KSDVYSFGVVLLELLTGRKPVD 201
            APE  ++G+L    + D++S GV+L  LL G  P D
Sbjct: 182 AAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 61.3 bits (149), Expect = 6e-11
 Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 4/93 (4%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            L+YLH +   ++++RD++  N++L +D   KI DF L  +     A + +    GT  Y
Sbjct: 260 ALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 315

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE        +  D +  GVV+ E++ GR P
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 60.3 bits (147), Expect = 8e-11
 Identities = 41/180 (22%), Positives = 68/180 (37%), Gaps = 46/180 (25%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
             +  +L+H N+V L     E +   L ++  T G L +                     
Sbjct: 56  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE--------------------- 94

Query: 97  RVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKI 139
              I         DA+         + Y H      I+HR+++  N+LL    +    K+
Sbjct: 95  --DIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL 149

Query: 140 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           ADF L+ +  D  +        GT GY +PE       ++  D+++ GV+L  LL G  P
Sbjct: 150 ADFGLAIEVND--SEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 60.5 bits (147), Expect = 1e-10
 Identities = 45/198 (22%), Positives = 76/198 (38%), Gaps = 57/198 (28%)

Query: 26  PKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
                 D++++   +SV+++L H NL++L       N  VL  E+   G L D       
Sbjct: 123 KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD------- 175

Query: 83  VQGAQPGPVLDWMTRVRIA--------VDAAR-------GLEYLHEKVQPSIIHRDIRSS 127
                           RI         +D          G+ ++H+     I+H D++  
Sbjct: 176 ----------------RIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPE 216

Query: 128 NVLLF--EDFKAKIADFNLSNQAPDMAARLHSTRVL----GTFGYHAPEYAMTGQLTQKS 181
           N+L    +  + KI DF L+        R      L    GT  + APE      ++  +
Sbjct: 217 NILCVNRDAKQIKIIDFGLA-------RRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPT 269

Query: 182 DVYSFGVVLLELLTGRKP 199
           D++S GV+   LL+G  P
Sbjct: 270 DMWSVGVIAYMLLSGLSP 287

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 60.0 bits (146), Expect = 1e-10
 Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 6/95 (6%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLS-NQAPDMAARLHSTRVLGT 163
           RGL+Y+H     +++HRD++ +N+ +  ED   KI DF L+    P  + + H +  L T
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187

Query: 164 FGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 197
             Y +P   ++    T+  D+++ G +  E+LTG+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 60.1 bits (146), Expect = 1e-10
 Identities = 27/99 (27%), Positives = 46/99 (46%), Gaps = 12/99 (12%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            + +LH     +I+HRD++  N+LL ++ + +++DF  S                GT GY
Sbjct: 212 AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLRELC-GTPGY 265

Query: 167 HAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE              ++ D+++ GV+L  LL G  P
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 59.9 bits (146), Expect = 2e-10
 Identities = 36/93 (38%), Positives = 53/93 (56%), Gaps = 5/93 (5%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            L++LH      II+RD++  N+LL E+   K+ DF LS ++ D   + +S    GT  Y
Sbjct: 138 ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE       TQ +D +SFGV++ E+LTG  P
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 59.1 bits (144), Expect = 2e-10
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 5/93 (5%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            L +LH+K    II+RD++  N++L      K+ DF L  ++       H+    GT  Y
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEY 187

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE  M     +  D +S G ++ ++LTG  P
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 58.0 bits (141), Expect = 6e-10
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 5/93 (5%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            LEYLH +    +++RDI+  N++L +D   KI DF L  +     A + +    GT  Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEY 171

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE        +  D +  GVV+ E++ GR P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 57.5 bits (140), Expect = 7e-10
 Identities = 38/166 (22%), Positives = 71/166 (42%), Gaps = 19/166 (11%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++  LKH+N+V L           L +EF     L        G     P  V  ++ 
Sbjct: 52  ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG--DLDPEIVKSFLF 108

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN--QAPDMAAR 154
           ++       +GL + H +   +++HRD++  N+L+  + + K+A+F L+     P    R
Sbjct: 109 QL------LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---R 156

Query: 155 LHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKP 199
            +S  V+ T  Y  P+        +   D++S G +  EL    +P
Sbjct: 157 CYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 58.2 bits (141), Expect = 7e-10
 Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 9/98 (9%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            ++ +H+      +HRDI+  N+L+  +   ++ADF    +  +      S  V GT  Y
Sbjct: 187 AIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDY 242

Query: 167 HAPEYAMTGQLTQKS-----DVYSFGVVLLELLTGRKP 199
            +PE     +  +       D +S GV + E+L G  P
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 57.3 bits (139), Expect = 9e-10
 Identities = 26/107 (24%), Positives = 49/107 (45%), Gaps = 15/107 (14%)

Query: 103 DAAR-------GLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMA 152
           +A+         + ++H+     ++HRD++  N+L     ++ + KI DF  +   P   
Sbjct: 107 EASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163

Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
             L +     T  Y APE        +  D++S GV+L  +L+G+ P
Sbjct: 164 QPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 57.8 bits (140), Expect = 9e-10
 Identities = 23/100 (23%), Positives = 39/100 (39%), Gaps = 11/100 (11%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            ++ +H       +HRDI+  N+LL      ++ADF    +       + S   +GT  Y
Sbjct: 174 AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKL-RADGTVRSLVAVGTPDY 229

Query: 167 HAPEYAMTGQLTQKSDVY-------SFGVVLLELLTGRKP 199
            +PE          +  Y       + GV   E+  G+ P
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 57.8 bits (140), Expect = 9e-10
 Identities = 34/123 (27%), Positives = 52/123 (42%), Gaps = 16/123 (13%)

Query: 89  GPVLDWMTRVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 140
           G +++ M+   +    AR         L+ +H       IHRD++  N+LL +    K+A
Sbjct: 154 GDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLA 210

Query: 141 DFNLSNQAPDMAARLHSTRVLGTFGYHAPE----YAMTGQLTQKSDVYSFGVVLLELLTG 196
           DF    +          T V GT  Y +PE        G   ++ D +S GV L E+L G
Sbjct: 211 DFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

Query: 197 RKP 199
             P
Sbjct: 270 DTP 272

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 57.3 bits (139), Expect = 1e-09
 Identities = 24/99 (24%), Positives = 50/99 (50%), Gaps = 14/99 (14%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLS---NQAPDMAARLHSTRVL 161
           + L+Y H      I+HRD++  NV++  E  K ++ D+ L+   +   +   R+ ++R  
Sbjct: 141 KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRY- 195

Query: 162 GTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKP 199
               +  PE  +  Q+   S D++S G +L  ++  ++P
Sbjct: 196 ----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 57.3 bits (139), Expect = 1e-09
 Identities = 39/196 (19%), Positives = 70/196 (35%), Gaps = 58/196 (29%)

Query: 30  PDDEKQL---VSVVSRLKH-ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG 85
            D   ++   ++V+   K    ++ L       +  +L  E+A  G +            
Sbjct: 69  QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFS---------- 118

Query: 86  AQPGPVLDWMTRVRIA---------VDAAR-------GLEYLHEKVQPSIIHRDIRSSNV 129
                                     D  R       G+ YLH+    +I+H D++  N+
Sbjct: 119 -------------LCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNI 162

Query: 130 LL---FEDFKAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDV 183
           LL   +     KI DF +S     A ++        ++GT  Y APE      +T  +D+
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKIGHACEL------REIMGTPEYLAPEILNYDPITTATDM 216

Query: 184 YSFGVVLLELLTGRKP 199
           ++ G++   LLT   P
Sbjct: 217 WNIGIIAYMLLTHTSP 232

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 56.9 bits (138), Expect = 1e-09
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 7/94 (7%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            L YLHE+    II+RD++  NVLL  +   K+ D+ +  +         +    GT  Y
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 176

Query: 167 HAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKP 199
            APE  + G+    S D ++ GV++ E++ GR P
Sbjct: 177 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 56.4 bits (137), Expect = 2e-09
 Identities = 44/170 (25%), Positives = 77/170 (45%), Gaps = 26/170 (15%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATM--GSLHDILHGRKGVQGAQPGPVLDW 94
           +S++  LKHEN+V L       N   L +EF         D        +G +   V  +
Sbjct: 54  ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 154
             ++       +GL + HE     I+HRD++  N+L+ +  + K+ DF L+ +A  +   
Sbjct: 114 QWQL------LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA-RAFGIPVN 163

Query: 155 LHSTRVLGTFGYHAPE-------YAMTGQLTQKSDVYSFGVVLLELLTGR 197
             S+ V+ T  Y AP+       Y      +   D++S G +L E++TG+
Sbjct: 164 TFSSEVV-TLWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 56.5 bits (137), Expect = 2e-09
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 5/93 (5%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GL++LH K    I++RD++  N+LL +D   KIADF +  +     A+ ++    GT  Y
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDY 184

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE  +  +     D +SFGV+L E+L G+ P
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 56.5 bits (137), Expect = 2e-09
 Identities = 27/93 (29%), Positives = 42/93 (45%), Gaps = 5/93 (5%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            L YLH     +I++RD++  N+LL       + DF L  +  ++     ++   GT  Y
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEY 205

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE        +  D +  G VL E+L G  P
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 56.5 bits (137), Expect = 2e-09
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 7/94 (7%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            L +LH+K    II+RD++  NVLL  +   K+ADF +  +   +   + +    GT  Y
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGTPDY 190

Query: 167 HAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKP 199
            APE  +   L   + D ++ GV+L E+L G  P
Sbjct: 191 IAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 5/93 (5%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GL +L  K    II+RD++  NV+L  +   KIADF +  +  ++   + +    GT  Y
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDY 508

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE        +  D ++FGV+L E+L G+ P
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 56.1 bits (136), Expect = 3e-09
 Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 8/96 (8%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL-GTFG 165
            LE+LH+     II+RDI+  N+LL  +    + DF LS +   +A          GT  
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE--FVADETERAYDFCGTIE 225

Query: 166 YHAPEYAMTGQL--TQKSDVYSFGVVLLELLTGRKP 199
           Y AP+    G     +  D +S GV++ ELLTG  P
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 55.6 bits (135), Expect = 3e-09
 Identities = 44/163 (26%), Positives = 79/163 (48%), Gaps = 17/163 (10%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S++  L H N+V L+          L +EF     L  +L   K   G Q   +  ++ 
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT--GLQDSQIKIYLY 126

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           ++       RG+ + H+     I+HRD++  N+L+  D   K+ADF L+ +A  +  R +
Sbjct: 127 QL------LRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLA-RAFGIPVRSY 176

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKS--DVYSFGVVLLELLTGR 197
           +  V+ T  Y AP+  M G     +  D++S G +  E++TG+
Sbjct: 177 THEVV-TLWYRAPDVLM-GSKKYSTSVDIWSIGCIFAEMITGK 217

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 55.8 bits (135), Expect = 4e-09
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 7/94 (7%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
            L YLHE+    II+RD++  NVLL  +   K+ D+ +  +         +    GT  Y
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 219

Query: 167 HAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKP 199
            APE  + G+    S D ++ GV++ E++ GR P
Sbjct: 220 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 55.3 bits (134), Expect = 5e-09
 Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 5/93 (5%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 166
           GL +L  K    II+RD++  NV+L  +   KIADF +  +         +    GT  Y
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDY 187

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE        +  D ++FGV+L E+L G+ P
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 55.5 bits (134), Expect = 6e-09
 Identities = 27/115 (23%), Positives = 43/115 (37%), Gaps = 24/115 (20%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
            G  ++HE     IIHRD++ +N LL +D   K+ DF L+              +     
Sbjct: 140 LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196

Query: 166 --------------------YHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKP 199
                               Y APE  +  +  T+  D++S G +  ELL   + 
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 54.8 bits (133), Expect = 6e-09
 Identities = 40/168 (23%), Positives = 78/168 (46%), Gaps = 27/168 (16%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           +S++  LKH N+V+L          VL +E      L  +L   +G  G +      ++ 
Sbjct: 51  ISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG--GLESVTAKSFLL 107

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           ++        G+ Y H++    ++HRD++  N+L+  + + KIADF L+ +A  +  R +
Sbjct: 108 QL------LNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA-RAFGIPVRKY 157

Query: 157 STRVLGTFGYHAPE-------YAMTGQLTQKSDVYSFGVVLLELLTGR 197
           +  ++ T  Y AP+       Y      +   D++S G +  E++ G 
Sbjct: 158 THEIV-TLWYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 54.6 bits (132), Expect = 7e-09
 Identities = 46/242 (19%), Positives = 83/242 (34%), Gaps = 60/242 (24%)

Query: 24  KSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 82
           K P +      + V ++ + + H N++EL+ +  E +   L +E    GS+         
Sbjct: 48  KQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS------- 100

Query: 83  VQGAQPGPVLDWMTRVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIRSSN 128
                            I        ++A+         L++LH K    I HRD++  N
Sbjct: 101 ----------------HIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPEN 141

Query: 129 VLLF---EDFKAKIADFNLS------NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ 179
           +L     +    KI DF+L            ++     T   G+  Y APE         
Sbjct: 142 ILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAPEVVEAFSEEA 200

Query: 180 KS-----DVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG 234
                  D++S GV+L  LL+G  P                     ++ + + +    +G
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPPFVGR-CGSDCGWDRGEACPACQNMLFESI---QEG 256

Query: 235 EY 236
           +Y
Sbjct: 257 KY 258

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 54.3 bits (131), Expect = 1e-08
 Identities = 28/112 (25%), Positives = 50/112 (44%), Gaps = 23/112 (20%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 165
           + ++YLH      ++HRD++ SN+LL  +   K+ADF LS    ++    ++  +     
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 166 -------------------YHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 197
                              Y APE  +     T+  D++S G +L E+L G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 54.3 bits (131), Expect = 1e-08
 Identities = 26/98 (26%), Positives = 43/98 (43%), Gaps = 10/98 (10%)

Query: 105 ARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARLHSTRVL 161
              +++LH     +I HRD++  N+L     +D   K+ DF  + +          T   
Sbjct: 138 GTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQTPC- 190

Query: 162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            T  Y APE     +  +  D++S GV++  LL G  P
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 53.8 bits (130), Expect = 1e-08
 Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 15/162 (9%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS++  LKH N+V L           L +E+     L   L             V  ++ 
Sbjct: 51  VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN--IINMHNVKLFLF 107

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           ++       RGL Y H +    ++HRD++  N+L+ E  + K+ADF L+ +A  +  + +
Sbjct: 108 QL------LRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTY 157

Query: 157 STRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGR 197
              V+ T  Y  P+  + +   + + D++  G +  E+ TGR
Sbjct: 158 DNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 53.3 bits (129), Expect = 2e-08
 Identities = 42/167 (25%), Positives = 66/167 (39%), Gaps = 29/167 (17%)

Query: 41  SRLKHENLVELLGYCVEGNLRV-----LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
              +H N+V L+  C            L +E        D+    +      P P L   
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDL----RTYLDKAPPPGLPAE 120

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
           T   +     RGL++LH      I+HRD++  N+L+      K+ADF L        AR+
Sbjct: 121 TIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL--------ARI 169

Query: 156 HS-----TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 197
           +S     T V+ T  Y APE  +        D++S G +  E+   +
Sbjct: 170 YSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 53.6 bits (129), Expect = 2e-08
 Identities = 26/96 (27%), Positives = 43/96 (44%), Gaps = 12/96 (12%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLF-EDFKAKIADFNLSNQAPDMAARLH--STRVLG 162
           R + ++H      I HRDI+  N+L+  +D   K+ DF  + +       +    +R   
Sbjct: 152 RAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-- 206

Query: 163 TFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 197
              Y APE  +     T   D++S G V  EL+ G+
Sbjct: 207 ---YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 53.1 bits (128), Expect = 3e-08
 Identities = 24/93 (25%), Positives = 43/93 (46%), Gaps = 10/93 (10%)

Query: 108 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL-GTFGY 166
            EYLH      +I+RD++  N+L+ +    ++ DF  + +          T  L GT   
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEA 204

Query: 167 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            APE  ++    +  D ++ GV++ E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 52.6 bits (127), Expect = 4e-08
 Identities = 42/183 (22%), Positives = 75/183 (40%), Gaps = 45/183 (24%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRV--------LAYEFATMGSLHDILHGRKGVQGAQP 88
           + ++  LKHEN+V L+  C               L ++F      HD+     G+     
Sbjct: 67  IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDL----AGL----- 113

Query: 89  GPVLDWMTRVRIAVDAA----------RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
                 ++ V +    +           GL Y+H      I+HRD++++NVL+  D   K
Sbjct: 114 ------LSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLK 164

Query: 139 IADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELL 194
           +ADF L+   + A +     ++ RV+ T  Y  PE  +         D++  G ++ E+ 
Sbjct: 165 LADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 223

Query: 195 TGR 197
           T  
Sbjct: 224 TRS 226

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 52.6 bits (127), Expect = 4e-08
 Identities = 40/167 (23%), Positives = 65/167 (38%), Gaps = 29/167 (17%)

Query: 41  SRLKHENLVELLGYCVEGNLR-----VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
              +H N+V L   C            L +E        D+           P P +   
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDL----TTYLDKVPEPGVPTE 120

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
           T   +     RGL++LH      ++HRD++  N+L+    + K+ADF L        AR+
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARI 169

Query: 156 HS-----TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 197
           +S     T V+ T  Y APE  +        D++S G +  E+   +
Sbjct: 170 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 51.8 bits (125), Expect = 6e-08
 Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 19/164 (11%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ +L+HENLV LL  C +     L +EF    ++ D L       G     V  ++ 
Sbjct: 75  IKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFP--NGLDYQVVQKYLF 131

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS--NQAPDMAAR 154
           ++        G+ + H     +IIHRDI+  N+L+ +    K+ DF  +    AP     
Sbjct: 132 QI------INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---E 179

Query: 155 LHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGR 197
           ++   V  T  Y APE  +   +  +  DV++ G ++ E+  G 
Sbjct: 180 VYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 51.9 bits (125), Expect = 6e-08
 Identities = 26/96 (27%), Positives = 41/96 (42%), Gaps = 10/96 (10%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLSNQAPDMAARLH--STRVLG 162
           R +  LH     ++ HRDI+  NVL+   D   K+ DF  + +       +    +R   
Sbjct: 140 RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-- 196

Query: 163 TFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 197
              Y APE     Q  T   D++S G +  E++ G 
Sbjct: 197 ---YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 51.9 bits (125), Expect = 7e-08
 Identities = 29/111 (26%), Positives = 50/111 (45%), Gaps = 9/111 (8%)

Query: 105 ARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKA-KIADFNLSNQAPDMAARLHSTRV 160
            + +EYLH +    ++HRD++ SN+L      + ++ +I DF  + Q       L  T  
Sbjct: 126 TKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM-TPC 181

Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 211
             T  + APE           D++S GV+L  +LTG  P  +      + +
Sbjct: 182 -YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 51.6 bits (124), Expect = 9e-08
 Identities = 33/104 (31%), Positives = 41/104 (39%), Gaps = 28/104 (26%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQAPDMAARLHS------- 157
           R L Y+H      I HRDI+  N+LL  D    K+ DF          A+          
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS--------AKQLVRGEPNVS 215

Query: 158 ---TRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 197
              +R      Y APE        T   DV+S G VL ELL G+
Sbjct: 216 YICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 51.4 bits (124), Expect = 9e-08
 Identities = 36/94 (38%), Positives = 50/94 (53%), Gaps = 10/94 (10%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL-GTFG 165
            LEYLH K    II+RD++  N+LL ++   KI DF  +   PD+      T  L GT  
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPD 168

Query: 166 YHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           Y APE   T    +  D +SFG+++ E+L G  P
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 51.0 bits (123), Expect = 1e-07
 Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 27/168 (16%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++  L H N++ LL      +   L ++F     L  I+          P  +  +M 
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYML 119

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                    +GLEYLH+     I+HRD++ +N+LL E+   K+ADF L+        R +
Sbjct: 120 MT------LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAY 169

Query: 157 STRVLGTFGYHAPE-------YAMTGQLTQKSDVYSFGVVLLELLTGR 197
           + +V+ T  Y APE       Y          D+++ G +L ELL   
Sbjct: 170 THQVV-TRWYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 50.7 bits (122), Expect = 1e-07
 Identities = 36/170 (21%), Positives = 68/170 (40%), Gaps = 27/170 (15%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS++  L+H N++EL       +   L +E+A    L   +     V       +  ++ 
Sbjct: 84  VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVS---MRVIKSFLY 139

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA-----KIADFNL--SNQAP 149
           ++        G+ + H +     +HRD++  N+LL     +     KI DF L  +   P
Sbjct: 140 QL------INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190

Query: 150 DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKS--DVYSFGVVLLELLTGR 197
               R  +  ++ T  Y  PE  + G     +  D++S   +  E+L   
Sbjct: 191 I---RQFTHEII-TLWYRPPEILL-GSRHYSTSVDIWSIACIWAEMLMKT 235

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 28/96 (29%), Positives = 40/96 (41%), Gaps = 12/96 (12%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQAPDMAARLH--STRVLG 162
           R L Y+H      I HRDI+  N+LL       K+ DF  +         +    +R   
Sbjct: 152 RSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-- 206

Query: 163 TFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 197
              Y APE        T   D++S G V+ EL+ G+
Sbjct: 207 ---YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 50.5 bits (121), Expect = 2e-07
 Identities = 26/98 (26%), Positives = 43/98 (43%), Gaps = 9/98 (9%)

Query: 105 ARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMAARLHSTRVL 161
              ++YLH     +I HRD++  N+L      +   K+ DF  + +         +T   
Sbjct: 171 GEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPC- 224

Query: 162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
            T  Y APE     +  +  D++S GV++  LL G  P
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 49.9 bits (120), Expect = 3e-07
 Identities = 38/168 (22%), Positives = 67/168 (39%), Gaps = 27/168 (16%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++ +LKH NLV LL          L +E+    ++   L   +  +G     V     
Sbjct: 53  IRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ--RGVPEHLVKSITW 109

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
           +        + + + H+    + IHRD++  N+L+ +    K+ DF          ARL 
Sbjct: 110 QT------LQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGF--------ARLL 152

Query: 157 S------TRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGR 197
           +         + T  Y +PE  +         DV++ G V  ELL+G 
Sbjct: 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 50.1 bits (120), Expect = 3e-07
 Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 13/97 (13%)

Query: 107 GLEYLHEKVQPSIIHRDIRSSNVLLFE------DFKAKIADFNLSNQAPDMAARLHSTRV 160
           GL+Y+H +    IIH DI+  NVL+          + KIAD   +    +       TR 
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 200

Query: 161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 197
                Y +PE  +       +D++S   ++ EL+TG 
Sbjct: 201 -----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.9 bits (118), Expect = 5e-07
 Identities = 47/310 (15%), Positives = 95/310 (30%), Gaps = 76/310 (24%)

Query: 4   WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVS--VVSRLKHENLVELLGYCVEGNLR 61
           +L    + E+  PS         ++   ++ Q+ +   VSRL+               LR
Sbjct: 93  FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL-----------KLR 141

Query: 62  VLAYEFATMGSLHDILHGRKG---------------VQGAQPGPVLDWMT--RVRIAVDA 104
               E     ++  ++ G  G               VQ      +  W+           
Sbjct: 142 QALLELRPAKNV--LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-WLNLKNCNSPETV 198

Query: 105 ARGLEYLHEKVQPSIIHRDIRSSNV-LLFEDFKAKIADFNLSNQAPDMAARL------HS 157
              L+ L  ++ P+   R   SSN+ L     +A++     S    +    L       +
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC---LLVLLNVQN 255

Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 217
            +    F        +T   T+   V  F   L    T    +DH       +L    TP
Sbjct: 256 AKAWNAFNLSCK-ILLT---TRFKQVTDF---LSAATTTHISLDHH----SMTL----TP 300

Query: 218 RLSEDKVKQCVDPKLKGEYPPKGVA----KLAAVAALC------------VQYEAEFRPN 261
              +  + + +D + + + P + +     +L+ +A               V  + +    
Sbjct: 301 DEVKSLLLKYLDCRPQ-DLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCD-KLTTI 358

Query: 262 MSIVVKALQP 271
           +   +  L+P
Sbjct: 359 IESSLNVLEP 368

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 48.7 bits (116), Expect = 9e-07
 Identities = 28/129 (21%), Positives = 49/129 (37%), Gaps = 29/129 (22%)

Query: 106 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS---NQAPDMAARLHSTRVLG 162
            G++Y+H      I+HRD++ +N L+ +D   K+ DF L+   +   +  ++L  +    
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 163 TFG----------------------YHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKP 199
                                    Y APE  +  +  T+  DV+S G +  ELL   K 
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283

Query: 200 VDHTMPRGQ 208
                    
Sbjct: 284 NVAYHADRG 292

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 45.9 bits (109), Expect = 7e-06
 Identities = 42/180 (23%), Positives = 68/180 (37%), Gaps = 42/180 (23%)

Query: 27  KNYPDDEKQLVSVVSRLKHEN---LV-ELLGYCVEGNLRVLAYEFATMGSLHDIL--HGR 80
           K+  + +  +V +       N   LV E+L Y                 +L+D+L     
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-----------------NLYDLLRNTNF 151

Query: 81  KGVQGAQPGPVLDWMTRVR-IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA-- 137
           +GV           +   R  A      L +L    + SIIH D++  N+LL    ++  
Sbjct: 152 RGVS----------LNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI 200

Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 197
           KI DF  S Q            +   F Y +PE  +        D++S G +L+E+ TG 
Sbjct: 201 KIVDFGSSCQLGQR----IYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 45.4 bits (108), Expect = 8e-06
 Identities = 31/113 (27%), Positives = 49/113 (43%), Gaps = 13/113 (11%)

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK---IADFNLSNQAPDMA 152
           T + +A      +EY+H K   + IHRD++  N L+    K     I DF L+ +  D  
Sbjct: 106 TVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162

Query: 153 ARLH-----STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKP 199
              H     +  + GT  Y A      G + +++ D+ S G VL+    G  P
Sbjct: 163 THQHIPYRENKNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 45.1 bits (107), Expect = 1e-05
 Identities = 32/106 (30%), Positives = 49/106 (46%), Gaps = 11/106 (10%)

Query: 95  MTRVR-IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA--KIADFNLSNQAPDM 151
           +  VR  A    + L+ LH+     IIH D++  N+LL +  ++  K+ DF  S      
Sbjct: 199 LPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255

Query: 152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 197
                 +R    F Y APE  +  +     D++S G +L ELLTG 
Sbjct: 256 VYTYIQSR----F-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 25/115 (21%), Positives = 44/115 (38%), Gaps = 15/115 (13%)

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK-----IADFNLSNQAPD 150
           T    A      ++ +HEK   S+++RDI+  N L+            + DF +     D
Sbjct: 107 TVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163

Query: 151 MAARLH-----STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKP 199
              + H        + GT  Y        G + +++ D+ + G V +  L G  P
Sbjct: 164 PVTKQHIPYREKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 41.8 bits (98), Expect = 1e-04
 Identities = 36/190 (18%), Positives = 56/190 (29%), Gaps = 64/190 (33%)

Query: 57  EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQ 116
            G    + +E      L   +          P P +  + +  +     +GL+YLH K +
Sbjct: 116 NGTHICMVFEVLGH-HLLKWIIKSNY--QGLPLPCVKKIIQQVL-----QGLDYLHTKCR 167

Query: 117 PSIIHRDIRSSNVLL--------------------------------------------- 131
             IIH DI+  N+LL                                             
Sbjct: 168 --IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPL 225

Query: 132 ----FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 187
                E  K KIAD   +          H T  + T  Y + E  +       +D++S  
Sbjct: 226 EPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTA 280

Query: 188 VVLLELLTGR 197
            +  EL TG 
Sbjct: 281 CMAFELATGD 290

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 41.5 bits (98), Expect = 1e-04
 Identities = 24/107 (22%), Positives = 40/107 (37%), Gaps = 37/107 (34%)

Query: 103 DAAR-------GLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMA 152
           +A+         ++YLH     +I HRD++  N+L      +   K+ DF     A +  
Sbjct: 118 EASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF---AKE-- 169

Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
                    G   Y            +  D++S GV++  LL G  P
Sbjct: 170 -------TTGE-KY-----------DKSCDMWSLGVIMYILLCGYPP 197

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 41.5 bits (97), Expect = 2e-04
 Identities = 32/113 (28%), Positives = 52/113 (46%), Gaps = 13/113 (11%)

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK---IADFNLSNQAPDMA 152
           T + +A      +E++H K   S +HRDI+  N L+    +A    I DF L+ +  D +
Sbjct: 104 TVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160

Query: 153 ARLH-----STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKP 199
              H     +  + GT  Y A      G + +++ D+ S G VL+  L G  P
Sbjct: 161 THQHIPYRENKNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 40.5 bits (95), Expect = 3e-04
 Identities = 29/112 (25%), Positives = 50/112 (44%), Gaps = 12/112 (10%)

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI--ADFNLSNQAPDMAA 153
           T +++ +     LEY+HE      +H DI+++N+LL      ++  AD+ LS +      
Sbjct: 152 TVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208

Query: 154 RLH----STRVL-GTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKP 199
                    +   GT  +     A  G  L+++SDV   G  +L  L G+ P
Sbjct: 209 HKQYQENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 40.4 bits (95), Expect = 3e-04
 Identities = 27/115 (23%), Positives = 49/115 (42%), Gaps = 15/115 (13%)

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK-----IADFNLSNQAPD 150
           T + IA+     +EY+H K   ++I+RD++  N L+            I DF L+ +  D
Sbjct: 106 TVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162

Query: 151 MAARLH-----STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKP 199
              + H        + GT  Y        G + +++ D+ + G + +  L G  P
Sbjct: 163 PETKKHIPYREHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 40.1 bits (94), Expect = 5e-04
 Identities = 32/205 (15%), Positives = 71/205 (34%), Gaps = 35/205 (17%)

Query: 11  VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY-CVEGNLRVLAYEFAT 69
           ++       NE+    +     +      +       +   +G+   +   R L      
Sbjct: 82  LDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS-- 139

Query: 70  MG-SLHDILH--GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRS 126
           +G SL   L    +          VL   + +++A      LE+LHE      +H ++ +
Sbjct: 140 LGRSLQSALDVSPKH---------VLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA 187

Query: 127 SNVLLFEDFKAKI--ADFNLSNQAPD----MAARLHSTRVL-GTFGYHAPEYA-----MT 174
            N+ +  + ++++  A +  + +       +A    S     G       E+        
Sbjct: 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGD-----LEFISMDLHKG 242

Query: 175 GQLTQKSDVYSFGVVLLELLTGRKP 199
              +++SD+ S G  +L+ L G  P
Sbjct: 243 CGPSRRSDLQSLGYCMLKWLYGFLP 267

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	285
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.77
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.6
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.35
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.09
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.86
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.73
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.52
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.19
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.16
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.07
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.87
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.31
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.17
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	96.67
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.4
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.93
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	95.86
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	95.83
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	95.59
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	93.75
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	91.59
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	90.36
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.77
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.63
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	89.58
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	88.17
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	87.57
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	86.61
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	85.27
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	84.95
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	82.64

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-53  Score=365.42  Aligned_cols=246  Identities=21%  Similarity=0.307  Sum_probs=204.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.++.+++.||+|......  ....+.+.+|+++|++++|||||+++++|.+++.+||||||+++|+|.+++....
T Consensus        89 ~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~  166 (346)
T 4fih_A           89 IVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR  166 (346)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGG--CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHSC
T ss_pred             EEEEEEECCCCCEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcCC
Confidence            69999999999999999886543  3446788999999999999999999999999999999999999999999997643


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                +++..+..++.|++.||.|||++   ||+||||||+|||++.++.+||+|||++........  ......
T Consensus       167 ----------l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~  231 (346)
T 4fih_A          167 ----------MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV  231 (346)
T ss_dssp             ----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCC
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--cccccc
Confidence                      89999999999999999999999   999999999999999999999999999976543222  124467


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+..            ...+  .......++
T Consensus       232 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~------------~~~~--~~~~~~~~s  297 (346)
T 4fih_A          232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD------------NLPP--RLKNLHKVS  297 (346)
T ss_dssp             SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------------SSCC--CCSCGGGSC
T ss_pred             cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc------------CCCC--CCCccccCC
Confidence            99999999999999999999999999999999999999976543222211111            0011  112344677


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCC
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAA  280 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  280 (285)
                      +++.+||.+||+.||++|||++++++  ..+++...||+
T Consensus       298 ~~~~dli~~~L~~dP~~R~ta~e~l~--Hp~~~~~~~p~  334 (346)
T 4fih_A          298 PSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPPA  334 (346)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCCCGG
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhc--CHhhcCCCCCc
Confidence            88999999999999999999999998  56665554443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.7e-54  Score=367.66  Aligned_cols=238  Identities=19%  Similarity=0.291  Sum_probs=201.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.++.+++.||+|...+........+.+.+|++++++++|||||++++++.+++.+||||||+++|+|.+++....
T Consensus        39 ~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~  118 (350)
T 4b9d_A           39 KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK  118 (350)
T ss_dssp             CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTT
T ss_pred             EEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcC
Confidence            69999999999999999887655555557789999999999999999999999999999999999999999999997654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+++........  .....
T Consensus       119 ~~-------~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~  186 (350)
T 4b9d_A          119 GV-------LFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL--ARACI  186 (350)
T ss_dssp             TC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH--HHHHH
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCccc--ccccC
Confidence            32       278999999999999999999999   9999999999999999999999999999876543221  23356


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+......               .+.... ....+..++
T Consensus       187 GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~---------------~i~~~~-~~~~~~~~s  250 (350)
T 4b9d_A          187 GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL---------------KIISGS-FPPVSLHYS  250 (350)
T ss_dssp             SCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---------------HHHHTC-CCCCCTTSC
T ss_pred             CCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---------------HHHcCC-CCCCCccCC
Confidence            9999999999999999999999999999999999999997654322111               111111 112345677


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +++.+||.+||+.||++|||++++++
T Consensus       251 ~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          251 YDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            88999999999999999999999986

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2e-53  Score=363.64  Aligned_cols=254  Identities=24%  Similarity=0.352  Sum_probs=196.7

Q ss_pred             Cceeeee-----eeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCT-----CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      +||++..     ..++..+|+|..+.  ......++|.+|+++|++++|||||+++|++.+.+..+|||||+++|+|.++
T Consensus        56 ~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~  133 (329)
T 4aoj_A           56 KVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF  133 (329)
T ss_dssp             EEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHH
T ss_pred             EEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHH
Confidence            5788853     34577889997753  2334467899999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCC------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCc
Q 023220           77 LHGRKGVQG------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD  150 (285)
Q Consensus        77 l~~~~~~~~------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~  150 (285)
                      +........      ......+++..++.++.|++.|+.|||++   +++||||||+|||++.++.+||+|||+++....
T Consensus       134 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~  210 (329)
T 4aoj_A          134 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS  210 (329)
T ss_dssp             HHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             HHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcccccceeccC
Confidence            976543211      01122489999999999999999999999   999999999999999999999999999986544


Q ss_pred             ccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcC
Q 023220          151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD  229 (285)
Q Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
                      ...........||+.|+|||++.+..++.++|||||||++|||++ |+.||.......                +...+.
T Consensus       211 ~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~----------------~~~~i~  274 (329)
T 4aoj_A          211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE----------------AIDCIT  274 (329)
T ss_dssp             ---------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH----------------HHHHHH
T ss_pred             CCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH----------------HHHHHH
Confidence            333333345678999999999999999999999999999999998 899997643221                111112


Q ss_pred             CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          230 PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       230 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      ...+...+..+++++.+++.+||+.||++|||+.++++.|+.+.+.+
T Consensus       275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          275 QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence            22234556778889999999999999999999999999999998764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.7e-53  Score=355.07  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=192.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||++...   ..+++|..+.........+.|.+|++++++++|||||+++|++.+ +.++|||||+++|+|.+++....
T Consensus        51 ~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~  126 (307)
T 3omv_A           51 TVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQE  126 (307)
T ss_dssp             EEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSC
T ss_pred             EEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcC
Confidence            57888533   347888776555555567789999999999999999999998865 46899999999999999997553


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||++................
T Consensus       127 ~--------~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~  195 (307)
T 3omv_A          127 T--------KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT  195 (307)
T ss_dssp             C--------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CC
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccc
Confidence            2        289999999999999999999999   99999999999999999999999999997654333332334467


Q ss_pred             cccCcCCCccccc---CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          162 GTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       162 ~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ||+.|+|||++.+   ..|+.++|||||||++|||++|+.||.+.............          ....|. ....+.
T Consensus       196 GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~----------~~~~p~-~~~~~~  264 (307)
T 3omv_A          196 GSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR----------GYASPD-LSKLYK  264 (307)
T ss_dssp             CCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT----------TCCCCC-STTSCT
T ss_pred             cCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc----------CCCCCC-cccccc
Confidence            9999999999864   35899999999999999999999999765432111111000          001111 123455


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      .+++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            67889999999999999999999999999998776543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.6e-53  Score=356.55  Aligned_cols=252  Identities=21%  Similarity=0.300  Sum_probs=203.3

Q ss_pred             Cceeeee-----eeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCT-----CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      +||++.-     ...++.+|+|..+.. ......++|.+|+.++++++|||||+++|++.+++..+|||||+++|+|.++
T Consensus        41 ~Vykg~~~~~~~~~~~~~VAvK~l~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~  119 (308)
T 4gt4_A           41 KVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF  119 (308)
T ss_dssp             EEEEEEEC-------CEEEEEEECCC--CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHH
T ss_pred             EEEEEEEcCCccCCCCeEEEEEEECcc-cChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHH
Confidence            5788753     235567889987543 3445678899999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCC
Q 023220           77 LHGRKGVQG-------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP  149 (285)
Q Consensus        77 l~~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~  149 (285)
                      +........       ......+++..++.++.|++.|+.|||++   +++||||||+|||++.++.+||+|||+++...
T Consensus       120 L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~  196 (308)
T 4gt4_A          120 LVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY  196 (308)
T ss_dssp             HHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCSCCBCGGG
T ss_pred             HHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEECCcccceecc
Confidence            975432111       01122489999999999999999999999   99999999999999999999999999997654


Q ss_pred             cccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhc
Q 023220          150 DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV  228 (285)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
                      ............||+.|+|||.+.+..++.++|||||||++|||++ |..||.+....                .+...+
T Consensus       197 ~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~----------------~~~~~i  260 (308)
T 4gt4_A          197 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----------------DVVEMI  260 (308)
T ss_dssp             GGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH----------------HHHHHH
T ss_pred             CCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHH
Confidence            4333333445678999999999999999999999999999999998 89999765422                222222


Q ss_pred             CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          229 DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ......+.+..+++.+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       261 ~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          261 RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            233334567788899999999999999999999999999998764

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.9e-53  Score=359.38  Aligned_cols=241  Identities=22%  Similarity=0.203  Sum_probs=197.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.++.+++.||+|..+....       ..+|++++++++|||||++++++.+++.+||||||+++|+|.+++....
T Consensus        73 ~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~  145 (336)
T 4g3f_A           73 EVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG  145 (336)
T ss_dssp             EEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS
T ss_pred             EEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC
Confidence            589999999999999998864321       2479999999999999999999999999999999999999999997654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC-eeEEeccccCCCCCccccc---ccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-KAKIADFNLSNQAPDMAAR---LHS  157 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~---~~~  157 (285)
                      .         +++..+..++.|++.||.|||++   ||+||||||+|||++.+| .+||+|||++.........   ...
T Consensus       146 ~---------l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~  213 (336)
T 4g3f_A          146 C---------LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG  213 (336)
T ss_dssp             S---------CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecC
Confidence            2         89999999999999999999999   999999999999999887 6999999999765432111   112


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+.....              .....+
T Consensus       214 ~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--------------~~~~~~  279 (336)
T 4g3f_A          214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP--------------PIREIP  279 (336)
T ss_dssp             CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC--------------GGGGSC
T ss_pred             CccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC--------------CchhcC
Confidence            234699999999999999999999999999999999999999987654333222211110              011235


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      +.+++.+.++|.+||+.||.+|||+.|+++.|.++++.
T Consensus       280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            66788899999999999999999999999998877643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.4e-53  Score=359.90  Aligned_cols=254  Identities=25%  Similarity=0.383  Sum_probs=202.6

Q ss_pred             Cceeeeee-----eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTC-----QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++...     .++..+++|..+.  ......++|.+|+++|++++|||||+++|++.+++..+|||||+++|+|.++
T Consensus        28 ~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~  105 (299)
T 4asz_A           28 KVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF  105 (299)
T ss_dssp             CEEEEEECSCC----CEEEEEEEECS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHH
T ss_pred             EEEEEEECCcccCCCCEEEEEEEeCC--CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHH
Confidence            58888543     3467788887653  2333467899999999999999999999999999999999999999999999


Q ss_pred             hccCCCC----CCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc
Q 023220           77 LHGRKGV----QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA  152 (285)
Q Consensus        77 l~~~~~~----~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~  152 (285)
                      +......    ........+++..++.++.|++.|+.|||++   +++||||||+|||++.++.+||+|||+++......
T Consensus       106 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  182 (299)
T 4asz_A          106 LRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD  182 (299)
T ss_dssp             HHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG
T ss_pred             HHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcccceecCCCC
Confidence            9764310    0011112399999999999999999999999   99999999999999999999999999997544333


Q ss_pred             ccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc
Q 023220          153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK  231 (285)
Q Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
                      .........||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....                .+...+...
T Consensus       183 ~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~----------------~~~~~i~~~  246 (299)
T 4asz_A          183 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----------------EVIECITQG  246 (299)
T ss_dssp             CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----------------HHHHHHHHT
T ss_pred             ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----------------HHHHHHHcC
Confidence            2222334568999999999999999999999999999999998 89999765322                121222222


Q ss_pred             cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          232 LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      .....+..+++++.+++.+||+.||++|||+.++.+.|+++.+..
T Consensus       247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            233456778889999999999999999999999999999887643

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.5e-53  Score=359.48  Aligned_cols=235  Identities=21%  Similarity=0.274  Sum_probs=199.6

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.++.+++.||+|.+.+.. ......+.+.+|+++|++++||||++++++|.+++.+||||||+.+|+|.+++...
T Consensus        47 ~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~  126 (311)
T 4aw0_A           47 TVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI  126 (311)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc
Confidence            69999999999999999876543 23445788999999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||++...............
T Consensus       127 ~~---------l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~  194 (311)
T 4aw0_A          127 GS---------FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF  194 (311)
T ss_dssp             SS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCC
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCc
Confidence            42         89999999999999999999999   9999999999999999999999999999765433333333456


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+.....               ..+....  ..++..+
T Consensus       195 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---------------~~i~~~~--~~~p~~~  257 (311)
T 4aw0_A          195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF---------------AKIIKLE--YDFPEKF  257 (311)
T ss_dssp             CSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---------------HHHHHTC--CCCCTTC
T ss_pred             ccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---------------HHHHcCC--CCCCccc
Confidence            7999999999999999999999999999999999999999765432211               1111111  1345567


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIV  265 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~l  265 (285)
                      ++++.++|.+||+.||++|||++++
T Consensus       258 s~~~~dli~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          258 FPKARDLVEKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             CHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred             CHHHHHHHHHHccCCHhHCcChHHH
Confidence            7889999999999999999999885

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2e-52  Score=365.99  Aligned_cols=245  Identities=20%  Similarity=0.300  Sum_probs=204.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.++.+++.||+|.....  .....+.+.+|+++|++++|||||+++++|.+++.+||||||+.+|+|.+++....
T Consensus       166 ~V~~a~~~~tg~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~~  243 (423)
T 4fie_A          166 IVCIATVRSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR  243 (423)
T ss_dssp             EEEEEEETTTCCEEEEEEEEST--TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHSC
T ss_pred             EEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhccC
Confidence            6999999999999999987643  34457789999999999999999999999999999999999999999999997653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                +++..+..++.|++.||.|||++   ||+||||||+|||++.+|.+||+|||++........  ......
T Consensus       244 ----------l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~  308 (423)
T 4fie_A          244 ----------MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV  308 (423)
T ss_dssp             ----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCE
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccc
Confidence                      89999999999999999999999   999999999999999999999999999976543222  224457


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+..            ...+  .......++
T Consensus       309 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~------------~~~~--~~~~~~~~s  374 (423)
T 4fie_A          309 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD------------NLPP--RLKNLHKVS  374 (423)
T ss_dssp             ECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------------SCCC--CCSCTTSSC
T ss_pred             cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc------------CCCC--CCcccccCC
Confidence            99999999999999999999999999999999999999976543322211111            0111  112334567


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                      +++.+||.+||+.||++|||+.++++  ..+++...||
T Consensus       375 ~~~~dli~~~L~~dP~~R~ta~ell~--Hp~~~~~~~p  410 (423)
T 4fie_A          375 PSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPP  410 (423)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCCCG
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhc--CHHhcCCCCC
Confidence            88999999999999999999999998  5666554444

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-52  Score=351.91  Aligned_cols=240  Identities=20%  Similarity=0.300  Sum_probs=194.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe----CCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE----GNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l   77 (285)
                      +||+|.+..++..+++|............+.+.+|++++++++|||||+++++|.+    .+.++|||||+.+|+|.+++
T Consensus        41 ~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l  120 (290)
T 3fpq_A           41 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL  120 (290)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHH
T ss_pred             EEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHH
Confidence            58999999999999999887666565567889999999999999999999999875    34679999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCCeEEcc-CCeeEEeccccCCCCCccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNVLLFE-DFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~--~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~  154 (285)
                      .....         +++..+..++.|++.||.|||++   |  |+||||||+|||++. ++.+||+|||++......   
T Consensus       121 ~~~~~---------l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~---  185 (290)
T 3fpq_A          121 KRFKV---------MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---  185 (290)
T ss_dssp             HHHSS---------CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT---
T ss_pred             HhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC---
Confidence            76542         89999999999999999999999   8  999999999999974 789999999999754322   


Q ss_pred             ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                       ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.........  .            ..+.......
T Consensus       186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~--~------------~~i~~~~~~~  249 (290)
T 3fpq_A          186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--Y------------RRVTSGVKPA  249 (290)
T ss_dssp             -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--H------------HHHTTTCCCG
T ss_pred             -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH--H------------HHHHcCCCCC
Confidence             1234579999999998865 6999999999999999999999999754322111  0            0111111111


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ..+...++++.++|.+||+.||++|||++++++  ..+++
T Consensus       250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~--Hp~~~  287 (290)
T 3fpq_A          250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFFQ  287 (290)
T ss_dssp             GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGC
T ss_pred             CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc--Ccccc
Confidence            123345667999999999999999999999987  44444

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.3e-52  Score=343.85  Aligned_cols=238  Identities=21%  Similarity=0.245  Sum_probs=188.5

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.++.+++.||+|...+.. ......+.+.+|++++++++||||+++++++.+.+..++||||+ +|+|.+++...
T Consensus        28 ~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~  106 (275)
T 3hyh_A           28 KVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQR  106 (275)
T ss_dssp             CEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHS
T ss_pred             EEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHc
Confidence            69999999999999999876543 33445678999999999999999999999999999999999999 57999998765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.|++.||.|||++   |++||||||+|||++.++.+||+|||++........   ....
T Consensus       107 ~~---------l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~---~~~~  171 (275)
T 3hyh_A          107 DK---------MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTS  171 (275)
T ss_dssp             CS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------------
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc---cCCe
Confidence            42         99999999999999999999999   999999999999999999999999999976543221   2345


Q ss_pred             ccccCcCCCcccccCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          161 LGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      .||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+........               .+.+..  ...+..
T Consensus       172 ~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~---------------~i~~~~--~~~p~~  234 (275)
T 3hyh_A          172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK---------------NISNGV--YTLPKF  234 (275)
T ss_dssp             ---CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHHHTC--CCCCTT
T ss_pred             eECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH---------------HHHcCC--CCCCCC
Confidence            79999999999998876 579999999999999999999997643221111               111111  134556


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      +++++.++|.+||+.||++|||++++++  ..+++
T Consensus       235 ~s~~~~~li~~~L~~dP~~R~s~~eil~--hpw~k  267 (275)
T 3hyh_A          235 LSPGAAGLIKRMLIVNPLNRISIHEIMQ--DDWFK  267 (275)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHH--CHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHc--Ccccc
Confidence            7788999999999999999999999998  45554

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.5e-52  Score=349.71  Aligned_cols=235  Identities=21%  Similarity=0.232  Sum_probs=188.4

Q ss_pred             Cceeeeee---eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTC---QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      +||+|.+.   .+++.||+|...+..........+.+|++++++++||||+++++++.+++.+||||||+++|+|.+++.
T Consensus        39 ~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~  118 (304)
T 3ubd_A           39 KVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS  118 (304)
T ss_dssp             EEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHH
T ss_pred             EEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHH
Confidence            58998764   356789999886655444445678899999999999999999999999999999999999999999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....         +++..+..++.|++.||.|||++   |++||||||+|||++.++.+||+|||+++.......  ...
T Consensus       119 ~~~~---------l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~  184 (304)
T 3ubd_A          119 KEVM---------FTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAY  184 (304)
T ss_dssp             HHCC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C--CCC
T ss_pred             hcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc--ccc
Confidence            6542         89999999999999999999999   999999999999999999999999999975433222  223


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ...||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+......               .+....  ...+.
T Consensus       185 ~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~---------------~i~~~~--~~~p~  247 (304)
T 3ubd_A          185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT---------------MILKAK--LGMPQ  247 (304)
T ss_dssp             SCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHHHCC--CCCCT
T ss_pred             ccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH---------------HHHcCC--CCCCC
Confidence            4579999999999999999999999999999999999999998654322211               111111  23456


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNM-----SIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~-----~~ll~  267 (285)
                      .+++++.++|.+||+.||++|||+     +++++
T Consensus       248 ~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          248 FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            678899999999999999999984     67775

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.7e-50  Score=346.99  Aligned_cols=256  Identities=21%  Similarity=0.300  Sum_probs=200.1

Q ss_pred             Cceeeeeeeecc-----ccChhhhhhccCCCCCChhHHHHHHHHccCCC-CcccccceEEEeC-CeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQVEE-----SYPSHENERLKSPKNYPDDEKQLVSVVSRLKH-ENLVELLGYCVEG-NLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~   74 (285)
                      +||++....+..     .+++|...... .....+.+.+|+++|++++| ||||+++|+|.+. +.++|||||+++|+|.
T Consensus        79 ~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~  157 (353)
T 4ase_A           79 QVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS  157 (353)
T ss_dssp             EEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHH
T ss_pred             EEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHH
Confidence            588887665544     35555443211 12234678899999999976 9999999999764 5689999999999999


Q ss_pred             HHhccCCCC-------CCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220           75 DILHGRKGV-------QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus        75 ~~l~~~~~~-------~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      ++++.....       ........+++..++.++.|++.|+.|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus       158 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~vKi~DFGlar~  234 (353)
T 4ase_A          158 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD  234 (353)
T ss_dssp             HHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred             HHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCCCEEECcchhhhh
Confidence            999754321       0111223489999999999999999999999   999999999999999999999999999986


Q ss_pred             CCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhh
Q 023220          148 APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQ  226 (285)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (285)
                      ..............||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+....               +.+..
T Consensus       235 ~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~---------------~~~~~  299 (353)
T 4ase_A          235 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---------------EEFCR  299 (353)
T ss_dssp             TTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---------------HHHHH
T ss_pred             cccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH---------------HHHHH
Confidence            644333333345568999999999999999999999999999999998 99999764321               11222


Q ss_pred             hcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          227 CVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       227 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      .+....+...+..+++++.+++.+||+.||++|||+.++++.|+++++..
T Consensus       300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            22233344556778889999999999999999999999999999998654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-48  Score=330.33  Aligned_cols=241  Identities=20%  Similarity=0.305  Sum_probs=181.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC------------eeeEEEeeCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN------------LRVLAYEFAT   69 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------------~~~lv~e~~~   69 (285)
                      +||+|.++.+++.||+|.++.. ......+.+.+|+++|++++|||||++++++.+.+            .+|++|||+.
T Consensus        20 ~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~   98 (299)
T 4g31_A           20 VVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCR   98 (299)
T ss_dssp             EEEEEEETTTCCEEEEEEEEEC-SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCC
T ss_pred             EEEEEEECCCCCEEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCC
Confidence            6899999999999999987532 23334577899999999999999999999987544            3699999999


Q ss_pred             CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCC
Q 023220           70 MGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP  149 (285)
Q Consensus        70 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~  149 (285)
                      +|+|.+++.......      ......++.++.|++.||.|||++   |++||||||+|||++.++.+||+|||+++...
T Consensus        99 gg~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~  169 (299)
T 4g31_A           99 KENLKDWMNGRCTIE------ERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD  169 (299)
T ss_dssp             SCCHHHHHHTCCSGG------GSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCCC----
T ss_pred             CCcHHHHHHhcCCCC------hhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCccceecC
Confidence            999999998654211      145667899999999999999999   99999999999999999999999999997654


Q ss_pred             ccccc----------ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 023220          150 DMAAR----------LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL  219 (285)
Q Consensus       150 ~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  219 (285)
                      .....          .......||+.|+|||++.+..|+.++|||||||++|+|++   ||......  ..         
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--~~---------  235 (299)
T 4g31_A          170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--VR---------  235 (299)
T ss_dssp             ----------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--HH---------
T ss_pred             CCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--HH---------
Confidence            32211          11123469999999999999999999999999999999996   77532110  00         


Q ss_pred             chhhhhhhcCCccCCCCC---hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          220 SEDKVKQCVDPKLKGEYP---PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                         .+....+    ...+   ...++.+.++|.+||+.||++|||+.++++  ..+++.
T Consensus       236 ---~~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~--h~~~~~  285 (299)
T 4g31_A          236 ---TLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE--NAVFED  285 (299)
T ss_dssp             ---HHHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGCC
T ss_pred             ---HHHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhCC
Confidence               0001100    1122   234456788999999999999999999998  455544

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.7e-48  Score=328.42  Aligned_cols=257  Identities=20%  Similarity=0.258  Sum_probs=187.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHH--HHHHHHccCCCCcccccceEEEeCC----eeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEK--QLVSVVSRLKHENLVELLGYCVEGN----LRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~--~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~   75 (285)
                      .||++..  .++.+|+|......     .+.+.  .|+..+.+++||||+++++++.+++    .++|||||+++|+|.+
T Consensus        18 ~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~   90 (303)
T 3hmm_A           18 EVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD   90 (303)
T ss_dssp             EEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHH
T ss_pred             EEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHH
Confidence            5888854  46788999764322     23333  4555667889999999999998654    5799999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD  150 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~-----~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~  150 (285)
                      +++...          +++..++.++.|++.||.|||+++     +++++||||||+|||++.++.+||+|||++.....
T Consensus        91 ~l~~~~----------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  160 (303)
T 3hmm_A           91 YLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             HHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             HHHhCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence            998653          899999999999999999999752     34899999999999999999999999999865432


Q ss_pred             cccc--ccccccccccCcCCCcccccC------CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchh
Q 023220          151 MAAR--LHSTRVLGTFGYHAPEYAMTG------QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED  222 (285)
Q Consensus       151 ~~~~--~~~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (285)
                      ....  .......||+.|+|||++.+.      .++.++|||||||++|||++|..||.......... ..........+
T Consensus       161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~~~~~~~~  239 (303)
T 3hmm_A          161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVPSDPSVE  239 (303)
T ss_dssp             TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSCSSCCHH
T ss_pred             CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhcccccchHH
Confidence            2211  112235699999999998754      36789999999999999999998876543221111 11111111112


Q ss_pred             hhh-hhcCCccCCCCC-----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          223 KVK-QCVDPKLKGEYP-----PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       223 ~~~-~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      .+. .......+...+     .+.+..+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus       240 ~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence            222 222333333333     245678999999999999999999999999999987654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-48  Score=339.62  Aligned_cols=259  Identities=19%  Similarity=0.253  Sum_probs=199.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe------CCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE------GNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~   75 (285)
                      +||+|.++.+++.||+|.++.........+.+.+|+++|++++||||+++++++..      .+.+||||||+. |+|.+
T Consensus        69 ~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~  147 (398)
T 4b99_A           69 VVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQ  147 (398)
T ss_dssp             EEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHH
T ss_pred             EEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHH
Confidence            69999999999999999887655544456778899999999999999999998764      357899999996 58999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc--c
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA--A  153 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~--~  153 (285)
                      ++.....         +++..+..++.||+.||.|||++   |++||||||+|||++.++.+||+|||++.......  .
T Consensus       148 ~i~~~~~---------l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~  215 (398)
T 4b99_A          148 IIHSSQP---------LTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH  215 (398)
T ss_dssp             HHTSSSC---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------
T ss_pred             HHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecccCcccc
Confidence            9976542         99999999999999999999999   99999999999999999999999999997653221  1


Q ss_pred             cccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhh------
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQ------  226 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------  226 (285)
                      ........||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+.......+.......+......      
T Consensus       216 ~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~  295 (398)
T 4b99_A          216 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERV  295 (398)
T ss_dssp             CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CH
T ss_pred             ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhh
Confidence            1122346799999999998875 568999999999999999999999988765544443333222222111110      


Q ss_pred             --hc---CCccCC---CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          227 --CV---DPKLKG---EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       227 --~~---~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                        ..   .+....   ...+..++++.+||.+||+.||.+|||++++++  ..+++.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~  350 (398)
T 4b99_A          296 RAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR--HPFLAK  350 (398)
T ss_dssp             HHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT--SGGGTT
T ss_pred             hhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc--CHhhCc
Confidence              00   000000   011235678999999999999999999999998  455543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.1e-46  Score=340.00  Aligned_cols=242  Identities=18%  Similarity=0.214  Sum_probs=197.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.++.+++.||+|.+....  ....+.+.+|+++|++++||||++++++|.+.+.++|+|||+.+|+|.+++....
T Consensus       172 ~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~  249 (573)
T 3uto_A          172 VVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH  249 (573)
T ss_dssp             EEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTT
T ss_pred             EEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhC
Confidence            58999999999999999775322  2235678899999999999999999999999999999999999999999996543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc--CCeeEEeccccCCCCCcccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE--DFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      .        .+++..+..++.||+.||.|||++   |++||||||+|||++.  .+.+||+|||++........   ...
T Consensus       250 ~--------~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~---~~~  315 (573)
T 3uto_A          250 N--------KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKV  315 (573)
T ss_dssp             S--------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE---EEE
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc---eee
Confidence            2        289999999999999999999999   9999999999999985  48999999999976543222   233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.........+.....             .........
T Consensus       316 ~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~-------------~~~~~~~~~  382 (573)
T 3uto_A          316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW-------------NMDDSAFSG  382 (573)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-------------CCCSGGGTT
T ss_pred             eEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC-------------CCCcccccC
Confidence            4699999999999999999999999999999999999999986654322221111110             111122345


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      +++++.+||++||+.||.+|||+.++++  ..+++
T Consensus       383 ~s~~~~dli~~~L~~dp~~R~t~~e~l~--Hpw~~  415 (573)
T 3uto_A          383 ISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLT  415 (573)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTS
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc--CcCcC
Confidence            6778999999999999999999999998  44444

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.9e-45  Score=317.37  Aligned_cols=247  Identities=19%  Similarity=0.214  Sum_probs=183.3

Q ss_pred             Cceeeeee---eeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTC---QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      +||+|.++   .+++.+++|...+    .....++.+|+++|+.+ +||||++++++|.+.+++++||||+++|+|.+++
T Consensus        36 ~Vy~a~~~~~~~~~~~vAiK~i~~----~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~  111 (361)
T 4f9c_A           36 SVYLATAQLQVGPEEKIALKHLIP----TSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL  111 (361)
T ss_dssp             EEEEEEEEBTTSCEEEEEEEEECT----TSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH
T ss_pred             EEEEEEEcccCCCCCEEEEEEEcc----ccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH
Confidence            58999765   3567788886643    23456788999999998 6999999999999999999999999999999998


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC-CeeEEeccccCCCCCccccc--
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQAPDMAAR--  154 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~--  154 (285)
                      +.            +++..+..++.|++.||.|||++   ||+||||||+|||++.+ +.++|+|||+++........  
T Consensus       112 ~~------------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~  176 (361)
T 4f9c_A          112 NS------------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELL  176 (361)
T ss_dssp             TT------------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGG
T ss_pred             cC------------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccc
Confidence            42            88999999999999999999999   99999999999999876 79999999999643321100  


Q ss_pred             ------------------------ccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcc-c
Q 023220          155 ------------------------LHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRG-Q  208 (285)
Q Consensus       155 ------------------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~  208 (285)
                                              .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||....... .
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~  256 (361)
T 4f9c_A          177 KFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTA  256 (361)
T ss_dssp             GGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHH
Confidence                                    011224699999999998875 58999999999999999999999996543321 1


Q ss_pred             chhhhhhccc-------------------Cchhhhhhh---c------CC---------ccCCCCChhHHHHHHHHHHHh
Q 023220          209 QSLVTWATPR-------------------LSEDKVKQC---V------DP---------KLKGEYPPKGVAKLAAVAALC  251 (285)
Q Consensus       209 ~~~~~~~~~~-------------------~~~~~~~~~---~------~~---------~~~~~~~~~~~~~l~~li~~~  251 (285)
                      ...+......                   .+.......   +      .+         ..........++++.+||++|
T Consensus       257 l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~l  336 (361)
T 4f9c_A          257 LAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKL  336 (361)
T ss_dssp             HHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHH
T ss_pred             HHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHH
Confidence            1111100000                   000000000   0      00         000112234567899999999


Q ss_pred             cccCCCCCCCHHHHHH
Q 023220          252 VQYEAEFRPNMSIVVK  267 (285)
Q Consensus       252 l~~~p~~Rps~~~ll~  267 (285)
                      |+.||++|||++|+++
T Consensus       337 L~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          337 LDLNPASRITAEEALL  352 (361)
T ss_dssp             TCSCTTTSCCHHHHHT
T ss_pred             CcCChhHCcCHHHHhc
Confidence            9999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.5e-46  Score=339.03  Aligned_cols=236  Identities=20%  Similarity=0.242  Sum_probs=190.9

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChh---HHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDD---EKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~---~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      +||+|.++.+++.||+|...+... .......   ...++++++.++||||++++++|.+.+.+||||||+.||+|.+++
T Consensus       204 ~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l  283 (689)
T 3v5w_A          204 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL  283 (689)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHH
Confidence            599999999999999997754331 1222233   344577788899999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      .....         +++..+..++.||+.||.|||++   ||+||||||+|||++.+|++||+|||++.......    .
T Consensus       284 ~~~~~---------l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~  347 (689)
T 3v5w_A          284 SQHGV---------FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  347 (689)
T ss_dssp             HHHCC---------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC----C
T ss_pred             HhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCCC----C
Confidence            76542         89999999999999999999999   99999999999999999999999999997654322    2


Q ss_pred             cccccccCcCCCcccc-cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....||+.|+|||++. +..|+.++|+|||||++|+|++|.+||.+........+.            ..+...  ...+
T Consensus       348 ~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~------------~~i~~~--~~~~  413 (689)
T 3v5w_A          348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------------RMTLTM--AVEL  413 (689)
T ss_dssp             CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH------------HHHHHC--CCCC
T ss_pred             CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------------HhhcCC--CCCC
Confidence            3457999999999986 457999999999999999999999999754332211111            111111  1234


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPN-----MSIVVK  267 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll~  267 (285)
                      +..+++++.+||.+||+.||.+|++     ++++++
T Consensus       414 p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          414 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            5667889999999999999999998     677775

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.3e-45  Score=311.80  Aligned_cols=255  Identities=27%  Similarity=0.360  Sum_probs=192.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++..  .++.+++|............+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        52 ~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  129 (309)
T 3p86_A           52 TVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG  129 (309)
T ss_dssp             EEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTT
T ss_pred             EEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcC
Confidence            4788854  46668888776544444445678899999999999999999999999999999999999999999997643


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~--~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ..      ..+++..++.++.|++.||.|||+.   |  ++||||||+||+++.++.++|+|||++........  ....
T Consensus       130 ~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~  198 (309)
T 3p86_A          130 AR------EQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKS  198 (309)
T ss_dssp             HH------HHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----------------
T ss_pred             CC------CCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc--cccc
Confidence            11      1278999999999999999999999   9  99999999999999999999999999875433211  1234


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||.+.+..++.++|||||||++|+|++|+.||.........               ............+..
T Consensus       199 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~---------------~~~~~~~~~~~~~~~  263 (309)
T 3p86_A          199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV---------------AAVGFKCKRLEIPRN  263 (309)
T ss_dssp             ---CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH---------------HHHHHSCCCCCCCTT
T ss_pred             CCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---------------HHHHhcCCCCCCCcc
Confidence            56899999999999989999999999999999999999999765432111               111111122345566


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCCCCCC
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPVSE  284 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~~~  284 (285)
                      +++.+.++|.+||+.||.+|||+.++++.|+.+++...||+++.+
T Consensus       264 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~~~  308 (309)
T 3p86_A          264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD  308 (309)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----------
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCccc
Confidence            788899999999999999999999999999999998888777653

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.1e-44  Score=309.95  Aligned_cols=265  Identities=34%  Similarity=0.563  Sum_probs=214.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++... .+..+++|.....  .....+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        54 ~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  130 (321)
T 2qkw_B           54 KVYKGVLR-DGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD  130 (321)
T ss_dssp             EEEEEECT-TCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSC
T ss_pred             eEEEEEEC-CCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccC
Confidence            57888753 4677888865432  23346788999999999999999999999999999999999999999999997553


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..     ...+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++................
T Consensus       131 ~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  202 (321)
T 2qkw_B          131 LP-----TMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK  202 (321)
T ss_dssp             CC-----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCE
T ss_pred             CC-----ccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccC
Confidence            21     11389999999999999999999999   99999999999999999999999999986543322222223345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      |++.|+|||.+.+..++.++||||||+++|+|++|+.||....+........+.............+++......+...+
T Consensus       203 gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (321)
T 2qkw_B          203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESL  282 (321)
T ss_dssp             EETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHH
T ss_pred             CCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHH
Confidence            78999999999888899999999999999999999999987665544444433332222333445556666667788999


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                      ..+.+++.+||+.||++|||+.++++.|+.+++...
T Consensus       283 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          283 RKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence            999999999999999999999999999999887654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-43  Score=300.75  Aligned_cols=243  Identities=21%  Similarity=0.303  Sum_probs=199.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|......  ....+.+.+|+.++++++||||+++++++..++..++||||+.+++|.+++....
T Consensus        35 ~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  112 (297)
T 3fxz_A           35 TVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC  112 (297)
T ss_dssp             EEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC
T ss_pred             EEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhcC
Confidence            58999988889999999775443  2346778999999999999999999999999999999999999999999997653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                +++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ......
T Consensus       113 ----------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~  177 (297)
T 3fxz_A          113 ----------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMV  177 (297)
T ss_dssp             ----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCC
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCcc
Confidence                      88999999999999999999999   999999999999999999999999999865543222  123456


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      |++.|+|||.+.+..++.++|||||||++|+|++|..||..............              ........+..++
T Consensus       178 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~  243 (297)
T 3fxz_A          178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT--------------NGTPELQNPEKLS  243 (297)
T ss_dssp             SCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------------HCSCCCSCGGGSC
T ss_pred             CCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------CCCCCCCCccccC
Confidence            89999999999999999999999999999999999999976543222111110              0111123345667


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                      ..+.++|.+||+.||.+|||++++++  ..+++...
T Consensus       244 ~~~~~li~~~l~~dp~~Rps~~ell~--h~~~~~~~  277 (297)
T 3fxz_A          244 AIFRDFLNRCLEMDVEKRGSAKELLQ--HQFLKIAK  277 (297)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhh--ChhhcccC
Confidence            88999999999999999999999998  44554433

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-44  Score=305.69  Aligned_cols=251  Identities=25%  Similarity=0.349  Sum_probs=200.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..+++.+++|....  ......+.+.+|++++++++||||+++++++.+++..++||||+.+++|.+++....
T Consensus        25 ~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  102 (310)
T 3s95_A           25 QAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD  102 (310)
T ss_dssp             EEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCC
T ss_pred             EEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhcc
Confidence            589998888888899886632  233456788899999999999999999999999999999999999999999998643


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc-----
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH-----  156 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-----  156 (285)
                      .        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++...........     
T Consensus       103 ~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  171 (310)
T 3s95_A          103 S--------QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL  171 (310)
T ss_dssp             T--------TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------------
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccc
Confidence            2        289999999999999999999999   999999999999999999999999999865533221110     


Q ss_pred             -------ccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC
Q 023220          157 -------STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD  229 (285)
Q Consensus       157 -------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
                             .....|++.|+|||.+.+..++.++||||||+++|+|++|..||............          .......
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~----------~~~~~~~  241 (310)
T 3s95_A          172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL----------NVRGFLD  241 (310)
T ss_dssp             --------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB----------CHHHHHH
T ss_pred             cccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh----------hhhcccc
Confidence                   11346899999999999999999999999999999999999998754332211100          0111111


Q ss_pred             CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          230 PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       230 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                          ...+..+++.+.+++.+||+.||++|||+.++++.|+.+....+..
T Consensus       242 ----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~  287 (310)
T 3s95_A          242 ----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH  287 (310)
T ss_dssp             ----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred             ----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence                1124455667999999999999999999999999999887654433

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5e-44  Score=306.78  Aligned_cols=234  Identities=21%  Similarity=0.249  Sum_probs=196.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|....+++.+++|............+.+.+|++++++++||||+++++++...+..++||||+.+++|.+++....
T Consensus        30 ~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  109 (328)
T 3fe3_A           30 KVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG  109 (328)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC
T ss_pred             EEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC
Confidence            58999988889999999887665555556778899999999999999999999999999999999999999999997654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........   .....
T Consensus       110 ~---------l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~  174 (328)
T 3fe3_A          110 R---------MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFC  174 (328)
T ss_dssp             C---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---GGTTS
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---ccccc
Confidence            2         89999999999999999999999   999999999999999999999999999865433221   23456


Q ss_pred             cccCcCCCcccccCCCC-cccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLT-QKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      |++.|+|||.+.+..++ .++||||+||++|+|++|..||.+.........               +....  ...+...
T Consensus       175 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---------------i~~~~--~~~p~~~  237 (328)
T 3fe3_A          175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER---------------VLRGK--YRIPFYM  237 (328)
T ss_dssp             SSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---------------HHHCC--CCCCTTS
T ss_pred             CCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH---------------HHhCC--CCCCCCC
Confidence            89999999999888775 799999999999999999999976543221111               11111  1234456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ++++.+++.+||+.||.+|||++++++
T Consensus       238 s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          238 STDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             CHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            778999999999999999999999998

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=9e-44  Score=304.98  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=198.6

Q ss_pred             Cceeeeeeeeccc---cChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEES---YPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~---~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++....+++.   +++|..+... .....+.+.+|++++++++||||+++++++.+++..++||||+.+++|.+++.
T Consensus        64 ~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  142 (325)
T 3kul_A           64 EVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR  142 (325)
T ss_dssp             EEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHH
T ss_pred             EEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHH
Confidence            4788877655544   7888765322 22345678899999999999999999999999999999999999999999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc-cc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL-HS  157 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~  157 (285)
                      ....        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.......... ..
T Consensus       143 ~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  211 (325)
T 3kul_A          143 THDG--------QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT  211 (325)
T ss_dssp             TTTT--------CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEEC
T ss_pred             hccc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeec
Confidence            5432        289999999999999999999999   99999999999999999999999999997654322111 12


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......                .....+........
T Consensus       212 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~  275 (325)
T 3kul_A          212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR----------------DVISSVEEGYRLPA  275 (325)
T ss_dssp             C---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----------------HHHHHHHTTCCCCC
T ss_pred             cCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH----------------HHHHHHHcCCCCCC
Confidence            22345678999999998889999999999999999999 99999654322                12222222233345


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCCC
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAP  281 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  281 (285)
                      +..++..+.+++.+||+.||.+|||+.++++.|++++..+....+
T Consensus       276 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~  320 (325)
T 3kul_A          276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRA  320 (325)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC----
T ss_pred             CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccccc
Confidence            567788999999999999999999999999999999987665543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.8e-43  Score=308.31  Aligned_cols=254  Identities=24%  Similarity=0.338  Sum_probs=199.1

Q ss_pred             Cceeeeeee-------eccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQ-------VEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   73 (285)
                      .||+|....       ....+++|..+... .....+.+.+|+++++++ +||||+++++++.+.+..++||||+.+|+|
T Consensus        96 ~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L  174 (370)
T 2psq_A           96 QVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  174 (370)
T ss_dssp             EEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             eEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCH
Confidence            578886542       33457777665321 222356788999999999 899999999999999999999999999999


Q ss_pred             HHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220           74 HDILHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus        74 ~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      .+++.......       .......+++..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++.
T Consensus       175 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  251 (370)
T 2psq_A          175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR  251 (370)
T ss_dssp             HHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCSSCE
T ss_pred             HHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCCCEEEccccCCc
Confidence            99998654210       001112388999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhh
Q 023220          147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVK  225 (285)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
                      ...............+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......                +.
T Consensus       252 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~----------------~~  315 (370)
T 2psq_A          252 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----------------LF  315 (370)
T ss_dssp             ETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----------------HH
T ss_pred             ccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----------------HH
Confidence            5543322222333456788999999999899999999999999999999 999997643221                11


Q ss_pred             hhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          226 QCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      ..+........+..++.++.++|.+||+.||.+|||+.++++.|++++..
T Consensus       316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            12222223344566788899999999999999999999999999998753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.7e-44  Score=314.27  Aligned_cols=246  Identities=24%  Similarity=0.336  Sum_probs=200.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++....++..+++|..+... .....+.+.+|++++++++||||+++++++...+..++||||+.+|+|.+++....
T Consensus       129 ~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~  207 (377)
T 3cbl_A          129 EVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG  207 (377)
T ss_dssp             EEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG
T ss_pred             eEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC
Confidence            48898887778889999775321 22234567889999999999999999999999999999999999999999997543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.|+.|||++   |++||||+|+||+++.++.++|+|||++................
T Consensus       208 ~--------~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~  276 (377)
T 3cbl_A          208 A--------RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQ  276 (377)
T ss_dssp             G--------GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCE
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCC
Confidence            2        288999999999999999999999   99999999999999999999999999986543322211112223


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+.+..++.++|||||||++|+|++ |..||.....                ..+...+........+..+
T Consensus       277 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~  340 (377)
T 3cbl_A          277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN----------------QQTREFVEKGGRLPCPELC  340 (377)
T ss_dssp             EEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH----------------HHHHHHHHTTCCCCCCTTC
T ss_pred             CCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHcCCCCCCCCCC
Confidence            5678999999988889999999999999999998 9999975432                1222222333334456667


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      ++.+.++|.+||+.||.+|||+.++++.|+.+.+.
T Consensus       341 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          341 PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            88999999999999999999999999999988653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.5e-43  Score=304.40  Aligned_cols=238  Identities=21%  Similarity=0.287  Sum_probs=194.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCC----CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKN----YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||+|.+..+++.|++|..........    ..+.+.+|+.++++++||||+++++++.+....++||||+.+|+|.+++
T Consensus        27 ~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l  106 (361)
T 2yab_A           27 IVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL  106 (361)
T ss_dssp             EEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHH
Confidence            589999988999999998876544332    3578899999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC----eeEEeccccCCCCCcccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~----~~~l~df~~~~~~~~~~~  153 (285)
                      ....         .+++..+..++.|++.||.|||+.   |++||||||+||+++.++    .++|+|||++........
T Consensus       107 ~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~  174 (361)
T 2yab_A          107 AQKE---------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE  174 (361)
T ss_dssp             TTCS---------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC
T ss_pred             HhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc
Confidence            7643         289999999999999999999999   999999999999998776    799999999876543221


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                         .....|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+.........            
T Consensus       175 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------  239 (361)
T 2yab_A          175 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE------------  239 (361)
T ss_dssp             ---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH------------
T ss_pred             ---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc------------
Confidence               23456899999999999889999999999999999999999999765432221111110000000            


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          234 GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                       .....+++.+.++|.+||+.||.+|||+.++++
T Consensus       240 -~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          240 -EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             011345678999999999999999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.3e-43  Score=302.01  Aligned_cols=255  Identities=21%  Similarity=0.256  Sum_probs=186.4

Q ss_pred             Cceeeeeeeecc---ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCee------eEEEeeCCCCC
Q 023220            2 RRWLCCTCQVEE---SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR------VLAYEFATMGS   72 (285)
Q Consensus         2 ~~~~~~~~~~~~---~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------~lv~e~~~~~~   72 (285)
                      .||+|.....++   .+++|..+.........+.+.+|++++++++||||+++++++......      +++|||+.+++
T Consensus        38 ~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~  117 (323)
T 3qup_A           38 SVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGD  117 (323)
T ss_dssp             EEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCB
T ss_pred             EEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCc
Confidence            588888776665   678887766555555678899999999999999999999999877655      99999999999


Q ss_pred             HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc
Q 023220           73 LHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA  152 (285)
Q Consensus        73 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~  152 (285)
                      |.+++........   ...+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.......
T Consensus       118 L~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~  191 (323)
T 3qup_A          118 LHAFLLASRIGEN---PFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD  191 (323)
T ss_dssp             HHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             HHHHHHhhhcccc---ccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeeccccccccccc
Confidence            9999965432110   11288999999999999999999999   99999999999999999999999999997654433


Q ss_pred             ccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc
Q 023220          153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK  231 (285)
Q Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
                      .........+++.|+|||.+.+..++.++|||||||++|+|++ |..||..........                .+...
T Consensus       192 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~----------------~~~~~  255 (323)
T 3qup_A          192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN----------------YLIGG  255 (323)
T ss_dssp             ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----------------HHHTT
T ss_pred             cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH----------------HHhcC
Confidence            2222334456778999999999899999999999999999999 999997654322111                11111


Q ss_pred             cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          232 LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                      .....+..+++.+.+++.+||+.||.+|||+.++++.|++++..+.-
T Consensus       256 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~  302 (323)
T 3qup_A          256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV  302 (323)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred             CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence            12234556778899999999999999999999999999999865543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.3e-43  Score=301.75  Aligned_cols=246  Identities=20%  Similarity=0.308  Sum_probs=191.5

Q ss_pred             CceeeeeeeeccccChhhhhhc---cCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERL---KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||+|....+++.+++|+..+.   .......+.+.+|+.++++++||||+++++++.++. .+++++++.+|+|.+++.
T Consensus        30 ~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~  108 (327)
T 3poz_A           30 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVR  108 (327)
T ss_dssp             EEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHH
T ss_pred             EEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHH
Confidence            5899987777777654433222   223345678999999999999999999999998765 688999999999999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.............
T Consensus       109 ~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  177 (327)
T 3poz_A          109 EHKD--------NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE  177 (327)
T ss_dssp             HSTT--------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-----
T ss_pred             hcCC--------CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCccccccc
Confidence            6543        289999999999999999999999   99999999999999999999999999986543322222223


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......                +...+........+
T Consensus       178 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~  241 (327)
T 3poz_A          178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILEKGERLPQP  241 (327)
T ss_dssp             --CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HHHHHHTTCCCCCC
T ss_pred             CCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----------------HHHHHHcCCCCCCC
Confidence            3456779999999999999999999999999999999 999997654321                22222233333455


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      ..++.++.+++.+||+.||.+|||+.++++.|+++...
T Consensus       242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          242 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            66788899999999999999999999999999888753

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-42  Score=298.18  Aligned_cols=264  Identities=35%  Similarity=0.554  Sum_probs=210.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.. ..++.+++|....... ......+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        45 ~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  122 (326)
T 3uim_A           45 KVYKGRL-ADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP  122 (326)
T ss_dssp             EEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCS
T ss_pred             EEEEEEe-cCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhcc
Confidence            5888864 3578888987765432 2334578999999999999999999999999999999999999999999998654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ...     ..+++..++.++.|++.||.|||+....|++||||||+||+++.++.++|+|||++......... ......
T Consensus       123 ~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~  196 (326)
T 3uim_A          123 ESQ-----PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVR  196 (326)
T ss_dssp             TTC-----CCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSC-EECCCC
T ss_pred             ccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccccc-cccccc
Confidence            321     23899999999999999999999986668999999999999999999999999999755432221 123345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCC--CcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTM--PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      |++.|+|||.+.+..++.++||||||+++|+|++|..||....  .........+..............+.......+..
T Consensus       197 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (326)
T 3uim_A          197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE  276 (326)
T ss_dssp             SCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHH
T ss_pred             CCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHH
Confidence            8999999999988889999999999999999999999996321  11122233333444444455556666666778888


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      .+..+.+++.+||+.||.+|||+.++++.|++.-
T Consensus       277 ~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          277 EVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             HHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             HHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            9999999999999999999999999999997643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.1e-43  Score=296.22  Aligned_cols=255  Identities=20%  Similarity=0.264  Sum_probs=199.7

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..++..+++|....... .....+.+.+|+.++++++||||+++++++.+++..++||||+.+++|.+++...
T Consensus        26 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~  105 (294)
T 4eqm_A           26 TVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH  105 (294)
T ss_dssp             EEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH
T ss_pred             EEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhc
Confidence            589998888888999997644322 2234567889999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........ ......
T Consensus       106 ~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~  172 (294)
T 4eqm_A          106 GP---------LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHV  172 (294)
T ss_dssp             CS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------------
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc-cccCcc
Confidence            42         89999999999999999999999   999999999999999999999999999976543221 112334


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||.+.+..++.++||||||+++|+|++|+.||..........  ......          .+.........+
T Consensus       173 ~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~--~~~~~~----------~~~~~~~~~~~~  240 (294)
T 4eqm_A          173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI--KHIQDS----------VPNVTTDVRKDI  240 (294)
T ss_dssp             --CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH--HHHSSC----------CCCHHHHSCTTS
T ss_pred             ccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHhhcc----------CCCcchhcccCC
Confidence            68999999999999899999999999999999999999997654221110  000000          001111223456


Q ss_pred             HHHHHHHHHHhcccCCCCCC-CHHHHHHHhchhhcCCCCCCC
Q 023220          241 VAKLAAVAALCVQYEAEFRP-NMSIVVKALQPLLKSPPPAAP  281 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp-s~~~ll~~l~~~~~~~~~~~~  281 (285)
                      +..+.+++.+||+.||.+|| ++.++.+.|+++.........
T Consensus       241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~  282 (294)
T 4eqm_A          241 PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANED  282 (294)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred             CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence            77899999999999999998 999999999998876655443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.7e-43  Score=295.05  Aligned_cols=262  Identities=17%  Similarity=0.206  Sum_probs=197.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|............+.+.+|++++++++||||+++++++.+++..++||||+.+ ++.+.+....
T Consensus        17 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~   95 (292)
T 3o0g_A           17 TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCN   95 (292)
T ss_dssp             EEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTT
T ss_pred             EEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCC
Confidence            589999988899999998876666666678889999999999999999999999999999999999986 6666665432


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++........  ......
T Consensus        96 ~--------~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~  162 (292)
T 3o0g_A           96 G--------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEV  162 (292)
T ss_dssp             T--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--CCCSCC
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc--cccCCc
Confidence            2        289999999999999999999999   999999999999999999999999999875432211  123356


Q ss_pred             cccCcCCCcccccCC-CCcccchHhHHHHHHHHHhCCCCCCCC-CCcccchhhhhhcccCchhhh---hhhc--------
Q 023220          162 GTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHT-MPRGQQSLVTWATPRLSEDKV---KQCV--------  228 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~---~~~~--------  228 (285)
                      |++.|+|||.+.+.. ++.++|||||||++|+|++|..||... +.......+............   ....        
T Consensus       163 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (292)
T 3o0g_A          163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY  242 (292)
T ss_dssp             SCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC
T ss_pred             cccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccc
Confidence            789999999987765 799999999999999999988885433 222111111111111111100   0000        


Q ss_pred             -CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          229 -DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       229 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                       .........+..++.+.++|.+||+.||++|||++++++  ..++++..||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~pP  292 (292)
T 3o0g_A          243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--HPYFSDFCPP  292 (292)
T ss_dssp             CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTC---
T ss_pred             cCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc--CcccccCCCC
Confidence             000111233456788999999999999999999999998  6777665544

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.4e-43  Score=298.91  Aligned_cols=246  Identities=20%  Similarity=0.305  Sum_probs=194.3

Q ss_pred             CceeeeeeeeccccChhhhhhcc---CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLK---SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||+|....+++.+++|...+..   ......+.+.+|+.++++++||||+++++++..+. .+++++++.+|+|.+++.
T Consensus        30 ~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~  108 (327)
T 3lzb_A           30 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVR  108 (327)
T ss_dssp             EEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHH
T ss_pred             EEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHH
Confidence            58999888888888666443322   23446778999999999999999999999998765 688999999999999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.............
T Consensus       109 ~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~  177 (327)
T 3lzb_A          109 EHKD--------NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE  177 (327)
T ss_dssp             HTTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--------------
T ss_pred             hcCC--------CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccccccc
Confidence            6543        289999999999999999999999   99999999999999999999999999997654433332233


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......                ....+........+
T Consensus       178 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~  241 (327)
T 3lzb_A          178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILEKGERLPQP  241 (327)
T ss_dssp             --CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HHHHHHTTCCCCCC
T ss_pred             CCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHHHcCCCCCCC
Confidence            3456778999999999999999999999999999999 999997654322                22222222333445


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      ..++.++.+++.+||+.||.+|||+.++++.|+++...
T Consensus       242 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          242 PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            66788899999999999999999999999999998854

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=311.86  Aligned_cols=239  Identities=18%  Similarity=0.192  Sum_probs=196.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|............+.+.+|++++++++||||+++++++.+.+..++||||+.+|+|.+.+....
T Consensus        26 ~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~  105 (444)
T 3soa_A           26 VVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE  105 (444)
T ss_dssp             EEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS
T ss_pred             EEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC
Confidence            58999999999999999877655444456778899999999999999999999999999999999999999999997654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEc---cCCeeEEeccccCCCCCccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      .         +++..+..++.|++.||.|||++   |++||||||+||+++   .++.++|+|||++.........  ..
T Consensus       106 ~---------~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~--~~  171 (444)
T 3soa_A          106 Y---------YSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WF  171 (444)
T ss_dssp             C---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB--CC
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce--ee
Confidence            2         89999999999999999999999   999999999999998   4678999999999765432221  23


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ...|++.|+|||++.+..++.++||||+||++|+|++|..||...........+.....             ........
T Consensus       172 ~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-------------~~~~~~~~  238 (444)
T 3soa_A          172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY-------------DFPSPEWD  238 (444)
T ss_dssp             CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-------------CCCTTTTT
T ss_pred             cccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC-------------CCCccccc
Confidence            45689999999999988999999999999999999999999976543221111111000             01111223


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+++++.++|.+||+.||.+|||+.++++
T Consensus       239 ~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          239 TVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            56778999999999999999999999997

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.5e-43  Score=300.41  Aligned_cols=239  Identities=26%  Similarity=0.297  Sum_probs=192.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..+++.+++|...... .....+.+.+|+.++++++||||+++++++.+++..++||||+.+++|.+++....
T Consensus        22 ~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  100 (323)
T 3tki_A           22 EVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI  100 (323)
T ss_dssp             EEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTT
T ss_pred             EEEEEEECCCCcEEEEEEEEccc-ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcC
Confidence            58999988889999999875332 23345788999999999999999999999999999999999999999999997654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++................
T Consensus       101 ~---------~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  168 (323)
T 3tki_A          101 G---------MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC  168 (323)
T ss_dssp             B---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCC
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCc
Confidence            2         89999999999999999999999   99999999999999999999999999997554333222234457


Q ss_pred             cccCcCCCcccccCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      |++.|+|||.+.+..+ +.++|||||||++|+|++|..||..........              ..+............+
T Consensus       169 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--------------~~~~~~~~~~~~~~~~  234 (323)
T 3tki_A          169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--------------SDWKEKKTYLNPWKKI  234 (323)
T ss_dssp             SCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH--------------HHHHTTCTTSTTGGGS
T ss_pred             cCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH--------------HHHhcccccCCccccC
Confidence            8999999999987766 778999999999999999999997654322111              1111111111223456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +..+.++|.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          235 DSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            778999999999999999999999987

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.2e-43  Score=300.81  Aligned_cols=246  Identities=22%  Similarity=0.316  Sum_probs=195.0

Q ss_pred             CceeeeeeeeccccChhhhhhcc---CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLK---SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||+|....+++.+++|...+..   ......+.+.+|+.++++++||||+++++++.. +..++||+|+.+|+|.+++.
T Consensus        28 ~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~  106 (325)
T 3kex_A           28 TVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVR  106 (325)
T ss_dssp             EEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEEEEECCTTCBSHHHHH
T ss_pred             eEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHHHH
Confidence            58999888878876665443322   233455678889999999999999999999864 56789999999999999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.............
T Consensus       107 ~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  175 (325)
T 3kex_A          107 QHRG--------ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS  175 (325)
T ss_dssp             SSGG--------GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC--
T ss_pred             Hccc--------cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccccccccc
Confidence            6532        288889999999999999999999   99999999999999999999999999997664433332234


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...++..|+|||.+.+..++.++||||||+++|+|++ |..||........                ...+........+
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~  239 (325)
T 3kex_A          176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV----------------PDLLEKGERLAQP  239 (325)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH----------------HHHHHTTCBCCCC
T ss_pred             CCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH----------------HHHHHcCCCCCCC
Confidence            4557789999999998899999999999999999999 9999976543221                1111122222334


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      ..++.++.+++.+||+.||.+|||+.++++.|+++...
T Consensus       240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          240 QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            45666799999999999999999999999999988754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=297.94  Aligned_cols=238  Identities=20%  Similarity=0.263  Sum_probs=193.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCC----CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKN----YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||+|.+..++..+++|..........    ..+.+.+|++++++++||||+++++++.+....++||||+.+++|.+++
T Consensus        26 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  105 (326)
T 2y0a_A           26 VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL  105 (326)
T ss_dssp             EEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred             EEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHH
Confidence            589999988899999998765543322    3577899999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC----eeEEeccccCCCCCcccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~----~~~l~df~~~~~~~~~~~  153 (285)
                      ....         .+++..++.++.|++.||.|||+.   |++||||||+||+++.++    .++|+|||++........
T Consensus       106 ~~~~---------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~  173 (326)
T 2y0a_A          106 AEKE---------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE  173 (326)
T ss_dssp             TTSS---------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC
T ss_pred             HhcC---------CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc
Confidence            7643         289999999999999999999999   999999999999998877    799999999876543221


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                         .....|++.|+|||++.+..++.++|||||||++|+|++|..||...........+........             
T Consensus       174 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------  237 (326)
T 2y0a_A          174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE-------------  237 (326)
T ss_dssp             ---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC-------------
T ss_pred             ---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC-------------
Confidence               2345689999999999888999999999999999999999999976543221111111110000             


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          234 GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .......+..+.++|.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0111245678999999999999999999999997

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=9.1e-44  Score=300.75  Aligned_cols=263  Identities=21%  Similarity=0.276  Sum_probs=196.5

Q ss_pred             Cceeee----eeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe--CCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCC----TCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.    +..+++.+++|.....  .....+.+.+|++++++++||||+++++++..  ....++||||+.+++|.+
T Consensus        25 ~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~  102 (295)
T 3ugc_A           25 SVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD  102 (295)
T ss_dssp             EEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHH
T ss_pred             EEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHH
Confidence            478886    5567788888876522  23334678899999999999999999999864  356899999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-  154 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-  154 (285)
                      ++.....        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......... 
T Consensus       103 ~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (295)
T 3ugc_A          103 YLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF  171 (295)
T ss_dssp             HHHHCGG--------GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---------
T ss_pred             HHHhccc--------ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCCccee
Confidence            9976542        288999999999999999999999   9999999999999999999999999999765432211 


Q ss_pred             ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      .......++..|+|||.+.+..++.++||||||+++|+|++|..||...........................+......
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (295)
T 3ugc_A          172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL  251 (295)
T ss_dssp             ----CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCC
T ss_pred             eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcC
Confidence            11222346677999999999999999999999999999999999986432110000000000000011222223333344


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                      ..+..+++++.+++.+||+.||.+|||+.++++.|+++....+
T Consensus       252 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          252 PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            5567788899999999999999999999999999999887643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.4e-43  Score=303.86  Aligned_cols=238  Identities=18%  Similarity=0.237  Sum_probs=193.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..++..+++|............+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        44 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~  123 (362)
T 2bdw_A           44 VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE  123 (362)
T ss_dssp             EEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS
T ss_pred             EEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC
Confidence            58999998889999999886655444445778899999999999999999999999999999999999999999987653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC---CeeEEeccccCCCCCccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED---FKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                               .+++..++.++.|++.||.|||+.   |++||||||+||+++.+   +.++|+|||++........   ..
T Consensus       124 ---------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~  188 (362)
T 2bdw_A          124 ---------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WH  188 (362)
T ss_dssp             ---------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CC
T ss_pred             ---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cc
Confidence                     289999999999999999999999   99999999999999764   4599999999976543221   23


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ...|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+......             .......
T Consensus       189 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-------------~~~~~~~  255 (362)
T 2bdw_A          189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-------------YPSPEWD  255 (362)
T ss_dssp             CSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-------------CCTTGGG
T ss_pred             cCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-------------CCccccc
Confidence            356899999999999889999999999999999999999999765432111111110000             0011123


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+++++.++|.+||+.||.+|||+.++++
T Consensus       256 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          256 TVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             GSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            56778999999999999999999999886

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.1e-43  Score=297.95  Aligned_cols=254  Identities=22%  Similarity=0.325  Sum_probs=199.5

Q ss_pred             Cceeeeeeeec-----cccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVE-----ESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||+|.....+     ..+++|...... .....+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.++
T Consensus        38 ~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  116 (314)
T 2ivs_A           38 KVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF  116 (314)
T ss_dssp             EEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred             eEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHH
Confidence            47888764333     667777765322 223346788999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEec
Q 023220           77 LHGRKGVQG---------------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD  141 (285)
Q Consensus        77 l~~~~~~~~---------------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~d  141 (285)
                      +........               ......+++..++.++.|++.||.|||++   |++|+||||+||+++.++.++|+|
T Consensus       117 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli~~~~~~kl~D  193 (314)
T 2ivs_A          117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISD  193 (314)
T ss_dssp             HHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTEEEECC
T ss_pred             HHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEEcCCCCEEEcc
Confidence            986542100               00112388999999999999999999999   999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCc
Q 023220          142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLS  220 (285)
Q Consensus       142 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  220 (285)
                      ||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||........            
T Consensus       194 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------------  261 (314)
T 2ivs_A          194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL------------  261 (314)
T ss_dssp             CTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH------------
T ss_pred             ccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------------
Confidence            999875543332222334456788999999988889999999999999999999 9999976543221            


Q ss_pred             hhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          221 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                          ...+........+..+++.+.+++.+||+.||.+|||+.++++.|++++..
T Consensus       262 ----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          262 ----FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             ----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----HHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence                111122222344556778899999999999999999999999999998753

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=304.36  Aligned_cols=259  Identities=25%  Similarity=0.339  Sum_probs=203.7

Q ss_pred             Cceeeeeeee-------ccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQV-------EESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   73 (285)
                      .||+|....+       ...+++|..+.. ......+++.+|+++++++ +||||+++++++...+..++||||+.+|+|
T Consensus        84 ~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L  162 (382)
T 3tt0_A           84 QVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  162 (382)
T ss_dssp             EEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             EEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcH
Confidence            4788875432       235777766433 2222346788999999999 999999999999999999999999999999


Q ss_pred             HHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220           74 HDILHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus        74 ~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      .+++.......       .......+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DFG~a~  239 (382)
T 3tt0_A          163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR  239 (382)
T ss_dssp             HHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSCSCCC
T ss_pred             HHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCCCcEEEcccCccc
Confidence            99998654210       011122489999999999999999999999   99999999999999999999999999997


Q ss_pred             CCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhh
Q 023220          147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVK  225 (285)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
                      ...............+++.|+|||.+.+..++.++|||||||++|+|++ |..||......                .+.
T Consensus       240 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~----------------~~~  303 (382)
T 3tt0_A          240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----------------ELF  303 (382)
T ss_dssp             CSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----------------HHH
T ss_pred             ccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHH
Confidence            6654333223344556789999999999999999999999999999999 99999754321                222


Q ss_pred             hhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCC
Q 023220          226 QCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAA  280 (285)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  280 (285)
                      ..+........+..++.++.+++.+||+.||.+|||+.++++.|++++.......
T Consensus       304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  358 (382)
T 3tt0_A          304 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE  358 (382)
T ss_dssp             HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence            2222223334456677889999999999999999999999999999986554443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.7e-42  Score=298.24  Aligned_cols=235  Identities=20%  Similarity=0.210  Sum_probs=195.8

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.+..+++.|++|..++... .....+.+.+|++++++++||||+++++++.+.+..++||||+.+|+|.+++...
T Consensus        20 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~   99 (337)
T 1o6l_A           20 KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE   99 (337)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhc
Confidence            589999888899999997755322 3445678899999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++........  .....
T Consensus       100 ~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~  165 (337)
T 1o6l_A          100 RV---------FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTF  165 (337)
T ss_dssp             SC---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCC
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--ccccc
Confidence            42         89999999999999999999999   999999999999999999999999999875332211  12345


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.....               ..+....  ..++..+
T Consensus       166 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---------------~~i~~~~--~~~p~~~  228 (337)
T 1o6l_A          166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---------------ELILMEE--IRFPRTL  228 (337)
T ss_dssp             EECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---------------HHHHHCC--CCCCTTS
T ss_pred             ccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH---------------HHHHcCC--CCCCCCC
Confidence            6899999999999989999999999999999999999999764322111               1111111  1345567


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRP-----NMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp-----s~~~ll~  267 (285)
                      ++++.++|.+||+.||.+||     +++++++
T Consensus       229 s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            78899999999999999999     8999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-42  Score=289.97  Aligned_cols=242  Identities=25%  Similarity=0.372  Sum_probs=196.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.... ++.+++|.....   ....+++.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        25 ~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  100 (269)
T 4hcu_A           25 LVHLGYWLN-KDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR  100 (269)
T ss_dssp             EEEEEEETT-TEEEEEEEECTT---SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTT
T ss_pred             EEEEEEecC-CCeEEEEEeccc---ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcC
Confidence            578887654 555788776532   2235779999999999999999999999999999999999999999999997654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++......... ......
T Consensus       101 ~--------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~  168 (269)
T 4hcu_A          101 G--------LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTK  168 (269)
T ss_dssp             T--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTSTT
T ss_pred             c--------ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccc-cccCcc
Confidence            3        289999999999999999999999   9999999999999999999999999998754432211 123345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      +++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.......                ....+........+...
T Consensus       169 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~  232 (269)
T 4hcu_A          169 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----------------VVEDISTGFRLYKPRLA  232 (269)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------------HHHHHHTTCCCCCCTTS
T ss_pred             cccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH----------------HHHHHhcCccCCCCCcC
Confidence            6778999999998899999999999999999999 999997543321                11111112223344556


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      +..+.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          233 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            78899999999999999999999999999988753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-43  Score=301.90  Aligned_cols=257  Identities=23%  Similarity=0.315  Sum_probs=197.7

Q ss_pred             Cceeeeee-----eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTC-----QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++...     .++..+++|..+... .....+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.++
T Consensus        62 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  140 (343)
T 1luf_A           62 RVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF  140 (343)
T ss_dssp             EEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred             eEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHH
Confidence            57888776     334678888775322 223456788999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEec
Q 023220           77 LHGRKGVQG---------------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD  141 (285)
Q Consensus        77 l~~~~~~~~---------------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~d  141 (285)
                      +........               ......+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|
T Consensus       141 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~D  217 (343)
T 1luf_A          141 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIAD  217 (343)
T ss_dssp             HHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred             HHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEECCCCeEEEee
Confidence            976432110               00012489999999999999999999999   999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCc
Q 023220          142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLS  220 (285)
Q Consensus       142 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  220 (285)
                      ||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.......             
T Consensus       218 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------------  284 (343)
T 1luf_A          218 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-------------  284 (343)
T ss_dssp             CSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------------
T ss_pred             cCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH-------------
Confidence            999865433222222234557889999999998889999999999999999999 999997543211             


Q ss_pred             hhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          221 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                         ....+........+..++..+.+++.+||+.||.+|||+.++++.|+++.+....
T Consensus       285 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~  339 (343)
T 1luf_A          285 ---VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG  339 (343)
T ss_dssp             ---HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred             ---HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence               1111111112234556778899999999999999999999999999999876654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-43  Score=298.04  Aligned_cols=236  Identities=18%  Similarity=0.169  Sum_probs=191.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..++..+++|.....   ....+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        20 ~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~   96 (321)
T 1tki_A           20 IVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA   96 (321)
T ss_dssp             EEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS
T ss_pred             EEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcC
Confidence            5899998888899999876532   2234668899999999999999999999999999999999999999999997643


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc--CCeeEEeccccCCCCCcccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE--DFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      .        .+++..++.++.|++.||.|||+.   |++||||||+||+++.  ++.++|+|||++........   ...
T Consensus        97 ~--------~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~  162 (321)
T 1tki_A           97 F--------ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRL  162 (321)
T ss_dssp             C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEE
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc---ccc
Confidence            2        289999999999999999999999   9999999999999987  78999999999876543221   233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.........             .....
T Consensus       163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------~~~~~  229 (321)
T 1tki_A          163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE-------------EAFKE  229 (321)
T ss_dssp             EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH-------------HHHTT
T ss_pred             ccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh-------------hhhcc
Confidence            46899999999998888899999999999999999999999765432211111111111100             01124


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ++.++.+++.+||+.||.+|||+.++++
T Consensus       230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          230 ISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            5678999999999999999999999998

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=8.7e-43  Score=304.19  Aligned_cols=247  Identities=22%  Similarity=0.316  Sum_probs=187.8

Q ss_pred             Cceeeeee---eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTC---QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++...   ..+..+++|..+... .....+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++.
T Consensus        60 ~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~  138 (373)
T 2qol_A           60 EVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR  138 (373)
T ss_dssp             EEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH
T ss_pred             EEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHH
Confidence            47877655   346668888765322 22345678899999999999999999999999999999999999999999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc-cc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL-HS  157 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~  157 (285)
                      ....        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.......... ..
T Consensus       139 ~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  207 (373)
T 2qol_A          139 KHDA--------QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT  207 (373)
T ss_dssp             TTTT--------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------------
T ss_pred             hCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceec
Confidence            6432        289999999999999999999999   99999999999999999999999999997654322111 11


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......                .+...+........
T Consensus       208 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~----------------~~~~~i~~~~~~~~  271 (373)
T 2qol_A          208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----------------DVIKAVDEGYRLPP  271 (373)
T ss_dssp             ------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH----------------HHHHHHHTTEECCC
T ss_pred             cCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHcCCCCCC
Confidence            12234678999999998899999999999999999998 99999654321                12222222333344


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      +..++..+.+++.+||+.||.+||++.++++.|++++..+
T Consensus       272 ~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            5567788999999999999999999999999999998654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=307.21  Aligned_cols=252  Identities=23%  Similarity=0.305  Sum_probs=197.0

Q ss_pred             Cceeee-----eeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCC-----TCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      +||++.     +..++..+++|..+.. ........+.+|+.++++++||||+++++++.+....++||||+.+|+|.++
T Consensus        86 ~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~  164 (367)
T 3l9p_A           86 EVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF  164 (367)
T ss_dssp             CEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHH
T ss_pred             EEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHH
Confidence            588887     4455667888876432 2223345688899999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC---eeEEeccccCCCCCcccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF---KAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~---~~~l~df~~~~~~~~~~~  153 (285)
                      +........  ....+++..++.++.|++.||.|||++   |++||||||+||+++.++   .++|+|||++........
T Consensus       165 l~~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  239 (367)
T 3l9p_A          165 LRETRPRPS--QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY  239 (367)
T ss_dssp             HHHHSCCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSS
T ss_pred             HHhhccccC--ccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCccccccccccc
Confidence            976543211  112389999999999999999999999   999999999999998544   599999999864332222


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL  232 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
                      ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||......                .+...+....
T Consensus       240 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~----------------~~~~~i~~~~  303 (367)
T 3l9p_A          240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----------------EVLEFVTSGG  303 (367)
T ss_dssp             CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----------------HHHHHHHTTC
T ss_pred             cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHcCC
Confidence            222233457889999999998899999999999999999998 99999765322                1222222222


Q ss_pred             CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          233 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      ....+..++..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus       304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            3344556778899999999999999999999999999988754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.5e-42  Score=300.67  Aligned_cols=237  Identities=22%  Similarity=0.278  Sum_probs=194.5

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.+..+++.|++|...... ......+.+.+|++++++++||||+++++++.+.+..++||||+.+|+|.+++...
T Consensus        30 ~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~  109 (384)
T 4fr4_A           30 KVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN  109 (384)
T ss_dssp             CEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTT
T ss_pred             EEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhc
Confidence            68999999999999999765433 23445678889999999999999999999999999999999999999999999865


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.......   .....
T Consensus       110 ~~---------l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~  174 (384)
T 4fr4_A          110 VH---------FKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTM  174 (384)
T ss_dssp             CC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCC
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC---ceecc
Confidence            42         89999999999999999999999   99999999999999999999999999997554322   12445


Q ss_pred             ccccCcCCCccccc---CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          161 LGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       161 ~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      .||+.|+|||++.+   ..++.++|+|||||++|+|++|..||.............            .+..  .....+
T Consensus       175 ~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~------------~~~~--~~~~~p  240 (384)
T 4fr4_A          175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH------------TFET--TVVTYP  240 (384)
T ss_dssp             CSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH------------HHHH--CCCCCC
T ss_pred             CCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH------------HHhh--cccCCC
Confidence            68999999999864   458899999999999999999999997654322211111            1111  112345


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPN-MSIVVK  267 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps-~~~ll~  267 (285)
                      ..++..+.++|.+||+.||.+||+ ++++++
T Consensus       241 ~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          241 SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            667788999999999999999998 777764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.6e-42  Score=288.13  Aligned_cols=240  Identities=28%  Similarity=0.412  Sum_probs=193.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCC-----CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKN-----YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||+|....+++.+++|..........     ..+.+.+|++++++++||||+++++++.+..  +++|||+.+++|.+.
T Consensus        34 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~  111 (287)
T 4f0f_A           34 LVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHR  111 (287)
T ss_dssp             CEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHH
T ss_pred             eEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHH
Confidence            689999888899999997754433322     2378899999999999999999999997665  699999999999998


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCCeEEccCCe-----eEEeccccCCCCC
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNVLLFEDFK-----AKIADFNLSNQAP  149 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~--~~h~di~~~nil~~~~~~-----~~l~df~~~~~~~  149 (285)
                      +.....        .+++..++.++.|++.|+.|||+.   |  ++|+||||+||+++.++.     ++|+|||++....
T Consensus       112 l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~  180 (287)
T 4f0f_A          112 LLDKAH--------PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV  180 (287)
T ss_dssp             HHCTTS--------CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCS
T ss_pred             HhcccC--------CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccc
Confidence            865432        289999999999999999999999   9  999999999999987776     9999999987543


Q ss_pred             cccccccccccccccCcCCCcccc--cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh
Q 023220          150 DMAARLHSTRVLGTFGYHAPEYAM--TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC  227 (285)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (285)
                      ..     .....|++.|+|||.+.  ...++.++|||||||++|+|++|+.||..........             ....
T Consensus       181 ~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-------------~~~~  242 (287)
T 4f0f_A          181 HS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-------------INMI  242 (287)
T ss_dssp             SC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-------------HHHH
T ss_pred             cc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-------------HHHH
Confidence            32     23356899999999984  4457899999999999999999999997654321111             1111


Q ss_pred             cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          228 VDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       228 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      .........+..+++.+.+++.+||+.||.+|||++++++.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            222233345667788899999999999999999999999999764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.1e-42  Score=293.71  Aligned_cols=258  Identities=19%  Similarity=0.211  Sum_probs=192.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+.. ++.+++|............+.+.+|++++++++||||+++++++.+.+..++||||+.+ +|.+++....
T Consensus        36 ~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~  113 (311)
T 3niz_A           36 VVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENK  113 (311)
T ss_dssp             EEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCT
T ss_pred             EEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhcc
Confidence            589997754 77889998876655555668899999999999999999999999999999999999985 8888886543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ......
T Consensus       114 ~--------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~  180 (311)
T 3niz_A          114 T--------GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEV  180 (311)
T ss_dssp             T--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCC
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc--cccCCc
Confidence            2        289999999999999999999999   999999999999999999999999999875432221  123346


Q ss_pred             cccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhh------hcCCcc--
Q 023220          162 GTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQ------CVDPKL--  232 (285)
Q Consensus       162 ~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~--  232 (285)
                      |++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+..............      +.....  
T Consensus       181 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (311)
T 3niz_A          181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQV  260 (311)
T ss_dssp             CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCC
T ss_pred             ccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccccc
Confidence            7999999999876 4679999999999999999999999987654443322221111111110000      000000  


Q ss_pred             -----CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          233 -----KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       233 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                           .....+.+++++.++|.+||+.||.+|||++++++  ..+++..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~  307 (311)
T 3niz_A          261 FEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN--HPYFKDL  307 (311)
T ss_dssp             CCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGTTS
T ss_pred             ccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc--CcccccC
Confidence                 00112335668999999999999999999999998  4555443

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-42  Score=297.98  Aligned_cols=257  Identities=22%  Similarity=0.324  Sum_probs=197.6

Q ss_pred             Cceeeeee-----eeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTC-----QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|...     .++..+++|..... ......+.+.+|+++++++ +||||+++++++...+..++||||+.+|+|.+
T Consensus        60 ~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~  138 (344)
T 1rjb_A           60 KVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN  138 (344)
T ss_dssp             EEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred             eeEEeeeeccccCCcceEEEEEecccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHH
Confidence            47888752     34556888877533 2344678899999999999 99999999999999999999999999999999


Q ss_pred             HhccCCCCCC--------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEec
Q 023220           76 ILHGRKGVQG--------------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD  141 (285)
Q Consensus        76 ~l~~~~~~~~--------------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~d  141 (285)
                      ++........              ......+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|
T Consensus       139 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~D  215 (344)
T 1rjb_A          139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICD  215 (344)
T ss_dssp             HHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECC
T ss_pred             HHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEEcCCCcEEeCC
Confidence            9976542100              01112378999999999999999999999   999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCc
Q 023220          142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLS  220 (285)
Q Consensus       142 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  220 (285)
                      ||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......             
T Consensus       216 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------------  282 (344)
T 1rjb_A          216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA-------------  282 (344)
T ss_dssp             CGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-------------
T ss_pred             CccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH-------------
Confidence            999976543332222334456788999999988889999999999999999998 999997654321             


Q ss_pred             hhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          221 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                        .....+........+..+++.+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus       283 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          283 --NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             --HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             --HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence              1112222222334455667889999999999999999999999999999876543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.9e-42  Score=293.94  Aligned_cols=254  Identities=23%  Similarity=0.290  Sum_probs=190.4

Q ss_pred             Cceeeeeee---eccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC-----eeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQ---VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN-----LRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L   73 (285)
                      .||+|....   ++..+++|............+.+.+|++++++++||||+++++++.+..     ..+++|||+.+++|
T Consensus        49 ~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L  128 (313)
T 3brb_A           49 SVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL  128 (313)
T ss_dssp             CEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBH
T ss_pred             EEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCH
Confidence            578886654   4457888887655544445677899999999999999999999998755     34999999999999


Q ss_pred             HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc
Q 023220           74 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        74 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  153 (285)
                      .+++........   ...+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........
T Consensus       129 ~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~  202 (313)
T 3brb_A          129 HTYLLYSRLETG---PKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY  202 (313)
T ss_dssp             HHHHHHTTBTTS---CCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSCC--------
T ss_pred             HHHHHHhhhhcC---CccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCcceecccccc
Confidence            999854321111   11389999999999999999999999   999999999999999999999999999876543322


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL  232 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
                      ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||..........                .+....
T Consensus       203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~----------------~~~~~~  266 (313)
T 3brb_A          203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD----------------YLLHGH  266 (313)
T ss_dssp             --------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH----------------HHHTTC
T ss_pred             cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH----------------HHHcCC
Confidence            222233456788999999999899999999999999999999 889997654321111                111111


Q ss_pred             CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          233 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                      ....+..++..+.+++.+||+.||.+|||+.++++.|+++++..+
T Consensus       267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            223445667889999999999999999999999999999986554

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.8e-42  Score=311.47  Aligned_cols=245  Identities=24%  Similarity=0.325  Sum_probs=203.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++....++..+++|..+..   ....+.+.+|++++++++||||+++++++......++||||+.+|+|.+++....
T Consensus       235 ~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~  311 (495)
T 1opk_A          235 EVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN  311 (495)
T ss_dssp             SEEEEEEGGGTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSC
T ss_pred             EEEEEEEcCCCeEEEEEEecCc---ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcC
Confidence            5899988877888999887542   2346889999999999999999999999999999999999999999999997643


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++......... ......
T Consensus       312 ~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~  380 (495)
T 1opk_A          312 RQ-------EVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAK  380 (495)
T ss_dssp             TT-------TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE-CCTTCC
T ss_pred             cC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCcee-ecCCCc
Confidence            22       288999999999999999999999   9999999999999999999999999999765432211 122334


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+.+..++.++|||||||++|+|++ |..||......                .+...+....+...+..+
T Consensus       381 ~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~  444 (495)
T 1opk_A          381 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------QVYELLEKDYRMERPEGC  444 (495)
T ss_dssp             CCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----------------GHHHHHHTTCCCCCCTTC
T ss_pred             CCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHcCCCCCCCCCC
Confidence            5678999999998889999999999999999999 99999765422                122222333344556677


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      ++.+.++|.+||+.||.+|||+.++++.|+.+....
T Consensus       445 ~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~  480 (495)
T 1opk_A          445 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  480 (495)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred             CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence            889999999999999999999999999999887543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.8e-42  Score=302.74  Aligned_cols=257  Identities=16%  Similarity=0.190  Sum_probs=194.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|............+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        42 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  121 (389)
T 3gni_B           42 TVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF  121 (389)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTC
T ss_pred             EEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhc
Confidence            58999999899999999887766556667788899999999999999999999999999999999999999999997653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-----cc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-----LH  156 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~  156 (285)
                      ..       .+++..+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||.+.........     ..
T Consensus       122 ~~-------~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  191 (389)
T 3gni_B          122 MD-------GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF  191 (389)
T ss_dssp             TT-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCC
T ss_pred             cc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccc
Confidence            22       289999999999999999999999   9999999999999999999999999987543221111     01


Q ss_pred             ccccccccCcCCCccccc--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhc-cc------Cchhhh---
Q 023220          157 STRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT-PR------LSEDKV---  224 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~------~~~~~~---  224 (285)
                      .....|++.|+|||++.+  ..++.++|||||||++|+|++|+.||................ +.      ...+..   
T Consensus       192 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (389)
T 3gni_B          192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMS  271 (389)
T ss_dssp             CTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------------------
T ss_pred             cccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccc
Confidence            122367889999999987  578999999999999999999999997654332211100000 00      000000   


Q ss_pred             ----------hhhc---------CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          225 ----------KQCV---------DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       225 ----------~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                                ....         ........+..+++.+.++|.+||+.||.+|||++++++.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          272 PSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ----------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                      0000         0000112344567789999999999999999999999863

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.4e-42  Score=297.00  Aligned_cols=233  Identities=22%  Similarity=0.267  Sum_probs=192.4

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|....+++.+++|...... ......+.+.+|+++++.++||||+++++++.+.+..++||||+ +|+|.+++...
T Consensus        24 ~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~  102 (336)
T 3h4j_B           24 KVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK  102 (336)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHc
Confidence            58999988889999999765432 23445678999999999999999999999999999999999999 57898888655


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........   ....
T Consensus       103 ~~---------l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~~~  167 (336)
T 3h4j_B          103 KR---------MTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTS  167 (336)
T ss_dssp             CS---------CCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TCCC
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc---cccc
Confidence            32         89999999999999999999999   999999999999999999999999999876543221   2345


Q ss_pred             ccccCcCCCcccccCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          161 LGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      .|++.|+|||.+.+..+ +.++|||||||++|+|++|..||...........+                . ......+..
T Consensus       168 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i----------------~-~~~~~~p~~  230 (336)
T 3h4j_B          168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV----------------N-SCVYVMPDF  230 (336)
T ss_dssp             TTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----------------C-SSCCCCCTT
T ss_pred             cCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----------------H-cCCCCCccc
Confidence            68999999999988776 68999999999999999999999754322111100                0 011233555


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .++.+.++|.+||+.||.+|||++++++
T Consensus       231 ~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          231 LSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            6788999999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.4e-42  Score=294.29  Aligned_cols=260  Identities=24%  Similarity=0.349  Sum_probs=200.1

Q ss_pred             Cceeee----eeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC--CeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCC----TCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG--NLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.    +..+++.+++|...... .....+.+.+|++++++++||||+++++++.+.  ...++||||+.+++|.+
T Consensus        36 ~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~  114 (302)
T 4e5w_A           36 KVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE  114 (302)
T ss_dssp             EEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHH
T ss_pred             EEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHH
Confidence            478887    56778889999876543 344568899999999999999999999999876  66899999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-  154 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-  154 (285)
                      ++.....        .+++..++.++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||++......... 
T Consensus       115 ~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  183 (302)
T 4e5w_A          115 YLPKNKN--------KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY  183 (302)
T ss_dssp             HHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEE
T ss_pred             HHHhccc--------cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccCCCcce
Confidence            9965432        289999999999999999999999   9999999999999999999999999998765432211 


Q ss_pred             ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      .......++..|+|||.+.+..++.++|+||||+++|+|++|..|+......... .................+......
T Consensus       184 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  262 (302)
T 4e5w_A          184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK-MIGPTHGQMTVTRLVNTLKEGKRL  262 (302)
T ss_dssp             ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCGGGHHHHHHHHHHTTCCC
T ss_pred             eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhh-ccCCcccccCHHHHHHHHhccCCC
Confidence            1223345778899999999888999999999999999999999986432110000 000000111112223333334444


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ..+..+++.+.+++.+||+.||.+|||+.++++.|+++++
T Consensus       263 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          263 PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            5667788899999999999999999999999999998864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.5e-42  Score=286.72  Aligned_cols=237  Identities=27%  Similarity=0.424  Sum_probs=183.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCC--CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP--KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++...  ++.+++|..+.....  ....+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++..
T Consensus        22 ~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   99 (271)
T 3dtc_A           22 KVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG   99 (271)
T ss_dssp             EEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS
T ss_pred             EEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc
Confidence            47888653  667888876544322  34567889999999999999999999999999999999999999999999964


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC---eeeCCCCCCCeEEcc--------CCeeEEeccccCCCC
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS---IIHRDIRSSNVLLFE--------DFKAKIADFNLSNQA  148 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~---~~h~di~~~nil~~~--------~~~~~l~df~~~~~~  148 (285)
                      ..          +++..++.++.|++.|+.|||++   |   ++||||+|+||+++.        ++.++|+|||++...
T Consensus       100 ~~----------~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~  166 (271)
T 3dtc_A          100 KR----------IPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW  166 (271)
T ss_dssp             SC----------CCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----
T ss_pred             CC----------CCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEEccCCccccc
Confidence            42          89999999999999999999999   8   899999999999986        678999999998755


Q ss_pred             CcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhc
Q 023220          149 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV  228 (285)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
                      ....    .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||........               .....
T Consensus       167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---------------~~~~~  227 (271)
T 3dtc_A          167 HRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV---------------AYGVA  227 (271)
T ss_dssp             -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH---------------HHHHH
T ss_pred             cccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---------------HHhhh
Confidence            4322    1234689999999999988899999999999999999999999975432111               11122


Q ss_pred             CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          229 DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      ........+..+++.+.+++.+||+.||.+|||+.++++.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          228 MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            22223345566778899999999999999999999999999764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6e-42  Score=292.65  Aligned_cols=256  Identities=20%  Similarity=0.236  Sum_probs=194.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|..+... .....+.+.+|++++++++||||+++++++.+.+..++||||+. ++|.+++....
T Consensus        20 ~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~   97 (317)
T 2pmi_A           20 TVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRT   97 (317)
T ss_dssp             EEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHH
T ss_pred             EEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhcc
Confidence            58999998889999999876433 34456889999999999999999999999999999999999998 59999886543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ....   ...+++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ......
T Consensus        98 ~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~  169 (317)
T 2pmi_A           98 VGNT---PRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEV  169 (317)
T ss_dssp             SSSC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC--CCCCCC
T ss_pred             cccc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc--cCCCCc
Confidence            2111   11288999999999999999999999   999999999999999999999999999865432211  123346


Q ss_pred             cccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhh---hhh--hcCCcc---
Q 023220          162 GTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDK---VKQ--CVDPKL---  232 (285)
Q Consensus       162 ~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~--~~~~~~---  232 (285)
                      |++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+...........   ...  ...+..   
T Consensus       170 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (317)
T 2pmi_A          170 VTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQR  249 (317)
T ss_dssp             SCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCC
T ss_pred             ccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccc
Confidence            79999999998764 689999999999999999999999987654333222211111110000   000  000000   


Q ss_pred             ---------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          233 ---------KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       233 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                               ........+.++.++|.+||+.||++|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          250 PPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                     00112235678999999999999999999999997

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=8.8e-42  Score=288.69  Aligned_cols=253  Identities=14%  Similarity=0.133  Sum_probs=199.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.+..+++.+++|....    ....+.+.+|+++++++ +|+|++++++++.+....+++|||+ +++|.+++...
T Consensus        25 ~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~   99 (298)
T 1csn_A           25 VIFEGTNLLNNQQVAIKFEPR----RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC   99 (298)
T ss_dssp             EEEEEEETTTTEEEEEEEEEC----CTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred             EEEEEEECCCCcEEEEEEecc----CCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHh
Confidence            589998888889999997643    23456788999999999 8999999999999999999999999 88999999864


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCe-----eEEeccccCCCCCccccc-
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK-----AKIADFNLSNQAPDMAAR-  154 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~-----~~l~df~~~~~~~~~~~~-  154 (285)
                      ..        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.     ++|+|||++......... 
T Consensus       100 ~~--------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (298)
T 1csn_A          100 GR--------KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ  168 (298)
T ss_dssp             TT--------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC
T ss_pred             cc--------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccc
Confidence            32        289999999999999999999999   9999999999999987765     999999998755432211 


Q ss_pred             ----ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          155 ----LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       155 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                          .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||........................      
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------  242 (298)
T 1csn_A          169 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL------  242 (298)
T ss_dssp             BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH------
T ss_pred             cccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH------
Confidence                1123456899999999999989999999999999999999999999875433222111110000000000      


Q ss_pred             ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          231 KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                         ......+++++.+++.+||+.||++|||+.++++.|+++++....+
T Consensus       243 ---~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          243 ---RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             ---HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             ---HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence               0112345678999999999999999999999999999998765443

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.1e-41  Score=291.63  Aligned_cols=235  Identities=20%  Similarity=0.269  Sum_probs=193.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++....+++.+++|.....  .....+.+.+|+.++++++||||+++++++...+..++||||+.+++|.+++....
T Consensus        60 ~V~~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  137 (321)
T 2c30_A           60 IVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR  137 (321)
T ss_dssp             EEEEEEETTTCCEEEEEEEETT--TCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCC
T ss_pred             EEEEEEECCCCcEEEEEEEecc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcC
Confidence            5899988878889999987543  23456778999999999999999999999999999999999999999999987542


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ......
T Consensus       138 ----------l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~  202 (321)
T 2c30_A          138 ----------LNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLV  202 (321)
T ss_dssp             ----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCC
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--cccccc
Confidence                      89999999999999999999999   999999999999999999999999999865543221  123456


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      |++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+            .....+.  ......++
T Consensus       203 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~------------~~~~~~~--~~~~~~~~  268 (321)
T 2c30_A          203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL------------RDSPPPK--LKNSHKVS  268 (321)
T ss_dssp             SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------------HHSSCCC--CTTGGGSC
T ss_pred             CCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------hcCCCCC--cCccccCC
Confidence            899999999999888999999999999999999999999765432111111            1111111  11233457


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +.+.+++.+||+.||++|||+.++++
T Consensus       269 ~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          269 PVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            78999999999999999999999998

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.7e-42  Score=291.25  Aligned_cols=245  Identities=24%  Similarity=0.336  Sum_probs=194.4

Q ss_pred             Cceeeee--eeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCT--CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||+|..  ..+...+++|..+.........+.+.+|++++++++||||+++++++ ..+..++||||+.+++|.+++..
T Consensus        32 ~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~  110 (291)
T 1xbb_A           32 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ  110 (291)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH
T ss_pred             eeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh
Confidence            4788843  45567788888766554455577899999999999999999999999 56678999999999999999986


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-cccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-LHST  158 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~  158 (285)
                      ...         +++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++......... ....
T Consensus       111 ~~~---------~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  178 (291)
T 1xbb_A          111 NRH---------VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  178 (291)
T ss_dssp             CTT---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CcC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccc
Confidence            542         88999999999999999999999   9999999999999999999999999998654332211 1112


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......                +...+........+
T Consensus       179 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~  242 (291)
T 1xbb_A          179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGERMGCP  242 (291)
T ss_dssp             --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHHHTTCCCCCC
T ss_pred             cCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHHHHcCCCCCCC
Confidence            2345688999999988888999999999999999999 999997653321                11222222223445


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      ..++..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          243 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            66788899999999999999999999999999988743

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.5e-42  Score=290.27  Aligned_cols=236  Identities=23%  Similarity=0.257  Sum_probs=185.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCC------------------------CCCChhHHHHHHHHccCCCCcccccceEEEe
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP------------------------KNYPDDEKQLVSVVSRLKHENLVELLGYCVE   57 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~------------------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   57 (285)
                      .||+|.+..+++.+++|........                        ....+.+.+|++++++++||||+++++++.+
T Consensus        28 ~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  107 (298)
T 2zv2_A           28 VVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDD  107 (298)
T ss_dssp             EEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             EEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            5899988888999999977544321                        1235778999999999999999999999986


Q ss_pred             --CCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC
Q 023220           58 --GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF  135 (285)
Q Consensus        58 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~  135 (285)
                        ....++||||+.+++|.+++...          .+++..++.++.|++.||.|||+.   |++||||||+||+++.++
T Consensus       108 ~~~~~~~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~  174 (298)
T 2zv2_A          108 PNEDHLYMVFELVNQGPVMEVPTLK----------PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDG  174 (298)
T ss_dssp             SSSSEEEEEEECCTTCBSCCSSCSS----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTS
T ss_pred             CCCCEEEEEEecCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCC
Confidence              56889999999999998765433          289999999999999999999999   999999999999999999


Q ss_pred             eeEEeccccCCCCCcccccccccccccccCcCCCcccccCC---CCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhh
Q 023220          136 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV  212 (285)
Q Consensus       136 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~  212 (285)
                      .++|+|||++.........  .....|++.|+|||.+.+..   ++.++|||||||++|+|++|..||..........  
T Consensus       175 ~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--  250 (298)
T 2zv2_A          175 HIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS--  250 (298)
T ss_dssp             CEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--
T ss_pred             CEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHH--
Confidence            9999999998755432211  23356899999999987654   3788999999999999999999997543211111  


Q ss_pred             hhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          213 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                                   .+............+++.+.++|.+||+.||.+|||+.++++
T Consensus       251 -------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          251 -------------KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             -------------HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -------------HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence                         111111111223456778999999999999999999999876

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.6e-42  Score=286.98  Aligned_cols=243  Identities=21%  Similarity=0.259  Sum_probs=193.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++... .+..+++|..+..   ....+++.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        23 ~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   98 (268)
T 3sxs_A           23 VVKLGKWK-GQYDVAVKMIKEG---SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG   98 (268)
T ss_dssp             EEEEEEET-TTEEEEEEEECBT---TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG
T ss_pred             eEEEEEec-CceeEEEEEeccC---CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC
Confidence            47888443 4556788776532   2235778999999999999999999999999999999999999999999997643


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++......... ......
T Consensus        99 ~--------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~  166 (268)
T 3sxs_A           99 K--------GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSVGTK  166 (268)
T ss_dssp             G--------GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-ECCSCC
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh-cccCCC
Confidence            2        289999999999999999999999   9999999999999999999999999998654432221 122344


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      +++.|+|||.+.+..++.++|+||||+++|+|++ |..||.........                ..+........+...
T Consensus       167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~  230 (268)
T 3sxs_A          167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV----------------LKVSQGHRLYRPHLA  230 (268)
T ss_dssp             CCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----------------HHHHTTCCCCCCTTS
T ss_pred             cCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH----------------HHHHcCCCCCCCCcC
Confidence            5678999999988889999999999999999998 99999754322111                111111122334455


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      ++.+.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          231 SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            778999999999999999999999999999987653

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.2e-42  Score=296.10  Aligned_cols=256  Identities=22%  Similarity=0.292  Sum_probs=191.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCe----eeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL----RVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~~~~~~L~~~   76 (285)
                      .||+|.+..+++.+++|........ ......+.+|+.++++++||||+++++++.....    .++||||+.+++|.++
T Consensus        27 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~  106 (311)
T 3ork_A           27 EVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI  106 (311)
T ss_dssp             EEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHH
T ss_pred             EEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHH
Confidence            5899998888999999987653322 2234578899999999999999999999876543    4999999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-c
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-L  155 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~  155 (285)
                      +.....         +++..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++......... .
T Consensus       107 l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  174 (311)
T 3ork_A          107 VHTEGP---------MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT  174 (311)
T ss_dssp             HHHHCS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-----------
T ss_pred             HHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccc
Confidence            976542         89999999999999999999999   9999999999999999999999999999765432211 1


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE  235 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
                      ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.................. ..            ..
T Consensus       175 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~------------~~  241 (311)
T 3ork_A          175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI-PP------------SA  241 (311)
T ss_dssp             -------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-CH------------HH
T ss_pred             cccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-Cc------------cc
Confidence            122345899999999999989999999999999999999999999765432211111000000 00            00


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhchhhcCCCCCCCC
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPN-MSIVVKALQPLLKSPPPAAPV  282 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps-~~~ll~~l~~~~~~~~~~~~~  282 (285)
                      ....++.++.++|.+||+.||.+||+ ++++...|.+.....+|.+|.
T Consensus       242 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~  289 (311)
T 3ork_A          242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK  289 (311)
T ss_dssp             HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCC
T ss_pred             ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCc
Confidence            12335678999999999999999995 555667777777666665554

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.5e-42  Score=289.84  Aligned_cols=244  Identities=24%  Similarity=0.331  Sum_probs=202.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|....++..+++|....   .....+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        28 ~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~  104 (288)
T 3kfa_A           28 EVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN  104 (288)
T ss_dssp             SEEEEEEGGGTEEEEEEEECS---CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCC
T ss_pred             eEEEeEecCCCEEEEEEecCc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcc
Confidence            689999888888899887753   23345788899999999999999999999999999999999999999999997644


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++......... ......
T Consensus       105 ~~-------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~  173 (288)
T 3kfa_A          105 RQ-------EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAK  173 (288)
T ss_dssp             TT-------TSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE-EETTEE
T ss_pred             cC-------CccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccc-cccCCc
Confidence            32       289999999999999999999999   9999999999999999999999999998765432211 122344


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      +++.|+|||.+.+..++.++|+||||+++|+|++ |..||.......                ....+........+..+
T Consensus       174 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~  237 (288)
T 3kfa_A          174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEKDYRMERPEGC  237 (288)
T ss_dssp             ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----------------HHHHHHTTCCCCCCTTC
T ss_pred             cccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHhccCCCCCCCCC
Confidence            6778999999998899999999999999999999 999997654321                11222222333445667


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      ++.+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       238 ~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          238 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            78899999999999999999999999999988753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.5e-43  Score=299.74  Aligned_cols=262  Identities=24%  Similarity=0.307  Sum_probs=200.5

Q ss_pred             eeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC--CeeeEEEeeCCCCCHHHHhccCCC
Q 023220            5 LCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG--NLRVLAYEFATMGSLHDILHGRKG   82 (285)
Q Consensus         5 ~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~   82 (285)
                      ++....+++.+++|..... ......+.+.+|++++++++||||+++++++.+.  ...++||||+.+++|.+++.... 
T Consensus        53 ~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-  130 (318)
T 3lxp_A           53 DPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-  130 (318)
T ss_dssp             CSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC-
T ss_pred             ccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC-
Confidence            3344567788888887543 2223456789999999999999999999999874  67899999999999999997653 


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-ccccccc
Q 023220           83 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-LHSTRVL  161 (285)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~  161 (285)
                               +++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++......... .......
T Consensus       131 ---------~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  198 (318)
T 3lxp_A          131 ---------IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD  198 (318)
T ss_dssp             ---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CC
T ss_pred             ---------CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCC
Confidence                     88999999999999999999999   9999999999999999999999999999765432211 1123345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ++..|+|||.+.+..++.++||||||+++|+|++|..||........ ..................+........+..++
T Consensus       199 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (318)
T 3lxp_A          199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELLERGERLPRPDKCP  277 (318)
T ss_dssp             CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCC
T ss_pred             CCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHHhcccCCCCCcccc
Confidence            67889999999988899999999999999999999999864321100 00001111111222333444444556677788


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCCC
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAP  281 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  281 (285)
                      ..+.++|.+||+.||.+|||+.++++.|+++.+...+++|
T Consensus       278 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p  317 (318)
T 3lxp_A          278 AEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP  317 (318)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence            8999999999999999999999999999999877666655

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.2e-41  Score=295.81  Aligned_cols=237  Identities=19%  Similarity=0.201  Sum_probs=183.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|.....   ....+.+.+|+.++++++||||+++++++.+.+..++||||+.+|+|.+++....
T Consensus        35 ~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  111 (361)
T 3uc3_A           35 VARLMRDKLTKELVAVKYIERG---AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG  111 (361)
T ss_dssp             SEEEEEETTTCCEEEEEEEESS---TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS
T ss_pred             EEEEEEECCCCcEEEEEEEecC---ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC
Confidence            6899999989999999987532   3345788999999999999999999999999999999999999999999997644


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCe--eEEeccccCCCCCcccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK--AKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      .         +++..++.++.|++.||.|||+.   |++||||||+||+++.++.  ++|+|||++.......   ....
T Consensus       112 ~---------~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~  176 (361)
T 3uc3_A          112 R---------FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKS  176 (361)
T ss_dssp             S---------CCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------------
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC---CCCC
Confidence            2         89999999999999999999999   9999999999999987665  9999999986432221   1234


Q ss_pred             cccccCcCCCcccccCCCCcc-cchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQK-SDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ..|++.|+|||++.+..++.+ +|||||||++|+|++|+.||..........           .....+...........
T Consensus       177 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~  245 (361)
T 3uc3_A          177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR-----------KTIQRILSVKYSIPDDI  245 (361)
T ss_dssp             ----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH-----------HHHHHHHTTCCCCCTTS
T ss_pred             CcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH-----------HHHHHHhcCCCCCCCcC
Confidence            568999999999988877655 899999999999999999998654322211           11111222222122223


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+++.+.++|.+||+.||.+|||+.++++
T Consensus       246 ~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          246 RISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             CCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            45678999999999999999999999997

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=287.91  Aligned_cols=251  Identities=22%  Similarity=0.293  Sum_probs=195.3

Q ss_pred             Cceeeeeeeecc---ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCee-eEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEE---SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR-VLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~---~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~lv~e~~~~~~L~~~l   77 (285)
                      .||+|.......   .+++|..... ......+.+.+|++++++++||||+++++++.+.+.. +++|+|+.+++|.+++
T Consensus        36 ~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~  114 (298)
T 3pls_A           36 VVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI  114 (298)
T ss_dssp             EEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHH
T ss_pred             eEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHH
Confidence            478887544333   5777766432 2222356788999999999999999999999876655 9999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc--cc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA--RL  155 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~  155 (285)
                      .....        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ..
T Consensus       115 ~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  183 (298)
T 3pls_A          115 RSPQR--------NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ  183 (298)
T ss_dssp             HCTTC--------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSC
T ss_pred             hcccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccc
Confidence            76432        288999999999999999999999   999999999999999999999999999976543221  11


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCC-CCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP-VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|..| |.......                ....+......
T Consensus       184 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~----------------~~~~~~~~~~~  247 (298)
T 3pls_A          184 QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----------------LTHFLAQGRRL  247 (298)
T ss_dssp             CSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG----------------HHHHHHTTCCC
T ss_pred             cCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH----------------HHHHhhcCCCC
Confidence            22334578899999999998999999999999999999995555 43332211                11111112223


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCC
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAA  280 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  280 (285)
                      ..+..+++.+.+++.+||+.||.+|||+.++++.|+++++...+..
T Consensus       248 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~  293 (298)
T 3pls_A          248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH  293 (298)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred             CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence            3455567889999999999999999999999999999987665443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.1e-42  Score=302.02  Aligned_cols=255  Identities=22%  Similarity=0.285  Sum_probs=198.9

Q ss_pred             Cceeee-----eeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCC-eeeEEEeeCCCCCHH
Q 023220            2 RRWLCC-----TCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGN-LRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~   74 (285)
                      .||+|.     ...+++.+++|..+... .....+.+.+|+++++++ +||||+++++++.+.+ ..++||||+.+|+|.
T Consensus        37 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~  115 (359)
T 3vhe_A           37 QVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS  115 (359)
T ss_dssp             EEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHH
T ss_pred             eEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHH
Confidence            478887     45556788888775322 222345788999999999 8899999999998755 489999999999999


Q ss_pred             HHhccCCCCC---------------------------------------------------------CCCCCCCCCHHHH
Q 023220           75 DILHGRKGVQ---------------------------------------------------------GAQPGPVLDWMTR   97 (285)
Q Consensus        75 ~~l~~~~~~~---------------------------------------------------------~~~~~~~~~~~~~   97 (285)
                      +++.......                                                         .......+++..+
T Consensus       116 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  195 (359)
T 3vhe_A          116 TYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL  195 (359)
T ss_dssp             HHHHTTTTSBCSCC------------------------------------------------------CTTTTCBCHHHH
T ss_pred             HHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHH
Confidence            9997654210                                                         0001223889999


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccccCCC
Q 023220           98 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL  177 (285)
Q Consensus        98 ~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  177 (285)
                      +.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++................|++.|+|||.+.+..+
T Consensus       196 ~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  272 (359)
T 3vhe_A          196 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY  272 (359)
T ss_dssp             HHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCC
Confidence            99999999999999999   999999999999999999999999999976543332222344567889999999999899


Q ss_pred             CcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCC
Q 023220          178 TQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEA  256 (285)
Q Consensus       178 ~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  256 (285)
                      +.++||||||+++|+|++ |..||........               +...+........+..+++++.+++.+||+.||
T Consensus       273 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP  337 (359)
T 3vhe_A          273 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP  337 (359)
T ss_dssp             CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred             CchhhhhhHHHHHHHHHhcCCCCCCccchhHH---------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence            999999999999999998 9999976543211               111111222233455667889999999999999


Q ss_pred             CCCCCHHHHHHHhchhhcC
Q 023220          257 EFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       257 ~~Rps~~~ll~~l~~~~~~  275 (285)
                      .+|||+.++++.|+.+++.
T Consensus       338 ~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          338 SQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             GGSCCHHHHHHHHHHHHHH
T ss_pred             hhCCCHHHHHHHHHHHHHH
Confidence            9999999999999998864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.6e-42  Score=294.65  Aligned_cols=258  Identities=27%  Similarity=0.333  Sum_probs=195.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC----eeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN----LRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l   77 (285)
                      .||++...  ++.+++|......   .......+|+.++++++||||+++++++....    .+++||||+.+|+|.+++
T Consensus        39 ~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l  113 (322)
T 3soc_A           39 CVWKAQLL--NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL  113 (322)
T ss_dssp             EEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHH
T ss_pred             EEEEEEEC--CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHH
Confidence            57888543  6778888764321   22344556888899999999999999998754    469999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------CCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV-------QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD  150 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~-------~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~  150 (285)
                      ....          +++..++.++.|++.||.|||+..       +.|++||||||+||+++.++.++|+|||++.....
T Consensus       114 ~~~~----------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~  183 (322)
T 3soc_A          114 KANV----------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA  183 (322)
T ss_dssp             HHCC----------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECT
T ss_pred             HhcC----------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccccc
Confidence            7653          899999999999999999999751       23799999999999999999999999999965443


Q ss_pred             ccccccccccccccCcCCCcccccC-----CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh
Q 023220          151 MAARLHSTRVLGTFGYHAPEYAMTG-----QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK  225 (285)
Q Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
                      ...........|++.|+|||.+.+.     .++.++|||||||++|+|++|+.||.+.......................
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  263 (322)
T 3soc_A          184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ  263 (322)
T ss_dssp             TSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHH
T ss_pred             ccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhh
Confidence            3222223345689999999998763     45678899999999999999999998765544433333323333333332


Q ss_pred             hhc-CCccCCCCC-----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          226 QCV-DPKLKGEYP-----PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       226 ~~~-~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ... ........+     ...++.+.++|.+||+.||++|||+.++++.|+++.+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          264 EVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            222 222222222     2456779999999999999999999999999998865

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.1e-41  Score=292.61  Aligned_cols=248  Identities=15%  Similarity=0.168  Sum_probs=196.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|.....    ...+.+.+|+++++++ +||||+++++++...+..++||||+ +++|.+++...
T Consensus        24 ~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~   98 (330)
T 2izr_A           24 ELRLGKNLYTNEYVAIKLEPMK----SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC   98 (330)
T ss_dssp             SEEEEEETTTTEEEEEEEEETT----CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred             eEEEEEECCCCcEEEEEEeccc----cchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc
Confidence            6899998888999999976532    2346789999999999 9999999999999999999999999 88999999864


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCe-----eEEeccccCCCCCcccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK-----AKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~-----~~l~df~~~~~~~~~~~~~  155 (285)
                      ..        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.     ++|+|||++..........
T Consensus        99 ~~--------~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~  167 (330)
T 2izr_A           99 DR--------TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKK  167 (330)
T ss_dssp             TT--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCC
T ss_pred             CC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCc
Confidence            22        289999999999999999999999   9999999999999998887     9999999997543322111


Q ss_pred             -----cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          156 -----HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       156 -----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                           ......|++.|+|||.+.+..++.++|||||||++|+|++|..||..................       ....+
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-------~~~~~  240 (330)
T 2izr_A          168 HIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT-------KRATP  240 (330)
T ss_dssp             BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH-------HHHSC
T ss_pred             cccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh-------hccCC
Confidence                 123456899999999999999999999999999999999999999875433222111111000       00000


Q ss_pred             ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          231 KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      .  ......++ ++.+++.+||+.||.+||++.++++.|+.+...
T Consensus       241 ~--~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          241 I--EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             H--HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             H--HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence            0  00012234 899999999999999999999999999888743

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.6e-42  Score=287.02  Aligned_cols=239  Identities=21%  Similarity=0.296  Sum_probs=194.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC--CeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG--NLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++...  ++.+++|..+.........+.+.+|+.++++++||||+++++++.+.  +..+++|||+.+++|.+++..
T Consensus        25 ~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  102 (271)
T 3kmu_A           25 ELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE  102 (271)
T ss_dssp             EEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHS
T ss_pred             eEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhh
Confidence            47888663  66688887766554445567889999999999999999999999877  778999999999999999986


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~--~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      ....       .+++..++.++.|++.||.|||+.   |  ++|+||+|+||+++.++.++++|||.+.....       
T Consensus       103 ~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------  165 (271)
T 3kmu_A          103 GTNF-------VVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------  165 (271)
T ss_dssp             CSSC-------CCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------
T ss_pred             cccC-------CCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc-------
Confidence            5432       289999999999999999999999   8  99999999999999999999998887654322       


Q ss_pred             cccccccCcCCCcccccCCCCc---ccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQ---KSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~---~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      ....|++.|+|||.+.+..++.   ++||||||+++|+|++|+.||.......               ............
T Consensus       166 ~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------------~~~~~~~~~~~~  230 (271)
T 3kmu_A          166 PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME---------------IGMKVALEGLRP  230 (271)
T ss_dssp             TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH---------------HHHHHHHSCCCC
T ss_pred             cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH---------------HHHHHHhcCCCC
Confidence            2345789999999988765544   7999999999999999999997543211               111222222333


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ..+..++..+.+++.+||+.||++|||++++++.|+++.+
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            4566678889999999999999999999999999998764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.2e-42  Score=294.42  Aligned_cols=257  Identities=21%  Similarity=0.305  Sum_probs=201.0

Q ss_pred             Cceeeee-----eeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCT-----CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||++..     ..++..+++|...... .....+.+.+|+++++++ +||||+++++++.+.+..++||||+.+++|.+
T Consensus        38 ~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  116 (313)
T 1t46_A           38 KVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN  116 (313)
T ss_dssp             EEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred             ceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHH
Confidence            4777763     3456778888765332 122357788999999999 99999999999999999999999999999999


Q ss_pred             HhccCCCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220           76 ILHGRKGVQG---------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus        76 ~l~~~~~~~~---------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      ++........         ......+++..++.++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||++.
T Consensus       117 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  193 (313)
T 1t46_A          117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR  193 (313)
T ss_dssp             HHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGS
T ss_pred             HHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCCEEEccccccc
Confidence            9976542100         01112389999999999999999999999   99999999999999999999999999997


Q ss_pred             CCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhh
Q 023220          147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVK  225 (285)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
                      ...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||........               ..
T Consensus       194 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---------------~~  258 (313)
T 1t46_A          194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---------------FY  258 (313)
T ss_dssp             CTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---------------HH
T ss_pred             cccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH---------------HH
Confidence            6654333222333456788999999988899999999999999999998 9999976543211               11


Q ss_pred             hhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          226 QCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                      ..+........+..++..+.+++.+||+.||.+|||+.++++.|+++++..+
T Consensus       259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            1111122223345567889999999999999999999999999999987544

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.4e-41  Score=287.39  Aligned_cols=259  Identities=33%  Similarity=0.524  Sum_probs=199.7

Q ss_pred             CceeeeeeeeccccChhhhhhcc--CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLK--SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++..  .+..+++|......  ......+.+.+|+.++++++||||+++++++.+.+..+++|||+.+++|.+++..
T Consensus        46 ~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  123 (307)
T 2nru_A           46 VVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC  123 (307)
T ss_dssp             EEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT
T ss_pred             EEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHh
Confidence            4788765  46677787665433  2234467889999999999999999999999999999999999999999999975


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ....      ..+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++..............
T Consensus       124 ~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  194 (307)
T 2nru_A          124 LDGT------PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR  194 (307)
T ss_dssp             GGGC------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSS
T ss_pred             ccCC------CCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccc
Confidence            3221      1389999999999999999999999   999999999999999999999999999865443222222334


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||.+.+ .++.++|+||||+++|+|++|..||...........+...... ....+...+++.. ...+..
T Consensus       195 ~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~  271 (307)
T 2nru_A          195 IVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIED-EEKTIEDYIDKKM-NDADST  271 (307)
T ss_dssp             CCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHT-TSCCHHHHSCSSC-SCCCHH
T ss_pred             cCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhh-hhhhhhhhccccc-cccchH
Confidence            568999999998765 4789999999999999999999999865433222111110000 0111223333332 345678


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      .++.+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       272 ~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          272 SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            88999999999999999999999999999998753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.1e-41  Score=298.60  Aligned_cols=243  Identities=20%  Similarity=0.233  Sum_probs=193.2

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||+|....+++.|++|..++... .....+.+.+|..++.++ +||||+++++++.+.+..++||||+.+|+|..++..
T Consensus        67 ~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~  146 (396)
T 4dc2_A           67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR  146 (396)
T ss_dssp             EEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHH
Confidence            589999999999999998765543 344567788999999887 899999999999999999999999999999999976


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++........  ....
T Consensus       147 ~~~---------l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~  212 (396)
T 4dc2_A          147 QRK---------LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTST  212 (396)
T ss_dssp             HSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCC
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCCC--cccc
Confidence            542         89999999999999999999999   999999999999999999999999999975322211  2344


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchh-hhhhhcCCccCCCCCh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED-KVKQCVDPKLKGEYPP  238 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  238 (285)
                      ..||+.|+|||++.+..++.++|+|||||++|+|++|+.||..........       ..... ....+...  ...++.
T Consensus       213 ~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~-------~~~~~~~~~~i~~~--~~~~p~  283 (396)
T 4dc2_A          213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------QNTEDYLFQVILEK--QIRIPR  283 (396)
T ss_dssp             CCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCHHHHHHHHHHC--CCCCCT
T ss_pred             ccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc-------hhhHHHHHHHHhcc--ccCCCC
Confidence            568999999999999999999999999999999999999997543211100       00001 11111111  123556


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNM------SIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~------~~ll~  267 (285)
                      .++.++.++|++||+.||.+||++      +++++
T Consensus       284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence            678889999999999999999985      56655

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-42  Score=291.50  Aligned_cols=232  Identities=21%  Similarity=0.295  Sum_probs=195.1

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.+..+++.|++|..++... .....+.+.+|+.+++.++||||+++++++.+....++||||+.+|+|.+++...
T Consensus        21 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~  100 (318)
T 1fot_A           21 RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS  100 (318)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHc
Confidence            589999888899999997754332 2345677889999999999999999999999999999999999999999999865


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++......     ....
T Consensus       101 ~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~  163 (318)
T 1fot_A          101 QR---------FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTL  163 (318)
T ss_dssp             SS---------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCC
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc-----cccc
Confidence            42         89999999999999999999999   9999999999999999999999999998754331     2335


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||++.+..++.++|+|||||++|+|++|..||........               ...+....  ..++...
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---------------~~~i~~~~--~~~p~~~  226 (318)
T 1fot_A          164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---------------YEKILNAE--LRFPPFF  226 (318)
T ss_dssp             CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---------------HHHHHHCC--CCCCTTS
T ss_pred             cCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---------------HHHHHhCC--CCCCCCC
Confidence            689999999999998999999999999999999999999976432211               11122211  1345567


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRP-----NMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp-----s~~~ll~  267 (285)
                      ++++.++|.+||+.||.+||     +++++++
T Consensus       227 ~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            78899999999999999999     8999985

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.2e-42  Score=289.27  Aligned_cols=247  Identities=24%  Similarity=0.366  Sum_probs=182.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++...   ..+++|..+.........+.+.+|++++++++||||++++++. .....++||||+.+++|.+++....
T Consensus        39 ~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~  114 (289)
T 3og7_A           39 TVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASE  114 (289)
T ss_dssp             EEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC-
T ss_pred             EEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhcc
Confidence            46776543   3477777765555555567889999999999999999999965 4556899999999999999996543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||++................
T Consensus       115 ~--------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  183 (289)
T 3og7_A          115 T--------KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS  183 (289)
T ss_dssp             ----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------------------
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccccccccccC
Confidence            2        289999999999999999999999   99999999999999999999999999987554322222223456


Q ss_pred             cccCcCCCcccc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          162 GTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       162 ~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      |++.|+|||.+.   +..++.++||||||+++|+|++|+.||.............           .....+........
T Consensus       184 gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~  252 (289)
T 3og7_A          184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV-----------GRGSLSPDLSKVRS  252 (289)
T ss_dssp             CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH-----------HHTSCCCCTTSSCT
T ss_pred             CCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh-----------cccccCcchhhccc
Confidence            899999999886   5678889999999999999999999997643321111000           00000001112344


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      .+++.+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus       253 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          253 NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            567889999999999999999999999999998865

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=292.23  Aligned_cols=252  Identities=18%  Similarity=0.215  Sum_probs=190.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|............+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        18 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~   97 (311)
T 4agu_A           18 VVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR   97 (311)
T ss_dssp             EEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSS
T ss_pred             EEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhc
Confidence            58999988889999999776554444446778899999999999999999999999999999999999989998887554


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++.........  .....
T Consensus        98 ~---------~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~  163 (311)
T 4agu_A           98 G---------VPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY--YDDEV  163 (311)
T ss_dssp             C---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------------
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--cCCCc
Confidence            2         89999999999999999999999   9999999999999999999999999998755432211  23346


Q ss_pred             cccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC---------Cc
Q 023220          162 GTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD---------PK  231 (285)
Q Consensus       162 ~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~  231 (285)
                      |++.|+|||.+.+ ..++.++||||+|+++|+|++|..||.+.........+.................         +.
T Consensus       164 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (311)
T 4agu_A          164 ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPD  243 (311)
T ss_dssp             --GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCC
T ss_pred             CCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCC
Confidence            7899999999876 5679999999999999999999999987654433322222111111110000000         00


Q ss_pred             cCCC-----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          232 LKGE-----YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       232 ~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ....     ..+.++..+.+++.+||+.||.+|||++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          244 PEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000     01346778999999999999999999999987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5e-42  Score=306.65  Aligned_cols=251  Identities=29%  Similarity=0.418  Sum_probs=196.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.... +..+++|..+...   ...+.+.+|++++++++||||+++++++.+ +..++||||+.+|+|.+++....
T Consensus       199 ~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~  273 (452)
T 1fmk_A          199 EVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET  273 (452)
T ss_dssp             EEEEEEETT-TEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHH
T ss_pred             EEEEEEECC-CceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcC
Confidence            478886654 3457888765422   345789999999999999999999999876 66899999999999999997532


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.|++.||.|||++   |++||||+|+||+++.++.++|+|||++......... ......
T Consensus       274 ~~-------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~  342 (452)
T 1fmk_A          274 GK-------YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAK  342 (452)
T ss_dssp             HT-------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------------
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee-cccCCc
Confidence            11       288999999999999999999999   9999999999999999999999999999765432211 112334


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....                .+...+....+...+..+
T Consensus       343 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----------------~~~~~i~~~~~~~~~~~~  406 (452)
T 1fmk_A          343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----------------EVLDQVERGYRMPCPPEC  406 (452)
T ss_dssp             CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HHHHHHHTTCCCCCCTTS
T ss_pred             ccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHcCCCCCCCCCC
Confidence            6778999999998899999999999999999999 99999754321                122222223334556678


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCCCCCC
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPVSE  284 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~~~  284 (285)
                      ++.+.++|.+||+.||.+|||++++++.|+.+.....|..-+.+
T Consensus       407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~~~  450 (452)
T 1fmk_A          407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE  450 (452)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccccccc
Confidence            88999999999999999999999999999999987766554443

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.6e-41  Score=291.11  Aligned_cols=255  Identities=25%  Similarity=0.327  Sum_probs=197.2

Q ss_pred             Cceeeeeeeecccc--ChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESY--PSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~--~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||+|....++..+  ++|..+.. ......+.+.+|+++++++ +||||+++++++.+.+..++||||+.+++|.+++.
T Consensus        40 ~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  118 (327)
T 1fvr_A           40 QVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR  118 (327)
T ss_dssp             EEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH
T ss_pred             eEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHH
Confidence            58999887776655  67766432 3344567899999999999 99999999999999999999999999999999997


Q ss_pred             cCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcc
Q 023220           79 GRKGVQG-------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM  151 (285)
Q Consensus        79 ~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~  151 (285)
                      .......       ......+++..++.++.|++.||.|||+.   |++||||+|+||+++.++.++|+|||++......
T Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~  195 (327)
T 1fvr_A          119 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY  195 (327)
T ss_dssp             TTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEE
T ss_pred             hcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEcccCcCcccccc
Confidence            6530000       00011389999999999999999999999   9999999999999999999999999998643322


Q ss_pred             cccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                      .   ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......                ....+..
T Consensus       196 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----------------~~~~~~~  256 (327)
T 1fvr_A          196 V---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----------------LYEKLPQ  256 (327)
T ss_dssp             C---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------------HHHHGGG
T ss_pred             c---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH----------------HHHHhhc
Confidence            1   1223446788999999988888999999999999999998 999997653211                1111122


Q ss_pred             ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          231 KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                      ......+..+++.+.+++.+||+.||.+|||+.++++.|++++......
T Consensus       257 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  305 (327)
T 1fvr_A          257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY  305 (327)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence            2223345567788999999999999999999999999999998765543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.8e-42  Score=287.89  Aligned_cols=242  Identities=21%  Similarity=0.301  Sum_probs=195.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++... .+..+++|..+..   ....+++.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        39 ~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  114 (283)
T 3gen_A           39 VVKYGKWR-GQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR  114 (283)
T ss_dssp             EEEEEEET-TTEEEEEEEECTT---SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGG
T ss_pred             eEEEEEEc-CCCeEEEEEecCC---CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhc
Confidence            47777444 4555777766532   2235788999999999999999999999999999999999999999999997643


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||++......... ......
T Consensus       115 ~--------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~  182 (283)
T 3gen_A          115 H--------RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSK  182 (283)
T ss_dssp             G--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-STTSTT
T ss_pred             c--------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc-cccCCc
Confidence            2        289999999999999999999999   9999999999999999999999999998755432211 123344


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      +++.|+|||.+.+..++.++|+||||+++|+|++ |+.||.......                ....+........+...
T Consensus       183 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~  246 (283)
T 3gen_A          183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQGLRLYRPHLA  246 (283)
T ss_dssp             SCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----------------HHHHHHTTCCCCCCTTC
T ss_pred             cCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH----------------HHHHHhcccCCCCCCcC
Confidence            6778999999998889999999999999999998 999997543221                11111222223344556


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      ++.+.+++.+||+.||.+|||+.++++.|+.++..
T Consensus       247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          247 SEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            77899999999999999999999999999998754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.2e-41  Score=291.21  Aligned_cols=253  Identities=21%  Similarity=0.298  Sum_probs=196.2

Q ss_pred             Cceeeeee-----eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTC-----QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||+|...     .++..+++|...... .......+.+|++++++++||||+++++++.+.+..++||||+.+++|.++
T Consensus        40 ~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~  118 (322)
T 1p4o_A           40 MVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY  118 (322)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred             EEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHH
Confidence            57888766     456778888765322 222345688999999999999999999999999999999999999999999


Q ss_pred             hccCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           77 LHGRKGVQ-GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        77 l~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      +....... .......+++..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++..........
T Consensus       119 l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  195 (322)
T 1p4o_A          119 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR  195 (322)
T ss_dssp             HHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEE
T ss_pred             HHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCccccccccccccc
Confidence            97532100 000001278899999999999999999999   99999999999999999999999999987554332222


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........                ...+......
T Consensus       196 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----------------~~~~~~~~~~  259 (322)
T 1p4o_A          196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----------------LRFVMEGGLL  259 (322)
T ss_dssp             GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH----------------HHHHHTTCCC
T ss_pred             cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH----------------HHHHHcCCcC
Confidence            2233456788999999998889999999999999999999 8999975432211                1111111112


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ..+..++..+.+++.+||+.||.+|||+.++++.|++.+.
T Consensus       260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            3355677889999999999999999999999999998754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.8e-42  Score=288.80  Aligned_cols=251  Identities=19%  Similarity=0.267  Sum_probs=189.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.+ .+++.+++|............+.+.+|++++++++||||+++++++.+.+..++||||+.+ +|.+++....
T Consensus        17 ~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~   94 (288)
T 1ob3_A           17 VVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCE   94 (288)
T ss_dssp             EEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTST
T ss_pred             EEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcc
Confidence            5888877 5577889998766555566678899999999999999999999999999999999999985 9999987643


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .++...+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++........  ......
T Consensus        95 ~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~  161 (288)
T 1ob3_A           95 G--------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEI  161 (288)
T ss_dssp             T--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------
T ss_pred             c--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--cccccc
Confidence            2        288999999999999999999999   999999999999999999999999999864322111  122345


Q ss_pred             cccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchh---hhh--hhcCCcc---
Q 023220          162 GTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED---KVK--QCVDPKL---  232 (285)
Q Consensus       162 ~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~--~~~~~~~---  232 (285)
                      |++.|+|||.+.+. .++.++|||||||++|+|++|..||...........+..........   ...  ...++..   
T Consensus       162 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T 1ob3_A          162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY  241 (288)
T ss_dssp             CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCC
T ss_pred             ccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccc
Confidence            78999999998764 58999999999999999999999998654332221111110000000   000  0011111   


Q ss_pred             ----CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          233 ----KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       233 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                          ........++++.++|.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                11122346788999999999999999999999987

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7e-42  Score=287.26  Aligned_cols=244  Identities=24%  Similarity=0.322  Sum_probs=183.0

Q ss_pred             Cceeeeeeeec---cccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVE---ESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++.....+   ..+++|..+.. ......+.+.+|+.++++++||||+++++++. .+..++||||+.+++|.+++.
T Consensus        30 ~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~  107 (281)
T 1mp8_A           30 DVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ  107 (281)
T ss_dssp             EEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHH
T ss_pred             eEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHH
Confidence            47888765433   34666655432 22234567889999999999999999999985 456799999999999999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......... ...
T Consensus       108 ~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~  175 (281)
T 1mp8_A          108 VRKY--------SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KAS  175 (281)
T ss_dssp             HTTT--------TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------------
T ss_pred             hcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccccc-ccc
Confidence            6532        289999999999999999999999   9999999999999999999999999998765432211 122


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||..........                .+........+
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~----------------~i~~~~~~~~~  239 (281)
T 1mp8_A          176 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG----------------RIENGERLPMP  239 (281)
T ss_dssp             ---CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----------------HHHTTCCCCCC
T ss_pred             cCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHH----------------HHHcCCCCCCC
Confidence            3345778999999988889999999999999999996 999997654322111                11111122345


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      ..+++.+.+++.+||+.||.+|||+.++++.|+.+++.
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            66788899999999999999999999999999988753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.2e-42  Score=297.04  Aligned_cols=240  Identities=22%  Similarity=0.252  Sum_probs=190.3

Q ss_pred             CceeeeeeeeccccChhhhhhcc---CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLK---SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||+|.+..+++.+++|......   ......+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+.+.
T Consensus        39 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~  118 (351)
T 3c0i_A           39 VVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIV  118 (351)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHH
Confidence            58999998899999999765432   223356789999999999999999999999999999999999999999988875


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCe---eEEeccccCCCCCcccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK---AKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~---~~l~df~~~~~~~~~~~~~  155 (285)
                      .....     ...+++..++.++.|++.||.|||++   |++||||||+||+++.++.   ++|+|||++........  
T Consensus       119 ~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--  188 (351)
T 3c0i_A          119 KRADA-----GFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--  188 (351)
T ss_dssp             HHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--
T ss_pred             Hhccc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--
Confidence            43211     11288999999999999999999999   9999999999999976554   99999999876543221  


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC-
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG-  234 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  234 (285)
                      ......|++.|+|||++.+..++.++|||||||++|+|++|..||.......                ...+....... 
T Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------------~~~i~~~~~~~~  252 (351)
T 3c0i_A          189 VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL----------------FEGIIKGKYKMN  252 (351)
T ss_dssp             BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH----------------HHHHHHTCCCCC
T ss_pred             eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH----------------HHHHHcCCCCCC
Confidence            1234568999999999998889999999999999999999999997642110                00111100000 


Q ss_pred             -CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          235 -EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       235 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                       .....+++++.++|.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             001235678999999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2e-41  Score=302.54  Aligned_cols=237  Identities=27%  Similarity=0.362  Sum_probs=192.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC-eeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN-LRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++...  ++.+++|..+.    ....+.+.+|++++++++||||+++++++.... ..++||||+.+|+|.+++...
T Consensus       208 ~V~~~~~~--~~~vavK~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~  281 (450)
T 1k9a_A          208 DVMLGDYR--GNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR  281 (450)
T ss_dssp             EEEEEEET--TEEEEEEEESS----CTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH
T ss_pred             eEEEEEec--CCeEEEEEeCC----chHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc
Confidence            46777543  45688887653    235788999999999999999999999987765 789999999999999999865


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...       .++...++.++.|++.|+.|||++   |++||||+|+||+++.++.++|+|||++.......     ...
T Consensus       282 ~~~-------~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~  346 (450)
T 1k9a_A          282 GRS-------VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTG  346 (450)
T ss_dssp             CTT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------
T ss_pred             CCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cCC
Confidence            321       278899999999999999999999   99999999999999999999999999986433211     122


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      .++..|+|||.+.+..++.++||||||+++|+|++ |..||.......                +...+....+...+..
T Consensus       347 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----------------~~~~i~~~~~~~~p~~  410 (450)
T 1k9a_A          347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVPRVEKGYKMDAPDG  410 (450)
T ss_dssp             CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT----------------HHHHHHTTCCCCCCTT
T ss_pred             CCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCCCCCCCc
Confidence            46788999999999999999999999999999998 999997543221                1112222233455667


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      +++.+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus       411 ~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          411 CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            888999999999999999999999999999988754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.2e-41  Score=283.17  Aligned_cols=239  Identities=25%  Similarity=0.285  Sum_probs=193.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|....... ....+.+.+|+.++++++||||+++++++.+++..++||||+.+++|.+++....
T Consensus        22 ~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  100 (276)
T 2yex_A           22 EVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI  100 (276)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT
T ss_pred             EEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhcc
Confidence            589998888889999998754432 3346788999999999999999999999999999999999999999999987543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                               .++...++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++................
T Consensus       101 ---------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  168 (276)
T 2yex_A          101 ---------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC  168 (276)
T ss_dssp             ---------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCC
T ss_pred             ---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCc
Confidence                     289999999999999999999999   99999999999999999999999999987554322222233456


Q ss_pred             cccCcCCCcccccCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      |++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.........              ...+............+
T Consensus       169 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~  234 (276)
T 2yex_A          169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--------------YSDWKEKKTYLNPWKKI  234 (276)
T ss_dssp             SCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--------------HHHHHTTCTTSTTGGGS
T ss_pred             cccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--------------HHHhhhcccccCchhhc
Confidence            8899999999887765 67899999999999999999999765432111              01111111111123456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +..+.++|.+||+.||.+|||++++++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          235 DSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            778999999999999999999999987

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-42  Score=288.50  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=197.4

Q ss_pred             Cceeeeee--eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTC--QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++...  ..+..+++|..+.. ......+.+.+|++++++++||||+++++++ ..+..++||||+.+++|.+++..
T Consensus        25 ~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~  102 (287)
T 1u59_A           25 SVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG  102 (287)
T ss_dssp             EEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTT
T ss_pred             eEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh
Confidence            47888643  34556788876543 2233466788999999999999999999999 45568999999999999999965


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-cccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-LHST  158 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~  158 (285)
                      ...        .+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++......... ....
T Consensus       103 ~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  171 (287)
T 1u59_A          103 KRE--------EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  171 (287)
T ss_dssp             CTT--------TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred             CCc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence            432        289999999999999999999999   9999999999999999999999999998755432211 1122


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.......                ....+........+
T Consensus       172 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~~~~i~~~~~~~~~  235 (287)
T 1u59_A          172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------------VMAFIEQGKRMECP  235 (287)
T ss_dssp             SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----------------HHHHHHTTCCCCCC
T ss_pred             cccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH----------------HHHHHhcCCcCCCC
Confidence            3346788999999988889999999999999999998 999997654321                11111122223455


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCC
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAA  280 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  280 (285)
                      ..+++.+.++|.+||+.||.+|||+.++++.|+.+......+.
T Consensus       236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~  278 (287)
T 1u59_A          236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  278 (287)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred             CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence            6778899999999999999999999999999999986554443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=9.6e-42  Score=286.64  Aligned_cols=238  Identities=19%  Similarity=0.236  Sum_probs=194.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..++..+++|............+.+.+|++++++++||||+++++++.+.+..+++|||+.+++|.+.+....
T Consensus        21 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~  100 (284)
T 3kk8_A           21 VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE  100 (284)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS
T ss_pred             EEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcC
Confidence            58999988889999999887666555556788899999999999999999999999999999999999999998887654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCe---eEEeccccCCCCCccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK---AKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      .         +++..++.++.|++.|+.|||+.   |++||||+|+||+++.++.   ++|+|||++........   ..
T Consensus       101 ~---------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~  165 (284)
T 3kk8_A          101 F---------YSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WH  165 (284)
T ss_dssp             S---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CC
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---cc
Confidence            2         89999999999999999999999   9999999999999976554   99999999865443221   23


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ...|++.|+|||.+.+..++.++||||||+++|+|++|..||.................             ........
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------~~~~~~~~  232 (284)
T 3kk8_A          166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY-------------DYPSPEWD  232 (284)
T ss_dssp             CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-------------CCCTTTTT
T ss_pred             CCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc-------------cCCchhhc
Confidence            35689999999999998999999999999999999999999976543221111111000             01111223


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+++.+.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          233 TVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            56778999999999999999999999988

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=9.2e-42  Score=295.16  Aligned_cols=232  Identities=17%  Similarity=0.195  Sum_probs=195.0

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|....+++.|++|...+.. ......+.+.+|++++++++||||+++++++.+.+..++||||+.+|+|.+++...
T Consensus        56 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~  135 (350)
T 1rdq_E           56 RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI  135 (350)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc
Confidence            58999988889999999765433 23345678899999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++......     ....
T Consensus       136 ~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~  198 (350)
T 1rdq_E          136 GR---------FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTL  198 (350)
T ss_dssp             CC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCC
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-----cccc
Confidence            32         89999999999999999999999   9999999999999999999999999998755332     2334


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||++.+..++.++|+|||||++|+|++|..||........               ...+....  ..++..+
T Consensus       199 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---------------~~~i~~~~--~~~p~~~  261 (350)
T 1rdq_E          199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---------------YEKIVSGK--VRFPSHF  261 (350)
T ss_dssp             EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---------------HHHHHHCC--CCCCTTC
T ss_pred             cCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH---------------HHHHHcCC--CCCCCCC
Confidence            689999999999998999999999999999999999999976543211               11111111  1345567


Q ss_pred             HHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPN-----MSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps-----~~~ll~  267 (285)
                      +.++.++|.+||+.||.+||+     ++++++
T Consensus       262 ~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            788999999999999999998     888876

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2e-41  Score=289.84  Aligned_cols=238  Identities=21%  Similarity=0.280  Sum_probs=193.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCC----CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKN----YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||+|.+..+++.+++|..........    ..+.+.+|+.++++++||||+++++++.+.+..++||||+.+++|.+++
T Consensus        27 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  106 (321)
T 2a2a_A           27 IVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL  106 (321)
T ss_dssp             EEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred             EEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHH
Confidence            589999888889999998765543332    3577899999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC----eeEEeccccCCCCCcccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~----~~~l~df~~~~~~~~~~~  153 (285)
                      .....         +++..++.++.|++.||.|||+.   |++|+||+|+||+++.++    .++|+|||++........
T Consensus       107 ~~~~~---------~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~  174 (321)
T 2a2a_A          107 AQKES---------LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE  174 (321)
T ss_dssp             HTCSC---------EEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC
T ss_pred             HhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc
Confidence            76432         89999999999999999999999   999999999999999887    799999999875543221


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                         .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+........             
T Consensus       175 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-------------  238 (321)
T 2a2a_A          175 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD-------------  238 (321)
T ss_dssp             ---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-------------
T ss_pred             ---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC-------------
Confidence               2344689999999999988899999999999999999999999976543221111110000000             


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          234 GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .......++.+.++|.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0011245677999999999999999999999997

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=298.96  Aligned_cols=235  Identities=19%  Similarity=0.228  Sum_probs=191.2

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||+|.+..+++.|++|..++.. ......+.+.+|.++++.+ +||||+++++++.+.+..++||||+.+|+|.+++..
T Consensus        38 ~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~  117 (353)
T 3txo_A           38 KVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK  117 (353)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred             EEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH
Confidence            58999998889999999776432 2234567788999999988 799999999999999999999999999999999976


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++........  ....
T Consensus       118 ~~~---------~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~--~~~~  183 (353)
T 3txo_A          118 SRR---------FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTAT  183 (353)
T ss_dssp             HSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCCc--cccc
Confidence            542         89999999999999999999999   999999999999999999999999999875332221  1234


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..||+.|+|||++.+..++.++|+|||||++|+|++|..||.........               ..+....  ..++..
T Consensus       184 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~---------------~~i~~~~--~~~p~~  246 (353)
T 3txo_A          184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF---------------EAILNDE--VVYPTW  246 (353)
T ss_dssp             --CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---------------HHHHHCC--CCCCTT
T ss_pred             cCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH---------------HHHHcCC--CCCCCC
Confidence            56899999999998888999999999999999999999999765432211               1111111  134555


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNM------SIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~------~~ll~  267 (285)
                      .+.++.++|++||+.||.+||++      +++++
T Consensus       247 ~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          247 LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            77889999999999999999998      77765

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.8e-41  Score=290.63  Aligned_cols=246  Identities=17%  Similarity=0.217  Sum_probs=176.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|....+++.+++|.....     ....+.+|+++++++. ||||+++++++.+....++||||+.+++|.+++...
T Consensus        26 ~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  100 (325)
T 3kn6_A           26 ICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK  100 (325)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC
T ss_pred             EEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc
Confidence            5899999888999999987532     3567889999999996 999999999999999999999999999999999875


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC---eeEEeccccCCCCCcccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF---KAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      ..         +++..+..++.|++.||.|||++   |++||||||+||+++.++   .++|+|||++.........  .
T Consensus       101 ~~---------~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--~  166 (325)
T 3kn6_A          101 KH---------FSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--L  166 (325)
T ss_dssp             SC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--c
Confidence            42         89999999999999999999999   999999999999997665   8999999998754332211  2


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC--C
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG--E  235 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  235 (285)
                      ....|++.|+|||.+.+..++.++|||||||++|+|++|..||...........        ..+....+.......  .
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--------~~~~~~~i~~~~~~~~~~  238 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS--------AVEIMKKIKKGDFSFEGE  238 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC--------HHHHHHHHTTTCCCCCSH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc--------HHHHHHHHHcCCCCCCcc
Confidence            334578999999999999999999999999999999999999976543211000        001111111111110  1


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      ....+++++.++|.+||+.||.+|||++++++  ..+++..
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--h~w~~~~  277 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY--NEWLQDG  277 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT--CGGGCTT
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc--ChhhccC
Confidence            11345778999999999999999999999986  5555443

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-41  Score=283.07  Aligned_cols=241  Identities=24%  Similarity=0.349  Sum_probs=194.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++... .++.+++|......   ...+.+.+|++++++++||||+++++++.+.+..+++|||+.+++|.+++....
T Consensus        23 ~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   98 (267)
T 3t9t_A           23 LVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR   98 (267)
T ss_dssp             EEEEEEET-TTEEEEEEEECTTT---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTT
T ss_pred             eEEEEEec-CCCeEEEEEccccC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCc
Confidence            47888664 45567777665432   234788999999999999999999999999999999999999999999997653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........ .......
T Consensus        99 ~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~  166 (267)
T 3t9t_A           99 G--------LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTK  166 (267)
T ss_dssp             T--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTT
T ss_pred             c--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc-ccccccc
Confidence            2        288999999999999999999999   999999999999999999999999999875433221 1123345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+.+..++.++|+||||+++|+|++ |..||........                ...+........+...
T Consensus       167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------------~~~i~~~~~~~~~~~~  230 (267)
T 3t9t_A          167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----------------VEDISTGFRLYKPRLA  230 (267)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------HHHHHTTCCCCCCTTS
T ss_pred             ccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH----------------HHHHhcCCcCCCCccC
Confidence            6778999999988889999999999999999999 8999975432111                1111111222334556


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      +..+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          231 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            7789999999999999999999999999998875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.7e-42  Score=300.24  Aligned_cols=253  Identities=21%  Similarity=0.278  Sum_probs=192.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceEEEeCC--eeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGN--LRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||+|.+..+++.+++|............+.+.+|+.+++++. ||||+++++++...+  ..++||||+. ++|.+++.
T Consensus        24 ~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~  102 (388)
T 3oz6_A           24 IVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIR  102 (388)
T ss_dssp             CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHH
Confidence            6899999999999999987654444445667789999999996 999999999998544  6899999998 59999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc------
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA------  152 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~------  152 (285)
                      .+.          ++...+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.......      
T Consensus       103 ~~~----------~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~  169 (388)
T 3oz6_A          103 ANI----------LEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI  169 (388)
T ss_dssp             HTC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCG
T ss_pred             cCC----------CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccc
Confidence            643          88999999999999999999999   99999999999999999999999999986542210      


Q ss_pred             -------------ccccccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 023220          153 -------------ARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR  218 (285)
Q Consensus       153 -------------~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (285)
                                   .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  249 (388)
T 3oz6_A          170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDF  249 (388)
T ss_dssp             GGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence                         0111223468999999999876 57899999999999999999999999877654443333222222


Q ss_pred             CchhhhhhhcCC-----------------ccCC-------------CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          219 LSEDKVKQCVDP-----------------KLKG-------------EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       219 ~~~~~~~~~~~~-----------------~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                      ...+.+..+..+                 ....             .....+++++.++|.+||+.||.+|||++++++.
T Consensus       250 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          250 PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             CCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             CCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence            222111111000                 0000             0111446789999999999999999999999984

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=294.31  Aligned_cols=237  Identities=19%  Similarity=0.343  Sum_probs=187.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCC--CcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH--ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++.+. .++.|++|............+.+.+|++++++++|  |||+++++++.++...++|||+ .+++|.+++..
T Consensus        24 ~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~  101 (343)
T 3dbq_A           24 KVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK  101 (343)
T ss_dssp             EEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHH
T ss_pred             EEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHh
Confidence            58888774 47788999876555444556788999999999977  9999999999999999999995 56799999987


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||+.   |++||||||+||+++ ++.++|+|||++..............
T Consensus       102 ~~~---------~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~  168 (343)
T 3dbq_A          102 KKS---------IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS  168 (343)
T ss_dssp             SCC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----------
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCC
Confidence            542         88999999999999999999999   999999999999997 57899999999987654333222334


Q ss_pred             cccccCcCCCccccc-----------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhc
Q 023220          160 VLGTFGYHAPEYAMT-----------GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV  228 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
                      ..|++.|+|||.+.+           ..++.++|||||||++|+|++|+.||......              .......+
T Consensus       169 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------------~~~~~~~~  234 (343)
T 3dbq_A          169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--------------ISKLHAII  234 (343)
T ss_dssp             -CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--------------HHHHHHHH
T ss_pred             CcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--------------HHHHHHHh
Confidence            568999999999864           56789999999999999999999999653221              12233344


Q ss_pred             CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          229 DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ++......+...+.++.+++.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            444444556666778999999999999999999999987

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-41  Score=295.99  Aligned_cols=247  Identities=21%  Similarity=0.245  Sum_probs=195.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC------eeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN------LRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.+..+++.+++|............+++.+|++++++++||||+++++++....      ..++||||+ +++|.+
T Consensus        40 ~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~  118 (367)
T 1cm8_A           40 AVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGK  118 (367)
T ss_dssp             CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHH
T ss_pred             EEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHH
Confidence            6899999888999999977554434444677889999999999999999999998653      459999999 679999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++....          +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......    
T Consensus       119 ~~~~~~----------l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----  181 (367)
T 1cm8_A          119 LMKHEK----------LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----  181 (367)
T ss_dssp             HHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS----
T ss_pred             HHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccccc----
Confidence            997643          88999999999999999999999   9999999999999999999999999998754321    


Q ss_pred             cccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC-----
Q 023220          156 HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD-----  229 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  229 (285)
                       .....+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+.......+.+....+..     
T Consensus       182 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  260 (367)
T 1cm8_A          182 -MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  260 (367)
T ss_dssp             -CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             -cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence             233567999999999877 6789999999999999999999999987665444333322222222221111100     


Q ss_pred             -----C----ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          230 -----P----KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       230 -----~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                           +    ..........++.+.+++.+||+.||.+|||++++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                 0    0011223455778999999999999999999999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.1e-41  Score=290.73  Aligned_cols=250  Identities=22%  Similarity=0.294  Sum_probs=187.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|.....  .....+.+.+|++++.++ +||||+++++++.+.+..++||||+.+++|.+++...
T Consensus        28 ~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  105 (316)
T 2ac3_A           28 RVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR  105 (316)
T ss_dssp             EEEEEECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH
T ss_pred             EEEEEEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc
Confidence            5899998888999999987543  344567899999999985 7999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCe---eEEeccccCCCCCcccc----
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK---AKIADFNLSNQAPDMAA----  153 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~---~~l~df~~~~~~~~~~~----  153 (285)
                      ..         +++..++.++.|++.||.|||++   |++||||||+||+++.++.   ++|+|||++........    
T Consensus       106 ~~---------~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (316)
T 2ac3_A          106 RH---------FNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI  173 (316)
T ss_dssp             SS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccc
Confidence            42         88999999999999999999999   9999999999999987765   99999999865432111    


Q ss_pred             -cccccccccccCcCCCccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh
Q 023220          154 -RLHSTRVLGTFGYHAPEYAMT-----GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC  227 (285)
Q Consensus       154 -~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (285)
                       ........|++.|+|||.+.+     ..++.++|||||||++|+|++|..||..........................+
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  253 (316)
T 2ac3_A          174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI  253 (316)
T ss_dssp             --------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHH
T ss_pred             cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHH
Confidence             011123458999999999865     45788999999999999999999999875432211000000000000001111


Q ss_pred             cCCccCCCCC----hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          228 VDPKLKGEYP----PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       228 ~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .....  ..+    ..++..+.++|.+||+.||.+|||+.++++
T Consensus       254 ~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          254 QEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            11111  112    235678999999999999999999999998

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1e-41  Score=290.09  Aligned_cols=257  Identities=18%  Similarity=0.228  Sum_probs=191.2

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.....+..+++|....... .....+.+.+|++++++++||||+++++++...+..+++|||+.+++|.+++...
T Consensus        47 ~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  126 (310)
T 2wqm_A           47 EVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHF  126 (310)
T ss_dssp             EEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHH
T ss_pred             eEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHh
Confidence            588998877888899987764322 2334567889999999999999999999999999999999999999999998642


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...     ...++...++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........  .....
T Consensus       127 ~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~  196 (310)
T 2wqm_A          127 KKQ-----KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSL  196 (310)
T ss_dssp             HHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------------------
T ss_pred             ccc-----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc--ccccc
Confidence            110     01288999999999999999999999   999999999999999999999999999876543221  12334


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||.+.+..++.++||||||+++|+|++|..||.+........             ...+............+
T Consensus       197 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~  263 (310)
T 2wqm_A          197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-------------CKKIEQCDYPPLPSDHY  263 (310)
T ss_dssp             --CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHH-------------HHHHHTTCSCCCCTTTS
T ss_pred             CCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHH-------------HHHhhcccCCCCccccc
Confidence            57899999999998889999999999999999999999997543211100             01111111111122456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCCC
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAP  281 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  281 (285)
                      ++++.+++.+||+.||.+|||+.++++.|+++....++|+.
T Consensus       264 ~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~  304 (310)
T 2wqm_A          264 SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE  304 (310)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence            77899999999999999999999999999999877776653

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=291.38  Aligned_cols=228  Identities=22%  Similarity=0.264  Sum_probs=191.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCC------CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCC-CHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKN------YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMG-SLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~-~L~   74 (285)
                      .||++.+..+++.+++|..........      ..+.+.+|++++++++||||+++++++.+.+..++||||+.+| +|.
T Consensus        39 ~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~  118 (335)
T 3dls_A           39 FVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLF  118 (335)
T ss_dssp             SEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHH
T ss_pred             EEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHH
Confidence            689999988899999998776543322      4567888999999999999999999999999999999999776 999


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  154 (285)
                      +++.....         +++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........ 
T Consensus       119 ~~~~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-  185 (335)
T 3dls_A          119 AFIDRHPR---------LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL-  185 (335)
T ss_dssp             HHHHTCCC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred             HHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceECCCCCc-
Confidence            99986542         89999999999999999999999   999999999999999999999999999875543221 


Q ss_pred             ccccccccccCcCCCcccccCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          155 LHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                        .....|++.|+|||.+.+..+ +.++|||||||++|+|++|..||......                     ...  .
T Consensus       186 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------------~~~--~  240 (335)
T 3dls_A          186 --FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------------VEA--A  240 (335)
T ss_dssp             --BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------------TTT--C
T ss_pred             --eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------------Hhh--c
Confidence              233468999999999988877 78999999999999999999999642110                     000  0


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          234 GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...+..+++++.++|.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          241 IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1223346678999999999999999999999998

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-41  Score=291.64  Aligned_cols=247  Identities=21%  Similarity=0.320  Sum_probs=188.8

Q ss_pred             Cceeeeeeeecc----ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEE----SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||+|.......    .+++|..+... .......+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++
T Consensus        59 ~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  137 (333)
T 1mqb_A           59 EVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL  137 (333)
T ss_dssp             EEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHH
T ss_pred             EEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHH
Confidence            578887654433    37777664322 2223456889999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc-c
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL-H  156 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~  156 (285)
                      .....        .+++..++.++.|++.||.|||+.   |++||||+|+||+++.++.++|+|||++.......... .
T Consensus       138 ~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  206 (333)
T 1mqb_A          138 REKDG--------EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT  206 (333)
T ss_dssp             HHTTT--------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------------
T ss_pred             HhCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccccccc
Confidence            76432        289999999999999999999999   99999999999999999999999999987654322111 1


Q ss_pred             ccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC
Q 023220          157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE  235 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......                .+...+.......
T Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----------------~~~~~~~~~~~~~  270 (333)
T 1mqb_A          207 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----------------EVMKAINDGFRLP  270 (333)
T ss_dssp             ----CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHHHHHHTTCCCC
T ss_pred             cCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH----------------HHHHHHHCCCcCC
Confidence            122345678999999998899999999999999999998 99999654321                1111111122233


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      .+..++..+.+++.+||+.||.+||++.++++.|++++...
T Consensus       271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            45567788999999999999999999999999999887543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=288.19  Aligned_cols=258  Identities=20%  Similarity=0.231  Sum_probs=195.7

Q ss_pred             CceeeeeeeeccccChhhhhhccC---CCCCChhHHHHHHHHccCC---CCcccccceEEEeCC-----eeeEEEeeCCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS---PKNYPDDEKQLVSVVSRLK---HENLVELLGYCVEGN-----LRVLAYEFATM   70 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~-----~~~lv~e~~~~   70 (285)
                      .||+|.+..+++.+++|.......   .......+.+|++++++++   ||||+++++++....     ..+++||++. 
T Consensus        24 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-  102 (308)
T 3g33_A           24 TVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-  102 (308)
T ss_dssp             CEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-
T ss_pred             EEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-
Confidence            689999988999999998765442   2334567888888888774   999999999998765     5799999997 


Q ss_pred             CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCc
Q 023220           71 GSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD  150 (285)
Q Consensus        71 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~  150 (285)
                      ++|.+++......       .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.....
T Consensus       103 ~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  172 (308)
T 3g33_A          103 QDLRTYLDKAPPP-------GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSY  172 (308)
T ss_dssp             CBHHHHHHTCCTT-------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSCTTTSTT
T ss_pred             cCHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCccccccCC
Confidence            5999999865432       289999999999999999999999   999999999999999999999999999976543


Q ss_pred             ccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhh----
Q 023220          151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQ----  226 (285)
Q Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----  226 (285)
                      ...   .....|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.........+..............    
T Consensus       173 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (308)
T 3g33_A          173 QMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL  249 (308)
T ss_dssp             CCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSS
T ss_pred             Ccc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhc
Confidence            221   2345689999999999988999999999999999999999999987654333222221111111110000    


Q ss_pred             ---hcCC---ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          227 ---CVDP---KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       227 ---~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                         ...+   .......+.+++.+.++|.+||+.||++|||+.++++  ..+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--h~~~~~  302 (308)
T 3g33_A          250 PRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ--HSYLHK  302 (308)
T ss_dssp             CGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--STTC--
T ss_pred             cccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc--CccccC
Confidence               0000   0000112345678999999999999999999999997  455443

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.7e-42  Score=295.93  Aligned_cols=263  Identities=21%  Similarity=0.258  Sum_probs=200.2

Q ss_pred             Cceeee----eeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEE--eCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCC----TCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV--EGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.    +..++..+++|.....  .....+.+.+|++++++++||||+++++++.  +....++||||+.+++|.+
T Consensus        38 ~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~  115 (327)
T 3lxl_A           38 SVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD  115 (327)
T ss_dssp             EEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHH
T ss_pred             EEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHH
Confidence            478886    5667788888876532  2233466899999999999999999999887  4567899999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-  154 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-  154 (285)
                      ++.....        .+++..++.++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||++......... 
T Consensus       116 ~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  184 (327)
T 3lxl_A          116 FLQRHRA--------RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY  184 (327)
T ss_dssp             HHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEE
T ss_pred             HHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccCCccc
Confidence            9976432        289999999999999999999999   9999999999999999999999999999755432211 


Q ss_pred             ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      .......++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ................+......
T Consensus       185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  263 (327)
T 3lxl_A          185 VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERDVPALSRLLELLEEGQRL  263 (327)
T ss_dssp             ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC----CCHHHHHHHHHHTTCCC
T ss_pred             eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-cccccccccHHHHHHHhhcccCC
Confidence            11233457788999999998889999999999999999999999986432211000 00011111122333344444455


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                      ..+..+++.+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus       264 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  307 (327)
T 3lxl_A          264 PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG  307 (327)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred             CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence            56777889999999999999999999999999999998754443

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-41  Score=289.87  Aligned_cols=251  Identities=18%  Similarity=0.179  Sum_probs=190.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|........ ....+.+.+|+.++++++||||+++++++..++..+++|||+.+++|.+++...
T Consensus        49 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  128 (309)
T 2h34_A           49 DVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ  128 (309)
T ss_dssp             EEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH
T ss_pred             eEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc
Confidence            5899988888889999987654332 233577889999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++......... .....
T Consensus       129 ~~---------~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~  195 (309)
T 2h34_A          129 GP---------LAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNT  195 (309)
T ss_dssp             CS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----------------
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccccc-ccccc
Confidence            32         89999999999999999999999   9999999999999999999999999998755432211 12234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||.+.+..++.++|+||||+++|+|++|..||............   ....           ......+..+
T Consensus       196 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~-----------~~~~~~~~~~  261 (309)
T 2h34_A          196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI---NQAI-----------PRPSTVRPGI  261 (309)
T ss_dssp             -CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH---HSCC-----------CCGGGTSTTC
T ss_pred             CCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh---ccCC-----------CCccccCCCC
Confidence            5889999999999888999999999999999999999999754321110000   0000           0011224456


Q ss_pred             HHHHHHHHHHhcccCCCCCC-CHHHHHHHhchhhcCCCCC
Q 023220          241 VAKLAAVAALCVQYEAEFRP-NMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp-s~~~ll~~l~~~~~~~~~~  279 (285)
                      +..+.++|.+||+.||.+|| |++++++.|++++....+.
T Consensus       262 ~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~  301 (309)
T 2h34_A          262 PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD  301 (309)
T ss_dssp             CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred             CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence            67899999999999999999 9999999999988766544

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4e-41  Score=310.80  Aligned_cols=244  Identities=24%  Similarity=0.347  Sum_probs=194.4

Q ss_pred             Cceeeeeee--eccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQ--VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++....  .+..+++|..+.. ......+.+.+|++++++++||||+++++++.. +..++||||+.+|+|.+++..
T Consensus       351 ~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~  428 (613)
T 2ozo_A          351 SVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG  428 (613)
T ss_dssp             EEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTT
T ss_pred             EEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhh
Confidence            578876543  3455888877543 334467889999999999999999999999976 568999999999999999975


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc-ccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL-HST  158 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~  158 (285)
                      ...        .+++..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++.......... ...
T Consensus       429 ~~~--------~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  497 (613)
T 2ozo_A          429 KRE--------EIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  497 (613)
T ss_dssp             CTT--------TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             ccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence            432        289999999999999999999999   99999999999999999999999999997654322111 111


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...+++.|+|||.+.+..++.++|||||||++|+|++ |+.||......                .+...+....+...+
T Consensus       498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~p  561 (613)
T 2ozo_A          498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----------------EVMAFIEQGKRMECP  561 (613)
T ss_dssp             ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH----------------HHHHHHHTTCCCCCC
T ss_pred             CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH----------------HHHHHHHcCCCCCCC
Confidence            2335678999999998899999999999999999998 99999765432                122222233334556


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ..+++++.++|.+||+.||.+|||+.++++.|+.+..
T Consensus       562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            7788899999999999999999999999999988763

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.4e-42  Score=316.99  Aligned_cols=245  Identities=23%  Similarity=0.331  Sum_probs=198.1

Q ss_pred             Cceeeee--eeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCT--CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||+|..  ..+...+++|..+.........+.+.+|++++++++||||+++++++.. +..++||||+.+|+|.+++..
T Consensus       384 ~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~  462 (635)
T 4fl3_A          384 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ  462 (635)
T ss_dssp             EEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH
T ss_pred             EEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhh
Confidence            5788844  3456788999887665555667889999999999999999999999975 457899999999999999976


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-cccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-LHST  158 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~  158 (285)
                      ...         +++..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++......... ....
T Consensus       463 ~~~---------l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  530 (635)
T 4fl3_A          463 NRH---------VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  530 (635)
T ss_dssp             CTT---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred             CCC---------CCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence            542         89999999999999999999999   9999999999999999999999999998654322211 1122


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.+...                ..+...+........+
T Consensus       531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----------------~~~~~~i~~~~~~~~p  594 (635)
T 4fl3_A          531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----------------SEVTAMLEKGERMGCP  594 (635)
T ss_dssp             ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHHHHHTTCCCCCC
T ss_pred             CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHcCCCCCCC
Confidence            2345778999999999899999999999999999998 9999975432                2222333333344556


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      ..++.++.++|.+||+.||++|||++++++.|+.+..+
T Consensus       595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            77888999999999999999999999999999987643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.4e-41  Score=285.40  Aligned_cols=257  Identities=18%  Similarity=0.193  Sum_probs=197.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC--eeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN--LRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||+|.+..+++.+++|....... ....+.+.+|++++++++||||+++++++....  ..++||||+.+++|.+++..
T Consensus        24 ~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  102 (319)
T 4euu_A           24 NVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE  102 (319)
T ss_dssp             EEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHS
T ss_pred             EEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHH
Confidence            589999988899999998764333 234677889999999999999999999998765  77999999999999999986


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE----ccCCeeEEeccccCCCCCcccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL----FEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~----~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      .....      .+++..++.++.|++.||.|||+.   |++||||||+||++    +.++.++|+|||++........  
T Consensus       103 ~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~--  171 (319)
T 4euu_A          103 PSNAY------GLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--  171 (319)
T ss_dssp             GGGTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC--
T ss_pred             hcccc------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc--
Confidence            53211      289999999999999999999999   99999999999999    7788899999999976543221  


Q ss_pred             cccccccccCcCCCcccc--------cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCccc-chhhhhhcccCchhhhh-
Q 023220          156 HSTRVLGTFGYHAPEYAM--------TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ-QSLVTWATPRLSEDKVK-  225 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~--------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~-  225 (285)
                       .....|++.|+|||.+.        +..++.++|||||||++|+|++|..||........ ...........+..... 
T Consensus       172 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~  250 (319)
T 4euu_A          172 -FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG  250 (319)
T ss_dssp             -BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEE
T ss_pred             -eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchh
Confidence             23346899999999876        46789999999999999999999999975432211 11111111000000000 


Q ss_pred             --hh------c--CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          226 --QC------V--DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       226 --~~------~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                        ..      +  ............+..+.+++.+||+.||++|||++++++....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             EECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             hhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence              00      0  0011124557889999999999999999999999999998754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.4e-41  Score=285.31  Aligned_cols=249  Identities=22%  Similarity=0.299  Sum_probs=189.9

Q ss_pred             Cceeeeeeeec---cccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEE-eCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVE---ESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV-EGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||+|.....+   ..+++|..... ......+.+.+|+.++++++||||+++++++. .++..+++|||+.+++|.+++
T Consensus        40 ~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l  118 (298)
T 3f66_A           40 CVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI  118 (298)
T ss_dssp             EEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHH
T ss_pred             eEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHH
Confidence            47888654332   23566655432 12223567889999999999999999999864 456789999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc--c
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR--L  155 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~  155 (285)
                      .....        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.........  .
T Consensus       119 ~~~~~--------~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  187 (298)
T 3f66_A          119 RNETH--------NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVH  187 (298)
T ss_dssp             HCTTC--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-
T ss_pred             Hhccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchhccc
Confidence            76432        278999999999999999999999   9999999999999999999999999999765433211  1


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      ......+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...........                .......
T Consensus       188 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~----------------~~~~~~~  251 (298)
T 3f66_A          188 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY----------------LLQGRRL  251 (298)
T ss_dssp             ----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH----------------HHTTCCC
T ss_pred             cccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH----------------HhcCCCC
Confidence            1223456788999999998899999999999999999999 5666654432211111                1111122


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                      ..+..++..+.+++.+||+.||.+|||+.++++.|++++.....
T Consensus       252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          252 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            23445677899999999999999999999999999999876543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-41  Score=297.39  Aligned_cols=237  Identities=19%  Similarity=0.189  Sum_probs=191.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|......  ......+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        66 ~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~  143 (387)
T 1kob_A           66 VVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED  143 (387)
T ss_dssp             EEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT
T ss_pred             EEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhc
Confidence            58999988888999998765321  1124578899999999999999999999999999999999999999999997543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc--CCeeEEeccccCCCCCcccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE--DFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      .        .+++..++.++.|++.||.|||+.   |++||||||+||+++.  .+.++|+|||++........   ...
T Consensus       144 ~--------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~  209 (387)
T 1kob_A          144 Y--------KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKV  209 (387)
T ss_dssp             C--------CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEE
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc---eee
Confidence            2        289999999999999999999999   9999999999999974  57799999999876543221   123


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..             ............
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~-------------~~~~~~~~~~~~  276 (387)
T 1kob_A          210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR-------------CDWEFDEDAFSS  276 (387)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH-------------CCCCCCSSTTTT
T ss_pred             eccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------CCCCCCcccccc
Confidence            4689999999999988899999999999999999999999976543211111100             001111222345


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +++++.++|.+||+.||.+|||+.++++
T Consensus       277 ~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          277 VSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            6788999999999999999999999998

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.1e-41  Score=304.25  Aligned_cols=237  Identities=22%  Similarity=0.273  Sum_probs=193.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.|++|............+.+.+|++++++++||||+++++++.+....++||||+.+++|.+.+....
T Consensus        37 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  116 (486)
T 3mwu_A           37 EVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK  116 (486)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS
T ss_pred             EEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC
Confidence            58999998899999999876655555567889999999999999999999999999999999999999999999887654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEc---cCCeeEEeccccCCCCCccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      .         +++..+..++.|++.||.|||++   |++||||||+||+++   .++.++|+|||++........   ..
T Consensus       117 ~---------~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~  181 (486)
T 3mwu_A          117 R---------FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MK  181 (486)
T ss_dssp             S---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc---cC
Confidence            2         89999999999999999999999   999999999999995   456799999999875543221   23


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ...|++.|+|||++.+ .++.++||||+||++|+|++|..||.+.........+......             .......
T Consensus       182 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------------~~~~~~~  247 (486)
T 3mwu_A          182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA-------------FDLPQWR  247 (486)
T ss_dssp             CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-------------SCSGGGG
T ss_pred             CCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------CCCcccC
Confidence            4568999999999876 5899999999999999999999999765432211111110000             0011123


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+++++.++|.+||+.||.+|||+.++++
T Consensus       248 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          248 TISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             GSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            56778999999999999999999999998

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1e-41  Score=292.74  Aligned_cols=251  Identities=16%  Similarity=0.166  Sum_probs=183.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.+..+++.+++|..+.........+.+.+|++++++++||||+++++++.+++..++||||+.+ +|.+++....
T Consensus        49 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~  127 (329)
T 3gbz_A           49 EVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP  127 (329)
T ss_dssp             EEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCT
T ss_pred             EEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcC
Confidence            589999998999999998876666666677888999999999999999999999999999999999985 9999998664


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE-----ccCCeeEEeccccCCCCCccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-----FEDFKAKIADFNLSNQAPDMAARLH  156 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~-----~~~~~~~l~df~~~~~~~~~~~~~~  156 (285)
                      .         +++..++.++.|++.||.|||+.   |++||||||+||++     +..+.++|+|||++........  .
T Consensus       128 ~---------~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~  193 (329)
T 3gbz_A          128 D---------VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--Q  193 (329)
T ss_dssp             T---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc--c
Confidence            3         89999999999999999999999   99999999999999     4556699999999864332111  1


Q ss_pred             ccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh-cCCccC-
Q 023220          157 STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC-VDPKLK-  233 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-  233 (285)
                      .....|++.|+|||.+.+. .++.++|||||||++|+|++|..||...........+............... ..+... 
T Consensus       194 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (329)
T 3gbz_A          194 FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQ  273 (329)
T ss_dssp             ------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhh
Confidence            2334578999999998774 4799999999999999999999999876543322222111111110000000 000000 


Q ss_pred             -----------CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          234 -----------GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       234 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                                 ......+++++.++|.+||+.||.+|||++++++
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          274 SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                       0011225678999999999999999999999987

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=296.87  Aligned_cols=237  Identities=20%  Similarity=0.217  Sum_probs=191.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..++..+++|..+...  ....+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus       104 ~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~  181 (373)
T 2x4f_A          104 QVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES  181 (373)
T ss_dssp             CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTG
T ss_pred             EEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC
Confidence            68999888888899999775422  1235678899999999999999999999999999999999999999999886543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE--ccCCeeEEeccccCCCCCcccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL--FEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~--~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      .        .+++..++.++.|++.||.|||+.   |++||||||+||++  +.++.++|+|||++........   ...
T Consensus       182 ~--------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~  247 (373)
T 2x4f_A          182 Y--------NLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKV  247 (373)
T ss_dssp             G--------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCC
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---ccc
Confidence            2        288999999999999999999999   99999999999999  5678999999999876543221   233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||.+.+..++.++|||||||++|+|++|..||...........+......             ........
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-------------~~~~~~~~  314 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD-------------LEDEEFQD  314 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-------------SCSGGGTT
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------------CChhhhcc
Confidence            45899999999998888999999999999999999999999765432211111100000             00111234


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +++++.++|.+||+.||.+|||+.++++
T Consensus       315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          315 ISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            5678999999999999999999999997

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.4e-42  Score=288.85  Aligned_cols=242  Identities=23%  Similarity=0.405  Sum_probs=188.1

Q ss_pred             Cceeeeeeeecc-------ccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQVEE-------SYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~-------~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   74 (285)
                      +||++....+++       .+++|.....  .....+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.
T Consensus        23 ~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  100 (289)
T 4fvq_A           23 KIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLD  100 (289)
T ss_dssp             EEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHH
T ss_pred             eEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHH
Confidence            588998877664       4777765432  2345678899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCe--------eEEeccccCC
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK--------AKIADFNLSN  146 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~--------~~l~df~~~~  146 (285)
                      +++.....        .+++..++.++.|++.||.|||++   |++||||||+||+++.++.        ++|+|||++.
T Consensus       101 ~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~  169 (289)
T 4fvq_A          101 TYLKKNKN--------CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI  169 (289)
T ss_dssp             HHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCT
T ss_pred             HHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccCcccc
Confidence            99986542        288999999999999999999999   9999999999999998877        9999999986


Q ss_pred             CCCcccccccccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCC-CCCCCCCcccchhhhhhcccCchhhh
Q 023220          147 QAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRK-PVDHTMPRGQQSLVTWATPRLSEDKV  224 (285)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
                      .....      ....+++.|+|||.+.+ ..++.++||||||+++|+|++|.. ||..........              
T Consensus       170 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~--------------  229 (289)
T 4fvq_A          170 TVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ--------------  229 (289)
T ss_dssp             TTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH--------------
T ss_pred             cccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH--------------
Confidence            54332      22346888999999887 678999999999999999999554 443322111110              


Q ss_pred             hhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCC
Q 023220          225 KQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAA  280 (285)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  280 (285)
                        ....  ....+...+.++.+++.+||+.||.+|||+.++++.|+++++...+++
T Consensus       230 --~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~  281 (289)
T 4fvq_A          230 --FYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR  281 (289)
T ss_dssp             --HHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred             --Hhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence              0000  112233345569999999999999999999999999999998655544

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.2e-41  Score=292.70  Aligned_cols=255  Identities=24%  Similarity=0.336  Sum_probs=196.9

Q ss_pred             Cceeeeee-------eeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCH
Q 023220            2 RRWLCCTC-------QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   73 (285)
                      .||+|...       ..+..+++|..+... .....+.+.+|+++++++ +||||+++++++.+.+..++||||+.+++|
T Consensus        50 ~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L  128 (334)
T 2pvf_A           50 QVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  128 (334)
T ss_dssp             EEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBH
T ss_pred             eEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcH
Confidence            47888654       345567777665322 222356788999999999 999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220           74 HDILHGRKGVQGA-------QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus        74 ~~~l~~~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      .+++.........       .....+++..++.++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||++.
T Consensus       129 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~  205 (334)
T 2pvf_A          129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR  205 (334)
T ss_dssp             HHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             HHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCCCEEEccccccc
Confidence            9999865421100       0112388999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhh
Q 023220          147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVK  225 (285)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
                      ...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......                +.
T Consensus       206 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~~  269 (334)
T 2pvf_A          206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----------------LF  269 (334)
T ss_dssp             ECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----------------HH
T ss_pred             cccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH----------------HH
Confidence            5543322222333456788999999988889999999999999999999 999997543221                11


Q ss_pred             hhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          226 QCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      ..+........+..++..+.+++.+||+.||.+|||+.++++.|++++...
T Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          270 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            111111222345567788999999999999999999999999999998543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.4e-41  Score=301.82  Aligned_cols=235  Identities=19%  Similarity=0.199  Sum_probs=185.6

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|...... ........+.+|++++++++||||+++++++.+.+..++||||+.+|+|.+++...
T Consensus       163 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  242 (446)
T 4ejn_A          163 KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE  242 (446)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHH
T ss_pred             EEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhc
Confidence            58999998899999999776543 34445677889999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ..         +++..+..++.|++.||.|||+ .   |++||||||+||+++.++.++|+|||++........  ....
T Consensus       243 ~~---------~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~  308 (446)
T 4ejn_A          243 RV---------FSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKT  308 (446)
T ss_dssp             SC---------CCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CC
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc--cccc
Confidence            42         8999999999999999999998 8   999999999999999999999999999875433222  1234


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|+.||..........               .+....  ..++..
T Consensus       309 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~---------------~i~~~~--~~~p~~  371 (446)
T 4ejn_A          309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---------------LILMEE--IRFPRT  371 (446)
T ss_dssp             SSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHHHCC--CCCCTT
T ss_pred             ccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH---------------HHHhCC--CCCCcc
Confidence            568999999999999999999999999999999999999997654321111               111111  134556


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRP-----NMSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~  267 (285)
                      +++++.++|.+||+.||.+||     |++++++
T Consensus       372 ~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          372 LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            778899999999999999999     9999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.8e-41  Score=284.43  Aligned_cols=237  Identities=24%  Similarity=0.348  Sum_probs=192.9

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..++..+++|...... ......+.+.+|++++++++||||+++++++.+....+++|||+.+++|.+++...
T Consensus        24 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~  103 (279)
T 3fdn_A           24 NVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL  103 (279)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH
T ss_pred             EEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc
Confidence            58999888888889999764432 22345677889999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         ++...++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++.......    ....
T Consensus       104 ~~---------~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~  167 (279)
T 3fdn_A          104 SK---------FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDL  167 (279)
T ss_dssp             SS---------CCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC------------
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc----cccc
Confidence            42         88999999999999999999999   99999999999999999999999999886543322    2334


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+.               .  .....+...
T Consensus       168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------------~--~~~~~~~~~  230 (279)
T 3fdn_A          168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---------------R--VEFTFPDFV  230 (279)
T ss_dssp             CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---------------H--TCCCCCTTS
T ss_pred             CCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH---------------h--CCCCCCCcC
Confidence            68999999999998889999999999999999999999997543221111111               0  112334556


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      +..+.++|.+||+.||.+|||++++++  ..++
T Consensus       231 ~~~~~~li~~~l~~~p~~Rps~~e~l~--h~~~  261 (279)
T 3fdn_A          231 TEGARDLISRLLKHNPSQRPMLREVLE--HPWI  261 (279)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHH--CHHH
T ss_pred             CHHHHHHHHHHhccChhhCCCHHHHhh--Cccc
Confidence            778999999999999999999999998  4444

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.8e-41  Score=297.60  Aligned_cols=237  Identities=19%  Similarity=0.345  Sum_probs=188.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC--CCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK--HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||+|.+.. ++.+++|............+.+.+|++++++++  ||||+++++++...+..++||| +.+++|.+++..
T Consensus        71 ~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~  148 (390)
T 2zmd_A           71 KVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK  148 (390)
T ss_dssp             EEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH
T ss_pred             EEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh
Confidence            588887765 788999987655544555678899999999996  5999999999999999999999 456799999986


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..++.++.|++.||.|||+.   |++||||||+||+++ ++.++|+|||++..............
T Consensus       149 ~~~---------~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~  215 (390)
T 2zmd_A          149 KKS---------IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS  215 (390)
T ss_dssp             CSS---------CCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CC
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCC
Confidence            542         88889999999999999999999   999999999999996 57899999999986654332222334


Q ss_pred             cccccCcCCCccccc-----------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhc
Q 023220          160 VLGTFGYHAPEYAMT-----------GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV  228 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
                      ..|++.|+|||++.+           ..++.++|||||||++|+|++|..||......              ...+..++
T Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------------~~~~~~~~  281 (390)
T 2zmd_A          216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--------------ISKLHAII  281 (390)
T ss_dssp             SCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--------------HHHHHHHH
T ss_pred             CCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--------------HHHHHHHh
Confidence            568999999999865           36889999999999999999999999653221              12223334


Q ss_pred             CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          229 DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ++......+...+.++.++|.+||+.||.+|||+.++++
T Consensus       282 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            444444455555778999999999999999999999987

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-41  Score=304.45  Aligned_cols=244  Identities=23%  Similarity=0.356  Sum_probs=195.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.... +..+++|..+..   ....+.+.+|++++++++||||+++++++. .+..++||||+.+|+|.+++....
T Consensus       203 ~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~  277 (454)
T 1qcf_A          203 EVWMATYNK-HTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDE  277 (454)
T ss_dssp             EEEEEEETT-TEEEEEEEECTT---SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHH
T ss_pred             EEEEEEECC-ccEEEEEEecCC---CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhcc
Confidence            478886543 455788876542   235788999999999999999999999986 567899999999999999997543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++......... ......
T Consensus       278 ~~-------~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~  346 (454)
T 1qcf_A          278 GS-------KQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAK  346 (454)
T ss_dssp             HH-------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH-TTCSSS
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee-ccCCCc
Confidence            11       178889999999999999999999   9999999999999999999999999999765432211 112334


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+....++.++||||||+++|+|++ |+.||.+....                .+...+........+..+
T Consensus       347 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~----------------~~~~~i~~~~~~~~~~~~  410 (454)
T 1qcf_A          347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----------------EVIRALERGYRMPRPENC  410 (454)
T ss_dssp             SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----------------HHHHHHHHTCCCCCCTTS
T ss_pred             ccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHcCCCCCCCCCC
Confidence            5778999999998899999999999999999999 99999754321                111112222333445677


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                      ++.+.++|.+||+.||.+|||++++++.|+.+.....
T Consensus       411 ~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~  447 (454)
T 1qcf_A          411 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE  447 (454)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence            8899999999999999999999999999999886543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.4e-42  Score=295.42  Aligned_cols=234  Identities=21%  Similarity=0.215  Sum_probs=193.0

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||+|..+.+++.|++|..++.. ......+.+..|.++++.+ +||||+++++++.+.+..++||||+.+|+|.+++..
T Consensus        32 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~  111 (345)
T 1xjd_A           32 KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS  111 (345)
T ss_dssp             EEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHH
Confidence            58999998889999999776543 1234567788899999877 999999999999999999999999999999999976


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++........  ....
T Consensus       112 ~~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~  177 (345)
T 1xjd_A          112 CHK---------FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNT  177 (345)
T ss_dssp             HSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCC
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC--cccC
Confidence            432         89999999999999999999999   999999999999999999999999999875432211  1344


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......               +...  ...++..
T Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---------------i~~~--~~~~p~~  240 (345)
T 1xjd_A          178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS---------------IRMD--NPFYPRW  240 (345)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---------------HHHC--CCCCCTT
T ss_pred             CCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH---------------HHhC--CCCCCcc
Confidence            5689999999999998999999999999999999999999976543221111               1111  1123455


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMS-IVV  266 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~-~ll  266 (285)
                      +++++.++|.+||+.||.+||++. +++
T Consensus       241 ~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          241 LEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            678899999999999999999997 665

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.2e-41  Score=303.09  Aligned_cols=248  Identities=18%  Similarity=0.195  Sum_probs=188.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC------CeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG------NLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.+..+++.+++|............+++.+|+.+++.++||||+++++++...      ...++||||+.+ +|.+
T Consensus        77 ~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~  155 (464)
T 3ttj_A           77 IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQ  155 (464)
T ss_dssp             EEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHH
T ss_pred             EEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHH
Confidence            589999999999999998765544455567888999999999999999999999754      356999999986 6777


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      .+...           +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.......   
T Consensus       156 ~~~~~-----------l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  218 (464)
T 3ttj_A          156 VIQME-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---  218 (464)
T ss_dssp             HHTSC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----CC---
T ss_pred             HHhhc-----------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---
Confidence            77532           78899999999999999999999   99999999999999999999999999997654321   


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh-------hhhc
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV-------KQCV  228 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~  228 (285)
                      ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.........+..       ..+.
T Consensus       219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~  298 (464)
T 3ttj_A          219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV  298 (464)
T ss_dssp             CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHH
T ss_pred             ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHh
Confidence            123456899999999999999999999999999999999999999876644433322221111111111       1111


Q ss_pred             CCccC--C----------------CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          229 DPKLK--G----------------EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       229 ~~~~~--~----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .....  .                ......++++.++|.+||+.||++|||++++++
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          299 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             TTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            10000  0                001122678999999999999999999999998

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.1e-41  Score=291.95  Aligned_cols=235  Identities=20%  Similarity=0.199  Sum_probs=194.3

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||+|.+..+++.|++|..++... .....+.+..|..++..+ +||+|+++++++.+.+..++||||+.+|+|.+++..
T Consensus        35 ~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~  114 (353)
T 2i0e_A           35 KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ  114 (353)
T ss_dssp             EEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh
Confidence            589999988999999997765432 234567788999999988 899999999999999999999999999999999976


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ....
T Consensus       115 ~~~---------~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~  180 (353)
T 2i0e_A          115 VGR---------FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKT  180 (353)
T ss_dssp             HSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCC
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc--cccc
Confidence            432         89999999999999999999999   999999999999999999999999999875332211  1234


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||++.+..++.++|+|||||++|+|++|+.||........               ...+....  ..++..
T Consensus       181 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---------------~~~i~~~~--~~~p~~  243 (353)
T 2i0e_A          181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---------------FQSIMEHN--VAYPKS  243 (353)
T ss_dssp             CCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---------------HHHHHHCC--CCCCTT
T ss_pred             ccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH---------------HHHHHhCC--CCCCCC
Confidence            5689999999999999999999999999999999999999976543211               11111111  134556


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPN-----MSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps-----~~~ll~  267 (285)
                      ++.++.++|.+||+.||.+||+     ++++++
T Consensus       244 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          244 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            7888999999999999999995     577765

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.4e-41  Score=291.11  Aligned_cols=244  Identities=19%  Similarity=0.217  Sum_probs=193.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||+|....+++.|++|..++.... ....+.+.+|..+++++ +||||+++++++.+.+..++||||+.+|+|.+++..
T Consensus        24 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~  103 (345)
T 3a8x_A           24 KVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR  103 (345)
T ss_dssp             EEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH
Confidence            5899998888999999988654432 23456678899999988 899999999999999999999999999999999976


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++........  ....
T Consensus       104 ~~~---------l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~--~~~~  169 (345)
T 3a8x_A          104 QRK---------LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTST  169 (345)
T ss_dssp             HSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC--CBCC
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCCC--cccc
Confidence            532         89999999999999999999999   999999999999999999999999999875322211  1234


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||++.+..++.++|+|||||++|+|++|..||...........      .........+...  ....+..
T Consensus       170 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------~~~~~~~~~i~~~--~~~~p~~  241 (345)
T 3a8x_A          170 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ------NTEDYLFQVILEK--QIRIPRS  241 (345)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------------CHHHHHHHHHHC--CCCCCTT
T ss_pred             cCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc------ccHHHHHHHHHcC--CCCCCCC
Confidence            5689999999999998999999999999999999999999975322110000      0000011111111  1234566


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNM------SIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~------~~ll~  267 (285)
                      .+.++.++|.+||+.||.+||++      +++++
T Consensus       242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence            78889999999999999999995      66664

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.5e-41  Score=291.57  Aligned_cols=240  Identities=20%  Similarity=0.258  Sum_probs=180.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|..+...    ..+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        68 ~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  143 (349)
T 2w4o_A           68 IVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG  143 (349)
T ss_dssp             EEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS
T ss_pred             EEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcC
Confidence            58999888888889999876432    34567889999999999999999999999999999999999999999997653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc---CCeeEEeccccCCCCCccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                               .+++..++.++.|++.||.|||+.   |++||||||+||+++.   ++.++|+|||++........   ..
T Consensus       144 ---------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---~~  208 (349)
T 2w4o_A          144 ---------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MK  208 (349)
T ss_dssp             ---------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------------
T ss_pred             ---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc---cc
Confidence                     289999999999999999999999   9999999999999975   88999999999876543211   23


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc--cCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK--LKGEY  236 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  236 (285)
                      ...|++.|+|||.+.+..++.++|||||||++|+|++|..||........              ....+....  .....
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------------~~~~i~~~~~~~~~~~  274 (349)
T 2w4o_A          209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--------------MFRRILNCEYYFISPW  274 (349)
T ss_dssp             ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--------------HHHHHHTTCCCCCTTT
T ss_pred             cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--------------HHHHHHhCCCccCCch
Confidence            34689999999999988899999999999999999999999975433211              011111111  11122


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      ...++.++.++|.+||+.||++|||+.++++  ..++...
T Consensus       275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~~~  312 (349)
T 2w4o_A          275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ--HPWVTGK  312 (349)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTTST
T ss_pred             hhhCCHHHHHHHHHHccCChhhCcCHHHHhc--CcccCCC
Confidence            3456778999999999999999999999998  5555443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.1e-41  Score=300.80  Aligned_cols=234  Identities=22%  Similarity=0.255  Sum_probs=194.3

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|....+++.+++|....... .....+.+.+|+++++.++||||+++++++.+.+..++||||+.+++|.+++...
T Consensus        31 ~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~  110 (476)
T 2y94_A           31 KVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN  110 (476)
T ss_dssp             CEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSS
T ss_pred             EEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhc
Confidence            689998888899999997754332 2345678999999999999999999999999999999999999999999999764


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........   ....
T Consensus       111 ~~---------l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~---~~~~  175 (476)
T 2y94_A          111 GR---------LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTS  175 (476)
T ss_dssp             SS---------CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC---BCCC
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccccc---cccc
Confidence            32         89999999999999999999999   999999999999999999999999999876543221   2334


Q ss_pred             ccccCcCCCcccccCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          161 LGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      .|++.|+|||++.+..+ +.++||||+||++|+|++|..||........               ...+.+..  ...+..
T Consensus       176 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---------------~~~i~~~~--~~~p~~  238 (476)
T 2y94_A          176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL---------------FKKICDGI--FYTPQY  238 (476)
T ss_dssp             CSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH---------------HHHHHTTC--CCCCTT
T ss_pred             CCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH---------------HHHHhcCC--cCCCcc
Confidence            68999999999988766 6899999999999999999999976543211               11111111  123445


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .++++.++|.+||+.||.+|||+.++++
T Consensus       239 ~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          239 LNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            6778999999999999999999999997

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.8e-41  Score=283.12  Aligned_cols=245  Identities=23%  Similarity=0.316  Sum_probs=198.1

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..++..+++|...... ......+.+.+|++++++++||||+++++++.+.+..+++|||+.+++|.+++...
T Consensus        29 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  108 (284)
T 2vgo_A           29 NVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH  108 (284)
T ss_dssp             EEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH
T ss_pred             EEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhc
Confidence            58999888888889998765432 22345678899999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++.......    ....
T Consensus       109 ~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~  172 (284)
T 2vgo_A          109 GR---------FDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTM  172 (284)
T ss_dssp             SS---------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCC
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccc
Confidence            42         88999999999999999999999   99999999999999999999999999885443221    2334


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||.+.+..++.++|+||||+++|+|++|..||.........               ..+...  ....+..+
T Consensus       173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------------~~~~~~--~~~~~~~~  235 (284)
T 2vgo_A          173 CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH---------------RRIVNV--DLKFPPFL  235 (284)
T ss_dssp             CSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---------------HHHHTT--CCCCCTTS
T ss_pred             cCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH---------------HHHhcc--ccCCCCcC
Confidence            6889999999999888999999999999999999999999754322111               111111  11344566


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH--HhchhhcCCCCC
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLLKSPPPA  279 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~--~l~~~~~~~~~~  279 (285)
                      +..+.++|.+||+.||.+|||+.++++  .++.......||
T Consensus       236 ~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~  276 (284)
T 2vgo_A          236 SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPP  276 (284)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCC
T ss_pred             CHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCC
Confidence            788999999999999999999999997  444444333333

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.3e-41  Score=303.28  Aligned_cols=237  Identities=23%  Similarity=0.272  Sum_probs=191.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..++..+++|............+.+.+|++++++++||||+++++++.+....++||||+.+|+|.+.+....
T Consensus        52 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~  131 (494)
T 3lij_A           52 EVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM  131 (494)
T ss_dssp             EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS
T ss_pred             EEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcC
Confidence            58999998899999999887766666678899999999999999999999999999999999999999999999887654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc---CCeeEEeccccCCCCCccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      .         +++..++.++.|++.||.|||+.   |++||||||+||+++.   ++.++|+|||++........   ..
T Consensus       132 ~---------~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~---~~  196 (494)
T 3lij_A          132 K---------FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MK  196 (494)
T ss_dssp             S---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC---BC
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc---cc
Confidence            2         88999999999999999999999   9999999999999975   45599999999876543221   23


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ...|++.|+|||++. ..++.++||||+||++|+|++|..||.+.........+........             .....
T Consensus       197 ~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------------~~~~~  262 (494)
T 3lij_A          197 ERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD-------------SPEWK  262 (494)
T ss_dssp             CCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------------SGGGT
T ss_pred             ccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------------chhcc
Confidence            456899999999876 4689999999999999999999999986543222111111110000             01113


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+++.+.++|.+||+.||.+|||+.++++
T Consensus       263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          263 NVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            45678999999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.5e-41  Score=283.51  Aligned_cols=235  Identities=20%  Similarity=0.293  Sum_probs=189.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe----CCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE----GNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||++.+..++..+++|............+.+.+|+.++++++||||+++++++..    ....++||||+.+++|.+++
T Consensus        41 ~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  120 (290)
T 1t4h_A           41 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL  120 (290)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHH
T ss_pred             EEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHH
Confidence            58999888888889988877666555567889999999999999999999999875    35689999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCCeEEc-cCCeeEEeccccCCCCCccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNVLLF-EDFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~--~~h~di~~~nil~~-~~~~~~l~df~~~~~~~~~~~~  154 (285)
                      .....         +++..++.++.|++.||.|||+.   |  ++|+||+|+||+++ .++.++|+|||++.......  
T Consensus       121 ~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~--  186 (290)
T 1t4h_A          121 KRFKV---------MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--  186 (290)
T ss_dssp             HHHSS---------CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS--
T ss_pred             HHccC---------CCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc--
Confidence            76432         88999999999999999999999   8  99999999999997 78899999999986543221  


Q ss_pred             ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                        .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||..........              ..........
T Consensus       187 --~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--------------~~~~~~~~~~  249 (290)
T 1t4h_A          187 --AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--------------RRVTSGVKPA  249 (290)
T ss_dssp             --BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH--------------HHHTTTCCCG
T ss_pred             --cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH--------------HHHhccCCcc
Confidence              233458999999998764 58999999999999999999999997543221111              1111111111


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+...++++.++|.+||+.||.+|||+.++++
T Consensus       250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            123334567999999999999999999999987

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.7e-40  Score=287.41  Aligned_cols=263  Identities=18%  Similarity=0.239  Sum_probs=198.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe--------CCeeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--------GNLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~~~L   73 (285)
                      .||+|.+..+++.+++|..............+.+|++++++++||||+++++++..        .+..++||||+.+ +|
T Consensus        32 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l  110 (351)
T 3mi9_A           32 EVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DL  110 (351)
T ss_dssp             SEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EH
T ss_pred             EEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CH
Confidence            68999998889999999887766666778889999999999999999999999987        4468999999985 77


Q ss_pred             HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc
Q 023220           74 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        74 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  153 (285)
                      .+.+.....        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........
T Consensus       111 ~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  179 (351)
T 3mi9_A          111 AGLLSNVLV--------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN  179 (351)
T ss_dssp             HHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSS
T ss_pred             HHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhccccccccc
Confidence            777765432        289999999999999999999999   999999999999999999999999999865432111


Q ss_pred             --cccccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh---
Q 023220          154 --RLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC---  227 (285)
Q Consensus       154 --~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---  227 (285)
                        ........|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...............   
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (351)
T 3mi9_A          180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY  259 (351)
T ss_dssp             SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccc
Confidence              111233467999999998876 45799999999999999999999999876544333322222111111111000   


Q ss_pred             --cCCc-c-CCC---CCh-----hHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          228 --VDPK-L-KGE---YPP-----KGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       228 --~~~~-~-~~~---~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                        .... . ...   ...     ..++.+.++|.+||+.||.+|||++++++  ..++...+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~~  320 (351)
T 3mi9_A          260 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--HDFFWSDPM  320 (351)
T ss_dssp             GGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGGSSSC
T ss_pred             hhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC--CCCcCCCCC
Confidence              0000 0 000   000     12456899999999999999999999998  566654443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.6e-41  Score=282.24  Aligned_cols=235  Identities=18%  Similarity=0.176  Sum_probs=189.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..++..+++|......  ....+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        24 ~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  101 (277)
T 3f3z_A           24 EVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR  101 (277)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC
T ss_pred             EEEEEEeCCCCcEEEEEeehhhc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC
Confidence            58899888888888888765433  2346789999999999999999999999999999999999999999999987654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE---ccCCeeEEeccccCCCCCccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      .         +++..++.++.|++.|+.|||+.   |++|+||+|+||++   +.++.++|+|||++.......   ...
T Consensus       102 ~---------~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~  166 (277)
T 3f3z_A          102 V---------FRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMR  166 (277)
T ss_dssp             S---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBC
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---chh
Confidence            2         89999999999999999999999   99999999999999   788899999999986544322   123


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ...|++.|+|||.+.+. ++.++||||||+++|+|++|..||...........+.......+...             ..
T Consensus       167 ~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------~~  232 (277)
T 3f3z_A          167 TKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD-------------WL  232 (277)
T ss_dssp             CCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH-------------HT
T ss_pred             ccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh-------------hh
Confidence            45689999999987654 89999999999999999999999976543221111111110100000             01


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+++.+.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          233 NVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            35678999999999999999999999987

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.7e-41  Score=281.67  Aligned_cols=246  Identities=23%  Similarity=0.311  Sum_probs=175.9

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.+..+++.+++|...... ......+.+.+|+.++++++||||+++++++.+.+..+++|||+.+++|.+++...
T Consensus        26 ~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  105 (278)
T 3cok_A           26 GVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR  105 (278)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTC
T ss_pred             EEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhc
Confidence            58999887788889999765433 22345678999999999999999999999999999999999999999999999764


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..        .+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++.........  ....
T Consensus       106 ~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~  172 (278)
T 3cok_A          106 VK--------PFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTL  172 (278)
T ss_dssp             SS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----------
T ss_pred             cC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--ceec
Confidence            32        289999999999999999999999   9999999999999999999999999998654422211  1234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||.+.+..++.++|+||||+++|+|++|..||..........               ......  ...+..+
T Consensus       173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~~--~~~~~~~  235 (278)
T 3cok_A          173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---------------KVVLAD--YEMPSFL  235 (278)
T ss_dssp             -------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC--CCCCTTS
T ss_pred             cCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---------------HHhhcc--cCCcccc
Confidence            57899999999988888999999999999999999999997654321111               111111  1234456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                      +.++.++|.+||+.||++|||++++++  ..++......
T Consensus       236 ~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~~~~~  272 (278)
T 3cok_A          236 SIEAKDLIHQLLRRNPADRLSLSSVLD--HPFMSRNSST  272 (278)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTT--STTTC-----
T ss_pred             CHHHHHHHHHHcccCHhhCCCHHHHhc--CccccCCCCc
Confidence            778999999999999999999999998  4555544433

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.8e-41  Score=289.72  Aligned_cols=240  Identities=18%  Similarity=0.234  Sum_probs=195.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|..+...........+.+|+.+++++ .||||+++++++.+.+..++||||+.+++|.+++...
T Consensus        44 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  123 (327)
T 3lm5_A           44 VVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE  123 (327)
T ss_dssp             EEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSC
T ss_pred             EEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHh
Confidence            589999988899999998887776666778999999999999 5699999999999999999999999999999998654


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc---CCeeEEeccccCCCCCcccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      ...       .+++..++.++.|++.||.|||+.   |++||||+|+||+++.   ++.++|+|||++........   .
T Consensus       124 ~~~-------~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~  190 (327)
T 3lm5_A          124 LAE-------MVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---L  190 (327)
T ss_dssp             C-C-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------
T ss_pred             ccc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---c
Confidence            322       289999999999999999999999   9999999999999987   78999999999976543221   2


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ....|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+...             .........
T Consensus       191 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------------~~~~~~~~~  257 (327)
T 3lm5_A          191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-------------NVDYSEETF  257 (327)
T ss_dssp             ---CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------CCCCCTTTT
T ss_pred             ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc-------------ccccCchhh
Confidence            3356899999999999889999999999999999999999999765432221111111             111122333


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..++..+.++|.+||+.||.+|||++++++
T Consensus       258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          258 SSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            456778999999999999999999999987

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.9e-41  Score=294.03  Aligned_cols=235  Identities=15%  Similarity=0.174  Sum_probs=182.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHc-cCCCCcccccceEEEe----CCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVS-RLKHENLVELLGYCVE----GNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~   76 (285)
                      +||+|.+..+++.|++|....       ...+.+|++++. ..+||||+++++++..    ....++||||+.+|+|.++
T Consensus        77 ~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~  149 (400)
T 1nxk_A           77 KVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR  149 (400)
T ss_dssp             EEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHH
T ss_pred             EEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHH
Confidence            589999988999999998752       357788999875 4589999999999876    5678999999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc---CCeeEEeccccCCCCCcccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~  153 (285)
                      +......       .+++..+..++.|++.||.|||+.   |++||||||+||+++.   ++.++|+|||++........
T Consensus       150 l~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~  219 (400)
T 1nxk_A          150 IQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS  219 (400)
T ss_dssp             HHCC----------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred             HHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCCc
Confidence            9865322       289999999999999999999999   9999999999999987   78999999999875443221


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc--
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK--  231 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  231 (285)
                         .....|++.|+|||++.+..++.++|||||||++|+|++|..||...........           ....+....  
T Consensus       220 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-----------~~~~i~~~~~~  285 (400)
T 1nxk_A          220 ---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----------MKTRIRMGQYE  285 (400)
T ss_dssp             ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS-----------HHHHHHHTCCC
T ss_pred             ---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH-----------HHHHHHcCccc
Confidence               2345679999999999988999999999999999999999999976543221100           000000000  


Q ss_pred             cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          232 LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ........++.++.++|.+||+.||.+|||+.++++
T Consensus       286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111112356778999999999999999999999998

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8.9e-42  Score=293.33  Aligned_cols=254  Identities=22%  Similarity=0.329  Sum_probs=194.4

Q ss_pred             Cceeeeeeeecc-----ccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEE-----SYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|....++.     .+++|...... .....+.+.+|+++++++ +||||+++++++.+.+..++||||+.+|+|.+
T Consensus        61 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~  139 (333)
T 2i1m_A           61 KVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN  139 (333)
T ss_dssp             EEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred             ceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHH
Confidence            478887655444     35555543221 122356788999999999 89999999999999999999999999999999


Q ss_pred             HhccCCCCC-----CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCc
Q 023220           76 ILHGRKGVQ-----GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD  150 (285)
Q Consensus        76 ~l~~~~~~~-----~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~  150 (285)
                      ++.......     .......+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.....
T Consensus       140 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  216 (333)
T 2i1m_A          140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN  216 (333)
T ss_dssp             HHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGG
T ss_pred             HHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEEECcccccccccc
Confidence            997532100     000011378999999999999999999999   999999999999999999999999999976543


Q ss_pred             ccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcC
Q 023220          151 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD  229 (285)
Q Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
                      ...........+++.|+|||.+.+..++.++||||||+++|+|++ |..||........               ......
T Consensus       217 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---------------~~~~~~  281 (333)
T 2i1m_A          217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK---------------FYKLVK  281 (333)
T ss_dssp             CTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH---------------HHHHHH
T ss_pred             ccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH---------------HHHHHh
Confidence            322222233456788999999988889999999999999999998 9999976432211               111112


Q ss_pred             CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          230 PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       230 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      .......+...++.+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       282 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          282 DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence            222223345567789999999999999999999999999988764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=287.84  Aligned_cols=259  Identities=19%  Similarity=0.171  Sum_probs=192.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCC---CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP---KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||+|.+..+++.+++|........   ....+.+.+|++++++++||||+++++++.+.+..++||||+.+ +|.+++.
T Consensus        25 ~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~  103 (346)
T 1ua2_A           25 TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIK  103 (346)
T ss_dssp             EEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHT
T ss_pred             EEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHH
Confidence            5899999888999999987653322   23456788999999999999999999999999999999999986 8988887


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  ...
T Consensus       104 ~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~  170 (346)
T 1ua2_A          104 DNSL--------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYT  170 (346)
T ss_dssp             TCCS--------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCC
T ss_pred             hcCc--------CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cCC
Confidence            6432        278889999999999999999999   999999999999999999999999999976543221  123


Q ss_pred             ccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh------hhcCCc
Q 023220          159 RVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK------QCVDPK  231 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~  231 (285)
                      ...|++.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.........+.............      ......
T Consensus       171 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  250 (346)
T 1ua2_A          171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK  250 (346)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             cccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccccccc
Confidence            45689999999998754 57899999999999999999999998765433222111111111110000      000000


Q ss_pred             cCCC-----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          232 LKGE-----YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       232 ~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      ....     .....+.++.++|.+||+.||.+|||+.++++  ..++...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--h~~f~~~  298 (346)
T 1ua2_A          251 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MKYFSNR  298 (346)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--SGGGTSS
T ss_pred             ccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc--ChhhhcC
Confidence            0000     11345678999999999999999999999998  4555443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.8e-41  Score=298.63  Aligned_cols=237  Identities=16%  Similarity=0.171  Sum_probs=193.7

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|....+++.|++|..++.. ......+.+.+|+.+++.++||||+++++++.+....++||||+.+|+|.+++...
T Consensus        84 ~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~  163 (410)
T 3v8s_A           84 EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY  163 (410)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC
T ss_pred             EEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC
Confidence            58999999899999999765432 22345677889999999999999999999999999999999999999999999764


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      .          +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......... .....
T Consensus       164 ~----------~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~-~~~~~  229 (410)
T 3v8s_A          164 D----------VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTA  229 (410)
T ss_dssp             C----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE-ECCSC
T ss_pred             C----------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc-cccCC
Confidence            3          88999999999999999999999   9999999999999999999999999999755432211 12345


Q ss_pred             ccccCcCCCcccccCC----CCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc--cCC
Q 023220          161 LGTFGYHAPEYAMTGQ----LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK--LKG  234 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~----~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  234 (285)
                      .||+.|+|||++.+..    ++.++|+|||||++|+|++|+.||.+.+......               .+....  ...
T Consensus       230 ~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~---------------~i~~~~~~~~~  294 (410)
T 3v8s_A          230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS---------------KIMNHKNSLTF  294 (410)
T ss_dssp             CSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---------------HHHTHHHHCCC
T ss_pred             cCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH---------------HHHhccccccC
Confidence            6899999999987665    7899999999999999999999997654322211               111111  111


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEF--RPNMSIVVK  267 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~ll~  267 (285)
                      .....++.++.++|.+||+.+|.+  ||+++++++
T Consensus       295 p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          295 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            112356788999999999999988  999999997

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.9e-41  Score=287.70  Aligned_cols=235  Identities=20%  Similarity=0.243  Sum_probs=181.6

Q ss_pred             Cceeeeee---eeccccChhhhhhccC--CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTC---QVEESYPSHENERLKS--PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~---~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||+|.+.   .+++.+++|..++...  .......+.+|++++++++||||+++++++.+.+..++||||+.+++|.++
T Consensus        32 ~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  111 (327)
T 3a62_A           32 KVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ  111 (327)
T ss_dssp             EEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHH
T ss_pred             EEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHH
Confidence            47888764   5678889997765432  233456678899999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH  156 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  156 (285)
                      +.....         +++..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++........  .
T Consensus       112 l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~  177 (327)
T 3a62_A          112 LEREGI---------FMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--V  177 (327)
T ss_dssp             HHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-----------
T ss_pred             HHhCCC---------CCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc--c
Confidence            976542         88999999999999999999999   999999999999999999999999999865432221  1


Q ss_pred             ccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||........               ...+...  ....
T Consensus       178 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---------------~~~i~~~--~~~~  240 (327)
T 3a62_A          178 THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT---------------IDKILKC--KLNL  240 (327)
T ss_dssp             -CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---------------HHHHHHT--CCCC
T ss_pred             ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---------------HHHHHhC--CCCC
Confidence            2335689999999999988899999999999999999999999976543211               1111111  1133


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK  267 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~  267 (285)
                      +..++..+.++|.+||+.||.+||     ++.++++
T Consensus       241 p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          241 PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            456678899999999999999999     7888876

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.7e-41  Score=282.23  Aligned_cols=238  Identities=24%  Similarity=0.344  Sum_probs=191.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe----------------CCeeeEEE
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE----------------GNLRVLAY   65 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~   65 (285)
                      .||++....+++.+++|.....      .+.+.+|++++++++||||+++++++..                ....+++|
T Consensus        26 ~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~   99 (284)
T 2a19_B           26 QVFKAKHRIDGKTYVIKRVKYN------NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM   99 (284)
T ss_dssp             CEEEEEETTTCCEEEEEEEECC------SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEE
T ss_pred             EEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEE
Confidence            6899988878888999877532      3578899999999999999999998864                34579999


Q ss_pred             eeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccC
Q 023220           66 EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS  145 (285)
Q Consensus        66 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~  145 (285)
                      ||+.+++|.+++......       .+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++
T Consensus       100 e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  169 (284)
T 2a19_B          100 EFCDKGTLEQWIEKRRGE-------KLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLV  169 (284)
T ss_dssp             CCCCSCBHHHHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             eccCCCCHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcchhh
Confidence            999999999999754321       288999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh
Q 023220          146 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK  225 (285)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
                      ........   .....|++.|+|||.+.+..++.++||||||+++|+|++|..|+....                 ....
T Consensus       170 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----------------~~~~  229 (284)
T 2a19_B          170 TSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----------------KFFT  229 (284)
T ss_dssp             EESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----------------HHHH
T ss_pred             eecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----------------HHHH
Confidence            65543221   233468999999999998889999999999999999999988873210                 0011


Q ss_pred             hhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          226 QCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                      ....    ...+..++..+.++|.+||+.||.+|||+.++++.|..+.+.+...
T Consensus       230 ~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~  279 (284)
T 2a19_B          230 DLRD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN  279 (284)
T ss_dssp             HHHT----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred             Hhhc----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence            1111    1223445677999999999999999999999999999988766544

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.4e-41  Score=284.31  Aligned_cols=240  Identities=25%  Similarity=0.377  Sum_probs=183.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++...  ++.+++|...    .....+.+.+|++++++++||||+++++++.+  ..++||||+.+++|.+++....
T Consensus        23 ~V~~~~~~--~~~vavK~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~   94 (307)
T 2eva_A           23 VVCKAKWR--AKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAE   94 (307)
T ss_dssp             EEEEEEET--TEEEEEEECS----STTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSS
T ss_pred             eEEEEEEC--CeeEEEEEec----ChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccC
Confidence            46777543  4556777653    23346788999999999999999999998874  4789999999999999998654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCCCeeeCCCCCCCeEEccCCe-eEEeccccCCCCCcccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE---KVQPSIIHRDIRSSNVLLFEDFK-AKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~~~~~~h~di~~~nil~~~~~~-~~l~df~~~~~~~~~~~~~~~  157 (285)
                      ..      ..++...++.++.|++.||.|||+   +   |++||||||+||+++.++. ++|+|||++......     .
T Consensus        95 ~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~---~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~  160 (307)
T 2eva_A           95 PL------PYYTAAHAMSWCLQCSQGVAYLHSMQPK---ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----M  160 (307)
T ss_dssp             SE------ECCCHHHHHHHHHHHHHHHHHHHTCSSS---CCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred             CC------CccCHHHHHHHHHHHHHHHHHHHhCCCC---CeecCCCChhHEEEeCCCCEEEEcccccccccccc-----c
Confidence            21      127888999999999999999999   7   9999999999999988876 799999998654322     1


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..........              ............+
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--------------~~~~~~~~~~~~~  226 (307)
T 2eva_A          161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI--------------MWAVHNGTRPPLI  226 (307)
T ss_dssp             ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH--------------HHHHHTTCCCCCB
T ss_pred             ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH--------------HHHHhcCCCCCcc
Confidence            23458999999999998899999999999999999999999997543221110              0001111122334


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                      ..++..+.+++.+||+.||.+|||+.++++.|+.+.+..+
T Consensus       227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence            5567789999999999999999999999999998875443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4e-41  Score=286.80  Aligned_cols=237  Identities=19%  Similarity=0.194  Sum_probs=182.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|.................|+..+.++ +||||+++++++.+++..++||||+ +++|.+++...
T Consensus        72 ~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~  150 (311)
T 3p1a_A           72 EVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW  150 (311)
T ss_dssp             EEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHH
T ss_pred             EEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhc
Confidence            589999888899999997654333333334455566555555 9999999999999999999999999 56998888765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........   ....
T Consensus       151 ~~--------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~  216 (311)
T 3p1a_A          151 GA--------SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQ  216 (311)
T ss_dssp             CS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---------CC
T ss_pred             CC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCCC---Cccc
Confidence            32        289999999999999999999999   999999999999999999999999999865543221   2334


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||++.+ .++.++|||||||++|+|++|..|+.....                  ...+.........+..+
T Consensus       217 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------------------~~~~~~~~~~~~~~~~~  277 (311)
T 3p1a_A          217 EGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------------------WQQLRQGYLPPEFTAGL  277 (311)
T ss_dssp             CCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------------------HHHHTTTCCCHHHHTTS
T ss_pred             CCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------------------HHHHhccCCCcccccCC
Confidence            58999999998876 789999999999999999999776643211                  11111111111112345


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ++.+.++|.+||+.||++|||++++++  ..+++
T Consensus       278 ~~~l~~li~~~L~~dP~~Rpt~~ell~--hp~~~  309 (311)
T 3p1a_A          278 SSELRSVLVMMLEPDPKLRATAEALLA--LPVLR  309 (311)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGS
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHh--Ccccc
Confidence            678999999999999999999999997  44444

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.4e-41  Score=290.55  Aligned_cols=252  Identities=21%  Similarity=0.286  Sum_probs=191.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|............+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        40 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~  119 (331)
T 4aaa_A           40 MVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN  119 (331)
T ss_dssp             SEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTT
T ss_pred             EEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhcc
Confidence            68999998889999999876555444456678899999999999999999999999999999999999988888866543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus       120 ~---------~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~  185 (331)
T 4aaa_A          120 G---------LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEV  185 (331)
T ss_dssp             C---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--------------CC
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCc
Confidence            2         89999999999999999999999   999999999999999999999999999876543221  123346


Q ss_pred             cccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh---------hhhcCCc
Q 023220          162 GTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV---------KQCVDPK  231 (285)
Q Consensus       162 ~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~  231 (285)
                      |++.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+............         .....+.
T Consensus       186 ~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (331)
T 4aaa_A          186 ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPE  265 (331)
T ss_dssp             CCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCC
T ss_pred             CCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCcc
Confidence            88999999998765 6899999999999999999999999876543322211111111110000         0000111


Q ss_pred             cCCC-----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          232 LKGE-----YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       232 ~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ....     ..+.+++.+.++|.+||+.||.+|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          266 IKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1111     11245778999999999999999999999886

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.2e-41  Score=280.80  Aligned_cols=245  Identities=18%  Similarity=0.280  Sum_probs=193.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCC----CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKN----YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||+|.+..+++.+++|..+.......    ..+.+.+|++++++++||||+++++++.+....++||||+.+++|.+++
T Consensus        20 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   99 (283)
T 3bhy_A           20 IVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL   99 (283)
T ss_dssp             EEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred             EEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHH
Confidence            589998888889999997765543322    4678899999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC----eeEEeccccCCCCCcccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~----~~~l~df~~~~~~~~~~~  153 (285)
                      .....         +++..++.++.|++.||.|||+.   |++|+||+|+||+++.++    .++|+|||++........
T Consensus       100 ~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~  167 (283)
T 3bhy_A          100 AEKES---------LTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE  167 (283)
T ss_dssp             HHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC----
T ss_pred             HhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc
Confidence            76432         89999999999999999999999   999999999999998876    899999999875533221


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                         .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+........             
T Consensus       168 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------  231 (283)
T 3bhy_A          168 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-------------  231 (283)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC-------------
T ss_pred             ---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc-------------
Confidence               2334588999999999888899999999999999999999999976543221111111000000             


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH--Hhchhhc
Q 023220          234 GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLLK  274 (285)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~--~l~~~~~  274 (285)
                      .......++.+.+++.+||+.||.+|||+.++++  .++.+..
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          232 EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            0111244667999999999999999999999997  3444443

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-41  Score=293.62  Aligned_cols=249  Identities=22%  Similarity=0.296  Sum_probs=185.5

Q ss_pred             Cceeeeeeee---ccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe-CCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQV---EESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE-GNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||+|.....   +..+++|..+.. ......+++.+|+.++++++||||+++++++.. .+..++||||+.+++|.+++
T Consensus       104 ~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l  182 (373)
T 3c1x_A          104 CVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI  182 (373)
T ss_dssp             EEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHH
Confidence            5788865432   234667765432 223345778899999999999999999998754 45789999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc--c
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR--L  155 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~  155 (285)
                      .....        .+++..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++.........  .
T Consensus       183 ~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~  251 (373)
T 3c1x_A          183 RNETH--------NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH  251 (373)
T ss_dssp             HCTTC--------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------------
T ss_pred             hhccc--------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccccccccc
Confidence            76432        278899999999999999999999   9999999999999999999999999999755322211  1


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      ......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||............                ......
T Consensus       252 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~----------------~~~~~~  315 (373)
T 3c1x_A          252 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----------------LQGRRL  315 (373)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH----------------HTTCCC
T ss_pred             ccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH----------------HcCCCC
Confidence            1123446778999999999999999999999999999999 77788654432211111                111112


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                      ..+..++..+.+++.+||+.||.+|||+.++++.|+.++.....
T Consensus       316 ~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          316 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence            23455678899999999999999999999999999999876543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=291.07  Aligned_cols=257  Identities=19%  Similarity=0.245  Sum_probs=188.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|..+... .......+.+|++++++++||||+++++++.+.+..++||||+.+ +|.+++....
T Consensus        17 ~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~   94 (324)
T 3mtl_A           17 TVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG   94 (324)
T ss_dssp             EEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHTT
T ss_pred             EEEEEEECCCCcEEEEEEEeccc-ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhcC
Confidence            58999888889999999775433 222333455799999999999999999999999999999999974 8989887653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.........  .....
T Consensus        95 ~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~  161 (324)
T 3mtl_A           95 N--------IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YDNEV  161 (324)
T ss_dssp             T--------CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------------
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccc--ccccc
Confidence            2        288999999999999999999999   9999999999999999999999999998654322211  23346


Q ss_pred             cccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhc---------CCc
Q 023220          162 GTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV---------DPK  231 (285)
Q Consensus       162 ~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~  231 (285)
                      |++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+................         .+.
T Consensus       162 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
T 3mtl_A          162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPK  241 (324)
T ss_dssp             -CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCC
T ss_pred             CcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccccc
Confidence            7899999999876 567999999999999999999999998765443333222211111111111110         000


Q ss_pred             cC----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH--Hhchhh
Q 023220          232 LK----GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLL  273 (285)
Q Consensus       232 ~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~--~l~~~~  273 (285)
                      ..    ......+++++.++|.+||+.||.+|||++++++  .|..+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          242 YRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             CCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             ccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence            00    0112345678999999999999999999999988  344443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.2e-40  Score=282.56  Aligned_cols=234  Identities=24%  Similarity=0.332  Sum_probs=194.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..+++.+++|...... .....+.+.+|+.++++++||||+++++++.+....++||||+.+++|.+++....
T Consensus        37 ~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  115 (303)
T 3a7i_A           37 EVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP  115 (303)
T ss_dssp             EEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTSC
T ss_pred             EEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcCC
Confidence            58999888888899999875443 33457889999999999999999999999999999999999999999999997542


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                +++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus       116 ----------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~  180 (303)
T 3a7i_A          116 ----------LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFV  180 (303)
T ss_dssp             ----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCC
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc--ccCccC
Confidence                      89999999999999999999999   999999999999999999999999999865543221  123456


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      |++.|+|||.+.+..++.++|+||||+++|+|++|..||...........                +........+..++
T Consensus       181 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----------------~~~~~~~~~~~~~~  244 (303)
T 3a7i_A          181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL----------------IPKNNPPTLEGNYS  244 (303)
T ss_dssp             SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----------------HHHSCCCCCCSSCC
T ss_pred             CCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH----------------hhcCCCCCCccccC
Confidence            88999999999988899999999999999999999999975432211111                00111122344567


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+.+++.+||+.||.+|||+.++++
T Consensus       245 ~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          245 KPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            78999999999999999999999987

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.9e-41  Score=307.42  Aligned_cols=247  Identities=29%  Similarity=0.422  Sum_probs=198.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.... ...+++|..+...   ...+.+.+|+++|++++||||+++++++.+ +..++||||+.+|+|.+++....
T Consensus       282 ~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~  356 (535)
T 2h8h_A          282 EVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET  356 (535)
T ss_dssp             EEEEEEETT-TEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHH
T ss_pred             EEEEEEECC-CceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcC
Confidence            478886544 3457787765422   345789999999999999999999999876 66899999999999999997532


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.|++.||.|||++   |++||||+|+|||++.++.++|+|||++......... ......
T Consensus       357 ~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~  425 (535)
T 2h8h_A          357 GK-------YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAK  425 (535)
T ss_dssp             HT-------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH-TTCSTT
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee-cccCCc
Confidence            11       288999999999999999999999   9999999999999999999999999999766432211 122334


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....                .+...+....+...+..+
T Consensus       426 ~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~----------------~~~~~i~~~~~~~~~~~~  489 (535)
T 2h8h_A          426 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----------------EVLDQVERGYRMPCPPEC  489 (535)
T ss_dssp             SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH----------------HHHHHHHTTCCCCCCTTC
T ss_pred             CcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHcCCCCCCCCCC
Confidence            6778999999998899999999999999999999 99999754321                122222223334456677


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCC
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAA  280 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  280 (285)
                      ++.+.++|.+||+.||++|||++++++.|+.+.....|.-
T Consensus       490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~  529 (535)
T 2h8h_A          490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY  529 (535)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSS
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCccc
Confidence            8899999999999999999999999999999987766543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5e-41  Score=288.03  Aligned_cols=238  Identities=17%  Similarity=0.229  Sum_probs=185.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC----------------------
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN----------------------   59 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----------------------   59 (285)
                      .||+|....+++.|++|..+... .....+.+.+|++++++++||||+++++++.+..                      
T Consensus        21 ~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   99 (332)
T 3qd2_B           21 VVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPL   99 (332)
T ss_dssp             EEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------------
T ss_pred             EEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccc
Confidence            58999988889999999876433 3445678999999999999999999999986543                      


Q ss_pred             -----------------------------------eeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHH
Q 023220           60 -----------------------------------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDA  104 (285)
Q Consensus        60 -----------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi  104 (285)
                                                         ..+++|||+.+++|.+++.......      ......++.++.|+
T Consensus       100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~------~~~~~~~~~i~~qi  173 (332)
T 3qd2_B          100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE------DREHGVCLHIFIQI  173 (332)
T ss_dssp             --------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG------GSCHHHHHHHHHHH
T ss_pred             cCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc------chhhHHHHHHHHHH
Confidence                                               3799999999999999998754321      25666789999999


Q ss_pred             HHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc----------ccccccccccCcCCCccccc
Q 023220          105 ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR----------LHSTRVLGTFGYHAPEYAMT  174 (285)
Q Consensus       105 ~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~~~aPE~~~~  174 (285)
                      +.||.|||+.   |++||||||+||+++.++.++|+|||++.........          .......|++.|+|||.+.+
T Consensus       174 ~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  250 (332)
T 3qd2_B          174 AEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG  250 (332)
T ss_dssp             HHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHC
T ss_pred             HHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcC
Confidence            9999999999   9999999999999999999999999998765432211          11233468999999999999


Q ss_pred             CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhccc
Q 023220          175 GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQY  254 (285)
Q Consensus       175 ~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  254 (285)
                      ..++.++|||||||++|+|++|..|+....     .            ....... ..........++++.++|.+||+.
T Consensus       251 ~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~------------~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~  312 (332)
T 3qd2_B          251 NNYSHKVDIFSLGLILFELLYSFSTQMERV-----R------------IITDVRN-LKFPLLFTQKYPQEHMMVQDMLSP  312 (332)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----H------------HHHHHHT-TCCCHHHHHHCHHHHHHHHHHHCS
T ss_pred             CCCcchhhHHHHHHHHHHHHHcCCChhHHH-----H------------HHHHhhc-cCCCcccccCChhHHHHHHHHccC
Confidence            899999999999999999999876642110     0            0000000 000111234456789999999999


Q ss_pred             CCCCCCCHHHHHH
Q 023220          255 EAEFRPNMSIVVK  267 (285)
Q Consensus       255 ~p~~Rps~~~ll~  267 (285)
                      ||.+|||+.++++
T Consensus       313 ~p~~Rps~~~~l~  325 (332)
T 3qd2_B          313 SPTERPEATDIIE  325 (332)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             CCCcCCCHHHHhh
Confidence            9999999999997

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.8e-41  Score=281.74  Aligned_cols=245  Identities=25%  Similarity=0.373  Sum_probs=192.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++... .+..+++|.....   ....+.+.+|++++++++||||+++++++.. +..+++|||+.+++|.+++....
T Consensus        28 ~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~  102 (279)
T 1qpc_A           28 EVWMGYYN-GHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPS  102 (279)
T ss_dssp             EEEEEEET-TTEEEEEEEECTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHH
T ss_pred             EEEEEEEc-CCcEEEEEEecCC---cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCC
Confidence            47877643 3445777766432   2346789999999999999999999999874 45799999999999999997542


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++......... ......
T Consensus       103 ~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~  171 (279)
T 1qpc_A          103 GI-------KLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAK  171 (279)
T ss_dssp             HH-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCC
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc-cccCCC
Confidence            11       188999999999999999999999   9999999999999999999999999998765432211 122344


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ++..|+|||.+.+..++.++||||||+++|+|++ |..||.......                ....+........+..+
T Consensus       172 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~  235 (279)
T 1qpc_A          172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------------VIQNLERGYRMVRPDNC  235 (279)
T ss_dssp             CCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHHHTTCCCCCCTTC
T ss_pred             CccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH----------------HHHHHhcccCCCCcccc
Confidence            6778999999988888999999999999999999 999997543211                11111112222345566


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                      ++.+.+++.+||+.||.+|||+.++++.|+.+.....+
T Consensus       236 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence            78899999999999999999999999999998865443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.3e-41  Score=289.23  Aligned_cols=253  Identities=23%  Similarity=0.315  Sum_probs=194.1

Q ss_pred             Cceeee-----eeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCC-----TCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++.     +..++..+++|..... .......++.+|+.++++++||||+++++++.+....++||||+.+++|.++
T Consensus        45 ~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  123 (327)
T 2yfx_A           45 EVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSF  123 (327)
T ss_dssp             CEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHH
T ss_pred             eEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHH
Confidence            588887     4456677888877422 2233456788999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc---CCeeEEeccccCCCCCcccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~  153 (285)
                      +........  ....+++..++.++.|++.||.|||+.   |++||||+|+||+++.   +..++|+|||++........
T Consensus       124 l~~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~  198 (327)
T 2yfx_A          124 LRETRPRPS--QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY  198 (327)
T ss_dssp             HHHTSCCSS--STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC---
T ss_pred             HHhhccccc--ccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECccccccccccccc
Confidence            987643211  112388999999999999999999999   9999999999999984   45699999998854322221


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL  232 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
                      ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......                ....+....
T Consensus       199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~~~~~~~~~  262 (327)
T 2yfx_A          199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----------------VLEFVTSGG  262 (327)
T ss_dssp             ---CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----------------HHHHHHTTC
T ss_pred             cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH----------------HHHHHhcCC
Confidence            112233457889999999988889999999999999999998 999997543211                111111122


Q ss_pred             CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          233 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      ....+..++..+.++|.+||+.||.+|||+.++++.|+.+...+
T Consensus       263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            22345567788999999999999999999999999999887543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.8e-41  Score=290.05  Aligned_cols=233  Identities=22%  Similarity=0.308  Sum_probs=187.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|........ ....+.+.+|++++++++||||+++++++...+..++||||+. |+|.+++...
T Consensus        69 ~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~  147 (348)
T 1u5q_A           69 AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH  147 (348)
T ss_dssp             EEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHH
T ss_pred             EEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHh
Confidence            5899988888889999977543221 2234678899999999999999999999999999999999997 5888887543


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......      ...
T Consensus       148 ~~--------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~  210 (348)
T 1u5q_A          148 KK--------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSF  210 (348)
T ss_dssp             TS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCC
T ss_pred             cC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC------Ccc
Confidence            22        289999999999999999999999   9999999999999999999999999998765431      234


Q ss_pred             ccccCcCCCcccc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          161 LGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       161 ~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      .|++.|+|||.+.   ...++.++|||||||++|+|++|..||.........               ..+.........+
T Consensus       211 ~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~---------------~~~~~~~~~~~~~  275 (348)
T 1u5q_A          211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------------YHIAQNESPALQS  275 (348)
T ss_dssp             CSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---------------HHHHHSCCCCCCC
T ss_pred             cCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---------------HHHHhcCCCCCCC
Confidence            6899999999884   467899999999999999999999999754322111               1111111111223


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+++.+.++|.+||+.||++|||++++++
T Consensus       276 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            456778999999999999999999999987

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.7e-40  Score=280.39  Aligned_cols=252  Identities=17%  Similarity=0.221  Sum_probs=193.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEE-EeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC-VEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.+..+++.+++|.....    ...+.+.+|++++++++|++++..++.+ ......+++|||+ +++|.+++...
T Consensus        24 ~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~   98 (296)
T 4hgt_A           24 DIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC   98 (296)
T ss_dssp             EEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred             EEEEEEEcCCCceEEEEeeccc----ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHh
Confidence            5899988888889999864332    2345688999999999988877777665 6677889999999 78999999753


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE---ccCCeeEEeccccCCCCCccccc---
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMAAR---  154 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~---~~~~~~~l~df~~~~~~~~~~~~---  154 (285)
                      ..        .+++..++.++.|++.||.|||+.   |++||||||+||++   +.++.++|+|||++.........   
T Consensus        99 ~~--------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~  167 (296)
T 4hgt_A           99 SR--------KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI  167 (296)
T ss_dssp             TS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred             cC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccC
Confidence            32        289999999999999999999999   99999999999999   78899999999999755432211   


Q ss_pred             --ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc
Q 023220          155 --LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL  232 (285)
Q Consensus       155 --~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
                        .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||..................    .   ...+  
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~---~~~~--  238 (296)
T 4hgt_A          168 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----K---MSTP--  238 (296)
T ss_dssp             CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----H---HHSC--
T ss_pred             CCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc----c---ccch--
Confidence              1123456899999999999989999999999999999999999999865433222111110000    0   0000  


Q ss_pred             CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          233 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                      .......+++++.+++.+||+.||.+|||+.++++.|+.+......
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence            0001133467899999999999999999999999999999865443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=291.58  Aligned_cols=257  Identities=21%  Similarity=0.302  Sum_probs=196.3

Q ss_pred             Cceeee----eeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC--eeeEEEeeCCCCCHHH
Q 023220            2 RRWLCC----TCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN--LRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.    ...+++.+++|....  ......+.+.+|++++++++||||+++++++...+  ..++||||+.+++|.+
T Consensus        56 ~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~  133 (326)
T 2w1i_A           56 SVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD  133 (326)
T ss_dssp             EEEEEEECTTSSSCCEEEEEEEESS--CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHH
T ss_pred             EEEEEEeccccCCCceEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHH
Confidence            478876    455678888887654  23334567889999999999999999999987544  6799999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-  154 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-  154 (285)
                      ++.....        .+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++......... 
T Consensus       134 ~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~  202 (326)
T 2w1i_A          134 YLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY  202 (326)
T ss_dssp             HHHHSTT--------SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEE
T ss_pred             HHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcccccccc
Confidence            9986542        288999999999999999999999   9999999999999999999999999998765432211 


Q ss_pred             ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC----chhhhhhhcCC
Q 023220          155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL----SEDKVKQCVDP  230 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  230 (285)
                      .......++..|+|||.+.+..++.++||||||+++|+|++|..||......    .........    ....+...+..
T Consensus       203 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  278 (326)
T 2w1i_A          203 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIVFHLIELLKN  278 (326)
T ss_dssp             ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred             ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchhhhHHHHHHHhhc
Confidence            1112234667899999998888899999999999999999999998532110    000000000    01112222233


Q ss_pred             ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          231 KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      ......+..++.++.++|.+||+.||.+|||+.++++.|+.+...
T Consensus       279 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          279 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            333345667788999999999999999999999999999987643

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.9e-40  Score=279.09  Aligned_cols=253  Identities=17%  Similarity=0.227  Sum_probs=195.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEE-EeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC-VEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|.....    ...+.+.+|++++++++|++++..+..+ ..+...+++|||+ +++|.+++...
T Consensus        24 ~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~   98 (296)
T 3uzp_A           24 DIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC   98 (296)
T ss_dssp             EEEEEEETTTTEEEEEEEEESC----SSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred             EEEEEEEcCCCcEEEEEEecCC----cchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhh
Confidence            5899988888899999976432    2346789999999999998877766665 5677889999999 78999999743


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE---ccCCeeEEeccccCCCCCcccccc--
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMAARL--  155 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~--  155 (285)
                      ..        .+++..++.++.|++.||.|||++   |++||||||+||++   +.++.++|+|||++..........  
T Consensus        99 ~~--------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  167 (296)
T 3uzp_A           99 SR--------KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI  167 (296)
T ss_dssp             TT--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred             cc--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccc
Confidence            32        289999999999999999999999   99999999999999   488899999999987554322210  


Q ss_pred             ---cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc
Q 023220          156 ---HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL  232 (285)
Q Consensus       156 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
                         ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||..................    .. .  .+  
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~~-~--~~--  238 (296)
T 3uzp_A          168 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----KM-S--TP--  238 (296)
T ss_dssp             CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----HH-H--SC--
T ss_pred             ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc----cc-C--Cc--
Confidence               123456899999999999989999999999999999999999999865432221111100000    00 0  00  


Q ss_pred             CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          233 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                      .......+++++.+++.+||+.||.+|||+.++++.|+.+......+
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  285 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence            00012345678999999999999999999999999999998766543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.1e-41  Score=290.49  Aligned_cols=248  Identities=22%  Similarity=0.173  Sum_probs=187.5

Q ss_pred             CceeeeeeeeccccChhhhhhcc---CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLK---SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||+|.+..++..+++|......   ......+.+.+|++++++++||||+++++++.+.+..++||||+.+|+|.+++.
T Consensus        41 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~  120 (345)
T 3hko_A           41 VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN  120 (345)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEE
T ss_pred             EEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHH
Confidence            58999988888999999765432   234556789999999999999999999999999999999999999999999996


Q ss_pred             cCCCCCC-------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 023220           79 GRKGVQG-------------------------------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS  127 (285)
Q Consensus        79 ~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~  127 (285)
                      .......                               ......+++..++.++.|++.||.|||+.   |++||||+|+
T Consensus       121 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~  197 (345)
T 3hko_A          121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPE  197 (345)
T ss_dssp             EEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred             HhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCCChh
Confidence            3111000                               00011246778899999999999999999   9999999999


Q ss_pred             CeEEccCC--eeEEeccccCCCCCcccc--cccccccccccCcCCCccccc--CCCCcccchHhHHHHHHHHHhCCCCCC
Q 023220          128 NVLLFEDF--KAKIADFNLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVD  201 (285)
Q Consensus       128 nil~~~~~--~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~pf~  201 (285)
                      ||+++.++  .++|+|||++........  ........|++.|+|||.+.+  ..++.++|||||||++|+|++|+.||.
T Consensus       198 NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  277 (345)
T 3hko_A          198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFP  277 (345)
T ss_dssp             GEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             hEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            99998766  899999999864322111  111234568999999999865  578899999999999999999999997


Q ss_pred             CCCCcccchhhhhhcccCchhhhhhhcCCccC--CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          202 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK--GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .........               .+......  ......+++.+.++|.+||+.||.+|||+.++++
T Consensus       278 ~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          278 GVNDADTIS---------------QVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             CSSHHHHHH---------------HHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             CCChHHHHH---------------HHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            654322111               11111111  1112345778999999999999999999999988

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5e-41  Score=302.77  Aligned_cols=237  Identities=23%  Similarity=0.286  Sum_probs=192.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|........ ....+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++...
T Consensus        41 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  120 (484)
T 3nyv_A           41 EVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR  120 (484)
T ss_dssp             EEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC
T ss_pred             EEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhc
Confidence            5899999989999999987654433 445778999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE---ccCCeeEEeccccCCCCCcccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      ..         +++..++.++.|++.||.|||++   |++||||||+||++   +.++.++|+|||++.......   ..
T Consensus       121 ~~---------~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~  185 (484)
T 3nyv_A          121 KR---------FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KM  185 (484)
T ss_dssp             SC---------CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC---SH
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc---cc
Confidence            42         89999999999999999999999   99999999999999   567899999999986443221   12


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ....|++.|+|||++.+ .++.++||||+||++|+|++|..||.+.........+......             ......
T Consensus       186 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------------~~~~~~  251 (484)
T 3nyv_A          186 KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT-------------FELPQW  251 (484)
T ss_dssp             HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------------CCSGGG
T ss_pred             ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-------------CCCccc
Confidence            33468999999998876 6899999999999999999999999765432221111110000             001112


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+++++.++|.+||+.||.+|||+.++++
T Consensus       252 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          252 KKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            356778999999999999999999999997

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.4e-41  Score=281.35  Aligned_cols=243  Identities=20%  Similarity=0.266  Sum_probs=189.1

Q ss_pred             Cceeeeeee---eccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQ---VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||+|....   .+..+++|...... .....+.+.+|++++++++||||+++++++.++ ..+++|||+.+++|.+++.
T Consensus        27 ~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~  104 (281)
T 3cc6_A           27 EVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLE  104 (281)
T ss_dssp             EEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHH
T ss_pred             eEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHH
Confidence            478886543   23347777665432 222457788999999999999999999998754 5689999999999999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....        .+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++......... ...
T Consensus       105 ~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~  172 (281)
T 3cc6_A          105 RNKN--------SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KAS  172 (281)
T ss_dssp             HHTT--------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----------
T ss_pred             hccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccccc-ccc
Confidence            6432        288999999999999999999999   9999999999999999999999999998765432211 122


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...........                +........+
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~----------------~~~~~~~~~~  236 (281)
T 3cc6_A          173 VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV----------------LEKGDRLPKP  236 (281)
T ss_dssp             CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH----------------HHHTCCCCCC
T ss_pred             cCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH----------------HhcCCCCCCC
Confidence            3446778999999988889999999999999999998 9999975433221111                1111122334


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ..+++.+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence            5567889999999999999999999999999998764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-40  Score=301.59  Aligned_cols=237  Identities=23%  Similarity=0.279  Sum_probs=190.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-----------CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-----------KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATM   70 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   70 (285)
                      .||+|....++..+++|........           ....+.+.+|++++++++||||+++++++.+....++||||+.+
T Consensus        51 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g  130 (504)
T 3q5i_A           51 EVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEG  130 (504)
T ss_dssp             EEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCC
Confidence            5899999888999999987654432           24567889999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC---eeEEeccccCCC
Q 023220           71 GSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF---KAKIADFNLSNQ  147 (285)
Q Consensus        71 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~---~~~l~df~~~~~  147 (285)
                      |+|.+++.....         +++..++.++.|++.||.|||+.   |++||||||+||+++.++   .++|+|||++..
T Consensus       131 g~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  198 (504)
T 3q5i_A          131 GELFEQIINRHK---------FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF  198 (504)
T ss_dssp             CBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECCCTTCEE
T ss_pred             CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEECCCCEE
Confidence            999999876542         89999999999999999999999   999999999999998775   699999999975


Q ss_pred             CCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh
Q 023220          148 APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC  227 (285)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (285)
                      ......   .....|++.|+|||++. ..++.++||||+||++|+|++|..||.+.........+..........     
T Consensus       199 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-----  269 (504)
T 3q5i_A          199 FSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN-----  269 (504)
T ss_dssp             CCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH-----
T ss_pred             cCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc-----
Confidence            543221   23456899999999876 468999999999999999999999998654332221111111111100     


Q ss_pred             cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          228 VDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       228 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                              ....+++++.++|.+||+.||.+|||++++++
T Consensus       270 --------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          270 --------DWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             --------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                    01235678999999999999999999999987

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=288.22  Aligned_cols=255  Identities=18%  Similarity=0.169  Sum_probs=192.4

Q ss_pred             Cceeeeeee---eccccChhhhhhccCC---------CCCChhHHHHHHHHccCCCCcccccceEEEe----CCeeeEEE
Q 023220            2 RRWLCCTCQ---VEESYPSHENERLKSP---------KNYPDDEKQLVSVVSRLKHENLVELLGYCVE----GNLRVLAY   65 (285)
Q Consensus         2 ~~~~~~~~~---~~~~~~~k~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~   65 (285)
                      .||+|....   ....+++|........         ......+.+|+..++.++||||+++++++..    ....++||
T Consensus        52 ~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~  131 (345)
T 2v62_A           52 LIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVM  131 (345)
T ss_dssp             CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEE
T ss_pred             EEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEE
Confidence            689998876   6777777765432110         1134456778889999999999999999988    77889999


Q ss_pred             eeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC--eeEEeccc
Q 023220           66 EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF--KAKIADFN  143 (285)
Q Consensus        66 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~--~~~l~df~  143 (285)
                      ||+ +++|.+++....         .+++..++.++.|++.||.|||+.   |++||||||+||+++.++  .++|+|||
T Consensus       132 e~~-~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kL~Dfg  198 (345)
T 2v62_A          132 ERL-GIDLQKISGQNG---------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYG  198 (345)
T ss_dssp             ECE-EEEHHHHCBGGG---------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEEECCCT
T ss_pred             ecc-CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEEEEeCC
Confidence            999 889999998654         289999999999999999999999   999999999999998877  99999999


Q ss_pred             cCCCCCcccccc-----cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccch--hhhhhc
Q 023220          144 LSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS--LVTWAT  216 (285)
Q Consensus       144 ~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~  216 (285)
                      ++..........     ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||..........  ......
T Consensus       199 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  278 (345)
T 2v62_A          199 LSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLL  278 (345)
T ss_dssp             TCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHH
T ss_pred             CceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhc
Confidence            996554322110     1133468999999999998889999999999999999999999996432111110  000000


Q ss_pred             ccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                      ...+ .......       ....+++++.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       279 ~~~~-~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  331 (345)
T 2v62_A          279 DELP-QSVLKWA-------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLG  331 (345)
T ss_dssp             HTTT-HHHHHHS-------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCC
T ss_pred             cccc-HHHHhhc-------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCccc
Confidence            0000 0000100       011456789999999999999999999999999998765433

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.5e-41  Score=288.26  Aligned_cols=255  Identities=22%  Similarity=0.286  Sum_probs=196.4

Q ss_pred             Cceeeee-----eeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCC-eeeEEEeeCCCCCHH
Q 023220            2 RRWLCCT-----CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGN-LRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~   74 (285)
                      .||+|..     ..+++.+++|..+... .....+.+.+|+.+++++ +||||+++++++...+ ..+++|||+.+++|.
T Consensus        42 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~  120 (316)
T 2xir_A           42 QVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS  120 (316)
T ss_dssp             EEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHH
T ss_pred             eEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHH
Confidence            4788863     3455778888765322 222345788999999999 7899999999988755 589999999999999


Q ss_pred             HHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220           75 DILHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus        75 ~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      +++.......       .......+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++..
T Consensus       121 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  197 (316)
T 2xir_A          121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD  197 (316)
T ss_dssp             HHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred             HHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEECCCccccc
Confidence            9998654210       000112378999999999999999999999   999999999999999999999999999976


Q ss_pred             CCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhh
Q 023220          148 APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQ  226 (285)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (285)
                      ..............+++.|+|||.+.+..++.++||||||+++|+|++ |..||........               ...
T Consensus       198 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---------------~~~  262 (316)
T 2xir_A          198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---------------FCR  262 (316)
T ss_dssp             TTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---------------HHH
T ss_pred             cccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH---------------HHH
Confidence            543322222334557889999999998899999999999999999998 9999976432211               111


Q ss_pred             hcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          227 CVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       227 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      .+........+..+++.+.+++.+||+.||.+|||+.++++.|+.+++.
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          263 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            1111112233455677899999999999999999999999999998754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.3e-41  Score=292.52  Aligned_cols=231  Identities=19%  Similarity=0.182  Sum_probs=181.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHH-HccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSV-VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||+|.++.++..|++|...+.... ......+.+|..+ ++.++||||+++++++.+.+..++||||+.+|+|.+++..
T Consensus        53 ~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~  132 (373)
T 2r5t_A           53 KVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR  132 (373)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred             EEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh
Confidence            5899999888999999987655432 3345566677776 5678999999999999999999999999999999999976


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++.......  .....
T Consensus       133 ~~~---------~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~~~~~  198 (373)
T 2r5t_A          133 ERC---------FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTST  198 (373)
T ss_dssp             HSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--CCCCS
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC--Ccccc
Confidence            542         88999999999999999999999   99999999999999999999999999986432211  12334


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..||+.|+|||++.+..++.++|+|||||++|+|++|..||........               ...+....  ...+..
T Consensus       199 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---------------~~~i~~~~--~~~~~~  261 (373)
T 2r5t_A          199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---------------YDNILNKP--LQLKPN  261 (373)
T ss_dssp             BSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH---------------HHHHHHSC--CCCCSS
T ss_pred             ccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---------------HHHHHhcc--cCCCCC
Confidence            5689999999999999999999999999999999999999975432211               11222111  123456


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMS  263 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~  263 (285)
                      ++..+.++|.+||+.||.+||++.
T Consensus       262 ~~~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          262 ITNSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred             CCHHHHHHHHHHcccCHHhCCCCC
Confidence            778899999999999999999974

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-40  Score=279.51  Aligned_cols=239  Identities=21%  Similarity=0.243  Sum_probs=185.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..++..+++|...... .....+.+.+|++++++++||||+++++++.+....++||||+.+++|.+++....
T Consensus        37 ~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  115 (285)
T 3is5_A           37 DVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQ  115 (285)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHH
T ss_pred             EEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhh
Confidence            58999888888888888776544 23346889999999999999999999999999999999999999999999885432


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE---ccCCeeEEeccccCCCCCccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ..     ...+++..++.++.|++.||.|||+.   |++||||+|+||++   +.++.++|+|||++........   ..
T Consensus       116 ~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~  184 (285)
T 3is5_A          116 AR-----GKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---ST  184 (285)
T ss_dssp             HH-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----------
T ss_pred             hc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc---Cc
Confidence            10     01289999999999999999999999   99999999999999   4567899999999976543221   23


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ...|++.|+|||.+. ..++.++||||||+++|+|++|..||...............             .+... ....
T Consensus       185 ~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~-------------~~~~~-~~~~  249 (285)
T 3is5_A          185 NAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-------------EPNYA-VECR  249 (285)
T ss_dssp             --CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------CCCCC-C--C
T ss_pred             CcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC-------------Ccccc-cccC
Confidence            456899999999875 56889999999999999999999999765432221111111             11110 1112


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..++.+.+++.+||+.||.+|||+.++++
T Consensus       250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          250 PLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            24677999999999999999999999987

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=8.2e-41  Score=299.41  Aligned_cols=253  Identities=17%  Similarity=0.210  Sum_probs=182.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC-----CeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG-----NLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~   76 (285)
                      +||+|.+..+++.|++|............+++.+|++++++++||||+++++++...     ...++|||++. ++|.++
T Consensus        68 ~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~  146 (458)
T 3rp9_A           68 HVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKL  146 (458)
T ss_dssp             CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHH
T ss_pred             EEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhh
Confidence            689999999999999998765444444567788999999999999999999998533     56899999985 599999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc--
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR--  154 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--  154 (285)
                      +.....         +++..+..++.||+.||.|||+.   |++||||||+|||++.++.++|+|||++.........  
T Consensus       147 ~~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  214 (458)
T 3rp9_A          147 FRTPVY---------LTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS  214 (458)
T ss_dssp             HHSSCC---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCC
T ss_pred             cccCCC---------CCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCcccccc
Confidence            976542         89999999999999999999999   9999999999999999999999999999765321110  


Q ss_pred             -----------------------ccccccccccCcCCCccc-ccCCCCcccchHhHHHHHHHHHh-----------CCCC
Q 023220          155 -----------------------LHSTRVLGTFGYHAPEYA-MTGQLTQKSDVYSFGVVLLELLT-----------GRKP  199 (285)
Q Consensus       155 -----------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~l~~-----------g~~p  199 (285)
                                             .......||+.|+|||++ .+..++.++|||||||++|+|++           |+++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~  294 (458)
T 3rp9_A          215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPL  294 (458)
T ss_dssp             CCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCS
T ss_pred             ccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccccccc
Confidence                                   112334679999999976 45678999999999999999998           6666


Q ss_pred             CCCCCCc--------------------ccchhhhhhcccCchhhhhh--------hcC---Ccc---CCCCChhHHHHHH
Q 023220          200 VDHTMPR--------------------GQQSLVTWATPRLSEDKVKQ--------CVD---PKL---KGEYPPKGVAKLA  245 (285)
Q Consensus       200 f~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~--------~~~---~~~---~~~~~~~~~~~l~  245 (285)
                      |.+....                    .+...+.........+.+..        .+.   ...   .....+..++++.
T Consensus       295 f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  374 (458)
T 3rp9_A          295 FPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAI  374 (458)
T ss_dssp             CC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHH
T ss_pred             CCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHH
Confidence            6554310                    00011111111111111110        000   000   0111234577899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHH
Q 023220          246 AVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +||.+||+.||.+|||++++++
T Consensus       375 dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          375 HLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhccCccccCCHHHHhc
Confidence            9999999999999999999998

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.5e-41  Score=290.58  Aligned_cols=247  Identities=20%  Similarity=0.274  Sum_probs=191.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-----CCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-----HENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      +||+|.+..+++.+++|..+.   .....+.+..|+++++.++     ||||+++++++...+..++|||++ +++|.++
T Consensus        50 ~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~  125 (360)
T 3llt_A           50 RVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEI  125 (360)
T ss_dssp             EEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHH
T ss_pred             EEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHH
Confidence            589999888899999998753   2233566778999999986     999999999999999999999999 7899999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-----------------------
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-----------------------  133 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-----------------------  133 (285)
                      +......       .+++..++.++.|++.||.|||+.   |++||||||+||+++.                       
T Consensus       126 ~~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~  195 (360)
T 3llt_A          126 ITRNNYN-------GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR  195 (360)
T ss_dssp             HHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEE
T ss_pred             HHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccccccccccc
Confidence            9865432       288999999999999999999999   9999999999999975                       


Q ss_pred             --CCeeEEeccccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchh
Q 023220          134 --DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL  211 (285)
Q Consensus       134 --~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~  211 (285)
                        ++.++|+|||++......     .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus       196 ~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  270 (360)
T 3llt_A          196 TKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAM  270 (360)
T ss_dssp             ESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence              788999999998653321     2345689999999999999999999999999999999999999987654433333


Q ss_pred             hhhhcccCchhhhhhhcCCc---------cCCCC--------------------ChhHHHHHHHHHHHhcccCCCCCCCH
Q 023220          212 VTWATPRLSEDKVKQCVDPK---------LKGEY--------------------PPKGVAKLAAVAALCVQYEAEFRPNM  262 (285)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~---------~~~~~--------------------~~~~~~~l~~li~~~l~~~p~~Rps~  262 (285)
                      +.......+...........         .....                    ....++.+.++|.+||+.||++|||+
T Consensus       271 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta  350 (360)
T 3llt_A          271 MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSP  350 (360)
T ss_dssp             HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCH
Confidence            33322222222111111000         00000                    01112678899999999999999999


Q ss_pred             HHHHH
Q 023220          263 SIVVK  267 (285)
Q Consensus       263 ~~ll~  267 (285)
                      +++++
T Consensus       351 ~elL~  355 (360)
T 3llt_A          351 AELLK  355 (360)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.1e-40  Score=281.30  Aligned_cols=235  Identities=20%  Similarity=0.229  Sum_probs=189.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|......  ....+.+.+|++++++++||||+++++++.+.+..+++|||+.+++|.+++....
T Consensus        24 ~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  101 (304)
T 2jam_A           24 EVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG  101 (304)
T ss_dssp             EEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS
T ss_pred             eEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC
Confidence            58999888888899999876432  2335678899999999999999999999999999999999999999999987654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE---ccCCeeEEeccccCCCCCccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      .         +++..++.++.|++.||.|||+.   |++|+||+|+||++   +.++.++|+|||++.......    ..
T Consensus       102 ~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~----~~  165 (304)
T 2jam_A          102 V---------YTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MS  165 (304)
T ss_dssp             C---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT----TH
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc----cc
Confidence            2         88999999999999999999999   99999999999999   778899999999986543221    22


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ...|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+...             ..........
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------~~~~~~~~~~  232 (304)
T 2jam_A          166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG-------------YYEFESPFWD  232 (304)
T ss_dssp             HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC-------------CCCCCTTTTT
T ss_pred             cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-------------CCCCCccccc
Confidence            345889999999999888999999999999999999999999765332111111000             0011122334


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .++..+.++|.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          233 DISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             TSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            56788999999999999999999999987

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.8e-42  Score=286.47  Aligned_cols=243  Identities=19%  Similarity=0.208  Sum_probs=191.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe--CCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||++.+..+++.+++|............+.+.+|++++++++||||+++++++.+  ....++||||+.+++|.+++..
T Consensus        21 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  100 (279)
T 2w5a_A           21 RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK  100 (279)
T ss_dssp             EEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHH
T ss_pred             EEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHh
Confidence            58999888888889999876554444456778999999999999999999998854  5688999999999999999975


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----eeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS-----IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~-----~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  154 (285)
                      ....     ...+++..++.++.|++.||.|||+.   |     ++|+||+|+||+++.++.++|+|||++.........
T Consensus       101 ~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~  172 (279)
T 2w5a_A          101 GTKE-----RQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF  172 (279)
T ss_dssp             HHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHH
T ss_pred             hccc-----CCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccccc
Confidence            4211     11288999999999999999999999   8     999999999999999999999999998654322111


Q ss_pred             ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                        .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||........                ...+......
T Consensus       173 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~i~~~~~~  234 (279)
T 2w5a_A          173 --AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL----------------AGKIREGKFR  234 (279)
T ss_dssp             --HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHTCCC
T ss_pred             --ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH----------------HHHHhhcccc
Confidence              1234578999999999988899999999999999999999999976532111                1111111112


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                      ..+..++.++.+++.+||+.||.+|||+.++++.+.
T Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            334566788999999999999999999999998543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.8e-41  Score=289.32  Aligned_cols=234  Identities=19%  Similarity=0.296  Sum_probs=186.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.+..+++.|++|......      ....+|++++.++ +||||+++++++.+++..++||||+.+|+|.+++...
T Consensus        37 ~V~~~~~~~~~~~~avK~~~~~~------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~  110 (342)
T 2qr7_A           37 VCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ  110 (342)
T ss_dssp             EEEEEEETTTTEEEEEEEEETTT------CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC
T ss_pred             EEEEEEECCCCCEEEEEEEEccc------CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc
Confidence            58999998899999999876432      2345788888888 8999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC----CeeEEeccccCCCCCccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED----FKAKIADFNLSNQAPDMAARLH  156 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~----~~~~l~df~~~~~~~~~~~~~~  156 (285)
                      ..         +++..+..++.|++.||.|||+.   |++||||||+||++...    +.++|+|||++........  .
T Consensus       111 ~~---------~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~  176 (342)
T 2qr7_A          111 KF---------FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--L  176 (342)
T ss_dssp             TT---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--C
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--c
Confidence            42         89999999999999999999999   99999999999998543    3599999999875433221  1


Q ss_pred             ccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC--ccCC
Q 023220          157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP--KLKG  234 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  234 (285)
                      .....|++.|+|||++.+..++.++|+|||||++|+|++|..||............            ..+...  ....
T Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~------------~~i~~~~~~~~~  244 (342)
T 2qr7_A          177 LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL------------ARIGSGKFSLSG  244 (342)
T ss_dssp             BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH------------HHHHHCCCCCCS
T ss_pred             eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH------------HHHccCCcccCc
Confidence            23356799999999998878899999999999999999999999754221111111            111111  1112


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .....+++++.++|.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            233456788999999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7.8e-41  Score=304.07  Aligned_cols=240  Identities=19%  Similarity=0.259  Sum_probs=196.0

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|....+++.|++|...+.. ........+.+|++++++++||||+++++++.+.+..++||||+.+|+|.+++...
T Consensus       199 ~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~  278 (576)
T 2acx_A          199 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM  278 (576)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSS
T ss_pred             EEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhc
Confidence            58999988889999999765432 22345677889999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...       .+++..++.++.||+.||.|||++   |++||||||+||+++.++.++|+|||++........   ....
T Consensus       279 ~~~-------~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~---~~~~  345 (576)
T 2acx_A          279 GQA-------GFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGR  345 (576)
T ss_dssp             SSC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---EECC
T ss_pred             CCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCcc---cccc
Confidence            422       289999999999999999999999   999999999999999999999999999976543221   2334


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .||+.|+|||++.+..++.++|+|||||++|+|++|..||..........            .+...+. .....++..+
T Consensus       346 ~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~------------~i~~~i~-~~~~~~p~~~  412 (576)
T 2acx_A          346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE------------EVERLVK-EVPEEYSERF  412 (576)
T ss_dssp             CSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH------------HHHHHHH-HCCCCCCTTS
T ss_pred             CCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH------------HHHHHhh-cccccCCccC
Confidence            68999999999998889999999999999999999999998654321111            1111110 0112345567


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRP-----NMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp-----s~~~ll~  267 (285)
                      ++++.++|.+||+.||.+||     +++++++
T Consensus       413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            78899999999999999999     7888886

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=287.82  Aligned_cols=253  Identities=22%  Similarity=0.319  Sum_probs=193.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe----CCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE----GNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||+|.+..+++.+++|....  ......+.+.+|++++++++||||+++++++..    ....++||||+.+++|.+++
T Consensus        44 ~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  121 (317)
T 2buj_A           44 YVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI  121 (317)
T ss_dssp             EEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHH
T ss_pred             EEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHH
Confidence            589998888889999997643  223346778899999999999999999999873    34779999999999999998


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc--
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL--  155 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--  155 (285)
                      ......     ...+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++..........  
T Consensus       122 ~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~  193 (317)
T 2buj_A          122 ERLKDK-----GNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ  193 (317)
T ss_dssp             HHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHH
T ss_pred             HHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccc
Confidence            753211     11389999999999999999999999   99999999999999999999999999876543211100  


Q ss_pred             -----cccccccccCcCCCcccccCC---CCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh
Q 023220          156 -----HSTRVLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC  227 (285)
Q Consensus       156 -----~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (285)
                           ......|++.|+|||.+.+..   ++.++||||||+++|+|++|+.||........              .....
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--------------~~~~~  259 (317)
T 2buj_A          194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--------------SVALA  259 (317)
T ss_dssp             HHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--------------CHHHH
T ss_pred             cccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--------------hhhHH
Confidence                 011234688999999987553   68899999999999999999999953211000              00000


Q ss_pred             cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          228 VDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       228 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                      ............++..+.++|.+||+.||.+|||+.++++.|+.+....++
T Consensus       260 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          260 VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence            111111223345677899999999999999999999999999987644433

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.8e-40  Score=285.63  Aligned_cols=235  Identities=20%  Similarity=0.309  Sum_probs=193.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|........ ....+.+.+|+.++++++||||+++++++.+.+..++||||+.+++|.+++...
T Consensus        56 ~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  135 (335)
T 2owb_A           56 KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR  135 (335)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhcc
Confidence            5899988888889999977654332 234677889999999999999999999999999999999999999999998764


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||++........  .....
T Consensus       136 ~~---------l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~  201 (335)
T 2owb_A          136 KA---------LTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVL  201 (335)
T ss_dssp             CS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCC
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc--ccccc
Confidence            32         89999999999999999999999   999999999999999999999999999875532221  12335


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|+..|+|||.+.+..++.++||||||+++|+|++|..||..........               .+...  ....+..+
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---------------~~~~~--~~~~~~~~  264 (335)
T 2owb_A          202 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL---------------RIKKN--EYSIPKHI  264 (335)
T ss_dssp             CSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---------------HHHHT--CCCCCTTS
T ss_pred             CCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH---------------HHhcC--CCCCCccC
Confidence            68899999999998889999999999999999999999997543211111               11111  11234456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +..+.++|.+||+.||++|||++++++
T Consensus       265 ~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          265 NPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            778999999999999999999999997

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=8.1e-41  Score=296.61  Aligned_cols=239  Identities=15%  Similarity=0.137  Sum_probs=192.6

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|....+++.|++|...+.. ......+.+.+|+.++..++||||+++++++.+.+..++||||+.+|+|.+++...
T Consensus        89 ~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~  168 (437)
T 4aw2_A           89 EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF  168 (437)
T ss_dssp             EEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTT
T ss_pred             EEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHc
Confidence            58999988889999999765422 22334566889999999999999999999999999999999999999999999763


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..        .+++..+..++.|++.||.|||+.   |++||||||+|||++.++.++|+|||++......... .....
T Consensus       169 ~~--------~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~  236 (437)
T 4aw2_A          169 ED--------RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVA  236 (437)
T ss_dssp             TT--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECCSC
T ss_pred             cC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc-ccccc
Confidence            22        289999999999999999999999   9999999999999999999999999998654332211 12335


Q ss_pred             ccccCcCCCcccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC
Q 023220          161 LGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE  235 (285)
Q Consensus       161 ~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
                      .||+.|+|||++.     ...++.++|+|||||++|+|++|+.||...+.......+               +.......
T Consensus       237 ~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i---------------~~~~~~~~  301 (437)
T 4aw2_A          237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI---------------MNHKERFQ  301 (437)
T ss_dssp             CSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---------------HTHHHHCC
T ss_pred             cCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh---------------hhcccccc
Confidence            6899999999986     456899999999999999999999999865432222111               11110011


Q ss_pred             ---CChhHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 023220          236 ---YPPKGVAKLAAVAALCVQYEAEF--RPNMSIVVK  267 (285)
Q Consensus       236 ---~~~~~~~~l~~li~~~l~~~p~~--Rps~~~ll~  267 (285)
                         ....+++++.++|++||..+|++  ||+++++++
T Consensus       302 ~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          302 FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence               12346778999999999988888  999999987

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.5e-40  Score=279.29  Aligned_cols=240  Identities=23%  Similarity=0.320  Sum_probs=181.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHcc--CCCCcccccceEEEeC----CeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSR--LKHENLVELLGYCVEG----NLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~~~~lv~e~~~~~~L~~   75 (285)
                      .||++..  .++.+++|.....     ..+.+.+|.+++..  ++||||+++++++...    ...++||||+.+|+|.+
T Consensus        23 ~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~   95 (301)
T 3q4u_A           23 EVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD   95 (301)
T ss_dssp             EEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHH
T ss_pred             EEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHH
Confidence            4788754  5677888876432     34556667777766  7999999999987542    45799999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH--------EKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--------~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      +++...          +++..++.++.|++.||.|||        +.   |++||||||+||+++.++.++|+|||++..
T Consensus        96 ~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  162 (301)
T 3q4u_A           96 YLQLTT----------LDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAVM  162 (301)
T ss_dssp             HHTTCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             HHhhcc----------cCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence            996542          899999999999999999999        88   999999999999999999999999999854


Q ss_pred             CCccccc--ccccccccccCcCCCcccccC------CCCcccchHhHHHHHHHHHhC----------CCCCCCCCCcccc
Q 023220          148 APDMAAR--LHSTRVLGTFGYHAPEYAMTG------QLTQKSDVYSFGVVLLELLTG----------RKPVDHTMPRGQQ  209 (285)
Q Consensus       148 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~~l~~l~~g----------~~pf~~~~~~~~~  209 (285)
                      .......  .......|++.|+|||.+.+.      .++.++|||||||++|+|++|          ..||.........
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~  242 (301)
T 3q4u_A          163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS  242 (301)
T ss_dssp             EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence            3222111  112234689999999998776      445789999999999999999          7777654322111


Q ss_pred             hhhhhhcccCchhhhhhhc-CCccCCC-----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          210 SLVTWATPRLSEDKVKQCV-DPKLKGE-----YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      .           ....... .......     .....+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       243 ~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          243 F-----------EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             H-----------HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             h-----------hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            0           1111111 1111111     2235788999999999999999999999999999875

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.9e-40  Score=289.38  Aligned_cols=248  Identities=19%  Similarity=0.196  Sum_probs=182.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC------eeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN------LRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.+..+++.+++|............+.+.+|+.+++.++||||+++++++...+      ..++||||+.+ +|.+
T Consensus        40 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~  118 (371)
T 2xrw_A           40 IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQ  118 (371)
T ss_dssp             EEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHH
T ss_pred             EEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHH
Confidence            5899998888999999987654434444567889999999999999999999998654      77999999975 8888


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      .+...           ++...+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++.......   
T Consensus       119 ~~~~~-----------~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---  181 (371)
T 2xrw_A          119 VIQME-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---  181 (371)
T ss_dssp             HHHSC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-----------
T ss_pred             HHhhc-----------cCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccccc---
Confidence            88632           78899999999999999999999   99999999999999999999999999997654321   


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh-------hhhc
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV-------KQCV  228 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~  228 (285)
                      ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.......+.........+..       ....
T Consensus       182 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  261 (371)
T 2xrw_A          182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV  261 (371)
T ss_dssp             --------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHH
T ss_pred             ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHH
Confidence            123356899999999999989999999999999999999999999876543222211111111000000       0000


Q ss_pred             --CCc------------cCCC----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          229 --DPK------------LKGE----YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       229 --~~~------------~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                        .+.            ....    .....+.++.++|.+||+.||.+|||++++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          262 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence              000            0000    11234778999999999999999999999998

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.1e-40  Score=279.42  Aligned_cols=236  Identities=28%  Similarity=0.370  Sum_probs=183.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC-CeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG-NLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++..  .++.+++|..+.    ....+.+.+|++++++++||||+++++++... +..+++|||+.+++|.+++...
T Consensus        36 ~V~~~~~--~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  109 (278)
T 1byg_A           36 DVMLGDY--RGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR  109 (278)
T ss_dssp             EEEEEEE--TTEEEEEEECCC----CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH
T ss_pred             eEEEEEE--cCCEEEEEEecc----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhc
Confidence            4777744  356677776642    33568899999999999999999999997654 4789999999999999999754


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...       .+++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++.......     ...
T Consensus       110 ~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~  174 (278)
T 1byg_A          110 GRS-------VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTG  174 (278)
T ss_dssp             HHH-------HCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------------
T ss_pred             ccc-------cCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-----cCC
Confidence            321       268889999999999999999999   99999999999999999999999999987543321     223


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      .+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.......                ....+........+..
T Consensus       175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~  238 (278)
T 1byg_A          175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVPRVEKGYKMDAPDG  238 (278)
T ss_dssp             -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----------------HHHHHTTTCCCCCCTT
T ss_pred             CccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHhcCCCCCCccc
Confidence            46788999999988889999999999999999998 999997543211                1111122222344566


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      +++.+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          239 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            78889999999999999999999999999998764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=284.47  Aligned_cols=249  Identities=20%  Similarity=0.227  Sum_probs=186.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++...   ..+++|..+.........+.+.+|+.++++++||||+++++++.+.+..+++|||+.+++|.+++....
T Consensus        48 ~V~~~~~~---~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~  124 (319)
T 2y4i_B           48 QVYHGRWH---GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK  124 (319)
T ss_dssp             EEEEEEES---SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC
T ss_pred             EEEEEEEc---CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcC
Confidence            46777543   357788776666666677888899999999999999999999999999999999999999999997653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc---ccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA---RLHST  158 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~  158 (285)
                      .        .+++..++.++.|++.||.|||+.   |++|+||+|+||+++ ++.++|+|||++........   .....
T Consensus       125 ~--------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  192 (319)
T 2y4i_B          125 I--------VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLR  192 (319)
T ss_dssp             C--------CCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCB
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccc
Confidence            2        288999999999999999999999   999999999999998 67999999999765432111   11122


Q ss_pred             ccccccCcCCCccccc---------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC
Q 023220          159 RVLGTFGYHAPEYAMT---------GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD  229 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~---------~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
                      ...|++.|+|||.+.+         ..++.++||||||+++|+|++|..||...........               ...
T Consensus       193 ~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---------------~~~  257 (319)
T 2y4i_B          193 IQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ---------------MGT  257 (319)
T ss_dssp             CCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH---------------HHT
T ss_pred             cCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---------------hcc
Confidence            3457899999998864         3578899999999999999999999976543211111               101


Q ss_pred             CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCC
Q 023220          230 PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAA  280 (285)
Q Consensus       230 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  280 (285)
                      ..........++..+.+++.+||+.||.+|||+.++++.|+.+.+.....+
T Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~  308 (319)
T 2y4i_B          258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS  308 (319)
T ss_dssp             TCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------
T ss_pred             CCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCC
Confidence            111111122345679999999999999999999999999999987665543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.9e-40  Score=279.11  Aligned_cols=235  Identities=20%  Similarity=0.309  Sum_probs=193.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|........ ....+.+.+|+.++++++||||+++++++.+.+..+++|||+.+++|.+++...
T Consensus        30 ~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  109 (294)
T 2rku_A           30 KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR  109 (294)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred             EEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhc
Confidence            5899988888889999977554332 234677889999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||++........  .....
T Consensus       110 ~~---------~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~  175 (294)
T 2rku_A          110 KA---------LTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVL  175 (294)
T ss_dssp             CS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCC
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccc
Confidence            32         89999999999999999999999   999999999999999999999999999875432221  12334


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .|++.|+|||.+.+..++.++|+||||+++|+|++|..||.........               ..+...  ....+...
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---------------~~~~~~--~~~~~~~~  238 (294)
T 2rku_A          176 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY---------------LRIKKN--EYSIPKHI  238 (294)
T ss_dssp             CSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---------------HHHHTT--CCCCCTTS
T ss_pred             cCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---------------HHHhhc--cCCCcccc
Confidence            6889999999998888999999999999999999999999764322111               111111  11234556


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +..+.+++.+||+.||.+|||++++++
T Consensus       239 ~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          239 NPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            778999999999999999999999997

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=291.25  Aligned_cols=261  Identities=18%  Similarity=0.192  Sum_probs=200.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC--eeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN--LRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||+|.+..+++.+++|....... ....+.+.+|++++++++||||+++++++....  ..++||||+.+++|.+++..
T Consensus        24 ~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  102 (396)
T 4eut_A           24 NVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE  102 (396)
T ss_dssp             EEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTS
T ss_pred             EEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHh
Confidence            589999988899999998764332 334677889999999999999999999998765  77999999999999999976


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE----ccCCeeEEeccccCCCCCcccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL----FEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~----~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ....      ..+++..++.++.|++.||.|||+.   |++||||||+||++    +.++.++|+|||++........  
T Consensus       103 ~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~--  171 (396)
T 4eut_A          103 PSNA------YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--  171 (396)
T ss_dssp             GGGT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG--
T ss_pred             hhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc--
Confidence            4321      1289999999999999999999999   99999999999999    7778899999999976543222  


Q ss_pred             cccccccccCcCCCccccc--------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcc-cchhhhhhcccCchhhh--
Q 023220          156 HSTRVLGTFGYHAPEYAMT--------GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRG-QQSLVTWATPRLSEDKV--  224 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~--  224 (285)
                       .....|++.|+|||.+.+        ..++.++|||||||++|+|++|+.||....... ....+.......+....  
T Consensus       172 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~  250 (396)
T 4eut_A          172 -FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG  250 (396)
T ss_dssp             -SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEE
T ss_pred             -cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchh
Confidence             233568999999998764        456789999999999999999999997543211 11111111111110000  


Q ss_pred             -hhh------cC--CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          225 -KQC------VD--PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       225 -~~~------~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                       ...      +.  ...........+..+.+++.+||+.||++|||+.++++.++.++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             EECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             heeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence             000      00  0111234577889999999999999999999999999999888754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.6e-40  Score=276.81  Aligned_cols=244  Identities=21%  Similarity=0.245  Sum_probs=189.7

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||++.+..+++.+++|...... ......+.+.+|++++++++||||+++++++.+.+..+++|||+.+++|.+++...
T Consensus        26 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  105 (276)
T 2h6d_A           26 KVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH  105 (276)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH
T ss_pred             EEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhcc
Confidence            48889888788889999765432 23455678999999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         ++...++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||++........   ....
T Consensus       106 ~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~  170 (276)
T 2h6d_A          106 GR---------VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTS  170 (276)
T ss_dssp             CS---------CCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc---eecc
Confidence            32         88999999999999999999999   999999999999999999999999999876543221   2234


Q ss_pred             ccccCcCCCcccccCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          161 LGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      .+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||..........               .+...  ....+..
T Consensus       171 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---------------~~~~~--~~~~~~~  233 (276)
T 2h6d_A          171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK---------------KIRGG--VFYIPEY  233 (276)
T ss_dssp             ------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHHHC--CCCCCTT
T ss_pred             cCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH---------------HhhcC--cccCchh
Confidence            57899999999887765 689999999999999999999997543211111               11000  1123445


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                      ++..+.+++.+||+.||.+|||+.++++  ..+++...|+
T Consensus       234 ~~~~l~~li~~~l~~~p~~Rps~~~~l~--h~~~~~~~~~  271 (276)
T 2h6d_A          234 LNRSVATLLMHMLQVDPLKRATIKDIRE--HEWFKQDLPS  271 (276)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHHTTCCG
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHHh--ChhhccCchh
Confidence            6778999999999999999999999998  4555554443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.8e-40  Score=278.90  Aligned_cols=233  Identities=16%  Similarity=0.210  Sum_probs=188.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|..............+.+|+..+.++ +||||+++++++.+.+..++||||+.+++|.+++...
T Consensus        26 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  105 (289)
T 1x8b_A           26 SVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISEN  105 (289)
T ss_dssp             EEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH
T ss_pred             EEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhh
Confidence            589999988899999998876555555677888999999999 9999999999999999999999999999999999764


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC-------------------CeeEEec
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-------------------FKAKIAD  141 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~-------------------~~~~l~d  141 (285)
                      ....     ..+++..++.++.|++.||.|||++   |++||||||+||+++.+                   ..++|+|
T Consensus       106 ~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D  177 (289)
T 1x8b_A          106 YRIM-----SYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD  177 (289)
T ss_dssp             HHHT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------CCCEEECC
T ss_pred             cccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcc
Confidence            2100     1289999999999999999999999   99999999999999844                   4799999


Q ss_pred             cccCCCCCcccccccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCc
Q 023220          142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLS  220 (285)
Q Consensus       142 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  220 (285)
                      ||.+......      ....|++.|+|||.+.+. .++.++|||||||++|+|++|.+++.....               
T Consensus       178 fg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---------------  236 (289)
T 1x8b_A          178 LGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---------------  236 (289)
T ss_dssp             CTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---------------
T ss_pred             cccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---------------
Confidence            9998654431      223588999999998765 566899999999999999999887643211               


Q ss_pred             hhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          221 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                         ...+. .......+..+++.+.+++.+||+.||.+|||+.++++
T Consensus       237 ---~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 ---WHEIR-QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ---HHHHH-TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHHH-cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence               00111 11112344566788999999999999999999999987

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.9e-40  Score=288.65  Aligned_cols=258  Identities=14%  Similarity=0.150  Sum_probs=188.2

Q ss_pred             Cceeeeeeee-----ccccChhhhhhccC---------CCCCChhHHHHHHHHccCCCCcccccceEEEeC----CeeeE
Q 023220            2 RRWLCCTCQV-----EESYPSHENERLKS---------PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG----NLRVL   63 (285)
Q Consensus         2 ~~~~~~~~~~-----~~~~~~k~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~l   63 (285)
                      .||+|....+     +..+++|.......         .......+.+|+..++.++||||+++++++...    ...++
T Consensus        50 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~l  129 (364)
T 3op5_A           50 CIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFM  129 (364)
T ss_dssp             EEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEE
T ss_pred             EEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEE
Confidence            5888876554     46677776432210         001123344455566777899999999998764    45799


Q ss_pred             EEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEc--cCCeeEEec
Q 023220           64 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF--EDFKAKIAD  141 (285)
Q Consensus        64 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~--~~~~~~l~d  141 (285)
                      ||||+ +++|.+++.....        .+++..++.++.|++.||.|||+.   |++||||||+||+++  .++.++|+|
T Consensus       130 v~e~~-g~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~~~kl~D  197 (364)
T 3op5_A          130 IMDRF-GSDLQKIYEANAK--------RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVD  197 (364)
T ss_dssp             EEECE-EEEHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTTCEEECC
T ss_pred             EEeCC-CCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCCeEEEEE
Confidence            99999 8899999976532        289999999999999999999999   999999999999999  889999999


Q ss_pred             cccCCCCCccccccc-----ccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 023220          142 FNLSNQAPDMAARLH-----STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT  216 (285)
Q Consensus       142 f~~~~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  216 (285)
                      ||++...........     .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||................
T Consensus       198 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~  277 (364)
T 3op5_A          198 YGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIR  277 (364)
T ss_dssp             CTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHH
T ss_pred             CCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHH
Confidence            999965543221111     122348999999999999899999999999999999999999997533221111000000


Q ss_pred             ccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                         .......+.++.+.   ...++.++.+++.+||+.||.+||++.++++.|+.++....
T Consensus       278 ---~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  332 (364)
T 3op5_A          278 ---YRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG  332 (364)
T ss_dssp             ---HHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ---hhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence               00111111111111   13456789999999999999999999999999999886543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.8e-41  Score=292.54  Aligned_cols=247  Identities=22%  Similarity=0.248  Sum_probs=179.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC------CeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG------NLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~   75 (285)
                      .||++.+..+++.+++|............+.+.+|++++++++||||+++++++...      ...+++++++ +++|.+
T Consensus        44 ~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~  122 (367)
T 2fst_X           44 SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNN  122 (367)
T ss_dssp             CEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-
T ss_pred             EEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHH
Confidence            689999888899999998765433334457788999999999999999999999754      5679999999 569988


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++....          +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......    
T Consensus       123 ~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----  185 (367)
T 2fst_X          123 IVKCQK----------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----  185 (367)
T ss_dssp             ----CC----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--------------
T ss_pred             HHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccccc----
Confidence            887532          89999999999999999999999   9999999999999999999999999998764321    


Q ss_pred             cccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhh--------
Q 023220          156 HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQ--------  226 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------  226 (285)
                       .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.........+....        
T Consensus       186 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~  264 (367)
T 2fst_X          186 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  264 (367)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred             -CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence             233568999999999876 6789999999999999999999999987665443333322222222111111        


Q ss_pred             hcCCccCC------CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          227 CVDPKLKG------EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       227 ~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+......      ......++.+.++|.+||+.||.+|||+.++++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            11100000      011234678999999999999999999999997

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.6e-40  Score=279.36  Aligned_cols=235  Identities=22%  Similarity=0.305  Sum_probs=192.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++....+++.+++|....    ....+.+.+|++++++++||||+++++++...+..++||||+.+++|.+++....
T Consensus        44 ~Vy~~~~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  119 (314)
T 3com_A           44 SVYKAIHKETGQIVAIKQVPV----ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN  119 (314)
T ss_dssp             EEEEEEETTTCCEEEEEEEET----TSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT
T ss_pred             EEEEEEECCCCCEEEEEecCc----hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcC
Confidence            589998888888899987754    2346789999999999999999999999999999999999999999999986432


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........  ......
T Consensus       120 ~--------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~  186 (314)
T 3com_A          120 K--------TLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVI  186 (314)
T ss_dssp             C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCC
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccC
Confidence            2        289999999999999999999999   999999999999999999999999999865443221  123346


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      |++.|+|||.+.+..++.++||||||+++|+|++|..||.............            .  ........+..++
T Consensus       187 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------~--~~~~~~~~~~~~~  252 (314)
T 3com_A          187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP------------T--NPPPTFRKPELWS  252 (314)
T ss_dssp             SCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------------H--SCCCCCSSGGGSC
T ss_pred             CCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh------------c--CCCcccCCcccCC
Confidence            8899999999998889999999999999999999999997543221111000            0  0111112244567


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+.++|.+||+.||.+|||+.++++
T Consensus       253 ~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          253 DNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHh
Confidence            78999999999999999999999987

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=280.39  Aligned_cols=238  Identities=20%  Similarity=0.232  Sum_probs=185.8

Q ss_pred             CceeeeeeeeccccChhhhhhcc--CCCCCChhHHHHHHHHccCCCCcccccceEEE--eCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLK--SPKNYPDDEKQLVSVVSRLKHENLVELLGYCV--EGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||+|.+..++..+++|......  ......+.+.+|++++++++||||+++++++.  +....++||||+.++ |.+++
T Consensus        20 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~   98 (305)
T 2wtk_C           20 KVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEML   98 (305)
T ss_dssp             EEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHH
T ss_pred             EEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHH
Confidence            58999888888889988765433  22344678899999999999999999999984  455789999999875 77777


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      ......       .+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||++............
T Consensus        99 ~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~  168 (305)
T 2wtk_C           99 DSVPEK-------RFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC  168 (305)
T ss_dssp             HHSTTC-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEE
T ss_pred             HhCccc-------ccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCcccccccc
Confidence            654322       289999999999999999999999   9999999999999999999999999998755332222222


Q ss_pred             cccccccCcCCCcccccCC--CCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQ--LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE  235 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
                      ....|++.|+|||.+.+..  ++.++||||||+++|+|++|..||.........               ..+...  ...
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~i~~~--~~~  231 (305)
T 2wtk_C          169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF---------------ENIGKG--SYA  231 (305)
T ss_dssp             CCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---------------HHHHHC--CCC
T ss_pred             ccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---------------HHHhcC--CCC
Confidence            3445899999999987643  377999999999999999999999754321111               111111  112


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+..+++.+.++|.+||+.||.+|||++++++
T Consensus       232 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          232 IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            34556778999999999999999999999997

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.4e-40  Score=288.99  Aligned_cols=249  Identities=18%  Similarity=0.235  Sum_probs=192.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..++..+++|..... ......+.+.+|+.++++++||||+++++++.+++..++||||+.+++|.+++....
T Consensus        48 ~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  126 (360)
T 3eqc_A           48 VVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG  126 (360)
T ss_dssp             EEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS
T ss_pred             EEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC
Confidence            5899988888899999987543 223345678899999999999999999999999999999999999999999997654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      .         +++..+..++.|++.|+.|||+ .   |++|+||||+||+++.++.++|+|||++......    .....
T Consensus       127 ~---------~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~  190 (360)
T 3eqc_A          127 R---------IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSF  190 (360)
T ss_dssp             S---------CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCC
Confidence            2         8899999999999999999998 6   8999999999999999999999999988543221    12345


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhh-------------------------
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA-------------------------  215 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-------------------------  215 (285)
                      .|++.|+|||.+.+..++.++|||||||++|+|++|+.||...............                         
T Consensus       191 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (360)
T 3eqc_A          191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD  270 (360)
T ss_dssp             CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------------
T ss_pred             CCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccC
Confidence            6899999999999989999999999999999999999999765432221111000                         


Q ss_pred             -cccCc-hhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          216 -TPRLS-EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       216 -~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                       .+... .+....+............++.++.++|.+||+.||.+|||++++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ---CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence             00000 01111111111111222346778999999999999999999999987

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.2e-39  Score=288.53  Aligned_cols=237  Identities=20%  Similarity=0.231  Sum_probs=178.9

Q ss_pred             CceeeeeeeeccccChhhhhhccC------CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS------PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.+..+++.+++|.......      .......+.+|++++++++||||+++++++.. +..++||||+.+++|.+
T Consensus       150 ~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~  228 (419)
T 3i6u_A          150 EVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFD  228 (419)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGG
T ss_pred             EEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHH
Confidence            589999999999999997765432      12234568899999999999999999999854 55799999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC---CeeEEeccccCCCCCccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED---FKAKIADFNLSNQAPDMA  152 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~---~~~~l~df~~~~~~~~~~  152 (285)
                      ++.....         +++..++.++.|++.||.|||+.   |++||||||+||+++.+   +.++|+|||++.......
T Consensus       229 ~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  296 (419)
T 3i6u_A          229 KVVGNKR---------LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS  296 (419)
T ss_dssp             GTSSSCC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC---
T ss_pred             HHhccCC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccceecCCCc
Confidence            8876542         89999999999999999999999   99999999999999654   459999999998754322


Q ss_pred             ccccccccccccCcCCCccccc---CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccch-hhhhhcccCchhhhhhhc
Q 023220          153 ARLHSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS-LVTWATPRLSEDKVKQCV  228 (285)
Q Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  228 (285)
                         ......|++.|+|||.+.+   ..++.++|||||||++|+|++|..||.......... .+........        
T Consensus       297 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~--------  365 (419)
T 3i6u_A          297 ---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI--------  365 (419)
T ss_dssp             -----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC--------
T ss_pred             ---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC--------
Confidence               1234568999999999853   567889999999999999999999997643321111 1100000000        


Q ss_pred             CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          229 DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                           ......+++.+.++|.+||+.||.+|||++++++
T Consensus       366 -----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          366 -----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             -----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -----chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                 0011235678999999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.7e-40  Score=278.63  Aligned_cols=247  Identities=25%  Similarity=0.262  Sum_probs=188.3

Q ss_pred             Cceeeeeeeec---cccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVE---ESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~---~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||+|......   ..+++|..+.... .....+.+.+|++++++++||||+++++++.... .++++||+.+++|.+++
T Consensus        33 ~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l  111 (291)
T 1u46_A           33 VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRL  111 (291)
T ss_dssp             CCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHH
T ss_pred             eEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHH
Confidence            58888643322   2477777654432 2335678889999999999999999999998765 78999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-cc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-LH  156 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~  156 (285)
                      .....        .+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++......... ..
T Consensus       112 ~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  180 (291)
T 1u46_A          112 RKHQG--------HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM  180 (291)
T ss_dssp             HHHGG--------GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC
T ss_pred             HhccC--------CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccccccchhh
Confidence            76432        288999999999999999999999   9999999999999999999999999998655432211 11


Q ss_pred             ccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC
Q 023220          157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE  235 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||........               ...+........
T Consensus       181 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~  245 (291)
T 1u46_A          181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---------------LHKIDKEGERLP  245 (291)
T ss_dssp             -----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---------------HHHHHTSCCCCC
T ss_pred             hccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH---------------HHHHHccCCCCC
Confidence            223446778999999988888999999999999999999 9999976542211               111112222223


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      .+..++..+.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus       246 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            4456778899999999999999999999999999988654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=287.58  Aligned_cols=252  Identities=15%  Similarity=0.194  Sum_probs=192.0

Q ss_pred             Cceeeeeeee--------ccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccc---------------cceEEEe-
Q 023220            2 RRWLCCTCQV--------EESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVE---------------LLGYCVE-   57 (285)
Q Consensus         2 ~~~~~~~~~~--------~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~---------------~~~~~~~-   57 (285)
                      .||+|....+        ++.+++|.....       +.+.+|++++++++||||++               +++++.. 
T Consensus        57 ~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~  129 (352)
T 2jii_A           57 ILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQ  129 (352)
T ss_dssp             EEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEET
T ss_pred             EEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccC
Confidence            4888888763        788888877532       57889999999999999988               5677766 


Q ss_pred             CCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC--
Q 023220           58 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF--  135 (285)
Q Consensus        58 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~--  135 (285)
                      +...++||||+ +++|.+++......       .+++..++.++.|++.||.|||++   |++||||||+||+++.++  
T Consensus       130 ~~~~~lv~e~~-~~~L~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~~~  198 (352)
T 2jii_A          130 DKYRFLVLPSL-GRSLQSALDVSPKH-------VLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQS  198 (352)
T ss_dssp             TTEEEEEEECC-CEEHHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETTEEE
T ss_pred             CcEEEEEecCC-CcCHHHHHHhCCcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCCCCc
Confidence            67889999999 88999999865211       289999999999999999999999   999999999999999988  


Q ss_pred             eeEEeccccCCCCCcccccc-----cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccch
Q 023220          136 KAKIADFNLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS  210 (285)
Q Consensus       136 ~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~  210 (285)
                      .++|+|||++..........     ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||..........
T Consensus       199 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  278 (352)
T 2jii_A          199 QVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI  278 (352)
T ss_dssp             EEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred             eEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHH
Confidence            89999999997655332211     1123468999999999998899999999999999999999999997643211110


Q ss_pred             hhhhhcccCchhhhhhhcCCccCC--CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          211 LVTWATPRLSEDKVKQCVDPKLKG--EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                       ....      ....... +....  .....+++.+.+++.+||+.||.+|||++++++.|+++++....+
T Consensus       279 -~~~~------~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  341 (352)
T 2jii_A          279 -MKQK------QKFVDKP-GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS  341 (352)
T ss_dssp             -HHHH------HHHHHSC-CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             -HHHH------HhccCCh-hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence             0000      0000000 00000  011234678999999999999999999999999999998665433

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8.5e-41  Score=297.08  Aligned_cols=253  Identities=19%  Similarity=0.212  Sum_probs=186.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC-----CeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG-----NLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~   76 (285)
                      .||+|.+..+++.+++|............+++.+|+.++++++||||+++++++...     ...++||||+. ++|.++
T Consensus        41 ~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~  119 (432)
T 3n9x_A           41 YVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKL  119 (432)
T ss_dssp             EEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHH
T ss_pred             EEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHH
Confidence            589999999999999998865444444567888999999999999999999999766     57899999997 599999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc--
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR--  154 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--  154 (285)
                      +.....         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.........  
T Consensus       120 ~~~~~~---------l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  187 (432)
T 3n9x_A          120 FKTPIF---------LTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI  187 (432)
T ss_dssp             HHSSCC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC--------
T ss_pred             HhccCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccc
Confidence            976542         89999999999999999999999   9999999999999999999999999999765432211  


Q ss_pred             ------------------ccccccccccCcCCCccc-ccCCCCcccchHhHHHHHHHHHhCCCCCC-----------CCC
Q 023220          155 ------------------LHSTRVLGTFGYHAPEYA-MTGQLTQKSDVYSFGVVLLELLTGRKPVD-----------HTM  204 (285)
Q Consensus       155 ------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~pf~-----------~~~  204 (285)
                                        .......||+.|+|||++ ....++.++|||||||++|+|++|..||.           +.+
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~  267 (432)
T 3n9x_A          188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSS  267 (432)
T ss_dssp             -----------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSC
T ss_pred             cccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCcc
Confidence                              112345689999999986 45678999999999999999998555443           221


Q ss_pred             Cc-----------------ccchhhhhhcccCchhh--------hhhhcCCcc-CCC-----CChhHHHHHHHHHHHhcc
Q 023220          205 PR-----------------GQQSLVTWATPRLSEDK--------VKQCVDPKL-KGE-----YPPKGVAKLAAVAALCVQ  253 (285)
Q Consensus       205 ~~-----------------~~~~~~~~~~~~~~~~~--------~~~~~~~~~-~~~-----~~~~~~~~l~~li~~~l~  253 (285)
                      .-                 .+...+.......+.+.        ....+.... ...     ..+..++++.++|.+||+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~  347 (432)
T 3n9x_A          268 CFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLK  347 (432)
T ss_dssp             SCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSC
T ss_pred             ccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhc
Confidence            10                 00001111111111111        111111000 000     113467789999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 023220          254 YEAEFRPNMSIVVK  267 (285)
Q Consensus       254 ~~p~~Rps~~~ll~  267 (285)
                      .||.+|||++++++
T Consensus       348 ~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          348 FNPNKRITIDQALD  361 (432)
T ss_dssp             SSTTTSCCHHHHHT
T ss_pred             CCcccCCCHHHHhc
Confidence            99999999999998

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.5e-40  Score=298.84  Aligned_cols=243  Identities=18%  Similarity=0.234  Sum_probs=195.7

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|....+++.|++|...+... .....+.+.+|++++++++||||+++++++.+....++||||+.+|+|.+++...
T Consensus       200 ~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~  279 (543)
T 3c4z_A          200 EVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNV  279 (543)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTS
T ss_pred             EEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHh
Confidence            589999888899999997754332 2345678889999999999999999999999999999999999999999998754


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...     ...+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++........  .....
T Consensus       280 ~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~  349 (543)
T 3c4z_A          280 DED-----NPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGY  349 (543)
T ss_dssp             STT-----SCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--CBCCC
T ss_pred             hcc-----cccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc--ccccc
Confidence            321     11389999999999999999999999   999999999999999999999999999976543221  12334


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .||+.|+|||++.+..++.++|+|||||++|+|++|..||..........           .....+...  ...++..+
T Consensus       350 ~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~-----------~~~~~i~~~--~~~~p~~~  416 (543)
T 3c4z_A          350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-----------ELKQRVLEQ--AVTYPDKF  416 (543)
T ss_dssp             CSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH-----------HHHHHHHHC--CCCCCTTS
T ss_pred             cCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH-----------HHHHHHhhc--ccCCCccc
Confidence            78999999999999999999999999999999999999997653221111           111111111  12345667


Q ss_pred             HHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNM-----SIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~-----~~ll~  267 (285)
                      +..+.++|.+||+.||.+||++     +++++
T Consensus       417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            8889999999999999999965     66664

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.3e-40  Score=277.36  Aligned_cols=239  Identities=23%  Similarity=0.299  Sum_probs=188.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..++..+++|.....  .....+.+.+|+.+++.++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        37 ~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  114 (295)
T 2clq_A           37 IVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW  114 (295)
T ss_dssp             EEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTT
T ss_pred             EEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhc
Confidence            5899988888888999877543  34457889999999999999999999999999999999999999999999997653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-CCeeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..      ..+++..+..++.|++.||.|||+.   |++|+||+|+||+++. ++.++|+|||++........  .....
T Consensus       115 ~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~  183 (295)
T 2clq_A          115 GP------LKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETF  183 (295)
T ss_dssp             CC------CTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCC
T ss_pred             cC------CCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--ccccc
Confidence            21      1267889999999999999999999   9999999999999987 88999999999865433221  12334


Q ss_pred             ccccCcCCCcccccC--CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          161 LGTFGYHAPEYAMTG--QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      .|++.|+|||.+.+.  .++.++||||||+++|+|++|+.||........              ..............+.
T Consensus       184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~~~~~  249 (295)
T 2clq_A          184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--------------AMFKVGMFKVHPEIPE  249 (295)
T ss_dssp             CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--------------HHHHHHHHCCCCCCCT
T ss_pred             CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--------------HHHhhccccccccccc
Confidence            688999999998764  378999999999999999999999964322110              0000000111223455


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .++.++.+++.+||+.||++|||+.++++
T Consensus       250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          250 SMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            67788999999999999999999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1e-39  Score=279.59  Aligned_cols=252  Identities=17%  Similarity=0.222  Sum_probs=193.4

Q ss_pred             Cceeeeee-eeccccChhhhhhccCCCCCChhHHHHHHHHccC---CCCcccccceEEE-----eCCeeeEEEeeCCCCC
Q 023220            2 RRWLCCTC-QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL---KHENLVELLGYCV-----EGNLRVLAYEFATMGS   72 (285)
Q Consensus         2 ~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~   72 (285)
                      .||+|.+. ..+..+++|..............+.+|+++++.+   +||||+++++++.     .....+++|||+. ++
T Consensus        26 ~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~  104 (326)
T 1blx_A           26 KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QD  104 (326)
T ss_dssp             EEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CB
T ss_pred             EEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CC
Confidence            58888874 5677889998876666666667788888888776   8999999999987     4567899999998 59


Q ss_pred             HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc
Q 023220           73 LHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA  152 (285)
Q Consensus        73 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~  152 (285)
                      |.+++......       .+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++.......
T Consensus       105 L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (326)
T 1blx_A          105 LTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM  174 (326)
T ss_dssp             HHHHHHHSCTT-------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG
T ss_pred             HHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccccccCCC
Confidence            99999765432       288999999999999999999999   99999999999999999999999999997654322


Q ss_pred             ccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhh------
Q 023220          153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQ------  226 (285)
Q Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------  226 (285)
                         ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.........+..............      
T Consensus       175 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  251 (326)
T 1blx_A          175 ---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR  251 (326)
T ss_dssp             ---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG
T ss_pred             ---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccch
Confidence               12345688999999999988899999999999999999999999987654322211111111100000000      


Q ss_pred             -hc---CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          227 -CV---DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       227 -~~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                       ..   ...........++..+.++|.+||+.||.+|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          252 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             00   000111233456788999999999999999999999996

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-39  Score=276.95  Aligned_cols=248  Identities=22%  Similarity=0.325  Sum_probs=185.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC--CCCcccccceEEEeC----CeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL--KHENLVELLGYCVEG----NLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~----~~~~lv~e~~~~~~L~~   75 (285)
                      .||++...  ++.+++|.....     ......+|.+++..+  +||||+++++++...    ...++||||+.+++|.+
T Consensus        52 ~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~  124 (337)
T 3mdy_A           52 EVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYD  124 (337)
T ss_dssp             EEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHH
T ss_pred             EEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHH
Confidence            47887553  677888876432     234555666666655  999999999999887    78899999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD  150 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~-----~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~  150 (285)
                      ++....          +++..++.++.|++.||.|||+.+     ..|++||||||+||+++.++.++|+|||++.....
T Consensus       125 ~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~  194 (337)
T 3mdy_A          125 YLKSTT----------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS  194 (337)
T ss_dssp             HHHHCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             HhhccC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeecc
Confidence            997653          899999999999999999999651     23799999999999999999999999999865433


Q ss_pred             ccccc--cccccccccCcCCCcccccCCCCcc------cchHhHHHHHHHHHhC----------CCCCCCCCCcccchhh
Q 023220          151 MAARL--HSTRVLGTFGYHAPEYAMTGQLTQK------SDVYSFGVVLLELLTG----------RKPVDHTMPRGQQSLV  212 (285)
Q Consensus       151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~------~DiwslG~~l~~l~~g----------~~pf~~~~~~~~~~~~  212 (285)
                      .....  ......|++.|+|||.+.+...+..      +|||||||++|+|++|          +.||........    
T Consensus       195 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~----  270 (337)
T 3mdy_A          195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP----  270 (337)
T ss_dssp             --------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC----
T ss_pred             ccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC----
Confidence            22111  1123468999999999987766554      9999999999999999          555543322111    


Q ss_pred             hhhcccCchhhhhhh-cCCccCCCCC-----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          213 TWATPRLSEDKVKQC-VDPKLKGEYP-----PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       213 ~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                             ........ .........+     ..+++++.+++.+||+.||++|||+.++++.|+++.+...
T Consensus       271 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          271 -------SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             -------CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             -------chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence                   11111111 1111222222     3778899999999999999999999999999999987653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.9e-40  Score=284.46  Aligned_cols=238  Identities=18%  Similarity=0.287  Sum_probs=188.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCC------CCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPK------NYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~------~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   74 (285)
                      .||+|....+++.+++|.........      ...+.+.+|+.+++++ +||||+++++++......++||||+.+++|.
T Consensus       109 ~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~  188 (365)
T 2y7j_A          109 VVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF  188 (365)
T ss_dssp             EEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHH
T ss_pred             EEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHH
Confidence            58999888888999999775433211      1245678899999999 8999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  154 (285)
                      +++.....         +++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........ 
T Consensus       189 ~~l~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~-  255 (365)
T 2y7j_A          189 DYLTEKVA---------LSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-  255 (365)
T ss_dssp             HHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC-
T ss_pred             HHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccccCCCcc-
Confidence            99976432         89999999999999999999999   999999999999999999999999999865543221 


Q ss_pred             ccccccccccCcCCCccccc------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhc
Q 023220          155 LHSTRVLGTFGYHAPEYAMT------GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV  228 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
                        .....|++.|+|||.+.+      ..++.++|||||||++|+|++|..||...........+..........      
T Consensus       256 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~------  327 (365)
T 2y7j_A          256 --LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP------  327 (365)
T ss_dssp             --BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH------
T ss_pred             --cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc------
Confidence              234568999999998863      357889999999999999999999997643221111111000000000      


Q ss_pred             CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          229 DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                             .....+..+.++|.+||+.||.+|||+.++++
T Consensus       328 -------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          328 -------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             -------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                   00234567999999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6e-41  Score=293.11  Aligned_cols=233  Identities=15%  Similarity=0.161  Sum_probs=178.0

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHH---HHHccCCCCcccccc-------eEEEeCC-----------
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLV---SVVSRLKHENLVELL-------GYCVEGN-----------   59 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~~~~~~-----------   59 (285)
                      .||+|.+..+++.+++|...... ......+.+.+|+   +.+++++||||++++       +++.+.+           
T Consensus        88 ~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (377)
T 3byv_A           88 AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDE  167 (377)
T ss_dssp             EEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC----
T ss_pred             EEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCC
Confidence            58999988889999999886543 2334567888999   556666899999998       6666553           


Q ss_pred             ------eeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc
Q 023220           60 ------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE  133 (285)
Q Consensus        60 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~  133 (285)
                            ..+++|||+ +|+|.+++........  ....+++..++.++.|++.||.|||+.   |++||||||+||+++.
T Consensus       168 ~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~  241 (377)
T 3byv_A          168 RDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS--THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQ  241 (377)
T ss_dssp             --CEEESEEEEEECC-SEEHHHHHHHHHHTTT--TTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred             CceEEEEEEEEEecc-CCCHHHHHHhcccccc--ccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence                  278999999 5799999976432110  001244588889999999999999999   9999999999999999


Q ss_pred             CCeeEEeccccCCCCCcccccccccccccccCcCCCcccccC-----------CCCcccchHhHHHHHHHHHhCCCCCCC
Q 023220          134 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-----------QLTQKSDVYSFGVVLLELLTGRKPVDH  202 (285)
Q Consensus       134 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~DiwslG~~l~~l~~g~~pf~~  202 (285)
                      ++.++|+|||++......     .....| +.|+|||.+.+.           .++.++|||||||++|+|++|+.||..
T Consensus       242 ~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~  315 (377)
T 3byv_A          242 RGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK  315 (377)
T ss_dssp             TCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcc
Confidence            999999999998753321     123456 899999999877           789999999999999999999999976


Q ss_pred             CCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          203 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .........+               .      .....+++++.++|.+||+.||.+|||+.++++
T Consensus       316 ~~~~~~~~~~---------------~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          316 DAALGGSEWI---------------F------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             ----CCSGGG---------------G------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             cccccchhhh---------------h------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            5432211110               0      011345678999999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.2e-40  Score=286.42  Aligned_cols=256  Identities=19%  Similarity=0.248  Sum_probs=194.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC-----CeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG-----NLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~   76 (285)
                      .||+|.+..++..+++|..... ......+.+.+|++++++++||||+++++++...     ...+++||++.+ +|.++
T Consensus        42 ~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~  119 (364)
T 3qyz_A           42 MVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKL  119 (364)
T ss_dssp             EEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHH
T ss_pred             EEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHH
Confidence            5899988888889999977532 2223347788999999999999999999999754     367999999975 99999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc-
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL-  155 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-  155 (285)
                      +....          +++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.......... 
T Consensus       120 l~~~~----------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  186 (364)
T 3qyz_A          120 LKTQH----------LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG  186 (364)
T ss_dssp             HHHCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCC
T ss_pred             HHhCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccc
Confidence            97653          89999999999999999999999   99999999999999999999999999997654332211 


Q ss_pred             cccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC-----
Q 023220          156 HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD-----  229 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  229 (285)
                      ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+.........+....+.+     
T Consensus       187 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  266 (364)
T 3qyz_A          187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN  266 (364)
T ss_dssp             TTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred             cccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHH
Confidence            1233468999999998654 4589999999999999999999999987665444333322222222222111110     


Q ss_pred             ---Ccc-CC-----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          230 ---PKL-KG-----EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       230 ---~~~-~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                         ... ..     ...+..+.++.++|.+||+.||.+|||++++++  ..+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~~~  318 (364)
T 3qyz_A          267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA--HPYLE  318 (364)
T ss_dssp             HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGT
T ss_pred             HHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc--Ccchh
Confidence               000 00     112345678999999999999999999999998  44443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=292.25  Aligned_cols=241  Identities=15%  Similarity=0.105  Sum_probs=189.5

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|..+.+++.|++|...+.. ......+.+.+|..++..++||||+++++++.+.+..++||||+.+|+|.+++...
T Consensus        76 ~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~  155 (412)
T 2vd5_A           76 EVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF  155 (412)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhc
Confidence            58999988899999999765422 12234567889999999999999999999999999999999999999999999764


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..        .+++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......... .....
T Consensus       156 ~~--------~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~-~~~~~  223 (412)
T 2vd5_A          156 GE--------RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVA  223 (412)
T ss_dssp             SS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECSSC
T ss_pred             CC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCcc-cccee
Confidence            21        289999999999999999999999   9999999999999999999999999998655432211 12235


Q ss_pred             ccccCcCCCcccc-------cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          161 LGTFGYHAPEYAM-------TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       161 ~~~~~~~aPE~~~-------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                      .||+.|+|||++.       ...++.++|+|||||++|+|++|+.||...+.......+.....        ..    ..
T Consensus       224 ~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--------~~----~~  291 (412)
T 2vd5_A          224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE--------HL----SL  291 (412)
T ss_dssp             CSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--------HC----CC
T ss_pred             ccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--------Cc----CC
Confidence            6899999999987       35689999999999999999999999976543222111110000        00    00


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 023220          234 GEYPPKGVAKLAAVAALCVQYEAEFR---PNMSIVVK  267 (285)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~~ll~  267 (285)
                      ...+..+++++.++|++||. +|.+|   |+++++++
T Consensus       292 p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            11124567789999999999 99998   58999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.5e-40  Score=292.73  Aligned_cols=260  Identities=18%  Similarity=0.236  Sum_probs=192.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC------CCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL------KHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.+..+++.+++|..+..   ....+.+.+|+++++.+      +|+||+.+++++...+..+++||++. ++|.+
T Consensus       112 ~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~  187 (429)
T 3kvw_A          112 QVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYE  187 (429)
T ss_dssp             EEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHH
T ss_pred             EEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHH
Confidence            5899999888999999987532   22345677788888877      67799999999999999999999996 59999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCe--eEEeccccCCCCCcccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK--AKIADFNLSNQAPDMAA  153 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~--~~l~df~~~~~~~~~~~  153 (285)
                      ++......       .+++..+..++.|++.||.|||+.   |++||||||+||+++.++.  ++|+|||++......  
T Consensus       188 ~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~--  255 (429)
T 3kvw_A          188 LIKKNKFQ-------GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR--  255 (429)
T ss_dssp             HHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC--
T ss_pred             HHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecCCc--
Confidence            98765432       289999999999999999999999   9999999999999999887  999999998653321  


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh------hh
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK------QC  227 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~  227 (285)
                         .....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.......+.....      .+
T Consensus       256 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~  332 (429)
T 3kvw_A          256 ---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNF  332 (429)
T ss_dssp             ---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHH
T ss_pred             ---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhc
Confidence               233468899999999999899999999999999999999999998765433322222111111111000      00


Q ss_pred             cCCc---------------------------c---------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          228 VDPK---------------------------L---------KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       228 ~~~~---------------------------~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      ++..                           .         ........++.+.+||.+||+.||.+|||++++++  ..
T Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~--Hp  410 (429)
T 3kvw_A          333 VSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR--HP  410 (429)
T ss_dssp             BCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT--ST
T ss_pred             cCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC--Ch
Confidence            0000                           0         00011123567999999999999999999999999  66


Q ss_pred             hhcCCCCCCCC
Q 023220          272 LLKSPPPAAPV  282 (285)
Q Consensus       272 ~~~~~~~~~~~  282 (285)
                      +++...|.+|.
T Consensus       411 w~~~~~~~~~~  421 (429)
T 3kvw_A          411 WLRRRLPKPPT  421 (429)
T ss_dssp             TTC--------
T ss_pred             hhccCCCCCCc
Confidence            66655554443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.6e-40  Score=280.16  Aligned_cols=254  Identities=25%  Similarity=0.274  Sum_probs=175.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||++.+..+++.+++|...... .....+.+.+|++++++++||||+++++++...+..++||||+.+++|.+++....
T Consensus        30 ~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  108 (303)
T 2vwi_A           30 VVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIV  108 (303)
T ss_dssp             CEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHH
T ss_pred             EEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHh
Confidence            68999888888999999775433 23446778899999999999999999999999999999999999999999987421


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc---ccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA---RLHST  158 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~  158 (285)
                      ... ......+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........   .....
T Consensus       109 ~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  184 (303)
T 2vwi_A          109 AKG-EHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK  184 (303)
T ss_dssp             HTT-TTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC------------
T ss_pred             hcc-ccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhc
Confidence            100 00111389999999999999999999999   999999999999999999999999998864432211   11112


Q ss_pred             ccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.............. .....  .....    ......
T Consensus       185 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~--~~~~~----~~~~~~  257 (303)
T 2vwi_A          185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ-NDPPS--LETGV----QDKEML  257 (303)
T ss_dssp             ---CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT-SSCCC--TTC---------CCC
T ss_pred             ccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc-cCCCc--ccccc----ccchhh
Confidence            3458899999998865 5689999999999999999999999976543222111100 00000  00000    011223


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..++..+.+++.+||+.||.+|||+.++++
T Consensus       258 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          258 KKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            445678999999999999999999999997

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.5e-39  Score=303.06  Aligned_cols=235  Identities=20%  Similarity=0.200  Sum_probs=196.5

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||++.+..+++.|++|..++.. ......+.+..|.+++..+ +||+|+.+++++.+.+.++|||||+.+|+|.+++..
T Consensus       356 ~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~  435 (674)
T 3pfq_A          356 KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ  435 (674)
T ss_dssp             CEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH
T ss_pred             EEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh
Confidence            68999999999999999876532 2344577888999999988 799999999999999999999999999999999986


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..++.++.||+.||.|||+.   |++||||||+|||++.++.++|+|||++........  ....
T Consensus       436 ~~~---------~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~  501 (674)
T 3pfq_A          436 VGR---------FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKT  501 (674)
T ss_dssp             HSS---------CCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCC
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCCc--cccc
Confidence            542         89999999999999999999999   999999999999999999999999999874322211  2344


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+....               ...+....  ..++..
T Consensus       502 ~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~---------------~~~i~~~~--~~~p~~  564 (674)
T 3pfq_A          502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---------------FQSIMEHN--VAYPKS  564 (674)
T ss_dssp             CCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---------------HHHHHSSC--CCCCTT
T ss_pred             ccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH---------------HHHHHhCC--CCCCcc
Confidence            5689999999999999999999999999999999999999976543211               12222222  245567


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNM-----SIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~-----~~ll~  267 (285)
                      ++.++.++|++||+.||.+||++     +++++
T Consensus       565 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            78899999999999999999997     77765

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.4e-40  Score=279.46  Aligned_cols=246  Identities=19%  Similarity=0.344  Sum_probs=188.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC--CCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK--HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||+|.+.. ++.+++|............+.+.+|++++++++  |+||+++++++.+.+..+++|| +.+++|.+++..
T Consensus        43 ~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~  120 (313)
T 3cek_A           43 KVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK  120 (313)
T ss_dssp             EEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH
T ss_pred             EEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh
Confidence            478887754 777888877655444445678899999999997  5999999999999999999999 456799999986


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..++.++.|++.||.|||+.   |++|+||+|+||++++ +.++|+|||++..............
T Consensus       121 ~~~---------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~  187 (313)
T 3cek_A          121 KKS---------IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDS  187 (313)
T ss_dssp             CSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC------------
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCccccccccC
Confidence            542         88999999999999999999999   9999999999999965 7999999999976543332222234


Q ss_pred             cccccCcCCCccccc-----------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhc
Q 023220          160 VLGTFGYHAPEYAMT-----------GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV  228 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
                      ..|++.|+|||.+.+           ..++.++||||||+++|+|++|..||......              ........
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------------~~~~~~~~  253 (313)
T 3cek_A          188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--------------ISKLHAII  253 (313)
T ss_dssp             --CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--------------HHHHHHHH
T ss_pred             CCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH--------------HHHHHHHH
Confidence            468999999999865           46788999999999999999999999654321              11223333


Q ss_pred             CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          229 DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                      ++......+...+..+.++|.+||+.||.+|||+.++++  ..+++..+.
T Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~~~~~~~  301 (313)
T 3cek_A          254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQIQTH  301 (313)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHCC--
T ss_pred             hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc--CccccCCCC
Confidence            444444455556788999999999999999999999998  445544433

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.7e-39  Score=280.68  Aligned_cols=250  Identities=18%  Similarity=0.212  Sum_probs=188.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCC---------------hhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEe
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYP---------------DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYE   66 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~---------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   66 (285)
                      .||+|.+  +++.+++|............               +.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        46 ~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  123 (348)
T 2pml_X           46 KIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYE  123 (348)
T ss_dssp             CEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEE
T ss_pred             EEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            6899877  78889999766544332211               889999999999999999999999999999999999


Q ss_pred             eCCCCCHHHH------hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCCeeEE
Q 023220           67 FATMGSLHDI------LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKAKI  139 (285)
Q Consensus        67 ~~~~~~L~~~------l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~~~~l  139 (285)
                      |+.+++|.++      +.....       ..+++..++.++.|++.||.|||+ .   |++|+||+|+||+++.++.++|
T Consensus       124 ~~~~~~L~~~~~~~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~~~~kl  193 (348)
T 2pml_X          124 YMENDSILKFDEYFFVLDKNYT-------CFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKNGRVKL  193 (348)
T ss_dssp             CCTTCBSSEESSSEESSCSSSC-------CCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTTSCEEE
T ss_pred             ccCCCcHHHHHHHhhhhhhccc-------cCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCCCcEEE
Confidence            9999999998      443211       138999999999999999999999 9   9999999999999999999999


Q ss_pred             eccccCCCCCcccccccccccccccCcCCCcccccC-CCCc-ccchHhHHHHHHHHHhCCCCCCCCCCc-ccchhhhhhc
Q 023220          140 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQ-KSDVYSFGVVLLELLTGRKPVDHTMPR-GQQSLVTWAT  216 (285)
Q Consensus       140 ~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~  216 (285)
                      +|||++......    ......|+..|+|||.+.+. .++. ++||||||+++|+|++|..||...... .....+....
T Consensus       194 ~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~  269 (348)
T 2pml_X          194 SDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN  269 (348)
T ss_dssp             CCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCC
T ss_pred             eccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC
Confidence            999998754332    12345689999999999877 5665 999999999999999999999865441 1111111000


Q ss_pred             ccCchh--hhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          217 PRLSED--KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       217 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...+..  .......+.........++..+.+++.+||+.||.+|||+.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          270 IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000000  000000000001112456778999999999999999999999998

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.1e-39  Score=274.67  Aligned_cols=235  Identities=22%  Similarity=0.267  Sum_probs=190.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|............+.+.+|++++++++||||+++++++.+.+..++++|++.+++|.+++....
T Consensus        37 ~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  116 (287)
T 2wei_A           37 EVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK  116 (287)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS
T ss_pred             EEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC
Confidence            58999888889999999887666666677889999999999999999999999999999999999999999999887543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC---CeeEEeccccCCCCCccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED---FKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      .         +++..++.++.|++.||.|||+.   |++|+||+|+||+++.+   +.++|+|||++........   ..
T Consensus       117 ~---------~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~  181 (287)
T 2wei_A          117 R---------FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MK  181 (287)
T ss_dssp             S---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CS
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cc
Confidence            2         89999999999999999999999   99999999999999654   4799999999865433221   12


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC--CC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG--EY  236 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  236 (285)
                      ...+++.|+|||.+.+ .++.++|+||||+++|+|++|..||...........               +.......  ..
T Consensus       182 ~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---------------~~~~~~~~~~~~  245 (287)
T 2wei_A          182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR---------------VETGKYAFDLPQ  245 (287)
T ss_dssp             CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---------------HHHCCCCCCSGG
T ss_pred             cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH---------------HHcCCCCCCchh
Confidence            3347889999998765 488999999999999999999999976543211111               10111100  11


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...++.++.++|.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          246 WRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            1345678999999999999999999999998

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.6e-40  Score=287.55  Aligned_cols=246  Identities=19%  Similarity=0.263  Sum_probs=188.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCee------eEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR------VLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------~lv~e~~~~~~L~~   75 (285)
                      .||+|.+..+++.+++|............+.+.+|+.++++++||||+++++++...+..      ++||||+. ++|.+
T Consensus        57 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~  135 (371)
T 4exu_A           57 SVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQK  135 (371)
T ss_dssp             EEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHH
T ss_pred             EEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHH
Confidence            589999988899999998765544444567888999999999999999999999877654      99999997 58988


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++...           +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......    
T Consensus       136 ~~~~~-----------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----  197 (371)
T 4exu_A          136 IMGME-----------FSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----  197 (371)
T ss_dssp             HTTSC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC----------
T ss_pred             HhhcC-----------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC----
Confidence            87432           88999999999999999999999   9999999999999999999999999999754332    


Q ss_pred             cccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh-------
Q 023220          156 HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC-------  227 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  227 (285)
                       .....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+.........+....+       
T Consensus       198 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  276 (371)
T 4exu_A          198 -MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS  276 (371)
T ss_dssp             ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHH
T ss_pred             -cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhh
Confidence             233467999999999877 67899999999999999999999999876533322222111111111111100       


Q ss_pred             ----cCCccCC---CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          228 ----VDPKLKG---EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       228 ----~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                          .......   ...+..++.+.++|.+||+.||.+|||++++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          277 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                0000000   112345778999999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=282.62  Aligned_cols=246  Identities=19%  Similarity=0.257  Sum_probs=187.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCe------eeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL------RVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~~L~~   75 (285)
                      .||+|.+..+++.+++|............+.+.+|+.++++++||||+++++++.....      .+++|||+. ++|.+
T Consensus        39 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~  117 (353)
T 3coi_A           39 SVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQK  117 (353)
T ss_dssp             EEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGG
T ss_pred             EEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHH
Confidence            58999988889999999876544444446778899999999999999999999987654      499999997 58888


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++...           +++..++.++.|++.||.|||++   |++||||+|+||+++.++.++|+|||++......    
T Consensus       118 ~~~~~-----------~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~----  179 (353)
T 3coi_A          118 IMGLK-----------FSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----  179 (353)
T ss_dssp             TTTSC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC--------
T ss_pred             HhcCC-----------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC----
Confidence            77432           88999999999999999999999   9999999999999999999999999998764322    


Q ss_pred             cccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhh--------
Q 023220          156 HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQ--------  226 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------  226 (285)
                       .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+.........+....        
T Consensus       180 -~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  258 (353)
T 3coi_A          180 -MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS  258 (353)
T ss_dssp             -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred             -ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence             233467899999998876 6789999999999999999999999987654322222111111111111100        


Q ss_pred             h---cCCcc---CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          227 C---VDPKL---KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       227 ~---~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .   +....   ........++.+.++|.+||+.||.+|||++++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0   00000   11233466788999999999999999999999987

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.7e-39  Score=278.69  Aligned_cols=244  Identities=22%  Similarity=0.308  Sum_probs=188.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHcc--CCCCcccccceEEEeCC----eeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSR--LKHENLVELLGYCVEGN----LRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~   75 (285)
                      .||++..  .++.+++|.....     ..+.+.+|++++..  ++||||+++++++....    ..++||||+.+++|.+
T Consensus        57 ~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~  129 (342)
T 1b6c_B           57 EVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD  129 (342)
T ss_dssp             EEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHH
T ss_pred             EEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHH
Confidence            4788765  4677888876432     34667788888887  79999999999998876    7899999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH--------EKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--------~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      ++....          +++..++.++.|++.||.|||        +.   |++||||||+||+++.++.++|+|||++..
T Consensus       130 ~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~  196 (342)
T 1b6c_B          130 YLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGLAVR  196 (342)
T ss_dssp             HHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             HHhccC----------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCCcee
Confidence            997643          899999999999999999999        88   999999999999999999999999999864


Q ss_pred             CCccccc--ccccccccccCcCCCcccccC------CCCcccchHhHHHHHHHHHhC----------CCCCCCCCCcccc
Q 023220          148 APDMAAR--LHSTRVLGTFGYHAPEYAMTG------QLTQKSDVYSFGVVLLELLTG----------RKPVDHTMPRGQQ  209 (285)
Q Consensus       148 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~~l~~l~~g----------~~pf~~~~~~~~~  209 (285)
                      .......  .......|++.|+|||.+.+.      .++.++||||||+++|+|++|          ..||........ 
T Consensus       197 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~-  275 (342)
T 1b6c_B          197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP-  275 (342)
T ss_dssp             EETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-
T ss_pred             ccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc-
Confidence            4322111  012334689999999998765      234689999999999999999          677765432111 


Q ss_pred             hhhhhhcccCchhhhh-hhcCCccCCCCC-----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          210 SLVTWATPRLSEDKVK-QCVDPKLKGEYP-----PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       210 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                                ...... ...........+     ...+..+.+++.+||+.||.+|||+.++++.|+++.+..
T Consensus       276 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          276 ----------SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             ----------CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ----------cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence                      011111 111222222222     356789999999999999999999999999999988654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-39  Score=283.71  Aligned_cols=247  Identities=17%  Similarity=0.240  Sum_probs=185.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe------------------------
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE------------------------   57 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------------------------   57 (285)
                      +||+|.+..+++.|++|......      ....+|+++++.++||||+++++++..                        
T Consensus        22 ~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (383)
T 3eb0_A           22 IVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNG   95 (383)
T ss_dssp             EEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------------------
T ss_pred             EEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccc
Confidence            58999998899999999765322      222379999999999999999999844                        


Q ss_pred             --------------CCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCC
Q 023220           58 --------------GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRD  123 (285)
Q Consensus        58 --------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~d  123 (285)
                                    ....++||||+.+ +|.+.+......     ...+++..++.++.|++.||.|||+.   |++|||
T Consensus        96 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---gi~H~D  166 (383)
T 3eb0_A           96 VNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRS-----GRSIPMNLISIYIYQLFRAVGFIHSL---GICHRD  166 (383)
T ss_dssp             --------------CCEEEEEECCCSE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSC
T ss_pred             cccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---cCccCc
Confidence                          3347899999985 877776531100     01289999999999999999999999   999999


Q ss_pred             CCCCCeEEc-cCCeeEEeccccCCCCCcccccccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCC
Q 023220          124 IRSSNVLLF-EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVD  201 (285)
Q Consensus       124 i~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~  201 (285)
                      |||+||+++ .++.++|+|||++........   .....|++.|+|||.+.+. .++.++||||+||++|+|++|+.||.
T Consensus       167 ikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  243 (383)
T 3eb0_A          167 IKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS  243 (383)
T ss_dssp             CCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence            999999997 688999999999975433221   2344678999999988765 48999999999999999999999998


Q ss_pred             CCCCcccchhhhhhcccCchhhhhhhcCCc-------------cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          202 HTMPRGQQSLVTWATPRLSEDKVKQCVDPK-------------LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +.........+.........+.+... ++.             .....+...++++.++|.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~i~~~~g~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          244 GETSIDQLVRIIQIMGTPTKEQMIRM-NPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHH-CTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCChHHHHHHHHHHhCCCCHHHHHHh-CcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            76544433322222222222221111 110             011134456778999999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=283.08  Aligned_cols=245  Identities=19%  Similarity=0.210  Sum_probs=174.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceEEE--------eCCeeeEEEeeCCCCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCV--------EGNLRVLAYEFATMGS   72 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--------~~~~~~lv~e~~~~~~   72 (285)
                      .||+|.+..+++.+++|.....  .....+.+.+|+.+++++. ||||+++++++.        .....+++|||+. |+
T Consensus        43 ~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~  119 (337)
T 3ll6_A           43 FVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQ  119 (337)
T ss_dssp             EEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EE
T ss_pred             EEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CC
Confidence            5899988888899999976332  2334567889999999995 999999999994        3345799999996 59


Q ss_pred             HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCCeEEccCCeeEEeccccCCCCCc
Q 023220           73 LHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD  150 (285)
Q Consensus        73 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~--~~h~di~~~nil~~~~~~~~l~df~~~~~~~~  150 (285)
                      |.+++......      ..+++..++.++.|++.||.|||+.   |  ++|+||||+||+++.++.++|+|||++.....
T Consensus       120 L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  190 (337)
T 3ll6_A          120 LVEFLKKMESR------GPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH  190 (337)
T ss_dssp             HHHHHHHHHTT------CSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSS
T ss_pred             HHHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccceeccc
Confidence            98888652211      0289999999999999999999999   9  99999999999999999999999999976543


Q ss_pred             ccccc----------cccccccccCcCCCccc---ccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 023220          151 MAARL----------HSTRVLGTFGYHAPEYA---MTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP  217 (285)
Q Consensus       151 ~~~~~----------~~~~~~~~~~~~aPE~~---~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  217 (285)
                      .....          ......|++.|+|||.+   .+..++.++||||||+++|+|++|..||.......          
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----------  260 (337)
T 3ll6_A          191 YPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----------  260 (337)
T ss_dssp             CC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred             cCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----------
Confidence            22110          01133478999999988   46678899999999999999999999996543211          


Q ss_pred             cCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          218 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                               ..............+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus       261 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          261 ---------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             --------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             ---------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence                     111111112223344568999999999999999999999999999885443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.6e-39  Score=278.17  Aligned_cols=237  Identities=21%  Similarity=0.241  Sum_probs=181.6

Q ss_pred             CceeeeeeeeccccChhhhhhccC------CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS------PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.+..+++.+++|.......      .......+.+|++++++++||||+++++++.... .++||||+.+++|.+
T Consensus        25 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~  103 (322)
T 2ycf_A           25 EVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFD  103 (322)
T ss_dssp             EEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHH
T ss_pred             EEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHH
Confidence            589998888888999997754332      2234557889999999999999999999997665 799999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCe---eEEeccccCCCCCccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK---AKIADFNLSNQAPDMA  152 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~---~~l~df~~~~~~~~~~  152 (285)
                      ++.....         +++..++.++.|++.||.|||++   |++||||+|+||+++.++.   ++|+|||++.......
T Consensus       104 ~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  171 (322)
T 2ycf_A          104 KVVGNKR---------LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS  171 (322)
T ss_dssp             HHSTTCC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH
T ss_pred             HHhccCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccceeccccc
Confidence            9875532         89999999999999999999999   9999999999999987654   9999999987553321


Q ss_pred             ccccccccccccCcCCCcccc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccc-hhhhhhcccCchhhhhhhc
Q 023220          153 ARLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ-SLVTWATPRLSEDKVKQCV  228 (285)
Q Consensus       153 ~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  228 (285)
                      .   .....|++.|+|||.+.   ...++.++|||||||++|+|++|..||......... ..+........        
T Consensus       172 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------  240 (322)
T 2ycf_A          172 L---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI--------  240 (322)
T ss_dssp             H---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC--------
T ss_pred             c---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC--------
Confidence            1   12345789999999874   456889999999999999999999999765432111 11100000000        


Q ss_pred             CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          229 DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                           ......++..+.+++.+||+.||.+|||+.++++
T Consensus       241 -----~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          241 -----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -----chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence                 0011235678999999999999999999999984

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.5e-39  Score=289.37  Aligned_cols=248  Identities=19%  Similarity=0.236  Sum_probs=192.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCC-CcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH-ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.|++|.....    ...+++.+|+++++.++| +++..+..++......++||||+ +++|.+++...
T Consensus        22 ~Vy~a~~~~~~~~vAvK~~~~~----~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~   96 (483)
T 3sv0_A           22 EIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC   96 (483)
T ss_dssp             EEEEEEETTTCCEEEEEEEETT----CSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred             EEEEEEECCCCcEEEEEEeccc----cccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhh
Confidence            5899998888999999965432    234568899999999977 55666666677888889999999 78999999753


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE---ccCCeeEEeccccCCCCCccccc---
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMAAR---  154 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~---~~~~~~~l~df~~~~~~~~~~~~---  154 (285)
                      ..        .+++..++.++.||+.||.|||++   |++||||||+|||+   +.++.++|+|||++.........   
T Consensus        97 ~~--------~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (483)
T 3sv0_A           97 SR--------KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI  165 (483)
T ss_dssp             TT--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred             cC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccc
Confidence            32        289999999999999999999999   99999999999999   68899999999999755432221   


Q ss_pred             --ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc
Q 023220          155 --LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL  232 (285)
Q Consensus       155 --~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
                        .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.........................       
T Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~-------  238 (483)
T 3sv0_A          166 PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE-------  238 (483)
T ss_dssp             CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH-------
T ss_pred             ccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH-------
Confidence              11224568999999999999999999999999999999999999998754432222221111000000000       


Q ss_pred             CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          233 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                        .....++.++.+++.+||+.+|++||++.++++.|+.++.
T Consensus       239 --~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          239 --ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             --HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             --HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence              0112346789999999999999999999999999998853

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=277.26  Aligned_cols=236  Identities=24%  Similarity=0.330  Sum_probs=182.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEe------CCeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVE------GNLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~   74 (285)
                      .||+|....+++.+++|.....   ....+.+.+|+.+++++ +||||+++++++..      .+..++||||+.+++|.
T Consensus        39 ~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~  115 (326)
T 2x7f_A           39 QVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT  115 (326)
T ss_dssp             EEEEEEETTTCCEEEEEEEECC---SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHH
T ss_pred             EEEEEEECCCCCeEEEEEEecC---cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHH
Confidence            5899988888888999977532   33467899999999999 89999999999987      46889999999999999


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  154 (285)
                      +++......       .++...++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........ 
T Consensus       116 ~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-  184 (326)
T 2x7f_A          116 DLIKNTKGN-------TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-  184 (326)
T ss_dssp             HHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC--------
T ss_pred             HHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc-
Confidence            999765321       288999999999999999999999   999999999999999999999999999876543221 


Q ss_pred             ccccccccccCcCCCcccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC
Q 023220          155 LHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD  229 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
                       ......|++.|+|||.+.     +..++.++|||||||++|+|++|..||...........               +..
T Consensus       185 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---------------~~~  248 (326)
T 2x7f_A          185 -RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---------------IPR  248 (326)
T ss_dssp             -------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---------------HHH
T ss_pred             -ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH---------------hhc
Confidence             123346889999999986     45688999999999999999999999975432211111               000


Q ss_pred             CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          230 PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       230 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..........++..+.++|.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00111123445678999999999999999999999988

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.2e-40  Score=277.57  Aligned_cols=236  Identities=20%  Similarity=0.261  Sum_probs=185.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|....++..+++|.....  .....+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....
T Consensus        34 ~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~  111 (302)
T 2j7t_A           34 KVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD  111 (302)
T ss_dssp             CEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHT
T ss_pred             EEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhc
Confidence            6899988888888988876543  33456788999999999999999999999999999999999999999999886532


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++.......  .......
T Consensus       112 ~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  178 (302)
T 2j7t_A          112 R--------GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRDSFI  178 (302)
T ss_dssp             S--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-----
T ss_pred             c--------CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc--ccccccc
Confidence            2        289999999999999999999999   99999999999999999999999999864321111  1122345


Q ss_pred             cccCcCCCcccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC-ccCCC
Q 023220          162 GTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP-KLKGE  235 (285)
Q Consensus       162 ~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  235 (285)
                      |++.|+|||.+.     +..++.++|+||||+++|+|++|..||..........               ..... .....
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~~~~~~~  243 (302)
T 2j7t_A          179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL---------------KIAKSDPPTLL  243 (302)
T ss_dssp             CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---------------HHHHSCCCCCS
T ss_pred             CChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH---------------HHhccCCcccC
Confidence            889999999873     5678899999999999999999999997654321110               01000 00112


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+..++..+.++|.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            34556778999999999999999999999987

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.4e-39  Score=278.30  Aligned_cols=251  Identities=18%  Similarity=0.187  Sum_probs=186.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCe-------eeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL-------RVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-------~~lv~e~~~~~~L~   74 (285)
                      .||+|....++..+++|....   .......+.++++.++.++||||+++++++.....       .++||||+.+ +|.
T Consensus        38 ~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~  113 (360)
T 3e3p_A           38 TVQLGKEKSTGMSVAIKKVIQ---DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLH  113 (360)
T ss_dssp             -CEEEEETTTCCEEEEEEEEC---CTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHH
T ss_pred             EEEEEEECCCCCEEEEEEEec---CccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHH
Confidence            689999888889999997643   34456678889999999999999999999975433       7899999986 555


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeeeCCCCCCCeEEcc-CCeeEEeccccCCCCCcc
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH--EKVQPSIIHRDIRSSNVLLFE-DFKAKIADFNLSNQAPDM  151 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--~~~~~~~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~  151 (285)
                      ..+......     ...++...+..++.|++.|+.|||  +.   |++||||||+||+++. ++.++|+|||++......
T Consensus       114 ~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~  185 (360)
T 3e3p_A          114 RCCRNYYRR-----QVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS  185 (360)
T ss_dssp             HHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTT
T ss_pred             HHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCC
Confidence            444321100     012888999999999999999999  88   9999999999999996 899999999999765432


Q ss_pred             cccccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          152 AARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                      ..   .....|++.|+|||.+.+. .++.++|||||||++|+|++|..||...........+.........+........
T Consensus       186 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3e3p_A          186 EP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPS  262 (360)
T ss_dssp             SC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT
T ss_pred             CC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccc
Confidence            22   2344679999999998665 4799999999999999999999999876544333322222222222211111000


Q ss_pred             ---------------ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          231 ---------------KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       231 ---------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                                     ..........+.++.++|.+||+.||.+|||+.++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          263 HTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                           0011223346789999999999999999999999998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.8e-39  Score=273.39  Aligned_cols=238  Identities=19%  Similarity=0.242  Sum_probs=189.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-------CCCChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-------KNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   73 (285)
                      .||+|....+++.+++|........       ....+.+.+|+++++++. ||||+++++++...+..++||||+.+++|
T Consensus        32 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  111 (298)
T 1phk_A           32 VVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL  111 (298)
T ss_dssp             EEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred             EEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcH
Confidence            5899988888899999987543321       122466788999999995 99999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc
Q 023220           74 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        74 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  153 (285)
                      .+++.....         +++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........
T Consensus       112 ~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  179 (298)
T 1phk_A          112 FDYLTEKVT---------LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK  179 (298)
T ss_dssp             HHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC
T ss_pred             HHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhcCCCcc
Confidence            999976532         89999999999999999999999   999999999999999999999999999865443221


Q ss_pred             cccccccccccCcCCCcccc------cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh
Q 023220          154 RLHSTRVLGTFGYHAPEYAM------TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC  227 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (285)
                         .....+++.|+|||.+.      ...++.++||||||+++|+|++|..||...........+...            
T Consensus       180 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------  244 (298)
T 1phk_A          180 ---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG------------  244 (298)
T ss_dssp             ---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------
T ss_pred             ---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC------------
Confidence               23346889999999875      446789999999999999999999999754322111111000            


Q ss_pred             cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          228 VDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       228 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                       ...........++..+.+++.+||+.||.+|||+.++++
T Consensus       245 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          245 -NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence             000111122456788999999999999999999999987

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.2e-39  Score=280.19  Aligned_cols=242  Identities=14%  Similarity=0.132  Sum_probs=189.6

Q ss_pred             Cceee-----eeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC---CCcccccceEEEeCCeeeEEEeeCCCCCH
Q 023220            2 RRWLC-----CTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK---HENLVELLGYCVEGNLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~-----~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   73 (285)
                      .||+|     .+..++..+++|....     .....+.+|+++++.++   |+||+.+++++...+..++||||+.+|+|
T Consensus        80 ~Vy~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L  154 (365)
T 3e7e_A           80 QVYEATQGDLNDAKNKQKFVLKVQKP-----ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL  154 (365)
T ss_dssp             EEEEEEC-------CCCCEEEEEESS-----CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBH
T ss_pred             EEEEEEecCCcccccCcEEEEEEeCC-----CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcH
Confidence            58999     4667788888887653     34667888888888886   99999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-----------CCeeEEecc
Q 023220           74 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-----------DFKAKIADF  142 (285)
Q Consensus        74 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-----------~~~~~l~df  142 (285)
                      .+++........    ..+++..++.++.|++.||.|||+.   |++||||||+||+++.           ++.++|+||
T Consensus       155 ~~~l~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DF  227 (365)
T 3e7e_A          155 LNAINLYKNTPE----KVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL  227 (365)
T ss_dssp             HHHHHHHHTSTT----CSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTTEEECCC
T ss_pred             HHHHHHhhcccc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCCEEEeeC
Confidence            999975321111    1389999999999999999999999   9999999999999998           899999999


Q ss_pred             ccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchh
Q 023220          143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED  222 (285)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (285)
                      |++................||+.|+|||++.+..++.++|||||||++|+|++|+.||.........             
T Consensus       228 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------------  294 (365)
T 3e7e_A          228 GQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-------------  294 (365)
T ss_dssp             TTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-------------
T ss_pred             chhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-------------
Confidence            9996433222222234456899999999999999999999999999999999999999543221000             


Q ss_pred             hhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCC-CCHHHHHHHhchhhcCC
Q 023220          223 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR-PNMSIVVKALQPLLKSP  276 (285)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R-ps~~~ll~~l~~~~~~~  276 (285)
                           +..... ..  ..++.+.+++.+||+.+|.+| |++.++.+.|++++...
T Consensus       295 -----~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          295 -----PEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             -----ECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             -----echhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                 000000 01  235678999999999999999 58889999998887653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.9e-40  Score=288.28  Aligned_cols=266  Identities=17%  Similarity=0.213  Sum_probs=181.4

Q ss_pred             Cceeeeee--eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe--CCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTC--QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||+|...  .+...|++|....    ....+.+.+|++++++++||||+++++++..  ....++||||+.+ +|.+++
T Consensus        36 ~Vy~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~  110 (405)
T 3rgf_A           36 HVYKAKRKDGKDDKDYALKQIEG----TGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHII  110 (405)
T ss_dssp             EEEEEEESSSSCCCCEEEEECSS----SSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHH
T ss_pred             EEEEEEEccCCCCeEEEEEEECC----CCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHH
Confidence            58999844  5678898887753    3345688999999999999999999999964  6788999999975 888877


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE----ccCCeeEEeccccCCCCCcccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL----FEDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~----~~~~~~~l~df~~~~~~~~~~~  153 (285)
                      ..............+++..++.++.|++.||.|||+.   |++||||||+||++    +.++.++|+|||++........
T Consensus       111 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~  187 (405)
T 3rgf_A          111 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK  187 (405)
T ss_dssp             HHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-------
T ss_pred             HHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCc
Confidence            5332111111111289999999999999999999999   99999999999999    6778999999999976543221


Q ss_pred             c-ccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccc---------hhhhhhcccCchh
Q 023220          154 R-LHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ---------SLVTWATPRLSED  222 (285)
Q Consensus       154 ~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~---------~~~~~~~~~~~~~  222 (285)
                      . .......|++.|+|||++.+. .++.++|||||||++|+|++|..||.........         ..+..........
T Consensus       188 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~  267 (405)
T 3rgf_A          188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK  267 (405)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTT
T ss_pred             ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChh
Confidence            1 112345689999999998874 5899999999999999999999999765432100         0000000000000


Q ss_pred             hhh------------hhcCCccCC---------CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          223 KVK------------QCVDPKLKG---------EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       223 ~~~------------~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                      ...            .........         ......++.+.+||.+||+.||.+|||++++++  ..++...+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~--hp~f~~~~  341 (405)
T 3rgf_A          268 DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ--DPYFLEDP  341 (405)
T ss_dssp             TCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTSSS
T ss_pred             hcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc--ChhhccCC
Confidence            000            000000000         000112457899999999999999999999998  66665443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.5e-39  Score=276.06  Aligned_cols=243  Identities=13%  Similarity=0.184  Sum_probs=186.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceEEEe--CCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVE--GNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||+|.+..+++.+++|..+     ....+.+.+|++++++++ ||||+++++++.+  ....+++|||+.+++|.+++.
T Consensus        51 ~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~  125 (330)
T 3nsz_A           51 EVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ  125 (330)
T ss_dssp             EEEEEEETTTCCEEEEEEEC-----SCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG
T ss_pred             EEEEEEECCCCcEEEEEEec-----ccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH
Confidence            58999888889999999875     234678999999999997 9999999999997  667899999999999999985


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC-eeEEeccccCCCCCcccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-KAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      .            ++...+..++.|++.||.|||+.   |++||||||+||+++.++ .++|+|||++........   .
T Consensus       126 ~------------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~  187 (330)
T 3nsz_A          126 T------------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---Y  187 (330)
T ss_dssp             G------------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---C
T ss_pred             h------------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---c
Confidence            3            78899999999999999999999   999999999999999766 899999999975433221   2


Q ss_pred             cccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccch-hhhhhcccCc------------hhh
Q 023220          158 TRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS-LVTWATPRLS------------EDK  223 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~------------~~~  223 (285)
                      ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.......... .+........            ...
T Consensus       188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (330)
T 3nsz_A          188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR  267 (330)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTH
T ss_pred             ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccc
Confidence            33467889999999876 568999999999999999999999996543221110 0000000000            000


Q ss_pred             hhhhc--------CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          224 VKQCV--------DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       224 ~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .....        ...........+++++.++|.+||+.||.+|||++++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000        001111223346788999999999999999999999998

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=277.75  Aligned_cols=258  Identities=18%  Similarity=0.259  Sum_probs=190.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEE--------------eCCeeeEEEee
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV--------------EGNLRVLAYEF   67 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--------------~~~~~~lv~e~   67 (285)
                      .||++.+..+++.+++|.....  .....+.+.+|++++++++||||+++++++.              +....++||||
T Consensus        26 ~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~  103 (320)
T 2i6l_A           26 LVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY  103 (320)
T ss_dssp             CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEEC
T ss_pred             EEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeec
Confidence            5899998888899999976432  2334567889999999999999999999873              34678999999


Q ss_pred             CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEc-cCCeeEEeccccCC
Q 023220           68 ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF-EDFKAKIADFNLSN  146 (285)
Q Consensus        68 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~-~~~~~~l~df~~~~  146 (285)
                      +. ++|.+++....          ++...++.++.|++.||.|||+.   |++|+||||+||+++ .++.++|+|||++.
T Consensus       104 ~~-~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~  169 (320)
T 2i6l_A          104 ME-TDLANVLEQGP----------LLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLAR  169 (320)
T ss_dssp             CS-EEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTTCB
T ss_pred             cC-CCHHHHhhcCC----------ccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCcccc
Confidence            98 59999997532          88999999999999999999999   999999999999997 56799999999997


Q ss_pred             CCCccccc-ccccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh
Q 023220          147 QAPDMAAR-LHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV  224 (285)
Q Consensus       147 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
                      ........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+....+....+..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (320)
T 2i6l_A          170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR  249 (320)
T ss_dssp             CC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHH
T ss_pred             ccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhh
Confidence            65432111 11223456889999998765 67899999999999999999999999876543322222222121111111


Q ss_pred             hhhcC------------Ccc-CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          225 KQCVD------------PKL-KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       225 ~~~~~------------~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                      .+...            +.. .....+.++.++.++|.+||+.||.+|||+.++++  ..+++...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~~  313 (320)
T 2i6l_A          250 QELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS--HPYMSIYS  313 (320)
T ss_dssp             HHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT--SHHHHTTC
T ss_pred             hhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC--Cccccccc
Confidence            11110            000 00112346778999999999999999999999998  55555433

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7e-40  Score=275.99  Aligned_cols=241  Identities=22%  Similarity=0.207  Sum_probs=176.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.+++|..+.........+.+.++...++.++||||+++++++.+.+..++||||+.+ +|.+++....
T Consensus        22 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~  100 (290)
T 3fme_A           22 VVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVI  100 (290)
T ss_dssp             EEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHH
T ss_pred             EEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHH
Confidence            589999888899999998765443333344455566668889999999999999999999999999975 8877775421


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..     ...+++..++.++.|++.||.|||++.  |++||||||+||+++.++.++|+|||++........   .....
T Consensus       101 ~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~  170 (290)
T 3fme_A          101 DK-----GQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDA  170 (290)
T ss_dssp             HT-----TCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------------------C
T ss_pred             hc-----CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccC
Confidence            10     012899999999999999999999842  899999999999999999999999999876543222   23346


Q ss_pred             cccCcCCCccc----ccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          162 GTFGYHAPEYA----MTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       162 ~~~~~~aPE~~----~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      |++.|+|||.+    .+..++.++||||+|+++|+|++|..||.......              ................
T Consensus       171 ~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~~~~  236 (290)
T 3fme_A          171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--------------QQLKQVVEEPSPQLPA  236 (290)
T ss_dssp             CCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH--------------HHHHHHHHSCCCCCCT
T ss_pred             CCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH--------------HHHHHHhccCCCCccc
Confidence            88999999996    45578899999999999999999999997532211              1111111111222223


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..++.++.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            456778999999999999999999999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3e-40  Score=288.10  Aligned_cols=240  Identities=9%  Similarity=0.020  Sum_probs=170.7

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhHHHHH---HHHccCCCCcccccc-------eEEEeC------------
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDEKQLV---SVVSRLKHENLVELL-------GYCVEG------------   58 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~~~~~------------   58 (285)
                      .||+|.+..+++.+++|....... .....+.+.+|+   ..|+. +||||++++       +++...            
T Consensus        77 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~  155 (371)
T 3q60_A           77 VVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQ  155 (371)
T ss_dssp             EEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTSCSSSBCSCC-
T ss_pred             EEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCc
Confidence            589999888899999998776443 223355666774   55555 799988755       455433            


Q ss_pred             -----CeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 023220           59 -----NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR------VRIAVDAARGLEYLHEKVQPSIIHRDIRSS  127 (285)
Q Consensus        59 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~------~~~~~qi~~~l~~lh~~~~~~~~h~di~~~  127 (285)
                           ...++||||+. ++|.+++......        +....+      +.++.|++.||.|||++   |++||||||+
T Consensus       156 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--------~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrDikp~  223 (371)
T 3q60_A          156 DDYAVANYLLLMPAAS-VDLELLFSTLDFV--------YVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPD  223 (371)
T ss_dssp             --CCEEEEEEEECCCS-EEHHHHHHHHHHS--------CCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             ccceeeeEEEEecCCC-CCHHHHHHHhccc--------cchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCcCCHH
Confidence                 33799999998 7999999764221        344445      67789999999999999   9999999999


Q ss_pred             CeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCccccc--CCCCcccchHhHHHHHHHHHhCCCCCCCCCC
Q 023220          128 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMP  205 (285)
Q Consensus       128 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~  205 (285)
                      ||+++.++.++|+|||++.......     ....+++.|+|||.+.+  ..++.++|||||||++|+|++|+.||....+
T Consensus       224 NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~  298 (371)
T 3q60_A          224 NLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP  298 (371)
T ss_dssp             GEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred             HEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence            9999999999999999997654322     13456799999999987  6789999999999999999999999986643


Q ss_pred             cccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          206 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .......        ...................+++.+.++|.+||+.||++|||+.++++
T Consensus       299 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          299 GIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             ccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            2211100        00000111111222223466788999999999999999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2e-39  Score=281.81  Aligned_cols=256  Identities=18%  Similarity=0.222  Sum_probs=183.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCC---------ChhHHHHHHHHccCCCCcccccceEEEe-----CCeeeEEEee
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNY---------PDDEKQLVSVVSRLKHENLVELLGYCVE-----GNLRVLAYEF   67 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~   67 (285)
                      .||++.+.. +..+++|...........         .+.+.+|++++++++||||+++++++..     ....++||||
T Consensus        37 ~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  115 (362)
T 3pg1_A           37 AVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL  115 (362)
T ss_dssp             EEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEEC
T ss_pred             EEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEcc
Confidence            478887755 777888877654443332         2788999999999999999999999854     3367999999


Q ss_pred             CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220           68 ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus        68 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      +. ++|.+++.....        .+++..++.++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||++..
T Consensus       116 ~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  183 (362)
T 3pg1_A          116 MR-TDLAQVIHDQRI--------VISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLARE  183 (362)
T ss_dssp             CS-EEHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCTTC---
T ss_pred             CC-CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEecCcccc
Confidence            98 588888875432        289999999999999999999999   999999999999999999999999999975


Q ss_pred             CCcccccccccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhh---
Q 023220          148 APDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDK---  223 (285)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---  223 (285)
                      ......   .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+...........   
T Consensus       184 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (362)
T 3pg1_A          184 DTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM  260 (362)
T ss_dssp             ---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             cccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhh
Confidence            433221   234567889999998876 6789999999999999999999999987653322222211111111111   


Q ss_pred             -----hhhhcCCccC-------CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          224 -----VKQCVDPKLK-------GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       224 -----~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                           ..........       ....+..++.+.++|.+||+.||.+|||+.++++  ..+++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~  322 (362)
T 3pg1_A          261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR--HPYFES  322 (362)
T ss_dssp             TSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGTT
T ss_pred             ccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc--Cchhhh
Confidence                 1111111110       0112344678999999999999999999999998  444443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-39  Score=282.20  Aligned_cols=241  Identities=20%  Similarity=0.229  Sum_probs=189.4

Q ss_pred             Cceeeeee---eeccccChhhhhhccC--CCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTC---QVEESYPSHENERLKS--PKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~---~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.+.   .+++.+++|..+....  .....+.+.+|+++++++ +||||+++++++...+..++||||+.+++|.+
T Consensus        69 ~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  148 (355)
T 1vzo_A           69 KVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFT  148 (355)
T ss_dssp             EEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHH
T ss_pred             EEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHH
Confidence            47888764   4678888887764332  233456677899999999 69999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++.....         +++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......... 
T Consensus       149 ~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-  215 (355)
T 1vzo_A          149 HLSQRER---------FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-  215 (355)
T ss_dssp             HHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-
T ss_pred             HHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC-
Confidence            9976542         88999999999999999999999   9999999999999999999999999998754332211 


Q ss_pred             cccccccccCcCCCccccc--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          156 HSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                      ......|++.|+|||.+.+  ..++.++|||||||++|+|++|..||...........+           ......  ..
T Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-----------~~~~~~--~~  282 (355)
T 1vzo_A          216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-----------SRRILK--SE  282 (355)
T ss_dssp             GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH-----------HHHHHH--CC
T ss_pred             cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH-----------HHHHhc--cC
Confidence            1233568999999999875  34789999999999999999999999754332211111           011111  11


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 023220          234 GEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVKA  268 (285)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~~  268 (285)
                      ...+..++..+.++|.+||+.||.+||     |+.++++.
T Consensus       283 ~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          283 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            234556778899999999999999999     99999874

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.5e-39  Score=285.68  Aligned_cols=247  Identities=19%  Similarity=0.232  Sum_probs=183.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC------CeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG------NLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|....+++.+++|......      ....+|++++++++||||+++++++...      ..+++||||+.+ +|.+
T Consensus        69 ~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~  141 (420)
T 1j1b_A           69 VVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYR  141 (420)
T ss_dssp             EEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHH
T ss_pred             EEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHH
Confidence            58999888889999999764322      2234799999999999999999998542      246799999986 6666


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC-CeeEEeccccCCCCCccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~  154 (285)
                      .+......     ...+++..++.++.|++.||.|||+.   |++||||||+|||++.+ +.++|+|||++........ 
T Consensus       142 ~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~-  212 (420)
T 1j1b_A          142 VARHYSRA-----KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-  212 (420)
T ss_dssp             HHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-
T ss_pred             HHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC-
Confidence            65431100     01289999999999999999999999   99999999999999954 6789999999975433221 


Q ss_pred             ccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          155 LHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                        .....|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+.........+.+... ++...
T Consensus       213 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~-~~~~~  289 (420)
T 1j1b_A          213 --NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM-NPNYT  289 (420)
T ss_dssp             --CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH-CSCCC
T ss_pred             --ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh-Chhhh
Confidence              2335689999999998765 7899999999999999999999999876543333222222222222222211 11110


Q ss_pred             C-------------CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          234 G-------------EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       234 ~-------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .             .++...++++.+||.+||+.||.+|||+.++++
T Consensus       290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            0             023345778999999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.1e-39  Score=276.78  Aligned_cols=247  Identities=15%  Similarity=0.239  Sum_probs=190.3

Q ss_pred             Cceeeee-eeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCc------ccccceEEEeCCeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCT-CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHEN------LVELLGYCVEGNLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~~~lv~e~~~~~~L~   74 (285)
                      .||+|.+ ...+..+++|..+..   ....+.+.+|+++++.++|++      ++++++++...+..++||||+ +++|.
T Consensus        29 ~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~  104 (339)
T 1z57_A           29 KVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTY  104 (339)
T ss_dssp             EEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred             EEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHH
Confidence            4888877 456778888876532   223567888999999887654      999999999999999999999 67999


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-------------------CC
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-------------------DF  135 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-------------------~~  135 (285)
                      +++......       .+++..++.++.|++.||.|||++   |++||||||+||+++.                   ++
T Consensus       105 ~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~  174 (339)
T 1z57_A          105 DFIKENGFL-------PFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP  174 (339)
T ss_dssp             HHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCC
T ss_pred             HHHHhcCCC-------CCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccccccCC
Confidence            999765432       288999999999999999999999   9999999999999987                   66


Q ss_pred             eeEEeccccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 023220          136 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA  215 (285)
Q Consensus       136 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  215 (285)
                      .++|+|||++......     .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+...
T Consensus       175 ~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  249 (339)
T 1z57_A          175 DIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI  249 (339)
T ss_dssp             CEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHH
T ss_pred             CceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            7999999998654321     23346899999999999889999999999999999999999999876544333322222


Q ss_pred             cccCchhhhhhh--------------------------cCCc-cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          216 TPRLSEDKVKQC--------------------------VDPK-LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       216 ~~~~~~~~~~~~--------------------------~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ....+.......                          ..+. .........++++.++|.+||+.||.+|||+.++++
T Consensus       250 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence            222221111100                          0000 011234566889999999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7e-39  Score=281.51  Aligned_cols=246  Identities=17%  Similarity=0.212  Sum_probs=178.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC------eeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN------LRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~   75 (285)
                      +||+|....+++ +++|......      ....+|+++++.++||||+++++++....      ..++||||+.+ ++.+
T Consensus        55 ~V~~a~~~~~~~-~aikk~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~  126 (394)
T 4e7w_A           55 VVFQAKLVESDE-VAIKKVLQDK------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYR  126 (394)
T ss_dssp             EEEEEEETTTEE-EEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHH
T ss_pred             EEEEEEECCCCe-EEEEEEecCc------chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHH
Confidence            588887766666 5555443221      12237999999999999999999996543      37899999987 4444


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEc-cCCeeEEeccccCCCCCccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF-EDFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~-~~~~~~l~df~~~~~~~~~~~~  154 (285)
                      .+......     ...+++..++.++.|++.||.|||+.   |++||||||+||+++ .++.++|+|||++........ 
T Consensus       127 ~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~-  197 (394)
T 4e7w_A          127 ASRHYAKL-----KQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP-  197 (394)
T ss_dssp             HHHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-
T ss_pred             HHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC-
Confidence            33211000     00289999999999999999999999   999999999999999 799999999999975432221 


Q ss_pred             ccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc-
Q 023220          155 LHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL-  232 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  232 (285)
                        .....|++.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+.......+.........+.+... ++.. 
T Consensus       198 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~-~~~~~  274 (394)
T 4e7w_A          198 --NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM-NPNYM  274 (394)
T ss_dssp             --CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH-CGGGS
T ss_pred             --CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh-Chhhh
Confidence              2345678999999998765 5899999999999999999999999876544333322222222222221111 1110 


Q ss_pred             ------------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          233 ------------KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       233 ------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                                  ...++...++++.++|.+||+.||.+|||+.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                        00122346778999999999999999999999997

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.2e-38  Score=296.22  Aligned_cols=243  Identities=24%  Similarity=0.321  Sum_probs=188.8

Q ss_pred             Cceeeeeeeec---cccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVE---ESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||++.....+   ..+++|..+.. ......+.+.+|+.++++++||||+++++++. ++..++||||+.+|+|.+++.
T Consensus       405 ~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~  482 (656)
T 2j0j_A          405 DVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ  482 (656)
T ss_dssp             CEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHH
T ss_pred             EEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHH
Confidence            57888765433   34555554321 12223477889999999999999999999985 456899999999999999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....        .+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......... ...
T Consensus       483 ~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~  550 (656)
T 2j0j_A          483 VRKF--------SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KAS  550 (656)
T ss_dssp             HTTT--------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--------
T ss_pred             hccC--------CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-ecc
Confidence            5532        288999999999999999999999   9999999999999999999999999999765432211 122


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.......                ..+........+
T Consensus       551 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~----------------~~i~~~~~~~~~  614 (656)
T 2j0j_A          551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----------------GRIENGERLPMP  614 (656)
T ss_dssp             ---CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----------------HHHHHTCCCCCC
T ss_pred             CCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH----------------HHHHcCCCCCCC
Confidence            3346778999999998899999999999999999997 99999765332111                111111223345


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ..+++.+.++|.+||+.||.+|||+.++++.|+.++.
T Consensus       615 ~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            6678899999999999999999999999999998864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.7e-39  Score=279.92  Aligned_cols=251  Identities=19%  Similarity=0.222  Sum_probs=186.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC-----CeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG-----NLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++....+++.+++|..... ........+.+|++++++++||||+++++++...     ...+++|||+. ++|.++
T Consensus        26 ~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~  103 (353)
T 2b9h_A           26 VVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRV  103 (353)
T ss_dssp             EEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHH
T ss_pred             EEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHH
Confidence            5899988888889999977432 2222345677999999999999999999988754     67899999997 599999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc-
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL-  155 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-  155 (285)
                      +....          +++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.......... 
T Consensus       104 ~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  170 (353)
T 2b9h_A          104 ISTQM----------LSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS  170 (353)
T ss_dssp             HHHCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred             HhhcC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccccccccc
Confidence            87642          89999999999999999999999   99999999999999999999999999987554221110 


Q ss_pred             -------cccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCc-h-----
Q 023220          156 -------HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLS-E-----  221 (285)
Q Consensus       156 -------~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~-----  221 (285)
                             ......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+........ .     
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (353)
T 2b9h_A          171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC  250 (353)
T ss_dssp             ---------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTT
T ss_pred             CccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccc
Confidence                   0122457899999998764 6789999999999999999999999987653322221111111100 0     


Q ss_pred             ---hhhhhhcCCccC------CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          222 ---DKVKQCVDPKLK------GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       222 ---~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                         ............      ....+.+++++.++|.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          251 IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence               001111000000      0112356778999999999999999999999998

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.7e-39  Score=275.63  Aligned_cols=256  Identities=22%  Similarity=0.272  Sum_probs=181.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHH--HccCCCCcccccceEEEe-----CCeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSV--VSRLKHENLVELLGYCVE-----GNLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~   74 (285)
                      .||++.  ..++.+++|.....     ..+.+..|.++  +..++||||+++++.+..     ...+++||||+.+|+|.
T Consensus        28 ~Vy~~~--~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~  100 (336)
T 3g2f_A           28 AVYKGS--LDERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLX  100 (336)
T ss_dssp             EEEEEE--ETTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHH
T ss_pred             EEEEEE--ECCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHH
Confidence            478873  35777888876432     23445555555  445899999999986542     23668999999999999


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeeeCCCCCCCeEEccCCeeEEeccccCCCC
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV------QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA  148 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~------~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~  148 (285)
                      +++....          .++..++.++.|++.||.|||+..      ..|++||||||+||+++.++.++|+|||++...
T Consensus       101 ~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~  170 (336)
T 3g2f_A          101 KYLSLHT----------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL  170 (336)
T ss_dssp             HHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHHhhcc----------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeec
Confidence            9997654          688899999999999999999762      228999999999999999999999999999654


Q ss_pred             Ccccc------cccccccccccCcCCCccccc-------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCccc-ch-hhh
Q 023220          149 PDMAA------RLHSTRVLGTFGYHAPEYAMT-------GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ-QS-LVT  213 (285)
Q Consensus       149 ~~~~~------~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~-~~~  213 (285)
                      .....      ........|++.|+|||.+.+       ..++.++|||||||++|+|++|..||........ .. ...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  250 (336)
T 3g2f_A          171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT  250 (336)
T ss_dssp             SSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHH
T ss_pred             ccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhc
Confidence            32111      111223468999999999876       3456789999999999999999777654322111 11 111


Q ss_pred             hhcccCchhhhhhhc-CCccCCCC------ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          214 WATPRLSEDKVKQCV-DPKLKGEY------PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       214 ~~~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ............... ........      ...+++++.++|.+||+.||++|||+.++++.|++++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          251 EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            111111112221111 11111222      23467789999999999999999999999999999884

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.6e-38  Score=272.22  Aligned_cols=236  Identities=17%  Similarity=0.183  Sum_probs=161.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHH-HHHccCCCCcccccceEEEe----CCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLV-SVVSRLKHENLVELLGYCVE----GNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||+|.+..+++.+++|....       .....+|+ ..++.++||||+++++++..    ....++||||+.+|+|.++
T Consensus        44 ~V~~~~~~~~~~~vavK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~  116 (336)
T 3fhr_A           44 KVLECFHRRTGQKCALKLLYD-------SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR  116 (336)
T ss_dssp             EEEEEEETTTCCEEEEEEEES-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHH
T ss_pred             EEEEEEECCCCCEEEEEEecC-------cHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHH
Confidence            589999988899999998743       12333333 44567799999999999976    4458999999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc---CCeeEEeccccCCCCCcccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~  153 (285)
                      +......       .+++..++.++.|++.||.|||+.   |++||||+|+||+++.   ++.++|+|||++....... 
T Consensus       117 l~~~~~~-------~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-  185 (336)
T 3fhr_A          117 IQERGDQ-------AFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-  185 (336)
T ss_dssp             HHTC-CC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred             HHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc-
Confidence            9865422       289999999999999999999999   9999999999999975   4569999999986543221 


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                         .....+++.|+|||.+.+..++.++||||||+++|+|++|..||..............        . .........
T Consensus       186 ---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--------~-~~~~~~~~~  253 (336)
T 3fhr_A          186 ---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--------R-IRLGQYGFP  253 (336)
T ss_dssp             ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------CCC
T ss_pred             ---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH--------h-hhccccccC
Confidence               2334578999999999888889999999999999999999999976543211100000        0 000000111


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          234 GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ......++..+.++|.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1122456778999999999999999999999998

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.1e-38  Score=273.05  Aligned_cols=247  Identities=15%  Similarity=0.228  Sum_probs=187.2

Q ss_pred             Cceeeeeeeec-cccChhhhhhccCCCCCChhHHHHHHHHccCCCCc------ccccceEEEeCCeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQVE-ESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHEN------LVELLGYCVEGNLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~~~lv~e~~~~~~L~   74 (285)
                      .||+|.+..++ ..+++|..+..   ....+.+.+|++++++++|++      ++.+++++...+..++||||+. +++.
T Consensus        34 ~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  109 (355)
T 2eu9_A           34 KVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLG-KNTF  109 (355)
T ss_dssp             EEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCC-CBHH
T ss_pred             EEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccC-CChH
Confidence            58899886655 67888876531   233567888999999997665      8999999999999999999995 5777


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE-------------------ccCC
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-------------------FEDF  135 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~-------------------~~~~  135 (285)
                      +++......       .+++..++.++.|++.||.|||++   |++||||||+||++                   +.++
T Consensus       110 ~~l~~~~~~-------~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~  179 (355)
T 2eu9_A          110 EFLKENNFQ-------PYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT  179 (355)
T ss_dssp             HHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCC
T ss_pred             HHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccccCCC
Confidence            777654322       289999999999999999999999   99999999999999                   5678


Q ss_pred             eeEEeccccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 023220          136 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA  215 (285)
Q Consensus       136 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  215 (285)
                      .++|+|||++......     .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...........+...
T Consensus       180 ~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  254 (355)
T 2eu9_A          180 SIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI  254 (355)
T ss_dssp             CEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             cEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9999999998653321     23346899999999999989999999999999999999999999876543332222222


Q ss_pred             cccCchhhhhhhc--------------------------CC-ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          216 TPRLSEDKVKQCV--------------------------DP-KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       216 ~~~~~~~~~~~~~--------------------------~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ....+........                          .+ ..........+.++.++|.+||+.||.+|||+.++++
T Consensus       255 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          255 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            2222211111000                          00 0011223455778999999999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=270.39  Aligned_cols=237  Identities=20%  Similarity=0.255  Sum_probs=174.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|....+++.+++|............+.+.++..+++.++||||+++++++.+.+..++||||+ ++.+..+.....
T Consensus        40 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~  118 (318)
T 2dyl_A           40 QVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQ  118 (318)
T ss_dssp             CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHT
T ss_pred             eEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhc
Confidence            6899988888899999987654433333344555666788889999999999999999999999999 456666654322


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      .        .+++..++.++.|++.||.|||+ .   |++|+||+|+||+++.++.++|+|||++........   ....
T Consensus       119 ~--------~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~  184 (318)
T 2dyl_A          119 G--------PIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRS  184 (318)
T ss_dssp             S--------CCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---------------
T ss_pred             c--------CCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---cccc
Confidence            1        28999999999999999999998 7   899999999999999999999999999865543221   2334


Q ss_pred             ccccCcCCCcccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC-ccCC
Q 023220          161 LGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP-KLKG  234 (285)
Q Consensus       161 ~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  234 (285)
                      .+++.|+|||.+.     ...++.++||||||+++|+|++|..||........              ........ ....
T Consensus       185 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~~  250 (318)
T 2dyl_A          185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--------------VLTKVLQEEPPLL  250 (318)
T ss_dssp             --CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--------------HHHHHHHSCCCCC
T ss_pred             CCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--------------HHHHHhccCCCCC
Confidence            5889999999984     45678899999999999999999999975332111              01111000 0001


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .....++.++.++|.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            112345678999999999999999999999886

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.3e-38  Score=272.28  Aligned_cols=227  Identities=17%  Similarity=0.245  Sum_probs=187.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCC----CCChhHHHHHHHHccCC--CCcccccceEEEeCCeeeEEEeeCCC-CCHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPK----NYPDDEKQLVSVVSRLK--HENLVELLGYCVEGNLRVLAYEFATM-GSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L~   74 (285)
                      .||+|.+..+++.+++|.........    ...+.+.+|+.++++++  |+||+++++++...+..++++|++.+ ++|.
T Consensus        58 ~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~  137 (320)
T 3a99_A           58 SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF  137 (320)
T ss_dssp             EEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHH
T ss_pred             EEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHH
Confidence            58999888888999999876654433    34567788999999996  59999999999999999999999976 7999


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEc-cCCeeEEeccccCCCCCcccc
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF-EDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~-~~~~~~l~df~~~~~~~~~~~  153 (285)
                      +++.....         +++..++.++.|++.||.|||+.   |++||||+|+||+++ .++.++|+|||++....... 
T Consensus       138 ~~l~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~-  204 (320)
T 3a99_A          138 DFITERGA---------LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-  204 (320)
T ss_dssp             HHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC-
T ss_pred             HHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc-
Confidence            99976432         88999999999999999999999   999999999999999 78899999999987554321 


Q ss_pred             cccccccccccCcCCCcccccCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL  232 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
                         .....|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.....     .            ..    .  
T Consensus       205 ---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~------------~~----~--  258 (320)
T 3a99_A          205 ---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I------------IR----G--  258 (320)
T ss_dssp             ---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H------------HH----C--
T ss_pred             ---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----h------------hc----c--
Confidence               233458999999999887666 6889999999999999999999964210     0            00    0  


Q ss_pred             CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          233 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ....+..+++.+.++|.+||+.||.+|||++++++
T Consensus       259 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          259 QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            01123445678999999999999999999999998

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2e-38  Score=268.33  Aligned_cols=237  Identities=20%  Similarity=0.310  Sum_probs=178.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe-------------CCeeeEEEeeC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE-------------GNLRVLAYEFA   68 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------------~~~~~lv~e~~   68 (285)
                      .||++.+..+++.+++|.....   ....+.+.+|+.++++++||||+++++++.+             .+..++||||+
T Consensus        21 ~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~   97 (303)
T 1zy4_A           21 QVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYC   97 (303)
T ss_dssp             EEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECC
T ss_pred             EEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecC
Confidence            5899988888889999977432   2235678899999999999999999998865             34679999999


Q ss_pred             CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCC
Q 023220           69 TMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA  148 (285)
Q Consensus        69 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~  148 (285)
                      .+++|.+++.....        .++...++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||++...
T Consensus        98 ~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  166 (303)
T 1zy4_A           98 ENGTLYDLIHSENL--------NQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNV  166 (303)
T ss_dssp             CSCBHHHHHHHSCG--------GGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCCSCT
T ss_pred             CCCCHHHhhhcccc--------ccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcchhhc
Confidence            99999999975432        278889999999999999999999   9999999999999999999999999998765


Q ss_pred             Ccccc------------cccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 023220          149 PDMAA------------RLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA  215 (285)
Q Consensus       149 ~~~~~------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  215 (285)
                      .....            ........|++.|+|||.+.+. .++.++|||||||++|+|++   ||......  .....  
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~--~~~~~--  239 (303)
T 1zy4_A          167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER--VNILK--  239 (303)
T ss_dssp             TC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--HHHHH--
T ss_pred             ccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH--HHHHH--
Confidence            42110            1112234578999999998764 68999999999999999998   55321100  00000  


Q ss_pred             cccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          216 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                             .+ ...........+...+..+.+++.+||+.||.+|||+.++++
T Consensus       240 -------~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          240 -------KL-RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             -------HH-HSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------hc-cccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence                   00 001112223345566778999999999999999999999997

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.9e-38  Score=278.59  Aligned_cols=248  Identities=20%  Similarity=0.233  Sum_probs=187.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC--------CCcccccceEEE----eCCeeeEEEeeCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK--------HENLVELLGYCV----EGNLRVLAYEFAT   69 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~----~~~~~~lv~e~~~   69 (285)
                      +||+|.+..+++.+++|..+..   ....+.+.+|++++++++        |+||+++++++.    +....++||||+.
T Consensus        52 ~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~  128 (397)
T 1wak_A           52 TVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG  128 (397)
T ss_dssp             EEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred             eEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccC
Confidence            5899998888999999987532   234567889999999985        788999999988    4568899999995


Q ss_pred             CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC--------------
Q 023220           70 MGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF--------------  135 (285)
Q Consensus        70 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~--------------  135 (285)
                       ++|.+.+......       .+++..++.++.|++.||.|||+++  |++||||||+||+++.++              
T Consensus       129 -~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~~~~~  198 (397)
T 1wak_A          129 -HHLLKWIIKSNYQ-------GLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQ  198 (397)
T ss_dssp             -CBHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC---
T ss_pred             -ccHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhhHHHh
Confidence             5666666544321       2899999999999999999999853  799999999999998765              


Q ss_pred             -----------------------------------eeEEeccccCCCCCcccccccccccccccCcCCCcccccCCCCcc
Q 023220          136 -----------------------------------KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQK  180 (285)
Q Consensus       136 -----------------------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  180 (285)
                                                         .++|+|||++......     .....|++.|+|||++.+..++.+
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~  273 (397)
T 1wak_A          199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTP  273 (397)
T ss_dssp             ------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTH
T ss_pred             hcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcH
Confidence                                               7999999998755332     233468999999999999899999


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCCCcccch------hhhhhcccCchhhhh------hhcCCc-----------------
Q 023220          181 SDVYSFGVVLLELLTGRKPVDHTMPRGQQS------LVTWATPRLSEDKVK------QCVDPK-----------------  231 (285)
Q Consensus       181 ~DiwslG~~l~~l~~g~~pf~~~~~~~~~~------~~~~~~~~~~~~~~~------~~~~~~-----------------  231 (285)
                      +|||||||++|+|++|+.||..........      .+.......+...+.      .+....                 
T Consensus       274 ~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (397)
T 1wak_A          274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV  353 (397)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHH
T ss_pred             HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHh
Confidence            999999999999999999998654332111      010111111110000      000000                 


Q ss_pred             --cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          232 --LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       232 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                        .....+...+..+.++|.+||+.||.+|||++++++
T Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             HHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             hhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence              011345677889999999999999999999999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=269.92  Aligned_cols=227  Identities=18%  Similarity=0.234  Sum_probs=179.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCC----CCChhHHHHHHHHccC----CCCcccccceEEEeCCeeeEEEee-CCCCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPK----NYPDDEKQLVSVVSRL----KHENLVELLGYCVEGNLRVLAYEF-ATMGS   72 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~~iv~~~~~~~~~~~~~lv~e~-~~~~~   72 (285)
                      .||+|.+..+++.+++|.........    .....+.+|+.++.++    +||||+++++++...+..++++|+ +.+++
T Consensus        46 ~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~  125 (312)
T 2iwi_A           46 TVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQD  125 (312)
T ss_dssp             EEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEE
T ss_pred             EEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCC
Confidence            58999888888899999775443221    2344566788888888    899999999999999999999999 77889


Q ss_pred             HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEc-cCCeeEEeccccCCCCCcc
Q 023220           73 LHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF-EDFKAKIADFNLSNQAPDM  151 (285)
Q Consensus        73 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~-~~~~~~l~df~~~~~~~~~  151 (285)
                      |.+++.....         +++..++.++.|++.||.|||+.   |++|+||+|+||+++ .++.++|+|||++......
T Consensus       126 L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~  193 (312)
T 2iwi_A          126 LFDYITEKGP---------LGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE  193 (312)
T ss_dssp             HHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS
T ss_pred             HHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC
Confidence            9999976532         89999999999999999999999   999999999999999 8899999999998755432


Q ss_pred             cccccccccccccCcCCCcccccCCCC-cccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          152 AARLHSTRVLGTFGYHAPEYAMTGQLT-QKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                      .    .....|+..|+|||.+.+..+. .++||||||+++|+|++|+.||.....                  .   ...
T Consensus       194 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------------~---~~~  248 (312)
T 2iwi_A          194 P----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------------I---LEA  248 (312)
T ss_dssp             C----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------------H---HHT
T ss_pred             c----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------------------H---hhh
Confidence            2    2334588999999998876664 589999999999999999999963210                  0   000


Q ss_pred             ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          231 KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                        ....+..++..+.++|.+||+.||.+|||++++++
T Consensus       249 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          249 --ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              11234556778999999999999999999999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=8.1e-38  Score=273.74  Aligned_cols=252  Identities=18%  Similarity=0.187  Sum_probs=188.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CC-----cccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HE-----NLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.+..+++.+++|..+..   ....+.+..|+++++.++ |+     +|+.+++++...+..++||||+.+ +|.+
T Consensus        69 ~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~  144 (382)
T 2vx3_A           69 QVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYD  144 (382)
T ss_dssp             EEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCC-BHHH
T ss_pred             EEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCC-CHHH
Confidence            5899998888899999987532   223456777888888884 45     499999999999999999999965 9999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeeeCCCCCCCeEEc--cCCeeEEeccccCCCCCcc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH--EKVQPSIIHRDIRSSNVLLF--EDFKAKIADFNLSNQAPDM  151 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--~~~~~~~~h~di~~~nil~~--~~~~~~l~df~~~~~~~~~  151 (285)
                      ++......       .+++..+..++.|++.||.|||  +.   |++||||||+||+++  .++.++|+|||++......
T Consensus       145 ~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~~---~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~  214 (382)
T 2vx3_A          145 LLRNTNFR-------GVSLNLTRKFAQQMCTALLFLATPEL---SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR  214 (382)
T ss_dssp             HHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHTSTTT---CEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred             HHhhcCcC-------CCCHHHHHHHHHHHHHHHHHhccCCC---CEEcCCCCcccEEEecCCCCcEEEEeccCceecccc
Confidence            99765422       2889999999999999999999  56   999999999999994  4778999999998755321


Q ss_pred             cccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh------h
Q 023220          152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV------K  225 (285)
Q Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~  225 (285)
                           .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+....      .
T Consensus       215 -----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  289 (382)
T 2vx3_A          215 -----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKAR  289 (382)
T ss_dssp             -----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHH
T ss_pred             -----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHH
Confidence                 23356889999999999989999999999999999999999999876543332222211111111000      0


Q ss_pred             hhcCCc-----------------------------------------cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHH
Q 023220          226 QCVDPK-----------------------------------------LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSI  264 (285)
Q Consensus       226 ~~~~~~-----------------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  264 (285)
                      ..++..                                         -.........+++.++|.+||+.||++|||+++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e  369 (382)
T 2vx3_A          290 KFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYY  369 (382)
T ss_dssp             HHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             HHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHH
Confidence            000000                                         000111233468999999999999999999999


Q ss_pred             HHHHhchhhc
Q 023220          265 VVKALQPLLK  274 (285)
Q Consensus       265 ll~~l~~~~~  274 (285)
                      +++  ..+++
T Consensus       370 ~L~--hp~f~  377 (382)
T 2vx3_A          370 ALQ--HSFFK  377 (382)
T ss_dssp             HTT--SGGGC
T ss_pred             Hhc--Ccccc
Confidence            987  44443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.5e-38  Score=274.81  Aligned_cols=248  Identities=17%  Similarity=0.242  Sum_probs=184.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-----------CCcccccceEEEeCC----eeeEEEe
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-----------HENLVELLGYCVEGN----LRVLAYE   66 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~~~----~~~lv~e   66 (285)
                      .||+|.+..+++.+++|.....   ....+.+.+|+.++++++           ||||+++++++...+    ..+++||
T Consensus        34 ~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e  110 (373)
T 1q8y_A           34 TVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE  110 (373)
T ss_dssp             EEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEEC
T ss_pred             EEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEe
Confidence            5899988888899999977521   223467788999999886           899999999998654    7899999


Q ss_pred             eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEc------cCCeeEEe
Q 023220           67 FATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF------EDFKAKIA  140 (285)
Q Consensus        67 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~------~~~~~~l~  140 (285)
                      ++ +++|.+++......       .+++..++.++.|++.||.|||++.  |++||||||+||+++      ..+.++|+
T Consensus       111 ~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~~kl~  180 (373)
T 1q8y_A          111 VL-GENLLALIKKYEHR-------GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIA  180 (373)
T ss_dssp             CC-CEEHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEEEC
T ss_pred             cC-CCCHHHHHHHhhcc-------CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcceEEEc
Confidence            99 77999999764322       2889999999999999999999942  899999999999995      34489999


Q ss_pred             ccccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccc------hhhhh
Q 023220          141 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ------SLVTW  214 (285)
Q Consensus       141 df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~------~~~~~  214 (285)
                      |||++......     .....|++.|+|||.+.+..++.++|||||||++|+|++|..||.........      ..+..
T Consensus       181 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (373)
T 1q8y_A          181 DLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE  255 (373)
T ss_dssp             CCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred             ccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHH
Confidence            99998655432     23346899999999999989999999999999999999999999865421110      00000


Q ss_pred             hcccCchhhh------hhhcCC-------------------ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          215 ATPRLSEDKV------KQCVDP-------------------KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       215 ~~~~~~~~~~------~~~~~~-------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .....+....      ..+.+.                   ......+...+.++.++|.+||+.||.+|||++++++
T Consensus       256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence            0011111000      000000                   0012356788999999999999999999999999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.5e-38  Score=269.62  Aligned_cols=244  Identities=23%  Similarity=0.236  Sum_probs=165.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHH-HHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVS-VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|....+++.+++|........ ....++.+|+. +++.++||||+++++++...+..++||||+.+ +|.+++...
T Consensus        37 ~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~  114 (327)
T 3aln_A           37 SVNKMVHKPSGQIMAVKRIRSTVDE-KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYV  114 (327)
T ss_dssp             EEEEEEETTTTEEEEEEEEECCCCH-HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHH
T ss_pred             EEEEEEEcCCCCEEEEEEeecccCc-hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHH
Confidence            5899988888899999987643222 22334455555 77788999999999999999999999999985 888777631


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ....    ...+++..+..++.|++.|+.|||+..  |++|+||+|+||+++.++.++|+|||++........   ....
T Consensus       115 ~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~  185 (327)
T 3aln_A          115 YSVL----DDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRD  185 (327)
T ss_dssp             HHTT----CCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-------------
T ss_pred             Hhhh----cccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccC
Confidence            1000    012899999999999999999999842  899999999999999999999999999976543221   2234


Q ss_pred             ccccCcCCCccc----ccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          161 LGTFGYHAPEYA----MTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       161 ~~~~~~~aPE~~----~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      .|++.|+|||.+    .+..++.++||||||+++|+|++|..||.......... ..          ......+......
T Consensus       186 ~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~----------~~~~~~~~~~~~~  254 (327)
T 3aln_A          186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL-TQ----------VVKGDPPQLSNSE  254 (327)
T ss_dssp             --------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CC----------CCCSCCCCCCCCS
T ss_pred             CCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH-HH----------HhcCCCCCCCCcc
Confidence            688999999998    45668999999999999999999999997543211000 00          0000011111122


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...++..+.+++.+||+.||.+|||+.++++
T Consensus       255 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          255 EREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            3456778999999999999999999999875

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.8e-37  Score=259.99  Aligned_cols=220  Identities=15%  Similarity=0.099  Sum_probs=173.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+++|........ ....+.+.+|+..+++++||||+++++++.+.+..++||||+.+++|.+++..+
T Consensus        46 ~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~  125 (286)
T 3uqc_A           46 QFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS  125 (286)
T ss_dssp             EEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC
T ss_pred             EEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC
Confidence            5899999888899999988654332 223478899999999999999999999999999999999999999999999643


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                                 .....+..++.|++.||.|||++   |++||||||+||+++.++.++|++++                 
T Consensus       126 -----------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-----------------  174 (286)
T 3uqc_A          126 -----------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-----------------  174 (286)
T ss_dssp             -----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----------------
T ss_pred             -----------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----------------
Confidence                       34557889999999999999999   99999999999999999999997543                 


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchh-hhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL-VTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                           |++       .++.++|||||||++|+|++|+.||........... .........           ........
T Consensus       175 -----~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~  231 (286)
T 3uqc_A          175 -----TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI-----------EPADIDRD  231 (286)
T ss_dssp             -----CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBC-----------CHHHHCTT
T ss_pred             -----ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCC-----------ChhhcccC
Confidence                 222       268899999999999999999999987654321100 000000000           00011234


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      +++++.++|.+||+.||.+| |+.++++.|+++....
T Consensus       232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          232 IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            66789999999999999999 9999999999987543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.3e-37  Score=282.57  Aligned_cols=259  Identities=21%  Similarity=0.213  Sum_probs=190.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe------CCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE------GNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~   75 (285)
                      .||++.+..++..+++|..+.. ......+.+.+|++++++++||||+++++++..      ++..++||||+.+++|.+
T Consensus        29 ~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~  107 (676)
T 3qa8_A           29 YVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRK  107 (676)
T ss_dssp             BCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHH
T ss_pred             EEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHH
Confidence            6899998888999999987542 223345678899999999999999999998765      667799999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCe---eEEeccccCCCCCccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK---AKIADFNLSNQAPDMA  152 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~---~~l~df~~~~~~~~~~  152 (285)
                      ++......      ..+++..++.++.|++.||.|||+.   |++||||+|+||+++.++.   ++|+|||++.......
T Consensus       108 ~L~~~~~~------~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~  178 (676)
T 3qa8_A          108 YLNQFENC------CGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE  178 (676)
T ss_dssp             HHHSSSCT------TCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC
T ss_pred             HHHhcccC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccccccccccc
Confidence            99864321      1278889999999999999999999   9999999999999986654   8999999997654322


Q ss_pred             ccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhh--------hhcccCchhhh
Q 023220          153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT--------WATPRLSEDKV  224 (285)
Q Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~--------~~~~~~~~~~~  224 (285)
                      .   .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.............        ....... ...
T Consensus       179 ~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~-g~~  254 (676)
T 3qa8_A          179 L---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT-GAV  254 (676)
T ss_dssp             C---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS-SSC
T ss_pred             c---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc-ccc
Confidence            1   234568999999999998999999999999999999999999997542111000000        0000000 000


Q ss_pred             hhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHhchhhc
Q 023220          225 KQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSI-----VVKALQPLLK  274 (285)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~-----ll~~l~~~~~  274 (285)
                      ...-...........+++.+.++|.+||+.||.+|||+++     ..+.++.+.+
T Consensus       255 ~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          255 KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             CCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             ccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            0000001112345678999999999999999999999977     4455555543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.7e-37  Score=270.93  Aligned_cols=229  Identities=18%  Similarity=0.232  Sum_probs=168.4

Q ss_pred             eeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCC
Q 023220            8 TCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA   86 (285)
Q Consensus         8 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~   86 (285)
                      ....++.+++|....     ...+.+.+|+++++++ +||||+++++++.+....++|||++. |+|.+++......   
T Consensus        44 ~~~~~~~vAvK~~~~-----~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~---  114 (432)
T 3p23_A           44 GMFDNRDVAVKRILP-----ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA---  114 (432)
T ss_dssp             EESSSSEEEEEEECT-----TTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCC---
T ss_pred             EEeCCeEEEEEEECH-----HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCC---
Confidence            344567788886642     2345567899999999 89999999999999999999999997 5999999865432   


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-----CCeeEEeccccCCCCCcccc-ccccccc
Q 023220           87 QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-----DFKAKIADFNLSNQAPDMAA-RLHSTRV  160 (285)
Q Consensus        87 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-----~~~~~l~df~~~~~~~~~~~-~~~~~~~  160 (285)
                           .....++.++.|++.||.|||+.   |++||||||+||+++.     ...++|+|||++........ .......
T Consensus       115 -----~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~  186 (432)
T 3p23_A          115 -----HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV  186 (432)
T ss_dssp             -----CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------C
T ss_pred             -----ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeecccc
Confidence                 34445678999999999999999   9999999999999943     33578999999876543211 1122345


Q ss_pred             ccccCcCCCcccc---cCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          161 LGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       161 ~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      .|++.|+|||++.   ...++.++|||||||++|+|++ |..||............    ...          .......
T Consensus       187 ~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~----~~~----------~~~~~~~  252 (432)
T 3p23_A          187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL----GAC----------SLDCLHP  252 (432)
T ss_dssp             CSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT----TCC----------CCTTSCT
T ss_pred             CCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh----ccC----------CccccCc
Confidence            6899999999987   4567789999999999999999 99999643321111000    000          0000112


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ....+..+.++|.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            3455677899999999999999999999984

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9e-37  Score=271.27  Aligned_cols=242  Identities=18%  Similarity=0.265  Sum_probs=172.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||.+ ....++.+++|.....     ..+.+.+|+++++++ +||||+++++++.+.+..++||||+. |+|.+++...
T Consensus        30 ~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~  102 (434)
T 2rio_A           30 TVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESK  102 (434)
T ss_dssp             CEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC
T ss_pred             EEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhcc
Confidence            45654 3445778888866432     245678999999876 89999999999999999999999996 5999999865


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccC-------------CeeEEeccccCCC
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-------------FKAKIADFNLSNQ  147 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~-------------~~~~l~df~~~~~  147 (285)
                      .......  ....+..++.++.|++.||.|||+.   |++||||||+||+++.+             +.++|+|||++..
T Consensus       103 ~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~  177 (434)
T 2rio_A          103 NVSDENL--KLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK  177 (434)
T ss_dssp             --------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEE
T ss_pred             CCCchhh--hhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEccccccee
Confidence            4321100  0113335678999999999999999   99999999999999754             4899999999976


Q ss_pred             CCcccccc--cccccccccCcCCCccccc-------CCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 023220          148 APDMAARL--HSTRVLGTFGYHAPEYAMT-------GQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP  217 (285)
Q Consensus       148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  217 (285)
                      ........  ......|++.|+|||++.+       ..++.++|||||||++|+|++ |..||........ ....   .
T Consensus       178 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-~i~~---~  253 (434)
T 2rio_A          178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-NIIR---G  253 (434)
T ss_dssp             CCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH-HHHH---T
T ss_pred             cCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH-HHhc---C
Confidence            54322111  1223468999999999865       568899999999999999999 9999965432211 0000   0


Q ss_pred             cCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          218 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...        .+.........++.++.++|.+||+.||.+|||+.++++
T Consensus       254 ~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          254 IFS--------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             CCC--------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC--------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            000        011111234567889999999999999999999999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.9e-36  Score=255.36  Aligned_cols=212  Identities=15%  Similarity=0.231  Sum_probs=167.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHH-ccCCCCcccccceEEEe----CCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVV-SRLKHENLVELLGYCVE----GNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||+|.+..+++.+++|....       ...+.+|++++ +..+||||+++++++..    ....++||||+.+++|.++
T Consensus        33 ~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  105 (299)
T 3m2w_A           33 KVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR  105 (299)
T ss_dssp             EEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHH
T ss_pred             EEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHH
Confidence            589999888899999998752       46778899988 56699999999999987    6678999999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc---CCeeEEeccccCCCCCcccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~  153 (285)
                      +......       .+++..++.++.|++.||.|||+.   |++||||||+||+++.   ++.++|+|||++....    
T Consensus       106 l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----  171 (299)
T 3m2w_A          106 IQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----  171 (299)
T ss_dssp             HHHCTTC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred             HHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence            9875422       289999999999999999999999   9999999999999998   7889999999874321    


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                                          +..++.++|||||||++|+|++|..||.............           ..+...  .
T Consensus       172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~-----------~~~~~~--~  218 (299)
T 3m2w_A          172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-----------TRIRMG--Q  218 (299)
T ss_dssp             --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC-----------CSSCTT--C
T ss_pred             --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH-----------HHHhhc--c
Confidence                                2346789999999999999999999997543221100000           000000  0


Q ss_pred             CCCC----hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          234 GEYP----PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       234 ~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...+    ..++.++.+++.+||+.||.+|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0111    345778999999999999999999999998

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.8e-36  Score=282.06  Aligned_cols=226  Identities=16%  Similarity=0.213  Sum_probs=176.4

Q ss_pred             Cceeeeeee-eccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCe-----eeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQ-VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL-----RVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~~lv~e~~~~~~L~~   75 (285)
                      +||++.+.. ++..+++|..... ......+.+.+|++++++++||||+++++++...+.     .++||||+.+++|.+
T Consensus        95 ~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~  173 (681)
T 2pzi_A           95 WIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR  173 (681)
T ss_dssp             EEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC-
T ss_pred             EEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHH
Confidence            588998765 5677888866432 222345678899999999999999999999987665     699999999999988


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++...           +++..++.++.|++.+|.|||++   |++||||||+||+++.+ .++|+|||++......    
T Consensus       174 ~~~~~-----------l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~----  234 (681)
T 2pzi_A          174 SKGQK-----------LPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----  234 (681)
T ss_dssp             ---CC-----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC----
T ss_pred             HHhCC-----------CCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC----
Confidence            77541           89999999999999999999999   99999999999999986 8999999998754332    


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE  235 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
                        ....|++.|+|||.+.+. ++.++|||||||++|+|++|..||........           .            ...
T Consensus       235 --~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------~------------~~~  288 (681)
T 2pzi_A          235 --GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------P------------EDD  288 (681)
T ss_dssp             --SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------C------------TTC
T ss_pred             --CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-----------c------------ccc
Confidence              334689999999988765 48899999999999999999988864211100           0            000


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhchhh
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRP-NMSIVVKALQPLL  273 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~ll~~l~~~~  273 (285)
                      .....++.+.++|.+||+.||.+|| +++++...|..+.
T Consensus       289 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          289 PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            1122356799999999999999999 5666777666554

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-35  Score=261.28  Aligned_cols=232  Identities=15%  Similarity=0.127  Sum_probs=167.3

Q ss_pred             CceeeeeeeeccccChhhhhhc-cCCCCCChhHHHHHHHHccCCC-Ccccccc---------eE------------EEe-
Q 023220            2 RRWLCCTCQVEESYPSHENERL-KSPKNYPDDEKQLVSVVSRLKH-ENLVELL---------GY------------CVE-   57 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~---------~~------------~~~-   57 (285)
                      .||+|.+..+++.+++|..... .......+.+.+|+.+++.++| +|.....         +.            +.. 
T Consensus        93 ~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (413)
T 3dzo_A           93 AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDE  172 (413)
T ss_dssp             EEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-----------
T ss_pred             EEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCC
Confidence            5899999988999999977632 2334457889999999999977 3221111         11            111 


Q ss_pred             ----CCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc
Q 023220           58 ----GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE  133 (285)
Q Consensus        58 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~  133 (285)
                          ....+++|+.+. ++|.++++......  .....+++..++.++.|++.||.|||++   |++||||||+|||++.
T Consensus       173 ~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiKp~NILl~~  246 (413)
T 3dzo_A          173 RDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQ  246 (413)
T ss_dssp             ----CCSEEEEEECCS-EEHHHHHHHHHHHT--TTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred             ccccccceEEEeehhc-CCHHHHHHHhhccc--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcccceEEEec
Confidence                124577777764 69999885210000  0001278889999999999999999999   9999999999999999


Q ss_pred             CCeeEEeccccCCCCCcccccccccccccccCcCCCccc----------ccCCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 023220          134 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYA----------MTGQLTQKSDVYSFGVVLLELLTGRKPVDHT  203 (285)
Q Consensus       134 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~  203 (285)
                      ++.++|+|||++......     .....| +.|+|||.+          .+..++.++|||||||++|+|++|+.||...
T Consensus       247 ~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~  320 (413)
T 3dzo_A          247 RGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD  320 (413)
T ss_dssp             TCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTT
T ss_pred             CCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            999999999998754432     233456 999999998          4456788999999999999999999999765


Q ss_pred             CCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 023220          204 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVV  266 (285)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll  266 (285)
                      .......               ....      ....+++.+.++|.+||+.||.+|||+.+++
T Consensus       321 ~~~~~~~---------------~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          321 AALGGSE---------------WIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             GGGSCSG---------------GGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             chhhhHH---------------HHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            3221111               0101      0123457899999999999999999976653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.6e-35  Score=251.89  Aligned_cols=226  Identities=13%  Similarity=0.075  Sum_probs=166.5

Q ss_pred             CceeeeeeeeccccChhhhhhccC------CCCCChhHHHHHHHHccCC--------------------------CCccc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS------PKNYPDDEKQLVSVVSRLK--------------------------HENLV   49 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~l~--------------------------h~~iv   49 (285)
                      .||+|.+  +++.+++|.......      .....+.+.+|++++++++                          ||||+
T Consensus        35 ~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv  112 (336)
T 2vuw_A           35 EVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLL  112 (336)
T ss_dssp             EEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHH
T ss_pred             EEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHH
Confidence            5899976  578899998875542      2334478899999999886                          45555


Q ss_pred             ccceEEEe-------------CCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcC
Q 023220           50 ELLGYCVE-------------GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH-EKV  115 (285)
Q Consensus        50 ~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh-~~~  115 (285)
                      ++++++.+             .+..++||||+.+|++.+.+...          .+++..++.++.|++.||.||| +. 
T Consensus       113 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----------~~~~~~~~~i~~qi~~aL~~lH~~~-  181 (336)
T 2vuw_A          113 KAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----------LSSLATAKSILHQLTASLAVAEASL-  181 (336)
T ss_dssp             HHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----------CCCHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHhC-
Confidence            55555543             67899999999988766666432          2899999999999999999999 99 


Q ss_pred             CCCeeeCCCCCCCeEEccCC--------------------eeEEeccccCCCCCcccccccccccccccCcCCCcccccC
Q 023220          116 QPSIIHRDIRSSNVLLFEDF--------------------KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG  175 (285)
Q Consensus       116 ~~~~~h~di~~~nil~~~~~--------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  175 (285)
                        |++||||||+|||++.++                    .++|+|||++.....       ....||+.|+|||++.+.
T Consensus       182 --~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~~g~  252 (336)
T 2vuw_A          182 --RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLFTGD  252 (336)
T ss_dssp             --CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGGGCCC
T ss_pred             --CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhhhcCC
Confidence              999999999999999887                    899999999975432       234689999999999876


Q ss_pred             CCCcccchHhHHHH-HHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh-h-hcCCccCCCCChhHHHHHHHHHHHhc
Q 023220          176 QLTQKSDVYSFGVV-LLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK-Q-CVDPKLKGEYPPKGVAKLAAVAALCV  252 (285)
Q Consensus       176 ~~~~~~DiwslG~~-l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~l~~li~~~l  252 (285)
                      . +.++||||+|++ .++++.|..||....         |...  ....+. . .............+++++.++|.+||
T Consensus       253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---------~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L  320 (336)
T 2vuw_A          253 G-DYQFDIYRLMKKENNNRWGEYHPYSNVL---------WLHY--LTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTML  320 (336)
T ss_dssp             S-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---------HHHH--HHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred             C-ccceehhhhhCCCCcccccccCCCcchh---------hhhH--HHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHh
Confidence            6 889999998777 667788988884210         0000  000000 0 00111111123467899999999999


Q ss_pred             ccCCCCCCCHHHHH
Q 023220          253 QYEAEFRPNMSIVV  266 (285)
Q Consensus       253 ~~~p~~Rps~~~ll  266 (285)
                      ++|     |+++++
T Consensus       321 ~~d-----sa~e~l  329 (336)
T 2vuw_A          321 NFS-----SATDLL  329 (336)
T ss_dssp             GSS-----SHHHHH
T ss_pred             ccC-----CHHHHH
Confidence            976     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=2e-30  Score=237.05  Aligned_cols=173  Identities=16%  Similarity=0.086  Sum_probs=124.4

Q ss_pred             eeeccccChhhhhhccCC--------CCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            9 CQVEESYPSHENERLKSP--------KNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         9 ~~~~~~~~~k~~~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .-..+.|++|........        +...+++.+|+++|+++ .|+||+++++++++++..||||||++|++|.+++..
T Consensus       256 ~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~  335 (569)
T 4azs_A          256 YFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA  335 (569)
T ss_dssp             EEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT
T ss_pred             ccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh
Confidence            345666667765443222        22346799999999999 799999999999999999999999999999999987


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         ++..   .|+.||+.||.|+|++   ||+||||||+|||++.+|.+||+|||+++........  ...
T Consensus       336 ~~~---------l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~--~~t  398 (569)
T 4azs_A          336 GEE---------IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW--PTN  398 (569)
T ss_dssp             TCC---------CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC--SHH
T ss_pred             CCC---------CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc--ccC
Confidence            643         5543   5889999999999999   9999999999999999999999999999765443222  234


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCC
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP  199 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p  199 (285)
                      ..||+.|+|||++.+. +...+|+||+|++++.+.++..+
T Consensus       399 ~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          399 LVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             ceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            5689999999998764 56789999999988777554433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.89  E-value=1.1e-24  Score=198.11  Aligned_cols=149  Identities=15%  Similarity=0.154  Sum_probs=124.8

Q ss_pred             ChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 023220           30 PDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLE  109 (285)
Q Consensus        30 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~  109 (285)
                      .+++.+|++++++++||||+.+..++...+..++||||+++++|.+++..                 +..++.|++.+|.
T Consensus       383 ~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~  445 (540)
T 3en9_A          383 KSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-----------------NLDIAYKIGEIVG  445 (540)
T ss_dssp             HHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-----------------CTHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-----------------HHHHHHHHHHHHH
Confidence            35578999999999999999777777777788999999999999999865                 3479999999999


Q ss_pred             HHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc-----cccccccccCcCCCccccc--CCCCcccc
Q 023220          110 YLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMT--GQLTQKSD  182 (285)
Q Consensus       110 ~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~D  182 (285)
                      |||++   |++||||||+||+++.  .++|+|||++..........     ......||+.|+|||++..  ..|+..+|
T Consensus       446 ~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d  520 (540)
T 3en9_A          446 KLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYD  520 (540)
T ss_dssp             HHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCT
T ss_pred             HHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHh
Confidence            99999   9999999999999998  99999999998765432211     1124568999999999876  56788899


Q ss_pred             hHhHHHHHHHHHhCCCCC
Q 023220          183 VYSFGVVLLELLTGRKPV  200 (285)
Q Consensus       183 iwslG~~l~~l~~g~~pf  200 (285)
                      +||.++-..+-..++.+|
T Consensus       521 ~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          521 RWEIILELMKDVERRARY  538 (540)
T ss_dssp             THHHHHHHHHHHHTCSCC
T ss_pred             HHHHHHHHHHHHHhcccc
Confidence            999998888877776655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.77  E-value=1.1e-19  Score=152.17  Aligned_cols=120  Identities=12%  Similarity=0.073  Sum_probs=94.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCC----C------------CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEE
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPK----N------------YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAY   65 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~----~------------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   65 (285)
                      .||+|.. .+++.+++|..+......    .            ....+.+|++++++++  | +++.+++.. +..++||
T Consensus       105 ~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvm  179 (282)
T 1zar_A          105 AVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLM  179 (282)
T ss_dssp             EEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEE
T ss_pred             eEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEE
Confidence            4888887 678889999775332211    1            2456889999999999  5 777776654 4569999


Q ss_pred             eeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccC
Q 023220           66 EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS  145 (285)
Q Consensus        66 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~  145 (285)
                      ||+++++|.+ +...               ....++.|++.|+.|||+.   |++||||||+||+++ ++.++|+|||++
T Consensus       180 E~~~g~~L~~-l~~~---------------~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG~a  239 (282)
T 1zar_A          180 ELIDAKELYR-VRVE---------------NPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQS  239 (282)
T ss_dssp             ECCCCEEGGG-CCCS---------------CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred             EecCCCcHHH-cchh---------------hHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence            9999999988 4211               2346999999999999999   999999999999999 999999999987


Q ss_pred             C
Q 023220          146 N  146 (285)
Q Consensus       146 ~  146 (285)
                      .
T Consensus       240 ~  240 (282)
T 1zar_A          240 V  240 (282)
T ss_dssp             E
T ss_pred             e
Confidence            4

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.60  E-value=5.7e-16  Score=127.85  Aligned_cols=127  Identities=15%  Similarity=0.095  Sum_probs=91.7

Q ss_pred             Cceeeeeeeeccc--cChhhhhhccCCCC----------------------CChhHHHHHHHHccCCCCcccccceEEEe
Q 023220            2 RRWLCCTCQVEES--YPSHENERLKSPKN----------------------YPDDEKQLVSVVSRLKHENLVELLGYCVE   57 (285)
Q Consensus         2 ~~~~~~~~~~~~~--~~~k~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   57 (285)
                      .||+|.....++.  +++|..+.......                      ....+.+|++.+.++.|+++.-..-+.. 
T Consensus        62 ~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-  140 (258)
T 1zth_A           62 NVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY-  140 (258)
T ss_dssp             EEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE-
T ss_pred             EEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc-
Confidence            5899987667777  89997543211100                      0136789999999998886422222221 


Q ss_pred             CCeeeEEEeeCCC-C----CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeeeCCCCCCCeEE
Q 023220           58 GNLRVLAYEFATM-G----SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH-EKVQPSIIHRDIRSSNVLL  131 (285)
Q Consensus        58 ~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh-~~~~~~~~h~di~~~nil~  131 (285)
                       +..++||||+.+ |    +|.++...            .+...+..++.|++.++.+|| +.   |++||||||.|||+
T Consensus       141 -~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp~NILl  204 (258)
T 1zth_A          141 -MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLYQEA---ELVHADLSEYNIMY  204 (258)
T ss_dssp             -ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCSTTSEEE
T ss_pred             -CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEE
Confidence             246899999942 3    67776532            223457789999999999999 99   99999999999999


Q ss_pred             ccCCeeEEeccccCCC
Q 023220          132 FEDFKAKIADFNLSNQ  147 (285)
Q Consensus       132 ~~~~~~~l~df~~~~~  147 (285)
                      +.  .++|+|||++..
T Consensus       205 ~~--~~~liDFG~a~~  218 (258)
T 1zth_A          205 ID--KVYFIDMGQAVT  218 (258)
T ss_dssp             SS--SEEECCCTTCEE
T ss_pred             cC--cEEEEECccccc
Confidence            98  899999999854

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.35  E-value=3.6e-13  Score=116.16  Aligned_cols=125  Identities=10%  Similarity=0.018  Sum_probs=82.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCC------------Chh--------HHHHHHHHccCCCCcccccceEEEeCCee
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNY------------PDD--------EKQLVSVVSRLKHENLVELLGYCVEGNLR   61 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~------------~~~--------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   61 (285)
                      .||+|.+. .++.+|+|..+........            ...        ...|...|.++.+.++....-+...  ..
T Consensus       110 ~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~~--~~  186 (397)
T 4gyi_A          110 DIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQS--RH  186 (397)
T ss_dssp             EEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEEE--TT
T ss_pred             EEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeecc--Cc
Confidence            58999775 4677899976543221110            011        1235566666644443222212122  23


Q ss_pred             eEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC------
Q 023220           62 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF------  135 (285)
Q Consensus        62 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~------  135 (285)
                      +|||||+.+++|.++...               .....++.|++.++.+||+.   |++||||||.|||+++++      
T Consensus       187 ~LVME~i~G~~L~~l~~~---------------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d~~  248 (397)
T 4gyi_A          187 TIVMSLVDALPMRQVSSV---------------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAEDPS  248 (397)
T ss_dssp             EEEEECCSCEEGGGCCCC---------------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSCTT
T ss_pred             eEEEEecCCccHhhhccc---------------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCccccc
Confidence            799999998888655321               12356789999999999999   999999999999998776      


Q ss_pred             ----eeEEeccccCCC
Q 023220          136 ----KAKIADFNLSNQ  147 (285)
Q Consensus       136 ----~~~l~df~~~~~  147 (285)
                          .++|+||+.+..
T Consensus       249 ~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          249 SITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SEEEEEEECCCTTCEE
T ss_pred             ccccceEEEEeCCccc
Confidence                489999997743

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.09  E-value=2.6e-10  Score=93.89  Aligned_cols=126  Identities=12%  Similarity=0.044  Sum_probs=92.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||++...  ++.+.+|.......  .....+.+|+++++.+. +..+.++++++.+.+..++|||+++|.+|.+.+...
T Consensus        29 ~v~~~~~~--~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~  104 (263)
T 3tm0_A           29 KVYKLVGE--NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE  104 (263)
T ss_dssp             EEEEEECS--SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCTT
T ss_pred             eEEEEECC--CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCCc
Confidence            46666432  45677776643221  22456889999999884 677888999999988999999999998988764211


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV---------------------------------------------  115 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---------------------------------------------  115 (285)
                                    .....++.++..++..||+..                                             
T Consensus       105 --------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  170 (263)
T 3tm0_A          105 --------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL  170 (263)
T ss_dssp             --------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred             --------------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence                          123467889999999999810                                             


Q ss_pred             -----------CCCeeeCCCCCCCeEEccCCeeEEeccccC
Q 023220          116 -----------QPSIIHRDIRSSNVLLFEDFKAKIADFNLS  145 (285)
Q Consensus       116 -----------~~~~~h~di~~~nil~~~~~~~~l~df~~~  145 (285)
                                 ...++|+|+++.||+++.+..+.|+||+.+
T Consensus       171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence                       025999999999999987655679999865

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.86  E-value=2.6e-09  Score=87.49  Aligned_cols=120  Identities=13%  Similarity=-0.005  Sum_probs=81.8

Q ss_pred             ceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCc--ccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHEN--LVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      ||++.. ..+..+.+|.....     ....+.+|+++++.+.+.+  +.+++++...++..++|||+++|.+|.  ... 
T Consensus        36 v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~-  106 (264)
T 1nd4_A           36 VFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH-  106 (264)
T ss_dssp             EEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC-
T ss_pred             EEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc-
Confidence            555522 22345666654321     3467889999999885444  456888888777889999999987773  211 


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV---------------------------------------------  115 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---------------------------------------------  115 (285)
                                 ..   ...++.+++..+..||...                                             
T Consensus       107 -----------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A          107 -----------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             -----------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             -----------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence                       11   1256667777777777641                                             


Q ss_pred             ----------CCCeeeCCCCCCCeEEccCCeeEEeccccC
Q 023220          116 ----------QPSIIHRDIRSSNVLLFEDFKAKIADFNLS  145 (285)
Q Consensus       116 ----------~~~~~h~di~~~nil~~~~~~~~l~df~~~  145 (285)
                                ..+++|+|++|.||+++.++.+.|+||+.+
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a  212 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL  212 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence                      012999999999999987755679999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.73  E-value=1.8e-08  Score=86.71  Aligned_cols=107  Identities=19%  Similarity=0.211  Sum_probs=81.3

Q ss_pred             ChhHHHHHHHHccCCC--CcccccceEEEeC---CeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHH
Q 023220           30 PDDEKQLVSVVSRLKH--ENLVELLGYCVEG---NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDA  104 (285)
Q Consensus        30 ~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi  104 (285)
                      ...+.+|+++++.+..  ..+.+++.++.+.   +..++|||+++|..+.+....           .++......++.++
T Consensus        80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~~-----------~l~~~~~~~~~~~l  148 (359)
T 3dxp_A           80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSLP-----------GMSPAERTAIYDEM  148 (359)
T ss_dssp             --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTCT-----------TCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCccc-----------cCCHHHHHHHHHHH
Confidence            4578889999998864  4577888887766   347899999998766432111           16777888899999


Q ss_pred             HHHHHHHhhcC-------------------------------------------------------CCCeeeCCCCCCCe
Q 023220          105 ARGLEYLHEKV-------------------------------------------------------QPSIIHRDIRSSNV  129 (285)
Q Consensus       105 ~~~l~~lh~~~-------------------------------------------------------~~~~~h~di~~~ni  129 (285)
                      +.+|..||...                                                       ...++|+|+++.||
T Consensus       149 ~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Ni  228 (359)
T 3dxp_A          149 NRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNL  228 (359)
T ss_dssp             HHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGE
T ss_pred             HHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcE
Confidence            99999999730                                                       13799999999999


Q ss_pred             EEccCCe--eEEeccccCCC
Q 023220          130 LLFEDFK--AKIADFNLSNQ  147 (285)
Q Consensus       130 l~~~~~~--~~l~df~~~~~  147 (285)
                      +++.++.  +.|+||+.+..
T Consensus       229 l~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          229 MFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             EECSSSSCEEEECCCTTCEE
T ss_pred             EEeCCCCcEEEEECcccccc
Confidence            9987653  68999998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.52  E-value=2.3e-08  Score=84.09  Aligned_cols=154  Identities=18%  Similarity=0.163  Sum_probs=95.8

Q ss_pred             ChhHHHHHHHHccC-CCCcc--cccceEEEeCC---eeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHH
Q 023220           30 PDDEKQLVSVVSRL-KHENL--VELLGYCVEGN---LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVD  103 (285)
Q Consensus        30 ~~~~~~e~~~l~~l-~h~~i--v~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~q  103 (285)
                      ...+.+|+++++.+ .+..+  ..++......+   ..++||++++|.++.......           ++......++.+
T Consensus        54 ~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~~-----------l~~~~~~~~~~~  122 (304)
T 3sg8_A           54 STNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLNN-----------LPKQSQNQAAKD  122 (304)
T ss_dssp             HHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHHT-----------SCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccccc-----------CCHHHHHHHHHH
Confidence            46788999999888 33333  33333332332   348899999987776433221           566667777777


Q ss_pred             HHHHHHHHhhc-------------------------------------------------------CCCCeeeCCCCCCC
Q 023220          104 AARGLEYLHEK-------------------------------------------------------VQPSIIHRDIRSSN  128 (285)
Q Consensus       104 i~~~l~~lh~~-------------------------------------------------------~~~~~~h~di~~~n  128 (285)
                      ++..++.||+.                                                       ....++|+|+++.|
T Consensus       123 l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N  202 (304)
T 3sg8_A          123 LARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDH  202 (304)
T ss_dssp             HHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGG
T ss_pred             HHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCccc
Confidence            77777777751                                                       01358999999999


Q ss_pred             eEEcc--CCeeEEeccccCCCCCcccccccccccccccCc---CCCcccc-----cCCC---------CcccchHhHHHH
Q 023220          129 VLLFE--DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY---HAPEYAM-----TGQL---------TQKSDVYSFGVV  189 (285)
Q Consensus       129 il~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~---~aPE~~~-----~~~~---------~~~~DiwslG~~  189 (285)
                      |+++.  +..+.++||+.+...........      ....   ..|+...     ....         .-..+.|++|.+
T Consensus       203 ~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~------~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~  276 (304)
T 3sg8_A          203 ILFDTEKNTICGIIDFGDAAISDPDNDFIS------LMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKI  276 (304)
T ss_dssp             EEEETTTTEEEEECCCTTCEEECTTHHHHT------TCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCEEEEEeCCCCccCChHHHHHH------HHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHH
Confidence            99998  55678999988754321111000      0000   1222110     0001         112588999999


Q ss_pred             HHHHHhCCCCC
Q 023220          190 LLELLTGRKPV  200 (285)
Q Consensus       190 l~~l~~g~~pf  200 (285)
                      +|.+.+|..+|
T Consensus       277 ~~~~~~g~~~~  287 (304)
T 3sg8_A          277 IYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTTCHHH
T ss_pred             HHHHHcCCHHH
Confidence            99999998876

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.19  E-value=1.3e-05  Score=62.85  Aligned_cols=145  Identities=13%  Similarity=0.069  Sum_probs=96.1

Q ss_pred             CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcc
Q 023220           72 SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM  151 (285)
Q Consensus        72 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~  151 (285)
                      +|.+++.....        ++++.++|.++.|.+.++.-+-...  .-..+-+.|..|++..+|.|-+.+ +.+.     
T Consensus        34 SL~eIL~~~~~--------PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----   97 (229)
T 2yle_A           34 SLEEILRLYNQ--------PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD-----   97 (229)
T ss_dssp             EHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------
T ss_pred             cHHHHHHHcCC--------CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-----
Confidence            79999976653        3999999999999999987773221  111334567899999999998874 1110     


Q ss_pred             cccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCc
Q 023220          152 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK  231 (285)
Q Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
                               .....+.+||... ...+.+.-|||||+++|.-+--..|=                               
T Consensus        98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e-------------------------------  136 (229)
T 2yle_A           98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE-------------------------------  136 (229)
T ss_dssp             ------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT-------------------------------
T ss_pred             ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc-------------------------------
Confidence                     1133577888753 34568889999999999887533321                               


Q ss_pred             cCCCCChhHHHHHHHHHHHhccc-------------------------CCCCCCCHHHHHHHhchhhcCC
Q 023220          232 LKGEYPPKGVAKLAAVAALCVQY-------------------------EAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~-------------------------~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                         .-+.+.++.|..||..|..-                         .+..|++++++++..+.-++.+
T Consensus       137 ---~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~~p  203 (229)
T 2yle_A          137 ---NEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLPTE  203 (229)
T ss_dssp             ---TEEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTSSSG
T ss_pred             ---ccchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhccCc
Confidence               12344566788888888765                         3468889999998877666544

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.16  E-value=5.4e-06  Score=68.06  Aligned_cols=126  Identities=12%  Similarity=-0.005  Sum_probs=80.9

Q ss_pred             ceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            3 RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         3 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      ||+.........+.+|....-     ...++.+|.+.|+.+. +-.+.++++++.+.+..++||++++|.++.+......
T Consensus        41 v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~  115 (272)
T 4gkh_A           41 IYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP  115 (272)
T ss_dssp             EEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG
T ss_pred             EEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH
Confidence            455443333344555544321     2456788999998873 3346778888899999999999999877766543221


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----------------------------------------------
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEK-----------------------------------------------  114 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~-----------------------------------------------  114 (285)
                                   .....+..++...+.-||..                                               
T Consensus       116 -------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          116 -------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             -------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             -------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence                         11223344444444444421                                               


Q ss_pred             --------CCCCeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220          115 --------VQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus       115 --------~~~~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                              ....++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                    01137899999999999987767799998663

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.87  E-value=6.9e-05  Score=62.77  Aligned_cols=106  Identities=17%  Similarity=0.127  Sum_probs=68.2

Q ss_pred             ChhHHHHHHHHccCCCC---cccccceEEE-eCCeeeEEEeeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHH
Q 023220           30 PDDEKQLVSVVSRLKHE---NLVELLGYCV-EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAA  105 (285)
Q Consensus        30 ~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~  105 (285)
                      ...+.+|.++|+.+.+.   .+.+.+.+.. ..+..+++|++++|.++....-..           ++......++.++.
T Consensus        53 ~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~~-----------l~~~~~~~~~~~lg  121 (306)
T 3tdw_A           53 ADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMAV-----------LPDDAKDRLALQLA  121 (306)
T ss_dssp             HHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHTT-----------SCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhhh-----------CCHHHHHHHHHHHH
Confidence            46788999999998642   3555565654 344568999999987776532111           23333344444444


Q ss_pred             HHHHHHhhc---------------------------------------------------------CCCCeeeCCCCCCC
Q 023220          106 RGLEYLHEK---------------------------------------------------------VQPSIIHRDIRSSN  128 (285)
Q Consensus       106 ~~l~~lh~~---------------------------------------------------------~~~~~~h~di~~~n  128 (285)
                      ..+..||+.                                                         ....++|+|+++.|
T Consensus       122 ~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N  201 (306)
T 3tdw_A          122 EFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDH  201 (306)
T ss_dssp             HHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGG
T ss_pred             HHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCccc
Confidence            444444432                                                         12257999999999


Q ss_pred             eEEcc---CCe-eEEeccccCC
Q 023220          129 VLLFE---DFK-AKIADFNLSN  146 (285)
Q Consensus       129 il~~~---~~~-~~l~df~~~~  146 (285)
                      |+++.   ++. +.|+||+.+.
T Consensus       202 ~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          202 FLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             EEECTTCSSCCEEEECCCTTCE
T ss_pred             EEEecCCCCCceEEEEehhhcC
Confidence            99987   345 4899998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.31  E-value=0.00037  Score=59.45  Aligned_cols=44  Identities=5%  Similarity=-0.064  Sum_probs=31.4

Q ss_pred             hhHHHHHHHHccCCC---CcccccceEEEeC---CeeeEEEeeCCCCCHH
Q 023220           31 DDEKQLVSVVSRLKH---ENLVELLGYCVEG---NLRVLAYEFATMGSLH   74 (285)
Q Consensus        31 ~~~~~e~~~l~~l~h---~~iv~~~~~~~~~---~~~~lv~e~~~~~~L~   74 (285)
                      ..+.+|+++++.+..   -.+.+++.+..+.   +..++|||+++|..+.
T Consensus        72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred             hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence            567889999888832   3466677776554   3458999999876654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=96.67  E-value=0.0042  Score=53.71  Aligned_cols=29  Identities=21%  Similarity=0.423  Sum_probs=24.8

Q ss_pred             CeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          118 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      .++|||+.+.||+++.+ .+.++||..+..
T Consensus       228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          228 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             EEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             ceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            79999999999999876 488999976643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.93  E-value=0.02  Score=47.46  Aligned_cols=29  Identities=24%  Similarity=0.187  Sum_probs=24.4

Q ss_pred             CeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          118 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      .++|+|+.+.||+ ..++.+.++||+.+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            5899999999999 5566789999987643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=95.86  E-value=0.019  Score=47.98  Aligned_cols=56  Identities=16%  Similarity=0.047  Sum_probs=40.5

Q ss_pred             cccChhhhhhccCCCCCChhHHHHHHHHccCC---CCcccccceEEEeCCeeeEEEeeCCCCCH
Q 023220           13 ESYPSHENERLKSPKNYPDDEKQLVSVVSRLK---HENLVELLGYCVEGNLRVLAYEFATMGSL   73 (285)
Q Consensus        13 ~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   73 (285)
                      ..|.+|.....     ....+..|.+.|+.+.   ...+.+.+.+....+..++|||++++..+
T Consensus        60 ~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           60 QTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             CEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             CeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            44555554321     2567888999988883   36688888888877889999999987643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=95.83  E-value=0.018  Score=48.34  Aligned_cols=30  Identities=23%  Similarity=0.500  Sum_probs=26.0

Q ss_pred             CeeeCCCCCCCeEEccC----CeeEEeccccCCC
Q 023220          118 SIIHRDIRSSNVLLFED----FKAKIADFNLSNQ  147 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~----~~~~l~df~~~~~  147 (285)
                      .++|||+.+.||+++.+    +.+.++||+.+..
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            79999999999999874    6789999987754

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=95.59  E-value=0.02  Score=48.00  Aligned_cols=29  Identities=24%  Similarity=0.352  Sum_probs=26.1

Q ss_pred             CeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220          118 SIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      +++|+|+.+.||+++.++.+.++||+.+.
T Consensus       223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          223 NLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             ceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            89999999999999877889999998653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=93.75  E-value=0.066  Score=46.56  Aligned_cols=30  Identities=23%  Similarity=0.438  Sum_probs=26.5

Q ss_pred             CeeeCCCCCCCeEEccCCeeEEeccccCCCC
Q 023220          118 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQA  148 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~  148 (285)
                      .++|||+++.||+++.++ +.++||+.+...
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            899999999999998776 999999887543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=91.59  E-value=0.068  Score=44.46  Aligned_cols=29  Identities=28%  Similarity=0.490  Sum_probs=24.8

Q ss_pred             CeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220          118 SIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      +++|+|+.+.||+++.+..+.++||+.+.
T Consensus       188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            79999999999999877556899998653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=90.36  E-value=0.28  Score=40.75  Aligned_cols=27  Identities=22%  Similarity=0.321  Sum_probs=23.8

Q ss_pred             CeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220          118 SIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      .++|||+++.||+++ + .+.++||+.+.
T Consensus       196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             EECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             eeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            689999999999998 4 88999998664

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.77  E-value=0.66  Score=36.19  Aligned_cols=122  Identities=7%  Similarity=0.100  Sum_probs=80.3

Q ss_pred             HHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 023220           36 LVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMG-SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEK  114 (285)
Q Consensus        36 e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~  114 (285)
                      |+.+|.. .||+.++. .+-.+.+.+.+.++.-+++ ++.. ++.            .+....+.++.+|+....+++  
T Consensus        36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~------------~~~~eKlr~l~ni~~l~~~~~--   98 (215)
T 4ann_A           36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS------------FTKNEKLRYLLNIKNLEEVNR--   98 (215)
T ss_dssp             GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG------------SCHHHHHHHHHHGGGGGGGGG--
T ss_pred             HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh------------cCHHHHHHHHHHHHHHHHHhc--
Confidence            4444444 78988886 5666666655555544322 4444 222            677899999999988774443  


Q ss_pred             CCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHH
Q 023220          115 VQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELL  194 (285)
Q Consensus       115 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~  194 (285)
                         .-+|--++|+|++++.++.+++.=.|+..                   -++|..     +++..=.-.+=|++..++
T Consensus        99 ---~r~tf~L~P~NL~f~~~~~p~i~~RGik~-------------------~l~P~~-----~~ee~fL~qyKAliiall  151 (215)
T 4ann_A           99 ---TRYTFVLAPDELFFTRDGLPIAKTRGLQN-------------------VVDPLP-----VSEAEFLTRYKALVICAF  151 (215)
T ss_dssp             ---SSEECCCSGGGEEECTTSCEEESCCEETT-------------------TBSCCC-----CCHHHHHHHHHHHHHHHH
T ss_pred             ---CceEEEEecceEEEcCCCCEEEEEccCcc-------------------CCCCCC-----CCHHHHHHHHHHHHHHHH
Confidence               45788899999999999999998655432                   123321     122222336778889999


Q ss_pred             hCCCCCC
Q 023220          195 TGRKPVD  201 (285)
Q Consensus       195 ~g~~pf~  201 (285)
                      .++..|+
T Consensus       152 ~~K~~Fe  158 (215)
T 4ann_A          152 NEKQSFD  158 (215)
T ss_dssp             CTTCCHH
T ss_pred             cCCCCHH
Confidence            9988884

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.63  E-value=0.97  Score=35.36  Aligned_cols=120  Identities=10%  Similarity=0.104  Sum_probs=79.5

Q ss_pred             HHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-HHhh
Q 023220           36 LVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMG-SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLE-YLHE  113 (285)
Q Consensus        36 e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~-~lh~  113 (285)
                      ++.+|.. .||++  -..+-.+.+.+.+.++--+++ ++..+ +.            .+....+.++.+++.... +++ 
T Consensus        41 e~~lL~~-~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-~~------------~~~~eKlrll~nl~~L~~~~~~-  103 (219)
T 4ano_A           41 ELEVLKE-VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-RK------------TTLLSRIRAAIHLVSKVKHHSA-  103 (219)
T ss_dssp             GGGGGGG-SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-HT------------SCHHHHHHHHHHHHHHHSSCCS-
T ss_pred             HHHHHhc-cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-Hh------------cCHHHHHHHHHHHHHHHHHhhh-
Confidence            3434444 78888  455556777777766665443 55544 22            678899999999887655 443 


Q ss_pred             cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccccccCcCCCcccccCCCCcccchH-hHHHHHHH
Q 023220          114 KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVY-SFGVVLLE  192 (285)
Q Consensus       114 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diw-slG~~l~~  192 (285)
                          .-+|--++|+|++++.++.+++.=.|+-.                   -++|...     ++ .|.| ++=|++..
T Consensus       104 ----~r~tf~l~P~NL~f~~~~~p~i~hRGi~~-------------------~lpP~e~-----~e-e~fl~qyKali~a  154 (219)
T 4ano_A          104 ----RRLIFIVCPENLMFNRALEPFFLHVGVKE-------------------SLPPDEW-----DD-ERLLREVKATVLA  154 (219)
T ss_dssp             ----SSEECCCCGGGEEECTTCCEEESCCEETT-------------------TBSSCSC-----CH-HHHHHHHHHHHHH
T ss_pred             ----CceeEEEeCceEEEeCCCcEEEEEcCCcc-------------------cCCCCCC-----CH-HHHHHHHHHHHHH
Confidence                56788899999999999999998665432                   2334321     11 2333 67778888


Q ss_pred             HHhCCCCCC
Q 023220          193 LLTGRKPVD  201 (285)
Q Consensus       193 l~~g~~pf~  201 (285)
                      ++.++..|+
T Consensus       155 ll~~K~~Fe  163 (219)
T 4ano_A          155 LTEGEYRFD  163 (219)
T ss_dssp             HTTCSSCHH
T ss_pred             HHcCCCCHH
Confidence            888888774

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=89.58  E-value=0.3  Score=41.05  Aligned_cols=30  Identities=27%  Similarity=0.329  Sum_probs=26.5

Q ss_pred             CeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          118 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      .++|+|+.+.||+++.++.+.++||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            799999999999999877899999976643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=88.17  E-value=0.21  Score=42.46  Aligned_cols=28  Identities=21%  Similarity=0.466  Sum_probs=23.7

Q ss_pred             CeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220          118 SIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      .++|+|+.+.||+++.+. +.++||+.+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            699999999999998654 8999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=87.57  E-value=0.53  Score=41.43  Aligned_cols=34  Identities=15%  Similarity=0.095  Sum_probs=22.7

Q ss_pred             HHHHHHHccCCCCcc-cccceEEEeCCeeeEEEeeCCCC
Q 023220           34 KQLVSVVSRLKHENL-VELLGYCVEGNLRVLAYEFATMG   71 (285)
Q Consensus        34 ~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~   71 (285)
                      .+|..+++.+...++ .++++.+.  +  .+|++|++|.
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            578888888855444 45666652  2  2599999863

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=86.61  E-value=0.28  Score=42.81  Aligned_cols=36  Identities=14%  Similarity=0.087  Sum_probs=24.0

Q ss_pred             hhHHHHHHHHccCCCCcc-cccceEEEeCCeeeEEEeeCCC
Q 023220           31 DDEKQLVSVVSRLKHENL-VELLGYCVEGNLRVLAYEFATM   70 (285)
Q Consensus        31 ~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~   70 (285)
                      +.+.+|+.+++.+...++ .++++.+.  +  .+|++|++|
T Consensus       120 ~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~l~G  156 (429)
T 1nw1_A          120 SHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEYIPS  156 (429)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECCCCE
T ss_pred             HHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEEeCC
Confidence            566789999888843334 55665543  2  388999975

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=85.27  E-value=0.45  Score=40.76  Aligned_cols=29  Identities=31%  Similarity=0.545  Sum_probs=25.5

Q ss_pred             CeeeCCCCCCCeEEccC----CeeEEeccccCC
Q 023220          118 SIIHRDIRSSNVLLFED----FKAKIADFNLSN  146 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~----~~~~l~df~~~~  146 (285)
                      .++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            69999999999999876    689999998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=82.64  E-value=0.67  Score=39.92  Aligned_cols=29  Identities=34%  Similarity=0.493  Sum_probs=24.1

Q ss_pred             CeeeCCCCCCCeEE------ccCCeeEEeccccCC
Q 023220          118 SIIHRDIRSSNVLL------FEDFKAKIADFNLSN  146 (285)
Q Consensus       118 ~~~h~di~~~nil~------~~~~~~~l~df~~~~  146 (285)
                      .++|+|+.+.||++      +.+..+.++||..+.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            36799999999999      345679999998774

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	285
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-59
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-52
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-50
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-48
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-48
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-47
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-47
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-47
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-47
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-47
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-47
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-46
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-46
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-45
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-45
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-45
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-44
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-43
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-42
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-42
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-42
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-42
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-41
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-40
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-40
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-39
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-38
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-35
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-34
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-33
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-33
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-32
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-32
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-31
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-31
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-31
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-30
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-30
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-29
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-28
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-28
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-27
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-27
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-26
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-26
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-26
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-25
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-25
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-24
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-23
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-22
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-22
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-20
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-18
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-18
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-17
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-16
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-07

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 4e-59
 Identities = 64/262 (24%), Positives = 113/262 (43%), Gaps = 29/262 (11%)

Query: 22  RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 78
            L      P   +     V V+ + +H N++  +GY     L  +  ++    SL+  LH
Sbjct: 37  MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLH 95

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
             +           + +  + IA   A+G++YLH K   SIIHRD++S+N+ L ED   K
Sbjct: 96  IIETK--------FEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVK 144

Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLT 195
           I DF L+      +      ++ G+  + APE          + +SDVY+FG+VL EL+T
Sbjct: 145 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204

Query: 196 GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYE 255
           G+ P  +   R Q               V +        +        +  + A C++ +
Sbjct: 205 GQLPYSNINNRDQI-----------IFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKK 253

Query: 256 AEFRPNMSIVVKALQPLLKSPP 277
            + RP    ++ +++ L +S P
Sbjct: 254 RDERPLFPQILASIELLARSLP 275

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 8e-52
 Identities = 61/254 (24%), Positives = 105/254 (41%), Gaps = 27/254 (10%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
            LK     PD      +++ +L+H+ LV L     +  +  +  E+   GSL D L    
Sbjct: 44  SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS 102

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
           G++       L     + +A   A G+ ++ E+   + IHRD+R++N+L+ +    KIAD
Sbjct: 103 GIK-------LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIAD 152

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           F L+    D               + APE    G  T KSDV+SFG++L E++T  +   
Sbjct: 153 FGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

Query: 202 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 261
             M               +  +V Q ++   +   P     +L  +  LC +   E RP 
Sbjct: 212 PGM---------------TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 256

Query: 262 MSIVVKALQPLLKS 275
              +   L+    +
Sbjct: 257 FDYLRSVLEDFFTA 270

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 1e-50
 Identities = 56/266 (21%), Positives = 100/266 (37%), Gaps = 30/266 (11%)

Query: 25  SPKNYPDDEKQL---VSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR 80
            P  +  + + L   + V+S L  H N+V LLG C  G   ++  E+   G L + L  +
Sbjct: 62  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121

Query: 81  KG---------VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 131
           +                   LD    +  +   A+G+ +L  K   + IHRD+ + N+LL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178

Query: 132 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLL 191
                 KI DF L+    + +  +          + APE       T +SDV+S+G+ L 
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238

Query: 192 ELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALC 251
           EL +        MP               + K  + +    +   P    A++  +   C
Sbjct: 239 ELFSLGSSPYPGMP--------------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTC 284

Query: 252 VQYEAEFRPNMSIVVKALQPLLKSPP 277
              +   RP    +V+ ++  +    
Sbjct: 285 WDADPLKRPTFKQIVQLIEKQISEST 310

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 2e-50
 Identities = 50/261 (19%), Positives = 101/261 (38%), Gaps = 32/261 (12%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRV----LAYEFATMGSLHDILHGRKGVQGAQPGPVL 92
           +     L+HEN++  +    + N       L  ++   GSL D L+             +
Sbjct: 48  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------V 97

Query: 93  DWMTRVRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 147
                +++A+  A GL +LH ++     +P+I HRD++S N+L+ ++    IAD  L+ +
Sbjct: 98  TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157

Query: 148 APDMAARLH--STRVLGTFGYHAPEYAMT------GQLTQKSDVYSFGVVLLELLTGRKP 199
                  +       +GT  Y APE           +  +++D+Y+ G+V  E+      
Sbjct: 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217

Query: 200 ----VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAK-LAAVAALCVQY 254
                D+ +P         +   + +   +Q + P +   +      + +A +   C   
Sbjct: 218 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277

Query: 255 EAEFRPNMSIVVKALQPLLKS 275
               R     + K L  L + 
Sbjct: 278 NGAARLTALRIKKTLSQLSQQ 298

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-48
 Identities = 59/254 (23%), Positives = 105/254 (41%), Gaps = 27/254 (10%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
            ++      +D  +   V+ +L H  LV+L G C+E     L +EF   G L D L  ++
Sbjct: 36  TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR 95

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
           G+            T + + +D   G+ YL E     +IHRD+ + N L+ E+   K++D
Sbjct: 96  GLF--------AAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD 144

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           F ++    D      ST       + +PE     + + KSDV+SFGV++ E+ +  K   
Sbjct: 145 FGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 203

Query: 202 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 261
                             S  +V + +    +   P      +  +   C +   E RP 
Sbjct: 204 ENR---------------SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPA 248

Query: 262 MSIVVKALQPLLKS 275
            S +++ L  + +S
Sbjct: 249 FSRLLRQLAEIAES 262

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-48
 Identities = 51/249 (20%), Positives = 102/249 (40%), Gaps = 27/249 (10%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
             ++ +  H N++ L G   +    ++  E+   G+L   L  + G            + 
Sbjct: 60  AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQ 111

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            V +    A G++YL      + +HRD+ + N+L+  +   K++DF LS    D     +
Sbjct: 112 LVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 168

Query: 157 ST-RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 215
           +T        + APE     + T  SDV+SFG+V+ E++T  +     +           
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----------- 217

Query: 216 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 275
               S  +V + ++   +   P    + +  +   C Q E   RP  + +V  L  L+++
Sbjct: 218 ----SNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

Query: 276 PPPAAPVSE 284
           P     +++
Sbjct: 274 PDSLKTLAD 282

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 1e-47
 Identities = 70/257 (27%), Positives = 109/257 (42%), Gaps = 27/257 (10%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
            LK     P+   Q   V+ +L+HE LV+L     E  +  +  E+ + GSL D L G  
Sbjct: 48  TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGET 106

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
           G         L     V +A   A G+ Y+    + + +HRD+R++N+L+ E+   K+AD
Sbjct: 107 G-------KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVAD 156

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           F L+    D               + APE A+ G+ T KSDV+SFG++L EL T  +   
Sbjct: 157 FGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 215

Query: 202 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 261
                          P +   +V   V+   +   PP+    L  +   C + E E RP 
Sbjct: 216 ---------------PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 260

Query: 262 MSIVVKALQPLLKSPPP 278
              +   L+    S  P
Sbjct: 261 FEYLQAFLEDYFTSTEP 277

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 1e-47
 Identities = 56/267 (20%), Positives = 105/267 (39%), Gaps = 32/267 (11%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR 80
           + K+  +  +     + ++++L  HEN+V LLG C       L +E+   G L + L  +
Sbjct: 76  KEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK 135

Query: 81  KG--------------VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRS 126
           +               ++  +   VL +   +  A   A+G+E+L  K   S +HRD+ +
Sbjct: 136 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192

Query: 127 SNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSF 186
            NVL+      KI DF L+      +  +          + APE    G  T KSDV+S+
Sbjct: 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252

Query: 187 GVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAA 246
           G++L E+ +        +P                    + +    K + P     ++  
Sbjct: 253 GILLWEIFSLGVNPYPGIPVDAN--------------FYKLIQNGFKMDQPFYATEEIYI 298

Query: 247 VAALCVQYEAEFRPNMSIVVKALQPLL 273
           +   C  +++  RP+   +   L   L
Sbjct: 299 IMQSCWAFDSRKRPSFPNLTSFLGCQL 325

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  158 bits (401), Expect = 1e-47
 Identities = 53/243 (21%), Positives = 97/243 (39%), Gaps = 29/243 (11%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
            S++ +  H N++ L G   +    ++  EF   GSL   L    G            + 
Sbjct: 78  ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--------TVIQ 129

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            V +    A G++YL      + +HRD+ + N+L+  +   K++DF LS    D  +   
Sbjct: 130 LVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186

Query: 157 STRVLG---TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 213
            T  LG      + APE     + T  SDV+S+G+V+ E+++  +     M         
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------- 237

Query: 214 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 273
                 +   V   ++   +   P    + L  +   C Q +   RP    +V  L  ++
Sbjct: 238 ------TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291

Query: 274 KSP 276
           ++P
Sbjct: 292 RNP 294

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  157 bits (399), Expect = 2e-47
 Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 26/255 (10%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
            LK      ++  +  +V+  +KH NLV+LLG C       +  EF T G+L D L    
Sbjct: 49  TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 108

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
                     +  +  + +A   +  +EYL +K   + IHRD+ + N L+ E+   K+AD
Sbjct: 109 R-------QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVAD 158

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           F LS          H         + APE     + + KSDV++FGV+L E+ T      
Sbjct: 159 FGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217

Query: 202 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 261
                          P +   +V + ++   + E P     K+  +   C Q+    RP+
Sbjct: 218 ---------------PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 262

Query: 262 MSIVVKALQPLLKSP 276
            + + +A + + +  
Sbjct: 263 FAEIHQAFETMFQES 277

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (399), Expect = 3e-47
 Identities = 57/268 (21%), Positives = 102/268 (38%), Gaps = 33/268 (12%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
           + ++  +   D ++  ++++   + N+V+LLG C  G    L +E+   G L++ L    
Sbjct: 52  KEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMS 111

Query: 82  G---------------VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRS 126
                              +   P L    ++ IA   A G+ YL E      +HRD+ +
Sbjct: 112 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLAT 168

Query: 127 SNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSF 186
            N L+ E+   KIADF LS                    +  PE     + T +SDV+++
Sbjct: 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228

Query: 187 GVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAA 246
           GVVL E+ +      + M                E+ +    D  +    P     +L  
Sbjct: 229 GVVLWEIFSYGLQPYYGMAH--------------EEVIYYVRDGNIL-ACPENCPLELYN 273

Query: 247 VAALCVQYEAEFRPNMSIVVKALQPLLK 274
           +  LC       RP+   + + LQ + +
Sbjct: 274 LMRLCWSKLPADRPSFCSIHRILQRMCE 301

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 8e-47
 Identities = 52/249 (20%), Positives = 94/249 (37%), Gaps = 27/249 (10%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
            +K      D+  +   V+  L HE LV+L G C +     +  E+   G L + L   +
Sbjct: 35  MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR 94

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
                           + +  D    +EYL  K     +HRD+ + N L+ +    K++D
Sbjct: 95  HR--------FQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSD 143

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           F LS    D      S        +  PE  M  + + KSD+++FGV++ E+ +  K   
Sbjct: 144 FGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 202

Query: 202 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 261
                           R +  +  + +   L+   P     K+  +   C   +A+ RP 
Sbjct: 203 ---------------ERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPT 247

Query: 262 MSIVVKALQ 270
             I++  + 
Sbjct: 248 FKILLSNIL 256

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 9e-47
 Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 31/235 (13%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
            SV+++L+H NLV+LLG  VE    + +  E+   GSL D L  R          VL   
Sbjct: 51  ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGD 103

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
             ++ ++D    +EYL      + +HRD+ + NVL+ ED  AK++DF L+ +A       
Sbjct: 104 CLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156

Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 215
                     + APE     + + KSDV+SFG++L E+ +  +                 
Sbjct: 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-------------- 201

Query: 216 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 270
            PR+    V   V+   K + P      +  V   C   +A  RP+   + + L+
Sbjct: 202 -PRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-46
 Identities = 42/190 (22%), Positives = 78/190 (41%), Gaps = 15/190 (7%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
            L+      +   + + V+       +V   G         +  E    GSL  +L    
Sbjct: 40  HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 99

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
                     +      ++++   +GL YL EK    I+HRD++ SN+L+    + K+ D
Sbjct: 100 R---------IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCD 148

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           F +S Q  D      +   +GT  Y +PE       + +SD++S G+ L+E+  GR P+ 
Sbjct: 149 FGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204

Query: 202 HTMPRGQQSL 211
               +  + +
Sbjct: 205 PPDAKELELM 214

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 9e-46
 Identities = 58/240 (24%), Positives = 104/240 (43%), Gaps = 28/240 (11%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
             ++ +L +  +V L+G C    L +L  E A  G LH  L G++          +    
Sbjct: 60  AQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE--------IPVSN 110

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARL 155
              +    + G++YL EK   + +HRD+ + NVLL     AKI+DF LS     D +   
Sbjct: 111 VAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167

Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 215
             +       ++APE     + + +SDV+S+GV + E L+  +                 
Sbjct: 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK---------------P 212

Query: 216 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 275
             ++   +V   ++   + E PP+   +L A+ + C  Y+ E RP+   V + ++    S
Sbjct: 213 YKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 2e-45
 Identities = 46/241 (19%), Positives = 92/241 (38%), Gaps = 27/241 (11%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
             V++ + + ++  LLG C+   ++++  +    G L D +   K               
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNI--------GSQY 112

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
            +   V  A+G+ YL ++    ++HRD+ + NVL+      KI DF L+          H
Sbjct: 113 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           +        + A E  +    T +SDV+S+GV + EL+T        +P  +        
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------- 221

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 276
                  +   ++   +   PP     +  +   C   +A+ RP    ++     + + P
Sbjct: 222 -------ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274

Query: 277 P 277
            
Sbjct: 275 Q 275

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 4e-45
 Identities = 54/242 (22%), Positives = 91/242 (37%), Gaps = 29/242 (11%)

Query: 37  VSVVSRLKHENLVELLGYCVEG-NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
             ++    H N++ LLG C+      ++   +   G L + +                  
Sbjct: 79  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--------PTVK 130

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--MAA 153
             +   +  A+G+++L        +HRD+ + N +L E F  K+ADF L+    D    +
Sbjct: 131 DLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187

Query: 154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 213
             + T       + A E   T + T KSDV+SFGV+L EL+T   P     P    +   
Sbjct: 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD 242

Query: 214 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 273
                     + Q          P      L  V   C   +AE RP+ S +V  +  + 
Sbjct: 243 IT------VYLLQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292

Query: 274 KS 275
            +
Sbjct: 293 ST 294

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 9e-45
 Identities = 58/258 (22%), Positives = 104/258 (40%), Gaps = 32/258 (12%)

Query: 22  RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 78
            LK+  N P  + +L    +V+ +L +  +V ++G C   +  +L  E A +G L+  L 
Sbjct: 41  ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQ 99

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
             +          +     + +    + G++YL E    + +HRD+ + NVLL     AK
Sbjct: 100 QNRH---------VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAK 147

Query: 139 IADFNLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 197
           I+DF LS     D       T       ++APE     + + KSDV+SFGV++ E  +  
Sbjct: 148 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 207

Query: 198 KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAE 257
           +                    +   +V   ++   +   P     ++  +  LC  Y+ E
Sbjct: 208 QK---------------PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVE 252

Query: 258 FRPNMSIVVKALQPLLKS 275
            RP  + V   L+     
Sbjct: 253 NRPGFAAVELRLRNYYYD 270

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 2e-44
 Identities = 62/260 (23%), Positives = 109/260 (41%), Gaps = 32/260 (12%)

Query: 30  PDDEKQL---VSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ- 84
            DD +     + V+ +L  H N++ LLG C       LA E+A  G+L D L   + ++ 
Sbjct: 51  KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 110

Query: 85  ------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
                        L     +  A D ARG++YL +K     IHRD+ + N+L+ E++ AK
Sbjct: 111 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 167

Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 198
           IADF LS         +  T       + A E       T  SDV+S+GV+L E+++   
Sbjct: 168 IADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224

Query: 199 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEF 258
                M               +  ++ + +    + E P     ++  +   C + +   
Sbjct: 225 TPYCGM---------------TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYE 269

Query: 259 RPNMSIVVKALQPLLKSPPP 278
           RP+ + ++ +L  +L+    
Sbjct: 270 RPSFAQILVSLNRMLEERKT 289

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 1e-43
 Identities = 58/247 (23%), Positives = 94/247 (38%), Gaps = 36/247 (14%)

Query: 24  KSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR 80
           K+       E QL   V + S L+H N++ L GY  +     L  E+A +G+++  L   
Sbjct: 41  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 100

Query: 81  KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 140
                       D         + A  L Y H K    +IHRDI+  N+LL    + KIA
Sbjct: 101 SK---------FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 148

Query: 141 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 200
           DF  S  AP        T + GT  Y  PE        +K D++S GV+  E L G+ P 
Sbjct: 149 DFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 204

Query: 201 DHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP 260
           +    +     ++       +   +   D                 + +  +++    RP
Sbjct: 205 EANTYQETYKRISRVEFTFPDFVTEGARD-----------------LISRLLKHNPSQRP 247

Query: 261 NMSIVVK 267
            +  V++
Sbjct: 248 MLREVLE 254

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 3e-42
 Identities = 59/247 (23%), Positives = 94/247 (38%), Gaps = 27/247 (10%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
            +K   + P++ K+ + +   L HEN+V+  G+  EGN++ L  E+ + G L D +    
Sbjct: 39  DMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI 98

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
           G         +      R       G+ YLH      I HRDI+  N+LL E    KI+D
Sbjct: 99  G---------MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISD 146

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPV 200
           F L+             ++ GT  Y APE     +   +  DV+S G+VL  +L G  P 
Sbjct: 147 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 206

Query: 201 DHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP 260
           D      Q+                   + K       K  +   A+    +      R 
Sbjct: 207 DQPSDSCQE--------------YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI 252

Query: 261 NMSIVVK 267
            +  + K
Sbjct: 253 TIPDIKK 259

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 4e-42
 Identities = 52/245 (21%), Positives = 89/245 (36%), Gaps = 32/245 (13%)

Query: 24  KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 83
              +   +D    + +++   H N+V+LL      N   +  EF   G++  ++   +  
Sbjct: 47  TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP 106

Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
                   L       +       L YLH+     IIHRD+++ N+L   D   K+ADF 
Sbjct: 107 --------LTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFG 155

Query: 144 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-----TQKSDVYSFGVVLLELLTGRK 198
           +S +      R  S   +GT  + APE  M           K+DV+S G+ L+E+     
Sbjct: 156 VSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213

Query: 199 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEF 258
           P     P                 K+ +   P L    P +  +        C++   + 
Sbjct: 214 PHHELNPMRVL------------LKIAKSEPPTL--AQPSRWSSNFKDFLKKCLEKNVDA 259

Query: 259 RPNMS 263
           R   S
Sbjct: 260 RWTTS 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 4e-42
 Identities = 48/254 (18%), Positives = 90/254 (35%), Gaps = 37/254 (14%)

Query: 22  RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVE----GNLRVLAYEFATMGSLH 74
            L+  K    + ++      ++  L+H N+V                VL  E  T G+L 
Sbjct: 41  ELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 100

Query: 75  DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF-E 133
             L   K         V+             +GL++LH +  P IIHRD++  N+ +   
Sbjct: 101 TYLKRFK---------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGP 150

Query: 134 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 193
               KI D  L+           +  V+GT  + APE     +  +  DVY+FG+ +LE+
Sbjct: 151 TGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEM 205

Query: 194 LTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQ 253
            T   P        Q                ++         +    + ++  +   C++
Sbjct: 206 ATSEYPYSECQNAAQI--------------YRRVTSGVKPASFDKVAIPEVKEIIEGCIR 251

Query: 254 YEAEFRPNMSIVVK 267
              + R ++  ++ 
Sbjct: 252 QNKDERYSIKDLLN 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 5e-42
 Identities = 44/235 (18%), Positives = 91/235 (38%), Gaps = 27/235 (11%)

Query: 37  VSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           V+++  LKH N+V      ++       +  E+   G L  ++      +G +    LD 
Sbjct: 54  VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-----KGTKERQYLDE 108

Query: 95  MTRVRIAVDAARGLEYLHEK--VQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
              +R+       L+  H +     +++HRD++ +NV L      K+ DF L+       
Sbjct: 109 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 168

Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 212
           +   +   +GT  Y +PE        +KSD++S G +L EL     P      +      
Sbjct: 169 S--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA--- 223

Query: 213 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 267
                     K+++    ++   Y      +L  +    +  +   RP++  +++
Sbjct: 224 ---------GKIREGKFRRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEILE 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  144 bits (364), Expect = 5e-42
 Identities = 50/251 (19%), Positives = 94/251 (37%), Gaps = 38/251 (15%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V  + +L+H N ++  G  +  +   L  E+    +   +   +K          L  + 
Sbjct: 66  VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---------LQEVE 116

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
              +   A +GL YLH     ++IHRD+++ N+LL E    K+ DF  ++          
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168

Query: 157 STRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 213
               +GT  + APE  +    GQ   K DV+S G+  +EL   + P+ +           
Sbjct: 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---- 223

Query: 214 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 273
                     + Q   P L+  +  +           C+Q   + RP   +++K     +
Sbjct: 224 --------YHIAQNESPALQSGHWSEYFRNF---VDSCLQKIPQDRPTSEVLLK--HRFV 270

Query: 274 KSPPPAAPVSE 284
               P   + +
Sbjct: 271 LRERPPTVIMD 281

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 6e-42
 Identities = 62/245 (25%), Positives = 102/245 (41%), Gaps = 26/245 (10%)

Query: 37  VSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG-------VQGAQP 88
           + ++  + KH+N++ LLG C +     +  E+A+ G+L + L  R+             P
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 89  GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 148
              L     V  A   ARG+EYL  K     IHRD+ + NVL+ ED   KIADF L+   
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

Query: 149 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 208
             +     +T       + APE       T +SDV+SFGV+L E+ T        +P   
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 242

Query: 209 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 268
                        +++ + +    + + P     +L  +   C       RP    +V+ 
Sbjct: 243 ------------VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

Query: 269 LQPLL 273
           L  ++
Sbjct: 291 LDRIV 295

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 8e-41
 Identities = 55/239 (23%), Positives = 98/239 (41%), Gaps = 19/239 (7%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP-GPVLDWM 95
            SV+      ++V LLG   +G   ++  E  T G L   L   +      P        
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
             +++A + A G+ YL+       +HRD+ + N ++ EDF  KI DF ++    +     
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190

Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 215
              + L    + +PE    G  T  SDV+SFGVVL E+ T  +     +           
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL----------- 239

Query: 216 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 274
               S ++V + V      + P      L  +  +C QY  + RP+   ++ +++  ++
Sbjct: 240 ----SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 3e-40
 Identities = 57/263 (21%), Positives = 97/263 (36%), Gaps = 29/263 (11%)

Query: 25  SPKNYPDDEKQLVSVVSRLK----HENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHG 79
                  + + L+S +  L     H N+V LLG C + G   ++  EF   G+L   L  
Sbjct: 52  KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 111

Query: 80  RKG-------VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 132
           ++                 L     +  +   A+G+E+L  +     IHRD+ + N+LL 
Sbjct: 112 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168

Query: 133 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLE 192
           E    KI DF L+         +          + APE       T +SDV+SFGV+L E
Sbjct: 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 228

Query: 193 LLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCV 252
           + +        +   ++                + +    +   P     ++      C 
Sbjct: 229 IFSLGASPYPGVKIDEE--------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCW 274

Query: 253 QYEAEFRPNMSIVVKALQPLLKS 275
             E   RP  S +V+ L  LL++
Sbjct: 275 HGEPSQRPTFSELVEHLGNLLQA 297

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 8e-40
 Identities = 54/253 (21%), Positives = 96/253 (37%), Gaps = 28/253 (11%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
           +  +  +  +   Q    + +  H ++V+L+G   E  + ++  E  T+G L   L  RK
Sbjct: 44  KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII-MELCTLGELRSFLQVRK 102

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 141
                     LD  + +  A   +  L YL  K     +HRDI + NVL+  +   K+ D
Sbjct: 103 YS--------LDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 151

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           F LS    D      +++      + APE     + T  SDV+ FGV + E+L       
Sbjct: 152 FGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210

Query: 202 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 261
             +                  +++      +    PP     L ++   C  Y+   RP 
Sbjct: 211 QGVKNNDVI-----------GRIENGERLPMPPNCPP----TLYSLMTKCWAYDPSRRPR 255

Query: 262 MSIVVKALQPLLK 274
            + +   L  +L+
Sbjct: 256 FTELKAQLSTILE 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 3e-39
 Identities = 58/235 (24%), Positives = 86/235 (36%), Gaps = 27/235 (11%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           V+ +  L H NL+ L G  +   ++ +  E A +GSL D L   +G             T
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLGT 112

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP-DMAARL 155
             R AV  A G+ YL  K     IHRD+ + N+LL      KI DF L    P +    +
Sbjct: 113 LSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 169

Query: 156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 215
                   F + APE   T   +  SD + FGV L E+ T  +     +   Q       
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------ 223

Query: 216 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 270
                   + +      +   P      +  V   C  ++ E RP    +   L 
Sbjct: 224 --------LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 1e-38
 Identities = 56/249 (22%), Positives = 97/249 (38%), Gaps = 33/249 (13%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + V+   K+ N+V  L   + G+   +  E+   GSL D++               D   
Sbjct: 68  ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----------DEGQ 117

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
              +  +  + LE+LH      +IHRDI+S N+LL  D   K+ DF    Q      +  
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSK 172

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
            + ++GT  + APE         K D++S G++ +E++ G  P  +  P           
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------- 225

Query: 217 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ-PLLKS 275
                  +     P+L  + P K  A        C+  + E R +     + LQ   LK 
Sbjct: 226 -----YLIATNGTPEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAK---ELLQHQFLKI 275

Query: 276 PPPAAPVSE 284
             P + ++ 
Sbjct: 276 AKPLSSLTP 284

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 4e-35
 Identities = 42/192 (21%), Positives = 68/192 (35%), Gaps = 12/192 (6%)

Query: 38  SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 97
            V+SRL H   V+L     +         +A  G L   +               D    
Sbjct: 60  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCT 110

Query: 98  VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 157
                +    LEYLH      IIHRD++  N+LL ED   +I DF  +      + +  +
Sbjct: 111 RFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167

Query: 158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 217
              +GT  Y +PE        + SD+++ G ++ +L+ G  P            +     
Sbjct: 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY 227

Query: 218 RLSEDKVKQCVD 229
              E    +  D
Sbjct: 228 DFPEKFFPKARD 239

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  125 bits (315), Expect = 2e-34
 Identities = 46/206 (22%), Positives = 78/206 (37%), Gaps = 19/206 (9%)

Query: 27  KNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 83
             YP D+  +   +S++++L H  L+ L     +    VL  EF + G L D +      
Sbjct: 64  TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK 123

Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL--FEDFKAKIAD 141
                   +     +     A  GL+++HE    SI+H DI+  N++    +    KI D
Sbjct: 124 --------MSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIID 172

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           F L+ +         +T    T  + APE      +   +D+++ GV+   LL+G  P  
Sbjct: 173 FGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 229

Query: 202 HTMPRGQQSLVTWATPRLSEDKVKQC 227
                     V        ED     
Sbjct: 230 GEDDLETLQNVKRCDWEFDEDAFSSV 255

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  122 bits (307), Expect = 2e-33
 Identities = 46/242 (19%), Positives = 84/242 (34%), Gaps = 32/242 (13%)

Query: 27  KNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 83
             +  D++ +   +  +S L+H  LV L     + N  V+ YEF + G L + +      
Sbjct: 61  TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 120

Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF--EDFKAKIAD 141
                   +     V       +GL ++HE    + +H D++  N++       + K+ D
Sbjct: 121 --------MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLID 169

Query: 142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 201
           F L+       +   +T   GT  + APE A    +   +D++S GV+   LL+G  P  
Sbjct: 170 FGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226

Query: 202 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 261
                                 VK C D  +                   +  +   R  
Sbjct: 227 GENDDETL------------RNVKSC-DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 273

Query: 262 MS 263
           + 
Sbjct: 274 IH 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 8e-33
 Identities = 39/210 (18%), Positives = 78/210 (37%), Gaps = 19/210 (9%)

Query: 23  LKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
            K  K    D+  +   +S+++  +H N++ L          V+ +EF +   + + ++ 
Sbjct: 35  AKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN- 93

Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL--FEDFKA 137
                       L+    V         L++LH     +I H DIR  N++         
Sbjct: 94  -------TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTI 143

Query: 138 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 197
           KI +F  + Q        +   +     Y+APE      ++  +D++S G ++  LL+G 
Sbjct: 144 KIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200

Query: 198 KPVDHTMPRGQQSLVTWATPRLSEDKVKQC 227
            P      +     +  A     E+  K+ 
Sbjct: 201 NPFLAETNQQIIENIMNAEYTFDEEAFKEI 230

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 1e-32
 Identities = 39/241 (16%), Positives = 75/241 (31%), Gaps = 19/241 (7%)

Query: 33  EKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL 92
           E  ++  +   +H N+V L   C                 +              P P +
Sbjct: 57  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD---QDLTTYLDKVPEPGV 113

Query: 93  DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
              T   +     RGL++LH      ++HRD++  N+L+    + K+ADF L+       
Sbjct: 114 PTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 170

Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 212
                T V+ T  Y APE  +        D++S G +  E+   +     +    Q   +
Sbjct: 171 ---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227

Query: 213 ----------TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 262
                      W        +       +   ++          +   C+ +    R + 
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287

Query: 263 S 263
            
Sbjct: 288 Y 288

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  120 bits (302), Expect = 2e-32
 Identities = 48/245 (19%), Positives = 92/245 (37%), Gaps = 33/245 (13%)

Query: 33  EKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL 92
           E+ ++S+VS      +V +       +      +    G LH  L               
Sbjct: 54  ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-------- 105

Query: 93  DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
                   A +   GLE++H +    +++RD++ +N+LL E    +I+D  L+       
Sbjct: 106 -EADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160

Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 211
                   +GT GY APE    G      +D +S G +L +LL G  P      + +  +
Sbjct: 161 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 217

Query: 212 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 271
                     D++   +  +L   + P    +L ++    +Q +   R     + +  Q 
Sbjct: 218 ----------DRMTLTMAVELPDSFSP----ELRSLLEGLLQRDVNRRL--GCLGRGAQE 261

Query: 272 LLKSP 276
           + +SP
Sbjct: 262 VKESP 266

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  116 bits (292), Expect = 9e-32
 Identities = 44/234 (18%), Positives = 80/234 (34%), Gaps = 35/234 (14%)

Query: 37  VSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 95
           V ++ ++  H N+++L           L ++    G L D L  +           L   
Sbjct: 60  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEK 110

Query: 96  TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 155
              +I       +  LH+    +I+HRD++  N+LL +D   K+ DF  S Q        
Sbjct: 111 ETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--- 164

Query: 156 HSTRVLGTFGYHAPEYAMTGQL------TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 209
               V GT  Y APE              ++ D++S GV++  LL G  P  H       
Sbjct: 165 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 224

Query: 210 SLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 263
            ++     +    +     D              +  + +  +  + + R    
Sbjct: 225 RMIMSGNYQFGSPEWDDYSDT-------------VKDLVSRFLVVQPQKRYTAE 265

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 1e-31
 Identities = 44/210 (20%), Positives = 74/210 (35%), Gaps = 14/210 (6%)

Query: 20  NERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
            + +    +      +   +    +H  L  +              E+   G L   +  
Sbjct: 37  KDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS 96

Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
                        D       A +   GL++LH K    I++RD++  N+LL +D   KI
Sbjct: 97  CHK---------FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKI 144

Query: 140 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           ADF +  +     A+  +    GT  Y APE  +  +     D +SFGV+L E+L G+ P
Sbjct: 145 ADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202

Query: 200 VDHTMPRGQQSLVTWATPRLSEDKVKQCVD 229
                       +    P       K+  D
Sbjct: 203 FHGQDEEELFHSIRMDNPFYPRWLEKEAKD 232

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  116 bits (291), Expect = 2e-31
 Identities = 43/262 (16%), Positives = 83/262 (31%), Gaps = 30/262 (11%)

Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC-VEGNLRVLAYEFATMGSLHDILHGRK 81
           L+  K           +   ++    +  + +C  EG+  V+  E              +
Sbjct: 39  LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR 98

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAK 138
                         T + +A      +EY+H K   + IHRD++  N L+          
Sbjct: 99  K---------FSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVY 146

Query: 139 IADFNLSNQAPD-----MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 193
           I DF L+ +  D           +  + GT  Y +    +  + +++ D+ S G VL+  
Sbjct: 147 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 206

Query: 194 LTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQ 253
             G  P        ++            +K        L   YP     + A     C  
Sbjct: 207 NLGSLPWQGLKAATKRQKY-----ERISEKKMSTPIEVLCKGYPS----EFATYLNFCRS 257

Query: 254 YEAEFRPNMSIVVKALQPLLKS 275
              + +P+ S + +  + L   
Sbjct: 258 LRFDDKPDYSYLRQLFRNLFHR 279

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  115 bits (289), Expect = 2e-31
 Identities = 53/240 (22%), Positives = 86/240 (35%), Gaps = 31/240 (12%)

Query: 37  VSVVSRLKHENLVELLGYCVE----GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL 92
               + L H  +V +          G L  +  E+    +L DI+H             +
Sbjct: 58  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------M 108

Query: 93  DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 152
                + +  DA + L + H+     IIHRD++ +N+++      K+ DF ++    D  
Sbjct: 109 TPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165

Query: 153 ARLHST-RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 211
             +  T  V+GT  Y +PE A    +  +SDVYS G VL E+LTG  P     P      
Sbjct: 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 225

Query: 212 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-NMSIVVKALQ 270
                P     + +                  L AV    +    E R    + +   L 
Sbjct: 226 HVREDPIPPSARHEGLSAD-------------LDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  114 bits (285), Expect = 2e-30
 Identities = 44/193 (22%), Positives = 76/193 (39%), Gaps = 17/193 (8%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
             ++S + H  ++ + G   +     +  ++   G L  +L   +               
Sbjct: 55  RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---------PNPV 105

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
               A +    LEYLH K    II+RD++  N+LL ++   KI DF  +   PD+     
Sbjct: 106 AKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----- 157

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           +  + GT  Y APE   T    +  D +SFG+++ E+L G  P   +        +  A 
Sbjct: 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE 217

Query: 217 PRLSEDKVKQCVD 229
            R      +   D
Sbjct: 218 LRFPPFFNEDVKD 230

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  112 bits (282), Expect = 5e-30
 Identities = 50/245 (20%), Positives = 84/245 (34%), Gaps = 34/245 (13%)

Query: 25  SPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 81
           + K     E  +   ++V+ ++KH N+V L      G    L  +  + G L D +  + 
Sbjct: 43  AKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 102

Query: 82  GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAK 138
                            R+       ++YLH+     I+HRD++  N+L +   ED K  
Sbjct: 103 ---------FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIM 150

Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 198
           I+DF LS      +     +   GT GY APE       ++  D +S GV+   LL G  
Sbjct: 151 ISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207

Query: 199 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEF 258
           P            +  A             + +    Y               ++ + E 
Sbjct: 208 PFYDENDAKLFEQILKA-------------EYEFDSPYWDDISDSAKDFIRHLMEKDPEK 254

Query: 259 RPNMS 263
           R    
Sbjct: 255 RFTCE 259

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  111 bits (278), Expect = 1e-29
 Identities = 35/259 (13%), Positives = 75/259 (28%), Gaps = 30/259 (11%)

Query: 27  KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA 86
           ++     +        L     +  + Y  +  L  +        SL D+L         
Sbjct: 41  RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD-------- 92

Query: 87  QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK-----AKIAD 141
             G      T    A      ++ +HEK   S+++RDI+  N L+            + D
Sbjct: 93  LCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVD 149

Query: 142 FNLSNQAPDMAARLH-----STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 196
           F +     D   + H        + GT  Y +    +  + +++ D+ + G V +  L G
Sbjct: 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 209

Query: 197 RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEA 256
             P         +            +++ +        E       +             
Sbjct: 210 SLPWQGLKAATNKQKY---------ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAF 260

Query: 257 EFRPNMSIVVKALQPLLKS 275
           +  P+   +      +L+ 
Sbjct: 261 DATPDYDYLQGLFSKVLER 279

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 4e-28
 Identities = 48/262 (18%), Positives = 94/262 (35%), Gaps = 33/262 (12%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATM----GSLHDIL 77
                + Y     + + ++ R +HEN++ +        +  +   +         L+ +L
Sbjct: 42  SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL 101

Query: 78  HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 137
             +           L             RGL+Y+H     +++HRD++ SN+LL      
Sbjct: 102 KTQH----------LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDL 148

Query: 138 KIADFNLSNQA-PDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLT 195
           KI DF L+  A PD       T  + T  Y APE  +  +  T+  D++S G +L E+L+
Sbjct: 149 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 208

Query: 196 GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG--------------EYPPKGV 241
            R          Q + +       S++ +   ++ K +                  P   
Sbjct: 209 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD 268

Query: 242 AKLAAVAALCVQYEAEFRPNMS 263
           +K   +    + +    R  + 
Sbjct: 269 SKALDLLDKMLTFNPHKRIEVE 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 8e-28
 Identities = 52/261 (19%), Positives = 91/261 (34%), Gaps = 30/261 (11%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           + ++  L H N++ LL      +   L ++F        I               L    
Sbjct: 51  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---------LTPSH 101

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
                +   +GLEYLH+     I+HRD++ +N+LL E+   K+ADF L+           
Sbjct: 102 IKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRA 156

Query: 157 STRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 215
            T  + T  Y APE     ++     D+++ G +L ELL     +       Q + +   
Sbjct: 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 216

Query: 216 TPRLSED------KVKQCVDPKLKGEYPPKGVAKLAAVAAL-----CVQYEAEFRPNMSI 264
               +E+       +   V  K     P   +   A    L        +    R   + 
Sbjct: 217 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT- 275

Query: 265 VVKALQ-PLLKSPPPAAPVSE 284
             +AL+     + P   P  +
Sbjct: 276 --QALKMKYFSNRPGPTPGCQ 294

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 2e-27
 Identities = 40/222 (18%), Positives = 75/222 (33%), Gaps = 18/222 (8%)

Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR------VLAYEFATMGSLHDI 76
           +K        + + + ++ +L H N+V L  +      +       L  ++         
Sbjct: 50  IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109

Query: 77  LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-F 135
            H  +  Q       L  +          R L Y+H      I HRDI+  N+LL  D  
Sbjct: 110 RHYSRAKQT------LPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 160

Query: 136 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 195
             K+ DF  + Q        + + +   +             T   DV+S G VL ELL 
Sbjct: 161 VLKLCDFGSAKQLVR--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 218

Query: 196 GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP 237
           G+          Q   +       + +++++      + ++P
Sbjct: 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 260

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 3e-27
 Identities = 46/231 (19%), Positives = 83/231 (35%), Gaps = 32/231 (13%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
           VS++  ++H N++ L          +L  E    G L D L  ++          L    
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------LTEEE 114

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED----FKAKIADFNLSNQAPDMA 152
                     G+ YLH      I H D++  N++L +      + KI DF L+++     
Sbjct: 115 ATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171

Query: 153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 212
                  + GT  + APE      L  ++D++S GV+   LL+G  P      +   + V
Sbjct: 172 ---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 228

Query: 213 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 263
           +              V+ + + EY     A         +  + + R  + 
Sbjct: 229 SA-------------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 266

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  101 bits (253), Expect = 5e-26
 Identities = 38/252 (15%), Positives = 83/252 (32%), Gaps = 25/252 (9%)

Query: 24  KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 83
           K  +  P    + +S++  LKH N+V+L          VL +E         +     G 
Sbjct: 38  KEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG- 96

Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
                   L+ +T     +    G+ Y H++    ++HRD++  N+L+  + + KIADF 
Sbjct: 97  --------LESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFG 145

Query: 144 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT 203
           L+        +     ++  +         + + +   D++S G +  E++ G       
Sbjct: 146 LARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204

Query: 204 MPRGQQSLVTWATPRLSE------------DKVKQCVDPKLKGEYPPKGVAKLAAVAALC 251
               Q   +       +             D      +P     +          + +  
Sbjct: 205 SEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKM 264

Query: 252 VQYEAEFRPNMS 263
           ++ +   R    
Sbjct: 265 LKLDPNQRITAK 276

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 7e-26
 Identities = 47/271 (17%), Positives = 87/271 (32%), Gaps = 28/271 (10%)

Query: 24  KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 83
              +  P    + +S++  L H N+V+LL      N   L +EF        +       
Sbjct: 39  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 98

Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
                   +             +GL + H      ++HRD++  N+L+  +   K+ADF 
Sbjct: 99  --------IPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFG 147

Query: 144 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT 203
           L+ +A  +  R ++  V+  +             +   D++S G +  E++T R      
Sbjct: 148 LA-RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

Query: 204 MPRGQQSLVTWATPRLSEDKVKQCVD--------PKLKGEYPPKGVAKLAAVA----ALC 251
               Q   +        E                PK   +   K V  L        +  
Sbjct: 207 SEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 266

Query: 252 VQYEAEFRPNMSIVVKALQ-PLLKSPPPAAP 281
           + Y+   R +      AL  P  +      P
Sbjct: 267 LHYDPNKRISAK---AALAHPFFQDVTKPVP 294

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 9e-26
 Identities = 42/203 (20%), Positives = 65/203 (32%), Gaps = 14/203 (6%)

Query: 27  KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA 86
           K+          V+   +H  L  L       +      E+A  G L   L         
Sbjct: 46  KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE------ 99

Query: 87  QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 146
                    T  R     A  +  L       +++RDI+  N++L +D   KI DF L  
Sbjct: 100 ------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

Query: 147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPR 206
           +     A +      GT  Y APE        +  D +  GVV+ E++ GR P  +    
Sbjct: 154 EGISDGATMK--TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

Query: 207 GQQSLVTWATPRLSEDKVKQCVD 229
               L+     R       +   
Sbjct: 212 RLFELILMEEIRFPRTLSPEAKS 234

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 1e-25
 Identities = 37/203 (18%), Positives = 72/203 (35%), Gaps = 24/203 (11%)

Query: 37  VSVVSRLK--HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 94
           V ++ ++      ++ LL +    +  VL  E              +G         L  
Sbjct: 58  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--------LQE 109

Query: 95  MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLSNQAPDMAA 153
                        + + H      ++HRDI+  N+L+     + K+ DF       D   
Sbjct: 110 ELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 164

Query: 154 RLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHT--MPRGQQS 210
               T   GT  Y  PE+    +   + + V+S G++L +++ G  P +H   + RGQ  
Sbjct: 165 --VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 222

Query: 211 LVTWATPRLSEDKVKQC--VDPK 231
                +    +  ++ C  + P 
Sbjct: 223 FRQRVSSEC-QHLIRWCLALRPS 244

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 4e-25
 Identities = 39/267 (14%), Positives = 85/267 (31%), Gaps = 29/267 (10%)

Query: 23  LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC----VEGNLRVLAYEFATMGSLHDILH 78
           LK  ++ P   +++       +  ++V ++             ++  E    G L   + 
Sbjct: 42  LKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 101

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
            R                   I       ++YLH     +I HRD++  N+L        
Sbjct: 102 DRGD-------QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNA 151

Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 198
           I        A +  +    T    T  Y APE     +  +  D++S GV++  LL G  
Sbjct: 152 ILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211

Query: 199 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEF 258
           P            +        + +++     +       +   ++  +    ++ E   
Sbjct: 212 PFYSNHGLAISPGM--------KTRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 262

Query: 259 RPNMSIVVKALQ-PLLK--SPPPAAPV 282
           R  ++   + +  P +   +  P  P+
Sbjct: 263 RMTIT---EFMNHPWIMQSTKVPQTPL 286

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.5 bits (239), Expect = 7e-24
 Identities = 48/277 (17%), Positives = 93/277 (33%), Gaps = 26/277 (9%)

Query: 24  KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 83
              + +P    + + ++  LKHEN+V L+  C          + +         H   G+
Sbjct: 47  NEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL 106

Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
                          R+      GL Y+H      I+HRD++++NVL+  D   K+ADF 
Sbjct: 107 LSNVLVK-FTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG 162

Query: 144 LSNQ--APDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPV 200
           L+        +     T  + T  Y  PE  +  +      D++  G ++ E+ T    +
Sbjct: 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222

Query: 201 DHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAAL---------- 250
                + Q +L++     ++ +      + +L  +       K      L          
Sbjct: 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 282

Query: 251 -----CVQYEAEFRPNMSIVVKALQ-PLLKSPPPAAP 281
                 +  +   R +      AL      S P  + 
Sbjct: 283 DLIDKLLVLDPAQRIDSD---DALNHDFFWSDPMPSD 316

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.9 bits (235), Expect = 3e-23
 Identities = 43/215 (20%), Positives = 81/215 (37%), Gaps = 15/215 (6%)

Query: 22  RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 78
           +L  P       K+    + ++  ++HEN++ LL             +F  +        
Sbjct: 50  KLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDL 109

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
           G+           L       +     +GL Y+H      IIHRD++  N+ + ED + K
Sbjct: 110 GKLMKHEK-----LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELK 161

Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 198
           I DF L+ QA        +  V+  +           + TQ  D++S G ++ E++TG+ 
Sbjct: 162 ILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217

Query: 199 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK 233
               +    Q   +   T     + V++    + K
Sbjct: 218 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.7 bits (229), Expect = 1e-22
 Identities = 32/176 (18%), Positives = 66/176 (37%), Gaps = 13/176 (7%)

Query: 24  KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 83
              +  P    + + ++  LKH+N+V L           L +EF               +
Sbjct: 39  DDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL 98

Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 143
                                 +GL + H +   +++HRD++  N+L+  + + K+A+F 
Sbjct: 99  D---------PEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFG 146

Query: 144 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 199
           L+ +A  +  R +S  V+  +             +   D++S G +  EL    +P
Sbjct: 147 LA-RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 93.3 bits (231), Expect = 2e-22
 Identities = 32/193 (16%), Positives = 63/193 (32%), Gaps = 17/193 (8%)

Query: 37  VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 96
             ++  +    LV+L     + +   +  E+   G +   L                   
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---------FSEPH 142

Query: 97  RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 156
               A       EYLH      +I+RD++  N+L+ +    ++ DF  + +         
Sbjct: 143 ARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----R 194

Query: 157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 216
           +  + GT    APE  ++    +  D ++ GV++ E+  G  P     P      +    
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254

Query: 217 PRLSEDKVKQCVD 229
            R          D
Sbjct: 255 VRFPSHFSSDLKD 267

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.8 bits (214), Expect = 2e-20
 Identities = 46/216 (21%), Positives = 76/216 (35%), Gaps = 17/216 (7%)

Query: 21  ERLKSPKNYPDDEKQLVSVVSRLKHE-NLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 79
             +       +  +    V+  ++    LV L           L  ++   G L   L  
Sbjct: 63  ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ 122

Query: 80  RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 139
           R+                     +    LE+LH+     II+RDI+  N+LL  +    +
Sbjct: 123 RER---------FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL 170

Query: 140 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LTQKSDVYSFGVVLLELLTGR 197
            DF LS +         +    GT  Y AP+    G     +  D +S GV++ ELLTG 
Sbjct: 171 TDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

Query: 198 KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK 233
            P      +  Q+ ++    + SE    Q +    K
Sbjct: 230 SPFTVDGEKNSQAEISRRILK-SEPPYPQEMSALAK 264

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 81.2 bits (199), Expect = 3e-18
 Identities = 31/188 (16%), Positives = 70/188 (37%), Gaps = 10/188 (5%)

Query: 22  RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI----- 76
            ++  K Y +  +  + ++ R+   +  +         L++L +      +   +     
Sbjct: 45  IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE 104

Query: 77  --LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FE 133
                   +        +  +   +I+     GL+Y+H +    IIH DI+  NVL+   
Sbjct: 105 VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIV 162

Query: 134 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 193
           D    +    +++         H T  + T  Y +PE  +       +D++S   ++ EL
Sbjct: 163 DSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFEL 222

Query: 194 LTGRKPVD 201
           +TG    +
Sbjct: 223 ITGDFLFE 230

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.7 bits (198), Expect = 4e-18
 Identities = 46/215 (21%), Positives = 76/215 (35%), Gaps = 15/215 (6%)

Query: 22  RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 78
           +L  P       K+    + ++  +KHEN++ LL             +   +  L     
Sbjct: 50  KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 109

Query: 79  GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 138
                        L       +     RGL+Y+H      IIHRD++ SN+ + ED + K
Sbjct: 110 NNIVKCQK-----LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 161

Query: 139 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 198
           I DF L+    D      +  V   +              Q  D++S G ++ ELLTGR 
Sbjct: 162 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

Query: 199 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK 233
               T    Q  L+         + +K+      +
Sbjct: 218 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 77.6 bits (190), Expect = 5e-17
 Identities = 31/188 (16%), Positives = 65/188 (34%), Gaps = 26/188 (13%)

Query: 30  PDDEKQLVSVVSRLK----HENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRKGV 83
           P  +K++   +  L+      N++ L     +       L +E         +       
Sbjct: 70  PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---- 125

Query: 84  QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADF 142
                   L          +  + L+Y H      I+HRD++  NV++  E  K ++ D+
Sbjct: 126 --------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDW 174

Query: 143 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 201
            L+               + +  +  PE  +  Q+     D++S G +L  ++  ++P  
Sbjct: 175 GLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231

Query: 202 HTMPRGQQ 209
           H      Q
Sbjct: 232 HGHDNYDQ 239

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.8 bits (185), Expect = 3e-16
 Identities = 40/200 (20%), Positives = 70/200 (35%), Gaps = 27/200 (13%)

Query: 22  RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCV------EGNLRVLAYEFATMGS 72
           +L  P       K+    + ++  + H+N++ LL          E     L  E      
Sbjct: 49  KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL 108

Query: 73  LHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 132
              I                D      +      G+++LH      IIHRD++ SN+++ 
Sbjct: 109 CQVIQMEL------------DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVK 153

Query: 133 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLE 192
            D   KI DF L+            T  + T  Y APE  +     +  D++S G ++ E
Sbjct: 154 SDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210

Query: 193 LLTGRKPVDHTMPRGQQSLV 212
           ++  +          Q + V
Sbjct: 211 MVRHKILFPGRDYIDQWNKV 230

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 48.2 bits (114), Expect = 2e-07
 Identities = 18/126 (14%), Positives = 31/126 (24%), Gaps = 21/126 (16%)

Query: 34  KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 93
             L    +R +   L +L G  V                    L+               
Sbjct: 54  SVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------------R 101

Query: 94  WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS-----NQA 148
                 +       +   +      I+H D+   NVL+  +    I DF  S        
Sbjct: 102 VENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGW 157

Query: 149 PDMAAR 154
            ++  R
Sbjct: 158 REILER 163

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	285
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.7
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.86
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.56
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.14
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.0
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	93.95
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	87.23

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=346.14  Aligned_cols=244  Identities=25%  Similarity=0.275  Sum_probs=196.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.++.+++.||+|...... .....+.+.+|++++++++||||+++++++.+++..++||||+.+|+|.+++....
T Consensus        20 ~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~   98 (271)
T d1nvra_          20 EVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI   98 (271)
T ss_dssp             EEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT
T ss_pred             EEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCC
Confidence            58999999999999999875432 33456789999999999999999999999999999999999999999999997554


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                               .+++..+..++.|++.||.|||++   |++||||||+|||++.++.+||+|||++................
T Consensus        99 ---------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~  166 (271)
T d1nvra_          99 ---------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC  166 (271)
T ss_dssp             ---------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCC
T ss_pred             ---------CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccccee
Confidence                     289999999999999999999999   99999999999999999999999999997664433333344567


Q ss_pred             cccCcCCCcccccCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      ||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...........              ..............+
T Consensus       167 GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~--------------~~~~~~~~~~~~~~~  232 (271)
T d1nvra_         167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--------------DWKEKKTYLNPWKKI  232 (271)
T ss_dssp             SCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH--------------HHHTTCTTSTTGGGS
T ss_pred             eCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH--------------HHhcCCCCCCccccC
Confidence            9999999999988776 5789999999999999999999976543222111              111111111223456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ++++.++|.+||+.||++|||++++++  ..+++
T Consensus       233 s~~~~~li~~~L~~dP~~R~t~~eil~--hpwf~  264 (271)
T d1nvra_         233 DSAPLALLHKILVENPSARITIPDIKK--DRWYN  264 (271)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTT
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhC
Confidence            788999999999999999999999987  44443

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-52  Score=342.07  Aligned_cols=233  Identities=24%  Similarity=0.329  Sum_probs=198.6

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.++.+++.|++|...+.. ......+.+.+|++++++++||||+++++++.+++..++||||+++|+|.+++...
T Consensus        21 ~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~  100 (263)
T d2j4za1          21 NVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL  100 (263)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred             EEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhc
Confidence            58999999999999999765433 33456788899999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.|++.||.|||++   |++||||||+|||++.++.++|+|||++.......    ....
T Consensus       101 ~~---------l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~  164 (263)
T d2j4za1         101 SK---------FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTL  164 (263)
T ss_dssp             SS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEET
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc----cccc
Confidence            42         89999999999999999999999   99999999999999999999999999997654322    2345


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......               .+....  ...+..+
T Consensus       165 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~---------------~i~~~~--~~~p~~~  227 (263)
T d2j4za1         165 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK---------------RISRVE--FTFPDFV  227 (263)
T ss_dssp             TEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---------------HHHTTC--CCCCTTS
T ss_pred             CCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH---------------HHHcCC--CCCCccC
Confidence            68999999999999999999999999999999999999997654322211               111111  1345567


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ++++.++|.+||+.||++|||++++++
T Consensus       228 s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         228 TEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            888999999999999999999999987

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=343.93  Aligned_cols=240  Identities=22%  Similarity=0.308  Sum_probs=199.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.+..+++.||+|......  ....+.+.+|++++++++||||+++++++.+++..++||||+.+|+|.+++..+.
T Consensus        35 ~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~  112 (293)
T d1yhwa1          35 TVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC  112 (293)
T ss_dssp             EEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC
T ss_pred             EEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhccC
Confidence            69999999999999999876443  2346789999999999999999999999999999999999999999999987653


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                                +++..+..++.|++.||.|||++   |++||||||+|||++.++.++|+|||++........  ......
T Consensus       113 ----------l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~  177 (293)
T d1yhwa1         113 ----------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMV  177 (293)
T ss_dssp             ----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCC
T ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccc
Confidence                      89999999999999999999999   999999999999999999999999999976543222  234456


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      ||+.|+|||++.+..++.++||||+||++|+|++|+.||.+............              ........+..++
T Consensus       178 gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~--------------~~~~~~~~~~~~s  243 (293)
T d1yhwa1         178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT--------------NGTPELQNPEKLS  243 (293)
T ss_dssp             SCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------------HCSCCCSSGGGSC
T ss_pred             cCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh--------------CCCCCCCCcccCC
Confidence            99999999999999999999999999999999999999976543221111100              0111123345678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      +.+.++|.+||+.||.+|||+.++++  ..+++
T Consensus       244 ~~~~~li~~~L~~dP~~R~s~~eil~--Hp~~~  274 (293)
T d1yhwa1         244 AIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLK  274 (293)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHTT--CGGGG
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhc--CHhhC
Confidence            88999999999999999999999987  44443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=341.54  Aligned_cols=250  Identities=25%  Similarity=0.380  Sum_probs=194.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|..   +..+++|..+.........+.+.+|++++++++||||+++++++.+ +..++||||+++|+|.+++....
T Consensus        23 ~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~   98 (276)
T d1uwha_          23 TVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIE   98 (276)
T ss_dssp             EEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSC
T ss_pred             EEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhcc
Confidence            5788743   3458999887666666677899999999999999999999998754 56799999999999999997553


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.||.|||++   |++||||||+|||++.++.+||+|||++................
T Consensus        99 ~--------~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~  167 (276)
T d1uwha_          99 T--------KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS  167 (276)
T ss_dssp             C--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CC
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccc
Confidence            2        289999999999999999999999   99999999999999999999999999997665433332334457


Q ss_pred             cccCcCCCcccccC---CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          162 GTFGYHAPEYAMTG---QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       162 ~~~~~~aPE~~~~~---~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ||+.|+|||++.+.   .++.++|||||||++|||++|+.||.+..............          ...+. ....+.
T Consensus       168 gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~----------~~~p~-~~~~~~  236 (276)
T d1uwha_         168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG----------YLSPD-LSKVRS  236 (276)
T ss_dssp             CCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT----------SCCCC-GGGSCT
T ss_pred             cCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC----------CCCCc-chhccc
Confidence            89999999998643   57899999999999999999999998654322211111000          00111 112345


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                      .+++++.+++.+||+.||.+|||++++++.|+.+.+..|
T Consensus       237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         237 NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            667889999999999999999999999999998876543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-52  Score=346.64  Aligned_cols=235  Identities=21%  Similarity=0.275  Sum_probs=194.5

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.++.+++.||+|...+.. ......+.+.+|++++++++||||+++++++.+.+..++||||+.+|+|.+++...
T Consensus        23 ~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~  102 (288)
T d1uu3a_          23 TVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI  102 (288)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhcc
Confidence            69999999999999999765433 23445688999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++...............
T Consensus       103 ~~---------l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~  170 (288)
T d1uu3a_         103 GS---------FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF  170 (288)
T ss_dssp             SS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----------C
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcccccccc
Confidence            43         89999999999999999999999   9999999999999999999999999999766543333333445


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.....               ..+....  ..++..+
T Consensus       171 ~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---------------~~i~~~~--~~~p~~~  233 (288)
T d1uu3a_         171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF---------------QKIIKLE--YDFPEKF  233 (288)
T ss_dssp             CCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---------------HHHHTTC--CCCCTTC
T ss_pred             cCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH---------------HHHHcCC--CCCCccC
Confidence            7999999999999999999999999999999999999999765432211               1111111  1345567


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIV  265 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~l  265 (285)
                      ++++.++|.+||+.||.+|||++++
T Consensus       234 s~~~~~li~~~L~~dP~~R~t~~e~  258 (288)
T d1uu3a_         234 FPKARDLVEKLLVLDATKRLGCEEM  258 (288)
T ss_dssp             CHHHHHHHHTTSCSSGGGSTTSGGG
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHH
Confidence            7889999999999999999999985

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.9e-51  Score=340.60  Aligned_cols=245  Identities=23%  Similarity=0.310  Sum_probs=205.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|....++..||+|..+.   .....+++.+|++++++++||||+++++++.+++..+++|||+.+|+|.+++....
T Consensus        32 ~Vy~a~~~~~~~~vAvK~i~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~  108 (287)
T d1opja_          32 EVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN  108 (287)
T ss_dssp             SEEEEEEGGGTEEEEEEECCT---TCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSC
T ss_pred             EEEEEEECCCCeEEEEEEECC---ccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhcc
Confidence            699999998899999997653   23446789999999999999999999999999999999999999999999997643


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.|++.||.|||++   |++||||||+|||++.++.+||+|||++......... ......
T Consensus       109 ~~-------~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~-~~~~~~  177 (287)
T d1opja_         109 RQ-------EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAK  177 (287)
T ss_dssp             TT-------TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-EETTEE
T ss_pred             cc-------chHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce-eecccc
Confidence            32       289999999999999999999999   9999999999999999999999999999866433221 123345


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      |++.|+|||.+.+..++.++|||||||++|+|++|..||.....               ...+...+........+..++
T Consensus       178 g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~---------------~~~~~~~i~~~~~~~~~~~~~  242 (287)
T d1opja_         178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---------------LSQVYELLEKDYRMERPEGCP  242 (287)
T ss_dssp             ECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC---------------HHHHHHHHHTTCCCCCCTTCC
T ss_pred             ccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch---------------HHHHHHHHhcCCCCCCCccch
Confidence            78899999999999999999999999999999997776643321               122223333344455667788


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      +++.+++.+||+.||++|||++++++.|+.+.+.
T Consensus       243 ~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         243 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            8999999999999999999999999999988764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=336.19  Aligned_cols=235  Identities=20%  Similarity=0.293  Sum_probs=190.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe----CCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE----GNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l   77 (285)
                      +||+|.+..++..+++|............+.+.+|++++++++||||+++++++.+    ...+++||||+++|+|.+++
T Consensus        24 ~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l  103 (270)
T d1t4ha_          24 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL  103 (270)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHH
T ss_pred             EEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHH
Confidence            69999999889999999877666555557789999999999999999999999875    34679999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCCeEEc-cCCeeEEeccccCCCCCccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNVLLF-EDFKAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~--~~h~di~~~nil~~-~~~~~~l~df~~~~~~~~~~~~  154 (285)
                      .....         +++..+..++.|++.||.|||++   +  ++||||||+|||++ .++.+||+|||++.......  
T Consensus       104 ~~~~~---------~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~--  169 (270)
T d1t4ha_         104 KRFKV---------MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--  169 (270)
T ss_dssp             HHHSS---------CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS--
T ss_pred             hcccc---------ccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc--
Confidence            76542         89999999999999999999999   8  99999999999996 57899999999997543221  


Q ss_pred             ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          155 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                        .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..........              ..+.......
T Consensus       170 --~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~--------------~~i~~~~~~~  232 (270)
T d1t4ha_         170 --AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--------------RRVTSGVKPA  232 (270)
T ss_dssp             --BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH--------------HHHTTTCCCG
T ss_pred             --cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH--------------HHHHcCCCCc
Confidence              234579999999998865 59999999999999999999999997543221110              0111110111


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+...++++.++|.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            123345667999999999999999999999987

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.9e-51  Score=341.85  Aligned_cols=247  Identities=21%  Similarity=0.323  Sum_probs=189.2

Q ss_pred             Cceeeeeeeeccc---cChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEES---YPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~---~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||+|....+++.   +++|..... ......+++.+|+++|++++||||++++|++.+++..++||||+++|+|.+++.
T Consensus        41 ~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~  119 (299)
T d1jpaa_          41 EVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR  119 (299)
T ss_dssp             EEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHH
T ss_pred             EEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeec
Confidence            5899977655443   455544321 223345678999999999999999999999999999999999999999999887


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc--
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH--  156 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~--  156 (285)
                      ....        .+++..++.++.|++.||.|||++   |++||||||+|||++.++.+||+|||+++..........  
T Consensus       120 ~~~~--------~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~  188 (299)
T d1jpaa_         120 QNDG--------QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT  188 (299)
T ss_dssp             TTTT--------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------------
T ss_pred             cccC--------CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCCcceee
Confidence            6543        289999999999999999999999   999999999999999999999999999976543322211  


Q ss_pred             -ccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          157 -STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       157 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                       .....|++.|+|||.+.+..++.++|||||||++|||++ |..||......                .+...+....+.
T Consensus       189 ~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~----------------~~~~~i~~~~~~  252 (299)
T d1jpaa_         189 SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ----------------DVINAIEQDYRL  252 (299)
T ss_dssp             -------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHHHHHHTTCCC
T ss_pred             ecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHcCCCC
Confidence             122357889999999999999999999999999999998 89999754322                122222233334


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      ..+..+++.+.+++.+||+.||.+|||+.++++.|+++++.+
T Consensus       253 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         253 PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence            556678889999999999999999999999999999998753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-51  Score=339.57  Aligned_cols=242  Identities=20%  Similarity=0.275  Sum_probs=197.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.+..++..+|+|.....  .....+.+.+|++++++++||||+++++++.+.+..++||||+.+|+|.+++....
T Consensus        27 ~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~  104 (288)
T d2jfla1          27 KVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE  104 (288)
T ss_dssp             EEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT
T ss_pred             EEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcC
Confidence            5899999999999999987543  34456789999999999999999999999999999999999999999999976532


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..+..++.|++.||.|||++   |++||||||+|||++.++.+||+|||++........  ......
T Consensus       105 ~--------~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--~~~~~~  171 (288)
T d2jfla1         105 R--------PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFI  171 (288)
T ss_dssp             S--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--HHTCCC
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc--cccccc
Confidence            2        289999999999999999999999   999999999999999999999999999865443221  123457


Q ss_pred             cccCcCCCcccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          162 GTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       162 ~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ||+.|+|||++.     +..++.++|||||||++|+|++|+.||.+..+......+...              .......
T Consensus       172 Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~--------------~~~~~~~  237 (288)
T d2jfla1         172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS--------------EPPTLAQ  237 (288)
T ss_dssp             SCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS--------------CCCCCSS
T ss_pred             cccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--------------CCCCCCc
Confidence            899999999874     446789999999999999999999999765443221111100              0011233


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      +..+++++.++|.+||+.||++|||++++++  ..+++
T Consensus       238 ~~~~s~~~~~li~~~L~~dp~~R~t~~ell~--hp~~~  273 (288)
T d2jfla1         238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ--HPFVT  273 (288)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--SGGGC
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccC
Confidence            4567889999999999999999999999987  34443

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=341.72  Aligned_cols=243  Identities=18%  Similarity=0.216  Sum_probs=185.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe--CCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||+|.++.+++.|++|........+...+.+.+|++++++++||||+++++++.+  ++.+++||||+.+|+|.+++..
T Consensus        19 ~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~   98 (269)
T d2java1          19 RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK   98 (269)
T ss_dssp             EEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHh
Confidence            58999999999999999876655444456778999999999999999999999864  4567999999999999999864


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV--QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      ....     ...+++..++.++.|++.||.|||+.+  ..+++||||||+|||++.++.++|+|||++........  ..
T Consensus        99 ~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~  171 (269)
T d2java1          99 GTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FA  171 (269)
T ss_dssp             HHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---------
T ss_pred             cccc-----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC--cc
Confidence            3210     012899999999999999999999971  11399999999999999999999999999976543222  12


Q ss_pred             cccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          158 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......               .+.+ ......+
T Consensus       172 ~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~---------------~i~~-~~~~~~~  235 (269)
T d2java1         172 KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---------------KIRE-GKFRRIP  235 (269)
T ss_dssp             ----CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---------------HHHH-TCCCCCC
T ss_pred             ccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHH---------------HHHc-CCCCCCC
Confidence            34568999999999999999999999999999999999999997654321111               1111 1112345


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+++++.++|.+||+.||.+|||+.++++
T Consensus       236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         236 YRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            567788999999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=337.53  Aligned_cols=243  Identities=23%  Similarity=0.334  Sum_probs=195.4

Q ss_pred             Cceeeeee--eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTC--QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||+|...  .+.+.+++|..+.........+++.+|++++++++||||++++|++..+ ..++||||+++|+|.+++..
T Consensus        22 ~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~  100 (277)
T d1xbba_          22 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQ  100 (277)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHH
T ss_pred             EEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhh
Confidence            58888643  3456789998765555555678899999999999999999999999654 56899999999999999986


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc-ccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA-RLHST  158 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~  158 (285)
                      ...         +++..++.++.||+.||.|||++   |++||||||+||+++.++.++|+|||+++....... .....
T Consensus       101 ~~~---------l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_         101 NRH---------VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             CTT---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             ccC---------CCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            543         89999999999999999999999   999999999999999999999999999975433221 11223


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...||+.|+|||.+.+..++.++|||||||++|||++ |+.||.+....                .+...+....+...+
T Consensus       169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~----------------~~~~~i~~~~~~~~p  232 (277)
T d1xbba_         169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----------------EVTAMLEKGERMGCP  232 (277)
T ss_dssp             --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HHHHHHHTTCCCCCC
T ss_pred             ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH----------------HHHHHHHcCCCCCCC
Confidence            4568899999999999899999999999999999997 89999764321                222222233344566


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ..+|+++.++|.+||+.||.+|||++++++.|+...
T Consensus       233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            778889999999999999999999999998887654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-50  Score=332.38  Aligned_cols=241  Identities=24%  Similarity=0.364  Sum_probs=188.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|... .++.+++|..+.   .....+++.+|++++++++||||++++|++.+++..++||||+.+|+|.+++....
T Consensus        20 ~Vy~~~~~-~~~~vAvK~i~~---~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~   95 (263)
T d1sm2a_          20 LVHLGYWL-NKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR   95 (263)
T ss_dssp             CEEEEEET-TTEEEEEEECCS---SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT
T ss_pred             EEEEEEEC-CCCEEEEEEECC---CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccc
Confidence            68999765 355688887653   33446789999999999999999999999999999999999999999999987654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .        .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++........ ......
T Consensus        96 ~--------~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~  163 (263)
T d1sm2a_          96 G--------LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTK  163 (263)
T ss_dssp             T--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------------
T ss_pred             c--------CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce-eeccee
Confidence            3        288999999999999999999999   9999999999999999999999999999765433221 123356


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhC-CCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG-RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      |++.|+|||++.+..++.++|||||||++|||+++ .+||.....                ..+...+........+..+
T Consensus       164 gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~----------------~~~~~~i~~~~~~~~p~~~  227 (263)
T d1sm2a_         164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------------SEVVEDISTGFRLYKPRLA  227 (263)
T ss_dssp             -CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH----------------HHHHHHHHHTCCCCCCTTS
T ss_pred             cCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH----------------HHHHHHHHhcCCCCCcccc
Confidence            88999999999999999999999999999999995 555543322                1111222222333445667


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ++++.+++.+||+.||++|||++++++.|+++.+
T Consensus       228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            7899999999999999999999999999998864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-50  Score=339.25  Aligned_cols=237  Identities=21%  Similarity=0.248  Sum_probs=181.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.++.+++.||+|........ ...+.+.+|++++++++||||+++++++.+++..++||||+++|+|.+++....
T Consensus        24 ~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~  102 (307)
T d1a06a_          24 EVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG  102 (307)
T ss_dssp             GEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS
T ss_pred             EEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhccc
Confidence            6999999999999999987644332 234678899999999999999999999999999999999999999999997654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEc---cCCeeEEeccccCCCCCccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      .         +++..+..++.|++.||.|||++   |++||||||+||++.   .++.++|+|||++........   ..
T Consensus       103 ~---------l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~---~~  167 (307)
T d1a06a_         103 F---------YTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LS  167 (307)
T ss_dssp             C---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------------
T ss_pred             C---------CCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCCe---ee
Confidence            2         89999999999999999999999   999999999999994   578999999999976543221   23


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCCh
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP  238 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+...             ..........
T Consensus       168 ~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-------------~~~~~~~~~~  234 (307)
T d1a06a_         168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA-------------EYEFDSPYWD  234 (307)
T ss_dssp             -----CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT-------------CCCCCTTTTT
T ss_pred             eeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc-------------CCCCCCcccc
Confidence            456999999999999999999999999999999999999999765432211111100             1111123345


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          239 KGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+++++.++|.+||+.||++|||++++++
T Consensus       235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         235 DISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            67788999999999999999999999998

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-50  Score=340.22  Aligned_cols=249  Identities=17%  Similarity=0.225  Sum_probs=194.4

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.+..+++.+|+|..+.. ......+++.+|+.+|++++||||++++++|.+.++.++||||+.+|+|.+++....
T Consensus        21 ~V~~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~   99 (322)
T d1s9ja_          21 VVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG   99 (322)
T ss_dssp             CEEEEEETTTTEEEEEEEEECC-CCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS
T ss_pred             EEEEEEECCCCcEEEEEEEChh-hCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC
Confidence            6999999999999999988643 344556789999999999999999999999999999999999999999999997654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      .         +++..+..++.|++.||.|||+ +   |++||||||+|||++.++.++|+|||++......    .....
T Consensus       100 ~---------l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~  163 (322)
T d1s9ja_         100 R---------IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSF  163 (322)
T ss_dssp             S---------CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---
T ss_pred             C---------CCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccc
Confidence            2         8999999999999999999996 7   8999999999999999999999999998654321    12345


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhh-hccc---------------------
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW-ATPR---------------------  218 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~---------------------  218 (285)
                      .||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......... ....                     
T Consensus       164 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (322)
T d1s9ja_         164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD  243 (322)
T ss_dssp             CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------------
T ss_pred             cCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccc
Confidence            799999999999999999999999999999999999999976543221111000 0000                     


Q ss_pred             ----Cch-hhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          219 ----LSE-DKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       219 ----~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                          ... +..................+.++.++|.+||+.||.+|||++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             --CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                000 0000000100001111235678999999999999999999999988

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=337.43  Aligned_cols=250  Identities=22%  Similarity=0.337  Sum_probs=196.3

Q ss_pred             Cceeeeeeeecc-----ccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEE-----SYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|....+.+     .+++|..... ........+.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.+
T Consensus        52 ~Vy~a~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~  130 (325)
T d1rjba_          52 KVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN  130 (325)
T ss_dssp             EEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred             EEEEEEEcCCCcccceeEEEEEEeccc-cCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHH
Confidence            588887765444     3556654332 2344577899999999998 89999999999999999999999999999999


Q ss_pred             HhccCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEec
Q 023220           76 ILHGRKGVQ--------------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD  141 (285)
Q Consensus        76 ~l~~~~~~~--------------~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~d  141 (285)
                      ++.......              .......+++..++.++.|++.||.|||++   |++||||||+||+++.++.+||+|
T Consensus       131 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill~~~~~~Kl~D  207 (325)
T d1rjba_         131 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICD  207 (325)
T ss_dssp             HHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECC
T ss_pred             HHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhccccccCCeEEEee
Confidence            997654211              011223489999999999999999999999   999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCc
Q 023220          142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLS  220 (285)
Q Consensus       142 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  220 (285)
                      ||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |..||.+.....             
T Consensus       208 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~-------------  274 (325)
T d1rjba_         208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA-------------  274 (325)
T ss_dssp             CGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-------------
T ss_pred             ccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH-------------
Confidence            999976554333323334567999999999999999999999999999999997 899997654321             


Q ss_pred             hhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 023220          221 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ  270 (285)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  270 (285)
                        .+..++....+.+.+..+++++.+||.+||+.||++|||+++|++.|.
T Consensus       275 --~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         275 --NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             --HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence              122223333344556678889999999999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=332.46  Aligned_cols=243  Identities=24%  Similarity=0.351  Sum_probs=195.5

Q ss_pred             Cceeeeeeee--ccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQV--EESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||+|.....  +..+++|..+.. ..+...+++.+|+++|++++||||++++|++.++ ..++||||+++|+|.+++..
T Consensus        24 ~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~  101 (285)
T d1u59a_          24 SVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVG  101 (285)
T ss_dssp             EEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTT
T ss_pred             EEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhc
Confidence            5899865433  335788876532 2334467899999999999999999999999754 57999999999999999865


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-cccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-LHST  158 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~  158 (285)
                      ...        .+++..++.++.|++.||.|||++   |++||||||+||+++.++.+||+|||++......... ....
T Consensus       102 ~~~--------~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~  170 (285)
T d1u59a_         102 KRE--------EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  170 (285)
T ss_dssp             CTT--------TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred             ccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccccccc
Confidence            432        289999999999999999999999   9999999999999999999999999999765432221 1223


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...|++.|+|||.+.+..++.++|||||||++|||++ |+.||......                .+...+....+...+
T Consensus       171 ~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~p  234 (285)
T d1u59a_         171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----------------EVMAFIEQGKRMECP  234 (285)
T ss_dssp             SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----------------HHHHHHHTTCCCCCC
T ss_pred             ccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHcCCCCCCC
Confidence            3457889999999998899999999999999999998 99999764322                122222223334556


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhh
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL  273 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  273 (285)
                      ..+++++.++|.+||+.||++|||+.++++.|+...
T Consensus       235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            778899999999999999999999999999988655

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-49  Score=335.71  Aligned_cols=233  Identities=21%  Similarity=0.282  Sum_probs=191.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.||+|........ ....+++.+|++++++++||||+++++++.+++..++||||+.+|+|..++...
T Consensus        30 ~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~  109 (309)
T d1u5ra_          30 AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK  109 (309)
T ss_dssp             EEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHT
T ss_pred             EEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhC
Confidence            6999999999999999987543322 223467889999999999999999999999999999999999998887776554


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..++.++.|++.||.|||++   |++||||||+|||++.++.++|+|||++.....      ....
T Consensus       110 ~~---------l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~  171 (309)
T d1u5ra_         110 KP---------LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSF  171 (309)
T ss_dssp             SC---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCC
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC------CCcc
Confidence            32         89999999999999999999999   999999999999999999999999999976433      2345


Q ss_pred             ccccCcCCCccccc---CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          161 LGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       161 ~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      .||+.|+|||++.+   ..++.++|||||||++|+|++|..||.+......               ...+.........+
T Consensus       172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~---------------~~~i~~~~~~~~~~  236 (309)
T d1u5ra_         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---------------LYHIAQNESPALQS  236 (309)
T ss_dssp             CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---------------HHHHHHSCCCCCSC
T ss_pred             ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH---------------HHHHHhCCCCCCCC
Confidence            69999999999864   4588999999999999999999999976543211               11111111111223


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ..+++.+.++|.+||+.||.+|||++++++
T Consensus       237 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            456788999999999999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=330.36  Aligned_cols=253  Identities=28%  Similarity=0.383  Sum_probs=200.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|....++ .+|+|.....   ....+.+.+|+.++++++||||++++|++.+ +..++||||+.+|+|.+++....
T Consensus        32 ~Vy~~~~~~~~-~vAiK~l~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~  106 (285)
T d1fmka3          32 EVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET  106 (285)
T ss_dssp             EEEEEEETTTE-EEEEEECCTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHH
T ss_pred             EEEEEEECCCC-EEEEEEECcc---cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcc
Confidence            58999776654 4888876533   3345789999999999999999999999865 55799999999999999987543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.|++.|++|||++   |++||||||+||+++.++.++|+|||++........ .......
T Consensus       107 ~~-------~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~  175 (285)
T d1fmka3         107 GK-------YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAK  175 (285)
T ss_dssp             HT-------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------------
T ss_pred             cc-------cchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc-eeecccc
Confidence            22       289999999999999999999999   999999999999999999999999999976543222 2233456


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      |++.|+|||.+....++.++|||||||++|||++|..|+.....               .......+......+.+..++
T Consensus       176 gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~---------------~~~~~~~i~~~~~~~~~~~~~  240 (285)
T d1fmka3         176 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---------------NREVLDQVERGYRMPCPPECP  240 (285)
T ss_dssp             CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---------------HHHHHHHHHTTCCCCCCTTSC
T ss_pred             ccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC---------------HHHHHHHHHhcCCCCCCcccC
Confidence            89999999999999999999999999999999996665543221               111222222233345667788


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCCCCCCC
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPVSET  285 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~~~~  285 (285)
                      +++.++|.+||+.||++|||++++++.|+.+.....|+-+|+|+
T Consensus       241 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~~~  284 (285)
T d1fmka3         241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN  284 (285)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSCC
T ss_pred             HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCCCC
Confidence            89999999999999999999999999999999888888877764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-49  Score=330.93  Aligned_cols=238  Identities=20%  Similarity=0.261  Sum_probs=195.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCC----CCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPK----NYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      +||+|.++.+++.||+|...+.....    ...+.+.+|+++|++++||||+++++++.+.+..++||||+.+|+|.+++
T Consensus        25 ~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i  104 (293)
T d1jksa_          25 VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL  104 (293)
T ss_dssp             EEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchh
Confidence            58999999999999999876544322    24578999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC----eeEEeccccCCCCCcccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~----~~~l~df~~~~~~~~~~~  153 (285)
                      .....         +++..++.++.|++.||.|||+.   |++||||||+||+++.++    .++++|||++........
T Consensus       105 ~~~~~---------l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~  172 (293)
T d1jksa_         105 AEKES---------LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE  172 (293)
T ss_dssp             HHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB
T ss_pred             ccccc---------cchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhhcCCCcc
Confidence            76542         89999999999999999999999   999999999999998766    599999999876543222


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                         .....|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.........+........             
T Consensus       173 ---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------  236 (293)
T d1jksa_         173 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE-------------  236 (293)
T ss_dssp             ---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC-------------
T ss_pred             ---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-------------
Confidence               2335689999999999998999999999999999999999999986543222111111110100             


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          234 GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ...+..++.++.++|++||+.||.+|||++++++
T Consensus       237 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1112345678999999999999999999999997

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=329.89  Aligned_cols=258  Identities=18%  Similarity=0.143  Sum_probs=193.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCC---CCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP---KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      +||+|.+..+++.||+|..+.....   ....+.+.+|+.++++++||||+++++++.+++..++||||+.++++..+..
T Consensus        13 ~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~   92 (299)
T d1ua2a_          13 TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD   92 (299)
T ss_dssp             EEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTT
T ss_pred             EEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhh
Confidence            6999999999999999987654332   2346789999999999999999999999999999999999999877766655


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ...         .+++..+..++.|++.||.|||++   |++||||||+||+++.++.+||+|||++.........  ..
T Consensus        93 ~~~---------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~~  158 (299)
T d1ua2a_          93 NSL---------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YT  158 (299)
T ss_dssp             CCS---------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CC
T ss_pred             ccc---------CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc--cc
Confidence            433         288889999999999999999999   9999999999999999999999999999765443222  23


Q ss_pred             ccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcC---CccC-
Q 023220          159 RVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD---PKLK-  233 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-  233 (285)
                      ...||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.........+.........+.......   .... 
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK  238 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence            3568999999998865 4679999999999999999999999987654433322222111111111100000   0000 


Q ss_pred             --CC-----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          234 --GE-----YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       234 --~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                        ..     .....++++.++|++||+.||++|||++|+++  ..+++.
T Consensus       239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~--Hp~f~~  285 (299)
T d1ua2a_         239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MKYFSN  285 (299)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--SGGGTS
T ss_pred             cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC--CHhhCC
Confidence              00     11245678999999999999999999999998  444443

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.9e-49  Score=339.26  Aligned_cols=237  Identities=19%  Similarity=0.191  Sum_probs=195.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.+..+++.||+|......  ....+.+.+|+++|++++||||++++++|.+++.+++||||+++|+|.+++....
T Consensus        44 ~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~  121 (352)
T d1koba_          44 VVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED  121 (352)
T ss_dssp             EEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT
T ss_pred             EEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcC
Confidence            58999999999999999765322  1224677899999999999999999999999999999999999999999876543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEc--cCCeeEEeccccCCCCCcccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF--EDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      .        .+++..++.++.||+.||.|||++   |++||||||+|||++  .++.++|+|||++........   ...
T Consensus       122 ~--------~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~---~~~  187 (352)
T d1koba_         122 Y--------KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKV  187 (352)
T ss_dssp             C--------CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEE
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc---eee
Confidence            2        289999999999999999999999   999999999999997  578999999999976543221   233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+...             +..........
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-------------~~~~~~~~~~~  254 (352)
T d1koba_         188 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-------------DWEFDEDAFSS  254 (352)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC-------------CCCCCSSTTTT
T ss_pred             ccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------CCCCCcccccC
Confidence            56899999999999999999999999999999999999999765432221111111             11112233456


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +++++.++|.+||+.||.+|||+.++++
T Consensus       255 ~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         255 VSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            7788999999999999999999999987

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-48  Score=335.41  Aligned_cols=237  Identities=17%  Similarity=0.202  Sum_probs=194.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.++.+++.||+|......  ....+.+.+|++++++++||||+++++++.+.+..++||||+.+|+|.+++....
T Consensus        41 ~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~  118 (350)
T d1koaa2          41 VVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH  118 (350)
T ss_dssp             EEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTT
T ss_pred             EEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhc
Confidence            58999999999999999775322  2235678899999999999999999999999999999999999999999986543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEc--cCCeeEEeccccCCCCCcccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF--EDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      .        .+++..+..++.||+.||.|||++   |++||||||+|||++  .++.++|+|||++........   ...
T Consensus       119 ~--------~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~  184 (350)
T d1koaa2         119 N--------KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKV  184 (350)
T ss_dssp             S--------CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC---EEE
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccc---cce
Confidence            2        289999999999999999999999   999999999999995  467899999999976543222   234


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....             ..........
T Consensus       185 ~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-------------~~~~~~~~~~  251 (350)
T d1koaa2         185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD-------------WNMDDSAFSG  251 (350)
T ss_dssp             ECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-------------CCSCCGGGGG
T ss_pred             ecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------CCCCcccccC
Confidence            568999999999999999999999999999999999999997654322211111111             0111122345


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +++++.++|.+||+.||.+|||++++++
T Consensus       252 ~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         252 ISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            6788999999999999999999999998

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-49  Score=327.80  Aligned_cols=248  Identities=20%  Similarity=0.300  Sum_probs=192.4

Q ss_pred             Cceeeeeeeec----cccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVE----ESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||+|......    ..+++|...... .....+++.+|++++++++||||++++|++.+.+..+++|||+.++++.+++
T Consensus        22 ~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~  100 (283)
T d1mqba_          22 EVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL  100 (283)
T ss_dssp             EEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHH
T ss_pred             EEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhh
Confidence            58888755433    357777664322 2233557889999999999999999999999999999999999999999988


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-cc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-LH  156 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~  156 (285)
                      .....        .+++..++.++.|++.|+.|||++   +++||||||+|||++.++.+||+|||+++........ ..
T Consensus       101 ~~~~~--------~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~  169 (283)
T d1mqba_         101 REKDG--------EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT  169 (283)
T ss_dssp             HHTTT--------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------------
T ss_pred             hcccc--------cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCccceE
Confidence            76543        289999999999999999999999   9999999999999999999999999999765432221 12


Q ss_pred             ccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|..|+.....               ...+...+....+...
T Consensus       170 ~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~---------------~~~~~~~i~~~~~~~~  234 (283)
T d1mqba_         170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------------NHEVMKAINDGFRLPT  234 (283)
T ss_dssp             ----CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---------------HHHHHHHHHTTCCCCC
T ss_pred             eccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC---------------HHHHHHHHhccCCCCC
Confidence            2334578999999999999999999999999999999996666543221               1222233333444556


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                      +..++..+.++|.+||+.||++|||+.++++.|+++++.+
T Consensus       235 ~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         235 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence            6778889999999999999999999999999999998753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=332.26  Aligned_cols=235  Identities=20%  Similarity=0.206  Sum_probs=199.3

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.++.+++.||+|..++.. ......+.+.+|+.+|++++||||+++++++.+.+.+++||||+.+|+|.+++...
T Consensus        20 ~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~   99 (337)
T d1o6la_          20 KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE   99 (337)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcc
Confidence            68999999999999999876543 23445788899999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.|++.||.|||++   |++||||||+|||++.+|.++|+|||++........  .....
T Consensus       100 ~~---------~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~  165 (337)
T d1o6la_         100 RV---------FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTF  165 (337)
T ss_dssp             SC---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCC
T ss_pred             cC---------CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc--ccccc
Confidence            53         89999999999999999999999   999999999999999999999999999976543222  23445


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .||+.|+|||++.+..++.++|+||+||++|+|++|++||.+.+......               .+...  ...++..+
T Consensus       166 ~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~---------------~i~~~--~~~~p~~~  228 (337)
T d1o6la_         166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---------------LILME--EIRFPRTL  228 (337)
T ss_dssp             EECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHHHC--CCCCCTTS
T ss_pred             eeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHH---------------HHhcC--CCCCCccC
Confidence            78999999999999999999999999999999999999998765322111               11111  12346667


Q ss_pred             HHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRPN-----MSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps-----~~~ll~  267 (285)
                      ++++.++|.+||+.||.+||+     ++++++
T Consensus       229 s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            888999999999999999995     888887

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-49  Score=326.60  Aligned_cols=242  Identities=25%  Similarity=0.365  Sum_probs=193.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|... .+..+|+|..+.   .....+.+.+|++++++++||||++++|++.+ +..++||||+++|+|.+++....
T Consensus        28 ~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~  102 (272)
T d1qpca_          28 EVWMGYYN-GHTKVAVKSLKQ---GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPS  102 (272)
T ss_dssp             EEEEEEET-TTEEEEEEEECT---TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHH
T ss_pred             EEEEEEEC-CCCEEEEEEEcc---CcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcC
Confidence            58998754 456688887643   33456789999999999999999999998865 55799999999999999876543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..++.++.|++.||.|||++   |++||||||+||+++.++.+||+|||+++........ ......
T Consensus       103 ~~-------~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~  171 (272)
T d1qpca_         103 GI-------KLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAK  171 (272)
T ss_dssp             HH-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCC
T ss_pred             CC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc-cccccC
Confidence            22       289999999999999999999999   9999999999999999999999999999765433221 233456


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhHH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV  241 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
                      |++.|+|||.+.+..++.++|||||||++|||++|..|+.....               ...+...+....+...+..++
T Consensus       172 gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~---------------~~~~~~~i~~~~~~~~p~~~~  236 (272)
T d1qpca_         172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---------------NPEVIQNLERGYRMVRPDNCP  236 (272)
T ss_dssp             CCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---------------HHHHHHHHHTTCCCCCCTTCC
T ss_pred             CcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC---------------HHHHHHHHHhcCCCCCcccCh
Confidence            88999999999988899999999999999999996555432221               111222222233344566778


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          242 AKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      +++.+++.+||+.||++|||++++++.|+.+.+
T Consensus       237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            899999999999999999999999999988764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=321.10  Aligned_cols=238  Identities=21%  Similarity=0.307  Sum_probs=197.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.. ..+..+++|..+..   ....+++.+|+.++++++||||++++|++.+++.+++||||+.+|+|.+++....
T Consensus        19 ~Vy~~~~-~~~~~vAvK~l~~~---~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~   94 (258)
T d1k2pa_          19 VVKYGKW-RGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR   94 (258)
T ss_dssp             EEEEEEE-TTTEEEEEEEEESS---SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGG
T ss_pred             EEEEEEE-CCCCEEEEEEECcC---cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccc
Confidence            5889875 45667888876532   3346789999999999999999999999999999999999999999999976654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..        +++..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++......... ......
T Consensus        95 ~~--------~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~  162 (258)
T d1k2pa_          95 HR--------FQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSK  162 (258)
T ss_dssp             GC--------CCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSC
T ss_pred             cC--------CcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccC
Confidence            32        88999999999999999999999   9999999999999999999999999999765433222 223456


Q ss_pred             cccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          162 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      |++.|+|||.+.+..++.++|||||||++|||++ |+.||......                .+...+....+...+..+
T Consensus       163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~----------------~~~~~i~~~~~~~~p~~~  226 (258)
T d1k2pa_         163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----------------ETAEHIAQGLRLYRPHLA  226 (258)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----------------HHHHHHHTTCCCCCCTTC
T ss_pred             CCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH----------------HHHHHHHhCCCCCCcccc
Confidence            8899999999999999999999999999999998 89999755432                122222223334556677


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHhch
Q 023220          241 VAKLAAVAALCVQYEAEFRPNMSIVVKALQP  271 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  271 (285)
                      ++.+.++|.+||+.||++|||++++++.|..
T Consensus       227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         227 SEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            8899999999999999999999999998854

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.3e-48  Score=327.59  Aligned_cols=232  Identities=21%  Similarity=0.295  Sum_probs=197.7

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.++.+++.||+|..++.. ......+.+.+|+.++++++||||+++++++.+.+..++||||+.+|+|..++...
T Consensus        19 ~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~   98 (316)
T d1fota_          19 RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS   98 (316)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT
T ss_pred             EEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccccc
Confidence            59999999999999999875433 33455788999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.|++.||.|||++   |++||||||+|||++.++.+||+|||++......     ....
T Consensus        99 ~~---------~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~  161 (316)
T d1fota_          99 QR---------FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTL  161 (316)
T ss_dssp             SS---------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCC
T ss_pred             cc---------ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-----cccc
Confidence            53         78889999999999999999999   9999999999999999999999999999765432     2345


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....               ...+....  ...+..+
T Consensus       162 ~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---------------~~~i~~~~--~~~p~~~  224 (316)
T d1fota_         162 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---------------YEKILNAE--LRFPPFF  224 (316)
T ss_dssp             CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---------------HHHHHHCC--CCCCTTS
T ss_pred             cCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH---------------HHHHHcCC--CCCCCCC
Confidence            799999999999999999999999999999999999999976543211               11111111  2345667


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRP-----NMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp-----s~~~ll~  267 (285)
                      ++++.+++.+||+.||.+|+     |++++++
T Consensus       225 s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         225 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            78899999999999999996     8999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-48  Score=328.41  Aligned_cols=245  Identities=20%  Similarity=0.309  Sum_probs=191.2

Q ss_pred             CceeeeeeeeccccChhhhhhc---cCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERL---KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      .||+|....+++.+++|+..+.   .......+++.+|++++++++||||++++|++.+++ .+++++++.+++|.+++.
T Consensus        24 ~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~  102 (317)
T d1xkka_          24 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVR  102 (317)
T ss_dssp             EEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHH
T ss_pred             EEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeEEEEeccCCccccccc
Confidence            5899988777776665543222   233456778999999999999999999999998764 577889999999998887


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....        .+++..++.++.|++.||.|||++   |++||||||+||+++.++.+||+|||++.............
T Consensus       103 ~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  171 (317)
T d1xkka_         103 EHKD--------NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE  171 (317)
T ss_dssp             HTSS--------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-----
T ss_pred             cccc--------CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccccccccccc
Confidence            6543        289999999999999999999999   99999999999999999999999999987654433333334


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...||+.|+|||.+.+..++.++|||||||++|||++ |.+||.+.....                +...+....+...+
T Consensus       172 ~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~----------------~~~~i~~~~~~~~p  235 (317)
T d1xkka_         172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILEKGERLPQP  235 (317)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG----------------HHHHHHHTCCCCCC
T ss_pred             ccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHHHcCCCCCCC
Confidence            4568999999999999999999999999999999998 888987554322                22222223334556


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ..+++++.+++.+||+.||.+|||+.++++.|.++.+
T Consensus       236 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            7788899999999999999999999999999887754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.6e-48  Score=321.01  Aligned_cols=238  Identities=19%  Similarity=0.229  Sum_probs=195.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCC-------ChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNY-------PDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~-------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   73 (285)
                      +||+|.+..+++.||+|...+.......       .+.+.+|+.++++++ ||||+++++++.+++..+|||||+++|+|
T Consensus        18 ~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L   97 (277)
T d1phka_          18 VVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL   97 (277)
T ss_dssp             EEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred             EEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchH
Confidence            5899999899999999987665443322       346889999999996 99999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc
Q 023220           74 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        74 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  153 (285)
                      .+++..+..         +++..+..++.||+.||.|||++   |++||||||+||+++.++.++|+|||++........
T Consensus        98 ~~~l~~~~~---------l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~  165 (277)
T d1phka_          98 FDYLTEKVT---------LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK  165 (277)
T ss_dssp             HHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC
T ss_pred             HHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEccCCCc
Confidence            999976542         89999999999999999999999   999999999999999999999999999976543221


Q ss_pred             cccccccccccCcCCCccccc------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh
Q 023220          154 RLHSTRVLGTFGYHAPEYAMT------GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC  227 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (285)
                         .....||+.|.|||.+.+      ..++.++||||+||++|+|++|+.||.+.........+....           
T Consensus       166 ---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~-----------  231 (277)
T d1phka_         166 ---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN-----------  231 (277)
T ss_dssp             ---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----------
T ss_pred             ---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC-----------
Confidence               234568999999998753      356889999999999999999999998664332221111111           


Q ss_pred             cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          228 VDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       228 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                        ..........+++++.+++.+||+.||.+|||++++++
T Consensus       232 --~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         232 --YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             --CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              11112234467889999999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-48  Score=320.89  Aligned_cols=244  Identities=24%  Similarity=0.333  Sum_probs=184.7

Q ss_pred             Cceeeeeeeeccc---cChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEES---YPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~---~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      +||+|.....++.   +++|..+.. ......+.+.+|++++++++||||++++|++.+ +..++||||+.+|+|.+++.
T Consensus        22 ~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E~~~~g~l~~~~~   99 (273)
T d1mp8a_          22 DVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ   99 (273)
T ss_dssp             EEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEECCTTEEHHHHHH
T ss_pred             EEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEEeccCCcHHhhhh
Confidence            5899877655433   455544322 223345678999999999999999999999964 56899999999999999876


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST  158 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (285)
                      ....        .+++..++.++.|++.||.|||++   |++||||||+||+++.++.+||+|||++........ ....
T Consensus       100 ~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~-~~~~  167 (273)
T d1mp8a_         100 VRKY--------SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKAS  167 (273)
T ss_dssp             HTTT--------TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------------
T ss_pred             ccCC--------CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcc-eecc
Confidence            5442        289999999999999999999999   999999999999999999999999999976543222 1233


Q ss_pred             ccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCC
Q 023220          159 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP  237 (285)
Q Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
                      ...|++.|+|||.+.+..++.++|||||||++|||++ |.+||.........                ..+........+
T Consensus       168 ~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~----------------~~i~~~~~~~~~  231 (273)
T d1mp8a_         168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----------------GRIENGERLPMP  231 (273)
T ss_dssp             ---CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----------------HHHHTTCCCCCC
T ss_pred             ceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH----------------HHHHcCCCCCCC
Confidence            4567899999999999999999999999999999998 89999765432211                111122223456


Q ss_pred             hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          238 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      +.+++++.++|.+||+.||.+|||+.++++.|+.+++.
T Consensus       232 ~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            77888999999999999999999999999999988753

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.8e-48  Score=323.65  Aligned_cols=248  Identities=22%  Similarity=0.287  Sum_probs=192.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCC-CCCChhHHHHHHHHccCCCCcccccceEEEeCC----eeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN----LRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~   76 (285)
                      .||+|.+..+++.|++|..+..... ....+.+.+|++++++++||||+++++++...+    ..++||||+++++|.++
T Consensus        22 ~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~  101 (277)
T d1o6ya_          22 EVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI  101 (277)
T ss_dssp             EEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhh
Confidence            5899999999999999987654332 334567899999999999999999999998654    47899999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc-ccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA-ARL  155 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~  155 (285)
                      +.....         +++..++.++.|++.||.|||++   |++||||||+||+++.++..+++|||.+....... ...
T Consensus       102 ~~~~~~---------l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~  169 (277)
T d1o6ya_         102 VHTEGP---------MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT  169 (277)
T ss_dssp             HHHHCS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC-------
T ss_pred             hcccCC---------CCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcccccccc
Confidence            876542         89999999999999999999999   99999999999999999999999999875432221 111


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE  235 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..+..........             ++.....
T Consensus       170 ~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~-------------~~~~~~~  236 (277)
T d1o6ya_         170 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-------------DPIPPSA  236 (277)
T ss_dssp             ---------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-------------CCCCGGG
T ss_pred             ccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc-------------CCCCCch
Confidence            233456899999999999989999999999999999999999999765432221111110             0111112


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhchhhc
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRP-NMSIVVKALQPLLK  274 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~ll~~l~~~~~  274 (285)
                      ....+|+++.++|.+||+.||.+|| |+++++..|.++..
T Consensus       237 ~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            2345678899999999999999999 89999999988753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=320.32  Aligned_cols=266  Identities=18%  Similarity=0.234  Sum_probs=198.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.+..+++.||+|.++.........+++.+|++++++++||||+++++++.+++..++||||+.+ ++.+++....
T Consensus        17 ~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~   95 (298)
T d1gz8a_          17 VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASA   95 (298)
T ss_dssp             EEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTT
T ss_pred             EEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhc
Confidence            699999999999999999876666666789999999999999999999999999999999999999976 5555554332


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      ..       .+++..+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||.+........  ......
T Consensus        96 ~~-------~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~  163 (298)
T d1gz8a_          96 LT-------GIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEV  163 (298)
T ss_dssp             TT-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTTCCB
T ss_pred             cc-------CCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc--cceeec
Confidence            22       289999999999999999999999   999999999999999999999999999865432221  233456


Q ss_pred             cccCcCCCcccccCC-CCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchh---hhhhh--cCCcc---
Q 023220          162 GTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED---KVKQC--VDPKL---  232 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~~---  232 (285)
                      |++.|+|||.+.... ++.++|+||+||++|+|++|+.||.+.+.......+..........   .....  .....   
T Consensus       164 gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (298)
T d1gz8a_         164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW  243 (298)
T ss_dssp             CCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCC
T ss_pred             ccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccc
Confidence            899999999877665 4789999999999999999999998665333222111111111100   00000  00000   


Q ss_pred             -CC---CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCCCCC
Q 023220          233 -KG---EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPV  282 (285)
Q Consensus       233 -~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  282 (285)
                       ..   ......++++.+++++||+.||++|||+.++++  ..+++....|.|.
T Consensus       244 ~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~--H~ff~~~~~p~p~  295 (298)
T d1gz8a_         244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPH  295 (298)
T ss_dssp             CCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGTTCCCCCCC
T ss_pred             cccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC--CHhhccCCCCCCC
Confidence             00   011244678999999999999999999999998  5667666666663

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-48  Score=317.97  Aligned_cols=236  Identities=28%  Similarity=0.370  Sum_probs=187.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe-CCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|...  +..+++|..+.    ....+.+.+|++++++++||||++++|++.+ .+.+++||||+++|+|.+++...
T Consensus        22 ~Vy~~~~~--~~~vAvK~i~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~   95 (262)
T d1byga_          22 DVMLGDYR--GNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR   95 (262)
T ss_dssp             EEEEEEET--TEEEEEEECCC----CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH
T ss_pred             EEEEEEEC--CeEEEEEEECc----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhc
Confidence            58888764  45588887753    3356889999999999999999999999865 45689999999999999999654


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ...       .+++..++.++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||++.......     ...
T Consensus        96 ~~~-------~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~~~  160 (262)
T d1byga_          96 GRS-------VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTG  160 (262)
T ss_dssp             HHH-------HCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------------
T ss_pred             CCC-------CCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC-----ccc
Confidence            321       288999999999999999999999   99999999999999999999999999987643322     234


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      .++..|+|||.+.+..++.++|||||||++|||++ |++||......                .+...+....+...+..
T Consensus       161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~----------------~~~~~i~~~~~~~~~~~  224 (262)
T d1byga_         161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------------DVVPRVEKGYKMDAPDG  224 (262)
T ss_dssp             -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----------------GHHHHHTTTCCCCCCTT
T ss_pred             cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH----------------HHHHHHHcCCCCCCCcc
Confidence            56889999999999999999999999999999998 78888654322                22222333344556777


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      +++++.++|.+||+.||.+|||+.++++.|+++.+
T Consensus       225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            88899999999999999999999999999998764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-47  Score=327.77  Aligned_cols=232  Identities=17%  Similarity=0.193  Sum_probs=196.4

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.++.+++.||+|...+.. ......+.+.+|+++|++++||||+++++++.+....++||||+.+|+|.+++...
T Consensus        56 ~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~  135 (350)
T d1rdqe_          56 RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI  135 (350)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhc
Confidence            69999999999999999764332 33455678999999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccccccc
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV  160 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (285)
                      ..         +++..+..++.||+.||.|||++   |++||||||+|||++.++.++|+|||++......     ....
T Consensus       136 ~~---------l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~  198 (350)
T d1rdqe_         136 GR---------FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTL  198 (350)
T ss_dssp             CC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCC
T ss_pred             CC---------CCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccc
Confidence            42         89999999999999999999999   9999999999999999999999999999765432     2335


Q ss_pred             ccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChhH
Q 023220          161 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKG  240 (285)
Q Consensus       161 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||.+........               .+....  ...+..+
T Consensus       199 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---------------~i~~~~--~~~p~~~  261 (350)
T d1rdqe_         199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE---------------KIVSGK--VRFPSHF  261 (350)
T ss_dssp             EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHHHCC--CCCCTTC
T ss_pred             cCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH---------------HHhcCC--CCCCccC
Confidence            68999999999999999999999999999999999999997654322111               111111  1234567


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 023220          241 VAKLAAVAALCVQYEAEFRP-----NMSIVVK  267 (285)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rp-----s~~~ll~  267 (285)
                      ++++.++|++||+.||.+|+     |++++++
T Consensus       262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            78899999999999999994     8999986

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=323.69  Aligned_cols=236  Identities=18%  Similarity=0.169  Sum_probs=192.1

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      .||+|.++.+++.|++|.++...   .....+.+|+++|++++||||+++++++.+.+.+|+||||+.+|+|.+++....
T Consensus        20 ~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~   96 (321)
T d1tkia_          20 IVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA   96 (321)
T ss_dssp             EEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS
T ss_pred             EEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcC
Confidence            58999999999999999886432   223567899999999999999999999999999999999999999999997654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc--CCeeEEeccccCCCCCcccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE--DFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      .        .+++..+..++.||+.||.|||++   |++||||||+||+++.  .+.++|+|||++........   ...
T Consensus        97 ~--------~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~---~~~  162 (321)
T d1tkia_          97 F--------ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRL  162 (321)
T ss_dssp             C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEE
T ss_pred             C--------CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCc---ccc
Confidence            2        289999999999999999999999   9999999999999985  45799999999876543221   233


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..+++.|+|||...+..++.++||||+||++|+|++|..||...........+.......+.             .....
T Consensus       163 ~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------------~~~~~  229 (321)
T d1tkia_         163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE-------------EAFKE  229 (321)
T ss_dssp             EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH-------------HHHTT
T ss_pred             cccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh-------------hhccC
Confidence            46789999999999999999999999999999999999999765433222111111111110             01123


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      +++++.++|.+||+.||.+|||+.++++
T Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         230 ISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            5678999999999999999999999998

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-47  Score=319.13  Aligned_cols=255  Identities=24%  Similarity=0.310  Sum_probs=196.8

Q ss_pred             CceeeeeeeeccccChhhhhh-ccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENER-LKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      .||+|....++..++++..+. ....+...+.+.+|+++|+++ +||||++++|++.+.+..++||||+++|+|.+++..
T Consensus        25 ~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~  104 (309)
T d1fvra_          25 QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK  104 (309)
T ss_dssp             EEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHT
T ss_pred             EEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhh
Confidence            589998877766554443322 223344577899999999999 799999999999999999999999999999999976


Q ss_pred             CCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc
Q 023220           80 RKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA  152 (285)
Q Consensus        80 ~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~  152 (285)
                      .....       .......+++..++.++.|++.|+.|||+.   |++||||||+|||++.++.+||+|||++.......
T Consensus       105 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~  181 (309)
T d1fvra_         105 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV  181 (309)
T ss_dssp             TCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC
T ss_pred             ccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEccccccccccccc
Confidence            52100       000111389999999999999999999999   99999999999999999999999999987554322


Q ss_pred             ccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCC-CCCCCCCCcccchhhhhhcccCchhhhhhhcCCc
Q 023220          153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR-KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK  231 (285)
Q Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
                      .   .....|+..|+|||.+.+..++.++|||||||++|||++|. +||......                .+...+...
T Consensus       182 ~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~----------------~~~~~i~~~  242 (309)
T d1fvra_         182 K---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----------------ELYEKLPQG  242 (309)
T ss_dssp             C---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHHHHGGGT
T ss_pred             c---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH----------------HHHHHHHhc
Confidence            2   23445889999999999999999999999999999999965 567544321                122222222


Q ss_pred             cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCC
Q 023220          232 LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP  278 (285)
Q Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  278 (285)
                      .+...+..+++++.++|.+||+.||++|||++++++.|+++++....
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~  289 (309)
T d1fvra_         243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  289 (309)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence            33445667788999999999999999999999999999999976553

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.4e-47  Score=326.66  Aligned_cols=236  Identities=19%  Similarity=0.242  Sum_probs=190.3

Q ss_pred             CceeeeeeeeccccChhhhhhccC-CCCCChhH---HHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKS-PKNYPDDE---KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      +||+|.+..+++.||+|...+... .......+   .+++++++.++||||+++++++.+.+..++||||+.+|+|.+++
T Consensus        19 ~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l   98 (364)
T d1omwa3          19 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL   98 (364)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHH
Confidence            699999999999999997643221 12222333   34577888889999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  157 (285)
                      .....         +++..++.++.||+.||.|||++   |++||||||+|||++.++.+||+|||++.......    .
T Consensus        99 ~~~~~---------~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~  162 (364)
T d1omwa3          99 SQHGV---------FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  162 (364)
T ss_dssp             HHHCS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC----C
T ss_pred             Hhccc---------ccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCCc----c
Confidence            76542         88999999999999999999999   99999999999999999999999999997554321    2


Q ss_pred             cccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCC
Q 023220          158 TRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY  236 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
                      ....||+.|+|||++.. ..++.++|||||||++|+|++|+.||..............            ..  ......
T Consensus       163 ~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~------------~~--~~~~~~  228 (364)
T d1omwa3         163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------------TL--TMAVEL  228 (364)
T ss_dssp             CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH------------SS--SCCCCC
T ss_pred             cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------cc--cCCCCC
Confidence            34569999999999864 5689999999999999999999999976543322211111            11  111234


Q ss_pred             ChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 023220          237 PPKGVAKLAAVAALCVQYEAEFRPN-----MSIVVK  267 (285)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll~  267 (285)
                      +..+++++.++|.+||+.||.+|||     ++++++
T Consensus       229 ~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         229 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            5567888999999999999999999     688876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-47  Score=320.51  Aligned_cols=253  Identities=23%  Similarity=0.311  Sum_probs=197.3

Q ss_pred             Cceeeeee-----eeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTC-----QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      +||+|...     ..+..+|+|..... ...+..+++.+|++++++++||||+++++++.+.+..+++|||+.+|+|.++
T Consensus        28 ~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~  106 (301)
T d1lufa_          28 RVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF  106 (301)
T ss_dssp             EEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred             EEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHH
Confidence            58888653     23456888876532 2333467899999999999999999999999999999999999999999999


Q ss_pred             hccCCCCC---------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEec
Q 023220           77 LHGRKGVQ---------------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD  141 (285)
Q Consensus        77 l~~~~~~~---------------~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~d  141 (285)
                      +.......               .......+++..++.++.|++.|++|||++   +++||||||+||+++.++.+||+|
T Consensus       107 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NILld~~~~~Kl~D  183 (301)
T d1lufa_         107 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIAD  183 (301)
T ss_dssp             HHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred             HHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceEECCCCcEEEcc
Confidence            97543211               011122388999999999999999999999   999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCC-CCCCCCCCcccchhhhhhcccCc
Q 023220          142 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR-KPVDHTMPRGQQSLVTWATPRLS  220 (285)
Q Consensus       142 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~  220 (285)
                      ||++................|++.|+|||.+.+..++.++|||||||++|||++|. +||.+......            
T Consensus       184 FGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~------------  251 (301)
T d1lufa_         184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV------------  251 (301)
T ss_dssp             CSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------------
T ss_pred             chhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH------------
Confidence            99986543333222233456788999999999999999999999999999999985 57765433221            


Q ss_pred             hhhhhhhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          221 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                          ...+........+..+++++.+++.+||+.||++|||+.+++++|+++.+
T Consensus       252 ----~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         252 ----IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             ----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ----HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                11112222334566778899999999999999999999999999998753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=323.37  Aligned_cols=235  Identities=21%  Similarity=0.227  Sum_probs=195.1

Q ss_pred             CceeeeeeeeccccChhhhhhcc-CCCCCChhHHHHHHHHc-cCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhcc
Q 023220            2 RRWLCCTCQVEESYPSHENERLK-SPKNYPDDEKQLVSVVS-RLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG   79 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   79 (285)
                      +||+|.++.+++.||+|..++.. ......+.+..|..++. .++||||+++++++.+++..|+||||+.+|+|.+++..
T Consensus        17 ~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~   96 (320)
T d1xjda_          17 KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS   96 (320)
T ss_dssp             EEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhc
Confidence            69999999999999999876433 23445566777777765 68999999999999999999999999999999999976


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccc
Q 023220           80 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR  159 (285)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (285)
                      ...         +++..+..++.||+.||.|||++   |++||||||+|||++.++.++|+|||++........  ....
T Consensus        97 ~~~---------~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--~~~~  162 (320)
T d1xjda_          97 CHK---------FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNT  162 (320)
T ss_dssp             HSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCC
T ss_pred             cCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccc--cccc
Confidence            543         88999999999999999999999   999999999999999999999999999976543222  2344


Q ss_pred             cccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCCCChh
Q 023220          160 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK  239 (285)
Q Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
                      ..||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+.               ..  ....+..
T Consensus       163 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~---------------~~--~~~~p~~  225 (320)
T d1xjda_         163 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR---------------MD--NPFYPRW  225 (320)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------------HC--CCCCCTT
T ss_pred             cCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH---------------cC--CCCCCcc
Confidence            578999999999999999999999999999999999999998654332211111               11  1134556


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 023220          240 GVAKLAAVAALCVQYEAEFRPNMS-IVVK  267 (285)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~-~ll~  267 (285)
                      +++++.++|.+||+.||.+|||+. ++++
T Consensus       226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            788899999999999999999996 6754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-47  Score=317.48  Aligned_cols=253  Identities=26%  Similarity=0.355  Sum_probs=202.5

Q ss_pred             Cceeeeeeeec-------cccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQVE-------ESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~~-------~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   73 (285)
                      .||++....+.       ..||+|..+... ......++.+|+..+.++ +||||+++++++.+++..++||||+.+|+|
T Consensus        28 ~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l  106 (299)
T d1fgka_          28 QVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  106 (299)
T ss_dssp             CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred             EEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcH
Confidence            58888765544       357777764322 223356778899999888 899999999999999999999999999999


Q ss_pred             HHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220           74 HDILHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus        74 ~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      .+++.......       .......+++..++.++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++.
T Consensus       107 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~kl~dfg~~~  183 (299)
T d1fgka_         107 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR  183 (299)
T ss_dssp             HHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSTTCCC
T ss_pred             HHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCCCeEeccchhhc
Confidence            99997654211       011122389999999999999999999999   99999999999999999999999999998


Q ss_pred             CCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhh
Q 023220          147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVK  225 (285)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
                      ...............+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......                .+.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~----------------~~~  247 (299)
T d1fgka_         184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----------------ELF  247 (299)
T ss_dssp             CGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----------------HHH
T ss_pred             cccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----------------HHH
Confidence            7655444433455678899999999999999999999999999999998 78888654322                222


Q ss_pred             hhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          226 QCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ..+........+..+++++.++|.+||+.||.+|||+.++++.|++++.
T Consensus       248 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            2333334445566778899999999999999999999999999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-47  Score=322.66  Aligned_cols=235  Identities=16%  Similarity=0.190  Sum_probs=187.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEe----CCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVE----GNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~   76 (285)
                      +||+|.+..+++.||+|..+.       .+.+.+|++++.++ +||||++++++|.+    +..+|+||||+.+|+|.++
T Consensus        27 ~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~   99 (335)
T d2ozaa1          27 KVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR   99 (335)
T ss_dssp             EEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHH
T ss_pred             EEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHH
Confidence            699999999999999998752       46788999987654 89999999999976    4578999999999999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc---CCeeEEeccccCCCCCcccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~  153 (285)
                      +......       .+++..+..++.|++.||.|||++   |++||||||+||+++.   .+.++|+|||++........
T Consensus       100 i~~~~~~-------~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~  169 (335)
T d2ozaa1         100 IQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS  169 (335)
T ss_dssp             HHSCSCC-------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC
T ss_pred             HHhcCCC-------CcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCCc
Confidence            9764322       299999999999999999999999   9999999999999975   56799999999975543222


Q ss_pred             cccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                         .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.           ..+......
T Consensus       170 ---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~-----------~~i~~~~~~  235 (335)
T d2ozaa1         170 ---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-----------TRIRMGQYE  235 (335)
T ss_dssp             ---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------CCCSCSSS
T ss_pred             ---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH-----------HHHhcCCCC
Confidence               244579999999999999999999999999999999999999997654322111000           000011110


Q ss_pred             --CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          234 --GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       234 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                        ......+++++.++|.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              0112356788999999999999999999999988

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=312.75  Aligned_cols=244  Identities=25%  Similarity=0.264  Sum_probs=189.4

Q ss_pred             Cceeeeeeeec---cccChhhhhhccC-CCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVE---ESYPSHENERLKS-PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~---~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      .||+|.....+   ..|++|..++... .....+++.+|++++++++||||++++|++.+ +..++||||+.+|++.+.+
T Consensus        23 ~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~  101 (273)
T d1u46a_          23 VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRL  101 (273)
T ss_dssp             CCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhh
Confidence            58888643322   2567786655443 33446789999999999999999999999976 4678999999999999887


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-cc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-LH  156 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~  156 (285)
                      .....        .+++..++.++.|++.|+.|||++   |++||||||+||+++.++.++|+|||++......... ..
T Consensus       102 ~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~  170 (273)
T d1u46a_         102 RKHQG--------HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM  170 (273)
T ss_dssp             HHHGG--------GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC
T ss_pred             hcccC--------CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCCCccee
Confidence            65432        289999999999999999999999   9999999999999999999999999999765433222 12


Q ss_pred             ccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC
Q 023220          157 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE  235 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
                      .....|+..|+|||.+.+..++.++||||||+++|||++ |..||.+.....               ....+.....+.+
T Consensus       171 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---------------~~~~i~~~~~~~~  235 (273)
T d1u46a_         171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---------------ILHKIDKEGERLP  235 (273)
T ss_dssp             -----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------------HHHHHHTSCCCCC
T ss_pred             cCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---------------HHHHHHhCCCCCC
Confidence            233456789999999999999999999999999999998 899997554321               1222223333344


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchh
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL  272 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  272 (285)
                      .+..++..+.++|.+||+.||++|||+.++++.|+++
T Consensus       236 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            5667788999999999999999999999999988764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-46  Score=313.02  Aligned_cols=249  Identities=22%  Similarity=0.285  Sum_probs=194.7

Q ss_pred             Cceeeeeeeec---cccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe-CCeeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVE---ESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE-GNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l   77 (285)
                      +||++.....+   ..+++|.... .......+++.+|++++++++||||++++|++.. ++..++||||+.+|+|.+++
T Consensus        42 ~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~  120 (311)
T d1r0pa_          42 CVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI  120 (311)
T ss_dssp             EEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHH
T ss_pred             EEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhh
Confidence            57888764433   2467776643 2334446789999999999999999999999875 45889999999999999998


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc--c
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR--L  155 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~  155 (285)
                      ......        +++..++.++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++.........  .
T Consensus       121 ~~~~~~--------~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         121 RNETHN--------PTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             HCTTCC--------CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred             cccccc--------chHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence            765432        77888999999999999999999   9999999999999999999999999999765433221  1


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE  235 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
                      ......|+..|+|||.+....++.++||||||+++|||++|..||........               +...+....+..
T Consensus       190 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~---------------~~~~i~~g~~~~  254 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---------------ITVYLLQGRRLL  254 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------------------CHHHHHTTCCCC
T ss_pred             ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH---------------HHHHHHcCCCCC
Confidence            12234678999999999999999999999999999999998888764322111               111111112223


Q ss_pred             CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          236 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                      .+..+++++.++|.+||+.||++|||+.|+++.|+++.+...
T Consensus       255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~  296 (311)
T d1r0pa_         255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  296 (311)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence            455677889999999999999999999999999999987643

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=315.37  Aligned_cols=255  Identities=21%  Similarity=0.281  Sum_probs=188.3

Q ss_pred             Cceeeeeeeec-----cccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeC-CeeeEEEeeCCCCCHH
Q 023220            2 RRWLCCTCQVE-----ESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEG-NLRVLAYEFATMGSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~   74 (285)
                      +||+|....+.     +.+++|..+... .....+.+.+|+..+.++ +|+||+.+++++... ...+++|||+++|+|.
T Consensus        28 ~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~  106 (299)
T d1ywna1          28 QVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS  106 (299)
T ss_dssp             EEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHH
T ss_pred             EEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHH
Confidence            58888765443     456777654322 122345677788888777 689999999988754 4689999999999999


Q ss_pred             HHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220           75 DILHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus        75 ~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      +++.......       .......+++..++.++.|++.||.|||++   |++||||||+|||++.++.+||+|||+++.
T Consensus       107 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~Kl~DFGla~~  183 (299)
T d1ywna1         107 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD  183 (299)
T ss_dssp             HHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECC------
T ss_pred             HHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcEEEccCcchhh
Confidence            9997543210       001122389999999999999999999999   999999999999999999999999999976


Q ss_pred             CCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhC-CCCCCCCCCcccchhhhhhcccCchhhhhh
Q 023220          148 APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG-RKPVDHTMPRGQQSLVTWATPRLSEDKVKQ  226 (285)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (285)
                      ..............||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.....               .+..
T Consensus       184 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~---------------~~~~  248 (299)
T d1ywna1         184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------------EFCR  248 (299)
T ss_dssp             CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---------------HHHH
T ss_pred             ccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH---------------HHHH
Confidence            5544443334456789999999999999999999999999999999986 56776543221               1112


Q ss_pred             hcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          227 CVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       227 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      .+........+..+++++.++|.+||+.||++|||++++++.|+++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            2222223345666788899999999999999999999999999998753

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-46  Score=312.97  Aligned_cols=252  Identities=17%  Similarity=0.205  Sum_probs=192.9

Q ss_pred             Cceeeeeeee-ccccChhhhhhccCCCCCChhHHHHHHHHccC---CCCcccccceEEEe-----CCeeeEEEeeCCCCC
Q 023220            2 RRWLCCTCQV-EESYPSHENERLKSPKNYPDDEKQLVSVVSRL---KHENLVELLGYCVE-----GNLRVLAYEFATMGS   72 (285)
Q Consensus         2 ~~~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~   72 (285)
                      +||+|.+..+ ++.+|+|..+...........+.+|+.+++.+   +||||++++++|..     ....+++||++.+++
T Consensus        22 ~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~  101 (305)
T d1blxa_          22 KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL  101 (305)
T ss_dssp             EEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBH
T ss_pred             EEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCc
Confidence            5899988655 66789999877666666677788888887766   89999999999863     346799999998866


Q ss_pred             HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccc
Q 023220           73 LHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA  152 (285)
Q Consensus        73 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~  152 (285)
                      +.........        .+++..+..++.|++.||.|||++   |++||||||+|||++..+.++|+|||++.......
T Consensus       102 ~~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~  170 (305)
T d1blxa_         102 TTYLDKVPEP--------GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM  170 (305)
T ss_dssp             HHHHHHSCTT--------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG
T ss_pred             hhhhhhccCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhhhcccc
Confidence            6544433322        289999999999999999999999   99999999999999999999999999987654332


Q ss_pred             ccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhh-------
Q 023220          153 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK-------  225 (285)
Q Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------  225 (285)
                      .   .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+.............       
T Consensus       171 ~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  247 (305)
T d1blxa_         171 A---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR  247 (305)
T ss_dssp             G---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG
T ss_pred             c---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchh
Confidence            2   345679999999999999999999999999999999999999998765443332222211111111100       


Q ss_pred             ---hhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          226 ---QCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       226 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                         ...............++.+.+||++||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence               000111111234456778999999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=316.16  Aligned_cols=257  Identities=21%  Similarity=0.308  Sum_probs=203.5

Q ss_pred             Cceeeee-----eeeccccChhhhhhccCCCCCChhHHHHHHHHccC-CCCcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCT-----CQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|..     ..+...+++|..+... .......+.+|+.+++++ +||||+++++++.+....+++|||+.+|+|.+
T Consensus        38 ~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~  116 (311)
T d1t46a_          38 KVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN  116 (311)
T ss_dssp             EEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred             EEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHH
Confidence            4788753     3455678888765432 223455788999999999 79999999999999999999999999999999


Q ss_pred             HhccCCCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220           76 ILHGRKGVQG---------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus        76 ~l~~~~~~~~---------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      ++........         ......+++..++.++.|++.|++|||++   |++||||||+||+++.++.++++|||++.
T Consensus       117 ~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~ki~DfG~~~  193 (311)
T d1t46a_         117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR  193 (311)
T ss_dssp             HHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGS
T ss_pred             HHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccccccccccccCcccccccchhe
Confidence            9976542110         01222489999999999999999999999   99999999999999999999999999998


Q ss_pred             CCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCchhhhh
Q 023220          147 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVK  225 (285)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
                      ...............|++.|+|||.+.+..++.++|||||||++|+|++ |.+||......               +.+.
T Consensus       194 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~---------------~~~~  258 (311)
T d1t46a_         194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---------------SKFY  258 (311)
T ss_dssp             CTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---------------HHHH
T ss_pred             eccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH---------------HHHH
Confidence            7665444344455678999999999999999999999999999999998 55556443321               2222


Q ss_pred             hhcCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCC
Q 023220          226 QCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP  277 (285)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  277 (285)
                      .++....+...+...++.+.+||.+||+.||.+|||++++++.|++.+++..
T Consensus       259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~  310 (311)
T d1t46a_         259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (311)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccCC
Confidence            3333334444556678889999999999999999999999999999887643

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-45  Score=309.95  Aligned_cols=253  Identities=22%  Similarity=0.298  Sum_probs=200.0

Q ss_pred             Cceeeeeee-----eccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQ-----VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   76 (285)
                      .||++....     .+..||+|..+... .......+.+|+.++++++||||+++++++...+..++||||+.+|+|.++
T Consensus        35 ~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~  113 (308)
T d1p4oa_          35 MVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY  113 (308)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred             EEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHH
Confidence            578886643     34678888765332 223445688999999999999999999999999999999999999999999


Q ss_pred             hccCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           77 LHGRKGVQ-GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        77 l~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      +....... .......+++..+..++.|++.|+.|||++   +++||||||+|||++.++++||+|||++..........
T Consensus       114 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~  190 (308)
T d1p4oa_         114 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR  190 (308)
T ss_dssp             HHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEE
T ss_pred             HHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecccceeccCCccee
Confidence            86432100 000111278899999999999999999999   99999999999999999999999999998665544444


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhC-CCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccCC
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG-RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG  234 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
                      ......|++.|+|||.+.+..++.++||||||+++|||++| .+||.+....                .....+......
T Consensus       191 ~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~----------------~~~~~i~~~~~~  254 (308)
T d1p4oa_         191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----------------QVLRFVMEGGLL  254 (308)
T ss_dssp             GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----------------HHHHHHHTTCCC
T ss_pred             eccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHhCCCC
Confidence            44555689999999999999999999999999999999997 5777544321                111111122234


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          235 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      ..+..+++.+.++|.+||+.||.+|||++++++.|++.++
T Consensus       255 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            4566778899999999999999999999999999988765

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.8e-45  Score=308.05  Aligned_cols=251  Identities=17%  Similarity=0.212  Sum_probs=191.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.+. +++.||+|............+++.+|+.+|++++||||+++++++.+.+..+++++++.++.+..+.....
T Consensus        17 ~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~   95 (286)
T d1ob3a_          17 VVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG   95 (286)
T ss_dssp             EEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTT
T ss_pred             EEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcC
Confidence            58999775 67889999887766667778999999999999999999999999999999999999998766666655443


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                               .+++..+..++.|++.||.|||+.   |++||||||+||+++.++.++++|||.+........  ......
T Consensus        96 ---------~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~  161 (286)
T d1ob3a_          96 ---------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEI  161 (286)
T ss_dssp             ---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------
T ss_pred             ---------CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc--ccceec
Confidence                     299999999999999999999999   999999999999999999999999999865432221  123345


Q ss_pred             cccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhh---hh---------hc
Q 023220          162 GTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV---KQ---------CV  228 (285)
Q Consensus       162 ~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~---------~~  228 (285)
                      +++.|+|||.+.+. .++.++||||+||++|+|++|+.||...........+............   ..         ..
T Consensus       162 ~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (286)
T d1ob3a_         162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY  241 (286)
T ss_dssp             CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCC
T ss_pred             ccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccc
Confidence            78999999998754 5689999999999999999999999865443322221111111110000   00         00


Q ss_pred             CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          229 DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .+..........++++.++|++||+.||++|||++++++
T Consensus       242 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111112233456778999999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-46  Score=307.44  Aligned_cols=227  Identities=17%  Similarity=0.228  Sum_probs=186.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCC----CCChhHHHHHHHHccCC--CCcccccceEEEeCCeeeEEEeeCCC-CCHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPK----NYPDDEKQLVSVVSRLK--HENLVELLGYCVEGNLRVLAYEFATM-GSLH   74 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L~   74 (285)
                      +||+|.+..+++.+++|...+.....    ....++.+|+.++++++  ||||+++++++.+.+..++|||++.+ +++.
T Consensus        19 ~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~   98 (273)
T d1xwsa_          19 SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF   98 (273)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHH
T ss_pred             EEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHH
Confidence            68999999999999999876544332    23455778999999986  89999999999999999999999975 5888


Q ss_pred             HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-CCeeEEeccccCCCCCcccc
Q 023220           75 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        75 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~  153 (285)
                      +++.....         +++..++.++.|++.||.|||++   |++||||||+||+++. ++.++|+|||++....... 
T Consensus        99 ~~~~~~~~---------l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~-  165 (273)
T d1xwsa_          99 DFITERGA---------LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-  165 (273)
T ss_dssp             HHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC-
T ss_pred             HHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceeccccc-
Confidence            88865542         89999999999999999999999   9999999999999985 4799999999997543321 


Q ss_pred             cccccccccccCcCCCcccccCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc
Q 023220          154 RLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL  232 (285)
Q Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
                         .....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.....                  +.   ..  
T Consensus       166 ---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------------i~---~~--  219 (273)
T d1xwsa_         166 ---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------------II---RG--  219 (273)
T ss_dssp             ---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------------HH---HC--
T ss_pred             ---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------------Hh---hc--
Confidence               234568999999999987765 5779999999999999999999964210                  00   00  


Q ss_pred             CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          233 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ....+..+++++.++|.+||+.||++|||++++++
T Consensus       220 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         220 QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            01234456788999999999999999999999988

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-44  Score=306.62  Aligned_cols=260  Identities=16%  Similarity=0.183  Sum_probs=192.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe--------CCeeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--------GNLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~~~L   73 (285)
                      +||+|.+..+++.||+|............+++.+|+.+|++++||||+++++++..        .+..+++||++.++.+
T Consensus        25 ~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~  104 (318)
T d3blha1          25 EVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA  104 (318)
T ss_dssp             EEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHH
T ss_pred             EEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCcc
Confidence            69999999999999999887777777788999999999999999999999999864        3467999999987666


Q ss_pred             HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccc
Q 023220           74 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA  153 (285)
Q Consensus        74 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  153 (285)
                      ........         .++...++.++.|++.||.|||++   |++||||||+||+++.++.++++|||++........
T Consensus       105 ~~~~~~~~---------~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~  172 (318)
T d3blha1         105 GLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN  172 (318)
T ss_dssp             HHHTCTTC---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCC---
T ss_pred             chhhhccc---------ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeecccccc
Confidence            55544332         288999999999999999999999   999999999999999999999999999965442221


Q ss_pred             c--ccccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhc--
Q 023220          154 R--LHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV--  228 (285)
Q Consensus       154 ~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  228 (285)
                      .  .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.........+.........+......  
T Consensus       173 ~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  252 (318)
T d3blha1         173 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY  252 (318)
T ss_dssp             --CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC
T ss_pred             cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchh
Confidence            1  112234689999999998765 67899999999999999999999998765444333332222222211111100  


Q ss_pred             ------CCccCCCCC-------hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          229 ------DPKLKGEYP-------PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       229 ------~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                            .........       ...++.+.++|.+||+.||++|||++|+++  ..+.+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~--Hpff~~  310 (318)
T d3blha1         253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--HDFFWS  310 (318)
T ss_dssp             -------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGSS
T ss_pred             hhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc--Chhhcc
Confidence                  000000000       112456788999999999999999999998  666654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-45  Score=312.47  Aligned_cols=248  Identities=21%  Similarity=0.240  Sum_probs=195.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC------eeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN------LRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~   75 (285)
                      +||+|.+..+++.||+|..++........+.+.+|+++|++++||||++++++|...+      .+++||||+ +.+|..
T Consensus        33 ~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~  111 (346)
T d1cm8a_          33 AVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGK  111 (346)
T ss_dssp             CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHH
T ss_pred             EEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHH
Confidence            6999999999999999998765555555678889999999999999999999998654      569999999 458888


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      +.+...          +++..++.++.|++.||.|||++   |++||||||+|||++.++.++++|||++......    
T Consensus       112 ~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~----  174 (346)
T d1cm8a_         112 LMKHEK----------LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----  174 (346)
T ss_dssp             HHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS----
T ss_pred             HHHhcc----------ccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCCc----
Confidence            876543          99999999999999999999999   9999999999999999999999999999765432    


Q ss_pred             cccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhh--------
Q 023220          156 HSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQ--------  226 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------  226 (285)
                       .....|++.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+...............+.+....        
T Consensus       175 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (346)
T d1cm8a_         175 -MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  253 (346)
T ss_dssp             -CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             -cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhh
Confidence             2345689999999998764 568999999999999999999999987654333222222222211111100        


Q ss_pred             --hcCCcc----CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          227 --CVDPKL----KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       227 --~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                        ...+..    ........++++.+||++||+.||++|||+.++++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              000011    011233456789999999999999999999999983

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-45  Score=306.07  Aligned_cols=256  Identities=21%  Similarity=0.255  Sum_probs=186.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHH--HHHHHccCCCCcccccceEEEeCC----eeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQ--LVSVVSRLKHENLVELLGYCVEGN----LRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~--e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~   75 (285)
                      +||++..  .++.+|+|......     .+.+.+  |+..+.+++||||+++++++.+.+    ..++||||+.+|+|.+
T Consensus        18 ~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~   90 (303)
T d1vjya_          18 EVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD   90 (303)
T ss_dssp             EEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHH
T ss_pred             EEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHH
Confidence            5888853  56788888664322     234444  444556789999999999998654    5799999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD  150 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~-----~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~  150 (285)
                      +++...          +++..++.++.|++.|+.|+|..+     +.|++||||||+|||++.++.+||+|||++.....
T Consensus        91 ~l~~~~----------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~  160 (303)
T d1vjya_          91 YLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             HHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             HHhcCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence            998653          899999999999999999999621     22999999999999999999999999999865432


Q ss_pred             ccc--cccccccccccCcCCCcccccCC------CCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchh
Q 023220          151 MAA--RLHSTRVLGTFGYHAPEYAMTGQ------LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED  222 (285)
Q Consensus       151 ~~~--~~~~~~~~~~~~~~aPE~~~~~~------~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (285)
                      ...  ........||+.|+|||.+.+..      ++.++|||||||++|||++|..||............ .........
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~~~~~~~  239 (303)
T d1vjya_         161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVPSDPSVE  239 (303)
T ss_dssp             TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSCSSCCHH
T ss_pred             CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-cccccchHH
Confidence            221  11223456899999999887542      567899999999999999999888654322221111 111111111


Q ss_pred             hh-hhhcCCccCCCCC-----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcC
Q 023220          223 KV-KQCVDPKLKGEYP-----PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS  275 (285)
Q Consensus       223 ~~-~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  275 (285)
                      .. ....+...+...+     .+.+..+.+++.+||+.||.+|||+.++++.|+++..+
T Consensus       240 ~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            11 2223333333332     24566799999999999999999999999999988754

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-44  Score=299.92  Aligned_cols=262  Identities=16%  Similarity=0.177  Sum_probs=202.2

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEEeeCCCCCHHHHhccCC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK   81 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   81 (285)
                      +||+|.+..+++.||+|..+.........+++.+|+.++++++||||+++++++.+....+++++++.++++..++....
T Consensus        17 ~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~   96 (292)
T d1unla_          17 TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG   96 (292)
T ss_dssp             EEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTT
T ss_pred             EEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccccc
Confidence            69999999999999999987766666677899999999999999999999999999999999999999988888876554


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccccccccc
Q 023220           82 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL  161 (285)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  161 (285)
                      .         +++..+..++.|++.||+|||++   |++||||||+||+++.++.++|+|||.+.........  .....
T Consensus        97 ~---------~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~~  162 (292)
T d1unla_          97 D---------LDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEV  162 (292)
T ss_dssp             C---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSCC
T ss_pred             c---------cchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc--ceeec
Confidence            2         88999999999999999999999   9999999999999999999999999999765432221  23345


Q ss_pred             cccCcCCCcccccCC-CCcccchHhHHHHHHHHHhCCCCCCCCCCcc-cchhhhhhcccCchhhh---hhh---------
Q 023220          162 GTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHTMPRG-QQSLVTWATPRLSEDKV---KQC---------  227 (285)
Q Consensus       162 ~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~---~~~---------  227 (285)
                      +++.|.|||.+.... ++.++||||+||++|+|++|+.||....... ....+............   ...         
T Consensus       163 ~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (292)
T d1unla_         163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY  242 (292)
T ss_dssp             SCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC
T ss_pred             cccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccc
Confidence            678899999887654 6899999999999999999999975433211 11111111111110000   000         


Q ss_pred             cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCCCCC
Q 023220          228 VDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA  279 (285)
Q Consensus       228 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  279 (285)
                      .............++.+.+|+++||+.||.+|||++|+++  ..++++.-||
T Consensus       243 ~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~--Hp~f~~~~~~  292 (292)
T d1unla_         243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--HPYFSDFCPP  292 (292)
T ss_dssp             CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGSSCSCC
T ss_pred             cccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc--ChhhcCCCCC
Confidence            0011112233456778999999999999999999999988  4566655554

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-44  Score=306.71  Aligned_cols=253  Identities=19%  Similarity=0.221  Sum_probs=190.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeCC----eeeEEEeeCCCCCHHHHh
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN----LRVLAYEFATMGSLHDIL   77 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l   77 (285)
                      +||+|.+..+++.+|+|.+.+.. .....+++++|+++|++++||||+++++++....    ..+++++++.+|+|.+++
T Consensus        23 ~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l  101 (345)
T d1pmea_          23 MVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL  101 (345)
T ss_dssp             CEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHH
T ss_pred             EEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhh
Confidence            69999999999999999876432 3334567889999999999999999999997643    234455666688999999


Q ss_pred             ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccc-cc
Q 023220           78 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-LH  156 (285)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~  156 (285)
                      ....          +++..+..++.|++.||.|||++   |++||||||+|||++.++.++|+|||++......... ..
T Consensus       102 ~~~~----------l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~  168 (345)
T d1pmea_         102 KTQH----------LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF  168 (345)
T ss_dssp             HHCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCT
T ss_pred             hcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcccee
Confidence            7653          89999999999999999999999   9999999999999999999999999999755432221 12


Q ss_pred             ccccccccCcCCCcccc-cCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhh--------
Q 023220          157 STRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC--------  227 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  227 (285)
                      .....|++.|+|||++. +..++.++||||+||++|+|++|..||...........................        
T Consensus       169 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (345)
T d1pmea_         169 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY  248 (345)
T ss_dssp             TCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHH
T ss_pred             eccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcc
Confidence            23456899999999985 446789999999999999999999999876543333222222222211111000        


Q ss_pred             -c-CCccC-C---CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 023220          228 -V-DPKLK-G---EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA  268 (285)
Q Consensus       228 -~-~~~~~-~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (285)
                       . .+... .   ...+..++++.+++.+||+.||.+|||++++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         249 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0 00000 0   0122345679999999999999999999999983

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=304.16  Aligned_cols=253  Identities=19%  Similarity=0.204  Sum_probs=185.9

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC------CeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG------NLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~   75 (285)
                      +||+|.+..+++.||+|..+...      ....+|+++|++++||||++++++|...      .++++||||+.++.+..
T Consensus        35 ~Vy~a~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~  108 (350)
T d1q5ka_          35 VVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV  108 (350)
T ss_dssp             EEEEEEETTTCCEEEEEEEECCS------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHH
T ss_pred             EEEEEEECCCCCEEEEEEECccc------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHH
Confidence            69999999999999999875432      2234799999999999999999998643      35799999998654333


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC-eeEEeccccCCCCCccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-KAKIADFNLSNQAPDMAAR  154 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~  154 (285)
                      +......      ...+++..+..++.|++.||.|||++   |++||||||+|||++.++ .++|+|||++........ 
T Consensus       109 l~~~~~~------~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~-  178 (350)
T d1q5ka_         109 ARHYSRA------KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-  178 (350)
T ss_dssp             HHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC-
T ss_pred             HHhhhhc------cCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCcc-
Confidence            3221110      01289999999999999999999999   999999999999999765 899999999875533221 


Q ss_pred             ccccccccccCcCCCccccc-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc-
Q 023220          155 LHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL-  232 (285)
Q Consensus       155 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  232 (285)
                        .....|++.|+|||.+.+ ..++.++||||+||++|+|++|..||...........+.........+.......... 
T Consensus       179 --~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~  256 (350)
T d1q5ka_         179 --NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE  256 (350)
T ss_dssp             --CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred             --cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence              233568999999998775 4689999999999999999999999987654433332222222222222221111100 


Q ss_pred             -----------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH--Hhchh
Q 023220          233 -----------KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPL  272 (285)
Q Consensus       233 -----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~--~l~~~  272 (285)
                                 ........++++.+||.+||+.||++|||+.|+++  .|+.+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence                       01122345778999999999999999999999996  34444

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-43  Score=299.72  Aligned_cols=240  Identities=20%  Similarity=0.237  Sum_probs=192.1

Q ss_pred             Cceeeeeee---eccccChhhhhhccC--CCCCChhHHHHHHHHccCCC-CcccccceEEEeCCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQ---VEESYPSHENERLKS--PKNYPDDEKQLVSVVSRLKH-ENLVELLGYCVEGNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~---~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   75 (285)
                      .||+|.+..   +++.||+|..++...  .....+.+.+|++++++++| |||+++++++.+....+++|||+.+|+|.+
T Consensus        39 ~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~  118 (322)
T d1vzoa_          39 KVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFT  118 (322)
T ss_dssp             EEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHH
T ss_pred             EEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHH
Confidence            589997754   467899998765432  23456778899999999977 899999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      ++.....         +++..+..++.|++.|+.|+|++   |++||||||+||+++.++.++|+|||++......... 
T Consensus       119 ~i~~~~~---------~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~-  185 (322)
T d1vzoa_         119 HLSQRER---------FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-  185 (322)
T ss_dssp             HHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-
T ss_pred             HHHhccc---------ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhcccccc-
Confidence            9987653         78899999999999999999999   9999999999999999999999999998765433222 


Q ss_pred             cccccccccCcCCCcccccC--CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCccC
Q 023220          156 HSTRVLGTFGYHAPEYAMTG--QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK  233 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
                      ......|++.|+|||.+.+.  .++.++|||||||++|+|++|..||...........+..           ....  ..
T Consensus       186 ~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~-----------~~~~--~~  252 (322)
T d1vzoa_         186 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-----------RILK--SE  252 (322)
T ss_dssp             GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH-----------HHHH--CC
T ss_pred             cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-----------hccc--CC
Confidence            12345689999999998754  468899999999999999999999987654333221111           1111  11


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 023220          234 GEYPPKGVAKLAAVAALCVQYEAEFRPN-----MSIVVK  267 (285)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll~  267 (285)
                      ...+..+++++.++|++||+.||++|||     ++|+++
T Consensus       253 ~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            2345667889999999999999999994     788886

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-43  Score=302.62  Aligned_cols=248  Identities=17%  Similarity=0.177  Sum_probs=185.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEe------CCeeeEEEeeCCCCCHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE------GNLRVLAYEFATMGSLHD   75 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~   75 (285)
                      +||+|.+..+++.||+|..+.........+++.+|+.++++++||||++++++|..      ..+.|+||||+.+ ++.+
T Consensus        32 ~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~  110 (355)
T d2b1pa1          32 IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQ  110 (355)
T ss_dssp             EEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHH
T ss_pred             EEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHH
Confidence            59999999999999999987666555566788999999999999999999999963      3688999999976 5555


Q ss_pred             HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCcccccc
Q 023220           76 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL  155 (285)
Q Consensus        76 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  155 (285)
                      .+...           +++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|||++........  
T Consensus       111 ~~~~~-----------~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~--  174 (355)
T d2b1pa1         111 VIQME-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--  174 (355)
T ss_dssp             HHTSC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred             hhhcC-----------CCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccccccc--
Confidence            55422           88999999999999999999999   999999999999999999999999999876543222  


Q ss_pred             cccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchh-------hh----
Q 023220          156 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED-------KV----  224 (285)
Q Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~----  224 (285)
                       .....+|+.|+|||++.+..++.++||||+||++++|++|+.||.+.+.......+.........+       ..    
T Consensus       175 -~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  253 (355)
T d2b1pa1         175 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV  253 (355)
T ss_dssp             -------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHH
T ss_pred             -cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHh
Confidence             244568999999999999999999999999999999999999998765433322211111110000       00    


Q ss_pred             -----------hhhcCCcc---CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          225 -----------KQCVDPKL---KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       225 -----------~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                                 ........   ........++++.+||++||+.||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                       00000000   01112345788999999999999999999999997

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.3e-42  Score=288.84  Aligned_cols=250  Identities=14%  Similarity=0.128  Sum_probs=195.8

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCC-CcccccceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH-ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      .||+|.+..+++.+|+|.....    ...+.+.+|++.++.++| +|++.+++++..+...++||||+ +++|.+++...
T Consensus        20 ~Vy~a~~~~~~~~vAvK~~~~~----~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~   94 (293)
T d1csna_          20 VIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC   94 (293)
T ss_dssp             EEEEEEETTTTEEEEEEEEECC----TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred             EEEEEEECCCCCEEEEEEEccc----cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhh
Confidence            5899999988999999975432    234567889999999966 89999999999999999999999 56999998765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEcc-----CCeeEEeccccCCCCCccccc-
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-----DFKAKIADFNLSNQAPDMAAR-  154 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~-----~~~~~l~df~~~~~~~~~~~~-  154 (285)
                      ..        .++...+..++.|++.||.|||++   |++||||||+||+++.     .+.++|+|||++......... 
T Consensus        95 ~~--------~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (293)
T d1csna_          95 GR--------KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ  163 (293)
T ss_dssp             TT--------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC
T ss_pred             cc--------chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCcccc
Confidence            42        289999999999999999999999   9999999999999974     578999999999754322111 


Q ss_pred             ----ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCC
Q 023220          155 ----LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP  230 (285)
Q Consensus       155 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
                          .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+......................      
T Consensus       164 ~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~------  237 (293)
T d1csna_         164 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL------  237 (293)
T ss_dssp             BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH------
T ss_pred             ceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh------
Confidence                1123356999999999999999999999999999999999999999865543332211111000000000      


Q ss_pred             ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhcCC
Q 023220          231 KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP  276 (285)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  276 (285)
                         ......+|+++.+++..|++.+|++||+++.+.+.|+.+++..
T Consensus       238 ---~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         238 ---RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             ---HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ---HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence               0112345678999999999999999999999999998887544

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-43  Score=301.83  Aligned_cols=248  Identities=21%  Similarity=0.231  Sum_probs=188.0

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCcccccceEEEeC-----CeeeEEEeeCCCCCHHHH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG-----NLRVLAYEFATMGSLHDI   76 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~   76 (285)
                      +||+|.+..+++.||+|...+........+++.+|+++|++++||||+++++++...     ...+++++++.+|+|.++
T Consensus        33 ~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~  112 (348)
T d2gfsa1          33 SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI  112 (348)
T ss_dssp             SEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHH
T ss_pred             EEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhh
Confidence            699999999999999998876554444566788999999999999999999998643     334667777888999999


Q ss_pred             hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccCCCCCccccccc
Q 023220           77 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH  156 (285)
Q Consensus        77 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  156 (285)
                      +..+.          +++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|||.+......     
T Consensus       113 ~~~~~----------l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----  174 (348)
T d2gfsa1         113 VKCQK----------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----  174 (348)
T ss_dssp             HTTCC----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTGG-----
T ss_pred             ccccc----------ccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCcc-----
Confidence            96543          89999999999999999999999   9999999999999999999999999998765432     


Q ss_pred             ccccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchh--------hhhhh
Q 023220          157 STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED--------KVKQC  227 (285)
Q Consensus       157 ~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~~  227 (285)
                      .....|++.|+|||...+. .++.++||||+||++|+|++|..||.+.+.......+.........+        .....
T Consensus       175 ~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  254 (348)
T d2gfsa1         175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY  254 (348)
T ss_dssp             GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred             cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhh
Confidence            2345688999999987765 45889999999999999999999998765433322222111111111        01111


Q ss_pred             cCCccCCC------CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          228 VDPKLKGE------YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       228 ~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ........      .....++++.+||++||+.||.+|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            11000000      11235678999999999999999999999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.7e-42  Score=288.95  Aligned_cols=248  Identities=17%  Similarity=0.196  Sum_probs=185.7

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCCCccccc-ceEEEeCCeeeEEEeeCCCCCHHHHhccC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVEL-LGYCVEGNLRVLAYEFATMGSLHDILHGR   80 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~-~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   80 (285)
                      +||+|.+..+++.||+|.....    ...+++.+|++++++++|++++.. .+++.+++..++||||+. +++...+...
T Consensus        22 ~Vy~a~~~~~~~~vAvK~~~~~----~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~   96 (299)
T d1ckia_          22 DIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFC   96 (299)
T ss_dssp             EEEEEEETTTTEEEEEEEEESC----TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHT
T ss_pred             EEEEEEECCCCCEEEEEEEchh----ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cchhhhhhhc
Confidence            6899999888999999976542    234568899999999987765555 555677888899999995 4776666543


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEc---cCCeeEEeccccCCCCCccccc---
Q 023220           81 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAAR---  154 (285)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~---~~~~~~l~df~~~~~~~~~~~~---  154 (285)
                      ..        .+++..+..++.|++.||.|||++   |++||||||+||+++   .+..++++|||++.........   
T Consensus        97 ~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~  165 (299)
T d1ckia_          97 SR--------KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI  165 (299)
T ss_dssp             TT--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBC
T ss_pred             cC--------CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccce
Confidence            32        289999999999999999999999   999999999999985   4557999999999765432211   


Q ss_pred             --ccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCchhhhhhhcCCcc
Q 023220          155 --LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL  232 (285)
Q Consensus       155 --~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
                        .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..................       ....+  
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-------~~~~~--  236 (299)
T d1ckia_         166 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-------KMSTP--  236 (299)
T ss_dssp             CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH-------HHHSC--
T ss_pred             eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc-------cCCCC--
Confidence              1123456899999999999999999999999999999999999999765433222211110000       00000  


Q ss_pred             CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhchhhc
Q 023220          233 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK  274 (285)
Q Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  274 (285)
                      .......+|+++.+++.+||+.||.+||+++++.+.|+.+..
T Consensus       237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            001123456789999999999999999999999998887753

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.6e-42  Score=294.24  Aligned_cols=243  Identities=13%  Similarity=0.176  Sum_probs=185.3

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-CCcccccceEEEe--CCeeeEEEeeCCCCCHHHHhc
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVE--GNLRVLAYEFATMGSLHDILH   78 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~   78 (285)
                      +||+|.+..+++.||+|..+.     ...+++.+|+++|++++ ||||+++++++..  ....++||||+.+++|.++.+
T Consensus        50 ~V~~a~~~~~~~~vAiK~i~~-----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~  124 (328)
T d3bqca1          50 EVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ  124 (328)
T ss_dssp             EEEEEEETTTTEEEEEEEECS-----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTT
T ss_pred             EEEEEEECCCCCEEEEEEECH-----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhc
Confidence            699999999999999998753     34678899999999995 9999999999984  356899999999999877642


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCC-eeEEeccccCCCCCcccccccc
Q 023220           79 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-KAKIADFNLSNQAPDMAARLHS  157 (285)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~  157 (285)
                                  .+++..+..++.|++.||.|||++   |++||||||+|||++.++ .++|+|||++........   .
T Consensus       125 ------------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~  186 (328)
T d3bqca1         125 ------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---Y  186 (328)
T ss_dssp             ------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---C
T ss_pred             ------------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCc---c
Confidence                        189999999999999999999999   999999999999998654 689999999975543221   2


Q ss_pred             cccccccCcCCCcccccC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCcccch-hhhh-hccc-----------Cchhh
Q 023220          158 TRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS-LVTW-ATPR-----------LSEDK  223 (285)
Q Consensus       158 ~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~-~~~~-----------~~~~~  223 (285)
                      ....+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||.......... .+.. ....           .....
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  266 (328)
T d3bqca1         187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR  266 (328)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred             cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence            445689999999998765 47899999999999999999999997654322111 1100 0000           00000


Q ss_pred             hhhhcC--------CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          224 VKQCVD--------PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       224 ~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      ......        ..........+++++.+||++||+.||.+|||++++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000        00111223456778999999999999999999999997

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-35  Score=255.57  Aligned_cols=248  Identities=18%  Similarity=0.239  Sum_probs=175.5

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCC-----------CCcccccceEEEe--CCeeeEEEeeC
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-----------HENLVELLGYCVE--GNLRVLAYEFA   68 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~--~~~~~lv~e~~   68 (285)
                      +||+|.+..+++.||+|..+...   ...+.+.+|+.+++.++           |+||+++++++..  ....++++.+.
T Consensus        28 ~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~  104 (362)
T d1q8ya_          28 TVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE  104 (362)
T ss_dssp             EEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEEC
T ss_pred             EEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeec
Confidence            69999999999999999875321   23467788999988875           5789999998864  34556666665


Q ss_pred             CCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEccCC------eeEEe
Q 023220           69 TMG-SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDF------KAKIA  140 (285)
Q Consensus        69 ~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~------~~~l~  140 (285)
                      ..+ +...........       .+++..+..++.|++.|+.|||+ .   |++||||||+|||++.++      .++++
T Consensus       105 ~~~~~~~~~~~~~~~~-------~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~kl~  174 (362)
T d1q8ya_         105 VLGENLLALIKKYEHR-------GIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIA  174 (362)
T ss_dssp             CCCEEHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEEEEEC
T ss_pred             cccccccccccccccc-------CCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccceeeEe
Confidence            544 333333322221       28899999999999999999998 7   999999999999998654      48999


Q ss_pred             ccccCCCCCcccccccccccccccCcCCCcccccCCCCcccchHhHHHHHHHHHhCCCCCCCCCCcccc------hhhhh
Q 023220          141 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ------SLVTW  214 (285)
Q Consensus       141 df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~------~~~~~  214 (285)
                      |||.+.....     ......|++.|+|||.+.+..++.++|+||+||++++|++|+.||.........      .....
T Consensus       175 dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~  249 (362)
T d1q8ya_         175 DLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE  249 (362)
T ss_dssp             CCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred             eccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence            9999864332     123456899999999999999999999999999999999999999754322111      00000


Q ss_pred             hcccCchhhh------hhhcC---------C----------ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 023220          215 ATPRLSEDKV------KQCVD---------P----------KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK  267 (285)
Q Consensus       215 ~~~~~~~~~~------~~~~~---------~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (285)
                      .....+....      ....+         .          ..........++.+.+||.+||+.||.+|||++++++
T Consensus       250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1011111100      00000         0          0122345677889999999999999999999999998

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.70  E-value=1.7e-18  Score=134.68  Aligned_cols=153  Identities=12%  Similarity=0.077  Sum_probs=103.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCC----CC------------CChhHHHHHHHHccCCCCcccccceEEEeCCeeeEEE
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSP----KN------------YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAY   65 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~----~~------------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   65 (285)
                      .||+|.+. .++.+++|..+.....    ..            .......|+..+.++.|.+++..+++..    .+++|
T Consensus        15 ~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvm   89 (191)
T d1zara2          15 AVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG----NAVLM   89 (191)
T ss_dssp             EEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET----TEEEE
T ss_pred             EEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC----CEEEE
Confidence            58999764 4678899965432211    00            0123346888899999999988776532    37999


Q ss_pred             eeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEccCCeeEEeccccC
Q 023220           66 EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS  145 (285)
Q Consensus        66 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~  145 (285)
                      |++.+..+.+                ++...+..++.|++.++.+||+.   |++||||||+|||++++ .++|+|||++
T Consensus        90 e~~~~~~~~~----------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG~a  149 (191)
T d1zara2          90 ELIDAKELYR----------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQS  149 (191)
T ss_dssp             ECCCCEEGGG----------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred             Eeeccccccc----------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECCCc
Confidence            9998755432                23334567999999999999999   99999999999999965 5899999988


Q ss_pred             CCCCcccccccccccccccCcCCCc-----ccccCCCCcccchHhHHHH
Q 023220          146 NQAPDMAARLHSTRVLGTFGYHAPE-----YAMTGQLTQKSDVYSFGVV  189 (285)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~aPE-----~~~~~~~~~~~DiwslG~~  189 (285)
                      .........          .|....     ......|+..+|+||+.--
T Consensus       150 ~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         150 VEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             EETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             ccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            554321110          111110     0113467888999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.86  E-value=3.4e-05  Score=60.92  Aligned_cols=48  Identities=10%  Similarity=-0.035  Sum_probs=35.5

Q ss_pred             ChhHHHHHHHHccCC-CCcccccceEEEeCCeeeEEEeeCCCCCHHHHh
Q 023220           30 PDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDIL   77 (285)
Q Consensus        30 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   77 (285)
                      ...+.+|..++..+. +--+.+++.+..+++..++||++.+|.++.+..
T Consensus        53 ~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~  101 (263)
T d1j7la_          53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY  101 (263)
T ss_dssp             TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred             hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence            445778888877663 334567778888888899999999887775543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.56  E-value=4.3e-05  Score=59.98  Aligned_cols=66  Identities=11%  Similarity=-0.036  Sum_probs=42.6

Q ss_pred             CceeeeeeeeccccChhhhhhccCCCCCChhHHHHHHHHccCCC--CcccccceEEEeCCeeeEEEeeCCCCCH
Q 023220            2 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH--ENLVELLGYCVEGNLRVLAYEFATMGSL   73 (285)
Q Consensus         2 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L   73 (285)
                      +||+... ..+..+.+|...     ......+..|.+.++.+..  -.+.+++.+..+++..++||++++|.++
T Consensus        26 ~v~r~~~-~~~~~~vlK~~~-----~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          26 AVFRLSA-QGRPVLFVKTDL-----SGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             EEEEEEC-TTSCCEEEEEEC-----SCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             eEEEEEe-CCCCEEEEEeCC-----ccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3566532 334555566443     2234567888888887733  3356677777888888999999986443

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.14  E-value=0.001  Score=55.63  Aligned_cols=29  Identities=21%  Similarity=0.423  Sum_probs=24.9

Q ss_pred             CeeeCCCCCCCeEEccCCeeEEeccccCCC
Q 023220          118 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQ  147 (285)
Q Consensus       118 ~~~h~di~~~nil~~~~~~~~l~df~~~~~  147 (285)
                      .++|||+.+.|||++++ .++++|+..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCC-ceEEechhhccc
Confidence            59999999999999876 489999987644

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.00  E-value=0.0091  Score=47.78  Aligned_cols=31  Identities=26%  Similarity=0.460  Sum_probs=26.7

Q ss_pred             CCCeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220          116 QPSIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus       116 ~~~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      ..|++|+|+.++|++++.+...-++||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            3479999999999999988777899998663

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=93.95  E-value=0.021  Score=47.23  Aligned_cols=37  Identities=14%  Similarity=0.065  Sum_probs=24.4

Q ss_pred             hhHHHHHHHHccCCCCcc-cccceEEEeCCeeeEEEeeCCCC
Q 023220           31 DDEKQLVSVVSRLKHENL-VELLGYCVEGNLRVLAYEFATMG   71 (285)
Q Consensus        31 ~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~   71 (285)
                      -+..+|.++++.+.-.++ .++++++.+    .+|++|+.|.
T Consensus        89 idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~  126 (395)
T d1nw1a_          89 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSR  126 (395)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEE
T ss_pred             hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccc
Confidence            445678888888843343 466666642    5788998764

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=87.23  E-value=0.36  Score=38.28  Aligned_cols=29  Identities=17%  Similarity=0.269  Sum_probs=23.2

Q ss_pred             CCCeeeCCCCCCCeEEccCCeeEEeccccCC
Q 023220          116 QPSIIHRDIRSSNVLLFEDFKAKIADFNLSN  146 (285)
Q Consensus       116 ~~~~~h~di~~~nil~~~~~~~~l~df~~~~  146 (285)
                      ..+++|+|+.+.||+++++  ..++||+-+.
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhcc
Confidence            3479999999999999754  4578998664